PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Delonnay, PB				Delonnay, Paul B.			Returning Home to Haiti - Providing Medical Care after the Earthquake	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Med Ctr, Boston, MA USA	Boston Medical Center									0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMpv1001789	http://dx.doi.org/10.1056/NEJMpv1001789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20173033				2022-12-28	WOS:000275365900036
J	Merchant, RM; Leigh, JE; Lurie, N				Merchant, Raina M.; Leigh, Janet E.; Lurie, Nicole			Health Care Volunteers and Disaster Response - First, Be Prepared	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Merchant, Raina M.] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA; [Merchant, Raina M.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Leigh, Janet E.] Louisiana State Univ, Hlth Sci Ctr, Robert Wood Johnson Fdn, Hlth Policy Fellows Program, New Orleans, LA USA; [Merchant, Raina M.; Leigh, Janet E.; Lurie, Nicole] Dept Hlth & Human Serv, Off Assistant Secretary Preparedness & Response, Washington, DC USA	Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; University of Pennsylvania; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Robert Wood Johnson Foundation (RWJF)	Merchant, RM (corresponding author), Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA.								0	32	32	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					872	873		10.1056/NEJMp1001737	http://dx.doi.org/10.1056/NEJMp1001737			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20181966				2022-12-28	WOS:000275365900003
J	Allcott, H; Mullainathan, S				Allcott, Hunt; Mullainathan, Sendhil			Behavior and Energy Policy	SCIENCE			English	Editorial Material							CONSERVATION; ELECTRICITY; PSYCHOLOGY; ECONOMICS		[Allcott, Hunt] MIT, Dept Econ, Cambridge, MA 02142 USA; [Mullainathan, Sendhil] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University	Allcott, H (corresponding author), MIT, Dept Econ, Cambridge, MA 02142 USA.	allcott@mit.edu						Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; AIGNER DJ, 1984, J ECONOMETRICS, V26, P1, DOI 10.1016/0304-4076(84)90010-1; ALLCOTT H, 2010, RETHINKING REAL TIME, P34512; Allcott H, 2009, SOCIAL NORMS ENERGY, V5; Arimura T.H., 2009, 0948 RES FUT; Ashraf N, 2006, Q J ECON, V121, P635, DOI 10.1162/qjec.2006.121.2.635; Aubin C, 1995, J APPL ECONOM, V10, pS171, DOI 10.1002/jae.3950100510; Banerjee Abhijit V., 2008, 14467 NBER; Bertrand M., 2009, 968 YAL U EC GROWTH; BRENNAN T, 2008, 0827 RES FUT; Charles D, 2009, SCIENCE, V325, P804, DOI 10.1126/science.325_804; CREYTS J, 2008, REDUCING US GREENHOU, P34512; Davenport TH, 2009, HARVARD BUS REV, V87, P68; Fischer C, 2008, ENERG EFFIC, V1, P79, DOI 10.1007/s12053-008-9009-7; Friedrich Katherine, 2009, U092 ACEEE; Granade H.C., 2009, UNLOCKING ENERGY EFF; HAUSMAN JA, 1979, BELL J ECON, V10, P33, DOI 10.2307/3003318; JAFFE AB, 1994, RESOUR ENERGY ECON, V16, P91, DOI 10.1016/0928-7655(94)90001-9; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Larrick RP, 2008, SCIENCE, V320, P1593, DOI 10.1126/science.1154983; Levitt SD, 2009, EUR ECON REV, V53, P1, DOI 10.1016/j.euroecorev.2008.12.001; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Nolan JM, 2008, PERS SOC PSYCHOL B, V34, P913, DOI 10.1177/0146167208316691; SHIPPEE G, 1980, ENVIRON MANAGE, V4, P297, DOI 10.1007/BF01869423; STERN PC, 1992, AM PSYCHOL, V47, P1224, DOI 10.1037/0003-066X.47.10.1224; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; WOLAK F, 2006, 151 U CAL EN I CTR S, P34512	27	451	455	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1204	1205		10.1126/science.1180775	http://dx.doi.org/10.1126/science.1180775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	563VD	20203035				2022-12-28	WOS:000275162100021
J	Baggish, AL; Hutter, AM; Wang, F; Yared, K; Weiner, RB; Kupperman, E; Picard, MH; Wood, MJ				Baggish, Aaron L.; Hutter, Adolph M., Jr.; Wang, Francis; Yared, Kibar; Weiner, Rory B.; Kupperman, Eli; Picard, Michael H.; Wood, Malissa J.			Cardiovascular Screening in College Athletes With and Without Electrocardiography A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							EUROPEAN-SOCIETY; CLINICAL-SIGNIFICANCE; RECOMMENDATIONS; CARDIOLOGY; DISEASE; DEATH; HEART	Background: Although cardiovascular screening is recommended for athletes before participating in sports, the role of 12-lead electrocardiography (ECG) remains uncertain. To date, no prospective data that compare screening with and without ECG have been available. Objective: To compare the performance of preparticipation screening limited to medical history and physical examination with a strategy that integrates these with ECG. Design: Cross-sectional comparison of screening strategies. Setting: University Health Services, Harvard University, Cambridge, Massachusetts. Participants: 510 collegiate athletes who received cardiovascular screening before athletic participation. Measurements: Each participant had routine history and examination limited screening and ECG. They received transthoracic echocardiography (TTE) to detect or exclude cardiac findings with relevance to sports participation. The performance of screening with history and examination only was compared with that of screening that integrated history, examination, and ECG. Results: Cardiac abnormalities with relevance to sports participation risk were observed on TTE in 11 of 510 participants (prevalence, 2.2%). Screening with history and examination alone detected abnormalities in 5 of these 11 athletes (sensitivity, 45.5% [95% CI, 16.8% to 76.2%]; specificity, 94.4% [CI, 92.0% to 96.2%]). Electrocardiography detected 5 additional participants with cardiac abnormalities (for a total of 10 of 11 participants), thereby improving the overall sensitivity of screening to 90.9% (CI, 58.7% to 99.8%). However, including ECG reduced the specificity of screening to 82.7% (CI, 79.1% to 86.0%) and was associated with a false-positive rate of 16.9% (vs. 5.5% for screening with history and examination only). Limitation: Definitive conclusions regarding the effect of ECG inclusion on sudden death rates cannot be made. Conclusion: Adding ECG to medical history and physical examination improves the overall sensitivity of preparticipation cardiovascular screening in athletes. However, this strategy is associated with an increased rate of false-positive results when current ECG interpretation criteria are used.	[Baggish, Aaron L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Baggish, AL (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Yawkey 5B,55 Fruit St, Boston, MA 02114 USA.	abaggish@partners.org	Wood, Malissa/T-3201-2019	Picard, Michael/0000-0002-9264-3243				Baggish AL, 2008, J APPL PHYSIOL, V104, P1121, DOI 10.1152/japplphysiol.01170.2007; Bille K, 2006, EUR J CARDIOV PREV R, V13, P859, DOI 10.1097/01.hjr.0000238397.50341.4a; Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Choo JK, 2002, AM J CARDIOL, V90, P198, DOI 10.1016/S0002-9149(02)02454-2; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Douglas PS, 2008, J AM COLL CARDIOL, V52, P1997, DOI 10.1016/j.jacc.2008.07.069; Faber L, 2008, J AM COLL CARDIOL, V51, P1040, DOI 10.1016/j.jacc.2007.11.047; *IT MIN HLTH, 1982, GAZZETTA UFFICI 0305, P63; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1322, DOI 10.1016/j.jacc.2005.02.007; MARON BJ, 1987, J AM COLL CARDIOL, V10, P1214, DOI 10.1016/S0735-1097(87)80121-3; Myerburg RJ, 2007, CIRCULATION, V116, P2616, DOI 10.1161/CIRCULATIONAHA.107.733519; Pelliccia A, 2000, CIRCULATION, V102, P278; Pelliccia A, 2005, EUR HEART J, V26, P1422, DOI 10.1093/eurheartj/ehi325; Pelliccia A, 2005, J AM COLL CARDIOL, V46, P690, DOI 10.1016/j.jacc.2005.04.052; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; Pelliccia A, 1999, ANN INTERN MED, V130, P23, DOI 10.7326/0003-4819-130-1-199901050-00005; Pelliccia A, 2008, J AM COLL CARDIOL, V52, P1990, DOI 10.1016/j.jacc.2008.08.055; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; Thompson PD, 2006, JAMA-J AM MED ASSOC, V296, P1648, DOI 10.1001/jama.296.13.1648; Thompson PD, 2009, CIRCULATION, V119, P1072, DOI 10.1161/CIRCULATIONAHA.108.843862	23	211	213	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2010	152	5					269	W79		10.7326/0003-4819-152-5-201003020-00004	http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565XJ	20194232				2022-12-28	WOS:000275329600001
J	Bond, JQ; Alonso, DM; Wang, D; West, RM; Dumesic, JA				Bond, Jesse Q.; Alonso, David Martin; Wang, Dong; West, Ryan M.; Dumesic, James A.			Integrated Catalytic Conversion of gamma-Valerolactone to Liquid Alkenes for Transportation Fuels	SCIENCE			English	Article							CARBON-DIOXIDE; BIOMASS; CO2; OLIGOMERIZATION; HYDROCARBONS; CHEMISTRY; EPOXIDES; METHANOL; ACID	Efficient synthesis of renewable fuels remains a challenging and important line of research. We report a strategy by which aqueous solutions of gamma-valerolactone (GVL), produced from biomass-derived carbohydrates, can be converted to liquid alkenes in the molecular weight range appropriate for transportation fuels by an integrated catalytic system that does not require an external source of hydrogen. The GVL feed undergoes decarboxylation at elevated pressures (e. g., 36 bar) over a silica/alumina catalyst to produce a gas stream composed of equimolar amounts of butene and carbon dioxide. This stream is fed directly to an oligomerization reactor containing an acid catalyst (e. g., H ZSM-5, Amberlyst-70), which couples butene monomers to form condensable alkenes with molecular weights that can be targeted for gasoline and/or jet fuel applications. The effluent gaseous stream of CO2 at elevated pressure can potentially be captured and then treated or sequestered to mitigate greenhouse gas emissions from the process.	[Bond, Jesse Q.; Alonso, David Martin; Wang, Dong; West, Ryan M.; Dumesic, James A.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Alonso, David Martin/AAC-3364-2019; Wang, Dong/L-2581-2014	Alonso, David Martin/0000-0002-8937-7407; Bond, Jesse/0000-0002-8883-4151	Defense Advanced Research Projects Agency (DARPA); U.S. Department of Energy (DOE), Office of Basic Energy Sciences; DOE Great Lakes Bioenergy Research Center	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Great Lakes Bioenergy Research Center(United States Department of Energy (DOE))	This work was supported through funding from the Defense Advanced Research Projects Agency (DARPA) (Surf-cat: Catalysts for Production of JP-8 range molecules from Lignocellulosic Biomass). The views, opinions, and/or findings contained here are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of DARPA or the Department of Defense. In addition, this work was supported in part by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, and by the DOE Great Lakes Bioenergy Research Center (www.greatlakesbioenergy.org), which is supported by the U. S. DOE, Office of Science, Office of Biological and Environmental Research, through Cooperative Agreement between The Board of Regents of the University of Wisconsin System and the U. S. DOE. A patent application has been filed in association with the Wisconsin Alumni Research Foundation based on the technology reported here. We thank R. Oakes, T. Reigle, and C. Skadahl for their assistance in our investigation of the production of butene from GVL.	Ahmed I, 2001, U.S. Patent, Patent No. [6190427, 6, 190, 427]; CEJKA J, 2007, INTRO ZEOLITE SCI PR, P895; CENTI G, 2007, CATALYSIS RENEWABLES, P137; Coates GW, 2004, ANGEW CHEM INT EDIT, V43, P6618, DOI 10.1002/anie.200460442; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Darensbourg DJ, 2007, CHEM REV, V107, P2388, DOI 10.1021/cr068363q; Elliot D, 1999, US Patent, Patent No. 5883266; Fitzpatrick S. W., 2002, DOECE41178 BIOMETICS; Haszeldine RS, 2009, SCIENCE, V325, P1647, DOI 10.1126/science.1172246; Heeres H, 2009, GREEN CHEM, V11, P1247, DOI 10.1039/b904693c; Horvath IT, 2008, GREEN CHEM, V10, P238, DOI 10.1039/b712863k; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Huber GW, 2009, SCI AM, V301, P52, DOI 10.1038/scientificamerican0709-52; Huber GW., 2007, BREAKING CHEM ENG BA; Koppatz S, 2009, FUEL PROCESS TECHNOL, V90, P914, DOI 10.1016/j.fuproc.2009.03.016; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Mantilla A, 2005, CATAL TODAY, V107-08, P707, DOI 10.1016/j.cattod.2005.07.153; Manzer LE, 2004, APPL CATAL A-GEN, V272, P249, DOI 10.1016/j.apcata.2004.05.048; MATAR S, 2000, CHEM PETROCHEMICAL P, P248; Mehdi H, 2008, TOP CATAL, V48, P49, DOI 10.1007/s11244-008-9047-6; QUANN RJ, 1988, IND ENG CHEM RES, V27, P565, DOI 10.1021/ie00076a006; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Sakurai H, 1996, CATAL TODAY, V29, P361, DOI 10.1016/0920-5861(95)00305-3; Simonetti DA, 2007, GREEN CHEM, V9, P1073, DOI 10.1039/b704476c; SKUPINSKA J, 1991, CHEM REV, V91, P613, DOI 10.1021/cr00004a007; Toyir J, 2001, APPL CATAL B-ENVIRON, V34, P255, DOI 10.1016/S0926-3373(01)00203-X; Wick M, 2001, APPL MICROBIOL BIOT, V56, P687, DOI 10.1007/s002530100695	28	850	909	19	704	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1110	1114		10.1126/science.1184362	http://dx.doi.org/10.1126/science.1184362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185721				2022-12-28	WOS:000274901100030
J	Knowles, SM				Knowles, Sherry M.			Fixing the Legal Framework for Pharmaceutical Research	SCIENCE			English	Editorial Material							INNOVATION		GlaxoSmithKline, King Of Prussia, PA 19406 USA	GlaxoSmithKline	Knowles, SM (corresponding author), GlaxoSmithKline, King Of Prussia, PA 19406 USA.	sherry.m.knowles@gsk.com						Bunch JN, 2005, TEX LAW REV, V83, P1747; Cahoy DR, 2003, AM BUS LAW J, V41, P1, DOI 10.1111/j.1744-1714.2003.tb00001.x; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2002, PHARMACOECONOMICS, V20, P1, DOI 10.2165/00019053-200220003-00001; DIMASI JA, 1991, J HEALTH ECON, V10, P107, DOI 10.1016/0167-6296(91)90001-4; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Higgins MJ, 2009, SCIENCE, V326, P370, DOI 10.1126/science.1176116; 1995, Patent No. 6410516	8	8	8	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1083	1084		10.1126/science.1184188	http://dx.doi.org/10.1126/science.1184188			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560KJ	20150445				2022-12-28	WOS:000274901100018
J	Fedorov, AV; Brierley, CM; Emanuel, K				Fedorov, Alexey V.; Brierley, Christopher M.; Emanuel, Kerry			Tropical cyclones and permanent El Nino in the early Pliocene epoch	NATURE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE; ATMOSPHERE; MODEL; CIRCULATIONS; SIMULATION; LAYER; ICE	Tropical cyclones (also known as hurricanes and typhoons) are now believed to be an important component of the Earth's climate system(1-3). In particular, by vigorously mixing the upper ocean, they can affect the ocean's heat uptake, poleward heat transport, and hence global temperatures. Changes in the distribution and frequency of tropical cyclones could therefore become an important element of the climate response to global warming. A potential analogue to modern greenhouse conditions, the climate of the early Pliocene epoch (approximately 5 to 3 million years ago) can provide important clues to this response. Here we describe a positive feedback between hurricanes and the upper-ocean circulation in the tropical Pacific Ocean that may have been essential for maintaining warm, El Nino-like conditions(4-6) during the early Pliocene. This feedback is based on the ability of hurricanes to warm water parcels that travel towards the Equator at shallow depths and then resurface in the eastern equatorial Pacific as part of the ocean's wind-driven circulation(7,8). In the present climate, very few hurricane tracks intersect the parcel trajectories; consequently, there is little heat exchange between waters at such depths and the surface. More frequent and/or stronger hurricanes in the central Pacific imply greater heating of the parcels, warmer temperatures in the eastern equatorial Pacific, warmer tropics and, in turn, even more hurricanes. Using a downscaling hurricane model(9,10), we show dramatic shifts in the tropical cyclone distribution for the early Pliocene that favour this feedback. Further calculations with a coupled climate model support our conclusions. The proposed feedback should be relevant to past equable climates and potentially to contemporary climate change.	[Fedorov, Alexey V.; Brierley, Christopher M.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Emanuel, Kerry] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Yale University; Massachusetts Institute of Technology (MIT)	Fedorov, AV (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	alexey.fedorov@yale.edu	Brierley, Chris M/A-8417-2009; fedorov, alexey/F-1879-2010	Brierley, Chris M/0000-0002-9195-6731; 	NSF; Department of Energy Office of Science; David and Lucile Packard Foundation; Div Atmospheric & Geospace Sciences [0850639] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Department of Energy Office of Science(United States Department of Energy (DOE)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank G. Philander, M. Barreiro, R. Pacanowski, C. Ravelo, P. deMenocal, T. Herbert, Y. Rosenthal, K. Lawrence, P. Dekens, A. Haywood, C. Wunsch and M. Huber for numerous discussions and encouragement. Financial support was provided by grants to A. V. F. from the NSF, the Department of Energy Office of Science, and the David and Lucile Packard Foundation. We thank B. Dobbins for help with computer simulations. This research used resources of the National Energy Research Scientific Computing Center.	Barreiro M, 2008, ANNU REV EARTH PL SC, V36, P33, DOI 10.1146/annurev.earth.36.090507.143219; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; BRIERLEY CM, PALEOCEANOG IN PRESS, DOI DOI 10.1029/2009PA001809; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; D'Asaro EA, 2003, J PHYS OCEANOGR, V33, P561, DOI 10.1175/1520-0485(2003)033<0561:TOBLBH>2.0.CO;2; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; Dowsett HJ, 2009, PHILOS T R SOC A, V367, P109, DOI 10.1098/rsta.2008.0206; DOWSETT HJ, 1999, 99535 USGS GEOL SURV; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2006, B AM METEOROL SOC, V87, P299, DOI 10.1175/BAMS-87-3-299; Emanuel K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001002; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Guilyardi E, 2009, B AM METEOROL SOC, V90, P325, DOI 10.1175/2008BAMS2387.1; Hack JJ, 2006, J CLIMATE, V19, P2267, DOI 10.1175/JCLI3764.1; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Haywood AM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000799; Haywood AM, 2004, EARTH PLANET SC LETT, V218, P363, DOI 10.1016/S0012-821X(03)00685-X; Jacob SD, 2000, J PHYS OCEANOGR, V30, P1407, DOI 10.1175/1520-0485(2000)030<1407:TOMLRT>2.0.CO;2; Jansen M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036796; Knutson TR, 2008, NAT GEOSCI, V1, P359, DOI 10.1038/ngeo202; Korty RL, 2008, J CLIMATE, V21, P638, DOI 10.1175/2007JCLI1659.1; Marlow JR, 2000, SCIENCE, V290, P2288; MCCREARY JP, 1994, J PHYS OCEANOGR, V24, P466; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Randall DA., 2007, CLIMATE CHANGE 2007; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; ROBINSON MM, 2008, EOS, V89, P501, DOI DOI 10.1029/2008E0490001; Sriver RL, 2007, NATURE, V447, P577, DOI 10.1038/nature05785; Thompson RS, 1996, MAR MICROPALEONTOL, V27, P27, DOI 10.1016/0377-8398(95)00051-8; Tziperman E, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001652; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Woodruff JD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002043; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	39	166	174	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1066	U84		10.1038/nature08831	http://dx.doi.org/10.1038/nature08831			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182509	Green Submitted			2022-12-28	WOS:000275108400033
J	Madan, V; Lear, JT; Szeimies, RM				Madan, Vishal; Lear, John T.; Szeimies, Rolf-Markus			Non-melanoma skin cancer	LANCET			English	Article							BASAL-CELL CARCINOMA; RENAL-TRANSPLANT RECIPIENTS; RANDOMIZED CONTROLLED-TRIAL; IMIQUIMOD 5-PERCENT CREAM; 5-YEAR FOLLOW-UP; AMINOLEVULINATE PHOTODYNAMIC THERAPY; HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS-CELL; SURGICAL EXCISION; SUN EXPOSURE	The rising incidence and morbidity of non-melanoma skin cancers has generated great interest in untravelling of their pathogenesis and in the search for new non-invasive treatments. Whereas the role of cumulative sun exposure in pathogenesis of squamous-cell carcinoma seems clear, the relation between sun-exposure patterns and subtypes of basal-cell carcinoma remains undetermined. Several complex genotypic, phenotypic, and environmental factors contribute to pathogenesis of non-melanoma skin cancers. Unlike basal-cell carcinoma, squamous-cell carcinomas can arise from precursor lesions. Diagnosis of non-melanoma skin cancer is made clinically and confirmed by histological testing. Prognosis depends on lesion and host characteristics, which also dictate choice of treatment. Prevention strategies aim at reduction of sun exposure, but are of unproven benefit, especially for basal-cell carcinoma. Surgical excision with predetermined margins is the mainstay of treatment for squamous-cell carcinoma and for most basal-cell carcinomas. Of the new non-invasive treatments, only photodynamic therapy and topical imiquimod have become established treatments for specific subtypes of basal-cell carcinoma, and the search for more effective and tissue-salvaging therapies continues.	[Madan, Vishal; Lear, John T.] Salford Royal Hosp NHS Fdn Trust, Dermatol Ctr, Salford M6 8HD, Lancs, England; [Szeimies, Rolf-Markus] Univ Klinikum Regensburg, Dermatol Klin & Poliklin, Regensburg, Germany	Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Regensburg	Lear, JT (corresponding author), Salford Royal Hosp NHS Fdn Trust, Dermatol Ctr, Salford M6 8HD, Lancs, England.	john.lear@srft.nhs.uk	lear, john/I-5465-2015	lear, john/0000-0002-2969-9922	3M Healthcare; Galderma; LEO; Novartis; Shire; Stiefel; Almirall; Almirall-Hermal; Biocam; Energist; Intendis; Meda; Photocure; Photonamic; Waldmann Medizintechnik	3M Healthcare(3M); Galderma; LEO(LEO Pharma); Novartis(Novartis); Shire; Stiefel; Almirall(Almirall); Almirall-Hermal(Almirall); Biocam; Energist; Intendis; Meda; Photocure; Photonamic; Waldmann Medizintechnik	VM. declares that he has no conflicts of interest. JTL has received honoraria for presentations and research funding from 3M Healthcare, Galderma, LEO, Novartis, Shire, Stiefel, and Almirall. R-MS has received honoraria for presentations and research funding from Almirall-Hermal, Biocam, Energist, Galderma, Intendis, Meda, Photocure, Photonamic, Waldmann Medizintechnik, and 3M Healthcare, and is a member of the advisory boards of Galderma, Peplin, and Intendis.	American Cancer Society, DET GUID SKIN CANC B; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Avril MF, 1997, BRIT J CANCER, V76, P100, DOI 10.1038/bjc.1997.343; Basset-Seguin N, 2008, EUR J DERMATOL, V18, P547, DOI 10.1684/ejd.2008.0472; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Bastiaens MT, 1998, J INVEST DERMATOL, V110, P880, DOI 10.1046/j.1523-1747.1998.00217.x; Bath-Hextall F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005414.pub2; Bath-Hextall FJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003412.pub2; Bavinck JNB, 2008, J INVEST DERMATOL, V128, P1355, DOI 10.1038/jid.2008.123; Beham A, 1998, Adv Anat Pathol, V5, P269, DOI 10.1097/00125480-199809000-00001; Benjamin CL, 2007, TOXICOL APPL PHARM, V224, P241, DOI 10.1016/j.taap.2006.12.006; Boldrini L, 2003, INT J MOL MED, V11, P607; Brantsch KD, 2008, LANCET ONCOL, V9, P713, DOI 10.1016/S1470-2045(08)70178-5; Brash DE, 2006, BRIT J DERMATOL, V154, P8, DOI 10.1111/j.1365-2133.2006.07230.x; Brellier F, 2008, BRIT J DERMATOL, V159, P445, DOI 10.1111/j.1365-2133.2008.08650.x; Brewster DH, 2007, BRIT J DERMATOL, V156, P1295, DOI 10.1111/j.1365-2133.2007.07892.x; Caccialanza M, 2001, EUR J DERMATOL, V11, P25; Campbell SM, 2008, BRIT J DERMATOL, V159, P387, DOI 10.1111/j.1365-2133.2008.08668.x; Campolmi P, 2008, DERMATOL THER, V21, P402, DOI 10.1111/j.1529-8019.2008.00221.x; Campolmi P, 2002, DERMATOL SURG, V28, P909, DOI 10.1046/j.1524-4725.2002.02076.x; *CANC RES UK, SUNSMART; Cancer Research UK, CANCERSTATS KEY FACT; Chen J, 2008, JNCI-J NATL CANCER I, V100, P1215, DOI 10.1093/jnci/djn260; Cherpelis BS, 2002, DERMATOL SURG, V28, P268, DOI 10.1046/j.1524-4725.2002.01169.x; CHILDERS BJ, 1994, PLAST RECONSTR SURG, V93, P1169, DOI 10.1097/00006534-199405000-00009; Chren MM, 2007, J INVEST DERMATOL, V127, P1351, DOI 10.1038/sj.jid.5700740; Cox NH, 2007, BRIT J DERMATOL, V156, P11, DOI 10.1111/j.1365-2133.2006.07610.x; Danaee H, 2006, J INVEST DERMATOL, V126, P1152, DOI 10.1038/sj.jid.5700209; de Haas ERM, 2006, J INVEST DERMATOL, V126, P2679, DOI 10.1038/sj.jid.5700460; de Vries E, 2004, J INVEST DERMATOL, V123, P634, DOI 10.1111/j.0022-202X.2004.23306.x; Demirkan  N C, 2000, Pathol Oncol Res, V6, P272; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Diffey BL, 2005, BRIT J DERMATOL, V153, P679, DOI 10.1111/j.1365-2133.2005.06799.x; Dinehart SM, 2005, DERMATOL SURG, V31, P1379; DRAKE LA, 1993, J AM ACAD DERMATOL, V28, P628, DOI 10.1016/S0190-9622(08)81782-3; Dummer R, 2003, BRIT J DERMATOL, V149, P57, DOI 10.1046/j.0366-077X.2003.05630.x; Eigentler TK, 2007, J AM ACAD DERMATOL, V57, P616, DOI 10.1016/j.jaad.2007.05.022; English DR, 1997, CANCER CAUSE CONTROL, V8, P271, DOI 10.1023/A:1018440801577; Galletly NP, 2008, BRIT J DERMATOL, V159, P152, DOI 10.1111/j.1365-2133.2008.08577.x; Gawkrodger DJ, 2004, OCCUP MED-OXFORD, V54, P458, DOI 10.1093/occmed/kqh098; Geisse J, 2004, J AM ACAD DERMATOL, V50, P722, DOI 10.1016/j.jaad.2003.11.066; GLASS AG, 1989, JAMA-J AM MED ASSOC, V262, P2097, DOI 10.1001/jama.262.15.2097; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Gollnick H, 2008, EUR J DERMATOL, V18, P677, DOI 10.1684/ejd.2008.0519; Goodwin RG, 2004, CLIN EXP DERMATOL, V29, P328, DOI 10.1111/j.1365-2230.2004.01523.x; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green A, 1992, Epithelial Cell Biol, V1, P47; Griffiths RW, 2005, BRIT J PLAST SURG, V58, P795, DOI 10.1016/j.bjps.2005.02.010; Gross K, 2007, DERMATOL SURG, V33, P433, DOI 10.1111/j.1524-4725.2007.33090.x; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HALL VL, 1986, CLIN RADIOL, V37, P33, DOI 10.1016/S0009-9260(86)80161-1; Han A, 2007, CANCER-AM CANCER SOC, V109, P1053, DOI 10.1002/cncr.22509; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Ho WL, 2008, BRIT J DERMATOL, V158, P217, DOI 10.1111/j.1365-2133.2007.08363.x; Hobbs J, 1999, J AM ACAD DERMATOL, V41, P496, DOI 10.1016/S0190-9622(99)70129-5; Hoey SEH, 2007, BRIT J DERMATOL, V156, P1301, DOI 10.1111/j.1365-2133.2007.07936.x; Holme SA, 2000, BRIT J DERMATOL, V143, P1224, DOI 10.1046/j.1365-2133.2000.03892.x; Huber A, 2004, DERMATOL SURG, V30, P429, DOI 10.1111/j.1524-4725.2004.30116.x; Humphreys TR, 1998, ARCH DERMATOL, V134, P1247, DOI 10.1001/archderm.134.10.1247; Karagas MR, 2007, J INVEST DERMATOL, V127, P2901, DOI 10.1038/sj.jid.5700934; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1995, SKIN CANC MECH HUMAN, P79; Katalinic A, 2003, BRIT J DERMATOL, V149, P1200, DOI 10.1111/j.1365-2133.2003.05554.x; Kennedy C, 2005, BRIT J DERMATOL, V152, P194, DOI 10.1111/j.1365-2133.2005.06411.x; Kleinerman RA, 2009, PEDIATR RADIOL, V39, pS27, DOI 10.1007/s00247-008-1015-6; KRICKER A, 1995, INT J CANCER, V60, P482, DOI 10.1002/ijc.2910600410; KRICKER A, 1995, INT J CANCER, V60, P489, DOI 10.1002/ijc.2910600411; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kuijpers Danielle I, 2006, J Drugs Dermatol, V5, P642; LANDTHALER M, 1995, ARCH DERMATOL, V131, P182, DOI 10.1001/archderm.131.2.182; Lear JT, 2000, BRIT J DERMATOL, V142, P8, DOI 10.1046/j.1365-2133.2000.03339.x; Lear JT, 2005, CLIN EXP DERMATOL, V30, P49, DOI 10.1111/j.1365-2230.2004.01669.x; Lear JT, 1996, CARCINOGENESIS, V17, P1891, DOI 10.1093/carcin/17.9.1891; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P452, DOI 10.1016/j.jaad.2005.04.087; Lichter MD, 2000, ARCH DERMATOL, V136, P1007, DOI 10.1001/archderm.136.8.1007; LINDELOF B, 1991, LANCET, V338, P91, DOI 10.1016/0140-6736(91)90083-2; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Liu CY, 2002, ANN PHARMACOTHER, V36, P1897; Madan V, 2005, PHOTODIAGN PHOTODYN, V2, P273, DOI 10.1016/S1572-1000(05)00101-8; Mallon E, 1996, DERMATOL SURG, V22, P854, DOI 10.1111/j.1524-4725.1996.tb00588.x; Man I, 2005, BRIT J DERMATOL, V152, P755, DOI 10.1111/j.1365-2133.2005.06537.x; Marehbian J, 2007, CANCER CAUSE CONTROL, V18, P895, DOI 10.1007/s10552-007-9034-4; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; MARKS R, 1998, LANCET, V331, P795; McCord MW, 2000, INT J RADIAT ONCOL, V47, P89, DOI 10.1016/S0360-3016(99)00533-7; McCormack CJ, 1997, ARCH DERMATOL, V133, P593, DOI 10.1001/archderm.133.5.593; Moloney FJ, 2006, BRIT J DERMATOL, V154, P790, DOI 10.1111/j.1365-2133.2006.07156.x; Moloney FJ, 2006, BRIT J DERMATOL, V154, P498, DOI 10.1111/j.1365-2133.2005.07021.x; Morton CA, 2008, BRIT J DERMATOL, V159, P1245, DOI 10.1111/j.1365-2133.2008.08882.x; Mosterd K, 2008, BRIT J DERMATOL, V159, P864, DOI 10.1111/j.1365-2133.2008.08787.x; Mosterd K, 2008, LANCET ONCOL, V9, P1149, DOI 10.1016/S1470-2045(08)70260-2; Motley R, 2003, BRIT J PLAST SURG, V56, P85, DOI 10.1016/S0007-1226(03)00028-6; MOTLEY RJ, 1995, BRIT J DERMATOL, V132, P437, DOI 10.1111/j.1365-2133.1995.tb08679.x; National Collaborating Centre for Cancer, 2006, IMPR OUTC PEOPL SKIN; Neale RE, 2007, J AM ACAD DERMATOL, V56, P380, DOI 10.1016/j.jaad.2006.08.039; Newman JC, 2007, DERMATOL SURG, V33, P957, DOI 10.1111/j.1524-4725.2007.33198.x; Odenbro A, 2005, BRIT J CANCER, V92, P1326, DOI 10.1038/sj.bjc.6602475; Otley CC, 2006, AUSTRALAS J DERMATOL, V47, P231, DOI 10.1111/j.1440-0960.2006.00287.x; Otto AI, 1999, CANCER RES, V59, P1212; Pacifico A, 2008, BRIT J DERMATOL, V158, P291, DOI 10.1111/j.1365-2133.2007.08360.x; Petit JY, 2000, PLAST RECONSTR SURG, V105, P2544, DOI 10.1097/00006534-200006000-00039; Punjabi S, 2008, INT J DERMATOL, V47, P78, DOI 10.1111/j.1365-4632.2007.03363.x; Ramachandran S, 2001, PHARMACOGENETICS, V11, P247, DOI 10.1097/00008571-200104000-00008; Ramachandran S, 2001, CANCER, V92, P354, DOI 10.1002/1097-0142(20010715)92:2<354::AID-CNCR1330>3.0.CO;2-F; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; REYMANN F, 1979, DERMATOLOGICA, V158, P368, DOI 10.1159/000250782; Rhodes LE, 2007, ARCH DERMATOL, V143, P1131, DOI 10.1001/archderm.143.9.1131; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Rippey JJ, 1998, HISTOPATHOLOGY, V32, P393; Rodriguez-Vigil T, 2007, J AM ACAD DERMATOL, V56, P91, DOI 10.1016/j.jaad.2006.07.007; Rowert-Huber J, 2007, BRIT J DERMATOL, V156, P8, DOI 10.1111/j.1365-2133.2007.07860.x; Rosso S, 1996, BRIT J CANCER, V73, P1447, DOI 10.1038/bjc.1996.275; ROWE DE, 1989, J DERMATOL SURG ONC, V15, P315, DOI 10.1111/j.1524-4725.1989.tb03166.x; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; ROWE DE, 1989, J DERMATOL SURG ONC, V15, P424, DOI 10.1111/j.1524-4725.1989.tb03249.x; Runger TM, 2007, J INVEST DERMATOL, V127, P2103, DOI 10.1038/sj.jid.5700988; Salasche SJ, 2000, J AM ACAD DERMATOL, V42, pS4, DOI 10.1067/mjd.2000.103342; Saleh S, 2007, HUM PATHOL, V38, P1023, DOI 10.1016/j.humpath.2006.12.006; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; Scotto J., 1983, NIH PUB; Sedda AF, 2008, CLIN EXP DERMATOL, V33, P745, DOI 10.1111/j.1365-2230.2008.02852.x; SEXTON M, 1990, J AM ACAD DERMATOL, V23, P1118, DOI 10.1016/0190-9622(90)70344-H; Shamanin V, 1996, JNCI-J NATL CANCER I, V88, P802, DOI 10.1093/jnci/88.12.802; Shay JW, 1996, TRENDS GENET, V12, P129, DOI 10.1016/0168-9525(96)30018-8; Slater, 2002, MINIMUM DATASET HIST, P1; SLOAN KB, 1990, ARCH DERMATOL RES, V282, P484, DOI 10.1007/BF00402629; Soler AM, 2001, BRIT J DERMATOL, V145, P467, DOI 10.1046/j.1365-2133.2001.04407.x; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Soufir N, 2002, J INVEST DERMATOL, V119, P1355, DOI 10.1046/j.1523-1747.2002.19603.x; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x; Stern RS, 1998, JNCI-J NATL CANCER I, V90, P1278, DOI 10.1093/jnci/90.17.1278; Sterry W, 2006, EUR J DERMATOL, V16, P467, DOI 10.1684/ejd.2006.0035; Szeimies RM, 2006, BRIT J DERMATOL, V154, P16, DOI 10.1111/j.1365-2133.2006.07232.x; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; Thissen MRTM, 2000, DERMATOL SURG, V26, P759, DOI 10.1046/j.1524-4725.2000.ds00064.x; Tucker SB, 2006, J AM ACAD DERMATOL, V54, P1033, DOI 10.1016/j.jaad.2006.02.035; Ulrich M, 2007, BRIT J DERMATOL, V157, P56, DOI 10.1111/j.1365-2133.2007.08275.x; Veness MJ, 2008, J MED IMAG RADIAT ON, V52, P278, DOI 10.1111/j.1440-1673.2008.01956.x; Veness MJ, 2008, LANCET ONCOL, V9, P702, DOI 10.1016/S1470-2045(08)70185-2; Veness MJ, 2006, AUSTRALAS J DERMATOL, V47, P28, DOI 10.1111/j.1440-0960.2006.00218.x; Veness MJ, 2005, LARYNGOSCOPE, V115, P870, DOI 10.1097/01.MLG.0000158349.64337.ED; Vidal D, 2007, ARCH DERMATOL, V143, P266, DOI 10.1001/archderm.143.2.266; Walker P, 2006, AUSTRALAS J DERMATOL, V47, P1, DOI 10.1111/j.1440-0960.2006.00216.x; WEINSTOCK MA, 1995, ARCH DERMATOL, V131, P701, DOI 10.1001/archderm.131.6.701; Wentzell JM, 2008, DERMATOL SURG, V34, P851, DOI 10.1111/j.1524-4725.2008.34161.x; Wilkins K, 2006, J AM ACAD DERMATOL, V54, P189, DOI 10.1016/j.jaad.2004.11.060; WILSON BD, 1992, ARCH DERMATOL, V128, P1597, DOI 10.1001/archderm.128.12.1597; WOLF DJ, 1987, ARCH DERMATOL, V123, P340, DOI 10.1001/archderm.123.3.340; Wong CSM, 2003, BMJ-BRIT MED J, V327, P794, DOI 10.1136/bmj.327.7418.794; World Health Organization, ULTR RAD INTERSUN PR; Yu M, 2008, J INVEST DERMATOL, V128, P1797, DOI 10.1038/sj.jid.5701243; Zeitouni NC, 2003, MOL IMMUNOL, V39, P1133, DOI 10.1016/S0161-5890(03)00083-X; 2007, J CUTAN MED SURG, V11, P45	154	553	569	2	85	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					673	685		10.1016/S0140-6736(09)61196-X	http://dx.doi.org/10.1016/S0140-6736(09)61196-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20171403				2022-12-28	WOS:000275210900036
J	Mogk, A; Bukau, B				Mogk, Axel; Bukau, Bernd			When the Beginning Marks the End	SCIENCE			English	Editorial Material							N-TERMINAL ACETYLTRANSFERASES; RULE PATHWAY; DEGRADATION; PROTEIN; YEAST; TROPOMYOSIN; PROTEOMICS; SYSTEM; ACTIN		[Mogk, Axel; Bukau, Bernd] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Mogk, A (corresponding author), Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	bukau@zmbh.uni-heidelberg.de		Bukau, Bernd/0000-0003-0521-7199				Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Garrels JI, 1997, ELECTROPHORESIS, V18, P1347, DOI 10.1002/elps.1150180810; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Varshavsky A, 2000, BIOL CHEM, V381, P779, DOI 10.1515/BC.2000.101	13	12	12	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					966	967		10.1126/science.1187274	http://dx.doi.org/10.1126/science.1187274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167776				2022-12-28	WOS:000274625800028
J	Parry, SW; Tan, MP				Parry, Steve W.; Tan, Maw Pin			An approach to the evaluation and management of syncope in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ORTHOSTATIC HYPOTENSION; VASOVAGAL SYNCOPE; DIAGNOSIS; CONSCIOUSNESS; GUIDELINES; HISTORY; ATTACKS; TRIAL; RULE		[Parry, Steve W.] Univ Newcastle, Royal Victoria Infirm, Falls & Syncope Serv, Newcastle Upon Tyne NE5 4PL, Tyne & Wear, England; Univ Newcastle, Inst Ageing & Hlth, Wolfson Ctr, Newcastle Upon Tyne NE5 4PL, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Parry, SW (corresponding author), Univ Newcastle, Royal Victoria Infirm, Falls & Syncope Serv, Newcastle Upon Tyne NE5 4PL, Tyne & Wear, England.	swparry@hotmail.com	Tan, Maw Pin/G-6917-2011; Hug, Balthasar L./G-1568-2010	Tan, Maw Pin/0000-0002-3400-8540; 				Alboni P, 2001, J AM COLL CARDIOL, V37, P1921, DOI 10.1016/S0735-1097(01)01241-4; Ballard C, 2000, ANN NY ACAD SCI, V903, P442, DOI 10.1111/j.1749-6632.2000.tb06396.x; Baron-Esquivias G, 2006, EUROPACE, V8, P122, DOI 10.1093/europace/euj035; Blanc JJ, 2002, EUR HEART J, V23, P815, DOI 10.1053/euhj.2001.2975; BRIGNOLE M, 1992, AM J CARDIOL, V69, P1039, DOI 10.1016/0002-9149(92)90860-2; Brignole M, 2006, EUR HEART J, V27, P76, DOI 10.1093/eurheartj/ehi647; Colivicchi F, 2003, EUR HEART J, V24, P811, DOI 10.1016/S0195-668X(02)00827-8; Del Rosso A, 2008, HEART, V94, P1620, DOI 10.1136/hrt.2008.143123; Del Rosso A, 2005, AM J CARDIOL, V96, P1431, DOI 10.1016/j.amjcard.2005.07.047; DVLA, 2009, MED PRACT GLANC GUID; Farwell DJ, 2004, HEART, V90, P52, DOI 10.1136/heart.90.1.52; Fedorowski A, 2010, EUR HEART J, V31, P85, DOI 10.1093/eurheartj/ehp329; Flammang D, 1997, CIRCULATION, V96, P1201, DOI 10.1161/01.CIR.96.4.1201; Kerr SRJ, 2006, ARCH INTERN MED, V166, P515, DOI 10.1001/archinte.166.5.515; Krahn AD, 2001, CIRCULATION, V104, P46, DOI 10.1161/01.CIR.104.1.46; Low PA, 1997, JAMA-J AM MED ASSOC, V278, P388; Mathias CJ, 2004, EUR J NEUROL, V11, P613, DOI 10.1111/j.1468-1331.2004.00840.x; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Nordkamp LRAO, 2009, AM J EMERG MED, V27, P271, DOI 10.1016/j.ajem.2008.02.022; Parry SW, 2006, HEART, V92, P792, DOI 10.1136/hrt.2004.053348; Parry SW, 2009, HEART, V95, P416, DOI 10.1136/hrt.2007.136457; Parry SW, 2005, J AM COLL CARDIOL, V45, P1840, DOI 10.1016/j.jacc.2005.02.060; Parry SW, 2005, J AM GERIATR SOC, V53, P74, DOI 10.1111/j.1532-5415.2005.53013.x; Quinn JV, 2005, AM J EMERG MED, V23, P782, DOI 10.1016/j.ajem.2004.11.009; Quinn JV, 2004, ANN EMERG MED, V43, P224, DOI 10.1016/S0196-0644(03)00823-0; Raj SR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.03.013; Sheldon R, 2006, CIRCULATION, V113, P1164, DOI 10.1161/CIRCULATIONAHA.105.535161; Sivakumaran S, 2003, AM J MED, V115, P1, DOI 10.1016/S0002-9343(03)00233-X; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Sun BC, 2005, AM J CARDIOL, V95, P668, DOI 10.1016/j.amjcard.2004.11.013; Tan MP, 2008, J AM COLL CARDIOL, V51, P599, DOI 10.1016/j.jacc.2007.11.025; van Dijk N, 2008, J CARDIOVASC ELECTR, V19, P48, DOI 10.1111/j.1540-8167.2007.00984.x; van Dijk N, 2006, J AM COLL CARDIOL, V48, P1652, DOI 10.1016/j.jacc.2006.06.059; Vardas PE, 2007, EUR HEART J, V28, P2256, DOI 10.1093/eurheartj/ehm305; Zaidi A, 2000, J AM COLL CARDIOL, V36, P181, DOI 10.1016/S0735-1097(00)00700-2	35	38	42	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2010	340								c880	10.1136/bmj.c880	http://dx.doi.org/10.1136/bmj.c880			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JX	20172928				2022-12-28	WOS:000274739200012
J	Astafiev, O; Zagoskin, AM; Abdumalikov, AA; Pashkin, YA; Yamamoto, T; Inomata, K; Nakamura, Y; Tsai, JS				Astafiev, O.; Zagoskin, A. M.; Abdumalikov, A. A., Jr.; Pashkin, Yu. A.; Yamamoto, T.; Inomata, K.; Nakamura, Y.; Tsai, J. S.			Resonance Fluorescence of a Single Artificial Atom	SCIENCE			English	Article							CIRCUIT; PHOTONS; CAVITY; STATES; QUBIT; FIELD	An atom in open space can be detected by means of resonant absorption and reemission of electromagnetic waves, known as resonance fluorescence, which is a fundamental phenomenon of quantum optics. We report on the observation of scattering of propagating waves by a single artificial atom. The behavior of the artificial atom, a superconducting macroscopic two-level system, is in a quantitative agreement with the predictions of quantum optics for a pointlike scatterer interacting with the electromagnetic field in one-dimensional open space. The strong atom-field interaction as revealed in a high degree of extinction of propagating waves will allow applications of controllable artificial atoms in quantum optics and photonics.	[Astafiev, O.; Pashkin, Yu. A.; Yamamoto, T.; Nakamura, Y.; Tsai, J. S.] NEC Nano Elect Res Labs, Tsukuba, Ibaraki 3058501, Japan; [Astafiev, O.; Abdumalikov, A. A., Jr.; Pashkin, Yu. A.; Yamamoto, T.; Inomata, K.; Nakamura, Y.; Tsai, J. S.] RIKEN, Adv Sci Inst, Tsukuba, Ibaraki 3058501, Japan; [Zagoskin, A. M.] Univ Loughborough, Dept Phys, Loughborough LE11 3TU, Leics, England	NEC Corporation; RIKEN; Loughborough University	Astafiev, O (corresponding author), NEC Nano Elect Res Labs, Tsukuba, Ibaraki 3058501, Japan.	astf@zb.jp.nec.com	Pashkin, Yuri/M-8540-2015; Zagoskin, Alexandre M/B-2904-2011; Astafiev, Oleg/L-9771-2013; Nakamura, Yasunobu/H-1300-2012; Inomata, Kunihiro/L-3275-2018; Tsai, Jaw-Shen/I-7813-2012	Pashkin, Yuri/0000-0003-4767-8217; Zagoskin, Alexandre M/0000-0002-1189-5116; Nakamura, Yasunobu/0000-0003-0424-630X; Inomata, Kunihiro/0000-0002-1151-4512; 	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology kakenhi "Quantum Cybernetics."	Abdumalikov AA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.180502; Astafiev O, 2007, NATURE, V449, P588, DOI 10.1038/nature06141; Baur M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.243602; Bishop LS, 2009, NAT PHYS, V5, P105, DOI 10.1038/NPHYS1154; BURSHTEIN AI, 1965, SOV PHYS JETP-USSR, V21, P567; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Fragner A, 2008, SCIENCE, V322, P1357, DOI 10.1126/science.1164482; Gerhardt I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.033601; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; Mollow B. R., 1969, Physical Review, V188, P1969, DOI 10.1103/PhysRev.188.1969; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Muller A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.187402; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Rakhmanov AL, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144507; RAUTIAN SG, 1962, SOV PHYS JETP-USSR, V14, P328; Schoelkopf R. J., 2002, QUANTUM NOISE MESOSC, P175; SCHUDA F, 1974, J PHYS B-AT MOL OPT, V7, pL198, DOI 10.1088/0022-3700/7/7/002; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Scully M.O., 1997, QUANTUM OPT; Shen JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213001; Tey MK, 2008, NAT PHYS, V4, P924, DOI 10.1038/nphys1096; Vamivakas AN, 2007, NANO LETT, V7, P2892, DOI 10.1021/nl0717255; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wrigge G, 2008, NAT PHYS, V4, P60, DOI 10.1038/nphys812; WU FY, 1975, PHYS REV LETT, V35, P1426, DOI 10.1103/PhysRevLett.35.1426; Yoshihara F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167001; Zumofen G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.180404	28	496	501	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					840	843		10.1126/science.1181918	http://dx.doi.org/10.1126/science.1181918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150495	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000274408300054
J	Barrett, CB				Barrett, Christopher B.			Measuring Food Insecurity	SCIENCE			English	Editorial Material							NUTRITIONAL-STATUS; POVERTY	Food security is a growing concern worldwide. More than 1 billion people are estimated to lack sufficient dietary energy availability, and at least twice that number suffer micronutrient deficiencies. Because indicators inform action, much current research focuses on improving food insecurity measurement. Yet estimated prevalence rates and patterns remain tenuous because measuring food security, an elusive concept, remains difficult.	Cornell Univ, Dept Appl Econ & Management, Ithaca, NY 14853 USA	Cornell University	Barrett, CB (corresponding author), Cornell Univ, Dept Appl Econ & Management, Warren Hall, Ithaca, NY 14853 USA.	cbb2@cornell.edu	Barrett, Christopher B./A-9750-2009	Barrett, Christopher B./0000-0001-9139-2721				Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Barrett C.B, 2002, HDB AGR EC B, V2; Barrett CB, 2005, FOOD AID 50 YEARS; BARRETT CB, 2010, INT STUDIES COMPENDI; Bickel G., 2000, J COOK GUIDE MEASURI; Carter MR, 2006, J DEV STUD, V42, P178, DOI 10.1080/00220380500405261; Chantarat S, 2007, AM J AGR ECON, V89, P1262, DOI 10.1111/j.1467-8276.2007.01094.x; Chen S, 2008, DEV WORLD IS POORER; Darnton-Hill I, 2005, AM J CLIN NUTR, V81, p1198S; Dasgupta P, 1997, J ECONOMETRICS, V77, P5, DOI 10.1016/S0304-4076(96)01804-0; FAO, 2009, MOR PEOPL EV AR VICT; FAO, 2005, VOLUNTARY GUIDELINES; FAO, 2006, STAT FOOD AGR 2006 F; Fogel R., 2004, ESCAPE HUNGER PREMAT, DOI [10.1017/CBO9780511817649, DOI 10.1017/CBO9780511817649]; Food and Agriculture Organization (FAO), FOOD SEC STAT; Food and Agriculture Organization (FAO), 2010, STATE FOOD INSECURIT; Frongillo Edward A, 2006, J Nutr, V136, p1409S; Horton S, COPENHAGEN CONSENSUS; *INT FED RED CROSS, WORLD DIS REP; Maxwell DG, 1996, FOOD POLICY, V21, P291, DOI 10.1016/0306-9192(96)00005-X; Mude AG, 2009, FOOD POLICY, V34, P329, DOI 10.1016/j.foodpol.2009.05.003; National Research Council Committee on National Statistics Division of Behavioral and Social Sciences and Education, 2005, MEAS FOOD INS HUNG P; *SCI COUNC CONS GR, 2009, STRIP REV SOC SCI CG; SEN AMARTYA, 1981, POVERTY FAMINES ESSA, P1; Shapouri S., 2009, FOOD SECURITY ASSESS; Smith L. C., 2006, FOOD INSECURITY SUBS, V146; *UNU FAO WHO, 2004, HUM EN REQ; Webb Patrick, 2006, J Nutr, V136, p1404S; WHO, VIT MIN NUTR INF SYS; World Bank, 2006, REP NUTR CENTR DEV; World Food Program, 2009, EM FOOD SEC ASS HDB, V2nd	31	560	579	14	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					825	828		10.1126/science.1182768	http://dx.doi.org/10.1126/science.1182768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554AQ	20150491				2022-12-28	WOS:000274408300048
J	Fedoroff, NV; Battisti, DS; Beachy, RN; Cooper, PJM; Fischhoff, DA; Hodges, CN; Knauf, VC; Lobell, D; Mazur, BJ; Molden, D; Reynolds, MP; Ronald, PC; Rosegrant, MW; Sanchez, PA; Vonshak, A; Zhu, JK				Fedoroff, N. V.; Battisti, D. S.; Beachy, R. N.; Cooper, P. J. M.; Fischhoff, D. A.; Hodges, C. N.; Knauf, V. C.; Lobell, D.; Mazur, B. J.; Molden, D.; Reynolds, M. P.; Ronald, P. C.; Rosegrant, M. W.; Sanchez, P. A.; Vonshak, A.; Zhu, J. -K.			Radically Rethinking Agriculture for the 21st Century	SCIENCE			English	Editorial Material								Population growth, arable land and fresh water limits, and climate change have profound implications for the ability of agriculture to meet this century's demands for food, feed, fiber, and fuel while reducing the environmental impact of their production. Success depends on the acceptance and use of contemporary molecular techniques, as well as the increasing development of farming systems that use saline water and integrate nutrient flows.	[Fedoroff, N. V.] US Dept State, Off Sci & Technol, USAID, Washington, DC 20520 USA; [Battisti, D. S.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Beachy, R. N.] Natl Inst Food & Agr, USDA, Washington, DC 20250 USA; [Cooper, P. J. M.] Int Crops Res Inst Semi Arid Trop, Nairobi, Kenya; [Fischhoff, D. A.] Monsanto Co, St Louis, MO 63167 USA; [Hodges, C. N.] Seawater Fdn, Tucson, AZ 85711 USA; [Knauf, V. C.] Arcadia Biosci, Davis, CA 95618 USA; [Lobell, D.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Lobell, D.] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA; [Mazur, B. J.] DuPont Expt Stn, Wilmington, DE 19805 USA; [Molden, D.] Int Water Management Inst, Battaramulla, Colombo, Sri Lanka; [Reynolds, M. P.] Int Maize & Wheat Improvement Ctr, Texcoco 56130, Edo De Mexico, Mexico; [Ronald, P. C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Rosegrant, M. W.] Int Food Policy Res Inst, Washington, DC 20006 USA; [Sanchez, P. A.] Columbia Univ, Earth Inst, Palisades, NY 10964 USA; [Vonshak, A.] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-84990 Sede Boqer, Israel; [Zhu, J. -K.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Zhu, J. -K.] King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Technol, Thuwal, Saudi Arabia	United States Agency for International Development (USAID); University of Washington; University of Washington Seattle; United States Department of Agriculture (USDA); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Monsanto; Stanford University; Stanford University; DuPont; CGIAR; International Water Management Institute (IWMI); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of California System; University of California Davis; CGIAR; International Food Policy Research Institute (IFPRI); Columbia University; Ben Gurion University; University of California System; University of California Riverside; King Abdullah University of Science & Technology	Fedoroff, NV (corresponding author), US Dept State, Off Sci & Technol, USAID, Washington, DC 20520 USA.	fedoroff@state.gov	Battisti, David S/A-3340-2013; Ronald, Pamela/AAK-7664-2020; Zhu, Jian-Kang/F-7658-2011; Reynolds, Matthew M/S-3578-2016	Battisti, David S/0000-0003-4871-1293; Zhu, Jian-Kang/0000-0001-5134-731X; Reynolds, Matthew M/0000-0002-4291-4316; Vonshak, Avigad/0000-0001-8737-0749; Lobell, David/0000-0002-5969-3476; Molden, David/0000-0003-3201-9518	NIGMS NIH HHS [R01 GM059138-15, R01 GM070795-09, R01 GM059138, R01 GM070795] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138, R01GM070795] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2007, CONSERVATION GLOBAL; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Brookes G., 2008, AgBioForum, V11, P21; Comprehensive Assessment of Water Management in Agriculture, 2007, WAT FOOD WAT LIF COM; FAO (Food and Agriculture Organization of the United Nations), 2009, STAT WORLD FISH AQ 2; Fath B. D., 2008, ENCY ECOLOGY ECOLOGI, V3, P2463, DOI DOI 10.1016/B978-008045405-4.00065-3; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; James C., 2008, GLOBAL STATUS COMMER; Land Commodities Asset Management AG, 2009, LAND COMM GLOB AGR F; Lantican MA, 2003, AGR ECON, V29, P353, DOI 10.1016/S0169-5150(03)00062-8; Morison JIL, 2008, PHILOS T R SOC B, V363, P639, DOI 10.1098/rstb.2007.2175; Qaderi MM, 2009, ENVIRON SCI ENG, P1, DOI 10.1007/978-3-540-88246-6_1; Rothbard S., 2002, TILAPIA FARMING 21 C, P60; Royal Society, 2009, REAP BEN SCI SUST IN; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; *UN FAO, 2001, INT AGR AQ; World Bank, 2008, AGRIC RURAL DEV, P1, DOI 10.1596/978-0-8213-7163- 3	18	440	470	11	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					833	834		10.1126/science.1186834	http://dx.doi.org/10.1126/science.1186834			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150494	Green Accepted, Green Published			2022-12-28	WOS:000274408300051
J	Zealley, IA; Chakraverty, S				Zealley, Ian A.; Chakraverty, Sam			The role of interventional radiology in trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BLUNT ABDOMINAL-TRAUMA; NONOPERATIVE MANAGEMENT; SPLENIC EMBOLIZATION; ARTERIAL EMBOLIZATION; PELVIC FRACTURE; COMPLICATIONS; INJURIES; LIVER; ANGIOEMBOLIZATION; SPLENECTOMY	Summary points Interventional radiological techniques to stop bleeding are a minimally invasive alternative to surgery in blunt abdominal trauma In haemodynamically stable patients with trauma, interventional radiology has an established role in the management of solid organ injuries In haemodynamically unstable patients with trauma, interventional radiology is effective in stemming haemorrhage from pelvic fractures Recent series suggest that in a wider range of haemodynamically unstable patients interventional radiological techniques may further reduce the number of patients needing surgery The overall quality of the evidence for interventional radiological and surgical interventions in trauma is poor	[Zealley, Ian A.; Chakraverty, Sam] Ninewells Hosp, Sch Med, Dept Radiol, Dundee DD1 9SY, Scotland	University of Dundee	Zealley, IA (corresponding author), Ninewells Hosp, Sch Med, Dept Radiol, Dundee DD1 9SY, Scotland.	ian.zealley@nhs.net						Agolini SF, 1997, J TRAUMA, V43, P395, DOI 10.1097/00005373-199709000-00001; *AM COLL SURG, 2008, ATLS ADV TRAUMA; Cassar K, 2002, J ROY COLL SURG EDIN, V47, P731; Chow SJD, 2009, INJURY, V40, P844, DOI 10.1016/j.injury.2008.11.022; Dabbs DN, 2009, J TRAUMA, V66, P621, DOI 10.1097/TA.0b013e31819919f2; Dinkel HP, 2002, RADIOLOGY, V223, P723, DOI 10.1148/radiol.2233011216; Duchesne JC, 2008, J TRAUMA, V65, P1346, DOI 10.1097/TA.0b013e31818c29ea; Ekeh AP, 2005, AM J SURG, V189, P335, DOI 10.1016/j.amjsurg.2004.11.033; Fang JF, 2006, WORLD J SURG, V30, P176, DOI 10.1007/s00268-005-0194-7; Fata P, 2005, J TRAUMA, V59, P836, DOI 10.1097/01.ta.0000187652.55405.73; Frevert S, 2008, INJURY, V39, P1290, DOI 10.1016/j.injury.2008.07.004; Gaarder C, 2007, INJURY, V38, P1075, DOI 10.1016/j.injury.2007.02.001; Gaarder C, 2006, J TRAUMA, V61, P192, DOI 10.1097/01.ta.0000223466.62589.d9; Gibson DE, 2006, J EMERG MED, V31, P215, DOI 10.1016/j.jemermed.2005.09.015; Haan JM, 2004, J TRAUMA, V56, P542, DOI 10.1097/01.TA.0000114069.73054.45; Hagiwara A, 2004, J TRAUMA, V57, P271, DOI 10.1097/01.TA.0000131198.79153.3C; *HEALTHCARE COMM, 2006, INVEST 10 MATERN; Hershberger RC, 2009, J TRAUMA, V67, P660, DOI 10.1097/TA.0b013e3181b2894c; Holden A, 2008, INJURY, V39, P1275, DOI 10.1016/j.injury.2008.04.019; Johnson JW, 2002, J TRAUMA, V52, P1102, DOI 10.1097/00005373-200206000-00013; Kessel D, 2008, BRIT MED J, V336, P1205, DOI 10.1136/bmj.a168; Kozar RA, 2005, J TRAUMA, V59, P1066, DOI 10.1097/01.ta.0000188937.75879.ab; Miller PR, 2003, J TRAUMA, V54, P437, DOI 10.1097/01.TA.0000053397.33827.DD; *NAT CONF ENQUIRY, 2007, TRAUMA WHO CARES; *SCOT INTERCOLL G, 2008, SIGN 50 GUIDELINE; *SCOT INTERCOLL G, MANAGE ACUTE UPPER; Sofocleous CT, 2005, CARDIOVASC INTER RAD, V28, P39, DOI 10.1007/s00270-004-0042-4; Tominaga GT, 2009, J TRAUMA, V67, P289, DOI 10.1097/TA.0b013e3181a5e7e2; Totterman A, 2006, ACTA ORTHOP, V77, P462, DOI 10.1080/17453670610046406; Travis T, 2008, J VASC INTERV RADIOL, V19, P840, DOI 10.1016/j.jvir.2008.02.011; Velmahos GC, 2003, ARCH SURG-CHICAGO, V138, P475, DOI 10.1001/archsurg.138.5.475; Wiseman J, 2006, AM SURGEON, V72, P947; Wu SC, 2008, WORLD J SURG, V32, P476, DOI 10.1007/s00268-007-9322-x; Zacharias S R, 1999, AACN Clin Issues, V10, P95, DOI 10.1097/00044067-199902000-00009	34	25	27	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2010	340								c497	10.1136/bmj.c497	http://dx.doi.org/10.1136/bmj.c497			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZQ	20142319				2022-12-28	WOS:000274476600015
J	Capelson, M; Liang, Y; Schulte, R; Mair, W; Wagner, U; Hetzer, MW				Capelson, Maya; Liang, Yun; Schulte, Roberta; Mair, William; Wagner, Ulrich; Hetzer, Martin W.			Chromatin-Bound Nuclear Pore Components Regulate Gene Expression in Higher Eukaryotes	CELL			English	Article							RNA-POLYMERASE-II; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; P-TEFB; TRANSCRIPTIONAL CONTROL; SPATIAL-ORGANIZATION; MOBILE NUCLEOPORIN; TERMINAL DOMAIN; IN-VIVO; COMPLEX	Nuclear pore complexes have recently been shown to play roles in gene activation; however their potential involvement in metazoan transcription remains unclear. Here we show that the nucleoporins Sec13, Nup98, and Nup88, as well as a group of FG-repeat nucleoporins, bind to the Drosophila genome at functionally distinct loci that often do not represent nuclear envelope contact sites. Whereas Nup88 localizes to silent loci, Sec13, Nup98, and a subset of FG-repeat nucleoporins bind to developmentally regulated genes undergoing transcription induction. Strikingly, RNAi-mediated knockdown of intranuclear Sec13 and Nup98 specifically inhibits transcription of their target genes and prevents efficient reactivation of transcription after heat shock, suggesting an essential role of NPC components in regulating complex gene expression programs of multicellular organisms.	[Capelson, Maya; Liang, Yun; Schulte, Roberta; Mair, William; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA; [Wagner, Ulrich] Univ Calif Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92037 USA	Salk Institute; Ludwig Institute for Cancer Research	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cellular Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu	Liang, Yun/K-5639-2013	Mair, William/0000-0002-0661-1342	NIHGMS [R01GM057438]; Damon Runyon Cancer Research Foundation [DRG 1952-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057438] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tony Hunter and members of the Hetzer lab for critically reading the manuscript, Leanne Jones and members of her lab for sharing fly reagents and expertise, and Andy Dillin for sharing injection and microscopy equipment. We also thank Elissa P. Lei, P. A. Fisher, S. Gigliotti, and C. Samakovlis for generously providing antibodies and Daniel Anderson for help with image analysis. The project was supported by R01GM057438 from the NIHGMS. M. C. was supported by the Damon Runyon Cancer Research Foundation fellowship (DRG 1952-07).	Agudo D, 2004, INT J CANCER, V109, P717, DOI 10.1002/ijc.20034; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; ASHBURNER M, 1967, CHROMOSOMA, V21, P398, DOI 10.1007/BF00336950; ASHBURNER M, 1971, NATURE-NEW BIOL, V230, P222, DOI 10.1038/newbio230222a0; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Gigliotti S, 1998, J CELL BIOL, V142, P1195, DOI 10.1083/jcb.142.5.1195; GREBER UF, 1990, EMBO J, V9, P1495, DOI 10.1002/j.1460-2075.1990.tb08267.x; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hamann S, 1998, NUCLEIC ACIDS RES, V26, P4108, DOI 10.1093/nar/26.18.4108; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; HUET F, 1993, DEVELOPMENT, V118, P613; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; MIRAULT ME, 1977, COLD SPRING HARB SYM, V42, P819, DOI 10.1101/SQB.1978.042.01.082; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; SPRADLING A, 1975, CELL, V4, P395, DOI 10.1016/0092-8674(75)90160-9; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; Uv AE, 2000, GENE DEV, V14, P1945; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374	59	318	325	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					372	U100		10.1016/j.cell.2009.12.054	http://dx.doi.org/10.1016/j.cell.2009.12.054			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144761	Green Accepted, Bronze			2022-12-28	WOS:000274297700015
J	Gorbsky, GJ				Gorbsky, Gary J.			Duct Tape for Broken Chromosomes	CELL			English	Editorial Material							DROSOPHILA-MELANOGASTER; CHECKPOINT; TELOMERES; ANAPHASE; KINASES; BUBR1		Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Gorbsky, GJ (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	gjg@omrf.org		Gorbsky, Gary/0000-0003-3076-4725	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050412] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM050412-18, R01 GM050412-17, R01 GM050412] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Choi E, 2008, FEBS LETT, V582, P1700, DOI 10.1016/j.febslet.2008.04.028; Huang HM, 2009, CELL CYCLE, V8, P1164, DOI 10.4161/cc.8.8.8151; LaFountain JR, 2002, J CELL SCI, V115, P1541; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Musaro M, 2008, NAT GENET, V40, P362, DOI 10.1038/ng.2007.64; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Titen SWA, 2008, GENETICS, V180, P1821, DOI 10.1534/genetics.108.093625	9	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2					178	180		10.1016/j.cell.2010.01.005	http://dx.doi.org/10.1016/j.cell.2010.01.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141831	Bronze			2022-12-28	WOS:000273826500008
J	Dowdy, SC; Mariani, A				Dowdy, Sean C.; Mariani, Andrea			Lymphadenectomy in endometrial cancer: when, not if	LANCET			English	Editorial Material							SYSTEMATIC PELVIC LYMPHADENECTOMY; RANDOMIZED CLINICAL-TRIAL; NO LYMPHADENECTOMY		[Dowdy, Sean C.; Mariani, Andrea] Mayo Clin, Div Gynecol Surg, Rochester, MN 55905 USA	Mayo Clinic	Dowdy, SC (corresponding author), Mayo Clin, Div Gynecol Surg, Rochester, MN 55905 USA.	dowdy.sean@mayo.edu						Bakkum-Gamez JN, 2008, MAYO CLIN PROC, V83, P97, DOI 10.4065/83.1.97; Dowdy SC, 2008, GYNECOL ONCOL, V111, P418, DOI 10.1016/j.ygyno.2008.08.021; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Mariani A, 2004, GYNECOL ONCOL, V95, P120, DOI 10.1016/j.ygyno.2004.06.042; Mariani A, 2002, GYNECOL ONCOL, V84, P437, DOI 10.1006/gyno.2001.6550; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Uccella S, 2009, LANCET, V373, P1170, DOI 10.1016/S0140-6736(09)60677-2; Uccella S, 2009, JNCI-J NATL CANCER I, V101, P897, DOI 10.1093/jnci/djp124	10	20	20	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 3	2010	375	9721					1138	1140		10.1016/S0140-6736(09)62068-7	http://dx.doi.org/10.1016/S0140-6736(09)62068-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20188409				2022-12-28	WOS:000276858200005
J	Paterson, S; Vogwill, T; Buckling, A; Benmayor, R; Spiers, AJ; Thomson, NR; Quail, M; Smith, F; Walker, D; Libberton, B; Fenton, A; Hall, N; Brockhurst, MA				Paterson, Steve; Vogwill, Tom; Buckling, Angus; Benmayor, Rebecca; Spiers, Andrew J.; Thomson, Nicholas R.; Quail, Mike; Smith, Frances; Walker, Danielle; Libberton, Ben; Fenton, Andrew; Hall, Neil; Brockhurst, Michael A.			Antagonistic coevolution accelerates molecular evolution	NATURE			English	Article							LOCAL ADAPTATION; BACTERIA; PHAGE	The Red Queen hypothesis proposes that coevolution of interacting species (such as hosts and parasites) should drive molecular evolution through continual natural selection for adaptation and counter-adaptation(1-3). Although the divergence observed at some host-resistance(4-6) and parasite-infectivity(7-9) genes is consistent with this, the long time periods typically required to study coevolution have so far prevented any direct empirical test. Here we show, using experimental populations of the bacterium Pseudomonas fluorescens SBW25 and its viral parasite, phage Phi 2 (refs 10, 11), that the rate of molecular evolution in the phage was far higher when both bacterium and phage coevolved with each other than when phage evolved against a constant host genotype. Coevolution also resulted in far greater genetic divergence between replicate populations, which was correlated with the range of hosts that coevolved phage were able to infect. Consistent with this, the most rapidly evolving phage genes under coevolution were those involved in host infection. These results demonstrate, at both the genomic and phenotypic level, that antagonistic coevolution is a cause of rapid and divergent evolution, and is likely to be a major driver of evolutionary change within species.	[Paterson, Steve; Vogwill, Tom; Libberton, Ben; Fenton, Andrew; Hall, Neil; Brockhurst, Michael A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Buckling, Angus; Benmayor, Rebecca] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Spiers, Andrew J.] Univ Abertay Dundee, SIMBIOS Ctr, Dundee DD1 1HG, Scotland; [Thomson, Nicholas R.; Quail, Mike; Smith, Frances; Walker, Danielle] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Liverpool; University of Oxford; University of Abertay Dundee; Wellcome Trust Sanger Institute	Brockhurst, MA (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	michael.brockhurst@liverpool.ac.uk	Fenton, Andy/B-5972-2009; Hall, Neil/A-8717-2013; Brockhurst, Michael A/A-6247-2009; Paterson, Steve/D-2154-2009; Spiers, Andrew/I-3535-2012; Thomson, Nicholas/P-5988-2014	Fenton, Andy/0000-0002-7676-917X; Hall, Neil/0000-0002-7995-3810; Paterson, Steve/0000-0002-1307-2981; Spiers, Andrew/0000-0003-0463-8629; Libberton, Ben/0000-0001-9104-679X; Thomson, Nicholas/0000-0002-4432-8505; Buckling, Angus/0000-0003-1170-4604; Vogwill, Tom/0000-0003-1044-6623; Hall, Neil/0000-0003-2808-0009; Brockhurst, Michael/0000-0003-0362-820X	Natural Environment Research Council; Wellcome Trust; Leverhulme Trust; European Research Council; Natural Environment Research Council [NE/F001193/1, NBAF010002] Funding Source: researchfish; NERC [NE/F001193/1, NBAF010002] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to M. Begon and G. Hurst for comments on previous drafts of this manuscript. We acknowledge funding from the Natural Environment Research Council, the Wellcome Trust, the Leverhulme Trust and the European Research Council. We are grateful for technical assistance from staff at the Centre for Genomic Research, University of Liverpool.	Abedon S.T, 2005, BACTERIOPHAGES; Barrett LG, 2009, MOL BIOL EVOL, V26, P2499, DOI 10.1093/molbev/msp166; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Benmayor R, 2009, CURR BIOL, V19, P764, DOI 10.1016/j.cub.2009.03.023; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Bull JJ, 1997, GENETICS, V147, P1497; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; EXCOFFIER L, 1992, GENETICS, V131, P479; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; Morgan AD, 2006, J EVOLUTION BIOL, V19, P1956, DOI 10.1111/j.1420-9101.2006.01148.x; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Poullain V, 2008, EVOLUTION, V62, P1, DOI 10.1111/j.1558-5646.2007.00260.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANTOS MA, 1991, NUCLEIC ACIDS RES, V19, P5442, DOI 10.1093/nar/19.19.5442; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Thompson J.N., 2005, INTERSPEC INTERACT; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; VANVALEN L, 1974, J MOL EVOL, V3, P89, DOI 10.1007/BF01796554; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	27	346	357	4	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					275	U154		10.1038/nature08798	http://dx.doi.org/10.1038/nature08798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20182425	Green Accepted			2022-12-28	WOS:000275366100046
J	Sharma, CM; Hoffmann, S; Darfeuille, F; Reignier, J; Findeiss, S; Sittka, A; Chabas, S; Reiche, K; Hackermuller, J; Reinhardt, R; Stadler, PF; Vogel, J				Sharma, Cynthia M.; Hoffmann, Steve; Darfeuille, Fabien; Reignier, Jeremy; Findeiss, Sven; Sittka, Alexandra; Chabas, Sandrine; Reiche, Kristin; Hackermueller, Joerg; Reinhardt, Richard; Stadler, Peter F.; Vogel, Joerg			The primary transcriptome of the major human pathogen Helicobacter pylori	NATURE			English	Article							ESCHERICHIA-COLI; RNA-POLYMERASE; GENE-EXPRESSION; COMPARATIVE GENOMICS; MESSENGER-RNA; 6S RNA; IDENTIFICATION; PROMOTER; SEQUENCE; BACTERIA	Genome sequencing of Helicobacter pylori has revealed the potential proteins and genetic diversity of this prevalent human pathogen, yet little is known about its transcriptional organization and noncoding RNA output. Massively parallel cDNA sequencing (RNA-seq) has been revolutionizing global transcriptomic analysis. Here, using a novel differential approach (dRNA-seq) selective for the 5' end of primary transcripts, we present a genome-wide map of H. pylori transcriptional start sites and operons. We discovered hundreds of transcriptional start sites within operons, and opposite to annotated genes, indicating that complexity of gene expression from the small H. pylori genome is increased by uncoupling of polycistrons and by genome-wide antisense transcription. We also discovered an unexpected number of similar to 60 small RNAs including the e-subdivision counterpart of the regulatory 6S RNA and associated RNA products, and potential regulators of cis- and trans-encoded target messenger RNAs. Our approach establishes a paradigm for mapping and annotating the primary transcriptomes of many living species.	[Sharma, Cynthia M.; Sittka, Alexandra; Vogel, Joerg] Max Planck Inst Infect Biol, RNA Biol Grp, D-10117 Berlin, Germany; [Hoffmann, Steve; Findeiss, Sven; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, D-04107 Leipzig, Germany; [Hoffmann, Steve; Findeiss, Sven; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; [Darfeuille, Fabien; Reignier, Jeremy; Chabas, Sandrine] INSERM, U869, F-33076 Bordeaux, France; [Darfeuille, Fabien; Reignier, Jeremy; Chabas, Sandrine] Univ Bordeaux, F-33076 Bordeaux, France; [Reiche, Kristin; Hackermueller, Joerg; Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol, RNom Grp, D-04103 Leipzig, Germany; [Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Stadler, Peter F.] Max Planck Inst Math Sci, D-04103 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, D-97080 Wurzburg, Germany	Max Planck Society; Leipzig University; Leipzig University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Fraunhofer Gesellschaft; Max Planck Society; Max Planck Society; University of Vienna; The Santa Fe Institute; University of Wurzburg	Vogel, J (corresponding author), Max Planck Inst Infect Biol, RNA Biol Grp, D-10117 Berlin, Germany.	joerg.vogel@uni-wuerzburg.de	Darfeuille, Fabien/M-3883-2014; Stadler, Peter F. F/L-7857-2015; Sharma, Cynthia/D-2869-2013; Hackermüller, Jörg/F-2494-2016; Vogel, Jörg/D-5574-2011; Hoffmann, Steve/E-1438-2013	Darfeuille, Fabien/0000-0003-1167-6113; Stadler, Peter F. F/0000-0002-5016-5191; Hackermüller, Jörg/0000-0003-4920-7072; Vogel, Jörg/0000-0003-2220-1404; Sharma, Cynthia Mira/0000-0002-2321-9705; Reiche, Kristin/0000-0002-4452-4872; Reinhardt, Richard/0000-0001-9376-2132; Findeiss, Sven/0000-0002-3311-7745	NGFN, BMBF, Germany; DFG [SPP1258]; Regulatory RNAs in Prokaryotes [VO8751/2, VO8751/4, STA850/7-1]; University of Leipzig; Freistaat Sachsen; German Research Foundation IZBI [BIZ6/1-4]; Volkswagen Stiftung [I/82 720]; French Agence Nationale de la Recherche [ANR-07-JCJC-0104-01]; French Association de la Recherche contre le Cancer (ARC); La Ligue Nationale contre le Cancer (LNCC)	NGFN, BMBF, Germany(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Regulatory RNAs in Prokaryotes; University of Leipzig; Freistaat Sachsen; German Research Foundation IZBI; Volkswagen Stiftung(Volkswagen); French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Association de la Recherche contre le Cancer (ARC); La Ligue Nationale contre le Cancer (LNCC)	We thank F. Seifert; H. Hamoutene and B. Timmermann for technical support; M. Schmid for mass spectrometry analysis; H. De Reuse, A. van Vliet and M. K. Waldor for discussions; F. Thummler for library preparation; M. Droege for pyrosequencing support. J. V. and R. R. are supported by NGFN+ grants (BMBF, Germany), and J. V. and P. F. S. by DFG Priority Program SPP1258 Sensory and Regulatory RNAs in Prokaryotes (Grants VO8751/2, VO8751/4; STA850/7-1). S. H. was supported by a formel. 1 grant of the University of Leipzig, the Freistaat Sachsen (LIFE project), the German Research Foundation IZBI (BIZ6/1-4) and Volkswagen Stiftung (I/82 720). F. D. is supported by the French Agence Nationale de la Recherche (ANR-07-JCJC-0104-01), the French Association de la Recherche contre le Cancer (ARC) and La Ligue Nationale contre le Cancer (LNCC). We thank D. Rose for his supporting work and S. Washietl for a pre-release of the RNAcode software.	Akada JK, 2000, MOL MICROBIOL, V36, P1071, DOI 10.1046/j.1365-2958.2000.01918.x; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Appelmelk BJ, 1998, INFECT IMMUN, V66, P70, DOI 10.1128/IAI.66.1.70-76.1998; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Beier D, 1997, J BACTERIOL, V179, P4676, DOI 10.1128/jb.179.15.4676-4683.1997; Boneca IG, 2003, NUCLEIC ACIDS RES, V31, P1704, DOI 10.1093/nar/gkg250; Brock JE, 2008, RNA, V14, P2159, DOI 10.1261/rna.1089208; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Croxen MA, 2007, J BACTERIOL, V189, P3359, DOI 10.1128/JB.00012-07; Forsyth MH, 1999, J BACTERIOL, V181, P2261, DOI 10.1128/JB.181.7.2261-2266.1999; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Fujita Y, 2005, HELICOBACTER, V10, P567, DOI 10.1111/j.1523-5378.2005.00364.x; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Jenks PJ, 2001, RES MICROBIOL, V152, P725, DOI 10.1016/S0923-2508(01)01253-0; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Petersen L, 2003, J MOL BIOL, V326, P1361, DOI 10.1016/S0022-2836(03)00034-2; Pflock M, 2005, INFECT IMMUN, V73, P6437, DOI 10.1128/IAI.73.10.6437-6445.2005; Phadnis SH, 1996, INFECT IMMUN, V64, P905, DOI 10.1128/IAI.64.3.905-912.1996; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Shirai M, 1999, GENE, V239, P351, DOI 10.1016/S0378-1119(99)00389-3; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Spohn G, 1999, J BACTERIOL, V181, P593, DOI 10.1128/JB.181.2.593-599.1999; Spohn G, 1997, MOL MICROBIOL, V26, P361, DOI 10.1046/j.1365-2958.1997.5831949.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Thompson LJ, 2003, INFECT IMMUN, V71, P2643, DOI 10.1128/IAI.71.5.2643-2655.2003; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vanet A, 2000, J MOL BIOL, V297, P335, DOI 10.1006/jmbi.2000.3576; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Yada T, 2001, DNA RES, V8, P97, DOI 10.1093/dnares/8.3.97	50	853	875	0	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					250	255		10.1038/nature08756	http://dx.doi.org/10.1038/nature08756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20164839				2022-12-28	WOS:000275366100040
J	Hajat, S; O'Connor, M; Kosatsky, T				Hajat, Shakoor; O'Connor, Madeline; Kosatsky, Tom			Health effects of hot weather: from awareness of risk factors to effective health protection	LANCET			English	Review							HEAT-RELATED MORTALITY; TEMPERATURE-RELATED MORTALITY; HOSPITAL ADMISSIONS; AUGUST 2003; CARDIOVASCULAR-DISEASES; AMBIENT-TEMPERATURE; ELDERLY-PEOPLE; PUBLIC-HEALTH; EXTREME HEAT; US CITIES	Because of the increasing concerns about climate change and deadly heatwaves in the past, the health effects of hot weather are fast becoming a global public health challenge for the 21st century. Some cities across the world have introduced public health protection measures, with the timely provision of appropriate home-based prevention advice to the general public being the most crucial point of intervention. In this Review, we report current epidemiological and physiological evidence about the range of health effects associated with hot weather, and draw attention to the interplay between climate factors, human susceptibility, and adaptation measures that contribute to heat burdens. We focus on the evidence base for the most commonly provided heat-protection advice, and make recommendations about the optimum clinical and public health practice that are expected to reduce health problems associated with current and future hot weather.	[Hajat, Shakoor] Univ London London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, London WC1E 7HT, England; [Hajat, Shakoor; Kosatsky, Tom] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [O'Connor, Madeline] Montreal Publ Hlth Dept, Montreal, PQ, Canada	University of London; London School of Hygiene & Tropical Medicine	Hajat, S (corresponding author), Univ London London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, Keppel St, London WC1E 7HT, England.	shakoor.hajat@lshtm.ac.uk			Wellcome Trust [076583/Z/05/Z]; McGill University Health Centre, Montreal, QC, Canada; British Columbia Centre for Disease Control, Vancouver, BC, Canada	Wellcome Trust(Wellcome TrustEuropean Commission); McGill University Health Centre, Montreal, QC, Canada; British Columbia Centre for Disease Control, Vancouver, BC, Canada	SH is funded by a Wellcome Trust Research Career Development Fellowship (076583/Z/05/Z); MOC was funded by the Research Institute of the McGill University Health Centre, Montreal, QC, Canada; and TK is funded by the British Columbia Centre for Disease Control, Vancouver, BC, Canada.	ALBERT C, 2006, B INFORM SANTE PUBLI, V17, P5; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Argaud L, 2007, ARCH INTERN MED, V167, P2177, DOI 10.1001/archinte.167.20.ioi70147; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Bark N, 1998, PSYCHIATR SERV, V49, P1088, DOI 10.1176/ps.49.8.1088; Bassil KL, 2008, CAN J PUBLIC HEALTH, V99, P339, DOI 10.1007/BF03403768; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Blum LN, 1998, JAMA-J AM MED ASSOC, V279, P1514, DOI 10.1001/jama.279.19.1514; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Cerutti B, 2006, SOZ PRAVENTIV MED, V51, P185, DOI 10.1007/s00038-006-0026-z; Claessens YE, 2006, CRIT CARE, V10, DOI 10.1186/cc5092; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Dear K, 2005, ARCH ENVIRON OCCUP H, V60, P205, DOI 10.3200/AEOH.60.4.205-212; Dolney TJ, 2006, ENVIRON RES, V101, P94, DOI 10.1016/j.envres.2005.08.008; Donoghue ER, 1997, AM J FOREN MED PATH, V18, P11, DOI 10.1097/00000433-199703000-00002; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; ELLIS FP, 1972, ENVIRON RES, V5, P1, DOI 10.1016/0013-9351(72)90019-9; ELLIS FP, 1976, T ROY SOC TROP MED H, V70, P419, DOI 10.1016/0035-9203(76)90122-X; Golden JS, 2008, INT J BIOMETEOROL, V52, P471, DOI 10.1007/s00484-007-0142-3; Grandjean AC, 2000, J AM COLL NUTR, V19, P591, DOI 10.1080/07315724.2000.10718956; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Hashizume M, 2009, INT J EPIDEMIOL, V38, P1689, DOI 10.1093/ije/dyn376; Huq S, 2007, ENVIRON URBAN, V19, P3, DOI 10.1177/0956247807078058; *IPCC 2007, 2007, CLIM CHANG 2007 IMP; JOHNSON SJ, 1993, OCCUP HEALTH SAF, V62, P65; JOKINEN E, 1990, PEDIATRICS, V86, P282; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Kaiser R, 2001, AM J FOREN MED PATH, V22, P303, DOI 10.1097/00000433-200109000-00022; Kaiser T, 2007, J COMB THEORY B, V97, P1, DOI 10.1016/j.jctb.2006.03.002; Kalkstein LS, 1997, ENVIRON HEALTH PERSP, V105, P84, DOI 10.2307/3433067; KALKSTEIN LS, 1993, LANCET, V342, P1397, DOI 10.1016/0140-6736(93)92757-K; Keatinge WR, 2003, BRIT MED J, V327, P512, DOI 10.1136/bmj.327.7414.512; Keim SM, 2002, ANN AGR ENV MED, V9, P1; Kenney WL, 2003, J APPL PHYSIOL, V95, P2598, DOI 10.1152/japplphysiol.00202.2003; Kilbourne E. M., 1997, PUBLIC HLTH CONSEQUE, P245; KILBOURNE EM, 1982, JAMA-J AM MED ASSOC, V247, P3332, DOI 10.1001/jama.247.24.3332; Kilbourne EM, 2002, AM J PREV MED, V22, P328, DOI 10.1016/S0749-3797(02)00412-9; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Kukkonen-Harjula K, 2006, INT J CIRCUMPOL HEAL, V65, P195, DOI 10.3402/ijch.v65i3.18102; Kwok JSS, 2005, ANN PHARMACOTHER, V39, P1940, DOI 10.1345/aph.1G130; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; Ledrans Martine, 2004, Rev Prat, V54, P1289; Leonardi G, 2006, SOZ PRAVENTIV MED, V51, P194, DOI 10.1007/s00038-006-5039-0; Linares C, 2008, EUR J PUBLIC HEALTH, V18, P317, DOI 10.1093/eurpub/ckm108; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; MACK GW, 1994, J APPL PHYSIOL, V76, P1615, DOI 10.1152/jappl.1994.76.4.1615; MARTINEZ BF, 1989, JAMA-J AM MED ASSOC, V262, P2246, DOI 10.1001/jama.262.16.2246; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Michelozzi P, 2005, Euro Surveill, V10, P161, DOI 10.2807/esm.10.07.00556-en; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Naughton MP, 2002, AM J PREV MED, V22, P221, DOI 10.1016/S0749-3797(02)00421-X; Nitschke M, 2007, MED J AUSTRALIA, V187, P662, DOI 10.5694/j.1326-5377.2007.tb01466.x; O'Brien KK, 2001, MIL MED, V166, P405, DOI 10.1093/milmed/166.5.405; O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; Pandolf KB, 1997, EXP AGING RES, V23, P69, DOI 10.1080/03610739708254027; Ren C, 2008, OCCUP ENVIRON MED, V65, P255, DOI 10.1136/oem.2007.033878; Rocklov J, 2009, EUR RESPIR J, V33, P245, DOI 10.1183/09031936.00037808; SCHUMAN SH, 1972, ENVIRON RES, V5, P59, DOI 10.1016/0013-9351(72)90020-5; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Sessler DI, 2009, CRIT CARE MED, V37, pS203, DOI 10.1097/CCM.0b013e3181aa5568; Sheridan SC, 2003, CLIM RES, V24, P255, DOI 10.3354/cr024255; Smargiassi A, 2009, J EPIDEMIOL COMMUN H, V63, P659, DOI 10.1136/jech.2008.078147; Stafoggia M, 2008, J EPIDEMIOL COMMUN H, V62, P209, DOI 10.1136/jech.2007.060715; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Stafoggia M, 2009, EPIDEMIOLOGY, V20, P575, DOI 10.1097/EDE.0b013e31819ecdf0; STEADMAN RG, 1979, J APPL METEOROL, V18, P861, DOI 10.1175/1520-0450(1979)018<0861:TAOSPI>2.0.CO;2; STEADMAN RG, 1984, J CLIM APPL METEOROL, V23, P1674, DOI 10.1175/1520-0450(1984)023<1674:AUSOAT>2.0.CO;2; Stookey JD, 1999, EUR J EPIDEMIOL, V15, P181, DOI 10.1023/A:1007559725607; Stoops J. L., 2004, POSSIBLE CONNECTION; Sumukadas D, 2009, J EPIDEMIOL COMMUN H, V63, P305, DOI 10.1136/jech.2008.080838; Toulemon L, 2008, POP STUD-J DEMOG, V62, P39, DOI 10.1080/00324720701804249; Vanakoski J, 1998, CLIN PHARMACOKINET, V34, P311, DOI 10.2165/00003088-199834040-00004; Vandentorren S, 2006, EUR J PUBLIC HEALTH, V16, P583, DOI 10.1093/eurpub/ckl063; Worfolk JB, 2000, GERIATR NURS, V21, P70, DOI 10.1067/mgn.2000.107131; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; HEATWAVE PLAN ENGLAN	90	268	275	9	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2010	375	9717					856	863		10.1016/S0140-6736(09)61711-6	http://dx.doi.org/10.1016/S0140-6736(09)61711-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570MO	20153519				2022-12-28	WOS:000275682600035
J	Hittinger, CT; Goncalves, P; Sampaio, JP; Dover, J; Johnston, M; Rokas, A				Hittinger, Chris Todd; Goncalves, Paula; Sampaio, Jose Paulo; Dover, Jim; Johnston, Mark; Rokas, Antonis			Remarkably ancient balanced polymorphisms in a multi-locus gene network	NATURE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; POPULATION GENOMICS; YEAST; SELECTION; SUBSTITUTION; EVOLUTION; DNA; KUDRIAVZEVII	Local adaptations within species are often governed by several interacting genes scattered throughout the genome. Single-locus models of selection cannot explain the maintenance of such complex variation because recombination separates co-adapted alleles. Here we report a previously unrecognized type of intraspecific multi-locus genetic variation that has been maintained over a vast period. The galactose (GAL) utilization gene network of Saccharomyces kudriavzevii, a relative of brewer's yeast, exists in two distinct states: a functional gene network in Portuguese strains and, in Japanese strains, a non-functional gene network of allelic pseudogenes. Genome sequencing of all available S. kudriavzevii strains revealed that none of the functional GAL genes were acquired from other species. Rather, these polymorphisms have been maintained for nearly the entire history of the species, despite more recent gene flow genome-wide. Experimental evidence suggests that inactivation of the GAL3 and GAL80 regulatory genes facilitated the origin and long-term maintenance of the two gene network states. This striking example of a balanced unlinked gene network polymorphism introduces a remarkable type of intraspecific variation that may be widespread.	[Hittinger, Chris Todd; Dover, Jim; Johnston, Mark] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Hittinger, Chris Todd; Dover, Jim; Johnston, Mark] Washington Univ, Sch Med, Dept Genet, Ctr Genome Sci, St Louis, MO 63108 USA; [Goncalves, Paula; Sampaio, Jose Paulo] Univ Nova Lisboa, Ctr Recursos Microbiol, Dept Ciencias Vida, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL); Universidade Nova de Lisboa; Vanderbilt University	Johnston, M (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	mark.johnston@ucdenver.edu	Gonçalves, Paula/B-4016-2010; Sampaio, Jose Paulo/C-5532-2011; Johnston, Mark/R-6156-2019; Rokas, Antonis/A-9775-2008; Johnston, Mark/K-3543-2019; Gonçalves, Paula/CAH-0730-2022	Gonçalves, Paula/0000-0003-2103-1060; Sampaio, Jose Paulo/0000-0001-8145-5274; Rokas, Antonis/0000-0002-7248-6551; Johnston, Mark/0000-0002-4932-7229; Gonçalves, Paula/0000-0003-2103-1060	James S. McDonnell Foundation; National Institutes of Health [2T32HG00045, 5R01GM032540]; Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/BIA-BDE/71734/2006]; Searle Scholars Program; National Science Foundation [DEB-0844968]; Vanderbilt University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032540] Funding Source: NIH RePORTER; Division Of Environmental Biology [0844968] Funding Source: National Science Foundation	James S. McDonnell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Searle Scholars Program; National Science Foundation(National Science Foundation (NSF)); Vanderbilt University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank E. Barrio; B. L. Williams; the Centraalbureau voor Schimmelcultures, Netherlands and the National Institute of Technology and Evaluation Biological Resource Center, Japan for providing strains; J. Fay for critical reading of the manuscript; and the Howard Hughes Medical Institute (HHMI) and S. B. Carroll for supporting preliminary experiments when C. T. H. was a HHMI Predoctoral Fellow. This work was also supported by the James S. McDonnell Foundation (C. T. H., M. J.); the National Institutes of Health (C. T. H., 2T32HG00045; M. J., 5R01GM032540); the Fundacao para a Ciencia e a Tecnologia, Portugal (P. G. and J. P. S., PTDC/BIA-BDE/71734/2006); the Searle Scholars Program (A. R.); the National Science Foundation (A. R., DEB-0844968) and Vanderbilt University (A. R.). C. T. H. is the Maclyn McCarty Fellow of the Helen Hay Whitney Foundation.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bensasson D, 2008, GENETICS, V178, P2161, DOI 10.1534/genetics.107.083980; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coyne J.A., 2004, SPECIATION; DOBZHANSKY T, 1958, P NATL ACAD SCI USA, V44, P622, DOI 10.1073/pnas.44.6.622; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MacLean RC, 2007, J EVOLUTION BIOL, V20, P1333, DOI 10.1111/j.1420-9101.2007.01351.x; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Navarro A, 2002, GENETICS, V161, P849; Neher RA, 2009, P NATL ACAD SCI USA, V106, P6866, DOI 10.1073/pnas.0812560106; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ptashne M, 2001, GENES SIGNALS; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; WRIGHT S, 1980, EVOLUTION, V34, P825, DOI 10.1111/j.1558-5646.1980.tb04022.x; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	109	112	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					54	U61		10.1038/nature08791	http://dx.doi.org/10.1038/nature08791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20164837	Green Accepted			2022-12-28	WOS:000275117500032
J	Kastor, J				Kastor, John			The Complexity That Killed Health Care Reform (Again)	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Maryland Sch Med, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore									0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9								10.1056/NEJMpv1001600	http://dx.doi.org/10.1056/NEJMpv1001600			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	20164479				2022-12-28	WOS:000275108300033
J	Pittas, AG; Chung, M; Trikalinos, T; Mitri, J; Brendel, M; Patel, K; Lichtenstein, AH; Lau, J; Balk, EM				Pittas, Anastassios G.; Chung, Mei; Trikalinos, Thomas; Mitri, Joanna; Brendel, Michael; Patel, Kamal; Lichtenstein, Alice H.; Lau, Joseph; Balk, Ethan M.			Systematic Review: Vitamin D and Cardiometabolic Outcomes	ANNALS OF INTERNAL MEDICINE			English	Review							D SUPPLEMENTATION; BLOOD-PRESSURE; DOUBLE-BLIND; CARDIOVASCULAR-DISEASE; 25-HYDROXYVITAMIN-D LEVELS; CALCIUM SUPPLEMENTATION; MYOCARDIAL-INFARCTION; D DEFICIENCY; WEIGHT-LOSS; RISK	Background: Vitamin D may modify risk for cardiometabolic outcomes (type 2 diabetes, hypertension, or cardiovascular disease). Purpose: To examine the association between vitamin D status, including the effect of vitamin D supplementation, and cardiometabolic outcomes in generally healthy adults. Data Sources: English-language studies in MEDLINE (inception to 4 November 2009) and the Cochrane Central Register of Controlled Trials (fourth quarter of 2009). Study Selection: 11 reviewers screened citations to identify longitudinal cohort studies that reported associations between vitamin D status and cardiometabolic outcomes, including randomized trials of vitamin D supplementation. Data Extraction: 5 independent reviewers extracted data about study conduct, participant characteristics, outcomes, and quality. Differences were resolved by consensus. Data Synthesis: 13 observational studies (14 cohorts) and 18 trials were eligible. Three of 6 analyses (from 4 different cohorts) reported a lower incident diabetes risk in the highest versus the lowest vitamin D status groups. Eight trials found no effect of vitamin D supplementation on glycemia or incident diabetes. In meta-analysis of 3 cohorts, lower 25-hydroxyvitamin D concentration was associated with incident hypertension (relative risk, 1.8 [95% CI, 1.3 to 2.4]). In meta-analyses of 10 trials, supplementation nonsignificantly reduced systolic blood pressure (weighted mean difference, -1.9 mm Hg [CI, -4.2 to 0.4 mm Hg]) and did not affect diastolic blood pressure (weighted mean difference, -0.1 mm Hg [CI, -0.7 to 0.5 mm Hg]). Lower 25-hydroxyvitamin D concentration was associated with incident cardiovascular disease in 5 of 7 analyses (6 cohorts). Four trials found no effect of supplementation on cardiovascular outcomes. Limitations: Studies included primarily white participants. Observational studies were heterogeneous. Several trials reported post hoc analyses. Conclusion: The association between vitamin D status and cardiometabolic outcomes is uncertain. Trials showed no clinically significant effect of vitamin D supplementation at the dosages given. Primary Funding Source: National Institute of Diabetes and Digestive and Kidney Disease, the National Institutes of Health Office of Dietary Supplements, U. S. Food and Drug Administration, Agency for Healthcare Research and Quality, and Public Health Agency of Canada.	[Balk, Ethan M.] Tufts Univ, Tufts Evidence Based Practice Ctr, Tufts Med Ctr, Boston, MA 02111 USA; Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; United States Department of Agriculture (USDA)	Balk, EM (corresponding author), Tufts Univ, Tufts Evidence Based Practice Ctr, Tufts Med Ctr, Box 63,800 Washington St, Boston, MA 02111 USA.	ebalk@tuftsmedicalcenter.org	Balk, Ethan/AAJ-2547-2020		AHRQ [HHSA 290-2007-10055-I]; National Institute of Diabetes and Digestive and Kidney Disease [R01DK76092, R01DK79003, R21DK78867]; U.S. Department of Health and Human Services; Public Health Agency of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079003, R21DK078867, R01DK076092] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Health and Human Services; Public Health Agency of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By AHRQ (contract HHSA 290-2007-10055-I), National Institutes of Health (research grants R01DK76092 and R01DK79003 from the National Institute of Diabetes and Digestive and Kidney Disease and the Office of Dietary Supplements and grant R21DK78867 from the National Institute of Diabetes and Digestive and Kidney Disease), U.S. Department of Health and Human Services, and the Public Health Agency of Canada.	*AG HEALTHC RES QU, 2009, METH REF GUID EFF CO; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Borges ACR, 1999, HYPERTENSION, V34, P897, DOI 10.1161/01.HYP.34.4.897; Borges ACR, 1999, BRIT J PHARMACOL, V127, P772, DOI 10.1038/sj.bjp.0702581; Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; FLECK A, 1989, LANCET, V1, P613; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Jacobs DR, 2003, AM J CLIN NUTR, V78, p508S, DOI 10.1093/ajcn/78.3.508S; Jorde R, 2009, EUR J NUTR, V48, P349, DOI 10.1007/s00394-009-0020-3; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Krause R, 1998, LANCET, V352, P709, DOI 10.1016/S0140-6736(05)60827-6; LaCroix AZ, 2009, J GERONTOL A-BIOL, V64, P559, DOI 10.1093/gerona/glp006; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Lichtenstein AH, 2008, J NUTR, V138, P2297, DOI 10.3945/jn.108.097154; Liu S, 2005, DIABETES CARE, V28, P2926, DOI 10.2337/diacare.28.12.2926; MACCARTHY EP, 1989, HYPERTENSION, V13, P954, DOI 10.1161/01.HYP.13.6.954; Major GC, 2007, AM J CLIN NUTR, V85, P54; Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Nemerovski CW, 2009, PHARMACOTHERAPY, V29, P691, DOI 10.1592/phco.29.6.691; NILAS L, 1984, INT J OBESITY, V8, P407; OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751; Ohsawa M, 2000, CIRCULATION, V102, P2867; Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633; Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Prentice A, 2008, AM J CLIN NUTR, V88, p500S, DOI 10.1093/ajcn/88.2.500S; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Rostand SG, 1997, HYPERTENSION, V30, P150, DOI 10.1161/01.HYP.30.2.150; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; SCRAGG R, 1995, EUR J CLIN NUTR, V49, P640; Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; VONHURST PR, 2009, BR J NUTR, P1; VOORS AW, 1979, J CHRON DIS, V32, P157, DOI 10.1016/0021-9681(79)90044-4; Wang L, 2008, HYPERTENSION, V51, P1073, DOI 10.1161/HYPERTENSIONAHA.107.107821; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	60	551	573	1	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2010	152	5					307	W101		10.7326/0003-4819-152-5-201003020-00009	http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00009			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565XJ	20194237	Green Accepted			2022-12-28	WOS:000275329600006
J	Jefferies, JL; Towbin, JA				Jefferies, John Lynn; Towbin, Jeffrey A.			Dilated cardiomyopathy	LANCET			English	Article							AMERICAN-HEART-ASSOCIATION; ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR ASSIST DEVICE; ANKYRIN REPEAT PROTEIN; CARDIAC RESYNCHRONIZATION; NATRIURETIC PEPTIDE; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOSUPPRESSIVE THERAPY; CARDIOVASCULAR-DISEASE; CYTOSKELETAL PROTEINS	Dilated cardiomyopathy is characterised by left ventricular dilation that is associated with systolic dysfunction. Diastolic dysfunction and impaired right ventricular function can develop. Affected individuals are at risk of left or right ventricular failure, or both. Heart failure symptoms can be exercise-induced or persistent at rest. Many patients are asymptomatic. Chronically treated patients sometimes present acutely with decompensated heart failure. Other life-threatening risks are ventricular arrhythmias and atrioventricular block, syncope, and sudden death. Genetic inheritance arises in 30-48% of patients, and inflammatory disorders such as myocarditis or toxic effects from medications, alcohol, or illicit drugs also result in dilated cardiomyopathy. Genes that cause dilated cardiomyopathy generally encode cytoskeletal and sarcomeric (contractile apparatus) proteins, although disturbance of calcium homeostasis also seems to be important. In children, disrupted mitochondrial function and metabolic abnormalities have a causal role. Treatments focus on improvement of cardiac efficiency and reduction of mechanical stress. Arrhythmia therapy and prevention of sudden death continue to be mainstays of treatment. Despite progress over the past 10 years, outcomes need to be improved.	[Towbin, Jeffrey A.] Cincinnati Childrens Hosp, Inst Heart, Cincinnati, OH 45229 USA; [Jefferies, John Lynn] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; Baylor College of Medicine	Towbin, JA (corresponding author), Cincinnati Childrens Hosp, Inst Heart, Cincinnati, OH 45229 USA.	jeffrey.towbin@cchmc.org	Towbin, Jeffrey A./J-5595-2019; Siu, Sam C/G-3346-2011	Towbin, Jeffrey A./0000-0002-6585-714X; Siu, Sam C/0000-0002-1104-3669				Abe T, 2001, Heart Fail Rev, V6, P195; Afonso L, 2007, AM J CARDIOL, V100, P1040, DOI 10.1016/j.amjcard.2007.04.049; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Arimura T, 2007, Acta Myol, V26, P153; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Barresi R, 2000, J MED GENET, V37, P102, DOI 10.1136/jmg.37.2.102; Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660; Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Bestetti RB, 1997, INT J CARDIOL, V60, P187, DOI 10.1016/S0167-5273(97)00083-1; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; Bowles NE, 2000, HERZ, V25, P168, DOI 10.1007/s000590050003; Bowles Neil E, 2005, Heart Fail Clin, V1, P407, DOI 10.1016/j.hfc.2005.06.011; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Caforio ALP, 2008, AUTOIMMUNITY, V41, P35, DOI 10.1080/08916930701619235; Caforio ALP, 2007, CIRCULATION, V115, P76, DOI 10.1161/CIRCULATIONAHA.106.641472; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cooper LT, 2007, J AM COLL CARDIOL, V50, P1914, DOI 10.1016/j.jacc.2007.09.008; Cooper LT, 2008, AM J CARDIOL, V102, P1535, DOI 10.1016/j.amjcard.2008.07.041; Cox GF, 1997, CURR OPIN CARDIOL, V12, P329; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; DRORY Y, 1991, AM J CARDIOL, V68, P1388, DOI 10.1016/0002-9149(91)90251-F; Duboscq-Bidot L, 2008, CARDIOVASC RES, V77, P118, DOI 10.1093/cvr/cvm015; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Ellis Christopher R, 2007, Cardiol Rev, V15, P170, DOI 10.1097/CRD.0b013e31806450c4; Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1; Frazier OH, 2001, J THORAC CARDIOV SUR, V122, P1186, DOI 10.1067/mtc.2001.118274; Friedrich MG, 2008, JACC-CARDIOVASC IMAG, V1, P652, DOI 10.1016/j.jcmg.2008.07.011; Frustaci A, 2003, CIRCULATION, V107, P857, DOI 10.1161/01.CIR.0000048147.15962.31; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Hernandez AF, 2009, J AM COLL CARDIOL, V53, P184, DOI 10.1016/j.jacc.2008.09.031; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; Hilfiker-Kleiner D, 2008, TRENDS CARDIOVAS MED, V18, P173, DOI 10.1016/j.tcm.2008.05.002; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Huang CH, 2009, BASIC RES CARDIOL, V104, P228, DOI 10.1007/s00395-008-0765-5; Hunt SA, 2005, J AM COLL CARDIOL, V46, P1; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jaakkola K, 2000, J AM COLL CARDIOL, V36, P122, DOI 10.1016/S0735-1097(00)00706-3; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Karkkainen S, 2007, ANN MED, V39, P91, DOI 10.1080/07853890601145821; Klatsky Arthur L, 2009, Expert Rev Cardiovasc Ther, V7, P499, DOI 10.1586/erc.09.22; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; KOYAMA T, 2005, J CARDIOVASC SURG, V20, P39; Kuhl U, 2003, CIRCULATION, V107, P2793, DOI 10.1161/01.CIR.0000072766.67150.51; Laonigro I, 2009, EUR J HEART FAIL, V11, P453, DOI 10.1093/eurjhf/hfp037; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; LeWinter MM, 2005, HEART FAIL REV, V10, P249, DOI 10.1007/s10741-005-5254-4; Li HS, 2008, AUTOIMMUN REV, V7, P168, DOI 10.1016/j.autrev.2007.11.010; Li Y, 2006, J IMMUNOL, V177, P8234, DOI 10.4049/jimmunol.177.11.8234; Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0; Liu J, 2009, CURR MOL MED, V9, P287, DOI 10.2174/156652409787847218; Liu W, 2006, AUTOIMMUNITY, V39, P461, DOI 10.1080/08916930600893709; Lozano M D, 1997, J Card Fail, V3, P97, DOI 10.1016/S1071-9164(97)90041-5; MacLellan WR, 2003, NAT MED, V9, P1455, DOI 10.1038/nm1203-1455; Maisch B, 2004, HERZ, V29, P624, DOI 10.1007/s00059-004-2628-7; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mann DL, 2007, ANN THORAC SURG, V84, P1226, DOI 10.1016/j.athoracsur.2007.03.095; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; McNally EM, 2007, ANNU REV PATHOL-MECH, V2, P87, DOI 10.1146/annurev.pathol.2.010506.091936; McNamara DM, 2001, CIRCULATION, V103, P2254; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Mobini R, 2003, J AUTOIMMUN, V20, P345, DOI 10.1016/S0896-8411(03)00042-8; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Mullens W, 2009, J AM COLL CARDIOL, V53, P765, DOI 10.1016/j.jacc.2008.11.024; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Murphy RT, 2004, LANCET, V363, P371, DOI 10.1016/S0140-6736(04)15468-8; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pantazis AA, 2009, CURR OPIN CARDIOL, V24, P209, DOI 10.1097/HCO.0b013e32832a11e7; Parks SB, 2008, AM HEART J, V156, P161, DOI 10.1016/j.ahj.2008.01.026; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8; Price JF, 2006, CIRCULATION, V114, P1063, DOI 10.1161/CIRCULATIONAHA.105.608869; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Redmann K, 1998, J CARDIAC SURG, V13, P453, DOI 10.1111/j.1540-8191.1998.tb01082.x; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Rodriguez-Perez JM, 2007, EXP MOL PATHOL, V82, P49, DOI 10.1016/j.yexmp.2006.10.002; ROGERS WJ, 1994, J AM COLL CARDIOL, V23, P393, DOI 10.1016/0735-1097(94)90426-X; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schofer J, 2009, CIRCULATION, V120, P326, DOI 10.1161/CIRCULATIONAHA.109.849885; Sharma MS, 2006, ANN THORAC SURG, V82, P926, DOI 10.1016/j.athoracsur.2006.02.087; Siminiak T, 2009, AM J CARDIOL, V104, P565, DOI 10.1016/j.amjcard.2009.04.021; Spencer CT, 2005, PEDIATR CARDIOL, V26, P632, DOI 10.1007/s00246-005-0873-z; Stamm Christof, 2009, Ther Adv Cardiovasc Dis, V3, P215, DOI 10.1177/1753944709336190; Sugiura T, 2005, J CARD FAIL, V11, P504, DOI 10.1016/j.cardfail.2005.04.025; Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9; Taneja V, 2007, J MOL CELL CARDIOL, V42, P1054, DOI 10.1016/j.yjmcc.2007.03.898; Taylor MRG, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-27; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; Towbin JA, 1999, PEDIATR CLIN N AM, V46, P289, DOI 10.1016/S0031-3955(05)70119-X; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Towbin JA, 2006, J CARDIOVASC ELECTR, V17, P919, DOI 10.1111/j.1540-8167.2006.00530.x; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; Tulner SA, 2007, J CARD FAIL, V13, P178, DOI 10.1016/j.cardfail.2006.11.010; van Kimmenade RRJ, 2009, J AM COLL CARDIOL, V53, P884, DOI 10.1016/j.jacc.2008.11.032; van Tintelen JP, 2007, AM HEART J, V154, P1130, DOI 10.1016/j.ahj.2007.07.038; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Vatta M, 2002, LANCET, V359, P936, DOI 10.1016/S0140-6736(02)08026-1; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Wallace KB, 2007, CARDIOVASC TOXICOL, V7, P101, DOI 10.1007/s12012-007-0008-2; WILDE AA, 2008, PACING CLIN ELECT S1, V31, P41; Wilhelmi MH, 2005, EUR J CARDIO-THORAC, V27, P122, DOI 10.1016/j.ejcts.2004.09.027; Wojnicz R, 2001, CIRCULATION, V104, P39, DOI 10.1161/01.CIR.104.1.39; Yamada S, 2008, STEM CELLS, V26, P2644, DOI 10.1634/stemcells.2008-0187; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; Zolk O, 2000, CIRCULATION, V101, P2674, DOI 10.1161/01.CIR.101.23.2674	130	364	400	5	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					752	762		10.1016/S0140-6736(09)62023-7	http://dx.doi.org/10.1016/S0140-6736(09)62023-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20189027				2022-12-28	WOS:000275211200032
J	Chakravarthy, U; Evans, J; Rosenfeld, PJ				Chakravarthy, Usha; Evans, Jennifer; Rosenfeld, Philip J.			Age related macular degeneration	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMPLEMENT C3; RISK; RANIBIZUMAB; SAFETY; ANTIOXIDANTS; THERAPY		[Chakravarthy, Usha] Inst Clin Sci, Ctr Vasc & Vis Sci, Belfast BT12 6BA, Antrim, North Ireland; [Evans, Jennifer] Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1E 7HT, England; [Rosenfeld, Philip J.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	University of London; London School of Hygiene & Tropical Medicine; Bascom Palmer Eye Institute; University of Miami	Chakravarthy, U (corresponding author), Inst Clin Sci, Ctr Vasc & Vis Sci, Belfast BT12 6BA, Antrim, North Ireland.	u.chakravarthy@qub.ac.uk	Evans, Jennifer/F-4672-2012	Evans, Jennifer/0000-0002-6137-2030; Chakravarthy, Usha/0000-0002-2606-3734				Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; [Anonymous], 2005, ARCH OPHTHALMOL-CHIC, V123, P1570, DOI DOI 10.1001/ARCHOPHT.123.11.1570; Avila MP, 2009, RETINA-J RET VIT DIS, V29, P157, DOI 10.1097/IAE.0b013e3181985915; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; CHAKRAVARTHY U, 2007, BRIT MED J, V10, P269; ELDEM B, 2009, RET C SCI ABSTR; Emerich DF, 2008, CURR OPIN MOL THER, V10, P506; ERFURTH US, 2009, RET C SCI ABSTR; Fletcher AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1396, DOI 10.1001/archopht.126.10.1396; Fung AE, 2006, BRIT J OPHTHALMOL, V90, P1344, DOI 10.1136/bjo.2006.099598; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Hughes AE, 2007, PLOS MED, V4, P1993, DOI 10.1371/journal.pmed.0040355; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Landa G, 2008, CURR EYE RES, V33, P1011, DOI 10.1080/02713680802484637; *NAT I HLTH CLIN E, 2008, PEG RAN TREATM AG RE; Nguyen QD, 2009, OPHTHALMOLOGY, V116, P2141, DOI 10.1016/j.ophtha.2009.04.030; Owen CG, 2003, BRIT J OPHTHALMOL, V87, P312, DOI 10.1136/bjo.87.3.312; Parisi V, 2008, OPHTHALMOLOGY, V115, P324, DOI 10.1016/j.ophtha.2007.05.029; Rich RM, 2006, RETINA-J RET VIT DIS, V26, P495, DOI 10.1097/01.iae.0000225766.75009.3a; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Royal College of Ophthalmologists, 2009, AG REL MAC DEG GUID; Satia JA, 2009, AM J EPIDEMIOL, V169, P815, DOI 10.1093/aje/kwn409; Schnatbaum K, 2006, BIOORG MED CHEM LETT, V16, P5088, DOI 10.1016/j.bmcl.2006.07.036; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Virgili G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004763.pub2; Witkin AJ, 2009, OPHTHALMOLOGY, V116, P956, DOI 10.1016/j.ophtha.2008.12.018; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Woo JH, 2009, ACTA OPHTHALMOL, V87, P262, DOI 10.1111/j.1755-3768.2008.01376.x; Wormald R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002030.pub3; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zhou J, 2008, J NEUROCHEM, V106, P2080, DOI 10.1111/j.1471-4159.2008.05558.x	35	53	56	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2010	340								c981	10.1136/bmj.c981	http://dx.doi.org/10.1136/bmj.c981			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TI	20189972	Green Accepted			2022-12-28	WOS:000275001400011
J	Godlee, F; Chalmers, I				Godlee, Fiona; Chalmers, Iain			Publishing information about ongoing clinical trials for patients	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chalmers, Iain] James Lind Initiat, Oxford OX2 7LG, England			fgodlee@bmj.com						CAMPBELL M, 2002, SCOPING STUDY EXPLOR; *CANC RES UK, CANCERHELP UK TRIALS; *DEP HLTH, 2008, 60 YEARS NHS RES; Department of Health, 2005, RES GOV FRAM HLTH SO; Ghersi D, 2008, LANCET, V372, P1531, DOI 10.1016/S0140-6736(08)61635-9; HANLEY B, 2004, DEV WEBSITE CLIN TRI; Jenkins V, 2000, BRIT J CANCER, V82, P1783, DOI 10.1054/bjoc.2000.1142; Jenkinson C, 2005, HEALTH EXPECT, V8, P244, DOI 10.1111/j.1369-7625.2005.00335.x; *NAT RES ETH SERV, 2008, RES SUMM REG; Staley K., 2009, EXPLORING IMPACT PUB; UK Clinical Research Collaboration, 2005, CLIN RES UK SINGL SY; World Medical Association, 2008, DECL HELS ETH PRINC; 2001, BBC RADIO       0828, V4	13	14	14	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2010	340								c725	10.1136/bmj.c725	http://dx.doi.org/10.1136/bmj.c725			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TG	20181639				2022-12-28	WOS:000275001200015
J	Logue, J; Thompson, L; Romanes, F; Wilson, DC; Thompson, J; Sattar, N				Logue, Jennifer; Thompson, Lorna; Romanes, Finn; Wilson, David C.; Thompson, Joyce; Sattar, Naveed		Guideline Dev Grp	Management of obesity: summary of SIGN guideline	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-PROFESSIONALS; ATTITUDES		[Logue, Jennifer; Sattar, Naveed] Univ Glasgow, Fac Med, Div Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Thompson, Lorna] SIGN, Edinburgh EH7 5EA, Midlothian, Scotland; [Romanes, Finn; Thompson, Joyce] NHS Tayside, Directorate Publ Hlth, Dundee DD3 8EA, Scotland; [Wilson, David C.] Univ Edinburgh, Edinburgh EH9 1UW, Midlothian, Scotland	University of Glasgow; University of Dundee; University of Edinburgh	Logue, J (corresponding author), Univ Glasgow, Fac Med, Div Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland.	j.logue@clinmed.gla.ac.uk	Logue, Jennifer/O-5076-2019	Logue, Jennifer/0000-0001-9549-2738				Cleator J, 2002, INT J OBESITY, V26, P581, DOI 10.1038/sj.ijo.0801945; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Fervers B, 2006, INT J QUAL HEALTH C, V18, P167, DOI 10.1093/intqhc/mzi108; Government Office of Science, 2008, FOR TACKL OB FUT CHO; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hankey CR, 2004, PUBLIC HEALTH NUTR, V7, P337, DOI 10.1079/PHN2003526; Leslie WS, 2005, J EVAL CLIN PRACT, V11, P462, DOI 10.1111/j.1365-2753.2005.00552.x; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Schwartz MB, 2003, OBES RES, V11, P1033, DOI 10.1038/oby.2003.142; *SCOTT GOV, 2008, SCOTT HLTH SURV; Scottish Intercollegiate Guidelines Network (SIGN), 2010, MAN OB; Story MT, 2002, PEDIATRICS, V110, P210; Walker A., 2003, COST DOING NOTHING E; World Health Organization, 2000, WHO TECHN REP SER, V894	15	54	55	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2010	340								c154	10.1136/bmj.c154	http://dx.doi.org/10.1136/bmj.c154			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TG	20181637				2022-12-28	WOS:000275001200012
J	Kirkham, JJ; Dwan, KM; Altman, DG; Gamble, C; Dodd, S; Smyth, R; Williamson, PR				Kirkham, Jamie J.; Dwan, Kerry M.; Altman, Douglas G.; Gamble, Carrol; Dodd, Susanna; Smyth, Rebecca; Williamson, Paula R.			The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PUBLICATION BIAS; CLINICAL-TRIALS	Objective To examine the prevalence of outcome reporting bias-the selection for publication of a subset of the original recorded outcome variables on the basis of the results-and its impact on Cochrane reviews. Design A nine point classification system for missing outcome data in randomised trials was developed and applied to the trials assessed in a large, unselected cohort of Cochrane systematic reviews. Researchers who conducted the trials were contacted and the reason sought for the non-reporting of data. A sensitivity analysis was undertaken to assess the impact of outcome reporting bias on reviews that included a single meta-analysis of the review primary outcome. Results More than half (157/283 (55%)) the reviews did not include full data for the review primary outcome of interest from all eligible trials. The median amount of review outcome data missing for any reason was 10%, whereas 50% or more of the potential data were missing in 70 (25%) reviews. It was clear from the publications for 155 (6%) of the 2486 assessable trials that the researchers had measured and analysed the review primary outcome but did not report or only partially reported the results. For reports that did not mention the review primary outcome, our classification regarding the presence of outcome reporting bias was shown to have a sensitivity of 88% (95% CI 65% to 100%) and specificity of 80% (95% CI 69% to 90%) on the basis of responses from 62 trialists. A third of Cochrane reviews (96/283 (34%)) contained at least one trial with high suspicion of outcome reporting bias for the review primary outcome. In a sensitivity analysis undertaken for 81 reviews with a single meta-analysis of the primary outcome of interest, the treatment effect estimate was reduced by 20% or more in 19 (23%). Of the 42 meta-analyses with a statistically significant result only, eight (19%) became nonsignificant after adjustment for outcome reporting bias and 11 (26%) would have overestimated the treatment effect by 20% or more. Conclusions Outcome reporting bias is an under-recognised problem that affects the conclusions in a substantial proportion of Cochrane reviews. Individuals conducting systematic reviews need to address explicitly the issue of missing outcome data for their review to be considered a reliable source of evidence. Extra care is required during data extraction, reviewers should identify when a trial reports that an outcome was measured but no results were reported or events observed, and contact with trialists should be encouraged.	[Kirkham, Jamie J.; Dwan, Kerry M.; Gamble, Carrol; Dodd, Susanna; Williamson, Paula R.] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3GS, Merseyside, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England; [Smyth, Rebecca] Univ Liverpool, Liverpool L69 3GB, Merseyside, England	University of Liverpool; University of Oxford; University of Liverpool	Williamson, PR (corresponding author), Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3GS, Merseyside, England.	prw@liv.ac.uk	Williamson, Paula R/B-6425-2016; Smyth, Rebecca MD/P-5124-2014; Kirkham, Jamie/AAD-4490-2019; Dwan, Kerry/AFK-6469-2022; Dwan, Kerry/AAG-4726-2022; Altman, Douglas G/A-9714-2012; Gamble, Carrol/AAE-9895-2019	Williamson, Paula R/0000-0001-9802-6636; Smyth, Rebecca MD/0000-0002-2108-1503; Kirkham, Jamie/0000-0003-2579-9325; Dwan, Kerry/0000-0001-6918-1215; Dwan, Kerry/0000-0001-6918-1215; Gamble, Carrol/0000-0002-3021-1955	Medical Research Council [G0500952]; MRC [G0500952, G0800792] Funding Source: UKRI; Medical Research Council [G0800792] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Outcome Reporting Bias In Trials (ORBIT) project was funded by the Medical Research Council (grant number G0500952). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Alderson P., 2004, COCHRANE DB SYST REV, P18, DOI [10.1002/14651858.CD001208.pub2, DOI 10.1002/14651858.CD001208.PUB2]; Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Clarke M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004002.pub2; CLARKE M, 2008, PLOS MED, V5, pE120; Copas J, 2004, BIOMETRICS, V60, P146, DOI 10.1111/j.0006-341X.2004.00161.x; Dwan K, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-66; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Egger M., 2008, SYSTEMATIC REV HLTH, V2nd, DOI DOI 10.1002/9780470693926.CH12; Furukawa TA, 2007, JAMA-J AM MED ASSOC, V297, P468, DOI 10.1001/jama.297.5.468-b; Ghersi D, 2008, B WORLD HEALTH ORGAN, V86, P492, DOI 10.2471/BLT.08.053769; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; *WHO, 2005, WHO INT CLIN TRIALS; Williamson PR, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-9; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025	21	520	529	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2010	340								c365	10.1136/bmj.c365	http://dx.doi.org/10.1136/bmj.c365			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JR	20156912	Green Submitted, Bronze			2022-12-28	WOS:000274738600003
J	Sundar, S; Chakravarty, J; Agarwal, D; Rai, M; Murray, HW				Sundar, Shyam; Chakravarty, Jaya; Agarwal, Dipti; Rai, Madhukar; Murray, Henry W.			Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL MILTEFOSINE; KALA-AZAR; MULTICENTER; INFUSIONS; AMBISOME; TRIAL	BACKGROUND Some 50% of patients with visceral leishmaniasis (kala-azar) worldwide live in the Indian state of Bihar. Liposomal amphotericin B is an effective treatment when administered in short courses. We wanted to determine whether the efficacy of a single infusion of liposomal amphotericin B was inferior to conventional parenteral therapy, consisting of 15 alternate-day infusions of amphotericin B deoxycholate. METHODS In this open-label study, we randomly assigned 412 patients in a 3: 1 ratio to receive either liposomal amphotericin B (liposomal-therapy group) or amphotericin B deoxycholate (conventional-therapy group). Liposomal amphotericin B (at a dose of 10 mg per kilogram of body weight) was given once, and patients were discharged home 24 hours later. Amphotericin B deoxycholate, which was administered in 15 infusions of 1 mg per kilogram, was given every other day during a 29-day hospitalization. We determined the cure rate 6 months after treatment. RESULTS A total of 410 patients-304 of 304 patients (100%) in the liposomal-therapy group and 106 of 108 patients (98%) in the conventional-therapy group-had apparent cure responses at day 30. Cure rates at 6 months were similar in the two groups: 95.7% (95% confidence interval [CI], 93.4 to 97.9) in the liposomal-therapy group and 96.3% (95% CI, 92.6 to 99.9) in the conventional-therapy group. Adverse events in the liposomal-therapy group were infusion-related fever or rigors (in 40%) and increased anemia or thrombocytopenia (in 2%); such events in the conventional-therapy group were fever or rigors (in 64%), increased anemia (in 19%), and hypokalemia (in 2%). Nephrotoxicity or hepatotoxicity developed in no more than 1% of patients in each group. CONCLUSIONS A single infusion of liposomal amphotericin B was not inferior to and was less expensive than conventional therapy with amphotericin B deoxycholate. (ClinicalTrials.gov number, NCT00628719.)	[Sundar, Shyam; Chakravarty, Jaya; Agarwal, Dipti; Rai, Madhukar] Banaras Hindu Univ, Inst Med Sci, Dept Med, Kala Azar Med Res Ctr, Varanasi 221005, Uttar Pradesh, India; [Murray, Henry W.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Banaras Hindu University (BHU); Cornell University	Sundar, S (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Med, Kala Azar Med Res Ctr, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com			Sitaram Memorial Trust; Varanasi Physicians Research and Education Foundation	Sitaram Memorial Trust; Varanasi Physicians Research and Education Foundation	Supported by the Sitaram Memorial Trust and the Varanasi Physicians Research and Education Foundation.	Adler-Moore Jill, 2003, Curr Opin Investig Drugs, V4, P179; Berman J, 2009, AM J TROP MED HYG, V80, P689, DOI 10.4269/ajtmh.2009.80.689; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Murray H. W., 2004, EXPERT REV ANTI-INFE, V2, P462; Murray Henry W, 2004, Expert Rev Anti Infect Ther, V2, P279, DOI 10.1586/14787210.2.2.279; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; National Cancer Institute, 2006, COMM TERM CRIT ADV E; Olliaro P, 2009, TROP MED INT HEALTH, V14, P918, DOI 10.1111/j.1365-3156.2009.02306.x; Sundar S, 2005, B WORLD HEALTH ORGAN, V83, P394; Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971; Sundar S, 2003, CLIN INFECT DIS, V37, P800, DOI 10.1086/377542; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2002, AM J TROP MED HYG, V66, P143, DOI 10.4269/ajtmh.2002.66.143; Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419; SUNDAR S, 1994, BRIT MED J, V308, P307, DOI 10.1136/bmj.308.6924.307; Sundar S, 2008, CLIN INFECT DIS, V47, P1000, DOI 10.1086/591972; Sundar S, 2007, CLIN INFECT DIS, V45, P556, DOI 10.1086/520665; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Syriopoulou V, 2003, CLIN INFECT DIS, V36, P560, DOI 10.1086/367843; Thakur CP, 2001, INT J ANTIMICROB AG, V17, P67, DOI 10.1016/S0924-8579(00)00312-5; Walsh TJ, 2001, ANTIMICROB AGENTS CH, V45, P3487, DOI 10.1128/AAC.45.12.3487-3496.2001	22	273	279	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					504	512		10.1056/NEJMoa0903627	http://dx.doi.org/10.1056/NEJMoa0903627			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147716	Bronze			2022-12-28	WOS:000274397200007
J	Edwards, AD; Brocklehurst, P; Gunn, AJ; Halliday, H; Juszczak, E; Levene, M; Strohm, B; Thoresen, M; Whitelaw, A; Azzopardi, D				Edwards, A. David; Brocklehurst, Peter; Gunn, Alistair J.; Halliday, Henry; Juszczak, Edmund; Levene, Malcolm; Strohm, Brenda; Thoresen, Marianne; Whitelaw, Andrew; Azzopardi, Denis			Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHOLE-BODY HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; THERAPEUTIC HYPOTHERMIA; NEUROPROTECTIVE THERAPY; MILD HYPOTHERMIA; NEWBORN-INFANTS; TERM INFANTS; ASPHYXIA; SAFETY; BIRTH	Objective To determine whether moderate hypothermia after hypoxic-ischaemic encephalopathy in neonates improves survival and neurological outcome at 18 months of age. Design A meta-analysis was performed using a fixed effect model. Risk ratios, risk difference, and number needed to treat, plus 95% confidence intervals, were measured. Data sources Studies were identified from the Cochrane central register of controlled trials, the Oxford database of perinatal trials, PubMed, previous reviews, and abstracts. Review methods Reports that compared whole body cooling or selective head cooling with normal care in neonates with hypoxic-ischaemic encephalopathy and that included data on death or disability and on specific neurological outcomes of interest to patients and clinicians were selected. Results We found three trials, encompassing 767 infants, that included information on death and major neurodevelopmental disability after at least 18 months' follow-up. We also identified seven other trials with mortality information but no appropriate neurodevelopmental data. Therapeutic hypothermia significantly reduced the combined rate of death and severe disability in the three trials with 18 month outcomes ( risk ratio 0.81, 95% confidence interval 0.71 to 0.93, P=0.002; risk difference -0.11, 95% CI -0.18 to -0.04), with a number needed to treat of nine ( 95% CI 5 to 25). Hypothermia increased survival with normal neurological function ( risk ratio 1.53,95% CI 1.22 to 1.93, P<0.001; risk difference 0.12, 95% CI 0.06 to 0.18), with a number needed to treat of eight ( 95% CI 5 to 17), and in survivors reduced the rates of severe disability (P=0.006), cerebral palsy (P=0.004), and mental and the psychomotor developmental index of less than 70 (P=0.01 and P=0.02, respectively). No significant interaction between severity of encephalopathy and treatment effect was detected. Mortality was significantly reduced when we assessed all 10 trials (1320 infants; relative risk 0.78, 95% CI 0.66 to 0.93, P=0.005; risk difference -0.07, 95% CI -0.12 to -0.02), with a number needed to treat of 14 ( 95% CI 8 to 47). Conclusions In infants with hypoxic-ischaemic encephalopathy, moderate hypothermia is associated with a consistent reduction in death and neurological impairment at 18 months.	[Edwards, A. David; Azzopardi, Denis] Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, London SW7 2AZ, England; [Edwards, A. David; Azzopardi, Denis] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, MRC, London W12 0NN, England; [Brocklehurst, Peter; Juszczak, Edmund; Strohm, Brenda] Univ Oxford, Dept Publ Hlth, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Gunn, Alistair J.] Univ Auckland, Sch Med Sci, Dept Physiol, Auckland 1142, New Zealand; [Halliday, Henry] Royal Matern Hosp, Royal Jubilee Matern Serv, Belfast BT12 6BA, Antrim, North Ireland; [Halliday, Henry] Queens Univ Belfast, Dept Child Hlth, Belfast BT12 6BL, Antrim, North Ireland; [Levene, Malcolm] Univ Leeds, Leeds LS1 3BR, W Yorkshire, England; [Levene, Malcolm] Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; [Thoresen, Marianne; Whitelaw, Andrew] Univ Bristol, St Michaels Hosp, Fac Med & Dent, Dept Clin Sci S Bristol, Bristol BS2 8EG, Avon, England	Imperial College London; Imperial College London; University of Oxford; University of Auckland; Queens University Belfast; University of Leeds; Leeds General Infirmary; University of Leeds; University of Bristol	Azzopardi, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, London SW7 2AZ, England.	d.azzopardi@imperial.ac.uk	Brocklehurst, Peter/B-5804-2011; Edwards, Anthony/HCI-9626-2022	Halliday, Henry/0000-0001-7978-4992; Edwards, Anthony David/0000-0003-4801-7066; Gunn, Alistair/0000-0003-0656-7035	Health Research Council of New Zealand; MRC [G0100126, MC_U120081323, G0200270] Funding Source: UKRI; Medical Research Council [MC_U120081323, G0200270, G0100126] Funding Source: researchfish	Health Research Council of New Zealand(Health Research Council of New Zealand); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AJG was supported by the Health Research Council of New Zealand. Imperial College London (ADE and DA) and University of Oxford (PB, EJ, and BS) are Comprehensive Biomedical Research Centres.	Akisu M, 2003, PROSTAG LEUKOTR ESS, V69, P45, DOI 10.1016/S0952-3278(03)00055-3; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; BARKS J, 2005, NEONATAL HYPOTHERMIA; Barnett AL, 2004, ARCH DIS CHILD, V89, P637, DOI 10.1136/adc.2002.019349; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Bayley N, 1993, BAYLEY SCALES INFANT; Blackmon LR, 2006, PEDIATRICS, V117, P942, DOI 10.1542/peds.2005-2950; *COCHR NEON REV GR, 2009, GUID REV ED; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Gunn AJ, 2008, PEDIATRICS, V121, P648, DOI 10.1542/peds.2007-3310; Higgins RD, 2006, J PEDIATR-US, V148, P170, DOI 10.1016/j.jpeds.2005.12.009; Hoehn T, 2008, RESUSCITATION, V78, P7, DOI 10.1016/j.resuscitation.2008.04.027; JACOBS SE, 2008, P HOT TOP NEON C WAS; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kirpalani H, 2007, PEDIATRICS, V120, P1126, DOI 10.1542/peds.2006-2776; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Shah PS, 2007, ARCH PEDIAT ADOL MED, V161, P951, DOI 10.1001/archpedi.161.10.951; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2008, PEDIATRICS, V122, pE791, DOI 10.1542/peds.2008-0456; SIMBRUNER G, 2008, P HOT TOP NEON C WAS; Wyatt JS, 2007, PEDIATRICS, V119, P912, DOI 10.1542/peds.2006-2839; Zhou Wen-hao, 2003, Zhonghua Er Ke Za Zhi, V41, P460	29	618	645	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2010	340								c363	10.1136/bmj.c363	http://dx.doi.org/10.1136/bmj.c363			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZS	20144981	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000274476800002
J	Bakris, GL; Sarafidis, PA; Weir, MR; Dahlof, B; Pitt, B; Jamerson, K; Velazquez, EJ; Staikos-Byrne, L; Kelly, RY; Shi, V; Chiang, YT; Weber, MA				Bakris, George L.; Sarafidis, Pantelis A.; Weir, Matthew R.; Dahlof, Bjorn; Pitt, Bertram; Jamerson, Kenneth; Velazquez, Eric J.; Staikos-Byrne, Linda; Kelly, Roxzana Y.; Shi, Victor; Chiang, Yann-Tong; Weber, Michael A.		ACCOMPLISH Trial Investigators	Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial	LANCET			English	Article							CONVERTING-ENZYME-INHIBITOR; DIABETIC-NEPHROPATHY; NITRIC-OXIDE; PROGRESSION; BENAZEPRIL; AMLODIPINE; ALBUMINURIA; MORTALITY; DISEASE	Background The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing cardiovascular morbidity and mortality. We assessed the effects of these drug combinations on progression of chronic kidney disease. Methods ACCOMPLISH was a double-blind, randomised trial undertaken in five countries (USA, Sweden, Norway, Denmark, and Finland). 11506 patients with hypertension who were at high risk for cardiovascular events were randomly assigned via a central, telephone-based interactive voice response system in a 1:1 ratio to receive benazepril (20 mg) plus amlodipine (5 mg; n=5744) or benazepril (20 mg) plus hydrochlorothiazide (12.5 mg; n=5762), orally once daily. Drug doses were force-titrated for patients to attain recommended blood pressure goals. Progression of chronic kidney disease, a prespecified endpoint, was defined as doubling of serum creatinine concentration or end-stage renal disease (estimated glomerular filtration rate <15 mL/min/1.73 m(2) or need for dialysis). Analysis was by intention to treat (ITT). This trial is registered with ClinicalTrials.gov, number NCT00170950. Findings The trial was terminated early (mean follow-up 2.9 years [SD 0.4]) because of superior efficacy of benazepril plus amlodipine compared with benazepril plus hydrochlorothiazide. At trial completion, vital status was not known for 143 (1%) patients who were lost to follow-up (benazepril plus amlodipine, n=70; benazepril plus hydrochlorothiazide, n=73). All randomised patients were included in the ITT analysis. There were 113 (2.0%) events of chronic kidney disease progression in the benazepril plus amlodipine group compared with 215 (3.7%) in the benazepril plus hydrochlorothiazide group (HR 0.52,0.41-0.65, p<0.0001). The most frequent adverse event in patients with chronic kidney disease was peripheral oedema (benazepril plus amlodipine, 189 of 561, 33.7%; benazepril plus hydrochlorothiazide, 85 of 532,16.0%). In patients with chronic kidney disease, angio-oedema was more frequent in the benazepril plus amlodipine group than in the benazepril plus hydrochlorothiazide group. In patients without chronic kidney disease, dizziness, hypokalaemia, and hypotension were more frequent in the benazepril plus hydrochlorothiazide group than in the benazepril plus amlodipine group. Interpretation Initial antihypertensive treatment with benazepril plus amlodipine should be considered in preference to benazepril plus hydrochlorothiazide since it slows progression of nephropathy to a greater extent.	[Bakris, George L.] Univ Chicago, Pritzker Sch Med, Dept Med, Hypertens Dis Unit, Chicago, IL 60637 USA; [Sarafidis, Pantelis A.] Aristotle Univ Thessaloniki, AHEPA Hosp, Dept Med 1, Sect Nephrol & Hypertens, GR-54006 Thessaloniki, Greece; [Weir, Matthew R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Dahlof, Bjorn] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Pitt, Bertram; Jamerson, Kenneth] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Velazquez, Eric J.] Duke Univ, Sch Med, Durham, NC USA; [Staikos-Byrne, Linda; Kelly, Roxzana Y.; Shi, Victor; Chiang, Yann-Tong] Novartis Pharmaceut, E Hanover, NJ USA; [Weber, Michael A.] SUNY Downstate Med Coll, Brooklyn, NY USA	University of Chicago; Aristotle University of Thessaloniki; Ahepa University Hospital; University System of Maryland; University of Maryland Baltimore; Sahlgrenska University Hospital; University of Michigan System; University of Michigan; Duke University; Novartis; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Bakris, GL (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Med, Hypertens Dis Unit, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	gbakris@gmail.com	Sarafidis, Pantelis/AFO-2131-2022; Weir, Matthew R/ABC-3654-2021	Sarafidis, Pantelis/0000-0002-9174-4018; Weir, Matthew R/0000-0001-8820-5702; Palomaki, Ari/0000-0001-9759-4332	Novartis; Diachi-Sankyo; Merck; Boeringher Ingelheim	Novartis(Novartis); Diachi-Sankyo; Merck(Merck & Company); Boeringher Ingelheim	Authors have received research grants or consulting or lecture fees from Novartis (GLB, MRW, MAW, BD, BP, KJ, and Ely), Diachi-Sankyo (GLB, MRW, MAW, KJ), Merck (GLB. MRW, MAW, BD), and Boeringher Ingelheim (GLB. MRW. MAW), all companies that manufacture combination products involving angiotensin-receptor blockers with either annlodipine or hydrochlorothiazide. LSB, RYK, VS, and YTC are employees of Novartis.	Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Bakris GL, 2008, KIDNEY INT, V73, P1303, DOI 10.1038/ki.2008.102; Bakris GL, 2005, HYPERTENSION, V46, P1309, DOI 10.1161/01.HYP.0000190585.54734.48; Bakris GL, 2003, ARCH INTERN MED, V163, P1555, DOI 10.1001/archinte.163.13.1555; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Busby Douglas E, 2004, J Clin Hypertens (Greenwich), V6, P8, DOI 10.1111/j.1524-6175.2004.04237.x; CAMPINSFALCO P, 1989, ANALYST, V114, P603, DOI 10.1039/an9891400603; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Duka I, 2008, CURR OPIN NEPHROL HY, V17, P457, DOI 10.1097/MNH.0b013e328309a497; Estacio RO, 2000, DIABETES CARE, V23, pB54; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Jamerson KA, 2004, AM J HYPERTENS, V17, P793, DOI 10.1016/j.amjhyper.2004.05.004; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Jerums G, 2008, AM J NEPHROL, V28, P614, DOI 10.1159/000117461; Khosla N, 2006, CLIN J AM SOC NEPHRO, V1, P229, DOI 10.2215/CJN.00840805; LAGAKOS SW, 1984, BIOMETRICS, V40, P1037, DOI 10.2307/2531154; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Mishra SI, 2005, CURR HYPERTENS REP, V7, P385, DOI 10.1007/s11906-005-0076-2; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Sarafidis PA, 2007, AM J KIDNEY DIS, V49, P12, DOI 10.1053/j.ajkd.2006.10.014; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Siragy HM, 2006, J CARDIOVASC PHARM, V47, P636, DOI 10.1097/01.fjc.0000211750.01326.b3; So WY, 2006, DIABETES CARE, V29, P2046, DOI 10.2337/dc06-0248; Strippoli GFM, 2004, BMJ-BRIT MED J, V329, P828, DOI 10.1136/bmj.38237.585000.7C; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zhang XP, 1998, CIRCULATION, V97, P576	32	353	387	1	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1173	1181		10.1016/S0140-6736(09)62100-0	http://dx.doi.org/10.1016/S0140-6736(09)62100-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20170948				2022-12-28	WOS:000276858200029
J	Summerskill, W				Summerskill, William			Paper of the year 2009: results	LANCET			English	Editorial Material							ECHOCARDIOGRAPHY; EXERCISE		The Lancet, London NW1 7BY, England		Summerskill, W (corresponding author), The Lancet, London NW1 7BY, England.							Bouzas-Mosquera A, 2009, J AM COLL CARDIOL, V53, P1981, DOI 10.1016/j.jacc.2009.01.067; Flachskampf FA, 2009, J AM COLL CARDIOL, V53, P1991, DOI 10.1016/j.jacc.2009.02.033; MOSQUERA AB, 2008, PREDICTION MORTALITY; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Phillips A, 2010, LANCET, V375, P96, DOI 10.1016/S0140-6736(09)62103-6; Summerskill W, 2010, LANCET, V375, P359, DOI 10.1016/S0140-6736(10)60109-2	6	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					622	623		10.1016/S0140-6736(10)60246-2	http://dx.doi.org/10.1016/S0140-6736(10)60246-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JT	20171386				2022-12-28	WOS:000275210900010
J	Xu, H; Zuend, SJ; Woll, MG; Tao, Y; Jacobsen, EN				Xu, Hao; Zuend, Stephan J.; Woll, Matthew G.; Tao, Ye; Jacobsen, Eric N.			Asymmetric Cooperative Catalysis of Strong Bronsted Acid-Promoted Reactions Using Chiral Ureas	SCIENCE			English	Article							DIELS-ALDER REACTIONS; LEWIS-ACID	Cationic organic intermediates participate in a wide variety of useful synthetic transformations, but their high reactivity can render selectivity in competing pathways difficult to control. Here, we describe a strategy for inducing enantioselectivity in reactions of protio-iminium ions, wherein a chiral catalyst interacts with the highly reactive intermediate through a network of noncovalent interactions. This interaction leads to an attenuation of the reactivity of the iminium ion and allows high enantioselectivity in cycloadditions with electron-rich alkenes (the Povarov reaction). A detailed experimental and computational analysis of this catalyst system has revealed the precise nature of the catalyst-substrate interactions and the likely basis for enantioinduction.	[Xu, Hao; Zuend, Stephan J.; Woll, Matthew G.; Tao, Ye; Jacobsen, Eric N.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jacobsen@chemistry.harvard.edu		Tao, Ye/0000-0002-6846-5109	NIH [GM-43214, P50 GM-69721]; Dreyfus Foundation; American Chemical Society; Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043214, P50GM069721, R01GM043214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dreyfus Foundation; American Chemical Society(American Chemical Society); Roche(Roche Holding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (grants GM-43214 and P50 GM-69721) and by fellowship support from the Dreyfus Foundation (to H. X.), the American Chemical Society and Roche (to S.J.Z.), and the American Chemical Society through the Irving S. Sigal Postdoctoral Fellowship (to M. G. W.). We thank L. P. C. Nielsen for helpful discussions. Metrical parameters for a derivative of compound 4a<INF>exo</INF> are available free of charge from the Cambridge Crystallographic Data Centre.	Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Akiyama T, 2006, J AM CHEM SOC, V128, P13070, DOI 10.1021/ja064676r; Batey RA, 1999, CHEM COMMUN, P651, DOI 10.1039/a809614g; Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Elia GR, 1996, CAN J CHEM, V74, P591, DOI 10.1139/v96-063; Frisch M.J., 2016, GAUSSIAN16 REV B01; GONZALEZ J, 1992, J ORG CHEM, V57, P3031, DOI 10.1021/jo00037a016; Hatano M, 2008, J AM CHEM SOC, V130, P16858, DOI 10.1021/ja806875c; Isaacs N., 1995, PHYSICAL ORGANIC CHE, P296; ISHIHARA K, 1994, J AM CHEM SOC, V116, P11179, DOI 10.1021/ja00103a052; Ishitani H, 1996, TETRAHEDRON LETT, V37, P7357, DOI 10.1016/0040-4039(96)01655-3; KELLY TR, 1994, J AM CHEM SOC, V116, P7072, DOI 10.1021/ja00095a009; Klausen RS, 2009, ORG LETT, V11, P887, DOI 10.1021/ol802887h; Kouznetsov VV, 2009, TETRAHEDRON, V65, P2721, DOI 10.1016/j.tet.2008.12.059; LEESON PD, 1992, J MED CHEM, V35, P1954, DOI 10.1021/jm00089a004; Liu H, 2009, J AM CHEM SOC, V131, P4598, DOI 10.1021/ja900806q; Mayr H, 1997, J AM CHEM SOC, V119, P12727, DOI 10.1021/ja972860u; Nakashima D, 2006, J AM CHEM SOC, V128, P9626, DOI 10.1021/ja062508t; Raheem IT, 2007, J AM CHEM SOC, V129, P13404, DOI 10.1021/ja076179w; Schreiner PR, 2002, ORG LETT, V4, P217, DOI 10.1021/ol017117s; SEEBACH D, 1975, ANGEW CHEM INT EDIT, V14, P634, DOI 10.1002/anie.197506342; Sessler JL, 2006, MONOGR SUPRAMOL CHEM, P1, DOI 10.1039/9781847552471; Takamura M, 2001, J AM CHEM SOC, V123, P6801, DOI 10.1021/ja010654n; Tan KL, 2007, ANGEW CHEM INT EDIT, V46, P1315, DOI 10.1002/anie.200603354; Uraguchi D, 2004, J AM CHEM SOC, V126, P11804, DOI 10.1021/ja046185h; Vachal P, 2002, J AM CHEM SOC, V124, P10012, DOI 10.1021/ja027246j; Weil T, 2008, ORG LETT, V10, P1513, DOI 10.1021/ol800149y; WITHERUP KM, 1995, J AM CHEM SOC, V117, P6682, DOI 10.1021/ja00130a005; Xia CF, 2002, TETRAHEDRON LETT, V43, P9405, DOI 10.1016/S0040-4039(02)02331-6; Yamamoto H, 2005, ANGEW CHEM INT EDIT, V44, P1924, DOI 10.1002/anie.200460394	32	396	399	6	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					986	990		10.1126/science.1182826	http://dx.doi.org/10.1126/science.1182826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	556XE	20167783	Green Accepted			2022-12-28	WOS:000274625800037
J	Huppa, JB; Axmann, M; Mortelmaier, MA; Lillemeier, BF; Newell, EW; Brameshuber, M; Klein, LO; Schutz, GJ; Davis, MM				Huppa, Johannes B.; Axmann, Markus; Moertelmaier, Manuel A.; Lillemeier, Bjoern F.; Newell, Evan W.; Brameshuber, Mario; Klein, Lawrence O.; Schuetz, Gerhard J.; Davis, Mark M.			TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity	NATURE			English	Article							T-CELL-RECEPTOR; 2-DIMENSIONAL DISSOCIATION-CONSTANT; IMMUNOLOGICAL SYNAPSE; ADHESION MOLECULES; RECOGNITION; ACTIVATION; COMPLEX; BINDING; SENSITIVITY; ANTIGEN	The recognition of foreign antigens by T lymphocytes is essential to most adaptive immune responses. It is driven by specific T-cell antigen receptors (TCRs) binding to antigenic peptide-major histocompatibility complex (pMHC) molecules on other cells(1). If productive, these interactions promote the formation of an immunological synapse(2,3). Here we show that synaptic TCR-pMHC binding dynamics differ significantly from TCR-pMHC binding in solution. We used single-molecule microscopy and fluorescence resonance energy transfer (FRET) between fluorescently tagged TCRs and their cognate pMHC ligands to measure the kinetics of TCR-pMHC binding in situ. When compared with solution measurements, the dissociation of this complex was increased significantly (4-12-fold). Disruption of actin polymers reversed this effect, indicating that cytoskeletal dynamics destabilize this interaction directly or indirectly. Nevertheless, TCR affinity for pMHC was significantly elevated as the result of a large (about 100-fold) increase in the association rate, a likely consequence of complementary molecular orientation and clustering. In helper T cells, the CD4 molecule has been proposed to bind cooperatively with the TCR to the same pMHC complex. However, CD4 blockade had no effect on the synaptic TCR affinity, nor did it destabilize TCR-pMHC complexes, indicating that the TCR binds pMHC independently of CD4.	[Huppa, Johannes B.; Moertelmaier, Manuel A.; Lillemeier, Bjoern F.; Newell, Evan W.; Klein, Lawrence O.; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Beckman Ctr B221, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Axmann, Markus; Moertelmaier, Manuel A.; Brameshuber, Mario; Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Stanford University; Howard Hughes Medical Institute; Johannes Kepler University Linz	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Huppa, Johannes Bernhard/AAY-9471-2021; Newell, Evan W/F-9711-2012; Schuetz, Gerhard/B-1243-2008	Huppa, Johannes Bernhard/0000-0003-2634-8198; Newell, Evan W/0000-0002-2889-243X; Schuetz, Gerhard/0000-0003-1542-1089; Brameshuber, Mario/0000-0001-8672-2255; Moertelmaier, Manuel/0000-0003-4239-9809; Davis, Mark/0000-0001-6868-657X; Lillemeier, Bjorn/0000-0002-9425-6327; Axmann, Markus/0000-0001-9818-9734	National Institutes of Health [RO1 AI52211]; Howard Hughes Medical Institute; Frontier Research Center (iFREC); Wilhelm Macke Stiftung; American Cancer Society; National Science Foundation; Austrian Science Fund [Y250-B10]; Austrian Ministry for Science and Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052211, T32AI007290, R01AI022511] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [Y 250] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Frontier Research Center (iFREC); Wilhelm Macke Stiftung; American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry for Science and Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank F. E. Tynan, A. K. Chakraborty and S. R. Quake for helpful discussions, and P. P. J. Ebert for help with the flow cytometry experiments. This work was supported by grants from the National Institutes of Health (RO1 AI52211) and the Howard Hughes Medical Institute to M. M. D. J. B. H. is partly supported by the Immunology Frontier Research Center (iFREC) consortium, M. A. M. received a postdoctoral fellowship from the Wilhelm Macke Stiftung, and E.W.N. from the American Cancer Society's Steven Stanley and Edward Albert Bielfelt Fund. L.O.K. is supported by a National Science Foundation predoctoral fellowship. M. A., M. B. and G. J. S. received grants from the Austrian Science Fund (project Y250-B10) and the GEN-AU project of the Austrian Ministry for Science and Research.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Fricke GM, 2006, BIOPHYS CHEM, V119, P205, DOI 10.1016/j.bpc.2005.09.019; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; Zhu DM, 2007, BIOPHYS J, V92, P1022, DOI 10.1529/biophysj.106.089649	30	342	353	6	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					963	U143		10.1038/nature08746	http://dx.doi.org/10.1038/nature08746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164930	Green Accepted			2022-12-28	WOS:000274582700049
J	Persell, SD; Dolan, NC; Friesema, EM; Thompson, JA; Kaiser, D; Baker, DW				Persell, Stephen D.; Dolan, Nancy C.; Friesema, Elisha M.; Thompson, Jason A.; Kaiser, Darren; Baker, David W.			Frequency of Inappropriate Medical Exceptions to Quality Measures	ANNALS OF INTERNAL MEDICINE			English	Article							PAY-FOR-PERFORMANCE; ADMINISTRATIVE DATA; INFORMATION-TECHNOLOGY; ACHIEVABLE BENCHMARKS; DIABETIC-RETINOPATHY; PRACTICE GUIDELINES; CLAIMS DATA; OF-CARE; DISEASE; PHYSICIANS	Background: Quality improvement programs that allow physicians to document medical reasons for deviating from guidelines preserve clinicians' judgment while enabling them to strive for high performance. However, physician misconceptions or gaming potentially limit programs. Objective: To implement computerized decision support with mechanisms to document medical exceptions to quality measures and to perform peer review of exceptions and provide feedback when appropriate. Design: Observational study. Setting: Large internal medicine practice. Participants: Patients eligible for 1 or more quality measures. Measurements: A peer-review panel judged medical exceptions to 16 chronic disease and prevention quality measures as appropriate, inappropriate, or of uncertain appropriateness. Medical records were reviewed after feedback was given to determine whether care changed. Results: Physicians recorded 650 standardized medical exceptions during 7 months. The reporting tool was used without any medical reason 36 times (5.5%). Of the remaining 614 exceptions, 93.6% were medically appropriate, 3.1% were inappropriate, and 3.3% were of uncertain appropriateness. Frequencies of inappropriate exceptions were 7 (6.9%) for coronary heart disease, 0 (0%) for heart failure, 10 (10.8%) for diabetes, and 2 (0.6%) for preventive services. After physicians received direct feedback about inappropriate exceptions, 8 of 19 (42%) changed management. The peer-review process took less than 5 minutes per case, but for each change in clinical care, 65 reviews were required. Limitation: The findings could differ at other sites or if financial incentives were in place. Conclusion: Physician-recorded medical exceptions were correct most of the time. Peer review of medical exceptions can identify myths and misconceptions, but the process needs to be more efficient to be sustainable.	[Persell, Stephen D.] Northwestern Univ, Div Gen Internal Med, Chicago, IL 60611 USA	Northwestern University	Persell, SD (corresponding author), Northwestern Univ, Div Gen Internal Med, 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.	spersell@nmff.org			Agency for Healthcare Research and Quality [1R18HS17163-01, 1K08HS015647-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015647, R18HS017163] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (grant 1R18HS17163-01). Dr. Persell was supported by a career development award (1K08HS015647-01) from the Agency for Healthcare Research and Quality.	*AM MED ASS, PCPI MEAS; Baker DW, 2007, ANN INTERN MED, V146, P270, DOI 10.7326/0003-4819-146-4-200702200-00006; Baker DW, 1999, AM HEART J, V138, P826, DOI 10.1016/S0002-8703(99)70006-2; Bergerhoff K, 2002, ENDOCRIN METAB CLIN, V31, P779, DOI 10.1016/S0889-8529(02)00017-8; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; CHEW EY, 1995, ARCH OPHTHALMOL-CHIC, V113, P52, DOI 10.1001/archopht.1995.01100010054020; Chin MH, 1997, J GEN INTERN MED, V12, P523, DOI 10.1046/j.1525-1497.1997.07105.x; Cohen DE, 2006, AM J CARDIOL, V97, p77C, DOI 10.1016/j.amjcard.2005.12.014; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Fowles J B, 1998, J Ambul Care Manage, V21, P24; Fowles JB, 1997, EVAL HEALTH PROF, V20, P324, DOI 10.1177/016327879702000305; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Glueck CJ, 2006, CLIN THER, V28, P933, DOI 10.1016/j.clinthera.2006.06.004; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Jacobson TA, 2008, MAYO CLIN PROC, V83, P687, DOI 10.4065/83.6.687; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Kiefe CI, 1998, INT J QUAL HEALTH C, V10, P443, DOI 10.1093/intqhc/10.5.443; Lewis JH, 2007, HEPATOLOGY, V46, P1453, DOI 10.1002/hep.21848; LITZELMAN DK, 1993, J GEN INTERN MED, V8, P311, DOI 10.1007/BF02600144; Litzelman DK, 1996, J GEN INTERN MED, V11, P497, DOI 10.1007/BF02599049; MacLean CH, 2006, MED CARE, V44, P141, DOI 10.1097/01.mlr.0000196960.12860.de; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Newton KM, 1999, J CLIN EPIDEMIOL, V52, P199, DOI 10.1016/S0895-4356(98)00161-9; Peabody JW, 2004, MED CARE, V42, P1066, DOI 10.1097/00005650-200411000-00005; Persell SD, 2006, ARCH INTERN MED, V166, P2272, DOI 10.1001/archinte.166.20.2272; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Solberg LI, 2006, AM J MED QUAL, V21, P238, DOI 10.1177/1062860606288243; Stein EA, 2008, AM J CARDIOL, V101, P490, DOI 10.1016/j.amjcard.2007.09.099; Tang PC, 2007, J AM MED INFORM ASSN, V14, P10, DOI 10.1197/jamia.M2198; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Wachter RM, 2006, JAMA-J AM MED ASSOC, V295, P2780, DOI 10.1001/jama.295.23.2780; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wu B, 2002, AM J MED QUAL, V17, P61, DOI 10.1177/106286060201700204	39	49	50	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2010	152	4					225	U49		10.7326/0003-4819-152-4-201002160-00007	http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560AF	20157137				2022-12-28	WOS:000274873300004
J	Kitamura, T; Iwami, T; Kawamura, T; Nagao, K; Tanaka, H; Nadkarni, VM; Berg, RA; Hiraide, A				Kitamura, Tetsuhisa; Iwami, Taku; Kawamura, Takashi; Nagao, Ken; Tanaka, Hideharu; Nadkarni, Vinay M.; Berg, Robert A.; Hiraide, Atsushi		Fire & Disaster Management Agcy	Conventional and chest-compression-only cardiopulmonary resuscitation by bystanders for children who have out-of-hospital cardiac arrests: a prospective, nationwide, population-based cohort study	LANCET			English	Article							AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; ASSISTED VENTILATION; TASK-FORCE; RECOMMENDED GUIDELINES; STROKE-FOUNDATION; UTSTEIN STYLE; EPIDEMIOLOGY; CPR; STATEMENT	Background The American Heart Association recommends cardiopulmonary resuscitation (CPR) by bystanders with chest compression only for adults who have cardiac arrests, but not for children. We assessed the effect of CPR (conventional with rescue breathing or chest compression only) by bystanders on outcomes after out-of-hospital cardiac arrests in children. Methods In a nationwide, prospective, population-based, observational study, we enrolled 5170 children aged 17 years and younger who had an out-of-hospital cardiac arrest from Jan 1,2005, to Dec 31,2007. Data collected included age, cause, and presence and type of CPR by bystander. The primary endpoint was favourable neurological outcome 1 month after an out-of-hospital cardiac arrest, defined as Glasgow-Pittsburgh cerebral performance category 1 or 2. Findings 3675 (71%) children had arrests of non-cardiac causes and 1495 (29%) cardiac causes. 1551 (30%) received conventional CPR and 888 (17%) compression-only CPR. Data for type of CPR by bystander were not available for 12 children. Children who were given CPR by a bystander had a significantly higher rate of favourable neurological outcome than did those not given CPR (4.5% [110/2439] vs 1.9% [53/2719]; adjusted odds ratio [OR] 2.59,95% CI 1.81-3.71). In children aged 1-17 years who had arrests of non-cardiac causes, favourable neurological outcome was more common after bystander CPR than no CPR (5.1% [51/1004] vs 1-5% [20/1293]; OR 4.17, 2.37-7.32). However, conventional CPR produced more favourable neurological outcome than did compression-only CPR (7.2% [45/624] vs 1.6% [six of 380]; OR 5.54, 2.52-16.99). In children aged 1-17 years who had arrests of cardiac causes, favourable neurological outcome was more common after bystander CPR than no CPR (9.5% [42/440] vs 4.1% [14/339]; OR 2.21, 1.08-4.54), and did not differ between conventional and compression-only CPR (9.9% [28/282] vs 8.9% [14/158]; OR 1.20, 0.55-2.66). In infants (aged <1 year), outcomes were uniformly poor (1.7% [36/2082] with favourable neurological outcome). Interpretation For children who have out-of-hospital cardiac arrests from non-cardiac causes, conventional CPR (with rescue breathing) by bystander is the preferable approach to resuscitation. For arrests of cardiac causes, either conventional or compression-only CPR is similarly effective.	[Iwami, Taku] Kyoto Univ, Hlth Serv, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan; [Nagao, Ken] Nihon Univ Hosp, Dept Cardiol, Tokyo, Japan; [Tanaka, Hideharu] Kokushikan Univ, Grad Sch Sport Syst, Tokyo, Japan; [Nadkarni, Vinay M.; Berg, Robert A.] Univ Penn, Sch Med, Dept Anesthesia & Crit Care Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Hiraide, Atsushi] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068501, Japan	Kyoto University; Nihon University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Kyoto University	Iwami, T (corresponding author), Kyoto Univ, Hlth Serv, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	iwamit@e-mail.jp	IWAMI, Taku/HCH-0599-2022; Kitamura, Tetsuhisa/AAA-2555-2020	IWAMI, Taku/0000-0002-4150-7065; Kitamura, Tetsuhisa/0000-0003-0107-0580	Fire and Disaster Management Agency; Ministry of Education, Culture, Sports, Science and Technology (Japan); Fire and Disaster Management Agency [19390458]	Fire and Disaster Management Agency; Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fire and Disaster Management Agency	Fire and Disaster Management Agency and the Ministry of Education, Culture, Sports, Science and Technology (Japan).r We thank all the emergency medical service personnel and participating physicians in Japan, and the Fire and Disaster Management Agency and Institute for Fire Safety and Disaster Preparedness of Japan for their generous cooperation in establishing and following the Utstein database. This study was supported by a grant for Emergency Management Scientific Research from the Fire and Disaster Management Agency (study concerning strategy for applying the results of Utstein report for improvement of emergency service), and partially by a Grant-in-Aid for Scientific Research (19390458)	*AMB SERV PLANN OF, 2009, EFF 1 CARD ARR; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], 2007, JAP GUID EM CAR CARD; Atkins DL, 2009, CIRCULATION, V119, P1484, DOI 10.1161/CIRCULATIONAHA.108.802678; Berg RA, 1997, CIRCULATION, V95, P1635; Berg RA, 1997, CIRCULATION, V96, P4364; Berg RA, 1999, CRIT CARE MED, V27, P1893, DOI 10.1097/00003246-199909000-00030; Berg RA, 2000, CIRCULATION, V101, P1743; Bohm K, 2007, CIRCULATION, V116, P2908, DOI 10.1161/CIRCULATIONAHA.107.710194; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; *EUR RES COUNC, 2005, RESUSCITATION, V67, pS1, DOI DOI 10.1016/J.RESUSCITATION.2005.10.001; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; Handley AJ, 2009, RESUSCITATION, V80, P752, DOI 10.1016/j.resuscitation.2009.03.031; Herlitz J, 2005, RESUSCITATION, V64, P37, DOI 10.1016/j.resuscitation.2004.06.019; HICKEY RW, 1995, ANN EMERG MED, V25, P495, DOI 10.1016/S0196-0644(95)70265-2; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; *JAP STAT ASS, 2006, 2005 POP CENS JAP; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; KOSTER RW, 2009, BEHALF BOARD EUROPEA; KUISMA M, 1995, RESUSCITATION, V30, P141, DOI 10.1016/0300-9572(95)00888-Z; Lopez-Herce J, 2005, PEDIATR EMERG CARE, V21, P807; Nagao K, 2007, LANCET, V369, P920; Nishiyama C, 2008, RESUSCITATION, V79, P90, DOI 10.1016/j.resuscitation.2008.05.009; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Schindler MB, 1996, NEW ENGL J MED, V335, P1473, DOI 10.1056/NEJM199611143352001; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Suominen P, 1997, ACTA ANAESTH SCAND, V41, P260, DOI 10.1111/j.1399-6576.1997.tb04677.x; The Japan Circulation Society, CALL PUSH; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; Waalewijn RA, 2001, RESUSCITATION, V50, P273, DOI 10.1016/S0300-9572(01)00354-9; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157; ZARITSKY A, 1995, CIRCULATION, V92, P2006, DOI 10.1161/01.CIR.92.7.2006	35	294	306	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1347	1354		10.1016/S0140-6736(10)60064-5	http://dx.doi.org/10.1016/S0140-6736(10)60064-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588GW	20202679	Green Submitted			2022-12-28	WOS:000277057800025
J	Des Jarlais, DC; Arasteh, K; Gwadz, M				Des Jarlais, Don C.; Arasteh, Kamyar; Gwadz, Marya			Increasing HIV prevention and care for injecting drug users	LANCET			English	Editorial Material									[Des Jarlais, Don C.; Arasteh, Kamyar] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Gwadz, Marya] Natl Dev & Res Inst Inc, New York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; National Development & Research Institutes, Inc	Des Jarlais, DC (corresponding author), Beth Israel Deaconess Med Ctr, New York, NY 10003 USA.	dcdesjarla@aol.com			NIAID NIH HHS [R01AI070005, R01 AI070005, R01AI 083035, R01 AI083035] Funding Source: Medline; NIDA NIH HHS [R01 DA003574, R01DA003574] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070005, R01AI083035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003574] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bandura A., 1977, SOCIAL LEARNING THEO, V1; *COMM PREV HIV INF, 2006, PREV HIV INF INJ DRU; Des Jarlais DC, 2010, DRUG ALCOHOL DEPEN, V109, P154, DOI 10.1016/j.drugalcdep.2009.12.028; Des Jarlais DC, 2010, ADDICTION, V105, P155, DOI 10.1111/j.1360-0443.2009.02747.x; Hammett TM, 2005, J URBAN HEALTH, V82, pIV34, DOI 10.1093/jurban/jti106; Kahneman D, 2000, CHOICES VALUES FRAME; Lau RR, 1998, APPL PSYCHOL-INT REV, V47, P29, DOI 10.1111/j.1464-0597.1998.tb00011.x; Ledgerwood DM, 2006, DRUG ALCOHOL DEPEN, V83, P65, DOI 10.1016/j.drugalcdep.2005.10.012; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; SEMAAN S, RIGHT BASED IN PRESS; Silverman K., 1999, MOTIVATING BEHAV CHA	12	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					961	963		10.1016/S0140-6736(10)60314-5	http://dx.doi.org/10.1016/S0140-6736(10)60314-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	575YU	20189639	Bronze, Green Published			2022-12-28	WOS:000276110700006
J	Lutes, AA; Neaves, WB; Baumann, DP; Wiegraebe, W; Baumann, P				Lutes, Aracely A.; Neaves, William B.; Baumann, Diana P.; Wiegraebe, Winfried; Baumann, Peter			Sister chromosome pairing maintains heterozygosity in parthenogenetic lizards	NATURE			English	Article							CNEMIDOPHORUS-TESSELATUS; SKIN HISTOCOMPATIBILITY; TEIID LIZARDS	Although bisexual reproduction has proven to be highly successful, parthenogenetic all-female populations occur frequently in certain taxa, including the whiptail lizards of the genus Aspidoscelis. Allozyme analysis revealed a high degree of fixed heterozygosity in these parthenogenetic species(1,2), supporting the view that they originated from hybridization events between related sexual species. It has remained unclear how the meiotic program is altered to produce diploid eggs while maintaining heterozygosity. Here we show that meiosis commences with twice the number of chromosomes in parthenogenetic versus sexual species, a mechanism that provides the basis for generating gametes with unreduced chromosome content without fundamental deviation from the classic meiotic program. Our observation of synaptonemal complexes and chiasmata demonstrate that a typical meiotic program occurs and that heterozygosity is not maintained by bypassing recombination. Instead, fluorescent in situ hybridization probes that distinguish between homologues reveal that bivalents form between sister chromosomes, the genetically identical products of the first of two premeiotic replication cycles. Sister chromosome pairing provides a mechanism for the maintenance of heterozygosity, which is critical for offsetting the reduced fitness associated with the lack of genetic diversity in parthenogenetic species.	[Lutes, Aracely A.; Neaves, William B.; Baumann, Diana P.; Wiegraebe, Winfried; Baumann, Peter] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Lutes, Aracely A.; Baumann, Peter] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Neaves, William B.] Univ Missouri, Sch Med, Kansas City, MO 64110 USA; [Baumann, Peter] Howard Hughes Med Inst, Kansas City, MO 64110 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Missouri System; University of Missouri Kansas City; Howard Hughes Medical Institute	Baumann, P (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	peb@stowers.org		Baumann, Peter/0000-0003-4892-1485	Stowers Institute for Medical Research; Pew Charitable Trusts	Stowers Institute for Medical Research; Pew Charitable Trusts	We thank the staff of the Reptile Facility for their dedication to animal husbandry; C. Painter and his colleagues at the New Mexico Department of Game and Fish for scientific collection permits; F. Li for electron microscopy; the Stowers Institute Microscopy, Cytometry and Molecular Biology Facilities for support; and S. Hawley, J. Cole, C. Townsend and members of the Baumann and Blanchette laboratories for discussions and comments. We also thank S. Hawley for critical reading of the manuscript. This work was funded by the Stowers Institute for Medical Research, and the Pew Scholars Program in the Biological Sciences sponsored by the Pew Charitable Trusts. P. B. is an Early Career Scientist with the Howard Hughes Medical Institute.	Cordes JE, 2006, COPEIA, P14, DOI 10.1643/0045-8511(2006)006[0014:EASIOS]2.0.CO;2; Cordes JE, 2003, J HERPETOL, V37, P185, DOI 10.1670/0022-1511(2003)037[0185:SHBSPC]2.0.CO;2; CUELLAR O, 1977, TRANSPLANTATION, V24, P127, DOI 10.1097/00007890-197708000-00006; CUELLAR O, 1971, J MORPHOL, V133, P139, DOI 10.1002/jmor.1051330203; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DESSAUER HC, 1986, J HERED, V77, P8, DOI 10.1093/oxfordjournals.jhered.a110176; DESSAUER HC, 1989, EVOLUTION ECOLOGY UN, V466, P49; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; LOWE C H, 1966, Journal of the Arizona Academy of Science, V4, P81; MACGREGOR HC, 1964, SCIENCE, V143, P1043, DOI 10.1126/science.143.3610.1043; MASLIN TP, 1967, J EXP ZOOL, V166, P137, DOI 10.1002/jez.1401660114; Moore Melody K., 1997, Methods in Cell Science, V19, P161, DOI 10.1023/A:1009716712646; Neaves W. B., 1971, Breviora, VNo. 381, P1; NEAVES WB, 1969, J EXP ZOOL, V171, P175, DOI 10.1002/jez.1401710205; NEAVES WB, 1968, SCIENCE, V160, P1004, DOI 10.1126/science.160.3831.1004; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PARKER ED, 1976, GENETICS, V84, P791; Reeder TW, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)365<0001:PROWLO>2.0.CO;2; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Townsend C.R., 1979, International Zoo Yearbook, V19, P80, DOI 10.1111/j.1748-1090.1979.tb00533.x; VRIJENHOEK RC, 1989, EVOLUTION ECOLOGY UN, V466, P19; WHITE M. J. D., 1963, AUSTRALIAN JOUR ZOOL, V11, P1, DOI 10.1071/ZO9630001; Wright J. W., 1967, Mammalian Chromosomes Newsletter, V8, P95	24	73	79	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					283	U164		10.1038/nature08818	http://dx.doi.org/10.1038/nature08818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20173738	Green Accepted			2022-12-28	WOS:000275366100048
J	Jardine, M				Jardine, Moira			Sunscreen for the Young Earth	SCIENCE			English	Editorial Material							MASS-LOSS RATES		Univ St Andrews, Dept Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	University of St Andrews	Jardine, M (corresponding author), Univ St Andrews, Dept Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.	mmj@st-and.ac.uk						Donati JF, 2007, MON NOT R ASTRON SOC, V380, P1297, DOI 10.1111/j.1365-2966.2007.12194.x; Holzwarth V, 2007, ASTRON ASTROPHYS, V463, P11, DOI 10.1051/0004-6361:20066486; Stevenson DJ, 2001, NATURE, V412, P214, DOI 10.1038/35084155; Tarduno JA, 2010, SCIENCE, V327, P1238, DOI 10.1126/science.1183445; Wood BE, 2001, ASTROPHYS J, V547, pL49, DOI 10.1086/318888	5	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1206	1207		10.1126/science.1187051	http://dx.doi.org/10.1126/science.1187051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203036				2022-12-28	WOS:000275162100022
J	Karnath, HO; Borchers, S; Himmelbach, M				Karnath, Hans-Otto; Borchers, Svenja; Himmelbach, Marc			Comment on "Movement Intention After Parietal Cortex Stimulation in Humans"	SCIENCE			English	Editorial Material							ELECTRICAL-STIMULATION; INSIGHTS; SYSTEM; FMRI	Desmurget et al. (Reports, 8 May 2009, p. 811) applied direct electrical stimulation (DES) to the human cortex to study the origin of movement intention. Their interpretation assumed that DES causes cortical activation, whereas it is possible that it actually evokes deactivation. The lack of certain knowledge about the true effects of DES limits its use for validation of cognitive models.	[Karnath, Hans-Otto; Borchers, Svenja; Himmelbach, Marc] Univ Tubingen, Sect Neuropsychol, Ctr Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Karnath, Hans-Otto] Georgia Inst Technol, Ctr Adv Brain Imaging, Atlanta, GA 30332 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University System of Georgia; Georgia Institute of Technology	Karnath, HO (corresponding author), Univ Tubingen, Sect Neuropsychol, Ctr Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.	Karnath@uni-tuebingen.de		Himmelbach, Marc/0000-0002-7771-2968				BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Gharabaghi A, 2006, NEUROPSYCHOLOGIA, V44, P2578, DOI 10.1016/j.neuropsychologia.2006.04.006; Giussani C, 2009, J NEUROSURG, V110, P289, DOI 10.3171/2007.8.17566; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W, 1954, EPILEPSY FUNCTIONAL; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034	13	10	10	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970								10.1126/science.1183735	http://dx.doi.org/10.1126/science.1183735			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203033				2022-12-28	WOS:000275162100017
J	O'Shea, JJ; Paul, WE				O'Shea, John J.; Paul, William E.			Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4(+) T Cells	SCIENCE			English	Review							ROR-GAMMA-T; TH17 CELLS; FATE DETERMINATION; INTERLEUKIN 22; TGF-BETA; DIFFERENTIATION; INFLAMMATION; LYMPHOCYTES; GENERATION; POPULATION	CD4(+) T cells are critical for host defense but are also major drivers of immune-mediated disease. These T cells specialize to become distinct subsets and produce restricted patterns of cytokines, which are tailored to combat various microbial pathogens. Although classically viewed as distinct lineages, recent work calls into question whether helper CD4(+) T cell subsets are more appropriately viewed as terminally differentiated cells or works in progress. Herein, we review recent advances that pertain to this topic and the mechanisms that contribute to helper CD4(+) T cell commitment and plasticity. The therapeutic implications of these new findings are also considered.	[O'Shea, John J.; Paul, William E.] NIAID, Mol Immunol & Inflammat Branch, NIAMSD, Immunol Lab,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	O'Shea, JJ (corresponding author), NIAID, Mol Immunol & Inflammat Branch, NIAMSD, Immunol Lab,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov			National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041106, ZIAAR041167, ZIAAR041159, Z01AR041132] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	J.O'S. and W. E. P. are supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases and National Institute of Allergy and Infectious Disease intramural research programs, respectively.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Awasthi A, 2009, SCIENCE, V325, P953, DOI 10.1126/science.1178752; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dong C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.49.pe1; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	48	921	960	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1098	1102		10.1126/science.1178334	http://dx.doi.org/10.1126/science.1178334			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185720	Green Accepted			2022-12-28	WOS:000274901100027
J	Li, SL; Miller, N; Lin, DNC; Fortney, JJ				Li, Shu-lin; Miller, N.; Lin, Douglas N. C.; Fortney, Jonathan J.			WASP-12b as a prolate, inflated and disrupting planet from tidal dissipation	NATURE			English	Article							GIANT PLANETS; EXTRASOLAR PLANET; STARS; PERIOD; DISKS; ACCRETION; EVOLUTION; RADII; ORBIT; MASS	The class of exotic Jupiter-mass planets that orbit very close to their parent stars were not explicitly expected before their discovery(1). The recently discovered(2) transiting planet WASP-12b has a mass M = 1.4 +/- 0.1 Jupiter masses (M-J), a mean orbital distance of only 3.1 stellar radii ( meaning it is subject to intense tidal forces), and a period of 1.1 days. Its radius 1.79 +/- 0.09 R-J is unexpectedly large and its orbital eccentricity 0.049 +/- 0.015 is even more surprising because such close orbits are usually quickly circularized. Here we report an analysis of its properties, which reveals that the planet is losing mass to its host star at a rate of about 10(-7) M-J per year. The planet's surface is distorted by the star's gravity and the light curve produced by its prolate shape will differ by about ten per cent from that of a spherical planet. We conclude that dissipation of the star's tidal perturbation in the planet's convective envelope provides the energy source for its large volume. We predict up to 10 mJy CO band-head (2.292 mu m) emission from a tenuous disk around the host star, made up of tidally stripped planetary gas. It may also contain a detectable resonant super-Earth, as a hypothetical perturber that continually stirs up WASP-12b's eccentricity.	[Li, Shu-lin] Peking Univ, Dept Astron, Beijing 100871, Peoples R China; [Li, Shu-lin; Lin, Douglas N. C.] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Miller, N.; Lin, Douglas N. C.; Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	Peking University; Peking University; University of California System; University of California Santa Cruz	Lin, DNC (corresponding author), Chinese Acad Sci, Natl Astron Observ China, Beijing 100012, Peoples R China.	lin@ucolick.org	Li, Shulin/D-6478-2011; Fortney, Jonathan/F-8813-2014	Fortney, Jonathan/0000-0002-9843-4354	Kavli Foundation; NASA; JPL; NSF	Kavli Foundation; NASA(National Aeronautics & Space Administration (NASA)); JPL; NSF(National Science Foundation (NSF))	This work is supported by the Kavli Foundation, which enabled the initiation and development of this work at KIAA-PKU. It is also supported by NASA, JPL and the NSF.	ADAMS FC, 1988, ASTROPHYS J, V326, P865, DOI 10.1086/166144; Bodenheimer P, 2003, ASTROPHYS J, V592, P555, DOI 10.1086/375565; Bodenheimer P, 2001, ASTROPHYS J, V548, P466, DOI 10.1086/318667; Dobbs-Dixon I, 2004, ASTROPHYS J, V610, P464, DOI 10.1086/421510; Dobbs-Dixon I, 2008, ASTROPHYS J, V673, P513, DOI 10.1086/523786; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Guillot T, 1996, ASTROPHYS J, V459, pL35, DOI 10.1086/309935; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Hebb L, 2009, ASTROPHYS J, V693, P1920, DOI 10.1088/0004-637X/693/2/1920; Hellier C, 2009, NATURE, V460, P1098, DOI 10.1038/nature08245; Hubbard WB, 2007, ICARUS, V187, P358, DOI 10.1016/j.icarus.2006.10.019; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; LIN DNC, 1979, MON NOT R ASTRON SOC, V188, P191, DOI 10.1093/mnras/188.2.191; Lunine J. I, 1993, PROTOSTARS PLANETS, P749; MAYOR M, 1995, ASTROPHYS J, V378, P355; Meibom S, 2006, ASTROPHYS J, V653, P621, DOI 10.1086/508252; Munoz AG, 2007, PLANET SPACE SCI, V55, P1426, DOI 10.1016/j.pss.2007.03.007; Najita J, 1996, ASTROPHYS J, V462, P919, DOI 10.1086/177205; Ogilvie GI, 2007, ASTROPHYS J, V661, P1180, DOI 10.1086/515435; Ogilvie GI, 2004, ASTROPHYS J, V610, P477, DOI 10.1086/421454; PEALE SJ, 1979, SCIENCE, V203, P892, DOI 10.1126/science.203.4383.892; Sasselov DD, 2003, ASTROPHYS J, V596, P1327, DOI 10.1086/378145; Tanaka H, 2002, ASTROPHYS J, V565, P1257, DOI 10.1086/324713; Vauclair S, 2004, ASTROPHYS J, V605, P874, DOI 10.1086/382668; YODER CF, 1981, ICARUS, V47, P1, DOI 10.1016/0019-1035(81)90088-9	26	99	99	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1054	1056		10.1038/nature08715	http://dx.doi.org/10.1038/nature08715			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182506	Green Submitted			2022-12-28	WOS:000275108400030
J	Richardson, CE; Kooistra, T; Kim, DH				Richardson, Claire E.; Kooistra, Tristan; Kim, Dennis H.			An essential role for XBP-1 in host protection against immune activation in C. elegans	NATURE			English	Article							UNFOLDED PROTEIN-RESPONSE; PLASMA-CELL DIFFERENTIATION; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; ENDOPLASMIC-RETICULUM; ER STRESS; BACTERIA; PATHWAY; INDUCE; KINASE	The detection and compensatory response to the accumulation of unfolded proteins in the endoplasmic reticulum (ER), termed the unfolded protein response (UPR), represents a conserved cellular homeostatic mechanism with important roles in normal development and in the pathogenesis of disease(1). The IRE1-XBP1/Hac1 pathway is a major branch of the UPR that has been conserved from yeast to human(2-6). X-box binding protein 1 (XBP1) is required for the differentiation of the highly secretory plasma cells of the mammalian adaptive immune system(7,8), but recent work also points to reciprocal interactions between the UPR and other aspects of immunity and inflammation(9-11). We have been studying innate immunity in the nematode Caenorhabditis elegans, having established a principal role for a conserved PMK-1 p38 mitogen-activated protein kinase (MAPK) pathway in mediating resistance to microbial pathogens(12). Here we show that during C. elegans development, XBP-1 has an essential role in protecting the host during activation of innate immunity. Activation of the PMK-1-mediated response to infection with Pseudomonas aeruginosa induces the XBP-1-dependent UPR. Whereas a loss-of-function xbp-1 mutant develops normally in the presence of relatively non-pathogenic bacteria, infection of the xbp-1 mutant with P. aeruginosa leads to disruption of ER morphology and larval lethality. Unexpectedly, the larval lethality phenotype on pathogenic P. aeruginosa is suppressed by loss of PMK-1-mediated immunity. Furthermore, hyperactivation of PMK-1 causes larval lethality in the xbp-1 mutant even in the absence of pathogenic bacteria. Our data establish innate immunity as a physiologically relevant inducer of ER stress during C. elegans development and indicate that an ancient, conserved role for XBP-1 may be to protect the host organism from the detrimental effects of mounting an innate immune response to microbes.	[Richardson, Claire E.; Kooistra, Tristan; Kim, Dennis H.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kim, DH (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dhkim@mit.edu		Richardson, Claire/0000-0002-7532-1808	NIH [DK43351, DK57521, R01-GM084477]; Howard Hughes Medical Institute; Burroughs Wellcome Fund; Ellison Medical Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ellison Medical Foundation(Lawrence Ellison Foundation)	Electron microscopy was performed by M. McKee in the Microscopy Core of the Center for Systems Biology/Program in Membrane Biology at Massachusetts General Hospital (supported by NIH grants DK43351 and DK57521). We thank E. Hartwieg and G. Voeltz for discussions regarding the interpretation of electron microscopy images. We thank T. Stiernagle and the Caenorhabditis Genetics Center (supported by the NIH), and S. Mitani and the National Bioresource Project of Japan for strains. T. K. was supported by summer research fellowships from the Howard Hughes Medical Institute. This work was supported by NIH grant R01-GM084477, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, and an Ellison Medical Foundation New Scholar Award (to D. H. K.).	Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	35	209	221	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1092	U114		10.1038/nature08762	http://dx.doi.org/10.1038/nature08762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182512	Green Submitted, Green Accepted			2022-12-28	WOS:000275108400039
J	Kriemler, S; Zahner, L; Schindler, C; Meyer, U; Hartmann, T; Hebestreit, H; Brunner-La Rocca, HP; van Mechelen, W; Puder, JJ				Kriemler, Susi; Zahner, Lukas; Schindler, Christian; Meyer, Ursina; Hartmann, Tim; Hebestreit, Helge; Brunner-La Rocca, Hans Peter; van Mechelen, Willem; Puder, Jardena J.			Effect of school based physical activity programme (KISS) on fitness and adiposity in primary schoolchildren: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; PREVENT CHILDHOOD OBESITY; SHUTTLE RUN TEST; CARDIOVASCULAR RISK; METABOLIC SYNDROME; UNITED-STATES; CHILDREN; ADOLESCENTS; OVERWEIGHT; HEALTH	Objective To assess the effectiveness of a school based physical activity programme during one school year on physical and psychological health in young schoolchildren. Design Cluster randomised controlled trial. Setting 28 classes from 15 elementary schools in Switzerland randomly selected and assigned in a 4: 3 ratio to an intervention (n=16) or control arm (n=12) after stratification for grade ( first and fifth grade), from August 2005 to June 2006. Participants 540 children, of whom 502 consented and presented at baseline. Intervention Children in the intervention arm (n=297) received a multi-component physical activity programme that included structuring the three existing physical education lessons each week and adding two additional lessons a week, daily short activity breaks, and physical activity homework. Children (n=205) and parents in the control group were not informed of an intervention group. For most outcome measures, the assessors were blinded. Main outcome measures Primary outcome measures included body fat ( sum of four skinfolds), aerobic fitness ( shuttle run test), physical activity (accelerometry), and quality of life ( questionnaires). Secondary outcome measures included body mass index and cardiovascular risk score ( average z score of waist circumference, mean blood pressure, blood glucose, inverted high density lipoprotein cholesterol, and triglycerides). Results 498 children completed the baseline and follow-up assessments ( mean age 6.9 (SD 0.3) years for first grade, 11.1 (0.5) years for fifth grade). After adjustment for grade, sex, baseline values, and clustering within classes, children in the intervention arm compared with controls showed more negative changes in the z score of the sum of four skinfolds (-0.12, 95% confidence interval -0.21 to -0.03; P=0.009). Likewise, their z scores for aerobic fitness increased more favourably (0.17, 0.01 to 0.32; P=0.04), as did those for moderate-vigorous physical activity in school (1.19, 0.78 to 1.60; P<0.001), all day moderate-vigorous physical activity (0.44, 0.05 to 0.82; P=0.03), and total physical activity in school (0.92, 0.35 to 1.50; P=0.003). Z scores for overall daily physical activity (0.21, -0.21 to 0.63) and physical quality of life (0.42, -1.23 to 2.06) as well as psychological quality of life (0.59, -0.85 to 2.03) did not change significantly. Conclusions A school based multi-component physical activity intervention including compulsory elements improved physical activity and fitness and reduced adiposity in children.	[Kriemler, Susi; Meyer, Ursina; Hartmann, Tim] Univ Basel, Inst Exercise & Hlth Sci, CH-4052 Basel, Switzerland; [Kriemler, Susi; Schindler, Christian] Univ Basel, Swiss Trop & Publ Hlth Inst, CH-4052 Basel, Switzerland; [Hebestreit, Helge] Univ Childrens Hosp, D-97080 Wurzburg, Germany; [Brunner-La Rocca, Hans Peter] Med Univ Ctr Maastricht, NL-6202 Maastricht, Netherlands; [van Mechelen, Willem] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, NL-1081 Amsterdam, Netherlands; [van Mechelen, Willem] Vrije Univ Amsterdam Med Ctr, EM GO Inst, NL-1081 Amsterdam, Netherlands; [Puder, Jardena J.] Univ Lausanne, Serv Endocrinol Diabet & Metab, CH-1011 Lausanne, Switzerland	University of Basel; University of Basel; Swiss Tropical & Public Health Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Lausanne	Kriemler, S (corresponding author), Univ Basel, Inst Exercise & Hlth Sci, CH-4052 Basel, Switzerland.	susi.kriemler@unibas.ch	Meyer, Ursina/B-3919-2011; van Mechelen, Willem/C-8463-2013; Bujan, Miren Karmele/F-5542-2014; Brunner-La Rocca, Hans-Peter/AAF-7330-2021; Schindler, Christian/D-3472-2015; Hebestreit, Helge/AAO-7110-2020	Puder, Jardena/0000-0002-0460-7614; van Mechelen, Willem/0000-0001-7136-6382; Brunner-La Rocca, Hans-Peter/0000-0002-4356-8566	Swiss Federal Office of Sports [SWI05-013]; Swiss National Science Foundation [PMPDB-114401]; Diabetes Foundation of the Region of Basel; ESRC [ES/G007462/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish	Swiss Federal Office of Sports; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Diabetes Foundation of the Region of Basel; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by the Swiss Federal Office of Sports ( grant number SWI05-013), the Swiss National Science Foundation ( grant number PMPDB-114401), and the Diabetes Foundation of the Region of Basel. The funding sources had no role in the design and conduct of the study or in the collection, management, analysis, and interpretation of the data.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; BAO WH, 1994, ARCH INTERN MED, V154, P1842; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Connelly JB, 2007, PUBLIC HEALTH, V121, P510, DOI 10.1016/j.puhe.2006.11.015; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Fredriks AM, 2005, EUR J PEDIATR, V164, P216, DOI 10.1007/s00431-004-1586-7; Freedman DS, 2007, AM J CLIN NUTR, V86, P33, DOI 10.1093/ajcn/86.1.33; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1848; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; Manios Y, 1998, HEALTH EDUC RES, V13, P593, DOI 10.1093/her/13.4.593; McKenzie TL, 1997, RES Q EXERCISE SPORT, V68, P280, DOI 10.1080/02701367.1997.10608009; Moses S, 2007, SCHWEIZ Z SPORTMED S, V55, P62; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rose G., 2008, ROSES STRATEGY PREVE; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; SUMMERBELL CD, 2002, COCHRANE DB SYST REV; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Woringer V, 2003, SOZ PRAVENTIV MED, V48, P121, DOI 10.1007/s00038-003-0103-5; Zahner L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-147	39	330	331	6	207	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2010	340								c785	10.1136/bmj.c785	http://dx.doi.org/10.1136/bmj.c785			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	561TF	20179126	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000275001100020
J	Messina, G; Biressi, S; Monteverde, S; Magli, A; Cassano, M; Perani, L; Roncaglia, E; Tagliafico, E; Starnes, L; Campbell, CE; Grossi, M; Goldhamer, DJ; Gronostajski, RM; Cossu, G				Messina, Graziella; Biressi, Stefano; Monteverde, Stefania; Magli, Alessandro; Cassano, Marco; Perani, Laura; Roncaglia, Elena; Tagliafico, Enrico; Starnes, Linda; Campbell, Christine E.; Grossi, Milena; Goldhamer, David J.; Gronostajski, Richard M.; Cossu, Giulio			Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle	CELL			English	Article							NUCLEAR-FACTOR-I; GENE-EXPRESSION; BETA-GLOBIN; ENHANCER; BINDING; PROTEIN; PROGENITORS; DOWNSTREAM; INTERACTS; MYOBLASTS	Skeletal myogenesis, like hematopoiesis, occurs in successive developmental stages that involve different cell populations and expression of different genes. We show here that the transcription factor nuclear factor one X (Nfix), whose expression is activated by Pax7 in fetal muscle, in turn activates the transcription of fetal specific genes such as MCK and beta-enolase while repressing embryonic genes such as slow myosin. In the case of the MCK promoter, Nfix forms a complex with PKC theta that binds, phosphorylates, and activates MEF2A. Premature expression of Nfix activates fetal and suppresses embryonic genes in embryonic muscle, whereas muscle-specific ablation of Nfix prevents fetal and maintains embryonic gene expression in the fetus. Therefore, Nfix acts as a transcriptional switch from embryonic to fetal myogenesis.	[Messina, Graziella; Monteverde, Stefania; Perani, Laura; Cossu, Giulio] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy; [Messina, Graziella; Cossu, Giulio] Univ Milan, Dept Biol, I-20133 Milan, Italy; [Biressi, Stefano] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Magli, Alessandro; Roncaglia, Elena; Tagliafico, Enrico] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41125 Modena, Italy; [Cassano, Marco] KULeuven, Stem Cell Inst Leuven, B-3000 Louvain, Belgium; [Starnes, Linda] Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00161 Rome, Italy; [Campbell, Christine E.; Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, New York State Ctr Excellence Bioinformat & Life, Dev Genom Grp,Program Neurosci, Buffalo, NY 14214 USA; [Grossi, Milena] Univ Roma La Sapienza, Dept Cell & Dev Biol, I-00185 Rome, Italy; [Goldhamer, David J.] Univ Connecticut, Dept Mol & Cell Biol, Ctr Regenerat Biol, Storrs, CT 06269 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Stanford University; Universita di Modena e Reggio Emilia; KU Leuven; Sapienza University Rome; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Sapienza University Rome; University of Connecticut	Cossu, G (corresponding author), Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy.	cossu.giulio@hsr.it	Perani, Laura/AAN-2838-2020; Magli, Alessandro/K-5961-2019; Messina, Graziella/A-1469-2014; Tagliafico, Enrico/C-9079-2009; Cassano, Marco/T-3473-2019; Biressi, Stefano/AAD-8956-2020	Perani, Laura/0000-0001-8616-3377; Magli, Alessandro/0000-0003-3874-2838; Messina, Graziella/0000-0001-8189-0727; Tagliafico, Enrico/0000-0003-0981-2542; Cassano, Marco/0000-0002-8526-1319; Cossu, Giulio/0000-0001-5863-9593; Starnes, Linda/0000-0002-7322-9928; Gronostajski, Richard/0000-0003-4264-208X; Biressi, Stefano Augusto Maria/0000-0001-8631-3419	EC; ERC; Ministry of Research (FIRB) and of Health; Telethon; AFM; Fondazione Roma; Duchenne Parent Project (Italy); NASA [NNJ06HA59]; NIHLBI [H080624]; NIH [AR052777]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052777] Funding Source: NIH RePORTER	EC(European CommissionEuropean Commission Joint Research Centre); ERC(European Research Council (ERC)European Commission); Ministry of Research (FIRB) and of Health; Telethon(Fondazione Telethon); AFM(Association Francaise contre les Myopathies); Fondazione Roma(Fondazione RomaEuropean Commission); Duchenne Parent Project (Italy); NASA(National Aeronautics & Space Administration (NASA)); NIHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from EC (Optistem, Angioscaff), ERC, Ministry of Research (FIRB) and of Health, Telethon, AFM, Fondazione Roma, and the Duchenne Parent Project (Italy). R. M. G. and C. E. C. were supported by grants from NASA (NNJ06HA59) and NIHLBI (H080624). D.J.G. was supported by grant from the NIH (AR052777). We thank C. Bonfanti, S. Benedetti, A. Innocenzi, A. Dellavalle, G. Cusella-De Angelis, M. Bouche', S. Molinari, F. Cotelli, L. Del Giacco, A. Pistocchi, L. Jovine, M. Sampaolesi, and C. Nervi for help and discussion; C. Bachurski for the NFI-Engrailed construct; S. Schiaffino for the NFATc4 plasmid; and M. Buckingham and S. Tajbakhsh for critical reading of this manuscript. We also thank A. Palini for the cell sorting, the Centre for Conditional Mutagenesis (CFCM), and C. Panzeri (ALEMBIC) for the electron microscopy.	Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Biressi S, 2007, DEV BIOL, V304, P633, DOI 10.1016/j.ydbio.2007.01.016; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chaudhry AZ, 1998, J BIOL CHEM, V273, P18538, DOI 10.1074/jbc.273.29.18538; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chen JCJ, 2005, GENESIS, V41, P116, DOI 10.1002/gene.20104; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; FEO S, 1995, MOL CELL BIOL, V15, P5991; Ferrari S, 1997, CELL GROWTH DIFFER, V8, P23; FUNK WD, 1992, P NATL ACAD SCI USA, V89, P9484, DOI 10.1073/pnas.89.20.9484; GEORGEWEINSTEIN M, 1993, DEV BIOL, V156, P209, DOI 10.1006/dbio.1993.1071; Gillis TE, 2007, PHYSIOL GENOMICS, V32, P16, DOI 10.1152/physiolgenomics.00197.2007; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; GUNNING P, 1991, FASEB J, V5, P3064, DOI 10.1096/fasebj.5.15.1835946; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Jiang P, 2002, DEV BIOL, V243, P281, DOI 10.1006/dbio.2002.0574; Johanson M, 1999, BIOCHEM BIOPH RES CO, V265, P222, DOI 10.1006/bbrc.1999.1390; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kaufmann U, 1999, J CELL SCI, V112, P55; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; KRUSE U, 1991, NUCLEIC ACIDS RES, V19, P6641, DOI 10.1093/nar/19.23.6641; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Messina G, 2005, MOL BIOL CELL, V16, P1469, DOI 10.1091/mbc.e04-07-0612; Molinari S, 2004, MOL CELL BIOL, V24, P2944, DOI 10.1128/MCB.24.7.2944-2957.2004; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; Peterson KR, 2003, CURR OPIN HEMATOL, V10, P123, DOI 10.1097/00062752-200303000-00004; Saka Y, 2008, METHODS, V45, P192, DOI 10.1016/j.ymeth.2008.06.005; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Starnes LM, 2009, BLOOD, V114, P1753, DOI 10.1182/blood-2008-12-196196; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Zappelli F, 1996, DEV BIOL, V180, P156, DOI 10.1006/dbio.1996.0292	39	127	128	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					554	566		10.1016/j.cell.2010.01.027	http://dx.doi.org/10.1016/j.cell.2010.01.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178747	Bronze			2022-12-28	WOS:000274668400018
J	Song, CM; Qu, ZH; Blumm, N; Barabasi, AL				Song, Chaoming; Qu, Zehui; Blumm, Nicholas; Barabasi, Albert-Laszlo			Limits of Predictability in Human Mobility	SCIENCE			English	Article								A range of applications, from predicting the spread of human and electronic viruses to city planning and resource management in mobile communications, depend on our ability to foresee the whereabouts and mobility of individuals, raising a fundamental question: To what degree is human behavior predictable? Here we explore the limits of predictability in human dynamics by studying the mobility patterns of anonymized mobile phone users. By measuring the entropy of each individual's trajectory, we find a 93% potential predictability in user mobility across the whole user base. Despite the significant differences in the travel patterns, we find a remarkable lack of variability in predictability, which is largely independent of the distance users cover on a regular basis.	[Song, Chaoming; Qu, Zehui; Blumm, Nicholas; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Dept Phys, Boston, MA 02115 USA; [Song, Chaoming; Qu, Zehui; Blumm, Nicholas; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Dept Biol, Boston, MA 02115 USA; [Song, Chaoming; Qu, Zehui; Blumm, Nicholas; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Dept Comp Sci, Boston, MA 02115 USA; [Song, Chaoming; Qu, Zehui; Blumm, Nicholas; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Song, Chaoming; Qu, Zehui; Blumm, Nicholas; Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Qu, Zehui] Univ Elect Sci & Technol China, Sch Engn & Comp Sci, Chengdu 610054, Peoples R China	Northeastern University; Northeastern University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Electronic Science & Technology of China	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Dept Phys, Boston, MA 02115 USA.	alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522	James S. McDonnell Foundation; NSF [DMR-0426737, IIS-0513650]; Defense Threat Reduction Agency [HDTRA1-08-1-0027]; U.S. Army Research Laboratory [W911NF-09-2-0053]; China Scholarship Council	James S. McDonnell Foundation; NSF(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); China Scholarship Council(China Scholarship Council)	We thank M. Gonzales, P. Wang, J. Bagrow, and J. A. Aslam for discussions and comments on the manuscript. This work was supported by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems, NSF within the Information Technology Research (DMR-0426737) and IIS-0513650 programs, the Defense Threat Reduction Agency award HDTRA1-08-1-0027, and the Network Science Collaborative Technology Alliance sponsored by the U.S. Army Research Laboratory under agreement number W911NF-09-2-0053. Z.Q. was supported by a fellowship from the China Scholarship Council.	Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Erlang A.K., 1909, NYT TIDSSKRIFT MAT B, V20, P33; Fano RM., 1961, TRANSMISSION INFORM; Gabrielli A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.208701; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gonzalez MC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088702; Grinstein G, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.012101; Harry JD, 2005, IEEE SPECTRUM, V42, P36, DOI 10.1109/MSPEC.2005.1413729; Havlin S, 2002, ADV PHYS, V51, P187, DOI 10.1080/00018730110116353; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Metzler R, 2007, CHAOS SOLITON FRACT, V34, P129, DOI 10.1016/j.chaos.2007.01.055; NAVET N, 2008, NATURAL COMPUTING CO; SHO WS, 2002, IEEE COMMUN MAG, V41, P86; Song LB, 2004, IEEE INFOCOM SER, P1414; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053	26	1912	2031	29	544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1018	1021		10.1126/science.1177170	http://dx.doi.org/10.1126/science.1177170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167789				2022-12-28	WOS:000274625800046
J	Lopez-Campos, JL; Vieyra-Herrera, G				Luis Lopez-Campos, Jose; Vieyra-Herrera, Gerardo			Prosthetic-Valve Dehiscence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Luis Lopez-Campos, Jose; Vieyra-Herrera, Gerardo] Inst Nacl Cardiol Ignacio Chavez, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico	Lopez-Campos, JL (corresponding author), Inst Nacl Cardiol Ignacio Chavez, Mexico City, DF, Mexico.	drlopezcampos@yahoo.com.mx	Lopez-Campos Bodineau, Jose Luis/Q-1637-2018	Lopez-Campos Bodineau, Jose Luis/0000-0003-1703-1367					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					E20	E20		10.1056/NEJMicm0805989	http://dx.doi.org/10.1056/NEJMicm0805989			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556ED	20164481				2022-12-28	WOS:000274571200012
J	Decousus, H; Quere, I; Presles, E; Becker, F; Barrellier, MT; Chanut, M; Gillet, JL; Guenneguez, H; Leandri, C; Mismetti, P; Pichot, O; Leizorovicz, A				Decousus, Herve; Quere, Isabelle; Presles, Emilie; Becker, Francois; Barrellier, Marie-Therese; Chanut, Myriam; Gillet, Jean-Luc; Guenneguez, Herve; Leandri, Christine; Mismetti, Patrick; Pichot, Olivier; Leizorovicz, Alain		POST Study Grp	Superficial Venous Thrombosis and Venous Thromboembolism A Large, Prospective Epidemiologic Study	ANNALS OF INTERNAL MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; RISK-FACTORS; UNFRACTIONATED HEPARIN; INITIAL TREATMENT; RANDOMIZED-TRIAL; THROMBOPHLEBITIS; FONDAPARINUX; METAANALYSIS; THERAPY	Background: Superficial venous thrombosis (SVT) is perceived to have a benign prognosis. Objective: To assess the prevalence of venous thromboembolism in patients with SVT and to determine the 3-month incidence of thromboembolic complications. Design: National cross-sectional and prospective epidemiologic cohort study. (ClinicalTrials.gov registration number: NCT00818688) Setting: French office-and hospital-based vascular medicine specialists. Patients: 844 consecutive patients with symptomatic SVT of the lower limbs that was at least 5 cm on compression ultrasonography. Measurements: Incidence of venous thromboembolism and extension or recurrence of SVT in patients with isolated SVT at presentation. Results: Among 844 patients with SVT at inclusion (median age, 65 years; 547 women), 210 (24.9%) also had deep venous thrombosis (DVT) or symptomatic pulmonary embolism. Among 600 patients without DVT or pulmonary embolism at inclusion who were eligible for 3-month follow-up, 58 (10.2%) developed thromboembolic complications at 3 months (pulmonary embolism, 3 [0.5%]; DVT, 15 [2.8%]; extension of SVT, 18 [3.3%]; and recurrence of SVT, 10 [1.9%]), despite 540 patients (90.5%) having received anticoagulants. Risk factors for complications at 3 months were male sex, history of DVT or pulmonary embolism, previous cancer, and absence of varicose veins. Limitation: The findings are from a specialist referral setting, and the study was terminated before the target patient population was reached because of slow recruitment. Conclusion: A substantial number of patients with SVT exhibit venous thromboembolism at presentation, and some that do not can develop this complication in the subsequent 3 months.	Univ Hosp, St Etienne, France; St Eloi Univ Hosp, Montpellier, France; Univ Hosp Geneva, Geneva, Switzerland; Univ Hosp, Caen, France; Megival Clin, St Aubin Sur Scie, France; UMR 5558, Lyon, France	CHU de St Etienne; Universite de Montpellier; CHU de Montpellier; University of Geneva; CHU de Caen NORMANDIE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Decousus, H (corresponding author), CHU St Etienne, Serv Med & Therapeut, Grp Rech Thrombose, Hop Nord,INSERM DHOS,Ctr Invest Clin CIE3,EA 3065, F-42055 St Etienne, France.	herve.decousus@chu-st-etienne.fr	Quere, Isabelle/AAB-8519-2020	Quere, Isabelle/0000-0002-1492-9764	GlaxoSmithKline; sanofi-aventis; Ministere Francais de la Sante et des Sports; Societe Francaise de Medecine Vasculaire; Societe Francaise de Phlebologie	GlaxoSmithKline(GlaxoSmithKline); sanofi-aventis(Sanofi-Aventis); Ministere Francais de la Sante et des Sports; Societe Francaise de Medecine Vasculaire; Societe Francaise de Phlebologie	By GlaxoSmithKline, sanofi-aventis, the Ministere Francais de la Sante et des Sports (Programme Hospitalier de Recherche Clinique), the Societe Francaise de Medecine Vasculaire, and the Societe Francaise de Phlebologie.	BERGQVIST D, 1986, BRIT MED J, V292, P658, DOI 10.1136/bmj.292.6521.658-a; Bounameaux H, 1997, ARCH INTERN MED, V157, P1822, DOI 10.1001/archinte.157.16.1822; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2003, NEW ENGL J MED, V349, P1695; *CLINICALTRIALS GO, NCT00443053 CLINICAL; *CLINICALTRIALS GO, NCT00264381 CLINICAL; *CLINICALTRIALS GO, NCT00362947 CLINICAL; Decousus H, 2005, J THROMB HAEMOST, V3, P1149, DOI 10.1111/j.1538-7836.2005.01445.x; Decousus H, 2003, CURR OPIN PULM MED, V9, P393, DOI 10.1097/00063198-200309000-00009; Decousus H, 2003, ARCH INTERN MED, V163, P1657; Di Minno G, 2005, J THROMB HAEMOST, V3, P1459, DOI 10.1111/j.1538-7836.2005.01458.x; Di Nisio M, 2007, COCHRANE DB SYST REV; Dolovich LR, 2000, ARCH INTERN MED, V160, P181, DOI 10.1001/archinte.160.2.181; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Gorty S, 2004, VASC MED, V9, P1, DOI 10.1191/1358863x04vm516oa; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Leon L, 2005, EUR J VASC ENDOVASC, V29, P10, DOI 10.1016/j.ejvs.2004.09.021; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Milio G, 2008, THROMB RES, V123, P194, DOI 10.1016/j.thromres.2008.01.013; Prandoni P, 2005, J THROMB HAEMOST, V3, P1152; Quenet S, 2003, J VASC SURG, V38, P944, DOI 10.1016/S0741-5214(03)00607-4; Samama MM, 2003, HAEMATOLOGICA, V88, P1410; Uncu H, 2009, PHLEBOLOGY, V24, P56, DOI 10.1258/phleb.2008.008025; van Dongen CJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001100.PUB2; van Weert H, 2006, J FAM PRACTICE, V55, P52	25	198	204	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2010	152	4					218	U39		10.7326/0003-4819-152-4-201002160-00006	http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560AF	20157136				2022-12-28	WOS:000274873300003
J	Gebbers, R; Adamchuk, VI				Gebbers, Robin; Adamchuk, Viacheslav I.			Precision Agriculture and Food Security	SCIENCE			English	Editorial Material								Precision agriculture comprises a set of technologies that combines sensors, information systems, enhanced machinery, and informed management to optimize production by accounting for variability and uncertainties within agricultural systems. Adapting production inputs site-specifically within a field and individually for each animal allows better use of resources to maintain the quality of the environment while improving the sustainability of the food supply. Precision agriculture provides a means to monitor the food production chain and manage both the quantity and quality of agricultural produce.	[Gebbers, Robin] Leibniz Inst Agr Engn ATB, Dept Agr Engn, D-14469 Potsdam, Germany; [Adamchuk, Viacheslav I.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA	Leibniz Institut fur Agrartechnik und Biookonomie (ATB); University of Nebraska System; University of Nebraska Lincoln	Gebbers, R (corresponding author), Leibniz Inst Agr Engn ATB, Dept Agr Engn, Max Eyth Allee 100, D-14469 Potsdam, Germany.	rgebbers@atb-potsdam.de						Adamchuk VI, 2004, COMPUT ELECTRON AGR, V44, P71, DOI 10.1016/j.compag.2004.03.002; [Anonymous], 2006, HDB PRECISION AGR; BAURIEGEL E, 2009, PRECISION AGR 09, P203; Frazier B. E., 1997, The state of site specific management for agriculture., P149; Griffin T. W., 2005, Revista de Politica Agricola, V14, P20; Heege HJ, 2008, PRECIS AGRIC, V9, P115, DOI 10.1007/s11119-008-9055-3; Heraud J. A., 2009, ASABE DISTINGUISHED, V33, P1; IPEMA, 2009, PRECISION LIVESTOCK, P135; Maltz E, 2009, PRECISION LIVESTOCK, P17; McBratney Alex, 2005, Precision Agriculture, V6, P7, DOI 10.1007/s11119-005-0681-8; MOORE M, 1998, THESIS SILSOE COLL C; Pierce FJ, 1999, ADV AGRON, V67, P1, DOI 10.1016/S0065-2113(08)60513-1; Robert PC, 2002, PLANT SOIL, V247, P143, DOI 10.1023/A:1021171514148; Stafford J. V., 2006, HDB PRECISION AGR, P19; van Henten E.J., 2009, PRECISION AGR 09	15	551	576	25	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					828	831		10.1126/science.1183899	http://dx.doi.org/10.1126/science.1183899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150492				2022-12-28	WOS:000274408300049
J	Blumenthal, K; Volpp, KG				Blumenthal, Karen; Volpp, Kevin G.			Enhancing the Effectiveness of Food Labeling in Restaurants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFORMATION; CHOICES		[Blumenthal, Karen; Volpp, Kevin G.] Univ Penn, Ctr Hlth Incent, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Univ Penn, Dept Hlth Care Management, Wharton Sch, Philadelphia, PA 19104 USA; [Blumenthal, Karen; Volpp, Kevin G.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Volpp, KG (corresponding author), Univ Penn, Ctr Hlth Incent, Leonard Davis Inst Hlth Econ, 1232 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu		Volpp, Kevin/0000-0003-1423-4599				Downs J. S., 2009, NY TIMES, pA31; Downs JS, 2009, AM ECON REV, V99, P159, DOI 10.1257/aer.99.2.159; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Fitch RC, 2009, AM J HEALTH PROMOT, V24, P129, DOI 10.4278/ajhp.08031426; Fung A, 2007, FULL DISCLOSURE PERI; Harnack LJ, 2008, INT J BEHAV NUTR PHY, V5, DOI [10.1186/1479-5868-5-51, 10.1186/1479-5868-5-63]; Lando AM, 2007, J NUTR EDUC BEHAV, V39, P157, DOI 10.1016/j.jneb.2006.12.010; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Rothman RL, 2006, AM J PREV MED, V31, P391, DOI 10.1016/j.amepre.2006.07.025; THALER RH, 1981, J POLIT ECON, V89, P392, DOI 10.1086/260971	10	39	40	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					553	554		10.1001/jama.2010.85	http://dx.doi.org/10.1001/jama.2010.85			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145233				2022-12-28	WOS:000274378700028
J	Leydon, GM; Turner, S; Smith, H; Little, P				Leydon, G. M.; Turner, S.; Smith, H.; Little, P.		UTIS Team	Women's views about management and cause of urinary tract infection: qualitative interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIBIOTIC-RESISTANCE; PRIMARY-CARE; PRESCRIBING STRATEGIES; RANDOMIZED-TRIAL; SORE THROAT; CIPROFLOXACIN; IMPACT	Objectives To explore the views of women with urinary tract infection on the acceptability of different strategies for managing the infection, including delayed use of antibiotics, and the cause of infection. Design Qualitative interview study with semistructured one to one interviews within a randomised controlled trial of different management strategies. Analysis drew on some of the principles of constant comparison to generate key themes grounded in reported experiences and understandings. Setting Seven general practices across four counties in southern England. Participants 21 women presenting to general practices who were taking part in the larger trial. Results Women preferred not to take antibiotics and were open to alternative management approaches. With a strategy of "antibiotic delay" some women felt a lack of validation or that they were not listened to by their general practitioner. Women attributed urinary tract infection to lifestyle habits and behaviours, such as poor hygiene, general "negligence," and even a "penalty of growing old." Conclusion A clear acknowledgment of women's triggers to consult is needed. If women are asked to delay taking antibiotics, the clinician must address the particular worries that women might have and explain the rationale for not using antibiotics immediately.	[Leydon, G. M.; Little, P.] Univ Southampton, Sch Med, Aldermoor Hlth Ctr, Community Clin Sci Div, Southampton SO16 5ST, Hants, England; [Smith, H.] Univ Brighton, Brighton & Sussex Med Sch, Brighton BN1 9PH, E Sussex, England	University of Southampton; University of Brighton; University of Sussex	Leydon, GM (corresponding author), Univ Southampton, Sch Med, Aldermoor Hlth Ctr, Community Clin Sci Div, Southampton SO16 5ST, Hants, England.	gerry@soton.ac.uk	Leydon, Geraldine M/C-4968-2011; Smith, Helen E/M-2449-2016; Moore, Michael/C-3447-2011	Smith, Helen E/0000-0003-1883-6124; Moore, Michael/0000-0002-5127-4509; Rumsby, Kate/0000-0002-8573-3718; Little, Paul/0000-0003-3664-1873; Leydon, Geraldine Marie/0000-0001-5986-3300	Health Technology Assessment programme [97/14/06]; National Institute for Health Research [97/14/06] Funding Source: researchfish	Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Health Technology Assessment programme grant reference: 97/14/06. The HTA had no involvement in the research process or writing of this article.	AHMED M, 2001, TODAYS THERAPEUTIC T, V19, P63; Albert X, 2004, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD001209.pub2, DOI 10.1002/14651858.CD001209.PUB2]; Arason VA, 1996, BMJ-BRIT MED J, V313, P387; AVORN J, 1994, JAMA-J AM MED ASSOC, V271, P751, DOI 10.1001/jama.271.10.751; Barbour RS, 2000, FAM PRACT, V17, P83, DOI 10.1093/fampra/17.1.83; Blaxter M, 1997, SOC SCI MED, V44, P747, DOI 10.1016/S0277-9536(96)00192-X; Bunton R., 1995, SOCIOLOGY HLTH PROMO; Butler CC, 2001, J ANTIMICROB CHEMOTH, V48, P435, DOI 10.1093/jac/48.3.435; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; DeAlleaume L, 2006, J FAM PRACTICE, V55, P338; Everitt H, 2003, BRIT J GEN PRACT, V53, P36; Fourcroy JL, 2005, ANTIMICROB AGENTS CH, V49, P4137, DOI 10.1128/AAC.49.10.4137-4143.2005; Foxman B, 2002, AM J MED, V113, p5S; Goessens W H F, 2007, Ned Tijdschr Geneeskd, V151, P748; Hart CA, 1998, BMJ-BRIT MED J, V316, P1255, DOI 10.1136/bmj.316.7140.1255; Henry DC, 1999, CLIN THER, V21, P966, DOI 10.1016/S0149-2918(99)80018-6; LEE JBL, 2007, MEDICINE, V35, P423; LEIBOVICI L, 1991, Q J MED, V78, P43; Leydon GM, 2009, BRIT J GEN PRACT, V59, P490, DOI 10.3399/bjgp09X453459; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; McIsaac WJ, 2002, ARCH INTERN MED, V162, P600, DOI 10.1001/archinte.162.5.600; McNulty CAM, 2006, J ANTIMICROB CHEMOTH, V58, P1000, DOI 10.1093/jac/dkl368; Milo G, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004682.pub2; *OPCS, 1994, MORB STAT GEN PRACT; Patton MQ., 2015, QUALITATIVE RES EVAL, V3; Silverman D., 1993, INTERPRETING QUALITA; Stivers T, 2002, SOC SCI MED, V54, P1111, DOI 10.1016/S0277-9536(01)00085-5; Tam VH, 2007, J INFECT DIS, V195, P1818, DOI 10.1086/518003; 1995, MEREC B, V6, P29	31	64	66	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2010	340								c279	10.1136/bmj.c279	http://dx.doi.org/10.1136/bmj.c279			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CX	20139217	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000274343700004
J	Heidorn, SJ; Milagre, C; Whittaker, S; Nourry, A; Niculescu-Duvas, I; Dhomen, N; Hussain, J; Reis-Filho, JS; Springer, CJ; Pritchard, C; Marais, R				Heidorn, Sonja J.; Milagre, Carla; Whittaker, Steven; Nourry, Arnaud; Niculescu-Duvas, Ion; Dhomen, Nathalie; Hussain, Jahan; Reis-Filho, Jorge S.; Springer, Caroline J.; Pritchard, Catrin; Marais, Richard			Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF	CELL			English	Article							B-RAF; K-RAS; ACTIVATION; MELANOMA; INHIBITOR; PATHWAY; HETERODIMERIZATION; MUTATIONS; MECHANISM	We describe a mechanism of tumorigenesis mediated by kinase-dead BRAF in the presence of oncogenic RAS. We show that drugs that selectively inhibit BRAF drive RAS-dependent BRAF binding to CRAF, CRAF activation, and MEK-ERK signaling. This does not occur when oncogenic BRAF is inhibited, demonstrating that BRAF inhibition per se does not drive pathway activation; it only occurs when BRAF is inhibited in the presence of oncogenic RAS. Kinase-dead BRAF mimics the effects of the BRAF-selective drugs and kinase-dead Braf and oncogenic Ras cooperate to induce melanoma in mice. Our data reveal another paradigm of BRAF-mediated signaling that promotes tumor progression. They highlight the importance of understanding pathway signaling in clinical practice and of genotyping tumors prior to administering BRAF-selective drugs, to identify patients who are likely to respond and also to identify patients who may experience adverse effects.	[Heidorn, Sonja J.; Milagre, Carla; Whittaker, Steven; Dhomen, Nathalie; Marais, Richard] Inst Canc Res, Signal Transduct Team, Sect Cell & Mol Biol, London SW3 6JB, England; [Hussain, Jahan; Pritchard, Catrin] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Nourry, Arnaud; Niculescu-Duvas, Ion; Springer, Caroline J.] Inst Canc Res, Gene & Oncogene Targeting Team, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Leicester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK	Marais, R (corresponding author), Inst Canc Res, Signal Transduct Team, Sect Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.	richard.marais@icr.ac.uk	Whittaker, Steven/AAS-9874-2020	Marais, Richard/0000-0001-7484-4183; Springer, Caroline/0000-0002-0650-4002; Dhomen, Nathalie/0000-0003-1961-2173; Whittaker, Steven/0000-0001-9062-7947; Pritchard, Catrin/0000-0003-1859-4487; Gill, Sonja/0000-0002-7273-9053	Institute of Cancer Research, Cancer Research UK [C107/A10433]; Wellcome Trust [080333/Z/06/Z]; Breakthrough Breast Cancer; NHS	Institute of Cancer Research, Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Breakthrough Breast Cancer; NHS	The Institute of Cancer Research, Cancer Research UK (C107/A10433), and the Wellcome Trust (080333/Z/06/Z) funded this work. J.S.R.-F. is funded in part by Breakthrough Breast Cancer. We acknowledge NHS funding to the NIHR Biomedical Research Centre. We thank Professor Nick Hayward (QIMR, Queensland) for D04, MM415, and MM485 cell lines; Professor Tyler Jacks (MIT, Boston) for the Kras LSL-G12D mice; Dr. Kay Savage (ICR) and Annette Lane (ICR) for technical assistance with histological and immunohistochemical preparations; and Alice Smith (ICR) for technical assistance with DNA sequencing. All ICR authors are part of a "Rewards to Inventors Scheme," which could provide financial benefit to any authors that contribute to any program that is subsequently commercialized.	[Anonymous], 1988, LAB ANIM-UK, V22, P195; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; FLAHERTY K, 2009, J CLIN ONCOL, V27, pS15; Frye SV, 2009, NAT CHEM BIOL, V5, P448, DOI 10.1038/nchembio.f.11; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Halilovic E, 2008, CURR OPIN PHARMACOL, V8, P419, DOI 10.1016/j.coph.2008.06.014; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Ikenoue T, 2003, CANCER RES, V63, P8132; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schwartz GK, 2009, J CLIN ONCOL S, V27, p15s; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yajima I, 2006, GENESIS, V44, P34, DOI 10.1002/gene.20182	32	1109	1142	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					209	221		10.1016/j.cell.2009.12.040	http://dx.doi.org/10.1016/j.cell.2009.12.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141835	Green Published, hybrid			2022-12-28	WOS:000273826500012
J	Lopez-Herce, J; Alvarez, AC				Lopez-Herce, Jesus; Carrillo Alvarez, Angel			Bystander CPR for paediatric out-of-hospital cardiac arrest	LANCET			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; EPIDEMIOLOGY; OUTCOMES; MODEL		[Lopez-Herce, Jesus; Carrillo Alvarez, Angel] Hosp Gen Univ Gregorio Maranon, Pediat Intens Care Serv, Madrid 28009, Spain	General University Gregorio Maranon Hospital	Lopez-Herce, J (corresponding author), Hosp Gen Univ Gregorio Maranon, Pediat Intens Care Serv, Madrid 28009, Spain.	pielvi@ya.com	Lopez-Herce, Jesus/A-1602-2019	Lopez-Herce, Jesus/0000-0001-6105-9178				Atkins DL, 2009, CIRCULATION, V119, P1484, DOI 10.1161/CIRCULATIONAHA.108.802678; Connolly M, 2007, RESUSCITATION, V72, P270, DOI 10.1016/j.resuscitation.2006.06.031; Ewy GA, 2007, CIRCULATION, V116, P2525, DOI 10.1161/CIRCULATIONAHA.107.711820; International Liaison Committee on Resuscitation, 2005, Resuscitation, V67, P271; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Kellum MJ, 2008, ANN EMERG MED, V52, P244, DOI 10.1016/j.annemergmed.2008.02.006; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Lopez-Herce J, 2005, PEDIATR EMERG CARE, V21, P807; Nagao K, 2007, LANCET, V369, P920; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Taniguchi T, 2007, RESUSCITATION, V75, P82, DOI 10.1016/j.resuscitation.2007.02.019; Yannopoulos D, 2010, CRIT CARE MED, V38, P254, DOI 10.1097/CCM.0b013e3181b42f6c; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157	14	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1321	1322		10.1016/S0140-6736(10)60316-9	http://dx.doi.org/10.1016/S0140-6736(10)60316-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20202678				2022-12-28	WOS:000277057800004
J	Fowkes, FGR; Price, JF; Stewart, MCW; Butcher, I; Leng, GC; Pell, ACH; Sandercock, PAG; Fox, KAA; Lowe, GDO; Murray, GD				Fowkes, F. Gerald R.; Price, Jacqueline F.; Stewart, Marlene C. W.; Butcher, Isabella; Leng, Gillian C.; Pell, Alistair C. H.; Sandercock, Peter A. G.; Fox, Keith A. A.; Lowe, Gordon D. O.; Murray, Gordon D.		Aspirin Asymptomatic Atheroscleros	Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DOSE ASPIRIN; PERIPHERAL ARTERIAL-DISEASE; HEART-DISEASE; RISK; INTERVENTIONS; MORTALITY; MEN	Context A low ankle brachial index (ABI) indicates atherosclerosis and an increased risk of cardiovascular and cerebrovascular events. Screening for a low ABI can identify an asymptomatic higher risk group potentially amenable to preventive treatments. Objective To determine the effectiveness of aspirin in preventing events in people with a low ABI identified on screening the general population. Design, Setting, and Participants The Aspirin for Asymptomatic Atherosclerosis trial was an intention-to-treat double-blind randomized controlled trial conducted from April 1998 to October 2008, involving 28 980 men and women aged 50 to 75 years living in central Scotland, free of clinical cardiovascular disease, recruited from a community health registry, and had an ABI screening test. Of those, 3350 with a low ABI (<= 0.95) were entered into the trial, which was powered to detect a 25% proportional risk reduction in events. Interventions Once daily 100 mg aspirin ( enteric coated) or placebo. Main Outcome Measures The primary end point was a composite of initial fatal or nonfatal coronary event or stroke or revascularization. Two secondary end points were ( 1) all initial vascular events defined as a composite of a primary end point event or angina, intermittent claudication, or transient ischemic attack; and ( 2) all-cause mortality. Results After a mean (SD) follow-up of 8.2 (1.6) years, 357 participants had a primary end point event (13.5 per 1000 person-years, 95% confidence interval [CI], 12.2-15.0). No statistically significant difference was found between groups (13.7 events per 1000 person-years in the aspirin group vs 13.3 in the placebo group; hazard ratio [HR], 1.03; 95% CI, 0.84-1.27). Avascular event comprising the secondary end point occurred in 578 participants (22.8 per 1000 person-years; 95% CI, 21.0-24.8) and no statistically significant difference between groups ( 22.8 events per 1000 person-years in the aspirin group vs 22.9 in the placebo group; HR, 1.00; 95% CI, 0.85-1.17). There was no significant difference in all-cause mortality between groups ( 176 vs 186 deaths, respectively; HR, 0.95; 95% CI, 0.77-1.16). An initial event of major hemorrhage requiring admission to hospital occurred in 34 participants (2.5 per 1000 person-years) in the aspirin group and 20 (1.5 per 1000 person-years) in the placebo group ( HR, 1.71; 95% CI, 0.99-2.97). Conclusion Among participants without clinical cardiovascular disease, identified with a low ABI based on screening a general population, the administration of aspirin compared with placebo did not result in a significant reduction in vascular events. Trial Registration isrctn.org Identifier: ISRCTN66587262 JAMA. 2010;303(9):841-848 www.jama.com	[Fowkes, F. Gerald R.] Univ Edinburgh, Ctr Populat Hlth Sci, Wolfson Unit Prevent Peripheral Vasc Dis, Edinburgh EH8 9AG, Midlothian, Scotland; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Sandercock, Peter A. G.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Leng, Gillian C.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Pell, Alistair C. H.] Monklands Hosp, Dept Cardiol, Airdrie, Lanark, Scotland; [Lowe, Gordon D. O.] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine; Monklands Hospital; University of Glasgow	Fowkes, FGR (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Wolfson Unit Prevent Peripheral Vasc Dis, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	gerry.fowkes@ed.ac.uk	Fox, keith A A/I-3742-2013; Lindley, Richard/B-8148-2013; Morling, Jo/AAH-7385-2020; Deary, Ian J/C-6297-2009	Lindley, Richard/0000-0002-0104-5679; Morling, Jo/0000-0003-0772-2893; Deary, Ian J/0000-0002-1733-263X; Fox, Keith/0000-0002-0140-2752; Stewart, Marlene/0000-0001-7939-7001; Sandercock, Peter/0000-0001-8484-0135; Price, Jackie/0000-0003-3251-3970; Murray, Gordon/0000-0001-9866-4734	British Heart Foundation and Chief Scientist's Office, Scotland; Bayer HealthCare; MRC [G0800803] Funding Source: UKRI; Medical Research Council [G0800803] Funding Source: researchfish	British Heart Foundation and Chief Scientist's Office, Scotland; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The trial was funded by the British Heart Foundation and Chief Scientist's Office, Scotland. Bayer HealthCare provided the aspirin and placebo tablets and funds for packaging, dispensing, and some statistical analysis.	Ajjan R, 2008, DIABETOLOGIA, V51, P385, DOI 10.1007/s00125-007-0898-3; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; EBORALL HC, 2004, LAY ATTITUDES CARDIO; Ebrahim S, 1997, BMJ-BRIT MED J, V314, P1666, DOI 10.1136/bmj.314.7095.1666; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Meade TW, 1998, LANCET, V351, P233; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; *OFF CHIEF STAT SC, SCOTT IND MULT DEPR; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; OGREN M, 1993, LANCET, V342, P1138, DOI 10.1016/0140-6736(93)92123-B; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Price JF, 2008, EUR J CARDIOV PREV R, V15, P370, DOI 10.1097/HJR.0b013e3282f8b36a; Price JF, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1198; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; *US PREV SERV TASK, 2005, SCREEN PER ART DIS R	33	454	469	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					841	848		10.1001/jama.2010.221	http://dx.doi.org/10.1001/jama.2010.221			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197530	Bronze			2022-12-28	WOS:000275059500017
J	Lang, AE; Schmidt, G; Schlosser, A; Hey, TD; Larrinua, IM; Sheets, JJ; Mannherz, HG; Aktories, K				Lang, Alexander E.; Schmidt, Gudula; Schlosser, Andreas; Hey, Timothy D.; Larrinua, Ignacio M.; Sheets, Joel J.; Mannherz, Hans G.; Aktories, Klaus			Photorhabdus luminescens Toxins ADP-Ribosylate Actin and RhoA to Force Actin Clustering	SCIENCE			English	Article							YERSINIA-PESTIS; PROTEINS; BIOCHEMISTRY; COMPLEXES; PROFILIN; BIOLOGY	The bacterium Photorhabdus luminescens is mutualistically associated with entomopathogenetic nematodes. These nematodes invade insect larvae and release the bacteria from their intestine, which kills the insects through the action of toxin complexes. We elucidated the mode of action of two of these insecticidal toxins from P. luminescens. We identified the biologically active components TccC3 and TccC5 as adenosine diphosphate (ADP)-ribosyltransferases, which modify unusual amino acids. TccC3 ADP-ribosylated threonine-148 of actin, resulting in actin polymerization. TccC5 ADP-ribosylated Rho guanosine triphosphatase proteins at glutamine-61 and glutamine-63, inducing their activation. The concerted action of both toxins inhibited phagocytosis of target insect cells and induced extensive intracellular polymerization and clustering of actin. Several human pathogenic bacteria produce related toxins.	[Lang, Alexander E.; Schmidt, Gudula; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Lang, Alexander E.] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Schlosser, Andreas] Univ Freiburg, Core Facil Prote, Zentrum Biosyst Anal, D-79104 Freiburg, Germany; [Hey, Timothy D.; Larrinua, Ignacio M.; Sheets, Joel J.] Dow AgroSci, Discovery Res, Indianapolis, IN 46268 USA; [Mannherz, Hans G.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Mannherz, Hans G.] Ruhr Univ Bochum, Abt Anat & Embryol, D-44801 Bochum, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Dow Chemical Company; Max Planck Society; Ruhr University Bochum	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Mannherz, Hans Georg/HHM-2867-2022	Aktories, Klaus/0000-0002-5397-0436; Mannherz, Hans Georg/0000-0001-8158-5722	Deutsche Forschungsgemeinschaft DFG	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	We thank Agilent Technologies for supporting us with instrumentation, R. S. Goody (Dortmund, Germany) for help in stopped-flow measurements, and M. Geyer (Dortmund, Germany) for providing profilin. The study was financially supported by the Deutsche Forschungsgemeinschaft DFG to K. A. and H. G. M.	AKTORIES K, 1989, J CELL BIOL, V109, P1385, DOI 10.1083/jcb.109.4.1385; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Ffrench-Constant R, 2003, FEMS MICROBIOL REV, V26, P433, DOI 10.1111/j.1574-6976.2003.tb00625.x; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Hares MC, 2008, MICROBIOL-SGM, V154, P3503, DOI 10.1099/mic.0.2008/018440-0; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Lee SC, 2007, J MOL BIOL, V366, P1558, DOI 10.1016/j.jmb.2006.12.057; Mannherz HG, 2007, J MOL BIOL, V366, P745, DOI 10.1016/j.jmb.2006.11.100; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; SUN HQ, 1995, CURR OPIN CELL BIOL, V7, P102, DOI 10.1016/0955-0674(95)80051-4; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Waterfield N, 2005, CELL MICROBIOL, V7, P373, DOI 10.1111/j.1462-5822.2004.00467.x; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3	23	171	177	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1139	1142		10.1126/science.1184557	http://dx.doi.org/10.1126/science.1184557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185726				2022-12-28	WOS:000274901100039
J	Gore, ME; Griffin, CL; Hancock, B; Patel, PM; Pyle, L; Aitchison, M; James, N; Oliver, RTD; Mardiak, J; Hussain, T; Sylvester, R; Parmar, MKB; Royston, P; Mulders, PFA				Gore, Martin E.; Griffin, Clare L.; Hancock, Barry; Patel, Poulam M.; Pyle, Lynda; Aitchison, Michael; James, Nicholas; Oliver, Roderick T. D.; Mardiak, Jozef; Hussain, Tahera; Sylvester, Richard; Parmar, Mahesh K. B.; Royston, Patrick; Mulders, Peter F. A.			Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial	LANCET			English	Article							DOSE RECOMBINANT INTERLEUKIN-2; CLINICAL-TRIALS; SURVIVAL; MEDROXYPROGESTERONE; VINBLASTINE; SUNITINIB; CANCER	Background In metastatic renal cell carcinoma combinations of interferon alfa-2a, interleukin-2, and fluorouracil produce higher response rates and longer progression-free survival than do single agents. We aimed to compare overall survival in patients receiving combination treatment or interferon alfa-2a. Methods RE04/30012 was an open-label randomised trial undertaken in 50 centres across eight countries. 1006 treatment-naive patients diagnosed with advanced metastatic renal cell carcinoma were randomly allocated (1 to 1) by minimisation to receive interferon alfa-2a alone or combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil. Treatment was not masked. The primary endpoint was overall survival. Treatment groups were compared with a non-stratified log-rank test. Analysis was by intention to treat. This study is registered, number ISRCTN 46518965. Findings 502 patients were randomly assigned to receive interferon alfa-2a and 504 to receive combined treatment. Median follow-up was 37.2 months (24.8-52.3). Median overall survival was 18.8 months (17.0-23.2) for patients receiving interferon alfa-2a versus 18.6 months (16.5-20.6) for those receiving combination therapy. overall survival did not differ between the two groups (hazard ratio 1.05 [95% Cl 0.90-1.21], p=0.55; absolute difference 0.3% (-5.1. to 5.6) at 1 year and 2.7% (-8.2 to 2.9) at 3 years). Serious adverse events were reported in 113 (23%) patients receiving interferon alfa-2a and 131 (26%) of those receiving combined treatment. Interpretation Although combination therapy does not improve overall or progression-free survival compared with interferon alfa-2a alone, immunotherapy might still have a role because it can produce remissions that are of clinically relevant length in some patients. identification of patients who will benefit from immunotherapy is crucial.	[Gore, Martin E.] Royal Marsden Hosp NHS Trust, Dept Med, London SW3 6JJ, England; [Griffin, Clare L.; Hussain, Tahera; Parmar, Mahesh K. B.; Royston, Patrick] MRC, Clin Trials Unit, London, England; [Hancock, Barry] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Patel, Poulam M.] Univ Nottingham, Nottingham NG7 2RD, England; [Aitchison, Michael] Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland; [James, Nicholas] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham, W Midlands, England; [Oliver, Roderick T. D.] QMUL, Barts & London Med Sch, Inst Canc, London, England; [Mardiak, Jozef] Natl Canc Inst, Bratislava, Slovakia; [Sylvester, Richard] European Org Res & Treatment Canc Headquarters, Brussels, Belgium; [Mulders, Peter F. A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Royal Marsden NHS Foundation Trust; Medical Research Council Clinical Trials Unit; Weston Park Hospital; University of Nottingham; Beatson Oncology Centre; Cancer Research UK; University of Birmingham; University of London; Queen Mary University London; National Institute of Oncology (NOU); European Organisation for Research & Treatment of Cancer; Radboud University Nijmegen	Gore, ME (corresponding author), Royal Marsden Hosp NHS Trust, Dept Med, Fulham Rd, London SW3 6JJ, England.	Martin.Gore@rmh.nhs.uk	James, Nick/AAL-6802-2020; Mulders, Peter F.A./H-8076-2014	James, Nicholas/0000-0002-7314-8204	National Cancer Institute (Bethesda, MD, USA) [5U10 CA11488-32, 5U10 CA011488-38]; EORTC Charitable Trust; UK National Health Service; MRC [E164/52] Funding Source: UKRI; Medical Research Council [E164/52] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U10CA011488] Funding Source: NIH RePORTER	National Cancer Institute (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EORTC Charitable Trust; UK National Health Service; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all patients who participated in this trial and the research staff at the clinical centres, who helped to recruit participants and provide data. This report was supported by grants numbers 5U10 CA11488-32 to 5U10 CA011488-38 from the National Cancer Institute (Bethesda, MD, USA) and the EORTC Charitable Trust. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute, Schering-Plough provided free interferon and Chiron provided interleukin-2 at a discounted rate to M RC centres. Roche AG and Chiron provided support to the EORTC. MG acknowledges UK National Health Service funding to the National Institute for Health Research Biomedical Research Centre at the Royal Marsden Hospital.	Atkins MB, 2004, CLIN CANCER RES, V10, p6342S, DOI 10.1158/1078-0432.CCR-040029; Atzpodien J, 2001, BRIT J CANCER, V85, P1130, DOI 10.1054/bjoc.2001.2076; Atzpodien J, 2004, J CLIN ONCOL, V22, P1188, DOI 10.1200/JCO.2004.06.155; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; De Mulder PHM, 2004, ANN ONCOL, V15, P319, DOI 10.1093/annonc/mdh946; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Figlin R, 1997, CANCER J SCI AM, V3, pS92; Fisher RI, 2000, CANCER J SCI AM, V6, pS55; FOSSA S, 1995, BRIT J UROL, V76, P286, DOI 10.1111/j.1464-410X.1995.tb07702.x; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; HARKINS D, NATL CANC I SEER CAN; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; JONES M, 1993, CANCER BIOTHERAPY, V8, P275, DOI 10.1089/cbr.1993.8.275; KRIEGMAIR M, 1995, UROLOGY, V45, P758, DOI 10.1016/S0090-4295(99)80079-X; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Negrier S, 2007, CANCER-AM CANCER SOC, V110, P2468, DOI 10.1002/cncr.23056; Pyrhonen S, 1999, J CLIN ONCOL, V17, P2859, DOI 10.1200/JCO.1999.17.9.2859; Ritchie A, 1999, LANCET, V353, P14; Rosenberg SA, 1998, ANN SURG, V228, P307, DOI 10.1097/00000658-199809000-00004; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Royston P, 2001, STATA J, V1, P1, DOI 10.1177/1536867X0100100101; STEINECK G, 1990, ACTA ONCOL, V29, P155, DOI 10.3109/02841869009126537; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122	30	75	77	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					641	648		10.1016/S0140-6736(09)61921-8	http://dx.doi.org/10.1016/S0140-6736(09)61921-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20153039	Bronze, Green Published			2022-12-28	WOS:000275210900032
J	Shishido, H; Shibauchi, T; Yasu, K; Kato, T; Kontani, H; Terashima, T; Matsuda, Y				Shishido, H.; Shibauchi, T.; Yasu, K.; Kato, T.; Kontani, H.; Terashima, T.; Matsuda, Y.			Tuning the Dimensionality of the Heavy Fermion Compound CeIn3	SCIENCE			English	Article							SPIN FLUCTUATIONS; SUPERCONDUCTIVITY; CRITICALITY; PRESSURE; FIELD	Condensed-matter systems that are both low-dimensional and strongly interacting often exhibit unusual electronic properties. Strongly correlated electrons with greatly enhanced effective mass are present in heavy fermion compounds, whose electronic structure is essentially three-dimensional. We realized experimentally a two-dimensional heavy fermion system, adjusting the dimensionality in a controllable fashion. Artificial superlattices of the antiferromagnetic heavy fermion compound CeIn3 and the conventional metal LaIn3 were grown epitaxially. By reducing the thickness of the CeIn3 layers, the magnetic order was suppressed and the effective electron mass was further enhanced. Heavy fermions confined to two dimensions display striking deviations from the standard Fermi liquid low-temperature electronic properties, and these are associated with the dimensional tuning of quantum criticality.	[Shishido, H.; Shibauchi, T.; Yasu, K.; Kato, T.; Matsuda, Y.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Shishido, H.; Terashima, T.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto 6068501, Japan; [Kontani, H.] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan	Kyoto University; Kyoto University; Nagoya University	Matsuda, Y (corresponding author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	matsuda@scphys.kyoto-u.ac.jp	Shibauchi, Takasada/B-9349-2008; Kontani, Hiroshi/V-5117-2017; Matsuda, Yuji/ABH-7166-2020	Shibauchi, Takasada/0000-0001-5831-4924; Kontani, Hiroshi/0000-0002-8127-7903; Matsuda, Yuji/0000-0001-9947-9418; shishido, hiroaki/0000-0003-2196-6827	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [23654118] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Izaki, N. Kawakami, H. Kurata, K. Miyake, and A. Tanaka for discussion. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science and by a Grant-in-Aid for the Global Centers of Excellence program "The Next Generation of Physics, Spun from Universality and Emergence" from the Ministry of Education, Culture, Sports, Science and Technology.	Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.257001; FULLERTON EE, 1992, PHYS REV B, V45, P9292, DOI 10.1103/PhysRevB.45.9292; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Groten D, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.144425; Hegger H, 2000, PHYS REV LETT, V84, P4986, DOI 10.1103/PhysRevLett.84.4986; HEWSON AC, 2003, KONDON PROBLEM HEAVY; Ida Y, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.084708; Izaki M, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2787969; Jourdan M, 1999, NATURE, V398, P47, DOI 10.1038/17977; KASHIBA SI, 1986, J PHYS SOC JPN, V55, P1341, DOI 10.1143/JPSJ.55.1341; Kawasaki S, 2004, J PHYS SOC JPN, V73, P1647, DOI 10.1143/JPSJ.73.1647; Knafo W, 2003, J PHYS-CONDENS MAT, V15, P3741, DOI 10.1088/0953-8984/15/22/308; Knebel G, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.024425; Kontani H, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/2/026501; LAWRENCE JM, 1980, PHYS REV B, V22, P4379, DOI 10.1103/PhysRevB.22.4379; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Moriya T, 2000, ADV PHYS, V49, P555, DOI 10.1080/000187300412248; Nakajima Y, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.024703; Neumann M, 2007, SCIENCE, V317, P1356, DOI 10.1126/science.1143607; Petrovic C, 2001, J PHYS-CONDENS MAT, V13, pL337, DOI 10.1088/0953-8984/13/17/103; Sachdev S., 2000, QUANTUM PHASE TRANSI; Shibauchi T, 2008, P NATL ACAD SCI USA, V105, P7120, DOI 10.1073/pnas.0712292105; Shishido H, 2005, J PHYS SOC JPN, V74, P1103, DOI 10.1143/JPSJ.74.1103; Zheng GQ, 2001, PHYS REV LETT, V86, P4664, DOI 10.1103/PhysRevLett.86.4664	24	117	120	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					980	983		10.1126/science.1183376	http://dx.doi.org/10.1126/science.1183376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167781	Green Submitted			2022-12-28	WOS:000274625800035
J	Raj, A; Rifkin, SA; Andersen, E; van Oudenaarden, A				Raj, Arjun; Rifkin, Scott A.; Andersen, Erik; van Oudenaarden, Alexander			Variability in gene expression underlies incomplete penetrance	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GATA-FACTOR; C-ELEGANS; SINGLE-CELL; TRANSCRIPTION; SKN-1; ENDODERM; POP-1; ELT-2; DIFFERENTIATION	The phenotypic differences between individual organisms can often be ascribed to underlying genetic and environmental variation. However, even genetically identical organisms in homogeneous environments vary, indicating that randomness in developmental processes such as gene expression may also generate diversity. To examine the consequences of gene expression variability in multicellular organisms, we studied intestinal specification in the nematode Caenorhabditis elegans in which wild-type cell fate is invariant and controlled by a small transcriptional network. Mutations in elements of this network can have indeterminate effects: some mutant embryos fail to develop intestinal cells, whereas others produce intestinal precursors. By counting transcripts of the genes in this network in individual embryos, we show that the expression of an otherwise redundant gene becomes highly variable in the mutants and that this variation is subjected to a threshold, producing an ON/OFF expression pattern of the master regulatory gene of intestinal differentiation. Our results demonstrate that mutations in developmental networks can expose otherwise buffered stochastic variability in gene expression, leading to pronounced phenotypic variation.	[Raj, Arjun; Rifkin, Scott A.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Raj, Arjun; Rifkin, Scott A.; Andersen, Erik; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Andersen, Erik] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Princeton University	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Rifkin, Scott/0000-0001-8476-3256; Raj, Arjun/0000-0002-2915-6960; Andersen, Erik/0000-0003-0229-9651	National Institutes of Health (NIH); National Science Foundation [DMS-0603392]; Burroughs-Wellcome Fund; NIH NRSA [5F32GM080966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080966] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. R. Horvitz for early discussions and technical assistance. We also thank H. R. Horvitz and J. Gore for a critical reading of the manuscript. This work was funded by a National Institutes of Health (NIH) Director's Pioneer Award to A.v.O. A. R. was supported by a National Science Foundation MSPRF fellowship DMS-0603392 and a Burroughs-Wellcome Fund Career Award at the Scientific Interface. S. A. R. was supported by an NIH NRSA postdoctoral fellowship 5F32GM080966.	Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Broitman-Maduro G, 2005, DEV CELL, V8, P427, DOI 10.1016/j.devcel.2005.01.014; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goszczynski B, 2005, GENETICS, V171, P545, DOI 10.1534/genetics.105.044909; HORVITZ HR, 1980, GENETICS, V96, P435; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Laubichler MD, 2002, MUTATING CONCEPTS EV, P63; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maduro MF, 2005, DEV BIOL, V285, P510, DOI 10.1016/j.ydbio.2005.06.022; Maduro MF, 2005, DEV BIOL, V284, P509, DOI 10.1016/j.ydbio.2005.05.016; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Maduro MF, 2009, BBA-GENE REGUL MECH, V1789, P250, DOI 10.1016/j.bbagrm.2008.07.013; Maduro MF, 2007, DEV BIOL, V301, P590, DOI 10.1016/j.ydbio.2006.08.029; McGhee J.D., 2007, C ELEGANS INTESTINE, P1; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Romaschoff DD, 1925, J PSYCHOL NEUROL, V31, P323; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; SUEI GM, 2007, SCIENCE, V315, P1716; Timofeeff-Ressowsky NW, 1925, J PSYCHOL NEUROL, V31, P305; Vogt O, 1926, Z GESAMTE NEUROL PSY, V101, P805, DOI 10.1007/BF02878364; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Waddington C. H, 1940, ORG AND GENES; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Walker AK, 2000, J BIOL CHEM, V275, P22166, DOI 10.1074/jbc.M001746200; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Zhu JW, 1998, GENE DEV, V12, P3809, DOI 10.1101/gad.12.24.3809; Zhu JW, 1997, GENE DEV, V11, P2883, DOI 10.1101/gad.11.21.2883	50	454	465	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					913	U84		10.1038/nature08781	http://dx.doi.org/10.1038/nature08781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164922	Green Submitted, Green Accepted			2022-12-28	WOS:000274582700038
J	Joshi, D; James, A; Quaglia, A; Westbrook, RH; Heneghan, MA				Joshi, Deepak; James, Andra; Quaglia, Alberto; Westbrook, Rachel H.; Heneghan, Michael A.			Liver disease in pregnancy	LANCET			English	Review							ACUTE FATTY LIVER; HERPES-SIMPLEX-VIRUS; CIRCULATING ANGIOGENIC FACTORS; ACUTE VIRAL-HEPATITIS; LOW PLATELETS HELLP; INTRAHEPATIC CHOLESTASIS; HYPEREMESIS GRAVIDARUM; RISK-FACTORS; URSODEOXYCHOLIC ACID; FULMINANT-HEPATITIS	Severe liver disease in pregnancy is rare. Pregnancy-related liver disease is the most frequent cause of liver dysfunction in pregnancy and provides a real threat to fetal and maternal survival. A rapid diagnosis differentiating between liver disease related and unrelated to pregnancy is required in women who present with liver dysfunction during pregnancy. Research has improved our understanding of the pathogenesis of pregnancy-related liver disease, which has translated into improved maternal and fetal outcomes. Here, we provide an overview of liver diseases that occur in pregnancy, an update on the key mechanisms involved in their pathogenesis, and assessment of available treatment options.	[Joshi, Deepak; Quaglia, Alberto; Westbrook, Rachel H.; Heneghan, Michael A.] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; [James, Andra] Duke Univ, Med Ctr, Dept Maternal Fetal Med Obstet & Gynaecol, Durham, NC USA	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Duke University	Heneghan, MA (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	michael.heneghan@kch.nhs.uk		James, Andra/0000-0003-4570-6595				Aggarwal N, 1999, AUST NZ J OBSTET GYN, V39, P503, DOI 10.1111/j.1479-828X.1999.tb03145.x; Armenti Vincent T, 2005, Clin Transpl, P69; Bacq Y, 2007, GASTROEN CLIN BIOL, V31, P1135, DOI 10.1016/S0399-8320(07)78351-3; Banait Vaibhav S, 2007, Indian J Gastroenterol, V26, P6; Bhatia V, 2008, HEPATOLOGY, V48, P1577, DOI 10.1002/hep.22493; Bhattacharya S, 2008, QJM-INT J MED, V101, P307, DOI 10.1093/qjmed/hcn007; Brewer GJ, 2000, HEPATOLOGY, V31, P364, DOI 10.1002/hep.510310216; Browning MF, 2006, OBSTET GYNECOL, V107, P115, DOI 10.1097/01.AOG.0000191297.47183.bd; BRUNT PW, 1974, GUT, V15, P52, DOI 10.1136/gut.15.1.52; Butt AA, 2006, ALIMENT PHARM THER, V24, P585, DOI 10.1111/j.1365-2036.2006.03020.x; Caniggia I, 2000, PLACENTA, V21, pS25, DOI 10.1053/plac.1999.0522; Castro MA, 1999, AM J OBSTET GYNECOL, V181, P389, DOI 10.1016/S0002-9378(99)70567-3; Castro MA, 1996, J REPROD MED, V41, P839; Ch'ng CL, 2002, GUT, V51, P876, DOI 10.1136/gut.51.6.876; Christopher V, 2006, LIVER TRANSPLANT, V12, P1138, DOI 10.1002/lt.20810; COLIN JF, 1994, GASTROEN CLIN BIOL, V18, P378; Conchillo JM, 2002, NETH J MED, V60, P374; Devarbhavi H, 2008, J HEPATOL, V49, P930, DOI 10.1016/j.jhep.2008.07.030; Dixon PH, 2009, GUT, V58, P537, DOI 10.1136/gut.2008.159541; Egerman RS, 1999, CLIN OBSTET GYNECOL, V42, P381, DOI 10.1097/00003081-199906000-00022; Elinav E, 2006, GASTROENTEROLOGY, V130, P1129, DOI 10.1053/j.gastro.2006.01.007; Eloranta ML, 2003, SCAND J GASTROENTERO, V38, P648, DOI 10.1080/00365520310000807; Fairweather D V, 1978, Obstet Gynecol Annu, V7, P91; Farr RW, 1997, CLIN INFECT DIS, V24, P1191, DOI 10.1086/513646; Fell DB, 2006, OBSTET GYNECOL, V107, P277, DOI 10.1097/01.AOG.0000195059.82029.74; Fesenmeier MF, 2005, AM J OBSTET GYNECOL, V192, P1416, DOI 10.1016/j.ajog.2004.12.035; Floreani A, 2006, ALIMENT PHARM THERAP, V23, P1649, DOI 10.1111/j.1365-2036.2006.02869.x; Fonseca JE, 2005, AM J OBSTET GYNECOL, V193, P1591, DOI 10.1016/j.ajog.2005.07.037; Glantz A, 2005, HEPATOLOGY, V42, P1399, DOI 10.1002/hep.20952; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glantz A, 2008, HEPATOLOGY, V47, P544, DOI 10.1002/hep.21987; GOODWIN TM, 1992, AM J OBSTET GYNECOL, V167, P648, DOI 10.1016/S0002-9378(11)91565-8; Hay JE, 2008, HEPATOLOGY, V47, P1067, DOI 10.1002/hep.22130; Heneghan MA, 2001, GUT, V48, P97, DOI 10.1136/gut.48.1.97; Ibdah JA, 2005, NAT CLIN PRACT GASTR, V2, P494, DOI 10.1038/ncpgasthep0287; Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204; JACKSON S, 1992, J CLIN INVEST, V90, P1219, DOI 10.1172/JCI115983; Jain AB, 2003, TRANSPLANTATION, V76, P827, DOI 10.1097/01.TP.0000084823.89528.89; Kainz A, 2000, TRANSPLANTATION, V70, P1718, DOI 10.1097/00007890-200012270-00010; KALLEN B, 1987, EUR J OBSTET GYN R B, V26, P291; Kang A H, 1999, Obstet Gynecol Surv, V54, P463, DOI 10.1097/00006254-199907000-00026; Keitel V, 2006, GASTROENTEROLOGY, V131, P624, DOI 10.1053/j.gastro.2006.05.003; KHUROO MS, 1980, AM J MED, V68, P113, DOI 10.1016/0002-9343(80)90180-1; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; KLEIN NA, 1991, GASTROENTEROLOGY, V100, P239, DOI 10.1016/0016-5085(91)90607-M; Knight M, 2008, GUT, V57, P951, DOI 10.1136/gut.2008.148676; Ko CW, 2005, HEPATOLOGY, V41, P359, DOI 10.1002/hep.20534; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; Kuscu NK, 2002, POSTGRAD MED J, V78, P76, DOI 10.1136/pmj.78.916.76; Lee C, 2006, COCHRANE DB SYST REV, V2; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lim W, 2007, BMJ-BRIT MED J, V334, P1318, DOI 10.1136/bmj.39205.484572.55; Lindseth G, 2004, RES NURS HEALTH, V27, P382, DOI 10.1002/nur.20041; Magann EF, 1999, CLIN OBSTET GYNECOL, V42, P532, DOI 10.1097/00003081-199909000-00009; Marschall HU, 2005, GASTROENTEROLOGY, V129, P476, DOI 10.1053/j.gastro.2005.05.009; Martin JN, 2006, AM J OBSTET GYNECOL, V195, P914, DOI 10.1016/j.ajog.2005.08.044; Masuyama H, 2006, AM J OBSTET GYNECOL, V194, P551, DOI 10.1016/j.ajog.2005.08.034; Mazzella G, 2001, HEPATOLOGY, V33, P504, DOI 10.1053/jhep.2001.22647; Mendez-Sanchez Nahum, 2006, Ann Hepatol, V5, P227; Mihu D, 2007, J GASTROINTEST LIVER, V16, P419; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; Nagy S, 2003, OBSTET GYNECOL, V102, P121, DOI 10.1016/S0029-7844(03)00369-7; National Institute for Clinical Excellence, 2003, ANT CAR ROUT CAR HLT; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Pinna AD, 2002, DIGEST DIS SCI, V47, P750, DOI 10.1023/A:1014779614525; Poupon R, 2005, J HEPATOL, V42, P418, DOI 10.1016/j.jhep.2004.08.029; Rautou PE, 2009, GUT, V58, P606, DOI 10.1136/gut.2008.167577; REYES H, 1982, HEPATOLOGY, V2, P87; REYES H, 1994, GUT, V35, P101, DOI 10.1136/gut.35.1.101; ROBINSON CJ, 2007, AM J OBSTET GYNECOL, V197, P174; ROLFES DB, 1986, HISTOPATHOLOGY, V10, P555, DOI 10.1111/j.1365-2559.1986.tb02510.x; Ropponen A, 2006, HEPATOLOGY, V43, P723, DOI 10.1002/hep.21111; Russell MA, 1998, SEMIN PERINATOL, V22, P156, DOI 10.1016/S0146-0005(98)80048-7; Salahuddin S, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.010; SCHAEFER E, 1993, EUR J PEDIATR, V152, P581, DOI 10.1007/BF01954085; Schneider G, 2007, HEPATOLOGY, V45, P150, DOI 10.1002/hep.21500; Schramm C, 2006, AM J GASTROENTEROL, V101, P556, DOI 10.1111/j.1572-0241.2006.00479.x; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Sebire NJ, 2001, BRIT J OBSTET GYNAEC, V108, P61, DOI 10.1111/j.1471-0528.2001.00021.x; Shames BD, 2005, LIVER TRANSPLANT, V11, P224, DOI 10.1002/lt.20285; Shellock FG, 1999, J MAGN RESON IMAGING, V10, P477, DOI 10.1002/(SICI)1522-2586(199909)10:3<477::AID-JMRI33>3.0.CO;2-E; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P125, DOI 10.1016/0002-9378(95)90099-3; Sibai BM, 2003, SEMIN PERINATOL, V27, P239, DOI 10.1016/S0146-0005(03)00022-3; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; Singh Sarman, 2003, Indian Journal of Pediatrics, V70, P37, DOI 10.1007/BF02722743; Sookoian Silvia, 2006, Ann Hepatol, V5, P190; SREENIVASAN MA, 1978, INDIAN J MED RES, V67, P197; Stander HJ, 1934, AM J OBSTET GYNECOL, V28, P61, DOI 10.1016/S0002-9610(35)90283-5; STEVEN MM, 1981, GUT, V22, P592, DOI 10.1136/gut.22.7.592; STEVEN MM, 1979, Q J MED, V48, P519; SULLIVAN CA, 1994, AM J OBSTET GYNECOL, V171, P940, DOI 10.1016/S0002-9378(94)70063-X; TANDON BN, 1982, INDIAN J MED RES, V75, P739; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; TSEGA E, 1992, CLIN INFECT DIS, V14, P961, DOI 10.1093/clinids/14.4.961; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; Walsh SW, 2000, FASEB J, V14, P1289, DOI 10.1096/fj.14.10.1289; WALSHE JM, 1986, Q J MED, V58, P81; Wang JS, 2002, CHINESE MED J-PEKING, V115, P1510; WEINSTEIN L, 1982, AM J OBSTET GYNECOL, V142, P159, DOI 10.1016/S0002-9378(16)32330-4; Willner IR, 1998, ANN INTERN MED, V128, P111, DOI 10.7326/0003-4819-128-2-199801150-00006; Yang Z, 2002, AM J OBSTET GYNECOL, V187, P715, DOI 10.1067/mob.2002.125893; Yost NP, 2003, OBSTET GYNECOL, V102, P1250, DOI 10.1016/j.obstetgynecol.2003.08.013; Zarrinpar A, 2007, AM SURGEON, V73, P1013; Zinkernagel AS, 2006, ANTIVIR THER, V11, P131	107	203	241	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					594	605		10.1016/S0140-6736(09)61495-1	http://dx.doi.org/10.1016/S0140-6736(09)61495-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560YO	20159293				2022-12-28	WOS:000274941900033
J	Ejeta, G				Ejeta, Gebisa			African Green Revolution Needn't Be a Mirage	SCIENCE			English	Editorial Material								Africa missed out on the scientific breakthroughs that revolutionized agriculture in Asia. However, with locally developed and locally relevant technologies, a built-up human and institutional capacity, and supportive national policy and leadership, an African Green Revolution can be a reality.	Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ejeta, G (corresponding author), Purdue Univ, Dept Agron, Lilly Hall Life Sci,915 W State St, W Lafayette, IN 47907 USA.	gejeta@purdue.edu		Adedokun, Olajire/0000-0001-6002-7377				Andrew H., 2000, KNOWLEDGE TECHNOLOGY, V13, P70, DOI [DOI 10.1007/S12130-000-1005-Y, 10.1007/s12130-000-1005-y]; Collier P, 2008, OXFORD REV ECON POL, V24, P337, DOI 10.1093/oxrep/grn019; Collinson M.P., 2000, HIST FARMING SYSTEMS, DOI 10.1079/9780851994055.0000; *G8 SUMM 2009, RESP LEAD SUST FUT; Gabre-Madhin EZ, 2004, WORLD DEV, V32, P745, DOI 10.1016/j.worlddev.2003.11.004; GLICKMAN D, 2009, CHICAGO COUNCIL GLOB; HOLMES H, 2005, AFRICAN FOOD CRISIS; Kates RW, 2007, P NATL ACAD SCI USA, V104, P16747, DOI 10.1073/pnas.0708566104; Mutume G., 2007, AFRICA RENEWAL, V21, P10; RUTTAN VH, 1994, AGR ENV HLTH SUSTAIN; Witcombe JR, 2005, EXP AGR, V41, P299, DOI 10.1017/S0014479705002656	11	55	56	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					831	832		10.1126/science.1187152	http://dx.doi.org/10.1126/science.1187152			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554AQ	20150493				2022-12-28	WOS:000274408300050
J	Muglia, LJ; Katz, M				Muglia, Louis J.; Katz, Michael			CURRENT CONCEPTS The Enigma of Spontaneous Preterm Birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROGESTERONE-RECEPTOR GENE; GESTATIONAL-AGE; INTRAUTERINE INFECTION; BACTERIAL VAGINOSIS; AFRICAN-AMERICAN; US-BORN; WOMEN; WEIGHT; DELIVERY; DISEASE		[Muglia, Louis J.] Vanderbilt Univ, Med Ctr, Dept Pediat, Sch Med, Nashville, TN 37232 USA; [Muglia, Louis J.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Katz, Michael] March Dimes Fdn, White Plains, NY USA	Vanderbilt University; Vanderbilt University	Muglia, LJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Sch Med, 2213 Garland Ave,11476 MRB IV, Nashville, TN 37232 USA.	louis.muglia@vanderbilt.edu						ADAMS MM, 1993, OBSTET GYNECOL, V81, P65; Ahman E, 2007, NEONATAL PERINATAL M; Bettegowda VR, 2008, CLIN PERINATOL, V35, P309, DOI 10.1016/j.clp.2008.03.002; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chen CY, 2008, MOL PHYLOGENET EVOL, V47, P637, DOI 10.1016/j.ympev.2007.12.026; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Collins JW, 2007, ETHNIC DIS, V17, P113; Collins JW, 2004, AM J PUBLIC HEALTH, V94, P2132, DOI 10.2105/AJPH.94.12.2132; Collins JW, 2002, AM J EPIDEMIOL, V155, P210, DOI 10.1093/aje/155.3.210; *COMM UND PREM BIR, 2006, PRET BIRTH CAUS CONS; David RJ, 1997, NEW ENGL J MED, V337, P1209, DOI 10.1056/NEJM199710233371706; Diaz-Cueto L, 2008, INT J GYNECOL OBSTET, V103, P153, DOI 10.1016/j.ijgo.2008.06.008; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Ehn NL, 2007, PEDIATR RES, V62, P630, DOI 10.1203/PDR.0b013e3181567bfc; FAIMAN C, 1981, REPROD BIOL GREAT AP, P45; Geronimus AT, 1996, SOC SCI MED, V42, P589, DOI 10.1016/0277-9536(95)00159-X; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Howard DL, 2006, PEDIATRICS, V118, pE1399, DOI 10.1542/peds.2006-0665; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kistka ZAF, 2007, AM J OBSTET GYNECOL, V196, P241, DOI [10.1016/j.ajog.2006.10.873, 10.1016/j.ajog.2006.06.093]; Kistka ZAF, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.12.014; Kupferminc MJ, 1999, NEW ENGL J MED, V341, P384; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Luo G, 2008, REPROD SCI, V15, P147, DOI 10.1177/1933719107310990; MacDorman Marian F, 2007, Natl Vital Stat Rep, V56, P1; Martin JA., 2009, NATL VITAL STAT REP, V57, P1; Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; Nygren P, 2008, ANN INTERN MED, V148, P220, DOI 10.7326/0003-4819-148-3-200802050-00008; Okun N, 2005, OBSTET GYNECOL, V105, P857, DOI 10.1097/01.AOG.0000157108.32059.8f; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Plunkett J, 2009, HUM HERED, V68, P209, DOI 10.1159/000224641; Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009; Raynes-Greenow CH, 2004, COCHRANE DB SYST REV, V1; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; ROMERO R, 2008, AM J OBSTET GYNECOL, V198; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Smith V, 2009, EUR J OBSTET GYN R B, V142, P3, DOI 10.1016/j.ejogrb.2008.09.008; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Ward K, 2005, OBSTET GYNECOL, V106, P1235, DOI 10.1097/01.AOG.0000189091.35982.85; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333	50	448	469	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					529	535		10.1056/NEJMra0904308	http://dx.doi.org/10.1056/NEJMra0904308			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147718				2022-12-28	WOS:000274397200010
J	Tan, KR; Brown, M; Labouebe, G; Yvon, C; Creton, C; Fritschy, JM; Rudolph, U; Luscher, C				Tan, Kelly R.; Brown, Matthew; Labouebe, Gwenael; Yvon, Cedric; Creton, Cyril; Fritschy, Jean-Marc; Rudolph, Uwe; Luescher, Christian			Neural bases for addictive properties of benzodiazepines	NATURE			English	Article							VENTRAL TEGMENTAL AREA; EVOKED SYNAPTIC PLASTICITY; DOPAMINE NEURONS; IN-VIVO; GABA(B) RECEPTORS; MODULATION; ABUSE; CELLS; ACID; ALPHA-1-BETA-2-GAMMA-2	Benzodiazepines are widely used in clinics and for recreational purposes, but will lead to addiction in vulnerable individuals. Addictive drugs increase the levels of dopamine and also trigger long-lasting synaptic adaptations in the mesolimbic reward system that ultimately may induce the pathological behaviour. The neural basis for the addictive nature of benzodiazepines, however, remains elusive. Here we show that benzodiazepines increase firing of dopamine neurons of the ventral tegmental area through the positive modulation of GABA(A) (gamma-aminobutyric acid type A) receptors in nearby interneurons. Such disinhibition, which relies on alpha 1-containing GABA(A) receptors expressed in these cells, triggers drug-evoked synaptic plasticity in excitatory afferents onto dopamine neurons and underlies drug reinforcement. Taken together, our data provide evidence that benzodiazepines share defining pharmacological features of addictive drugs through cell-type-specific expression of alpha 1-containing GABA(A) receptors in the ventral tegmental area. The data also indicate that subunit-selective benzodiazepines sparing alpha 1 may be devoid of addiction liability.	[Tan, Kelly R.; Brown, Matthew; Labouebe, Gwenael; Yvon, Cedric; Creton, Cyril; Luescher, Christian] Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland; [Fritschy, Jean-Marc] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Rudolph, Uwe] Harvard Univ, Sch Med, Lab Genet Neuropharmacol, McLean Hosp, Belmont, MA 02478 USA; [Rudolph, Uwe] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland; [Luescher, Christian] Geneva Neurosci Ctr, CH-1211 Geneva, Switzerland	University of Geneva; University of Zurich; Harvard University; McLean Hospital; Harvard University; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Brown, Matthew/0000-0001-6983-962X; Fritschy, Jean-Marc/0000-0002-8552-3702	National Institute on Drug Abuse (NIDA) [DA019022]; Swiss National Science Foundation; Swiss Initiative in Systems Biology; European Commission [LSHM-CT-2005-19063]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019022] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Initiative in Systems Biology; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Luscher laboratory as well as M. Frerking, M. Serafin and H. Mohler for critical reading of the manuscript. Y. Yanagawa provided the GAD67-GFP Delta neo mouse line, and we thank K. A. Miczek and H. U. Zeilhofer for help with the GABA<INF>A</INF> mutant mouse lines. This work is supported by the National Institute on Drug Abuse (NIDA; DA019022; C. L., P. Slesinger), the Swiss National Science Foundation, the Swiss Initiative in Systems Biology (Neurochoice) and the European Commission Coordination Action ENINET (LSHM-CT-2005-19063). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDA or the National Institutes of Health.	ARENDT RM, 1987, PSYCHOPHARMACOLOGY, V93, P72, DOI 10.1007/BF02439589; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; BERRIDGE KC, 1995, NEUROSCI BIOBEHAV R, V19, P121, DOI 10.1016/0149-7634(94)00026-W; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Doherty M, 2007, BRAIN RES, V1150, P62, DOI 10.1016/j.brainres.2007.02.081; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; FUCHS V, 1984, DRUG ALCOHOL DEPEN, V14, P179, DOI 10.1016/0376-8716(84)90043-7; GRACE AA, 1979, EUR J PHARMACOL, V59, P211, DOI 10.1016/0014-2999(79)90283-8; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Heikkinen AE, 2009, NEUROPSYCHOPHARMACOL, V34, P290, DOI 10.1038/npp.2008.89; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Koob GF, 2009, PHARMACOPSYCHIATRY, V42, pS32, DOI 10.1055/s-0029-1216356; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Long P, 2009, J BIOL CHEM, V284, P8717, DOI 10.1074/jbc.M805322200; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Luscher C, 2008, NAT NEUROSCI, V11, P737, DOI 10.1038/nn0708-737; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MOHLER H, 1992, ADV BIOCHEM PSYCHOPH, V47, P41; Morris HV, 2009, APPETITE, V52, P675, DOI 10.1016/j.appet.2009.03.006; O'Brien P, 2005, CHEM WORLD-UK, V2, P28; Okada H, 2004, J NEUROCHEM, V89, P7, DOI 10.1111/j.1471-4159.2004.02271.x; Paxinos G, 2004, MOUSE BRAIN STEREOTA; PILOTTO R, 1984, PSYCHOPHARMACOLOGY, V84, P174, DOI 10.1007/BF00427442; Poncer JC, 1996, NEUROPHARMACOLOGY, V35, P1169, DOI 10.1016/S0028-3908(96)00055-X; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Rowlett JK, 2005, P NATL ACAD SCI USA, V102, P915, DOI 10.1073/pnas.0405621102; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sigel E, 1998, MOL PHARMACOL, V54, P1097, DOI 10.1124/mol.54.6.1097; Soyka M, 2000, PHARMACOPSYCHIATRY, V33, P138, DOI 10.1055/s-2000-11224; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102; YERBURY RE, 1989, PHARMACOL BIOCHEM BE, V33, P303, DOI 10.1016/0091-3057(89)90504-2; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	48	241	246	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					769	U78		10.1038/nature08758	http://dx.doi.org/10.1038/nature08758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148031	Green Accepted			2022-12-28	WOS:000274394300031
J	Ransom, M; Dennehey, BK; Tyler, JK				Ransom, Monica; Dennehey, Briana K.; Tyler, Jessica K.			Chaperoning Histones during DNA Replication and Repair	CELL			English	Review							CHROMATIN ASSEMBLY FACTOR-1; DOUBLE-STRAND BREAK; H3 LYSINE-56 ACETYLATION; FISSION YEAST SCM3; CENP-A; SACCHAROMYCES-CEREVISIAE; HUMAN-CELLS; IN-VIVO; STRUCTURAL BASIS; S-PHASE		[Ransom, Monica; Dennehey, Briana K.; Tyler, Jessica K.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Tyler, JK (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jessica.tyler@ucdenver.edu		Dennehey, Briana/0000-0002-9238-1079; Tyler, Jessica/0000-0001-9765-1659; Ransom, Monica/0000-0002-7527-7122	GM; NCI; NATIONAL CANCER INSTITUTE [R01CA095641, T32CA082086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER	GM; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH funding to J.K.T. from GM and NCI. We are extremely grateful for the kind assistance of Siddhartha Roy with the generation of figures.	Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Escargueil AE, 2008, MUTAT RES-REV MUTAT, V658, P259, DOI 10.1016/j.mrrev.2008.01.004; Finn RM, 2008, BIOPHYS J, V95, P1314, DOI 10.1529/biophysj.108.130021; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Galvani A, 2008, MOL CELL BIOL, V28, P3672, DOI 10.1128/MCB.00510-07; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hertel L, 1999, EXP CELL RES, V250, P313, DOI 10.1006/excr.1999.4495; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Ito T, 1996, MOL CELL BIOL, V16, P3112; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Jiao R, 2007, ONCOGENE, V26, P3811, DOI 10.1038/sj.onc.1210150; Jiao RJ, 2004, MOL CELL BIOL, V24, P4710, DOI 10.1128/MCB.24.11.4710-4719.2004; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kim JA, 2009, P NATL ACAD SCI USA, V106, P1151, DOI 10.1073/pnas.0812578106; KRUDE T, 1995, EXP CELL RES, V220, P304, DOI 10.1006/excr.1995.1320; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Ling XF, 1996, GENE DEV, V10, P686, DOI 10.1101/gad.10.6.686; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; PRIOR CP, 1980, CELL, V20, P597, DOI 10.1016/0092-8674(80)90306-2; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Ray-Gallet D, 2007, CHROMOSOMA, V116, P487, DOI 10.1007/s00412-007-0112-x; Raynard S, 2008, GENE DEV, V22, P2903, DOI 10.1101/gad.1742408; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Schlesinger MB, 2000, GENETICS, V155, P1593; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SMERDON MJ, 1978, P NATL ACAD SCI USA, V75, P4238, DOI 10.1073/pnas.75.9.4238; SMERDON MJ, 1982, J BIOL CHEM, V257, P13441; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	101	245	248	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					183	195		10.1016/j.cell.2010.01.004	http://dx.doi.org/10.1016/j.cell.2010.01.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141833	Green Accepted, Bronze			2022-12-28	WOS:000273826500010
J	Harrington, MJ; Masic, A; Holten-Andersen, N; Waite, JH; Fratzl, P				Harrington, Matthew J.; Masic, Admir; Holten-Andersen, Niels; Waite, J. Herbert; Fratzl, Peter			Iron-Clad Fibers: A Metal-Based Biological Strategy for Hard Flexible Coatings	SCIENCE			English	Article							MUSSEL ADHESIVE; MYTILUS-EDULIS; BYSSAL THREADS; CROSS-LINKING; PROTEINS; COMPLEXES; COORDINATION; CATECHOLATE; PEPTIDES; CUTICLE	The extensible byssal threads of marine mussels are shielded from abrasion in wave-swept habitats by an outer cuticle that is largely proteinaceous and approximately fivefold harder than the thread core. Threads from several species exhibit granular cuticles containing a protein that is rich in the catecholic amino acid 3,4-dihydroxyphenylalanine (dopa) as well as inorganic ions, notably Fe3+. Granular cuticles exhibit a remarkable combination of high hardness and high extensibility. We explored byssus cuticle chemistry by means of in situ resonance Raman spectroscopy and demonstrated that the cuticle is a polymeric scaffold stabilized by catecholato-iron chelate complexes having an unusual clustered distribution. Consistent with byssal cuticle chemistry and mechanics, we present a model in which dense cross-linking in the granules provides hardness, whereas the less cross-linked matrix provides extensibility.	[Harrington, Matthew J.; Masic, Admir; Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany; [Waite, J. Herbert] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Holten-Andersen, Niels] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	Max Planck Society; University of California System; University of California Santa Barbara; University of Chicago	Harrington, MJ (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany.	Matt.Harrington@mpikg.mpg.de	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830; Holten-Andersen, Niels/0000-0002-5318-9674; Masic, Admir/0000-0002-1207-4926	Alexander von Humboldt Foundation; Federal Ministry of Education and Research; NIH [R01DE018468]; Danish Natural Science Research Council [272-08-0087]; Materials Research and Engineering Center Program of NSF [DMR05-20415]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015415] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Natural Science Research Council(Danish Natural Science Research Council); Materials Research and Engineering Center Program of NSF; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	L. Bertinetti (University of Torino) provided technical expertise in operating diffuse-reflectance ultraviolet-vis spectrometry. S. Wasko assisted with scanning electron microscopy (SEM). P. F., M.J.H., and A. M. are grateful for support by the Alexander von Humboldt Foundation and the Max Planck Society in the framework of the Max Planck Research Award funded by the Federal Ministry of Education and Research. M.J.H. was partially funded by an Alexander von Humboldt Research Fellowship for Postdoctoral Researchers. J.H.W. was funded by a grant from NIH (R01DE018468). N.H.A. thanks the Danish Natural Science Research Council for a post-doctoral fellowship (272-08-0087). This work made use of the Materials Research Laboratory central facilities at UCSB supported by the Materials Research and Engineering Center Program of NSF under award DMR05-20415.	AVDEEF A, 1978, J AM CHEM SOC, V100, P5362, DOI 10.1021/ja00485a018; BENEDICT CV, 1986, J MORPHOL, V189, P171, DOI 10.1002/jmor.1051890207; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; Carrington E, 2004, AM MALACOL BULL, V18, P135; Chan CM, 2002, POLYMER, V43, P2981, DOI 10.1016/S0032-3861(02)00120-9; Haemers S, 2005, BIOMATERIALS, V26, P1231, DOI 10.1016/j.biomaterials.2004.04.032; Haemers S, 2002, LANGMUIR, V18, P4903, DOI 10.1021/la025626c; Harrington MJ, 2008, BIOMACROMOLECULES, V9, P1480, DOI 10.1021/bm8000827; Harrington MJ, 2009, J STRUCT BIOL, V167, P47, DOI 10.1016/j.jsb.2009.03.001; Holten-Andersen N, 2007, NAT MATER, V6, P669, DOI 10.1038/nmat1956; Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012; Holten-Andersen N, 2009, BIOCHEMISTRY-US, V48, P2752, DOI 10.1021/bi900018m; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Lichtenegger HC, 2003, P NATL ACAD SCI USA, V100, P9144, DOI 10.1073/pnas.1632658100; MICHAUDSORET I, 1995, BIOCHEMISTRY-US, V34, P5504, DOI 10.1021/bi00016a022; Ohrstrom L, 1996, J AM CHEM SOC, V118, P3283, DOI 10.1021/ja953409a; Pires MM, 2009, J AM CHEM SOC, V131, P2706, DOI 10.1021/ja8088845; Schmitt L, 2000, BIOPHYS J, V78, P3275, DOI 10.1016/S0006-3495(00)76863-9; Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759; Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200; TAYLOR SW, 1994, INORG CHEM, V33, P5819, DOI 10.1021/ic00103a032; Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s; Vaccaro E, 2001, BIOMACROMOLECULES, V2, P906, DOI 10.1021/bm0100514; WAITE JH, 1985, BIOCHEMISTRY-US, V24, P5010, DOI 10.1021/bi00340a008; Wemeke SW, 2007, J EXP BIOL, V210, P2137, DOI 10.1242/jeb.006098; Zhang ZS, 1996, INORG CHEM, V35, P1571, DOI 10.1021/ic941303v; ZUCCARELLO LV, 1981, TISSUE CELL, V13, P701, DOI 10.1016/S0040-8166(81)80007-9	29	678	704	27	586	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					216	220		10.1126/science.1181044	http://dx.doi.org/10.1126/science.1181044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20203014	Green Accepted			2022-12-28	WOS:000276459600039
J	von Engelhardt, J; Mack, V; Sprengel, R; Kavenstock, N; Li, KW; Stern-Bach, Y; Smit, AB; Seeburg, PH; Monyer, H				von Engelhardt, Jakob; Mack, Volker; Sprengel, Rolf; Kavenstock, Netta; Li, Ka Wan; Stern-Bach, Yael; Smit, August B.; Seeburg, Peter H.; Monyer, Hannah			CKAMP44: A Brain-Specific Protein Attenuating Short-Term Synaptic Plasticity in the Dentate Gyrus	SCIENCE			English	Article							AMPA RECEPTORS; KAINATE RECEPTORS; GLUTAMATE; DESENSITIZATION; DEACTIVATION; TRAFFICKING; AFFINITY	CKAMP44, identified here by a proteomic approach, is a brain-specific type I transmembrane protein that associates with AMPA receptors in synaptic spines. CKAMP44 expressed in Xenopus oocytes reduced GluA1- and A2-mediated steady-state currents, but did not affect kainate-or N-methyl-D-aspartate (NMDA) receptor-mediated currents. Mouse hippocampal CA1 pyramidal neurons expressed CKAMP44 at low abundance, and overexpression of CKAMP44 led to stronger and faster AMPA receptor desensitization, slower recovery from desensitization, and a reduction in the paired-pulse ratio of AMPA currents. By contrast, dentate gyrus granule cells exhibited strong CKAMP44 expression, and CKAMP44 knockout increased the paired-pulse ratio of AMPA currents in lateral and medial perforant path-granule cell synapses. CKAMP44 thus modulates short-term plasticity at specific excitatory synapses.	[von Engelhardt, Jakob; Mack, Volker; Monyer, Hannah] Univ Heidelberg, Dept Clin Neurobiol, D-6910 Heidelberg, Germany; [Mack, Volker; Li, Ka Wan; Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Sprengel, Rolf; Seeburg, Peter H.] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Kavenstock, Netta; Stern-Bach, Yael] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam; Max Planck Society; Hebrew University of Jerusalem	Monyer, H (corresponding author), Univ Heidelberg, Dept Clin Neurobiol, D-6910 Heidelberg, Germany.	monyer@urz.uni-hd.de	Smit, August B/E-8410-2011; von Engelhardt, Jakob/AAD-4920-2021; von Engelhardt, Jakob/G-7397-2015	von Engelhardt, Jakob/0000-0003-3861-3294; von Engelhardt, Jakob/0000-0003-3861-3294; Monyer, Hannah/0000-0002-9332-5749; li, ka wan/0000-0001-6983-5055	Schilling Foundation; EU-Synapse [LSHM-CT-2005-019055]; Nationales Genomforschungsnetz (NGFN); Center for Medical Systems Biology; Max Planck Society;  [SFB636]	Schilling Foundation; EU-Synapse; Nationales Genomforschungsnetz (NGFN); Center for Medical Systems Biology; Max Planck Society(Max Planck Society); 	We thank M. K. Schwarz for recombinant adeno-associated virus delivery into the brains of mouse pups, A. Zivkovich for electrophysiological experiments during the initial stages of this project, L. Layer and S. Giese for help with molecular cloning, R. van der Schors for his contribution to the mass spectrometry, and R. Hinz-Herkommer, I. Preugschat-Gumprecht, and R. Zilberstein for technical assistance. Supported by the Schilling Foundation (H. M.); EU-Synapse LSHM-CT-2005-019055 (H. M., P. H. S., Y.S.B.); SFB636 (R. S. P.) and Nationales Genomforschungsnetz (NGFN) (R. S. P.); the Center for Medical Systems Biology (K. W. L. and A. B. S.); and the Max Planck Society (R. S. P. and P. H. S.). The experimentally verified cDNA CKAMP44 sequences are annotated at the National Center for Biotechnology Information under the accession numbers GU479981 (CKAMP44a) and GU479982 (CKAMP44b).	Chen L, 2003, MOL PHARMACOL, V64, P703, DOI 10.1124/mol.64.3.703; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Heinemann SH, 2007, CELL MOL LIFE SCI, V64, P1329, DOI 10.1007/s00018-007-6565-5; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Wall MJ, 2005, EUR J NEUROSCI, V21, P2149, DOI 10.1111/j.1460-9568.2005.04048.x; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	19	195	198	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1518	1522		10.1126/science.1184178	http://dx.doi.org/10.1126/science.1184178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20185686				2022-12-28	WOS:000275715200051
J	Garcia-Tsao, G; Bosch, J				Garcia-Tsao, Guadalupe; Bosch, Jaime			Current Concepts: Management of Varices and Variceal Hemorrhage in Cirrhosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PORTAL HYPERTENSIVE GASTROPATHY; RANDOMIZED CONTROLLED-TRIAL; VENOUS-PRESSURE GRADIENT; INTRAHEPATIC PORTOSYSTEMIC SHUNT; SMALL ESOPHAGEAL-VARICES; NATURAL-HISTORY; PHARMACOLOGICAL-TREATMENT; CYANOACRYLATE INJECTION; ENDOSCOPIC TREATMENT; BAND LIGATION		[Garcia-Tsao, Guadalupe] Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA; [Bosch, Jaime] Univ Barcelona, Hosp Clin, Hepat Hemodynam Lab, Liver Unit, Barcelona, Spain	Yale University; University of Barcelona; Hospital Clinic de Barcelona	Garcia-Tsao, G (corresponding author), Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA.		Bosch, Jaime/AAF-1006-2022; Bosch, Jaime/AFF-8344-2022; Garcia-Tsao, Guadalupe/ABF-7374-2020		Fundacion Banco Bilbao Vizcaya Argentaria, Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas [PI 09/01261]; Yale Liver Center (NIH) [P30 DK34989]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	Fundacion Banco Bilbao Vizcaya Argentaria, Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas(Instituto de Salud Carlos III); Yale Liver Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the Fundacion Banco Bilbao Vizcaya Argentaria, Instituto de Salud Carlos III (PI 09/01261, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas), and Yale Liver Center (NIH P30 DK34989).	Abraldes JG, 2003, HEPATOLOGY, V37, P902, DOI 10.1053/jhep.2003.50133; Abraldes JG, 2008, J HEPATOL, V48, P229, DOI 10.1016/j.jhep.2007.10.008; Abraldes JG, 2007, J HEPATOL, V46, P1040, DOI 10.1016/j.jhep.2007.01.020; Abraldes JG, 2009, GASTROENTEROLOGY, V136, P1651, DOI 10.1053/j.gastro.2009.01.043; Bambha K, 2008, GUT, V57, P814, DOI 10.1136/gut.2007.137489; Banares R, 2002, HEPATOLOGY, V36, P1367, DOI 10.1053/jhep.2002.36947; Banares R, 2002, HEPATOLOGY, V35, P609, DOI 10.1053/jhep.2002.31354; Bernard B, 1999, HEPATOLOGY, V29, P1655, DOI 10.1002/hep.510290608; Berzigotti, 2008, AM J GASTROENTEROL, V103, P2167, DOI 10.1111/j.1572-0241.2007.02140.x; Berzigotti A, 2008, AM J GASTROENTEROL, V103, P1159, DOI 10.1111/j.1572-0241.2008.01826.x; Bosch J, 2003, LANCET, V361, P952, DOI 10.1016/S0140-6736(03)12778-X; Bosch J, 2008, J HEPATOL, V48, pS68, DOI 10.1016/j.jhep.2008.01.021; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; Bureau C, 2004, GASTROENTEROLOGY, V126, P469, DOI 10.1053/j.gastro.2003.11.016; Cales P, 2001, NEW ENGL J MED, V344, P23, DOI 10.1056/NEJM200101043440104; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; Garcia-Pagan JC, 2009, J HEPATOL, V51, P632, DOI 10.1016/j.jhep.2009.06.009; Garcia-Pagan JC, 2008, HEPATOLOGY, V48, p373A; Casado M, 1998, GASTROENTEROLOGY, V114, P1296, DOI 10.1016/S0016-5085(98)70436-6; D'Amico G, 1999, SEMIN LIVER DIS, V19, P475, DOI 10.1055/s-2007-1007133; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; D'Amico G, 2004, HEPATOLOGY, V39, P30, DOI 10.1002/hep.20018; D'Amico G, 2006, GASTROENTEROLOGY, V131, P1611, DOI 10.1053/j.gastro.2006.09.013; de Franchis R, 2005, J HEPATOL, V43, P547, DOI 10.1016/j.jhep.2005.07.001; de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009; de Franchis R, 2008, HEPATOLOGY, V47, P1595, DOI 10.1002/hep.22227; DEFRANCHIS R, 1988, NEW ENGL J MED, V319, P983; DeLeve LD, 2009, HEPATOLOGY, V49, P1729, DOI 10.1002/hep.22772; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Garcia-Pagan JC, 2009, GUT, V58, P1144, DOI 10.1136/gut.2008.171207; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; GARCIATSAO G, 2009, HEPATOLOGY      1130; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; Gluud LL, 2007, AM J GASTROENTEROL, V102, P2842, DOI 10.1111/j.1572-0241.2007.01564.x; Gonzalez R, 2008, ANN INTERN MED, V149, P109, DOI 10.7326/0003-4819-149-2-200807150-00007; Gonzalez-Abraldes J, 2001, GASTROENTEROLOGY, V121, P382, DOI 10.1053/gast.2001.26288; Groszmann RJ, 2005, NEW ENGL J MED, V353, P2254, DOI 10.1056/NEJMoa044456; Henderson JM, 2006, GASTROENTEROLOGY, V130, P1643, DOI 10.1053/j.gastro.2006.02.008; Hubmann R, 2006, ENDOSCOPY, V38, P896, DOI 10.1055/s-2006-944662; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Iwakiri Y, 2007, J HEPATOL, V46, P927, DOI 10.1016/j.jhep.2007.02.006; Kovalak M, 2007, GASTROINTEST ENDOSC, V65, P82, DOI 10.1016/j.gie.2006.08.023; LAINE L, 1995, ANN INTERN MED, V123, P280, DOI 10.7326/0003-4819-123-4-199508150-00007; Lo GH, 2007, ENDOSCOPY, V39, P679, DOI 10.1055/s-2007-966591; Lo GH, 2001, HEPATOLOGY, V33, P1060, DOI 10.1053/jhep.2001.24116; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Merkel C, 2004, GASTROENTEROLOGY, V127, P476, DOI 10.1053/j.gastro.2004.05.004; Merli M, 2003, J HEPATOL, V38, P266, DOI 10.1016/S0168-8278(02)00420-8; Moitinho E, 1999, GASTROENTEROLOGY, V117, P626, DOI 10.1016/S0016-5085(99)70455-5; Monescillo A, 2004, HEPATOLOGY, V40, P793, DOI 10.1002/hep.20386; PEREZAYUSO RM, 1991, LANCET, V337, P1431, DOI 10.1016/0140-6736(91)93125-S; Primignani M, 2000, GASTROENTEROLOGY, V119, P181, DOI 10.1053/gast.2000.8555; Rengstorff DS, 2004, GASTROINTEST ENDOSC, V59, P553, DOI 10.1016/S0016-5107(03)02865-7; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Ripoll Cristina, 2007, Curr Treat Options Gastroenterol, V10, P483, DOI 10.1007/s11938-007-0048-5; Ripoll C, 2009, J HEPATOL, V50, P923, DOI 10.1016/j.jhep.2009.01.014; Ryan BM, 2004, GASTROENTEROLOGY, V126, P1175, DOI 10.1053/j.gastro.2004.01.058; Sarin SK, 2000, AM J GASTROENTEROL, V95, P2888, DOI 10.1016/S0002-9270(00)01993-6; Schepke M, 2001, GASTROENTEROLOGY, V121, P389, DOI 10.1053/gast.2001.26295; Tan H, 2006, HEPATOLOGY, V43, P1410, DOI 10.1002/hep.21226; Tan PC, 2006, HEPATOLOGY, V43, P690, DOI 10.1002/hep.21145; Tripathi D, 2009, HEPATOLOGY, V50, P825, DOI 10.1002/hep.23045; Villanueva C, 2006, J HEPATOL, V45, P560, DOI 10.1016/j.jhep.2006.05.016; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665	66	550	618	3	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					823	832		10.1056/NEJMra0901512	http://dx.doi.org/10.1056/NEJMra0901512			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	20200386	Green Submitted, Green Published			2022-12-28	WOS:000275108300009
J	Kissa, K; Herbomel, P				Kissa, Karima; Herbomel, Philippe			Blood stem cells emerge from aortic endothelium by a novel type of cell transition	NATURE			English	Article							HAEMOGENIC ENDOTHELIUM; ZEBRAFISH DEVELOPMENT; TRANSGENIC ZEBRAFISH; HEMATOPOIETIC-CELLS; EMBRYOS	The ontogeny of haematopoietic stem cells (HSCs) during embryonic development is still highly debated, especially their possible lineage relationship to vascular endothelial cells(1,2). The first anatomical site from which cells with long-term HSC potential have been isolated is the aorta-gonad-mesonephros (AGM), more specifically the vicinity of the dorsal aortic floor(3). But although some authors have presented evidence that HSCs may arise directly from the aortic floor into the dorsal aortic lumen(4), others support the notion that HSCs first emerge within the underlying mesenchyme(5). Here we show by non-invasive, high-resolution imaging of live zebrafish embryos, that HSCs emerge directly from the aortic floor, through a stereotyped process that does not involve cell division but a strong bending then egress of single endothelial cells from the aortic ventral wall into the sub-aortic space, and their concomitant transformation into haematopoietic cells. The process is polarized not only in the dorso-ventral but also in the rostro-caudal versus medio-lateral direction, and depends on Runx1 expression: in Runx1-deficient embryos, the exit events are initially similar, but much rarer, and abort into violent death of the exiting cell. These results demonstrate that the aortic floor is haemogenic and that HSCs emerge from it into the sub-aortic space, not by asymmetric cell division but through a new type of cell behaviour, which we call an endothelial haematopoietic transition.	[Kissa, Karima; Herbomel, Philippe] Inst Pasteur, Unite Macrophages & Dev Immun, F-75724 Paris 15, France; [Kissa, Karima; Herbomel, Philippe] CNRS, URA2578, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Herbomel, P (corresponding author), Inst Pasteur, Unite Macrophages & Dev Immun, 25 Rue Dr Roux, F-75724 Paris 15, France.	philippe.herbomel@pasteur.fr	Kissa, Karima/N-6801-2018	Kissa, Karima/0000-0002-7683-3661				Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Dieterlen-Lievre F, 2006, TRENDS CARDIOVAS MED, V16, P128, DOI 10.1016/j.tcm.2006.02.005; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Soroldoni Daniele, 2009, V546, P117, DOI 10.1007/978-1-60327-977-2_8; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yoshimoto M, 2009, NATURE, V457, P801, DOI 10.1038/457801a; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034	21	638	656	4	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					112	U125		10.1038/nature08761	http://dx.doi.org/10.1038/nature08761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20154732				2022-12-28	WOS:000275117500044
J	Meyerhoff, A; Lietman, P				Meyerhoff, Andrea; Lietman, Paul			Losing the Opportunity to Study Influenza Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Meyerhoff, Andrea] Johns Hopkins Sch Med, Div Clin Pharmacol, Dept Med, Baltimore, MD 21287 USA; [Lietman, Paul] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21287 USA; [Lietman, Paul] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21287 USA; [Meyerhoff, Andrea] GexGroup Inc, Washington, DC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Meyerhoff, A (corresponding author), Johns Hopkins Sch Med, Div Clin Pharmacol, Dept Med, Osler 501,600 N Wolfe St, Baltimore, MD 21287 USA.	ameyerh1@jhmi.edu						*DEP HLTH HUM SERV, 2009, SUMM REP NAT BIOD SC; *FDA, FDA APPR LAB MED OFF; FDA, EM US AUTH PER 4 FAC; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; MEYERHOFF A, 2009, NY TIMES        0520, pA23; Tran TH, 2009, LANCET, V373, P2085, DOI 10.1016/S0140-6736(09)61131-4; DATABASE PERAMIVIR S	7	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					878	879		10.1001/jama.2010.234	http://dx.doi.org/10.1001/jama.2010.234			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197536				2022-12-28	WOS:000275059500023
J	Bazari, F; Hind, M; Ong, YE				Bazari, Farid; Hind, Matthew; Ong, Yee Ean			Horner's syndrome-not to be sneezed at	LANCET			English	Editorial Material							ARTERY DISSECTION		[Bazari, Farid] Kingston Hosp, Dept Resp Med, Surrey KT2 7QB, England; [Hind, Matthew] Royal Brompton Hosp, Dept Resp Med, London SW3 6LY, England; [Ong, Yee Ean] Univ London St Georges Hosp, Dept Resp Med, London, England	Royal Brompton Hospital; St Georges University London	Bazari, F (corresponding author), Kingston Hosp, Dept Resp Med, Galsworthy Rd, Surrey KT2 7QB, England.	farid.bazari@kingstonhospital.nhs.uk	Hind, Matthew/AAC-4384-2021	Hind, Matthew/0000-0002-9966-9446				BOGOUSSLAVSKY J, 1987, ARCH NEUROL-CHICAGO, V44, P479, DOI 10.1001/archneur.1987.00520170009012; Ducrocq X, 1999, REV NEUROL-FRANCE, V155, P575; Georgiadis D, 2009, NEUROLOGY, V72, P1810, DOI 10.1212/WNL.0b013e3181a2a50a; Grau AJ, 1997, STROKE, V28, P453, DOI 10.1161/01.STR.28.2.453; Lyrer P, 2004, STROKE, V35, P613, DOI 10.1161/01.STR.0000112970.63735.FC	5	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					776	776		10.1016/S0140-6736(09)62025-0	http://dx.doi.org/10.1016/S0140-6736(09)62025-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20189030				2022-12-28	WOS:000275211200035
J	Botker, HE; Kharbanda, R; Schmidt, MR; Bottcher, M; Kaltoft, AK; Terkelsen, CJ; Munk, K; Andersen, NH; Hansen, TM; Trautner, S; Lassen, JF; Christiansen, EH; Krusell, LR; Kristensen, SD; Thuesen, L; Nielsen, SS; Rehling, M; Sorensen, HT; Redington, AN; Nielsen, TT				Botker, Hans Erik; Kharbanda, Rajesh; Schmidt, Michael R.; Bottcher, Morten; Kaltoft, Anne K.; Terkelsen, Christian J.; Munk, Kim; Andersen, Niels H.; Hansen, Troels M.; Trautner, Sven; Lassen, Jens Flensted; Christiansen, Evald Hoj; Krusell, Lars R.; Kristensen, Steen D.; Thuesen, Leif; Nielsen, Soren S.; Rehling, Michael; Sorensen, Henrik Toft; Redington, Andrew N.; Nielsen, Torsten T.			Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PRECONDITIONING PROTECTS; DEPENDENT MECHANISM; THROMBUS ASPIRATION; SIZE; REPERFUSION; INJURY; ARTERY; THROMBECTOMY; MORTALITY	Background Remote ischaemic preconditioning attenuates cardiac injury at elective surgery and angioplasty. We tested the hypothesis that remote ischaemic conditioning during evolving ST-elevation myocardial infarction, and done before primary percutaneous coronary intervention, increases myocardial salvage. Methods 333 consecutive adult patients with a suspected first acute myocardial infarction were randomly assigned in a 1:1 ratio by computerised block randomisation to receive primary percutaneous coronary intervention with (n=166 patients) versus without (n=167) remote conditioning (intermittent arm ischaemia through four cycles of 5-min inflation and 5-min deflation of a blood-pressure cuff). Allocation was concealed with opaque sealed envelopes. Patients received remote conditioning during transport to hospital, and primary percutaneous coronary intervention in hospital. The primary endpoint was myocardial salvage index at 30 days after primary percutaneous coronary intervention, measured by myocardial perfusion imaging as the proportion of the area at risk salvaged by treatment; analysis was per protocol. This study is registered with Clinical Trials.gov, number NCT00435266. Findings 82 patients were excluded on arrival at hospital because they did not meet inclusion criteria, 32 were lost to follow-up, and 77 did not complete the follow-up with data for salvage index. Median salvage index was 0.75 (IQR 0.50-0.93, n=73) in the remote conditioning group versus 0.55 (0.35-0.88, n=69) in the control group, with median difference of 0.10 (95% CI 0.01-0.22; p=0.0333); mean salvage index was 0.69 (SD 0.27) versus 0.57 (0.26), with mean difference of 0.12 (95% CI 0.01-0.21; p=0.0333). Major adverse coronary events were death (n=3 per group), reinfarction (n=1 per group), and heart failure (n=3 per group). Interpretation Remote ischaemic conditioning before hospital admission increases myocardial salvage, and has a favourable safety profile. Our findings merit a larger trial to establish the effect of remote conditioning on clinical outcomes.	[Botker, Hans Erik; Schmidt, Michael R.; Bottcher, Morten; Kaltoft, Anne K.; Terkelsen, Christian J.; Munk, Kim; Andersen, Niels H.; Lassen, Jens Flensted; Christiansen, Evald Hoj; Krusell, Lars R.; Kristensen, Steen D.; Thuesen, Leif; Nielsen, Torsten T.] Aarhus Univ Hosp Skejby, Dept Cardiol, DK-8200 Aarhus N, Denmark; [Nielsen, Soren S.; Rehling, Michael] Aarhus Univ Hosp Skejby, Dept Nucl Med, DK-8200 Aarhus, Denmark; [Sorensen, Henrik Toft] Aarhus Univ Hosp Skejby, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Kharbanda, Rajesh] John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Hansen, Troels M.] Aarhus Univ Hosp Aarhus, Dept Anaesthesiol, Mobile Emergency Care Unit, Aarhus C, Denmark; [Trautner, Sven] Falck Ambulance Serv, Copenhagen, Denmark; [Redington, Andrew N.] Univ Toronto, Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada	Aarhus University; Aarhus University; Aarhus University; University of Oxford; Aarhus University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Botker, HE (corresponding author), Aarhus Univ Hosp Skejby, Dept Cardiol, DK-8200 Aarhus N, Denmark.	heb@dadlnet.dk	Lassen, Jens Flensted/AAY-2127-2021; Bottcher, M./AAI-8098-2020; Sorensen, Henrik Toft/Z-6181-2019; terkelsen, christian/ABD-6294-2021	Lassen, Jens Flensted/0000-0001-7972-9192; Bottcher, M./0000-0002-2116-2370; Sorensen, Henrik Toft/0000-0003-4299-7040; terkelsen, christian juhl/0000-0003-0205-9551; Christiansen, Evald/0000-0002-8740-4862; Botker, Hans Erik/0000-0001-6358-8962; Kharbanda, Rajesh/0000-0002-5356-2395; Andersen, Niels Holmark/0000-0002-5394-3016; Munk, Kim/0000-0002-2609-8902	Fondation Leducq [06CVD]; Oxford Biomedical Research Centre	Fondation Leducq(Leducq Foundation); Oxford Biomedical Research Centre	The study was funded by a grant from Fondation Leducq (grant number 06CVD). RK was funded by the Oxford Biomedical Research Centre. We thank Mette Toftdal; paramedics and emergency physicians for study implementation before hospital admission; nurses Karrina Clausen and Anne Christine Christensen; secretaries Birgitte Monefeldt and Hanne Kjeldahl Schlosser, and the staff of the catheterisation laboratory, coronary care unit, and Department of Nuclear Medicine in Aarhus University Hospital Skejby, Denmark, for their enthusiastic support.	Aletras AH, 2006, CIRCULATION, V113, P1865, DOI 10.1161/CIRCULATIONAHA.105.576025; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Bohmer E, 2009, CARDIOLOGY, V113, P207, DOI 10.1159/000201991; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Carlsson M, 2009, JACC-CARDIOVASC IMAG, V2, P569, DOI 10.1016/j.jcmg.2008.11.018; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Chia S, 2008, JACC-CARDIOVASC INTE, V1, P415, DOI 10.1016/j.jcin.2008.04.010; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5; Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879; Gritsopoulos G, 2009, CARDIOVASC DRUG THER, V23, P193, DOI 10.1007/s10557-009-6168-5; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Kaltoft A, 2006, CIRCULATION, V114, P40, DOI 10.1161/CIRCULATIONAHA.105.595660; Kaltoft A, 2009, J NUCL CARDIOL, V16, P784, DOI 10.1007/s12350-009-9105-x; Kastrati A, 2002, LANCET, V359, P920, DOI 10.1016/S0140-6736(02)08022-4; Kharbanda RK, 2006, HEART, V92, P1506, DOI 10.1136/hrt.2004.042366; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Kristiansen SB, 2005, AM J PHYSIOL-HEART C, V288, pH1252, DOI 10.1152/ajpheart.00207.2004; MILLER TD, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.3.334; Ndrepepa G, 2004, J NUCL MED, V45, P725; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; Terkelsen CJ, 2006, EUR HEART J, V27, P267, DOI 10.1093/eurheartj/ehi606; Terkelsen CJ, 2005, EUR HEART J, V26, P770, DOI 10.1093/eurheartj/ehi100; Wang LX, 2008, J THORAC CARDIOV SUR, V136, P335, DOI 10.1016/j.jtcvs.2007.12.055	30	754	791	1	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					727	734		10.1016/S0140-6736(09)62001-8	http://dx.doi.org/10.1016/S0140-6736(09)62001-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20189026				2022-12-28	WOS:000275211200029
J	Schreiner, PR				Schreiner, Peter R.			Cooperativity Tames Reactive Catalysts	SCIENCE			English	Editorial Material									Univ Giessen, Inst Organ Chem, D-35392 Giessen, Germany	Justus Liebig University Giessen	Schreiner, PR (corresponding author), Univ Giessen, Inst Organ Chem, Heinrich Buff Ring 58, D-35392 Giessen, Germany.	prs@org.chemie.uni-giessen.de	Schreiner, Peter Richard R/A-4084-2008	Schreiner, Peter Richard R/0000-0002-3608-5515				Berkessel A, 2005, ASYMMETRIC ORGANOCATALYSIS: FROM BIOMIMETIC CONCEPTS TO APPLICATIONS IN ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/3527604677; Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r; Kotke M, 2007, SYNTHESIS-STUTTGART, P779, DOI 10.1055/s-2007-965917; Margelefsky EL, 2008, CHEM SOC REV, V37, P1118, DOI 10.1039/b710334b; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Pihko P., 2009, HYDROGEN BONDING ORG; Povarov L.S., 1967, RUSS CHEM REV+, V36, DOI [10.1070/RC1967v036n09ABEH001680, DOI 10.1070/RC1967V036N09ABEH001680]; Raheem IT, 2007, J AM CHEM SOC, V129, P13404, DOI 10.1021/ja076179w; Rowlands GJ, 2001, TETRAHEDRON, V57, P1865, DOI 10.1016/S0040-4020(01)00057-6; Rueping M, 2007, SYNLETT, P1441, DOI 10.1055/s-2007-980369; Schreiner PR, 2003, CHEM SOC REV, V32, P289, DOI 10.1039/b107298f; Schreiner PR, 2002, ORG LETT, V4, P217, DOI 10.1021/ol017117s; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Xu H, 2010, SCIENCE, V327, P986, DOI 10.1126/science.1182826; Yamamoto H, 2005, ANGEW CHEM INT EDIT, V44, P1924, DOI 10.1002/anie.200460394; Zhang ZG, 2009, CHEM SOC REV, V38, P1187, DOI 10.1039/b801793j	16	14	14	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					965	966		10.1126/science.1186764	http://dx.doi.org/10.1126/science.1186764			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167775				2022-12-28	WOS:000274625800027
J	Carlo, WA; Goudar, SS; Jehan, I; Chomba, E; Tshefu, A; Garces, A; Parida, S; Althabe, F; McClure, EM; Derman, RJ; Goldenberg, RL; Bose, C; Krebs, NF; Panigrahi, P; Buekens, P; Chakraborty, H; Hartwell, TD; Wright, LL				Carlo, Waldemar A.; Goudar, Shivaprasad S.; Jehan, Imtiaz; Chomba, Elwyn; Tshefu, Antoinette; Garces, Ana; Parida, Sailajanandan; Althabe, Fernando; McClure, Elizabeth M.; Derman, Richard J.; Goldenberg, Robert L.; Bose, Carl; Krebs, Nancy F.; Panigrahi, Pinaki; Buekens, Pierre; Chakraborty, Hrishikesh; Hartwell, Tyler D.; Wright, Linda L.		First Breath Study Grp	Newborn-Care Training and Perinatal Mortality in Developing Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEONATAL HEALTH; RESUSCITATION; IMPACT; INTERVENTIONS; BIRTH; STILLBIRTHS; HOSPITALS	BACKGROUND Of the 3.7 million neonatal deaths and 3.3 million stillbirths each year, 98% occur in developing countries. An evaluation of community-based interventions designed to reduce the number of these deaths is needed. METHODS With the use of a train-the-trainer model, local instructors trained birth attendants from rural communities in six countries (Argentina, Democratic Republic of Congo, Guatemala, India, Pakistan, and Zambia) in the World Health Organization Essential Newborn Care course (which focuses on routine neonatal care, resuscitation, thermoregulation, breast-feeding, "kangaroo" [skin-to-skin] care, care of the small baby, and common illnesses) and ( except in Argentina) in a modified version of the American Academy of Pediatrics Neonatal Resuscitation Program (which teaches basic resuscitation in depth). The Essential Newborn Care intervention was assessed among 57,643 infants with the use of a before-and-after design. The Neonatal Resuscitation Program intervention was assessed as a cluster-randomized, controlled trial involving 62,366 infants. The primary outcome was neonatal death in the first 7 days after birth. RESULTS The 7-day follow-up rate was 99.2%. After birth attendants were trained in the Essential Newborn Care course, there was no significant reduction from baseline in the rate of neonatal death from all causes in the 7 days after birth ( relative risk with training, 0.99; 95% confidence interval [CI], 0.81 to 1.22) or in the rate of perinatal death; there was a significant reduction in the rate of stillbirth ( relative risk with training, 0.69; 95% CI, 0.54 to 0.88; P = 0.003). In clusters of births in which attendants had been randomly assigned to receive training in the Neonatal Resuscitation Program, as compared with control clusters, there was no reduction in the rates of neonatal death in the 7 days after birth, stillbirth, or perinatal death. CONCLUSIONS The rate of neonatal death in the 7 days after birth did not decrease after the introduction of Essential Newborn Care training of community-based birth attendants, although the rate of stillbirths was reduced. Subsequent training in the Neonatal Resuscitation Program did not significantly reduce the mortality rates.	[Carlo, Waldemar A.] Univ Alabama Birmingham, Birmingham, AL 35233 USA; [Carlo, Waldemar A.; Chomba, Elwyn] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Chomba, Elwyn] Univ Teaching Hosp, Lusaka, Zambia; [Goudar, Shivaprasad S.] Jawaharlal Nehru Med Coll, Belgaum, India; [Parida, Sailajanandan] Sriramchandra Bhanja Med Coll, Cuttack, Orissa, India; [Jehan, Imtiaz] Aga Khan Univ, Karachi, Pakistan; [Tshefu, Antoinette] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Garces, Ana] San Carlos Univ, Guatemala City, Guatemala; [Althabe, Fernando] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [McClure, Elizabeth M.; Chakraborty, Hrishikesh; Hartwell, Tyler D.] RTI Int, Durham, NC USA; [Bose, Carl] Univ N Carolina, Chapel Hill, NC USA; [Derman, Richard J.] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA; [Goldenberg, Robert L.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Krebs, Nancy F.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Panigrahi, Pinaki] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Wright, Linda L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Buekens, Pierre] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA	University of Alabama System; University of Alabama Birmingham; University of Zambia; K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; Srirama Chandra Bhanja Medical College & Hospital; Aga Khan University; Universidad de San Carlos de Guatemala; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Missouri System; University of Missouri Kansas City; Drexel University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Tulane University	Carlo, WA (corresponding author), Univ Alabama Birmingham, 525 New Hillman Bldg,619 S 20th St, Birmingham, AL 35233 USA.	wcarlo@peds.uab.edu	GOUDAR, SHIVAPRASAD S/S-1217-2019	GOUDAR, SHIVAPRASAD S/0000-0002-8680-7053; McClure, Elizabeth/0000-0001-8659-5444; Derman, Richard/0000-0003-1148-1594; Chakraborty, Hrishikesh/0000-0001-9078-845X; Belizan, Jose/0000-0002-8412-3010; Pasha, Omrana/0000-0003-4046-3918	Eunice Kennedy Shriver National Institute of Child Health and Human Development Global Network for Women's and Children's Health Research [U01 HD040477, U01 HD043475, U01 HD043464, U01 HD040657, U01 HD042372, U01 HD040607, U01 HD040636, U01 HD040574]; Bill and Melinda Gates Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040657, U01HD040477, U01HD040636, U01HD042372, U01HD040607, U01HD043464] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD040574, U01HD043475] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development Global Network for Women's and Children's Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Global Network for Women's and Children's Health Research (U01 HD040477, U01 HD043475, U01 HD043464, U01 HD040657, U01 HD042372, U01 HD040607, U01 HD040636, and U01 HD040574) and by the Bill and Melinda Gates Foundation.	Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS82, DOI 10.1038/sj.jp.7211275; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; CARLO WA, 2009, ANN M PED AC SOC BAL; Carlo WA, 2009, J PEDIAT, V154; Chakraborty H, 2008, WILEY SER PROBAB ST, P67; Chakraborty H, 2009, CONTEMP CLIN TRIALS, V30, P71, DOI 10.1016/j.cct.2008.07.008; CONDEAGUDELO A, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002771.PUB2]; COWLES W, 2007, ACAD EMERG MED, V14, pE109, DOI DOI 10.1197/J.AEM.2007.02.004; DAGA S R, 1992, Indian Pediatrics, V29, P189; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Deorari AK, 2001, ANN TROP PAEDIATR, V21, P29, DOI 10.1080/02724930020028885; Ellis M, 2000, PAEDIATR PERINAT EP, V14, P39; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; KUMAR R, 1995, TROP DOCT, V25, P29, DOI 10.1177/004947559502500109; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; McClure EM, 2007, ACTA PAEDIATR, V96, P1135, DOI 10.1111/j.1651-2227.2007.00392.x; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; O'Hare BA, 2006, J TROP PEDIATRICS, V52, P376, DOI 10.1093/tropej/fml027; Opiyo N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001599; *SAS I, 2007, SAS SOFTW VERS 9 1 3; Senarath U, 2007, JOGNN-J OBST GYN NEO, V36, P531, DOI 10.1111/j.1552-6909.2007.00183.x; Senarath U, 2007, J TROP PEDIATRICS, V53, P113, DOI 10.1093/tropej/fml080; Spector JM, 2008, B WORLD HEALTH ORGAN, V86, P315, DOI 10.2471/BLT.07.049924; SPILKER B, 1997, GUIDE CLIN TRIALS; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stokes ME, 2000, CATEGORICAL DATA ANA; Uxa F, 2006, SEMIN FETAL NEONAT M, V11, P58, DOI 10.1016/j.siny.2005.10.006; Vidal SA, 2001, B WORLD HEALTH ORGAN, V79, P1024; *WHO, 1997, BAS NEWB RES PRACT G; World Health Organization, NEON PER MORT COUNTR; World Health Organization, 1996, ESS NEWB CAR; Zhu X. Y., 1997, SMJ, V38, P485	35	228	233	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					614	623		10.1056/NEJMsa0806033	http://dx.doi.org/10.1056/NEJMsa0806033			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556ED	20164485	Green Accepted			2022-12-28	WOS:000274571200009
J	Wade, MJ; Wilson, DS; Goodnight, C; Taylor, D; Bar-Yam, Y; de Aguiar, MAM; Stacey, B; Werfel, J; Hoelzer, GA; Brodie, ED; Fields, P; Breden, F; Linksvayer, TA; Fletcher, JA; Richerson, PJ; Bever, JD; Van Dyken, JD; Zee, P				Wade, Michael J.; Wilson, David S.; Goodnight, Charles; Taylor, Doug; Bar-Yam, Yaneer; de Aguiar, Marcus A. M.; Stacey, Blake; Werfel, Justin; Hoelzer, Guy A.; Brodie, Edmund D., III; Fields, Peter; Breden, Felix; Linksvayer, Timothy A.; Fletcher, Jeffrey A.; Richerson, Peter J.; Bever, James D.; Van Dyken, J. David; Zee, Peter			Multilevel and kin selection in a connected world	NATURE			English	Letter							PARASITE VIRULENCE; EVOLUTION; ADAPTATION; MODELS		[Wade, Michael J.; Bever, James D.; Van Dyken, J. David; Zee, Peter] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Wilson, David S.] SUNY Binghamton, Dept Biol, Binghamton, NY 13902 USA; [Wilson, David S.] SUNY Binghamton, Dept Anthropol, Binghamton, NY 13902 USA; [Goodnight, Charles] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Taylor, Doug; Brodie, Edmund D., III; Fields, Peter] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Bar-Yam, Yaneer; de Aguiar, Marcus A. M.; Stacey, Blake; Werfel, Justin] New England Complex Syst Inst, Cambridge, MA 02138 USA; [Hoelzer, Guy A.] Univ Nevada Reno, Dept Biol, Reno, NV 89557 USA; [Breden, Felix] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Linksvayer, Timothy A.] Univ Copenhagen, Ctr Social Evolut, Dept Biol, DK-2100 Copenhagen, Denmark; [Fletcher, Jeffrey A.] Portland State Univ, Syst Sci Grad Program, Portland, OR 97207 USA; [Richerson, Peter J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	Indiana University System; Indiana University Bloomington; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Vermont; University of Virginia; Nevada System of Higher Education (NSHE); University of Nevada Reno; Simon Fraser University; University of Copenhagen; Portland State University; University of California System; University of California Davis	Wade, MJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mjwade@indiana.edu	de Aguiar, Marcus A M/C-9137-2012; Fields, Peter/G-3075-2010; Brodie, Edmund D/B-2335-2013; Goodnight, Charles/K-3208-2019; de Aguiar, Marcus A. M./N-1377-2019	de Aguiar, Marcus A M/0000-0003-1379-7568; Breden, Felix/0000-0001-9762-6314; Linksvayer, Timothy/0000-0001-7034-1546	NIGMS NIH HHS [R01 GM084238, R01 GM084238-02, R01 GM092660] Funding Source: Medline; Division Of Integrative Organismal Systems [1027251] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084238, R01GM092660] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bijma P, 2008, J EVOLUTION BIOL, V21, P1175, DOI 10.1111/j.1420-9101.2008.01550.x; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; ESTER E, 2009, THESIS WAGENINGEN U; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Goodnight C, 2008, COMPLEXITY, V13, P23, DOI 10.1002/cplx.20209; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; HOLLDOBLER B, 2009, SUPERORGANISM BEAUTY, P35; Muir WM, 1996, POULTRY SCI, V75, P447, DOI 10.3382/ps.0750447; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Werfel J, 2004, P NATL ACAD SCI USA, V101, P11019, DOI 10.1073/pnas.0305059101; Wild G, 2009, NATURE, V459, P983, DOI 10.1038/nature08071	11	35	36	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					E8	E9		10.1038/nature08809	http://dx.doi.org/10.1038/nature08809			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164866	Green Accepted			2022-12-28	WOS:000274582700054
J	Campochiaro, PA				Campochiaro, Peter A.			The Complexity of Animal Model Generation for Complex Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MACULAR DEGENERATION; SUBRETINAL NEOVASCULARIZATION; CHOROIDAL NEOVASCULARIZATION; FUNDUS DYSTROPHY		[Campochiaro, Peter A.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21287 USA; [Campochiaro, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Campochiaro, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, 600 N Wolfe St,Maumenee 719, Baltimore, MD 21287 USA.	pcampo@jhmi.edu						Albert DM, 2010, ARCH OPHTHALMOL-CHIC, V128, P212, DOI 10.1001/archophthalmol.2009.395; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; ISHIBASHI T, 1985, ARCH OPHTHALMOL-CHIC, V103, P708; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Okamoto N, 1997, AM J PATHOL, V151, P281; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Weber BHF, 2002, INVEST OPHTH VIS SCI, V43, P2732; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352	10	1	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					657	658		10.1001/jama.2010.142	http://dx.doi.org/10.1001/jama.2010.142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555NK	20187264				2022-12-28	WOS:000274518600024
J	Toh, S; Hernandez-Diaz, S; Logan, R; Rossouw, JE; Hernan, MA				Toh, Sengwee; Hernandez-Diaz, Sonia; Logan, Roger; Rossouw, Jacques E.; Hernan, Miguel A.			Coronary Heart Disease in Postmenopausal Recipients of Estrogen Plus Progestin Therapy: Does the Increased Risk Ever Disappear? A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							MARGINAL STRUCTURAL MODELS; HORMONE-THERAPY; CARDIOVASCULAR-DISEASE; WOMEN; BENEFITS; HEALTHY; HRT	Background: Estrogen plus progestin therapy increases the risk for coronary heart disease (CHD) in postmenopausal women. However, this increased risk might be limited to the first years of use and to women who start therapy late in menopause. Objective: To estimate the effect of continuous estrogen plus progestin therapy on CHD risk over time and stratified by years since menopause. Design: Women's Health Initiative randomized, double-blinded, placebo-controlled trial. (ClinicalTrials.gov registration number: NCT00000611) Setting: 40 U. S. clinical centers. Patients: 16 608 postmenopausal women with an intact uterus at baseline from 1993 to 1998. Intervention: Conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d, or placebo. Measurements: Adherence-adjusted hazard ratios and CHD-free survival curves estimated through inverse probability weighting. Results: Compared with no use of hormone therapy, the hazard ratio for continuous use of estrogen plus progestin therapy was 2.36 (95% CI, 1.55 to 3.62) for the first 2 years and 1.69 (CI, 0.98 to 2.89) for the first 8 years. For women within 10 years after menopause, the hazard ratios were 1.29 (CI, 0.52 to 3.18) for the first 2 years and 0.64 (CI, 0.21 to 1.99) for the first 8 years, and the CHD-free survival curves for continuous use and no use of estrogen plus progestin crossed at about 6 years (CI, 2 years to 10 years). Limitation: The analysis may not have fully adjusted for joint determinants of adherence and CHD risk. Sample sizes for some subgroup analyses were small. Conclusion: No suggestion of a decreased risk for CHD was found within the first 2 years of estrogen plus progestin use, including in women who initiated therapy within 10 years after menopause. A possible cardioprotective effect in these women who initiated therapy closer to menopause became apparent only after 6 years of use.	Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; NHLBI, Bethesda, MD 20892 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Toh, S (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	darrentoh@post.harvard.edu	Toh, Sengwee/D-7567-2017	Toh, Sengwee/0000-0002-5160-0810; Hernan, Miguel/0000-0003-1619-8456	National Heart, Lung, and Blood Institute; National Institutes of Health [R01 HL080644-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080644] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.; By the National Institutes of Health (grant R01 HL080644-01).	*AM COLL OBST GYN, 2004, OBSTET GYNECOL S, V104, pS1; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Barnabei VM, 2005, OBSTET GYNECOL, V105, P1063, DOI 10.1097/01.AOG.0000158120.47542.18; Barrett-Connor E, 2007, AM J EPIDEMIOL, V166, P506, DOI 10.1093/aje/kwm214; Connelly MT, 2000, J GEN INTERN MED, V15, P542, DOI 10.1046/j.1525-1497.2000.03499.x; Cotter D, 2008, KIDNEY INT, V73, P347, DOI 10.1038/sj.ki.5002688; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2005, BIOMETRICS, V61, P922, DOI 10.1111/j.0006-341X.2005.454_7.x; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Hernan MA, 2008, EPIDEMIOLOGY, V19, P789, DOI 10.1097/EDE.0b013e318188e85f; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Johnson MS, 2005, ANN INTERN MED, V142, P855, DOI 10.7326/0003-4819-142-10-200505170-00011; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lobo RA, 2004, ARCH INTERN MED, V164, P482, DOI 10.1001/archinte.164.5.482; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Manson JE, 2007, AM J EPIDEMIOL, V166, P511, DOI 10.1093/aje/kwm213; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Mendelsohn ME, 2007, NEW ENGL J MED, V356, P2639, DOI 10.1056/NEJMe078072; Pines A, 2008, CLIMACTERIC, V11, P267, DOI 10.1080/13697130802226866; Prentice RL, 2005, AM J EPIDEMIOL, V162, P404, DOI 10.1093/aje/kwi223; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; THOMPSON WA, 1977, BIOMETRICS, V33, P463; Toh S., 2008, INT J BIOSTAT, DOI [10.2202/1557-4679.1117, DOI 10.2202/1557-4679.1117]; Utian WH, 2007, MENOPAUSE, V14, P168, DOI 10.1097/gme.0b013e31803167ab	27	74	78	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2010	152	4					211	U30		10.7326/0003-4819-152-4-201002160-00005	http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00005			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560AF	20157135	Green Accepted			2022-12-28	WOS:000274873300002
J	Benagiano, G; von Hertzen, H				Benagiano, Giuseppe; von Hertzen, Helena			Towards more effective emergency contraception?	LANCET			English	Editorial Material							CELL-CULTURE MODEL; RANDOMIZED-TRIAL; MIFEPRISTONE; LEVONORGESTREL; OVULATION; INTERCOURSE; PREGNANCY		[Benagiano, Giuseppe] Univ Rome, Dept Obstet & Gynaecol, I-00161 Rome, Italy; [von Hertzen, Helena] Concept Fdn, Geneva, Switzerland	Sapienza University Rome	Benagiano, G (corresponding author), Univ Rome, Dept Obstet & Gynaecol, I-00161 Rome, Italy.	giuseppe.benagiano@uniroma1.it						Austriaco N., 2007, NATL CATHOLIC BIOETH, V7, P703; Glasier AF, 2010, LANCET, V375, P555, DOI 10.1016/S0140-6736(10)60101-8; Hamel Ron, 2010, Health Prog, V91, P62; Lalitkumar PGL, 2007, HUM REPROD, V22, P3031, DOI 10.1093/humrep/dem297; LIU JH, 1987, J CLIN ENDOCR METAB, V65, P1135, DOI 10.1210/jcem-65-6-1135; Meng CX, 2009, FERTIL STERIL, V91, P256, DOI 10.1016/j.fertnstert.2007.11.007; Piaggio G, 2003, CONTRACEPTION, V68, P447, DOI 10.1016/S0010-7824(03)00142-2; Piaggio G, 1999, LANCET, V353, P697; POYSER NL, 1994, PROSTAG LEUKOTR ESS, V50, P245, DOI 10.1016/0952-3278(94)90161-9; Raymond EG, 2007, OBSTET GYNECOL, V109, P181, DOI 10.1097/01.AOG.0000250904.06923.4a; Stratton P, 2000, HUM REPROD, V15, P1092, DOI 10.1093/humrep/15.5.1092; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; Wilcox AJ, 2004, HUM REPROD, V19, P1539, DOI 10.1093/humrep/deh305; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301	14	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 13	2010	375	9714					527	528		10.1016/S0140-6736(10)60146-8	http://dx.doi.org/10.1016/S0140-6736(10)60146-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560YO	20159273				2022-12-28	WOS:000274941900004
J	Altman, MS				Altman, Michael S.			CO Prefers the Aisle Seat	SCIENCE			English	Editorial Material							SHAPE CHANGES; SURFACE; OXYGEN; RECONSTRUCTION; DYNAMICS; STEPS		Hong Kong Univ Sci & Technol, Dept Phys, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Altman, MS (corresponding author), Hong Kong Univ Sci & Technol, Dept Phys, Kowloon, Hong Kong, Peoples R China.	phaltman@ust.hk		Altman, Michael/0000-0003-0832-1717				COMSA G, 1982, SURF SCI, V119, P159, DOI 10.1016/0039-6028(82)90290-4; HAASE O, 1991, PHYS REV LETT, V66, P1725, DOI 10.1103/PhysRevLett.66.1725; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; HOOGERS G, 1993, SURF SCI, V286, P306, DOI 10.1016/0039-6028(93)90414-F; Jeong HC, 1999, SURF SCI REP, V34, P171, DOI 10.1016/S0167-5729(98)00010-7; LANG B, 1972, SURF SCI, V30, P454, DOI 10.1016/0039-6028(72)90012-X; Nolte P, 2008, SCIENCE, V321, P1654, DOI 10.1126/science.1160845; Pearl TP, 2001, J PHYS CHEM B, V105, P6300, DOI 10.1021/jp011165c; Roland C, 1996, MRS BULL, V21, P27, DOI 10.1557/S0883769400035302; Tao F, 2010, SCIENCE, V327, P850, DOI 10.1126/science.1182122	10	14	14	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					789	790		10.1126/science.1187483	http://dx.doi.org/10.1126/science.1187483			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150472				2022-12-28	WOS:000274408300028
J	Cheung, VG; Sherman, SL; Feingold, E				Cheung, Vivian G.; Sherman, Stephanie L.; Feingold, Eleanor			Genetic Control of Hotspots	SCIENCE			English	Editorial Material							MEIOTIC RECOMBINATION; INITIATION		[Cheung, Vivian G.] Univ Penn, Howard Hughes Med Inst, Dept Pediat, Philadelphia, PA 19104 USA; [Cheung, Vivian G.] Univ Penn, Howard Hughes Med Inst, Dept Genet, Philadelphia, PA 19104 USA; [Sherman, Stephanie L.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Feingold, Eleanor] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA	Howard Hughes Medical Institute; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cheung, VG (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Pediat, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Feingold, Eleanor/0000-0003-2898-6484	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [R01 HG001880-09S1, R01 HG001880] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001880] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495	13	17	17	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					791	792		10.1126/science.1187155	http://dx.doi.org/10.1126/science.1187155			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150474				2022-12-28	WOS:000274408300030
J	Krasteva, PV; Fong, JCN; Shikuma, NJ; Beyhan, S; Navarro, MVAS; Yildiz, FH; Sondermann, H				Krasteva, Petya V.; Fong, Jiunn C. N.; Shikuma, Nicholas J.; Beyhan, Sinem; Navarro, Marcos V. A. S.; Yildiz, Fitnat H.; Sondermann, Holger			Vibrio cholerae VpsT Regulates Matrix Production and Motility by Directly Sensing Cyclic di-GMP	SCIENCE			English	Article							RUGOSE COLONY MORPHOLOGY; O1 EL-TOR; BIOFILM FORMATION; ESCHERICHIA-COLI; IDENTIFICATION; TYPHIMURIUM; PROTEINS; SYSTEMS; CURLI	Microorganisms can switch from a planktonic, free-swimming life-style to a sessile, colonial state, called a biofilm, which confers resistance to environmental stress. Conversion between the motile and biofilm life-styles has been attributed to increased levels of the prokaryotic second messenger cyclic di-guanosine monophosphate (c-di-GMP), yet the signaling mechanisms mediating such a global switch are poorly understood. Here we show that the transcriptional regulator VpsT from Vibrio cholerae directly senses c-di-GMP to inversely control extracellular matrix production and motility, which identifies VpsT as a master regulator for biofilm formation. Rather than being regulated by phosphorylation, VpsT undergoes a change in oligomerization on c-di-GMP binding.	[Fong, Jiunn C. N.; Shikuma, Nicholas J.; Beyhan, Sinem; Yildiz, Fitnat H.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Krasteva, Petya V.; Navarro, Marcos V. A. S.; Sondermann, Holger] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	University of California System; University of California Santa Cruz; Cornell University	Yildiz, FH (corresponding author), Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA.	yildiz@metx.ucsc.edu; hs293@cornell.edu	Navarro, Marcos VAS/C-9141-2013; Krasteva, Petya/E-4132-2014; Krasteva, Petya Violinova/ABF-2168-2020	Krasteva, Petya/0000-0002-1858-8127; Krasteva, Petya Violinova/0000-0002-1858-8127; Shikuma, Nicholas/0000-0001-5518-5020; Navarro, Marcos/0000-0002-2461-0431	Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy; National Center for Research Resources of the NIH; NIH [1R01GM081373, R01AI055987]; PEW Scholar award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081373] Funding Source: NIH RePORTER	Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy; National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PEW Scholar award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Hubbard and W. Horne for providing access to light scattering and calorimetry, respectively, and to the staff at the National Synchrotron Light Source (NSLS; Brookhaven National Laboratories) for assistance with synchrotron data collection. The NSLS is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy, and by the National Center for Research Resources of the NIH. This work was supported by the NIH (1R01GM081373 to H. S. and R01AI055987 to F.H.Y.), and by a PEW Scholar award (H. S.). Atomic coordinates and structure factors have been deposited in the RCSB Protein Data Bank under ID code 3KLN and 3KLO. The microarray data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO series accession number GSE19479.	Beyhan S, 2008, J BACTERIOL, V190, P7392, DOI 10.1128/JB.00564-08; Beyhan S, 2007, MOL MICROBIOL, V63, P995, DOI 10.1111/j.1365-2958.2006.05568.x; Beyhan S, 2007, J BACTERIOL, V189, P388, DOI 10.1128/JB.00981-06; Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004; Chirwa NT, 2003, MICROBIOL-SGM, V149, P525, DOI 10.1099/mic.0.25841-0; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fong JCN, 2007, J BACTERIOL, V189, P2319, DOI 10.1128/JB.01569-06; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Mizunoe Y, 1999, INFECT IMMUN, V67, P958, DOI 10.1128/IAI.67.2.958-963.1999; Romling U, 1998, J BACTERIOL, V180, P722; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028	16	288	306	6	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					866	868		10.1126/science.1181185	http://dx.doi.org/10.1126/science.1181185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150502	Green Accepted			2022-12-28	WOS:000274408300062
J	Block, M; Ackermann, D; Blaum, K; Droese, C; Dworschak, M; Eliseev, S; Fleckenstein, T; Haettner, E; Herfurth, F; Hessberger, FP; Hofmann, S; Ketelaer, J; Ketter, J; Kluge, HJ; Marx, G; Mazzocco, M; Novikov, YN; Plass, WR; Popeko, A; Rahaman, S; Rodriguez, D; Scheidenberger, C; Schweikhard, L; Thirolf, PG; Vorobyev, GK; Weber, C				Block, M.; Ackermann, D.; Blaum, K.; Droese, C.; Dworschak, M.; Eliseev, S.; Fleckenstein, T.; Haettner, E.; Herfurth, F.; Hessberger, F. P.; Hofmann, S.; Ketelaer, J.; Ketter, J.; Kluge, H. -J.; Marx, G.; Mazzocco, M.; Novikov, Yu. N.; Plass, W. R.; Popeko, A.; Rahaman, S.; Rodriguez, D.; Scheidenberger, C.; Schweikhard, L.; Thirolf, P. G.; Vorobyev, G. K.; Weber, C.			Direct mass measurements above uranium bridge the gap to the island of stability	NATURE			English	Article							NUCLEAR-STRUCTURE INVESTIGATIONS; SUPERHEAVY NUCLEI; HEAVIEST NUCLEI; SHIPTRAP; ACCURACY; ELEMENTS	The mass of an atom incorporates all its constituents and their interactions(1). The difference between the mass of an atom and the sum of its building blocks (the binding energy) is a manifestation of Einstein's famous relation E = mc(2). The binding energy determines the energy available for nuclear reactions and decays (and thus the creation of elements by stellar nucleosynthesis), and holds the key to the fundamental question of how heavy the elements can be. Superheavy elements have been observed in challenging production experiments(2-4), but our present knowledge of the binding energy of these nuclides is based only on the detection of their decay products. The reconstruction from extended decay chains introduces uncertainties that render the interpretation difficult. Here we report direct mass measurements of transuranium nuclides. Located at the farthest tip of the actinide species on the proton number-neutron number diagram, these nuclides represent the gateway to the predicted island of stability. In particular, we have determined the mass values of No252-254 (atomic number 102) with the Penning trap mass spectrometer SHIPTRAP(5). The uncertainties are of the order of 10 keV/c(2) (representing a relative precision of 0.05 p.p.m.), despite minute production rates of less than one atom per second. Our experiments advance direct mass measurements by ten atomic numbers with no loss in accuracy, and provide reliable anchor points en route to the island of stability.	[Block, M.; Ackermann, D.; Dworschak, M.; Herfurth, F.; Hessberger, F. P.; Hofmann, S.; Kluge, H. -J.; Novikov, Yu. N.; Plass, W. R.; Scheidenberger, C.; Vorobyev, G. K.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Blaum, K.; Eliseev, S.; Ketter, J.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Droese, C.; Marx, G.; Schweikhard, L.] Ernst Moritz Arndt Univ Greifswald, D-17489 Greifswald, Germany; [Fleckenstein, T.; Haettner, E.; Plass, W. R.; Scheidenberger, C.] Univ Giessen, D-35390 Giessen, Germany; [Ketelaer, J.] Johannes Gutenberg Univ Mainz, D-55128 Mainz, Germany; [Kluge, H. -J.] Heidelberg Univ, D-69120 Heidelberg, Germany; [Mazzocco, M.] Univ Padua, Dipartimento Fis, I-35131 Padua, Italy; [Mazzocco, M.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Novikov, Yu. N.] PNPIRAS, Gatchina 188300, Russia; [Popeko, A.] Joint Inst Nucl Res, Flerov Lab Nucl React, Dubna 141980, Russia; [Rahaman, S.; Weber, C.] Univ Jyvaskyla, Jyvaskyla 40014, Finland; [Rodriguez, D.] Univ Granada, Dept FAMN, E-18071 Granada, Spain; [Thirolf, P. G.] Univ Munich, D-85748 Garching, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; Justus Liebig University Giessen; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Joint Institute for Nuclear Research - Russia; University of Jyvaskyla; University of Granada; University of Munich	Block, M (corresponding author), GSI Helmholtzzentrum Schwerionenforsch GmbH, Planckstr 1, D-64291 Darmstadt, Germany.	m.block@gsi.de	Schweikhard, Lutz/AAX-3044-2021; Novikov, Iurii N/M-7784-2013; Rodríguez, Daniel/A-1692-2009; Mazzocco, Marco/J-4393-2012; eliseev, sergey/AAC-3801-2022; Ackermann, Dieter/AAW-6913-2021; Block, Michael/I-2782-2015; RODRIGUEZ, Daniel/GWC-3563-2022	Novikov, Iurii N/0000-0002-5369-7142; Rodríguez, Daniel/0000-0002-2989-7566; eliseev, sergey/0000-0003-0210-7082; Ackermann, Dieter/0000-0001-6284-1516; Block, Michael/0000-0001-9282-8347; Plass, Wolfgang/0000-0003-2744-2645	German Federal Ministry of Education and Research; Max-Planck Society; Helmholtz Association; Junta de Andalucia	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max-Planck Society(Max Planck Society); Helmholtz Association(Helmholtz Association); Junta de Andalucia(Junta de Andalucia)	We thank D. Lunney for help with the preparation of the manuscript. The project was supported in part by the German Federal Ministry of Education and Research, the Max-Planck Society, and the Helmholtz Association. D. R. acknowledges support from Junta de Andalucia.	Audi G, 2003, NUCL PHYS A, V729, P337, DOI 10.1016/j.nuclphysa.2003.11.003; Audi G, 2006, INT J MASS SPECTROM, V251, P85, DOI 10.1016/j.ijms.2006.01.048; BEMIS CE, 1977, PHYS REV C, V15, P705, DOI 10.1103/PhysRevC.15.705; Bender M, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.034304; Blaum K, 2006, PHYS REP, V425, P1, DOI 10.1016/j.physrep.2005.10.011; Block M, 2007, EUR PHYS J D, V45, P39, DOI 10.1140/epjd/e2007-00189-2; Block M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.132501; BOLLEN G, 1990, J APPL PHYS, V68, P4355, DOI 10.1063/1.346185; Bollen G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.152501; Chaudhuri A, 2007, EUR PHYS J D, V45, P47, DOI 10.1140/epjd/e2007-00001-5; Cwiok S, 2005, NATURE, V433, P705, DOI 10.1038/nature03336; GHIORSO A, 1967, PHYS REV LETT, V18, P401, DOI 10.1103/PhysRevLett.18.401; Herzberg RD, 2006, NATURE, V442, P896, DOI 10.1038/nature05069; Hessberger FP, 2007, EUR PHYS J D, V45, P33, DOI 10.1140/epjd/e2007-00146-1; Hessberger FP, 2007, PHYS ATOM NUCL+, V70, P1445, DOI 10.1134/S1063778807080200; Hofmann S, 2000, REV MOD PHYS, V72, P733, DOI 10.1103/RevModPhys.72.733; Kaneko K, 2009, PHYS LETT B, V671, P42, DOI 10.1016/j.physletb.2008.11.072; Lunney D, 2003, REV MOD PHYS, V75, P1021, DOI 10.1103/RevModPhys.75.1021; Martin A, 2007, EUR PHYS J A, V34, P341, DOI 10.1140/epja/i2007-10520-5; MIKHEEV VL, 1967, ATOM ENERG, V22, P90; Moeller P., 1994, J PHYS G, V20, P1681; Morita K, 2004, J PHYS SOC JPN, V73, P2593, DOI 10.1143/JPSJ.73.2593; Neidherr D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.112501; Odom B, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030801; Oganessian Y, 2007, J PHYS G NUCL PARTIC, V34, pR165, DOI 10.1088/0954-3899/34/4/R01; Rainville S, 2005, NATURE, V438, P1096, DOI 10.1038/4381096a; Rauth C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.012501; ROOSBROECK JV, 2005, PHYS REV LETT, V92; Sulignano B, 2007, EUR PHYS J A, V33, P327, DOI 10.1140/epja/i2007-10469-3; Weber C, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.054310	30	149	151	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					785	788		10.1038/nature08774	http://dx.doi.org/10.1038/nature08774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148034				2022-12-28	WOS:000274394300034
J	Franks, PW; Hanson, RL; Knowler, WC; Sievers, ML; Bennett, PH; Looker, HC				Franks, Paul W.; Hanson, Robert L.; Knowler, William C.; Sievers, Maurice L.; Bennett, Peter H.; Looker, Helen C.			Childhood Obesity, Other Cardiovascular Risk Factors, and Premature Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; UNITED-STATES; METABOLIC SYNDROME; DIABETES-MELLITUS; PIMA-INDIANS; US CHILDREN; FOLLOW-UP; MORTALITY; ADOLESCENTS; OVERWEIGHT	BACKGROUND The effect of childhood risk factors for cardiovascular disease on adult mortality is poorly understood. METHODS In a cohort of 4857 American Indian children without diabetes (mean age, 11.3 years; 12,659 examinations) who were born between 1945 and 1984, we assessed whether body-mass index (BMI), glucose tolerance, and blood pressure and cholesterol levels predicted premature death. Risk factors were standardized according to sex and age. Proportional-hazards models were used to assess whether each risk factor was associated with time to death occurring before 55 years of age. Models were adjusted for baseline age, sex, birth cohort, and Pima or Tohono O'odham Indian heritage. RESULTS There were 166 deaths from endogenous causes (3.4% of the cohort) during a median follow-up period of 23.9 years. Rates of death from endogenous causes among children in the highest quartile of BMI were more than double those among children in the lowest BMI quartile (incidence-rate ratio, 2.30; 95% confidence interval [CI], 1.46 to 3.62). Rates of death from endogenous causes among children in the highest quartile of glucose intolerance were 73% higher than those among children in the lowest quartile (incidence-rate ratio, 1.73; 95% CI, 1.09 to 2.74). No significant associations were seen between rates of death from endogenous or external causes and childhood cholesterol levels or systolic or diastolic blood-pressure levels on a continuous scale, although childhood hypertension was significantly associated with premature death from endogenous causes (incidence-rate ratio, 1.57; 95% CI, 1.10 to 2.24). CONCLUSIONS Obesity, glucose intolerance, and hypertension in childhood were strongly associated with increased rates of premature death from endogenous causes in this population. In contrast, childhood hypercholesterolemia was not a major predictor of premature death from endogenous causes.	[Franks, Paul W.] Umea Univ Hosp, Genet Epidemiol & Clin Res Grp, Dept Publ Hlth & Clin Med, Med Sect, S-90187 Umea, Sweden; [Franks, Paul W.; Hanson, Robert L.; Knowler, William C.; Sievers, Maurice L.; Bennett, Peter H.; Looker, Helen C.] NIDDK, Diabet Epidemiol & Clin Res Sect, NIH, Phoenix, AZ USA; [Franks, Paul W.] Univ Cambridge, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Looker, Helen C.] Mt Sinai Sch Med, New York, NY USA	Umea University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Cambridge; Icahn School of Medicine at Mount Sinai	Franks, PW (corresponding author), Umea Univ Hosp, Genet Epidemiol & Clin Res Grp, Dept Publ Hlth & Clin Med, Med Sect, S-90187 Umea, Sweden.	paul.franks@medicin.umu.se	Franks, Paul/AAA-3300-2020; Hrafnkelsson, Hannes/C-8490-2011; Bennett, Peter/AAH-9605-2021; Hanson, Robert/O-3238-2015	Hanson, Robert/0000-0002-4252-7068; Franks, Paul/0000-0002-0520-7604	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Swedish Diabetes Association; Swedish Heart Lung Foundation; Swedish Research Council, Umea University; Vasterbotten regional health authority; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069000, ZIADK069097] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Diabetes Association; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council, Umea University(Swedish Research Council); Vasterbotten regional health authority; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intramural research program. Dr. Franks was supported in part by grants from the Swedish Diabetes Association, the Swedish Heart Lung Foundation, the Swedish Research Council, Umea University (Career Development Award), and the Vasterbotten regional health authority (Strategic Appointment 2006-09).	American Diabetes Association, 1999, DIABETES CARE, V22, pS1; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; BENNETT PH, 1971, LANCET, V2, P125; *CDCP, 2000, PUBL CDCP, V314; Dahl-Regis M, 2002, ANN REPORT CHIEF MED; *DEP HLTH HUM SERV, 2004, CHILD HLTH US 2004; DIPIETRO L, 1994, INT J OBESITY, V18, P585; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fagot-Campagna A, 2001, DIABETES CARE, V24, P834, DOI 10.2337/diacare.24.5.834; Franks PW, 2007, DIABETES, V56, P2964, DOI 10.2337/db06-1639; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HOWARD BV, 1983, CIRCULATION, V68, P714, DOI 10.1161/01.CIR.68.4.714; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lindsay RS, 2001, J CLIN ENDOCR METAB, V86, P4061, DOI 10.1210/jc.86.9.4061; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pavkov ME, 2006, JAMA-J AM MED ASSOC, V296, P421, DOI 10.1001/jama.296.4.421; PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502; PRENTICE RL, 1979, BIOMETRICS, V35, P25, DOI 10.2307/2529934; SIEVERS ML, 1990, J CLIN EPIDEMIOL, V43, P1231, DOI 10.1016/0895-4356(90)90024-J; *WHO DEP NONC DIS, 1999, REP WHO CONS DEF D 1	31	857	885	3	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					485	493		10.1056/NEJMoa0904130	http://dx.doi.org/10.1056/NEJMoa0904130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147714	Green Accepted, Green Published			2022-12-28	WOS:000274397200005
J	Kwong, LN; Chin, L				Kwong, Lawrence N.; Chin, Lynda			The Brothers RAF	CELL			English	Editorial Material							BRAF; CRAF; MUTATIONS; MELANOMA; INHIBITION; RESISTANCE; MECHANISM; PATHWAYS; CANCER; CELLS		[Kwong, Lawrence N.; Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chin, Lynda] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Chin, L (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu						[Anonymous], 2008, NATURE, V455, P1061; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Smalley KSM, 2009, ONCOGENE, V28, P85, DOI 10.1038/onc.2008.362; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946	9	18	19	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					180	182		10.1016/j.cell.2010.01.013	http://dx.doi.org/10.1016/j.cell.2010.01.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141832	Bronze			2022-12-28	WOS:000273826500009
J	Groffen, AJ; Martens, S; Arazola, RD; Cornelisse, LN; Lozovaya, N; de Jong, APH; Goriounova, NA; Habets, RLP; Takai, Y; Borst, JG; Brose, N; McMahon, HT; Verhage, M				Groffen, Alexander J.; Martens, Sascha; Arazola, Rocio Diez; Cornelisse, L. Niels; Lozovaya, Natalia; de Jong, Arthur P. H.; Goriounova, Natalia A.; Habets, Ron L. P.; Takai, Yoshimi; Borst, J. Gerard; Brose, Nils; McMahon, Harvey T.; Verhage, Matthijs			Doc2b Is a High-Affinity Ca2+ Sensor for Spontaneous Neurotransmitter Release	SCIENCE			English	Article							PRESYNAPTIC CALCIUM STORES; MEMBRANE-FUSION; SYNAPTOTAGMIN-I; PURKINJE-CELL; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; CEREBELLAR CORTEX; NEURONS; PROTEIN; EXOCYTOSIS	Synaptic vesicle fusion in brain synapses occurs in phases that are either tightly coupled to action potentials ( synchronous), immediately following action potentials (asynchronous), or as stochastic events in the absence of action potentials (spontaneous). Synaptotagmin-1, -2, and -9 are vesicle-associated Ca2+ sensors for synchronous release. Here we found that double C2 domain (Doc2) proteins act as Ca2+ sensors to trigger spontaneous release. Although Doc2 proteins are cytosolic, they function analogously to synaptotagmin-1 but with a higher Ca2+ sensitivity. Doc2 proteins bound to N-ethylmaleimide-sensitive factor attachment receptor (SNARE) complexes in competition with synaptotagmin-1. Thus, different classes of multiple C2 domain-containing molecules trigger synchronous versus spontaneous fusion, which suggests a general mechanism for synaptic vesicle fusion triggered by the combined actions of SNAREs and multiple C2 domain-containing proteins.	[Groffen, Alexander J.; Arazola, Rocio Diez; Cornelisse, L. Niels; Lozovaya, Natalia; de Jong, Arthur P. H.; Goriounova, Natalia A.; Verhage, Matthijs] Vrije Univ Amsterdam, CNCR, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Groffen, Alexander J.; Arazola, Rocio Diez; Cornelisse, L. Niels; Lozovaya, Natalia; de Jong, Arthur P. H.; Goriounova, Natalia A.; Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Martens, Sascha; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Lozovaya, Natalia; Goriounova, Natalia A.] Vrije Univ Amsterdam, CNCR, Dept Integrat Neurophysiol, NL-1081 HV Amsterdam, Netherlands; [Lozovaya, Natalia; Borst, J. Gerard] AA Bogomolets Physiol Inst, UA-01024 Kiev, Ukraine; [Habets, Ron L. P.; Takai, Yoshimi] Univ Med Ctr, Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Brose, Nils] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan; Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; MRC Laboratory Molecular Biology; Vrije Universiteit Amsterdam; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; Erasmus University Rotterdam; Erasmus MC; Kobe University; Max Planck Society	Groffen, AJ (corresponding author), Vrije Univ Amsterdam, CNCR, Dept Funct Genom, Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands.	sander.groffen@cncr.vu.nl; sascha.martens@univie.ac.at	Groffen, A.J.A./C-1118-2009; de Jong, Arthur PH/D-9500-2013; Goriounova, Natalia/ABE-6759-2020; Martens, Sascha/C-3693-2011	Groffen, A.J.A./0000-0003-0046-4027; Cornelisse, Lennart Niels/0000-0001-9425-2935; Martens, Sascha/0000-0003-3786-8199; verhage, matthijs/0000-0002-6085-7503; Goriounova, Natalia/0000-0002-5917-983X; de Jong, Arthur/0000-0002-7620-2704	EU [019055, F2-2009-241498]; U.K. Medical Research Council; European Molecular Biology Organization; Neuro-Bsik Mouse Phenomics Consortium [BSIK03053]; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish	EU(European Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Neuro-Bsik Mouse Phenomics Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Zalm, D. Schut, I. Saarloos, B. de Vries, C. van der Meer, and M. Schindler for technical assistance. H. Mansvelder and H. Lodder are acknowledged for expert advice and help in neurophysiology. This work was supported by the EU (EUSynapse project 019055 and Eurospin Health-F2-2009-241498 to M. V.), the U.K. Medical Research Council to H. M. M. and S. M., a European Molecular Biology Organization Long-Term Fellowship to S. M., and the Neuro-Bsik Mouse Phenomics Consortium BSIK03053 to M. V. The authors declare no conflicting interests.	Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BERNARD C, 1993, BRAIN RES, V626, P234, DOI 10.1016/0006-8993(93)90584-A; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; CHANPALAY V, 1971, Z ANAT ENTWICKLUNGS, V134, P200, DOI 10.1007/BF00519300; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Collin T, 2005, CURR OPIN NEUROBIOL, V15, P275, DOI 10.1016/j.conb.2005.05.003; De Crescenzo V, 2004, J NEUROSCI, V24, P1226, DOI 10.1523/JNEUROSCI.4286-03.2004; Duncan RR, 1999, J BIOL CHEM, V274, P27347, DOI 10.1074/jbc.274.39.27347; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fukuda N, 2009, DIABETES, V58, P377, DOI 10.2337/db08-0303; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; Groffen AJA, 2004, J BIOL CHEM, V279, P23740, DOI 10.1074/jbc.M400731200; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Kojima T, 1996, J BIOCHEM-TOKYO, V120, P671; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V384, P461, DOI 10.1016/j.bbrc.2009.04.133; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Womack M, 2002, J NEUROSCI, V22, P10603; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; ZENGEL JE, 1994, J PHYSIOL-LONDON, V477, P267, DOI 10.1113/jphysiol.1994.sp020189	42	227	231	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1614	1618		10.1126/science.1183765	http://dx.doi.org/10.1126/science.1183765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20150444	Green Accepted			2022-12-28	WOS:000275970600035
J	Hales, JM; Matichak, J; Barlow, S; Ohira, S; Yesudas, K; Bredas, JL; Perry, JW; Marder, SR				Hales, Joel M.; Matichak, Jonathan; Barlow, Stephen; Ohira, Shino; Yesudas, Kada; Bredas, Jean-Luc; Perry, Joseph W.; Marder, Seth R.			Design of Polymethine Dyes with Large Third-Order Optical Nonlinearities and Loss Figures of Merit	SCIENCE			English	Article							BOND-LENGTH ALTERNATION; DONOR-ACCEPTOR POLYENES; 2-PHOTON ABSORPTION; ORGANIC-MOLECULES; HYPERPOLARIZABILITY; SUSCEPTIBILITIES; CHROMOPHORES; STATES; GAMMA	All-optical switching applications require materials with large third-order nonlinearities and low nonlinear optical losses. We present a design approach that involves enhancing the real part of the third-order polarizability (gamma) of cyanine-like molecules through incorporation of polarizable chalcogen atoms into terminal groups, while controlling the molecular length to obtain favorable one-and two-photon absorption resonances that lead to suitably low optical loss and appreciable dispersion enhancement of the real part of gamma. We implemented this strategy in a soluble bis(selenopyrylium) heptamethine dye that exhibits a real part of gamma that is exceptionally large throughout the wavelength range used for telecommunications, and an imaginary part of gamma, a measure of nonlinear loss, that is smaller by two orders of magnitude. This combination is critical in enabling low-power, high-contrast optical switching.	[Perry, Joseph W.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Ctr Organ Photon & Elect, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Perry, JW (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	joe.perry@chemistry.gatech.edu; seth.marder@chemistry.gatech.edu	Yesudas, Kada/AAF-9770-2020; Perry, Joseph W/B-7191-2011; Bredas, Jean-Luc E/A-3431-2008; Barlow, Stephen/ABE-6100-2021; Marder, Seth/GRR-9990-2022; Barlow, Stephen/E-9754-2010	Perry, Joseph W/0000-0003-1101-7337; Bredas, Jean-Luc E/0000-0001-7278-4471; Barlow, Stephen/0000-0001-9059-9974; Hales, Joel/0000-0003-0598-3280	NSF [DMR-0120967]; Defense Advanced Research Projects Agency (DARPA) [W31P4Q-09-1-0012]; Office of Naval Research [N00014-04-0095, N00014-06-1-0897]	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research)	This material is based on work supported in part by the Science and Technology Centers Program of NSF under agreement DMR-0120967, the Defense Advanced Research Projects Agency (DARPA) MORPH Program and Office of Naval Research (N00014-04-0095 and N00014-06-1-0897), and the DARPA ZOE Program (W31P4Q-09-1-0012). We thank W. Hermann for helpful discussions and corroborative nonlinear optical characterization measurements.	Beverina L, 2005, J AM CHEM SOC, V127, P7282, DOI 10.1021/ja050688l; BREDAS JL, 1994, CHEM REV, V94, P243, DOI 10.1021/cr00025a008; Chung SJ, 2006, J AM CHEM SOC, V128, P14444, DOI 10.1021/ja065556m; CRAW JS, 1992, CHEM PHYS, V167, P77, DOI 10.1016/0301-0104(92)80024-P; Fu J, 2007, J OPT SOC AM B, V24, P56, DOI 10.1364/JOSAB.24.000056; GORMAN CB, 1995, CHEM MATER, V7, P215, DOI 10.1021/cm00049a033; Hales J. M., 2008, INTRO ORGANIC ELECT, P521; Hales JM, 2006, J AM CHEM SOC, V128, P11362, DOI 10.1021/ja063535m; HERMANN JP, 1974, OPT COMMUN, V12, P102, DOI 10.1016/0030-4018(74)90083-2; Hochberg M, 2006, NAT MATER, V5, P703, DOI 10.1038/nmat1719; KACHKOVSKI AD, 1984, DYES PIGMENTS, V5, P295, DOI 10.1016/0143-7208(84)80023-6; Kim TD, 2007, J AM CHEM SOC, V129, P488, DOI 10.1021/ja067970s; Kogej T, 1998, CHEM PHYS LETT, V298, P1, DOI 10.1016/S0009-2614(98)01196-8; Koos C, 2009, NAT PHOTONICS, V3, P216, DOI 10.1038/NPHOTON.2009.25; KUHN H, 1949, J CHEM PHYS, V17, P1198, DOI 10.1063/1.1747143; Kuzyk MG, 2000, OPT LETT, V25, P1183, DOI 10.1364/OL.25.001183; LU DQ, 1994, J AM CHEM SOC, V116, P10679, DOI 10.1021/ja00102a037; Marder SR, 1997, SCIENCE, V276, P1233, DOI 10.1126/science.276.5316.1233; MARDER SR, 1993, SCIENCE, V261, P186, DOI 10.1126/science.261.5118.186; May JC, 2005, OPT LETT, V30, P3057, DOI 10.1364/OL.30.003057; MEYERS F, 1994, J AM CHEM SOC, V116, P10703, DOI 10.1021/ja00102a040; MIZRAHI V, 1989, OPT LETT, V14, P1140, DOI 10.1364/OL.14.001140; Polyakov S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115421; Rumi M, 2000, J AM CHEM SOC, V122, P9500, DOI 10.1021/ja994497s; Scherer D, 2002, CHEM PHYS, V279, P179, DOI 10.1016/S0301-0104(02)00384-1; Thorley KJ, 2008, ANGEW CHEM INT EDIT, V47, P7095, DOI 10.1002/anie.200802687; Tolbert LM, 1997, J AM CHEM SOC, V119, P3253, DOI 10.1021/ja9626953	27	293	293	2	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1485	1488		10.1126/science.1185117	http://dx.doi.org/10.1126/science.1185117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	570YQ	20167746				2022-12-28	WOS:000275715200040
J	Boudsocq, M; Willmann, MR; McCormack, M; Lee, H; Shan, LB; He, P; Bush, J; Cheng, SH; Sheen, J				Boudsocq, Marie; Willmann, Matthew R.; McCormack, Matthew; Lee, Horim; Shan, Libo; He, Ping; Bush, Jenifer; Cheng, Shu-Hua; Sheen, Jen			Differential innate immune signalling via Ca2+ sensor protein kinases	NATURE			English	Article							GENE-EXPRESSION ANALYSIS; PLANT DEFENSE; MOLECULAR-PATTERNS; ARABIDOPSIS; CALCIUM; PERCEPTION; RESISTANCE; FLAGELLIN; IDENTIFICATION; TRANSDUCTION	Innate immunity represents the first line of inducible defence against microbial infection in plants and animals(1-3). In both kingdoms, recognition of pathogen- or microbe-associated molecular patterns (PAMPs or MAMPs, respectively), such as flagellin, initiates convergent signalling pathways involving mitogen-activated protein kinase ( MAPK) cascades and global transcriptional changes to boost immunity(1-4). Although Ca2+ has long been recognized as an essential and conserved primary mediator in plant defence responses, how Ca2+ signals are sensed and relayed into early MAMP signalling is unknown(5,6). Using a functional genomic screen and genome-wide gene expression profiling, here we show that four calcium-dependent protein kinases (CDPKs) are Ca2+-sensor protein kinases critical for transcriptional reprogramming in plant innate immune signalling. Unexpectedly, CDPKs and MAPK cascades act differentially in four MAMP-mediated regulatory programs to control early genes involved in the synthesis of defence peptides and metabolites, cell wall modifications and redox signalling. Transcriptome profile comparison suggests that CDPKs are the convergence point of signalling triggered by most MAMPs. Double, triple and quadruple cpk mutant plants display progressively diminished oxidative burst and gene activation induced by the 22-amino-acid peptide flg22, as well as compromised pathogen defence. In contrast to negative roles of calmodulin and a calmodulin-activated transcription factor in plant defence(7,8), the present study reveals Ca2+ signalling complexity and demonstrates key positive roles of specific CDPKs in initial MAMP signalling.	[Boudsocq, Marie; Willmann, Matthew R.; McCormack, Matthew; Lee, Horim; Shan, Libo; He, Ping; Bush, Jenifer; Cheng, Shu-Hua; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Boudsocq, Marie; Willmann, Matthew R.; McCormack, Matthew; Lee, Horim; Shan, Libo; He, Ping; Bush, Jenifer; Cheng, Shu-Hua; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Boudsocq, Marie; Willmann, Matthew R.; McCormack, Matthew; Lee, Horim; Shan, Libo; He, Ping; Bush, Jenifer; Cheng, Shu-Hua; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Boudsocq, M (corresponding author), CNRS, UPR2355, Inst Sci Vegetal, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	boudsocq@molbio.mgh.harvard.edu; willmann@sas.upenn.edu	Boudsocq, Marie/J-6074-2019; poinssot, benoit/B-2569-2009; Lee, Horim/I-6180-2019	Boudsocq, Marie/0000-0001-8945-6773; poinssot, benoit/0000-0001-5890-4318; He, Ping/0000-0002-5926-8349; Willmann, Matthew R./0000-0002-4146-8158	European Community; NSF; National Science Foundation; National Institute of Health; MGH CCIB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567, R01GM092893, R01GM097247, R01GM060493] Funding Source: NIH RePORTER	European Community(European Commission); NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH CCIB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. H. Liu and E. Baena-Gonzalez for contributing to the CPK clone collection, O.R. Patharkar for initial microarray data analysis, B. Mueller and G. Tena for offering qPCR primers, M. N. Soler and S. Bolte for assistance on confocal microscopy, C. Lauriere for discussions, S. P. Dinesh-Kumar for VIGS vectors, K. Schreiber and D. Desveaux for the seedling pathogen assay, and A. Gust and T. Nurnberger for the original PGN microarray data. Wethank the Salk Institute, Syngenta Biotechnology and A. Sessions for sharing the Arabidopsis T-DNA collections, and the Arabidopsis Biological Resource Center for providing Arabidopsis mutant seeds. This research has been supported by a Marie Curie International fellowship within the 6th European Community Framework Program to M. B., an NSF predoctoral fellowship to M. R. W., and grants from the National Science Foundation and the National Institute of Health, and the MGH CCIB fund to J. S.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alonso JM, 2003, METH MOL B, V236, P177; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; BOUDSOCQ M, 2009, ABIOTIC STRESS ADAPT, pCH4; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Lecourieux D, 2005, CELL CALCIUM, V38, P527, DOI 10.1016/j.ceca.2005.06.036; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Ma W, 2008, PLANT PHYSIOL, V148, P818, DOI 10.1104/pp.108.125104; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Romeis T, 2000, PLANT CELL, V12, P803, DOI 10.1105/tpc.12.5.803; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Schreiber K, 2008, PLANT J, V54, P522, DOI 10.1111/j.1365-313X.2008.03425.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; SHEEN J, 2008, BIOL PLANT MICROBE I, V6, pCH86; Uno YC, 2009, MOL GENET GENOMICS, V281, P375, DOI 10.1007/s00438-008-0419-1; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	38	560	588	8	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	2010	464	7287					418	U116		10.1038/nature08794	http://dx.doi.org/10.1038/nature08794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20164835	Green Accepted			2022-12-28	WOS:000275657100048
J	Goodman, A				Goodman, Annekathryn			Ministry of Touch -- Reflections on Disaster Work after the Haitian Earthquake.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Goodman, A (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMp1002311	http://dx.doi.org/10.1056/NEJMp1002311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20200361				2022-12-28	WOS:000275650400005
J	Meer, MV; Kondrashov, AS; Artzy-Randrup, Y; Kondrashov, FA				Meer, Margarita V.; Kondrashov, Alexey S.; Artzy-Randrup, Yael; Kondrashov, Fyodor A.			Compensatory evolution in mitochondrial tRNAs navigates valleys of low fitness	NATURE			English	Article							MOLECULAR PHYLOGENY; SECONDARY STRUCTURES; POPULATION-GENETICS; PROTEIN EVOLUTION; MISSING DATA; MUTATIONS; SELECTION; DIVERGENCE; DROSOPHILA; WHALES	A long-standing controversy in evolutionary biology is whether or not evolving lineages can cross valleys on the fitness landscape that correspond to low-fitness genotypes, which can eventually enable them to reach isolated fitness peaks(1-9). Here we study the fitness landscapes traversed by switches between different AU and GC Watson-Crick nucleotide pairs at complementary sites of mitochondrial transfer RNA stem regions in 83 mammalian species. We find that such Watson-Crick switches occur 30-40 times more slowly than pairs of neutral substitutions, and that alleles corresponding to GU and AC non-Watson-Crick intermediate states segregate within human populations at low frequencies, similar to those of non-synonymous alleles. Substitutions leading to a Watson Crick switch are strongly correlated, especially in mitochondrial tRNAs encoded on the GT-nucleotide-rich strand of the mitochondrial genome. Using these data we estimate that a typical Watson-Crick switch involves crossing a fitness valley of a depth of about 10(-3) or even about 10(-2), with AC intermediates being slightly more deleterious than GU intermediates. This compensatory evolution must proceed through rare intermediate variants that never reach fixation(2). The ubiquitous nature of compensatory evolution in mammalian mitochondrial tRNAs and other molecules(10,11) implies that simultaneous fixation of two alleles that are individually deleterious may be a common phenomenon at the molecular level.	[Meer, Margarita V.; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Kondrashov, Alexey S.; Artzy-Randrup, Yael] Univ Michigan, Inst Life Sci, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Artzy-Randrup, Yael] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 49109 USA; [Artzy-Randrup, Yael] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 49109 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kondrashov, FA (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, C Dr Aiguader 88,Barcelona Biomed Res Pk Bldg, Barcelona 08003, Spain.	fyodor.kondrashov@crg.es	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694				Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; BERISON DA, 2006, NUCLEIC ACIDS RES, V34, pD16; Chen Y, 2003, P NATL ACAD SCI USA, V100, P11499, DOI 10.1073/pnas.1932834100; Coyne JA, 2000, EVOLUTION, V54, P306, DOI 10.1111/j.0014-3820.2000.tb00033.x; Crow JF, 2008, ANNU REV GENET, V42, P1, DOI 10.1146/annurev.genet.42.110807.091612; Davis AR, 2007, BIOCHEMISTRY-US, V46, P13425, DOI 10.1021/bi701311c; Dobzhansky T, 1936, GENETICS, V21, P113; Donmez N, 2009, GENETICS, V181, P685, DOI 10.1534/genetics.108.097535; Douady CJ, 2002, MOL PHYLOGENET EVOL, V25, P200, DOI 10.1016/S1055-7903(02)00232-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Hatch LT, 2006, MOL PHYLOGENET EVOL, V41, P12, DOI 10.1016/j.ympev.2006.05.023; Horner DS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-16; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Innan H, 2001, GENETICS, V159, P389; Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Malyarchuk BA, 2002, HUM GENET, V111, P46, DOI 10.1007/s00439-002-0740-4; Matsui A, 2009, GENE, V441, P53, DOI 10.1016/j.gene.2008.08.024; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; ORR HA, 1995, GENETICS, V139, P1805; Piskol R, 2008, MOL BIOL EVOL, V25, P2483, DOI 10.1093/molbev/msn195; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Popadin KY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-441; Price SA, 2005, BIOL REV, V80, P445, DOI 10.1017/S1464793105006743; Querouil S, 2001, MOL PHYLOGENET EVOL, V20, P185, DOI 10.1006/mpev.2001.0974; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmitz J, 2005, CYTOGENET GENOME RES, V108, P26, DOI 10.1159/000080799; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; WADE MJ, 1991, SCIENCE, V253, P1015, DOI 10.1126/science.1887214; Weinreich DM, 2005, EVOLUTION, V59, P1175; Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	48	65	66	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					279	U159		10.1038/nature08691	http://dx.doi.org/10.1038/nature08691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20182427				2022-12-28	WOS:000275366100047
J	Kirchhoff, F				Kirchhoff, Frank			Questionable Calcium	SCIENCE			English	Editorial Material							SYNAPTIC ACTIVITY; ASTROCYTES; EXOCYTOSIS; GLUTAMATE; RELEASE		[Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kirchhoff, Frank] Univ Saarland, Inst Physiol, D-66421 Homburg, Germany	Max Planck Society; Saarland University	Kirchhoff, F (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany.	frank.kirchhoff@uks.eu	Kirchhoff, Frank/B-9335-2008	Kirchhoff, Frank/0000-0002-2324-2761				Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Inoue R, 2005, CURR PHARM DESIGN, V11, P1899, DOI 10.2174/1381612054021079; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008	12	12	13	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1212	1213		10.1126/science.1187420	http://dx.doi.org/10.1126/science.1187420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203041				2022-12-28	WOS:000275162100027
J	Macdonald, FA; Schmitz, MD; Crowley, JL; Roots, CF; Jones, DS; Maloof, AC; Strauss, JV; Cohen, PA; Johnston, DT; Schrag, DP				Macdonald, Francis A.; Schmitz, Mark D.; Crowley, James L.; Roots, Charles F.; Jones, David S.; Maloof, Adam C.; Strauss, Justin V.; Cohen, Phoebe A.; Johnston, David T.; Schrag, Daniel P.			Calibrating the Cryogenian	SCIENCE			English	Article							CONTINENTAL BREAK-UP; PALEOMAGNETIC CONSTRAINTS; PB GEOCHRONOLOGY; AGE CONSTRAINTS; MANTLE PLUME; GLACIATION; SUPERGROUP; LAURENTIA; CANADA	The Neoproterozoic was an era of great environmental and biological change, but a paucity of direct and precise age constraints on strata from this time has prevented the complete integration of these records. We present four high-precision U-Pb ages for Neoproterozoic rocks in northwestern Canada that constrain large perturbations in the carbon cycle, a major diversification and depletion in the microfossil record, and the onset of the Sturtian glaciation. A volcanic tuff interbedded with Sturtian glacial deposits, dated at 716.5 million years ago, is synchronous with the age of the Franklin large igneous province and paleomagnetic poles that pin Laurentia to an equatorial position. Ice was therefore grounded below sea level at very low paleolatitudes, which implies that the Sturtian glaciation was global in extent.	[Macdonald, Francis A.; Cohen, Phoebe A.; Johnston, David T.; Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Schmitz, Mark D.; Crowley, James L.] Boise State Univ, Dept Geosci, Boise, ID 83725 USA; [Roots, Charles F.] Geol Survey Canada, Whitehorse, YT YIA 1B5, Canada; [Jones, David S.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Maloof, Adam C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Harvard University; Idaho; Boise State University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Washington University (WUSTL); Princeton University	Macdonald, FA (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	fmacdon@fas.harvard.edu	Jones, David Stewart/P-3210-2019; Schmitz, Mark D/A-2540-2012	Jones, David Stewart/0000-0001-8478-3599; Johnston, David/0000-0002-2487-1084; Crowley, James/0000-0001-5069-0773; Macdonald, Francis/0000-0001-8416-4894; Schmitz, Mark/0000-0003-2888-0321; Strauss, Justin/0000-0003-3298-3227	Polar Continental Shelf Project; NSF [EAR 0417422]	Polar Continental Shelf Project(Natural Resources Canada); NSF(National Science Foundation (NSF))	We thank the Yukon Geological Survey for assistance with logistics and helicopter support, T. Petach and S. Petersen for assistance in the field, and D. Pearce and H. Yntema for preparing samples. Supported by the Polar Continental Shelf Project and NSF Geobiology and Environmental Geochemistry Program grant EAR 0417422.	Bendtsen J, 2002, CLIM DYNAM, V18, P595, DOI 10.1007/s00382-001-0198-4; Bowring SA, 2007, AM J SCI, V307, P1097, DOI 10.2475/10.2007.01; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Denyszyn SW, 2009, CAN J EARTH SCI, V46, P155, DOI 10.1139/E09-011; Donnadieu Y, 2004, NATURE, V428, P303, DOI 10.1038/nature02408; Eisbacher G.H., 1978, 7735 GEOL SURV CAN, P1; Evans DAD, 2000, AM J SCI, V300, P347, DOI 10.2475/ajs.300.5.347; Fanning CM, 2004, GEOLOGY, V32, P881, DOI 10.1130/G20609.1; Frimmel HE, 1996, J GEOL, V104, P459, DOI 10.1086/629839; Halverson Galen P., 2006, V27, P231; HEAMAN LM, 1992, EARTH PLANET SC LETT, V109, P117, DOI 10.1016/0012-821X(92)90078-A; Hoffman PF, 2009, PALAEOGEOGR PALAEOCL, V277, P158, DOI 10.1016/j.palaeo.2009.03.013; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffmann KH, 2004, GEOLOGY, V32, P817, DOI 10.1130/G20519.1; JONES DS, 2009, THESIS HARVARD U; Key RM, 2001, J AFR EARTH SCI, V33, P503, DOI 10.1016/S0899-5362(01)00098-7; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Lund K, 2003, GEOL SOC AM BULL, V115, P349, DOI 10.1130/0016-7606(2003)115<0349:SUPGON>2.0.CO;2; Macdonald FA, 2010, GEOLOGY, V38, P143, DOI 10.1130/G25637.1; MUSTARD PS, 1997, GEOL SURV CANADA B, V492; NORTH GR, 1981, REV GEOPHYS, V19, P91, DOI 10.1029/RG019i001p00091; PALMER HC, 1983, CAN J EARTH SCI, V20, P1456, DOI 10.1139/e83-131; PARK JK, 1994, PRECAMBRIAN RES, V69, P95, DOI 10.1016/0301-9268(94)90081-7; RAINBIRD RH, 1993, J GEOL, V101, P305, DOI 10.1086/648225; ROOTS CF, 1988, 882 GEOL SURV CAN PA, P29; Schoene B, 2006, GEOCHIM COSMOCHIM AC, V70, P426, DOI 10.1016/j.gca.2005.09.007; Sohl LE, 1999, GEOL SOC AM BULL, V111, P1120, DOI 10.1130/0016-7606(1999)111<1120:PPRIMC>2.3.CO;2; Xu B, 2009, PRECAMBRIAN RES, V168, P247, DOI 10.1016/j.precamres.2008.10.008; Zhang SH, 2008, TERRA NOVA, V20, P289, DOI 10.1111/j.1365-3121.2008.00819.x; Zhou CM, 2004, GEOLOGY, V32, P437, DOI 10.1130/G20286.1; [No title captured]	32	425	477	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1241	1243		10.1126/science.1183325	http://dx.doi.org/10.1126/science.1183325			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203045				2022-12-28	WOS:000275162100035
J	Norreys, PA				Norreys, Peter A.			Controlling Implosion Symmetry Around a Deuterium-Tritium Target	SCIENCE			English	Editorial Material							NATIONAL-IGNITION-FACILITY; PERFORMANCE		[Norreys, Peter A.] Rutherford Appleton Lab, Cent Laser Facil, STFC, Didcot OX11 0QX, Oxon, England; [Norreys, Peter A.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BZ, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London	Norreys, PA (corresponding author), Rutherford Appleton Lab, Cent Laser Facil, STFC, Didcot OX11 0QX, Oxon, England.	peter.norreys@stfc.ac.uk						Boehly TR, 1997, OPT COMMUN, V133, P495, DOI 10.1016/S0030-4018(96)00325-2; Glenzer SH, 2010, SCIENCE, V327, P1228, DOI 10.1126/science.1185634; Li CK, 2010, SCIENCE, V327, P1231, DOI 10.1126/science.1185747; Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638; Moses EI, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3116505; Moses EI, 2005, FUSION SCI TECHNOL, V47, P314, DOI 10.13182/FST47-314; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; Rygg JR, 2008, SCIENCE, V319, P1223, DOI 10.1126/science.1152640	8	6	6	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1208	1210		10.1126/science.1187275	http://dx.doi.org/10.1126/science.1187275			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203038				2022-12-28	WOS:000275162100024
J	Kidder, T				Kidder, Tracy			Recovering from Disaster -- Partners in Health and the Haitian Earthquake.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	9	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					769	772		10.1056/NEJMp1001705	http://dx.doi.org/10.1056/NEJMp1001705			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20164478				2022-12-28	WOS:000275108300001
J	Green, MJ; Myers, KR				Green, Michael J.; Myers, Kimberly R.			Graphic medicine: use of comics in medical education and patient care	BRITISH MEDICAL JOURNAL			English	Editorial Material							BOOKS; ART		[Green, Michael J.; Myers, Kimberly R.] Penn State Coll Med, Dept Humanities & Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Green, MJ (corresponding author), Penn State Coll Med, Dept Humanities & Med, 500 Univ Dr, Hershey, PA 17033 USA.	mjg15@psu.edu	Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749				Bitz M, 2004, J ADOLESC ADULT LIT, V47, P574; Carney RN, 2002, EDUC PSYCHOL REV, V14, P5, DOI 10.1023/A:1013176309260; CARTER JB, 2008, TEACHING VISUAL LITE; Dolev JC, 2001, JAMA-J AM MED ASSOC, V286, P1020, DOI 10.1001/jama.286.9.1020; Doxiadis A., 2009, LOGICOMIX EPIC SEARC; FIES B, 2006, MOMS CANC ABRAMS IMA; Fisher Douglas., 2004, ENGL J, V93, P19, DOI [10.2307/4128804, DOI 10.2307/4128804]; Gerde VW, 2008, J BUS ETHICS, V77, P245, DOI 10.1007/s10551-006-9347-3; GILLIES P A, 1990, Health Education Research, V5, P27, DOI 10.1093/her/5.1.27; GREEN MJ, 2009, INT J HEALTHCARE HUM, V3, P1; Hansen B, 2004, B HIST MED, V78, P148, DOI 10.1353/bhm.2004.0018; HARVEY J, 1997, HIV J BIOCOMMUN, V24, P16; Houts PS, 2001, PATIENT EDUC COUNS, V43, P231, DOI 10.1016/S0738-3991(00)00171-3; Johnstone M., 2006, LIVING BLACK DOG HIS; Kakalios J, 2005, PHYS SUPERHEROES; Marchetto MA, 2006, CANC VIXEN TRUE STOR; MAYER RE, 1994, J EDUC PSYCHOL, V86, P389, DOI 10.1037/0022-0663.86.3.389; MCALLISTER MP, 1992, J POP CULT, V26, P1, DOI 10.1111/j.0022-3840.1992.26021.x; McCloud S, 1994, UNDERSTANDING COMICS; Medikidz, MED INF KIDS; Montgomery Hunter K, 1991, DOCTORS STORIES NARR; Naghshineh S, 2008, J GEN INTERN MED, V23, P991, DOI 10.1007/s11606-008-0667-0; Pieper C, 2000, DIABETES RES CLIN PR, V50, P31, DOI DOI 10.1016/S0168-8227(00)81563-6; Sabin Roger, 1996, COMICS COMIX GRAPHIC; Satrapi Marjane, 2003, PERSEPOLIS; Squier SM, 2008, J MED HUMANIT, V29, P71, DOI 10.1007/s10912-008-9057-1; Versaci R., 2001, ENGL J, V91, P61, DOI DOI 10.2307/822347; VERSACI R, 2008, TEACHING VISUAL LITE; COMIC PROBLEMS	29	159	162	6	40	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2010	340								c863	10.1136/bmj.c863	http://dx.doi.org/10.1136/bmj.c863			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565FJ	20200064				2022-12-28	WOS:000275274400013
J	Guo, JH; Liu, XJ; Zhang, Y; Shen, JL; Han, WX; Zhang, WF; Christie, P; Goulding, KWT; Vitousek, PM; Zhang, FS				Guo, J. H.; Liu, X. J.; Zhang, Y.; Shen, J. L.; Han, W. X.; Zhang, W. F.; Christie, P.; Goulding, K. W. T.; Vitousek, P. M.; Zhang, F. S.			Significant Acidification in Major Chinese Croplands	SCIENCE			English	Article							WINTER-WHEAT; SOIL; BUDGETS; MANAGEMENT; CHEMISTRY; ALUMINUM; SYSTEMS; IMPACT; GRASS	Soil acidification is a major problem in soils of intensive Chinese agricultural systems. We used two nationwide surveys, paired comparisons in numerous individual sites, and several long-term monitoring-field data sets to evaluate changes in soil acidity. Soil pH declined significantly (P < 0.001) from the 1980s to the 2000s in the major Chinese crop-production areas. Processes related to nitrogen cycling released 20 to 221 kilomoles of hydrogen ion (H+) per hectare per year, and base cations uptake contributed a further 15 to 20 kilomoles of H+ per hectare per year to soil acidification in four widespread cropping systems. In comparison, acid deposition (0.4 to 2.0 kilomoles of H+ per hectare per year) made a small contribution to the acidification of agricultural soils across China.	[Guo, J. H.; Liu, X. J.; Zhang, Y.; Shen, J. L.; Han, W. X.; Zhang, W. F.; Christie, P.; Zhang, F. S.] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Christie, P.] Agri Food & Biosci Inst, Agri Environm Branch, Belfast BT9 5PX, Antrim, North Ireland; [Goulding, K. W. T.] Rothamsted Res, Dept Soil Sci, Harpenden AL5 2JQ, Herts, England; [Vitousek, P. M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	China Agricultural University; Agri-Food & Biosciences Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Stanford University	Zhang, FS (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	zhangfs@cau.edu.cn	Christie, Peter/B-7919-2008; Goulding, Keith WT/B-2635-2012; Han, Wenxuan/B-8791-2016; Zhang, Fusuo/AAV-4517-2021; Shen, Jianlin/G-1820-2014; Liu, Xuejun/AAA-7412-2022	Christie, Peter/0000-0002-1939-7277; Goulding, Keith WT/0000-0002-6465-1465; Han, Wenxuan/0000-0001-8678-7147; Shen, Jianlin/0000-0002-5853-094X; Guo, Jingheng/0000-0002-5286-958X; zhang, fusuo/0000-0001-8971-0129; Zhang, Ying/0000-0002-9964-9381	Chinese National Basic Research Program [2009CB118600, 2005CB422206]; NSFC [30821003]; Special Fund for Agricultural Profession [200803030]	Chinese National Basic Research Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Special Fund for Agricultural Profession	We thank X. J. Xiang for data collection, J. Wang for reference correction, and X. Shi and J. Ren for providing soil pH dynamics at two LTMF sites. Financial support for this work was provided by the Chinese National Basic Research Program (2009CB118600 and 2005CB422206), the Innovative Group Grant from NSFC (30821003), and the Special Fund for Agricultural Profession (200803030).	Blake L, 1999, EUR J SOIL SCI, V50, P401, DOI 10.1046/j.1365-2389.1999.00253.x; BLAKE L, 1994, SOIL USE MANAGE, V10, P51, DOI 10.1111/j.1475-2743.1994.tb00458.x; Chadwick OA, 2001, GEODERMA, V100, P321, DOI 10.1016/S0016-7061(01)00027-1; Chen X, 2006, NUTR CYCL AGROECOSYS, V74, P91, DOI 10.1007/s10705-005-1701-9; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fujii K, 2009, PLANT SOIL, V316, P241, DOI 10.1007/s11104-008-9776-0; Goulding K. W. T., 1998, Proceedings - Fertiliser Society; Guo JH, 2007, ENVIRON MONIT ASSESS, V129, P321, DOI 10.1007/s10661-006-9365-8; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Howarth R W, 2005, ECOSYSTEMS HUMAN WEL, V3, P295; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; JUO ASR, 1995, PLANT SOIL, V171, P245, DOI 10.1007/BF00010278; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Matsuyama N, 2005, SOIL SCI PLANT NUTR, V51, P117, DOI 10.1111/j.1747-0765.2005.tb00014.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; *SOIL SURV OFF CHI, 1994, CHIN SOIL SPEC, V1; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; WALLACE A, 1994, COMMUN SOIL SCI PLAN, V25, P87, DOI 10.1080/00103629409369010; Wang GH, 2007, AGR SYST, V94, P801, DOI 10.1016/j.agsy.2006.11.006; Xing GX, 2002, BIOGEOCHEMISTRY, V57, P405, DOI 10.1023/A:1016508323200; Zhao Q. G., 2002, MECH TEMPORAL SPATIA, P202; Zhu JH, 2005, AGR ECOSYST ENVIRON, V111, P70, DOI 10.1016/j.agee.2005.04.025; 1982, CHINA AGR YB	28	2222	3029	252	2543	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1008	1010		10.1126/science.1182570	http://dx.doi.org/10.1126/science.1182570			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20150447	Green Submitted			2022-12-28	WOS:000274625800043
J	Tammela, T; Alitalo, K				Tammela, Tuomas; Alitalo, Kari			Lymphangiogenesis: Molecular Mechanisms and Future Promise	CELL			English	Review							GROWTH-FACTOR-C; LYMPH-NODE LYMPHANGIOGENESIS; ENDOTHELIAL PROGENITOR CELLS; VEGF-C; BREAST-CANCER; TUMOR-METASTASIS; INFLAMMATORY LYMPHANGIOGENESIS; EMBRYONIC LYMPHANGIOGENESIS; PLATELET ACTIVATION; VESSEL DEVELOPMENT		[Tammela, Tuomas; Alitalo, Kari] Univ Helsinki, Lab Mol Canc Biol, FIN-00014 Helsinki, Finland; [Tammela, Tuomas; Alitalo, Kari] Univ Helsinki, Haartman Inst, Biomedicum Helsinki, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Alitalo, K (corresponding author), Univ Helsinki, Lab Mol Canc Biol, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	kari.alitalo@helsinki.fi	Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902; /0000-0003-3675-6961				Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Aurora AB, 2005, J IMMUNOL, V175, P6319, DOI 10.4049/jimmunol.175.10.6319; Backhed F, 2007, P NATL ACAD SCI USA, V104, P606, DOI 10.1073/pnas.0605957104; Baldwin ME, 2005, MOL CELL BIOL, V25, P2441, DOI 10.1128/MCB.25.6.2441-2449.2005; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; BAUMEISTER RG, 1981, LANCET, V1, P147; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Becker C, 2006, ANN SURG, V243, P313, DOI 10.1097/01.sla.0000201258.10304.16; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; Buttler K, 2006, DEV DYNAM, V235, P1554, DOI 10.1002/dvdy.20737; Buttler K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-43; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Clark B, 2005, QJM-INT J MED, V98, P343, DOI 10.1093/qjmed/hci053; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Cohen B, 2009, NEOPLASIA, V11, P921, DOI 10.1593/neo.09636; Connell FC, 2009, HUM GENET, V124, P625, DOI 10.1007/s00439-008-0586-5; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Cupedo T, 2005, J IMMUNOL, V174, P21, DOI 10.4049/jimmunol.174.1.21; D'Amico G, 2010, ARTERIOSCL THROM VAS, V30, P207, DOI 10.1161/ATVBAHA.109.196618; Dagenais SL, 2004, GENE EXPR PATTERNS, V4, P611, DOI 10.1016/j.modgep.2004.07.004; Danussi C, 2008, MOL CELL BIOL, V28, P4026, DOI 10.1128/MCB.02062-07; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Furtado GC, 2007, P NATL ACAD SCI USA, V104, P5026, DOI 10.1073/pnas.0606697104; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Haiko P, 2008, MOL CELL BIOL, V28, P4843, DOI 10.1128/MCB.02214-07; Hajjami HME, 2008, HISTOCHEM CELL BIOL, V130, P1063, DOI 10.1007/s00418-008-0525-5; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Harvey NL, 2008, ANN NY ACAD SCI, V1131, P82, DOI 10.1196/annals.1413.007; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2004, CANCER RES, V64, P3737, DOI 10.1158/0008-5472.CAN-04-0088; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hirashima M, 2008, DEV BIOL, V316, P149, DOI 10.1016/j.ydbio.2008.01.023; Hoerauf Achim, 2006, Expert Rev Anti Infect Ther, V4, P211, DOI 10.1586/14787210.4.2.211; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hoshida T, 2006, CANCER RES, V66, P8065, DOI 10.1158/0008-5472.CAN-06-1392; Hosking B, 2009, DEVELOPMENT, V136, P2385, DOI 10.1242/dev.034827; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Ikomi F, 2006, MICROCIRCULATION, V13, P365, DOI 10.1080/10739680600745810; Ikomi F, 2008, MICROCIRCULATION, V15, P591, DOI 10.1080/10739680701815538; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Issa A, 2009, CANCER RES, V69, P349, DOI 10.1158/0008-5472.CAN-08-1875; Jeltsch M, 2003, CELL TISSUE RES, V314, P69, DOI 10.1007/s00441-003-0777-2; Jin DH, 2008, CARDIOVASC RES, V80, P339, DOI 10.1093/cvr/cvn228; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jurisic G, 2009, CELL TISSUE RES, V335, P97, DOI 10.1007/s00441-008-0644-2; Kajiya K, 2006, J INVEST DERMATOL, V126, P919, DOI 10.1038/sj.jid.5700126; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Karpanen T, 2006, AM J PATHOL, V169, P708, DOI 10.2353/ajpath.2006.051200; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kim KE, 2007, ARTERIOSCL THROM VAS, V27, P564, DOI 10.1161/01.ATV.0000256458.82320.be; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; KOZLOWSKI H, 1975, ARCH GESCHWULSTFORSC, V45, P658; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Kyzas PA, 2005, J PATHOL, V206, P170, DOI 10.1002/path.1776; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; LEVICK JR, 1999, CARDIOVASCULAR REGUL, P127; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Ma GC, 2008, PRENATAL DIAG, V28, P1057, DOI 10.1002/pd.2130; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Morisada T, 2005, BLOOD, V105, P4649, DOI 10.1182/blood-2004-08-3382; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Okamoto N, 2007, J CLIN INVEST, V117, P997, DOI 10.1172/JCI30379; Okazaki T, 2009, AM J PATHOL, V174, P2378, DOI 10.2353/ajpath.2009.080942; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; OTSUKI Y, 1986, LYMPHOLOGY, V19, P55; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Pfarr KM, 2009, PARASITE IMMUNOL, V31, P664, DOI 10.1111/j.1365-3024.2009.01133.x; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Radhakrisihnan K, 2008, ANN NY ACAD SCI, V1131, P155, DOI 10.1196/annals.1413.015; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Roozendaal R, 2008, INT IMMUNOL, V20, P1483, DOI 10.1093/intimm/dxn110; Ruddell A, 2008, NEOPLASIA, V10, P706, DOI 10.1593/neo.08342; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Saban MR, 2004, BLOOD, V104, P3228, DOI 10.1182/blood-2004-04-1428; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; Shibata MA, 2008, CANCER GENE THER, V15, P776, DOI 10.1038/cgt.2008.43; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Stanton Anthony W. B., 2009, Lymphatic Research and Biology, V7, P29, DOI 10.1089/lrb.2008.1026; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Vondenhoff MF, 2009, DEVELOPMENT, V136, P29, DOI 10.1242/dev.028456; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; Wick N, 2008, AM J PATHOL, V173, P1202, DOI 10.2353/ajpath.2008.080101; Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wilting J, 2006, DEV BIOL, V292, P165, DOI 10.1016/j.ydbio.2005.12.043; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Wong SY, 2005, CANCER RES, V65, P9789, DOI 10.1158/0008-5472.CAN-05-0901; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Yoon CM, 2008, BLOOD, V112, P1129, DOI 10.1182/blood-2007-11-125203; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	162	954	983	8	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					460	476		10.1016/j.cell.2010.01.045	http://dx.doi.org/10.1016/j.cell.2010.01.045			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178740	Bronze			2022-12-28	WOS:000274668400011
J	Schuster, SC; Miller, W; Ratan, A; Tomsho, LP; Giardine, B; Kasson, LR; Harris, RS; Petersen, DC; Zhao, FQ; Qi, J; Alkan, C; Kidd, JM; Sun, YZ; Drautz, DI; Bouffard, P; Muzny, DM; Reid, JG; Nazareth, LV; Wang, QY; Burhans, R; Riemer, C; Wittekindt, NE; Moorjani, P; Tindall, EA; Danko, CG; Teo, WS; Buboltz, AM; Zhang, ZH; Ma, QY; Oosthuysen, A; Steenkamp, AW; Oostuisen, H; Venter, P; Gajewski, J; Zhang, Y; Pugh, BF; Makova, KD; Nekrutenko, A; Mardis, ER; Patterson, N; Pringle, TH; Chiaromonte, F; Mullikin, JC; Eichler, EE; Hardison, RC; Gibbs, RA; Harkins, TT; Hayes, VM				Schuster, Stephan C.; Miller, Webb; Ratan, Aakrosh; Tomsho, Lynn P.; Giardine, Belinda; Kasson, Lindsay R.; Harris, Robert S.; Petersen, Desiree C.; Zhao, Fangqing; Qi, Ji; Alkan, Can; Kidd, Jeffrey M.; Sun, Yazhou; Drautz, Daniela I.; Bouffard, Pascal; Muzny, Donna M.; Reid, Jeffrey G.; Nazareth, Lynne V.; Wang, Qingyu; Burhans, Richard; Riemer, Cathy; Wittekindt, Nicola E.; Moorjani, Priya; Tindall, Elizabeth A.; Danko, Charles G.; Teo, Wee Siang; Buboltz, Anne M.; Zhang, Zhenhai; Ma, Qianyi; Oosthuysen, Arno; Steenkamp, Abraham W.; Oostuisen, Hermann; Venter, Philippus; Gajewski, John; Zhang, Yu; Pugh, B. Franklin; Makova, Kateryna D.; Nekrutenko, Anton; Mardis, Elaine R.; Patterson, Nick; Pringle, Tom H.; Chiaromonte, Francesca; Mullikin, James C.; Eichler, Evan E.; Hardison, Ross C.; Gibbs, Richard A.; Harkins, Timothy T.; Hayes, Vanessa M.			Complete Khoisan and Bantu genomes from southern Africa	NATURE			English	Article							COPY NUMBER; SEQUENCE; INVERSION; MTDNA; GENE	The genetic structure of the indigenous hunter-gatherer peoples of southern Africa, the oldest known lineage of modern human, is important for understanding human diversity. Studies based on mitochondrial(1) and small sets of nuclear markers(2) have shown that these hunter-gatherers, known as Khoisan, San, or Bushmen, are genetically divergent from other humans(1,3). However, until now, fully sequenced human genomes have been limited to recently diverged populations(4-8). Here we present the complete genome sequences of an indigenous hunter-gatherer from the Kalahari Desert and a Bantu from southern Africa, as well as protein-coding regions from an additional three hunter-gatherers from disparate regions of the Kalahari. We characterize the extent of whole-genome and exome diversity among the five men, reporting 1.3 million novel DNA differences genome-wide, including 13,146 novel amino acid variants. In terms of nucleotide substitutions, the Bushmen seem to be, on average, more different from each other than, for example, a European and an Asian. Observed genomic differences between the hunter-gatherers and others may help to pinpoint genetic adaptations to an agricultural lifestyle. Adding the described variants to current databases will facilitate inclusion of southern Africans in medical research efforts, particularly when family and medical histories can be correlated with genome-wide data.	[Schuster, Stephan C.; Miller, Webb; Ratan, Aakrosh; Tomsho, Lynn P.; Giardine, Belinda; Kasson, Lindsay R.; Harris, Robert S.; Zhao, Fangqing; Qi, Ji; Sun, Yazhou; Drautz, Daniela I.; Wang, Qingyu; Burhans, Richard; Riemer, Cathy; Wittekindt, Nicola E.; Buboltz, Anne M.; Zhang, Zhenhai; Ma, Qianyi; Gajewski, John; Zhang, Yu; Pugh, B. Franklin; Makova, Kateryna D.; Nekrutenko, Anton; Chiaromonte, Francesca; Hardison, Ross C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Wartik Lab 310, University Pk, PA 16802 USA; [Petersen, Desiree C.; Tindall, Elizabeth A.; Teo, Wee Siang; Hayes, Vanessa M.] Univ New S Wales, Lowy Canc Res Ctr C25, Childrens Canc Inst Australia Med Res, Canc Genet Grp, Randwick, NSW 2031, Australia; [Alkan, Can; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Alkan, Can; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Bouffard, Pascal; Harkins, Timothy T.] Roche Diagnostics Corp, Indianapolis, IN 46250 USA; [Muzny, Donna M.; Reid, Jeffrey G.; Nazareth, Lynne V.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Moorjani, Priya] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Danko, Charles G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Venter, Philippus] Univ Limpopo, ZA-0727 Sovenga, South Africa; [Mardis, Elaine R.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Patterson, Nick] MIT, Broad Inst, Cambridge, MA 02142 USA; [Patterson, Nick] Harvard Univ, Cambridge Ctr, Cambridge, MA 02142 USA; [Pringle, Tom H.] Sperling Fdn, Eugene, OR 97405 USA; [Mullikin, James C.] NHGRI, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Children's Cancer Institute; University of New South Wales Sydney; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Roche Holding; Baylor College of Medicine; Harvard University; Harvard Medical School; Cornell University; University of Limpopo; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schuster, SC (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, Wartik Lab 310, University Pk, PA 16802 USA.	scs@bx.psu.edu; vhayes@ccia.unsw.edu.au	QI, JI/E-2797-2016; Zhang, Zhenhai/GRX-5887-2022; Alkan, Can/D-2982-2009; Mardis, Elaine/W-2202-2019; Giardine, Belinda M/A-1599-2010; Hayes, Vanessa M/GPP-2807-2022; Hardison, Ross C/G-1142-2010; Wittekindt, Nicola/G-3469-2013; Wang, Qingyu/AAN-3373-2020; Hayes, Vanessa/W-3728-2019; Danko, Charles/A-2869-2011; Zhao, Fangqing/P-6309-2019	Zhang, Zhenhai/0000-0002-4310-0525; Alkan, Can/0000-0002-5443-0706; Hayes, Vanessa M/0000-0002-4524-7280; Hardison, Ross C/0000-0003-4084-7516; Wittekindt, Nicola/0000-0002-3310-0919; Wang, Qingyu/0000-0001-8994-5438; Russell, Anne/0000-0003-4533-5069; Petersen, Desiree/0000-0002-0817-2574; Zhao, Fangqing/0000-0002-6216-1235; Nekrutenko, Anton/0000-0002-5987-8032; Danko, Charles/0000-0002-1999-7125; Kidd, Jeffrey/0000-0002-9631-1465	Pennsylvania State University; National Human Genome Research Institute, National Institutes of Health; NSF [DEB-0733029]; NIH [R01GM087472]; Gordon and Betty Moore Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160, U54HG003273, ZIAHG200330, ZIBHG000196, R01HG004909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087472] Funding Source: NIH RePORTER	Pennsylvania State University; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We particularly want to thank Archbishop Desmond Tutu, !Gubi, G/aq'o, D#kgao and !Ai, as well as their respective families and communities for their willingness to participate in this study. This work is supported by the Pennsylvania State University. The genome sequencing of the four Namibian individuals was supported by Roche Applied Sciences and the exome sequencing capture by Nimblegen (to S. C. S.). Sequencing of Archbishop Tutu's genome was supported by Applied Biosystems (whole genome) (to R. A. G.) and Roche Applied Sciences (exome) (to S. C. S.). Whole-genome genotyping and NRY haplotyping was supported by the Cancer Institute of New South Wales (to V. M. H.). Travel was supported by Penn State University (to S. C. S.) and Hyperion Asset Management Australia (to V. M. H.). We thank K. Walters for assistance in researching geographic facts and help with Fig. 1, B. Schultz for his help with Supplementary Table 5 and R.-A. Hardie for her help with Supplementary Fig. 8b. T. Loughran assisted with medical sample collection. We thank the 1000 Genome Project for early access and use of their data. This work was also supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (J.C.M.). A. R. was supported by an NSF grant DEB-0733029 and K. D. M. was supported by a grant R01GM087472 from NIH. S. C. S. is supported by the Gordon and Betty Moore Foundation. V. M. H. is a Cancer Institute of New South Wales Fellow.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Heine B., 2000, AFRICAN LANGUAGES IN; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kessova I, 2003, CURR MOL MED, V3, P509, DOI 10.2174/1566524033479609; Le Roux W., 2004, VOICES SAN LIVING SO; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	30	284	296	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					943	947		10.1038/nature08795	http://dx.doi.org/10.1038/nature08795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164927	Green Accepted, hybrid			2022-12-28	WOS:000274582700045
J	Deng, HX; Doonan, CJ; Furukawa, H; Ferreira, RB; Towne, J; Knobler, CB; Wang, B; Yaghi, OM				Deng, Hexiang; Doonan, Christian J.; Furukawa, Hiroyasu; Ferreira, Ricardo B.; Towne, John; Knobler, Carolyn B.; Wang, Bo; Yaghi, Omar M.			Multiple Functional Groups of Varying Ratios in Metal-Organic Frameworks	SCIENCE			English	Article							ZEOLITIC IMIDAZOLATE FRAMEWORKS; HYDROGEN STORAGE; CARBON-DIOXIDE; PORE-SIZE; CAPTURE; DESIGN	We show that metal-organic frameworks (MOFs) can incorporate a large number of different functionalities on linking groups in a way that mixes the linker, rather than forming separate domains. We made complex MOFs from 1,4-benzenedicarboxylate (denoted by "A" in this work) and its derivatives -NH2, -Br, -(Cl)(2), -NO2, -(CH3)(2), -C4H4, -(OC3H5)(2), and -(OC7H7)(2) (denoted by "B" to "I," respectively) to synthesize 18 multivariate (MTV) MOF-5 type structures that contain up to eight distinct functionalities in one phase. The backbone (zinc oxide and phenylene units) of these structures is ordered, but the distribution of functional groups is disordered. The complex arrangements of several functional groups within the pores can lead to properties that are not simply linear sums of those of the pure components. For example, a member of this series, MTV-MOF-5-EHI, exhibits up to 400% better selectivity for carbon dioxide over carbon monoxide compared with its best same-link counterparts.	[Deng, Hexiang; Doonan, Christian J.; Furukawa, Hiroyasu; Ferreira, Ricardo B.; Towne, John; Knobler, Carolyn B.; Wang, Bo; Yaghi, Omar M.] Univ Calif Los Angeles, Calif Nanosyst Inst, Dept Energy DOE, Inst Genom & Prote,Dept Chem & Biochem, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles	Yaghi, OM (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Dept Energy DOE, Inst Genom & Prote,Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	yaghi@chem.ucla.edu	WANG, BO/D-9762-2012; Deng, Hexiang/N-5616-2017; Barroso Ferreira, Ricardo/A-3679-2010; Doonan, christian/ABG-6033-2020; Furukawa, Hiroyasu/C-5910-2008; Yaghi, Omar M/C-6749-2013	WANG, BO/0000-0001-9092-3252; Deng, Hexiang/0000-0002-9398-7996; Furukawa, Hiroyasu/0000-0002-6082-1738; Yaghi, Omar/0000-0002-5611-3325	DOE Office of Basic Energy Sciences [DE-FG02-08ER15935]	DOE Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by DOE Office of Basic Energy Sciences (grant DE-FG02-08ER15935). We thank F. J. Uribe-Romo and R. Taylor for assistance and helpful discussions. MTV-MOF-5-AC and MTV-MOF-5-ACEF have been deposited into the Cambridge Crystallographic Data Centre (CCDC) under deposition numbers CCDC 747004 to 747007.	Banerjee R, 2008, SCIENCE, V319, P939, DOI 10.1126/science.1152516; Banerjee R, 2009, J AM CHEM SOC, V131, P3875, DOI 10.1021/ja809459e; Burrows AD, 2008, ANGEW CHEM INT EDIT, V47, P8482, DOI 10.1002/anie.200802908; Darling SB, 2007, PROG POLYM SCI, V32, P1152, DOI 10.1016/j.progpolymsci.2007.05.004; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Garibay SJ, 2009, INORG CHEM, V48, P7341, DOI 10.1021/ic900796n; Kaye SS, 2007, J AM CHEM SOC, V129, P14176, DOI 10.1021/ja076877g; Kitaura R, 2002, ANGEW CHEM INT EDIT, V41, P133, DOI 10.1002/1521-3773(20020104)41:1<133::AID-ANIE133>3.0.CO;2-R; Koh K, 2008, ANGEW CHEM INT EDIT, V47, P677, DOI 10.1002/anie.200705020; Kumazawa K, 2003, ANGEW CHEM INT EDIT, V42, P3909, DOI 10.1002/anie.200351797; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Millward AR, 2005, J AM CHEM SOC, V127, P17998, DOI 10.1021/ja0570032; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440	13	1369	1411	62	1823	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					846	850		10.1126/science.1181761	http://dx.doi.org/10.1126/science.1181761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150497				2022-12-28	WOS:000274408300056
J	Newman, DK				Newman, Dianne K.			Feasting on Minerals	SCIENCE			English	Editorial Material							PHOTOTROPHIC FE(II) OXIDATION; IRON; BACTERIA; MICROORGANISMS; OPERON		MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	Newman, DK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	dkn@mit.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Auernik KS, 2008, APPL ENVIRON MICROB, V74, P7723, DOI 10.1128/AEM.01545-08; Bathe S, 2007, APPL ENVIRON MICROB, V73, P2491, DOI 10.1128/AEM.02589-06; Blothe M, 2009, APPL ENVIRON MICROB, V75, P468, DOI 10.1128/AEM.01817-08; Chan CS, 2004, SCIENCE, V303, P1656, DOI 10.1126/science.1092098; Croal LR, 2007, J BACTERIOL, V189, P1774, DOI 10.1128/JB.01395-06; Crowe SA, 2008, P NATL ACAD SCI USA, V105, P15938, DOI 10.1073/pnas.0805313105; Druschel GK, 2008, GEOCHIM COSMOCHIM AC, V72, P3358, DOI 10.1016/j.gca.2008.04.035; Jerez CA, 2009, SOIL BIOL, V17, P239, DOI 10.1007/978-3-540-89621-0_13; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Miot J, 2009, APPL ENVIRON MICROB, V75, P5586, DOI 10.1128/AEM.00490-09; Miot J, 2009, GEOCHIM COSMOCHIM AC, V73, P696, DOI 10.1016/j.gca.2008.10.033; Poulain AJ, 2009, APPL ENVIRON MICROB, V75, P6639, DOI 10.1128/AEM.00054-09; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Singer SW, 2008, APPL ENVIRON MICROB, V74, P4454, DOI 10.1128/AEM.02799-07; TEMPLE KL, 1951, J BACTERIOL, V62, P605, DOI 10.1128/JB.62.5.605-611.1951; Toner BM, 2009, GEOCHIM COSMOCHIM AC, V73, P388, DOI 10.1016/j.gca.2008.09.035; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Weiss JV, 2007, GEOMICROBIOL J, V24, P559, DOI 10.1080/01490450701670152; Wilmes P, 2009, ISME J, V3, P266, DOI 10.1038/ismej.2008.90	21	16	17	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					793	794		10.1126/science.1184229	http://dx.doi.org/10.1126/science.1184229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150475				2022-12-28	WOS:000274408300031
J	Haskal, ZJ; Trerotola, S; Dolmatch, B; Schuman, E; Altman, S; Mietling, S; Berman, S; McLennan, G; Trimmer, C; Ross, J; Vesely, T				Haskal, Ziv J.; Trerotola, Scott; Dolmatch, Bart; Schuman, Earl; Altman, Sanford; Mietling, Samuel; Berman, Scott; McLennan, Gordon; Trimmer, Clayton; Ross, John; Vesely, Thomas			Stent Graft versus Balloon Angioplasty for Failing Dialysis-Access Grafts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTIMAL-MEDIAL HYPERPLASIA; VASCULAR ACCESS; NEOINTIMAL HYPERPLASIA; HEMODIALYSIS ACCESS; VENOUS ANASTOMOSIS; STENOSIS; PATENCY; BRACHYTHERAPY; PACLITAXEL; OUTCOMES	BACKGROUND The leading cause of failure of a prosthetic arteriovenous hemodialysis-access graft is venous anastomotic stenosis. Balloon angioplasty, the first-line therapy, has a tendency to lead to subsequent recoil and restenosis; however, no other therapies have yet proved to be more effective. This study was designed to compare conventional balloon angioplasty with an expanded polytetrafluoroethylene endovascular stent graft for revision of venous anastomotic stenosis in failing hemodialysis grafts. METHODS We conducted a prospective, multicenter trial, randomly assigning 190 patients who were undergoing hemodialysis and who had a venous anastomotic stenosis to undergo either balloon angioplasty alone or balloon angioplasty plus placement of the stent graft. Primary end points included patency of the treatment area and patency of the entire vascular access circuit. RESULTS At 6 months, the incidence of patency of the treatment area was significantly greater in the stent-graft group than in the balloon-angioplasty group (51% vs. 23%, P<0.001), as was the incidence of patency of the access circuit (38% vs. 20%, P = 0.008). In addition, the incidence of freedom from subsequent interventions at 6 months was significantly greater in the stent-graft group than in the balloon-angioplasty group (32% vs. 16%, P = 0.03 by the log-rank test and P = 0.04 by the Wilcoxon rank-sum test). The incidence of binary restenosis at 6 months was greater in the balloon-angioplasty group than in the stent-graft group (78% vs. 28%, P<0.001). The incidences of adverse events at 6 months were equivalent in the two treatment groups, with the exception of restenosis, which occurred more frequently in the balloon-angioplasty group (P<0.001). CONCLUSIONS In this study, percutaneous revision of venous anastomotic stenosis in patients with a prosthetic hemodialysis graft was improved with the use of a stent graft, which appears to provide longer-term and superior patency and freedom from repeat interventions than standard balloon angioplasty. (ClinicalTrials.gov number, NCT00678249.)	[Haskal, Ziv J.] Univ Maryland, Med Ctr, Div Vasc & Intervent Radiol, Baltimore, MD 21201 USA; [Trerotola, Scott] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Dolmatch, Bart; Trimmer, Clayton] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Schuman, Earl] Oregon Surg Consultants, Portland, OR USA; [Altman, Sanford] Open Access Vasc Access Ctr, Miami, FL USA; [Mietling, Samuel] Vasc Access Ctr, Augusta, GA USA; [Berman, Scott] Tucson Vasc Surg, Tucson, AZ USA; [McLennan, Gordon] Indiana Univ Sch Med, Indianapolis, IN USA; [Vesely, Thomas] Vasc Access Ctr Frontenac Grove, Frontenac, MO USA	University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University Bloomington	Haskal, ZJ (corresponding author), Univ Maryland, Med Ctr, Div Vasc & Intervent Radiol, 22 S Greene St,GK214, Baltimore, MD 21201 USA.	ziv2@mac.com	McLennan, Gordon/ABB-6507-2021	McLennan, Gordon/0000-0002-9173-0898	Bard Peripheral Vascular	Bard Peripheral Vascular	Supported by Bard Peripheral Vascular.	[Anonymous], 1997, Am J Kidney Dis, V30, pS150; [Anonymous], 2001, AM J KIDNEY DIS, V37, pS137, DOI [DOI 10.1016/S0272-6386(01)70007-8, 10.1016/s0272-6386(01)70007-8]; [Anonymous], 2006, AM J KIDNEY DIS S, V48, pS176, DOI DOI 10.1053/J.AJKD.2006.04.029; [Anonymous], 2009, USRDS 2009 ANN DAT R; [Anonymous], 1997, AM J KIDNEY DIS S, V30, pS160; Biuckians A, 2008, J VASC SURG, V47, P415, DOI 10.1016/j.jvs.2007.10.041; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Bochenek KM, 2003, J VASC INTERV RADIOL, V14, P1207, DOI 10.1097/01.RVI.0000085774.71254.48; Chan MR, 2007, SEMIN DIALYSIS, V20, P606, DOI 10.1111/j.1525-139X.2007.00370.x; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; FILLINGER MF, 1990, J VASC SURG, V12, P676, DOI 10.1067/mva.1990.24914; FILLINGER MF, 1989, AM J SURG, V158, P87, DOI 10.1016/0002-9610(89)90353-X; FILLINGER MF, 1990, J VASC SURG, V11, P556, DOI 10.1067/mva.1990.18322; Gray Richard J, 2003, J Vasc Interv Radiol, V14, pS433; Guiu B, 2007, J VASC INTERV RADIOL, V18, P994, DOI 10.1016/j.jvir.2007.05.012; Hoffer EK, 1997, J VASC INTERV RADIOL, V8, P965, DOI 10.1016/S1051-0443(97)70695-X; Huijbregts HJT, 2008, CLIN J AM SOC NEPHRO, V3, P714, DOI 10.2215/CJN.02950707; KANTERMAN RY, 1995, RADIOLOGY, V196, P582; KANTERMAN RY, 1995, RADIOLOGY, V195, P135, DOI 10.1148/radiology.195.1.7892454; Kohler TR, 2007, J VASC SURG, V45, P1029, DOI 10.1016/j.jvs.2007.01.057; Konner K, 2006, BLOOD PURIFICAT, V24, P287, DOI 10.1159/000091345; Krueger U, 2002, ARTIF ORGANS, V26, P571, DOI 10.1046/j.1525-1594.2002.07078.x; Lilly RZ, 2001, AM J KIDNEY DIS, V37, P945, DOI 10.1016/S0272-6386(05)80010-1; Longest PW, 2003, J BIOMECH ENG-T ASME, V125, P671, DOI 10.1115/1.1613298; Lumsden AB, 1997, J VASC SURG, V26, P382, DOI 10.1016/S0741-5214(97)70031-4; Luo ZY, 2005, CIRCULATION, V111, P1679, DOI 10.1161/01.CIR.0000160357.80517.92; Misra S, 2006, KIDNEY INT, V70, P2006, DOI 10.1038/sj.ki.5001869; Patel RI, 1998, RADIOLOGY, V209, P365, DOI 10.1148/radiology.209.2.9807560; Rajan DK, 2007, J VASC INTERV RADIOL, V18, P709, DOI 10.1016/j.jvir.2007.03.011; Rifkin BS, 2005, AM J KIDNEY DIS, V45, pE27, DOI 10.1053/j.ajkd.2004.11.001; Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.00750.x; Schwab SJ, 1999, KIDNEY INT, V55, P2078, DOI 10.1046/j.1523-1755.1999.00409.x; Sottiurai V S, 1989, Ann Vasc Surg, V3, P26, DOI 10.1016/S0890-5096(06)62381-9; Stevenson KB, 2002, AM J KIDNEY DIS, V39, P549, DOI 10.1053/ajkd.2002.31405; Sun S, 2003, J SURG RES, V115, P200, DOI 10.1016/S0022-4804(03)00253-1; *VASC ACC WORK GRO, 2006, AM J KIDNEY DIS S, V48, pS248, DOI DOI 10.1053/J.AJKD.2006.04.040.MEDLINE; Vesely TM, 2005, J VASC INTERV RADIOL, V16, P1593, DOI 10.1097/01.RVI.0000190928.19701.DD; Vogel PM, 2004, J VASC INTERV RADIOL, V15, P1051, DOI 10.1097/01.RVI.0000129915.48500.DC; Yevzlin AS, 2006, SEMIN DIALYSIS, V19, P535, DOI 10.1111/j.1525-139X.2006.00218.x	39	243	256	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					494	503		10.1056/NEJMoa0902045	http://dx.doi.org/10.1056/NEJMoa0902045			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147715				2022-12-28	WOS:000274397200006
J	Karim, SA; Karim, QA				Karim, Salim Abdool; Karim, Quarraisha Abdool			AIDS research must link to local policy	NATURE			English	Editorial Material									[Karim, Salim Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Congella, South Africa; [Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA	University of Kwazulu Natal; Columbia University	Karim, SA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Congella, South Africa.	caprisa@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Abdool/P-3117-2019; Karim, Salim Safurdeen Abdool/N-5947-2013	Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Abdool/0000-0002-4986-2133; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133					0	9	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 11	2010	463	7282					733	734		10.1038/463733a	http://dx.doi.org/10.1038/463733a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	553VG	20148015				2022-12-28	WOS:000274394300016
J	Truog, RD				Truog, Robert D.			Is It Always Wrong to Perform Futile CPR?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Truog, Robert D.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Truog, Robert D.] Childrens Hosp Boston, Div Crit Care Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA.								0	53	53	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					477	479		10.1056/NEJMp0908464	http://dx.doi.org/10.1056/NEJMp0908464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553WJ	20147712				2022-12-28	WOS:000274397200001
J	Chopra, V; Eagle, KA				Chopra, Vineet; Eagle, Kim A.			Perioperative beta-Blockers for Cardiac Risk Reduction Time for Clarity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONCARDIAC SURGERY		[Chopra, Vineet; Eagle, Kim A.] Univ Michigan Hlth Syst, Div Gen Internal Med, Ann Arbor, MI USA; [Eagle, Kim A.] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chopra, V (corresponding author), 3119 Taubman Hlth Ctr,1500 E Med Ctr Dr,SPC 5376, Ann Arbor, MI 48104 USA.	vineetc@med.umich.edu		Chopra, Vineet/0000-0001-8670-9376				American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, 2009, J Am Coll Cardiol, V54, P2102, DOI 10.1016/j.jacc.2009.07.004; Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; CARDIAC CMS, MEASURES SURG CARE I; Chopra V, 2009, AM J MED, V122, P222, DOI 10.1016/j.amjmed.2008.11.004; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Poldermans D, 2001, EUR HEART J, V22, P1353, DOI 10.1053/euhj.2000.2555; Poldermans D, 2009, ANESTHESIOLOGY, V111, P940, DOI 10.1097/ALN.0b013e3181ba3bf4; Zaman AG, 2000, ATHEROSCLEROSIS, V149, P251, DOI 10.1016/S0021-9150(99)00479-7	10	5	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					551	552		10.1001/jama.2010.68	http://dx.doi.org/10.1001/jama.2010.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145232				2022-12-28	WOS:000274378700027
J	Gunarathne, T; McKay, R; Pillans, L; Mckinlay, A; Crockett, P				Gunarathne, Tharaka; McKay, Rebecca; Pillans, Lesley; Mckinlay, Alastair; Crockett, Philip			Case report Refeeding syndrome in a patient with anorexia nervosa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gunarathne, Tharaka; McKay, Rebecca; Pillans, Lesley; Mckinlay, Alastair; Crockett, Philip] Royal Cornhill Hosp, N Scotland Inpatient Eating Disorder Unit, Eden Unit, Aberdeen AB25 2ZH, Scotland		Crockett, P (corresponding author), Royal Cornhill Hosp, N Scotland Inpatient Eating Disorder Unit, Eden Unit, Aberdeen AB25 2ZH, Scotland.	philipcrockett@nhs.net						Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Mehanna HM, 2008, BRIT MED J, V336, P1495, DOI 10.1136/bmj.a301; National Institute for Health and Clinical Excellence, 2006, NUTR SUPP AD CLIN GU; *NHS QUAL IMPR SCO, 2006, EAT DIS SCOTL SUMM R	4	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2010	340								c56	10.1136/bmj.c56	http://dx.doi.org/10.1136/bmj.c56			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZT	20147361				2022-12-28	WOS:000274476900004
J	Bai, F; Branch, RW; Nicolau, DV; Pilizota, T; Steel, BC; Maini, PK; Berry, RM				Bai, Fan; Branch, Richard W.; Nicolau, Dan V., Jr.; Pilizota, Teuta; Steel, Bradley C.; Maini, Philip K.; Berry, Richard M.			Conformational Spread as a Mechanism for Cooperativity in the Bacterial Flagellar Switch	SCIENCE			English	Article							TORQUE-GENERATING UNITS; RESPONSE REGULATOR CHEY; ESCHERICHIA-COLI; ALLOSTERIC MECHANISMS; MOTOR; CHEMOTAXIS; PROTEINS; ROTATION; BINDING; COMPLEX	The bacterial flagellar switch that controls the direction of flagellar rotation during chemotaxis has a highly cooperative response. This has previously been understood in terms of the classic two-state, concerted model of allosteric regulation. Here, we used high-resolution optical microscopy to observe switching of single motors and uncover the stochastic multistate nature of the switch. Our observations are in detailed quantitative agreement with a recent general model of allosteric cooperativity that exhibits conformational spread-the stochastic growth and shrinkage of domains of adjacent subunits sharing a particular conformational state. We expect that conformational spread will be important in explaining cooperativity in other large signaling complexes.	[Bai, Fan; Branch, Richard W.; Pilizota, Teuta; Steel, Bradley C.; Berry, Richard M.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Bai, Fan] Osaka Univ, Grad Sch Frontier Biosci, Nanobiol Labs, Suita, Osaka 5650871, Japan; [Nicolau, Dan V., Jr.; Maini, Philip K.] Univ Oxford, Inst Math, Ctr Math Biol, Oxford OX1 3LB, England; [Nicolau, Dan V., Jr.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94708 USA; [Pilizota, Teuta] Princeton Univ, Carl Icahn Lab, Princeton, NJ 08644 USA; [Maini, Philip K.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Oxford; Osaka University; University of Oxford; University of California System; University of California Berkeley; Princeton University; University of Oxford	Berry, RM (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	r.berry1@physics.ox.ac.uk		Bai, Fan/0000-0001-6119-8936; Pilizota, Teuta/0000-0002-2156-0221; Nicolau, Dan V/0000-0002-9956-0600	European Research; European Molecular Biology Organisation; Balliol College; Oxford University; Royal Society; Engineering and Physical Sciences Research Council; BBSRC [BB/H01991X/1, BB/E00458X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00458X/1, BB/H01991X/1] Funding Source: researchfish	European Research(European Research Council (ERC)); European Molecular Biology Organisation; Balliol College; Oxford University; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Special thanks to T. Duke and I. Graham for introducing the conformational spread model to us. We also thank H. C. Berg and K. Fahrner for the gift of strain KAF 84 and KAF 95. The research of F. B., T. P. and R. M. B. was supported by the European Research Grant NANOMOT (Synthetic Biomimetic Nanoengines: A Modular Platform for Engineering of Nanomechanical Actuator Building Blocks), that of B. C. S. by a fellowship from the European Molecular Biology Organisation, that of D.V.N. by the Devorguilla Scholarship from Balliol College and the Clarendon Scholarship from Oxford University, that of P. K. M. partially by a Royal Society Wolfson Research Merit Award, and that of R. W. B. by the Engineering and Physical Sciences Research Council. F. B. also thanks Y. Zhang for help with the analysis program.	Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; Bray D, 2002, P NATL ACAD SCI USA, V99, P7, DOI 10.1073/pnas.022641699; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; EIGEN M, 1967, Nobel Symposium, V5, P333; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Karpen JW, 2002, TRENDS BIOCHEM SCI, V27, P402, DOI 10.1016/S0968-0004(02)02124-2; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; Koshland DE, 2002, J BIOL CHEM, V277, P46841, DOI 10.1074/jbc.R200014200; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; LAPIDUS IR, 1988, J BACTERIOL, V170, P3627, DOI 10.1128/jb.170.8.3627-3632.1988; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Pilizota T, 2007, BIOPHYS J, V93, P264, DOI 10.1529/biophysj.106.091074; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Sagi Y, 2003, J BIOL CHEM, V278, P25867, DOI 10.1074/jbc.M303201200; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sowa Y, 2005, NATURE, V437, P916, DOI 10.1038/nature04003; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Stryer L., 1999, BIOCHEMISTRY; Tumer L, 1996, BIOPHYS J, V71, P2227, DOI 10.1016/S0006-3495(96)79425-0; van Albada SB, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.74; Van Way SM, 2004, J BACTERIOL, V186, P3173, DOI 10.1128/JB.186.10.3173-3181.2004; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Yuan JH, 2009, J MOL BIOL, V390, P394, DOI 10.1016/j.jmb.2009.05.039	35	145	145	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					685	689		10.1126/science.1182105	http://dx.doi.org/10.1126/science.1182105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133571	Green Published			2022-12-28	WOS:000274251800037
J	Spitzweck, B; Brankatschk, M; Dickson, BJ				Spitzweck, Bettina; Brankatschk, Marko; Dickson, Barry J.			Distinct Protein Domains and Expression Patterns Confer Divergent Axon Guidance Functions for Drosophila Robo Receptors	CELL			English	Article							LONG-RANGE GUIDANCE; ROUNDABOUT RECEPTOR; COMMISSURAL AXONS; CNS MIDLINE; LATERAL POSITION; GENETIC-ANALYSIS; SLIT; REPULSION; ROLES; RAC	The orthogonal array of axon pathways in the Drosophila CNS is constructed in part under the control of three Robo family axon guidance receptors: Robo1, Robo2 and Robo3. Each of these receptors is responsible for a distinct set of guidance decisions. To determine the molecular basis for these functional specializations, we used homologous recombination to create a series of 9 "robo swap'' alleles: expressing each of the three Robo receptors from each of the three robo loci. We demonstrate that the lateral positioning of longitudinal axon pathways relies primarily on differences in gene regulation, not distinct combinations of Robo proteins as previously thought. In contrast, specific features of the Robo1 and Robo2 proteins contribute to their distinct functions in commissure formation. These specializations allow Robo1 to prevent crossing and Robo2 to promote crossing. These data demonstrate how diversification of expression and structure within a single family of guidance receptors can shape complex patterns of neuronal wiring.	[Spitzweck, Bettina; Brankatschk, Marko; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at		Brankatschk, Marko/0000-0001-5274-4552; Dickson, Barry/0000-0003-0715-892X	Austrian Science Fund; Boehringer Ingelheim GmbH	Austrian Science Fund(Austrian Science Fund (FWF)); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank Greg Bashaw for communicating unpublished data, Martin Hasemeyer and Carlos Ribeiro for their critical review of the manuscript, and Ruth Fuchs for technical assistance. This work was supported in part by a grant from the Austrian Science Fund. Basic research at the IMP is sponsored by Boehringer Ingelheim GmbH.	Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Englund C, 2002, DEVELOPMENT, V129, P4941; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Goodhill GJ, 2003, NEURAL COMPUT, V15, P549, DOI 10.1162/089976603321192077; GOODMAN CS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1284-58; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Newsome TP, 2000, DEVELOPMENT, V127, P851; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	38	76	76	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					409	U158		10.1016/j.cell.2010.01.002	http://dx.doi.org/10.1016/j.cell.2010.01.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144763	Bronze			2022-12-28	WOS:000274297700018
J	Martin, HGS; Wang, YT				Martin, Henry G. S.; Wang, Yu Tian			Blocking the Deadly Effects of the NMDA Receptor in Stroke	CELL			English	Editorial Material							DEATH		[Martin, Henry G. S.; Wang, Yu Tian] Vancouver Coastal Hlth Res Inst, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Martin, Henry G. S.; Wang, Yu Tian] Univ British Columbia, Vancouver, BC V6T 2B5, Canada	Vancouver Coastal Health Research Institute; University of British Columbia	Wang, YT (corresponding author), Vancouver Coastal Hlth Res Inst, Brain Res Ctr, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	ytwang@interchange.ubc.ca	Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	Martin, Henry/0000-0002-6504-1044				Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Tovar KR, 2002, NEURON, V34, P253	9	54	64	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					174	176		10.1016/j.cell.2010.01.014	http://dx.doi.org/10.1016/j.cell.2010.01.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141829	Bronze			2022-12-28	WOS:000273826500006
J	Rego, AT; Fronzes, R; Waksman, G				Rego, Ana Toste; Fronzes, Remi; Waksman, Gabriel			SnapShot: Bacterial Appendages II	CELL			English	Editorial Material							SECRETION SYSTEM; NEEDLE		[Rego, Ana Toste; Fronzes, Remi; Waksman, Gabriel] Birkbeck & Univ Coll London, Inst Struct Mol Biol, London WC1E 7HX, England	University of London; Birkbeck University London	Rego, AT (corresponding author), Birkbeck & Univ Coll London, Inst Struct Mol Biol, London WC1E 7HX, England.		Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022	Toste Rego, Ana/0000-0002-8584-3386; Fronzes, Remi/0000-0003-3031-9824	Medical Research Council [G0800002] Funding Source: Medline; MRC [G0800002] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Deane JE, 2008, MOL MICROBIOL, V69, P267, DOI 10.1111/j.1365-2958.2008.06293.x; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	10	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2							294.e1	10.1016/j.cell.2010.01.006	http://dx.doi.org/10.1016/j.cell.2010.01.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141842	Bronze			2022-12-28	WOS:000273826500019
J	Saenz, SA; Siracusa, MC; Perrigoue, JG; Spencer, SP; Urban, JF; Tocker, JE; Budelsky, AL; Kleinschek, MA; Kastelein, RA; Kambayashi, T; Bhandoola, A; Artis, D				Saenz, Steven A.; Siracusa, Mark C.; Perrigoue, Jacqueline G.; Spencer, Sean P.; Urban, Joseph F., Jr.; Tocker, Joel E.; Budelsky, Alison L.; Kleinschek, Melanie A.; Kastelein, Robert A.; Kambayashi, Taku; Bhandoola, Avinash; Artis, David			IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; TYPE-2 IMMUNITY; IN-VIVO; IL-4; INNATE; INFLAMMATION; EXPRESSION; BASOPHILS	CD4(+) T helper 2 (T(H)2) cells secrete interleukin (IL)4, IL5 and IL13, and are required for immunity to gastrointestinal helminth infections(1). However, T(H)2 cells also promote chronic inflammation associated with asthma and allergic disorders(2). The nonhaematopoietic-cell-derived cytokines thymic stromal lymphopoietin, IL33 and IL25 (also known as IL17E) have been implicated in inducing T(H)2 cell-dependent inflammation at mucosal sites(3-6), but how these cytokines influence innate immune responses remains poorly defined. Here we show that IL25, a member of the IL17 cytokine family, promotes the accumulation of a lineage-negative (Lin(-)) multipotent progenitor (MPP) cell population in the gut-associated lymphoid tissue that promotes T(H)2 cytokine responses. The IL25-elicited cell population, termed MPPtype2 cells, was defined by the expression of Sca-1 (also known as Ly6a) and intermediate expression of c-Kit (c-Kit(int)), and exhibited multipotent capacity, giving rise to cells of monocyte/macrophage and granulocyte lineages both in vitro and in vivo. Progeny of MPPtype2 cells were competent antigen presenting cells, and adoptive transfer of MPPtype2 cells could promote T(H)2 cytokine responses and confer protective immunity to helminth infection in normally susceptible Il25(-/-) mice. The ability of IL25 to induce the emergence of an MPPtype2 cell population identifies a link between the IL17 cytokine family and extramedullary haematopoiesis, and suggests a previously unrecognized innate immune pathway that promotes T(H)2 cytokine responses at mucosal sites.	[Saenz, Steven A.; Siracusa, Mark C.; Perrigoue, Jacqueline G.; Spencer, Sean P.; Artis, David] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Kambayashi, Taku; Bhandoola, Avinash] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Urban, Joseph F., Jr.] USDA, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA; [Tocker, Joel E.; Budelsky, Alison L.] Amgen Inc, Dept Inflammat Res, Seattle, WA 98119 USA; [Kleinschek, Melanie A.; Kastelein, Robert A.] Schering Plough Biopharma, Discovery Res, Palo Alto, CA 94304 USA	University of Pennsylvania; University of Pennsylvania; United States Department of Agriculture (USDA); Amgen; Merck & Company	Artis, D (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	dartis@vet.upenn.edu		Urban, Joseph/0000-0002-1590-8869; Artis, David/0000-0002-1753-4100; Spencer, Sean/0000-0002-7328-5399	National Institutes of Health [AI61570, AI074878, AI083480, GM082187, AI007532-08]; Burroughs Wellcome Fund; National Institute of Diabetes and Digestive Kidney Disease Center [P30 DK50306]; University of Pennsylvania (URF, VCID and PGI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061570, R21AI083480, T32AI007532, R01AI095466, R01AI074878, R01AI102942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Diabetes and Digestive Kidney Disease Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Pennsylvania (URF, VCID and PGI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Artis laboratory for constructive discussions, M. Abt, D. Hill, G. Sonnenberg, P. Giacomin, M. Nair and K. Walsh for critical reading of the manuscript, and T. Chi and J. J. Bell for invaluable assistance with reagents and experimental design. Work in the Artis laboratory is supported by the National Institutes of Health (AI61570, AI074878 and AI083480 to D. A., F31 training grant GM082187 to S. A. S., and T32 training grant AI007532-08 to J. G. P.), the Burroughs Wellcome Fund (to D. A.), a National Institute of Diabetes and Digestive Kidney Disease Center Grant (P30 DK50306) and pilot grants from the University of Pennsylvania (URF, VCID and PGI) (to D. A.).	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Cardier JE, 1997, HEPATOLOGY, V26, P165; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; LYON MF, 1982, GENET RES, V39, P315, DOI 10.1017/S001667230002098X; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	30	441	463	1	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1362	U8		10.1038/nature08901	http://dx.doi.org/10.1038/nature08901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20200520	Green Accepted			2022-12-28	WOS:000277149000049
J	Warnke, PC				Warnke, Peter C.			A 31-Year-Old Woman With a Transformed Low-grade Glioma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LONG-TERM SURVIVAL; BRAIN-TUMORS; RADIATION-THERAPY; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; II GLIOMAS; INTERSTITIAL IRRADIATION; OLIGODENDROGLIAL TUMORS; INTRACTABLE EPILEPSY	Low-grade gliomas in adults have an incidence of 0.8 to 1.2 per 100 000, and their causes are unknown. Despite their histological classification as low-grade, they cannot be cured by any current treatment mode, and no class I evidence exists to guide initial treatment of these tumors. Median survival ranges between 7.5 years and 10 years, with a 5-year survival probability between 55% and 86%. The prognosis depends on age, World Health Organization (WHO) tumor grade, Karnofsky performance score, cytological type (oligodendroglioma vs astrocytoma), and, potentially, the extent of resection. Oligodendrogliomas with loss of heterozygosity on chromosomes 1p and 19q have a distinctly more favorable prognosis and therapeutic response rate. Low-grade tumors progress to high-grade gliomas with aggressive biological behavior at increasing frequency with advancing age. Ms P is a young woman with a previously treated oligodendroglioma, WHO grade II, with loss of heterozygosity on chromosomes 1p and 19q, which at a third resection had transformed into an oligodendroglioma of WHO grade III. She wants to know her current and future therapeutic options. JAMA. 2010;303(10):967-976	Beth Israel Deaconess Med Ctr, Div Neurol Surg, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Warnke, PC (corresponding author), Beth Israel Deaconess Med Ctr, Div Neurol Surg, 110 Francis St,Ste 3B, Boston, MA 02215 USA.	pwarnke@partners.org						Agulnik M, 2006, HEMATOL ONCOL CLIN N, V20, P1249, DOI 10.1016/j.hoc.2006.09.003; Ahmed Z, 2001, J Pak Med Assoc, V51, P154; Akai T, 2004, PATHOL RES PRACT, V200, P619, DOI 10.1016/j.prp.2004.06.008; Berger M S, 1995, Clin Neurosurg, V42, P437; BERGER MS, 1994, CANCER, V74, P1784, DOI 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D; BERGER MS, 1993, J NEUROSURG, V79, P62, DOI 10.3171/jns.1993.79.1.0062; Bidros DS, 2010, FUTURE ONCOL, V6, P117, DOI 10.2217/FON.09.135; Bowers DC, 2000, PEDIATR NEUROSURG, V32, P24, DOI 10.1159/000028893; Brodsky MC, 1995, J NEURO-OPHTHALMOL, V15, P236; Brown PD, 2003, NEURO-ONCOLOGY, V5, P161, DOI 10.1215/S1152851702000431; Ceyssens S, 2006, AM J NEURORADIOL, V27, P1432; Claus EB, 2006, CANCER-AM CANCER SOC, V106, P1358, DOI 10.1002/cncr.21733; Derlon JM, 2000, EUR J NUCL MED, V27, P778, DOI 10.1007/s002590000260; Dropcho Edward J., 2004, Curr Treat Options Neurol, V6, P265, DOI 10.1007/s11940-004-0026-3; Duffau H, 2006, J NEURO-ONCOL, V79, P77, DOI 10.1007/s11060-005-9109-6; Edvardsson T, 2005, PSYCHO-ONCOL, V14, P728, DOI 10.1002/pon.898; Fan GG, 2006, BRIT J RADIOL, V79, P652, DOI 10.1259/bjr/25349497; Friedman HS, 1998, MED PEDIATR ONCOL, V31, P16, DOI 10.1002/(SICI)1096-911X(199807)31:1<16::AID-MPO3>3.0.CO;2-2; Goerne R, 2008, CURR MED CHEM, V15, P1376, DOI 10.2174/092986708784567707; Gumprecht H, 2007, ZBL NEUROCHIR, V68, P19, DOI 10.1055/s-2007-970601; Herholz K, 1998, NEUROLOGY, V50, P1316, DOI 10.1212/WNL.50.5.1316; HOSHINO T, 1984, J NEUROSURG, V61, P895, DOI 10.3171/jns.1984.61.5.0895; Jacobs AH, 2005, J NUCL MED, V46, P1948; Jenkinson MD, 2006, NEURORADIOLOGY, V48, P703, DOI 10.1007/s00234-006-0122-z; Johannesen TB, 2003, EUR J CANCER, V39, P2355, DOI 10.1016/S0959-8049(03)00603-8; Johannesen TB, 2003, J NEUROSURG, V99, P854, DOI 10.3171/jns.2003.99.5.0854; Karim ABMF, 1996, INT J RADIAT ONCOL, V36, P549, DOI 10.1016/S0360-3016(96)00352-5; Keles GE, 2001, J NEUROSURG, V95, P735, DOI 10.3171/jns.2001.95.5.0735; Kesari S, 2009, CLIN CANCER RES, V15, P330, DOI 10.1158/1078-0432.CCR-08-0888; Kiebert GM, 1998, EUR J CANCER, V34, P1902, DOI 10.1016/S0959-8049(98)00268-8; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Krainik A, 2003, NEUROLOGY, V60, P587, DOI 10.1212/01.WNL.0000048206.07837.59; Kreth FW, 2006, CANCER, V106, P1372, DOI 10.1002/cncr.21750; Kreth FW, 1997, RADIOTHER ONCOL, V43, P253, DOI 10.1016/S0167-8140(97)01948-8; KRETH FW, 1995, J NEUROSURG, V82, P418, DOI 10.3171/jns.1995.82.3.0418; Laack NN, 2005, INT J RADIAT ONCOL, V63, P1175, DOI 10.1016/j.ijrobp.2005.04.016; Lang FF, 2006, J CLIN ONCOL, V24, P1236, DOI 10.1200/JCO.2005.05.2399; Lebrun C, 2007, EUR J NEUROL, V14, P391, DOI 10.1111/j.1468-1331.2007.01675.x; Leighton C, 1997, J CLIN ONCOL, V15, P1294, DOI 10.1200/JCO.1997.15.4.1294; Li XJ, 2002, J MAGN RESON IMAGING, V16, P229, DOI 10.1002/jmri.10147; Lo SS, 2001, INT J CANCER, V96, P71, DOI 10.1002/ijc.10359; Lombardi D, 1997, ADV STER F, V12, P70; MACDONALD DR, 1994, SEMIN ONCOL, V21, P236; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; Mardor Y, 2009, J PHARMACOL EXP THER, V330, P520, DOI 10.1124/jpet.109.154401; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Mehrkens JH, 2004, J NEUROL, V251, P1455, DOI 10.1007/s00415-004-0561-6; Michotte A, 2004, ACTA NEUROL BELG, V104, P148; Nemeckova J, 1995, Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove, V38, P175; Nimsky C, 2006, NEUROL RES, V28, P482, DOI 10.1179/016164106X115125; Nuutinen J, 2000, INT J RADIAT ONCOL, V48, P43, DOI 10.1016/S0360-3016(00)00604-0; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Pace A, 2003, ANN ONCOL, V14, P1722, DOI 10.1093/annonc/mdg502; Padma MV, 2003, J NEURO-ONCOL, V64, P227, DOI 10.1023/A:1025665820001; Paleologos Nina A, 2005, Expert Rev Neurother, V5, pS21; Pauliah M, 2007, MAGN RESON IMAGING, V25, P1292, DOI 10.1016/j.mri.2007.03.027; Popperl G, 2006, J NUCL MED, V47, P393; Pouratian N, 2007, NAT CLIN PRACT NEURO, V3, P628, DOI 10.1038/ncpneuro0634; Pouratian N, 2007, J NEURO-ONCOL, V82, P281, DOI 10.1007/s11060-006-9280-4; Reijneveld JC, 2005, NEURORADIOLOGY, V47, P887, DOI 10.1007/s00234-005-1435-z; Rijpkema M, 2003, NMR BIOMED, V16, P12, DOI 10.1002/nbm.807; Rodriguez FJ, 2008, J NEUROPATH EXP NEUR, V67, P240, DOI 10.1097/NEN.0b013e318165eb75; ROGERS LR, 1993, NEUROLOGY, V43, P1599, DOI 10.1212/WNL.43.8.1599; ROSSI GF, 1985, APPL NEUROPHYSIOL, V48, P127; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Scerrati M, 1996, J NEUROL NEUROSUR PS, V61, P291, DOI 10.1136/jnnp.61.3.291; SCERRATI M, 1994, ACTA NEUROCHIR, V131, P97, DOI 10.1007/BF01401459; Schramm J, 2006, ZBL NEUROCHIR, V67, P55, DOI 10.1055/s-2006-933408; Schramm J, 2008, NEUROSURGERY, V62, P1272, DOI [10.1227/01.NEU.0000249281.69384.D7, 10.1227/01.neu.0000333792.36715.29]; Schumacher T, 2002, EUR J NUCL MED MOL I, V29, P486, DOI 10.1007/s00259-001-0717-x; Shafqat S, 1999, NEUROLOGY, V52, P867, DOI 10.1212/WNL.52.4.867; Shaw E, 2002, J CLIN ONCOL, V20, P2267, DOI 10.1200/JCO.2002.09.126; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Soffietti R, 1998, NEUROSURGERY, V43, P1066, DOI 10.1097/00006123-199811000-00035; Steinmeier R, 2002, ONKOLOGIE, V25, P552, DOI 10.1159/000068627; Stieber V W, 2001, Curr Treat Options Oncol, V2, P495, DOI 10.1007/s11864-001-0071-z; The WHO, 2020, CLASSIFICATION TUMOU; Tosoni A, 2008, J NEURO-ONCOL, V89, P179, DOI 10.1007/s11060-008-9600-y; TOVI M, 1990, ACTA RADIOL, V31, P417; van den Bent M J, 2000, Forum (Genova), V10, P108; Van den Bent MJ, 2008, CRIT REV ONCOL HEMAT, V66, P262, DOI 10.1016/j.critrevonc.2007.11.007; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; van den Bent MJ, 2003, CANCER-AM CANCER SOC, V97, P1276, DOI 10.1002/cncr.11187; Vitaz TW, 2005, J NEURO-ONCOL, V73, P71, DOI 10.1007/s11060-004-2352-4; Voges J, 1999, CRIT REV NEUROSURG, V9, P223, DOI 10.1007/s003290050137; VOGES J, 1993, ACTA NEUROCHIR, P108; Walker C, 2006, BRIT J CANCER, V95, P1424, DOI 10.1038/sj.bjc.6603390; Walker C, 2004, CLIN CANCER RES, V10, P7182, DOI 10.1158/1078-0432.CCR-04-0681; Weber Marc-Andre, 2008, Expert Rev Neurother, V8, P1507, DOI 10.1586/14737175.8.10.1507; Yamada K, 2004, J CLIN NEUROSCI, V11, P263, DOI 10.1016/j.jocn.2003.03.004; Yamini Bakhtiar, 2005, Expert Rev Neurother, V5, pS13; Yong RL, 2009, CANCER RES, V69, P8932, DOI 10.1158/0008-5472.CAN-08-3873	94	3	3	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					967	976		10.1001/jama.2010.222	http://dx.doi.org/10.1001/jama.2010.222			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20159860				2022-12-28	WOS:000275319300024
J	Abdel-Latif, ME; Sugo, E				Abdel-Latif, Mohamed El-Amin; Sugo, Ella			Congenital Cytomegalovirus Infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Abdel-Latif, Mohamed El-Amin] Australian Natl Univ, Sch Med, Garran, ACT 2605, Australia; [Sugo, Ella] Prince Wales Hosp, Randwick, NSW 2031, Australia	Australian National University	Abdel-Latif, ME (corresponding author), Australian Natl Univ, Sch Med, Garran, ACT 2605, Australia.	abdel.latif.mohamed@act.gov.au	ABDEL-LATIF, Mohamed E./N-3372-2018	ABDEL-LATIF, Mohamed E./0000-0003-4306-2933					0	6	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					833	833		10.1056/NEJMicm0804100	http://dx.doi.org/10.1056/NEJMicm0804100			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20200387				2022-12-28	WOS:000275108300010
J	Wynia, MK; Ivey, SL; Hasnain-Wynia, R				Wynia, Matthew K.; Ivey, Susan L.; Hasnain-Wynia, Romana			Collection of Data on Patients' Race and Ethnic Group by Physician Practices.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE ORGANIZATIONS; PAY-FOR-PERFORMANCE; HIGH-QUALITY CARE; RACIAL DISPARITIES; MEDICAL-CARE; RACE/ETHNICITY; PERCEPTIONS; IMPROVEMENT; CHALLENGES		[Wynia, Matthew K.] Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA; [Wynia, Matthew K.] Univ Chicago, Chicago, IL 60637 USA; [Hasnain-Wynia, Romana] Northwestern Univ, Div Gen Internal Med, Inst Healthcare Studies, Ctr Healthcare Equ, Chicago, IL 60611 USA; [Ivey, Susan L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	American Medical Association; University of Chicago; Northwestern University; University of California System; University of California Berkeley	Wynia, MK (corresponding author), Amer Med Assoc, Inst Eth, 515 N State St, Chicago, IL 60610 USA.		Wynia, Matthew/T-2210-2019	Hasnain-Wynia, Romana/0000-0001-6009-3569				ABRAHAM C, 2007, GLOBE MAIL      0903; Agency for Healthcare Research and Quality, 2009, AHRQ PUBL; Anderson MR, 2001, FAM MED, V33, P430; [Anonymous], 2008, AHRQ PUBL, V08-0034 (1-4), P1; [Anonymous], PHYS CONS PERF IMPR; Audet AMJ, 2005, HEALTH AFFAIR, V24, P843, DOI 10.1377/hlthaff.24.3.843; BAUM N, 2010, MARKETING YOUR CLIN, P179; Bloche MG, 2004, NEW ENGL J MED, V351, P2035, DOI 10.1056/NEJMp048271; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Braun L, 2007, PLOS MED, V4, P1423, DOI 10.1371/journal.pmed.0040271; CALDWELL SH, 1995, ANN INTERN MED, V122, P614, DOI 10.7326/0003-4819-122-8-199504150-00010; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Chin MH, 2002, ACAD MED, V77, P202, DOI 10.1097/00001888-200203000-00005; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; *DEP HLTH HUM SERV, MEAN US MATR; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; FINUCANE TE, 1990, J GEN INTERN MED, V5, P120, DOI 10.1007/BF02600511; Fiscella K, 2008, ARCH INTERN MED, V168, P1843, DOI 10.1001/archinte.168.17.1843; GARREAU J, 2006, SMITHSONIAN MAGA OCT; Hasnain-Wynia R, 2006, HEALTH SERV RES, V41, P1501, DOI 10.1111/j.1475-6773.2006.00552.x; HASNAINWYNIA R, 2007, HLTH RES ED TRUST DI; HASNAINWYNIA R, 2007, COLLECTING RACE ETHN; *I MED, 2003, UN TREATM CONFR RAC; Institute of Medicine, 2009, RAC ETHN LANG DAT ST; KMETIK K, 2009, POWERPOINT PRESENTAT; Landon BE, 2008, ANN INTERN MED, V148, P353, DOI 10.7326/0003-4819-148-5-200803040-00006; Lurie N, 2005, CIRCULATION, V111, P1264, DOI 10.1161/01.CIR.0000157738.12783.71; *MN COMM MEAS, 2009, HDB COLL RAC ETHN LA; Nerenz DR, 2006, HEALTH SERV RES, V41, P1444, DOI 10.1111/j.1475-6773.2006.00613.x; Nerenz DR, 2005, HEALTH AFFAIR, V24, P409, DOI 10.1377/hlthaff.24.2.409; PEROT RT, 2001, RACIAL ETHNIC PRIMAR; *PRIMED PAT ED CTR, SHOULD YOUR PRACT CO; Reschovsky JD, 2008, HEALTH AFFAIR, V27, pW222, DOI 10.1377/hlthaff.27.3.w222; Risch N, 2006, NEW ENGL J MED, V354, P408, DOI 10.1056/NEJMe058265; ROAN S, 2009, LOS ANGELES TIM 0817; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; *RW JOHNS FDN, 2004, PHYS PERSP COMM BARR; *S AS HEART CTR EL, MISS STAT; Sabin JA, 2008, MED CARE, V46, P678, DOI 10.1097/MLR.0b013e3181653d58; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; SATEL S, 2002, NY TIMES        0505; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Sequist TD, 2008, ARCH INTERN MED, V168, P1145, DOI 10.1001/archinte.168.11.1145; Sequist TD, 2008, J GEN INTERN MED, V23, P678, DOI 10.1007/s11606-008-0510-7; Siegel B, 2009, NEW ENGL J MED, V361, P2401, DOI 10.1056/NEJMp0909323; Szilagyi PG, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e58; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Terris Darcey D, 2008, Qual Manag Health Care, V17, P19, DOI 10.1097/01.QMH.0000308634.59108.60; Ver Ploeg M., 2004, ELIMINATING HLTH DIS; Witzig R, 1996, ANN INTERN MED, V125, P675, DOI 10.7326/0003-4819-125-8-199610150-00008; ZIMMERMAN D, SETTING STAGE PRIORI	52	41	41	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					846	850		10.1056/NEJMsb0910799	http://dx.doi.org/10.1056/NEJMsb0910799			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20200391				2022-12-28	WOS:000275108300015
J	Markel, H				Markel, Howard			Abraham Flexner and His Remarkable Report on Medical Education A Century Later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FLEXNER,ABRAHAM		Univ Michigan, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Ctr Hist Med, 100 Simpson Inst,Box 0724,100 Observ, Ann Arbor, MI 48109 USA.	howard@umich.edu						BONNER TN, 1990, J HIST MED ALL SCI, V45, P3, DOI 10.1093/jhmas/45.1.3; BONNER TN, 2002, ICONOCLAST A FLEXNER, P17; FLEXNER A, 1912, COMMUNICATION   0204; FLEXNER A, 1960, AUTOBIOGRAPHY REVISI; Flexner A., 1908, AM COLL CRITICISM; Flexner A., 1930, U AM ENGLISH GERMAN; Flexner A, 1910, CARNEGIE FDN B; FLEXNER A, 1912, CARNEGIE FDN B, V6; FOX DM, 1980, B HIST MED, V54, P475; KING LS, 1984, JAMA-J AM MED ASSOC, V251, P1079, DOI 10.1001/jama.251.8.1079; LUDMERER KM, 1984, LEARNING HEAL DEV AM, P177; 1910, NY TIMES MAGAZI 0724, P1; 1959, NY TIMES        0922, P1; 1959, NY TIMES        0922, P35; 1910, CHICAGO DAILY T 0606, P1; 1910, WASHINGTON POST 0607, P4	16	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					888	890		10.1001/jama.2010.225	http://dx.doi.org/10.1001/jama.2010.225			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197539				2022-12-28	WOS:000275059500026
J	Wacholder, S; Chen, BE; Wilcox, A; Macones, G; Gonzalez, P; Befano, B; Hildesheim, A; Rodriguez, AC; Solomon, D; Herrero, R; Schiffman, M				Wacholder, Sholom; Chen, Bingshu Eric; Wilcox, Allen; Macones, George; Gonzalez, Paula; Befano, Brian; Hildesheim, Allan; Cecilia Rodriguez, Ana; Solomon, Diane; Herrero, Rolando; Schiffman, Mark		CVT Grp	Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOUBLE-BLIND	Objective To assess whether vaccination against human papillomavirus (HPV) increases the risk of miscarriage. Design Pooled analysis of two multicentre, phase three masked randomised controlled trials Setting Multicentre trials in several continents and in Costa Rica. Participants 26 130 women aged 15-25 at enrolment; 3599 pregnancies eligible for analysis. Interventions Participants were randomly assigned to receive three doses of bivalent HPV 16/18 VLP vaccine with AS04 adjuvant (n=13 075) or hepatitis A vaccine as control (n=13 055) over six months. Main outcome measures Miscarriage and other pregnancy outcomes. Results The estimated rate of miscarriage was 11.5% in pregnancies in women in the HPV arm and 10.2% in the control arm. The one sided P value for the primary analysis was 0.16; thus, overall, there was no significant increase in miscarriage among women assigned to the HPV vaccine arm. In secondary descriptive analyses, miscarriage rates were 14.7% in the HPV vaccine arm and 9.1% in the control arm in pregnancies that began within three months after nearest vaccination. Conclusion There is no evidence overall for an association between HPV vaccination and risk of miscarriage.	[Wacholder, Sholom; Hildesheim, Allan; Schiffman, Mark] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Chen, Bingshu Eric] Queens Univ, NCIC Clin Trials Grp, Kingston, ON K7L 3N6, Canada; [Wilcox, Allen] Natl Inst Environm Hlth Sci, Div Intramural Res, Res Triangle Pk, NC 27709 USA; [Macones, George] Washington Univ, Dept Obstet & Gynecol, St Louis, MO 63130 USA; [Gonzalez, Paula; Cecilia Rodriguez, Ana; Herrero, Rolando] Fdn INCIENSA, San Jose, Costa Rica; [Befano, Brian] Informat Management Serv Inc, Silver Spring, MD 20904 USA; [Solomon, Diane] NCI, Canc Prevent Div, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Queens University - Canada; Canadian Cancer Trials Group; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington University (WUSTL); Information Management Services, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wacholder, S (corresponding author), NCI, Div Canc Epidemiol & Genet, 6120 Execut Blvd, Rockville, MD 20852 USA.	WacholdS@mail.nih.gov	Schiffman, Mark/B-9766-2015; Wilcox, Allen J/C-7723-2019; Hildesheim, Allan/B-9760-2015	Wilcox, Allen J/0000-0002-3376-1311; Hildesheim, Allan/0000-0003-0257-2363; Chen, Bingshu/0000-0001-6139-0696; Befano, Brian/0000-0003-3614-210X	National Cancer Institute, NIH Office for Research on Women's Health in agreement with the Ministry of Health of Costa Rica [N01-CP-11005]; GSK Biologicals; National Cancer Institute (NCI), National Institutes of Health; National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	National Cancer Institute, NIH Office for Research on Women's Health in agreement with the Ministry of Health of Costa Rica(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); GSK Biologicals(GlaxoSmithKline); National Cancer Institute (NCI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The CVT trial is sponsored and funded by the National Cancer Institute (N01-CP-11005) with support from the NIH Office for Research on Women's Health and conducted in agreement with the Ministry of Health of Costa Rica. PATRICIA is funded by GSK Biologicals. GSK Biologicals contributed data from PATRICIA to the analysis, and commented on aspects of the trial at the design stage and after the results were shared with investigators of both trials, with the permission of the Data Safety Monitoring Board of CVT. GSK Biologicals had no role in study design and the collection, analysis, and interpretation of data from CVT in this paper, or in the writing of the article. GSK Biologicals took no part in the decision to submit an article for publication. The pooled analysis reported here was supported by the Intramural Research Programs of the National Cancer Institute (NCI) and the National Institute of Environmental Health Sciences, both parts of the National Institutes of Health.	BAIRD DD, 1995, EPIDEMIOLOGY, V6, P547, DOI 10.1097/00001648-199509000-00015; CDC (U. S. Centers for Disease Control and Prevention), 2008, ACIP GUID VACC REC P; *CDCP, 2008, GUID VACC PREGN WOM; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Herrero R, 2008, VACCINE, V26, P4795, DOI 10.1016/j.vaccine.2008.07.002; MARKOWITZ LE, 2007, MMWR RECOMM REP, P561; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Sjoborg KD, 2009, ACTA OBSTET GYN SCAN, V88, P255, DOI 10.1080/00016340802699100; THOMAS DC, 1992, EPIDEMIOLOGY, V3, P32, DOI 10.1097/00001648-199201000-00007; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wilcox AJ., 2010, FERTILITY PREGNANCY	13	59	61	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2010	340								c712	10.1136/bmj.c712	http://dx.doi.org/10.1136/bmj.c712			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565FI	20197322	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000275274300023
J	Davenport, A; Farrington, K				Davenport, Andrew; Farrington, Ken			Dialysis dose in acute kidney injury and chronic dialysis	LANCET			English	Editorial Material							NATIONAL COOPERATIVE DIALYSIS; CRITICALLY-ILL PATIENTS; HEMODIALYSIS-PATIENTS; MORTALITY; INTENSITY; MORBIDITY; SURVIVAL		[Davenport, Andrew] UCL, Sch Med, Ctr Nephrol, London NW3 2PF, England; [Farrington, Ken] Lister Hosp, Renal Unit, Stevenage, Herts, England	University of London; University College London; UCL Medical School; Lister Hospital	Davenport, A (corresponding author), UCL, Sch Med, Ctr Nephrol, Royal Free Campus, London NW3 2PF, England.	andrew.davenport@royalfree.nhs.uk	Farrington, Ken/V-1531-2019					Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; DAVENPORT A, 1993, LANCET, V341, P1614, DOI 10.1016/0140-6736(93)90757-8; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; LOWRIE EG, 1981, NEW ENGL J MED, V305, P1176, DOI 10.1056/NEJM198111123052003; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; PARKER TF, 1994, AM J KIDNEY DIS, V23, P670, DOI 10.1016/S0272-6386(12)70277-9; Spalding EM, 2008, KIDNEY INT, V74, P348, DOI 10.1038/ki.2008.185; TISHER CC, 1994, ANN INTERN MED, V121, P62	12	27	28	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					705	706		10.1016/S0140-6736(09)62062-6	http://dx.doi.org/10.1016/S0140-6736(09)62062-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20167358				2022-12-28	WOS:000275211200008
J	Levens, D; Gupta, A				Levens, David; Gupta, Ashutosh			Reliable Noise	SCIENCE			English	Editorial Material							C-MYC EXPRESSION; GENE-EXPRESSION; DNA; CELL		[Levens, David; Gupta, Ashutosh] NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Gupta, Ashutosh] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park	Levens, D (corresponding author), NCI, Pathol Lab, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	levensd@mail.nih.gov	Levens, David/C-9216-2009	Levens, David/0000-0002-7616-922X	NATIONAL CANCER INSTITUTE [ZIABC011011] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alligood K., 1997, CHAOS INTRO DYNAMICA; Alon U., 2006, INTRO SYSTEMS BIOL D; Benjamin LR, 2008, P NATL ACAD SCI USA, V105, P18296, DOI 10.1073/pnas.0803279105; Chung HJ, 2005, MOL CELLS, V20, P157; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Senoo-Matsuda N, 2007, P NATL ACAD SCI USA, V104, P18543, DOI 10.1073/pnas.0709021104; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962	14	6	6	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1088	1089		10.1126/science.1187268	http://dx.doi.org/10.1126/science.1187268			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185714				2022-12-28	WOS:000274901100021
J	Sriskantharajah, S; Ley, SC				Sriskantharajah, Srividya; Ley, Steven C.			Turning Off Inflammation Signaling	SCIENCE			English	Editorial Material							UBIQUITIN		[Sriskantharajah, Srividya; Ley, Steven C.] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Sriskantharajah, S (corresponding author), Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England.	sley@nimr.mrc.ac.uk			Medical Research Council [U117532003] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002	6	13	15	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1093	1094		10.1126/science.1187271	http://dx.doi.org/10.1126/science.1187271			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185718				2022-12-28	WOS:000274901100025
J	Lo, B; Parham, L; Cedars, M; Fisher, S; Gates, E; Giudice, L; Halme, DG; Hershon, W; Kriegstein, A; Rao, R; Roberts, C; Wagner, R				Lo, Bernard; Parham, Lindsay; Cedars, Marcelle; Fisher, Susan; Gates, Elena; Giudice, Linda; Halme, Dina Gould; Hershon, William; Kriegstein, Arnold; Rao, Radhika; Roberts, Clifford; Wagner, Richard			NIH Guidelines for Stem Cell Research and Gamete Donors	SCIENCE			English	Editorial Material							CONSENT; DONATION; OOCYTES; EMBRYO		[Lo, Bernard; Parham, Lindsay] Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; [Lo, Bernard] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lo, Bernard; Fisher, Susan; Gates, Elena; Giudice, Linda; Kriegstein, Arnold] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Cedars, Marcelle; Gates, Elena; Giudice, Linda] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Fisher, Susan] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Halme, Dina Gould] Univ Calif San Francisco, Sch Med, Off Dean, San Francisco, CA 94143 USA; [Hershon, William] Disabil Rights Calif, Oakland, CA 94612 USA; [Kriegstein, Arnold] Univ Calif San Francisco, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; [Rao, Radhika] Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA; [Roberts, Clifford] Univ Calif San Francisco, Off Vice Chancellor Res, San Francisco, CA 94143 USA; [Wagner, Richard] Univ Calif San Francisco, Human Res Protect Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR024131-04, UL1 RR024131] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adsuar N, 2005, FERTIL STERIL, V84, P1513, DOI 10.1016/j.fertnstert.2005.05.042; *AUSTR GOV NAT HLT, 2002, PROH HUM CLON REPR A; BERG JW, 2001, INFORMED CONSENT LEG; *EUR GROUP ETH SCI, 2007, ETH REV HESC FP7 RES; *HFEA, 1991, GUID CONS US STOR GA; hhs, 1979, BELM REP ETH PRINC G; *ISSCR, 2006, GUID COND HUM EMBR S; Kalfoglou AL, 2000, FERTIL STERIL, V74, P660, DOI 10.1016/S0015-0282(00)01489-8; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; KOROBKIN R, 2007, STEM CELL CENTURY LO; Lo B, 2003, SCIENCE, V301, P921, DOI 10.1126/science.1087038; Lo B, 2009, CELL STEM CELL, V4, P115, DOI 10.1016/j.stem.2009.01.013; Lomax GP, 2007, PLOS MED, V4, P803, DOI 10.1371/journal.pmed.0040114; National Research Council and Institute of Medicine of the National Academies, 2007, 2007 AM NAT AC GUID; *NEBAC, 1999, ETH ISS HUM STEM CEL; *NIH, 2009, NAT I HLTH GUID HUM; Streiffer R, 2008, HASTINGS CENT REP, V38, P40; Sugarman J, 2008, SCIENCE, V322, P379, DOI 10.1126/science.1164441	18	10	10	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					962	963		10.1126/science.1180725	http://dx.doi.org/10.1126/science.1180725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	556XE	20167773	Green Published, Green Accepted			2022-12-28	WOS:000274625800025
J	Morf, J; Schibler, U				Morf, Joerg; Schibler, Ueli			Circadian Cell-Cycle Progression: Cracking Open the Gate	CELL			English	Editorial Material							CYANOBACTERIA; DIVISION		[Morf, Joerg; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Morf, Joerg; Schibler, Ueli] NCCR Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Morf, J (corresponding author), Univ Geneva, Dept Mol Biol, Sci 3 30, CH-1211 Geneva 4, Switzerland.	joerg.morf@unige.ch; ueli.schibler@unige.ch		Morf, Jorg/0000-0002-0485-3380				Chen Z, 2007, CELL CYCLE, V6, P2906, DOI 10.4161/cc.6.23.5041; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023	5	3	4	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					458	459		10.1016/j.cell.2010.02.002	http://dx.doi.org/10.1016/j.cell.2010.02.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178739	Bronze			2022-12-28	WOS:000274668400010
J	Olsen, SK; Capili, AD; Lu, XQ; Tan, DS; Lima, CD				Olsen, Shaun K.; Capili, Allan D.; Lu, Xuequan; Tan, Derek S.; Lima, Christopher D.			Active site remodelling accompanies thioester bond formation in the SUMO E1	NATURE			English	Article							UBIQUITIN-ACTIVATING ENZYME; MECHANISTIC INSIGHTS; PROTEIN MODIFICATION	E1 enzymes activate ubiquitin (Ub) and ubiquitin-like (Ubl) proteins in two steps by carboxy-terminal adenylation and thioester bond formation to a conserved catalytic cysteine in the E1 Cys domain. The structural basis for these intermediates remains unknown. Here we report crystal structures for human SUMO E1 in complex with SUMO adenylate and tetrahedral intermediate analogues at 2.45 and 2.6 angstrom, respectively. These structures show that side chain contacts to ATP.Mg are released after adenylation to facilitate a 130 degree rotation of the Cys domain during thioester bond formation that is accompanied by remodelling of key structural elements including the helix that contains the E1 catalytic cysteine, the crossover and re-entry loops, and refolding of two helices that are required for adenylation. These changes displace side chains required for adenylation with side chains required for thioester bond formation. Mutational and biochemical analyses indicate these mechanisms are conserved in other E1s.	[Lu, Xuequan; Tan, Derek S.] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Olsen, Shaun K.; Capili, Allan D.; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Tan, DS (corresponding author), Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA.	tand@mskcc.org; limac@mskcc.org		Lima, Christopher/0000-0002-9163-6092; Olsen, Shaun/0000-0002-1265-7101	NCRR at the NIH [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH [R01 AI068038, R01 GM065872, F32 GM075695]; NYSTAR Watson Investigator Program; Rita Allen Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872, F32GM075695] Funding Source: NIH RePORTER	NCRR at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTAR Watson Investigator Program; Rita Allen Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Armstrong for Ub and Ub E1 clones and N. Takeda for assistance in graphic art preparation. This work is based on research conducted at the NE-CAT beamlines of the Advanced Photon Source, supported by RR-15301 from the NCRR at the NIH. Use of the APS is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. D. S. T. is an Alfred P. Sloan Research Fellow. X. L. and D. S. T. were supported by NIH R01 AI068038 and the NYSTAR Watson Investigator Program. S.K.O., A. D. C. and C. D. L. were supported by NIH R01 GM065872, F32 GM075695 (A. D. C.), and the Rita Allen Foundation (C. D. L.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; DeLano W.L, PYMOL MOL GRAPHICS S; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	33	146	151	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					906	U77		10.1038/nature08765	http://dx.doi.org/10.1038/nature08765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164921	Green Accepted			2022-12-28	WOS:000274582700037
J	Foy, R; Hempel, S; Rubenstein, L; Suttorp, M; Seelig, M; Shanman, R; Shekelle, PG				Foy, Robbie; Hempel, Susanne; Rubenstein, Lisa; Suttorp, Marika; Seelig, Michelle; Shanman, Roberta; Shekelle, Paul G.			Meta-analysis: Effect of Interactive Communication Between Collaborating Primary Care Physicians and Specialists	ANNALS OF INTERNAL MEDICINE			English	Review							DISEASE MANAGEMENT PROGRAM; MENTAL-HEALTH-SERVICES; RANDOMIZED-TRIAL; PSYCHIATRIC-CONSULTATION; GENERAL-PRACTITIONERS; QUALITY IMPROVEMENT; LIAISON PSYCHIATRY; DIABETES CARE; SHARED CARE; DEPRESSION	Background: Whether collaborative care models that enable interactive communication (timely, 2-way exchange of pertinent clinical information directly between primary care and specialist physicians) improve patient outcomes is uncertain. Purpose: To assess the effects of interactive communication between collaborating primary care physicians and key specialists on outcomes for patients receiving ambulatory care. Data Sources: PubMed, PsycInfo, EMBASE, CINAHL, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, and Web of Science through June 2008 and secondary references, with no language restriction. Study Selection: Studies that evaluated the effects of interactive communication between collaborating primary care physicians and specialists on outcomes for patients with diabetes, psychiatric conditions, or cancer. Data Extraction: Contextual, intervention, and outcome data from 23 studies were extracted by one reviewer and checked by another. Study quality was assessed with a 13-item checklist. Disagreement was resolved by consensus. Main outcomes for analysis were selected by reviewers who were blinded to study results. Data Synthesis: Meta-analysis indicated consistent effects across 11 randomized mental health studies (pooled effect size, -0.41 [95% CI, -0.73 to -0.10]), 7 nonrandomized mental health studies (pooled effect size, -0.47 [CI, -0.84 to -0.09]), and 5 nonrandomized diabetes studies (pooled effect size, -0.64 [CI, -0.93 to -0.34]). These findings remained robust to sensitivity analyses. Meta-regression indicated studies that included interventions to enhance the quality of information exchange had larger effects on patient outcomes than those that did not (-0.84 vs. -0.27; P = 0.002). Limitations: Because collaborative interventions were inherently multifaceted, the efficacy of interactive communication by itself cannot be established. Inclusion of study designs with lower internal validity increased risk for bias. No studies involved oncologists. Conclusion: Consistent and clinically important effects suggest a potential role of interactive communication for improving the effectiveness of primary care-specialist collaboration.	[Foy, Robbie] Univ Leeds, Leeds Inst Hlth Sci, Leeds LS2 9LJ, W Yorkshire, England; RAND Hlth Div, So Calif Evidence Based Practice Ctr, Santa Monica, CA USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Grp Hlth Cooperat Puget Sound, Seattle, WA USA	University of Leeds; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Group Health Cooperative	Foy, R (corresponding author), Univ Leeds, Leeds Inst Hlth Sci, Charles Thackrah Bldg,101 Clarendon Rd, Leeds LS2 9LJ, W Yorkshire, England.	r.foy@leeds.ac.uk		Foy, Robbie/0000-0003-0605-7713; Hempel, Susanne/0000-0003-1597-5110	RAND Health's Comprehensive Assessment of Reform Options Initiative; Veterans Affairs Center for the Study of Provider Behavior; Commonwealth Fund; Health Foundation	RAND Health's Comprehensive Assessment of Reform Options Initiative; Veterans Affairs Center for the Study of Provider Behavior; Commonwealth Fund; Health Foundation	RAND Health's Comprehensive Assessment of Reform Options Initiative, the Veterans Affairs Center for the Study of Provider Behavior, The Commonwealth Fund, and the Health Foundation.	Abrahamian H, 2002, J TELEMED TELECARE, V8, P350, DOI 10.1258/135763302320939248; Atlas SJ, 2009, ANN INTERN MED, V150, P325, DOI 10.7326/0003-4819-150-5-200903030-00008; BARR M, 2006, ADV MED HOME PATIENT; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berendsen AJ, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-4; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Bodlund O, 1999, SCAND J PRIM HEALTH, V17, P153; Boon H, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-15; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; Bower P, 2005, BRIT MED J, V330, P839, DOI 10.1136/bmj.330.7495.839; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Campbell MK, 2001, STAT MED, V20, P391, DOI 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z; Carr VJ, 1997, AUST NZ J PSYCHIAT, V31, P714; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chelminski PR, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-3; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Christensen H, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-25; Cochrane Effective Practice and Organisation of Care Review Group, 2002, DAT COLL CHECKL; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Craven MA, 2006, CAN J PSYCHIAT, V51, p7S; Datto CJ, 2003, GEN HOSP PSYCHIAT, V25, P169, DOI 10.1016/S0163-8343(03)00019-7; DATTO CJ, 2003, J CLIN OUTCOMES MANA, V10, P79; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; Davidson KW, 2003, ANN BEHAV MED, V26, P161, DOI 10.1207/S15324796ABM2603_01; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; Dietrich AJ, 2003, J AM BOARD FAM PRACT, V16, P107, DOI 10.3122/jabfm.16.2.107; Donner A, 2002, STAT MED, V21, P2971, DOI 10.1002/sim.1301; Doze S, 1999, J TELEMED TELECARE, V5, P38, DOI 10.1258/1357633991932379; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FELKER B, 1998, MED PSYCHIAT, V1, P36; Felker BL, 2004, PSYCHIAT SERV, V55, P442, DOI 10.1176/appi.ps.55.4.442; FERGUSON B, 1992, BRIT J PSYCHIAT, V160, P493, DOI 10.1192/bjp.160.4.493; Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; Forrest CB, 2003, BRIT MED J, V326, P692, DOI 10.1136/bmj.326.7391.692; Fraser Cynthia, 2006, BMC Med Res Methodol, V6, P41, DOI 10.1186/1471-2288-6-41; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gittell JH, 2000, MED CARE, V38, P807, DOI 10.1097/00005650-200008000-00005; Goodman DC, 2008, JAMA-J AM MED ASSOC, V299, P335, DOI 10.1001/jama.299.3.335; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Gunn J, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-88; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; Harris S, 2008, CAN FAM PHYSICIAN, V54, P550; Hedrick SC, 2003, J GEN INTERN MED, V18, P9, DOI 10.1046/j.1525-1497.2003.11109.x; HICKMAN M, 1994, J PUBLIC HEALTH MED, V16, P447, DOI 10.1093/oxfordjournals.pubmed.a043026; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hilty Donald M, 2007, Psychiatry (Edgmont), V4, P58; Hulscher MEJL, 2003, QUAL SAF HEALTH CARE, V12, P40, DOI 10.1136/qhc.12.1.40; Institute of Medicine, 2001, CROSSING QUALITY CHA; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; JACKSON G, 1993, BRIT J PSYCHIAT, V162, P375, DOI 10.1192/bjp.162.3.375; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kates N, 1997, GEN HOSP PSYCHIAT, V19, P324, DOI 10.1016/S0163-8343(97)00051-0; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P86, DOI 10.1016/0163-8343(92)90033-7; Katon W, 2002, J GEN INTERN MED, V17, P741, DOI 10.1046/j.1525-1497.2002.11051.x; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Katzelnick DJ, 2000, ARCH FAM MED, V9, P345, DOI 10.1001/archfami.9.4.345; Kennedy C, 2003, J TELEMED TELECARE, V9, P12, DOI 10.1258/135763303321159639; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; King EB, 2006, DIABETES EDUCATOR, V32, P723, DOI 10.1177/0145721706292599; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; KISKER CT, 1980, PEDIATRICS, V66, P900; LONGEST BB, 1999, HLTH CARE MANAGEMENT, P210; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Maislos M, 2002, ACTA DIABETOL, V39, P49, DOI 10.1007/s005920200012; McCulloch D K, 1998, Eff Clin Pract, V1, P12; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McKechnie A A, 1981, J R Coll Gen Pract, V31, P611; MOODY G, 2008, STATES ACTION BIMONT, P13; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Pincus HA, 2001, GEN HOSP PSYCHIAT, V23, P311, DOI 10.1016/S0163-8343(01)00165-7; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHADISH WRJ, 2002, STAT CONCLUSION VALI, P33; Sharma VK, 2001, INT J SOC PSYCHIATR, V47, P16, DOI 10.1177/002076400104700402; Shekelle P.G., 2006, EVID REP TECHNOL ASS, V132, P1, DOI DOI 10.23970/ahrqepcerta132; Simmons D, 2003, INTERN MED J, V33, P581, DOI 10.1111/j.1445-5994.2003.00491.x; Smit A, 2005, PRIMARY CARE COMMUN, V10, P39, DOI 10.1185/135525705X40382; Smith SM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004910.pub2; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Sutor Bruce, 2007, Minn Med, V90, P39; Sutton A.J., 2000, METHODS METAANALYSIS; THORN PA, 1973, BRIT MED J, V2, P534, DOI 10.1136/bmj.2.5865.534; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TYRER P, 1990, ACTA PSYCHIAT SCAND, V81, P359, DOI 10.1111/j.1600-0447.1990.tb05464.x; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; van der Feltz-Cornelis CM, 2006, PSYCHOTHER PSYCHOSOM, V75, P282, DOI 10.1159/000093949; Wagner E H, 1998, Eff Clin Pract, V1, P2; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; WOOD K, 1995, AUST NZ J PSYCHIAT, V29, P223, DOI 10.1080/00048679509075914; Worrall G, 1999, CAN MED ASSOC J, V161, P37; YANO EM, 1995, ARCH INTERN MED, V155, P1146, DOI 10.1001/archinte.155.11.1146; Younes N, 2008, SOC PSYCH PSYCH EPID, V43, P113, DOI 10.1007/s00127-007-0285-x	97	109	114	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2010	152	4					247	U95		10.7326/0003-4819-152-4-201002160-00010	http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00010			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560AF	20157139				2022-12-28	WOS:000274873300007
J	Dorale, JA; Onac, BP; Fornos, JJ; Gines, J; Gines, A; Tuccimei, P; Peate, DW				Dorale, Jeffrey A.; Onac, Bogdan P.; Fornos, Joan J.; Gines, Joaquin; Gines, Angel; Tuccimei, Paola; Peate, David W.			Sea-Level Highstand 81,000 Years Ago in Mallorca	SCIENCE			English	Article							PLEISTOCENE; ISLAND; STRATIGRAPHY; ISOSTASY; CLIMATE; STAGE-5; BERMUDA; FLORIDA; PERIOD; REEFS	Global sea level and Earth's climate are closely linked. Using speleothem encrustations from coastal caves on the island of Mallorca, we determined that western Mediterranean relative sea level was similar to 1 meter above modern sea level similar to 81,000 years ago during marine isotope stage (MIS) 5a. Although our findings seemingly conflict with the eustatic sea-level curve of far-field sites, they corroborate an alternative view that MIS 5a was at least as ice-free as the present, and they challenge the prevailing view of MIS 5 sea-level history and certain facets of ice-age theory.	[Dorale, Jeffrey A.; Peate, David W.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; [Onac, Bogdan P.] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Onac, Bogdan P.] Univ Babes Bolyai, Emil Racovita Inst Speleol Cluj, Dept Geol, R-3400 Cluj Napoca, Romania; [Fornos, Joan J.; Gines, Joaquin; Gines, Angel] Univ Illes Balears, Dept Ciencies Terra, Palma de Mallorca 07122, Spain; [Tuccimei, Paola] Univ Roma III, Dipartimento Sci Geol, I-00146 Rome, Italy	University of Iowa; State University System of Florida; University of South Florida; Babes Bolyai University from Cluj; Emil Racovita Institute of Speleology; Universitat de les Illes Balears; Roma Tre University	Dorale, JA (corresponding author), Univ Iowa, Dept Geosci, 121 Trowbridge Hall, Iowa City, IA 52242 USA.	jeffrey-dorale@uiowa.edu; bonac@cas.usf.edu	Peate, David W/A-1248-2007; Fornos, Joan J/E-1673-2012; Onac, Bogdan P./F-9061-2010	Peate, David W/0000-0002-7813-5824; Fornos, Joan J/0000-0002-3131-1085; Onac, Bogdan P./0000-0003-2332-6858	NSF [OISE-0826667]; University of South Florida [R058889]; Spanish Government [CGL2006-11242-C03-01, CGL2009-07392]	NSF(National Science Foundation (NSF)); University of South Florida; Spanish Government(Spanish GovernmentEuropean Commission)	This material is based on work supported by NSF (grant OISE-0826667 to B.P.O. and J.A.D.), the University of South Florida (grant R058889) to B.P.O., and the MICINN-FEDER Projects CGL2006-11242-C03-01 and CGL2009-07392 of the Spanish Government to J.J.F. We thank L. Vacher, V. Polyak, and E. A. Bettis III for stimulating discussions, three anonymous reviewers for insightful criticism that considerably improved the manuscript, and F. Gracia and K. Downey for some of the pictures.	BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Coyne MK, 2007, QUATERNARY SCI REV, V26, P536, DOI 10.1016/j.quascirev.2006.06.013; DODGE RE, 1983, SCIENCE, V219, P1423, DOI 10.1126/science.219.4591.1423; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; GINES J, 1995, ENDINS, V20, P71; Hearty PJ, 1998, QUATERNARY SCI REV, V17, P333, DOI 10.1016/S0277-3791(98)00046-8; HEARTY PJ, 1987, QUATERNARY SCI REV, V6, P245, DOI 10.1016/0277-3791(87)90007-2; Hodge EJ, 2008, J QUATERNARY SCI, V23, P713, DOI 10.1002/jqs.1198; Lambeck K, 2004, EARTH PLANET SC LETT, V224, P563, DOI 10.1016/j.epsl.2004.05.031; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; LI WX, 1989, NATURE, V339, P534, DOI 10.1038/339534a0; Ludwig KR, 1996, GEOLOGY, V24, P211, DOI 10.1130/0091-7613(1996)024<0211:SLRAKF>2.3.CO;2; Miller GH, 1999, QUATERNARY SCI REV, V18, P789, DOI 10.1016/S0277-3791(98)00075-4; Mitrovica JX, 2002, QUATERNARY SCI REV, V21, P2179, DOI 10.1016/S0277-3791(02)00080-X; Muhs DR, 2004, DEV QUA SCI, V1, P147; Muhs DR, 2002, QUATERNARY SCI REV, V21, P1355, DOI 10.1016/S0277-3791(01)00114-7; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pirazzoli PA, 2005, QUATERNARY SCI REV, V24, P1989, DOI 10.1016/j.quascirev.2004.06.026; Potter EK, 2004, EARTH PLANET SC LETT, V217, P171, DOI 10.1016/S0012-821X(03)00587-9; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Stocchi P, 2007, ANN GEOPHYS-ITALY, V50, P741; Toggweiler JR, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2006PA001405; Toscano MA, 1999, QUATERNARY SCI REV, V18, P753, DOI 10.1016/S0277-3791(98)00077-8; Tuccimei P, 2006, Z GEOMORPHOL, V50, P1; TUCCIMEI P, 2010, EARTH SURF PROCESS L, V35; VACHER HL, 1989, QUATERNARY SCI REV, V8, P159, DOI 10.1016/0277-3791(89)90004-8; Wehmiller JF, 2004, QUATERN INT, V120, P3, DOI 10.1016/j.quaint.2004.01.002	29	121	123	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					860	863		10.1126/science.1181725	http://dx.doi.org/10.1126/science.1181725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150501				2022-12-28	WOS:000274408300060
J	Tester, M; Langridge, P				Tester, Mark; Langridge, Peter			Breeding Technologies to Increase Crop Production in a Changing World	SCIENCE			English	Review							SALINITY TOLERANCE; SELECTION; DROUGHT; YIELD; IMPROVEMENT; BARLEY	To feed the several billion people living on this planet, the production of high-quality food must increase with reduced inputs, but this accomplishment will be particularly challenging in the face of global environmental change. Plant breeders need to focus on traits with the greatest potential to increase yield. Hence, new technologies must be developed to accelerate breeding through improving genotyping and phenotyping methods and by increasing the available genetic diversity in breeding germplasm. The most gain will come from delivering these technologies in developing countries, but the technologies will have to be economically accessible and readily disseminated. Crop improvement through breeding brings immense value relative to investment and offers an effective approach to improving food security.	[Tester, Mark; Langridge, Peter] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA 5064, Australia	University of Adelaide	Tester, M (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA 5064, Australia.	mark.tester@acpfg.com.au	Tester, Mark/J-2368-2017; Langridge, Peter/G-5864-2010	Tester, Mark/0000-0002-5085-8801; Langridge, Peter/0000-0001-9494-400X	Australian Research Council; Grains Research Development Corporation; South Australian State Government; University of Adelaide	Australian Research Council(Australian Research Council); Grains Research Development Corporation(Grains R&D Corp); South Australian State Government; University of Adelaide	We thank C. Morris for her helpful comments on the manuscript. Support for our research programs from the Australian Research Council, Grains Research Development Corporation, South Australian State Government, and the University of Adelaide is gratefully acknowledged. P. L. is the chief executive officer of the Australian Centre for Plant Functional Genomics.	Alston J.M., 2000, META ANAL RATES RETU; Alston JM, 2009, SCIENCE, V325, P1209, DOI 10.1126/science.1170451; Baenziger PS, 2006, CROP SCI, V46, P2230, DOI 10.2135/cropsci2005.11.0404gas; Bernardo R, 2006, CROP SCI, V46, P614, DOI 10.2135/cropsci2005.05-0088; Chapman SC, 2008, EUPHYTICA, V161, P195, DOI 10.1007/s10681-007-9623-z; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Darbani Behrooz, 2007, Biotechnology Journal, V2, P83, DOI 10.1002/biot.200600182; Eathington SR, 2007, CROP SCI, V47, pS154, DOI 10.2135/cropsci2007.04.0015IPBS; FAO, 2006, WORLD AGR 2030 2050; FAO, 2008, FAO LAND PLANT NUTR; FAO (Food and Agriculture Organization of the United Nations), 2009, DECL WORLD SUMM FOOD; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Finkel E, 2009, SCIENCE, V325, P380, DOI 10.1126/science.325_380; FISCHER RA, 2010, CROP SCI IN PRESS, V50; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Mayer JE, 2008, CURR OPIN PLANT BIOL, V11, P166, DOI 10.1016/j.pbi.2008.01.007; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; OECD-FAO, 2009, OECD FAO AGR OUTL 20; Peoples M. B., 1995, NITROGEN FERTILIZATI, P505; Rabinovich S., 1997, WHEAT PROSPECTS GLOB, V6, P401, DOI [10.1007/978-94-011-4896-2_55, DOI 10.1007/978-94-011-4896-2_55]; Reynolds M, 2009, ANN APPL BIOL, V155, P309, DOI 10.1111/j.1744-7348.2009.00351.x; RICHARDS RA, 1992, PLANT SOIL, V146, P89, DOI 10.1007/BF00012000; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Siles MM, 2004, CROP SCI, V44, P1960, DOI 10.2135/cropsci2004.1960; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Wong CK, 2008, THEOR APPL GENET, V116, P815, DOI 10.1007/s00122-008-0715-5; Wu XJ, 2009, AGRON J, V101, P688, DOI 10.2134/agronj2008.0128f	33	1302	1395	25	755	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					818	822		10.1126/science.1183700	http://dx.doi.org/10.1126/science.1183700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150489				2022-12-28	WOS:000274408300046
J	Chowdhury, BA; Dal Pan, G				Chowdhury, Badrul A.; Dal Pan, Gerald			The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISKS		[Chowdhury, Badrul A.] US FDA, Div Pulm & Allergy Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Dal Pan, Gerald] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, Div Pulm & Allergy Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							*DAILYMED, 2010, PROF DRUG LAB INF; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; Kramer JM, 2009, NEW ENGL J MED, V360, P1592, DOI 10.1056/NEJMp0810561; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; National Asthma Education and Prevention Program National Heart Lung and Blood Institute, 2007, NIH PUBL	5	180	190	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1169	1171		10.1056/NEJMp1002074	http://dx.doi.org/10.1056/NEJMp1002074			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20181964				2022-12-28	WOS:000276239500004
J	Tobin, VA; Hashimoto, H; Wacker, DW; Takayanagi, Y; Langnaese, K; Caquineau, C; Noack, J; Landgraf, R; Onaka, T; Leng, G; Meddle, SL; Engelmann, M; Ludwig, M				Tobin, Vicky A.; Hashimoto, Hirofumi; Wacker, Douglas W.; Takayanagi, Yuki; Langnaese, Kristina; Caquineau, Celine; Noack, Julia; Landgraf, Rainer; Onaka, Tatsushi; Leng, Gareth; Meddle, Simone L.; Engelmann, Mario; Ludwig, Mike			An intrinsic vasopressin system in the olfactory bulb is involved in social recognition	NATURE			English	Article							HYPOTHALAMIC MAGNOCELLULAR VASOPRESSIN; NEURONS IN-VIVO; MITRAL CELLS; OXYTOCIN; RECEPTOR; RELEASE; EXPRESSION; RESPONSES; ABLATION; NUCLEUS	Many peptides, when released as chemical messengers within the brain, have powerful influences on complex behaviours. Most strikingly, vasopressin and oxytocin, once thought of as circulating hormones whose actions were confined to peripheral organs, are now known to be released in the brain, where they have fundamentally important roles in social behaviours(1). In humans, disruptions of these peptide systems have been linked to several neurobehavioural disorders, including Prader-Willi syndrome, affective disorders and obsessive-compulsive disorder, and polymorphisms of V1a vasopressin receptor have been linked to autism(2,3). Here we report that the rat olfactory bulb contains a large population of interneurons which express vasopressin, that blocking the actions of vasopressin in the olfactory bulb impairs the social recognition abilities of rats and that vasopressin agonists and antagonists can modulate the processing of information by olfactory bulb neurons. The findings indicate that social information is processed in part by a vasopressin system intrinsic to the olfactory system.	[Tobin, Vicky A.; Hashimoto, Hirofumi; Wacker, Douglas W.; Caquineau, Celine; Leng, Gareth; Meddle, Simone L.; Ludwig, Mike] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Takayanagi, Yuki; Onaka, Tatsushi] Jichi Med Univ, Dept Physiol, Shimotsuke, Tochigi 3290498, Japan; [Langnaese, Kristina; Noack, Julia; Engelmann, Mario] Otto VonGuericke Univ Magdegurg, Inst Biochem & Cell Biol, D-39120 Magdeburg, Germany; [Noack, Julia] Otto VonGuericke Univ Magdegurg, Ctr Cellular Imaging & Innovat Dis Models, D-39120 Magdeburg, Germany; [Landgraf, Rainer] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Meddle, Simone L.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Meddle, Simone L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland	University of Edinburgh; Jichi Medical University; Otto von Guericke University; Otto von Guericke University; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Ludwig, M (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.ludwig@ed.ac.uk	Leng, Gareth/C-6688-2011; Takayanagi, Yuki/S-7998-2018; Onaka, Tatsushi/I-7115-2012; Meddle, Simone Louise/C-7748-2013	Leng, Gareth/0000-0002-2388-8466; Takayanagi, Yuki/0000-0003-3788-8229; Meddle, Simone Louise/0000-0002-5629-1332; Onaka, Tatsushi/0000-0001-5666-9035; Hashimoto, Hirofumi/0000-0003-1575-836X	Biotechnology and Biological Sciences Research Council; Japan Ministry of Education, Culture, Sports, Science and Technology; Deutsche Forschungsgemeinschaft; German Academic Exchange Service/Academic Research Collaboration; Japan Society for the Promotion of Science; Biotechnology and Biological Sciences Research Council [BB/F019009/1] Funding Source: researchfish; Medical Research Council [G0700176] Funding Source: researchfish; BBSRC [BB/F019009/1] Funding Source: UKRI; MRC [G0700176] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service/Academic Research Collaboration(Deutscher Akademischer Austausch Dienst (DAAD)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank V. Bishop, T. Gillespie, K. Richter and R. Murau for technical support; E. Mohr for vectors containing the total vasopressin sequence and a partial sequence; H. Gainer for vasopressin and oxytocin antibodies; Y. Ueta for the vasopressin-eGFP transgenic rats; K. Kohno and E. Kobayashi for the complementary DNA for the diphtheria toxin receptor and support for the production of transgenic rats, respectively; and D. Murphy for the DNA for the vasopressin promoter. This work was supported by grants from the Biotechnology and Biological Sciences Research Council ( M. L., S. L. M.), the Japan Ministry of Education, Culture, Sports, Science and Technology (T.O., Y. T.), the Deutsche Forschungsgemeinschaft ( M. E., J.N.) and the German Academic Exchange Service/Academic Research Collaboration ( M. L., M. E.), and by a fellowship from the Japan Society for the Promotion of Science awarded to H. H.	Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chen HY, 2005, J NEUROCYTOL, V34, P37, DOI 10.1007/s11068-005-5046-8; Debarbieux F, 2003, J NEUROSCI, V23, P5553; DeVito LM, 2009, J NEUROSCI, V29, P2676, DOI 10.1523/JNEUROSCI.5488-08.2009; Dluzen DE, 1998, PEPTIDES, V19, P999, DOI 10.1016/S0196-9781(98)00047-3; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; ENGELMANN M, 1995, PHYSIOL BEHAV, V58, P315, DOI 10.1016/0031-9384(95)00053-L; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Frank E, 2008, EUR J PHARMACOL, V583, P226, DOI 10.1016/j.ejphar.2007.11.063; Furukawa N, 2006, J BIOCHEM, V140, P831, DOI 10.1093/jb/mvj216; Gouzenes L, 1998, J NEUROSCI, V18, P1879; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; Hassan A, 2005, PHYSIOL GENOMICS, V21, P382, DOI 10.1152/physiolgenomics.00147.2004; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Ikeda K, 2003, J NEUROSCI, V23, P4667; Jiang MR, 1996, J NEUROSCI, V16, P6319; Kosaka Katsuko, 2005, Anatomical Science International, V80, P80, DOI 10.1111/j.1447-073x.2005.00092.x; LEVY F, 1995, BRAIN RES, V669, P197, DOI 10.1016/0006-8993(94)01236-B; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Ludwig M, 1997, EUR J NEUROSCI, V9, P2532, DOI 10.1111/j.1460-9568.1997.tb01682.x; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Murphy D, 2003, J NEUROENDOCRINOL, V15, P109, DOI 10.1046/j.1365-2826.2003.00964.x; Orlando GF, 2008, STRESS, V11, P42, DOI 10.1080/10253890701449867; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Sabatier N, 2004, J PHYSIOL-LONDON, V558, P161, DOI 10.1113/jphysiol.2004.063982; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tobin VA, 2008, ENDOCRINOLOGY, V149, P6136, DOI 10.1210/en.2008-0178; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; YAMAMURA Y, 1991, SCIENCE, V252, P572, DOI 10.1126/science.1850553	38	156	160	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					413	U110		10.1038/nature08826	http://dx.doi.org/10.1038/nature08826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20182426	Green Accepted			2022-12-28	WOS:000275657100047
J	Wilensky, GR				Wilensky, Gail R.			Health Care Reform -- Where Do We Go from Here?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Project HOPE, Bethesda, MD USA		Wilensky, GR (corresponding author), Project HOPE, Bethesda, MD USA.							*ABC NEWS POLL UN, HLTH CAR DEB PUBL AT; Iglehart JK, 2009, NEW ENGL J MED, V361, P1038, DOI 10.1056/NEJMp0907415; Wilensky GR, 2009, NEW ENGL J MED, V360, P653, DOI 10.1056/NEJMp0808003	3	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMp1002211	http://dx.doi.org/10.1056/NEJMp1002211			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20200364				2022-12-28	WOS:000275650400004
J	Lee, JH; Budanov, AV; Park, EJ; Birse, R; Kim, TE; Perkins, GA; Ocorr, K; Ellisman, MH; Bodmer, R; Bier, E; Karin, M				Lee, Jun Hee; Budanov, Andrei V.; Park, Eek Joong; Birse, Ryan; Kim, Teddy E.; Perkins, Guy A.; Ocorr, Karen; Ellisman, Mark H.; Bodmer, Rolf; Bier, Ethan; Karin, Michael			Sestrin as a Feedback Inhibitor of TOR That Prevents Age-Related Pathologies	SCIENCE			English	Article							EXTENDS LIFE-SPAN; DROSOPHILA; AUTOPHAGY; GROWTH; STRESS; TARGET; MTOR; MITOCHONDRIA; RESTRICTION; CONTRIBUTES	Sestrins are conserved proteins that accumulate in cells exposed to stress, potentiate adenosine monophosphate-activated protein kinase (AMPK), and inhibit activation of target of rapamycin (TOR). We show that the abundance of Drosophila sestrin (dSesn) is increased upon chronic TOR activation through accumulation of reactive oxygen species that cause activation of c-Jun amino-terminal kinase and transcription factor Forkhead box O (FoxO). Loss of dSesn resulted in age-associated pathologies including triglyceride accumulation, mitochondrial dysfunction, muscle degeneration, and cardiac malfunction, which were prevented by pharmacological activation of AMPK or inhibition of TOR. Hence, dSesn appears to be a negative feedback regulator of TOR that integrates metabolic and stress inputs and prevents pathologies caused by chronic TOR activation that may result from diminished autophagic clearance of damaged mitochondria, protein aggregates, or lipids.	[Kim, Teddy E.; Bier, Ethan] UCSD, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] UCSD, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] UCSD, Dept Neurosci, La Jolla, CA 92093 USA; [Lee, Jun Hee; Budanov, Andrei V.; Park, Eek Joong; Karin, Michael] UCSD, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Lee, Jun Hee; Budanov, Andrei V.; Park, Eek Joong; Karin, Michael] UCSD, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA; [Birse, Ryan; Ocorr, Karen; Bodmer, Rolf] Sanford Burnham Med Res Inst, Neurosci Aging & Stem Cell Res Ctr, Dev & Aging Program, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Bier, E (corresponding author), UCSD, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	ebier@ucsd.edu; karinoffice@ucsd.edu	Budanov, Andrei V/HGD-5487-2022	Budanov, Andrei V/0000-0002-7943-1000; Lee, Jun Hee/0000-0002-2200-6011; Perkins, Guy/0000-0002-1834-6646	NIH; Superfund Research Program [CA118165, ES006376, P42-ES010337, DK082080, P41RR004050, P30-CA23100, NS29870, AI070654]; NSF [IOS-074462]; Korea Research Foundation [KRF-2007-357-C00096]; Human Frontier Science Program Organization [LT00653/2008-L]; Natural Sciences and Engineering Research Council of Canada; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA118165] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070654, R01AI070654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK082080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R01ES006376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029870, R56NS029870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Superfund Research Program; NSF(National Science Foundation (NSF)); Korea Research Foundation(National Research Foundation of Korea); Human Frontier Science Program Organization(Human Frontier Science Program); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. McGinnis (UCSD), M. Tatar ( Brown Univ.), S. Oldham (Burnham Institute), U. Banerjee ( Univ. of California Los Angeles), I. K. Hariharan ( Univ. of California Berkeley), J. Brenman ( Univ. of North Carolina), O. Puig ( Merck), C. Wilson ( Oxford Univ.), L. Jones ( Salk Institute), M. Miura ( Univ. of Tokyo), Developmental Studies Hybridoma Bank ( Iowa), Drosophila Genomics Resource Center (DGRC) ( Indiana), DGRC ( Japan), Vienna Drosophila RNAi Center ( Austria), Cell Signaling Inc., Santa Cruz Biotechnology, and Bloomington and Harvard stock centers for fly strains, reagents, and access to lab equipment. We acknowledge help from J. Kim, M. Yoon, and R. Anderson in electron microscopy analysis; V. Temkin in ROS analysis; and M. Smelkinson, O. Cook, and A. Guichard in histochemistry. We thank M. Kim for suggestions and constructive criticism. This work was supported by grants and fellowships from the NIH and Superfund Research Program (CA118165, ES006376, and P42-ES010337 to M. K.; DK082080 to A. V. B.; P41RR004050 and P30-CA23100 to M. H. E.; and NS29870 and AI070654 to E. B.), NSF (IOS-074462 to E. B.), Korea Research Foundation (KRF-2007-357-C00096 to J. H. L.), Human Frontier Science Program Organization (LT00653/2008-L to J. H. L), and the Natural Sciences and Engineering Research Council of Canada ( to E. J. P.). M. K. is an American Cancer Society professor.	Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Harvey KF, 2008, J CELL BIOL, V180, P691, DOI 10.1083/jcb.200710100; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; KAPAHI P, 2004, SCI AGING KNOWLEDGE, pPE34; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; TAKAHASHI A, 1970, J GERONTOL, V25, P222, DOI 10.1093/geronj/25.3.222; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wessells R, 2009, AGING CELL, V8, P542, DOI 10.1111/j.1474-9726.2009.00504.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	31	421	444	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1223	1228		10.1126/science.1182228	http://dx.doi.org/10.1126/science.1182228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203043	Green Accepted			2022-12-28	WOS:000275162100030
J	Tripp, HJ; Bench, SR; Turk, KA; Foster, RA; Desany, BA; Niazi, F; Affourtit, JP; Zehr, JP				Tripp, H. James; Bench, Shellie R.; Turk, Kendra A.; Foster, Rachel A.; Desany, Brian A.; Niazi, Faheem; Affourtit, Jason P.; Zehr, Jonathan P.			Metabolic streamlining in an open-ocean nitrogen-fixing cyanobacterium	NATURE			English	Article							SUBTROPICAL NORTH PACIFIC; BLUE-GREEN-ALGAE; UNICELLULAR CYANOBACTERIA; N-2-FIXING CYANOBACTERIA; DIVERSITY; FIXATION; DNA; EXPRESSION; GENOMES; SYSTEM	Nitrogen (N-2)-fixing marine cyanobacteria are an important source of fixed inorganic nitrogen that supports oceanic primary productivity and carbon dioxide removal from the atmosphere(1). A globally distributed(2,3), periodically abundant(4) N-2-fixing(5) marine cyanobacterium, UCYN-A, was recently found to lack the oxygen-producing photosystem II complex(6) of the photosynthetic apparatus, indicating a novel metabolism, but remains uncultivated. Here we show, from metabolic reconstructions inferred from the assembly of the complete UCYN-A genome using massively parallel pyro-sequencing of paired-end reads, that UCYN-A has a photofermentative metabolism and is dependent on other organisms for essential compounds. We found that UCYN-A lacks a number of major metabolic pathways including the tricarboxylic acid cycle, but retains sufficient electron transport capacity to generate energy and reducing power from light. Unexpectedly, UCYN-A has a reduced genome (1.44 megabases) that is structurally similar to many chloroplasts and some bacteria, in that it contains inverted repeats of ribosomal RNA operons(7). The lack of biosynthetic pathways for several amino acids and purines suggests that this organism depends on other organisms, either in close association or in symbiosis, for critical nutrients. However, size fractionation experiments using natural populations have so far not provided evidence of a symbiotic association with another microorganism. The UCYN-A cyanobacterium is a paradox in evolution and adaptation to the marine environment, and is an example of the tight metabolic coupling between microorganisms in oligotrophic oceanic microbial communities.	[Tripp, H. James; Bench, Shellie R.; Turk, Kendra A.; Foster, Rachel A.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Desany, Brian A.; Niazi, Faheem; Affourtit, Jason P.] Roche Co, Branford, CT 06405 USA	University of California System; University of California Santa Cruz; Roche Holding	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, 1156 High St, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Zehr, Jonathan P/B-3513-2014; Bench, Shellie R/E-7679-2010	Zehr, Jonathan P/0000-0002-5691-5408; Foster, Rachel/0000-0002-8696-1835	Gordon and Betty Moore Foundation; US National Science Foundation (NSF); NSF Center for Microbial Oceanography: Research and Education	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Center for Microbial Oceanography: Research and Education(National Science Foundation (NSF))	This work was supported by the Gordon and Betty Moore Foundation, the US National Science Foundation (NSF) and the NSF Center for Microbial Oceanography: Research and Education. 454 Life Sciences, a Roche Company, provided sequencing services. Flow cytometry was done by B. Carter in the Microbial Environmental Genomics Applications: Modelling, Experimentation, and Remote Sensing (MEGAMER) facility of the University of California, Santa Cruz. We thank I. Hewson for sample collection and preliminary metagenomic analysis.	BELKIN S, 1978, ARCH MICROBIOL, V116, P109, DOI 10.1007/BF00408741; Biegala IC, 2008, AQUAT MICROB ECOL, V51, P45, DOI 10.3354/ame01185; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; Falcon LI, 2002, APPL ENVIRON MICROB, V68, P5760, DOI 10.1128/AEM.68.11.5760-5764.2002; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Helm RA, 2003, GENETICS, V165, P951; Janson S, 2002, CYANOBACTERIA IN SYMBIOSIS, P1; Kaneko T, 1996, PLANT MOL BIOL, V31, P193, DOI 10.1007/BF00020621; KIMURA M, 1986, PHILOS T ROY SOC B, V312, P343, DOI 10.1098/rstb.1986.0012; Kotani H, 1995, DNA Res, V2, P133, DOI 10.1093/dnares/2.3.133; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Misra HS, 2003, J PLANT PHYSIOL, V160, P33, DOI 10.1078/0176-1617-00846; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; PALMER JD, 1983, NATURE, V301, P92, DOI 10.1038/301092a0; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; SMITH AJ, 1967, J BACTERIOL, V94, P972, DOI 10.1128/JB.94.4.972-983.1967; Thauer RK, 2007, SCIENCE, V318, P1732, DOI 10.1126/science.1152209; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Urbach E, 1998, LIMNOL OCEANOGR, V43, P1615, DOI 10.4319/lo.1998.43.7.1615; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Winkler M, 2002, INT J HYDROGEN ENERG, V27, P1431, DOI 10.1016/S0360-3199(02)00095-2; Wunschiers R, 2001, BBA-BIOENERGETICS, V1503, P271, DOI 10.1016/S0005-2728(00)00204-8; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	30	210	216	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					90	94		10.1038/nature08786	http://dx.doi.org/10.1038/nature08786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20173737				2022-12-28	WOS:000275117500039
J	Punglia, RS; Saito, AM; Neville, BA; Earle, CC; Weeks, JC				Punglia, Rinaa S.; Saito, Akiko M.; Neville, Bridget A.; Earle, Craig C.; Weeks, Jane C.			Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RADIATION-THERAPY; CONSERVATIVE SURGERY; COMORBIDITY INDEX; OUTCOMES; TIME; SURVIVAL; DELAY	Objectives To determine if the length of interval between breast conserving surgery and start of radiotherapy affects local recurrence and to identify factors that might be associated with delay in older women with breast cancer. Design Retrospective cohort analysis with Cox proportional hazards models to study the association between time to radiotherapy and local recurrence, and propensity score and instrumental variable analyses to confirm findings. Logistic regression investigated factors associated with later start of radiotherapy. Setting Linked database ( Surveillance, Epidemiology, and End Results Program-Medicare) in the United States Participants 18 050 women aged over 65 with stage 0-II breast cancer diagnosed in 1991-2002 who received breast conserving surgery and radiotherapy but not chemotherapy. Main outcome measure Local recurrence. Results Median time from surgery to start of radiotherapy was 34 days, with 29.9% (n=5389) of women starting radiotherapy after six weeks. Just over 4% (n=734) of the cohort experienced a local recurrence. After adjustment for clinical and sociodemographic factors, intervals over six weeks were associated with increased likelihood of local recurrence (hazard ratio 1.19, 95% confidence interval 1.01 to 1.39, P=0.033). When the interval was modelled continuously ( assessing accumulation of risk by day), the effect was statistically stronger ( hazard ratio 1.005 per day, 1.002 to 1.008, P=0.004). Propensity score and instrumental variable analysis confirmed these findings. Instrumental variable analysis showed that intervals over six weeks were associated with a 0.96% increase in recurrence at five years (P=0.026). In multivariable analysis, starting radiotherapy after six weeks was significantly associated with positive nodes, comorbidity, history of low income, Hispanic ethnicity, non-white race, later year of diagnosis, and residence outside the southern states of the US. Conclusions There is a continuous relation between the interval from breast conserving surgery to radiotherapy and local recurrence in older women with breast cancer, suggesting that starting radiotherapy as soon as possible could minimise the risk of local recurrence. There are considerable disparities in time to starting radiotherapy after breast conserving surgery. Regions of the US known to have increased rates of breast conserving surgery had longer intervals before radiotherapy, suggesting limitations in capacity. Given the known negative impact of local recurrence on survival, mechanisms to ameliorate disparities and policies regarding waiting times for treatment might be warranted.	[Punglia, Rinaa S.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Neville, Bridget A.; Earle, Craig C.; Weeks, Jane C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Saito, Akiko M.] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Lab Clin Epidemiol & Hlth Serv Res, Aichi, Japan; [Earle, Craig C.] Inst Clin Evaluat Sci, Toronto, ON, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Nagoya Medical Center; University of Toronto	Punglia, RS (corresponding author), Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.	rpunglia@lroc.harvard.edu			National Institutes of Health [1K07 CA118629]; American Society of Clinical Oncology	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology	This study was supported in part by a grant from the National Institutes of Health (1K07 CA118629 to RSP) and from the American Society of Clinical Oncology (Career Development Award to RSP). It was first presented in part at the annual meeting of the American Society of Clinical Oncology, June 2008.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; *AHA, 2000, HOSP STAT; BallardBarbash R, 1996, JNCI-J NATL CANCER I, V88, P716, DOI 10.1093/jnci/88.11.716; Bellon JR, 2005, J CLIN ONCOL, V23, P1934, DOI 10.1200/JCO.2005.04.032; Buchholz TA, 2009, NEW ENGL J MED, V360, P63, DOI 10.1056/NEJMct0803525; Cefaro GA, 2007, BREAST J, V13, P575, DOI 10.1111/j.1524-4741.2007.00511.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dodwell D, 2006, BMJ-BRIT MED J, V332, P107, DOI 10.1136/bmj.332.7533.107; Fisher ER, 2001, CANCER-AM CANCER SOC, V91, P1679, DOI 10.1002/1097-0142(20010415)91:8+<1679::AID-CNCR1183>3.0.CO;2-8; Froud PJ, 2000, INT J RADIAT ONCOL, V46, P363, DOI 10.1016/S0360-3016(99)00412-5; GAGE I, 1995, INT J RADIAT ONCOL, V33, P245, DOI 10.1016/0360-3016(95)02001-R; Gilligan MA, 2002, MED CARE, V40, P181; Hebert-Croteau N, 2004, BREAST CANCER RES TR, V88, P187, DOI 10.1007/s10549-004-0594-7; Hillner BE, 1996, BREAST CANCER RES TR, V40, P75, DOI 10.1007/BF01806004; Huang J, 2003, J CLIN ONCOL, V21, P555, DOI 10.1200/JCO.2003.04.171; Jack RH, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-71; Johnston GM, 2004, CLIN INVEST MED, V27, P142; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lazovich DA, 1999, CANCER-AM CANCER SOC, V86, P628, DOI 10.1002/(SICI)1097-0142(19990815)86:4<628::AID-CNCR11>3.0.CO;2-L; Lim K S H, 2005, Australas Radiol, V49, P485, DOI 10.1111/j.1440-1673.2005.01391.x; Livi L, 2009, INT J RADIAT ONCOL, V73, P365, DOI 10.1016/j.ijrobp.2008.04.066; Mackillop WJ, 2007, RADIOTHER ONCOL, V84, P1, DOI 10.1016/j.radonc.2007.05.006; MACKILLOP WJ, 1994, INT J RADIAT ONCOL, V30, P221, DOI 10.1016/0360-3016(94)90538-X; Mikeljevic JS, 2004, BRIT J CANCER, V90, P1343, DOI 10.1038/sj.bjc.6601693; Morrow M, 2001, J CLIN ONCOL, V19, P2254, DOI 10.1200/JCO.2001.19.8.2254; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Olivotto IA, 2009, J CLIN ONCOL, V27, P16, DOI 10.1200/JCO.2008.18.1891; POTOSKY AL, 1993, MED CARE, V31, P732; Schafer C, 2005, STRAHLENTHER ONKOL, V181, P9, DOI 10.1007/s00066-005-1252-7; Smith BD, 2006, JNCI-J NATL CANCER I, V98, P681, DOI 10.1093/jnci/djj186; Warren JL, 2002, MED CARE, V40, P3; Whelan TJ, 2005, J CLIN ONCOL, V23, P1718, DOI 10.1200/JCO.2005.11.018	35	72	77	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2010	340								c845	10.1136/bmj.c845	http://dx.doi.org/10.1136/bmj.c845			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565FI	20197326	Green Published, hybrid			2022-12-28	WOS:000275274300024
J	Pfisterer, ME; Zellweger, MJ; Gersh, BJ				Pfisterer, Matthias E.; Zellweger, Michael J.; Gersh, Bernard J.			Management of stable coronary artery disease	LANCET			English	Review							OPTIMAL MEDICAL THERAPY; QUALITY-OF-LIFE; CONTROLLED CLINICAL-TRIAL; MYOCARDIAL-INFARCTION; ELDERLY-PATIENTS; RANDOMIZED-TRIAL; FOLLOW-UP; COST-EFFECTIVENESS; PROGNOSTIC VALUE; SILENT ISCHEMIA	Results of two randomised controlled trials for the management of mild-to-moderate chronic stable coronary artery disease (Clinical Outcomes Utilizing Revascularization and Aggressive drug Evaluation [COURAGE] and Bypass Angioplasty Revascularization Investigation type-2 Diabetes [BARI-2D]) have stimulated a vigorous debate about whether an initial strategy of revascularisation or a conservative approach with drugs is most effective. The conclusions of these two trials were clear: for some patients randomly assigned after angiography to revascularisation or pharmacological therapy, rates of death and myocardial infarction did not differ between the two strategies. What remains unresolved is how to generalise these data to patients without angiography, the role of stress testing, and the preferred approach to patients with relevant ischaemia on stress testing. This Review draws attention to the controversial issues in both management approaches, analyses the strengths and limitations of recent trials, and proposes a treatment algorithm that is applicable to daily clinical practice. Findings suggest that the severity of anginal symptoms and the extent of ischaemia in stress testing could help to identify patients who are at increased risk and who might benefit from an early invasive strategy. On the basis of the data and considerations presented, a strategy of initial optimum pharmacological therapy or direct invasive management can be tailored to an individual's circumstances and preferences.	[Pfisterer, Matthias E.; Zellweger, Michael J.] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland; [Gersh, Bernard J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	University of Basel; Mayo Clinic	Pfisterer, ME (corresponding author), Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland.	mpfisterer@uhbs.ch	Zellweger, Michael/AAB-4859-2022					Alderman EL, 1996, NEW ENGL J MED, V335, P217; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bech GJW, 2001, CIRCULATION, V103, P2928, DOI 10.1161/01.CIR.103.24.2928; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brown ML, 2008, NAT CLIN PRACT CARD, V5, P613, DOI 10.1038/ncpcardio1307; Chaitman BR, 2009, CIRCULATION, V120, P2529, DOI 10.1161/CIRCULATIONAHA.109.913111; Chamberlain DA, 1997, LANCET, V350, P461; Claude J, 2004, EUR HEART J, V25, P2195, DOI 10.1016/j.ehj.2004.09.013; Clayton TC, 2005, BMJ-BRIT MED J, V331, P869, DOI 10.1136/bmj.38603.656076.63; Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; FREY RL, 2009, NEW ENGL J MED, V360, P2503; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Hlatky MA, 2009, CIRCULATION, V120, P2550, DOI 10.1161/CIRCULATIONAHA.109.912709; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Jeger RV, 2004, CHEST, V125, P1124, DOI 10.1378/chest.125.3.1124; Jeremias A, 2009, AM J MED, V122, P152, DOI 10.1016/j.amjmed.2008.07.027; Kaiser C, 2004, EUR HEART J, V25, P1036, DOI 10.1016/j.ehj.2004.02.033; Kuster GM, 2003, AM J CARDIOL, V91, P436, DOI 10.1016/S0002-9149(02)03240-X; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; Mahmarian JJ, 2006, J AM COLL CARDIOL, V48, P2458, DOI 10.1016/j.jacc.2006.07.068; Maron DJ, 2009, AM J CARDIOL, V104, P1055, DOI 10.1016/j.amjcard.2009.05.056; O'Rourke RA, 2008, J AM COLL CARDIOL, V52, P905, DOI 10.1016/j.jacc.2008.06.015; Pepine CJ, 1997, J AM COLL CARDIOL, V29, P1483, DOI 10.1016/S0735-1097(97)00083-1; Pfisterer M, 2004, CIRCULATION, V110, P1213, DOI 10.1161/01.CIR.0000140983.69571.BA; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Pfisterer M, 2001, LANCET, V358, P951; Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; SERRUYS PW, 2005, EUROINTERVENTION, V2, P147; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 2003, J NUCL MED, V44, P134; Sianos Georgios, 2005, EuroIntervention, V1, P219; Steg PG, 2004, EUR HEART J, V25, P2187, DOI 10.1016/j.ehj.2004.10.019; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Weintraub WS, 2008, CIRC-CARDIOVASC QUAL, V1, P12, DOI 10.1161/CIRCOUTCOMES.108.798462; Yousef ZR, 2002, J AM COLL CARDIOL, V40, P869, DOI 10.1016/S0735-1097(02)02058-2; Zellweger MJ, 2009, J NUCL CARDIOL, V16, P193, DOI 10.1007/s12350-008-9016-2; Zeymer U, 2003, CIRCULATION, V108, P1324, DOI 10.1161/01.CIR.0000087605.09362.0E	48	41	43	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					763	772		10.1016/S0140-6736(10)60168-7	http://dx.doi.org/10.1016/S0140-6736(10)60168-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20189028				2022-12-28	WOS:000275211200033
J	Schlaepfer, TE; Fins, JJ				Schlaepfer, Thomas E.; Fins, Joseph J.			Deep Brain Stimulation and the Neuroethics of Responsible Publishing When One Is Not Enough	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schlaepfer, Thomas E.] Univ Hosp, Dept Psychiat & Psychotherapy, D-53105 Bonn, Germany; [Schlaepfer, Thomas E.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Schlaepfer, Thomas E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Fins, Joseph J.] Cornell Univ, Weill Med Coll, Div Med Eth, New York, NY 10021 USA; [Fins, Joseph J.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; [Fins, Joseph J.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Fins, Joseph J.] Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA	University of Bonn; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University; Cornell University; Cornell University; Cornell University	Schlaepfer, TE (corresponding author), Univ Hosp, Dept Psychiat, Sigmund Freud Str 25, D-53105 Bonn, Germany.	schlaepf@jhmi.edu	Schlaepfer, Thomas/A-2604-2008	Schlaepfer, Thomas/0000-0003-0612-9692; Fins, Joseph/0000-0002-7221-0053	NCRR NIH HHS [UL1-RR024966] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Agid Y, 2006, J NEURAL TRANSM-SUPP, P409; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Fins JJ, 2003, NEUROSURG CLIN N AM, V14, P303, DOI 10.1016/S1042-3680(02)00118-3; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Kuhn J, 2007, J NEUROL NEUROSUR PS, V78, P1152, DOI 10.1136/jnnp.2006.113092; Racine E, 2007, CAMB Q HEALTHC ETHIC, V16, P312, DOI 10.1017/S0963180107070351; Schlaepfer TE, 2005, LANCET, V366, P1420, DOI 10.1016/S0140-6736(05)67582-4; Synofzik Matthis, 2008, Biotechnology Journal, V3, P1511, DOI 10.1002/biot.200800187; U.S. Department of Health, 1977, FED REGISTER, V42, P26318	10	82	82	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					775	776		10.1001/jama.2010.140	http://dx.doi.org/10.1001/jama.2010.140			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559DD	20179289				2022-12-28	WOS:000274800000031
J	Nienhuis, WA; Stienstra, Y; Thompson, WA; Awuah, PC; Abass, KM; Tuah, W; Awua-Boateng, NY; Ampadu, EO; Siegmund, V; Schouten, JP; Adjei, O; Bretzel, G; van der Werf, TS				Nienhuis, Willemien A.; Stienstra, Ymkje; Thompson, William A.; Awuah, Peter C.; Abass, K. Mohammed; Tuah, Wilson; Awua-Boateng, Nana Yaa; Ampadu, Edwin O.; Siegmund, Vera; Schouten, Jan P.; Adjei, Ohene; Bretzel, Gisela; van der Werf, Tjip S.			Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial	LANCET			English	Article							BURULI ULCER; RISK-FACTORS; DISEASE; GHANA; PCR; DIAGNOSIS; LESIONS; STREPTOMYCIN; SENSITIVITY; COMBINATION	Background Surgical debridement was the standard treatment for Mycobacterium ulcerans infection (Buruli ulcer disease) until WHO issued provisional guidelines in 2004 recommending treatment with antimicrobial drugs (streptomycin and rifampicin) in addition to surgery. These recommendations were based on observational studies and a small pilot study with microbiological endpoints. We investigated the efficacy of two regimens of antimicrobial treatment in early-stage M ulcerans infection. Methods In this parallel, open-label, randomised trial undertaken in two sites in Ghana, patients were eligible for enrolment if they were aged 5 years or older and had early (duration <6 months), limited (cross-sectional diameter <10 cm), M ulcerans infection confirmed by dry-reagent-based PCR. Eligible patients were randomly assigned to receive intramuscular streptomycin (15 mg/kg once daily) and oral rifampicin (10 mg/kg once daily) for 8 weeks (8-week streptomycin group; n=76) or streptomycin and rifampicin for 4 weeks followed by rifampicin and clarithromycin (7.5 mg/kg once daily), both orally, for 4 weeks (4-week streptomycin plus 4-week clarithromycin group; n=75). Randomisation was done by computer-generated minimisation for study site and type of lesion (ulceration or no ulceration). The randomly assigned allocation was sent from a central site by cell-phone text message to the study coordinator. The primary endpoint was lesion heating at 1 year after the start of treatment without lesion recurrence or extensive surgical debridement. Analysis was by intention-to-treat. This trial is registered with ClinicalTrials.gov, number NCT00321178. Findings Four patients were lost to follow-up (8-week streptomycin, one; 4-week streptomycin plus 4-week clarithromycin, three). Since these four participants had healed lesions at their last assessment, they were included in the analysis for the primary endpoint. 73 (96%) participants in the 8-week streptomycin group and 68 (91%) in the 4-week streptomycin plus 4-week clarithromycin group had healed lesions at 1 year (odds ratio 2.49, 95% CI 0.66 to infinity; p=0.16, one-sided Fisher's exact test). No participants had lesion recurrence at I year. Three participants had vestibulotoxic events (8-week streptomycin, one; 4-week streptomycin plus 4-week clarithromycin, two). One participant developed an injection abscess and two participants developed an abscess close to the initial lesion, which was incised and drained (all three participants were in the 4-week streptomycin plus 4-week clarithromycin group). Interpretation Anti mycobacterial treatment for M ulcerans infection is effective in early, limited disease. 4 weeks of streptomycin and rifampicin followed by 4 weeks of rifampicin and clarithromycin has similar efficacy to 8 weeks of streptomycin and rifampicin; however, the number of injections of streptomycin can be reduced by switching to oral clarithromycin after 4 weeks.	[van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Infect Dis Serv, NL-9700 RB Groningen, Netherlands; [van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, TB Unit, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, NL-9700 RB Groningen, Netherlands; [Nienhuis, Willemien A.; Stienstra, Ymkje] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Schouten, Jan P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Thompson, William A.; Abass, K. Mohammed] Agogo Presbyterian Hosp, Agogo, Ghana; [Awuah, Peter C.; Tuah, Wilson] Nkawie Toase Govt Hosp, Nkawie, Ghana; [Awua-Boateng, Nana Yaa; Adjei, Ohene] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Ampadu, Edwin O.] Natl Buruli Ulcer Program, Accra, Ghana; [Siegmund, Vera; Bretzel, Gisela] Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Munich	van der Werf, TS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Infect Dis Serv, POB 30 001, NL-9700 RB Groningen, Netherlands.	t.s.van.der.werf@int.umcg.nl	Stienstra, Ymkje/F-2222-2010	Stienstra, Ymkje/0000-0002-8844-8859; van der Werf, Tjip/0000-0002-4824-1642	European Union [EU FP6 2003-INCO-Dev2-015476]; Buruli Ulcer Groningen Foundation; Netherlands Foundation for Research	European Union(European Commission); Buruli Ulcer Groningen Foundation; Netherlands Foundation for Research	We thank all study participants and health-care workers involved ill the trial. We thank Richard O Phillips for invaluable help during the start of the trial, Cari I Stek for occasional monitoring activities, tire "de Sprung" outpatient pharmacy team, University Medical Centre Groningen for drug supply, Marieke M de Waard and Janneke Huizinga for undertaking masked assessment of digital images of the participants' lesions, William R Faber, Paul D R Johnson, and Alan J Knell for serving on the data safety monitoring board, and Kingsley Asiedu, Global Buruli Ulcer Initiative, WHO, Geneva, Switzerland. This study was supported by the European Union (EU FP6 2003-INCO-Dev2-015476) and Buruli Ulcer Groningen Foundation. YS received a ZonMW AGIKO grant (Netherlands Foundation for Research). WAN is currently at the Department of Internal Medicine, Medical center Leeuwarden, Leeuwarden, Netherlands. YS is currently at Department of Internal Medicine, Division of infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre. University of Amsterdam, Amsterdam, Netherlands.	Amofah G, 1998, TROP DOCT, V28, P81, DOI 10.1177/004947559802800208; Benbow ME, 2008, EMERG INFECT DIS, V14, P1247, DOI 10.3201/eid1408.071503; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; CLANCEY JK, 1961, LANCET, V278, P951; Debacker M, 2005, EMERG INFECT DIS, V11, P584, DOI 10.3201/eid1104.041000; Debacker M, 2006, EMERG INFECT DIS, V12, P1325, DOI 10.3201/eid1209.050598; Espey David K., 2002, International Journal of Infectious Diseases, V6, P60, DOI 10.1016/S1201-9712(02)90138-4; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; Fay MP, 1996, BIOMETRICS, V52, P811, DOI 10.2307/2533044; FAY MP, 2009, INTERVAL WEIGHTED LO; FINKELSTEIN DM, 1986, BIOMETRICS, V42, P845, DOI 10.2307/2530698; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Herbinger KH, 2009, CLIN INFECT DIS, V48, P1055, DOI 10.1086/597398; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; MEYERS WM, 1974, AM J TROP MED HYG, V23, P919, DOI 10.4269/ajtmh.1974.23.919; NIENHUIS WA, 2008, 48 ANN ICAAC IDSA 46; Phillips R, 2005, J CLIN MICROBIOL, V43, P3650, DOI 10.1128/JCM.43.8.3650-3656.2005; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; Portaels F, 1997, J CLIN MICROBIOL, V35, P1097, DOI 10.1128/JCM.35.5.1097-1100.1997; Raghunathan PL, 2005, CLIN INFECT DIS, V40, P1445, DOI 10.1086/429623; REVILL WDL, 1973, LANCET, V2, P873; Rondini S, 2006, J PATHOL, V208, P119, DOI 10.1002/path.1864; Siegmund V, 2005, J CLIN MICROBIOL, V43, P271, DOI 10.1128/JCM.43.1.271-276.2005; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Stienstra Y, 2005, TROP MED INT HEALTH, V10, P1251, DOI 10.1111/j.1365-3156.2005.01519.x; Stienstra Y, 2003, J CLIN MICROBIOL, V41, P794, DOI 10.1128/JCM.41.2.794-797.2003; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; Teelken MA, 2003, ACTA TROP, V88, P51, DOI 10.1016/S0001-706X(03)00170-0; van der Werf TS, 1999, LANCET, V354, P1013, DOI 10.1016/S0140-6736(99)01156-3; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; van der Werf TS, 2003, LANCET, V362, P1062, DOI 10.1016/S0140-6736(03)14417-0; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; WHO, PROV GUID ROL SPEC A; World Health Organization (WHO), GLOB PLAN COMB NEGL	35	184	187	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					664	672		10.1016/S0140-6736(09)61962-0	http://dx.doi.org/10.1016/S0140-6736(09)61962-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20137805				2022-12-28	WOS:000275210900035
J	Lambert, JB; Gurusamy-Thangavelu, SA; Ma, KBA				Lambert, Joseph B.; Gurusamy-Thangavelu, Senthil A.; Ma, Kuangbiao			The Silicate-Mediated Formose Reaction: Bottom-Up Synthesis of Sugar Silicates	SCIENCE			English	Article							MAGNETIC-RESONANCE SPECTRA; PREBIOTIC SYNTHESIS; AQUEOUS-SOLUTION; RNA WORLD; RIBOSE; MINERALS; ORIGIN; MODEL; CHROMATOGRAPHY; FORMALDEHYDE	Understanding the mechanism of sugar formation and stabilization is important for constraining theories on the abiotic origin of complex biomolecules. Although previous studies have produced sugars from small molecules through the formose and related reactions, the product mixtures are complex and unstable. We have demonstrated that simple two-and three-carbon molecules (glycolaldehyde and glyceraldehyde), in the presence of aqueous sodium silicate, spontaneously form silicate complexes of four-and six-carbon sugars, respectively. Silicate selects for sugars with a specific stereochemistry and sequesters them from rapid decomposition. Given the abundance of silicate minerals, these observations suggest that formose-like reactions may provide a feasible pathway for the abiotic formation of biologically important sugars, such as ribose.	[Lambert, Joseph B.; Gurusamy-Thangavelu, Senthil A.; Ma, Kuangbiao] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University	Lambert, JB (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	jlambert@northwestern.edu	Gurusamy Thangavelu, Senthil/L-7353-2014	Gurusamy Thangavelu, Senthil/0000-0002-7298-0939	National Science Foundation; Dow Corning Corp.; Schlumberger Ltd.	National Science Foundation(National Science Foundation (NSF)); Dow Corning Corp.; Schlumberger Ltd.	This research was supported by the National Science Foundation, Dow Corning Corp., and Schlumberger Ltd.	Arrhenius GO, 2003, HELV CHIM ACTA, V86, P1569, DOI 10.1002/hlca.200390135; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Breslow R., 1959, TETRAHEDRON LETT, V1, P22, DOI DOI 10.1016/S0040-4039(01)99487-0); Butlerow A., 1861, JUSTUS LIEBIGS ANN C, V120, P295; CAIRNSSMITH AG, 1972, J THEOR BIOL, V35, P601, DOI 10.1016/0022-5193(72)90153-1; COLLINS GCS, 1971, J CHEM SOC B, P1352, DOI 10.1039/j29710001352; DECKER P, 1982, J CHROMATOGR, V244, P281, DOI 10.1016/S0021-9673(00)85692-7; GABEL NW, 1967, NATURE, V216, P453, DOI 10.1038/216453a0; Garcia-Jimenez F, 2005, J BRAZIL CHEM SOC, V16, P467, DOI 10.1590/S0103-50532005000300022; Hazen RM, 2003, NAT MATER, V2, P367, DOI 10.1038/nmat879; Holm NG, 2006, GEOCHEM T, V7, DOI 10.1186/1467-4866-7-7; Iqbal MZ, 2009, J CHROMATOGR A, V1216, P5116, DOI 10.1016/j.chroma.2009.04.065; Kastele X, 2005, CHEM-EUR J, V11, P6326, DOI 10.1002/chem.200500147; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kinrade SD, 2001, J CHEM SOC DALTON, P961, DOI 10.1039/b010111g; KOLB VM, 1994, J MOL EVOL, V38, P549; Krishnamurthy R, 1999, ORIGINS LIFE EVOL B, V29, P139, DOI 10.1023/A:1006540518676; Lambert JB, 2004, J AM CHEM SOC, V126, P9611, DOI 10.1021/ja031748v; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; LOEW O, 1886, J PRAKT CHEM, V34, P51; MATSUMOTO T, 1982, J CHEM SOC PERK T 1, P1975, DOI 10.1039/p19820001975; Orgel LE, 2000, P NATL ACAD SCI USA, V97, P12503, DOI 10.1073/pnas.220406697; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Pitsch S, 2000, HELV CHIM ACTA, V83, P2398, DOI 10.1002/1522-2675(20000906)83:9<2398::AID-HLCA2398>3.0.CO;2-5; QUE L, 1974, BIOCHEMISTRY-US, V13, P146, DOI 10.1021/bi00698a023; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; SCHWARTZ AW, 1993, J MOL EVOL, V36, P101, DOI 10.1007/BF00166245; SHAPIRO R, 1988, ORIGINS LIFE EVOL B, V18, P71, DOI 10.1007/BF01808782; SHIGEMASA Y, 1981, J CATAL, V69, P58, DOI 10.1016/0021-9517(81)90128-7; SHIGEMASA Y, 1984, CARBOHYD RES, V134, pC4, DOI 10.1016/0008-6215(84)85034-X; SOCHA RF, 1981, J CATAL, V67, P207, DOI 10.1016/0021-9517(81)90272-4; Springsteen G, 2004, J AM CHEM SOC, V126, P9578, DOI 10.1021/ja0483692; Stumm W, 1996, AQUATIC CHEM; Washington J, 2000, ORIGINS LIFE EVOL B, V30, P53, DOI 10.1023/A:1006692606492; Yang XF, 2008, J COLLOID INTERF SCI, V328, P41, DOI 10.1016/j.jcis.2008.08.061	35	111	112	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					984	986		10.1126/science.1182669	http://dx.doi.org/10.1126/science.1182669			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	556XE	20167782				2022-12-28	WOS:000274625800036
J	Li, W; You, LR; Cooper, J; Schiavon, G; Pepe-Caprio, A; Zhou, L; Ishii, R; Giovannini, M; Hanemann, CO; Long, SB; Erdjument-Bromage, H; Zhou, PB; Tempst, P; Giancotti, FG				Li, Wei; You, Liru; Cooper, Jonathan; Schiavon, Gaia; Pepe-Caprio, Angela; Zhou, Lu; Ishii, Ryohei; Giovannini, Marco; Hanemann, C. Oliver; Long, Stephen B.; Erdjument-Bromage, Hediye; Zhou, Pengbo; Tempst, Paul; Giancotti, Filippo G.			Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4(DCAF1) in the Nucleus	CELL			English	Article							NF2 TUMOR-SUPPRESSOR; CELL-PROLIFERATION; HUMAN SCHWANNOMA; PLASMA-MEMBRANE; NF2/MERLIN; PATHWAY; KINASE; LOCALIZATION; DEGRADATION; GROWTH	Current models imply that the FERM domain protein Merlin, encoded by the tumor suppressor NF2, inhibits mitogenic signaling at or near the plasma membrane. Here, we show that the closed, growth-inhibitory form of Merlin accumulates in the nucleus, binds to the E3 ubiquitin ligase CRL4(DCAF1), and suppresses its activity. Depletion of DCAF1 blocks the promitogenic effect of inactivation of Merlin. Conversely, enforced expression of a Merlin-insensitive mutant of DCAF1 counteracts the antimitogenic effect of Merlin. Re-expression of Merlin and silencing of DCAF1 implement a similar, tumor-suppressive program of gene expression. Tumor-derived mutations invariably disrupt Merlin's ability to interact with or inhibit CRL4(DCAF1). Finally, depletion of DCAF1 inhibits the hyperproliferation of Schwannoma cells from NF2 patients and suppresses the oncogenic potential of Merlin-deficient tumor cell lines. We propose that Merlin suppresses tumorigenesis by translocating to the nucleus to inhibit CRL4(DCAF1).	[Li, Wei; You, Liru; Cooper, Jonathan; Schiavon, Gaia; Pepe-Caprio, Angela; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Cooper, Jonathan] Cornell Univ, Sloan Kettering Div, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Zhou, Lu; Hanemann, C. Oliver] Univ Plymouth, Peninsula Coll Med & Dent, Plymouth PL6 8BU, Devon, England; [Ishii, Ryohei; Zhou, Pengbo] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Giovannini, Marco] Ctr Neural Tumor Res, House Ear Inst, Los Angeles, CA 90057 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; University of Plymouth; Cornell University; House Research Institute	Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.	f-giancotti@ski.mskcc.org	Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Li, Wei/0000-0001-5696-4309; Tempst, Paul/0000-0002-6680-3987; Ishii, Ryohei/0000-0003-2486-1393; Cooper, Jonathan/0000-0002-0301-1384	Baker Street Foundation and National Institutes of Health (NIH) Cancer Center [P30 CA08748]; Children's Tumor Foundation; NIH [R01 CA098210]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA098210] Funding Source: NIH RePORTER	Baker Street Foundation and National Institutes of Health (NIH) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Tumor Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Brugge, S. Jhanwar, and D. Lim for cell lines, M. Pagano for constructs, L. Fabrizio and M. Yaneva for help with mass spectrometry, and members of the Giancotti laboratory for discussions. This work was supported by the Baker Street Foundation and National Institutes of Health (NIH) Cancer Center Support Grant P30 CA08748. W. L. is recipient of a Young Investigator Award from the Children's Tumor Foundation. P.Z. was supported by NIH grant R01 CA098210.	Ahronowitz I, 2007, HUM MUTAT, V28, P1, DOI 10.1002/humu.20393; Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Gascard P, 1999, MOL BIOL CELL, V10, P1783, DOI 10.1091/mbc.10.6.1783; Gutmann DH, 2001, HUM MOL GENET, V10, P1519, DOI 10.1093/hmg/10.14.1519; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Kressel M, 2002, HUM MOL GENET, V11, P2269, DOI 10.1093/hmg/11.19.2269; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Luque CM, 1998, J BIOL CHEM, V273, P11643, DOI 10.1074/jbc.273.19.11643; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Pylayeva Y, 2007, METHOD ENZYMOL, V426, P439, DOI 10.1016/S0076-6879(07)26019-7; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200	41	219	228	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					477	490		10.1016/j.cell.2010.01.029	http://dx.doi.org/10.1016/j.cell.2010.01.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178741	Green Accepted, Bronze			2022-12-28	WOS:000274668400012
J	Wang, QJ; Zhang, YK; Yang, C; Xiong, H; Lin, Y; Yao, J; Li, H; Xie, L; Zhao, W; Yao, YF; Ning, ZB; Zeng, R; Xiong, Y; Guan, KL; Zhao, SM; Zhao, GP				Wang, Qijun; Zhang, Yakun; Yang, Chen; Xiong, Hui; Lin, Yan; Yao, Jun; Li, Hong; Xie, Lu; Zhao, Wei; Yao, Yufeng; Ning, Zhi-Bin; Zeng, Rong; Xiong, Yue; Guan, Kun-Liang; Zhao, Shimin; Zhao, Guo-Ping			Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux	SCIENCE			English	Article							COA SYNTHETASE; PROTEIN; LYSINE; SIR2	Lysine acetylation regulates many eukaryotic cellular processes, but its function in prokaryotes is largely unknown. We demonstrated that central metabolism enzymes in Salmonella were acetylated extensively and differentially in response to different carbon sources, concomitantly with changes in cell growth and metabolic flux. The relative activities of key enzymes controlling the direction of glycolysis versus gluconeogenesis and the branching between citrate cycle and glyoxylate bypass were all regulated by acetylation. This modulation is mainly controlled by a pair of lysine acetyltransferase and deacetylase, whose expressions are coordinated with growth status. Reversible acetylation of metabolic enzymes ensure that cells respond environmental changes via promptly sensing cellular energy status and flexibly altering reaction rates or directions. It represents a metabolic regulatory mechanism conserved from bacteria to mammals.	[Wang, Qijun; Xiong, Hui; Zhao, Shimin; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol, State Key Lab Genet Engn, Shanghai 200032, Peoples R China; [Lin, Yan; Yao, Jun; Xiong, Yue; Guan, Kun-Liang; Zhao, Shimin] Fudan Univ, Inst Biomed Sci, Mol Cell Biol Lab, Shanghai 200032, Peoples R China; [Zhang, Yakun; Xiong, Hui; Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, MOST Shanghai Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Yang, Chen; Li, Hong; Xie, Lu; Zhao, Wei; Ning, Zhi-Bin; Zeng, Rong; Zhao, Guo-Ping] Chinese Acad Sci, Bioinformat Ctr, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Yang, Chen; Li, Hong; Xie, Lu; Zhao, Wei; Ning, Zhi-Bin; Zeng, Rong; Zhao, Guo-Ping] Chinese Acad Sci, Lab Syst Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Yao, Yufeng] Shanghai Jiao Tong Univ, Lab Human Bacterial Pathogenesis, Dept Med Microbiol & Parasitol, Inst Med Sci,Sch Med, Shanghai 200025, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Zhao, SM (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol, State Key Lab Genet Engn, Shanghai 200032, Peoples R China.	zhaosm@fudan.edu.cn; gpzhao@sibs.ac.cn	Guan, Kun-Liang/ADK-7088-2022	Zhao, Wei/0000-0002-2422-8398; Zhao, Guo-Ping/0000-0002-7621-6620	state key development programs of basic research of China [2009CB918401, 2006CB806700]; national high technology research and development program of China [2006AA02A308]; National Natural Science Foundation of China [30830002]; Shanghai key basic research project, China [08JC1400900]; NATIONAL CANCER INSTITUTE [R01CA163834, R01CA068377] Funding Source: NIH RePORTER	state key development programs of basic research of China; national high technology research and development program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai key basic research project, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of Fudan Molecular Cell Biology laboratory for their inputs throughout this work. L. Wang of Nankai University, China, provided the S. Enterica G2466 for this study. This work is supported by state key development programs of basic research of China (2009CB918401 and 2006CB806700), national high technology research and development program of China (2006AA02A308), National Natural Science Foundation of China (30830002), and Shanghai key basic research project, China (08JC1400900).	Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hua Q, 2003, J BACTERIOL, V185, P7053, DOI 10.1128/JB.185.24.7053-7067.2003; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zamboni N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-209; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	16	759	790	5	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1004	1007		10.1126/science.1179687	http://dx.doi.org/10.1126/science.1179687			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167787	Green Accepted, Green Published			2022-12-28	WOS:000274625800042
J	Zhao, SM; Xu, W; Jiang, WQ; Yu, W; Lin, Y; Zhang, TF; Yao, J; Zhou, L; Zeng, YX; Li, H; Li, YX; Shi, J; An, WL; Hancock, SM; He, FC; Qin, LX; Chin, J; Yang, PY; Chen, X; Lei, QY; Xiong, Y; Guan, KL				Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Yu, Wei; Lin, Yan; Zhang, Tengfei; Yao, Jun; Zhou, Li; Zeng, Yaxue; Li, Hong; Li, Yixue; Shi, Jiong; An, Wenlin; Hancock, Susan M.; He, Fuchu; Qin, Lunxiu; Chin, Jason; Yang, Pengyuan; Chen, Xian; Lei, Qunying; Xiong, Yue; Guan, Kun-Liang			Regulation of Cellular Metabolism by Protein Lysine Acetylation	SCIENCE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE; GLUCONEOGENESIS; DEFICIENCY	Protein lysine acetylation has emerged as a key posttranslational modification in cellular regulation, in particular through the modification of histones and nuclear transcription regulators. We show that lysine acetylation is a prevalent modification in enzymes that catalyze intermediate metabolism. Virtually every enzyme in glycolysis, gluconeogenesis, the tricarboxylic acid (TCA) cycle, the urea cycle, fatty acid metabolism, and glycogen metabolism was found to be acetylated in human liver tissue. The concentration of metabolic fuels, such as glucose, amino acids, and fatty acids, influenced the acetylation status of metabolic enzymes. Acetylation activated enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase in fatty acid oxidation and malate dehydrogenase in the TCA cycle, inhibited argininosuccinate lyase in the urea cycle, and destabilized phosphoenolpyruvate carboxykinase in gluconeogenesis. Our study reveals that acetylation plays a major role in metabolic regulation.	[Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Yu, Wei; Zhang, Tengfei; Lei, Qunying; Xiong, Yue; Guan, Kun-Liang] Fudan Univ, Sch Life Sci, Shanghai 20032, Peoples R China; [Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Yu, Wei; Lin, Yan; Zhang, Tengfei; Lei, Qunying; Xiong, Yue; Guan, Kun-Liang] Fudan Univ, Mol & Cell Biol Lab, Shanghai 20032, Peoples R China; [Yao, Jun; He, Fuchu; Yang, Pengyuan; Chen, Xian] Fudan Univ, Ctr Prote, Inst Biomed Sci, Shanghai 20032, Peoples R China; [Zhou, Li; Zeng, Yaxue; Chen, Xian; Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Li, Hong; Qin, Lunxiu] Fudan Univ, Affiliated Zhongshan Hosp, Shanghai 20032, Peoples R China; [Li, Yixue; Shi, Jiong] Chinese Acad Sci, Shanghai Inst Biol Sci, Bioinformat Ctr, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [An, Wenlin; Hancock, Susan M.; Chin, Jason] MRC, Mol Biol Lab, Cambridge CB2 OQH, England; [Lei, Qunying; Guan, Kun-Liang] Fudan Univ, Dept Biol Chem, Shanghai 20032, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego	Xiong, Y (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 20032, Peoples R China.	yxiong@email.unc.edu; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; YU, WEI/C-3822-2012; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; He, Fuchu/0000-0002-8571-2351; YU, WEI/0000-0001-9898-4607	Chinese Ministry of Education; state key development programs of basic research of China [2009CB918401, 2006CB806700]; national high technology research and development program of China [2006AA02A308]; Chinese National Science Foundation [30600112, 30871255]; Shanghai key basic research projects [06JC14086, 07PJ14011, 08JC1400900]; NIH [R01GM51586, R01CA108941, R01CA65572]; MRC [MC_UP_A024_1008, MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009, MC_UP_A024_1008] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA065572, R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	Chinese Ministry of Education(Ministry of Education, China); state key development programs of basic research of China; national high technology research and development program of China(National High Technology Research and Development Program of China); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai key basic research projects; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of Fudan MCB laboratory for their valuable inputs throughout this study and S. Jackson for reading the manuscript. Supported by the 985 program from the Chinese Ministry of Education, state key development programs of basic research of China (grants 2009CB918401 and 2006CB806700), the national high technology research and development program of China (grant 2006AA02A308), Chinese National Science Foundation grants 30600112 and 30871255, Shanghai key basic research projects (grants 06JC14086, 07PJ14011, 08JC1400900), and NIH grants R01GM51586, R01CA108941, and R01CA65572 (K. L. G., X. C., and Y.X.).	ALVARES K, 1994, CANCER RES, V54, P2303; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; LARDY H, 1984, CURR TOP CELL REGUL, V24, P171; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Trevisson E, 2007, HUM MUTAT, V28, P694, DOI 10.1002/humu.20498; WATKINS PA, 1989, J CLIN INVEST, V83, P771, DOI 10.1172/JCI113956; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yeh CS, 2006, CANCER LETT, V233, P297, DOI 10.1016/j.canlet.2005.03.050; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	11	1378	1438	10	503	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1000	1004		10.1126/science.1179689	http://dx.doi.org/10.1126/science.1179689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167786	Green Accepted, Green Submitted			2022-12-28	WOS:000274625800041
J	Lumley, T; Rice, K				Lumley, Thomas; Rice, Kenneth			Potential for Revealing Individual-Level Information in Genome-wide Association Studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lumley, Thomas; Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rice, K (corresponding author), Univ Washington, Dept Biostat, F-600 Hlth Sci Bldg,Box 357232, Seattle, WA 98195 USA.	kenrice@u.washington.edu	Rice, Kenneth M/A-4150-2013	Rice, Kenneth M/0000-0001-5779-4495	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL087652] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL080295, R01 HL087652] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Jacobs KB, 2009, NAT GENET, V41, P1253, DOI 10.1038/ng.455; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Sankararaman S, 2009, NAT GENET, V41, P965, DOI 10.1038/ng.436; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Visscher PM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000628	10	26	27	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					659	660		10.1001/jama.2010.120	http://dx.doi.org/10.1001/jama.2010.120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555NK	20159874				2022-12-28	WOS:000274518600025
J	Horton, R				Horton, Richard			Offline: Long live the King	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 13	2010	375	9714					538	538		10.1016/S0140-6736(10)60204-8	http://dx.doi.org/10.1016/S0140-6736(10)60204-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560YO	20159278				2022-12-28	WOS:000274941900011
J	Riley, RD; Lambert, PC; Abo-Zaid, G				Riley, Richard D.; Lambert, Paul C.; Abo-Zaid, Ghada			Meta-analysis of individual participant data: rationale, conduct, and reporting	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENT DATA; RANDOMIZED-TRIALS; AGGREGATE DATA; OUTCOMES; LEVEL; MODEL		[Riley, Richard D.] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Lambert, Paul C.] Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester LE1 7RH, Leics, England; [Abo-Zaid, Ghada] Univ Birmingham, Sch Math Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Leicester; University of Birmingham	Riley, RD (corresponding author), Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England.	r.d.riley@bham.ac.uk	Riley, Richard David/ABE-5877-2020; Abo-Zaid, Ghada/AAY-7516-2020; Riley, Richard/G-2406-2011	Riley, Richard David/0000-0001-8699-0735; Lambert, Paul/0000-0002-5337-663X	Medical Research Council [G0800808] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abe O, 2005, LANCET, V366, P2087; Abrams KR, 2005, STAT MED, V24, P3823, DOI 10.1002/sim.2423; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Chia S, 2005, LANCET, V365, P1665, DOI 10.1016/S0140-6736(05)66524-5; Hernandez AV, 2006, ANN EPIDEMIOL, V16, P41, DOI 10.1016/j.annepidem.2005.09.007; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hutchon DJR, 2001, BRIT MED J, V322, P530, DOI 10.1136/bmj.322.7285.530; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; JENG GT, 1995, JAMA-J AM MED ASSOC, V274, P830, DOI 10.1001/jama.274.10.830; Jones AP, 2009, CLIN TRIALS, V6, P16, DOI 10.1177/1740774508100984; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mathew T, 1999, BIOMETRICS, V55, P1221, DOI 10.1111/j.0006-341X.1999.01221.x; McCormack K, 2004, BRIT J SURG, V91, P495, DOI 10.1002/bjs.4467; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Olkin I, 1998, BIOMETRICS, V54, P317, DOI 10.2307/2534018; OXMAN AD, 1995, JAMA-J AM MED ASSOC, V274, P845, DOI 10.1001/jama.274.10.845; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Riley RD, 2008, STAT MED, V27, P6111, DOI 10.1002/sim.3441; Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; Smith GD, 1997, BMJ-BRIT MED J, V315, P1610, DOI 10.1136/bmj.315.7122.1610; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wang JG, 2005, HYPERTENSION, V45, P907, DOI 10.1161/01.HYP.0000165020.14745.79; Whitehead A, 2001, STAT MED, V20, P2243, DOI 10.1002/sim.919	39	985	987	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2010	340								c221	10.1136/bmj.c221	http://dx.doi.org/10.1136/bmj.c221			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CX	20139215	Bronze			2022-12-28	WOS:000274343700010
J	Neill, DR; Wong, SH; Bellosi, A; Flynn, RJ; Daly, M; Langford, TKA; Bucks, C; Kane, CM; Fallon, PG; Pannell, R; Jolin, HE; McKenzie, ANJ				Neill, Daniel R.; Wong, See Heng; Bellosi, Agustin; Flynn, Robin J.; Daly, Maria; Langford, Theresa K. A.; Bucks, Christine; Kane, Colleen M.; Fallon, Padraic G.; Pannell, Richard; Jolin, Helen E.; McKenzie, Andrew N. J.			Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity	NATURE			English	Article							IL-13; CELLS; REQUIREMENT; LYMPHOCYTES; EXPRESSION; MICE	Innate immunity provides the first line of defence against invading pathogens and provides important cues for the development of adaptive immunity. Type-2 immunity-responsible for protective immune responses to helminth parasites(1,2) and the underlying cause of the pathogenesis of allergic asthma(3,4)-consists of responses dominated by the cardinal type-2 cytokines interleukin (IL) 4, IL5 and IL13 (ref. 5). T cells are an important source of these cytokines in adaptive immune responses, but the innate cell sources remain to be comprehensively determined. Here, through the use of novel Il13-eGFP reporter mice, we present the identification and functional characterization of a new innate type-2 immune effector leukocyte that we have named the nuocyte. Nuocytes expand in vivo in response to the type-2-inducing cytokines IL25 and IL33, and represent the predominant early source of IL13 during helminth infection with Nippostrongylus brasiliensis. In the combined absence of IL25 and IL33 signalling, nuocytes fail to expand, resulting in a severe defect in worm expulsion that is rescued by the adoptive transfer of in vitro cultured wild-type, but not IL13-deficient, nuocytes. Thus, nuocytes represent a critically important innate effector cell in type-2 immunity.	[Neill, Daniel R.; Wong, See Heng; Bellosi, Agustin; Flynn, Robin J.; Daly, Maria; Langford, Theresa K. A.; Pannell, Richard; Jolin, Helen E.; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Bucks, Christine; Kane, Colleen M.] Centocor R&D Inc, Immunol Discovery Res, Radnor, PA 19087 USA; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Inst Mol Med, Dublin 8, Ireland	MRC Laboratory Molecular Biology; Johnson & Johnson; Johnson & Johnson USA; Trinity College Dublin	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	anm@mrc-lmb.cam.ac.uk	Flynn, Robin/H-7387-2019; Fallon, Padraic/Y-2711-2019; Neill, Daniel/E-1403-2012; Flynn, Robin/A-7678-2010; Neill, Daniel/Q-6290-2019	Flynn, Robin/0000-0001-5304-3088; Fallon, Padraic/0000-0002-8401-7293; Neill, Daniel/0000-0002-7911-8153; Neill, Daniel/0000-0002-7911-8153	Asthma UK; Science Foundation Ireland; MRC [MC_U105178805] Funding Source: UKRI; Medical Research Council [MC_U105178805] Funding Source: researchfish; Asthma UK [07/001] Funding Source: researchfish	Asthma UK; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	We thank members of the McKenzie laboratory for their comments on the manuscript. We thank D. Cousins for assistance with preliminary microarray analysis. R.J.F. was supported by Asthma UK. P.G.F. is supported by Science Foundation Ireland.	Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HAIG DM, 1994, BLOOD, V83, P72; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Perrigoue JG, 2008, CELL MICROBIOL, V10, P1757, DOI 10.1111/j.1462-5822.2008.01174.x; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; TONO T, 1992, BLOOD, V80, P1448; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Voehringer D, 2009, TRENDS PARASITOL, V25, P551, DOI 10.1016/j.pt.2009.09.004; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	24	1516	1583	0	152	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1367	U9		10.1038/nature08900	http://dx.doi.org/10.1038/nature08900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20200518	Green Accepted			2022-12-28	WOS:000277149000050
J	He, YP; Wu, J; Dressman, DC; Iacobuzio-Donahue, C; Markowitz, SD; Velculescu, VE; Diaz, LA; Kinzler, KW; Vogelstein, B; Papadopoulos, N				He, Yiping; Wu, Jian; Dressman, Devin C.; Iacobuzio-Donahue, Christine; Markowitz, Sanford D.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas			Heteroplasmic mitochondrial DNA mutations in normal and tumour cells	NATURE			English	Article							POINT MUTATIONS; CONTROL REGION; STEM-CELLS; MTDNA; INDIVIDUALS; CANCER; REPLICATION; FREQUENCY; DYNAMICS; GENETICS	The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies(1). Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.	[He, Yiping; Wu, Jian; Dressman, Devin C.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [He, Yiping; Wu, Jian; Dressman, Devin C.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Howard Hughes Med Inst, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Howard Hughes Medical Institute	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@jhmi.edu; npapado1@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020; Papadopoulos, Nickolas/K-7272-2012	Velculescu, Victor/0000-0003-1195-438X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Diaz, Luis/0000-0002-7079-8914	The Virginia and D. K. Ludwig Fund for Cancer Research; National Institutes of Health [CA57345, CA 43460, CA 62924, CA121113]; NATIONAL CANCER INSTITUTE [R01CA121113, P50CA062924, R01CA057345, R01CA043460, R37CA043460, R37CA057345] Funding Source: NIH RePORTER	The Virginia and D. K. Ludwig Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Whalen, J. Ptak, L. Dobbyn and N. Silliman for expert technical assistance. This work was supported by The Virginia and D. K. Ludwig Fund for Cancer Research and by National Institutes of Health grants CA57345, CA 43460, CA 62924 and CA121113.	Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Coller HA, 2005, MUTAT RES-FUND MOL M, V578, P256, DOI 10.1016/j.mrfmmm.2005.05.014; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dobrowolski SF, 2009, HUM MUTAT, V30, P891, DOI 10.1002/humu.21003; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x; Jones JB, 2001, CANCER RES, V61, P1299; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kraytsberg Y, 2008, METHODS, V46, P269, DOI 10.1016/j.ymeth.2008.10.005; KRAYTSBERG Y, 2009, METHOD MOL BIOL, V329, P369; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Marzuki S, 1997, J NEUROL SCI, V145, P155, DOI 10.1016/S0022-510X(96)00241-9; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Osborne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005636; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Schneider PM, 2007, FORENSIC SCI INT, V165, P238, DOI 10.1016/j.forsciint.2006.06.067; Sekiguchi K, 2003, MITOCHONDRION, V2, P401, DOI 10.1016/S1567-7249(03)00028-X; Sekiguchi K, 2004, J FORENSIC SCI, V49, P986; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003; Wong LJC, 2003, CANCER RES, V63, P3866; Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606	30	389	405	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					610	U175		10.1038/nature08802	http://dx.doi.org/10.1038/nature08802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20200521	Green Accepted			2022-12-28	WOS:000275974200052
J	Walker, EP				Walker, Eric P.			HIV Clinic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												epwalker@uabmc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					819	819		10.1001/jama.2010.209	http://dx.doi.org/10.1001/jama.2010.209			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197520				2022-12-28	WOS:000275059500001
J	Wang, L; Manson, JE; Song, YQ; Sesso, HD				Wang, Lu; Manson, JoAnn E.; Song, Yiqing; Sesso, Howard D.			Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events	ANNALS OF INTERNAL MEDICINE			English	Review							RENIN-ANGIOTENSIN SYSTEM; HEART-DISEASE MORTALITY; CYTOSOLIC FREE CALCIUM; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; DOUBLE-BLIND; SERUM 25-HYDROXYVITAMIN-D; MYOCARDIAL-INFARCTION; CONTROLLED-TRIAL; DIETARY CALCIUM	Background: Vitamin D and calcium may affect the cardiovascular system independently and interactively. Purpose: To assess whether vitamin D and calcium supplements reduce the risk for cardiovascular events in adults. Data Sources: Studies published in English from 1966 to July 2009 in MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials. Study Selection: Two investigators independently selected 17 prospective studies and randomized trials that examined vitamin D supplementation, calcium supplementation, or both and subsequent cardiovascular events. Data Extraction: Three investigators extracted and checked data about study designs, participants, exposures or interventions, outcomes, and data quality. Data Synthesis: Five prospective studies of patients receiving dialysis and 1 study involving a general population showed consistent reductions in cardiovascular disease (CVD) mortality among adults who received vitamin D supplements. Four prospective studies of initially healthy persons found no differences in incidence of CVD between calcium supplement recipients and nonrecipients. Results of secondary analyses in 8 randomized trials showed a slight but statistically nonsignificant reduction in CVD risk (pooled relative risk, 0.90 [95% CI, 0.77 to 1.05]) with vitamin D supplementation at moderate to high doses (approximately 1000 IU/d) but not with calcium supplementation (pooled relative risk, 1.14 [CI, 0.92 to 1.41]), or a combination of vitamin D and calcium supplementation (pooled relative risk, 1.04 [CI, 0.92 to 1.18]) compared with placebo. Limitations: Only articles published in English that reported cardiovascular event outcomes were included. The small number of studies, the lack of trials designed specifically to assess primary effects on cardiovascular outcomes, and important between-study heterogeneity preclude definitive conclusions. Conclusion: Evidence from limited data suggests that vitamin D supplements at moderate to high doses may reduce CVD risk, whereas calcium supplements seem to have minimal cardiovascular effects. Further research is needed to elucidate the role of these supplements in CVD prevention. Primary Funding Source: The American Heart Association and the National Heart, Lung, and Blood Institute.	[Wang, Lu] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Wang, L (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	luwang@rics.bwh.harvard.edu			American Heart Association [0735390N]; National Heart, Lung, and Blood Institute [HL075445]	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By a scientist development grant from the American Heart Association (grant 0735390N) and a research grant from the National Heart, Lung, and Blood Institute (grant HL075445).	Abbott RD, 1996, STROKE, V27, P813, DOI 10.1161/01.STR.27.5.813; Al-Delaimy WK, 2003, AM J CLIN NUTR, V77, P814, DOI 10.1093/ajcn/77.4.814; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; Balk E, 2004, Evid Rep Technol Assess (Summ), P1; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; BOHR DF, 1963, SCIENCE, V139, P597, DOI 10.1126/science.139.3555.597; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; DRAZNIN B, 1988, J CLIN INVEST, V82, P1848, DOI 10.1172/JCI113801; DRAZNIN B, 1987, J BIOL CHEM, V262, P14385; FLEMING KH, 1994, J NUTR, V124, pS1426, DOI 10.1093/jn/124.suppl_8.1426S; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gysemans CA, 2005, ENDOCRINOLOGY, V146, P1956, DOI 10.1210/en.2004-1322; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; *I MED FOOD NUTR B, 2003, STAND COMM SCI EV DI; Iso H, 1999, STROKE, V30, P1772, DOI 10.1161/01.STR.30.9.1772; Jolma P, 2000, AM J PHYSIOL-HEART C, V279, pH1036, DOI 10.1152/ajpheart.2000.279.3.H1036; Lanham-New SA, 2008, P NUTR SOC, V67, P163, DOI 10.1017/S0029665108007003; Larsson SC, 2008, ARCH INTERN MED, V168, P459, DOI 10.1001/archinte.168.5.459; Levin A, 2005, KIDNEY INT, V68, P1973, DOI 10.1111/j.1523-1755.2005.00651.x; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; MACCARTHY EP, 1989, HYPERTENSION, V13, P954, DOI 10.1161/01.HYP.13.6.954; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Makynen H, 1996, CIRCULATION, V93, P1000, DOI 10.1161/01.CIR.93.5.1000; Marco MP, 2003, KIDNEY INT, V63, pS111, DOI 10.1046/j.1523-1755.63.s85.26.x; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Milner R D, 1967, Diabetologia, V3, P47, DOI 10.1007/BF01269910; Moyad MA, 2003, UROL ONCOL-SEMIN ORI, V21, P384, DOI 10.1016/S1078-1439(03)00108-X; Naves-Diaz M, 2008, KIDNEY INT, V74, P1070, DOI 10.1038/ki.2008.343; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; PORSTI I, 1990, CLIN EXP HYPERTENS A, V12, P1159, DOI 10.3109/10641969009074746; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Rammos G, 2008, INT UROL NEPHROL, V40, P419, DOI 10.1007/s11255-007-9244-4; Reid IR, 2008, OSTEOPOROSIS INT, V19, P1119, DOI 10.1007/s00198-008-0563-9; Reid IR, 2008, ARCH INTERN MED, V168, P2276, DOI 10.1001/archinte.168.20.2276; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; SUBAR AF, 1990, AM J EPIDEMIOL, V132, P1091, DOI 10.1093/oxfordjournals.aje.a115752; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Umesawa M, 2006, STROKE, V37, P20, DOI 10.1161/01.STR.0000195155.21143.38; Umesawa M, 2008, STROKE, V39, P2449, DOI 10.1161/STROKEAHA.107.512236; VANDERVIJVER LPL, 1992, INT J EPIDEMIOL, V21, P36, DOI 10.1093/ije/21.1.36; Vaskonen T, 2003, J NUTR BIOCHEM, V14, P492, DOI 10.1016/S0955-2863(03)00074-3; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wang AYM, 2008, AM J CLIN NUTR, V87, P1631, DOI 10.1093/ajcn/87.6.1631; Wang L, 2008, HYPERTENSION, V51, P1073, DOI 10.1161/HYPERTENSIONAHA.107.107821; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Zemel MB, 1998, MOL CELL BIOCHEM, V188, P129, DOI 10.1023/A:1006880708475; Zemel MB, 2001, J AM COLL NUTR, V20, p428S, DOI 10.1080/07315724.2001.10719180; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	67	381	408	2	49	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2010	152	5					315	U88		10.7326/0003-4819-152-5-201003020-00010	http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00010			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565XJ	20194238				2022-12-28	WOS:000275329600007
J	Wang, JB; Guo, JJ; Yang, L; Zhang, YD; Sun, ZQ; Zhang, YJ				Wang, Jing-Bo; Guo, Jeff J.; Yang, Li; Zhang, Yan-De; Sun, Zhao-Qi; Zhang, Yan-Jun			Rare diseases and legislation in China	LANCET			English	Editorial Material									[Guo, Jeff J.; Zhang, Yan-Jun] Univ Cincinnati, Med Ctr, Coll Pharm, Cincinnati, OH 45267 USA; [Wang, Jing-Bo] Peoples Liberat Army 309 Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Yang, Li] Jinan Normal Sch, Dept Med Serv, Jinan, Shandong, Peoples R China; [Zhang, Yan-De] Beijing Disabled Persons Federat, Beijing, Peoples R China; [Sun, Zhao-Qi] Anhui Univ, Sch Phys & Mat Sci, Hefei 230039, Anhui, Peoples R China	University System of Ohio; University of Cincinnati; Anhui University	Zhang, YJ (corresponding author), Univ Cincinnati, Med Ctr, Coll Pharm, Cincinnati, OH 45267 USA.	zhang2yj@mail.uc.edu	Zhang, Yanjun/G-1194-2012					Ayme S, 2008, LANCET, V371, P2048, DOI 10.1016/S0140-6736(08)60875-2; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; *CHIN CHAR FED, CALL CAMP 2010 RAR D; *CHIN DOLLS CAR SU, 2009, SEM RAR DIS LEG; *CHIN DOLLS CAR SU, CHIN DOLLS CAR SUP A; *CHIN STAT FOOD DR, 2007, PROV DRUG REG; LING H, 2009, CHINA MED HERALD, V6, P4; Remuzzi G, 2008, LANCET, V371, P1978, DOI 10.1016/S0140-6736(08)60847-8; SUN ZQ, 2008, PROPOSAL EXPEDITING; ZHANG YJ, CHIN J PHAR IN PRESS; 2008, LANCET, V371, P1972	11	33	40	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					708	709		10.1016/S0140-6736(10)60240-1	http://dx.doi.org/10.1016/S0140-6736(10)60240-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JW	20189012				2022-12-28	WOS:000275211200010
J	Ehlenbach, WJ; Hough, CL; Crane, PK; Haneuse, SJPA; Carson, SS; Curtis, JR; Larson, EB				Ehlenbach, William J.; Hough, Catherine L.; Crane, Paul K.; Haneuse, Sebastien J. P. A.; Carson, Shannon S.; Curtis, J. Randall; Larson, Eric B.			Association Between Acute Care and Critical Illness Hospitalization and Cognitive Function in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; PEOPLE AGED 65; SURVIVORS; DEMENTIA; OUTCOMES; EPIDEMIOLOGY; DYSFUNCTION; DISEASE; DELIRIUM; MEMORY	Context Studies suggest that many survivors of critical illness experience long-term cognitive impairment but have not included premorbid measures of cognitive functioning and have not evaluated risk for dementia associated with critical illness. Objectives To determine whether decline in cognitive function was greater among older individuals who experienced acute care or critical illness hospitalizations relative to those not hospitalized and to determine whether the risk for incident dementia differed by these exposures. Design, Setting, and Participants Analysis of data from a prospective cohort study from 1994 through 2007 comprising 2929 individuals 65 years old and older without dementia at baseline residing in the community in the Seattle area and belonging to the Group Health Cooperative. Participants with 2 or more study visits were included, and those who had a hospitalization for a diagnosis of primary brain injury were censored at the time of hospitalization. Individuals were screened with the Cognitive Abilities Screening Instrument (CASI) (score range, 0-100) every 2 years at follow-up visits, and those with a score less than 86 underwent a clinical examination for dementia. Main Outcome Measures Score on the CASI at follow-up study visits and incident dementia diagnosed in study participants, adjusted for baseline cognitive scores, age, and other risk factors. Results During a mean (SD) follow-up of 6.1 (3.2) years, 1601 participants had no hospitalization, 1287 had 1 or more noncritical illness hospitalizations, and 41 had 1 or more critical illness hospitalizations. The CASI score was assessed more than 45 days after discharge for 94.3% of participants. Adjusted CASI scores averaged 1.01 points lower for visits following acute care illness hospitalization compared with follow-up visits not following any hospitalization (95% confidence interval [CI], -1.33 to -0.70; P<.001) and 2.14 points lower on average for visits following critical illness hospitalization (95% CI, -4.24 to -0.03; P=.047). There were 146 cases of dementia among those not hospitalized, 228 cases of dementia among those with 1 or more noncritical illness hospitalizations, and 5 cases of dementia among those with 1 or more critical illness hospitalizations. The adjusted hazard ratio for incident dementia was 1.4 following a noncritical illness hospitalization (95% CI, 1.1 to 1.7; P=.001) and 2.3 following a critical illness hospitalization (95% CI, 0.9 to 5.7; P=.09). Conclusions Among a cohort of older adults without dementia at baseline, those who experienced acute care hospitalization and critical illness hospitalization had a greater likelihood of cognitive decline compared with those who had no hospitalization. Noncritical illness hospitalization was significantly associated with the development of dementia. JAMA. 2010; 303(8): 763-770	[Ehlenbach, William J.] Dept Vet Affairs, Hlth Serv Res & Dev, Seattle, WA 98101 USA; [Ehlenbach, William J.; Hough, Catherine L.; Crane, Paul K.; Curtis, J. Randall; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Haneuse, Sebastien J. P. A.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Carson, Shannon S.] Univ N Carolina, Div Pulm & Crit Care Med, Chapel Hill, NC USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Ehlenbach, WJ (corresponding author), Dept Vet Affairs, Hlth Serv Res & Dev, 1100 Olive Way,Ste 1400, Seattle, WA 98101 USA.	wje1@u.washington.edu	Ehlenbach, William J./R-5784-2019	Ehlenbach, William J./0000-0002-2864-5543; Crane, Paul/0000-0003-4278-7465	National Institutes of Health (NIH) National Institute on Aging [UO1 AG06781]; John A. Hartford Foundation; National Heart, Lung, and Blood Institute [1 K24 HL068593]; National Institute on Aging [R01 AG029672]; NIH [5T32HL007287-30]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL068593, R01HL096504, T32HL007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029672, U01AG006781] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John A. Hartford Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: The Adult Changes in Thought study is funded by a National Institutes of Health (NIH) National Institute on Aging Cooperative Grant (UO1 AG06781; principal investigator [PI]: Dr Larson). Additional funding for this study was provided by the John A. Hartford Foundation (PI: Dr Hough), a K24 Award from the National Heart, Lung, and Blood Institute (1 K24 HL068593; PI: Dr Curtis), and an R01 from the National Institute on Aging (R01 AG029672; PI: Dr Crane). Dr Ehlenbach was supported by an NIH Respiratory Research Training Grant (5T32HL007287-30; PI: Leonard Hudson, MD, University of Washington) and a Department of Veterans Affairs Health Services Research and Development Postdoctoral Fellowship.	Al-Saidi F, 2003, AM J RESP CRIT CARE, V167, pA737; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Carson Shannon S, 2006, J Intensive Care Med, V21, P173, DOI 10.1177/0885066605282784; Carson SS, 2003, CRIT CARE CLIN, V19, P605, DOI 10.1016/S0749-0704(03)00051-4; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Crane PK, 2008, J CLIN EPIDEMIOL, V61, P1018, DOI 10.1016/j.jclinepi.2007.11.011; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Girard TD, 2009, AM J RESP CRIT CARE, V179, pA5477; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P501; Hopkins RO, 2006, CLIN CHEST MED, V27, P679, DOI 10.1016/j.ccm.2006.06.003; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 2004, J INT NEUROPSYCH SOC, V10, P1005, DOI 10.1017/S135561770410711X; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; HOPKINS RO, 2005, INT NEUR SOC 33 ANN; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jackson JC, 2003, ARCH CLIN NEUROPSYCH, V18, P688; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; MARQUIS K, 2000, AM J RESP CRIT CARE, V161, pA383; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Rudolph JL, 2008, ANAESTHESIA, V63, P941, DOI 10.1111/j.1365-2044.2008.05523.x; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; SAMEJIMA F, 1997, GRADED RESPONSE MODE; *SCI SOFTW INT, 2003, PARSC WIND COMP PROG; STARR JM, 1994, DRUG SAFETY, V11, P310, DOI 10.2165/00002018-199411050-00003; SUCHYTA MR, 2004, AM J RESP CRIT CARE, V169, pA18; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Wang L, 2004, J AM GERIATR SOC, V52, P2045, DOI 10.1111/j.1532-5415.2004.52568.x; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zsembik BA, 2001, J GERONTOL B-PSYCHOL, V56, pS266, DOI 10.1093/geronb/56.5.S266	46	355	365	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					763	770		10.1001/jama.2010.167	http://dx.doi.org/10.1001/jama.2010.167			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559DD	20179286	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000274800000028
J	Dong, GG; Yang, Q; Wang, Q; Kim, YI; Wood, TL; Osteryoung, KW; van Oudenaarden, A; Golden, SS				Dong, Guogang; Yang, Qiong; Wang, Qiang; Kim, Yong-Ick; Wood, Thammajun L.; Osteryoung, Katherine W.; van Oudenaarden, Alexander; Golden, Susan S.			Elevated ATPase Activity of KaiC Applies a Circadian Checkpoint on Cell Division in Synechococcus elongatus	CELL			English	Article							GENE-EXPRESSION; BACILLUS-SUBTILIS; CLOCK SYSTEM; CYANOBACTERIA; PHOSPHORYLATION; PROTEIN; IDENTIFICATION; OSCILLATION; DOMAIN; FTSZ	A circadian clock coordinates physiology and behavior in diverse groups of living organisms. Another major cyclic cellular event, the cell cycle, is regulated by the circadian clock in the few cases where linkage of these cycles has been studied. In the cyanobacterium Synechococcus elongatus, the circadian clock gates cell division by an unknown mechanism. Using timelapse microscopy, we confirm the gating of cell division in the wild-type and demonstrate the regulation of cytokinesis by key clock components. Specifically, a state of the oscillator protein KaiC that is associated with elevated ATPase activity closes the gate by acting through a known clock output pathway to inhibit FtsZ ring formation at the division site. An activity that stimulates KaiC phosphorylation independently of the KaiA protein was also uncovered. We propose a model that separates the functions of KaiC ATPase and phosphorylation in cell division gating and other circadian behaviors.	[Dong, Guogang; Wood, Thammajun L.; Golden, Susan S.] Texas A&M Univ, Dept Biol, Ctr Biol Clocks Res, College Stn, TX 77843 USA; [Dong, Guogang; Kim, Yong-Ick; Golden, Susan S.] Univ Calif San Diego, Div Biol Sci, Ctr Chronobiol, La Jolla, CA 92093 USA; [Wang, Qiang; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Yang, Qiong; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; Michigan State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Golden, SS (corresponding author), Texas A&M Univ, Dept Biol, Ctr Biol Clocks Res, College Stn, TX 77843 USA.	sgolden@ucsd.edu	Kim, Yong-Ick/K-3535-2019; van Oudenaarden, Alexander/AAA-1705-2019; Wang, Qiang/P-7806-2016; Yang, Qiong/G-9630-2016	Kim, Yong-Ick/0000-0001-5491-616X; Wang, Qiang/0000-0002-7388-4703; Yang, Qiong/0000-0002-2442-2094	NIH [R01 GM62419, P01 NS39546, R01 GM068957]; American Recovery and Reinvestment Act; NSF [PHY-0548484]; DOE [DE-FG-02-06ER15808]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957, R01GM062419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Luitel for helpful discussions, A. LiWang for sharing instrumentation and unpublished data, C.-C. Zhang for providing the FtsZ antiserum, and A. Suescun for technical assistance. We are grateful to J. Xiao, T. Liu, and I. M. Axmann for constructive suggestions on the ATPase assays. This work was supported by grants from the NIH (R01 GM62419 and P01 NS39546 to S. S. G., R01 GM068957 to A.v.O.), the American Recovery and Reinvestment Act (S. S. G.), NSF (PHY-0548484 to A.v.O.), and DOE (DE-FG-02-06ER15808 to K.W.O.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Hayashi F, 2004, J BIOL CHEM, V279, P52331, DOI 10.1074/jbc.M406604200; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; Kutsuna S, 2007, J BACTERIOL, V189, P7690, DOI 10.1128/JB.00835-07; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Mackey Shannon R, 2007, Methods Mol Biol, V362, P115; Mackey SR, 2007, TRENDS MICROBIOL, V15, P381, DOI 10.1016/j.tim.2007.08.005; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mazouni K, 2004, MOL MICROBIOL, V52, P1145, DOI 10.1111/j.1365-2958.2004.04042.x; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Miyagishima SY, 2005, MOL MICROBIOL, V56, P126, DOI 10.1111/j.1365-2958.2005.04548.x; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mori T, 2001, J BACTERIOL, V183, P2439, DOI 10.1128/JB.183.8.2439-2444.2001; Mori Tetsuya, 2009, P183, DOI 10.1007/978-3-540-88431-6_11; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Takai N, 2006, J BIOL RHYTHM, V21, P235, DOI 10.1177/0748730406289400; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Zhang XF, 2006, MOL MICROBIOL, V60, P658, DOI 10.1111/j.1365-2958.2006.05138.x	49	100	100	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					529	539		10.1016/j.cell.2009.12.042	http://dx.doi.org/10.1016/j.cell.2009.12.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178745	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000274668400016
J	Baker, M				Baker, Monya			PROBE PROGRESS	NATURE			English	Editorial Material																			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					979	979		10.1038/463979a	http://dx.doi.org/10.1038/463979a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164932	Bronze			2022-12-28	WOS:000274582700052
J	Gill, IS; Aron, M; Gervais, DA; Jewett, MAS				Gill, Inderbir S.; Aron, Monish; Gervais, Debra A.; Jewett, Michael A. S.			Small Renal Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LAPAROSCOPIC PARTIAL NEPHRECTOMY; NEPHRON-SPARING SURGERY; CELL CARCINOMA; RADIOFREQUENCY ABLATION; RADICAL NEPHRECTOMY; TUMOR SIZE; PATHOLOGICAL FEATURES; COMPUTED-TOMOGRAPHY; ACTIVE SURVEILLANCE; NATURAL-HISTORY	A 65-year-old man with a history of well-controlled hypertension presents for a follow-up visit after an incidental finding of a small mass in the right kidney on an abdominal computed tomographic (CT) scan. (The scan had been ordered to evaluate pain in the lower quadrant, which resolved.) The mass is 3.2 cm in its largest dimension, anterior, heterogeneous, and solid, and it is in the right renal hilum near the main renal artery, vein, and ureter; the left kidney appears normal. The patient feels well, and his physical examination is unremarkable. His serum creatinine level is 1.2 mg per deciliter (106 mu mol per liter). How should this patient be further evaluated and treated?	[Gill, Inderbir S.; Aron, Monish] Univ So Calif, Keck Sch Med, Inst Urol, Ctr Robot Surg & Adv Laparoscopy, Los Angeles, CA 90089 USA; [Gervais, Debra A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Jewett, Michael A. S.] Univ Toronto, Princess Margaret Hosp, Dept Surg Oncol, Div Urol, Toronto, ON, Canada	University of Southern California; Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Gill, IS (corresponding author), Univ So Calif, Keck Sch Med, Inst Urol, Ctr Robot Surg & Adv Laparoscopy, 1441 Eastlake Ave,Suite 7416, Los Angeles, CA 90089 USA.	gillindy@gmail.com			Covidien; Pfizer; Novartis; Glaxo-Smith-Kline; Viventia Biotech; Wyeth	Covidien; Pfizer(Pfizer); Novartis(Novartis); Glaxo-Smith-Kline(GlaxoSmithKline); Viventia Biotech; Wyeth(Wyeth)	Dr. Gill reports having equity options in Hansen Medical; Dr. Gervais, receiving grant support from Covidien; and Dr. Jewett, receiving consulting fees from Pfizer, Novartis, Glaxo-Smith-Kline, and Viventia Biotech and grant support from Wyeth. No other potential conflict of interest relevant to this article was reported.	ARON M, 2010, J UROL          0118; Aron M, 2008, BJU INT, V102, P86, DOI 10.1111/j.1464-410X.2008.07580.x; Barocas DA, 2007, BJU INT, V99, P290, DOI 10.1111/j.1464-410X.2006.06607.x; Birnbaum BA, 2007, RADIOLOGY, V244, P767, DOI 10.1148/radiol.2443061537; Breen DJ, 2007, CARDIOVASC INTER RAD, V30, P936, DOI 10.1007/s00270-007-9090-x; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Chatterjee S, 2004, UROL ONCOL-SEMIN ORI, V22, P36, DOI 10.1016/S1078-1439(03)00099-1; Chawla SN, 2006, J UROLOGY, V175, P425, DOI 10.1016/S0022-5347(05)00148-5; Crispen PL, 2008, CANCER-AM CANCER SOC, V112, P1051, DOI 10.1002/cncr.23268; Fergany AF, 2000, J UROLOGY, V163, P442, DOI 10.1016/S0022-5347(05)67896-2; Frank I, 2003, J UROLOGY, V170, P2217, DOI 10.1097/01.ju.0000095475.12515.5e; Gervais DA, 2005, AM J ROENTGENOL, V185, P64, DOI 10.2214/ajr.185.1.01850064; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Gill IS, 2010, J UROLOGY, V183, P34, DOI 10.1016/j.juro.2009.08.114; Gill IS, 2005, J UROLOGY, V173, P1903, DOI 10.1097/01.ju.0000158154.28845.c9; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Hollingsworth JM, 2007, CANCER-AM CANCER SOC, V109, P1763, DOI 10.1002/cncr.22600; Hollingsworth JM, 2006, JNCI-J NATL CANCER I, V98, P1331, DOI 10.1093/jnci/djj362; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Israel GM, 2005, RADIOLOGY, V236, P441, DOI 10.1148/radiol.2362040218; Klatte T, 2008, J UROLOGY, V179, P1719, DOI 10.1016/j.juro.2008.01.018; Kunkle DA, 2007, J UROLOGY, V177, P849, DOI 10.1016/j.juro.2006.10.073; Lane BR, 2010, J UROLOGY, V183, P473, DOI 10.1016/j.juro.2009.10.023; Lau WKO, 2000, MAYO CLIN PROC, V75, P1236; Lee CT, 2000, J UROLOGY, V163, P730, DOI 10.1016/S0022-5347(05)67793-2; Lee CT, 2002, UROL ONCOL, V7, P135, DOI 10.1016/S1078-1439(01)00185-5; Ljungberg B, 2007, EUR UROL, V51, P1502, DOI 10.1016/j.eururo.2007.03.035; Nguyen MM, 2008, J UROLOGY, V179, P627, DOI 10.1016/j.juro.2007.09.086; Nguyen MM, 2006, J UROLOGY, V176, P2397, DOI 10.1016/j.juro.2006.07.144; Nguyen MM, 2009, J UROLOGY, V181, P1020, DOI 10.1016/j.juro.2008.11.023; Pahernik S, 2007, J UROLOGY, V178, P414, DOI 10.1016/j.juro.2007.03.129; Raman JD, 2008, J UROLOGY, V179, P2142, DOI 10.1016/j.juro.2008.01.119; Remzi M, 2006, J UROLOGY, V176, P896, DOI 10.1016/j.juro.2006.04.047; Richstone L, 2008, UROLOGY, V71, P36, DOI 10.1016/j.urology.2007.09.062; Rybicki FJ, 2003, AM J ROENTGENOL, V180, P1281, DOI 10.2214/ajr.180.5.1801281; Shannon BA, 2008, J UROLOGY, V180, P1257, DOI 10.1016/j.juro.2008.06.030; Silverman SG, 2008, RADIOLOGY, V249, P16, DOI 10.1148/radiol.2491070783; Siu W, 2007, UROL ONCOL-SEMIN ORI, V25, P115, DOI 10.1016/j.urolonc.2006.07.018; TADA S, 1983, CLIN RADIOL, V34, P437, DOI 10.1016/S0009-9260(83)80238-4; Turna B, 2008, UROLOGY, V72, P481, DOI 10.1016/j.urology.2008.01.056; Uzzo RG, 2001, J UROLOGY, V166, P6, DOI 10.1016/S0022-5347(05)66066-1; Van Poppel H, 2007, EUR UROL, V51, P1606, DOI 10.1016/j.eururo.2006.11.013; Volpe A, 2004, CANCER-AM CANCER SOC, V100, P738, DOI 10.1002/cncr.20025; Volpe A, 2007, J UROLOGY, V178, P379, DOI 10.1016/j.juro.2007.03.131; Volpe A, 2007, NAT CLIN PRACT UROL, V4, P2, DOI 10.1038/ncpuro0674; Yoshimura K, 2003, J UROLOGY, V169, P182, DOI 10.1016/S0022-5347(05)64063-3; Zagoria RJ, 2007, AM J ROENTGENOL, V189, P429, DOI 10.2214/AJR.07.2258	49	294	315	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					624	634		10.1056/NEJMcp0910041	http://dx.doi.org/10.1056/NEJMcp0910041			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556ED	20164486				2022-12-28	WOS:000274571200010
J	Moss, RH; Edmonds, JA; Hibbard, KA; Manning, MR; Rose, SK; van Vuuren, DP; Carter, TR; Emori, S; Kainuma, M; Kram, T; Meehl, GA; Mitchell, JFB; Nakicenovic, N; Riahi, K; Smith, SJ; Stouffer, RJ; Thomson, AM; Weyant, JP; Wilbanks, TJ				Moss, Richard H.; Edmonds, Jae A.; Hibbard, Kathy A.; Manning, Martin R.; Rose, Steven K.; van Vuuren, Detlef P.; Carter, Timothy R.; Emori, Seita; Kainuma, Mikiko; Kram, Tom; Meehl, Gerald A.; Mitchell, John F. B.; Nakicenovic, Nebojsa; Riahi, Keywan; Smith, Steven J.; Stouffer, Ronald J.; Thomson, Allison M.; Weyant, John P.; Wilbanks, Thomas J.			The next generation of scenarios for climate change research and assessment	NATURE			English	Article							MODEL; ATMOSPHERE	Advances in the science and observation of climate change are providing a clearer understanding of the inherent variability of Earth's climate system and its likely response to human and natural influences. The implications of climate change for the environment and society will depend not only on the response of the Earth system to changes in radiative forcings, but also on how humankind responds through changes in technology, economies, lifestyle and policy. Extensive uncertainties exist in future forcings of and responses to climate change, necessitating the use of scenarios of the future to explore the potential consequences of different response options. To date, such scenarios have not adequately examined crucial possibilities, such as climate change mitigation and adaptation, and have relied on research processes that slowed the exchange of information among physical, biological and social scientists. Here we describe a new process for creating plausible scenarios to investigate some of the most challenging and important questions about climate change confronting the global community.	[Moss, Richard H.; Edmonds, Jae A.; Smith, Steven J.; Thomson, Allison M.] Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Hibbard, Kathy A.; Meehl, Gerald A.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA; [Manning, Martin R.] Victoria Univ Wellington, New Zealand Climate Change Res Inst, Wellington, New Zealand; [Rose, Steven K.] Elect Power Res Inst, Washington, DC 20036 USA; [van Vuuren, Detlef P.; Kram, Tom] Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands; [Carter, Timothy R.] Finnish Environm Inst, Helsinki 00251, Finland; [Emori, Seita; Kainuma, Mikiko] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Mitchell, John F. B.] Met Off, Exeter EX1 3PB, Devon, England; [Nakicenovic, Nebojsa; Riahi, Keywan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Nakicenovic, Nebojsa] Vienna Univ Technol, A-1040 Vienna, Austria; [Stouffer, Ronald J.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; [Weyant, John P.] Stanford Univ, Stanford, CA 94305 USA; [Wilbanks, Thomas J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; National Center Atmospheric Research (NCAR) - USA; Victoria University Wellington; Electric Power Research Institute (EPRI); Netherlands National Institute for Public Health & the Environment; Finnish Environment Institute; National Institute for Environmental Studies - Japan; Met Office - UK; International Institute for Applied Systems Analysis (IIASA); Technische Universitat Wien; National Oceanic Atmospheric Admin (NOAA) - USA; Stanford University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Moss, RH (corresponding author), Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, 5825 Univ Res Court,Suite 3500, College Pk, MD 20740 USA.	rhm@pnl.gov	van Vuuren, Detlef P./A-4764-2009; Thomson, Allison/GRO-3207-2022; Riahi, Keywan/B-6426-2011; Carter, Timothy R/N-4411-2017; Smith, Steven/HDM-9496-2022; Emori, Seita/D-1950-2012; Thomson, Allison M/B-1254-2010; Smith, Steven/F-4502-2010	van Vuuren, Detlef P./0000-0003-0398-2831; Riahi, Keywan/0000-0001-7193-3498; Carter, Timothy R/0000-0002-4026-8859; Thomson, Allison M/0000-0001-5326-1755; Smith, Steven/0000-0003-3248-5607; Moss, Richard/0000-0001-5005-0063				Alcamo J., 1995, CLIMATE CHANGE 1994, P247; [Anonymous], 1998, REGIONAL IMPACTS CLI; Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Bradfield R, 2005, FUTURES, V37, P795, DOI 10.1016/j.futures.2005.01.003; CAIVIN K, 2009, ENERG ECON, V31, pS107; CARPENTER SR, 2005, ECOSYSTEMS HUMAN WEL, V2, P551; Carter T., 2007, GEN GUIDELINES USE S; Carter T.R., 2000, CLIMATE CHANGE 21 CE; Carter TR, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P133; CARTER TR, 1991, INT J CLIMATOL, V11, P251; Carter TR, 1994, IPCC TECHNICAL GUIDE; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clarke L., 2007, SCENARIOS GREENHOUSE; Clarke L, 2009, ENERG ECON, V31, pS63, DOI 10.1016/j.eneco.2009.10.014; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Downing TE, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P105; Fisher B, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P169; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gaffin SR, 2004, GLOBAL ENVIRON CHANG, V14, P105, DOI 10.1016/j.gloenvcha.2004.02.004; Grubler A, 2001, NATURE, V412, P15, DOI 10.1038/35083752; Grubler A, 2007, TECHNOL FORECAST SOC, V74, P980, DOI 10.1016/j.techfore.2006.05.023; Hafele Wolfgang, 1981, ENERGY FINITE WORLD; HANSEN J, 1988, J GEOPHYS RES-ATMOS, V93, P9341, DOI 10.1029/JD093iD08p09341; Herrera Amilcar O., 1976, CATASTROPHE NEW SOC; Hibbard K. A., 2007, EOS T, V88, P217, DOI DOI 10.1029/2007EO200002; Hijioka Y., 2008, J GLOBAL ENV ENG, V13, P97; HULME M, 1995, ENERG POLICY, V23, P347, DOI 10.1016/0301-4215(95)90159-5; Huntingford C, 2000, CLIM DYNAM, V16, P575, DOI 10.1007/s003820000067; Huntingford C, 2007, SCIENCE, V316, P829; Hurtt G. C., 2009, ILEAPS NEWSL, V7, P6; Intergovt Panel Climate Change, 1990, CLIMATE CHANGE: THE IPCC SCIENTIFIC ASSESSMENT, P1; International Energy Agency, 2009, WORLD EN OUTL; JEFFERSON M, 1983, POSITIVE EC, P122; Kahn H., 1967, YEAR 2000 FRAMEWORK; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; Lamarque J.-F., 2009, IGAC NEWSL, V41, P12; Le Treut H, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P93; Leggett J., 1992, CLIMATE CHANGE 1992, P69; LEONTIEF W, 1976, FUTURE WORLD EC STUD; Malone E, 2009, NEW HORIZ ENVIRON EC, P8; MANABE S, 1967, J ATMOS SCI, V24, P241, DOI 10.1175/1520-0469(1967)024<0241:TEOTAW>2.0.CO;2; MANABE S, 1975, J PHYS OCEANOGR, V5, P3, DOI 10.1175/1520-0485(1975)005<0003:AGOACM>2.0.CO;2; Matsuoka Y, 2006, ENERGY J, V3, P343; MEADOWS D H, 1972, P205; Mearns LO, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P739; Meehl GA, 2007, ICPO PUBLICATION, V112; Meehl GA, 2009, B AM METEOROL SOC, V90, P1467, DOI 10.1175/2009BAMS2778.1; MELILLO JM, 1995, GLOBAL BIOGEOCHEM CY, V9, P407; Mesarovic M. D., 1974, MANKIND TURNING POIN; Mitchell TD, 2003, CLIMATIC CHANGE, V60, P217, DOI 10.1023/A:1026035305597; MORITA T, 2007, CLIMATE CHANGE 2001, P115; Moss R.H., 2008, IPCC EXPERT M REPORT; Murphy J.M, 2009, UK CLIMATE PROJECTIO; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Nakicenovic N., 1998, MITIGATION ADAPTATIO, V3, P95, DOI DOI 10.1023/A:1009699523349; Parson E, 2007, GLOBAL CHANGE SCENAR; Pittock AB, 2001, NATURE, V413, P249, DOI 10.1038/35095194; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Rao S, 2008, IR08020 IIASA; Riahi K., 2006, ENERGY J, V3, P177; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Robertson J., 1983, SANE ALTERNATIVE CHO; Ruosteenoja K., 2003, FUTURE CLIMATE WORLD; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Schwartz P., 1996, ART LONG VIEW PLANNI; Smith J.B., 1996, VULNERABILITY ADAPTA, V1996th; Smith SJ, 2006, ENERG J, P373; Svedin U., 1987, SURPRISING FUTURES N; Taylor KE, 2009, SUMMARY CMIP5 EXPT D; U.S. Climate Change Science Program, 2003, STRAT PLAN CLIM CHAN; *UK CLIM IMP PROGR, 2001, SOC SCEN CLIM CHANG; *US DOE, 2009, SCI CHALL FUT DIR CL; Van der Linden P., 2009, ENSEMBLES CLIMATE CH; Van Vuuren DP, 2008, P NATL ACAD SCI USA, V105, P15258, DOI 10.1073/pnas.0711129105; van Vuuren D.P., 2008, WORK PLAN DATA EXCHA; van Vuuren DP, 2007, CLIMATIC CHANGE, V81, P119, DOI 10.1007/s10584-006-9172-9; van Vuuren DP, 2007, GLOBAL ENVIRON CHANG, V17, P114, DOI 10.1016/j.gloenvcha.2006.04.004; VANVUUREN DP, 2006, ENERGY J, V3, P201; Vuuren D, 2008, CLIMATIC CHANGE, V91, P237, DOI 10.1007/s10584-008-9485-y; Weyant J., 2009, REPORT 2 6 VERSUS 2; Weyant J, 1996, CLIMATE CHANGE 1995, P374; Weyant JR, 2006, ENERG J, P1; Wigley TML, 2007, HUMAN-INDUCED CLIMATE CHANGE: AN INTERDISCIPLINARY ASSESSMENT, P84, DOI 10.1017/CBO9780511619472.009; *WMO UNEP ICSU, 1984, WCP83 WMOUNEPICSU UN; *WMO UNEP ICSU, 1986, 661 WMOUNEPICSU UNES; *WORLD EN COUNC, 1993, EN TOM WORLD	86	4131	4286	97	2134	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					747	756		10.1038/nature08823	http://dx.doi.org/10.1038/nature08823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	553VG	20148028				2022-12-28	WOS:000274394300028
J	Brown, RE				Brown, Raeford E., Jr.			Coda: Don't Touch Me	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rbrow1@email.eky.edu	Brown, Raeford/I-1211-2019	Brown, Raeford/0000-0002-2295-2657				Brown RE, 2009, JAMA-J AM MED ASSOC, V302, P2409, DOI 10.1001/jama.2009.1675	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					494	494		10.1001/jama.303.6.494	http://dx.doi.org/10.1001/jama.303.6.494			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145217				2022-12-28	WOS:000274378700002
J	Shuhaiber, JH; Hur, K; Gibbons, R				Shuhaiber, Jeffrey H.; Hur, Kwan; Gibbons, Robert			The influence of preoperative use of ventricular assist devices on survival after heart transplantation: propensity score matched analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REJECTION; SUPPORT; BIAS	Objective To determine the influence of the preoperative placement of a left ventricular assist device on survival after heart transplantation. Design Prospective cohort study. Setting Organ sharing database with patient level data on heart transplants in the United States. Participants 2786 adults aged 18 or older in status 1A or 1B (highest priority for heart transplantation with either some form of ventricular assist device, intravenous inotrope, or life expectancy of less than seven days), based on the United Network for Organ Sharing Registry, 1996-2004. Main outcome measure Survival after heart transplantation in patients who did and did not receive a left ventricular assist device. Results The left ventricular assist device was not associated with decreased survival, even after the data were stratified by propensity score (the odds of being a treated patient). Inspection of the strata showed no difference in survival between patients who received the device and those who did not. The hazard ratios in strata 1 to 5 were 0.69, 1.37, 1.55, 0.75, and 1.19, respectively, and none was statistically significant. Conclusion Overall, survival after heart transplantation in patients who received a left ventricular assist device before transplantation was comparable to those who did not receive the device.	[Shuhaiber, Jeffrey H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Cardiovasc Surg, Cincinnati, OH 45229 USA; [Hur, Kwan; Gibbons, Robert] Univ Illinois, Ctr Hlth Stat, Chicago, IL USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shuhaiber, JH (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Cardiovasc Surg, MLC 2004, Cincinnati, OH 45229 USA.	jeffrey.shuhaiber@gmail.com						Ashton RC, 1996, J HEART LUNG TRANSPL, V15, P1151; Bank AJ, 2000, ANN THORAC SURG, V69, P1369, DOI 10.1016/S0003-4975(00)01083-3; Deng XH, 2003, ELEC SOC S, V2003, P653; DeNofrio D, 2000, TRANSPLANTATION, V69, P814; Frazier OH, 2001, J THORAC CARDIOV SUR, V122, P1186, DOI 10.1067/mtc.2001.118274; Gonzalez-Stawinski GV, 2005, TRANSPL P, V37, P1349, DOI 10.1016/j.transproceed.2004.12.111; Hosenpud JD, 2001, J HEART LUNG TRANSPL, V20, P805, DOI 10.1016/S1053-2498(01)00323-0; Jaski BE, 1999, J HEART LUNG TRANSPL, V18, P1031, DOI 10.1016/S1053-2498(99)00071-6; Massad MG, 1996, J THORAC CARDIOV SUR, V112, P1275, DOI 10.1016/S0022-5223(96)70141-1; Morgan JA, 2003, J THORAC CARDIOV SUR, V126, P1188, DOI 10.1016/S0022-5223(03)00935-8; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; ROSENBAUM PR, 1985, BIOMETRICS, V41, P103, DOI 10.2307/2530647; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; RUBIN DB, 1996, J AM STAT ASSOC, V91, P473, DOI DOI 10.2307/2291635	16	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2010	340								c392	10.1136/bmj.c392	http://dx.doi.org/10.1136/bmj.c392			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZT	20147346	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000274476900002
J	Smith, ZR; Long, JA				Smith, Zachery R.; Long, Jeff A.			Control of Arabidopsis apical-basal embryo polarity by antagonistic transcription factors	NATURE			English	Article							TRANSGENIC PLANTS; AUXIN GRADIENTS; GENE; MERISTEM; SHOOTS; TRANSFORMATION; PHABULOSA; PROTEINS; GROWTH; MUTANT	Plants, similarly to animals, form polarized axes during embryogenesis on which cell differentiation and organ patterning programs are orchestrated. During Arabidopsis embryogenesis, establishment of the shoot and root stem cell populations occurs at opposite ends of an apical-basal axis. Recent work has identified the PLETHORA (PLT) genes as master regulators of basal/root fate(1-3), whereas the master regulators of apical/shoot fate have remained elusive. Here we show that the PLT1 and PLT2 genes are direct targets of the transcriptional co-repressor TOPLESS (TPL) and that PLT1/2 are necessary for the homeotic conversion of shoots to roots in tpl-1 mutants. Using tpl-1 as a genetic tool, we identify the CLASS III HOMEODOMAIN-LEUCINE ZIPPER (HD-ZIP III) transcription factors as master regulators of embryonic apical fate, and show they are sufficient to drive the conversion of the embryonic root pole into a second shoot pole. Furthermore, genetic and misexpression studies show an antagonistic relationship between the PLT and HD-ZIP III genes in specifying the root and shoot poles.	[Smith, Zachery R.; Long, Jeff A.] Univ Calif San Diego, Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Smith, Zachery R.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Long, JA (corresponding author), Univ Calif San Diego, Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	long@salk.edu			Ray Thomas Edwards Foundation Career Development Award; National Institute of Health, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER	Ray Thomas Edwards Foundation Career Development Award; National Institute of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Sewell for technical assistance with plasmid construction and microscopy; R. Biddick, B. Crawford, Y. Jaillais, N. Krogan, J. Posakony, B. VanSchooten and D. Kelley for discussions and reading of the manuscript; E. York and SIO Unified Laboratory Facility for SEM analysis. This work was supported by a Ray Thomas Edwards Foundation Career Development Award, the National Institute of Health, NIGMS ( J. A. L.), Z.R.S. is a USCD Plant Systems Biology NSF-IGERT Fellow.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; GARBARINO JE, 1994, PLANT MOL BIOL, V24, P119, DOI 10.1007/BF00040579; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Grigg SP, 2009, CURR BIOL, V19, P1485, DOI 10.1016/j.cub.2009.06.070; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Long JA, 2002, DEVELOPMENT, V129, P2797; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Zhong RQ, 1999, PLANT PHYSIOL, V120, P53, DOI 10.1104/pp.120.1.53	24	130	147	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					423	U121		10.1038/nature08843	http://dx.doi.org/10.1038/nature08843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20190735	Green Accepted, Green Submitted			2022-12-28	WOS:000275657100049
J	Selvin, E; Steffes, MW; Zhu, H; Matsushita, K; Wagenknecht, L; Pankow, J; Coresh, J; Brancati, FL				Selvin, Elizabeth; Steffes, Michael W.; Zhu, Hong; Matsushita, Kunihiro; Wagenknecht, Lynne; Pankow, James; Coresh, Josef; Brancati, Frederick L.			Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; ENZYMATIC DETERMINATION; MORTALITY; A(1C); A1C; GLYCEMIA; CHOLESTEROL; MORBIDITY; OUTCOMES	Background: Fasting glucose is the standard measure used to diagnose diabetes in the United States. Recently, glycated hemoglobin was also recommended for this purpose. Methods: We compared the prognostic value of glycated hemoglobin and fasting glucose for identifying adults at risk for diabetes or cardiovascular disease. We measured glycated hemoglobin in whole-blood samples from 11,092 black or white adults who did not have a history of diabetes or cardiovascular disease and who attended the second visit (occurring in the 1990-1992 period) of the Atherosclerosis Risk in Communities (ARIC) study. Results: The glycated hemoglobin value at baseline was associated with newly diagnosed diabetes and cardiovascular outcomes. For glycated hemoglobin values of less than 5.0%, 5.0 to less than 5.5%, 5.5 to less than 6.0%, 6.0 to less than 6.5%, and 6.5% or greater, the multivariable-adjusted hazard ratios (with 95% confidence intervals) for diagnosed diabetes were 0.52 (0.40 to 0.69), 1.00 (reference), 1.86 (1.67 to 2.08), 4.48 (3.92 to 5.13), and 16.47 (14.22 to 19.08), respectively. For coronary heart disease, the hazard ratios were 0.96 (0.74 to 1.24), 1.00 (reference), 1.23 (1.07 to 1.41), 1.78 (1.48 to 2.15), and 1.95 (1.53 to 2.48), respectively. The hazard ratios for stroke were similar. In contrast, glycated hemoglobin and death from any cause were found to have a J-shaped association curve. All these associations remained significant after adjustment for the baseline fasting glucose level. The association between the fasting glucose levels and the risk of cardiovascular disease or death from any cause was not significant in models with adjustment for all covariates as well as glycated hemoglobin. For coronary heart disease, measures of risk discrimination showed significant improvement when glycated hemoglobin was added to models including fasting glucose. Conclusions: In this community-based population of nondiabetic adults, glycated hemoglobin was similarly associated with a risk of diabetes and more strongly associated with risks of cardiovascular disease and death from any cause as compared with fasting glucose. These data add to the evidence supporting the use of glycated hemoglobin as a diagnostic test for diabetes. N Engl J Med 2010;362:800-11.	[Selvin, Elizabeth] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [Selvin, Elizabeth; Matsushita, Kunihiro; Coresh, Josef; Brancati, Frederick L.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA; [Zhu, Hong; Coresh, Josef] Johns Hopkins Univ, Dept Biostat, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; [Selvin, Elizabeth; Coresh, Josef; Brancati, Frederick L.] Johns Hopkins Univ, Div Gen Internal Med, Dept Med, Baltimore, MD 21287 USA; [Steffes, Michael W.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Pankow, James] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Wagenknecht, Lynne] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center	Selvin, E (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 2024 E Monument St,Suite 2-600, Baltimore, MD 21287 USA.	lselvin@jhsph.edu	Zhu, Hong/G-3510-2012; Matsushita, Kunihiro/AAJ-5817-2020	Matsushita, Kunihiro/0000-0002-7179-718X; Ballantyne, Christie/0000-0002-6432-1730; Pankow, James/0000-0001-7076-483X	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R21 DK080294, K01 DK076595, K24 DK62222, P60 DK079637]; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055016, N01HC055022, N01HC055019, N01HC055018, N01HC055020, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R41HL055019, R42HL055018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, R21DK080294, K24DK062222, K01DK076595, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R21 DK080294 and K01 DK076595, to Dr. Selvin; and K24 DK62222, to Dr. Brancati); contracts with the National Heart, Lung, and Blood Institute (N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022); and an NIDDK grant (P60 DK079637, to Dr. Brancati through the Johns Hopkins Diabetes Research and Training Center).	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; *ATH RISK COMM COO, 1987, 10 U N CAR SCH PUBL; *ATH RISK COMM COO, 1987, 11 U N CAR SCH PUBL; *ATH RISK COMM COO, 1987, 2 U N CAR SCH PUBL H; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471; Blake GJ, 2004, ARCH INTERN MED, V164, P757, DOI 10.1001/archinte.164.7.757; Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; DCCT Res Grp, 1986, DIABETES, V35, P530; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Levitan EB, 2008, DIABETOLOGIA, V51, P267, DOI 10.1007/s00125-007-0882-y; Meigs JB, 1996, J CLIN EPIDEMIOL, V49, P411, DOI 10.1016/0895-4356(95)00513-7; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PHILLIPOU G, 1993, CLIN CHEM, V39, P2305; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Selvin E, 2005, LANCET NEUROL, V4, P821, DOI 10.1016/S1474-4422(05)70227-1; Selvin E, 2005, ARCH INTERN MED, V165, P1910, DOI 10.1001/archinte.165.16.1910; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Selvin E, 2009, DIABETES CARE, V32, P828, DOI 10.2337/dc08-1699; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Stout Robert L, 2007, J Insur Med, V39, P174; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	45	1046	1101	3	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					800	811		10.1056/NEJMoa0908359	http://dx.doi.org/10.1056/NEJMoa0908359			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	20200384	Green Accepted, Green Published			2022-12-28	WOS:000275108300007
J	Omer, SB; Hiremath, GS; Halsey, NA				Omer, Saad B.; Hiremath, Girish S.; Halsey, Neal A.			Respiratory administration of measles vaccine	LANCET			English	Editorial Material							AEROSOL; IMMUNIZATION; CHILDREN		[Omer, Saad B.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Omer, Saad B.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Omer, Saad B.] Emory Vaccine Ctr, Atlanta, GA USA; [Hiremath, Girish S.] INOVA Fairfax Hosp Children, Fairfax, VA USA; [Halsey, Neal A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Halsey, Neal A.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD USA	Emory University; Rollins School Public Health; Emory University; Emory University; Inova Fairfax Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Omer, SB (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	somer@emory.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474				[Anonymous], MMWR MORB MORTAL WKL; Bellanti JA, 2004, VACCINE, V22, P1214, DOI 10.1016/j.vaccine.2003.09.032; Fernandez-de Castro J, 1997, Salud Publica Mex, V39, P53; Hiremath GS, 2005, HUM VACCINES, V1, P30, DOI 10.4161/hv.1.1.1423; KHANUM S, 1987, LANCET, V1, P150; LiCalsi C, 2001, VACCINE, V19, P2629, DOI 10.1016/S0264-410X(00)00503-X; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; SABIN AB, 1983, JAMA-J AM MED ASSOC, V249, P2651, DOI 10.1001/jama.249.19.2651; SABIN AB, 1992, PEDIATRICS, V90, P162; Tosh PK, 2008, MAYO CLIN PROC, V83, P77, DOI 10.4065/83.1.77; *WHO, 2008, OUTC 61 WORLD HLTH A; *WHO, 2009, MEAS AER PROJ; World Health Organization, 2006, IN VACC RES STRAT PL	13	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					706	708		10.1016/S0140-6736(09)62028-6	http://dx.doi.org/10.1016/S0140-6736(09)62028-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JW	20189011				2022-12-28	WOS:000275211200009
J	Sun, TT; Tseng, SC; Lavker, RM				Sun, Tung-Tien; Tseng, Scheffer C.; Lavker, Robert M.			Location of corneal epithelial stem cells	NATURE			English	Letter							OCULAR SURFACE; CLONAL ANALYSIS; DIFFERENTIATION; MOVEMENT; CONJUNCTIVAL; ABSENCE; GROWTH; BULBAR; SKIN		[Sun, Tung-Tien] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Tseng, Scheffer C.] Ocular Surface Res & Educ Fdn, Ocular Surface Ctr, Dept Tissue Technol, Miami, FL 33173 USA; [Lavker, Robert M.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA	New York University; New York University; New York University; New York University; Northwestern University; Feinberg School of Medicine	Sun, TT (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	sunt01@nyumc.org	Sun, Tung-Tien/J-4425-2015	Sun, Tung-Tien/0000-0002-6841-1063				AURAN JD, 1995, OPHTHALMOLOGY, V102, P33; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DORAN TI, 1980, CELL, V22, P17, DOI 10.1016/0092-8674(80)90150-6; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Kenyon KR, 1989, OPHTHALMOLOGY, V96, P722; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Nagasaki T, 2005, INVEST OPHTH VIS SCI, V46, P126, DOI 10.1167/iovs.04-0356; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SUN TT, 1977, NATURE, V269, P489, DOI 10.1038/269489a0; Wei ZG, 1996, INVEST OPHTH VIS SCI, V37, P523; WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814	16	74	75	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 25	2010	463	7284					E10	E10		10.1038/nature08805	http://dx.doi.org/10.1038/nature08805			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182462				2022-12-28	WOS:000275108400045
J	Staiger, DO; Auerbach, DI; Buerhaus, PI				Staiger, Douglas O.; Auerbach, David I.; Buerhaus, Peter I.			Trends in the Work Hours of Physicians in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; INCOME GAP	Context Recent trends in hours worked by physicians may affect workforce needs but have not been thoroughly analyzed. Objectives To estimate trends in hours worked by US physicians and assess for association with physician fees. Design, Setting, and Participants A retrospective analysis of trends in hours worked among US physicians using nationally representative workforce information from the US Census Bureau Current Population Survey between 1976 and 2008 (N = 116 733). Trends were estimated among all US physicians and by residency status, sex, age, and work setting. Trends in hours were compared with national trends in physician fees, and estimated separately for physicians located in metropolitan areas with high and low fees in 2001. Main Outcome Measure Self-reported hours worked in the week before the survey. Results After remaining stable through the early 1990s, mean hours worked per week decreased by 7.2% between 1996 and 2008 among all physicians (from 54.9 hours per week in 1996-1998 to 51.0 hours per week in 2006-2008; 95% confidence interval [CI], 5.3%-9.0%; P<.001). Excluding resident physicians, whose hours decreased by 9.8% (95% CI, 5.8%-13.7%; P<.001) in the last decade due to duty hour limits imposed in 2003, nonresident physician hours decreased by 5.7% (95% CI, 3.8%-7.7%; P<.001). The decrease in hours was largest for nonresident physicians younger than 45 years (7.4%; 95% CI, 4.7%-10.2%; P<.001) and working outside of the hospital (6.4%; 95% CI, 4.1%-8.7%; P<.001), and the decrease was smallest for those aged 45 years or older (3.7%; 95% CI, 1.0%-6.5%; P=.008) and working in the hospital (4.0%; 95% CI, 0.4%-7.6%; P=.03). After adjusting for inflation, mean physician fees decreased nationwide by 25% between 1995 and 2006, coincident with the decrease in physician hours. In 2001, mean physician hours were less than 49 hours per week in metropolitan areas with the lowest physician fees, whereas physician hours remained more than 52 hours per week elsewhere (P<.001 for difference). Conclusion A steady decrease in hours worked per week during the last decade was observed for all physicians, which was temporally and geographically associated with lower physician fees. JAMA. 2010; 303(8): 747-753	[Staiger, Douglas O.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Staiger, Douglas O.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Auerbach, David I.] Congress Budget Off, Hlth & Human Resources Div, Washington, DC USA; [Buerhaus, Peter I.] Vanderbilt Univ, Med Ctr, Inst Med & Publ Hlth, Ctr Interdisciplinary Hlth Workforce Studies,Sch, Nashville, TN USA	Dartmouth College; National Bureau of Economic Research; Congressional Budget Office; Vanderbilt University	Staiger, DO (corresponding author), Dartmouth Coll, Dept Econ, Rockefeller Hall, Hanover, NH 03755 USA.	doug.staiger@dartmouth.edu			National Institute on Aging [2 P01 AG19783-06]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: This work was supported by grant 2 P01 AG19783-06 from the National Institute on Aging (Dr Staiger).	*AM COUNC GRAD MED, STAT JUST IMP FIN AP; *AM MED ASS, SOC MON SYST PUBL US; American Medical Association, 2009, PHYS CHAR DISTR US; Blumenthal D, 2004, NEW ENGL J MED, V350, P1780, DOI 10.1056/NEJMhpr033066; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Bodenheimer T, 2009, NEW ENGL J MED, V360, P2693, DOI 10.1056/NEJMp0902909; Bureau of Labor Statistics, 2020, HOUS DAT ANN AV TABL; Centers for Medicare & Medicaid Services, NAT HLTH EXP DAT HIS; Council on Graduate Medical Education, 2005, PHYS WORKF POL GUID; *CTR MED MED SERV, 2008 ANN REP BOARDS; *CTR MED MED SERV, 2002 ANN REP BOARDS; *CTR MED MED SERV, 1997, 1997 ANN REP BOARDS; Dill MJ, COMPLEXITIES PHYS SU; IGLEHART J, REFORM HLTH CARE WOR; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; Isaacs SL, 2009, NEW ENGL J MED, V360, P655, DOI 10.1056/NEJMp0808076; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, P442, DOI 10.1001/jama.289.4.442; Lasser KE, 2008, J GEN INTERN MED, V23, P1477, DOI 10.1007/s11606-008-0660-7; MCGUIRE TG, 1991, J HEALTH ECON, V10, P385, DOI 10.1016/0167-6296(91)90022-F; Mechanic D, 2003, JAMA-J AM MED ASSOC, V290, P941, DOI 10.1001/jama.290.7.941; *MED PAYM ADV COMM, REP C IMP INC MED PR; *MEDPAC, 1999, MED PHYS PAYM RAT CO; *MEDPAC, REP C MED PAYM POL S; Pham HH, 2004, HEALTH AFFAIR, V23, P70, DOI 10.1377/hlthaff.23.2.70; Rones PL, 1997, MON LABOR REV, V120, P3; Sandy LG, 2009, HEALTH AFFAIR, V28, P1136, DOI 10.1377/hlthaff.28.4.1136; *SEN FIN COMM, CALL ACT HLTH REF 20; Staiger DO, 2009, JAMA-J AM MED ASSOC, V302, P1674, DOI 10.1001/jama.2009.1461; Tu HT, 2006, LOSING GROUND PHYS I; U.S. Department of Health and Human Services, 2006, PHYS SUPPL DEM PROJ; *US CONGR BUDG OFF, KEY ISS AN MAJ HLTH; US Department of Health and Human Services, 2008, PHYS WORKF PROJ RES; *US GOV ACC OFF, REP HON P RYAN HOUS; WOOLDRIDGE JM, 2002, ECONOMETRIC ANAL CRO, pCH7; Zuger A, 2004, NEW ENGL J MED, V350, P69, DOI 10.1056/NEJMsr031703	35	105	105	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					747	753		10.1001/jama.2010.168	http://dx.doi.org/10.1001/jama.2010.168			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559DD	20179284	Bronze, Green Accepted			2022-12-28	WOS:000274800000026
J	Escudier, B				Escudier, Bernard			Chemo-immunotherapy in RCC: the end of a story	LANCET			English	Editorial Material							RENAL-CELL CARCINOMA; INTERFERON-ALPHA; RECOMBINANT INTERLEUKIN-2; COMBINATION; SUNITINIB; THERAPY		Inst Gustave Roussy, Dept Med Oncol, F-94805 Villejuif, France	UNICANCER; Gustave Roussy	Escudier, B (corresponding author), Inst Gustave Roussy, Dept Med Oncol, Rue Camille Desmoulins, F-94805 Villejuif, France.	bernard.escudier@igr.fr						Atzpodien J, 2001, BRIT J CANCER, V85, P1130, DOI 10.1054/bjoc.2001.2076; Atzpodien J, 2004, J CLIN ONCOL, V22, P1188, DOI 10.1200/JCO.2004.06.155; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Gore ME, 2010, LANCET, V375, P641, DOI 10.1016/S0140-6736(09)61921-8; Hanninen EL, 1996, J UROLOGY, V155, P19, DOI 10.1016/S0022-5347(01)66527-3; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Negrier S, 2000, J CLIN ONCOL, V18, P4009, DOI 10.1200/JCO.2000.18.24.4009; Negrier S, 2007, CANCER-AM CANCER SOC, V110, P2468, DOI 10.1002/cncr.23056; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Ritchie A, 1999, LANCET, V353, P14; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; WEST WH, 1987, NEW ENGL J MED, V316, P898, DOI 10.1056/NEJM198704093161502; YANG JC, 1994, J CLIN ONCOL, V12, P1572, DOI 10.1200/JCO.1994.12.8.1572	16	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					613	614		10.1016/S0140-6736(10)60209-7	http://dx.doi.org/10.1016/S0140-6736(10)60209-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20171385				2022-12-28	WOS:000275210900004
J	Wiseman, RL; Haynes, CM; Ron, D				Wiseman, R. Luke; Haynes, Cole M.; Ron, David			SnapShot: The Unfolded Protein Response	CELL			English	Editorial Material							ATF6; IRE1; RNA		[Wiseman, R. Luke] Scripps Res Inst, La Jolla, CA 92037 USA; [Haynes, Cole M.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Ron, David] NYU, Sch Med, New York, NY USA; [Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge, England	Scripps Research Institute; Memorial Sloan Kettering Cancer Center; New York University; University of Cambridge	Wiseman, RL (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.			Wiseman, Luke/0000-0001-9287-6840; Ron, David/0000-0002-3014-5636				Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	7	40	42	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					590	U162	590.e1	10.1016/j.cell.2010.02.006	http://dx.doi.org/10.1016/j.cell.2010.02.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178750	Bronze			2022-12-28	WOS:000274668400021
J	Bilham, R				Bilham, Roger			Lessons from the Haiti earthquake	NATURE			English	Editorial Material									Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Bilham, R (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	roger.bilham@colorado.edu		Bilham, Roger/0000-0002-5547-4102				Ali ST, 2008, GEOPHYS J INT, V174, P904, DOI 10.1111/j.1365-246X.2008.03634.x; BILHAM R, 1989, B SEISMOL SOC AM, V79, P425; Bilham R, 2009, B EARTHQ ENG, V7, P839, DOI 10.1007/s10518-009-9147-0; HOUGH SE, 2006, AFTER EARTH QUAKES; Kerr RA, 2010, SCIENCE, V327, P398, DOI 10.1126/science.327.5964.398; LAURSEN L, 2010, NATURE; Manaker DM, 2008, GEOPHYS J INT, V174, P889, DOI 10.1111/j.1365-246X.2008.03819.x; MCCANN W, 2004, P NSF CAR TSUN WORKS, P43; PRENTICE CS, 1993, GEOLOGY, V21, P49, DOI 10.1130/0091-7613(1993)021<0049:POTNAC>2.3.CO;2; ROSS S. S., 2010, 20101019 USGS; TUCKER B, 2010, ARCHITECTURE AID PRE; [No title captured]	12	118	121	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					878	879		10.1038/463878a	http://dx.doi.org/10.1038/463878a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164905				2022-12-28	WOS:000274582700023
J	Mook-Kanamori, DO; Steegers, EAP; Eilers, PH; Raat, H; Hofman, A; Jaddoe, VWV				Mook-Kanamori, Dennis O.; Steegers, Eric A. P.; Eilers, Paul H.; Raat, Hein; Hofman, Albert; Jaddoe, Vincent W. V.			Risk Factors and Outcomes Associated With First-Trimester Fetal Growth Restriction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BIRTH-WEIGHT; MATERNAL SMOKING; EARLY-CHILDHOOD; METABOLIC RISK; 1ST TRIMESTER; PREGNANCY; INFANT; LENGTH; COHORT; GAIN	Context Adverse environmental exposures lead to developmental adaptations in fetal life. The influences of maternal physical characteristics and lifestyle habits on first-trimester fetal adaptations and the postnatal consequences are not known. Objective To determine the risk factors and outcomes associated with first-trimester growth restriction. Design, Setting, and Participants Prospective evaluation of the associations of maternal physical characteristics and lifestyle habits with first-trimester fetal crown to rump length in 1631 mothers with a known and reliable first day of their last menstrual period and a regular menstrual cycle. Subsequently, we assessed the associations of first-trimester fetal growth restriction with the risks of adverse birth outcomes and postnatal growth acceleration until the age of 2 years. The study was based in Rotterdam, the Netherlands. Mothers were enrolled between 2001 and 2005. Main Outcome Measures First-trimester fetal growth was measured as fetal crown to rump length by ultrasound between the gestational age of 10 weeks 0 days and 13 weeks 6 days. Main birth outcomes were preterm birth (gestational age <37 weeks), low birth weight (<2500 g), and small size for gestational age (lowest fifth birth centile). Postnatal growth was measured until the age of 2 years. Results In the multivariate analysis, maternal age was positively associated with first-trimester fetal crown to rump length (difference per maternal year of age, 0.79 mm; 95% confidence interval [CI], 0.41 to 1.18 per standard deviation score increase). Higher diastolic blood pressure and higher hematocrit levels were associated with a shorter crown to rump length (differences, -0.40 mm; 95% CI, -0.74 to -0.06 and -0.52 mm; 95% CI, -0.90 to -0.14 per standard deviation increase, respectively). Compared with mothers who were nonsmokers and optimal users of folic acid supplements, those who both smoked and did not use folic acid supplements had shorter fetal crown to rump lengths (difference, -3.84 mm; 95% CI, -5.71 to -1.98). Compared with normal first-trimester fetal growth, first-trimester growth restriction was associated with increased risks of preterm birth (4.0% vs 7.2%; adjusted odds ratio [OR], 2.12; 95% CI, 1.24 to 3.61), low birth weight (3.5% vs 7.5%; adjusted OR, 2.42; 95% CI, 1.41 to 4.16), and small size for gestational age at birth (4.0% vs 10.6%; adjusted OR, 2.64; 95% CI, 1.64 to 4.25). Each standard deviation decrease in first-trimester fetal crown to rump length was associated with a postnatal growth acceleration until the age of 2 years (standard deviation score increase, 0.139 per 2 years; 95% CI, 0.097 to 0.181). Conclusions Maternal physical characteristics and lifestyle habits were independently associated with early fetal growth. First-trimester fetal growth restriction was associated with an increased risk of adverse birth outcomes and growth acceleration in early childhood. JAMA. 2010; 303(6): 527-534	[Mook-Kanamori, Dennis O.; Jaddoe, Vincent W. V.] Erasmus MC, Generat Study Grp R, NL-3000 CA Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, NL-3000 CA Rotterdam, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynecol, NL-3000 CA Rotterdam, Netherlands; [Eilers, Paul H.] Erasmus MC, Dept Biostat, NL-3000 CA Rotterdam, Netherlands; [Raat, Hein] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Jaddoe, VWV (corresponding author), Erasmus MC, Generat Study Grp AE 006 R, POB 2040, NL-3000 CA Rotterdam, Netherlands.	v.jaddoe@erasmusmc.nl			Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research [ZonMw 21000074, ZonMw 90700303]	Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research(Netherlands Organization for Health Research and Development)	The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, the Rotterdam Homecare Foundation, and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR), Rotterdam, the Netherlands. The first phase of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam, and the Netherlands Organization for Health Research (ZonMw 21000074). Dr Jaddoe reports receipt of funding from the Netherlands Organization for Health Research (ZonMw 90700303).	Aardenburg R, 2003, BJOG-INT J OBSTET GY, V110, P1001, DOI 10.1016/S1470-0328(03)02536-9; Bottomley C, 2009, HUM REPROD, V24, P284, DOI 10.1093/humrep/den389; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Bukowski R, 2007, BMJ-BRIT MED J, V334, P836, DOI 10.1136/bmj.39129.637917.AE; Bukowski R, 2007, AM J EPIDEMIOL, V165, P1216, DOI 10.1093/aje/kwm024; Dugoff L, 2004, AM J OBSTET GYNECOL, V191, P1446, DOI 10.1016/j.ajog.2004.06.052; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115; Jaddoe VWV, 2007, AM J EPIDEMIOL, V165, P1207, DOI 10.1093/aje/kwm014; Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P801, DOI 10.1007/s10654-008-9309-4; Jauniaux E, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.009; Kirchengast S, 1998, ANN HUM BIOL, V25, P17, DOI 10.1080/03014469800005402; Kuzawa CW, 2005, AM J HUM BIOL, V17, P5, DOI 10.1002/ajhb.20091; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Liu Y, 2004, AM J EPIDEMIOL, V160, P131, DOI 10.1093/aje/kwh188; Mukri F, 2008, BJOG-INT J OBSTET GY, V115, P1273, DOI 10.1111/j.1471-0528.2008.01833.x; *NAT COLL CTR WOM, NICE CLIN GUID ANT C; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Poon LCY, 2008, HYPERTENSION, V51, P1027, DOI 10.1161/HYPERTENSIONAHA.107.104646; ROBINSON HP, 1973, BMJ-BRIT MED J, V4, P28, DOI 10.1136/bmj.4.5883.28; *ROYAL COLL OBST G, ULTR SCREEN GUID; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Steegers-Theunissen RPM, 2000, BRIT J OBSTET GYNAEC, V107, P1513, DOI 10.1111/j.1471-0528.2000.tb11677.x; Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994; Troe EJWM, 2007, BJOG-INT J OBSTET GY, V114, P1557, DOI 10.1111/j.1471-0528.2007.01508.x; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Verburg BO, 2008, PRENATAL DIAG, V28, P323, DOI 10.1002/pd.1972; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003	32	189	193	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					527	534		10.1001/jama.2010.78	http://dx.doi.org/10.1001/jama.2010.78			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145229	Green Published, Bronze			2022-12-28	WOS:000274378700024
J	Martinez, C; Assimes, TL; Mines, D; Dell'Aniello, S; Suissa, S				Martinez, Carlos; Assimes, Themistocles L.; Mines, Daniel; Dell'Aniello, Sophie; Suissa, Samy			Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; VENTRICULAR-ARRHYTHMIA; DEPRESSIVE SYMPTOMS; ANTIPSYCHOTIC-DRUGS; UNITED-KINGDOM; TOXICITY; MORTALITY; ARREST; PREDICTORS; CISAPRIDE	Objective To assess whether use of the antidepressant venlafaxine is associated with an increased risk of sudden cardiac death or near death compared with other commonly used antidepressants. Design Population based observational study. Setting We did a nested case-control analysis within a new user cohort formed using the United Kingdom General Practice Research Database. Participants New users of venlafaxine, fluoxetine, citalopram, or dosulepin on or after 1 January 1995, aged 18 to 89 years, with a diagnosis of depression or anxiety. Participants were followed-up until February 2005, or the occurrence of sudden cardiac death or near death, identified from medical records indicating non-fatal acute ventricular tachyarrhythmia, sudden death due to cardiac causes, or out of hospital deaths from acute ischaemic cardiac events. For each case, 30 controls were selected matched for age, sex, calendar time, and indication. We used conditional logistic regression to calculate the adjusted odds ratio of sudden cardiac death or near death associated with current use of venlafaxine compared with current use of fluoxetine, citalopram or dosulepin. Results 207 384 participants were followed-up for an average of 3.3 years. There were 568 cases of sudden cardiac death or near death, which were matched to 14 812 controls. The adjusted odds ratio of sudden cardiac death or near death associated with venlafaxine use was 0.66 (95% confidence interval 0.38 to 1.14) relative to fluoxetine use, whereas compared with citalopram it was 0.89 (0.50 to 1.60) and with dosulepin 0.83 (0.46 to 1.52). Conclusions In this large, population based study, the use of venlafaxine was not associated with an excess risk of sudden cardiac death or near death compared with fluoxetine, dosulepin, or citalopram, in patients with depression or anxiety.	[Martinez, Carlos; Dell'Aniello, Sophie; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Martinez, Carlos; Dell'Aniello, Sophie; Suissa, Samy] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Martinez, Carlos; Dell'Aniello, Sophie; Suissa, Samy] McGill Univ, Dept Med, Montreal, PQ, Canada; [Martinez, Carlos] Carlos Martinez, Frankfurt, Germany; [Assimes, Themistocles L.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Mines, Daniel] Wyeth Ayerst Res, Philadelphia, PA USA	McGill University; McGill University; McGill University; Stanford University; Pfizer	Suissa, S (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, 3755 Cote Ste Catherine,Suite H4, Montreal, PQ H3T 1E2, Canada.	samy.suissa@mcgill.ca	subramanian, mohan S./D-4710-2009; Assimes, Themistocles Leonard/D-9696-2015	subramanian, mohan S./0000-0002-2236-5639; Assimes, Themistocles Leonard/0000-0003-2349-0009; Martinez, Carlos/0000-0001-6498-6428; Mines, Daniel/0000-0002-9134-2836	Wyeth; AstraZeneca; GlaxoSmithKline	Wyeth(Wyeth); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline)	This study was sponsored by Wyeth, which produces and markets venlafaxine. The contract for this research specified that the non-company authors had ultimate control over all aspects of the study, including control over publication. During the course of the study, however, any differences about the presentation or interpretation of findings that arose between the company author and external investigators were resolved through honest scientific debate. All authors had access to the statistical reports and tables supporting the publication.; DM is a employee of Wyeth and owns company stock options. SS has participated in advisory board meetings and conferences, participated as a speaker in scientific meetings by various companies (AstraZeneca, Boehringer Ingelheim, Glaxo SmithKline, Pfizer, and Sepracor), and received research grants from AstraZeneca, Wyeth, and GlaxoSmithKline. TA, SD, and CM have nothing to declare.	ANDA R, 1993, EPIDEMIOLOGY, V4, P285, DOI 10.1097/00001648-199307000-00003; *AR CTR ED RES THE, QT DRUG LISTS RISK G; Ariyo AA, 2000, CIRCULATION, V102, P1773; *BRIT MED ASS ROYA, 2009, BRIT NAT FORM, V58; Buckley NA, 2002, BRIT MED J, V325, P1332, DOI 10.1136/bmj.325.7376.1332; BUCKLEY NA, 1994, LANCET, V343, P159, DOI 10.1016/S0140-6736(94)90940-7; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P123; Chan CYY, 2007, CIRCULATION, V115, pE63, DOI 10.1161/CIRCULATIONAHA.106.657247; Cheeta S, 2004, BRIT J PSYCHIAT, V184, P41, DOI 10.1192/bjp.184.1.41; COLBRIDGE MG, 1999, J TOXICOL-CLIN TOXIC, V37, P383; De Maio VJ, 2000, ANN EMERG MED, V35, P138, DOI 10.1016/S0196-0644(00)70133-8; Egberts ACG, 1997, J CLIN PSYCHOPHARM, V17, P149, DOI 10.1097/00004714-199706000-00002; *EMC, 2008, EF SUMM PROD CHAR; Enger C, 2002, PHARMACOEPIDEM DR S, V11, P477, DOI 10.1002/pds.725; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; *GEN PRACT RES DAT, 2009, FACTS FIG; Heerdink ER, 2003, BRIT MED J, V326, P600; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; Hennessy S, 2008, PHARMACOEPIDEM DR S, V17, P1131, DOI 10.1002/pds.1632; Herlitz J, 2005, CORONARY ARTERY DIS, V16, P51, DOI 10.1097/00019501-200502000-00010; Johnson EM, 2006, AM J GERIAT PSYCHIAT, V14, P796, DOI 10.1097/01.JGP.0000204328.50105.b3; Kelly CA, 2004, J TOXICOL-CLIN TOXIC, V42, P67, DOI 10.1081/CLT-120028747; Khalifa M, 1999, J PHARMACOL EXP THER, V291, P280; LaPointe NMA, 2006, PHARMACOEPIDEM DR S, V15, P361, DOI 10.1002/pds.1155; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; *MED HEALTHC PROD, 2007, UPD SUMM COMM SAF ME; *MED HEALTHC PROD, 2005, EXP COMPL REV SAF AN; Medicines and Healthcare products Regulatory Agency, 2006, VENL EF SUMM BAS REG; Mines D, 2005, PHARMACOEPIDEM DR S, V14, P367, DOI 10.1002/pds.1095; Morgner A, 2002, CHIR GASTROENTEROL, V18, P24, DOI 10.1159/000051341; Nemeroff CB, 2008, BIOL PSYCHIAT, V63, P424, DOI 10.1016/j.biopsych.2007.06.027; PRATT CM, 1994, AM J CARDIOL, V73, P346, DOI 10.1016/0002-9149(94)90006-X; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P111; Rowan PJ, 2005, ANN EPIDEMIOL, V15, P316, DOI 10.1016/j.annepidem.2004.08.006; Rubino A, 2007, BMJ-BRIT MED J, V334, P242, DOI 10.1136/bmj.39041.445104.BE; Rudolph RL, 1998, J CLIN PSYCHIAT, V59, P116, DOI 10.4088/JCP.v59n0305; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Thase ME, 1998, J CLIN PSYCHIAT, V59, P502, DOI 10.4088/JCP.v59n1002; Walker AM, 1999, AM J MED, V107, P356, DOI 10.1016/S0002-9343(99)00241-7; Whyte IM, 2003, QJM-INT J MED, V96, P369, DOI 10.1093/qjmed/hcg062; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; PRODUCT MONOGRAPH EF	46	35	38	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2010	340								c249	10.1136/bmj.c249	http://dx.doi.org/10.1136/bmj.c249			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CX	20139216	hybrid, Green Published			2022-12-28	WOS:000274343700003
J	Vijay-Kumar, M; Aitken, JD; Carvalho, FA; Cullender, TC; Mwangi, S; Srinivasan, S; Sitaraman, SV; Knight, R; Ley, RE; Gewirtz, AT				Vijay-Kumar, Matam; Aitken, Jesse D.; Carvalho, Frederic A.; Cullender, Tyler C.; Mwangi, Simon; Srinivasan, Shanthi; Sitaraman, Shanthi V.; Knight, Rob; Ley, Ruth E.; Gewirtz, Andrew T.			Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5	SCIENCE			English	Article							OBESITY; INNATE; INFLAMMATION; IMMUNITY; COLITIS	Metabolic syndrome is a group of obesity-related metabolic abnormalities that increase an individual's risk of developing type 2 diabetes and cardiovascular disease. Here, we show that mice genetically deficient in Toll-like receptor 5 (TLR5), a component of the innate immune system that is expressed in the gut mucosa and that helps defend against infection, exhibit hyperphagia and develop hallmark features of metabolic syndrome, including hyperlipidemia, hypertension, insulin resistance, and increased adiposity. These metabolic changes correlated with changes in the composition of the gut microbiota, and transfer of the gut microbiota from TLR5-deficient mice to wild-type germ-free mice conferred many features of metabolic syndrome to the recipients. Food restriction prevented obesity, but not insulin resistance, in the TLR5-deficient mice. These results support the emerging view that the gut microbiota contributes to metabolic disease and suggest that malfunction of the innate immune system may promote the development of metabolic syndrome.	[Vijay-Kumar, Matam; Aitken, Jesse D.; Carvalho, Frederic A.; Gewirtz, Andrew T.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Cullender, Tyler C.; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Mwangi, Simon; Srinivasan, Shanthi; Sitaraman, Shanthi V.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Emory University; Cornell University; Emory University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gewirtz, AT (corresponding author), Emory Univ, Dept Pathol, Atlanta, GA 30322 USA.	agewirt@emory.edu	Vijay-Kumar, Matam/Q-8988-2019; Carvalho, Frédéric/K-2204-2015; Eckhardt, Erik/G-1567-2010; Knight, Rob/D-1299-2010; Srinivasan, Shanthi/A-6133-2013; Ley, Ruth E/M-8542-2014	Carvalho, Frédéric/0000-0003-1592-2369; Ley, Ruth E/0000-0002-9087-1672; Knight, Rob/0000-0002-0975-9019	NIH [DK061417, K01 (DK083275), DK06439]; Crohn's and Colitis Foundation of America (CCFA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK083275, R01DK061417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank F. A. Anania, D. G. Harrison, and I. R. Williams for valuable discussions and comments, and N. Scalfone and M. Hamady for technical assistance. This work was supported by an NIH grant (DK061417 and an associated American Recovery and Reinvestment Act supplement) and a Senior Award from the Crohn's and Colitis Foundation of America (CCFA) to A. T. G. M.V.-K. is a recipient of Career Development Awards from CCFA and K01 (DK083275) from NIH. This research used a Digestive Disease Research and Development Center (DDRDC) core facility that is supported by NIH grant DK06439.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007	16	1422	1525	6	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					228	231		10.1126/science.1179721	http://dx.doi.org/10.1126/science.1179721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20203013	Green Accepted			2022-12-28	WOS:000276459600042
J	Lambers Heerspink, HJ; de Zeeuw, D				Lambers Heerspink, Hiddo J.; de Zeeuw, Dick			Composite renal endpoints: was ACCOMPLISH accomplished?	LANCET			English	Editorial Material							HYDROCHLOROTHIAZIDE; HYPERTENSION; PROGRESSION; AMLODIPINE; INHIBITOR; LOSARTAN; DISEASE		[Lambers Heerspink, Hiddo J.; de Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, NL-9713 AV Groningen, Netherlands	University of Groningen	de Zeeuw, D (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, NL-9713 AV Groningen, Netherlands.	d.de.zeeuw@med.umcg.nl	de Zeeuw, Dick/E-9080-2014; Heerspink, Hiddo J Lambers/K-3358-2014	de Zeeuw, Dick/0000-0003-3434-7777; Heerspink, Hiddo J Lambers/0000-0002-3126-3730				Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Delles C, 2003, AM J HYPERTENS, V16, P1030, DOI 10.1016/j.amjhyper.2003.07.017; Herlitz H, 2001, NEPHROL DIAL TRANSPL, V16, P2158, DOI 10.1093/ndt/16.11.2158; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Sarafidis P. A., 2009, WORLD C NEPHR MIL IT; Vogt L, 2008, J AM SOC NEPHROL, V19, P999, DOI 10.1681/ASN.2007060693	10	15	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 3	2010	375	9721					1140	1142		10.1016/S0140-6736(10)60098-0	http://dx.doi.org/10.1016/S0140-6736(10)60098-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20170949				2022-12-28	WOS:000276858200006
J	Ginzburg, E; O'Neill, WW; Goldschmidt-Clermont, PJ; de Marchena, E; Pust, D; Green, BA				Ginzburg, Enrique; O'Neill, William W.; Goldschmidt-Clermont, Pascal J.; de Marchena, Eduardo; Pust, Daniel; Green, Barth A.			Rapid Medical Relief - Project Medishare and the Haitian Earthquake	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ginzburg, Enrique; Pust, Daniel] Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL 33152 USA; [O'Neill, William W.; Goldschmidt-Clermont, Pascal J.; de Marchena, Eduardo] Univ Miami, Dept Med, Leonard M Miller Sch Med, Miami, FL USA; [Green, Barth A.] Univ Miami, Dept Neurosurg, Leonard M Miller Sch Med, Miami, FL USA	University of Miami; University of Miami; University of Miami	Ginzburg, E (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL 33152 USA.								0	32	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMp1002026	http://dx.doi.org/10.1056/NEJMp1002026			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20181963				2022-12-28	WOS:000275365900006
J	Boisset, JC; van Cappellen, W; Andrieu-Soler, C; Galjart, N; Dzierzak, E; Robin, C				Boisset, Jean-Charles; van Cappellen, Wiggert; Andrieu-Soler, Charlotte; Galjart, Niels; Dzierzak, Elaine; Robin, Catherine			In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium	NATURE			English	Article							STEM-CELLS; AGM REGION; DEFINITIVE HEMATOPOIESIS; HAEMOGENIC ENDOTHELIUM; EMBRYO; EXPRESSION; GENERATION; MARKS; COLONIZATION; MIGRATION	Haematopoietic stem cells (HSCs), responsible for blood production in the adult mouse, are first detected in the dorsal aorta starting at embryonic day 10.5 (E10.5)(1-3). Immunohistological analysis of fixed embryo sections has revealed the presence of haematopoietic cell clusters attached to the aortic endothelium where HSCs might localize(4-6). The origin of HSCs has long been controversial and several candidates of the direct HSC precursors have been proposed (for review see ref. 7), including a specialized endothelial cell population with a haemogenic potential. Such cells have been described both in vitro in the embryonic stem cell (ESC) culture system(8,9) and retrospectively in vivo by endothelial lineage tracing(5,10) and conditional deletion experiments(11). Whether the transition from haemogenic endothelium to HSC actually occurs in the mouse embryonic aorta is still unclear and requires direct and real-time in vivo observation. To address this issue we used time-lapse confocal imaging and a new dissection procedure to visualize the deeply located aorta. Here we show the dynamic de novo emergence of phenotypically defined HSCs (Sca1(+), c-kit(+), CD41(+)) directly from ventral aortic haemogenic endothelial cells.	[Boisset, Jean-Charles; Andrieu-Soler, Charlotte; Galjart, Niels; Dzierzak, Elaine; Robin, Catherine] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Boisset, Jean-Charles; Dzierzak, Elaine; Robin, Catherine] Erasmus MC, Erasmus Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands; [van Cappellen, Wiggert] Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Robin, C (corresponding author), Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands.	c.robin@erasmusmc.nl	Galjart, Niels/D-1146-2010	Galjart, Niels/0000-0003-1964-3607; Andrieu-Soler, Charlotte/0000-0002-3287-6117	NWO [917-76-345]; NIH [R37 DKO54077]; BSIK [SCDD 03038]	NWO(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BSIK(Ministry of Economic Affairs, Netherlands)	We thank F. Grosveld for critical discussions, T. Graf and T. Schroeder for the CD41-YFP mice and the department of Neuroscience (Erasmus MC) for the tissue chopper. This work was supported by NWO (Vidi) grant 917-76-345 (C. R., J.-C.B.), NIH R37 DKO54077 (E. D.) and BSIK SCDD 03038 (E. D.).	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Corbel C, 2002, DEV BIOL, V243, P301, DOI 10.1006/dbio.2001.0553; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	30	618	635	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					116	U131		10.1038/nature08764	http://dx.doi.org/10.1038/nature08764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20154729				2022-12-28	WOS:000275117500045
J	Parks, M; Rosebraugh, C				Parks, Mary; Rosebraugh, Curtis			Weighing Risks and Benefits of Liraglutide -- The FDA's Review of a New Antidiabetic Therapy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COHORT		[Parks, Mary] US FDA, Div Metab & Endocrinol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Rosebraugh, Curtis] US FDA, Off Drug Evaluat 2, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Parks, M (corresponding author), US FDA, Div Metab & Endocrinol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Costante G, 2007, J CLIN ENDOCR METAB, V92, P450, DOI 10.1210/jc.2006-1590; Food and Drug Administration, 2008, GUID IND DIAB MELL E; MCCONNELL EE, 1986, J NATL CANCER I, V76, P283; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755	4	198	209	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					774	777		10.1056/NEJMp1001578	http://dx.doi.org/10.1056/NEJMp1001578			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20164475				2022-12-28	WOS:000275108300003
J	Renard, E				Renard, Eric			Closed-loop insulin delivery: is the holy grail near?	LANCET			English	Editorial Material							GLUCOSE CONTROL; PANCREAS		[Renard, Eric] CHU Montpellier, Montpellier, France; [Renard, Eric] Univ Montpellier 1, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Renard, E (corresponding author), CHU Montpellier, Montpellier, France.	e-renard@chu-montpellier.fr						Bruttomesso Daniela, 2009, J Diabetes Sci Technol, V3, P1014; Hovorka R, 2006, DIABETIC MED, V23, P1, DOI 10.1111/j.1464-5491.2005.01672.x; Hovorka R, 2010, LANCET; Hovorka R, 2007, J CLIN ENDOCR METAB, V92, P2960, DOI 10.1210/jc.2007-0434; Hovorka Roman, 2004, Diabetes Technol Ther, V6, P307, DOI 10.1089/152091504774197990; Nishida K, 2009, WORLD J GASTROENTERO, V15, P4105, DOI 10.3748/wjg.15.4105; Renard E, 2006, DIABETES METAB, V32, P497, DOI 10.1016/S1262-3636(06)72802-6; Renard E, 2006, DIABETES RES CLIN PR, V74, pS173, DOI 10.1016/S0168-8227(06)70026-2; Renard E, 2010, DIABETES CARE, V33, P121, DOI 10.2337/dc09-1080; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steil GM, 2006, DIABETES, V55, P3344, DOI 10.2337/db06-0419; Steil GM, 2004, ADV DRUG DELIVER REV, V56, P125, DOI 10.1016/j.addr.2003.08.011; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967	13	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					702	703		10.1016/S0140-6736(09)62165-6	http://dx.doi.org/10.1016/S0140-6736(09)62165-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20138356				2022-12-28	WOS:000275211200006
J	van Gool, WA; van de Beek, D; Eikelenboom, P				van Gool, Willem A.; van de Beek, Diederik; Eikelenboom, Piet			Systemic infection and delirium: when cytokines and acetylcholine collide	LANCET			English	Article							NEURODEGENERATIVE DISEASE; CHRONIC NEUROINFLAMMATION; BRAIN; INFLAMMATION; SEPSIS	Systemic infection and drugs with anticholinergic effects are well-recognised and prevalent risk factors for delirium in elderly people. Experimental findings and neuropathological observations suggest that activation of microglia is pivotal for mediation of the behavioural effects of systemic infections. The microglial response is usually regulated tightly, but defensive features could turn neurotoxic once microglial cells escape from cholinergic inhibition. A self-propelling neuroinflammatory reaction might follow, and this cascade could account for the strong association between delirium and long-term cognitive impairment and even dementia. Here, we propose a hypothetical model, suggesting that poor outcome after delirium can be averted in vulnerable elderly people by use of readily available drugs. Agents that either restore cholinergic control of microglia or directly inhibit neuroinflammation warrant testing in clinical trials.	[van Gool, Willem A.; van de Beek, Diederik; Eikelenboom, Piet] Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; [van de Beek, Diederik] Acad Med Ctr, CINIMA, NL-1100 DD Amsterdam, Netherlands; [Eikelenboom, Piet] GGZ InGeest, PCA Valeriuskliniek, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Gool, WA (corresponding author), Acad Med Ctr, Dept Neurol, H2-217,POB 22660, NL-1100 DD Amsterdam, Netherlands.	w.a.vangool@amc.uva.nl	van de beek, diederik/A-2935-2010; van de Beek, Diederik/Y-2713-2019; Eikelenboom, Piet/AAF-6359-2020; Van Gool, Willem A/G-5985-2012	van de Beek, Diederik/0000-0002-4571-044X; Van Gool, Willem/0000-0003-3174-8233				De Simone R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-4; Ebersoldt M, 2007, INTENS CARE MED, V33, P941, DOI 10.1007/s00134-007-0622-2; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hoozemans JJM, 2006, INT J DEV NEUROSCI, V24, P157, DOI 10.1016/j.ijdevneu.2005.11.001; Kat MG, 2008, DEMENT GERIATR COGN, V26, P1, DOI 10.1159/000140611; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; MacLullich AMJ, 2009, INT REV PSYCHIATR, V21, P30, DOI 10.1080/09540260802675031; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Nizri E, 2008, J NEUROIMMUNOL, V203, P12, DOI 10.1016/j.jneuroim.2008.06.018; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; WAAGE A, 1989, J EXP MED, V170, P1859, DOI 10.1084/jem.170.6.1859; Willard LB, 1999, NEUROSCIENCE, V88, P193	20	346	356	9	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					773	775		10.1016/S0140-6736(09)61158-2	http://dx.doi.org/10.1016/S0140-6736(09)61158-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20189029				2022-12-28	WOS:000275211200034
J	Shembade, N; Ma, A; Harhaj, EW				Shembade, Noula; Ma, Averil; Harhaj, Edward W.			Inhibition of NF-kappa B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes	SCIENCE			English	Article							CONJUGATING ENZYME; ACTIVATION; UBC13; RESPONSES; REQUIRES; SUSCEPTIBILITY; TERMINATION; TNFAIP3; REGION	A20 negatively regulates inflammation by inhibiting the nuclear factor kappa B (NF-kappa B) transcription factor in the tumor necrosis factor receptor (TNFR) and Toll-like receptor (TLR) pathways. A20 contains deubiquitinase and E3 ligase domains and thus has been proposed to function as a ubiquitin-editing enzyme downstream of TNFR1 by inactivating ubiquitinated RIP1. However, it remains unclear how A20 terminates NF-kappa B signaling downstream of TLRs. We have shown that A20 inhibited the E3 ligase activities of TRAF6, TRAF2, and cIAP1 by antagonizing interactions with the E2 ubiquitin conjugating enzymes Ubc13 and UbcH5c. A20, together with the regulatory molecule TAX1BP1, interacted with Ubc13 and UbcH5c and triggered their ubiquitination and proteasome-dependent degradation. These findings suggest a mechanism of A20 action in the inhibition of inflammatory signaling pathways.	[Shembade, Noula; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Miami; University of California System; University of California San Francisco	Shembade, N (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	nshembade@med.miami.edu; eharhaj@med.miami.edu			NIH [RO1GM083143, RO1CA135362]; NATIONAL CANCER INSTITUTE [R01CA135362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. C. Sun, L. Matesic, D. Abbott, C. Vincenz, P. Storz, R. Beyaert, and the Belgian Coordinated Collections of Microorganisms/Laboratory of Molecular Biology of Ghent University (BCCMTM/LMBP) for reagents and H. Ishikawa for assistance in the preparation of BMDMs and BMDCs. The project described was supported by NIH grants RO1GM083143 and RO1CA135362 awarded to E. W. H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute/National Institute of General Medical Sciences or the National Institutes of Health.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dieguez-Gonzalez R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2650; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Klinkenberg M, 2001, FEBS LETT, V498, P93, DOI 10.1016/S0014-5793(01)02504-2; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wooff J, 2004, FEBS LETT, V566, P229, DOI 10.1016/j.febslet.2004.04.038; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367	24	445	474	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1135	1139		10.1126/science.1182364	http://dx.doi.org/10.1126/science.1182364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185725	Green Accepted			2022-12-28	WOS:000274901100038
J	Samet, JM; Wipfli, HL				Samet, Jonathan M.; Wipfli, Heather L.			Globe still in grip of addiction	NATURE			English	Editorial Material							CHINA; DISEASE		[Samet, Jonathan M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; USC Inst Global Hlth, Los Angeles, CA 90033 USA	University of Southern California	Samet, JM (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	jsamet@usc.edu						*CANC RES UK, 2009, CANC STATS KEY FACTS; *CDCP, 2009, LUNG CANC TRENDS; *CORP ACC INT, 2008, PROT TOB IND INT 200; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michaels D, 2008, DOUBT IS THEIR PRODU, V1st; Muggli ME, 2008, PLOS MED, V5, P1729, DOI 10.1371/journal.pmed.0050251; Robinson S, 2008, GEN LIFESTYLE SURVEY; Shafey O, 2009, TOBACCO ATLAS, V3, P37; Wald N, 1991, UK SMOKING STAT; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2009, WHO REP GLOB TOB EP; Wright AA, 2007, NEW ENGL J MED, V356, P1493, DOI 10.1056/NEJMp078018; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; 2010, PEOPLES DAILY O 0118	14	30	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 25	2010	463	7284					1020	1021		10.1038/4631020a	http://dx.doi.org/10.1038/4631020a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	563DR	20182492				2022-12-28	WOS:000275108400017
J	Grainge, MJ; West, J; Card, TR				Grainge, Matthew J.; West, Joe; Card, Timothy R.			Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study	LANCET			English	Article							DEEP-VEIN THROMBOSIS; POPULATION-BASED COHORT; PULMONARY-EMBOLISM; RISK; OSTEOPOROSIS; PREVENTION; MORTALITY; DATABASE; RATES	Background Patients with inflammatory bowel disease who develop deep vein thrombosis or pulmonary embolism often have active disease at the time of thromboembolism. We therefore aimed to quantify the risk of venous thromboembolism prospectively during different activity phases of inflammatory bowel disease. Methods From the General Practice Research Database, we matched patients with prospectively recorded inflammatory bowel disease from November, 1987, until July, 2001 with up to five controls by age, sex, and general practice. A flare was defined as the period 120 days after a new corticosteroid prescription. We used Cox regression analysis with time-varying covariates to accommodate changes in the state of inflammatory bowel disease, and whether patients were at high risk of venous thromboembolism after hospitalisation. Findings 13 756 patients with inflammatory bowel disease and 71672 matched controls were included in the analysis, and of these 139 patients and 165 controls developed venous thromboembolism. Overall, patients with inflammatory bowel disease had a higher risk of venous thromboembolism than did controls (hazard ratio 3.4, 95% CI 2.7-4.3; p<0.0001; absolute risk 2.6 per 1000 per person-years). At the time of a flare, however, this increase in risk was much more prominent (8.4, 5.5-12.8; p<0.0001; 9.0 per 1000 person-years). This relative risk at the time of a flare was higher during non-hospitailised periods (15.8, 9.8-25.5; p<0.0001; 6.4 per 1000 person-years) than during hospitalised periods (3.2, 1.7-6.3; p=0.0006; 37.5 per 1000 person-years). Interpretation Trials of primary prophylaxis of venous thromboembolism are warranted to find out whether this important complication can be prevented.	[Grainge, Matthew J.; West, Joe; Card, Timothy R.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [West, Joe; Card, Timothy R.] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Natl Inst Hlth, Nottingham Digest Dis Ctr,Res Biomed Res Unit, Nottingham, England; [Card, Timothy R.] Kings Mill Hosp, Dept Gastroenterol, Nottingham, England	University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Grainge, MJ (corresponding author), Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Sch Community Hlth Sci, Clin Sci Bldg Phase 2, Nottingham NG5 1PB, England.	matthew.grainge@nottingham.ac.uk	Card, Tim/J-8651-2013; West, Joe/I-6637-2012; West, Joe/M-3867-2019	Card, Tim/0000-0003-2555-2250; West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Grainge, Matthew/0000-0001-7181-4042	National Association for Colitis and Crohn's Disease; UK National Institute for Health Research	National Association for Colitis and Crohn's Disease; UK National Institute for Health Research(National Institute for Health Research (NIHR))	The National Association for Colitis and Crohn's Disease funded the purchase of data used in this study. JW is funded by a UK National Institute for Health Research clinician scientist fellowship.	ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bernstein CN, 2007, CAN J GASTROENTEROL, V21, P507, DOI 10.1155/2007/924257; Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430; Card T, 2004, GUT, V53, P251, DOI 10.1136/gut.2003.026799; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Grip O, 2000, SCAND J GASTROENTERO, V35, P619, DOI 10.1080/003655200750023589; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Irving PM, 2005, CLIN GASTROENTEROL H, V3, P617, DOI 10.1016/S1542-3565(05)00154-0; Jilma B, 2005, THROMB HAEMOSTASIS, V94, P797, DOI 10.1160/T04-10-0652; Kelman CW, 2003, BRIT MED J, V327, P1072, DOI 10.1136/bmj.327.7423.1072; Koutroubakis IE, 2008, AM J GASTROENTEROL, V103, P2281, DOI 10.1111/j.1572-0241.2008.02060.x; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Levitan N, 1999, MEDICINE, V78, P285, DOI 10.1097/00005792-199909000-00001; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; Lewis JD, 2004, GASTROENTEROLOGY, V126, P665, DOI 10.1053/j.gastro.2003.12.003; Miehsler W, 2004, GUT, V53, P542, DOI 10.1136/gut.2003.025411; Nguyen GC, 2008, AM J GASTROENTEROL, V103, P2272, DOI 10.1111/j.1572-0241.2008.02052.x; Novacek G, 2008, GASTROENTEROLOGY, V134, pA641; Schwarz T, 2003, ARCH INTERN MED, V163, P2759, DOI 10.1001/archinte.163.22.2759; Scott EM, 2000, GUT, V46, P1, DOI 10.1136/gut.46.suppl_1.I1; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Solem CA, 2004, AM J GASTROENTEROL, V99, P97, DOI 10.1046/j.1572-0241.2003.04026.x; *STAT CORP, 2007, SURV AN EP TABL STAT; TALBOT RW, 1986, MAYO CLIN PROC, V61, P140, DOI 10.1016/S0025-6196(12)65200-8; Valentine JF, 1999, AM J GASTROENTEROL, V94, P878; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	33	461	477	1	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					657	663		10.1016/S0140-6736(09)61963-2	http://dx.doi.org/10.1016/S0140-6736(09)61963-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20149425				2022-12-28	WOS:000275210900034
J	Norvell, A; McMahon, SB				Norvell, Amanda; McMahon, Steven B.			Rise of the Rival	SCIENCE			English	Editorial Material							HISTONE ACETYLATION		[Norvell, Amanda] Coll New Jersey, Dept Biol, Ewing, NJ 08628 USA; [McMahon, Steven B.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA	College of New Jersey; Jefferson University	Norvell, A (corresponding author), Coll New Jersey, Dept Biol, Ewing, NJ 08628 USA.	steven.mcmahon@jci.tju.edu		McMahon, Steven/0000-0002-3405-1768				ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Mellert HS, 2009, TRENDS BIOCHEM SCI, V34, P571, DOI 10.1016/j.tibs.2009.06.010; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	11	64	65	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					964	965		10.1126/science.1187159	http://dx.doi.org/10.1126/science.1187159			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167774				2022-12-28	WOS:000274625800026
J	Viswanathan, SR; Daley, GQ				Viswanathan, Srinivas R.; Daley, George Q.			Lin28: A MicroRNA Regulator with a Macro Role	CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; POSTTRANSCRIPTIONAL REGULATION; CAENORHABDITIS-ELEGANS; CANCER-CELLS; EXPRESSION; RNA; LIN-28; PROMOTES; TRANSFORMATION		[Viswanathan, Srinivas R.; Daley, George Q.] Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Viswanathan, Srinivas R.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Viswanathan, Srinivas R.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023				AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hartge P, 2009, NAT GENET, V41, P637, DOI 10.1038/ng0609-637; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MAN M, 2009, EMBO J, V28, P347; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	41	319	342	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					445	449		10.1016/j.cell.2010.02.007	http://dx.doi.org/10.1016/j.cell.2010.02.007			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178735	Bronze			2022-12-28	WOS:000274668400005
J	Javaux, EJ; Marshall, CP; Bekker, A				Javaux, Emmanuelle J.; Marshall, Craig P.; Bekker, Andrey			Organic-walled microfossils in 3.2-billion-year-old shallow-marine siliciclastic deposits	NATURE			English	Article							BARBERTON GREENSTONE-BELT; GA MOODIES GROUP; SOUTH-AFRICA; FOSSIL EVIDENCE; PILBARA CRATON; MICROBIAL MATS; MOUNTAIN LAND; ONVERWACHT; CHERTS; CARBON	Although the notion of an early origin and diversification of life on Earth during the Archaean eon has received increasing support in geochemical, sedimentological and palaeontological evidence, ambiguities and controversies persist regarding the biogenicity and syngeneity of the record older than Late Archaean(1-3). Non-biological processes are known to produce morphologies similar to some microfossils(4,5), and hydrothermal fluids have the potential to produce abiotic organic compounds with depleted carbon isotope values(6), making it difficult to establish unambiguous traces of life. Here we report the discovery of a population of large (up to about 300 mu m in diameter) carbonaceous spheroidal microstructures in Mesoarchaean shales and siltstones of the Moodies Group, South Africa, the Earth's oldest siliciclastic alluvial to tidal-estuarine deposits(7). These microstructures are interpreted as organic-walled microfossils on the basis of petrographic and geochemical evidence for their endogenicity and syngeneity, their carbonaceous composition, cellular morphology and ultrastructure, occurrence in populations, taphonomic features of soft wall deformation, and the geological context plausible for life, as well as a lack of abiotic explanation falsifying a biological origin. These are the oldest and largest Archaean organic-walled spheroidal microfossils reported so far. Our observations suggest that relatively large microorganisms cohabited with earlier reported benthic microbial mats(8) in the photic zone of marginal marine siliciclastic environments 3.2 billion years ago.	[Javaux, Emmanuelle J.] Univ Liege, Dept Geol, B-4000 Liege, Belgium; [Marshall, Craig P.] Univ Kansas, Dept Geol, Lawrence, KS 66044 USA; [Bekker, Andrey] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada	University of Liege; University of Kansas; University of Manitoba	Javaux, EJ (corresponding author), Univ Liege, Dept Geol, 17 Allee 6 Aout B18, B-4000 Liege, Belgium.	ej.javaux@ulg.ac.be		Bekker, Andrey/0000-0002-1154-0585	University of Liege Impulsion [CFRA0805]; University of Liege [RCFRA0036-J]; National Science Foundation [EAR-937 05-45484]; NASA Astrobiology Institute [NNA04CC09A]; Natural Sciences and Engineering Research Council of Canada; Australian Research Council	University of Liege Impulsion(University of Liege); University of Liege(University of Liege); National Science Foundation(National Science Foundation (NSF)); NASA Astrobiology Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council)	We thank M. Giraldo, J. Laval and N. Decloux for sample preparation; P. Compere for TEM imaging; C. Henrist for environmental SEM imaging and energy-dispersive X-ray analyses; T. Prokopiuk for carbon isotope analyses; J. Robertson for information on geology of the Agnes Gold Mine; and A. H. Knoll for comments on an earlier version of the manuscript. The study was supported by a University of Liege Impulsion Grant (CFRA0805) and a University of Liege grant (RCFRA0036-J) to E. J., a National Science Foundation grant (EAR-937 05-45484), a NASA Astrobiology Institute award (NNA04CC09A), a Natural Sciences and Engineering Research Council of Canada 938 Discovery grant to A. B., and Australian Research Council funding to C. M.	Akashi K, 1996, BIOPHYS J, V71, P3242, DOI 10.1016/S0006-3495(96)79517-6; Altermann W, 2001, J AFR EARTH SCI, V33, P427, DOI 10.1016/S0899-5362(01)00089-6; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Brasier M, 2006, PHILOS T R SOC B, V361, P887, DOI 10.1098/rstb.2006.1835; Buick R., 2001, PALEOBIOLOGY 2, P13; Butterfield Nicholas J., 1994, Fossils and Strata, V34, P1; Deamer D, 2006, PHILOS T R SOC B, V361, P1809, DOI 10.1098/rstb.2006.1905; DWORKIN M, 2006, PROKARYOTES, V7, P31; DWORKIN M, 2006, PROKARYOTES, V6, P1156; Eriksson KA, 2000, GEOLOGY, V28, P831, DOI 10.1130/0091-7613(2000)28<831:QTOTRT>2.0.CO;2; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; HEUBECK C, 1994, PRECAMBRIAN RES, V68, P257, DOI 10.1016/0301-9268(94)90033-7; Javaux EJ, 2004, GEOBIOLOGY, V2, P121, DOI 10.1111/j.1472-4677.2004.00027.x; Jones B, 2007, SEDIMENTOLOGY, V54, P921, DOI 10.1111/j.1365-3091.2007.00866.x; KAMO SL, 1994, TECTONICS, V13, P167, DOI 10.1029/93TC02254; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Marshall CP, 2007, PRECAMBRIAN RES, V155, P1, DOI 10.1016/j.precamres.2006.12.014; McCollom TM, 2006, EARTH PLANET SC LETT, V243, P74, DOI 10.1016/j.epsl.2006.01.027; Noffke N, 2008, GEOBIOLOGY, V6, P5, DOI 10.1111/j.1472-4669.2007.00118.x; Noffke N, 2006, GEOLOGY, V34, P253, DOI 10.1130/G22246.1; Pasteris JD, 2003, ASTROBIOLOGY, V3, P727, DOI 10.1089/153110703322736051; PFLUG H D, 1967, Review of Palaeobotany and Palynology, V5, P9, DOI 10.1016/0034-6667(67)90205-9; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Strauss H., 1992, PROTEROZOIC BIOSPHER, P709; Sugitani K, 2007, PRECAMBRIAN RES, V158, P228, DOI 10.1016/j.precamres.2007.03.006; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; van Zuilen MA, 2007, GEOCHIM COSMOCHIM AC, V71, P655, DOI 10.1016/j.gca.2006.09.029; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; WATERBURY JB, 1978, MICROBIOL REV, V42, P2, DOI 10.1128/MMBR.42.1.2-44.1978	31	188	197	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					934	U108		10.1038/nature08793	http://dx.doi.org/10.1038/nature08793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20139963				2022-12-28	WOS:000274582700043
J	Palomaki, GE; Melillo, S; Bradley, LA				Palomaki, Glenn E.; Melillo, Stephanie; Bradley, Linda A.			Association Between 9p21 Genomic Markers and Heart Disease A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-ARTERY-DISEASE; ABDOMINAL AORTIC-ANEURYSM; CHROMOSOME 9P21; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; GENETIC-VARIATION; SUSCEPTIBILITY LOCUS; 4 SNPS; SYSTEMATIC REVIEWS; WIDE ASSOCIATION	Context Associations between chromosome 9p21 single-nucleotide polymorphisms ( SNPs) and heart disease have been reported and replicated. If testing improves risk assessments using traditional factors, it may provide opportunities to improve public health. Objectives To perform a targeted systematic review of published literature for effect size, heterogeneity, publication bias, and strength of evidence and to consider whether testing might provide clinical utility. Data Sources Electronic search via HuGE Navigator through January 2009 and review of reference lists from included articles. Study Selection English-language articles that tested for 9p21 SNPs with coronary heart/artery disease or myocardial infarction as primary outcomes. Included articles also provided race, numbers of participants, and data to compute an odds ratio ( OR). Articles were excluded if reporting only intermediate outcomes (eg, atherosclerosis) or if all participants had existing disease. Twenty-five articles were initially identified and 16 were included. A follow-up search identified 6 additional articles. Data Extraction Independent extraction was performed by 2 reviewers and consensus was reached. Credibility of evidence was assessed using published Venice criteria. Data Synthesis Forty-seven distinct data sets from the 22 articles were analyzed, including 35 872 cases and 95 837 controls. The summary OR for heart disease among individuals with 2 vs 1 at-risk alleles was 1.25 (95% confidence interval [CI], 1.21-1.29), with low to moderate heterogeneity. Age at disease diagnosis was a significant covariate, with ORs of 1.35 (95% CI, 1.30-1.40) for age 55 years or younger and 1.21 (95% CI, 1.16-1.25) for age 75 years or younger. For a 65-year-old man, the 10-year heart disease risk for 2 vs 1 at-risk alleles would be 13.2% vs 11%. For a 40-year-old woman, the 10-year heart disease risk for 2 vs 1 at-risk alleles would be 2.4% vs 2.0%. Nearly identical but inverse results were found when comparing 1 vs 0 at-risk alleles. Three studies showed net reclassification indexes ranging from -0.1% to 4.8%. Conclusion We found a statistically significant association between 9p21 SNPs and heart disease that varied by age at disease onset, but the magnitude of the association was small. JAMA. 2010;303(7):648-656 www.jama.com	[Palomaki, Glenn E.] Brown Univ, Women & Infants Hosp, Alpert Med Sch, Providence, RI 02903 USA; [Melillo, Stephanie; Bradley, Linda A.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA USA; [Melillo, Stephanie] McKing Consulting Corp, Atlanta, GA USA	Brown University; Women & Infants Hospital Rhode Island; Centers for Disease Control & Prevention - USA	Palomaki, GE (corresponding author), Brown Univ, Women & Infants Hosp, Alpert Med Sch, 70 Elm St,2nd Floor, Providence, RI 02903 USA.	gpalomaki@ipmms.org			OPHG, Centers for Disease Control and Prevention [200-2003-01396-0128]	OPHG, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the OPHG, Centers for Disease Control and Prevention (contract 200-2003-01396-0128 to McKing Consulting Corp Inc).	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Anderson JL, 2008, AM HEART J, V156, P1155, DOI 10.1016/j.ahj.2008.07.006; Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; Borenstein M., 2009, INTRO METAANALYSIS; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Chen SN, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-3; Chen Z, 2009, MOL BIOL REP, V36, P889, DOI 10.1007/s11033-008-9259-7; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; *DECODE DIAGN LAB, PAT HAND; Dehghan A, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-30; Ding H, 2009, CIRC-CARDIOVASC GENE, V2, P338, DOI 10.1161/CIRCGENETICS.108.810226; Doria A, 2008, JAMA-J AM MED ASSOC, V300, P2389, DOI 10.1001/jama.2008.649; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Hiura Y, 2008, CIRC J, V72, P1213, DOI 10.1253/circj.72.1213; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hobbs FDR, 2004, HEART, V90, P1217, DOI 10.1136/hrt.2003.027680; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2009, ANN INTERN MED, V150, P139, DOI 10.7326/0003-4819-150-2-200901200-00012; Janssens ACJW, 2008, NEW ENGL J MED, V358, P2739; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Khoury MJ, 2009, GENET MED, V11, P559, DOI 10.1097/GIM.0b013e3181b13a6c; Khoury MJ, 2009, AM J EPIDEMIOL, V170, P269, DOI 10.1093/aje/kwp119; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Lemmens R, 2009, EUR J HUM GENET, V17, P1287, DOI 10.1038/ejhg.2009.42; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Marteau T, 2004, AM J MED GENET A, V128A, P285, DOI 10.1002/ajmg.a.30102; Marteau TM, 2001, BMJ-BRIT MED J, V322, P1056, DOI 10.1136/bmj.322.7293.1056; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mensah GA, 2007, VASC PHARMACOL, V46, P318, DOI 10.1016/j.vph.2006.10.019; *NAT LIB MED NIH, PUBMED HOM PAG; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; O'Neill SC, 2008, GENET MED, V10, P121, DOI [10.1097/GIM.0b013e31875f8e06, 10.1097/GIM.0b013e31815f8e06]; Ohta S, 2009, ORAL SURG ORAL MED O, V107, P81, DOI 10.1016/j.tripleo.2008.08.027; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Peng WH, 2009, CLIN CHEM LAB MED, V47, P917, DOI 10.1515/CCLM.2009.215; Pijl M, 2009, DIABETES CARE, V32, P597, DOI 10.2337/dc08-1049; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schedbauer A, 2007, FAM PRACT, V24, P380, DOI 10.1093/fampra/cmm030; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Sheridan SL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-60; Sposito AC, 2009, CURR MED RES OPIN, V25, P1171, DOI 10.1185/03007990902846423 ; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; Thompson AR, 2008, EUR J VASC ENDOVASC, V35, P19, DOI 10.1016/j.ejvs.2007.07.022; van der Net JB, 2009, AM HEART J, V158, P105, DOI 10.1016/j.ahj.2009.04.022; van Wyk JT, 2005, CHEST, V128, P2521, DOI 10.1378/chest.128.4.2521; Vignoli M, 2008, MELANOMA RES, V18, P431, DOI 10.1097/CMR.0b013e328319412f; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Watt A, 2008, INT J TECHNOL ASSESS, V24, P133, DOI 10.1017/S0266462308080185; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood G Craig, 2008, Genomic Med, V2, P33, DOI 10.1007/s11568-008-9023-z; *WORLD HEART ASS, CARD DIS RISK FACT; Ye S, 2008, J AM COLL CARDIOL, V52, P378, DOI 10.1016/j.jacc.2007.11.087; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zhang Q, 2009, ATHEROSCLEROSIS, V207, P26, DOI 10.1016/j.atherosclerosis.2009.04.017; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065; HUGE LIT FINDER	73	114	116	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					648	656		10.1001/jama.2010.118	http://dx.doi.org/10.1001/jama.2010.118			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555NK	20159873	Bronze			2022-12-28	WOS:000274518600023
J	Avni, T; Levcovich, A; Ad-El, DD; Leibovici, L; Paul, M				Avni, Tomer; Levcovich, Ariela; Ad-El, Dean D.; Leibovici, Leonard; Paul, Mical			Prophylactic antibiotics for burns patients: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DIGESTIVE-TRACT; SELECTIVE DECONTAMINATION; STAPHYLOCOCCUS-AUREUS; ACINETOBACTER-BAUMANNII; WOUND-INFECTION; LOCAL TREATMENT; INTENSIVE-CARE; RISK-FACTORS; MANAGEMENT; TEICOPLANIN	Objective To assess the evidence for prophylactic treatment with systemic antibiotics in burns patients. Design Systematic review and meta-analysis of randomised or quasi-randomised controlled trials recruiting burns inpatients that compared antibiotic prophylaxis ( systemic, non-absorbable, or topical) with placebo or no treatment. Data sources PubMed, Cochrane Library, LILACS, Embase, conference proceedings, and bibliographies. No language, date, or publication status restrictions were imposed. Review methods Two reviewers independently extracted data. The primary outcome was all cause mortality. Risk or rate ratios with 95% confidence intervals were pooled with a fixed effect model if no heterogeneity was present. Results 17 trials were included. Trials that assessed systemic antibiotic prophylaxis given for 4-14 days after admission showed a significant reduction in all cause mortality ( risk ratio 0.54, 95% confidence interval 0.34 to 0.87, five trials). The corresponding number needed to treat was 8 (5 to 33), with a control event rate of 26%. Perioperative non-absorbable or topical antibiotics alone did not significantly affect mortality. There was a reduction in pneumonia with systemic prophylaxis and a reduction in wound infections with perioperative prophylaxis. Staphylococcus aureus infection or colonisation was reduced with anti-staphylococcal antibiotics. In three trials, resistance to the antibiotic used for prophylaxis significantly increased (rate ratio 2.84, 1.38 to 5.83). The overall methodological quality of the trials was poor. Conclusions Prophylaxis with systemic antibiotics has a beneficial effect in burns patients, but the methodological quality of the data is weak. As such prophylaxis is currently not recommended for patients with severe burns other than perioperatively, there is a need for randomised controlled trials to assess its use.	[Avni, Tomer; Leibovici, Leonard; Paul, Mical] Tel Aviv Univ, Sackler Fac Med, Beilinson Hosp, Dept Med E,Rabin Med Ctr, Tel Aviv, Israel; [Levcovich, Ariela] Beilinson Med Ctr, Rabin Med Ctr, Dept Med B, Petah Tiqwa, Israel; [Ad-El, Dean D.] Beilinson Med Ctr, Rabin Med Ctr, Dept Plast Surg & Burns, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Paul, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Beilinson Hosp, Dept Med E,Rabin Med Ctr, Tel Aviv, Israel.	paulm@post.tau.ac.il						Alekseev A A, 1996, Khirurgiia (Mosk), P55; ALEXANDER JW, 1982, J TRAUMA, V22, P687, DOI 10.1097/00005373-198208000-00006; Alexander JW, 1984, B CLIN REV BURN INJU, V1, P20; Barret JP, 2001, BURNS, V27, P439, DOI 10.1016/S0305-4179(00)00147-9; Barret JP, 2000, PLAST RECONSTR SURG, V105, P62, DOI 10.1097/00006534-200001000-00010; BOYCE JM, 1983, JAMA-J AM MED ASSOC, V249, P2803, DOI 10.1001/jama.249.20.2803; CASON JS, 1968, LANCET, V1, P651; Chim H, 2007, BURNS, V33, P1008, DOI 10.1016/j.burns.2007.03.003; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; CULBERTSON GR, 1987, SURG GYNECOL OBSTET, V165, P25; D'Avignon LC, 2008, J TRAUMA, V64, pS277, DOI 10.1097/TA.0b013e318163c3e4; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de La Cal MA, 2005, ANN SURG, V241, P424, DOI 10.1097/01.sla.0000154148.58154.d5; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Demling RH, 1999, BURNS, V25, P256, DOI 10.1016/S0305-4179(98)00165-X; DESAI M H, 1991, Journal of Burn Care and Rehabilitation, V12, P521, DOI 10.1097/00004630-199111000-00006; DESAI MH, 1992, ARCH SURG-CHICAGO, V127, P159, DOI 10.1001/archsurg.1992.01420020041006; DEUTSCH D H, 1990, Journal of Burn Care and Rehabilitation, V11, P436, DOI 10.1097/00004630-199009000-00011; Donati L, 1998, J CHEMOTHERAPY, V10, P47, DOI 10.1179/joc.1998.10.1.47; DONATI L, 1994, INTENS CARE MED, V20, pS30, DOI 10.1007/BF01713980; DURTSCHI MB, 1982, J TRAUMA, V22, P11, DOI 10.1097/00005373-198201000-00003; Enoch S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1037; *EV BAS GUID GROUP, 2001, J BURN CARE REHABI S, V1, pS67; Falk PS, 2000, INFECT CONT HOSP EP, V21, P575, DOI 10.1086/501806; Fitzwater J, 2003, J TRAUMA, V54, P959, DOI 10.1097/01.TA.0000029382.26295.AB; Gafter-Gvili A, 2007, J ANTIMICROB CHEMOTH, V59, P5, DOI 10.1093/jac/dkl425; Gamelli RL, 2000, J BURN CARE REHABIL, V21, P64, DOI 10.1097/00004630-200021010-00012; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; GREMINGER RF, 1980, PLAST RECONSTR SURG, V66, P356, DOI 10.1097/00006534-198066030-00005; Herndon DN, 2000, CRIT CARE MED, V28, P1682, DOI 10.1097/00003246-200005000-00089; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hunt JP, 1998, J SURG RES, V80, P243, DOI 10.1006/jsre.1998.5488; Iakovlev V P, 1995, Antibiot Khimioter, V40, P38; IAKOVLEV VP, 1996, ANTIBIOT KHIMIOTERAP, V41, P24; JARRETT F, 1976, SURG FORUM, V27, P67; JARRETT F, 1978, SURGERY, V83, P523; Kimura A, 1998, J TRAUMA, V45, P383, DOI 10.1097/00005373-199808000-00032; Krutikov M. G., 2000, Antibiotiki i Khimioterapiya, V45, P37; KUNST MW, 1987, SCAND J PLAST RECONS, V21, P281, DOI 10.3109/02844318709086460; KUZIN MI, 1987, KHIRURGIYA, P14; LAFOREST NT, 1978, PHYS THER, V58, P32, DOI 10.1093/ptj/58.1.32; LAWRENCE JC, 1982, LANCET, V1, P1037; LEVINE BA, 1978, J TRAUMA, V18, P188, DOI 10.1097/00005373-197803000-00007; LIVINGSTON DH, 1990, PLAST RECONSTR SURG, V86, P1059, DOI 10.1097/00006534-199012000-00001; LOWBURY EJL, 1971, LANCET, V2, P1105; MANSON WL, 1987, SCAND J PLAST RECONS, V21, P269, DOI 10.3109/02844318709086457; MILLER LM, 1987, CURR THER RES CLIN E, V41, P946; Munster A M, 1989, J Burn Care Rehabil, V10, P327, DOI 10.1097/00004630-198907000-00007; Oliveira GA, 2001, INFECT CONT HOSP EP, V22, P443, DOI 10.1086/501932; Peck MD, 1998, J BURN CARE REHABIL, V19, P386, DOI 10.1097/00004630-199809000-00005; PERITI P, 1992, EUR J SURG, P3; Piel P, 1985, J Burn Care Rehabil, V6, P422, DOI 10.1097/00004630-198509000-00007; PROCTER D S C, 1971, South African Medical Journal, V45, P231; PRUITT BA, 1997, TXB SURG, P221; Ramos G, 2008, J BURN CARE RES, V29, P917, DOI 10.1097/BCR.0b013e31818b9e5c; Ressner RA, 2008, J AM COLL SURGEONS, V206, P439, DOI 10.1016/j.jamcollsurg.2007.09.017; RICHARD P, 1994, J INFECT DIS, V170, P377, DOI 10.1093/infdis/170.2.377; RIZZO A, 1974, MINERVA CHIR, V29, P463; Rodgers Gail L., 1997, Journal of Burn Care and Rehabilitation, V18, P342, DOI 10.1097/00004630-199707000-00012; Sanghavi P, 2009, LANCET, V373, P1282, DOI 10.1016/S0140-6736(09)60235-X; Sharma BR, 2007, INFECT DIS CLIN N AM, V21, P745, DOI 10.1016/j.idc.2007.06.003; Shoup M, 1998, ANN SURG, V228, P112, DOI 10.1097/00000658-199807000-00017; Silver GM, 2007, J BURN CARE RES, V28, P222, DOI 10.1097/BCR.0B013E318031AA44; Silvestri L, 2008, ANAESTH INTENS CARE, V36, P324, DOI 10.1177/0310057X0803600304; Silvestri L, 2007, J HOSP INFECT, V65, P187, DOI 10.1016/j.jhin.2006.10.014; Silvestri L, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.11.005; Simor AE, 2002, INFECT CONT HOSP EP, V23, P261, DOI 10.1086/502046; Sinha R, 1997, BURNS, V23, P626, DOI 10.1016/S0305-4179(97)00069-7; Soroff Harry S., 1994, Journal of Burn Care and Rehabilitation, V15, P13, DOI 10.1097/00004630-199401000-00003; Steer JA, 1997, BRIT J SURG, V84, P848; Steer JA, 1997, J ANTIMICROB CHEMOTH, V39, P383, DOI 10.1093/jac/39.3.383; THERON EJ, 1983, S AFR MED J, V64, P816; Ugburo AO, 2004, BURNS, V30, P43, DOI 10.1016/j.burns.2003.09.016; White CE, 2008, CRIT CARE MED, V36, pS318, DOI 10.1097/CCM.0b013e31817e2d64; Wibbenmeyer L, 2006, J BURN CARE RES, V27, P152, DOI 10.1097/01.BCR.0000203359.32756.F7; Xu Weishi, 2002, Zhonghua Shao Shang Za Zhi, V18, P75	77	64	69	6	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2010	340								c241	10.1136/bmj.c241	http://dx.doi.org/10.1136/bmj.c241			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JR	20156911	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000274738600002
J	Hung, RJ; Yazdani, U; Yoon, J; Wu, H; Yang, TH; Gupta, N; Huang, ZY; van Berkel, WJH; Terman, JR				Hung, Ruei-Jiun; Yazdani, Umar; Yoon, Jimok; Wu, Heng; Yang, Taehong; Gupta, Nidhi; Huang, Zhiyu; van Berkel, Willem J. H.; Terman, Jonathan R.			Mical links semaphorins to F-actin disassembly	NATURE			English	Article							GROWTH CONES; DROSOPHILA; COLLAPSE; MOLECULE; PROTEIN; 3A; MICROTUBULES; ORGANIZATION; CYTOSKELETON; MORPHOLOGY	How instructive cues present on the cell surface have their precise effects on the actin cytoskeleton is poorly understood. Semaphorins are one of the largest families of these instructive cues and are widely studied for their effects on cell movement, navigation, angiogenesis, immunology and cancer(1). Semaphorins/collapsins were characterized in part on the basis of their ability to drastically alter actin cytoskeletal dynamics in neuronal processes(2), but despite considerable progress in the identification of semaphorin receptors and their signalling pathways(3), the molecules linking them to the precise control of cytoskeletal elements remain unknown. Recently, highly unusual proteins of the Mical family of enzymes have been found to associate with the cytoplasmic portion of plexins, which are large cell-surface semaphorin receptors, and to mediate axon guidance, synaptogenesis, dendritic pruning and other cell morphological changes(4-7). Mical enzymes perform reduction-oxidation (redox) enzymatic reactions(4,5,8-10) and also contain domains found in proteins that regulate cell morphology(4,11). However, nothing is known of the role of Mical or its redox activity in mediating morphological changes. Here we report that Mical directly links semaphorins and their plexin receptors to the precise control of actin filament (F-actin) dynamics. We found that Mical is both necessary and sufficient for semaphorin-plexin-mediated F-actin reorganization in vivo. Likewise, we purified Mical protein and found that it directly binds F-actin and disassembles both individual and bundled actin filaments. We also found that Mical utilizes its redox activity to alter F-actin dynamics in vivo and in vitro, indicating a previously unknown role for specific redox signalling events in actin cytoskeletal regulation. Mical therefore is a novel F-actin-disassembly factor that provides a molecular conduit through which actin reorganization-a hallmark of cell morphological changes including axon navigation-can be precisely achieved spatiotemporally in response to semaphorins.	[Hung, Ruei-Jiun; Yazdani, Umar; Yoon, Jimok; Wu, Heng; Yang, Taehong; Gupta, Nidhi; Huang, Zhiyu; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Yazdani, Umar; Yoon, Jimok; Wu, Heng; Yang, Taehong; Gupta, Nidhi; Huang, Zhiyu; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Yazdani, Umar; Yoon, Jimok; Wu, Heng; Yang, Taehong; Gupta, Nidhi; Huang, Zhiyu; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Grad Program Neurosci, Dallas, TX 75390 USA; [van Berkel, Willem J. H.] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wageningen University & Research	Terman, JR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	jonathan.terman@utsouthwestern.edu	van Berkel, Willem J.H./O-2431-2014; Gupta, Nidhi/ADR-1996-2022	van Berkel, Willem J.H./0000-0002-6551-2782; Gupta, Nidhi/0000-0002-1086-1336	US National Institute of Mental Health [MH085923]; Basil O'Connor Starter Scholar Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085923] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Basil O'Connor Starter Scholar Research Award(March of Dimes); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Cowan, M. Rosen and T. Sudhof for comments on drafts of our manuscript and M. Bailey, C. Gilpin, H. He, T. Januszewski, H. Kramer, W. Lin, T. Wedgeworth, X. Zhang and the University of Texas Southwestern Electron Microscopy Core Facility for discussions and assistance. We also thank the Bloomington, Harvard and Japanese stock centres for flies and H. Aberle, L. Cooley, C. Goodman, A. Kolodkin, B. Lee, L. Luo, J. Merriam and X. Zhang for flies and/or reagents. This work was supported by the US National Institute of Mental Health (MH085923) and a Basil O'Connor Starter Scholar Research Award to J. R. T. J. R. T. is a Klingenstein Fellow and the Rita C. and William P. Clements, Jr, Scholar in Medical Research.	Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; BROADIE K, 1993, DEVELOPMENT, P227; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Geng W, 2000, GENETICS, V156, P1817; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Guild GM, 2002, J CELL SCI, V115, P641; Gupta N., 2008, FLAVINS FLAVOPROTEIN, P345; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; Nadella M, 2005, P NATL ACAD SCI USA, V102, P16830, DOI 10.1073/pnas.0504838102; Sakai JA, 2006, DEVELOPMENT, V133, P1035, DOI 10.1242/dev.02272; Sanchez-Soriano N, 2005, J NEUROSCI, V25, P78, DOI 10.1523/JNEUROSCI.2377-04.2005; Schmidt EF, 2008, J NEUROSCI, V28, P2287, DOI 10.1523/JNEUROSCI.5646-07.2008; Siebold C, 2005, P NATL ACAD SCI USA, V102, P16836, DOI 10.1073/pnas.0504997102; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Tilney LG, 2005, P NATL ACAD SCI USA, V102, P18785, DOI 10.1073/pnas.0509437102; Tilney LG, 2000, J CELL SCI, V113, P1255; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	30	188	194	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					823	827		10.1038/nature08724	http://dx.doi.org/10.1038/nature08724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148037	Green Accepted			2022-12-28	WOS:000274394300043
J	Chapman, JW; Nesbit, RL; Burgin, LE; Reynolds, DR; Smith, AD; Middleton, DR; Hill, JK				Chapman, Jason W.; Nesbit, Rebecca L.; Burgin, Laura E.; Reynolds, Don R.; Smith, Alan D.; Middleton, Douglas R.; Hill, Jane K.			Flight Orientation Behaviors Promote Optimal Migration Trajectories in High-Flying Insects	SCIENCE			English	Article							MONARCH BUTTERFLIES; COMPASS ORIENTATION; SOUTHERN BRITAIN; VANESSA-ATALANTA; BOUNDARY-LAYER; HIGH-ALTITUDE; WIND; MOTH; LEPIDOPTERA; MECHANISMS	Many insects undertake long-range seasonal migrations to exploit temporary breeding sites hundreds or thousands of kilometers apart, but the behavioral adaptations that facilitate these movements remain largely unknown. Using entomological radar, we showed that the ability to select seasonally favorable, high-altitude winds is widespread in large day-and night-flying migrants and that insects adopt optimal flight headings that partially correct for crosswind drift, thus maximizing distances traveled. Trajectory analyses show that these behaviors increase migration distances by 40% and decrease the degree of drift from seasonally optimal directions. These flight behaviors match the sophistication of those seen in migrant birds and help explain how high-flying insects migrate successfully between seasonal habitats.	[Chapman, Jason W.; Nesbit, Rebecca L.; Reynolds, Don R.; Smith, Alan D.] Rothamsted Res, Plant & Invertebrate Ecol Dept, Harpenden AL5 2JQ, Herts, England; [Nesbit, Rebecca L.; Hill, Jane K.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Burgin, Laura E.; Middleton, Douglas R.] Met Off, Exeter EX1 3PB, Devon, England; [Reynolds, Don R.] Univ Greenwich, Nat Resources Inst, Chatham ME4 4TB, Kent, England; [Burgin, Laura E.] Univ Exeter, Sch Geog, Exeter EX4 8RJ, Devon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of York - UK; Met Office - UK; University of Greenwich; University of Exeter	Chapman, JW (corresponding author), Rothamsted Res, Plant & Invertebrate Ecol Dept, Harpenden AL5 2JQ, Herts, England.	jason.chapman@bbsrc.ac.uk	Reynolds, Donald R/C-7361-2013; Chapman, Jason/H-8236-2012; Hill, Jane K/G-5151-2011; Hill, Jane K./AAJ-3374-2021; Burgin, Laura/I-4724-2012	Hill, Jane K./0000-0003-1871-7715; Burgin, Laura/0000-0003-1247-9971; Reynolds, Donald/0000-0001-8749-7491; Chapman, Jason/0000-0002-7475-4441	U.K. Biotechnology and Biological Sciences Research Council	U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Clark, L. Castle, D. Ladd, P. Clark, G. Hays, J. Phillips, T. Alerstam, D. Thomson, and M. Hort. Rothamsted Research receives grant-aided support from U.K. Biotechnology and Biological Sciences Research Council.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Carde RT, 2008, CURR BIOL, V18, pR472, DOI 10.1016/j.cub.2008.04.018; Chapman JW, 2008, CURR BIOL, V18, pR908, DOI 10.1016/j.cub.2008.08.014; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2004, INT J PEST MANAGE, V50, P225, DOI 10.1080/09670870410001731961; Chapman JW, 2004, B ENTOMOL RES, V94, P123, DOI 10.1079/BER2004287; Green M, 2002, J THEOR BIOL, V218, P485, DOI 10.1006/jtbi.2002.3094; Green M, 2004, ARDEA, V92, P145; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Mikkola K, 2003, ENTOMOL FENNICA, V14, P15; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Nesbit RL, 2009, ANIM BEHAV, V78, P1119, DOI 10.1016/j.anbehav.2009.07.039; Pollard E, 1998, ECOL LETT, V1, P77; Schmaljohann H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1609, DOI 10.1007/s00265-009-0758-x; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P507, DOI 10.1111/j.1365-2486.2005.00910.x; Srygley RB, 2008, INTEGR COMP BIOL, V48, P119, DOI 10.1093/icb/icn011; Stefanescu C, 2007, J ANIM ECOL, V76, P888, DOI 10.1111/j.1365-2656.2007.01262.x; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Wood CR, 2006, INT J BIOMETEOROL, V50, P193, DOI 10.1007/s00484-005-0014-7	22	208	231	9	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					682	685		10.1126/science.1182990	http://dx.doi.org/10.1126/science.1182990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133570				2022-12-28	WOS:000274251800036
J	Manchikanti, L				Manchikanti, Laxmaiah			CBT for low-back pain in primary care	LANCET			English	Editorial Material									Pain Management Ctr Paducah, Paducah, KY 42003 USA	Pain Management Center of Paducah	Manchikanti, L (corresponding author), Pain Management Ctr Paducah, Paducah, KY 42003 USA.	drlm@thepainmd.com						Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Croft PR, 1998, BRIT MED J, V316, P1356, DOI 10.1136/bmj.316.7141.1356; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Manchikanti L., 2010, PAIN PHYSICIAN, V13, pE65; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P699; National Institute for Health and Clinical Excellence, 2009, LOW BACK PAIN EARL M; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662	8	9	10	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					869	870		10.1016/S0140-6736(10)60277-2	http://dx.doi.org/10.1016/S0140-6736(10)60277-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20189240				2022-12-28	WOS:000275995300005
J	Chisholm, D; Stanciole, AE; Edejer, TTT; Evans, DB				Chisholm, Dan; Stanciole, Anderson E.; Edejer, Tessa Tan Torres; Evans, David B.			Economic impact of disease and injury: counting what matters	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ILLNESS; HEALTH; COST		[Chisholm, Dan; Stanciole, Anderson E.; Edejer, Tessa Tan Torres; Evans, David B.] WHO, Dept Hlth Syst Financing Hlth Syst & Serv, CH-1211 Geneva 27, Switzerland	World Health Organization	Chisholm, D (corresponding author), WHO, Dept Hlth Syst Financing Hlth Syst & Serv, CH-1211 Geneva 27, Switzerland.	chisholmd@who.int	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Edejer, Tessa/0000-0003-1068-332X				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Acemoglu D., 2007, DIS DEV EFFECT LIFE; Baltussen RM., 2003, MAKING CHOICES HLTH; Becker GS, 2005, AM ECON REV, V95, P277, DOI 10.1257/0002828053828563; Bhagava A, 2001, J HEALTH ECON, V20, P423, DOI 10.1016/S0167-6296(01)00073-X; Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Byford S, 2000, BRIT MED J, V320, P1335, DOI 10.1136/bmj.320.7245.1335; CUDDINGTON JT, 1993, WORLD BANK ECON REV, V7, P173, DOI 10.1093/wber/7.2.173; Drummond M, 1992, Pharmacoeconomics, V2, P1, DOI 10.2165/00019053-199202010-00001; Gertler P, 2002, AM ECON REV, V92, P51, DOI 10.1257/000282802760015603; HU TW, 1981, SYNTHESIS COST OF 1; JACK W, 2008, HLTH IMPROVEMENTS EC; Kambou G, 1993, Rev Econ Dev, V1, P37; Murphy KM, 2006, J POLIT ECON, V114, P871, DOI 10.1086/508033; Ruger JP, 2006, INT PUBLIC HLTH DIS, P601; SHIELL A, 1987, HEALTH POLICY, V8, P317, DOI 10.1016/0168-8510(87)90007-8; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Usher D., 1973, MEASUREMENT EC SOCIA, P193; Wagstaff A, 2007, J HEALTH ECON, V26, P82, DOI 10.1016/j.jhealeco.2006.07.001; World Health Organization, 2009, WHO GUID ID EC CONS	20	35	35	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2010	340								c924	10.1136/bmj.c924	http://dx.doi.org/10.1136/bmj.c924			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565FI	20197323				2022-12-28	WOS:000275274300025
J	Harvey, WF; Yang, M; Cooke, TDV; Segal, NA; Lane, N; Lewis, CE; Felson, DT				Harvey, William F.; Yang, Mei; Cooke, Theodore D. V.; Segal, Neil A.; Lane, Nancy; Lewis, Cora E.; Felson, David T.			Association of Leg-Length Inequality With Knee Osteoarthritis A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; RADIOGRAPHIC KNEE; JOINT; PROGRESSION	Background: Leg-length inequality is common in the general population and may accelerate development of knee osteoarthritis. Objective: To determine whether leg-length inequality is associated with prevalent, incident, and progressive knee osteoarthritis. Design: Prospective observational cohort study. Setting: Population samples from Birmingham, Alabama, and Iowa City, Iowa. Patients: 3026 participants aged 50 to 79 years with or at high risk for knee osteoarthritis. Measurements: The exposure was leg-length inequality, measured by full-limb radiography. The outcomes were prevalent, incident, and progressive knee osteoarthritis. Radiographic osteoarthritis was defined as Kellgren and Lawrence grade 2 or greater, and symptomatic osteoarthritis was defined as radiographic disease in a consistently painful knee. Results: Compared with leg-length inequality less than 1 cm, leg-length inequality of 1 cm or more was associated with prevalent radiographic (53% vs. 36%; odds ratio [OR], 1.9 [95% CI, 1.5 to 2.4]) and symptomatic (30% vs. 17%; OR, 2.0 [CI, 1.6 to 2.6]) osteoarthritis in the shorter leg, incident symptomatic osteoarthritis in the shorter leg (15% vs. 9%; OR, 1.7 [CI, 1.2 to 2.4]) and the longer leg (13% vs. 9%; OR, 1.5 [CI, 1.0 to 2.1]), and increased odds of progressive osteoarthritis in the shorter leg (29% vs. 24%; OR, 1.3 [CI, 1.0 to 1.7]). Limitations: Duration of follow-up may not be long enough to adequately identify cases of incidence and progression. Measurements of leg length, including radiography, are subject to measurement error, which could result in misclassification. Conclusion: Radiographic leg-length inequality was associated with prevalent, incident symptomatic, and progressive knee osteoarthritis. Leg-length inequality is a potentially modifiable risk factor for knee osteoarthritis.	[Harvey, William F.] Tufts Med Ctr, Boston, MA 02111 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Queens Univ, Kingston, ON, Canada; Univ Iowa, Iowa City, IA USA; Univ Calif Davis, Davis, CA 95616 USA; Univ Alabama Birmingham, Birmingham, AL USA	Tufts Medical Center; Boston University; Queens University - Canada; University of Iowa; University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham	Harvey, WF (corresponding author), Tufts Med Ctr, 800 Washington St,Box 406, Boston, MA 02111 USA.	wharvey@tuftsmedicalcenter.org	Segal, Neil A./B-2049-2008	Segal, Neil A./0000-0002-8294-080X; Felson, David/0000-0002-2668-2447	National Institute on Aging [U01-AG-18820, U01-AG-18832, U01-AG-18947, U01-AG-19069]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24-AR-048841]; National Institutes of Health; American College of Rheumatology Research and Education Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048841, P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG018820, U01AG018947, U01AG019069, U01AG018832] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Research and Education Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grants from the National Institute on Aging (U01-AG-18820, 18832, 18947, and 19069) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24-AR-048841), National Institutes of Health, and by the American College of Rheumatology Research and Education Foundation's Clinical Investigator Fellowship Award.	ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Bhave A, 1999, J BONE JOINT SURG AM, V81A, P529, DOI 10.2106/00004623-199904000-00010; Carlson M, 2007, PHYSIOTHER RES INT, V12, P29, DOI 10.1002/pri.351; Felson DT, 2008, J RHEUMATOL, V35, P2047; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P2986, DOI 10.1002/art.22851; Felson DT, 1997, OSTEOARTHR CARTILAGE, V5, P241, DOI 10.1016/S1063-4584(97)80020-9; Felson DT, 2004, RHEUM DIS CLIN N AM, V30, P783, DOI 10.1016/j.rdc.2004.07.005; FRIBERG O, 1983, SPINE, V8, P643, DOI 10.1097/00007632-198309000-00010; GILES LGF, 1981, SPINE, V6, P510, DOI 10.1097/00007632-198109000-00014; Golightly YM, 2007, OSTEOARTHR CARTILAGE, V15, P824, DOI 10.1016/j.joca.2007.01.009; Gurney B, 2002, GAIT POSTURE, V15, P195, DOI 10.1016/S0966-6362(01)00148-5; HELLSING AL, 1988, UPSALA J MED SCI, V93, P245, DOI 10.3109/03009738809178550; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kellgren JH, 1963, ATLAS STANDARD RADIO; KUJALA UM, 1987, INT J SPORTS MED, V8, P214, DOI 10.1055/s-2008-1025658; Moseley C F, 1989, Instr Course Lect, V38, P325; Niu J, 2009, ARTHRIT RHEUM-ARTHR, V61, P329, DOI 10.1002/art.24337; Segal NA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2433; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; SOUKKA A, 1991, SPINE, V16, P429, DOI 10.1097/00007632-199104000-00007; Souza RB, 2009, J ORTHOP SPORT PHYS, V39, P12, DOI 10.2519/jospt.2009.2885; STEVENS PM, 1989, ORTHOPEDICS, V12, P1457; SWEZEY RL, 1976, ARCH PHYS MED REHAB, V57, P387; VINK P, 1987, ACTA MORPHOL NEER SC, V25, P261; Woerman A L, 1984, J Orthop Sports Phys Ther, V5, P230; Zhang YQ, 1996, J RHEUMATOL, V23, P1130	26	106	111	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2010	152	5					287	W92		10.7326/0003-4819-152-5-201003020-00006	http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565XJ	20194234	Green Accepted			2022-12-28	WOS:000275329600003
J	To, TL; Maheshri, N				To, Tsz-Leung; Maheshri, Narendra			Noise Can Induce Bimodality in Positive Transcriptional Feedback Loops Without Bistability	SCIENCE			English	Article							GENE-EXPRESSION; CELL; MEMORY; MODULE	Transcriptional positive-feedback loops are widely associated with bistability, characterized by two stable expression states that allow cells to respond to analog signals in a digital manner. Using a synthetic system in budding yeast, we show that positive feedback involving a promoter with multiple transcription factor (TF) binding sites can induce a steady-state bimodal response without cooperative binding of the TF. Deterministic models of this system do not predict bistability. Rather, the bimodal response requires a short-lived TF and stochastic fluctuations in the TF's expression. Multiple binding sites provide these fluctuations. Because many promoters possess multiple binding sites and many TFs are unstable, positive-feedback loops in gene regulatory networks may exhibit bimodal responses, but not necessarily because of deterministic bistability, as is commonly thought.	[To, Tsz-Leung; Maheshri, Narendra] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Maheshri, N (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	narendra@mit.edu			NSF; Human Frontiers Science Program [RGY2007]; Massachusetts Institute of Technology	NSF(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program); Massachusetts Institute of Technology	We thank A. Raj for technical assistance with FISH, and C. J. Zopf, H. Kim, A. Raj, J. Gore, and K. Verstrepen for comments on the manuscript. This work was funded by an NSF Graduate Fellowship (to T.-L. T.), the Human Frontiers Science Program RGY2007 (to N.M.), and Massachusetts Institute of Technology startup funds (to N.M.)	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Alon U., 2006, INTRO SYSTEMS BIOL D; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; KELLER AD, 1995, J THEOR BIOL, V172, P169, DOI 10.1006/jtbi.1995.0014; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	21	201	203	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1142	1145		10.1126/science.1178962	http://dx.doi.org/10.1126/science.1178962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185727				2022-12-28	WOS:000274901100040
J	Flynn, TR; Hunter, GJ; Johnson, MM				Flynn, Thomas R.; Hunter, George J.; Johnson, Matthew M.			A Man with a Lesion on the Tongue Syphilis of the oral cavity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Flynn, Thomas R.] Harvard Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Cambridge, MA 02138 USA; [Hunter, George J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Johnson, Matthew M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Flynn, Thomas R.] Harvard Univ, Sch Med, Dept Oral & Maxillofacial Surg, Cambridge, MA 02138 USA; [Hunter, George J.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Johnson, Matthew M.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Flynn, TR (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Cambridge, MA 02138 USA.							Al-Johani KA, 2007, ORAL SURG ORAL MED O, V103, P642, DOI 10.1016/j.tripleo.2006.12.008; Bayazit YA, 2004, ORL-J OTO-RHIN-LARYN, V66, P275, DOI 10.1159/000081125; Deniz E, 2008, J ORAL MAXIL SURG, V66, P1659, DOI 10.1016/j.joms.2007.08.050; Diapera MJ, 2009, AM J OTOLARYNG, V30, P101, DOI 10.1016/j.amjoto.2008.02.014; Evans AS., 1998, BACTERIAL INFECT HUM, V3rd; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Jovanovic MB, 2008, OTOLARYNG HEAD NECK, V139, P468, DOI 10.1016/j.otohns.2008.05.011; Judson MA, 2007, AM J MED, V120, P403, DOI 10.1016/j.amjmed.2006.07.047; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kumar V., 2004, ROBBINS COTRAN PATHO; Lane Suzanne E, 2005, Curr Rheumatol Rep, V7, P270, DOI 10.1007/s11926-005-0036-5; Leão Jair Carneiro, 2006, Clinics, V61, P161, DOI 10.1590/S1807-59322006000200012; Martin-Ezquerra G, 2009, HUM PATHOL, V40, P624, DOI 10.1016/j.humpath.2008.10.017; Ozaki Shoichi, 2007, Allergol Int, V56, P87, DOI 10.2332/allergolint.R-07-141; Park Y, 2002, ORAL ONCOL, V38, P103, DOI 10.1016/S1368-8375(01)00020-3; Peterman TA, 2007, CURR OPIN INFECT DIS, V20, P54, DOI 10.1097/QCO.0b013e32801158cc; Porter SR, 2005, ALIMENT PHARM THER, V21, P295, DOI 10.1111/j.1365-2036.2005.02333.x; REICH RF, 1998, ORAL MAXIL SURG CLIN, V10, P95; Singh AE, 2008, INT J STD AIDS, V19, P464, DOI 10.1258/ijsa.2007.007302	19	6	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					740	748		10.1056/NEJMcpc0910089	http://dx.doi.org/10.1056/NEJMcpc0910089			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181976				2022-12-28	WOS:000274845600014
J	Karim, SSA; Naidoo, K; Grobler, A; Padayatchi, N; Baxter, C; Gray, A; Gengiah, T; Nair, G; Bamber, S; Singh, A; Khan, M; Pienaar, J; El-Sadr, W; Friedland, G; Karim, QA				Karim, Salim S. Abdool; Naidoo, Kogieleum; Grobler, Anneke; Padayatchi, Nesri; Baxter, Cheryl; Gray, Andrew; Gengiah, Tanuja; Nair, Gonasagrie; Bamber, Sheila; Singh, Aarthi; Khan, Munira; Pienaar, Jacqueline; El-Sadr, Wafaa; Friedland, Gerald; Karim, Quarraisha Abdool			Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; INFECTED PATIENTS; HIV PATIENTS; SURVIVAL; AIDS; THAILAND; AFRICA	BACKGROUND The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial. METHODS In an open-label, randomized, controlled trial in Durban, South Africa, we assigned 642 patients with both tuberculosis and HIV infection to start antiretroviral therapy either during tuberculosis therapy (in two integrated-therapy groups) or after the completion of such treatment (in one sequential-therapy group). The diagnosis of tuberculosis was based on a positive sputum smear for acid-fast bacilli. Only patients with HIV infection and a CD4+ cell count of less than 500 per cubic millimeter were included. All patients received standard tuberculosis therapy, prophylaxis with trimethoprim-sulfamethoxazole, and a once-daily antiretroviral regimen of didanosine, lamivudine, and efavirenz. The primary end point was death from any cause. RESULTS This analysis compares data from the sequential-therapy group and the combined integrated-therapy groups up to September 1, 2008, when the data and safety monitoring committee recommended that all patients receive integrated antiretroviral therapy. There was a reduction in the rate of death among the 429 patients in the combined integrated-therapy groups (5.4 deaths per 100 person-years, or 25 deaths), as compared with the 213 patients in the sequential-therapy group (12.1 per 100 person-years, or 27 deaths); a relative reduction of 56% (hazard ratio in the combined integrated-therapy groups, 0.44; 95% confidence interval, 0.25 to 0.79; P = 0.003). Mortality was lower in the combined integrated-therapy groups in all CD4+ count strata. Rates of adverse events during follow-up were similar in the two study groups. CONCLUSIONS The initiation of antiretroviral therapy during tuberculosis therapy significantly improved survival and provides further impetus for the integration of tuberculosis and HIV services. (ClinicalTrials.gov number, NCT00398996.)	[Karim, Salim S. Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, CAPRISA, ZA-4013 Durban, South Africa; [Karim, Salim S. Abdool; El-Sadr, Wafaa; Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [El-Sadr, Wafaa] Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, Mailman Sch Publ Hlth, New York, NY USA; [Friedland, Gerald] Yale Univ, Sch Med, Dept Internal Med & Epidemiol, New Haven, CT USA	University of Kwazulu Natal; Columbia University; Columbia University; Yale University	Karim, SSA (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, CAPRISA, 2nd Fl,Private Bag X7, ZA-4013 Durban, South Africa.	caprisa@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Abdool/P-3117-2019; Gray, Andrew/F-2104-2013; Hug, Balthasar L./G-1568-2010; padayatchi, nesri/Q-2780-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Abdool/0000-0002-4986-2133; Gray, Andrew/0000-0001-7815-8180; padayatchi, nesri/0000-0003-2543-9071; Grobler, Anneke/0000-0002-7809-7688; Gengiah, Tanuja/0000-0002-3405-5128; Naidoo, Kogieleum/0000-0002-8874-6661	U.S. President's Emergency Plan for AIDS Relief; Global Fund to fight AIDS, Tuberculosis and Malaria for drugs used in the trial; Comprehensive International Program of Research on AIDS for the research infrastructure; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	U.S. President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)); Global Fund to fight AIDS, Tuberculosis and Malaria for drugs used in the trial; Comprehensive International Program of Research on AIDS for the research infrastructure; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the U.S. President's Emergency Plan for AIDS Relief for the care of patients, the Global Fund to fight AIDS, Tuberculosis and Malaria for drugs used in the trial, and the Comprehensive International Program of Research on AIDS for the research infrastructure (including data management and laboratory and pharmacy facilities) to conduct the trial.	Burman W, 2007, INT J TUBERC LUNG D, V11, P1282; Chien JW, 1998, CHEST, V114, P933, DOI 10.1378/chest.114.3.933; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P705; de Olalla PG, 2002, INT J TUBERC LUNG D, V6, P1051; Fishman JE, 2000, AM J ROENTGENOL, V174, P43, DOI 10.2214/ajr.174.1.1740043; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; *HLTH SYST TRUST, DISTR HLTH BAR 2006; *JOINT UN PROGR HI, 2008, 2008 REP GLOB AIDS E; Karim SSA, 2006, AIDS, V20, pN7, DOI 10.1097/01.aids.0000247110.51338.73; Karim SSA, 2004, AIDS, V18, P975, DOI 10.1097/00002030-200404300-00004; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lawn SD, 2005, CLIN INFECT DIS, V41, P1683, DOI 10.1086/498030; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; MEINTJES G, 2009, 16 C RETR OPP INF MO; Meintjes G, 2009, CLIN INFECT DIS, V48, P667, DOI 10.1086/596764; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Piscitelli SC, 2001, NEW ENGL J MED, V344, P984, DOI 10.1056/NEJM200103293441307; *S AFR DEP HLTH, 2004, NAT ANT TREATM GUID; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Schluger NW, 1999, CLIN INFECT DIS, V28, P130, DOI 10.1086/515088; South African Department of Health, 2004, S AFR NAT TUB CONTR; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sungkanuparph S, 2006, J INFECTION, V52, P188, DOI 10.1016/j.jinf.2005.05.010; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2009, GLOB TUB CONTR EP ST	28	490	504	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					697	706		10.1056/NEJMoa0905848	http://dx.doi.org/10.1056/NEJMoa0905848			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181971	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000274845600008
J	Zimmerman, M				Zimmerman, Mark			Is underdiagnosis the main pitfall in diagnosing bipolar disorder? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEPRESSION; ANTIDEPRESSANTS; COMORBIDITY; RECOGNITION; PREVALENCE; ACCURACY		Rhode Isl Hosp, Providence, RI 02905 USA	Lifespan Health Rhode Island; Rhode Island Hospital	Zimmerman, M (corresponding author), Rhode Isl Hosp, Bayside Med Bldg,235 Plain St, Providence, RI 02905 USA.	mzimmerman@lifespan.org						Basco MR, 2000, AM J PSYCHIAT, V157, P1599, DOI 10.1176/appi.ajp.157.10.1599; Birnbaum HG, 2003, J CLIN PSYCHIAT, V64, P1201, DOI 10.4088/JCP.v64n1010; Bowden CL, 2001, PSYCHIAT SERV, V52, P51, DOI 10.1176/appi.ps.52.1.51; Ghaemi SN, 2000, J CLIN PSYCHIAT, V61, P804, DOI 10.4088/JCP.v61n1013; Hirschfeld RMA, 2005, J AM BOARD FAM PRACT, V18, P233, DOI 10.3122/jabfm.18.4.233; Hirschfeld RMA, 2004, J CLIN PSYCHIAT, V65, P5; Katzow JJ, 2003, BIPOLAR DISORD, V5, P436, DOI 10.1046/j.1399-5618.2003.00068.x; Manning JS, 1997, COMPR PSYCHIAT, V38, P102; Matza LS, 2005, J CLIN PSYCHIAT, V66, P1432, DOI 10.4088/JCP.v66n1114; Miller PR, 2001, PSYCHIAT RES, V105, P255, DOI 10.1016/S0165-1781(01)00317-1; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Shi LZ, 2004, J AFFECT DISORDERS, V82, P373, DOI 10.1016/j.jad.2004.03.009; Zimmerman M, 1999, AM J PSYCHIAT, V156, P1570, DOI 10.1176/ajp.156.10.1570; Zimmerman M, 1999, COMPR PSYCHIAT, V40, P182, DOI 10.1016/S0010-440X(99)90001-9; Zimmerman M, 1998, COMPR PSYCHIAT, V39, P265, DOI 10.1016/S0010-440X(98)90034-7; Zimmerman M, 2008, J CLIN PSYCHIAT, V69, P935, DOI 10.4088/JCP.v69n0608; Zimmerman M, 2009, BIPOLAR DISORD, V11, P759, DOI 10.1111/j.1399-5618.2009.00755.x	17	12	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2010	340								c855	10.1136/bmj.c855	http://dx.doi.org/10.1136/bmj.c855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	561TE	20176702				2022-12-28	WOS:000275001000014
J	Nesbit, J; Bradford, M; Jones, PL; Lucia, A; Sabin, JE; Palais, R; Benard, L; Beck, D; Jacquet, J; De Stefano, M; Auletta, A; Langella, C; Friedberg, J; Bielecki, A; Starr, H; Malone, M; Thiemann, C; Grady, D; Hochleitner, G; Gredel, C; Sparwasser, N; Jannis, S; Dempsey, W; Fredenburg, R; Godwin, D; Cham, J; Olson, E; Orlando, D; Manning, T; Kang, SH; Pokroy, B; Aizenberg, J; Zach, MP; Paves, H; Ilau, B; Taylor, R; Whitaker, BK; Carstens, BL				Nesbit, Jeff; Bradford, Monica; Jones, Peter Lloyd; Lucia, Andrew; Sabin, Jenny E.; Palais, Richard; Benard, Luc; Beck, Dave; Jacquet, Jennifer; De Stefano, Mario; Auletta, Antonia; Langella, Carla; Friedberg, Jeremy; Bielecki, Andrea; Starr, Harmony; Malone, Molly; Thiemann, Christian; Grady, Daniel; Hochleitner, Gregor; Gredel, Christian; Sparwasser, Nils; Jannis, Stacy; Dempsey, William; Fredenburg, Rebekah; Godwin, Dwayne; Cham, Jorge; Olson, Erin; Orlando, Daphne; Manning, Tim; Kang, Sung Hoon; Pokroy, Boaz; Aizenberg, Joanna; Zach, Michael P.; Paves, Heiti; Ilau, Birger; Taylor, Russell; Whitaker, Briana K.; Carstens, Briana L.			2009 VISUALIZATION CHALLENGE	SCIENCE			English	Editorial Material									[Nesbit, Jeff] NSF, Off Legislat & Publ Affairs, Arlington, VA USA; [Palais, Richard; Benard, Luc] Univ Calif Irvine, Irvine, CA USA; [Beck, Dave] Clarkson Univ, Potsdam, NY 13676 USA; [Jacquet, Jennifer] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [De Stefano, Mario; Auletta, Antonia; Langella, Carla] Univ Naples 2, Naples, Italy; [Starr, Harmony; Malone, Molly] Univ Utah, Salt Lake City, UT 84112 USA; [Thiemann, Christian; Grady, Daniel] Northwestern Univ, Evanston, IL 60208 USA; [Godwin, Dwayne] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27109 USA; [Kang, Sung Hoon; Pokroy, Boaz; Aizenberg, Joanna] Harvard Univ, Cambridge, MA 02138 USA; [Zach, Michael P.] Univ Wisconsin, Stevens Point, WI 54481 USA; [Paves, Heiti; Ilau, Birger] Tallinn Univ Technol, Tallinn, Estonia; [Taylor, Russell; Whitaker, Briana K.; Carstens, Briana L.] Univ N Carolina, Chapel Hill, NC USA	National Science Foundation (NSF); University of California System; University of California Irvine; Clarkson University; University of British Columbia; Universita della Campania Vanvitelli; Utah System of Higher Education; University of Utah; Northwestern University; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; University of Wisconsin System; University of Wisconsin Stevens Point; Tallinn University of Technology; University of North Carolina; University of North Carolina Chapel Hill	Nesbit, J (corresponding author), NSF, Off Legislat & Publ Affairs, Arlington, VA USA.		Langella, Carla/AHD-5603-2022; Palais, Richard/T-7458-2019; Pokroy, Boaz/C-8878-2011	Jones, Peter Lloyd/0000-0003-1445-4081					0	2	2	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					945	955		10.1126/science.327.5968.945	http://dx.doi.org/10.1126/science.327.5968.945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	556XE	20167764				2022-12-28	WOS:000274625800015
J	Chirik, PJ; Wieghardt, K				Chirik, Paul J.; Wieghardt, Karl			Radical Ligands Confer Nobility on Base-Metal Catalysts	SCIENCE			English	Editorial Material							ELECTRONIC-STRUCTURES; COMPLEXES; IRON; REDOX; MN; NI; CU; PD		[Chirik, Paul J.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Wieghardt, Karl] Max Planck Inst Bioinorgan Chem, D-45470 Mulheim, Germany	Cornell University; Max Planck Society	Chirik, PJ (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	pc92@cornell.edu; wieghardt@mpi-muelheim.mpg.de	Wieghardt, Karl/B-4179-2014	Wieghardt, Karl/0000-0003-0600-7855				Bart SC, 2004, J AM CHEM SOC, V126, P13794, DOI 10.1021/ja046753t; Bart SC, 2006, J AM CHEM SOC, V128, P13901, DOI 10.1021/ja064557b; BILLIG E, 1964, INORG CHEM, V3, P663, DOI 10.1021/ic50015a013; Bolm C, 2009, NAT CHEM, V1, P420, DOI 10.1038/nchem.315; Bouwkamp MW, 2006, J AM CHEM SOC, V128, P13340, DOI 10.1021/ja064711u; Britovsek GJP, 1998, CHEM COMMUN, P849, DOI 10.1039/a801933i; Budzelaar PHM, 2001, INORG CHEM, V40, P4649, DOI 10.1021/ic001457c; Chaudhuri P, 2001, J AM CHEM SOC, V123, P2213, DOI 10.1021/ja003831d; de Bruin B, 2000, INORG CHEM, V39, P2936, DOI 10.1021/ic000113j; De Bruin B, 2007, PROG INORG CHEM, V55, P247, DOI 10.1002/9780470144428.ch5; GRAY HB, 1962, J AM CHEM SOC, V84, P3596, DOI 10.1021/ja00877a045; Herebian D, 2003, J AM CHEM SOC, V125, P10997, DOI 10.1021/ja030124m; Jazdzewski BA, 2000, COORDIN CHEM REV, V200, P633, DOI 10.1016/S0010-8545(00)00342-8; Jorgensen CK., 1966, COORDIN CHEM REV, V1, P164, DOI [10.1016/S0010-8545(00)80170-8, DOI 10.1016/S0010-8545(00)80170-8]; Knijnenburg Q, 2006, DALTON T, P5442, DOI 10.1039/b612251e; Small BL, 1998, J AM CHEM SOC, V120, P7143, DOI 10.1021/ja981317q; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sylvester KT, 2009, J AM CHEM SOC, V131, P8772, DOI 10.1021/ja902478p; Ward MD, 2002, J CHEM SOC DALTON, P275, DOI 10.1039/b110131p; Zarkesh RA, 2008, ANGEW CHEM INT EDIT, V47, P4715, DOI 10.1002/anie.200800812	20	695	695	4	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					794	795		10.1126/science.1183281	http://dx.doi.org/10.1126/science.1183281			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150476				2022-12-28	WOS:000274408300032
J	Oka, H; Ignatiev, PA; Wedekind, S; Rodary, G; Niebergall, L; Stepanyuk, VS; Sander, D; Kirschner, J				Oka, H.; Ignatiev, P. A.; Wedekind, S.; Rodary, G.; Niebergall, L.; Stepanyuk, V. S.; Sander, D.; Kirschner, J.			Spin-Dependent Quantum Interference Within a Single Magnetic Nanostructure	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; CONFINEMENT; ISLANDS; SURFACE	Quantum interference is a coherent quantum phenomenon that takes place in confined geometries. Using spin-polarized scanning tunneling microscopy, we found that quantum interference of electrons causes spatial modulation of spin polarization within a single magnetic nanostructure. We observed changes in both the sign and magnitude of the spin polarization on a subnanometer scale. A comparison of our experimental results with ab initio calculations shows that at a given energy, the modulation of the spin polarization can be ascribed to the difference between the spatially modulated local density of states of the majority spin and the nonmodulated minority spin contribution.	[Oka, H.; Ignatiev, P. A.; Wedekind, S.; Rodary, G.; Niebergall, L.; Stepanyuk, V. S.; Sander, D.; Kirschner, J.] Max Planck Inst Mikrostrukturphys, D-06120 Halle, Germany	Max Planck Society	Stepanyuk, VS (corresponding author), Max Planck Inst Mikrostrukturphys, Weinberg 2, D-06120 Halle, Germany.	stepanyu@mpi-halle.de; sander@mpi-halle.de	Oka, Hirofumi/J-2537-2016	Oka, Hirofumi/0000-0002-1974-0338	Deutsche Forschungsgemeinschaft [SFB 762]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank F. Donati for enlightening discussions, N. Kurowsky for expert technical support, and O. O. Brovko for carefully reading this manuscript. Supported by Deutsche Forschungsgemeinschaft grant SFB 762.	Bode M, 2003, REP PROG PHYS, V66, P523, DOI 10.1088/0034-4885/66/4/203; Brovko OO, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205426; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; DELAFIGUERA J, 1993, PHYS REV B, V47, P13043, DOI 10.1103/PhysRevB.47.13043; Diekhoner L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.236801; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Li JT, 1998, PHYS REV LETT, V80, P3332, DOI 10.1103/PhysRevLett.80.3332; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Meier F, 2008, SCIENCE, V320, P82, DOI 10.1126/science.1154415; Negulyaev NN, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125437; Niebergall L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127204; Niebergall L, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195436; Pietzsch O, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.237203; Pietzsch O, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.057202; Rastei MV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246102; Rodary G, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3246150; Rodary G, 2008, JPN J APPL PHYS, V47, P9013, DOI 10.1143/JJAP.47.9013; Stepanyuk VS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.187201; STROSCIO JA, 1995, PHYS REV LETT, V75, P2960, DOI 10.1103/PhysRevLett.75.2960; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998; WILDBERGER K, 1995, PHYS REV LETT, V75, P509, DOI 10.1103/PhysRevLett.75.509; Wortmann D, 2001, PHYS REV LETT, V86, P4132, DOI 10.1103/PhysRevLett.86.4132	22	80	81	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					843	846		10.1126/science.1183224	http://dx.doi.org/10.1126/science.1183224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150496				2022-12-28	WOS:000274408300055
J	Tao, F; Dag, S; Wang, LW; Liu, Z; Butcher, DR; Bluhm, H; Salmeron, M; Somorjai, GA				Tao, Feng; Dag, Sefa; Wang, Lin-Wang; Liu, Zhi; Butcher, Derek R.; Bluhm, Hendrik; Salmeron, Miquel; Somorjai, Gabor A.			Break-Up of Stepped Platinum Catalyst Surfaces by High CO Coverage	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; IN-SITU; PHOTOELECTRON-SPECTROSCOPY; SHAPE CHANGES; NANOPARTICLES; OXIDATION; PT(111); RECONSTRUCTION; NANOCRYSTALS; ADSORPTION	Stepped single-crystal surfaces are viewed as models of real catalysts, which consist of small metal particles exposing a large number of low-coordination sites. We found that stepped platinum (Pt) surfaces can undergo extensive and reversible restructuring when exposed to carbon monoxide (CO) at pressures above 0.1 torr. Scanning tunneling microscopy and photoelectron spectroscopy studies under gaseous environments near ambient pressure at room temperature revealed that as the CO surface coverage approaches 100%, the originally flat terraces of (557) and (332) oriented Pt crystals break up into nanometer-sized clusters and revert to the initial morphology after pumping out the CO gas. Density functional theory calculations provide a rationale for the observations whereby the creation of increased concentrations of low-coordination Pt edge sites in the formed nanoclusters relieves the strong CO-CO repulsion in the highly compressed adsorbate film. This restructuring phenomenon has important implications for heterogeneous catalytic reactions.	[Tao, Feng; Butcher, Derek R.; Salmeron, Miquel; Somorjai, Gabor A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Tao, Feng; Butcher, Derek R.; Somorjai, Gabor A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Dag, Sefa; Wang, Lin-Wang] Univ Calif Berkeley, Lawrence Berkeley Lab, Computat Res Div, Berkeley, CA 94720 USA; [Liu, Zhi; Bluhm, Hendrik] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; [Bluhm, Hendrik] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Salmeron, Miquel] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Salmeron, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	mbsalmeron@lbl.gov; somorjai@berkeley.edu	Liu, Zhi/B-3642-2009; wang, lin/GSE-3040-2022	Liu, Zhi/0000-0002-8973-6561; 	Office of Basic Energy Sciences, Materials Sciences, and Chemical, Geosciences, and Biosciences Divisions; Office of Advanced Scientific Computing Research; U.S. Department of Energy [DE-AC02-05CH11231]	Office of Basic Energy Sciences, Materials Sciences, and Chemical, Geosciences, and Biosciences Divisions(United States Department of Energy (DOE)); Office of Advanced Scientific Computing Research; U.S. Department of Energy(United States Department of Energy (DOE))	The experimental work was supported by the director, Office of Basic Energy Sciences, Materials Sciences, and Chemical, Geosciences, and Biosciences Divisions. The theoretical work was supported by the Office of Advanced Scientific Computing Research. U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The computation uses the resources of National Energy Research Scientific Computing Center (NERSC) and the INCITE project allocations within the National Center for Computational Sciences (NCCS). XPS data were collected at the Advanced Light Source, Berkeley, CA. F. T. acknowledges the discussions with S. L. Bernasek, N. Kruse, T. Bligaard, and F. Ogletree.	Bar T, 2001, CATAL LETT, V74, P127, DOI 10.1023/A:1016685130974; Batteas JD, 1996, PHYS REV LETT, V77, P534, DOI 10.1103/PhysRevLett.77.534; BJORNEHOLM O, 1994, SURF SCI, V315, pL983, DOI 10.1016/0039-6028(94)90530-4; Bluhm H, 2007, MRS BULL, V32, P1022, DOI 10.1557/mrs2007.211; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; DUNPHY JC, 1993, SURF SCI, V280, P313, DOI 10.1016/0039-6028(93)90684-C; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Herranz T, 2009, J PHYS CHEM B, V113, P10721, DOI 10.1021/jp901602s; Kim WB, 2004, SCIENCE, V305, P1280, DOI 10.1126/science.1100860; Longwitz SR, 2004, J PHYS CHEM B, V108, P14497, DOI 10.1021/jp0492218; Nolte P, 2008, SCIENCE, V321, P1654, DOI 10.1126/science.1160845; Ogletree DF, 2002, REV SCI INSTRUM, V73, P3872, DOI 10.1063/1.1512336; Pearl TP, 2001, J CHEM PHYS, V115, P1916, DOI 10.1063/1.1381532; Rodriguez JA, 2007, SCIENCE, V318, P1757, DOI 10.1126/science.1150038; Salmeron M, 2008, SURF SCI REP, V63, P169, DOI 10.1016/j.surfrep.2008.01.001; Somorjai G.A., 1997, INTRO SURFACE CHEM C; Tao F, 2008, SCIENCE, V322, P932, DOI 10.1126/science.1164170; Tao F, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2960569; THOMAS JM, 1997, PRINCIPLES PRACTICES, pCH8; Traa, 2008, HDB HETEROGENEOUS CA, DOI DOI 10.1002/9783527610044.HETCAT0130; Trankenschuh B, 2007, SURF SCI, V601, P1108, DOI 10.1016/j.susc.2006.12.004; Trankenschuh B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2168441; Xie XW, 2009, NATURE, V458, P746, DOI 10.1038/nature07877	24	391	395	12	502	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					850	853		10.1126/science.1182122	http://dx.doi.org/10.1126/science.1182122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150498				2022-12-28	WOS:000274408300057
J	Hulme, M; Zorita, E; Stocker, TF; Price, J; Christy, JR				Hulme, Mike; Zorita, Eduardo; Stocker, Thomas F.; Price, Jeff; Christy, John R.			IPCC: cherish it, tweak it or scrap it?	NATURE			English	Editorial Material									[Hulme, Mike] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Zorita, Eduardo] GKSS Forschungszentrum Geesthacht GmbH, Geesthacht, Germany; [Stocker, Thomas F.] Univ Bern, CH-3012 Bern, Switzerland; [Christy, John R.] Univ Alabama, Huntsville, AL 35899 USA	University of East Anglia; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Bern; University of Alabama System; University of Alabama Huntsville	Hulme, M (corresponding author), Univ E Anglia, Norwich NR4 7TJ, Norfolk, England.		Stocker, Thomas/B-1273-2013; Hulme, Mike/F-9012-2010	Hulme, Mike/0000-0002-1273-7662					0	43	43	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 11	2010	463	7282					730	732		10.1038/463730a	http://dx.doi.org/10.1038/463730a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	553VG	20148014				2022-12-28	WOS:000274394300015
J	Rosenbaum, L				Rosenbaum, Lisa			Failing to Thrive	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New York Presbyterian Weill Cornell Med Ctr, Dept Cardiol, New York, NY USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Rosenbaum, L (corresponding author), New York Presbyterian Weill Cornell Med Ctr, Dept Cardiol, New York, NY USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					479	481		10.1056/NEJMp0908280	http://dx.doi.org/10.1056/NEJMp0908280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553WJ	20147713				2022-12-28	WOS:000274397200002
J	Ekman, P				Ekman, Paul			Darwin's Compassionate View of Human Nature	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ekman, Paul] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ekman, P (corresponding author), Paul Ekman Grp LLC, 300 Montgomery St,Ste 833, San Francisco, CA 94104 USA.	paulekman@me.com						Darwin C., 2004, DESCENT MAN SELECTIO; Darwin C., 1871, P475; LAMA D, 2008, EMOTIONAL AWARENESS, P149; LEAHY RL, 2005, COMPASSION CONCEPTUA; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Monroe K. R., 1996, HEART ALTRUISM PERCE; Spencer Herbert, 2002, PRINCIPLES BIOL	7	7	7	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					557	558		10.1001/jama.2010.101	http://dx.doi.org/10.1001/jama.2010.101			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	553PG	20145235				2022-12-28	WOS:000274378700030
J	O'Brien, PE; Sawyer, SM; Laurie, C; Brown, WA; Skinner, S; Veit, F; Paul, E; Burton, PR; McGrice, M; Anderson, M; Dixon, JB				O'Brien, Paul E.; Sawyer, Susan M.; Laurie, Cheryl; Brown, Wendy A.; Skinner, Stewart; Veit, Friederike; Paul, Eldho; Burton, Paul R.; McGrice, Melanie; Anderson, Margaret; Dixon, John B.			Laparoscopic Adjustable Gastric Banding in Severely Obese Adolescents A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOMEOSTASIS MODEL ASSESSMENT; CHILD HEALTH QUESTIONNAIRE; BARIATRIC SURGERY; WEIGHT-LOSS; INSULIN-RESISTANCE; RISK-FACTORS; OVERWEIGHT; GLUCOSE; POPULATION; MANAGEMENT	Context Adolescent obesity is a common and serious health problem affecting more than 5 million young people in the United States alone. Bariatric surgery is being evaluated as a possible treatment option. Laparoscopic adjustable gastric banding (gastric banding) has the potential to provide a safe and effective treatment. Objective To compare the outcomes of gastric banding with an optimal lifestyle program on adolescent obesity. Design, Setting, and Patients A prospective, randomized controlled trial of 50 adolescents between 14 and 18 years with a body mass index (BMI) higher than 35, recruited from the Melbourne, Australia, community, assigned either to a supervised lifestyle intervention or to undergo gastric banding, and followed up for 2 years. The study was performed between May 2005 and September 2008. Main Outcome Measures Weight loss. Secondary outcomes included change in metabolic syndrome, insulin resistance, quality of life, and adverse outcomes. Results Twenty-four of 25 patients in the gastric banding group and 18 of 25 in lifestyle group completed the study. Twenty-one (84%) in the gastric banding and 3 (12%) in the lifestyle groups lost more than 50% of excess weight, corrected for age. Overall, the mean changes in the gastric banding group were a weight loss of 34.6 kg (95% CI, 30.2-39.0), representing an excess weight loss of 78.8% (95% CI, 66.6%-91.0%), 12.7 BMI units (95% CI, 11.3-14.2), and a BMI z score change from 2.39 (95% CI, 2.05-2.73) to 1.32 (95% CI, 0.98-1.66). The mean losses in the lifestyle group were 3.0 kg (95% CI, 2.1-8.1), representing excess weight loss of 13.2% (95% CI, 2.6%-21.0%), 1.3 BMI units (95% CI, 0.4-2.9), and a BMI z score change from 2.41 (95% CI, 2.21-2.66) to 2.26 (95% CI, 1.91-2.43). At entry, 9 participants (36%) in the gastric banding group and 10 (40%) in the lifestyle group had the metabolic syndrome. At 24 months, none of the gastric banding group had the metabolic syndrome (P=.008; McNemar chi(2)) compared with 4 of the 18 completers (22%) in the lifestyle group (P=.13). The gastric banding group experienced improved quality of life with no perioperative adverse events. However, 8 operations (33%) were required in 7 patients for revisional procedures either for proximal pouch dilatation or tubing injury during follow-up. Conclusions Among obese adolescent participants, use of gastric banding compared with lifestyle intervention resulted in a greater percentage achieving a loss of 50% of excess weight, corrected for age. There were associated benefits to health and quality of life.	[O'Brien, Paul E.] Monash Univ, Alfred Hosp, Ctr Obes Res & Educ, Sch Med, Melbourne, Vic 3004, Australia; [Dixon, John B.] Dept Gen Practice, Obes Res Unit, Melbourne, Vic, Australia; [Paul, Eldho] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Sawyer, Susan M.; Veit, Friederike] Royal Childrens Hosp, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Sawyer, Susan M.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Sawyer, Susan M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute	O'Brien, PE (corresponding author), Monash Univ, Alfred Hosp, Ctr Obes Res & Educ, Sch Med, Melbourne, Vic 3004, Australia.	paul.obrien@med.monash.edu.au	Dixon, John B/A-5318-2011; Brown, Wendy Ann/H-7130-2014	Dixon, John B/0000-0001-5391-4082; Brown, Wendy Ann/0000-0002-0137-2688; Paul, Eldho/0000-0003-1263-7255	National Health and Medical Research Council [NHMRC-GA05-384215]; Allergan	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Allergan(AbbVieAllergan)	The study was funded by grant NHMRC-GA05-384215 from the National Health and Medical Research Council. The laparoscopic adjustable gastric bands used in the study were provided by the manufacturer, Allergan. The Centre for Obesity Research and Education receives an unrestricted research support grant from Allergan.	Allen JW, 2007, MED CLIN N AM, V91, P485, DOI 10.1016/j.mcna.2007.01.009; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Brown WA, 2008, OBES SURG, V18, P1104, DOI 10.1007/s11695-008-9485-z; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Connelly JB, 2007, PUBLIC HEALTH, V121, P510, DOI 10.1016/j.puhe.2006.11.015; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Deckelbaum RJ, 2001, OBES RES, V9, p239S, DOI 10.1038/oby.2001.125; DIGGLE P, 1994, APPL STAT-J ROY ST C, V43, P49; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Favretti F, 2002, AM J SURG, V184, p38S, DOI 10.1016/S0002-9610(02)01178-9; Fielding George A, 2005, Surg Obes Relat Dis, V1, P399, DOI 10.1016/j.soard.2005.04.006; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Garcia VF, 2005, PEDIATRICS, V115, P822, DOI 10.1542/peds.2004-1692; Inge TH, 2007, INT J OBESITY, V31, P1, DOI 10.1038/sj.ijo.0803525; Jolliffe CJ, 2007, J AM COLL CARDIOL, V49, P891, DOI 10.1016/j.jacc.2006.08.065; Keating CL, 2009, DIABETES CARE, V32, P567, DOI 10.2337/dc08-1749; Kuczmarski RJ, 2000, Adv Data, P1; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; Landgraf JM, 1996, CHQ USERS MANUAL; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; LUTTKHUIS HO, 2009, COCHRANE DB SYST REV; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mittermair R, 2009, OBES SURG, V19, P446, DOI 10.1007/s11695-008-9758-6; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; O'Brien PE, 2002, OBES SURG, V12, P652, DOI 10.1381/096089202321019639; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pratt JSA, 2009, OBESITY, V17, P901, DOI 10.1038/oby.2008.577; Rocchini AP, 2002, NEW ENGL J MED, V346, P854, DOI 10.1056/NEJM200203143461112; Roehrig HR, 2007, OBES SURG, V17, P873, DOI 10.1007/s11695-007-9162-7; *SPSS INC, 1999, SPSS WIND COMP PROGR; Treadwell JR, 2008, ANN SURG, V248, P763, DOI 10.1097/SLA.0b013e31818702f4; Waters E, 2000, AUST NZ J PUBL HEAL, V24, P207, DOI 10.1111/j.1467-842X.2000.tb00145.x; Waters EB, 2001, J ADOLESCENT HEALTH, V29, P140, DOI 10.1016/S1054-139X(01)00211-7	42	241	244	2	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					519	526		10.1001/jama.2010.81	http://dx.doi.org/10.1001/jama.2010.81			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145228	Bronze			2022-12-28	WOS:000274378700023
J	Kahr, V; Barrett, NA; Shankar-Hari, M; Slack, H; Preston, RL; Fhogartaigh, CN; Edgeworth, J; Beale, R				Kahr, Vanessa; Barrett, Nicholas A.; Shankar-Hari, Manu; Slack, Hannah; Preston, Rebecca L.; Fhogartaigh, Caoimhe Nic; Edgeworth, Jonathan; Beale, Richard			A life-threatening sore throat masquerading as swine flu	LANCET			English	Editorial Material							LEMIERRE-SYNDROME		[Kahr, Vanessa; Barrett, Nicholas A.; Shankar-Hari, Manu; Slack, Hannah; Beale, Richard] Guys & St Thomas NHS Fdn Trust, Dept Crit Care, London SE1 7LB, England; [Fhogartaigh, Caoimhe Nic; Edgeworth, Jonathan] Guys & St Thomas NHS Fdn Trust, Directorate Infect, London SE1 7LB, England; [Preston, Rebecca L.] Guys & St Thomas NHS Fdn Trust, Dept Radiol, London SE1 7LB, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Beale, R (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Crit Care, 5 Lambeth Palace Rd, London SE1 7LB, England.	richard.beale@gstt.nhs.uk	Beale, Richard J/J-7831-2013; Shankar-Hari, Manu/I-6948-2012	Shankar-Hari, Manu/0000-0002-5338-2538; Barrett, Nicholas/0000-0002-4641-8192				Chirinos JA, 2002, MEDICINE, V81, P458, DOI 10.1097/00005792-200211000-00006; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Hagelskjaer LH, 1998, EUR J CLIN MICROBIOL, V17, P561, DOI 10.1007/BF01708619; SINAVE CP, 1989, MEDICINE, V68, P85, DOI 10.1097/00005792-198903000-00002; Syed ML, 2007, LARYNGOSCOPE, V117, P1605, DOI 10.1097/MLG.0b013e318093ee0e	5	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					524	524		10.1016/S0140-6736(09)61875-4	http://dx.doi.org/10.1016/S0140-6736(09)61875-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20152545				2022-12-28	WOS:000274757900035
J	Kalverda, B; Pickersgill, H; Shloma, VV; Fornerod, M				Kalverda, Bernike; Pickersgill, Helen; Shloma, Victor V.; Fornerod, Maarten			Nucleoporins Directly Stimulate Expression of Developmental and Cell-Cycle Genes Inside the Nucleoplasm	CELL			English	Article							NUCLEAR-PORE COMPONENTS; SPATIAL-ORGANIZATION; PROTEIN; TRANSCRIPTION; GENOME; CHROMOSOMES; COMPLEXES; PHOSPHORYLATION; IDENTIFICATION; METHYLATION	Nuclear pore complexes (NPCs) mediate transport across the nuclear envelope. In yeast, they also interact with active genes, attracting or retaining them at the nuclear periphery. In higher eukaryotes, some NPC components (nucleoporins) are also found in the nucleoplasm, with a so far unknown function. We have functionally characterized nucleoporin-chromatin interactions specifically at the NPC or within the nucleoplasm in Drosophila. We analyzed genomic interactions of full-length nucleoporins Nup98, Nup50, and Nup62 and nucleoplasmic and NPC-tethered forms of Nup98. We found that nucleoporins predominantly interacted with transcriptionally active genes inside the nucleoplasm, in particular those involved in developmental regulation and the cell cycle. A smaller set of nonactive genes interacted with the NPC. Genes strongly interacting with nucleoplasmic Nup98 were downregulated upon Nup98 depletion and activated on nucleoplasmic Nup98 overexpression. Thus, nucleoporins stimulate developmental and cell-cycle gene expression away from the NPC by interacting with these genes inside the nucleoplasm.	[Kalverda, Bernike; Pickersgill, Helen; Fornerod, Maarten] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Shloma, Victor V.] Russian Acad Sci, Dept Mol & Cell Biol, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia	Netherlands Cancer Institute; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Fornerod, M (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.fornerod@nki.nl	Fornerod, Maarten/A-7503-2010; Shloma, Victor/N-7979-2015; Kalverda, Bernike/A-7691-2010	Fornerod, Maarten/0000-0002-6166-3030	Dutch Cancer Society [NKI-2004-3080]; Marie Curie European fellowship; Russian Foundation for Basic Research [08-04-01105a]; Program of Presidium RAS "Molecular and Cellular Biology'' [N22.4]; SB RAS [N37]; Science Schools [5104.2008.4]	Dutch Cancer Society(KWF Kankerbestrijding); Marie Curie European fellowship(European Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of Presidium RAS "Molecular and Cellular Biology''; SB RAS(Russian Academy of Sciences); Science Schools	We thank M. Hetzer and M. Capelson for Drosophila Nup98 antibody; J. Gro beta hans for Nup50 antibody; M. Roling for help with FISH experiments; N. Xylourgidis for help with scoring of FISH images; U. Braunschweig for the pCASPERGW-MycDam vector; L. Pagie and W. Meuleman for gene end alignment scripts; J. Delrow for providing cDNA microarrays; the NKI microarray facility for help with microarray experiments; A. Olszak, A. de Jong, M. Vogel, L. Oomen, and L. Brocks for technical help and advice; B. van Steensel for intellectual input and support; M. Hetzer and A. Akhtar for sharing unpublished data; F. v. Leeuwen, and N. Xylourgidis for critically reading the manuscript; and J. van Deursen and R. Wolthuis and members of the Fornerod and van Steensel labs for helpful discussions. This work was supported by the Dutch Cancer Society grant NKI-2004-3080. H. P. was funded by a Marie Curie European fellowship. V. V. S. was supported by the Russian Foundation for Basic Research grant N 08-04-01105a, Program of Presidium RAS "Molecular and Cellular Biology'' N22.4, Interdisciplinary integration project of SB RAS N37, and Science Schools grant 5104.2008.4.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; BEERMANN W, 1952, CHROMOSOMA, V5, P139; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ECHALIER G, 1997, DROSOPHILA CELLS CUL, P393; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kasper LH, 1999, MOL CELL BIOL, V19, P764; KLADDE MP, 1994, P NATL ACAD SCI USA, V91, P1361, DOI 10.1073/pnas.91.4.1361; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Lam DH, 2001, LEUKEMIA, V15, P1689, DOI 10.1038/sj.leu.2402269; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; STUURMAN N, 1995, J CELL SCI, V108, P3137; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Zimowska G, 1997, J CELL SCI, V110, P927	58	315	322	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					360	U81		10.1016/j.cell.2010.01.011	http://dx.doi.org/10.1016/j.cell.2010.01.011			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144760	Bronze			2022-12-28	WOS:000274297700014
J	Little, P; Merriman, R; Turner, S; Rumsby, K; Warner, G; Lowes, JA; Smith, H; Hawke, C; Leydon, G; Mullee, M; Moore, MV				Little, P.; Merriman, R.; Turner, S.; Rumsby, K.; Warner, G.; Lowes, J. A.; Smith, H.; Hawke, C.; Leydon, G.; Mullee, M.; Moore, M. V.			Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE CONSULTATIONS; RANDOMIZED CONTROLLED-TRIAL; PRESCRIBING STRATEGIES; OUTCOMES	Objective To assess the natural course and the important predictors of severe symptoms in urinary tract infection and the effect of antibiotics and antibiotic resistance. Design Observational study. Setting Primary care. Participants 839 non-pregnant adult women aged 18-70 presenting with suspected urinary tract infection. Main outcome measure Duration and severity of symptoms. Results 684 women provided some information on symptoms; 511 had both laboratory results and complete symptom diaries. For women with infections sensitive to antibiotics, severe symptoms, rated as a moderately bad problem or worse, lasted 3.32 days on average. After adjustment for other predictors, moderately bad symptoms lasted 56% longer (incidence rate ratio 1.56, 95% confidence interval 1.22 to 1.99, P<0.001) in women with resistant infections; 62% longer (1.62, 1.13 to 2.31, P=0.008) when no antibiotics prescribed; and 33% longer (1.33, 1.14 to 1.56, P<0.001) in women with urethral syndrome. The duration of symptoms was shorter if the doctor was perceived to be positive about diagnosis and prognosis (continuous 7 point scale: 0.91, 0.84 to 0.99; P=0.021) and longer when the woman had frequent somatic symptoms (1.03, 1.01 to 1.05, P=0.002; for each symptom), a history of cystitis, urinary frequency, and more severe symptoms at baseline. Conclusion Antibiotic resistance and not prescribing antibiotics are associated with a greater than 50% increase in the duration of more severe symptoms in women with uncomplicated urinary tract infection. Women with a history of cystitis, frequent somatic symptoms (high somatisation), and severe symptoms at baseline can be given realistic advice that they are likely to have severe symptoms lasting longer than three days.	[Warner, G.] Nightingale Surg, Romsey SO51 7QN, Hants, England; [Lowes, J. A.] Southampton Gen Hosp, Southampton Univ Hosp Trust, Microbiol Lab, Southampton SO16 6YD, Hants, England; [Smith, H.] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England; [Hawke, C.] Univ Sydney, Sch Rural Hlth, Orange, NSW, Australia; [Mullee, M.] Univ Southampton, Southampton Gen Hosp, Sch Med,RDSU, Community Clin Sci Div,Publ Hlth Sci & Med Stat G, Southampton SO16 6YD, Hants, England; [Little, P.; Merriman, R.; Turner, S.; Rumsby, K.; Moore, M. V.] Univ Southampton, Aldermoor Hlth Ctr, Primary Med Care Grp, Community Clin Sci Div,Sch Med, Southampton SO16 6ST, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Brighton; University of Sussex; University of Sydney; University of Southampton; University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	p.little@soton.ac.uk	Moore, Michael/C-3447-2011; Leydon, Geraldine M/C-4968-2011; Smith, Helen E/M-2449-2016	Moore, Michael/0000-0002-5127-4509; Smith, Helen E/0000-0003-1883-6124; Leydon, Geraldine Marie/0000-0001-5986-3300; Little, Paul/0000-0003-3664-1873; Rumsby, Kate/0000-0002-8573-3718	UK NHS Research and Development	UK NHS Research and Development	This study was funded by the health technology programme of UK NHS Research and Development.	Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Childs SJ, 1996, UROL CLIN N AM, V23, P43, DOI 10.1016/S0094-0143(05)70292-5; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; DOBBS FF, 1987, J ROY COLL GEN PRACT, V37, P100; European Confederation of Laboratory Medicine, 2000, Scand J Clin Lab Invest Suppl, V231, P1; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; Hummers-Pradier E, 2002, BRIT J GEN PRACT, V52, P752; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; Little P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13190; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 1999, BRIT MED J, V319, P736, DOI 10.1136/bmj.319.7212.736; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; Little P, 2001, BRIT J GEN PRACT, V51, P987; Little P, 2006, BRIT J GEN PRACT, V56, P606; McNulty CAM, 2006, J ANTIMICROB CHEMOTH, V58, P1000, DOI 10.1093/jac/dkl368; NICKEL J, 2005, CAN J UROL, P2728; Richards D, 2005, BMJ-BRIT MED J, V331, P143, DOI 10.1136/bmj.38496.452581.8F; *SMAC SUBGR ANT RE, 1998, PATH LEAST RES; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553	20	69	72	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2010	340								b5633	10.1136/bmj.b5633	http://dx.doi.org/10.1136/bmj.b5633			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CX	20139213	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000274343700001
J	Visel, A; Zhu, YW; May, D; Afzal, V; Gong, E; Attanasio, C; Blow, MJ; Cohen, JC; Rubin, EM; Pennacchio, LA				Visel, Axel; Zhu, Yiwen; May, Dalit; Afzal, Veena; Gong, Elaine; Attanasio, Catia; Blow, Matthew J.; Cohen, Jonathan C.; Rubin, Edward M.; Pennacchio, Len A.			Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice	NATURE			English	Article							CHROMOSOME 9P21; MYOCARDIAL-INFARCTION; TUMOR SUPPRESSION; HEART-DISEASE; INK4A LOCUS; ASSOCIATION; ATHEROSCLEROSIS; EXPRESSION; HYPERCHOLESTEROLEMIA; SUSCEPTIBILITY	Sequence polymorphisms in a 58-kilobase (kb) interval on chromosome 9p21 confer a markedly increased risk of coronary artery disease (CAD), the leading cause of death worldwide(1,2). The variants have a substantial effect on the epidemiology of CAD and other life-threatening vascular conditions because nearly one-quarter of Caucasians are homozygous for risk alleles. However, the risk interval is devoid of protein-coding genes and the mechanism linking the region to CAD risk has remained enigmatic. Here we show that deletion of the orthologous 70-kb non-coding interval on mouse chromosome 4 affects cardiac expression of neighbouring genes, as well as proliferation properties of vascular cells. Chr4(Delta 70kb/Delta 70kb) mice are viable, but show increased mortality both during development and as adults. Cardiac expression of two genes near the non-coding interval, Cdkn2a and Cdkn2b, is severely reduced in chr4(Delta 70kb/Delta 70kb) mice, indicating that distant-acting gene regulatory functions are located in the non-coding CAD risk interval. Allele-specific expression of Cdkn2b transcripts in heterozygous mice showed that the deletion affects expression through a cis-acting mechanism. Primary cultures of chr4(Delta 70kb/Delta 70kb) aortic smooth muscle cells exhibited excessive proliferation and diminished senescence, a cellular phenotype consistent with accelerated CAD pathogenesis. Taken together, our results provide direct evidence that the CAD risk interval has a pivotal role in regulation of cardiac Cdkn2a/b expression, and suggest that this region affects CAD progression by altering the dynamics of vascular cell proliferation.	[Visel, Axel; Zhu, Yiwen; May, Dalit; Afzal, Veena; Gong, Elaine; Attanasio, Catia; Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Visel, Axel; Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.] Joint Genome Inst, US DOE, Walnut Creek, CA 94598 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dept Mol Genet, Dallas, TX 75390 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	LAPennacchio@lbl.gov	Blow, Matthew/G-6369-2012; attanasio, catia/D-5042-2017; Visel, Axel/A-9398-2009	Blow, Matthew/0000-0002-8844-9149; attanasio, catia/0000-0001-8077-5719; Visel, Axel/0000-0002-4130-7784; Pennacchio, Len/0000-0002-8748-3732	National Heart, Lung, and Blood Institute; EMBO; Department of Energy, University of California [DE-AC02-05CH11231]; MMPC [DK59630]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681, R01HL082896, R21HL098940] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, U2CDK059630] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EMBO(European Molecular Biology Organization (EMBO)); Department of Energy, University of California(United States Department of Energy (DOE)University of California System); MMPC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Owens for critical suggestions and discussion, T. Ley for providing vector pTURBO-Cre, and D. Lee for help with plasma lipid analysis. L. A. P., E. M. R. and J.C.C. were supported by the National Heart, Lung, and Blood Institute, D. M. and C. A. by EMBO long-term fellowships and L. A. P. by the National Human Genome Research Institute. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. Plasma lipid analysis at the University of Cincinnati Mouse Metabolic Phenotyping Center was supported by MMPC DK59630. All animal work was reviewed and approved by the LBNL Animal Welfare and Research Committee.	Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Diez-Juan A, 2001, FASEB J, V15, P1989, DOI 10.1096/fj.01-0130com; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Gonzalez P, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-5; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Lemmens R, 2009, EUR J HUM GENET, V17, P1287, DOI 10.1038/ejhg.2009.42; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rodriguez I, 2007, CELL CYCLE, V6, P620, DOI 10.4161/cc.6.5.3927; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065	31	348	360	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					409	U103		10.1038/nature08801	http://dx.doi.org/10.1038/nature08801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20173736	Green Submitted, Green Accepted			2022-12-28	WOS:000275657100046
J	Lamb, SE; Hansen, Z; Lall, R; Castelnuova, E; Withers, EJ; Nichols, V; Potter, R; Underwood, MR				Lamb, Sarah E.; Hansen, Zara; Lall, Ranjit; Castelnuova, Emanuela; Withers, Emma J.; Nichols, Vivien; Potter, Rachel; Underwood, Martin R.		Back Skills Training Trial	Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis	LANCET			English	Article							ALEXANDER TECHNIQUE LESSONS; ECONOMIC-EVALUATION; PHYSICAL TREATMENTS; OUTCOME MEASURES; MASSAGE ATEAM; EXERCISE; DISABILITY; PHYSIOTHERAPY; QUESTIONNAIRE; GUIDELINES	Background Low-back pain is a common and costly problem. We estimated the effectiveness of a group cognitive behavioural intervention in addition to best practice advice in people with low-back pain in primary care. Methods In this pragmatic, multicentre, randomised controlled trial with parallel cost-effectiveness analysis undertaken in England, 701 adults with troublesome subacute or chronic low-back pain were recruited from 56 general practices and received an active management advisory consultation. Participants were randomly assigned by computer-generated block randomisation to receive an additional assessment and up to six sessions of a group cognitive behavioural intervention (n=468) or no further intervention (control; n=233). Primary outcomes were the change from baseline in Roland Morris disability questionnaire and modified Von Korff scores at 12 months. Assessment of outcomes was blinded and Wowed the intention-to-treat principle, including all randomised participants who provided follow-up data. This study is registered, number ISRCTN54717854. Findings 399 (85%) participants in the cognitive behavioural intervention group and 199 (85%) participants in the control group were included in the primary analysis at 12 months. The most frequent reason for participant withdrawal was unwillingness to complete questionnaires. At 12 months, mean change from baseline in the Roland Morris questionnaire score was 1.1 points (95% CI 0.39-1.72) in the control group and 2.4 points (1.89-2.84) in the cognitive behavioural intervention group (difference between groups 1.3 points, 0.56=2.06; p=0.0008). The modified Von Korff disability score changed by 5.4% (1.99-8.90) and 13.8% (11.39-16.28), respectively (difference between groups 8.4%, 4.47-12.32; p<0.0001). The modified Von Korff pain score changed by 6.4% (3.14-9.66) and 13.4% (10.77-15.96), respectively (difference between groups 7.0%, 3.12-10.81; p<0.0001). The additional quality-adjusted life-year (QALY) gained from cognitive behavioural intervention was 0.099; the incremental cost per QALY was 1786 pound, and the probability of cost-effectiveness was greater than 90% at a threshold of 3000 pound per QALY. There were no serious adverse events attributable to either treatment. Interpretation Over 1 year, the cognitive behavioural intervention had a sustained effect on troublesome subacute and chronic low-back pain at a low cost to the health-care provider.	[Lamb, Sarah E.; Hansen, Zara; Lall, Ranjit; Castelnuova, Emanuela; Withers, Emma J.; Nichols, Vivien; Potter, Rachel; Underwood, Martin R.] Univ Warwick, Warwick Clin Trials Unit, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Lamb, Sarah E.] Univ Oxford, Kadoorie Crit Care Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England	University of Warwick; University of Oxford	Lamb, SE (corresponding author), Univ Warwick, Warwick Clin Trials Unit, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	s.lamb@warwick.ac.uk	Underwood, Martin/D-6364-2015	Underwood, Martin/0000-0002-0309-1708; Lamb, Sarah/0000-0003-4349-7195; Lall, Ranjit/0000-0003-1737-2866; Pengel, Liset/0000-0001-9620-8639; Hills, Robert/0000-0003-0166-0062	National Institute for Health Research Health Technology Assessment Programme; National Institute for Health Research [01/75/01] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all the participants and general practices who participated in the Back Skills Training Trial. The funding for this trial was awarded by the National Institute for Health Research Health Technology Assessment Programme.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Chou R, 2007, ANN INTERN MED, V147, P492, DOI 10.7326/0003-4819-147-7-200710020-00007; Critchley DJ, 2007, SPINE, V32, P1474, DOI 10.1097/BRS.0b013e318067dc26; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Dolan P., 1995, SOCIAL TARIFF EUROQO; Hansen Z, 2010, PHYSIOTHERAPY, V96, P87, DOI 10.1016/j.physio.2009.09.008; Hayden JA, 2005, COCHRANE DB SYST REV, V20, DOI DOI 10.1002/14651858.CD000335.PUB2]; Hollinghurst S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2656; Jellema P, 2005, BMJ-BRIT MED J, V331, P84, DOI 10.1136/bmj.38495.686736.E0; Johnson RE, 2007, SPINE, V32, P1578, DOI 10.1097/BRS.0b013e318074f890; Lauridsen HH, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-82; Little P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a884; Manca A, 2004, BMJ-BRIT MED J, V329, P1381, DOI 10.1136/bmj.38282.607859.AE; Nicholas MK, 2007, EUR J PAIN, V11, P153, DOI 10.1016/j.ejpain.2005.12.008; *OFF NAT STAT, CONS PRIC; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pengel LHM, 2007, ANN INTERN MED, V146, P787, DOI 10.7326/0003-4819-146-11-200706050-00007; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Savigny P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1805; Savingy P, 2009, LOW BACK PAIN EARLY; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Somerville S, 2008, BRIT J GEN PRACT, V58, P790, DOI 10.3399/bjgp08X319909; Thompson I, 2005, LANG LEARN TECHNOL, V9, P1; Underwood M, 2004, BMJ-BRIT MED J, V329, P1377, DOI 10.1136/bmj.38282.669225AE; Underwood MR, 1999, SPINE, V24, P1104, DOI 10.1097/00007632-199906010-00010; van der Roer N, 2008, SPINE, V33, P445, DOI 10.1097/BRS.0b013e318163fa59; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	30	267	272	1	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					916	923		10.1016/S0140-6736(09)62164-4	http://dx.doi.org/10.1016/S0140-6736(09)62164-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20189241				2022-12-28	WOS:000275995300031
J	Clutton-Brock, T; Sheldon, BC				Clutton-Brock, Tim; Sheldon, Ben C.			The Seven Ages of Pan	SCIENCE			English	Editorial Material							POPULATIONS; CHIMPANZEES; FITNESS		[Clutton-Brock, Tim] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Cambridge; University of Oxford	Clutton-Brock, T (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@cam.ac.uk; ben.sheldon@zoo.ox.ac.uk	Hood, Sean David/H-5058-2014; Shrivastava, Prani/AAU-8347-2020; Sheldon, Ben C/A-8056-2010	Hood, Sean David/0000-0003-2852-7923; Sheldon, Ben C/0000-0002-5240-7828				Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Charpentier MJE, 2008, P NATL ACAD SCI USA, V105, P1988, DOI 10.1073/pnas.0711219105; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goodall J., 1968, ANIM BEHAV MONOGR, V1, P165; Harcourt AH, 2007, GORILLA SOC; Jones OR, 2008, J ANIM ECOL, V77, P612, DOI 10.1111/j.1365-2656.2008.01382.x; Kluijver H. N., 1951, Ardea, V39, P1; KOYAMA N, 1992, PRIMATES, V33, P33, DOI 10.1007/BF02382761; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; Lopez-Vaamonde C, 2009, J EVOLUTION BIOL, V22, P983, DOI 10.1111/j.1420-9101.2009.01706.x; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; Thompson ME, 2007, CURR BIOL, V17, P2150, DOI 10.1016/j.cub.2007.11.033; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; [No title captured]	16	31	32	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1207	1208		10.1126/science.1187796	http://dx.doi.org/10.1126/science.1187796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203037				2022-12-28	WOS:000275162100023
J	Sattar, N; Preiss, D; Murray, HM; Welsh, P; Buckley, BM; de Craen, AJM; Seshasai, SRK; McMurray, JJ; Freeman, DJ; Jukema, JW; Macfarlane, PW; Packard, CJ; Stott, DJ; Westendorp, RG; Shepherd, J; Davis, BR; Pressel, SL; Marchioli, R; Marfisi, RM; Maggioni, AP; Tavazzi, L; Tognoni, G; Kjekshus, J; Pedersen, TR; Cook, TJ; Gotto, AM; Clearfield, MB; Downs, JR; Nakamura, H; Ohashi, Y; Mizuno, K; Ray, KK; Ford, I				Sattar, Naveed; Preiss, David; Murray, Heather M.; Welsh, Paul; Buckley, Brendan M.; de Craen, Anton J. M.; Seshasai, Sreenivasa Rao Kondapally; McMurray, John J.; Freeman, Dilys J.; Jukema, J. Wouter; Macfarlane, Peter W.; Packard, Chris J.; Stott, David J.; Westendorp, Rudi G.; Shepherd, James; Davis, Barry R.; Pressel, Sara L.; Marchioli, Roberto; Marfisi, Rosa Maria; Maggioni, Aldo P.; Tavazzi, Luigi; Tognoni, Gianni; Kjekshus, John; Pedersen, Terje R.; Cook, Thomas J.; Gotto, Antonio M.; Clearfield, Michael B.; Downs, John R.; Nakamura, Haruo; Ohashi, Yasuo; Mizuno, Kyoichi; Ray, Kausik K.; Ford, Ian			Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials	LANCET			English	Article							CORONARY-HEART-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; PRAVASTATIN; EVENTS; ROSUVASTATIN; GLUCOSE; AVERAGE; ADIPONECTIN; OUTCOMES	Background Trials of statin therapy have had conflicting findings on the risk of development of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of published and unpublished data whether any relation exists between statin use and development of diabetes. Methods We searched Medline, Embase, and the Cochrane Central Register of Controlled Trials from. 1994 to 2009, for randomised controlled endpoint trials of statins. We included only trials with more than 1000 patients, with identical follow-up in both groups and duration of more than 1 year. We excluded trials of patients with organ transplants or who needed haemodialysis. We used the 12 statistic to measure heterogeneity between trials and calculated risk estimates for incident diabetes with random-effect meta-analysis. Findings We identified 13 statin trials with 91140 participants, of whom 4278 (2226 assigned statins and 2052 assigned control treatment) developed diabetes during a mean of 4 years. Statin therapy was associated with a 9% increased risk for incident diabetes (odds ratio [OR] 1.09; 95% CI 1.02-1.17), with little heterogeneity (I-2=11%) between trials. Meta-regression showed that risk of development of diabetes with statins was highest in trials with older participants, but neither baseline body-mass index nor change in LDL-cholesterol concentrations accounted for residual variation in risk. Treatment of 255 (95% CI 150-852) patients with statins for 4 years resulted in one extra case of diabetes. Interpretation Statin therapy is associated with a slightly increased risk of development of diabetes, but the risk is low both in absolute terms and when compared with the reduction in coronary events. Clinical practice in patients with moderate or high cardiovascular risk or existing cardiovascular disease should not change.	[Sattar, Naveed; Preiss, David; Welsh, Paul; McMurray, John J.] Univ Glasgow, Glasgow Cardiovasc Res Ctr, British Heart Fdn, Glasgow, Lanark, Scotland; [Murray, Heather M.; Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Buckley, Brendan M.] Cork Univ Hosp, Dept Pharmacol & Therapeut, Cork, Ireland; [de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Seshasai, Sreenivasa Rao Kondapally; Ray, Kausik K.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Freeman, Dilys J.] Univ Glasgow, Dept Reprod & Maternal Med, Glasgow, Lanark, Scotland; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Macfarlane, Peter W.; Packard, Chris J.; Stott, David J.; Shepherd, James] Univ Glasgow, Cardiovasc & Med Sci Div, Glasgow, Lanark, Scotland; [Westendorp, Rudi G.] Netherlands Consortium Healthy Aging, Leiden, Netherlands; [Marchioli, Roberto; Marfisi, Rosa Maria; Tognoni, Gianni] Consorzio Mario Negri Stud, Santa Maria Imbaro, Italy; [Maggioni, Aldo P.] ANMCO Res Ctr, Florence, Italy; [Tavazzi, Luigi] GVM Hosp Care & Res, Cotignola, Italy; [Kjekshus, John] Rikshosp Univ Hosp, Dept Cardiol, Oslo, Norway; [Pedersen, Terje R.] Ullevaal Univ Hosp, Ctr Preventat Med, Oslo, Norway; [Cook, Thomas J.] Agile 1, Paramus, NJ USA; [Gotto, Antonio M.] Cornell Univ, Weill Med Coll, Ithaca, NY 14853 USA; [Clearfield, Michael B.] Touro Univ, Coll Osteopath Med, Vallejo, CA USA; [Downs, John R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Nakamura, Haruo] Mitsukoshi Hlth & Welf Fdn, Tokyo, Japan; [Ohashi, Yasuo] Univ Tokyo, Dept Biostat Epidemiol & Prevent Hlth Sci, Tokyo, Japan; [Mizuno, Kyoichi] Nippon Med Sch, Dept Internal Med, Tokyo 113, Japan	University of Glasgow; University of Glasgow; University College Cork; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); University of Oslo; National Hospital Norway; University of Oslo; Cornell University; Touro University California; University of Texas System; University of Texas Health San Antonio; University of Tokyo; Nippon Medical School	Sattar, N (corresponding author), Univ Glasgow, Glasgow Cardiovasc Res Ctr, British Heart Fdn, Glasgow, Lanark, Scotland.	nsattar@clinmed.gla.ac.uk; d.preiss@clinmed.gla.ac.uk	Maggioni, Aldo Pietro/AAL-5334-2020; Murray, Heather/GQY-8016-2022; Ray, Kausik/Z-2055-2019; Tavazzi, Luigi/ABD-5119-2020; mcmurray, John/B-2467-2013; Welsh, Paul/H-5249-2019; Jukema, J. Wouter/ABD-6503-2021; Ford, Ian/ABE-6145-2020	Maggioni, Aldo Pietro/0000-0003-2764-6779; Tavazzi, Luigi/0000-0003-0336-8356; mcmurray, John/0000-0002-6317-3975; Welsh, Paul/0000-0002-7970-3643; Jukema, J. Wouter/0000-0002-3246-8359; Preiss, David/0000-0003-3139-1836	Merck Co; Pfizer; AstraZeneca; Bristol-Myers Squibb; BMS; Sanofi-Aventis; Servier; Roche; Diadexus Inc.; Merck & Co-Schering Plough; Daiichi-Sankyo Company; Banyu Pharmaceuticals; Novartis; Astellas Pharma; Shonogi Co; Kyowa Hakko Krini Co; Bayer Healthcare; Mitsubishi Tanabe Pharma; Schering Plough; Sankyo Company; Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO) [911-03-016]; Merk Bangu; Pzier, Japan; Cates Cambridge Trust; ORS Awards scheme at the University of Cambridge; Chest Heart and Stroke Scotland [Res08/A113] Funding Source: researchfish	Merck Co(Merck & Company); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); BMS(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Roche(Roche Holding); Diadexus Inc.; Merck & Co-Schering Plough; Daiichi-Sankyo Company(Daiichi Sankyo Company Limited); Banyu Pharmaceuticals; Novartis(Novartis); Astellas Pharma(Astellas Pharmaceuticals); Shonogi Co; Kyowa Hakko Krini Co; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Schering Plough(Merck & CompanySchering Plough Corporation); Sankyo Company; Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); Merk Bangu; Pzier, Japan; Cates Cambridge Trust; ORS Awards scheme at the University of Cambridge; Chest Heart and Stroke Scotland	Trials in this report were supported by research grants from the pharmaceutical industry. All authors apart from NS, DP. HMM, PW, SRKS, DJF, AJMdeC, and KKR were members ofsteering committees for some of these trials. NS has received consulting and lecture fees from Merck & Co, Pfizer, and AstraZeneca, and has received research grant support from Pfizer. JJMM has received payment from AstraZenca for advisory boards and lectures, JWJ has received research grants and minor speaker fees from Bristol-Myers Squibb, AstraZeneca, Pfizer, and Merck & Co. PWM has been involved in clinical trials of statins that were sponsored by BMS and AstraZeneca, and also received lecture fees from Bristol-Myers Squibb. CJP has received honoraria, research support, and has served on advisory boards for AstraZeneca, Merck & Co, Pfizer, Sanofi-Aventis, Servier, Roche, Bristol-Myers Squibb, and Diadexus Inc. DJS has received research funding from Bristol-Myers Squibb and funding for consultancy work from Pfizer and AstraZeneca. RGW has received support from Bristol-Myers Squibb as an investigator during the PROSPER trial. JS has worked as a consultant to AstraZeneca and a speaker for AstraZeneca and Pfizer. RM and RMM have received honoraria for lectures and institutional research grants from Bristol-Myers Squibb and AstraZeneca. APM has received research support and honoraria for lectures from AstraZeneca. IT has received honoraria for lectures and contributions for research from AstraZeneca, Pfizer, and Sanofi-Aventis. JK has served as chairman for the steering committees of the 4S and Corona trial, receiving honoraria for lectures and consultation from Merck & Co and AstraZeneca. TRP has received research grants from Pfizer and Merck & Co, and consulting and speaker honoraria from Pfizer, AstraZeneca, and Merck & Co-Schering Plough. TJC is a former employee and present contract employee of Merck & Co. and a shareholder in Merck & Co and Pfizer. AMG is a consultant for AstraZeneca, KOWZ Pharmaceuticals, Merck & Co, and Roche, is on advisory boards for DuPont and Novartis, and serves on corporate boards for Aegerion Pharmaceuticals, Arisaph Pharmaceuticals. and Vatera Capital. MBC has been a consultant and speaker for AstraZeneca, and a consultant for Merck & Co and GlaxoSmith Kline. YO has received consulting and lecture fees from Daiichi-Sankyo Company KM has received honoraria from Daiichi Sankyo, Banyu Pharmaceuticals, Pfizer, Novartis, Astellas Pharma, Shonogi & Co, Kyowa Hakko Krini Co, Bayer Healthcare, and Mitsubishi Tanabe Pharma. KKR has received honoraria for attending advisory boards and for giving lectures, and has received unrestricted education and research grants from Pfizer, AstraZeneca, Merck & Co, Bristol-Myers Squibb, and Schering Plough. I F has previously received research funding and honoraria for presentations from Bristol-Myers Squibb in relation to the WOSCOPS trial, and research funding and honoraria for presentations from Bristol-Myers Squibb and the Sankyo Company for the Prosper trial. JRD is a USA government employee and the views expressed here are not those of the Veteran Affairs or Federal Government. RGW receives support from the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO 911-03-016). GT was co-chairman (with LT) on the GISSI HF trial, which was in part funded by an institutional grant from AstraZeneca. HN has received honoraria from Dai-ichi Sankyo, Merk Bangu, and Pzier, Japan.; SRKS is supported by the Cates Cambridge Trust and the ORS Awards scheme at the University of Cambrige. DP, HMM, PW, BMB, AJMdeC, DJF, BRD, SLP, and JRD declare that they have no conflicts of interest.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Campeau L, 1997, NEW ENGL J MED, V336, P153; *CLIN DIR, JUPITER TRIAL WILL Y; Collins R, 2003, LANCET, V361, P2005; Costa A, 2003, DIABETIC MED, V20, P743, DOI 10.1046/j.1464-5491.2003.00993.x; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freeman DJ, 2001, CIRCULATION, V103, P357; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Gannage-Yared MH, 2005, METABOLISM, V54, P947, DOI 10.1016/j.metabol.2005.02.011; Gavin JR, 1997, DIABETES CARE, V20, P1183; GISSI Prevenzione Investigators, 2000, ITAL HEART J, V1, P810; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Keech A, 2003, DIABETES CARE, V26, P2713, DOI 10.2337/diacare.26.10.2713; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Lalli CA, 2008, METABOLISM, V57, P57, DOI 10.1016/j.metabol.2007.07.021; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Nakata M, 2006, DIABETOLOGIA, V49, P1881, DOI 10.1007/s00125-006-0269-5; PEDERSEN TR, 1994, LANCET, V344, P1383; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sabatine MS, 2004, CIRCULATION, V110, P834; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; Sugiyama S, 2007, ATHEROSCLEROSIS, V194, pE43, DOI 10.1016/j.atherosclerosis.2006.08.023; Szendroedi J, 2009, DIABETES CARE, V32, P209, DOI 10.2337/dc08-1123; Takagi T, 2008, ATHEROSCLEROSIS, V196, P114, DOI 10.1016/j.atherosclerosis.2007.02.013; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Yusuf S, 2009, LANCET, V373, P1152, DOI 10.1016/S0140-6736(09)60357-3; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	39	1674	1764	4	168	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					735	742		10.1016/S0140-6736(09)61965-6	http://dx.doi.org/10.1016/S0140-6736(09)61965-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20167359				2022-12-28	WOS:000275211200030
J	Jha, P; Kumar, R; Khera, A; Bhattacharya, M; Arora, P; Gajalakshmi, V; Bhatia, P; Kam, D; Bassani, DG; Sullivan, A; Suraweera, W; McLaughlin, C; Dhingra, N; Nagelkerke, N				Jha, Prabhat; Kumar, Rajesh; Khera, Ajay; Bhattacharya, Madhulekha; Arora, Paul; Gajalakshmi, Vendhan; Bhatia, Prakash; Kam, Derek; Bassani, Diego G.; Sullivan, Ashleigh; Suraweera, Wilson; McLaughlin, Catherine; Dhingra, Neeraj; Nagelkerke, Nico		Million Death Study Collaborators	HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TUBERCULOSIS PATIENTS; DEATHS; DISEASES; SMOKING; ADULTS	Objective To determine the rates of death and infection from HIV in India. Design Nationally representative survey of deaths. Setting 1.1 million homes in India. Population 123 000 deaths at all ages from 2001 to 2003. Main outcome measures HIV mortality and infection. Results HIV accounted for 8.1% (99% confidence interval 5.0% to 11.2%) of all deaths among adults aged 25-34 years. In this age group, about 40% of deaths from HIV were due to AIDS, 26% were due to tuberculosis, and the rest were attributable to other causes. Nationally, HIV infection accounted for about 100 000 ( 59 000 to 140 000) deaths or 3.2% (1.9% to 4.6%) of all deaths among people aged 15-59 years. Deaths from HIV were concentrated in the states and districts with higher HIV prevalence and in men. The mortality results imply an HIV prevalence at age 15-49 years of 0.26% (0.13% to 0.39%) in 2004, comparable to results from a 2005/6 household survey that tested for HIV (0.28%). Collectively, these data suggest that India had about 1.4-1.6 million HIV infected adults aged 15-49 years in 2004-6, about 40% lower than the official estimate of 2.3 million for 2006. All cause mortality increased in men aged 25-34 years between 1997 and 2002 in the states with higher HIV prevalence but declined after that. HIV prevalence in young pregnant women, a proxy measure of incidence in the general population, fell between 2000 and 2007. Thus, HIV mortality and prevalence may have fallen further since our study. Conclusion HIV attributable death and infection in India is substantial, although it is lower than previously estimated.	[Jha, Prabhat; Arora, Paul; Kam, Derek; Bassani, Diego G.; Sullivan, Ashleigh; Nagelkerke, Nico] Univ Toronto, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst, St Michaels Hosp,Dalla Lana Sch Publ Hlth, Toronto, ON M5C 1N8, Canada; [Kumar, Rajesh] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; [Khera, Ajay; Dhingra, Neeraj] Govt India, Natl AIDS Control Org, Minist Hlth & Family Welf, New Delhi 110001, India; [Bhattacharya, Madhulekha] Natl Inst Hlth & Family Welfare, New Delhi 110067, India; [Gajalakshmi, Vendhan] Epidemiol Res Ctr, Chennai 600010, Tamil Nadu, India; [Bhatia, Prakash] Osmania Med Coll & Hosp, Hyderabad, Andhra Pradesh, India; [Nagelkerke, Nico] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); United Arab Emirates University	Jha, P (corresponding author), Univ Toronto, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst, St Michaels Hosp,Dalla Lana Sch Publ Hlth, Toronto, ON M5C 1N8, Canada.	prabhat.jha@utoronto.ca	Suraweera, Wilson MG/O-8962-2014; Bassani, Diego/G-2827-2015; Bhattacharya, Madhulekha/ABU-4692-2022	Bassani, Diego/0000-0001-6704-3820; Pednekar, Mangesh/0000-0001-6266-5356; Suraweera, Wilson/0000-0001-9673-5746; K T, Shenoy/0000-0002-2826-6869; Shenoy, KT/0000-0001-8751-7456	US National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research (CIHR) [IEG-53506]; International Research Development Centre [102172]; Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto; Canada research chair program; CIHR Banting and Best Canada; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Research Development Centre; Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto; Canada research chair program(Canada Research Chairs); CIHR Banting and Best Canada(Canadian Institutes of Health Research (CIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	External funding is from the Fogarty International Centre of the US National Institutes of Health ( grant R01 TW05991-01), Canadian Institute of Health Research (CIHR; IEG-53506), International Research Development Centre ( grant 102172), and Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto (unrestricted CGHR support). PJ is supported by the Canada research chair program. PA is supported by supported by a CIHR Banting and Best Canada graduate scholarship. The funding sources had no role in the design or conduct of the study, or in the collection, analysis, or interpretation of the data. PJ had full access to all the data and had final responsibility for the decision to submit for publication.	Arora P, 2008, LANCET, V372, P289, DOI 10.1016/S0140-6736(08)61105-8; Berke Olaf, 2004, Int J Health Geogr, V3, P18, DOI 10.1186/1476-072X-3-18; Bernabe-Ortiz A, 2008, REV CHIL INFECTOL, V25, P104, DOI /S0716-10182008000300002; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Bhattacharya M, 2008, Indian J Public Health, V52, P21; Bhore AV, 2003, INT J STD AIDS, V14, P37, DOI 10.1258/095646203321043246; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Boerma JT, 1998, AIDS, V12, pS3; Chacko S, 1995, J Assoc Physicians India, V43, P535; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; *DEP EC SOC AFF UN, 2008, DEM YB 2006; Duarte EC, 2009, J EPIDEMIOL COMMUN H, V63, P233, DOI 10.1136/jech.2008.078972; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Hira SK, 2003, NATL MED J INDIA, V16, P126; Hira SK, 1999, LANCET, V354, P1175, DOI 10.1016/S0140-6736(99)03718-6; *IIPS ORC MACR, 2006, NAT FAM HLTH SURV 3; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2002, NATL MED J INDIA, V15, P32; JHA P, 2001, SCIENCE, V13, P292; JHA P, 2008, COMMONWEALTH HLTH MI; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013; Konde-Lule J K, 1995, Health Transit Rev, V5 Suppl, P27; Kumar R, 2006, Indian J Public Health, V50, P90; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; KUMAR R, 2005, NATL COMMISSION MACR, P58; KUMARASAMY N, 2009, INT J INFECT DI 0724; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; *NACO, 2006, NAT BEH SURV SURV 20; *NACO, 2006, ANN REP 2006; *NACO, 2001, NAT BAS HIGH RISK BR; *NACO, 2007, ART TREATM REP; *NACO MIN HLTH FAM, 2007, LAB MAN TECHN ICTCS; *NACO NAT I HLTH F, 2007, ANN HIV SENT SURV 20; *NACO NIMS, 2006, TECHN REP IND HIV ES; *NACO NIMS, 2007, TECHN REP IND HIV ES; Pandey A, 2009, INDIAN J MED RES, V129, P50; Raizada N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002970; *REG GEN IND, 2005, MED CERT CAUS DEATH; *REG GEN IND, 2005, SAMPL REG SYST STAT; Registrar General of India and Center for Global Health Research, 2009, CAUS DEATH IND 2001; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Sinha DN, 2006, TECHNICAL DOCUMENT V; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Sobhani R, 2007, INDIAN J MED RES, V126, P116; Swaminathan S, 2008, J BIOSCIENCES, V33, P527, DOI 10.1007/s12038-008-0071-2; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS WHO WORK G, 2003, UNAIDS0349E WHO WORK; Venkataramana CBS, 2001, TROP MED INT HEALTH, V6, P1040, DOI 10.1046/j.1365-3156.2001.00814.x; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102	56	34	34	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2010	340								c621	10.1136/bmj.c621	http://dx.doi.org/10.1136/bmj.c621			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TF	20179131	Green Published, hybrid			2022-12-28	WOS:000275001100018
J	Finniss, DG; Kaptchuk, TJ; Miller, F; Benedetti, F				Finniss, Damien G.; Kaptchuk, Ted J.; Miller, Franklin; Benedetti, Fabrizio			Biological, clinical, and ethical advances of placebo effects	LANCET			English	Review							IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; LOW-BACK-PAIN; COMPARING PLACEBO; OPIOID ACTIVITY; BRAIN ACTIVITY; ANALGESIA; EXPECTATION; ACUPUNCTURE; MECHANISMS	For many years, placebos have been defined by their inert content and their use as controls in clinical trials and treatments in clinical practice. Recent research shows that placebo effects are genuine psychobiological events attributable to the overall therapeutic context, and that these effects can be robust in both laboratory and clinical settings. There is also evidence that placebo effects can exist in clinical practice, even if no placebo is given. Further promotion and integration of laboratory and clinical research will allow advances in the ethical use of placebo mechanisms that are inherent in routine clinical care, and encourage the use of treatments that stimulate placebo effects.	[Finniss, Damien G.] Univ Sydney, Pain Management & Res Inst, Royal N Shore Hosp, St Leonards, NSW 2065, Australia; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Osher Res Ctr, Boston, MA USA; [Miller, Franklin] NIH, Dept Bioeth, Bethesda, MD 20892 USA; [Benedetti, Fabrizio] Univ Turin, Sch Med, Dept Neurosci, Turin, Italy; [Benedetti, Fabrizio] Natl Inst Neurosci, Turin, Italy	Royal North Shore Hospital; University of Sydney; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; University of Turin	Finniss, DG (corresponding author), Univ Sydney, Pain Management & Res Inst, Royal N Shore Hosp, Pacific Hwy, St Leonards, NSW 2065, Australia.	dfinniss@med.usyd.edu.au			National Center for Complementary Medicine [K24 AT004095]; National Institutes of Health; Bernard Osher Foundation, San Francisco, CA, USA; Istituto San Paolo; Regione Piemonte (Turin, Italy); Volkswagen Foundation (Hannover, Germany); National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER	National Center for Complementary Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bernard Osher Foundation, San Francisco, CA, USA; Istituto San Paolo; Regione Piemonte (Turin, Italy)(Regione Piemonte); Volkswagen Foundation (Hannover, Germany)(Volkswagen); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TJK is supported by a grant from National Center for Complementary Medicine (number K24 AT004095), National Institutes of Health and receives support from Bernard Osher Foundation, San Francisco, CA, USA. FB is supported by grants from Istituto San Paolo and Regione Piemonte (Turin, Italy) and Volkswagen Foundation (Hannover, Germany).	ADER R, 1975, PSYCHOSOM MED, V37, P333, DOI 10.1097/00006842-197507000-00007; Amanzio M, 2001, PAIN, V90, P205, DOI 10.1016/S0304-3959(00)00486-3; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Aronson J, 1999, BRIT MED J, V318, P716; Aulas JJ, 2003, ENCEPHALE, V29, P68; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Benedetti F, 2007, NEUROSCIENCE, V147, P260, DOI 10.1016/j.neuroscience.2007.02.020; Benedetti F, 2006, PAIN, V121, P133, DOI 10.1016/j.pain.2005.12.016; Benedetti F, 2004, NAT NEUROSCI, V7, P587, DOI 10.1038/nn1250; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 1997, PROG NEUROBIOL, V52, P109, DOI 10.1016/S0301-0082(97)00006-3; Benedetti F, 1997, PAIN, V71, P135, DOI 10.1016/S0304-3959(97)03346-0; Benedetti F, 1999, EUR J NEUROSCI, V11, P625, DOI 10.1046/j.1460-9568.1999.00465.x; Benedetti F, 1999, J NEUROSCI, V19, P3639; Benedetti F, 1996, PAIN, V64, P535, DOI 10.1016/0304-3959(95)00179-4; BENEDETTI F, 1995, LANCET, V346, P1231, DOI 10.1016/S0140-6736(95)92938-X; Benedetti F, 2003, PREVENT TREAT, V6; Benedetti F., 2020, PLACEBO EFFECTS, DOI [10.1093/oso/9780198843177.001.0001, DOI 10.1093/OSO/9780198843177.001.0001]; Benedetti F, 2006, J NEUROSCI, V26, P12014, DOI 10.1523/JNEUROSCI.2947-06.2006; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Benedetti F, 2009, J PHYSIOL-LONDON, V587, P3869, DOI 10.1113/jphysiol.2009.169425; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; BRODY H, 1982, ANN INTERN MED, V97, P112, DOI 10.7326/0003-4819-97-1-112; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; Colloca L, 2004, LANCET NEUROL, V3, P679, DOI 10.1016/S1474-4422(04)00908-1; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Cummings M, 2009, ACUPUNCT MED, V27, P26, DOI 10.1136/aim.2008.000281; de la Fuente-Fernandez- R, 2002, TRENDS NEUROSCI, V25, P302, DOI 10.1016/S0166-2236(02)02181-1; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Di Blasi Z, 2003, EVAL HEALTH PROF, V26, P166, DOI 10.1177/0163278703026002003; ERNST E, 1995, BMJ-BRIT MED J, V311, P551, DOI 10.1136/bmj.311.7004.551; FIELDS HL, 1984, TRENDS NEUROSCI, V7, P271, DOI 10.1016/S0166-2236(84)80193-9; Finniss DG, 2005, PAIN, V114, P3, DOI 10.1016/j.pain.2004.12.012; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; Goebel MU, 2002, FASEB J, V16, P1869, DOI 10.1096/fj.02-0389com; GRACELY RH, 1985, LANCET, V1, P43; GREVERT P, 1983, PAIN, V16, P129, DOI 10.1016/0304-3959(83)90203-8; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; HERRNSTEIN RJ, 1962, SCIENCE, V138, P677, DOI 10.1126/science.138.3541.677; Hrobjartsson A, 2006, J CLIN EPIDEMIOL, V59, P336, DOI 10.1016/j.jclinepi.2005.05.011; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hrobjartsson A, 2004, J INTERN MED, V256, P91, DOI 10.1111/j.1365-2796.2004.01355.x; Hrobjartsson A, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003974.PUB2; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2009, LANCET, V374, P1234, DOI 10.1016/S0140-6736(09)61775-X; Kaptchuk TJ, 2009, CULT MED PSYCHIAT, V33, P382, DOI 10.1007/s11013-009-9141-7; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kaptchuk TJ, 1998, ANN INTERN MED, V129, P1061, DOI 10.7326/0003-4819-129-12-199812150-00011; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Kerr CE, 2008, J ROY SOC MED, V101, P89, DOI 10.1258/jrsm.2007.071005; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Lanotte M, 2005, BRAIN BEHAV IMMUN, V19, P500, DOI 10.1016/j.bbi.2005.06.004; Leuchter AF, 2002, AM J PSYCHIAT, V159, P122, DOI 10.1176/appi.ajp.159.1.122; LEVINE JD, 1984, NATURE, V312, P755, DOI 10.1038/312755a0; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; LIPMAN JJ, 1990, PSYCHOPHARMACOLOGY, V102, P112, DOI 10.1007/BF02245754; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; Miller FG, 2005, PLOS MED, V2, P853, DOI 10.1371/journal.pmed.0020262; Miller FG, 2008, J ROY SOC MED, V101, P222, DOI 10.1258/jrsm.2008.070466; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; MOERMAN DE, 2003, PREVENT TREAT, V6, P1; Montgomery G, 1996, PSYCHOL SCI, V7, P174, DOI 10.1111/j.1467-9280.1996.tb00352.x; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Pacheco-Lopez G, 2006, BRAIN BEHAV IMMUN, V20, P430, DOI 10.1016/j.bbi.2006.05.003; PARK LC, 1965, ARCH GEN PSYCHIAT, V12, P336; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Pollo A, 2003, PAIN, V102, P125, DOI 10.1016/S0304-3959(02)00345-7; Pollo A, 2002, NEUROREPORT, V13, P1383, DOI 10.1097/00001756-200208070-00006; Pollo A, 2001, PAIN, V93, P77, DOI 10.1016/S0304-3959(01)00296-2; Pollo A, 2008, EUR J NEUROSCI, V28, P379, DOI 10.1111/j.1460-9568.2008.06344.x; Price DD, 2001, PAIN, V90, P201, DOI 10.1016/S0304-3959(01)00265-2; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Price DD, 2007, PAIN, V127, P63, DOI 10.1016/j.pain.2006.08.001; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; SHERMAN KJ, SPINE IN PRESS; Siegel Shepard, 2002, SCI PLACEBO, P133; STEITBERGER K, 1998, LANCET, V352, P364; Stewart-Williams S, 2004, HEALTH PSYCHOL, V23, P198, DOI 10.1037/0278-6133.23.2.198; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Vase L, 2003, PAIN, V105, P17, DOI 10.1016/S0304-3959(03)00073-3; Vase L, 2002, PAIN, V99, P443, DOI 10.1016/S0304-3959(02)00205-1; Verne GN, 2003, PAIN, V105, P223, DOI 10.1016/S0304-3959(03)00210-0; Volkow ND, 2003, J NEUROSCI, V23, P11461; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; VOUDOURIS NJ, 1989, PAIN, V38, P109, DOI 10.1016/0304-3959(89)90080-8; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	107	784	801	5	214	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					686	695		10.1016/S0140-6736(09)61706-2	http://dx.doi.org/10.1016/S0140-6736(09)61706-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JT	20171404	Green Accepted, Green Submitted			2022-12-28	WOS:000275210900037
J	Halic, M; Moazed, D				Halic, Mario; Moazed, Danesh			Dicer-Independent Primal RNAs Trigger RNAi and Heterochromatin Formation	CELL			English	Article							FISSION YEAST CENTROMERES; C-ELEGANS; HISTONE H3; SIRNA GENERATION; IN-VITRO; INTERFERENCE; RITS; COMPLEX; POLYMERASE; CHROMODOMAIN	Assembly of fission yeast pericentromeric heterochromatin and generation of small interfering RNAs (siRNAs) from noncoding centromeric transcripts are mutually dependent processes. How this interdependent positive feedback loop is first triggered is a fundamental unanswered question. Here, we show that two distinct Argonaute (Ago1)-dependent pathways mediate small RNA generation. RNA-dependent RNA polymerase complex (RDRC) and Dicer act on specific noncoding RNAs to generate siRNAs by a mechanism that requires the slicer activity of Ago1 but is independent of pre-existing heterochromatin. In the absence of RDRC or Dicer, a distinct class of small RNAs, called primal small RNAs (priRNAs), associates with Ago1. priRNAs are degradation products of abundant transcripts, which bind to Ago1 and target antisense transcripts that result from bidirectional transcription of DNA repeats. Our results suggest that a transcriptome surveillance mechanism based on random association of RNA degradation products with Argonaute triggers siRNA amplification and heterochromatin assembly within DNA repeats.	[Halic, Mario; Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Halic, Mario/X-2163-2018		EMBO; National Institutes of Health [GM72805]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061641, R01GM072805] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Moazed lab for helpful discussions, Aaron Johnson, Daniel Holoch, Geng Li, and Silvija Bilokapic for comments on the manuscript, and Serafin Colmenares for the observation that Rdp1 overexpression suppresses the requirement for Cid12. This work was supported by an EMBO long-term fellowship to M. H. and a grant from the National Institutes of Health to D. M. (GM72805). D. M. is a Howard Hughes Medical Institute investigator.	Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; DeBeauchamp JL, 2008, MOL CELL BIOL, V28, P2154, DOI 10.1128/MCB.01637-07; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Lee SR, 2009, RNA, V15, P1363, DOI 10.1261/rna.1630309; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315	40	133	142	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					504	516		10.1016/j.cell.2010.01.019	http://dx.doi.org/10.1016/j.cell.2010.01.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178743	Green Accepted, Bronze			2022-12-28	WOS:000274668400014
J	Tacconi, LJ; Genzel, R; Neri, R; Cox, P; Cooper, MC; Shapiro, K; Bolatto, A; Bouche, N; Bournaud, F; Burkert, A; Combes, F; Comerford, J; Davis, M; Schreiber, NMF; Garcia-Burillo, S; Gracia-Carpio, J; Lutz, D; Naab, T; Omont, A; Shapley, A; Sternberg, A; Weiner, B				Tacconi, L. J.; Genzel, R.; Neri, R.; Cox, P.; Cooper, M. C.; Shapiro, K.; Bolatto, A.; Bouche, N.; Bournaud, F.; Burkert, A.; Combes, F.; Comerford, J.; Davis, M.; Schreiber, N. M. Foerster; Garcia-Burillo, S.; Gracia-Carpio, J.; Lutz, D.; Naab, T.; Omont, A.; Shapley, A.; Sternberg, A.; Weiner, B.			High molecular gas fractions in normal massive star-forming galaxies in the young Universe	NATURE			English	Article							LYMAN BREAK GALAXY; SUBMILLIMETER GALAXIES; DISK GALAXIES; Z-SIMILAR-TO-2; CO; CLOUDS; SAMPLE; HALOES; M51	Stars form from cold molecular interstellar gas. As this is relatively rare in the local Universe, galaxies like the Milky Way form only a few new stars per year. Typical massive galaxies in the distant Universe formed stars an order of magnitude more rapidly(1,2). Unless star formation was significantly more efficient, this difference suggests that young galaxies were much more molecular-gas rich. Molecular gas observations in the distant Universe have so far largely been restricted to very luminous, rare objects, including mergers and quasars(3-5), and accordingly we do not yet have a clear idea about the gas content of more normal (albeit massive) galaxies. Here we report the results of a survey of molecular gas in samples of typical massive-star-forming galaxies at mean redshifts, < z > of about 1.2 and 2.3, when the Universe was respectively 40% and 24% of its current age. Our measurements reveal that distant star forming galaxies were indeed gas rich, and that the star formation efficiency is not strongly dependent on cosmic epoch. The average fraction of cold gas relative to total galaxy baryonic mass at z = 2.3 and z = 1.2 is respectively about 44% and 34%, three to ten times higher than in today's massive spiral galaxies(6). The slow decrease between z approximate to 2 and z approximate to 1 probably requires a mechanism of semi-continuous replenishment of fresh gas to the young galaxies.	[Tacconi, L. J.; Genzel, R.; Bouche, N.; Schreiber, N. M. Foerster; Gracia-Carpio, J.; Lutz, D.] Max Planck Inst Extraterr Phys MPE, D-85748 Garching, Germany; [Genzel, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Neri, R.; Cox, P.] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, Grenoble, France; [Cooper, M. C.; Weiner, B.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Shapiro, K.; Comerford, J.; Davis, M.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Bolatto, A.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Bournaud, F.] CEA Saclay, DAPNIA, Serv Astrophys, F-91191 Gif Sur Yvette, France; [Burkert, A.; Naab, T.] Univ Munich, Univ Sternwarte, D-81679 Munich, Germany; [Combes, F.] Observ Paris, LERMA, F-75014 Paris, France; [Garcia-Burillo, S.] OAN, Alcala De Henares 28800, Spain; [Omont, A.] Univ Paris 06, F-75014 Paris, France; [Omont, A.] CNRS, Inst Astrophys, F-75014 Paris, France; [Shapley, A.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Sternberg, A.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Max Planck Society; University of California System; University of California Berkeley; University of Arizona; University of California System; University of California Berkeley; University System of Maryland; University of Maryland College Park; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Munich; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Los Angeles; Tel Aviv University	Tacconi, LJ (corresponding author), Max Planck Inst Extraterr Phys MPE, Giessenbachstr 1, D-85748 Garching, Germany.	linda@mpe.mpg.de	Combes, Francoise/F-6046-2011; Bournaud, Frederic/K-1263-2013; Naab, Thorsten/AAE-9888-2019	Combes, Francoise/0000-0003-2658-7893; Naab, Thorsten/0000-0002-7314-2558; Garcia-Burillo, Santiago/0000-0003-0444-6897; Bolatto, Alberto/0000-0002-5480-5686; Gracia Carpio, Javier/0000-0003-4689-3134; Lutz, Dieter/0000-0003-0291-9582; Weiner, Benjamin/0000-0001-6065-7483	INSU/CNRS (France); MPG (Germany); IGN (Spain); Cluster of Excellence "Origin and Structure of the Universe"	INSU/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); MPG (Germany)(Max Planck Society); IGN (Spain); Cluster of Excellence "Origin and Structure of the Universe"	This work is based on observations carried out with the IRAM Plateau de Bure Interferometer. IRAM is supported by INSU/CNRS (France), MPG (Germany) and IGN (Spain). We thank B. Lazareff and the IRAM staff for their work in developing the new PdBI receiver systems, which made these technically difficult observations feasible. We are grateful to J. Blaizot, L.-M. Dansac, R. Dave, D. Keres, P. Ocvirk, C. Pichon and R. Teyssier for communicating unpublished results of their simulations and for discussions. A. B. and T.N. thank the Cluster of Excellence "Origin and Structure of the Universe" for support. M. C. C. is a Spitzer Fellow; A. B. is a Max Planck Fellow.	Baker AJ, 2004, ASTROPHYS J, V604, P125, DOI 10.1086/381798; Birnboim Y, 2003, MON NOT R ASTRON SOC, V345, P349, DOI 10.1046/j.1365-8711.2003.06955.x; Bolatto AD, 2008, ASTROPHYS J, V686, P948, DOI 10.1086/591513; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Combes F, 2006, ASTRON ASTROPHYS, V460, pL49, DOI 10.1051/0004-6361:20066559; Coppin KEK, 2007, ASTROPHYS J, V665, P936, DOI 10.1086/519789; COX P, 2007, IRAM ANN REPORT 2007; COX P, 2006, IRAM ANN REPORT 2006; Daddi E, 2008, ASTROPHYS J LETT, V673, pL21, DOI 10.1086/527377; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Dannerbauer H, 2009, ASTROPHYS J LETT, V698, pL178, DOI 10.1088/0004-637X/698/2/L178; Davies Michelle, 2007, Conservation Science Western Australia, V6, P1; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; DICKMAN RL, 1986, ASTROPHYS J, V309, P326, DOI 10.1086/164604; Erb DK, 2006, ASTROPHYS J, V647, P128, DOI 10.1086/505341; Greve TR, 2005, MON NOT R ASTRON SOC, V359, P1165, DOI 10.1111/j.1365-2966.2005.08979.x; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Leroy A, 2005, ASTROPHYS J, V625, P763, DOI 10.1086/429578; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Ocvirk P, 2008, MON NOT R ASTRON SOC, V390, P1326, DOI 10.1111/j.1365-2966.2008.13763.x; RAND RJ, 1990, ASTROPHYS J, V349, pL43, DOI 10.1086/185647; RAND RJ, 1992, ASTROPHYS J, V390, P66, DOI 10.1086/171259; SAGE LJ, 1993, ASTRON ASTROPHYS, V272, P123; Schreiber NMF, 2006, ASTROPHYS J, V645, P1062, DOI 10.1086/504403; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Steidel CC, 2004, ASTROPHYS J, V604, P534, DOI 10.1086/381960; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; YOUNG JS, 1991, ANNU REV ASTRON ASTR, V29, P581, DOI 10.1146/annurev.aa.29.090191.003053	31	782	785	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 11	2010	463	7282					781	784		10.1038/nature08773	http://dx.doi.org/10.1038/nature08773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148033	Green Submitted			2022-12-28	WOS:000274394300033
J	Turner, D; Little, P; Raftery, J; Turner, S; Smith, H; Rumsby, K; Mullee, M				Turner, David; Little, Paul; Raftery, James; Turner, Sheila; Smith, Helen; Rumsby, Kate; Mullee, Mark		UTIS Team	Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the cost effectiveness of different management strategies for urinary tract infections. Design Cost effectiveness analysis alongside a randomised controlled trial with a one month follow-up. Setting Primary care. Participants 309 non-pregnant adult women aged 18-70 presenting with suspected urinary tract infection. Interventions Patients were randomised to five basic management approaches: empirical antibiotics, empirical delayed (by 48 hours) antibiotics, or targeted antibiotics based on either a high symptom score (two or more of urine cloudiness, smell, nocturia, dysuria), dipstick results (nitrite or leucocytes and blood), or receipt of a positive result on midstream urine analysis. Main outcome measure Duration of symptoms and cost of care. Results Management with targeted antibiotics with midstream urine analysis was more costly over the period of one month. Costs for the midstream urine analysis and dipstick management groups were 37 pound and 35 pound, respectively; these compared with 31 pound for immediate antibiotics. Cost effectiveness acceptability curves suggested that if avoiding a day of moderately bad symptoms was valued at less than 10 pound, then immediate antibiotics is likely to be the most cost effective strategy. For values over 10 pound, targeted antibiotics with dipstick testing becomes the most cost effective strategy, though because of the uncertainty we can never be more than 70% certain that this strategy truly is the most cost effective. Conclusion Dipstick testing with targeted antibiotics is likely to be cost effective if the value of saving a day of moderately bad symptoms is 10 pound or more, but caution is required given the considerable uncertainty surrounding the estimates.	[Raftery, James] Univ Southampton, Wessex Inst, NETSCC, Southampton SO16 7NS, Hants, England; [Rumsby, Kate] Univ Southampton, Community Clin Sci Div, Wessex Res Practices Collaborat, Southampton SO16 6ST, Hants, England; [Mullee, Mark] Univ Southampton, Community Clin Sci Div, Res Design Serv S Cent, Southampton SO16 6ST, Hants, England; [Smith, Helen] Brighton & Sussex Med Sch, Div Publ Hlth & Primary Care, Brighton, E Sussex, England	University of Southampton; University of Southampton; University of Southampton; University of Brighton; University of Sussex		dturner@soton.ac.uk	Moore, Michael/C-3447-2011; Smith, Helen E/M-2449-2016; Turner, David A/E-1847-2013	Moore, Michael/0000-0002-5127-4509; Smith, Helen E/0000-0003-1883-6124; Turner, David A/0000-0002-1689-4147; Little, Paul/0000-0003-3664-1873; Rumsby, Kate/0000-0002-8573-3718	Health Technology Programme of UK NHS Research and Development; National Institute for Health Research [97/14/06] Funding Source: researchfish	Health Technology Programme of UK NHS Research and Development; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Health Technology Programme of UK NHS Research and Development.	[Anonymous], 2010, BBC; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Barry HC, 1997, J FAM PRACTICE, V44, P49; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; *BRIT MED ASS, 2006, BRIT NAT FORM BNF, V51; *BUR LAB STAT, 2008, CPI DET REP DAT APR; Curtis L, 2006, UNIT COSTS HLTH SOCI; *DEP HLTH, 2010, NHS REF COSTS 2005 0; Fenwick EAL, 2000, BRIT J GEN PRACT, V50, P635; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; Little P, 2006, BRIT J GEN PRACT, V56, P606; Lothgren M, 2000, HEALTH ECON, V9, P623, DOI 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V; National Institute for Health and Clinical Excellence (NICE), 2009, GUID METH TECHN APPR; *OFF NAT STAT, 2010, RET PRIC IND MONTHL; Rubin N, 1996, J CLIN EPIDEMIOL, V49, P1315, DOI 10.1016/S0895-4356(96)00218-1; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; 1991, MORBIDITY STAT GEN P	18	23	23	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 5	2010	340								c346	10.1136/bmj.c346	http://dx.doi.org/10.1136/bmj.c346			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CX	20139218	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000274343700005
J	Lichtenberger, BM; Tan, PK; Niederleithner, H; Ferrara, N; Petzelbauer, P; Sibilia, M				Lichtenberger, Beate M.; Tan, Poi Kiang; Niederleithner, Heide; Ferrara, Napoleone; Petzelbauer, Peter; Sibilia, Maria			Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development	CELL			English	Article							ENDOTHELIAL-GROWTH-FACTOR; FACTOR RECEPTOR; TYROSINE KINASE; EPIDERMAL-KERATINOCYTES; SKIN CARCINOGENESIS; THERAPEUTIC TARGET; ANTITUMOR EFFICACY; COLON-CANCER; LUNG-CANCER; INHIBITOR	It is established that tumor cell-derived VEGF acts on endothelial cells to promote angiogenesis and tumor growth. Here, we demonstrate that in K5-SOS-dependent mouse skin tumors, autocrine VEGF is required for tumor cell proliferation in a cell-autonomous and angiogenesis-independent manner. VEGF is upregulated in SOS-expressing tumors, and its deletion in epidermal cells delays tumorigenesis by suppressing angiogenesis and tumor cell proliferation. Epidermis-specific Flt1 deletion also impairs tumorigenesis and proliferation. Surprisingly, complete tumor inhibition occurs in the absence of VEGF in EGFR mutant mice, demonstrating that VEGFR and EGFR synergize in neoplastic cells to promote tumor growth. Mechanistically, K5-SOS upregulates VEGF, Flt1, and Neuropilin-1 in an Erk-dependent manner, thereby activating an autocrine proliferation loop, whereas EGFR prevents tumor cells from apoptosis. Moreover, Flt1 is upregulated in human SCC, and its inhibition in SCC cells impairs proliferation. Thus, in addition to regulating angiogenesis, VEGF has to be considered as a potent growth factor for epidermal tumors.	[Lichtenberger, Beate M.; Tan, Poi Kiang; Sibilia, Maria] Med Univ Vienna, Dept Med 1, Inst Canc Res, A-1090 Vienna, Austria; [Niederleithner, Heide; Petzelbauer, Peter] Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, A-1090 Vienna, Austria; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	Medical University of Vienna; Medical University of Vienna; Roche Holding; Genentech	Sibilia, M (corresponding author), Med Univ Vienna, Dept Med 1, Inst Canc Res, Borschkegasse 8A, A-1090 Vienna, Austria.	maria.sibilia@meduniwien.ac.at	petzelbauer, peter/GLU-3941-2022; Lichtenberger, Beate M./AAD-1717-2019	Lichtenberger, Beate M./0000-0001-6882-0257; Sibilia, Maria/0000-0001-6129-5613; Petzelbauer, Peter/0000-0001-7080-5259	Boehringer Ingelheim Fonds; EC [QLG1-CT-2001-00869, LSHC-CT-2006-037731]; Austrian Federal Government's GEN-AU [GZ 200.147/1-VI/1a/2006]; Austrian Science Fund [FWF-P18421, FWF-P18782, SFB-23-B13, DK W1212]; Boehringer Ingelheim Austria	Boehringer Ingelheim Fonds(Boehringer Ingelheim); EC(European CommissionEuropean Commission Joint Research Centre); Austrian Federal Government's GEN-AU; Austrian Science Fund(Austrian Science Fund (FWF)); Boehringer Ingelheim Austria(Boehringer Ingelheim)	We are grateful to Martina Hammer for mouse care, to Ernst Kriehuber, Martin Holcmann, and Barbara Drobits for assistance with FACS analysis and sorting, Gerald Prager and Christoph Zielinski for advice on extracellular VEGFR inhibitors, Jacques van Meel, Flavio Solca, and Frank Hilberg (Boehringer Ingelheim Austria) for providing the compounds BI-1120 and BI-2992, and Pfizer for providing Sunitinib and CI-1040. We thank Erwin F. Wagner, Dieter Maurer, Juan Guinea-Viniegra, and Helia Schonthaler for critical reading of the manuscript. B. M. L was recipient of a Boehringer Ingelheim Fonds fellowship. This project was supported by the EC programs QLG1-CT-2001-00869 and LSHC-CT-2006-037731 (Growthstop), the Austrian Federal Government's GEN-AU program "Austromouse" (GZ 200.147/1-VI/1a/2006), and the Austrian Science Fund grants FWF-P18421, FWF-P18782, SFB-23-B13, and DK W1212. N.F. is an employee of Genentech, Inc. This work was supported in part by a grant from Boehringer Ingelheim Austria.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Bachelder RE, 2001, CANCER RES, V61, P5736; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Casanova ML, 2002, CANCER RES, V62, P3402; Chung GG, 2006, CANCER, V106, P1677, DOI 10.1002/cncr.21783; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Eskens F, 2008, BRIT J CANCER, V98, P80, DOI 10.1038/sj.bjc.6604108; Fakhari M, 2002, J PEDIATR SURG, V37, P582, DOI 10.1053/jpsu.2002.31614; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gray MJ, 2005, CANCER RES, V65, P3664, DOI 10.1158/0008-5472.CAN-04-2229; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kamiya T, 2006, ONCOL REP, V15, P369; Kim EJ, 2005, EXP DERMATOL, V14, P625, DOI 10.1111/j.0906-6705.2005.00345.x; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Liu DX, 2007, J CLIN ENDOCR METAB, V92, P4686, DOI 10.1210/jc.2007-0097; Lunghi P, 2008, BLOOD, V112, P2450, DOI 10.1182/blood-2007-10-114348; Mercurio AM, 2004, SEMIN CANCER BIOL, V14, P115, DOI 10.1016/j.semcancer.2003.09.016; Mirones I, 2009, J INVEST DERMATOL, V129, P730, DOI 10.1038/jid.2008.292; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Potapova O, 2006, MOL CANCER THER, V5, P1280, DOI 10.1158/1535-7163.MCT-03-0156; Riely GJ, 2008, J THORAC ONCOL, V3, pS146, DOI 10.1097/JTO.0b013e318174e96e; Rossiter H, 2004, CANCER RES, V64, P3508, DOI 10.1158/0008-5472.CAN-03-2581; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tan DCW, 2001, FEBS LETT, V494, P150, DOI 10.1016/S0014-5793(01)02314-6; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Wilgus TA, 2005, AM J PATHOL, V167, P1257, DOI 10.1016/S0002-9440(10)61213-8; Zhou QY, 2008, CLIN CANCER RES, V14, P1540, DOI 10.1158/1078-0432.CCR-07-4544	46	268	279	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2					268	279		10.1016/j.cell.2009.12.046	http://dx.doi.org/10.1016/j.cell.2009.12.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141840	Bronze			2022-12-28	WOS:000273826500017
J	Breet, NJ; van Werkum, JW; Bouman, HJ; Kelder, JC; Ruven, HJT; Bal, ET; Deneer, VH; Harmsze, AM; van der Heyden, JAS; Rensing, BJWM; Suttorp, MJ; Hackeng, CM; ten Berg, JM				Breet, Nicoline J.; van Werkum, Jochem W.; Bouman, Heleen J.; Kelder, Johannes C.; Ruven, Henk J. T.; Bal, Egbert T.; Deneer, Vera H.; Harmsze, Ankie M.; van der Heyden, Jan A. S.; Rensing, Benno J. W. M.; Suttorp, Maarten J.; Hackeng, Christian M.; ten Berg, Jurrien M.			Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-CARE ASSAY; ANTIPLATELET THERAPY; ATHEROTHROMBOTIC EVENTS; CLOPIDOGREL RESISTANCE; INTERVENTION; REACTIVITY; PRETREATMENT; IMPACT; PCI	Context High on-treatment platelet reactivity is associated with atherothrombotic events following coronary stent implantation. Objective To evaluate the capability of multiple platelet function tests to predict clinical outcome. Design, Setting, and Patients Prospective, observational, single-center cohort study of 1069 consecutive patients taking clopidogrel undergoing elective coronary stent implantation between December 2005 and December 2007. On-treatment platelet reactivity was measured in parallel by light transmittance aggregometry, VerifyNow P2Y12 and Plateletworks assays, and the IMPACT-R and the platelet function analysis system (PFA-100) (with the Dade PFA collagen/adenosine diphosphate [ADP] cartridge and Innovance PFA P2Y). Cut-off values for high on-treatment platelet reactivity were established by receiver operating characteristic curve analysis. Main Outcome Measurement The primary end point was defined as a composite of all-cause death, nonfatal acute myocardial infarction, stent thrombosis, and ischemic stroke. The primary safety end point included TIMI (Thrombolysis In Myocardial Infarction) criteria major and minor bleeding. Results At 1-year follow-up, the primary end point occurred more frequently in patients with high on-treatment platelet reactivity when assessed by light transmittance aggregometry (11.7%; 95% confidence interval [CI], 8.9%-15.0% vs 6.0%; 95% CI, 4.2%-8.2%; P<.001), VerifyNow (13.3%; 95% CI, 10.2%-17.0% vs 5.7%; 95% CI, 4.1%-7.8%; P<.001) and Plateletworks (12.6%; 95% CI, 8.8%-17.2% vs 6.1%; 95% CI, 3.8%-9.2%; P=.005), which also had modest ability to discriminate between patients having and not having a primary event: light transmittance aggregometry (area under the curve [AUC], 0.63; 95% CI, 0.58-0.68), VerifyNow (AUC, 0.62; 95% CI, 0.57-0.67), and Plateletworks (AUC, 0.61; 95% CI, 0.53-0.69). The IMPACT-R, Dade PFA collagen/ADP, and Innovance PFA P2Y were unable to discriminate between patients with and without primary end point at 1-year follow-up (all AUCs included 0.50 in the CI). None of the tests identified patients at risk for bleeding. Conclusions Of the platelet function tests assessed, only light transmittance aggregometry, VerifyNow, and Plateletworks were significantly associated with the primary end point. However, the predictive accuracy of these tests was only modest. None of the tests provided accurate prognostic information to identify low-risk patients at higher risk of bleeding following stent implantation.	[Breet, Nicoline J.; van Werkum, Jochem W.; Bouman, Heleen J.; Kelder, Johannes C.; Bal, Egbert T.; van der Heyden, Jan A. S.; Rensing, Benno J. W. M.; Suttorp, Maarten J.; ten Berg, Jurrien M.] St Antonius Hosp, Dept Cardiol, NL-3435 CM Nieuwegein, Netherlands; [Ruven, Henk J. T.; Hackeng, Christian M.] St Antonius Hosp, Dept Clin Chem, NL-3435 CM Nieuwegein, Netherlands; [Deneer, Vera H.; Harmsze, Ankie M.] St Antonius Hosp, Dept Clin Pharm, NL-3435 CM Nieuwegein, Netherlands; [Breet, Nicoline J.; van Werkum, Jochem W.; Bouman, Heleen J.; Kelder, Johannes C.; Deneer, Vera H.; Harmsze, Ankie M.; Hackeng, Christian M.; ten Berg, Jurrien M.] St Antonius Ctr Platelet Funct Res, Nieuwegein, Netherlands	St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht	ten Berg, JM (corresponding author), St Antonius Hosp, Dept Cardiol, POB 2500, NL-3435 CM Nieuwegein, Netherlands.	berg03@antoniusziekenhuis.nl			Siemens Healthcare Diagnostics	Siemens Healthcare Diagnostics	Funding/Support: Siemens Healthcare Diagnostics provided the Dade PFA Collagen/ADP Test Cartridge and Innovance PFA P2Y without charge.	Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Bonello L, 2009, AM J CARDIOL, V103, P5, DOI 10.1016/j.amjcard.2008.08.048; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Elsenberg EHAM, 2009, THROMB HAEMOSTASIS, V102, P719, DOI 10.1160/TH09-05-0285; Geisler T, 2008, J THROMB HAEMOST, V6, P54; Geisler T, 2006, EUR HEART J, V27, P2420, DOI 10.1093/eurheartj/ehl275; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Pittens CACM, 2009, J THROMB HAEMOST, V7, P1929, DOI 10.1111/j.1538-7836.2009.03585.x; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Savion N, 2006, PATHOPHYSIOL HAEMO T, V35, P83, DOI 10.1159/000093548; Shaw JA, 2008, CARDIOVASC REVASCULA, V9, P218, DOI 10.1016/j.carrev.2008.05.002; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; STEIN B, 1995, CIRCULATION, V91, P979, DOI 10.1161/01.CIR.91.4.979; Steinhubl S, 2003, CIRCULATION, V108, P457; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; *TIMI STUD GROUP, DEF US TIMI TRIALS; van Werkum JW, 2006, J THROMB HAEMOST, V4, P2516, DOI 10.1111/j.1538-7836.2006.02187.x; van Werkum JW, 2008, PLATELETS, V19, P479, DOI 10.1080/09537100802317918; van Werkum JW, 2010, INT J CARDIOL, V140, P123, DOI 10.1016/j.ijcard.2008.10.046; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055	27	682	731	2	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					754	762		10.1001/jama.2010.181	http://dx.doi.org/10.1001/jama.2010.181			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559DD	20179285	Bronze			2022-12-28	WOS:000274800000027
J	Cassar, N; Dunjic, B; Cassar, K				Cassar, Noel; Dunjic, Branko; Cassar, Kevin			Picture Quiz An unusual case of calf pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CYSTIC ADVENTITIAL DISEASE; ARTERY ENTRAPMENT SYNDROME; POPLITEAL ARTERY; DIAGNOSIS		[Cassar, Noel; Dunjic, Branko; Cassar, Kevin] Mater Dei Hosp, Dept Surg, Msida 2090, Msd, Malta		Cassar, N (corresponding author), Mater Dei Hosp, Dept Surg, Msida 2090, Msd, Malta.	noel_mt@yahoo.com						Cassar K, 2005, EUR J VASC ENDOVASC, V29, P93, DOI 10.1016/j.ejvs.2004.09.006; CROLLA RMPH, 1993, J VASC SURG, V18, P1052, DOI 10.1016/0741-5214(93)90561-Y; ERDOES LS, 1994, J VASC SURG, V20, P978, DOI 10.1016/0741-5214(94)90236-4; FLANIGAN DP, 1978, ANN SURG, V189, P165; ISHIKAWA K, 1987, JPN J SURG, V17, P221, DOI 10.1007/BF02470692; JAY GD, 1989, J VASC SURG, V9, P448, DOI 10.1067/mva.1989.vs0090448; Levien Lewis J, 2003, Semin Vasc Surg, V16, P223, DOI 10.1016/S0895-7967(03)00028-0; Levien LJ, 1998, J VASC SURG, V28, P193, DOI 10.1016/S0741-5214(98)70155-7; Macedo TA, 2003, AM J ROENTGENOL, V181, P1259, DOI 10.2214/ajr.181.5.1811259; MCANESPEY D, 1991, Journal of Foot Surgery, V30, P160; Miller A, 1997, J VASC SURG, V26, P715, DOI 10.1016/S0741-5214(97)70076-4; NORGREN L, 2007, J VASC SURG S, V45; Pillai J, 2008, J VASC SURG, V48, p61S, DOI 10.1016/j.jvs.2008.09.049; Pursell R, 2004, J ROY SOC MED, V97, P77, DOI 10.1258/jrsm.97.2.77; ROSSET E, 1995, SURG RADIOL ANAT, V17, P161, DOI 10.1007/BF01627578; SIEUNARINE K, 1991, J CARDIOVASC SURG, V32, P702; Tsolakis IA, 1998, EUR J VASC ENDOVASC, V15, P188, DOI 10.1016/S1078-5884(98)80175-5; VELASQUEZ G, 1980, RADIOLOGY, V134, P19, DOI 10.1148/radiology.134.1.7350603; Wright LB, 2004, RADIOGRAPHICS, V24, P467, DOI 10.1148/rg.242035117	19	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2010	340								c716	10.1136/bmj.c716	http://dx.doi.org/10.1136/bmj.c716			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JT	20164139				2022-12-28	WOS:000274738800002
J	Cusimano, MD; Kwok, J				Cusimano, Michael D.; Kwok, Judith			Skiers, Snowboarders, and Safety Helmets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INJURIES; HEAD		[Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5W 1W8, Canada; [Cusimano, Michael D.; Kwok, Judith] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5W 1W8, Canada; [Cusimano, Michael D.; Kwok, Judith] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5W 1W8, Canada.	injuryprevention@smh.toronto.on.ca	Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022	Cusimano, Michael/0000-0002-9989-0650				Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Evans B, 2009, INT J INJ CONTROL SA, V16, P9, DOI 10.1080/17457300902732045; Jlrgensen U, 1998, Knee Surg Sports Traumatol Arthrosc, V6, P194; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; Lawrence L, 2008, PEDIATR EMERG CARE, V24, P219, DOI 10.1097/PEC.0b013e31816a9f0a; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; *NAT SKI AR ASS, NSAA MED CTR CURR RE; *OCC SAF HLTH ADM, QUICK TIPS SKI RES W; *OH DEP HLTH, OH REC FED FUND SAF; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293	10	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					661	662		10.1001/jama.2010.147	http://dx.doi.org/10.1001/jama.2010.147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555NK	20159875				2022-12-28	WOS:000274518600026
J	Lishko, PV; Botchkina, IL; Fedorenko, A; Kirichok, Y				Lishko, Polina V.; Botchkina, Inna L.; Fedorenko, Andriy; Kirichok, Yuriy			Acid Extrusion from Human Spermatozoa Is Mediated by Flagellar Voltage-Gated Proton Channel	CELL			English	Article							INTRACELLULAR PH; SPERM MOTILITY; BOVINE SPERM; HYPERACTIVATED MOTILITY; NA+/H+ EXCHANGER; MAMMALIAN SPERM; MALE-FERTILITY; BULL SPERM; CA2+; ZINC	Human spermatozoa are quiescent in the male reproductive system and must undergo activation once introduced into the female reproductive tract. This process is known to require alkalinization of sperm cytoplasm, but the mechanism responsible for transmembrane proton extrusion has remained unknown because of the inability to measure membrane conductance in human sperm. Here, by successfully patch clamping human spermatozoa, we show that proton channel Hv1 is their dominant proton conductance. Hv1 is confined to the principal piece of the sperm flagellum, where it is expressed at unusually high density. Robust flagellar Hv1-dependent proton conductance is activated by membrane depolarization, an alkaline extracellular environment, endocannabinoid anandamide, and removal of extracellular zinc, a potent Hv1 blocker. Hv1 allows only outward transport of protons and is therefore dedicated to inducing intracellular alkalinization and activating spermatozoa. The importance of Hv1 for sperm activation makes it an attractive target for controlling male fertility.	[Lishko, Polina V.; Botchkina, Inna L.; Fedorenko, Andriy; Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kirichok, Y (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2140,Genentech Hall,Room N272F,600, San Francisco, CA 94158 USA.	yuriy.kirichok@ucsf.edu	Lishko, Polina/L-1191-2017; Lishko, Polina/GQH-9569-2022		UCSF	UCSF	We thank David Clapham, Kenton Swartz, and Elena Grachova for their advice. Some images were acquired at the Nikon Imaging Center at UCSF/QB3. This work was funded by UCSF Program for Breakthrough Biomedical Research. P.V.L. and Y.K. conceived the project, designed the experiments, and wrote the manuscript. P.V.L. performed most of the electrophysiological and biochemical experiments. Y. K. and A. F. obtained some electrophysiological data. P.V.L. and I.L.B. performed immunocytochemistry and biochemistry experiments. All authors discussed the results and commented on the manuscript.	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; CARR DW, 1989, BIOL REPROD, V41, P907, DOI 10.1095/biolreprod41.5.907; CARR DW, 1985, BIOL REPROD, V33, P588, DOI 10.1095/biolreprod33.3.588; Cooper TG, 2005, HUM REPROD, V20, P9, DOI 10.1093/humrep/deh555; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; DASGUPTA S, 1993, J REPROD FERTIL, V99, P135; DeCoursey TE, 2008, CELL MOL LIFE SCI, V65, P2554, DOI 10.1007/s00018-008-8056-8; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; EHRENWALD E, 1990, MOL REPROD DEV, V25, P195, DOI 10.1002/mrd.1080250213; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; FLORMAN HM, 1989, DEV BIOL, V135, P133, DOI 10.1016/0012-1606(89)90164-4; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; GIROUXWIDEMANN V, 1991, MOL REPROD DEV, V29, P157, DOI 10.1002/mrd.1080290211; GOLTZ JS, 1988, BIOL REPROD, V39, P1129, DOI 10.1095/biolreprod39.5.1129; GUNN SA, 1958, AM J PHYSIOL, V193, P505, DOI 10.1152/ajplegacy.1958.193.3.505; Hamamah S, 1998, HUM REPROD, V13, P20, DOI 10.1093/humrep/13.suppl_4.20; Hamamah S, 1996, MOL HUM REPROD, V2, P219, DOI 10.1093/molehr/2.4.219; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Jimenez-Gonzalez MC, 2007, J CELL PHYSIOL, V213, P801, DOI 10.1002/jcp.21153; Jones JM, 2000, J ANDROL, V21, P616; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Lu J, 2008, BIOCHEM SOC T, V36, P1317, DOI 10.1042/BST0361317; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; PARRISH JJ, 1989, BIOL REPROD, V41, P683, DOI 10.1095/biolreprod41.4.683; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; RIFFO M, 1992, INT J ANDROL, V15, P229, DOI 10.1111/j.1365-2605.1992.tb01343.x; SAARANEN M, 1987, HUM REPROD, V2, P475, DOI 10.1093/oxfordjournals.humrep.a136573; Santi CM, 1998, J GEN PHYSIOL, V112, P33, DOI 10.1085/jgp.112.1.33; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHACKMANN RW, 1986, J BIOL CHEM, V261, P8719; Schuel H, 2005, BIOL REPROD, V73, P1078, DOI 10.1095/biolreprod.105.043273; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; TAJIMA Y, 1990, BIOCHIM BIOPHYS ACTA, V1034, P326, DOI 10.1016/0304-4165(90)90059-6; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Woo AL, 2002, MOL REPROD DEV, V62, P348, DOI 10.1002/mrd.90002; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	54	267	271	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					327	U23		10.1016/j.cell.2009.12.053	http://dx.doi.org/10.1016/j.cell.2009.12.053			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144758	Bronze			2022-12-28	WOS:000274297700011
J	Rehwinkel, J; Tan, CP; Goubau, D; Schulz, O; Pichlmair, A; Bier, K; Robb, N; Vreede, F; Barclay, W; Fodor, E; Sousa, CRE				Rehwinkel, Jan; Tan, Choon Ping; Goubau, Delphine; Schulz, Oliver; Pichlmair, Andreas; Bier, Katja; Robb, Nicole; Vreede, Frank; Barclay, Wendy; Fodor, Ervin; Reis e Sousa, Caetano			RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection	CELL			English	Article							INFLUENZA-A VIRUS; INDUCIBLE GENE-I; NS1 PROTEIN; INNATE IMMUNITY; 5'-TRIPHOSPHATE RNA; BETA-INTERFERON; VIRION RNA; PA SUBUNIT; RECOGNITION; BINDING	RIG-I is a key mediator of antiviral immunity, able to couple detection of infection by RNA viruses to the induction of interferons. Natural RIG-I stimulatory RNAs have variously been proposed to correspond to virus genomes, virus replication intermediates, viral transcripts, or self-RNA cleaved by RNase L. However, the relative contribution of each of these RNA species to RIG-I activation and interferon induction in virus-infected cells is not known. Here, we use three approaches to identify physiological RIG-I agonists in cells infected with influenza A virus or Sendai virus. We show that RIG-I agonists are exclusively generated by the process of virus replication and correspond to full-length virus genomes. Therefore, nongenomic viral transcripts, short replication intermediates, and cleaved self-RNA do not contribute substantially to interferon induction in cells infected with these negative strand RNA viruses. Rather, single-stranded RNA viral genomes bearing 50-triphosphates constitute the natural RIG-I agonists that trigger cell-intrinsic innate immune responses during infection.	[Rehwinkel, Jan; Tan, Choon Ping; Goubau, Delphine; Schulz, Oliver; Pichlmair, Andreas; Reis e Sousa, Caetano] Canc Res UK London Res Inst, Immunobiol Lab, London WC2A 3PX, England; [Tan, Choon Ping; Bier, Katja; Robb, Nicole; Vreede, Frank; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Barclay, Wendy] Univ London Imperial Coll Sci Technol & Med, Dept Virol, London W2 1PG, England	Cancer Research UK; University of Oxford; Imperial College London	Sousa, CRE (corresponding author), Canc Res UK London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Reis e Sousa, Caetano/ABD-7322-2021; Rehwinkel, Jan/CAG-1436-2022; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Rehwinkel, Jan/0000-0003-3841-835X; Reis e Sousa, Caetano/0000-0001-7392-2119; Schulz, Oliver/0000-0002-1493-3341; Fodor, Ervin/0000-0003-3249-196X; Vreede, Frank/0000-0001-9935-2337; Barclay, Wendy/0000-0002-3948-0895	FEBS; Human Frontier Science Program; Baxter and Alma Ricard Foundation; Biotechnology and Biological Sciences Research Council; MRC; Wellcome Trust; European Union (FLUINNATE); Cancer Research UK; MRC [G0700848] Funding Source: UKRI; Medical Research Council [G0700848] Funding Source: researchfish	FEBS; Human Frontier Science Program(Human Frontier Science Program); Baxter and Alma Ricard Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union (FLUINNATE)(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Peter Palese and Shizuo Akira for reagents and George Brownlee and all members of the Immunobiology laboratory for advice and critical discussions. J.R. is a recipient of FEBS and Human Frontier Science Program long-term fellowships. D. G. is a recipient of a Baxter and Alma Ricard Foundation scholarship. K. B. is a recipient of a Biotechnology and Biological Sciences Research Council studentship. E. F. is supported by grants from the MRC, Wellcome Trust, and the European Union (FLUINNATE). Work in the C. R. S. laboratory is funded by Cancer Research UK and a prize from Fondation Bettencourt-Schueller.	Bitko V, 2008, J VIROL, V82, P7977, DOI 10.1128/JVI.02762-07; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; DUESBERG PH, 1969, J MOL BIOL, V42, P485, DOI 10.1016/0022-2836(69)90237-X; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; HATADA E, 1992, J GEN VIROL, V73, P3325, DOI 10.1099/0022-1317-73-12-3325; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; JACKSON DA, 1982, NATURE, V296, P366, DOI 10.1038/296366a0; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Knipe DM, 2007, FIELDS VIROLOGY; KRUG RM, 1987, COLD SPRING HARB SYM, V52, P353, DOI 10.1101/SQB.1987.052.01.040; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	49	427	445	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					397	U143		10.1016/j.cell.2010.01.020	http://dx.doi.org/10.1016/j.cell.2010.01.020			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144762	Bronze			2022-12-28	WOS:000274297700017
J	Pape, JW; Deschamps, MM; Ford, H; Joseph, P; Johnson, WD; Fitzgerald, DW				Pape, Jean William; Deschamps, Marie Marcelle; Ford, Henri; Joseph, Patrice; Johnson, Warren D., Jr.; Fitzgerald, Daniel W.			The GHESKIO Refugee Camp after the earthquake in Haiti - Dispatch 2 from Port-au-Prince	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									GHESKIO Ctr, Weill Cornell Med Coll, Port au Prince, Haiti; Los Angeles Childrens Hosp, Los Angeles, CA USA; Ctr Global Hlth, New York, NY USA	Children's Hospital Los Angeles									0	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9								10.1056/NEJMpv1001785	http://dx.doi.org/10.1056/NEJMpv1001785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	20154302	Bronze			2022-12-28	WOS:000275108300032
J	Cannon, CP				Cannon, Christopher P.			Balancing the benefits of statins versus a new risk-diabetes	LANCET			English	Editorial Material							PREVENTION		[Cannon, Christopher P.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Cannon, Christopher P.] Harvard Univ, Sch Med, Boston, MA USA; [Cannon, Christopher P.] TIMI Study Off, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Cannon, CP (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	cpcannon@partners.org	Cannon, Christopher P/AAY-7644-2020	Cannon, Christopher P/0000-0003-4596-2791				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bangalore S, 2007, AM J CARDIOL, V100, P1254, DOI 10.1016/j.amjcard.2007.05.057; Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COOPERDEHOFF RM, 2010, DRUG INDUCED DIABETE; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Guyton JR, 2007, CURR OPIN LIPIDOL, V18, P415, DOI 10.1097/MOL.0b013e3282364add; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026	11	17	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					700	701		10.1016/S0140-6736(10)60234-6	http://dx.doi.org/10.1016/S0140-6736(10)60234-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20167360				2022-12-28	WOS:000275211200005
J	Dauwerse, L; Abma, TA; Wolbers, JG				Dauwerse, Linda; Abma, T. A.; Wolbers, John G.			A Patient's Journey The war in my head: coping with arteriovenous malformation after a brain haemorrhage	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dauwerse, Linda; Abma, T. A.] Vrije Univ Amsterdam, Med Ctr, Dept Med Humanities, NL-1007 MB Amsterdam, Netherlands; [Wolbers, John G.] Erasmus Univ, Med Ctr, Dept Neurosurg, NL-3000 CA Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Dauwerse, L (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Humanities, POB 7057, NL-1007 MB Amsterdam, Netherlands.	l.dauwerse@vumc.nl	Abma, Tineke/AER-4580-2022	Abma, Tineke/0000-0002-8902-322X					0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2010	340								b5400	10.1136/bmj.b5400	http://dx.doi.org/10.1136/bmj.b5400			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TI	20189968	Green Submitted			2022-12-28	WOS:000275001400001
J	Lo, B				Lo, Bernard			Serving Two Masters - Conflicts of Interest in Academic Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lo, B (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							*AAMC AAU ADV COMM, 2008, PROT PAT PRES INT AD; COX JD, 2003, COX HAZEN CORPORATIO, P202; Lo B, 2009, CONFLICT INTEREST ME; *PARTN HEALTHCARE, 2009, REP PARTN COMM INT I; WILSON D, 2010, NY TIMES        0103	5	41	41	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					669	671		10.1056/NEJMp1000213	http://dx.doi.org/10.1056/NEJMp1000213			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559SA	20181969				2022-12-28	WOS:000274845600001
J	Ginn, S				Ginn, Stephen			Case report A series of unfortunate events	BRITISH MEDICAL JOURNAL			English	Editorial Material							PSYCHOLOGICAL AUTOPSY; SUICIDE-PREVENTION; RISK		Lewisham Hosp, Ladywell Unit, London SE13 6LH, England	South London & Maudsley NHS Trust	Ginn, S (corresponding author), Lewisham Hosp, Ladywell Unit, London SE13 6LH, England.	stephen.ginn@slam.nhs.uk						Beck A.T., 1974, DEV SUICIDAL INTENT; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Cavanagh JTO, 1999, SOC PSYCH PSYCH EPID, V34, P645, DOI 10.1007/s001270050187; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; HAWTON K, 2009, NEW OXFORD TXB PSYCH, P969; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hjelmeland H, 2002, SUICIDE LIFE-THREAT, V32, P380, DOI 10.1521/suli.32.4.380.22336; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; National Institute for Health and Clinical Excellence, 2004, SELF HARM SHORT TERM; PATTERSON WM, 1983, PSYCHOSOMATICS, V24, P343, DOI 10.1016/S0033-3182(83)73213-5; Pirkis J, 1998, BRIT J PSYCHIAT, V173, P462, DOI 10.1192/bjp.173.6.462; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	14	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2010	340								c429	10.1136/bmj.c429	http://dx.doi.org/10.1136/bmj.c429			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	561TG	20181989				2022-12-28	WOS:000275001200013
J	Baker, M				Baker, Monya			The whole picture	NATURE			English	Editorial Material																		Lee H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3207156; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Tamguney G, 2009, P NATL ACAD SCI USA, V106, P15002, DOI 10.1073/pnas.0907339106	4	162	172	5	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					977	980		10.1038/463977a	http://dx.doi.org/10.1038/463977a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164931	Bronze			2022-12-28	WOS:000274582700051
J	Sidibe, M; Buse, K				Sidibe, Michel; Buse, Kent			Fomenting a prevention revolution for HIV	LANCET			English	Editorial Material									[Sidibe, Michel; Buse, Kent] Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland	UNAIDS	Buse, K (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland.	busek@unaids.org	Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110				England R, 2009, LANCET, V374, P1674, DOI 10.1016/S0140-6736(09)61984-X; FEUER C, 2009, ADAPTING REALITIES T; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Kaoma Kapya, 2009, GLOBALIZING CULTURE; Ottosson Daniel, 2009, STATE SPONSORED HOMO; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; SIDIBE M, 2009, COMMUNICATION    DEC; Starrs AM, 2009, LANCET, V374, P1674, DOI 10.1016/S0140-6736(09)61985-1; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2009, JOINT ACT RES UNAIDS; UNAIDS, 2009, MAPP RESTR ENTR STAY; United Nations General Assembly, 2001, DECL COMM HIV AIDS; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2008, REP EXP CONS POS SYN; 2008, LANCET INFECT DIS, V8, P457	16	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					533	535		10.1016/S0140-6736(10)60138-9	http://dx.doi.org/10.1016/S0140-6736(10)60138-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560YO	20159276				2022-12-28	WOS:000274941900008
J	Lister, S				Lister, Sam			Social Care No quick fix for long term care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Times, London, England		Lister, S (corresponding author), Times, London, England.	Sam.Lister@thetimes.co.uk						CUTHBERT M, 2010, PUBLIC FINANCE  0122; Department of Health, 2000, NHS PLAN GOV RESP RO; FERGUSON T, 1948, LANCET, V254, P417; LISTER S, 2009, TIMES           1120; Royal Commission on Long Term Care, 1999, RESP OLD AG LONG TER; 1954, BMJ, V1, P1425	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2010	340								c814	10.1136/bmj.c814	http://dx.doi.org/10.1136/bmj.c814			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZV	20150195				2022-12-28	WOS:000274477200006
J	Vogel, JP; Garvin, DF; Mockler, TC; Schmutz, J; Rokhsar, D; Bevan, MW; Barry, K; Lucas, S; Harmon-Smith, M; Lail, K; Tice, H; Grimwood, J; McKenzie, N; Huo, NX; Gu, YQ; Lazo, GR; Anderson, OD; You, FM; Luo, MC; Dvorak, J; Wright, J; Febrer, M; Idziak, D; Hasterok, R; Lindquist, E; Wang, M; Fox, SE; Priest, HD; Filichkin, SA; Givan, SA; Bryant, DW; Chang, JH; Wu, HY; Wu, W; Hsia, AP; Schnable, PS; Kalyanaraman, A; Barbazuk, B; Michael, TP; Hazen, SP; Bragg, JN; Laudencia-Chingcuanco, D; Weng, YQ; Haberer, G; Spannagl, M; Mayer, K; Rattei, T; Mitros, T; Lee, SJ; Rose, JKC; Mueller, LA; York, TL; Wicker, T; Buchmann, JP; Tanskanen, J; Schulman, AH; Gundlach, H; de Oliveira, AC; Maia, LD; Belknap, W; Jiang, N; Lai, JS; Zhu, LC; Ma, JX; Sun, C; Pritham, E; Salse, J; Murat, F; Abrouk, M; Bruggmann, R; Messing, J; Fahlgren, N; Sullivan, CM; Carrington, JC; Chapman, EJ; May, GD; Zhai, JX; Ganssmann, M; Gurazada, SGR; German, M; Meyers, BC; Green, PJ; Tyler, L; Wu, JJ; Thomson, J; Chen, S; Scheller, HV; Harholt, J; Ulvskov, P; Kimbrel, JA; Bartley, LE; Cao, PJ; Jung, KH; Sharma, MK; Vega-Sanchez, M; Ronald, P; Dardick, CD; De Bodt, S; Verelst, W; Inze, D; Heese, M; Schnittger, A; Yang, XH; Kalluri, UC; Tuskan, GA; Hua, ZH; Vierstra, RD; Cui, Y; Ouyang, SH; Sun, QX; Liu, ZY; Yilmaz, A; Grotewold, E; Sibout, R; Hematy, K; Mouille, G; Hofte, H; Pelloux, J; O'Connor, D; Schnable, J; Rowe, S; Harmon, F; Cass, CL; Sedbrook, JC; Byrne, ME; Walsh, S; Higgins, J; Li, PH; Brutnell, T; Unver, T; Budak, H; Belcram, H; Charles, M; Chalhoub, B; Baxter, I				Vogel, John P.; Garvin, David F.; Mockler, Todd C.; Schmutz, Jeremy; Rokhsar, Dan; Bevan, Michael W.; Barry, Kerrie; Lucas, Susan; Harmon-Smoth, Miranda; Lail, Kathleen; Tice, Hope; Grimwood, Jane; McKenzie, Neil; Huo, Naxin; Gu, Yong Q; Lazo, Gerard R.; Anderson, Olin D.; You, Frank M.; Luo, Ming-Cheng; Dvorak, Jan; Wright, Jan; Febrer, Melanie; Idziak, Dominika; Hasterok, Robert; Lindquist, Erika; Wang, Mei; Fox, Samuel E.; Priest, Henry D.; Filichkin, Sergei A.; Givan, Scott A.; Bryant, Douglas W.; Chang, Jeff H.; Wu, Haiyan; Wu, Wei; Hsia, An-Ping; Schnable, Patrick S.; Kalyanaraman, Anantharaman; Baarbazuk, Brad; Michael, Todd P.; Hazen, Samuel P.; Bragg, Jennifer N.; Laudencia-Chingcuanco, Debbie; Weng, Yiqun; Haberer, Georg; Spannagl, Mianuel; Mayer, Klaus; Rattei, Thomas; Mitros, Therese; Lee, Sang-Jik; Rose, Jocelyn K. C.; Mueller, Lukas A.; York, Thomas L.; Wicker, Thomas; Buchmann, Jan P.; Tanskanen, Jaakko; Schulman, Alan H.; Gundlach, Heidrun; de Oliveira, Antonio Costa; Maia, Luciano da C.; Belknap, William; Jiang, Ning; Lai, Jinsheng; Zhu, Liucun; Ma, Jianxin; Sun, Cheng; Pritham, Ellen; Salse, Jerome; Murat, Florent; Abrouk, Michael; Bruggmann, Remy; Messing, Joachim; Fahlgren, Noah; Sullivan, Christopher M.; Carrington, James C.; Chapman, Elisabeth J.; May, Greg D.; Zhai, Jixian; Ganssmann, Matthias; Gurazada, Sai Guna Ranjan; German, Marcelo; Meyers, Blake C.; Green, Pamela J.; Tyler, Ludmila; Wu, Jiajie; Thomson, James; Chen, Shan; Scheller, Henrik V.; Harholt, Jesper; Ulvskov, Peter; Kimbrel, Jeffrey A.; Bartley, Laura E.; Cao, Peijian; Jung, Ki-Hong; Sharma, Manoj K.; Vega-Sanchez, Miguel; Ronald, Pamela; Dardick, Christopher D.; De Bodt, Stefanie; Verelst, Wim; Inze, Dirk; Heese, Maren; Schnittger, Arp; Yang, Xiaohan; Kalluri, Udaya C.; Tuskan, Gerald A.; Hua, Zhihua; Vierstra, Richard D.; Cui, Yu; Ouyang, Shuhong; Sun, Qixin; Liu, Zhiyong; Yilmaz, Alper; Grotewold, Erich; Sibout, Richard; Hematy, Kian; Mouille, Gregory; Hoefte, Herman; Pelloux, Jerome; O'Connor, Devin; Schbnable, James; Rowe, Scott; Harmon, Frank; Cass, Cynthia L.; Sedbrook, John C.; Byrne, Mary E.; Walsh, Sean; Higgins, Janet; Li, Pinghua; Brutnell, Thomas; Unver, Turgay; Budak, Hikmet; Belcram, Harry; Charles, Mathieu; Chalhoub, Boulos; Baxter, Ivan		Int Brachypodium Initiative	Genome sequencing and analysis of the model grass Brachypodium distachyon	NATURE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; INTRASPECIES DIVERSITY; RICE; EVOLUTION; DIVERGENCE; WHEAT; MAP; IDENTIFICATION; TRITICEAE; DYNAMICS	Three subfamilies of grasses, the Ehrhartoideae, Panicoideae and Pooideae, provide the bulk of human nutrition and are poised to become major sources of renewable energy. Here we describe the genome sequence of the wild grass Brachypodium distachyon (Brachypodium), which is, to our knowledge, the first member of the Pooideae subfamily to be sequenced. Comparison of the Brachypodium, rice and sorghum genomes shows a precise history of genome evolution across a broad diversity of the grasses, and establishes a template for analysis of the large genomes of economically important pooid grasses such as wheat. The high-quality genome sequence, coupled with ease of cultivation and transformation, small size and rapid life cycle, will help Brachypodium reach its potential as an important model system for developing new energy and food crops.	[Vogel, John P.; Huo, Naxin; Gu, Yong Q; Lazo, Gerard R.; Anderson, Olin D.; Bragg, Jennifer N.; Laudencia-Chingcuanco, Debbie; Belknap, William; Tyler, Ludmila; Wu, Jiajie; Thomson, James] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Garvin, David F.] USDA ARS, Plant Sci Res Unit, St Paul, MN 55108 USA; [Garvin, David F.] Univ Minnesota, St Paul, MN 55108 USA; [Mockler, Todd C.; Fox, Samuel E.; Priest, Henry D.; Filichkin, Sergei A.; Givan, Scott A.; Bryant, Douglas W.; Chang, Jeff H.; Fahlgren, Noah; Sullivan, Christopher M.; Carrington, James C.; Chapman, Elisabeth J.; Kimbrel, Jeffrey A.] Oregon State Univ, Corvallis, OR 97331 USA; [Schmutz, Jeremy; Grimwood, Jane] HudsonAlpha Inst, Huntsville, AL 35806 USA; [Rokhsar, Dan; Barry, Kerrie; Lucas, Susan; Harmon-Smoth, Miranda; Lail, Kathleen; Tice, Hope; Febrer, Melanie; Lindquist, Erika; Wang, Mei] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Rokhsar, Dan; Mitros, Therese; Tyler, Ludmila] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Bevan, Michael W.; McKenzie, Neil; Wright, Jan; Byrne, Mary E.; Walsh, Sean; Higgins, Janet] John Innes Ctr, Norwich NR4 7UJ, Norfolk, England; [You, Frank M.; Luo, Ming-Cheng; Dvorak, Jan; Wu, Jiajie; Bartley, Laura E.; Cao, Peijian; Jung, Ki-Hong; Sharma, Manoj K.; Vega-Sanchez, Miguel; Ronald, Pamela] Univ Calif Davis, Davis, CA 95616 USA; [Idziak, Dominika; Hasterok, Robert] Univ Silesia, Katowice, Poland; [Wu, Haiyan; Wu, Wei; Hsia, An-Ping; Schnable, Patrick S.] Iowa State Univ, Ames, IA 50011 USA; [Kalyanaraman, Anantharaman] Washington State Univ, Pullman, WA 99163 USA; [Baarbazuk, Brad] Univ Florida, Gainesville, FL 32611 USA; [Michael, Todd P.; Bruggmann, Remy; Messing, Joachim] Rutgers State Univ, Piscataway, NJ 08855 USA; [Hazen, Samuel P.; Chen, Shan] Univ Massachusetts, Amherst, MA 01003 USA; [Weng, Yiqun] Univ Wisconsin, USDA ARS, Vegetable Crops Res Unit, Dept Hort, Madison, WI 53706 USA; [Haberer, Georg; Spannagl, Mianuel; Mayer, Klaus; Gundlach, Heidrun] Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Rattei, Thomas] Tech Univ Munich, D-80333 Munich, Germany; [Lee, Sang-Jik; Rose, Jocelyn K. C.] Cornell Univ, Ithaca, NY 14853 USA; [Mueller, Lukas A.; York, Thomas L.; Li, Pinghua; Brutnell, Thomas] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Wicker, Thomas; Buchmann, Jan P.] Univ Zurich, CH-8008 Zurich, Switzerland; [Tanskanen, Jaakko; Schulman, Alan H.] MTT Agrifood Res, FIN-00014 Helsinki, Finland; [Tanskanen, Jaakko; Schulman, Alan H.] Univ Helsinki, FIN-00014 Helsinki, Finland; [de Oliveira, Antonio Costa; Maia, Luciano da C.] Univ Fed Pelotas, BR-96001970 Pelotas, RS, Brazil; [Jiang, Ning] Michigan State Univ, E Lansing, MI 48824 USA; [Wu, Haiyan; Schnable, Patrick S.; Lai, Jinsheng; Cui, Yu; Ouyang, Shuhong; Sun, Qixin; Liu, Zhiyong] China Agr Univ, Beijing 10094, Peoples R China; [Zhu, Liucun; Ma, Jianxin] Purdue Univ, W Lafayette, IN 47907 USA; [Sun, Cheng; Pritham, Ellen] Univ Texas, Arlington, TX 76019 USA; [Salse, Jerome; Murat, Florent; Abrouk, Michael] INRA, UMR 1095, F-63100 Clermont Ferrand, France; [Chapman, Elisabeth J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [May, Greg D.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Zhai, Jixian; Ganssmann, Matthias; Gurazada, Sai Guna Ranjan; German, Marcelo; Meyers, Blake C.; Green, Pamela J.] Univ Delaware, Newark, DE 19716 USA; [Scheller, Henrik V.; Bartley, Laura E.; Cao, Peijian; Jung, Ki-Hong; Sharma, Manoj K.; Vega-Sanchez, Miguel; Ronald, Pamela] Joint Bioenergy Inst, Emeryville, CA 94720 USA; [Harholt, Jesper; Ulvskov, Peter] Univ Copenhagen, DK-1871 Frederiksberg, Denmark; [Dardick, Christopher D.] USDA ARS, Appalachian Fruit Res Stn, Kearneysville, WV 25430 USA; [De Bodt, Stefanie; Verelst, Wim; Inze, Dirk] VIB, VIB Dept Plant Syst Biol, B-9052 Ghent, Belgium; [De Bodt, Stefanie; Verelst, Wim; Inze, Dirk] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Heese, Maren; Schnittger, Arp] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Yang, Xiaohan; Kalluri, Udaya C.; Tuskan, Gerald A.] BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Yang, Xiaohan; Kalluri, Udaya C.; Tuskan, Gerald A.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Hua, Zhihua; Vierstra, Richard D.] Univ Wisconsin, Madison, WI 53706 USA; [Yilmaz, Alper; Grotewold, Erich] Ohio State Univ, Columbus, OH 43210 USA; [Sibout, Richard; Hematy, Kian; Mouille, Gregory; Hoefte, Herman] INRA, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France; [Pelloux, Jerome] Univ Picardie, F-80039 Amiens, France; [O'Connor, Devin; Schbnable, James; Rowe, Scott; Harmon, Frank] Univ Calif Berkeley, Plant Gene Express Ctr, Albany, CA 94710 USA; [Cass, Cynthia L.; Sedbrook, John C.] Illinois State Univ, Normal, IL 61790 USA; [Cass, Cynthia L.; Sedbrook, John C.] DOE, Great Lakes Bioenergy Res Ctr, Normal, IL 61790 USA; [Unver, Turgay; Budak, Hikmet] Sabanci Univ, T-34956 Istanbul, Turkey; [Belcram, Harry; Charles, Mathieu; Chalhoub, Boulos] INRA CNRS UEVE, Unite Rech Genomique Vegetale, F-91057 Evry, France; [Baxter, Ivan] USDA ARS, Donald Danforth Plant Sci Ctr, St Louis, MO 63130 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California Davis; University of Silesia in Katowice; Iowa State University; Washington State University; State University System of Florida; University of Florida; Rutgers State University New Brunswick; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Cornell University; Cornell University; Boyce Thompson Institute for Plant Research; University of Zurich; Natural Resources Institute Finland (Luke); University of Helsinki; Universidade Federal de Pelotas; Michigan State University; China Agricultural University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Texas System; University of Texas Arlington; INRAE; University of California System; University of California San Diego; National Center for Genome Resources (NCGR); University of Delaware; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of Copenhagen; United States Department of Agriculture (USDA); Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; Ohio State University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of California System; University of California Berkeley; Illinois State University; United States Department of Energy (DOE); Sabanci University; INRAE; Donald Danforth Plant Science Center; United States Department of Agriculture (USDA)	Vogel, JP (corresponding author), USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA.		Budak, Hikmet/U-8517-2019; Hématy, Kian/AAD-8989-2021; Schulman, Alan/A-9322-2011; Lazo, Gerard/A-8900-2009; Abrouk, Michael/F-8516-2014; Budak, Hikmet/S-5835-2017; Budak, Hikmet/F-4708-2010; Inzé, Dirk/AAW-6381-2021; Hasterok, Robert/A-1629-2008; Abrouk, Michael/W-1972-2017; Jung, Ki Hong/L-5570-2019; Schnittger, Arp/F-8989-2010; Rattei, Thomas/F-1366-2011; Oliveira, Antonio/F-7508-2012; Li, Ping/GYV-4914-2022; Yilmaz, Alper/R-1830-2019; Yang, Xiaohan/A-6975-2011; Scheller, Henrik/AAH-4770-2020; Higgins, Janet/A-5002-2011; Hua, Zhihua/AAD-1146-2021; KALLURI, UDAYA/A-6218-2011; Bartley, Laura/AAF-2217-2020; Luo, Ming-Cheng/C-5600-2011; Hua, Zhihua/B-8835-2012; Grimwood, Jane/ABD-5737-2021; Fahlgren, Noah/D-4404-2011; Yang, Xiaohan/AAM-2449-2020; Yilmaz, Alper/C-7075-2014; Cass, Carol E/F-5861-2010; Maia, Luciano C./G-4005-2016; Mueller, Lukas A/E-8840-2011; Kimbrel, Jeff/S-9638-2019; Ulvskov, Peter/I-1228-2014; Baxter, Ivan R/A-1052-2009; Schnittger, Arp/AAO-6920-2020; Mayer, Klaus FX/M-7941-2015; Jiang, Ning/G-6546-2012; Harholt, Jesper/F-3760-2011; Meyers, Blake/B-6535-2012; Carrington, James C/A-4656-2012; Vega-Sanchez, Miguel/K-3072-2012; Zhai, Jixian/HCH-9272-2022; Mockler, Todd C/L-2609-2013; Ronald, Pamela/AAK-7664-2020; Barry, Kerrie Whitelaw/AAA-5500-2020; Sun, Cheng/AAW-7354-2021; Tuskan, Gerald/A-6225-2011; Unver, Turgay/B-4819-2009; Oliveira, Antonio/K-5923-2019; Brutnell, Thomas/M-2840-2013; Scheller, Henrik V/A-8106-2008; Schmutz, Jeremy/N-3173-2013; Harholt, Jesper/F-6865-2014; Cao, Peijian/U-6776-2019; Buchmann, Jan Piotr/S-1727-2019; Wicker, Thomas/Z-1978-2019	Budak, Hikmet/0000-0002-2556-2478; Schulman, Alan/0000-0002-4126-6177; Lazo, Gerard/0000-0002-9160-2052; Abrouk, Michael/0000-0001-9082-1432; Budak, Hikmet/0000-0002-2556-2478; Budak, Hikmet/0000-0002-2556-2478; Inzé, Dirk/0000-0002-3217-8407; Abrouk, Michael/0000-0001-9082-1432; Jung, Ki Hong/0000-0003-0427-5901; Schnittger, Arp/0000-0001-7067-0091; Rattei, Thomas/0000-0002-0592-7791; Oliveira, Antonio/0000-0001-8835-8071; Yilmaz, Alper/0000-0002-8827-4887; Yang, Xiaohan/0000-0001-5207-4210; Scheller, Henrik/0000-0002-6702-3560; Bartley, Laura/0000-0001-8610-7551; Luo, Ming-Cheng/0000-0002-9744-5887; Fahlgren, Noah/0000-0002-5597-4537; Yang, Xiaohan/0000-0001-5207-4210; Yilmaz, Alper/0000-0002-8827-4887; Maia, Luciano C./0000-0002-4371-261X; Ulvskov, Peter/0000-0003-3776-818X; Baxter, Ivan R/0000-0001-6680-1722; Schnittger, Arp/0000-0001-7067-0091; Mayer, Klaus FX/0000-0001-6484-1077; Meyers, Blake/0000-0003-3436-6097; Carrington, James C/0000-0003-3572-129X; Vega-Sanchez, Miguel/0000-0003-0128-2743; Mockler, Todd C/0000-0002-0462-5775; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Sun, Cheng/0000-0001-7476-9224; Tuskan, Gerald/0000-0003-0106-1289; Unver, Turgay/0000-0001-6760-443X; Oliveira, Antonio/0000-0001-8835-8071; Brutnell, Thomas/0000-0002-3581-8211; Scheller, Henrik V/0000-0002-6702-3560; Schmutz, Jeremy/0000-0001-8062-9172; Harholt, Jesper/0000-0002-7984-0066; Buchmann, Jan Piotr/0000-0002-6842-1229; Hazen, Samuel/0000-0001-9131-8994; Sharma, Manoj K./0000-0002-4768-8733; York, Thomas/0000-0002-6829-5816; Schnable, Patrick/0000-0001-9169-5204; Hasterok, Robert/0000-0001-6667-2721; Rokhsar, Daniel/0000-0002-8704-2224; O'Connor, Devin/0000-0003-4071-8626; Rowe, Scott C/0000-0001-5691-079X; Kimbrel, Jeffrey/0000-0001-7213-9392; Mouille, Gregory/0000-0002-5493-754X; Schnable, James/0000-0001-6739-5527; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233; Laudencia-Chingcuanco, Debbie/0000-0002-9192-8255; Haberer, Georg/0000-0002-6612-6939; Grotewold, Erich/0000-0002-4720-7290; Michael, Todd/0000-0001-6272-2875; Hematy, Kian/0000-0002-3933-3852; , Thomas/0000-0002-6777-7135; zhu, liucun/0000-0002-8334-0216; Zhai, Jixian/0000-0002-0217-0666; Messing, Joachim/0000-0001-8260-2643; Gundlach, Heidrun/0000-0002-6757-0943; Idziak-Helmcke, Dominika/0000-0002-0713-2466; Chang, Jeff/0000-0002-1833-0695; KALLURI, UDAYA/0000-0002-5963-8370; Pelloux, Jerome/0000-0002-9371-1711; Murat, Florent/0000-0003-2116-2511; Vogel, John/0000-0003-1786-2689; Givan, Scott/0000-0002-0630-8589; Spannagl, Manuel/0000-0003-0701-7035; Bruggmann, Remy/0000-0001-5629-6363; Byrne, Mary/0000-0003-4309-3086	US Department of Energy Joint Genome Institute; BBSRC; EU; GABI Barlex; Oregon State Agricultural Research Foundation; BBSRC [BB/E004725/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E004725/1] Funding Source: researchfish	US Department of Energy Joint Genome Institute(United States Department of Energy (DOE)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); GABI Barlex; Oregon State Agricultural Research Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge the contributions of the late M. Gale, who identified the importance of conserved gene order in grass genomes. This work was mainly supported by the US Department of Energy Joint Genome Institute Community Sequencing Program project with J.P.V., D. F. G., T. C. M. and M. W. B., a BBSRC grant to M. W. B., an EU Contract Agronomics grant to M. W. B. and K. F. X. M., and GABI Barlex grant to K. F. X. M. Illumina transcriptome sequencing was supported by a DOE Plant Feedstock Genomics for Bioenergy grant and an Oregon State Agricultural Research Foundation grant to T. C. M.; small RNA research was supported by the DOE Plant Feedstock Genomics for Bioenergy grants to P.J.G. and T. C. M.; annotation was supported by a DOE Plant Feedstocks for Genomics Bioenergy grant to J.P.V. A full list of support and acknowledgements is in the Supplementary Information.	Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bennett MD, 2005, ANN BOT-LONDON, V95, P45, DOI 10.1093/aob/mci003; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Charles M, 2009, MOL BIOL EVOL, V26, P1651, DOI 10.1093/molbev/msp076; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Filiz E, 2009, GENOME, V52, P876, DOI [10.1139/G09-062, 10.1139/g09-062]; Fox S, 2009, METHODS MOL BIOL, V553, P79, DOI 10.1007/978-1-60327-563-7_5; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Global Perspective Studies Unit-Food and Agriculture Organization of the United Nation, 2006, WORLD AGR 2030 2050; Gray J, 2009, PLANT PHYSIOL, V149, P4, DOI 10.1104/pp.108.128504; Gu YQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-496; Huo NX, 2008, FUNCT INTEGR GENOMIC, V8, P135, DOI 10.1007/s10142-007-0062-7; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Somerville C, 2006, SCIENCE, V312, P1277, DOI 10.1126/science.1130034; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; US-DOE, 2006, BREAK BIOL BARR CELL; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vicient CM, 2005, J MOL EVOL, V61, P275, DOI 10.1007/s00239-004-0168-7; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wicker T, 2009, PLANT PHYSIOL, V149, P258, DOI 10.1104/pp.108.129734; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107	46	1317	1368	10	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					763	768		10.1038/nature08747	http://dx.doi.org/10.1038/nature08747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148030	Green Published, Bronze			2022-12-28	WOS:000274394300030
J	Mohrenschlager, M; Engst, R; Ring, J				Moehrenschlager, Matthias; Engst, Reinhard; Ring, Johannes			Picture Quiz Painless non-itching yellow-white spots on genital mucosa	BRITISH MEDICAL JOURNAL			English	Editorial Material							SEBACEOUS GLANDS		[Moehrenschlager, Matthias] Hochgebirgsklin Davos Wolfgang, Dept Dermatol & Allergol, CH-7265 Davos, Switzerland; [Engst, Reinhard; Ring, Johannes] Tech Univ Munich, Dept Dermatol & Allergy Biederstein, Div Environm Dermatol & Allergol GSF TUM, D-80802 Munich, Germany	Technical University of Munich	Mohrenschlager, M (corresponding author), Hochgebirgsklin Davos Wolfgang, Dept Dermatol & Allergol, CH-7265 Davos, Switzerland.	matthias.moehrenschlager@hgk.ch	Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152				Batistatou A, 2006, INT J SURG PATHOL, V14, P355, DOI 10.1177/1066896906291779; Belousova IE, 2005, INT J GYNECOL PATHOL, V24, P193, DOI 10.1097/01.PGP.0000155031.14510.E6; BURGDORF WH, 2009, BRAUNFALCOS DERMATOL; Fordyce JA, 1896, J CUTAN GENITO URIN, V14, P413; PALLER AS, 2006, HURWITZ CLIN PEDIAT	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 10	2010	340								c118	10.1136/bmj.c118	http://dx.doi.org/10.1136/bmj.c118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZT	20147360				2022-12-28	WOS:000274476900001
J	Park, EJ; Lee, JH; Yu, GY; He, GB; Ali, SR; Holzer, RG; Osterreicher, CH; Takahashi, H; Karin, M				Park, Eek Joong; Lee, Jun Hee; Yu, Guann-Yi; He, Guobin; Ali, Syed Raza; Holzer, Ryan G.; Oesterreicher, Christoph H.; Takahashi, Hiroyuki; Karin, Michael			Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression	CELL			English	Article							INDUCED INSULIN-RESISTANCE; SUBCUTANEOUS ADIPOSE-TISSUE; HEPATOCELLULAR-CARCINOMA; KAPPA-B; CHEMICAL HEPATOCARCINOGENESIS; COMPENSATORY PROLIFERATION; CANCER DEVELOPMENT; INTERLEUKIN-6; CELLS; SERUM	Epidemiological studies indicate that overweight and obesity are associated with increased cancer risk. To study how obesity augments cancer risk and development, we focused on hepatocellular carcinoma (HCC), the common form of liver cancer whose occurrence and progression are the most strongly affected by obesity among all cancers. We now demonstrate that either dietary or genetic obesity is a potent bona fide liver tumor promoter in mice. Obesity-promoted HCC development was dependent on enhanced production of the tumor-promoting cytokines IL-6 and TNF, which cause hepatic inflammation and activation of the oncogenic transcription factor STAT3. The chronic inflammatory response caused by obesity and enhanced production of IL-6 and TNF may also increase the risk of other cancers.	[Park, Eek Joong; Lee, Jun Hee; Yu, Guann-Yi; He, Guobin; Ali, Syed Raza; Holzer, Ryan G.; Oesterreicher, Christoph H.; Takahashi, Hiroyuki; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Park, Eek Joong; Lee, Jun Hee; Yu, Guann-Yi; He, Guobin; Ali, Syed Raza; Holzer, Ryan G.; Oesterreicher, Christoph H.; Takahashi, Hiroyuki; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Oesterreicher, Christoph H.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Ali, Syed/M-7418-2013; ali, syed/J-6124-2014; Yu, Guann-Yi/O-5139-2019	Yu, Guann-Yi/0000-0002-0580-8282; Lee, Jun Hee/0000-0002-2200-6011	Natural Sciences and Engineering Research Council of Canada; Korean Research Foundation; Philip Morris Foundation; American Diabetes Association; NIH [ES006376, CA118165]; Superfund Research [P42-ES010337]; Wellcome Trust [WT086755]; NATIONAL CANCER INSTITUTE [R01CA118165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R01ES006376] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Korean Research Foundation(National Research Foundation of Korea); Philip Morris Foundation; American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Superfund Research; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank David Brenner and the anonymous reviewers for their critical comments and Giovanni Solinas for his advice on metabolic measurements. We also thank Soo Young Lee, Helen Tran, and Katsumi Miyai for technical assistance and advice on liver pathology. E.J.P. and J.H.L. were supported in part by postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada and Korean Research Foundation, respectively. S.R.A. received a postdoctoral fellowship from the Philip Morris Foundation and G.Y.Y. was supported by an American Diabetes Association postdoctoral research grant to M. K. Work was supported by grants from the NIH (ES006376 and CA118165), the Superfund Research Program (P42-ES010337), and the Wellcome Trust (WT086755) to M.K., who is an American Cancer Society Research Professor.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Bisgaard HC, 1996, CLIN LAB MED, V16, P325, DOI 10.1016/S0272-2712(18)30272-5; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE799, DOI 10.1152/ajpendo.00155.2004; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Eriksen KW, 2001, LEUKEMIA, V15, P787, DOI 10.1038/sj.leu.2402093; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HE G, 2010, CANC CELL IN PRESS; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Johansson M, 2008, IMMUNOL REV, V222, P145, DOI 10.1111/j.1600-065X.2008.00600.x; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sheweita SA, 2003, CURR DRUG METAB, V4, P45, DOI 10.2174/1389200033336919; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang D, 2006, IEEE AERO EL SYS MAG, V21, P3, DOI 10.1109/MAES.2006.1705163; Wang Y, 2009, INT J CANCER, V124, P540, DOI 10.1002/ijc.23995; WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104	53	1195	1237	10	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					197	208		10.1016/j.cell.2009.12.052	http://dx.doi.org/10.1016/j.cell.2009.12.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141834	Green Accepted, Bronze			2022-12-28	WOS:000273826500011
J	Amundson, D; Dadekian, G; Etienne, M; Gleeson, T; Hicks, T; Killian, D; Kratovil, K; Lewis, C; Monsour, M; Pasiuk, B; Rhodes, D; Miller, EJ				Amundson, Dennis; Dadekian, Greg; Etienne, Mill; Gleeson, Todd; Hicks, Thomas; Killian, Dermot; Kratovil, Kristina; Lewis, Chris; Monsour, Michael; Pasiuk, Bret; Rhodes, Dolores; Miller, Edward J.			Practicing Internal Medicine Onboard the USNS COMFORT in the Aftermath of the Haitian Earthquake	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								On 12 January 2010, a 7.0-magnitude earthquake devastated the island nation of Haiti, leading to the world's largest humanitarian effort in over 6 decades. The catastrophe caused massive destruction of homes and buildings and overwhelmed the Haitian health care system. The United States responded immediately with a massive relief effort, sending U. S. military forces and civilian volunteers to Haiti's aid and providing a tertiary care medical center aboard the USNS COMFORT hospital ship. The COMFORT offered sophisticated medical care to a geographically isolated population and helped to transfer resource-intensive patients from other treatment facilities. Working collaboratively with the surgical staff, ancillary services, and nursing staff, internists aboard the COMFORT were integral to supporting the mission of the hospital ship and provided high-level care to the casualties. This article provides the perspective of the U. S. Navy internists who participated in the initial response to the Haitian earthquake disaster onboard the COMFORT.	[Miller, Edward J.] Natl Naval Med Ctr, Cardiol Sect, Dept Internal Med, Bethesda, MD 20889 USA; USN Hosp, Pensacola, FL 32512 USA; USN, Med Ctr Portsmouth, Portsmouth, VA 23708 USA; USN, San Diego Med Ctr, San Diego, CA 92152 USA	Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; United States Department of Defense; United States Navy; United States Department of Defense; United States Navy	Miller, EJ (corresponding author), Natl Naval Med Ctr, Cardiol Sect, Dept Internal Med, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	edward.miller@med.navy.mil		Miller, Edward/0000-0002-2156-5962					0	34	34	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					733	737		10.7326/0003-4819-152-11-201006010-00215	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00215			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20197507				2022-12-28	WOS:000278560000007
J	Lowry, L; Hoskin, P; Linch, D				Lowry, Lisa; Hoskin, Peter; Linch, David			Developments in the management of Hodgkin's lymphoma	LANCET			English	Editorial Material							INVOLVED-FIELD RADIOTHERAPY; 2 CYCLES; DISEASE; CHEMOTHERAPY; PROGRESSION; RADIATION; MORTALITY; TRIAL; PET		[Lowry, Lisa; Linch, David] UCL, Inst Canc, London WC1E 6BT, England; [Hoskin, Peter] Mt Vernon Canc Ctr, Dept Clin Oncol, London, England	University of London; University College London; Mount Vernon Cancer Centre	Linch, D (corresponding author), UCL, Inst Canc, Mortimer St, London WC1E 6BT, England.	d.linch@ucl.ac.uk		Hoskin, Peter/0000-0001-8323-9567				Aleman BMP, 2003, NEW ENGL J MED, V348, P2396, DOI 10.1056/NEJMoa022628; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Bonadonna G, 2004, J CLIN ONCOL, V22, P2835, DOI 10.1200/JCO.2004.12.170; *CANC RES UK, HODGK LYMPH SURV STA; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; DIEHL V, 2005, J CLIN ONCOL, V23, P6506; ENGERT A, 2007, BLOOD, V110, P211; Engert A, 2007, J CLIN ONCOL, V25, P3495, DOI 10.1200/JCO.2006.07.0482; Ferme C, 2007, NEW ENGL J MED, V357, P1916, DOI 10.1056/NEJMoa064601; Horning SJ, 2007, BLOOD, V110, p198A, DOI 10.1182/blood.V110.11.644.644; Hutchings M, 2006, BLOOD, V107, P52, DOI 10.1182/blood-2005-06-2252; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kobe C, 2008, BLOOD, V112, P3989, DOI 10.1182/blood-2008-06-155820; Meyer RM, 2005, J CLIN ONCOL, V23, P4634, DOI 10.1200/JCO.2005.09.085; Peggs KS, 2005, LANCET, V365, P1934, DOI 10.1016/S0140-6736(05)66659-7; *RAPID, UK CLIN RES NETW POR; *RATHL, UK CLIN RES NETW POR; Schiepers C, 2003, EUR J NUCL MED MOL I, V30, pS82, DOI 10.1007/s00259-003-1165-6; Schulz H, 2008, BLOOD, V111, P109, DOI 10.1182/blood-2007-03-078725; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Yung L, 2003, LANCET, V361, P943, DOI 10.1016/S0140-6736(03)12777-8	21	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2010	375	9717					786	788		10.1016/S0140-6736(09)61878-X	http://dx.doi.org/10.1016/S0140-6736(09)61878-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20171729				2022-12-28	WOS:000275682600008
J	Elderfield, H				Elderfield, Harry			Seawater Chemistry and Climate	SCIENCE			English	Editorial Material							MG/CA; OCEAN; FLANK; SR/CA		Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Elderfield, H (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	he101@cam.ac.uk						BERNER RA, 1991, AM J SCI, V291, P339, DOI 10.2475/ajs.291.4.339; Coggon RM, 2010, SCIENCE, V327, P1114, DOI 10.1126/science.1182252; Elderfield H, 1999, EARTH PLANET SC LETT, V172, P151, DOI 10.1016/S0012-821X(99)00191-0; HOLLAND HD, 2003, OCEANS MARINE GEOCHE, V6, P583; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; MCCAULEY SE, 1997, TECTONIC UPLIFT CLIM, P427; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; PALMER MR, 1992, EARTH PLANET SC LETT, V109, P37, DOI 10.1016/0012-821X(92)90072-4; Rowley DB, 2008, J GEOL, V116, P587, DOI 10.1086/592276; Rowley DB, 2002, GEOL SOC AM BULL, V114, P927, DOI 10.1130/0016-7606(2002)114<0927:ROPCAD>2.0.CO;2; SPENCER RJ, 1990, SPECIAL PUBLICATION, V2, P409; Tipper ET, 2006, EARTH PLANET SC LETT, V250, P241, DOI 10.1016/j.epsl.2006.07.037; WILKINSON BH, 1989, AM J SCI, V289, P1158, DOI 10.2475/ajs.289.10.1158	13	18	21	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1092	1093		10.1126/science.1186769	http://dx.doi.org/10.1126/science.1186769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185717				2022-12-28	WOS:000274901100024
J	Currie, BJ; McCarthy, JS				Currie, Bart J.; McCarthy, James S.			Permethrin and Ivermectin for Scabies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARCOPTES-SCABIEI; NURSING-HOMES; IN-VITRO; OUTBREAK; PEDICULOSIS; DEATHS; ERADICATION; MANAGEMENT; ACARICIDES; RESISTANCE	In a remote aboriginal community in tropical northern Australia, a mother comes to the health center with her 4-year-old son, who has multiple sores on the skin of his arms and legs. He is treated with a single dose of intramuscular penicillin G benzathine and with the application of topical 5% permethrin cream over his whole body. A week later, the pyoderma has substantially resolved, but the boy continues to scratch his hands and feet. The clinic nurse visits the family house and finds that skin sores are present on both infants who live in the household, three of the six young children, and one of the three adolescents. Some also have scratches and small interdigital excoriations, which are consistent with scabies. An infirm elderly aunt living in the house is found to have widespread areas of extensively crusted and scaly skin, which are especially prominent on her hands, elbows, armpits, knees, and buttocks. All the household members are given topical permethrin, and the aunt is referred to the hospital for oral ivermectin therapy.	[Currie, Bart J.] Royal Darwin Hosp, Menzies Sch Hlth Res, Darwin, NT, Australia; [Currie, Bart J.] Royal Darwin Hosp, No Terr Clin Sch, Darwin, NT, Australia; [McCarthy, James S.] Univ Queensland, Herston, Qld, Australia; [McCarthy, James S.] Queensland Inst Med Res, Herston, Qld 4006, Australia	Charles Darwin University; Menzies School of Health Research; Northern Territory Government; University of Queensland; QIMR Berghofer Medical Research Institute	Currie, BJ (corresponding author), Menzies Sch Hlth Res, POB 41096, Casuarina, NT 0811, Australia.	bart@menzies.edu.au		McCarthy, James/0000-0001-6596-9718	Australian National Health and Medical Research Council (NHMRC); Cooperative Research Centre for Aboriginal Health; Government of Queensland Smart State Program	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Aboriginal Health(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Government of Queensland Smart State Program	Supported by grants from the Australian National Health and Medical Research Council (NHMRC), the Cooperative Research Centre for Aboriginal Health, the Government of Queensland Smart State Program, and a Practitioner Fellowship from the NHMRC (to Dr. McCarthy).	Andersen BM, 2000, J HOSP INFECT, V45, P160, DOI 10.1053/jhin.1999.0716; [Anonymous], 2007, COCHRANE DATABASE SY; Barkwell R, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63020-6; Basanez MG, 2008, LANCET INFECT DIS, V8, P310, DOI 10.1016/S1473-3099(08)70099-9; Buehlmann M, 2009, INFECT CONT HOSP EP, V30, P354, DOI 10.1086/596113; CHIPPAUX JP, 1993, T ROY SOC TROP MED H, V87, P318, DOI 10.1016/0035-9203(93)90146-H; Chosidow O, 2006, NEW ENGL J MED, V354, P1718, DOI 10.1056/NEJMcp052784; Chosidow O, 2000, LANCET, V355, P819, DOI 10.1016/S0140-6736(99)09458-1; Coyne PE, 1997, LANCET, V350, P215, DOI 10.1016/S0140-6736(05)62378-1; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; Dannaoui E, 1999, EUR J DERMATOL, V9, P443; Diazgranados JA, 1997, LANCET, V349, P1698, DOI 10.1016/S0140-6736(05)62668-2; Edwards Geoffrey, 2003, Filaria J, V2 Suppl 1, pS8, DOI 10.1186/1475-2883-2-S1-S8; Flinders DC, 2004, AM FAM PHYSICIAN, V69, P341; Geary TG, 2005, TRENDS PARASITOL, V21, P530, DOI 10.1016/j.pt.2005.08.014; GREEN MS, 1989, EPIDEMIOL REV, V11, P126, DOI 10.1093/oxfordjournals.epirev.a036033; Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002401382731; Gyapong JO, 2003, TROP MED INT HEALTH, V8, P1093, DOI 10.1046/j.1360-2276.2003.01142.x; Hengge UR, 2006, LANCET INFECT DIS, V6, P769, DOI 10.1016/S1473-3099(06)70654-5; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Hu S, 2008, ARCH DERMATOL, V144, P1638, DOI 10.1001/archdermatol.2008.513; Huffam S E, 1998, Int J Infect Dis, V2, P152, DOI 10.1016/S1201-9712(98)90118-7; JIMENEZLUCHO VE, 1995, AM J INFECT CONTROL, V23, P44, DOI 10.1016/0196-6553(95)90008-X; Johnston G, 2005, BMJ-BRIT MED J, V331, P619, DOI 10.1136/bmj.331.7517.619; Leppard B, 2000, BRIT J DERMATOL, V143, P520, DOI 10.1111/j.1365-2133.2000.03704.x; Ly F, 2009, B WORLD HEALTH ORGAN, V87, P424, DOI 10.2471/BLT.08.052308; Mackenzie Charles D, 2003, Filaria J, V2 Suppl 1, pS5, DOI 10.1186/1475-2883-2-S1-S5; McCarthy JS, 2004, POSTGRAD MED J, V80, P382, DOI 10.1136/pgmj.2003.014563; MEINKING TL, 1995, NEW ENGL J MED, V333, P26, DOI 10.1056/NEJM199507063330105; Mellanby Kenneth, 1944, PARASITOLOGY, V35, P197, DOI 10.1017/S0031182000021612; Mounsey Kate E., 2007, Invertebrate Neuroscience, V7, P149, DOI 10.1007/s10158-007-0050-6; Mumcuoglu KY, 2008, PARASITE, V15, P248, DOI 10.1051/parasite/2008153248; Obasanjo OO, 2001, INFECT CONT HOSP EP, V22, P13, DOI 10.1086/501818; Owusu-Edusei K, 2009, SEX TRANSM DIS, V36, P297, DOI 10.1097/OLQ.0b013e31819241ef; Paasch U, 2000, INT J DERMATOL, V39, P463, DOI 10.1046/j.1365-4362.2000.00990.x; PACQUE M, 1990, LANCET, V336, P1486, DOI 10.1016/0140-6736(90)93187-T; Pasay C, 2008, MED VET ENTOMOL, V22, P82, DOI 10.1111/j.1365-2915.2008.00716.x; Pasay C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000354; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; Reintjes R, 1997, LANCET, V350, P215, DOI 10.1016/S0140-6736(05)62377-X; Roberts LJ, 2005, J INFECTION, V50, P375, DOI 10.1016/j.jinf.2004.08.033; Saez-de-Ocariz MD, 2002, CLIN EXP DERMATOL, V27, P264, DOI 10.1046/j.1365-2230.2002.01050.x; Scheinfeld N, 2004, AM J CLIN DERMATOL, V5, P31, DOI 10.2165/00128071-200405010-00005; Sullivan J R, 1997, Australas J Dermatol, V38, P137, DOI 10.1111/j.1440-0960.1997.tb01130.x; Tomalik-Scharte D, 2005, EUR J CLIN PHARMACOL, V61, P399, DOI 10.1007/s00228-005-0932-7; TWUMDANSO NA, 2003, FILARIA J S1, V2, pS3, DOI DOI 10.1186/1475-2883-2-S1-S3; Usha V, 2000, J AM ACAD DERMATOL, V42, P236, DOI 10.1016/S0190-9622(00)90131-2; Walton SF, 2000, T ROY SOC TROP MED H, V94, P92, DOI 10.1016/S0035-9203(00)90454-1; YONKOSKY D, 1990, J AM ACAD DERMATOL, V23, P1133, DOI 10.1016/0190-9622(90)70346-J; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	50	187	191	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					717	725		10.1056/NEJMct0910329	http://dx.doi.org/10.1056/NEJMct0910329			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181973				2022-12-28	WOS:000274845600010
J	Rajagopalan, S; Loudon, M				Rajagopalan, Sriram; Loudon, Malcolm			Abdominal-Wall Abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rajagopalan, Sriram; Loudon, Malcolm] Aberdeen Royal Infirm, Aberdeen, Scotland	University of Aberdeen	Rajagopalan, S (corresponding author), Aberdeen Royal Infirm, Aberdeen, Scotland.	surgeryram@doctors.org.uk							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8								10.1056/NEJMicm0810550	http://dx.doi.org/10.1056/NEJMicm0810550			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181968				2022-12-28	WOS:000274845600013
J	Miller, JD				Miller, James Dabney			Registering Clinical Trial Results The Next Step	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REGISTRATION				Miller, JD (corresponding author), Johns Hopkins Univ, Dept Hlth Policy & Management, Johns Hopkins Bloomberg Sch Publ Hlth, 4110 Greenway, Baltimore, MD 21218 USA.	jdmiller@jhsph.edu						Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Peng RD, 2006, AM J EPIDEMIOL, V163, P783, DOI 10.1093/aje/kwj093; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	5	25	26	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					773	774		10.1001/jama.2010.207	http://dx.doi.org/10.1001/jama.2010.207			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559DD	20179288				2022-12-28	WOS:000274800000030
J	Bodenschatz, E; Malinowski, SP; Shaw, RA; Stratmann, F				Bodenschatz, E.; Malinowski, S. P.; Shaw, R. A.; Stratmann, F.			Can We Understand Clouds Without Turbulence?	SCIENCE			English	Editorial Material							PARTICLES		[Bodenschatz, E.] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Bodenschatz, E.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Malinowski, S. P.] Univ Warsaw, Inst Geophys, PL-02093 Warsaw, Poland; [Shaw, R. A.] Michigan Technol Univ, Dept Phys, Houghton, MI 49931 USA; [Stratmann, F.] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany	Max Planck Society; Cornell University; University of Warsaw; Michigan Technological University; Leibniz Institut fur Tropospharenforschung (TROPOS)	Bodenschatz, E (corresponding author), Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany.	frank.stratmann@tropos.de	Malinowski, Szymon Piotr/A-5237-2010	Malinowski, Szymon Piotr/0000-0003-4987-7017; Bodenschatz, Eberhard/0000-0002-2901-0144; Shaw, Raymond/0000-0003-0390-2424				Bourgoin M, 2006, SCIENCE, V311, P835, DOI 10.1126/science.1121726; Chun JH, 2005, J FLUID MECH, V536, P219, DOI 10.1017/S0022112005004568; Haman KE, 2007, Q J ROY METEOR SOC, V133, P213, DOI 10.1002/qj.5; Heintzenberg J, 2009, CLOUDS IN THE PERTURBED CLIMATE SYSTEM: THEIR RELATIONSHIP TO ENERGY BALANCE, ATMOSPHERIC DYNAMICS, AND PRECIPITATION, P1, DOI 10.1109/CLEOE-EQEC.2009.5192754; Held IM, 2007, J ATMOS SCI, V64, P228, DOI 10.1175/JAS3825.1; HOUGHTON HG, 1959, SCIENCE, V129, P307, DOI 10.1126/science.129.3345.307; Lehmann K, 2009, J ATMOS SCI, V66, P3641, DOI 10.1175/2009JAS3012.1; Malinowski SP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075020; Pauluis O, 2010, COMMUN MATH SCI, V8, P295; Pinsky M, 2008, J ATMOS SCI, V65, P357, DOI 10.1175/2007JAS2358.1; Siebert H, 2006, B AM METEOROL SOC, V87, P1727, DOI 10.1175/BAMS-87-12-1727; Stan C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040822; Stevens B, 2005, MON WEATHER REV, V133, P1443, DOI 10.1175/MWR2930.1; Stevens B, 2009, NATURE, V461, P607, DOI 10.1038/nature08281; Stratmann F, 2009, CLOUDS IN THE PERTURBED CLIMATE SYSTEM: THEIR RELATIONSHIP TO ENERGY BALANCE, ATMOSPHERIC DYNAMICS, AND PRECIPITATION, P149; Toschi F, 2009, ANNU REV FLUID MECH, V41, P375, DOI 10.1146/annurev.fluid.010908.165210; Wang LP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075013; Warhaft Z, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/1/011201	19	109	111	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					970	971		10.1126/science.1185138	http://dx.doi.org/10.1126/science.1185138			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167779				2022-12-28	WOS:000274625800031
J	Yan, MH; Callahan, CA; Beyer, JC; Allamneni, KP; Zhang, G; Ridgway, JB; Niessen, K; Plowman, GD				Yan, Minhong; Callahan, Christopher A.; Beyer, Joseph C.; Allamneni, Krishna P.; Zhang, Gu; Ridgway, John Brady; Niessen, Kyle; Plowman, Greg D.			Chronic DLL4 blockade induces vascular neoplasms	NATURE			English	Letter							INHIBITS TUMOR-GROWTH; ENDOTHELIAL-CELLS; ANGIOGENESIS; MIGRATION		[Yan, Minhong; Zhang, Gu; Ridgway, John Brady; Niessen, Kyle; Plowman, Greg D.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Callahan, Christopher A.; Beyer, Joseph C.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Allamneni, Krishna P.] Genentech Inc, Dept Toxicol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Yan, MH (corresponding author), Genentech Inc, Dept Tumor Biol & Angiogenesis, 1 DNA Way, San Francisco, CA 94080 USA.	minhong@gene.com	Plowman, Greg/O-8032-2019; PLOWMAN, Greg D/E-2012-2011	Plowman, Gregory D/0000-0002-6465-309X				[Anonymous], PHASE 1 DOSE ESCALAT; [Anonymous], MULTIPLE ASCENDING D; Hicklin DJ, 2007, NAT BIOTECHNOL, V25, P300, DOI 10.1038/nbt0307-300; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; SETONROGERS S, 2007, NATURE REV CANC, V7, P72	9	217	236	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 11	2010	463	7282					E6	E7		10.1038/nature08751	http://dx.doi.org/10.1038/nature08751			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20147986				2022-12-28	WOS:000274394300027
J	Ederle, J; Dobson, J; Featherstone, RL; Bonati, LH; van der Worp, HB; de Borst, GJ; Lo, TH; Gaines, P; Dorman, PJ; Macdonald, S; Lyrer, PA; Hendriks, JM; McCollum, C; Nederkoorn, PJ; Brown, MM; Algra, A; Bamford, J; Beard, J; Bland, M; Bradbury, AW; Brown, MM; Clifton, A; Gaines, P; Hacke, W; Halliday, A; Malik, I; Mas, JL; McGuire, AJ; Sidhu, P; Venables, G; Bradbury, A; Brown, MM; Clifton, A; Gaines, P; Collins, R; Molynewc, A; Naylor, R; Warlow, C; Ferro, JM; Thomas, D; Bonati, LH; Coward, L; Dobson, J; Ederle, J; Featherstone, RF; Tindall, H; McCabe, DJH; Wallis, A; Brooks, M; Chambers, B; Chan, A; Chu, P; Clark, D; Dewey, H; Donnan, G; Fell, G; Hoare, M; Molan, M; Roberts, A; Roberts, N; Beiles, B; Bladin, C; Clifford, C; Fell, G; Grigg, M; New, G; Bell, R; Bower, S; Chong, W; Holt, M; Saunder, A; Than, PG; Gett, S; Leggett, D; McGahan, T; Quinn, J; Ray, M; Wong, A; Woodruff, P; Foreman, R; Schultz, D; Scroop, R; Stanley, B; Allard, B; Atkinson, N; Cambell, W; Davies, S; Field, P; Milne, P; Mitchell, P; Tress, B; Yan, B; Beasley, A; Dunbabin, D; Stary, D; Walker, S; Cras, P; d'Archambeau, O; Hendriks, JMH; Van Schil, P; Bosiers, M; Deloose, K; van Buggenhout, E; De Letter, J; Devos, V; Ghekiere, J; Vanhooren, G; Astarci, P; Hammer, F; Lacroix, V; Peeters, A; Verhelst, R; DeJaegher, L; Peeters, A; Verbist, J; Blair, JF; Caron, JL; Daneault, N; Giroux, MF; Guilbert, F; Lanthier, S; Lebrun, LH; Oliva, V; Raymond, J; Roy, D; Soulez, G; Weill, A; Hill, M; Hu, W; Hudion, M; Morrish, W; Sutherland, G; Wong, J; Alback, A; Harno, H; Ijas, P; Kaste, M; Lepantalo, M; Mustanoja, S; Paananen, T; Porras, M; Putaala, J; Railo, M; Sairanen, T; Soinne, L; Vehmas, A; Vikatmaa, P; Goertler, M; Halloul, Z; Skalej, M; Brennan, P; Kelly, C; Leahy, A; Moroney, J; Thornton, J; Koelemay, MJW; Nederkoorn, PJ; Reekers, JAA; Roos, YBWEM; Hendriks, JM; Koudstaal, PJ; Pattynama, PMT; van der Lugt, A; van Dijk, LC; van Sambeek, MRHM; van Urk, H; Verhagen, HJM; Bruininckx, CMA; de Bruijn, SF; Keunen, R; Knippenberg, B; Mosch, A; Treurniet, F; van Dijk, L; van Overhagen, H; Wever, J; de Beer, FC; van den Berg, JSP; van Hasselt, BAAM; Zeilstra, DJ; Boiten, J; van Otterloo, JCAD; de Vries, AC; Nieholt, GJLA; van der Kallen, BFW; Blankensteijn, JD; De Leeuw, FE; Kool, LJS; van der Vliet, JA; de Borst, GJ; de Kort, GAP; Kapelle, LJ; Lo, TH; Mali, WPTM; Moll, F; van der Worp, HB; Verhagen, H; Barber, PA; Bourchier, R; Hill, A; Holden, A; Stewart, J; Bakke, SJ; Krohg-Sorensen, K; Skjelland, M; Tennoe, B; Bialek, P; Biejat, Z; Czepiel, W; Czlonkowska, A; Dowzenko, A; Jedrzejewska, J; Kobayashi, A; Lelek, M; Polanski, J; Kirbis, J; Milosevic, Z; Zvan, B; Blasco, J; Chamorro, A; Macho, J; Obach, V; Riambau, V; San Roman, L; Branera, J; Canovas, D; Estela, J; Gaibar, AG; Perendreu, J; Bjorses, K; Gottsater, A; Ivancev, K; Maetzsch, T; Sonesson, B; Berg, B; Delle, M; Formgren, J; Gillgren, P; Kall, TB; Konrad, P; Nyman, N; Takolander, R; Andersson, T; Malmstedt, J; Soderman, M; Wahlgren, C; Wahlgren, N; Binaghi, S; Hirt, L; Michel, P; Ruchat, P; Bonati, LH; Engelter, ST; Fluri, F; Guerke, L; Jacob, AL; Kirsch, E; Lyrer, PA; Radue, EW; Stierli, P; Wasner, M; Wetzel, S; Bonvin, C; Kalangos, A; Lovblad, K; Murith, N; Ruefenacht, D; Sztajzel, R; Higgins, N; Kirkpatrick, PJ; Martin, P; Adam, D; Bell, J; Bradbury, AW; Crowe, P; Gannon, M; Henderson, MJ; Sandler, D; Shinton, RA; Scriven, JM; Wilmink, T; D'Souza, S; Egun, A; Guta, R; Punekar, S; Seriki, DM; Thomson, G; Brennan, A; Enevoldson, TP; Gilling-Smith, G; Gould, DA; Harris, PL; McWilliams, RG; Nasser, HC; White, R; Prakash, KG; Serracino-Inglott, F; Subramanian, G; Symth, JV; Walker, MG; Clarke, M; Davis, M; Dixit, SA; Dolman, P; Dyker, A; Ford, G; Golkar, A; Jackson, R; Jayakrishnan, V; Lambert, D; Lees, T; Louw, S; Macdonald, S; Mendelow, AD; Rodgers, H; Rose, J; Stansby, G; Wyatt, M; Baker, T; Baldwin, N; Jones, L; Mitchell, D; Munro, E; Thornton, M; Baker, D; Davis, N; Hamilton, G; McCabe, D; Platts, A; Tibballs, J; Beard, J; Cleveland, T; Dodd, D; Gaines, P; Lonsdale, R; Nair, R; Nassef, A; Nawaz, S; Venables, G; Belli, A; Clifton, A; Cloud, G; Halliday, A; Markus, H; McFarland, R; Morgan, R; Pereira, A; Thompson, A; Chataway, J; Cheshire, N; Gibbs, R; Hammady, M; Jenkins, M; Malik, I; Wolfe, J; Adiseshiah, M; Bishop, C; Brew, S; Brookes, J; Brown, MM; Jager, R; Kitchen, N; Ashleigh, R; Butterfield, S; Gamble, GE; McCollum, C; Nasim, A; O'Neill, P; Wong, J; Edwards, RD; Lees, KR; MacKay, AJ; Moss, J; Rogers, P				Ederle, Joerg; Dobson, Joanna; Featherstone, Roland L.; Bonati, Leo H.; van der Worp, H. Bart; de Borst, Gert J.; Lo, T. Hauw; Gaines, Peter; Dorman, Paul J.; Macdonald, Sumaira; Lyrer, Philippe A.; Hendriks, Johanna M.; McCollum, Charles; Nederkoorn, Paul J.; Brown, Martin M.; Algra, A.; Bamford, J.; Beard, J.; Bland, M.; Bradbury, A. W.; Brown, M. M.; Clifton, A.; Gaines, P.; Hacke, W.; Halliday, A.; Malik, I.; Mas, J. L.; McGuire, A. J.; Sidhu, P.; Venables, G.; Bradbury, A.; Brown, M. M.; Clifton, A.; Gaines, P.; Collins, R.; Molynewc, A.; Naylor, R.; Warlow, C.; Ferro, J. M.; Thomas, D.; Bonati, L. H.; Coward, L.; Dobson, J.; Ederle, J.; Featherstone, R. F.; Tindall, H.; McCabe, D. J. H.; Wallis, A.; Brooks, M.; Chambers, B.; Chan, A.; Chu, P.; Clark, D.; Dewey, H.; Donnan, G.; Fell, G.; Hoare, M.; Molan, M.; Roberts, A.; Roberts, N.; Beiles, B.; Bladin, C.; Clifford, C.; Fell, G.; Grigg, M.; New, G.; Bell, R.; Bower, S.; Chong, W.; Holt, M.; Saunder, A.; Than, P. G.; Gett, S.; Leggett, D.; McGahan, T.; Quinn, J.; Ray, M.; Wong, A.; Woodruff, P.; Foreman, R.; Schultz, D.; Scroop, R.; Stanley, B.; Allard, B.; Atkinson, N.; Cambell, W.; Davies, S.; Field, P.; Milne, P.; Mitchell, P.; Tress, B.; Yan, B.; Beasley, A.; Dunbabin, D.; Stary, D.; Walker, S.; Cras, P.; d'Archambeau, O.; Hendriks, J. M. H.; Van Schil, P.; Bosiers, M.; Deloose, K.; van Buggenhout, E.; De Letter, J.; Devos, V.; Ghekiere, J.; Vanhooren, G.; Astarci, P.; Hammer, F.; Lacroix, V.; Peeters, A.; Verhelst, R.; DeJaegher, L.; Peeters, A.; Verbist, J.; Blair, J-F; Caron, J. L.; Daneault, N.; Giroux, M-F; Guilbert, F.; Lanthier, S.; Lebrun, L-H; Oliva, V.; Raymond, J.; Roy, D.; Soulez, G.; Weill, A.; Hill, M.; Hu, W.; Hudion, M.; Morrish, W.; Sutherland, G.; Wong, J.; Alback, A.; Harno, H.; Ijas, P.; Kaste, M.; Lepantalo, M.; Mustanoja, S.; Paananen, T.; Porras, M.; Putaala, J.; Railo, M.; Sairanen, T.; Soinne, L.; Vehmas, A.; Vikatmaa, P.; Goertler, M.; Halloul, Z.; Skalej, M.; Brennan, P.; Kelly, C.; Leahy, A.; Moroney, J.; Thornton, J.; Koelemay, M. J. W.; Nederkoorn, P. J.; Reekers, J. A. A.; Roos, Y. B. W. E. M.; Hendriks, J. M.; Koudstaal, P. J.; Pattynama, P. M. T.; van der Lugt, A.; van Dijk, L. C.; van Sambeek, M. R. H. M.; van Urk, H.; Verhagen, H. J. M.; Bruininckx, C. M. A.; de Bruijn, S. F.; Keunen, R.; Knippenberg, B.; Mosch, A.; Treurniet, F.; van Dijk, L.; van Overhagen, H.; Wever, J.; de Beer, F. C.; van den Berg, J. S. P.; van Hasselt, B. A. A. M.; Zeilstra, D. J.; Boiten, J.; van Otterloo, J. C. A. de Mol; de Vries, A. C.; Nieholt, G. J. Lycklama A.; van der Kallen, B. F. W.; Blankensteijn, J. D.; De Leeuw, F. E.; Kool, L. J. Schultze; van der Vliet, J. A.; de Borst, G. J.; de Kort, G. A. P.; Kapelle, L. J.; Lo, T. H.; Mali, W. P. Th M.; Moll, F.; van der Worp, H. B.; Verhagen, H.; Barber, P. A.; Bourchier, R.; Hill, A.; Holden, A.; Stewart, J.; Bakke, S. J.; Krohg-Sorensen, K.; Skjelland, M.; Tennoe, B.; Bialek, P.; Biejat, Z.; Czepiel, W.; Czlonkowska, A.; Dowzenko, A.; Jedrzejewska, J.; Kobayashi, A.; Lelek, M.; Polanski, J.; Kirbis, J.; Milosevic, Z.; Zvan, B.; Blasco, J.; Chamorro, A.; Macho, J.; Obach, V.; Riambau, V.; San Roman, L.; Branera, J.; Canovas, D.; Estela, Jordi; Gimenez Gaibar, A.; Perendreu, J.; Bjorses, K.; Gottsater, A.; Ivancev, K.; Maetzsch, T.; Sonesson, B.; Berg, B.; Delle, M.; Formgren, J.; Gillgren, P.; Kall, T-B; Konrad, P.; Nyman, N.; Takolander, R.; Andersson, T.; Malmstedt, J.; Soderman, M.; Wahlgren, C.; Wahlgren, N.; Binaghi, S.; Hirt, L.; Michel, P.; Ruchat, P.; Bonati, L. H.; Engelter, S. T.; Fluri, F.; Guerke, L.; Jacob, A. L.; Kirsch, E.; Lyrer, P. A.; Radue, E-W; Stierli, P.; Wasner, M.; Wetzel, S.; Bonvin, C.; Kalangos, A.; Lovblad, K.; Murith, N.; Ruefenacht, D.; Sztajzel, R.; Higgins, N.; Kirkpatrick, P. J.; Martin, P.; Adam, D.; Bell, J.; Bradbury, A. W.; Crowe, P.; Gannon, M.; Henderson, M. J.; Sandler, D.; Shinton, R. A.; Scriven, J. M.; Wilmink, T.; D'Souza, S.; Egun, A.; Guta, R.; Punekar, S.; Seriki, D. M.; Thomson, G.; Brennan, A.; Enevoldson, T. P.; Gilling-Smith, G.; Gould, D. A.; Harris, P. L.; McWilliams, R. G.; Nasser, H-C; White, R.; Prakash, K. G.; Serracino-Inglott, F.; Subramanian, G.; Symth, J. V.; Walker, M. G.; Clarke, M.; Davis, M.; Dixit, S. A.; Dolman, P.; Dyker, A.; Ford, G.; Golkar, A.; Jackson, R.; Jayakrishnan, V.; Lambert, D.; Lees, T.; Louw, S.; Macdonald, S.; Mendelow, A. D.; Rodgers, H.; Rose, J.; Stansby, G.; Wyatt, M.; Baker, T.; Baldwin, N.; Jones, L.; Mitchell, D.; Munro, E.; Thornton, M.; Baker, D.; Davis, N.; Hamilton, G.; McCabe, D.; Platts, A.; Tibballs, J.; Beard, J.; Cleveland, T.; Dodd, D.; Gaines, P.; Lonsdale, R.; Nair, R.; Nassef, A.; Nawaz, S.; Venables, G.; Belli, A.; Clifton, A.; Cloud, G.; Halliday, A.; Markus, H.; McFarland, R.; Morgan, R.; Pereira, A.; Thompson, A.; Chataway, J.; Cheshire, N.; Gibbs, R.; Hammady, M.; Jenkins, M.; Malik, I.; Wolfe, J.; Adiseshiah, M.; Bishop, C.; Brew, S.; Brookes, J.; Brown, M. M.; Jaeger, R.; Kitchen, N.; Ashleigh, R.; Butterfield, S.; Gamble, G. E.; McCollum, C.; Nasim, A.; O'Neill, P.; Wong, J.; Edwards, R. D.; Lees, K. R.; MacKay, A. J.; Moss, J.; Rogers, P.		Int Carotid Stenting Study	Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial	LANCET			English	Article							ANGIOPLASTY	Background Stents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis, but previous trials have not established equivalent safety and efficacy. We compared the safety of carotid artery stenting with that of carotid endarterectomy. Methods The International Carotid Stenting Study (ICSS) is a multicentre, international, randomised controlled trial with blinded adjudication of outcomes. Patients with recently symptomatic carotid artery stenosis were randomly assigned in a 1:1 ratio to receive carotid artery stenting or carotid endarterectomy. Randomisation was by telephone call or fax to a central computerised service and was stratified by centre with minimisation for sex, age, contralateral occlusion, and side of the randomised artery. Patients and investigators were not masked to treatment assignment. Patients were followed up by independent clinicians not directly involved in delivering the randomised treatment. The primary outcome measure of the trial is the 3-year rate of fatal or disabling stroke in any territory, which has not been analysed yet. The main outcome measure for the interim safety analysis was the 120-day rate of stroke, death, or procedural myocardial infarction. Analysis was by intention to treat (ITT). This study is registered, number ISRCTN25337470. Findings The trial enrolled 1713 patients (stenting group, n=855; endarterectomy group, n=858). Two patients in the stenting group and one in the endarterectomy group withdrew immediately after randomisation, and were not included in the ITT analysis. Between randomisation and 120 days, there were 34 (Kaplan-Meier estimate 4.0%) events of disabling stroke or death in the stenting group compared with 27 (3.2%) events in the endarterectomy group (hazard ratio [HR] 1.28, 95% CI 0.77-2.11). The incidence of stroke, death, or procedural myocardial infarction was 8.5% in the stenting group compared with 5.2% in the endarterectomy group (72 vs 44 events; HR 1.69, 1.16-2.45, p=0.006), Risks of any stroke (65 vs 35 events; HR 1.92, 1.27-2.89) and all-cause death (19 vs seven events; HR 2.76, 1.16-6.56) were higher in the stenting group than in the endarterectomy group. Three procedural myocardial infarctions were recorded in the stenting group, all of which were fatal, compared with four, all non-fatal, in the endarterectomy group. There was one event of cranial nerve palsy in the stenting group compared with 45 in the endarterectomy group. There were also fewer haematomas of any severity in the stenting group than in the endarterectomy group (31 vs 50 events; p=0.0197). Interpretation Completion of long-term follow-up is needed to establish the efficacy of carotid artery stenting compared with endarterectomy. In the meantime, carotid endarterectomy should remain the treatment of choice for patients suitable for surgery.	[Brown, Martin M.] UCL, Inst Neurol, Natl Hosp Neurol & Neurosurg, Dept Brain Repair & Rehabil, London WC1N 3BG, England; [Dobson, Joanna] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, London WC1, England; [van der Worp, H. Bart] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [de Borst, Gert J.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Lo, T. Hauw] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Gaines, Peter] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield Vasc Inst, Sheffield, S Yorkshire, England; [Dorman, Paul J.] Newcastle Gen Hosp, Dept Neurol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Macdonald, Sumaira] Freeman Rd Hosp, Dept Radiol, Newcastle Upon Tyne, Tyne & Wear, England; [Lyrer, Philippe A.] Univ Basel, Univ Basel Hosp, Dept Neurol, CH-4003 Basel, Switzerland; [Lyrer, Philippe A.] Univ Basel, Univ Basel Hosp, Stroke Unit, CH-4003 Basel, Switzerland; [Hendriks, Johanna M.] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [McCollum, Charles] Univ Manchester, Sch Biomed, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Nederkoorn, Paul J.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1012 WX Amsterdam, Netherlands; [Ferro, J. M.; Thomas, D.] UCL, Inst Neurol, Cent Off Staff, London WC1N 3BG, England; [Brooks, M.; Chambers, B.; Chan, A.; Chu, P.; Clark, D.; Dewey, H.; Donnan, G.; Fell, G.; Hoare, M.; Molan, M.; Roberts, A.; Roberts, N.] Australia Austin Hlth, Heidelberg, Germany; [Fell, G.; Beiles, B.; Bladin, C.; Clifford, C.; Grigg, M.; New, G.] Monash Univ, Box Hill Hosp, Melbourne, Vic, Australia; [Bell, R.; Bower, S.; Chong, W.; Holt, M.; Saunder, A.; Than, P. G.] Monash Med Ctr, Clayton, Vic 3168, Australia; [Gett, S.; Leggett, D.; McGahan, T.; Quinn, J.; Ray, M.; Wong, A.; Woodruff, P.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Foreman, R.; Schultz, D.; Scroop, R.; Stanley, B.] Repatriat Gen Hosp, Adelaide, SA, Australia; [Allard, B.; Atkinson, N.; Cambell, W.; Davies, S.; Field, P.; Milne, P.; Mitchell, P.; Tress, B.; Yan, B.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Beasley, A.; Dunbabin, D.; Stary, D.; Walker, S.] Royal Hobart Hosp, Hobart, Tas, Australia; [Cras, P.; d'Archambeau, O.; Hendriks, J. M. H.; Van Schil, P.] Belgium Antwerp Univ Hosp, Antwerp, Belgium; [De Letter, J.; Devos, V.; Ghekiere, J.; Vanhooren, G.] AZ Sint Jan Brugge Oostende, Brugges, Belgium; [Astarci, P.; Hammer, F.; Lacroix, V.; Peeters, A.; Verhelst, R.] Clin Univ St Luc, B-1200 Brussels, Belgium; [Peeters, A.; DeJaegher, L.; Verbist, J.] Imelda Ziekenhuis, Bonheiden, Belgium; [Blair, J-F; Caron, J. L.; Daneault, N.; Giroux, M-F; Guilbert, F.; Lanthier, S.; Lebrun, L-H; Oliva, V.; Raymond, J.; Roy, D.; Soulez, G.; Weill, A.] Canada CHUM Notre Dame Hosp, Montreal, PQ, Canada; [Hill, M.; Hu, W.; Hudion, M.; Morrish, W.; Sutherland, G.; Wong, J.] Foothills Med Ctr, Calgary, AB, Canada; [Alback, A.; Harno, H.; Ijas, P.; Kaste, M.; Lepantalo, M.; Mustanoja, S.; Paananen, T.; Porras, M.; Putaala, J.; Railo, M.; Sairanen, T.; Soinne, L.; Vehmas, A.; Vikatmaa, P.] Finland Helsinki Univ, Cent Hosp, Helsinki, Finland; [Goertler, M.; Halloul, Z.; Skalej, M.] Germany Otto von Guericke Univ, Magdeburg, Germany; [Brennan, P.; Kelly, C.; Leahy, A.; Moroney, J.; Thornton, J.] Ireland Beaumont Hosp, Dublin, Ireland; [Koelemay, M. J. W.; Nederkoorn, P. J.; Reekers, J. A. A.; Roos, Y. B. W. E. M.] Netherlands Acad Med Ctr, Amsterdam, Netherlands; [Bruininckx, C. M. A.; de Bruijn, S. F.; Keunen, R.; Knippenberg, B.; Mosch, A.; Treurniet, F.; van Dijk, L.; van Overhagen, H.; Wever, J.] Haga Teaching Hosp, The Hague, Netherlands; [Boiten, J.; van Otterloo, J. C. A. de Mol; de Vries, A. C.; Nieholt, G. J. Lycklama A.; van der Kallen, B. F. W.] Med Ctr Haaglanden, The Hague, Netherlands; [Blankensteijn, J. D.; De Leeuw, F. E.; Kool, L. J. Schultze; van der Vliet, J. A.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [de Borst, G. J.; de Kort, G. A. P.; Kapelle, L. J.; Lo, T. H.; Mali, W. P. Th M.; Moll, F.; van der Worp, H. B.; Verhagen, H.] Univ Med Ctr, Utrecht, Netherlands; [Barber, P. A.; Bourchier, R.; Hill, A.; Holden, A.; Stewart, J.] New Zealand Auckland City Hosp, Auckland, New Zealand; [Bakke, S. J.; Krohg-Sorensen, K.; Skjelland, M.; Tennoe, B.] Univ Hosp, Norway Rikshosp, Oslo, Norway; [Bialek, P.; Biejat, Z.; Czepiel, W.; Czlonkowska, A.; Dowzenko, A.; Jedrzejewska, J.; Kobayashi, A.; Lelek, M.; Polanski, J.] Poland Inst Psychiat & Neurol, Dept Neurol 2, Warsaw, Poland; [Bialek, P.; Biejat, Z.; Czepiel, W.; Czlonkowska, A.; Dowzenko, A.; Jedrzejewska, J.; Kobayashi, A.; Lelek, M.; Polanski, J.] Poland Inst Psychiat & Neurol, Dept Neuroradiol, Warsaw, Poland; [Bialek, P.; Biejat, Z.; Czepiel, W.; Czlonkowska, A.; Dowzenko, A.; Jedrzejewska, J.; Kobayashi, A.; Lelek, M.; Polanski, J.] Med Univ Warsaw, Dept Gen Vasc & Oncol Surg 2, Warsaw, Poland; [Kirbis, J.; Milosevic, Z.; Zvan, B.] Slovenia Univ, Med Ctr, Ljubljana, Slovenia; [Blasco, J.; Chamorro, A.; Macho, J.; Obach, V.; Riambau, V.; San Roman, L.] Spain Hosp Clin, Barcelona, Spain; [Branera, J.; Canovas, D.; Estela, Jordi; Gimenez Gaibar, A.; Perendreu, J.] Parc Tauli Sabadell Hosp, Barcelona, Spain; [Bjorses, K.; Gottsater, A.; Ivancev, K.; Maetzsch, T.; Sonesson, B.] Sweden Malmo Univ Hosp, Malmo, Sweden; [Berg, B.; Delle, M.; Formgren, J.; Gillgren, P.; Kall, T-B; Konrad, P.; Nyman, N.; Takolander, R.] Soder Sjukhuset, S-10064 Stockholm, Sweden; [Andersson, T.; Malmstedt, J.; Soderman, M.; Wahlgren, C.; Wahlgren, N.] Karolinska Inst, Stockholm, Sweden; [Binaghi, S.; Hirt, L.; Michel, P.; Ruchat, P.] Switzerland Ctr Hosp Univ Vaudois, Lausanne, Switzerland; [Bonati, L. H.; Engelter, S. T.; Fluri, F.; Guerke, L.; Jacob, A. L.; Kirsch, E.; Lyrer, P. A.; Radue, E-W; Stierli, P.; Wasner, M.; Wetzel, S.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Bonvin, C.; Kalangos, A.; Lovblad, K.; Murith, N.; Ruefenacht, D.; Sztajzel, R.] Univ Hosp Geneva, Geneva, Switzerland; [Higgins, N.; Kirkpatrick, P. J.; Martin, P.] UK Addenbrookes Hosp, Cambridge, England; [Bradbury, A. W.; Adam, D.; Bell, J.; Crowe, P.; Gannon, M.; Henderson, M. J.; Sandler, D.; Shinton, R. A.; Scriven, J. M.; Wilmink, T.] K Varty Birmingham Heartlands Hosp, Birmingham, W Midlands, England; [D'Souza, S.; Egun, A.; Guta, R.; Punekar, S.; Seriki, D. M.; Thomson, G.] Lancashire Teaching Hosp NHS Trust, Preston, Lancs, England; [Brennan, A.; Enevoldson, T. P.; Gilling-Smith, G.; Gould, D. A.; Harris, P. L.; McWilliams, R. G.; Nasser, H-C; White, R.] Liverpool Royal Infirm, Liverpool, Merseyside, England; [Brennan, A.; Enevoldson, T. P.; Gilling-Smith, G.; Gould, D. A.; Harris, P. L.; McWilliams, R. G.; Nasser, H-C; White, R.] Walton Ctr, Liverpool, Merseyside, England; [Prakash, K. G.; Serracino-Inglott, F.; Subramanian, G.; Symth, J. V.; Walker, M. G.] Manchester Royal Infirm, Manchester, Lancs, England; [Dorman, Paul J.; Clarke, M.; Davis, M.; Dixit, S. A.; Dyker, A.; Ford, G.; Golkar, A.; Jackson, R.; Jayakrishnan, V.; Lambert, D.; Lees, T.; Louw, S.; Macdonald, S.; Mendelow, A. D.; Rodgers, H.; Rose, J.; Stansby, G.; Wyatt, M.] Newcastle Acute Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Baker, T.; Baldwin, N.; Jones, L.; Mitchell, D.; Munro, E.; Thornton, M.] Frenchay Hosp, N Bristol NHS Trust, Bristol, Avon, England; [Baker, D.; Davis, N.; Hamilton, G.; McCabe, D.; Platts, A.; Tibballs, J.] Royal Free Hosp, London, England; [Beard, J.; Gaines, P.; Venables, G.; Cleveland, T.; Dodd, D.; Lonsdale, R.; Nair, R.; Nassef, A.; Nawaz, S.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Clifton, A.; Halliday, A.; Belli, A.; Cloud, G.; Markus, H.; McFarland, R.; Morgan, R.; Pereira, A.; Thompson, A.] St Georges Univ London, London, England; [Clifton, A.; Halliday, A.; Belli, A.; Cloud, G.; Markus, H.; McFarland, R.; Morgan, R.; Pereira, A.; Thompson, A.] St Georges NHS Healthcare Trust, London, England; [Malik, I.; Chataway, J.; Cheshire, N.; Gibbs, R.; Hammady, M.; Jenkins, M.; Wolfe, J.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London, England; [Brown, M. M.; Adiseshiah, M.; Bishop, C.; Brew, S.; Brookes, J.; Jaeger, R.; Kitchen, N.] Univ Coll London Hosp NHS Fdn Trust, London, England; [Wong, J.; Ashleigh, R.; Butterfield, S.; Gamble, G. E.; McCollum, C.; Nasim, A.; O'Neill, P.] Univ S Manchester Hosp, Manchester, Lancs, England; [Edwards, R. D.; Lees, K. R.; MacKay, A. J.; Moss, J.; Rogers, P.] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Sheffield; Newcastle General Hospital; Newcastle Freeman Hospital; Newcastle University - UK; University of Basel; University of Basel; Erasmus University Rotterdam; Erasmus MC; University of Manchester; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Box Hill Hospital; Monash University; Monash University; Flinders University South Australia; Royal Melbourne Hospital; Royal Hobart Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Imeldaziekenhuis; University of Calgary; University of Helsinki; Helsinki University Central Hospital; Otto von Guericke University; University of Amsterdam; Academic Medical Center Amsterdam; Haga Hospital; Haaglanden Medical Center; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Auckland City Hospital; University of Oslo; National Hospital Norway; Institute of Psychiatry & Neurology; Institute of Psychiatry & Neurology; Medical University of Warsaw; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Sodersjukhuset Hospital; Karolinska Institutet; University of Basel; University of Geneva; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Walton Centre; University of Manchester; Newcastle Upon Tyne Hospitals NHS Foundation Trust; North Bristol NHS Trust; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Sheffield; St Georges University London; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Glasgow	Brown, MM (corresponding author), UCL, Inst Neurol, Natl Hosp Neurol & Neurosurg, Dept Brain Repair & Rehabil, Box 6,Queen Sq, London WC1N 3BG, England.	m.brown@ion.ucl.ac.uk	de Leeuw, H.F./L-4479-2015; Bonati, Leo/G-4058-2012; Halliday, Alison/AAA-2230-2022; Peeters, Anna/M-8284-2019; Raymond, Jean/D-3940-2011; Lövblad, Karl/AAF-7678-2020; Punekar, Shuja/AFO-2604-2022; Zeilstra, Dick J/N-1993-2019; van der Vliet, J. Adam/L-4721-2015; Van Schil, Paul/AAC-8139-2019; Hacke, Werner/ABE-8661-2020; Skjelland, Mona/B-7362-2016; Reekers, Jim/ABF-7580-2021; bladin, chris/B-9136-2013; Ijäs, Petra/F-8280-2015; van Sambeek, marc/CAF-1289-2022; Ford, Gary A/A-6353-2012; Morgan, Robert Anthony/AAH-9104-2021; Mali, Willem PThM/I-1123-2014; de Leeuw, Frank-Erik/E-4795-2012; Jones, Lyn I L/B-9573-2018; Skalej, Martin/G-2122-2013; Hirt, Lorenz/G-3553-2010; Barber, Philip A/C-7108-2016; Blankensteijn, Jan D/Q-9291-2016; Soinne, Lauri/E-3703-2019; Wever, Jan/AAJ-6870-2021; Roos, Yvo BWEM/B-9843-2013; Ford, Gary/AAY-6405-2020; Sutherland, Grant Robert/D-2606-2012; Gillgren, Peter/AAB-4724-2020; Bamford, John/ABE-6218-2021; Baker, Daryll M/ABF-7763-2021; hamilton, george/K-4764-2013; Soulez, Gilles/F-2834-2013; Mendelow, Alexander/AAW-2878-2021; moss, jon george/GWN-0387-2022; Vanhooren, Geert/H-4433-2011; Beiles, C Barry/I-2322-2019; Skjelland, Mona/Q-4674-2017	Bonati, Leo/0000-0003-1163-8133; Halliday, Alison/0000-0001-9828-3579; Peeters, Anna/0000-0003-4340-9132; Van Schil, Paul/0000-0002-1962-8821; Ijäs, Petra/0000-0002-7292-1971; Morgan, Robert Anthony/0000-0002-8108-5258; Mali, Willem PThM/0000-0003-4391-0904; Jones, Lyn I L/0000-0001-7439-7037; Hirt, Lorenz/0000-0002-2921-5000; Blankensteijn, Jan D/0000-0002-2062-8749; Ford, Gary/0000-0001-8719-4968; Gillgren, Peter/0000-0003-0538-3496; Vanhooren, Geert/0000-0001-6818-9346; Beiles, C Barry/0000-0001-5026-1661; Wahlgren, Carl Magnus/0000-0002-9619-3577; soulez, gilles/0000-0002-5566-3552; weill, alain/0000-0002-0281-6201; McCabe, Dominick J.H./0000-0003-0493-4516; San Roman, Luis/0000-0003-0735-4373; Czlonkowska, Anna/0000-0002-1956-1866; Engelter, Stefan/0000-0003-3855-6234; Skjelland, Mona/0000-0001-7950-4882; Zeilstra, Dick/0000-0001-7770-9913; Krohg-Sorensen, Kirsten/0000-0002-5713-809X; Guilbert, Francois/0000-0002-7866-0493; Malmstedt, Jonas/0000-0002-2758-9623; Hendriks, Jeroen/0000-0001-9145-3643; Halloul, Zuhir/0000-0003-2783-0453; Kaste, Markku/0000-0001-6557-6412; Skalej, Martin/0000-0001-9506-619X; Bonvin, Christophe/0000-0002-9058-8105; lovblad, karl-olof/0000-0003-2768-9779; Cloud, Geoffrey/0000-0002-8365-6907; Baker, Daryll/0000-0002-0098-405X; Sairanen, Tiina/0000-0002-2923-7445; Crowe, Philip/0000-0002-0927-3721; Donnan, Geoffrey/0000-0001-6324-3403; Tibballs, Jonathan/0000-0001-6562-3434; Schultz, David/0000-0001-6319-7574; GIMENEZ-GAIBAR, ANTONIO/0000-0002-1837-4989; Yan, Bernard/0000-0001-8802-9606; McGahan, Tim/0000-0003-2935-3072; Wyatt, Michael G/0000-0002-9144-4437; Gibbs, Richard/0000-0002-5421-9521; Brown, Martin M/0000-0002-3273-1356; Stansby, Gerard/0000-0001-5539-3049; Macho Fernandez, Juan Miguel/0000-0002-8417-7094	Gore Medical; Medical Research Council; Stroke Association; Sanofi-Synthelabo; European Union; Reta Lila Weston Trust for Medical Research; Swiss National Science Foundation [PBBSB-116873]; University of Basel; Department of Health's National Institute for Health Research Biomedical Research Centres; Medical Research Council [G0300411] Funding Source: researchfish; National Institute for Health Research [06/301/233, NF-SI-0507-10339] Funding Source: researchfish; MRC [G0300411] Funding Source: UKRI	Gore Medical; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Sanofi-Synthelabo; European Union(European Commission); Reta Lila Weston Trust for Medical Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PG holds a research grant from Gore Medical and has a consultant and proctorship agreement with Boston Scientific. SM holds consultancy agreements with CR Bard and WL Gore. All other authors have no relevant conflicts of interest to declare.; This study was funded by grants from the Medical Research Council, the Stroke Association, Sanofi-Synthelabo, and the European Union. MMB's Chair in Stroke Medicine is supported by the Reta Lila Weston Trust for Medical Research. JE and RLF are supported by a grant from Medical Research Council. LHB was supported by grants from the Swiss National Science Foundation (PBBSB-116873) and the University of Basel. This work was undertaken at University College London Hospital/University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme.	Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bonati LH, 2009, LANCET NEUROL, V8, P908, DOI 10.1016/S1474-4422(09)70227-3; Bond R, 2005, CEREBROVASC DIS, V20, P69, DOI 10.1159/000086509; Brown MM, 2001, LANCET, V357, P1729; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Ederle J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000515.pub3; Ederle J, 2009, LANCET NEUROL, V8, P898, DOI 10.1016/S1474-4422(09)70228-5; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Featherstone RL, 2004, CEREBROVASC DIS, V18, P69, DOI 10.1159/000078753; Laaksovirta Hannu, LANCET NEUROL, V9, P978, DOI [10.1016/S1474-4422(10)70184-8, DOI 10.1016/S1474-4422(10)70184-8, DOI 10.1016/S1474-4422(21)00252-0]; Lal BK, 2009, J VASC SURG, V50, P1224, DOI 10.1016/j.jvs.2009.09.003; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rothwell PM, 1997, BMJ-BRIT MED J, V315, P1571, DOI 10.1136/bmj.315.7122.1571; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	19	897	937	0	117	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					985	997		10.1016/S0140-6736(10)60239-5	http://dx.doi.org/10.1016/S0140-6736(10)60239-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20189239	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000276110700031
J	Poulikakos, PI; Zhang, C; Bollag, G; Shokat, KM; Rosen, N				Poulikakos, Poulikos I.; Zhang, Chao; Bollag, Gideon; Shokat, Kevan M.; Rosen, Neal			RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF	NATURE			English	Article							KINASE INHIBITOR; SELECTIVE INHIBITOR; ONCOGENIC BRAF; B-RAF; ACTIVATION; MECHANISM; CRAF; HETERODIMERIZATION; SENSITIVITY; MELANOMA	Tumours with mutant BRAF are dependent on the RAF-MEK-ERK signalling pathway for their growth(1-3). We found that ATP-competitive RAF inhibitors inhibit ERK signalling in cells with mutant BRAF, but unexpectedly enhance signalling in cells with wild-type BRAF. Here we demonstrate the mechanistic basis for these findings. We used chemical genetic methods to show that drug-mediated transactivation of RAF dimers is responsible for paradoxical activation of the enzyme by inhibitors. Induction of ERK signalling requires direct binding of the drug to the ATP-binding site of one kinase of the dimer and is dependent on RAS activity. Drug binding to one member of RAF homodimers (CRAF-CRAF) or heterodimers (CRAF-BRAF) inhibits one protomer, but results in transactivation of the drug-free protomer. In BRAF(V600E) tumours, RAS is not activated, thus transactivation is minimal and ERK signalling is inhibited in cells exposed to RAF inhibitors. These results indicate that RAF inhibitors will be effective in tumours in which BRAF is mutated. Furthermore, because RAF inhibitors do not inhibit ERK signalling in other cells, the model predicts that they would have a higher therapeutic index and greater antitumour activity than mitogen-activated protein kinase (MEK) inhibitors, but could also cause toxicity due to MEK/ERK activation. These predictions have been borne out in a recent clinical trial of the RAF inhibitor PLX4032 (refs 4, 5). The model indicates that promotion of RAF dimerization by elevation of wild-type RAF expression or RAS activity could lead to drug resistance in mutant BRAF tumours. In agreement with this prediction, RAF inhibitors do not inhibit ERK signalling in cells that coexpress BRAF(V600E) and mutant RAS.	[Poulikakos, Poulikos I.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA; [Poulikakos, Poulikos I.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Bollag, Gideon] Plexxikon Inc, Berkeley, CA 94710 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Plexxikon	Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA.	rosenn@mskcc.org	Rosen, Neal/ABF-2677-2020		Melanoma Research Alliance; Starr Cancer Consortium; NIH/NCI [1P01CA129243-02]; Joan's Legacy: United Against Lung Cancer Foundation; NIH [2R01EB001987]; The Children's Tumor Foundation; Waxman Foundation; NATIONAL CANCER INSTITUTE [P01CA129243, U01CA091178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER	Melanoma Research Alliance; Starr Cancer Consortium; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Joan's Legacy: United Against Lung Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Children's Tumor Foundation; Waxman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We are grateful to W. Kolch for the BRAF plasmids and M. Baccarini for the RAF knockout MEFs. We thank J. Blair for synthesis of JAB compounds and A. Dar, S. Chandarlapaty and D. Solit for discussions. This work has been funded by the Melanoma Research Alliance, the Starr Cancer Consortium, an NIH/NCI P01 grant (1P01CA129243-02) and by Joan's Legacy: United Against Lung Cancer Foundation ( P. I. P., N. R.). K. M. S. would like to thank NIH-2R01EB001987, The Children's Tumor Foundation and the Waxman Foundation for funding.	Bankston D, 2002, ORG PROCESS RES DEV, V6, P777, DOI 10.1021/op020205n; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chapman P, 2009, EJC SUPPL, V7, P5, DOI 10.1016/S1359-6349(09)72036-1; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Dummer R, 2008, J CLIN ONCOL S, V26; FLAHERTY K, 2009, J CLIN ONCOL S, V27, pNIL18; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun Y, 1999, ANTICANCER RES, V19, P919; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	26	1308	1353	1	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					427	U126		10.1038/nature08902	http://dx.doi.org/10.1038/nature08902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20179705	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000275657100050
J	De Backer, D; Biston, P; Devriendt, J; Madl, C; Chochrad, D; Aldecoa, C; Brasseur, A; Defrance, P; Gottignies, P; Vincent, J				De Backer, Daniel; Biston, Patrick; Devriendt, Jacques; Madl, Christian; Chochrad, Didier; Aldecoa, Cesar; Brasseur, Alexandre; Defrance, Pierre; Gottignies, Philippe; Vincent, Jean-Louis		SOAP II Investigators	Comparison of Dopamine and Norepinephrine in the Treatment of Shock.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEPTIC SHOCK; SEVERE SEPSIS; EPINEPHRINE; MANAGEMENT; MORTALITY; SEVERITY	Background: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. Methods: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0.19 microg per kilogram per minute for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added. The primary outcome was the rate of death at 28 days after randomization; secondary end points included the number of days without need for organ support and the occurrence of adverse events. Results: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine. The baseline characteristics of the groups were similar. There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42; P=0.10). However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%], P<0.001). A subgroup analysis showed that dopamine, as compared with norepinephrine, was associated with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock (P=0.03 for cardiogenic shock, P=0.19 for septic shock, and P=0.84 for hypovolemic shock, in Kaplan-Meier analyses). Conclusions: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events. (ClinicalTrials.gov number, NCT00314704.) N Engl J Med 2010;362:779-89.	[De Backer, Daniel; Brasseur, Alexandre; Vincent, Jean-Louis] Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium; [Devriendt, Jacques; Gottignies, Philippe] Univ Libre Bruxelles, Brugmann Univ Hosp, Dept Intens Care, Brussels, Belgium; [Chochrad, Didier] Ctr Hosp Etterbeek Ixelles, Dept Intens Care, Brussels, Belgium; [Biston, Patrick; Defrance, Pierre] Ctr Hosp Univ Charleroi, Dept Intens Care, Charleroi, Belgium; [Madl, Christian] Med Univ Vienna, Dept Med 3, Intens Care Unit 13H1, Vienna, Austria; [Aldecoa, Cesar] Rio Hortega Univ Hosp, Dept Anesthesia & Crit Care, Valladolid, Spain	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Medical University of Vienna; Hospital del Rio Hortega	De Backer, D (corresponding author), Erasme Univ Hosp, Dept Intens Care, Rte Lennik 808, B-1070 Brussels, Belgium.		De Backer, Daniel/AAF-4177-2020; Aldecoa, Cesar/G-6779-2016	De Backer, Daniel/0000-0001-9841-5762; Aldecoa, Cesar/0000-0001-9096-0387; Vincent, Jean-Louis/0000-0001-6011-6951; Aldecoa, Cesar/0000-0001-8789-5959; MELOT, Christian/0000-0002-6172-0330; Devriendt, Jacques/0000-0002-9899-2866	European Society of Intensive Care; European Critical Care Research Network	European Society of Intensive Care; European Critical Care Research Network	Supported in part by the European Society of Intensive Care through support from the European Critical Care Research Network	Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; [Anonymous], 1999, Crit Care Med, V27, P639; Antman EM, 2007, CIRCULATION, V115, pE411, DOI 10.1161/CIRCULATIONAHA.107.183508; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antman EM, 2005, CIRCULATION, V111, P2013; Beale Richard J, 2004, Crit Care Med, V32, pS455, DOI 10.1097/01.CCM.0000142909.86238.B1; Bertorello AM, 2005, AM J RESP CELL MOL, V33, P432, DOI 10.1165/rcmb.2005-0297TR; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Boulain T, 2009, J CRIT CARE, V24, P575, DOI 10.1016/j.jcrc.2008.11.003; De Backer D, 2003, CRIT CARE MED, V31, P1659, DOI 10.1097/01.CCM.0000063045.77339.B6; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy B, 2005, CRIT CARE MED, V33, P2172, DOI 10.1097/01.CCM.0000181297.14319.3C; LOEB HS, 1971, CIRCULATION, V44, P163, DOI 10.1161/01.CIR.44.2.163; Marchick MR, 2009, INTENS CARE MED, V35, P1261, DOI 10.1007/s00134-009-1448-x; MARIK PE, 1994, JAMA-J AM MED ASSOC, V272, P1354, DOI 10.1001/jama.272.17.1354; Martin C, 2000, CRIT CARE MED, V28, P2758, DOI 10.1097/00003246-200008000-00012; MULLNER M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003709.PUB2; Povoa PR, 2009, CRIT CARE MED, V37, P410, DOI 10.1097/CCM.0b013e3181958b1c; Sakr Y, 2006, CRIT CARE MED, V34, P589, DOI 10.1097/01.CCM.0000201896.45809.E3; Ungar A, 2004, CRIT CARE MED, V32, P1125, DOI 10.1097/01.CCM.0000124871.58281.D1; VandenBerghe G, 1996, CRIT CARE MED, V24, P1580, DOI 10.1097/00003246-199609000-00024; Varpula M, 2005, INTENS CARE MED, V31, P1066, DOI 10.1007/s00134-005-2688-z; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Whitehead J, 2000, DESIGN ANAL SEQUENTI; WINSLOW EJ, 1973, AM J MED, V54, P421, DOI 10.1016/0002-9343(73)90038-7	30	983	1022	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					779	789		10.1056/NEJMoa0907118	http://dx.doi.org/10.1056/NEJMoa0907118			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	20200382				2022-12-28	WOS:000275108300005
J	Gershenfeld, N; Samouhos, S; Nordman, B				Gershenfeld, Neil; Samouhos, Stephen; Nordman, Bruce			Intelligent Infrastructure for Energy Efficiency	SCIENCE			English	Editorial Material							SYSTEMS; DESIGN		[Gershenfeld, Neil; Samouhos, Stephen] MIT, Ctr Bits & Atoms, Cambridge, MA 02138 USA; [Nordman, Bruce] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Gershenfeld, N (corresponding author), MIT, Ctr Bits & Atoms, Cambridge, MA 02138 USA.	gersh@cba.mit.edu; bnordman@lbl.gov; stratos@mit.edu						Brambley MR, 2005, ADV SENSORS CONTROLS; Gershenfeld N, 2004, SCI AM, V291, P76, DOI 10.1038/scientificamerican1004-76; GERSHENFELD N, 2010, POPL 10; Gershenfeld N, 2006, IEEE CIRCUITS DEVICE, V22, P48, DOI 10.1109/MCD.2006.273000; KOPP D, 2009, COMMUNICATION; Krarti M, 2003, J SOL ENERG-T ASME, V125, P331, DOI 10.1115/1.1592186; Langbort C, 2004, IEEE T AUTOMAT CONTR, V49, P1502, DOI 10.1109/TAC.2004.834123; Postel Jon, 1981, 791 RFC; RAHIMI A, 2004, P 8 EUR C COMP VIS W; Roth Kurl W., 2005, ENERGY IMPACT COMMER; SALTZER JH, 1984, ACM T COMPUT SYST, V2, P277, DOI 10.1145/357401.357402; SUN A, UNPUB; U.S. Dept. of Energy, 2009, BUILD EN DAT BOOK	13	38	38	4	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1086	1088		10.1126/science.1174082	http://dx.doi.org/10.1126/science.1174082			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185713				2022-12-28	WOS:000274901100020
J	Southwell, DG; Froemke, RC; Alvarez-Buylla, A; Stryker, MP; Gandhi, SP				Southwell, Derek G.; Froemke, Robert C.; Alvarez-Buylla, Arturo; Stryker, Michael P.; Gandhi, Sunil P.			Cortical Plasticity Induced by Inhibitory Neuron Transplantation	SCIENCE			English	Article							FLUORESCENT PROTEIN EXPRESSION; OCULAR DOMINANCE PLASTICITY; DEVELOPING VISUAL-CORTEX; CRITICAL-PERIOD; GANGLIONIC EMINENCE; BASAL FOREBRAIN; ES CELLS; MOUSE; ADULT; BRAIN	Critical periods are times of pronounced brain plasticity. During a critical period in the postnatal development of the visual cortex, the occlusion of one eye triggers a rapid reorganization of neuronal responses, a process known as ocular dominance plasticity. We have shown that the transplantation of inhibitory neurons induces ocular dominance plasticity after the critical period. Transplanted inhibitory neurons receive excitatory synapses, make inhibitory synapses onto host cortical neurons, and promote plasticity when they reach a cellular age equivalent to that of endogenous inhibitory neurons during the normal critical period. These findings suggest that ocular dominance plasticity is regulated by the execution of a maturational program intrinsic to inhibitory neurons. By inducing plasticity, inhibitory neuron transplantation may facilitate brain repair.	[Southwell, Derek G.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Southwell, Derek G.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Froemke, Robert C.] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; [Stryker, Michael P.; Gandhi, Sunil P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 513 Parnassus Ave, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu; stryker@phy.ucsf.edu; sunil@phy.ucsf.edu		Alvarez-Buylla, Arturo/0000-0003-4426-8925; Froemke, Robert/0000-0002-1230-6811; Southwell, Derek/0000-0001-6465-3869; Stryker, Michael/0000-0003-1546-5831	National Institutes of Health [R01 NS048528, P50 MH077972, EY016317]; Dana Foundation [P0001351]; Adelson Medical Research Foundation; California Institute for Regenerative Medicine; NIDCD [K99/R00]; NATIONAL EYE INSTITUTE [F32EY016317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Adelson Medical Research Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kriegstein, P. Parker, and members of the Kriegstein laboratory for help with the electrophysiological recordings, R. Romero for assistance with histology, and P. McQuillen for sharing histology equipment. This work was funded by grants R01 NS048528 (A.A.-B.) and P50 MH077972 (M. P. S.) from the National Institutes of Health, grant P0001351 from the Dana Foundation (M. P. S.), and a grant from the Adelson Medical Research Foundation (M. P. S.). D. G. S. was supported by a predoctoral training grant from the California Institute for Regenerative Medicine. S. P. G. was supported by postdoctoral fellowship EY016317 from the National Institutes of Health. R. C. F. is a recipient of a NIDCD K99/R00 Career Award.	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	26	200	202	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1145	1148		10.1126/science.1183962	http://dx.doi.org/10.1126/science.1183962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185728	Green Accepted			2022-12-28	WOS:000274901100041
J	Han, JY; Yuan, P; Yang, H; Zhang, JQ; Soh, BS; Li, P; Lim, SL; Cao, SY; Tay, JL; Orlov, YL; Lufkin, T; Ng, HH; Tam, WL; Lim, B				Han, Jianyong; Yuan, Ping; Yang, Henry; Zhang, Jinqiu; Soh, Boon Seng; Li, Pin; Lim, Siew Lan; Cao, Suying; Tay, Junliang; Orlov, Yuriy L.; Lufkin, Thomas; Ng, Huck-Hui; Tam, Wai-Leong; Lim, Bing			Tbx3 improves the germ-line competency of induced pluripotent stem cells	NATURE			English	Article							SELF-RENEWAL; FIBROBLASTS; INDUCTION; NANOG; NETWORK; OCT4	Induced pluripotent stem (iPS) cells can be obtained by the introduction of defined factors into somatic cells(1). The combination of Oct4 (also known as Pou5f1), Sox2 and Klf4 (which we term OSK) constitutes the minimal requirement for generating iPS cells from mouse embryonic fibroblasts. These cells are thought to resemble embryonic stem cells (ESCs) on the basis of global gene expression analyses; however, few studies have tested the ability and efficiency of iPS cells to contribute to chimaerism, colonization of germ tissues, and most importantly, germ-line transmission and live birth from iPS cells produced by tetraploid complementation. Using genomic analyses of ESC genes that have roles in pluripotency and fusion-mediated somatic cell reprogramming, here we show that the transcription factor Tbx3 significantly improves the quality of iPS cells. iPS cells generated with OSK and Tbx3 (OSKT) are superior in both germ-cell contribution to the gonads and germline transmission frequency. However, global gene expression profiling could not distinguish between OSK and OSKT iPS cells. Genome-wide chromatin immunoprecipitation sequencing analysis of Tbx3-binding sites in ESCs suggests that Tbx3 regulates pluripotency-associated and reprogramming factors, in addition to sharing many common downstream regulatory targets with Oct4, Sox2, Nanog and Smad1. This study underscores the intrinsic qualitative differences between iPS cells generated by different methods, and highlights the need to rigorously characterize iPS cells beyond in vitro studies.	[Han, Jianyong; Yuan, Ping; Zhang, Jinqiu; Soh, Boon Seng; Li, Pin; Lim, Siew Lan; Cao, Suying; Tay, Junliang; Lufkin, Thomas; Ng, Huck-Hui; Tam, Wai-Leong; Lim, Bing] Stem Cell Dev Biol, Singapore 138648, Singapore; [Orlov, Yuriy L.] Genome Inst Singapore, Syst Biol, Singapore 138648, Singapore; [Han, Jianyong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Yang, Henry] Singapore Immunol Network, Singapore 138648, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lim, Bing] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); China Agricultural University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tam, WL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	tamwl@wi.mit.edu; limb1@gis.a-star.edu.sg	Orlov, Yuriy L/F-1520-2013; Ng, Huck Hui/A-1135-2009; Tam, Wai Leong/P-1497-2019; Lufkin, Thomas/B-5352-2011; Lufkin, Thomas/AAG-7476-2019	Orlov, Yuriy L/0000-0003-0587-1609; Tam, Wai Leong/0000-0003-2365-5264; Lufkin, Thomas/0000-0002-7902-4771; Lufkin, Thomas/0000-0002-7902-4771; Yuan, Ping/0000-0001-7243-3487; NG, HUCK HUI/0000-0001-6352-8417	Agency for Science, Technology and Research (Singapore); Singapore Stem Cell Consortium [SSCC-06-003]; National Institutes of Health (NIH) [DK047636, AI54973]; A*STAR Post-doctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR Post-doctoral Fellowship(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the Agency for Science, Technology and Research (Singapore) and the Singapore Stem Cell Consortium grant (SSCC-06-003). The work is also partially supported by National Institutes of Health (NIH) grants to B. L. (DK047636 and AI54973). W.-L. T. is supported by the A*STAR Post-doctoral Fellowship. We acknowledge the Genome Technology and Biology group for technical support. We are grateful to T. Huber, P. Robson and L. Stanton for critical comments, V. Cacheux-Rataboul for karyotype analyses, Y. Loon Lee, P. Gaughwin and colleagues from the Stem Cell and Developmental Biology group for technical assistance. We also thank T. Wakayama and N. Li for imparting mouse embryo manipulation techniques.	Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Eakin GS, 2006, NAT PROTOC, V1, P1145, DOI 10.1038/nprot.2006.173; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ohta H, 2008, BIOL REPROD, V79, P486, DOI 10.1095/biolreprod.107.067116; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	25	213	254	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1096	+		10.1038/nature08735	http://dx.doi.org/10.1038/nature08735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20139965	Green Accepted			2022-12-28	WOS:000275108400040
J	Iglehart, JK				Iglehart, John K.			Throwing Down the Gauntlet - Televised, Bipartisan Health Care Discussions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		TRUFFER CJ, HLTH AFFAIRS	1	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8								10.1056/NEJMp1001644	http://dx.doi.org/10.1056/NEJMp1001644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559SA	20147706				2022-12-28	WOS:000274845600004
J	Kang, C; Riazuddin, S; Mundorff, J; Krasnewich, D; Friedman, P; Mullikin, JC; Drayna, D				Kang, Changsoo; Riazuddin, Sheikh; Mundorff, Jennifer; Krasnewich, Donna; Friedman, Penelope; Mullikin, James C.; Drayna, Dennis			Mutations in the Lysosomal Enzyme-Targeting Pathway and Persistent Stuttering	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PSEUDO-HURLER POLYDYSTROPHY; I-CELL DISEASE; MUCOLIPIDOSIS-III; GENE; LINKAGE; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; PHENOTYPE; ETIOLOGY; SAMPLE	BACKGROUND Stuttering is a disorder of unknown cause characterized by repetitions, prolongations, and interruptions in the flow of speech. Genetic factors have been implicated in this disorder, and previous studies of stuttering have identified linkage to markers on chromosome 12. METHODS We analyzed the chromosome 12q23.3 genomic region in consanguineous Pakistani families, some members of which had nonsyndromic stuttering and in unrelated case and control subjects from Pakistan and North America. RESULTS We identified a missense mutation in the N-acetylglucosamine-1-phosphate transferase gene (GNPTAB), which encodes the alpha and beta catalytic subunits of GlcNAc-phosphotransferase (GNPT [EC 2.7.8.15]), that was associated with stuttering in a large, consanguineous Pakistani family. This mutation occurred in the affected members of approximately 10% of Pakistani families studied, but it occurred only once in 192 chromosomes from unaffected, unrelated Pakistani control subjects and was not observed in 552 chromosomes from unaffected, unrelated North American control subjects. This and three other mutations in GNPTAB occurred in unrelated subjects with stuttering but not in control subjects. We also identified three mutations in the GNPTG gene, which encodes the gamma subunit of GNPT, in affected subjects of Asian and European descent but not in control subjects. Furthermore, we identified three mutations in the NAGPA gene, which encodes the so-called uncovering enzyme, in other affected subjects but not in control subjects. These genes encode enzymes that generate the mannose-6-phosphate signal, which directs a diverse group of hydrolases to the lysosome. Deficits in this system are associated with the mucolipidoses, rare lysosomal storage disorders that are most commonly associated with bone, connective tissue, and neurologic symptoms. CONCLUSIONS Susceptibility to nonsyndromic stuttering is associated with variations in genes governing lysosomal metabolism.	[Kang, Changsoo; Drayna, Dennis] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA; [Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Friedman, Penelope] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Riazuddin, Sheikh] Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; [Mundorff, Jennifer] Hollins Commun Res Inst, Roanoke, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Punjab	Drayna, D (corresponding author), 5 Res Ct,Rm 2B-46, Rockville, MD 20850 USA.	drayna@nidcd.nih.gov	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022		National Institute on Deafness and Other Communication Disorders [Z01-000046-09]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000046] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by grants from the Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (Z01-000046-09, to Dr. Drayna) and the National Human Genome Research Institute (to Dr. Mullikin).	ANDREWS G, 1991, ARCH GEN PSYCHIAT, V48, P1034; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Bargal R, 2007, MOL GENET METAB, V91, P299, DOI 10.1016/j.ymgme.2007.04.007; Bargal R, 2006, MOL GENET METAB, V88, P359, DOI 10.1016/j.ymgme.2006.03.003; BLOODSTEIN O, 1961, J SPEECH HEAR DISORD, V26, P395, DOI 10.1044/jshd.2604.395; Bloodstein O., 2008, HDB STUTTERING; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dworzynski K, 2007, AM J SPEECH-LANG PAT, V16, P169, DOI 10.1044/1058-0360(2007/021); Felsenfeld S, 2000, BEHAV GENET, V30, P359, DOI 10.1023/A:1002765620208; Felsenfeld S, 1997, J SPEECH LANG HEAR R, V40, P778, DOI 10.1044/jslhr.4004.778; HOWIE PM, 1981, J SPEECH HEAR RES, V24, P317, DOI 10.1044/jshr.2403.317; KORNFELD S, 2001, METABOLIC MOL BASES, V3, P3469; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; LEROY JG, GENEREVIEWS; MCFARLANE WB, 1991, J FLUENCY DISORD, V16, P117; Ooki S, 2005, TWIN RES HUM GENET, V8, P69, DOI 10.1375/twin.8.1.69; Otomo T, 2009, J HUM GENET, V54, P145, DOI 10.1038/jhg.2009.3; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Raas-Rothschild A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015222; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; Riaz N, 2005, AM J HUM GENET, V76, P647, DOI 10.1086/429226; Riley G., 1994, STUTTERING SEVERITY; Shugart YY, 2004, AM J MED GENET A, V124A, P133, DOI 10.1002/ajmg.a.20347; Smuts I, 2009, ANN NY ACAD SCI, V1151, P77, DOI 10.1111/j.1749-6632.2008.03451.x; Suresh R, 2006, AM J HUM GENET, V78, P554, DOI 10.1086/501370; Tiede S, 2005, AM J MED GENET A, V137A, P235, DOI 10.1002/ajmg.a.30868; Viswanath N, 2004, HUM BIOL, V76, P401, DOI 10.1353/hub.2004.0050; Webster R. L., 1979, CONTROVERSIES STUTTE, P209; Wittke-Thompson JK, 2007, J FLUENCY DISORD, V32, P33, DOI 10.1016/j.jfludis.2006.12.002; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097	31	120	135	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					677	685		10.1056/NEJMoa0902630	http://dx.doi.org/10.1056/NEJMoa0902630			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20147709	Green Accepted			2022-12-28	WOS:000274845600006
J	Nguyen, GC; Yeo, EL				Nguyen, Geoffrey C.; Yeo, Erik L.			Prophylaxis of venous thromboembolism in IBD	LANCET			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; METAANALYSIS		[Nguyen, Geoffrey C.] Univ Toronto, Mt Sinai Hosp, Ctr Inflammatory Bowel Dis, Toronto, ON M5G 1X5, Canada; [Nguyen, Geoffrey C.] Johns Hopkins Div Gastroenterol & Hepatol, Baltimore, MD USA; [Yeo, Erik L.] Univ Toronto, Univ Hlth Network, Thrombosis Clin, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Johns Hopkins University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Nguyen, GC (corresponding author), Univ Toronto, Mt Sinai Hosp, Ctr Inflammatory Bowel Dis, Toronto, ON M5G 1X5, Canada.	geoff.nguyen@utoronto.ca	Nguyen, Geoffrey C/C-4614-2015	Nguyen, Geoffrey C/0000-0001-7083-7429				Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Nguyen GC, 2008, AM J GASTROENTEROL, V103, P2272, DOI 10.1111/j.1572-0241.2008.02052.x; Shen J, 2007, ALIMENT PHARM THER, V26, P653, DOI 10.1111/j.1365-2036.2007.03418.x; Solem CA, 2004, AM J GASTROENTEROL, V99, P97, DOI 10.1046/j.1572-0241.2003.04026.x; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X	11	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					616	617		10.1016/S0140-6736(10)60174-2	http://dx.doi.org/10.1016/S0140-6736(10)60174-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20149426				2022-12-28	WOS:000275210900006
J	Kat, L; Schipper, K; Knibbe, J; Abma, TA				Kat, Linda; Schipper, Karen; Knibbe, Jeroen; Abma, Tineke A.			A Patient's Journey Acquired brain injury	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kat, Linda; Schipper, Karen; Knibbe, Jeroen] Reinaerde, Amsterdam, Netherlands; [Schipper, Karen; Abma, Tineke A.] Vrije Univ Amsterdam Med Ctr, Dept Med Humanities, EMGO Inst, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Schipper, K (corresponding author), Reinaerde, Amsterdam, Netherlands.	k.schipper@vumc.nl	Abma, Tineke/AER-4580-2022	Abma, Tineke/0000-0002-8902-322X					0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2010	340								c808	10.1136/bmj.c808	http://dx.doi.org/10.1136/bmj.c808			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JX	20172926				2022-12-28	WOS:000274739200010
J	Rasmussen, M; Li, YR; Lindgreen, S; Pedersen, JS; Albrechtsen, A; Moltke, I; Metspalu, M; Metspalu, E; Kivisild, T; Gupta, R; Bertalan, M; Nielsen, K; Gilbert, MTP; Wang, Y; Raghavan, M; Campos, PF; Kamp, HM; Wilson, AS; Gledhill, A; Tridico, S; Bunce, M; Lorenzen, ED; Binladen, J; Guo, XS; Zhao, J; Zhang, XQ; Zhang, H; Li, Z; Chen, MF; Orlando, L; Kristiansen, K; Bak, M; Tommerup, N; Bendixen, C; Pierre, TL; Gronnow, B; Meldgaard, M; Andreasen, C; Fedorova, SA; Osipova, LP; Higham, TFG; Ramsey, CB; Hansen, TVO; Nielsen, FC; Crawford, MH; Brunak, S; Sicheritz-Ponten, T; Villems, R; Nielsen, R; Krogh, A; Wang, J; Willerslev, E				Rasmussen, Morten; Li, Yingrui; Lindgreen, Stinus; Pedersen, Jakob Skou; Albrechtsen, Anders; Moltke, Ida; Metspalu, Mait; Metspalu, Ene; Kivisild, Toomas; Gupta, Ramneek; Bertalan, Marcelo; Nielsen, Kasper; Gilbert, M. Thomas P.; Wang, Yong; Raghavan, Maanasa; Campos, Paula F.; Kamp, Hanne Munkholm; Wilson, Andrew S.; Gledhill, Andrew; Tridico, Silvana; Bunce, Michael; Lorenzen, Eline D.; Binladen, Jonas; Guo, Xiaosen; Zhao, Jing; Zhang, Xiuqing; Zhang, Hao; Li, Zhuo; Chen, Minfeng; Orlando, Ludovic; Kristiansen, Karsten; Bak, Mads; Tommerup, Niels; Bendixen, Christian; Pierre, Tracey L.; Gronnow, Bjarne; Meldgaard, Morten; Andreasen, Claus; Fedorova, Sardana A.; Osipova, Ludmila P.; Higham, Thomas F. G.; Ramsey, Christopher Bronk; Hansen, Thomas V. O.; Nielsen, Finn C.; Crawford, Michael H.; Brunak, Soren; Sicheritz-Ponten, Thomas; Villems, Richard; Nielsen, Rasmus; Krogh, Anders; Wang, Jun; Willerslev, Eske			Ancient human genome sequence of an extinct Palaeo-Eskimo	NATURE			English	Article							DNA; POLYMORPHISMS; DETERMINANT; RESOLUTION; COLOR; GENE	We report here the genome sequence of an ancient human. Obtained from similar to 4,000-year-old permafrost-preserved hair, the genome represents a male individual from the first known culture to settle in Greenland. Sequenced to an average depth of 20X, we recover 79% of the diploid genome, an amount close to the practical limit of current sequencing technologies. We identify 353,151 high-confidence single-nucleotide polymorphisms (SNPs), of which 6.8% have not been reported previously. We estimate raw read contamination to be no higher than 0.8%. We use functional SNP assessment to assign possible phenotypic characteristics of the individual that belonged to a culture whose location has yielded only trace human remains. We compare the high-confidence SNPs to those of contemporary populations to find the populations most closely related to the individual. This provides evidence for a migration from Siberia into the New World some 5,500 years ago, independent of that giving rise to the modern Native Americans and Inuit.	[Rasmussen, Morten; Lindgreen, Stinus; Gilbert, M. Thomas P.; Raghavan, Maanasa; Campos, Paula F.; Kamp, Hanne Munkholm; Lorenzen, Eline D.; Binladen, Jonas; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-2100 Copenhagen, Denmark; [Rasmussen, Morten; Lindgreen, Stinus; Gilbert, M. Thomas P.; Raghavan, Maanasa; Campos, Paula F.; Kamp, Hanne Munkholm; Lorenzen, Eline D.; Binladen, Jonas; Willerslev, Eske] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Rasmussen, Morten; Li, Yingrui; Gilbert, M. Thomas P.; Guo, Xiaosen; Zhao, Jing; Zhang, Xiuqing; Zhang, Hao; Li, Zhuo; Chen, Minfeng; Kristiansen, Karsten; Krogh, Anders; Wang, Jun; Willerslev, Eske] BGI Shenzhen, Sino Danish Genom Ctr, Shenzhen 518083, Peoples R China; [Lindgreen, Stinus; Pedersen, Jakob Skou; Albrechtsen, Anders; Moltke, Ida; Kamp, Hanne Munkholm; Kristiansen, Karsten; Nielsen, Rasmus; Krogh, Anders; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Metspalu, Mait; Metspalu, Ene; Kivisild, Toomas; Fedorova, Sardana A.; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-510101 Tartu, Estonia; [Metspalu, Mait; Metspalu, Ene; Kivisild, Toomas; Fedorova, Sardana A.; Villems, Richard] Estonian Bioctr, EE-510101 Tartu, Estonia; [Kivisild, Toomas] Univ Cambridge, Dept Biol Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Gupta, Ramneek; Bertalan, Marcelo; Nielsen, Kasper; Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Wang, Yong; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wang, Yong; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Raghavan, Maanasa; Higham, Thomas F. G.] Univ Oxford Archaeol & Hist Art Res Lab, Oxford OX1 3QY, England; [Wilson, Andrew S.; Gledhill, Andrew; Ramsey, Christopher Bronk] Univ Bradford, Sch Life Sci, Dept Archaeol Sci, Bradford BD7 1DP, W Yorkshire, England; [Tridico, Silvana] Australian Fed Police, Biol Criminalist, Weston, ACT 2611, Australia; [Tridico, Silvana; Bunce, Michael] Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Perth, WA 6150, Australia; [Orlando, Ludovic] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,INRA, F-69364 Lyon 07, France; [Bak, Mads; Tommerup, Niels] Univ Copenhagen, Dept Cellular & Mol Med, Panum Inst, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen, Denmark; [Bendixen, Christian] Aarhus Univ, Dept Genet & Biotechnol, DK-8830 Tjele, Denmark; [Pierre, Tracey L.] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3QY, England; [Gronnow, Bjarne] Natl Museum Denmark, DK-1220 Copenhagen, Denmark; [Meldgaard, Morten] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Andreasen, Claus] Greenland Natl Museum & Arch, DK-3900 Nuuk, Greenland; [Fedorova, Sardana A.] Russian Acad Med Sci, Yakut Res Ctr, Dept Mol Genet, Yakutsk 677019, Sakha, Russia; [Osipova, Ludmila P.] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Hansen, Thomas V. O.; Nielsen, Finn C.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Crawford, Michael H.] Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA; [Brunak, Soren] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Beijing Genomics Institute (BGI); University of Copenhagen; University of Tartu; Estonian Biocentre; University of Cambridge; Technical University of Denmark; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Oxford; University of Bradford; Murdoch University; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Copenhagen; Aarhus University; University of Cambridge; University of Copenhagen; Russian Academy of Medical Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Rigshospitalet; University of Copenhagen; University of Kansas; University of Copenhagen	Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Univ Pk 15, DK-2100 Copenhagen, Denmark.	wangj@genomics.org.cn; ewillerslev@snm.ku.dk	Willerslev, Eske/A-9619-2011; Tommerup, Niels/T-8776-2017; Gupta, Ramneek/G-7278-2012; Lorenzen, Eline/D-1442-2012; Kristiansen, Karsten/J-5148-2014; Fedorova, Sardana/K-5445-2017; Osipova, Ludmila P/O-6480-2014; Higham, Tom/Y-2707-2019; Albrechtsen, Anders/K-4281-2013; Lindgreen, Stinus/B-5594-2014; Gilbert, Marcus TP/A-8936-2013; Hansen, Thomas/GWZ-2858-2022; wang, yong/G-8398-2011; Kivisild, Toomas/P-5889-2017; Nielsen, Rasmus/D-4405-2009; Orlando, Ludovic/A-8932-2013; Ramsey, Christopher Bronk/AAQ-2227-2021; Pedersen, Jakob/G-3382-2012; Campos, Paula/ABF-9898-2021; Hansen, Thomas v. O./J-9361-2014; Metspalu, Mait/G-8671-2015; Li, Yingrui/K-1064-2015; Ramsey, Christopher Bronk/A-3277-2012; Campos, Paula F/B-1634-2010; Moltke, Ida/C-6158-2011; wang, yong/J-6713-2013; Pedersen, Jakob/C-4985-2009; Willerslev, Eske/AAA-5686-2019; Nielsen, Finn Cilius/AAA-4926-2020; Brunak, Soren/O-6621-2016; Krogh, Anders/M-1541-2014; Sicheritz-Ponten, Thomas/A-4325-2017; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Willerslev, Eske/0000-0002-7081-6748; Tommerup, Niels/0000-0003-2304-0112; Gupta, Ramneek/0000-0001-6841-6676; Lorenzen, Eline/0000-0002-6353-2819; Kristiansen, Karsten/0000-0002-6024-0917; Osipova, Ludmila P/0000-0001-7602-1156; Higham, Tom/0000-0002-5949-598X; Albrechtsen, Anders/0000-0001-7306-031X; Lindgreen, Stinus/0000-0001-5104-1054; Gilbert, Marcus TP/0000-0002-5805-7195; Kivisild, Toomas/0000-0002-6297-7808; Nielsen, Rasmus/0000-0003-0513-6591; Orlando, Ludovic/0000-0003-3936-1850; Ramsey, Christopher Bronk/0000-0002-8641-9309; Pedersen, Jakob/0000-0002-7236-4001; Hansen, Thomas v. O./0000-0003-4635-2653; Metspalu, Mait/0000-0003-3099-9161; Ramsey, Christopher Bronk/0000-0002-8641-9309; Campos, Paula F/0000-0003-1285-4671; Moltke, Ida/0000-0001-7052-8554; wang, yong/0000-0001-8772-7349; Raghavan, Maanasa/0000-0003-1997-0739; wilson, andrew/0000-0003-1346-937X; Fedorova, Sardana/0000-0002-6952-3868; Brunak, Soren/0000-0003-0316-5866; Bak, Mads/0000-0003-2762-1002; Nielsen, Kasper/0000-0002-5510-7767; Krogh, Anders/0000-0002-5147-6282; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Bunce, Michael/0000-0002-0302-4206	Danish National Research Foundation; Lundbeck Foundation; Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Fonden; Novo Nordisk Foundation; Estonian Science Foundation [7858]; EC DGR [205419]; EU RDF through Centre of Excellence in Genomics; Shenzhen Municipal Government; Yantian District local government of Shenzhen; National Natural Science Foundation of China [30725008]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Danish Strategic Research Council [2106-07-0021]; Australian Research Council; Danish Council for Independent Research Medical Sciences; National Science Foundation; NSF [OPP-990590, OPP-0327676]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; Lundbeck Foundation [R70-2010-6286, R24-2008-2527, R13-2007-1172] Funding Source: researchfish; Natural Environment Research Council [NRCF010002] Funding Source: researchfish; NERC [NRCF010002] Funding Source: UKRI	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Fonden(Villum Fonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Estonian Science Foundation; EC DGR; EU RDF through Centre of Excellence in Genomics; Shenzhen Municipal Government; Yantian District local government of Shenzhen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Australian Research Council(Australian Research Council); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Lundbeck Foundation(Lundbeckfonden); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Centre for Geogenetics, the Copenhagen branch of the Sino-Danish Genomic Centre and Wilhelm Johannsen Centre for Functional Genome Research were supported by Danish National Research Foundation, the Lundbeck Foundation, and the Danish Agency for Science, Technology and Innovation. Center for Biological Sequence Analysis was supported by Villum Kann Rasmussen Fonden; Center for Protein Reseaerch by the Novo Nordisk Foundation. E. W. thanks F. Paulsen for financial support to initiate the project. E. M. thanks Estonian Science Foundation for grant 7858, and R. V. EC DGR for FP7 Ecogene grant 205419 and EU RDF through Centre of Excellence in Genomics grant. J. W. thanks the Shenzhen Municipal Government, the Yantian District local government of Shenzhen, the National Natural Science Foundation of China (30725008), Ole Romer grant from the Danish Natural Science Research Council, the Solexa project (272-07-0196), and Danish Strategic Research Council (2106-07-0021). M. Bu. acknowledges the support of the Australian Research Council. A. K., S. L. and H. M. K. were supported by a grant from the Novo Nordisk Foundation and J. S. P. The Danish Council for Independent Research Medical Sciences. M. H. C. thanks the National Science Foundation for support of the Aleutian and Siberian projects through grants NSF OPP-990590 and OPP-0327676. We thank G. Hudjashov, M. Nelis, L. Anton, V. Soo, A. Wesolowska, H.-H. Staerfeldt, K. Rapacki, P. Wad Sackett, J. Li, H. Yu, Y. Huang, H. Zheng, H. Liang and T. Brand for technical help and Biobase for curation of selected phenotypes and Illumina's core facilities in Hayward, California and Chesterford, England. Use of HGMD Professional was licensed through DTV at the Technical University of Denmark.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Branicki W, 2008, J HUM GENET, V53, P966, DOI 10.1007/s10038-008-0338-3; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ellis JA, 2007, HUM GENET, V121, P451, DOI 10.1007/s00439-006-0317-8; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Handt O, 1996, AM J HUM GENET, V59, P368; Harritt RK, 1998, ETUDES INUIT STUDIES, V22, P61; Iida R, 2009, CELL BIOCHEM FUNCT, V27, P323, DOI 10.1002/cbf.1572; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Meldgaard J, 1952, AM ANTIQUITY, V17, P222, DOI 10.2307/276360; Meldgaard M., 2004, ANCIENT HARP SEAL HU; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PITULKO V, 1991, NATURE, V349, P374, DOI 10.1038/349374a0; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733	40	495	524	4	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					757	762		10.1038/nature08835	http://dx.doi.org/10.1038/nature08835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	553VG	20148029	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000274394300029
J	Hou, CH; Corces, VG				Hou, Chunhui; Corces, Victor G.			Nups Take Leave of the Nuclear Envelope to Regulate Transcription	CELL			English	Editorial Material							ORGANIZATION		[Hou, Chunhui; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	vcorces@emory.edu		Corces, Victor/0000-0001-5140-4337	NIGMS NIH HHS [R01 GM035463-25, R01 GM035463] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035463] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Hirose K, 2008, ONCOGENE, V27, P6056, DOI 10.1038/onc.2008.210; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; WATSON ML, 1959, J BIOPHYS BIOCHEM CY, V6, P147, DOI 10.1083/jcb.6.2.147	8	13	13	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					306	308		10.1016/j.cell.2010.01.036	http://dx.doi.org/10.1016/j.cell.2010.01.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144754	Bronze, Green Accepted			2022-12-28	WOS:000274297700007
J	Mathers, BM; Degenhardt, L; Ali, H; Wiessing, L; Hickman, M; Mattick, RP; Myers, B; Ambekar, A; Strathdee, SA				Mathers, Bradley M.; Degenhardt, Louisa; Ali, Hammad; Wiessing, Lucas; Hickman, Matthew; Mattick, Richard P.; Myers, Bronwyn; Ambekar, Atul; Strathdee, Steffanie A.		2009 Reference Grp UN HIV	HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage	LANCET			English	Article							SYRINGE DISTRIBUTION; USERS	Background Previous reviews have examined the existence of HIV prevention, treatment, and care services for injecting drug users (ID Us) worldwide, but they did not quantify the scale of coverage. We undertook a systematic review to estimate national, regional, and global coverage of HIV services in IDUs. Methods We did a systematic search of peer-reviewed (Medline, BioMed Central), internet, and grey-literature databases for data published in 2004 or later. A multistage process of data requests and verification was undertaken, involving UN agencies and national experts. National data were obtained for the extent of provision of the following core interventions for IDUs: needle and syringe programmes (NSPs), opioid substitution therapy (OST) and other drug treatment, HIV testing and counselling, antiretroviral therapy (ART), and condom programmes. We calculated national, regional, and global coverage of NSPs, OST, and ART on the basis of available estimates of IDU population sizes. Findings By 2009, NSPs had been implemented in 82 countries and OST in 70 countries; both interventions were available in 66 countries. Regional and national coverage varied substantially. Australasia (202 needle syringes per IDU per year) had by far the greatest rate of needle syringe distribution; Latin America and the Caribbean (0.3 needle syringes per IDU per year), Middle East and north Africa (0.5 needle syringes per IDU per year), and sub-Saharan Africa (0.1 needle syringes per IDU per year) had the lowest rates. OST coverage varied from less than or equal to one recipient per 100 IDUs in central Asia, Latin America, and sub-Saharan Africa, to very high levels in western Europe (61 recipients per 100 IDUs). The number of IDUs receiving ART varied from less than one per 100 HIV-positive IDUs (Chile, Kenya, Pakistan, Russia, and Uzbekistan) to more than 100 per 100 HIV-positive IDUs in six European countries. Worldwide, an estimated two needle syringes (range 1-4) were distributed per IDU per month, there were eight recipients (6-12) of OST per 100 IDUs, and four IDUs (range 2-18) received ART per 100 HIV-positive IDUs. Interpretation Worldwide coverage of HIV prevention, treatment, and care services in IDU populations is very low. There is an urgent need to improve coverage of these services in this at-risk population.	[Mathers, Bradley M.; Degenhardt, Louisa; Ali, Hammad; Mattick, Richard P.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [Wiessing, Lucas] European Monitoring Ctr Drugs & Drug Addict, Lisbon, Portugal; [Hickman, Matthew] Univ Bristol, Bristol, Avon, England; [Myers, Bronwyn] MRC, Alcohol & Drug Abuse Res Unit, Cape Town, South Africa; [Ambekar, Atul] All India Inst Med Sci, Natl Drug Dependence Treatment Ctr, New Delhi, India; [Ambekar, Atul] All India Inst Med Sci, Dept Psychiat, New Delhi, India; [Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, San Diego, CA 92103 USA	University of New South Wales Sydney; University of Bristol; All India Institute of Medical Sciences (AIIMS) New Delhi; National Drug Dependence Treatment Centre (NDDTC); All India Institute of Medical Sciences (AIIMS) New Delhi; University of California System; University of California San Diego	Mathers, BM (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	b.mathers@unsw.edu.au	Mathers, Bradley M/J-6118-2012; Ambekar, Atul/O-2220-2015; Degenhardt, Louisa J/D-4515-2012; Myers, Bronwyn/AAT-7788-2021; Strathdee, Steffanie A/B-9042-2009; Hickman, Matthew/Y-2400-2019	Mathers, Bradley M/0000-0003-2827-0697; Ambekar, Atul/0000-0002-1116-7741; Degenhardt, Louisa J/0000-0002-8513-2218; Myers, Bronwyn/0000-0003-0235-6716; Hickman, Matthew/0000-0001-9864-459X; Strathdee, Steffanie/0000-0002-7724-691X	UN Office on Drugs and Crime; Australian National Drug and Alcohol Research Centre, University of New South Wales; Australian National Health and Medical Research Council; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI	UN Office on Drugs and Crime; Australian National Drug and Alcohol Research Centre, University of New South Wales; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use is funded by the UN Office on Drugs and Crime. The Australian National Drug and Alcohol Research Centre, University of New South Wales, provided some funding towards the costs of this systematic review. Louisa Degenhardt is supported by an Australian National Health and Medical Research Council Senior Research Fellowship. This research was undertaken in consultation with, and with the consensus sign-off of, the 2009 members of the Reference Group to the UN on HIV and Injecting Drug Use and under the guidance of the Secretariat of the Reference Group. The following Reference Group members provided editorial comment on the manuscript: Tasnim Azim, Francisco I Bastos, Mauro Guarinieri, Adeeba Kamarulzaman, Kasia Malinowska-Sempruch, Jane C Maxwell, Pratima Murthy, Gerry Stimson, Abdalla Toufik, Mark Tyndall, and Tomas Zabransky. Linda Sigmundsdottir and Samantha Chivers provided assistance with searches of the grey literature. Muhammad Umer Rana, Christina Briegleb, Lisa Robins, and Jim Lemon provided input into data extraction and review. Anton Perkins provided technical support in developing the database and program to generate country reports. Chiara Bucello provided assistance with preparation of maps used in this report. Additionally, assistance in sourcing and verifying data was provided by over 250 individuals from various government, non-government, and research organisations around the world. These individuals are listed in webappendix pp 74-77	CALABRIA B, 2008, 293 NDARC; COOK C, GLOBAL STATE HARM RE; DEGENHARDT L, 2004, COMP QUANTIFICATION, P1109; Emmanuel F, 2009, JAIDS-J ACQ IMM DEF, V51, P85, DOI 10.1097/QAI.0b013e31819906f3; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; PALMATEER N, ADDICTION IN PRESS; Rachlis B, 2007, DRUG ALCOHOL DEPEN, V90, P107, DOI 10.1016/j.drugalcdep.2007.03.014; *SAMHSA OOAS, 2009, NSDUH REP INJ DRUG U; Saranga A, 2008, INT J DRUG POLICY, V19, pS25, DOI 10.1016/j.drugpo.2007.11.008; Tilson H, 2007, PREVENTING HIV INFEC; UNAIDS, 2008 REP GLOB AIDS E; United Nations Office on Drugs and Crime, WORLD DRUG REP 2009; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vickerman P, 2006, JAIDS-J ACQ IMM DEF, V42, P355, DOI 10.1097/01.qai.0000219788.73539.47; *WHO, UN ACC SCAL PRIOR HI; *WHO, GLOB HLTH A IN PRESS; Wiessing L, 2009, AM J PUBLIC HEALTH, V99, P1049, DOI 10.2105/AJPH.2008.141846; World Health Organization, 2009, ASS COMP TREATM PEOP; World Health Organization, RAP ADV ANT THER HIV; World Health Organization United Nations Office on Drugs and Crime Joint United Nations Programme on HIV/AIDS, 2008, TECHN GUID COUNTR SE	22	533	544	1	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					1014	1028		10.1016/S0140-6736(10)60232-2	http://dx.doi.org/10.1016/S0140-6736(10)60232-2			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20189638				2022-12-28	WOS:000276110700034
J	Pape, JW; Rouzier, V; Ford, H; Joseph, P; Johnson, WD; Fitzgerald, DW				Pape, Jean William; Rouzier, Vanessa; Ford, Henri; Joseph, Patrice; Johnson, Warren D., Jr.; Fitzgerald, Daniel W.			The GHESKIO Field Hospital and Clinics after the Earthquake in Haiti - Dispatch 3 from Port-au-Prince	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									GHESKIO Ctr, Weill Cornell Med Coll, Port au Prince, Haiti; Ctr Global Hlth, New York, NY USA; Los Angeles Childrens Hosp, Los Angeles, CA USA	Children's Hospital Los Angeles									0	23	24	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMpv1001787	http://dx.doi.org/10.1056/NEJMpv1001787			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20164476	Bronze			2022-12-28	WOS:000275365900035
J	Topisirovic, I; Sonenberg, N				Topisirovic, Ivan; Sonenberg, Nahum			Burn Out or Fade Away?	SCIENCE			English	Editorial Material							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; DROSOPHILA; AUTOPHAGY; GENES; CELLS		[Topisirovic, Ivan; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Topisirovic, Ivan; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University	Topisirovic, I (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca	Topisirovic, Ivan/A-9426-2008	Topisirovic, Ivan/0000-0002-5510-9762				Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	16	10	11	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1210	1211		10.1126/science.1187497	http://dx.doi.org/10.1126/science.1187497			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203039	Green Published			2022-12-28	WOS:000275162100025
J	Spence, D				Spence, Des			From the Frontline Bad medicine: type 2 diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material							DECLINE; DISEASE; COHORT					destwo@yahoo.co.uk						Burrows NR, 2010, DIABETES CARE, V33, P73, DOI 10.2337/dc09-0343; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Dale AC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.39582.447998.BE; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495	4	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2010	340								c1216	10.1136/bmj.c1216	http://dx.doi.org/10.1136/bmj.c1216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565FJ	20200060				2022-12-28	WOS:000275274400006
J	Hovorka, R; Allen, JM; Elleri, D; Chassin, LJ; Harris, J; Xing, DY; Kollman, C; Hovorka, T; Larsen, AMF; Nodale, M; De Palma, A; Wilinska, ME; Acerini, CL; Dunger, DB				Hovorka, Roman; Allen, Janet M.; Elleri, Daniela; Chassin, Ludovic J.; Harris, Julie; Xing, Dongyuan; Kollman, Craig; Hovorka, Tomas; Larsen, Anne Mette F.; Nodale, Marianna; De Palma, Alessandro; Wilinska, Malgorzata E.; Acerini, Carlo L.; Dunger, David B.			Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial	LANCET			English	Article							SEVERE HYPOGLYCEMIA; GLUCOSE; ROADMAP	Background Closed-loop systems link continuous glucose measurements to insulin delivery. We aimed to establish whether closed-loop insulin delivery could control overnight blood glucose in young people. Methods We undertook three randomised crossover studies in 19 patients aged 5-18 years with type 1 diabetes of duration 6.4 years (SD 4.0). We compared standard continuous subcutaneous insulin infusion and closed-loop delivery (n=13; APCam01); closed-loop delivery after rapidly and slowly absorbed meals (n=7; APCam02); and closed-loop delivery and standard treatment after exercise (n=10; APCam03). Allocation was by computer-generated random code. Participants were masked to plasma and sensor glucose. In APCam01, investigators were masked to plasma glucose. During closed-loop nights, glucose measurements were fed every 15 min into a control algorithm calculating rate of insulin infusion, and a nurse adjusted the insulin pump. During control nights, patients' standard pump settings were applied. Primary outcomes were time for which plasma glucose concentration was 3.91-8.00 mmol/L or 3.90 mmol/L or lower. Analysis was per protocol. This trial is registered, number ISRCTN18155883. Findings 17 patients were studied for 33 closed-loop and 21 continuous infusion nights. Primary outcomes did not differ significantly between treatment groups in APCam01 (12 analysed; target range, median 52% [IQR. 43-83] closed loop vs 39% [15-51] standard treatment, p=0.06; <= 3.90 mmol/L, 1% [0-7] vs 2% [0-41], p=0.13), APCam02 (six analysed; target range, rapidly 53% [48-57] vs slowly absorbed meal 55% [37-64], p=0.97; <= 3.90 mmol/L, 0% [0-4] vs 0% [0-0], p=0.16]), and APCam03 (nine analysed; target range 78% [60-92] closed loop vs 43% [25-65] control, p=0.0245, not significant at corrected level; <= 3.90 mmol/L, 10% [2-15] vs 6% [0-44], p=0.27). A secondary analysis of pooled data documented increased time in the target range (60% [51-88] vs 40% [18-61]; p=0.0022) and reduced time for which glucose concentrations were 3.90 mmol/L or lower (2.1% (0.0-10.0) vs 4.1% (0.0-42.0); p=0.0304). No events with plasma glucose concentration lower than 3.0 mmol/L were recorded during closed-loop delivery compared with nine events during standard treatment. Interpretation Closed-loop systems could reduce risk of nocturnal hypoglycaemia in children and adolescents with type 1 diabetes.	[Hovorka, Roman; Allen, Janet M.; Elleri, Daniela; Chassin, Ludovic J.; Hovorka, Tomas; Larsen, Anne Mette F.; Nodale, Marianna; De Palma, Alessandro; Wilinska, Malgorzata E.; Acerini, Carlo L.; Dunger, David B.] Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England; [Hovorka, Roman; Allen, Janet M.; Elleri, Daniela; Chassin, Ludovic J.; Harris, Julie; Larsen, Anne Mette F.; Wilinska, Malgorzata E.; Acerini, Carlo L.; Dunger, David B.] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England; [Xing, Dongyuan; Kollman, Craig] Jaeb Ctr Hlth Res, Tampa, FL USA	University of Cambridge; University of Cambridge; JAEB Center For Health Research	Hovorka, R (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Box 289,Hills Rd, Cambridge CB2 0QQ, England.	rh347@cam.ac.uk	Nodale, Marianna/AAD-6378-2019; Hovorka, Roman/O-1116-2019; Hovorka, Roman/J-4123-2016	Nodale, Marianna/0000-0002-0333-8918; Hovorka, Roman/0000-0003-2901-461X; Hovorka, Roman/0000-0003-2901-461X; Acerini, Carlo/0000-0003-2121-5871; Dunger, Professor David/0000-0002-2566-9304	Juvenile Diabetes Research Foundation [22-2006-1113, 22-2007-1801]; European Foundation for Study of Diabetes; Medical Research Council Centre for Obesity and Related Metabolic Diseases; National Institute for Health Research Cambridge Biomedical Research Centre; Addenbrooke's Wellcome Trust Clinical Research Facility; MRC [G0600717] Funding Source: UKRI; Medical Research Council [G0600717B, G0600717] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10274] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Foundation for Study of Diabetes; Medical Research Council Centre for Obesity and Related Metabolic Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Addenbrooke's Wellcome Trust Clinical Research Facility; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Juvenile Diabetes Research Foundation; European Foundation for Study of Diabetes; Medical Research Council Centre for Obesity and Related Metabolic Diseases; National Institute for Health Research Cambridge Biomedical Research Centre.; The data we obtained as part of APCam supported by Juvenile Diabetes Research Foundation (grants 22-2006-1113 and 22-2007-1801), European Foundation for Study of Diabetes, Medical Research Council Centre for Obesity and Related Metabolic Diseases, and National Institute for Health Research Cambridge Biomedical Research Centre. Smiths Medical supplied study pumps. Abbott Diabetes Care supplied Freestyle Navigator devices and sensors. Medtronic supplied Guardian RT devices and discounted sensors. Angie Watts provided laboratory support. Debbie Mundt and Jo Weston provided dietary support. Ulf Ekelund helped with designing peak VO<INF>2</INF> exercise assessment. Claire Pesterfield helped with recruitment of volunteers and paediatric diabetes nurse support. Nandu Tlialange helped with recruitment. Steve Luzio and colleagues measured plasma insulin. We thank staff at the Addenbrooke's Wellcome Trust Clinical Research Facility for their support and the study volunteers and their caregivers for their continuing support and participation.	Bequette B Wayne, 2005, Diabetes Technol Ther, V7, P28, DOI 10.1089/dia.2005.7.28; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Buckingham Bruce, 2005, Diabetes Technol Ther, V7, P440, DOI 10.1089/dia.2005.7.440; Buckingham B, 2009, DIABETES TECHNOL THE, V11, P93, DOI 10.1089/dia.2008.0032; Bulsara MK, 2004, DIABETES CARE, V27, P2293, DOI 10.2337/diacare.27.10.2293; Chassin Ludovic J, 2005, Diabetes Technol Ther, V7, P72, DOI 10.1089/dia.2005.7.72; Genuth S, 2001, J PEDIATR-US, V139, P804, DOI 10.1067/mpd.2001.118887; Gonder-Frederick L, 2008, PEDIATRICS, V121, pE489, DOI 10.1542/peds.2007-0808; Good P, 2005, PERMUTATION PARAMETR; Green A, 2000, LANCET, V355, P873; Hovorka R, 2006, DIABETIC MED, V23, P1, DOI 10.1111/j.1464-5491.2005.01672.x; Hovorka R, 2002, AM J PHYSIOL-ENDOC M, V282, pE992, DOI 10.1152/ajpendo.00304.2001; Hovorka R, 2006, DIABETES RES CLIN PR, V74, pS178, DOI 10.1016/S0168-8227(06)70027-4; Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; Kovatchev B, 2008, DIABETES CARE, V31, P1160, DOI 10.2337/dc07-2401; Kovatchev BP, 1998, DIABETES CARE, V21, P1870, DOI 10.2337/diacare.21.11.1870; LAPORTE RE, 1995, DIABETES AM, P37; Mazor E, 1998, IEEE T AERO ELEC SYS, V34, P103, DOI 10.1109/7.640267; McGarraugh G, 2009, DIABETES TECHNOL THE, V11, P145, DOI 10.1089/dia.2008.0047; McMahon SK, 2007, J CLIN ENDOCR METAB, V92, P963, DOI 10.1210/jc.2006-2263; PICKUP JC, 1978, BRIT MED J, V1, P204, DOI 10.1136/bmj.1.6107.204; Porter PA, 1997, J PEDIATR-US, V130, P366, DOI 10.1016/S0022-3476(97)70197-5; Renard E, 2006, DIABETES METAB, V32, P497, DOI 10.1016/S1262-3636(06)72802-6; Schaller HC, 2006, DIABETIC MED, V23, P90, DOI 10.1111/j.1464-5491.2006.01695.x; Steil GM, 2006, DIABETES, V55, P3344, DOI 10.2337/db06-0419; Steil Garry M, 2005, Expert Opin Drug Deliv, V2, P353, DOI 10.1517/17425247.2.2.353; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967; Wilinska Malgorzata E, 2009, J Diabetes Sci Technol, V3, P1109; Williams RM, 2004, ACTA PAEDIATR, V93, P440, DOI 10.1080/08035250410024934	30	293	303	1	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					743	751		10.1016/S0140-6736(09)61998-X	http://dx.doi.org/10.1016/S0140-6736(09)61998-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20138357				2022-12-28	WOS:000275211200031
J	Hughes, DA; Ferner, RE				Hughes, Dyfrig A.; Ferner, Robin E.			New drugs for old: disinvestment and NICE	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; HEALTH-CARE		[Hughes, Dyfrig A.] Bangor Univ, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales; [Ferner, Robin E.] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England	Bangor University; University of Birmingham	Hughes, DA (corresponding author), Bangor Univ, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales.	d.a.hughes@bangor.ac.uk	Hughes, Dyfrig/H-5252-2012	Hughes, Dyfrig/0000-0001-8247-7459; Ferner, Robin/0000-0003-3769-1346				*ASS BRIT PHARM IN, PHARM PRIC REG SCHM; Barrett A, 2006, BRIT MED J, V333, P1118, DOI 10.1136/bmj.39008.624051.BE; *DEP HLTH, 2006, SEL CRIT REF TOP NIC; Dowie J, 2004, HEALTH ECON, V13, P453, DOI 10.1002/hec.861; Elshaug AG, 2009, MED J AUSTRALIA, V190, P269, DOI 10.5694/j.1326-5377.2009.tb02394.x; *HOUS COMM HLTH CO, 2006, INFL PHARM IND, V1; Hoyle M, 2008, PHARMACOECONOMICS, V26, P589, DOI 10.2165/00019053-200826070-00006; Hughes D, 2006, PHARMACOECONOMICS, V24, P211, DOI 10.2165/00019053-200624030-00001; *MED HEALTHC PROD, 2008, DRUG SAFETY UPDATE, V2, P7; *NAT I HLTH CLIN E, 2009, CLIN PUBL HLTH DIR P; *NAT I HLTH CLIN E, 2009, COST SAV GUID; *NAT I HLTH CLIN E, 2008, SUPP DIS REINV HLTH; National Institute for Health and Clinical Excellence, 2009, APPR LIF EXT END LIF; Nelson AL, 2009, ANN INTERN MED, V151, P662, DOI 10.7326/0003-4819-151-9-200911030-00011; *NHS INF CTR PRESC, 2009, PRESCR DISP COMM STA; *NHS INF CTR PRESC, 2009, US NICE APPR MED NHS; O'Brien BJ, 2002, HEALTH ECON, V11, P175, DOI 10.1002/hec.655; Pearson Steven, 2007, J Health Serv Res Policy, V12, P160; Walley T, 2000, BRIT MED J, V320, P131, DOI 10.1136/bmj.320.7228.131; 2006, DRUG THER B, V44, P73	20	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2010	340								c572	10.1136/bmj.c572	http://dx.doi.org/10.1136/bmj.c572			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TH	20185495				2022-12-28	WOS:000275001300013
J	Bach, PB				Bach, Peter B.			A Map to Bad Policy - Hospital Efficiency Measures in the Dartmouth Atlas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Baker LC, 2008, HEALTH AFFAIR, V27, pW123, DOI 10.1377/hlthaff.27.2.w123; Palmer S, 1999, BRIT MED J, V318, P1136, DOI 10.1136/bmj.318.7191.1136; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Wennberg JE, 2005, HLTH AFF MILLWOOD S	5	51	52	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					569	574		10.1056/NEJMp0909947	http://dx.doi.org/10.1056/NEJMp0909947			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556ED	20164483	Green Accepted			2022-12-28	WOS:000274571200001
J	Beroukhim, R; Mermel, CH; Porter, D; Wei, G; Raychaudhuri, S; Donovan, J; Barretina, J; Boehm, JS; Dobson, J; Urashima, M; Mc Henry, KT; Pinchback, RM; Ligon, AH; Cho, YJ; Haery, L; Greulich, H; Reich, M; Winckler, W; Lawrence, MS; Weir, BA; Tanaka, KE; Chiang, DY; Bass, AJ; Loo, A; Hoffman, C; Prensner, J; Liefeld, T; Gao, Q; Yecies, D; Signoretti, S; Maher, E; Kaye, FJ; Sasaki, H; Tepper, JE; Fletcher, JA; Tabernero, J; Baselga, J; Tsao, MS; Demichelis, F; Rubin, MA; Janne, PA; Daly, MJ; Nucera, C; Levine, RL; Ebert, BL; Gabriel, S; Rustgi, AK; Antonescu, CR; Ladanyi, M; Letai, A; Garraway, LA; Loda, M; Beer, DG; True, LD; Okamoto, A; Pomeroy, SL; Singer, S; Golub, TR; Lander, ES; Getz, G; Sellers, WR; Meyerson, M				Beroukhim, Rameen; Mermel, Craig H.; Porter, Dale; Wei, Guo; Raychaudhuri, Soumya; Donovan, Jerry; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Urashima, Mitsuyoshi; Mc Henry, Kevin T.; Pinchback, Reid M.; Ligon, Azra H.; Cho, Yoon-Jae; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Loo, Alice; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Yecies, Derek; Signoretti, Sabina; Maher, Elizabeth; Kaye, Frederic J.; Sasaki, Hidefumi; Tepper, Joel E.; Fletcher, Jonathan A.; Tabernero, Josep; Baselga, Jose; Tsao, Ming-Sound; Demichelis, Francesca; Rubin, Mark A.; Janne, Pasi A.; Daly, Mark J.; Nucera, Carmelo; Levine, Ross L.; Ebert, Benjamin L.; Gabriel, Stacey; Rustgi, Anil K.; Antonescu, Cristina R.; Ladanyi, Marc; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Beer, David G.; True, Lawrence D.; Okamoto, Aikou; Pomeroy, Scott L.; Singer, Samuel; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Sellers, William R.; Meyerson, Matthew			The landscape of somatic copy-number alteration across human cancers	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EMBRYONIC STEM-CELLS; LUNG-CANCER; CHROMOSOMAL BREAKPOINT; MALIGNANT-MELANOMA; ADAPTER PROTEINS; ARRAY CGH; GENES; GENOME; AMPLIFICATION	A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers. Here we present high-resolution analyses of somatic copy-number alterations (SCNAs) from 3,131 cancer specimens, belonging largely to 26 histological types. We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions. Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-kappa B pathway. We show that cancer cells containing amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival. Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.	[Beroukhim, Rameen; Mermel, Craig H.; Wei, Guo; Raychaudhuri, Soumya; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Pinchback, Reid M.; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Daly, Mark J.; Ebert, Benjamin L.; Gabriel, Stacey; Garraway, Levi A.; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Meyerson, Matthew] Broad Inst MIT & Harvard, Canc Program, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Beroukhim, Rameen; Mermel, Craig H.; Wei, Guo; Raychaudhuri, Soumya; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Pinchback, Reid M.; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Daly, Mark J.; Ebert, Benjamin L.; Gabriel, Stacey; Garraway, Levi A.; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Meyerson, Matthew] Broad Inst MIT & Harvard, Med & Populat Genet Grp, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Beroukhim, Rameen; Mermel, Craig H.; Barretina, Jordi; Dobson, Jennifer; Haery, Leila; Greulich, Heidi; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Yecies, Derek; Signoretti, Sabina; Janne, Pasi A.; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Beroukhim, Rameen; Mermel, Craig H.; Barretina, Jordi; Dobson, Jennifer; Haery, Leila; Greulich, Heidi; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Yecies, Derek; Signoretti, Sabina; Janne, Pasi A.; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Beroukhim, Rameen; Mermel, Craig H.; Barretina, Jordi; Dobson, Jennifer; Haery, Leila; Greulich, Heidi; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Yecies, Derek; Signoretti, Sabina; Janne, Pasi A.; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Beroukhim, Rameen; Mermel, Craig H.; Barretina, Jordi; Dobson, Jennifer; Haery, Leila; Greulich, Heidi; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Yecies, Derek; Signoretti, Sabina; Janne, Pasi A.; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Beroukhim, Rameen; Raychaudhuri, Soumya; Ligon, Azra H.; Greulich, Heidi; Bass, Adam J.; Signoretti, Sabina; Fletcher, Jonathan A.; Janne, Pasi A.; Ebert, Benjamin L.; Loda, Massimo] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen; Raychaudhuri, Soumya; Ligon, Azra H.; Greulich, Heidi; Bass, Adam J.; Signoretti, Sabina; Fletcher, Jonathan A.; Janne, Pasi A.; Ebert, Benjamin L.; Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Beroukhim, Rameen; Greulich, Heidi; Ebert, Benjamin L.; Lander, Eric S.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen; Greulich, Heidi; Ebert, Benjamin L.; Lander, Eric S.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Beroukhim, Rameen; Greulich, Heidi; Ebert, Benjamin L.; Lander, Eric S.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Beroukhim, Rameen; Greulich, Heidi; Ebert, Benjamin L.; Lander, Eric S.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Cho, Yoon-Jae; Pomeroy, Scott L.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Nucera, Carmelo] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Porter, Dale; Donovan, Jerry; Mc Henry, Kevin T.; Loo, Alice; Sellers, William R.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Minato Ku, Tokyo 1058461, Japan; [Maher, Elizabeth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kaye, Frederic J.] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20889 USA; [Kaye, Frederic J.] Natl Naval Med Ctr, Bethesda, MD 20889 USA; [Sasaki, Hidefumi] Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan; [Chiang, Derek Y.; Tepper, Joel E.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet & Radiat Oncol, Chapel Hill, NC 27599 USA; [Tabernero, Josep; Baselga, Jose] Vall Hebron Univ Hosp, Res Inst, Vall Hebron Inst Oncol, Med Oncol Program, Barcelona 08035, Spain; [Tabernero, Josep; Baselga, Jose] Autonomous Univ Barcelona, E-08035 Barcelona, Spain; [Tsao, Ming-Sound] Princess Margaret Hosp, Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2M9, Canada; [Tsao, Ming-Sound] Princess Margaret Hosp, Univ Hlth Network, Div Appl Mol Oncol, Toronto, ON M5G 2M9, Canada; [Tsao, Ming-Sound] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Demichelis, Francesca; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Richard B Simches Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Levine, Ross L.; Antonescu, Cristina R.; Ladanyi, Marc; Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Levine, Ross L.; Antonescu, Cristina R.; Ladanyi, Marc; Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Rustgi, Anil K.] Univ Penn, Dept Med, GI Div, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Beer, David G.] Univ Michigan, Dept Surg, Thorac Surg Sect, Ann Arbor, MI 48109 USA; [True, Lawrence D.] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Minato Ku, Tokyo 1058461, Japan; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Novartis; Jikei University; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; Nagoya City University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cornell University; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Jikei University; Howard Hughes Medical Institute	Lander, ES (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge Ctr 7, Cambridge, MA 02142 USA.	lander@broadinstitute.org; gadgetz@broadinstitute.org; william.sellers@novartis.com; matthew_meyerson@dfci.harvard.edu	Mermel, Craig/AAZ-7322-2020; levine, ross/AAE-7658-2019; Tsao, Ming Sound/AFQ-7332-2022; Levine, Rodney L/D-9885-2011; Teh, Muy-Teck/B-9284-2016; Tsao, Ming-Sound/M-3503-2017; Meyerson, Matthew L/E-7123-2012; Tabernero, Josep/AAG-5026-2019; Demichelis, Francesca/J-9829-2016; Lawrence, Michael/AAC-8202-2020; Ladanyi, Marc/AAG-8585-2019; Chiang, Derek/L-6452-2019; kaye, frederic/E-2437-2011; Daly, Mark J/B-2453-2017; Barretina, Jordi/A-7192-2013	Mermel, Craig/0000-0002-0816-3395; Tsao, Ming Sound/0000-0002-9160-5405; Teh, Muy-Teck/0000-0002-7725-8355; Tabernero, Josep/0000-0002-2495-8139; Demichelis, Francesca/0000-0002-8266-8631; Daly, Mark J/0000-0002-0949-8752; Hoffman, Carter/0000-0002-4001-7902; Chiang, Derek/0000-0002-1131-6065; Boehm, Jesse/0000-0002-6795-6336; Raychaudhuri, Soumya/0000-0002-1901-8265; Reich, Michael/0000-0003-4735-5514; Rubin, Mark/0000-0002-8321-9950; Prensner, John/0000-0002-7024-636X; Singer, Samuel/0000-0001-9713-8230; Yecies, Derek/0000-0001-8534-4651; Meyerson, Matthew/0000-0002-9133-8108; Barretina, Jordi/0000-0002-3478-4080	National Institutes of Health (NIH) [P50CA90578, R01CA109038, R01CA109467, P01CA085859, P01CA 098101, K08CA122833]; Doris Duke Charitable Foundation; Sarah Thomas Monopoli Lung Cancer Research Fund; Seaman Corporation Fund for Lung Cancer Research; Lucas Foundation; NATIONAL CANCER INSTITUTE [P01CA098101, U24CA126546, R01CA109467, K08CA122833, K08CA134931, P01CA085859, R01CA109038, P50CA090578] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Sarah Thomas Monopoli Lung Cancer Research Fund; Seaman Corporation Fund for Lung Cancer Research; Lucas Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) (Dana-Farber/Harvard Cancer Center and Pacific Northwest Prostate Cancer SPOREs, P50CA90578, R01CA109038, R01CA109467, P01CA085859, P01CA 098101 and K08CA122833), the Doris Duke Charitable Foundation, the Sarah Thomas Monopoli Lung Cancer Research Fund, the Seaman Corporation Fund for Lung Cancer Research, and the Lucas Foundation. Medulloblastoma samples were obtained in collaboration with the Children's Oncology Group. N. Vena provided technical assistance with FISH, and I. Mellinghoff, P. S. Mischel, L. Liau and T. F. Cloughesy provided DNA samples. We thank T. Ried, R. Weinberg and B. Vogelstein for critical review of the manuscript and for comments about its context in the field of cancer genetics.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Arena V, 2003, GENE CHROMOSOME CANC, V38, P91, DOI 10.1002/gcc.10245; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; DALCIN P, 1993, CANCER GENET CYTOGEN, V68, P85, DOI 10.1016/0165-4608(93)90001-3; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; *GLAXOSMITHKLINE, GSK CANC CELL LIN GE; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; MITELMAN F, 2009, MITELMAN DATABASE CH, P2093; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Myllykangas S, 2007, SEMIN CANCER BIOL, V17, P42, DOI 10.1016/j.semcancer.2006.10.005; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Smith LT, 2006, GENE CHROMOSOME CANC, V45, P957, DOI 10.1002/gcc.20354; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Stuart D, 2009, CURR OPIN CELL BIOL, V21, P304, DOI 10.1016/j.ceb.2009.02.001; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; WU C, 2009, NF KB SIGNALING PATH; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou P, 2001, BLOOD, V97, P3902, DOI 10.1182/blood.V97.12.3902; 2001, NCI NCBIS SKY M FISH	49	2537	2642	4	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					899	905		10.1038/nature08822	http://dx.doi.org/10.1038/nature08822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164920	Green Submitted, Green Accepted			2022-12-28	WOS:000274582700036
J	Van Cleave, J; Gortmaker, SL; Perrin, JM				Van Cleave, Jeanne; Gortmaker, Steven L.; Perrin, James M.			Dynamics of Obesity and Chronic Health Conditions Among Children and Youth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SCHOOL-AGE-CHILDREN; BODY-MASS INDEX; PROSPECTIVE COHORT; CHILDHOOD ASTHMA; CONDUCT DISORDER; MATERNAL OBESITY; PREVALENCE; IMPACT; CARE	Context Rates of obesity and other childhood chronic conditions have increased over recent decades. Patterns of how conditions change over time have not been widely examined. Objective To evaluate change in prevalence of obesity and other chronic conditions in US children, including incidence, remission, and prevalence. Design, Setting, and Participants Prospective study using the National Longitudinal Survey of Youth-Child Cohort (1988-2006) of 3 nationally representative cohorts of children. Children were aged 2 through 8 years at the beginning of each study period, and cohorts were followed up for 6 years, from 1988 to 1994 ( cohort 1, n=2337), 1994 to 2000 ( cohort 2, n=1759), and 2000 to 2006 (n=905). Main Outcome Measures Parent report of a child having a health condition that limited activities or schooling or required medicine, special equipment, or specialized health services and that lasted at least 12 months. Obesity was defined as a body mass index at or above the 95th percentile for age. Chronic conditions were grouped into 4 categories: obesity, asthma, other physical conditions, and behavior/learning problems. Results The end-study prevalence of any chronic health condition was 12.8% (95% confidence interval [CI], 11.2%-14.5%) for cohort 1 in 1994, 25.1% ( 95% CI, 22.7%-27.6%) for cohort 2 in 2000, and 26.6% ( 95% CI, 23.5%-29.9%) for cohort 3 in 2006. There was substantial turnover in chronic conditions: 7.4% ( 95% CI, 6.5%-8.3%) of participants in all cohorts had a chronic condition at the beginning of the study that persisted to the end, 9.3% ( 95% CI, 8.3%-10.3%) reported conditions at the beginning that resolved within 6 years, and 13.4% ( 95% CI, 12.3%-14.6%) had new conditions that arose during the 6-year study period. The prevalence of having a chronic condition during any part of the 6-year study period was highest for cohort 3 (51.5%; 95% CI, 47.3%-55.0%), and there were higher rates among male ( adjusted odds ratio [AOR], 1.24; 95% CI, 1.07-1.42), Hispanic ( AOR, 1.36; 95% CI, 1.11-1.67), and black ( AOR, 1.60; 95% CI, 1.35-1.90) youth. Conclusions Prevalence of chronic conditions among children and youth increased from 1988 to 2006. However, presence of these conditions was dynamic over each 6-year cohort. JAMA. 2010; 303(7):623-630 www.jama.com	[Van Cleave, Jeanne; Perrin, James M.] MassGen Hosp Children, Ctr Child & Adolescent Hlth Policy, Boston, MA 02114 USA; [Van Cleave, Jeanne; Perrin, James M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gortmaker, Steven L.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Van Cleave, J (corresponding author), MassGen Hosp Children, Ctr Child & Adolescent Hlth Policy, 50 Staniford St 901, Boston, MA 02114 USA.	jvancleave@partners.org		Perrin, James/0000-0002-1810-3708	Robert Wood Johnson Foundation [033659]; Centers for Disease Control and Prevention [U48DP00064]; Maternal and Child Health Bureau [U53MC04773]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000064] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Maternal and Child Health Bureau; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Preparation of this work was supported by a Robert Wood Johnson Foundation Investigator Award in Health Policy Research (grant 033659), the Centers for Disease Control and Prevention (Prevention Research Centers grant U48DP00064), and a cooperative agreement with the Maternal and Child Health Bureau (U53MC04773). Role of the Sponsor: The funding agencies had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Baker P. C., 1989, NLSY CHILD HDB 1989; Barbaresi WJ, 2005, ARCH PEDIAT ADOL MED, V159, P37, DOI 10.1001/archpedi.159.1.37; Bethell CD, 2008, MATERN CHILD HLTH J, V12, P1, DOI 10.1007/s10995-007-0220-5; Cederlund M, 2008, J AUTISM DEV DISORD, V38, P72, DOI 10.1007/s10803-007-0364-6; Centers for Disease Control and Prevention, CTR DIS CONTR PREV G; Collins VR, 2008, J PEDIATR-US, V152, P20, DOI 10.1016/j.jpeds.2007.07.045; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Dietz WH, 2001, ANNU REV PUBL HEALTH, V22, P337, DOI 10.1146/annurev.publhealth.22.1.337; Eisenhower AS, 2009, SOC SCI MED, V68, P89, DOI 10.1016/j.socscimed.2008.09.033; Etzel RA, 2003, PEDIATRICS, V112, P233; Forrest CB, 1997, JAMA-J AM MED ASSOC, V277, P1787, DOI 10.1001/jama.277.22.1787; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Haberg SE, 2009, PAEDIATR PERINAT EP, V23, P352, DOI 10.1111/j.1365-3016.2009.01034.x; Halfon N, 1999, J AM ACAD CHILD PSY, V38, P600, DOI 10.1097/00004583-199905000-00023; Hesketh K, 2004, PUBLIC HEALTH NUTR, V7, P303, DOI 10.1079/PHN2003537; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; JESSOP DJ, 1995, ARCH PEDIAT ADOL MED, V149, P1105, DOI 10.1001/archpedi.1995.02170230059008; Koplan J., 2005, PREVENTING CHILDHOOD; LAHEY BB, 1995, J ABNORM PSYCHOL, V104, P83, DOI 10.1037/0021-843X.104.1.83; Law J, 2003, Cochrane Database Syst Rev, pCD004110, DOI 10.1002/14651858.CD004110; Maughan B, 2004, J CHILD PSYCHOL PSYC, V45, P609, DOI 10.1111/j.1469-7610.2004.00250.x; Neff JM, 2006, J AMBUL CARE MANAG, V29, P283, DOI 10.1097/00004479-200610000-00004; Newacheck PW, 2000, ARCH PEDIAT ADOL MED, V154, P287, DOI 10.1001/archpedi.154.3.287; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Pastor PN, 2005, PUBLIC HEALTH REP, V120, P383, DOI 10.1177/003335490512000405; PERRIN EC, 1993, PEDIATRICS, V91, P787; Perrin JM, 2007, JAMA-J AM MED ASSOC, V297, P2755, DOI 10.1001/jama.297.24.2755; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Racine AD, 2001, PEDIATRICS, V108, P1135, DOI 10.1542/peds.108.5.1135; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Reiss J, 2002, PEDIATRICS, V110, P1307; Riethmuller AM, 2009, PEDIATRICS, V124, pE782, DOI 10.1542/peds.2009-0333; Robbins JM, 2007, ARCH PEDIAT ADOL MED, V161, P17, DOI 10.1001/archpedi.161.1.17; Robertson CMT, 2007, JAMA-J AM MED ASSOC, V297, P2733, DOI 10.1001/jama.297.24.2733; Robison LM, 1999, CLIN PEDIATR, V38, P209, DOI 10.1177/000992289903800402; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Salsberry PJ, 2005, PEDIATRICS, V116, P1329, DOI 10.1542/peds.2004-2583; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Simpson BJ, 2000, PEDIATR INFECT DIS J, V19, P618, DOI 10.1097/00006454-200007000-00007; Spencer TJ, 2007, AMBUL PEDIATR, V7, P73, DOI 10.1016/j.ambp.2006.07.006; Szilagyi PG, 2004, PEDIATRICS, V113, pE395, DOI 10.1542/peds.113.5.e395; Troiano RP, 1998, PEDIATRICS, V101, P497; Watkins ML, 2003, PEDIATRICS, V111, P1152; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	50	412	416	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					623	630		10.1001/jama.2010.104	http://dx.doi.org/10.1001/jama.2010.104			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	555NK	20159870	Bronze, Green Published			2022-12-28	WOS:000274518600020
J	Levine, SJ; Wenzel, SE				Levine, Stewart J.; Wenzel, Sally E.			Narrative Review: The Role of Th2 Immune Pathway Modulation in the Treatment of Severe Asthma and Its Phenotypes	ANNALS OF INTERNAL MEDICINE			English	Review							SEVERE PERSISTENT ASTHMA; ANTI-IGE ANTIBODY; AIRWAY HYPERRESPONSIVENESS; UNCONTROLLED DISEASE; ALLERGIC-ASTHMA; OMALIZUMAB; EXACERBATIONS; INFLAMMATION; EOSINOPHILS; MEPOLIZUMAB	New therapeutic approaches are needed for patients with severe asthma who are refractory to standard therapy comprising high doses of inhaled corticosteroids plus long-acting beta(2)-agonists. Current treatment guidelines for patients with severe asthma from the National Asthma Education and Prevention Program recommend the addition of oral corticosteroids, which are associated with substantial morbidity, and, for those with allergic asthma, anti-IgE. Genetic and translational studies, as well as clinical trials, suggest that in a subgroup of patients, the pathobiology of severe asthma is mediated by immune pathways driven by T-helper 2 (Th2)-type CD4(+) T cells, which produce a characteristic repertoire of interleukins (ILs), including IL-4, IL-5, and IL-13. Therefore, biological modifiers of Th2-type ILs, such as monoclonal antibodies, soluble receptors, and receptor antagonists, are a rational strategy for developing new treatment approaches but will need to be targeted to selected patients in whom the appropriate Th2 immune pathway is "active." The benefits of immune-modifier therapies targeting Th2-type cytokines, however, need to be weighed against the toxicities associated with inhibition of key biological pathways, as well as the expense of future medications. Therefore, future clinical trials need to clearly establish the efficacy and safety of biological modifiers of Th2 immune pathways before these approaches can enter routine clinical practice for the treatment of severe asthma.	[Levine, Stewart J.] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; Univ Pittsburgh, Montefiore Med Ctr, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian	Levine, SJ (corresponding author), NHLBI, Pulm & Vasc Med Branch, NIH, Bldg 10,Room 6D03,MSC 1590, Bethesda, MD 20892 USA.	levines@nhlbi.nih.gov			National Heart, Lung, and Blood Institute, National Institute of Health; National Immunologic, Allergic and Infectious Disease Institute [AI 40600]; University of Pittsburgh; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006056, R01HL069174, ZIAHL006057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040600] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Immunologic, Allergic and Infectious Disease Institute; University of Pittsburgh(University of Pittsburgh); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By the Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institute of Health; the National Immunologic, Allergic and Infectious Disease Institute (AI 40600); and the University of Pittsburgh.	Balzar S, 2007, J ALLERGY CLIN IMMUN, V119, P855, DOI 10.1016/j.jaci.2006.12.642; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bousquet J, 2004, CHEST, V125, P1378, DOI 10.1378/chest.125.4.1378; Breekveldt-Postma NS, 2008, CURR MED RES OPIN, V24, P975, DOI [10.1185/030079908X280518, 10.1185/030079908X280518 ]; Chibana K, 2008, CLIN EXP ALLERGY, V38, P936, DOI 10.1111/j.1365-2222.2008.02969.x; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Food and Drug Administration, 2009, EARL COMM ONG SAF RE; Furst DE, 2008, ANN RHEUM DIS, V67, P2, DOI 10.1136/ard.2008.100834; *GEN, 2008, XOL OM PRESCR INF; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Heaton T, 2005, LANCET, V365, P142, DOI 10.1016/S0140-6736(05)17704-6; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; O'Byrne PM, 2007, AM J RESP CRIT CARE, V176, P1059, DOI 10.1164/rccm.200708-1264ED; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Partridge AH, 2006, ANN ONCOL, V17, P183, DOI 10.1093/annonc/mdj141; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Sandford AJ, 2000, J ALLERGY CLIN IMMUN, V106, P135, DOI 10.1067/mai.2000.107926; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Sorkness RL, 2008, J APPL PHYSIOL, V104, P394, DOI 10.1152/japplphysiol.00329.2007; Strunk RC, 2006, NEW ENGL J MED, V354, P2689, DOI 10.1056/NEJMct055184; Sullivan SD, 2007, ALLERGY, V62, P126, DOI 10.1111/j.1398-9995.2006.01254.x; TRUDEAU JBC, 2007, AM J RESP CRIT CARE, V175, pA837; Umetsu DT, 2005, LANCET, V365, P98, DOI 10.1016/S0140-6736(05)17714-9; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel SE, 2007, AM J RESP CRIT CARE, V175, P570, DOI 10.1164/rccm.200607-909OC; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wraight JM, 2002, RESPIROLOGY, V7, P133, DOI 10.1046/j.1440-1843.2002.00374.x; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	44	78	85	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2010	152	4					232	U56		10.7326/0003-4819-152-4-201002160-00008	http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560AF	20157138	Green Accepted			2022-12-28	WOS:000274873300005
J	Dalziel, K; Shaw, S				Dalziel, Kate; Shaw, Sarah			Easily Missed? Lichen sclerosus	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHIMOSIS; CHILDREN		[Dalziel, Kate] Royal Cornwall Hosp, Truro TR1 3LJ, England; [Shaw, Sarah] Stennack Surg, St Ives, England	Royal Cornwall Hospital	Dalziel, K (corresponding author), Royal Cornwall Hosp, Truro TR1 3LJ, England.	kate.dalziel@rcht.cornwall.nhs.uk						Birenbaum DL, 2007, J REPROD MED, V52, P28; Cooper SM, 2004, ARCH DERMATOL, V140, P702, DOI 10.1001/archderm.140.6.702; DALZIEL KL, 1995, J REPROD MED, V40, P351; Fidel PL, 2000, INFECT IMMUN, V68, P651, DOI 10.1128/IAI.68.2.651-657.2000; JORGENSEN ET, 1993, ACTA DERM-VENEREOL, V73, P55; Lynch PJ, 2007, J REPROD MED, V52, P3; Maronn ML, 2005, PEDIATRICS, V115, pE230, DOI 10.1542/peds.2004-1544; Mattioli G, 2002, PEDIATR SURG INT, V18, P273, DOI 10.1007/s003830100699; Neill SM, 2002, BRIT J DERMATOL, V147, P640, DOI 10.1046/j.1365-2133.2002.05012.x; Powell J, 2001, J AM ACAD DERMATOL, V44, P803, DOI 10.1067/mjd.2001.113474; Powell JJ, 1999, LANCET, V353, P1777, DOI 10.1016/S0140-6736(98)08228-2; Riddell L, 2000, SEX TRANSM INFECT, V76, P311, DOI 10.1136/sti.76.4.311; ZAKI I, 1996, CLIN EXP DERMATOL, V21, P234	13	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2010	340								c731	10.1136/bmj.c731	http://dx.doi.org/10.1136/bmj.c731			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JR	20156913				2022-12-28	WOS:000274738600004
J	Turnbull, L; Brown, S; Harvey, I; Olivier, C; Drew, P; Napp, V; Hanby, A; Brown, J				Turnbull, Lindsay; Brown, Sarah; Harvey, Ian; Olivier, Catherine; Drew, Phil; Napp, Vicky; Hanby, Andrew; Brown, Julia			Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial	LANCET			English	Article							FUNCTIONAL ASSESSMENT; THERAPY; SURGERY; QUALITY	Background MRI might improve diagnosis of breast cancer, reducing rates of reoperation efficacy of contrast-enhanced MRI in women with primary breast cancer. Methods We undertook an open, parallel group trial in 45 UK centres, with 1623 women aged 18 years or older with biopsy-proven primary breast cancer who were scheduled for wide local excision after triple assessment. Patients were randomly assigned to receive either MRI (n=816) or no further imaging (807), with use of a minimisation algorithm incorporating a random element. The primary endpoint was the proportion of patients undergoing a repeat operation or further mastectomy within 6 months of random assignment, or a pathologically avoidable mastectomy at initial operation. Analysis was by intention to treat. This study is registered, ISRCTN number 57474502. Findings 816 patients were randomly assigned to MRI and 807 to no MRI. Addition of MRI to conventional triple assessment was not significantly associated with reduced a reoperation rate, with 153 (19%) needing reoperation in the MRI group versus 156 (19%) in the no MRI group, (odds ratio 0.96, 95% CI 0.75-1.24; p=0.77).	[Turnbull, Lindsay; Harvey, Ian] Hull Royal Infirm, Ctr Magnet Resonance Invest, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Brown, Sarah; Olivier, Catherine; Napp, Vicky; Brown, Julia] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Drew, Phil] Royal Cornwall Hosp, Hull York Med Sch, Truro, England; [Hanby, Andrew] Wellcome Trust Res Labs, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of Hull; University of Leeds; Royal Cornwall Hospital; University of Hull; University of York - UK; University of Leeds	Turnbull, L (corresponding author), Hull Royal Infirm, Ctr Magnet Resonance Invest, Anlaby Rd, Kingston Upon Hull HU3 2JZ, N Humberside, England.	l.w.turnbull@hull.ac.uk		brown, julia/0000-0002-2719-7064; Napp, Vicky/0000-0001-6726-2222	National Institute for Health Research's Health Technology Assessment Programme [99/27/05]	National Institute for Health Research's Health Technology Assessment Programme	This project was funded by the National Institute for Health Research's Health Technology Assessment Programme (project number 99/27/05) and will be published in full in the Health Technology Assessment website. We thank the women who participated in this study, all other clinical trials research unit staff, past and present, who have contributed to the COMICE trial (trial coordination, statistics, data entry and administration, and database development and support), the additional members of the trial management group (B Dall, L G Walker, A Manca, M Sculpher, and S Walker), the trial steering committee (J Nichol], R G Newcombe, L Thnistle, T Lennard, D Dodwell, and H Bishop) and the DMrC (M Campbell, A Paterson, S Pinder, R Warren, A J Evans, R Rainsbury, and C Wells) for their important contributions.	[Anonymous], 2005, 58 NHS CANC SCREEN P; BALEN FG, 1997, P RADIOLOGY; *BASO SPEC GROUP M, 2000, AUD SCREEN DET BREAS; Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Davies JD, 1996, ANTICANCER RES, V16, P3971; Esserman L, 1999, J CLIN ONCOL, V17, P110, DOI 10.1200/JCO.1999.17.1.110; Fischer U, 1999, RADIOLOGY, V213, P881, DOI 10.1148/radiology.213.3.r99dc01881; FISCHER U, 1993, ROFO FORTSCHR RONTG, V158, P287, DOI 10.1055/s-2008-1032652; HARTSELL WF, 1994, INT J RADIAT ONCOL, V30, P49, DOI 10.1016/0360-3016(94)90518-5; HOLLAND R, 1985, CANCER, V56, P979, DOI 10.1002/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Houssami N, 2009, CA-CANCER J CLIN, V59, P290, DOI 10.3322/caac.20028; KAISER WA, 1989, RADIOLOGY, V170, P681, DOI 10.1148/radiology.170.3.2916021; Kind P., 1996, QUALITY LIFE PHARMAC, V2nd; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Kurtz J M, 1996, Recent Results Cancer Res, V140, P263; KURTZ JM, 1990, ANN SURG, V212, P38, DOI 10.1097/00000658-199007000-00006; LEOPOLD KA, 1989, INT J RADIAT ONCOL, V16, P11, DOI 10.1016/0360-3016(89)90004-7; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; *NHS BREAST SCREEN, 2008, AUD SCREEN DET BREAS; Tan JE, 1999, AM J CLIN ONCOL-CANC, V22, P414, DOI 10.1097/00000421-199908000-00020; Turnbull LW, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14010; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; INT C HARM HARM TRIP	25	404	418	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					563	571		10.1016/S0140-6736(09)62070-5	http://dx.doi.org/10.1016/S0140-6736(09)62070-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560YO	20159292	Bronze			2022-12-28	WOS:000274941900030
J	Hutson, JM				Hutson, Jeremy M.			Ultracold Chemistry	SCIENCE			English	Editorial Material							MOLECULES; GAS		Univ Durham, Dept Chem, Durham DH1 3LE, England	Durham University	Hutson, JM (corresponding author), Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.	j.m.hutson@durham.ac.uk	Hutson, Jeremy/F-4748-2012	Hutson, Jeremy/0000-0002-4344-6622				Bethlem HL, 2003, INT REV PHYS CHEM, V22, P73, DOI 10.1080/0144235021000046422; Buchler HP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060404; Cubizolles J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.240401; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Fioretti A, 1998, PHYS REV LETT, V80, P4402, DOI 10.1103/PhysRevLett.80.4402; Goral K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.170406; Herbig J, 2003, SCIENCE, V301, P1510, DOI 10.1126/science.1088876; Hudson JJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.023003; Lang F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.133005; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; Strecker KE, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080406; Weinstein DC, 1998, NATURE, V395, P921, DOI 10.1038/27706	14	26	26	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					788	789		10.1126/science.1186703	http://dx.doi.org/10.1126/science.1186703			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150471	Green Accepted			2022-12-28	WOS:000274408300027
J	Ospelkaus, S; Ni, KK; Wang, D; de Miranda, MHG; Neyenhuis, B; Quemener, G; Julienne, PS; Bohn, JL; Jin, DS; Ye, J				Ospelkaus, S.; Ni, K. -K.; Wang, D.; de Miranda, M. H. G.; Neyenhuis, B.; Quemener, G.; Julienne, P. S.; Bohn, J. L.; Jin, D. S.; Ye, J.			Quantum-State Controlled Chemical Reactions of Ultracold Potassium-Rubidium Molecules	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION; RYDBERG BLOCKADE; NOBEL LECTURE; ATOMS; COLLISIONS; GAS	How does a chemical reaction proceed at ultralow temperatures? Can simple quantum mechanical rules such as quantum statistics, single partial-wave scattering, and quantum threshold laws provide a clear understanding of the molecular reactivity under a vanishing collision energy? Starting with an optically trapped near-quantum-degenerate gas of polar (KRb)-K-40-Rb-87 molecules prepared in their absolute ground state, we report experimental evidence for exothermic atom-exchange chemical reactions. When these fermionic molecules were prepared in a single quantum state at a temperature of a few hundred nanokelvin, we observed p-wave-dominated quantum threshold collisions arising from tunneling through an angular momentum barrier followed by a short-range chemical reaction with a probability near unity. When these molecules were prepared in two different internal states or when molecules and atoms were brought together, the reaction rates were enhanced by a factor of 10 to 100 as a result of s-wave scattering, which does not have a centrifugal barrier. The measured rates agree with predicted universal loss rates related to the two-body van der Waals length.	[Ospelkaus, S.; Ni, K. -K.; Wang, D.; de Miranda, M. H. G.; Neyenhuis, B.; Quemener, G.; Bohn, J. L.; Jin, D. S.; Ye, J.] Univ Colorado, NIST, JILA, Boulder, CO 80309 USA; [Ospelkaus, S.; Ni, K. -K.; Wang, D.; de Miranda, M. H. G.; Neyenhuis, B.; Quemener, G.; Bohn, J. L.; Jin, D. S.; Ye, J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Julienne, P. S.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Julienne, P. S.] Univ Maryland, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Jin, DS (corresponding author), Univ Colorado, NIST, JILA, Boulder, CO 80309 USA.	jin@jilau1.colorado.edu; ye@jila.colorado.edu	Julienne, Paul S/E-9378-2012; Wang, Dajun/F-7026-2012; de Miranda, Marcio H. G./J-8293-2016; Ye, Jun/C-3312-2011	Julienne, Paul S/0000-0002-5494-1442; de Miranda, Marcio H. G./0000-0002-4502-3623; Ye, Jun/0000-0003-0076-2112; Quemener, Goulven/0000-0001-9396-7701	NIST Innovations in Measurement Science-Ultracold Stable Molecules; NSF Physics Frontier Center; U.S. Department of Energy; Air Force Office of Scientific Research MURI on Ultracold Molecules; NSF; Office of Naval Research [N0001409IP20041]	NIST Innovations in Measurement Science-Ultracold Stable Molecules(National Institute of Standards & Technology (NIST) - USA); NSF Physics Frontier Center(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Air Force Office of Scientific Research MURI on Ultracold Molecules; NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	Supported by NIST Innovations in Measurement Science-Ultracold Stable Molecules, NSF Physics Frontier Center at JILA, U.S. Department of Energy, Air Force Office of Scientific Research MURI on Ultracold Molecules, and a NSF graduate fellowship (B.N.) and by Office of Naval Research grant N0001409IP20041 (P.S.J.). We thank S. Kotochigova for providing her calculations of the van der Waals dispersion coefficients that are relevant to our experiments.	Aldegunde J, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033434; AMIOT C, 1990, J CHEM PHYS, V93, P8591, DOI 10.1063/1.459246; Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Avdeenkov AV, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052718; Balakrishnan N, 2001, CHEM PHYS LETT, V341, P652, DOI 10.1016/S0009-2614(01)00515-2; Bethe HA, 1935, PHYS REV, V47, P0747, DOI 10.1103/PhysRev.47.747; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Casavecchia P, 2000, REP PROG PHYS, V63, P355, DOI 10.1088/0034-4885/63/3/203; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; Cornell EA, 2002, REV MOD PHYS, V74, P875, DOI 10.1142/S0217979202014681; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Hudson ER, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.203201; Hutson JM, 2007, INT REV PHYS CHEM, V26, P1, DOI 10.1080/01442350601084562; Julienne PS, 2009, FARADAY DISCUSS, V142, P361, DOI 10.1039/b820917k; Ketterle W, 2002, REV MOD PHYS, V74, P1131, DOI [10.1103/RevModPhys.74.1131, 10.1142/S0217979202014668]; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kohler T, 2006, REV MOD PHYS, V78, P1311, DOI 10.1103/RevModPhys.78.1311; Kotochigova S, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041405; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Langevin P, 1905, ANN CHIM PHYS, V5, P245; Liu KP, 2001, ANNU REV PHYS CHEM, V52, P139, DOI 10.1146/annurev.physchem.52.1.139; MARINESCU M, 1994, PHYS REV A, V49, P982, DOI 10.1103/PhysRevA.49.982; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ospelkaus S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.030402; Pupillo G., 2009, COLD MOL THEORY EXPT; Regal CA, 2007, ADV ATOM MOL OPT PHY, V54, P1, DOI 10.1016/S1049-250X(06)54001-7; Sadeghpour HR, 2000, J PHYS B-AT MOL OPT, V33, pR93, DOI 10.1088/0953-4075/33/5/201; SCHNIEDER L, 1995, SCIENCE, V269, P207, DOI 10.1126/science.269.5221.207; STFALKE, 2006, J CHEM PHYS, V125; Ticknor C, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.032717; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; WIGNER EP, 1948, PHYS REV, V73, P1002, DOI 10.1103/PhysRev.73.1002; Yi S, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.041604; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875; Zirbel JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143201	38	703	706	8	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					853	857		10.1126/science.1184121	http://dx.doi.org/10.1126/science.1184121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150499	Green Submitted			2022-12-28	WOS:000274408300058
J	Yovel, Y; Falk, B; Moss, CF; Ulanovsky, N				Yovel, Yossi; Falk, Ben; Moss, Cynthia F.; Ulanovsky, Nachum			Optimal Localization by Pointing Off Axis	SCIENCE			English	Article							BAT ROUSETTUS-AEGYPTIACUS; BIG BROWN BAT; ECHOLOCATING BATS; MEGACHIROPTERAN BAT; SOUND LOCALIZATION; EPTESICUS-FUSCUS; ACQUISITION; TRACKING; BEHAVIOR; MAMMALS	Is centering a stimulus in the field of view an optimal strategy to localize and track it? We demonstrated, through experimental and computational studies, that the answer is no. We trained echolocating Egyptian fruit bats to localize a target in complete darkness, and we measured the directional aim of their sonar clicks. The bats did not center the sonar beam on the target, but instead pointed it off axis, accurately directing the maximum slope ("edge") of the beam onto the target. Information-theoretic calculations showed that using the maximum slope is optimal for localizing the target, at the cost of detection. We propose that the tradeoff between detection (optimized at stimulus peak) and localization (optimized at maximum slope) is fundamental to spatial localization and tracking accomplished through hearing, olfaction, and vision.	[Yovel, Yossi; Ulanovsky, Nachum] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Falk, Ben; Moss, Cynthia F.] Univ Maryland, Dept Psychol, Syst Res Inst, College Pk, MD 20742 USA; [Falk, Ben; Moss, Cynthia F.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA	Weizmann Institute of Science; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ulanovsky, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	nachum.ulanovsky@weizmann.ac.il	; Moss, Cynthia/J-5208-2017	Ulanovsky, Nachum/0000-0001-8598-4667; Yovel, Yossi/0000-0001-5429-9245; Moss, Cynthia/0000-0001-6916-0000	Human Frontiers Science Program; Weizmann Institute	Human Frontiers Science Program(Human Frontier Science Program); Weizmann Institute	We thank N. Sobel, J. Rubin, E. Simoni, A. Rubin, and N. Harper for comments on the manuscript; M. Holderied, I. Couzin, A. Arieli, E. Ahissar, and H.-U. Schnitzler for helpful discussions; and J. Barcelo for technical assistance. This study was funded by a Human Frontiers Science Program grant to N. U. and a Weizmann Institute Postdoctoral Fellowship to Y.Y.	Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Catania KC, 2006, NATURE, V444, P1024, DOI 10.1038/4441024a; Chiu C, 2008, P NATL ACAD SCI USA, V105, P13116, DOI 10.1073/pnas.0804408105; Dayan P, 2001, COMPUTATIONAL NEUROS; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Heffner RS, 1999, J COMP PSYCHOL, V113, P297, DOI 10.1037/0735-7036.113.3.297; HERBERT H, 1985, Z SAUGETIERKD, V50, P141; Holland RA, 2004, J EXP BIOL, V207, P4361, DOI 10.1242/jeb.01288; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; KALKO EKV, 1993, BEHAV ECOL SOCIOBIOL, V33, P415; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; MANABE T, 1978, SCIENCE, V200, P339, DOI 10.1126/science.635594; MASTERS WM, 1985, SCIENCE, V228, P1331, DOI 10.1126/science.4001947; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; METZNER W, 1989, NATURE, V341, P529, DOI 10.1038/341529a0; Nelson ME, 2006, J COMP PHYSIOL A, V192, P573, DOI 10.1007/s00359-006-0099-4; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; SUGA N, 1989, J EXP BIOL, V146, P277; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105	28	91	92	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					701	704		10.1126/science.1183310	http://dx.doi.org/10.1126/science.1183310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133574				2022-12-28	WOS:000274251800041
J	Yu, BK; Martins, IRS; Li, PL; Amarasinghe, GK; Umetani, J; Fernandez-Zapico, ME; Billadeau, DD; Machius, M; Tomchick, DR; Rosen, MK				Yu, Bingke; Martins, Ilidio R. S.; Li, Pilong; Amarasinghe, Gaya K.; Umetani, Junko; Fernandez-Zapico, Martin E.; Billadeau, Daniel D.; Machius, Mischa; Tomchick, Diana R.; Rosen, Michael K.			Structural and Energetic Mechanisms of Cooperative Autoinhibition and Activation of Vav1	CELL			English	Article							TYROSINE PHOSPHORYLATION; SH3 DOMAIN; PROTEINS; DYNAMICS; SRC; INTEGRATION; ONCOGENE; SIGNALS; GTPASES; MODEL	Vav proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases. They control processes including T cell activation, phagocytosis, and migration of normal and transformed cells. We report the structure and biophysical and cellular analyses of the five-domain autoinhibitory element of Vav1. The catalytic Dbl homology (DH) domain of Vav1 is controlled by two energetically coupled processes. The DH active site is directly, but weakly, inhibited by a helix from the adjacent Acidic domain. This core interaction is strengthened 10-fold by contacts of the calponin homology (CH) domain with the Acidic, pleckstrin homology, and DH domains. This construction enables efficient, step-wise relief of autoinhibition: initial phosphorylation events disrupt the modulatory CH contacts, facilitating phosphorylation of the inhibitory helix and consequent GEF activation. Our findings illustrate how the opposing requirements of strong suppression of activity and rapid kinetics of activation can be achieved in multidomain systems.	[Yu, Bingke; Martins, Ilidio R. S.; Li, Pilong; Amarasinghe, Gaya K.; Umetani, Junko; Machius, Mischa; Tomchick, Diana R.; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Yu, Bingke; Martins, Ilidio R. S.; Li, Pilong; Amarasinghe, Gaya K.; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Martins, Ilidio R. S.] Univ Coimbra, Fac Ciencias & Tecnol, Dept Bioquim, P-3001401 Coimbra, Portugal; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Dept Immunol, Rochester, MN 55905 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade de Coimbra; Mayo Clinic; Mayo Clinic	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu	, PEP-MX Core/AGV-4051-2022; Tomchick, Diana/HGV-2018-2022	Tomchick, Diana/0000-0002-7529-4643; Amarasinghe, Gaya/0000-0002-0418-9707	Foundation for Science and Technology (Portugal); Luso- American Development Foundation (Portugal); Cancer Research Institute; NIH [GM066930, AI065474, CA102721, CA136526]; Howard Hughes Medical Institute; U.S. Department of Energy [W-31-109-ENG-38]; NATIONAL CANCER INSTITUTE [R01CA136526, P50CA102701, P20CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066930] Funding Source: NIH RePORTER	Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology); Luso- American Development Foundation (Portugal); Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Carlos Amezcua and Chad Brautigam for technical assistance, Lewis Kay for providing NMR pulse sequences, Shae Padrick and Rama Ranganathan for discussion, and Yuh Min Chook for critical reading of the manuscript. I. R. S. M. was supported by fellowships from the Foundation for Science and Technology (Portugal) and the Luso- American Development Foundation (Portugal). G. K. A. was supported by a postdoctoral fellowship from the Cancer Research Institute. This work was supported by NIH grants GM066930 to M. K. R., AI065474 and CA102721 to D. D. B., and CA102721 and CA136526 to M. E. F. and by the Howard Hughes Medical Institute. D. D. B. is a Leukemia and Lymphoma Society Scholar. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Energy Research, under Contract No. W-31-109-ENG-38.	Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Amarasinghe GK, 2005, BIOCHEMISTRY-US, V44, P15257, DOI 10.1021/bi051126h; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; DeLano W.L, PYMOL MOL GRAPHICS S; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Korzhnev DM, 2004, J AM CHEM SOC, V126, P3964, DOI 10.1021/ja039587i; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	43	104	105	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					246	256		10.1016/j.cell.2009.12.033	http://dx.doi.org/10.1016/j.cell.2009.12.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141838	Green Accepted, Bronze			2022-12-28	WOS:000273826500015
J	Gupta, RK; Arany, Z; Seale, P; Mepani, RJ; Ye, L; Conroe, HM; Roby, YA; Kulaga, H; Reed, RR; Spiegelman, BM				Gupta, Rana K.; Arany, Zoltan; Seale, Patrick; Mepani, Rina J.; Ye, Li; Conroe, Heather M.; Roby, Yang A.; Kulaga, Heather; Reed, Randall R.; Spiegelman, Bruce M.			Transcriptional control of preadipocyte determination by Zfp423	NATURE			English	Article							PPAR-GAMMA; OLIGONUCLEOTIDE ARRAYS; CEREBELLAR DEVELOPMENT; ADIPOSE CONVERSION; ADIPOCYTE LINEAGE; GENE-EXPRESSION; IN-VIVO; CELLS; DIFFERENTIATION; ADIPOGENESIS	The worldwide epidemic of obesity has increased the urgency to develop a deeper understanding of physiological systems related to energy balance and energy storage, including the mechanisms controlling the development of fat cells (adipocytes). The differentiation of committed preadipocytes to adipocytes is controlled by PPAR gamma and several other transcription factors(1), but the molecular basis for preadipocyte determination is not understood. Using a new method for the quantitative analysis of transcriptional components, we identified the zinc-finger protein Zfp423 as a factor enriched in preadipose versus non-preadipose fibroblasts. Ectopic expression of Zfp423 in non-adipogenic NIH 3T3 fibroblasts robustly activates expression of Pparg in undifferentiated cells and permits cells to undergo adipocyte differentiation under permissive conditions. Short hairpin RNA (shRNA)-mediated reduction of Zfp423 expression in 3T3-L1 cells blunts preadipocyte Pparg expression and diminishes the ability of these cells to differentiate. Furthermore, both brown and white adipocyte differentiation is markedly impaired in Zfp423-deficient mouse embryos. Zfp423 regulates Pparg expression, in part, through amplification of the BMP signalling pathway, an effect dependent on the SMAD-binding capacity of Zfp423. This study identifies Zfp423 as a transcriptional regulator of preadipocyte determination.	[Gupta, Rana K.; Arany, Zoltan; Seale, Patrick; Mepani, Rina J.; Ye, Li; Conroe, Heather M.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gupta, Rana K.; Arany, Zoltan; Seale, Patrick; Mepani, Rina J.; Ye, Li; Conroe, Heather M.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Metab & Chron Dis, Boston, MA 02115 USA; [Gupta, Rana K.; Arany, Zoltan; Seale, Patrick; Mepani, Rina J.; Ye, Li; Conroe, Heather M.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Roby, Yang A.; Kulaga, Heather; Reed, Randall R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol,Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Gupta, Rana/R-3051-2019	Gupta, Rana/0000-0002-9001-4531	Ruth Kirstein NRSA [F32 DK079507-01]; NHLBI [K08 HL79172-01]; Smith Family Foundation; NIH [DK081605, DK31405]; NIDCD [R01DC008295]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R37DK031405, R01DK031405, F32DK079507, K99DK081605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008295] Funding Source: NIH RePORTER	Ruth Kirstein NRSA; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Smith Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to S. Kleiner and S. Kajimura for critical reading of the manuscript and to all members of the Spiegelman laboratory for useful discussions. We thank B. Wagner for technical assistance in using robotic liquid handlers, B. Seed's laboratory for help with high-through query of Primer bank, and J. Brestelli for performing high-throughput queries of the Primer 3 program. We are also grateful to D. Bernlohr for the FABP4 antiserum. R. K. G. is supported by the Ruth Kirstein NRSA (F32 DK079507-01), Z. A. is supported by K08 HL79172-01 (NHLBI) and the Smith Family Foundation Grant, P. S. is supported by NIH DK081605, and the research described in this study was supported by NIH DK31405 to B. M. S. and by NIDCD R01DC008295 to R. R. R.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05	27	355	367	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					619	U187		10.1038/nature08816	http://dx.doi.org/10.1038/nature08816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20200519	Green Accepted			2022-12-28	WOS:000275974200054
J	Seltzer, A				Seltzer, Abigail			Medical complicity, torture, and the war on terror	LANCET			English	Editorial Material									Med Fdn Care Victims Torture, London N7 7JW, England		Seltzer, A (corresponding author), Med Fdn Care Victims Torture, London N7 7JW, England.	aseltzer@torturecare.org.uk						*AM CIV LIB UN, 2009, REL BUSH ADM SECR LE; *CENTR INT AG OFF, 2004, COUNT DET INT ACT SE; Danner Mark, 2009, NEW YORK REV BOOKS, V56; LEWIS N, 2004, NY TIMES        1130; Maio G, 2001, LANCET, V357, P1609, DOI 10.1016/S0140-6736(00)04729-2; MAZZETTI M, 2009, NY TIMES        0416; Miles SH, 2004, LANCET, V364, P725, DOI 10.1016/S0140-6736(04)16902-X; Physicians for Human Rights, 2009, AID TORT HLTH PROF E; SANDS P, 2008, TORTURE TEAM, P200; STOUT D, 2009, NY TIMES        0115; World Medical Association, 1975, DECL TOK	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					872	873		10.1016/S0140-6736(09)61633-0	http://dx.doi.org/10.1016/S0140-6736(09)61633-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	574NA	20171730				2022-12-28	WOS:000275995300007
J	Tarduno, JA; Cottrell, RD; Watkeys, MK; Hofmann, A; Doubrovine, PV; Mamajek, EE; Liu, DJ; Sibeck, DG; Neukirch, LP; Usui, Y				Tarduno, John A.; Cottrell, Rory D.; Watkeys, Michael K.; Hofmann, Axel; Doubrovine, Pavel V.; Mamajek, Eric E.; Liu, Dunji; Sibeck, David G.; Neukirch, Levi P.; Usui, Yoichi			Geodynamo, Solar Wind, and Magnetopause 3.4 to 3.45 Billion Years Ago	SCIENCE			English	Article							GREENSTONE-BELT; SOUTH-AFRICA; EVOLUTION; MAGNETITE; SUN; CRYSTALS; VENUS	Stellar wind standoff by a planetary magnetic field prevents atmospheric erosion and water loss. Although the early Earth retained its water and atmosphere, and thus evolved as a habitable planet, little is known about Earth's magnetic field strength during that time. We report paleointensity results from single silicate crystals bearing magnetic inclusions that record a geodynamo 3.4 to 3.45 billion years ago. The measured field strength is similar to 50 to 70% that of the present-day field. When combined with a greater Paleoarchean solar wind pressure, the paleofield strength data suggest steady-state magnetopause standoff distances of <= 5 Earth radii, similar to values observed during recent coronal mass ejection events. The data also suggest lower-latitude aurora and increases in polar cap area, as well as heating, expansion, and volatile loss from the exosphere that would have affected long-term atmospheric composition.	[Tarduno, John A.; Cottrell, Rory D.; Doubrovine, Pavel V.; Usui, Yoichi] Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; [Tarduno, John A.; Mamajek, Eric E.; Neukirch, Levi P.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Watkeys, Michael K.; Hofmann, Axel] Univ KwaZulu Natal, Sch Geol Sci, ZA-4000 Durban, South Africa; [Doubrovine, Pavel V.] Univ Oslo, N-0316 Oslo, Norway; [Liu, Dunji] Chinese Acad Geol Sci, Beijing SHRIMP Ctr, Beijing 100037, Peoples R China; [Sibeck, David G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Usui, Yoichi] Tohoku Univ, Dept Earth Sci, Sendai, Miyagi 9808578, Japan	University of Rochester; University of Rochester; University of Kwazulu Natal; University of Oslo; Chinese Academy of Geological Sciences; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Tohoku University	Tarduno, JA (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	john@earth.rochester.edu	Usui, Yoichi/T-6254-2019; Sibeck, David G/D-4424-2012	Usui, Yoichi/0000-0003-2365-2485; Hofmann, Axel/0000-0002-8801-0443; Tarduno, John/0000-0002-0490-0124; Cottrell, Rory/0000-0003-4174-6389	NSF [EAR 0738844, EAR 0619467]; John Simon Guggenheim Foundation	NSF(National Science Foundation (NSF)); John Simon Guggenheim Foundation	We are grateful to the late William Goree for his encouragement and design of the small-bore SQUID magnetometer and to the staffs of William Goree Inc. and Applied Physics for final construction of the instrument. We thank J. Hopkins for assistance in the laboratory and G. Kloc for sample preparation. Supported by NSF grants EAR 0738844 and EAR 0619467 and the John Simon Guggenheim Foundation (J.A.T.).	Cottrell RD, 1999, EARTH PLANET SC LETT, V169, P1, DOI 10.1016/S0012-821X(99)00068-0; Cottrell RD, 2000, J GEOPHYS RES-SOL EA, V105, P23579, DOI 10.1029/2000JB900219; DUNLOP DJ, 1977, PHYS EARTH PLANET IN, V13, P325, DOI 10.1016/0031-9201(77)90117-0; Feinberg JM, 2005, GEOLOGY, V33, P513, DOI 10.1130/G21290.1; Griessmeier JM, 2004, ASTRON ASTROPHYS, V425, P753, DOI 10.1051/0004-6361:20035684; Gubbins D, 2004, GEOPHYS J INT, V157, P1407, DOI 10.1111/j.1365-246X.2004.02219.x; HALGEDAHL SL, 1980, J GEOPHYS RES, V85, P3690, DOI 10.1029/JB085iB07p03690; Hofmann A, 2007, DEV PREC G, V15, P571, DOI 10.1016/S0166-2635(07)15055-6; JAEGER JC, 1968, BASALT POLDERVAART, V2, P503; Korenaga J, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000241; Kulikov YN, 2007, SPACE SCI REV, V129, P207, DOI 10.1007/s11214-007-9192-4; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Lammer H, 2008, SPACE SCI REV, V139, P399, DOI 10.1007/s11214-008-9413-5; Lowe D. R., 1999, 329 GEOL SOC AM; Mamajek EE, 2008, ASTROPHYS J, V687, P1264, DOI 10.1086/591785; NEWKIRK G, 1980, GEOCHIM COSM SUPPL, V13, P293; Ozima M, 2005, NATURE, V436, P655, DOI 10.1038/nature03929; Rosenqvist L, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010927; SISCOE GL, 1975, J GEOPHYS RES-SPACE, V80, P4675, DOI 10.1029/JA080i034p04675; SISCOE GL, 1980, J GEOPHYS RES, V85, P3549, DOI 10.1029/JB085iB07p03549; Tarduno JA, 2006, REV GEOPHYS, V44, DOI 10.1029/2005RG000189; Tarduno JA, 2007, NATURE, V446, P657, DOI 10.1038/nature05667; Telleschi A, 2005, ASTROPHYS J, V622, P653, DOI 10.1086/428109; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; Usui Y, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002496; WILSON AH, 1994, PRECAMBRIAN RES, V67, P243, DOI 10.1016/0301-9268(94)90012-4; Winklhofer M, 1997, J GEOPHYS RES-SOL EA, V102, P22695, DOI 10.1029/97JB01730; Wood BE, 2006, SPACE SCI REV, V126, P3, DOI 10.1007/s11214-006-9006-0; Zhang TL, 2007, NATURE, V450, P654, DOI 10.1038/nature06026	29	200	208	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1238	1240		10.1126/science.1183445	http://dx.doi.org/10.1126/science.1183445			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203044				2022-12-28	WOS:000275162100034
J	Vuillermin, PJ; Robertson, CF; Carlin, JB; Brennan, SL; Biscan, MI; South, M				Vuillermin, P. J.; Robertson, C. F.; Carlin, J. B.; Brennan, S. L.; Biscan, M. I.; South, M.			Parent initiated prednisolone for acute asthma in children of school age: randomised controlled crossover trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL PREDNISOLONE; PRESCHOOL-CHILDREN; THERAPY; FLUTICASONE; MANAGEMENT	Objective To evaluate the efficacy of a short course of parent initiated oral prednisolone for acute asthma in children of school age. Design Double blind, randomised, placebo controlled, crossover trial in which episodes of asthma, rather than participants, were randomised to treatment. Setting The Barwon region of Victoria, Australia. Participants Children aged 5-12 years with a history of recurrent episodes of acute asthma. Intervention A short course of parent initiated treatment with prednisolone ( 1 mg/kg a day) or placebo. Main outcome measures The primary outcome measure was the mean daytime symptom score over seven days. Secondary outcome measures were mean night time symptom score over seven days, use of health resources, and school absenteeism. Results 230 children were enrolled in the study. Over a three year period, 131 (57%) of the participants contributed a total of 308 episodes of asthma that required parent initiated treatment: 155 episodes were treated with parent initiated prednisolone and 153 with placebo. The mean daytime symptom score was 15% lower in episodes treated with prednisolone than in those treated with placebo ( geometric mean ratio 0.85, 95% CI 0.74 to 0.98; P=0.023). Treatment with prednisolone was also associated with a 16% reduction in the night time symptom score ( geometric mean ratio 0.84, 95% CI 0.70 to 1.00; P=0.050), a reduced risk of health resource use ( odds ratio 0.54, 95% CI 0.34 to 0.86; P=0.010), and reduced school absenteeism( mean difference -0.4 days, 95% CI -0.8 to 0.0 days; P=0.045). Conclusion A short course of oral prednisolone initiated by parents when their child experiences an episode of acute asthma may reduce asthma symptoms, health resource use, and school absenteeism. However, the modest benefits of this strategy must be balanced against potential side effects of repeated short courses of an oral corticosteroid.	[Vuillermin, P. J.; Brennan, S. L.; Biscan, M. I.] Barwon Hlth, Geelong Hosp, Geelong, Vic 3220, Australia; [Robertson, C. F.] Royal Childrens Hosp, Dept Resp Med, Melbourne, Vic 3052, Australia; [South, M.] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic 3052, Australia; [Carlin, J. B.] Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Melbourne, Vic 3052, Australia; [Robertson, C. F.] Murdoch Childrens Res Inst, Dept Resp Med, Parkville, Vic 3052, Australia; [Carlin, J. B.] Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia; [South, M.] Murdoch Childrens Res Inst, Dept Gen Med, Parkville, Vic 3052, Australia; [Robertson, C. F.] Univ Melbourne, Dept Resp Med, Parkville, Vic 3052, Australia; [Carlin, J. B.] Univ Melbourne, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia; [South, M.] Univ Melbourne, Dept Gen Med, Parkville, Vic 3052, Australia	Geelong Hospital; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Murdoch Children's Research Institute; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne	Vuillermin, PJ (corresponding author), Barwon Hlth, Geelong Hosp, Geelong, Vic 3220, Australia.	peterv@barwonhealth.org.au	Carlin, John B/B-3492-2012; Carlin, John/AAG-4332-2020; Brennan-Olsen, Sharon/AAM-8595-2020	Carlin, John B/0000-0002-2694-9463; Carlin, John/0000-0002-2694-9463; Brennan-Olsen, Sharon/0000-0003-3269-5401; South, Mike/0000-0002-5530-2722	Murdoch Childrens Research Institute; National Health and Medical Research Council of Australia; Jack Brockhoff Foundation	Murdoch Childrens Research Institute; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Jack Brockhoff Foundation	PJV received scholarships from the Murdoch Childrens Research Institute and the National Health and Medical Research Council of Australia. The project was funded by the Jack Brockhoff Foundation, the Murdoch Childrens Research Institute, and the National Health and Medical Research Council of Australia. These funding bodies had no role in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	ALLEN DB, 1994, J ALLERGY CLIN IMMUN, V93, P967, DOI 10.1016/S0091-6749(94)70043-5; *ASTHM STRAT GROUP, 1999, ASTHM BEST PRACT GUI; Bernstein IL, 1995, ANN ALLERG ASTHMA IM, V75, P543; Bisgaard H, 2006, CHEST, V130, P1733, DOI 10.1378/chest.130.6.1733; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; BRODDE OE, 1988, EUR J CLIN PHARMACOL, V34, P145, DOI 10.1007/BF00614551; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; EDMONDS ML, 2003, COCHRANE DB SYST REV, V3; Ellenberg SS., 2002, DATA MONITORING COMM; GRANT CC, 1995, PEDIATRICS, V96, P224; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Kayani S, 2002, CHEST, V122, P624, DOI 10.1378/chest.122.2.624; Kelly HW, 2008, PEDIATRICS, V122, pE53, DOI 10.1542/peds.2007-3381; Khan MSR, 2003, J PAEDIATR CHILD H, V39, P432, DOI 10.1046/j.1440-1754.2003.00183.x; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Robertson CF, 2007, AM J RESP CRIT CARE, V175, P323, DOI 10.1164/rccm.200510-1546OC; RUBIN BK, 1990, PEDIATR PULM, V8, P45, DOI 10.1002/ppul.1950080112; Santanello NC, 1999, ARCH DIS CHILD, V80, P414, DOI 10.1136/adc.80.5.414; Schuh S, 2006, PEDIATRICS, V118, P644, DOI 10.1542/peds.2005-2842; SMITH M, 2003, COCHRANE DB SYST REV, V1; Streetman DD, 2002, ANN PHARMACOTHER, V36, P1249; Tan KS, 1997, AM J RESP CRIT CARE, V156, P28, DOI 10.1164/ajrccm.156.1.9610113; VUILLERMIN P, 2006, COCHRANE DB SYST REV, V3; Vuillermin PJ, 2007, MED J AUSTRALIA, V187, P221, DOI 10.5694/j.1326-5377.2007.tb01203.x; Vuillermin PJ, 2007, J PAEDIATR CHILD H, V43, P443, DOI 10.1111/j.1440-1754.2007.01108.x; Wolfe R, 1999, CONTROL CLIN TRIALS, V20, P547, DOI 10.1016/S0197-2456(99)00032-X; ZORA JA, 1986, J ALLERGY CLIN IMMUN, V77, P9, DOI 10.1016/0091-6749(86)90315-5	31	21	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2010	340								c843	10.1136/bmj.c843	http://dx.doi.org/10.1136/bmj.c843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565FH	20194353	Green Published, hybrid			2022-12-28	WOS:000275274200012
J	Horton, R				Horton, Richard			Offline: History lessons	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					710	710		10.1016/S0140-6736(10)60245-0	http://dx.doi.org/10.1016/S0140-6736(10)60245-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	564JW	20189013				2022-12-28	WOS:000275211200011
J	Ovize, M; Bonnefoy, E				Ovize, Michel; Bonnefoy, Eric			Giving the ischaemic heart a shot in the arm	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; REPERFUSION INJURY; SIZE		[Ovize, Michel; Bonnefoy, Eric] Hosp Civils Lyon, Hop Cardiovasc & Pneumol, F-69008 Lyon, France; [Ovize, Michel; Bonnefoy, Eric] Univ Lyon 1, F-69365 Lyon, France; [Ovize, Michel] INSERM 886, F-69008 Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ovize, M (corresponding author), Hosp Civils Lyon, Hop Cardiovasc & Pneumol, F-69008 Lyon, France.	michel.ovize@chu-lyon.fr	Ovize, michel/AAL-9247-2020					Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	10	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					699	700		10.1016/S0140-6736(09)62156-5	http://dx.doi.org/10.1016/S0140-6736(09)62156-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20189010				2022-12-28	WOS:000275211200004
J	Van de Velde, W; Zehirov, G; Szatmari, A; Debreczeny, M; Ishihara, H; Kevei, Z; Farkas, A; Mikulass, K; Nagy, A; Tiricz, H; Satiat-Jeunemaitre, B; Alunni, B; Bourge, M; Kucho, K; Abe, M; Kereszt, A; Maroti, G; Uchiumi, T; Kondorosi, E; Mergaert, P				Van de Velde, Willem; Zehirov, Grigor; Szatmari, Agnes; Debreczeny, Monika; Ishihara, Hironobu; Kevei, Zoltan; Farkas, Attila; Mikulass, Kata; Nagy, Andrea; Tiricz, Hilda; Satiat-Jeunemaitre, Beatrice; Alunni, Benoit; Bourge, Mickael; Kucho, Ken-ichi; Abe, Mikiko; Kereszt, Attila; Maroti, Gergely; Uchiumi, Toshiki; Kondorosi, Eva; Mergaert, Peter			Plant Peptides Govern Terminal Differentiation of Bacteria in Symbiosis	SCIENCE			English	Article							MEDICAGO-TRUNCATULA; LEGUME SYMBIOSIS; ANTIMICROBIAL PEPTIDES; RHIZOBIUM-MELILOTI; CELL-CYCLE; GENES; NODULES; ORGANIZATION; MODEL	Legume plants host nitrogen-fixing endosymbiotic Rhizobium bacteria in root nodules. In Medicago truncatula, the bacteria undergo an irreversible (terminal) differentiation mediated by hitherto unidentified plant factors. We demonstrated that these factors are nodule-specific cysteine-rich (NCR) peptides that are targeted to the bacteria and enter the bacterial membrane and cytosol. Obstruction of NCR transport in the dnf1-1 signal peptidase mutant correlated with the absence of terminal bacterial differentiation. On the contrary, ectopic expression of NCRs in legumes devoid of NCRs or challenge of cultured rhizobia with peptides provoked symptoms of terminal differentiation. Because NCRs resemble antimicrobial peptides, our findings reveal a previously unknown innovation of the host plant, which adopts effectors of the innate immune system for symbiosis to manipulate the cell fate of endosymbiotic bacteria.	[Van de Velde, Willem; Szatmari, Agnes; Satiat-Jeunemaitre, Beatrice; Alunni, Benoit; Bourge, Mickael; Kondorosi, Eva; Mergaert, Peter] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Zehirov, Grigor; Ishihara, Hironobu; Kucho, Ken-ichi; Abe, Mikiko; Uchiumi, Toshiki] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Szatmari, Agnes] Hungarian Acad Sci, Inst Plant Protect, H-1022 Budapest, Hungary; [Debreczeny, Monika; Kevei, Zoltan; Farkas, Attila; Mikulass, Kata; Nagy, Andrea; Tiricz, Hilda; Kereszt, Attila; Maroti, Gergely; Kondorosi, Eva] Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, H-6726 Szeged, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Kagoshima University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Kondorosi, E (corresponding author), CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France.	eva.kondorosi@isv.cnrs-gif.fr	Mergaert, Peter/M-1265-2019; Kevei, Zoltan/AAF-5054-2021; Satiat-Jeunemaitre, Beatrice/M-6055-2013	Mergaert, Peter/0000-0002-5919-7317; Kevei, Zoltan/0000-0002-3065-3198; Szatmari, Agnes/0000-0001-8768-8212; Satiat-Jeunemaitre, Beatrice/0000-0001-7125-0814; Bourge, Mickael/0000-0002-4111-6208; Maroti, Gergely/0000-0002-3705-0461; Kereszt, Attila/0000-0002-4421-6554; Kondorosi, Eva/0000-0002-4065-8515	Agence National de la Recherche [ANR-05-BLAN-0129]; Japanese Society for the Promotion of Science; Hungarian National Office for Research and Technology [OMFB-00441/2007]; French Ministry of Research	Agence National de la Recherche(French National Research Agency (ANR)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hungarian National Office for Research and Technology(National Office for Research and Technology); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We thank S. Long, T. Bisseling, G. Ferguson, and R. Whitford for helpful comments on the manuscript; S. Brown, M. Yamaura, P. Laporte, P. Durand, E. Klement, E. Magyarodi, and the IMAGIF platform for technical support; and S. Long, D. Wang, D. Barker, P. Ludden, and N. Suganuma for providing materials. This work was supported by the Agence National de la Recherche project ANR-05-BLAN-0129 (W.V.d. V., A. S., E. K. and P. M.), the Japanese Society for the Promotion of Science (G.Z. and T. U.), the Hungarian National Office for Research and Technology Teller program OMFB-00441/2007 (M. D., A. F., K. M., A.N., H. T., A. K., G. M. and E. K.), and a Ph.D. fellowship from the French Ministry of Research (B. A.). E. Kondorosi et al. European patent no. 09305547.3-2107 related to the antimicrobial activity of NCR peptides is pending.	Alunni B, 2007, MOL PLANT MICROBE IN, V20, P1138, DOI 10.1094/MPMI-20-9-1138; Beijerinck MW., 1888, BOT ZTG, V46, P725; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cheng JJ, 2007, MICROBIOL-SGM, V153, P375, DOI 10.1099/mic.0.2006/001362-0; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kondorosi E, 2000, CURR OPIN PLANT BIOL, V3, P488, DOI 10.1016/S1369-5266(00)00118-7; Latch JN, 1997, J BACTERIOL, V179, P2373, DOI 10.1128/jb.179.7.2373-2381.1997; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Oono R, 2009, NEW PHYTOL, V183, P967, DOI 10.1111/j.1469-8137.2009.02941.x; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sibley CD, 2006, MICROBIOL-SGM, V152, P443, DOI 10.1099/mic.0.28455-0; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Verma DPS, 1996, TRENDS MICROBIOL, V4, P364, DOI 10.1016/0966-842X(96)10053-6; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997	23	356	372	8	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1122	1126		10.1126/science.1184057	http://dx.doi.org/10.1126/science.1184057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185722				2022-12-28	WOS:000274901100034
J	Cain, KP; McCarthy, KD; Heilig, CM; Monkongdee, P; Tasaneeyapan, T; Kanara, N; Kimerling, ME; Chheng, P; Thai, S; Sar, B; Phanuphak, P; Teeratakulpisarn, N; Phanuphak, N; Nguyen, HD; Hoang, TQ; Le, HT; Varma, JK				Cain, Kevin P.; McCarthy, Kimberly D.; Heilig, Charles M.; Monkongdee, Patama; Tasaneeyapan, Theerawit; Kanara, Nong; Kimerling, Michael E.; Chheng, Phalkun; Thai, Sopheak; Sar, Borann; Phanuphak, Praphan; Teeratakulpisarn, Nipat; Phanuphak, Nittaya; Nguyen Huy Dung; Hoang Thi Quy; Le Hung Thai; Varma, Jay K.			An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; ISONIAZID PREVENTIVE THERAPY; IMMUNE RECONSTITUTION; INFECTED PERSONS; RISK-FACTORS; PULMONARY TUBERCULOSIS; SPUTUM SMEARS; PREVALENCE; RATES; DEATH	BACKGROUND Tuberculosis screening is recommended for people with human immunodeficiency virus (HIV) infection to facilitate early diagnosis and safe initiation of antiretroviral therapy and isoniazid preventive therapy. No internationally accepted, evidence-based guideline addresses the optimal means of conducting such screening, although screening for chronic cough is common. METHODS We consecutively enrolled people with HIV infection from eight outpatient clinics in Cambodia, Thailand, and Vietnam. For each patient, three samples of sputum and one each of urine, stool, blood, and lymph-node aspirate (for patients with lymphadenopathy) were obtained for mycobacterial culture. We compared the characteristics of patients who received a diagnosis of tuberculosis (on the basis of having one or more specimens that were culture-positive) with those of patients who did not have tuberculosis to derive an algorithm for screening and diagnosis. RESULTS Tuberculosis was diagnosed in 267 (15%) of 1748 patients (median CD4+ T-lymphocyte count, 242 per cubic millimeter; interquartile range, 82 to 396). The presence of a cough for 2 or 3 weeks or more during the preceding 4 weeks had a sensitivity of 22 to 33% for detecting tuberculosis. The presence of cough of any duration, fever of any duration, or night sweats lasting 3 or more weeks in the preceding 4 weeks was 93% sensitive and 36% specific for tuberculosis. In the 1199 patients with any of these symptoms, a combination of two negative sputum smears, a normal chest radiograph, and a CD4+ cell count of 350 or more per cubic millimeter helped to rule out a diagnosis of tuberculosis, whereas a positive diagnosis could be made only for the 113 patients (9%) with one or more positive sputum smears; mycobacterial culture was required for most other patients. CONCLUSIONS In persons with HIV infection, screening for tuberculosis should include asking questions about a combination of symptoms rather than only about chronic cough. It is likely that antiretroviral therapy and isoniazid preventive therapy can be started safely in people whose screening for all three symptoms is negative, whereas diagnosis in most others will require mycobacterial culture.	[Cain, Kevin P.; McCarthy, Kimberly D.; Heilig, Charles M.; Varma, Jay K.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Monkongdee, Patama; Tasaneeyapan, Theerawit; Varma, Jay K.] Thailand Minist Publ Hlth CDC Collaborat, Nonthaburi, Thailand; [Phanuphak, Praphan; Teeratakulpisarn, Nipat; Phanuphak, Nittaya] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Kanara, Nong] US CDC, Global AIDS Program, Phnom Penh, Cambodia; [Thai, Sopheak] Sihanouk Hosp Ctr Hope, Phnom Penh, Cambodia; [Sar, Borann] Inst Pasteur Cambodia, Phnom Penh, Cambodia; [Kimerling, Michael E.; Chheng, Phalkun] Univ Alabama Birmingham, Birmingham, AL USA; [Nguyen Huy Dung; Hoang Thi Quy] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam; [Le Hung Thai] US CDC, Global AIDS Program, Ho Chi Minh City, Vietnam; [Kimerling, Michael E.] Bill & Melinda Gates Fdn, Seattle, WA USA	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand; Thai Red Cross Society; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of Alabama System; University of Alabama Birmingham; Bill & Melinda Gates Foundation	Cain, KP (corresponding author), CDC, 1600 Clifton Rd,MS-E-10, Atlanta, GA 30333 USA.	kcain@cdc.gov	Heilig, Charles M/C-2753-2008; Phanuphak, Nittaya/AAA-8579-2019; Hug, Balthasar L./G-1568-2010	Heilig, Charles M/0000-0003-1075-1310; 	U.S. Agency for International Development	U.S. Agency for International Development(United States Agency for International Development (USAID))	Supported by a grant from the U.S. Agency for International Development.	Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; CHHENG P, 2008, INT J TUBERC LUNG S1, V12, P54; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; French MA, 2009, CLIN INFECT DIS, V48, P101, DOI 10.1086/595006; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Harries AD, 1998, INT J TUBERC LUNG D, V2, P999; Kimerling ME, 2002, INT J TUBERC LUNG D, V6, P988; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Manabe YC, 2007, JAIDS-J ACQ IMM DEF, V46, P456, DOI 10.1097/QAI.0b013e3181594c8c; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; SMITH RL, 1994, CHEST, V106, P684, DOI 10.1378/chest.106.3.684; Swaminathan S, 2004, INT J TUBERC LUNG D, V8, P896; WHO, 2008, GLOBAL TUBERCULOSIS; *WHO, 2007, WHOHTMTB2007379; *WHO, 2004, INT POL COLL TB HIV; Zhang HP, 1999, RECURSIVE PARTITIONI	29	197	204	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					707	716		10.1056/NEJMoa0907488	http://dx.doi.org/10.1056/NEJMoa0907488			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181972	Bronze			2022-12-28	WOS:000274845600009
J	Tricomi, E; Rangel, A; Camerer, CF; O'Doherty, JP				Tricomi, Elizabeth; Rangel, Antonio; Camerer, Colin F.; O'Doherty, John P.			Neural evidence for inequality-averse social preferences	NATURE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; FAIRNESS; RESPONSES; BRAIN; PREDICTION; PUNISHMENT; MOTIVES	A popular hypothesis in the social sciences is that humans have social preferences to reduce inequality in outcome distributions because it has a negative impact on their experienced reward(1-3). Although there is a large body of behavioural and anthropological evidence consistent with the predictions of these theories(1,4-6), there is no direct neural evidence for the existence of inequality-averse preferences. Such evidence would be especially useful because some behaviours that are consistent with a dislike for unequal outcomes could also be explained by concerns for social image(7) or reciprocity(8,9), which do not require a direct aversion towards inequality. Here we use functional MRI to test directly for the existence of inequality-averse social preferences in the human brain. Inequality was created by recruiting pairs of subjects and giving one of them a large monetary endowment. While both subjects evaluated further monetary transfers from the experimenter to themselves and to the other participant, we measured neural responses in the ventral striatum and ventromedial prefrontal cortex, two areas that have been shown to be involved in the valuation of monetary and primary rewards in both social and non-social contexts(10-14). Consistent with inequality-averse models of social preferences, we find that activity in these areas was more responsive to transfers to others than to self in the 'high-pay' subject, whereas the activity of the 'low-pay' subject showed the opposite pattern. These results provide direct evidence for the validity of this class of models, and also show that the brain's reward circuitry is sensitive to both advantageous and disadvantageous inequality.	[Rangel, Antonio; Camerer, Colin F.; O'Doherty, John P.] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Tricomi, Elizabeth] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [O'Doherty, John P.] Trinity Coll Dublin, Sch Psychol, Dublin 2, Ireland; [O'Doherty, John P.] Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland	California Institute of Technology; Rutgers State University Newark; Rutgers State University New Brunswick; Trinity College Dublin; Trinity College Dublin	O'Doherty, JP (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	johnpodoherty@gmail.com	sarinopoulos, isidoros/B-5453-2010; O'Doherty, John P/F-1204-2013	Tricomi, Elizabeth/0000-0002-3659-2656	US National Science Foundation [0617174]; Human Frontiers of Science Program; Gordon and Betty Moore Foundation; Caltech Brain Imaging Center	US National Science Foundation(National Science Foundation (NSF)); Human Frontiers of Science Program(Human Frontier Science Program); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Caltech Brain Imaging Center	We thank B. Bushong, N. Tetrault, S. Bray, J. Glascher and R. Lee for their assistance. This work was supported by grants from the US National Science Foundation to J.O.D. (0617174), from the Human Frontiers of Science Program to C. F. C., and from the Gordon and Betty Moore Foundation to J.O.D., A. R., C. F. C. and the Caltech Brain Imaging Center.	ADAMS JS, 1965, ADV EXP SOC PSYCHOL, V2, P267; AKERLOF GA, 1990, Q J ECON, V105, P255, DOI 10.2307/2937787; Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Andreoni J, 2009, ECONOMETRICA, V77, P1607, DOI 10.3982/ECTA7384; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Costa PT., 1992, REVISED NEO PERSONAL; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Frank R. H., 1985, CHOOSING RIGHT POND; FRANK RH, 1984, AM ECON REV, V74, P549; Gurven M, 2006, CURR ANTHROPOL, V47, P185, DOI 10.1086/499552; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; KAKWANI NC, 1977, ECON J, V87, P71, DOI 10.2307/2231833; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Krueger AB, 2004, J POLIT ECON, V112, P253, DOI 10.1086/381479; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; RABIN M, 1993, AM ECON REV, V83, P1281; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x	39	266	274	1	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1089	U109		10.1038/nature08785	http://dx.doi.org/10.1038/nature08785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	563DR	20182511				2022-12-28	WOS:000275108400038
J	Cook, S				Cook, Sophie			Global Health Linking up for better health care	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cook, S (corresponding author), BMJ, London WC1H 9JR, England.	scook@bmj.com						*AIMS, WAL AFR HLTH LINKS; *BRIT COUNC, UK INT HLTH LINKS FU; Crisp N., 2007, GLOBAL HLTH PARTNERS; GORDON M, WHAT DIFFERENCE ARE; Scottish Government, 2008, INT DEV POL; *TROP HLTH ED TRUS, 2006, CREAT PARTN HLTH THE; *WELSH ASS GOV, WAL AFR GRANT SCH 20; *WHO, PROGR MILL DEV GOALS; 2009, REFERENCE GUIDE POST	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 19	2010	340								c768	10.1136/bmj.c768	http://dx.doi.org/10.1136/bmj.c768			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JX	20172925				2022-12-28	WOS:000274739200009
J	Slichter, SJ; Kaufman, RM; Assmann, SF; McCullough, J; Triulzi, DJ; Strauss, RG; Gernsheimer, TB; Ness, PM; Brecher, ME; Josephson, CD; Konkle, BA; Woodson, RD; Ortel, TL; Hillyer, CD; Skerrett, DL; McCrae, KR; Sloan, SR; Uhl, L; George, JN; Aquino, VM; Manno, CS; McFarland, JG; Hess, JR; Leissinger, C; Granger, S; Exum, V; Hendrix, D; Ruys, N; Werndli, J; Koenig, K; Turman, N; Stublaski, J; Lankiewicz, M; Miller-Metcalfe, D; Graminske, S; Dora, R; Heldke, S; Divgi, AB; Boos, J; Beekman, S; Punzalan, R; Neufeld, EJ; Kang, T; Hedstrom, J; Harney, K; Malynn, B; Kelly, M; Rowe, B; Wallace, K; Slate, S; Bussel, J; Feldman, E; Nguyen, C; Cruz, J; Wissert, M; Adams, S; Anderson, T; Higgins, C; Mette, C; Petzold, E; Pinaroc, C; Thornburg, C; Telen, MJ; Castillejo, MI; Newman, J; Ieong, J; Johnson, J; Case, R; Fuller, A; Fuller, AK; Deyle, A; Corson, J; Hirata, A; Aboulafia, D; Matthews, D; Kruse-Jarres, R; Safah, H; Schmidt, C; Link, B; Raife, T; Swift, J; Schrock, D; Mitrou, M; Spanfelner, J; Carr, T; Chlebeck, T; Malcolm, S; Pulkrabek, S; Tsui, A; Miller, M; Hay, S; Terrell, D; Li, X; Buchanan, G; Cox, J; Hoffman, T; Paranjape, G; Stadtmauer, EA; Tarng, I; Kelty, M; Einarson, M; Hinkle, K; Parker, A; Wade, A; Nathanson, J; Braun, M; D'Andrea, P; Blanker, L; AuBuchon, J; Brambilla, D; Corbett, AS; Devlin, E; Erickson, J; Gerstenberger, E; Hayes, K; Miller, J; Scott, J; Nemo, G; Glynn, S; Harvath, L; Leifer, E; Mondoro, T; Wagner, E; Geyer, S; Lane, T; Lusher, J; McLeod, B; Reitsma, A; Roberson, P; Shapiro, A; Whitsett, C				Slichter, Sherrill J.; Kaufman, Richard M.; Assmann, Susan F.; McCullough, Jeffrey; Triulzi, Darrell J.; Strauss, Ronald G.; Gernsheimer, Terry B.; Ness, Paul M.; Brecher, Mark E.; Josephson, Cassandra D.; Konkle, Barbara A.; Woodson, Robert D.; Ortel, Thomas L.; Hillyer, Christopher D.; Skerrett, Donna L.; McCrae, Keith R.; Sloan, Steven R.; Uhl, Lynne; George, James N.; Aquino, Victor M.; Manno, Catherine S.; McFarland, Janice G.; Hess, John R.; Leissinger, Cindy; Granger, Suzanne; Exum, V.; Hendrix, D.; Ruys, N.; Werndli, J.; Koenig, K.; Turman, N.; Stublaski, J.; Lankiewicz, M.; Miller-Metcalfe, D.; Graminske, S.; Dora, R.; Heldke, S.; Divgi, A. B.; Boos, J.; Beekman, S.; Punzalan, R.; Neufeld, E. J.; Kang, T.; Hedstrom, J.; Harney, K.; Malynn, B.; Kelly, M.; Rowe, B.; Wallace, K.; Slate, S.; Bussel, J.; Feldman, E.; Nguyen, C.; Cruz, J.; Wissert, M.; Adams, S.; Anderson, T.; Higgins, C.; Mette, C.; Petzold, E.; Pinaroc, C.; Thornburg, C.; Telen, M. J.; Castillejo, M. -I.; Newman, J.; Ieong, J.; Johnson, J.; Case, R.; Fuller, A.; Fuller, A. K.; Deyle, A.; Corson, J.; Hirata, A.; Aboulafia, D.; Matthews, D.; Kruse-Jarres, R.; Safah, H.; Schmidt, C.; Link, B.; Raife, T.; Swift, J.; Schrock, D.; Mitrou, M.; Spanfelner, J.; Carr, T.; Chlebeck, T.; Malcolm, S.; Pulkrabek, S.; Tsui, A.; Miller, M.; Hay, S.; Terrell, D.; Li, X.; Buchanan, G.; Cox, J.; Hoffman, T.; Paranjape, G.; Stadtmauer, E. A.; Tarng, I.; Kelty, M.; Einarson, M.; Hinkle, K.; Parker, A.; Wade, A.; Nathanson, J.; Braun, M.; D'Andrea, P.; Blanker, L.; AuBuchon, J.; Brambilla, D.; Corbett, A. S.; Devlin, E.; Erickson, J.; Gerstenberger, E.; Hayes, K.; Miller, J.; Scott, J.; Nemo, G.; Glynn, S.; Harvath, L.; Leifer, E.; Mondoro, T.; Wagner, E.; Geyer, S.; Lane, T.; Lusher, J.; McLeod, B.; Reitsma, A.; Roberson, P.; Shapiro, A.; Whitsett, C.			Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACUTE MYELOID-LEUKEMIA; THROMBOCYTOPENIC PATIENTS; BLEEDING RISK; SURVIVAL; DESIGN	BACKGROUND We conducted a trial of prophylactic platelet transfusions to evaluate the effect of platelet dose on bleeding in patients with hypoproliferative thrombocytopenia. METHODS We randomly assigned hospitalized patients undergoing hematopoietic stem-cell transplantation or chemotherapy for hematologic cancers or solid tumors to receive prophylactic platelet transfusions at a low dose, a medium dose, or a high dose (1.1x10(11), 2.2x10(11), or 4.4x10(11) platelets per square meter of body-surface area, respectively), when morning platelet counts were 10,000 per cubic millimeter or lower. Clinical signs of bleeding were assessed daily. The primary end point was bleeding of grade 2 or higher (as defined on the basis of World Health Organization criteria). RESULTS In the 1272 patients who received at least one platelet transfusion, the primary end point was observed in 71%, 69%, and 70% of the patients in the low-dose group, the medium-dose group, and the high-dose group, respectively ( differences were not significant). The incidences of higher grades of bleeding, and other adverse events, were similar among the three groups. The median number of platelets transfused was significantly lower in the low-dose group (9.25x10(11)) than in the medium-dose group (11.25x10(11)) or the high-dose group (19.63x10(11)) (P = 0.002 for low vs. medium, P<0.001 for high vs. low and high vs. medium), but the median number of platelet transfusions given was significantly higher in the low-dose group ( five, vs. three in the medium-dose and three in the high-dose group; P<0.001 for low vs. medium and low vs. high). Bleeding occurred on 25% of the study days on which morning platelet counts were 5000 per cubic millimeter or lower, as compared with 17% of study days on which platelet counts were 6000 to 80,000 per cubic millimeter (P<0.001). CONCLUSIONS Low doses of platelets administered as a prophylactic transfusion led to a decreased number of platelets transfused per patient but an increased number of transfusions given. At doses between 1.1x10(11) and 4.4x10(11) platelets per square meter, the number of platelets in the prophylactic transfusion had no effect on the incidence of bleeding. (ClinicalTrials.gov number, NCT00128713.)	[Slichter, Sherrill J.; Gernsheimer, Terry B.] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Slichter, Sherrill J.; Gernsheimer, Terry B.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Kaufman, Richard M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Sloan, Steven R.] Childrens Hosp, Boston, MA 02115 USA; [Uhl, Lynne] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Assmann, Susan F.; Granger, Suzanne] New England Res Inst, Watertown, MA 02172 USA; [McCullough, Jeffrey] Fairview Univ Med Ctr, Minneapolis, MN USA; [Triulzi, Darrell J.] Univ Pittsburgh, Pittsburgh, PA USA; [Strauss, Ronald G.] Univ Iowa, Iowa City, IA USA; [Ness, Paul M.] Johns Hopkins Univ, Baltimore, MD USA; [Hess, John R.] Univ Maryland, Baltimore, MD 21201 USA; [Brecher, Mark E.] Univ N Carolina, Chapel Hill, NC USA; [Josephson, Cassandra D.; Hillyer, Christopher D.] Emory Univ, Atlanta, GA 30322 USA; [Konkle, Barbara A.] Univ Penn, Philadelphia, PA 19104 USA; [Manno, Catherine S.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Woodson, Robert D.; McFarland, Janice G.] Blood Ctr Wisconsin, Milwaukee, WI USA; [Woodson, Robert D.; McFarland, Janice G.] Univ Wisconsin, Madison, WI 53706 USA; [Ortel, Thomas L.] Duke Univ, Durham, NC USA; [Skerrett, Donna L.] Cornell Univ, Weill Coll, New York, NY 10021 USA; [McCrae, Keith R.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [George, James N.] Univ Oklahoma, Oklahoma City, OK USA; [Aquino, Victor M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Leissinger, Cindy] Tulane Univ Hosp & Clin, New Orleans, LA USA	Puget Sound Blood Center; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; HealthCore, Inc; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; Emory University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Versiti Blood Center of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; Duke University; Cornell University; Case Western Reserve University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tulane University	Slichter, SJ (corresponding author), Puget Sound Blood Ctr, 921 Terry Ave, Seattle, WA 98104 USA.	sjslichter@psbc.org	Josephson, Cassandra/AFS-2243-2022; Hay, Simon Iain/F-8967-2015; Neufeld, Ellis J./F-9331-2011; Konkle, Barbara A/AAD-7712-2022; Konkle, Barbara/GPX-3325-2022; Kaufman, Richard M/E-8890-2018	Hay, Simon Iain/0000-0002-0611-7272; Neufeld, Ellis J./0000-0001-8092-6281; Konkle, Barbara A/0000-0002-3959-8797; Kaufman, Richard M/0000-0003-1520-4535; Telen, Marilyn/0000-0003-3809-1780; Manno, Catherine/0000-0001-8029-0391	National Heart, Lung, and Blood Institute of the National Institutes of Health [HL072268, HL072033, HL072291, HL072196, HL072289, HL072248, HL072191, HL072299, HL072305, HL072274, HL072028, HL072359, HL072072, HL072355, HL072283, HL072346, HL072331, HL072290]; U.S. Army Medical Research Acquisition Activity; Z- Medica; Fenwal Laboratories; Cerus; Caridian-BCT; Mediware; Amgen; Baxter Healthcare; Bayer Healthcare; EMD Healthcare Communications Scientific Communication Group; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072355, U01HL072346, U01HL072299, U01HL072072, U01HL072248, U01HL072290, U01HL072305, U01HL072289, U01HL072359, U01HL072196, U01HL072033, U01HL072268, U01HL072331, U01HL072274, U01HL072283, U01HL072291, U01HL072191, U01HL072028] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Army Medical Research Acquisition Activity; Z- Medica; Fenwal Laboratories; Cerus; Caridian-BCT; Mediware; Amgen(Amgen); Baxter Healthcare; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); EMD Healthcare Communications Scientific Communication Group; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health to the Data Coordinating Center at New England Research Institutes (HL072268), Case Western Reserve University (HL072033), Children's Hospital Boston (HL072291), Cornell University (HL072196), Duke University (HL072289), Emory University (HL072248), Johns Hopkins University (HL072191), Massachusetts General Hospital (HL072299), Puget Sound Blood Center (HL072305), Tulane University (HL072274), University of Iowa (HL072028), University of Maryland (HL072359), University of Minnesota (HL072072), University of North Carolina (HL072355), University of Oklahoma (HL072283), University of Pennsylvania (HL072346), University of Pittsburgh (HL072331), and the Blood Center of Wisconsin (HL072290).; Dr. Slichter reports receiving grant support from U.S. Army Medical Research Acquisition Activity (Department of Defense), Navigant Biotechnologies, and Pall Medical; Dr. Assmann, receiving grant support from Z- Medica; Dr. Triulzi, receiving consulting fees from Fenwal Laboratories and Cerus and lecture fees from Pall; Dr. Strauss, receiving consulting fees from Caridian-BCT; Dr. Ness, receiving consulting fees from Fenwal Laboratories and Caridian-BCT; Dr. Brecher, receiving consulting fees from Fenwal Laboratories; Dr. Josephson, receiving lecture fees from Mediware; Dr. George, receiving consulting fees and grant support from Amgen; and Dr. Manno, receiving consulting fees and grant support from Baxter Healthcare, consulting fees from Bayer Healthcare, and lecture fees from EMD Healthcare Communications Scientific Communication Group. No other potential conflicts of interest relevant to this article	Brecher ME, 1999, TRANSFUSION, V39, P431; Cox D. R., 1984, ANAL SURVIVAL DATA; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Goodnough LT, 2001, BLOOD, V98, P1346, DOI 10.1182/blood.V98.5.1346; Hardin JW, 2012, GEN ESTIMATING EQUAT; Heddle NM, 2007, ISBT SCI SERIES, V2, P220, DOI 10.1111/j.1751-2824.2007.00093.x; Heddle NM, 2009, BLOOD, V113, P1564, DOI 10.1182/blood-2008-09-178236; Heddle NM, 2006, TRANSFUSION, V46, P903, DOI 10.1111/j.1537-2995.2006.00822.x; Heddle NM, 2003, TRANSFUSION, V43, P742, DOI 10.1046/j.1537-2995.2003.00418.x; Hersh JK, 1998, TRANSFUSION, V38, P637, DOI 10.1046/j.1537-2995.1998.38798346631.x; Klumpp TR, 1999, TRANSFUSION, V39, P674, DOI 10.1046/j.1537-2995.1999.39070674.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Nevo S, 1998, BLOOD, V91, P1469, DOI 10.1182/blood.V91.4.1469; Norol F, 1998, BLOOD, V92, P1448, DOI 10.1182/blood.V92.4.1448.416k10_1448_1453; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; *SAS I, 2000, SAS STAT SOFTW VERS; Sensebe L, 2005, BLOOD, V105, P862, DOI 10.1182/blood-2004-05-1841; Slichter SJ, 2006, J CLIN APHERESIS, V21, P78, DOI 10.1002/jca.20090; Slichter SJ, 2004, TRANSFUS MED REV, V18, P153, DOI 10.1016/j.tmrv.2004.03.003; Stanworth SJ, 2005, BRIT J HAEMATOL, V131, P588, DOI 10.1111/j.1365-2141.2005.05769.x; Tinmouth A, 2004, TRANSFUSION, V44, P1711, DOI 10.1111/j.0041-1132.2004.04118.x; Tinmouth AT, 2003, TRANSFUS MED REV, V17, P181, DOI 10.1016/S0887-7963(03)00018-X; Wandt H, 2005, BLOOD, V106, p129A; Whitaker B.I., 2007 NATL BLOOD COLL; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	27	398	408	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					600	613		10.1056/NEJMoa0904084	http://dx.doi.org/10.1056/NEJMoa0904084			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556ED	20164484	Green Published, Green Accepted			2022-12-28	WOS:000274571200008
J	Pandit, RJ; Innes, WA; Strong, NP; James, RA				Pandit, Ranjeet J.; Innes, William A.; Strong, Nick P.; James, Robert A.			Loss of vision? Clear as crystal!	LANCET			English	Editorial Material							CALCIFICATION; SIGN		[Pandit, Ranjeet J.; Innes, William A.; Strong, Nick P.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [James, Robert A.] Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Innes, WA (corresponding author), Royal Victoria Infirm, Dept Ophthalmol, Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	william.innes@nuth.nhs.uk		Innes, William/0000-0003-0131-0169				BERLYNE GM, 1968, LANCET, V2, P366; COGAN DG, 1948, ARCH OPHTHALMOL-CHIC, V40, P624, DOI 10.1001/archopht.1948.00900030639004; PORTER R, 1973, BRIT J OPHTHALMOL, V57, P665, DOI 10.1136/bjo.57.9.665; WALSH FB, 1953, AM J OPHTHALMOL, V36, P1657, DOI 10.1016/0002-9394(53)90001-4; WALSH FB, 1947, J CLIN ENDOCRINOL, V7, P644, DOI 10.1210/jcem-7-9-644	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					610	610		10.1016/S0140-6736(09)61911-5	http://dx.doi.org/10.1016/S0140-6736(09)61911-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560YO	20159294				2022-12-28	WOS:000274941900035
J	Heisler, IA; Meech, SR				Heisler, Ismael A.; Meech, Stephen R.			Low-Frequency Modes of Aqueous Alkali Halide Solutions: Glimpsing the Hydrogen Bonding Vibration	SCIENCE			English	Article							WATER-MOLECULES; LIGHT-SCATTERING; SOLVATION SHELLS; SALT-SOLUTIONS; AB-INITIO; DYNAMICS; SPECTROSCOPY; COMPLEX; FLUIDS; IONS	The solvation of ions in aqueous media is a fundamental process in biology and chemistry. Here, we report direct time-domain observations of the hydrogen bond vibrational mode formed between a halide ion (chloride, bromide, or iodide) and the surrounding water molecules. The frequency of the hydrogen bond mode is sensitive to both the atomic weight and the concentration of the ion. The peak frequencies fall in the 125 to 175 wave-number range, a spectral region accessed through time-domain polarization-resolved coherent Raman scattering using a diffractive optic method. The polarized Raman response observed is discussed in terms of the structure of the anion's solvation shell and modeled through calculations on water chloride clusters.	[Heisler, Ismael A.; Meech, Stephen R.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Meech, SR (corresponding author), Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England.	s.meech@uea.ac.uk	Heisler, Ismael/N-5809-2014	Heisler, Ismael/0000-0002-8581-4745; Meech, Stephen/0000-0001-5561-2782	Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/E010466/1] Funding Source: researchfish; EPSRC [EP/E010466/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to the Engineering and Physical Sciences Research Council for financial support and to M. Kondo and V. Oganesyan for assistance with the DFT calculations.	Ando K, 1999, ADV CHEM PHYS, V110, P381, DOI 10.1002/9780470141694.ch6; Ayotte P, 1998, J AM CHEM SOC, V120, P12361, DOI 10.1021/ja981979f; Bakker HJ, 2008, CHEM REV, V108, P1456, DOI 10.1021/cr0206622; Fecko CJ, 2002, J CHEM PHYS, V117, P1139, DOI 10.1063/1.1485070; FRENKEL D, 1980, J CHEM PHYS, V72, P2801, DOI 10.1063/1.439429; Goodno GD, 1998, J OPT SOC AM B, V15, P1791, DOI 10.1364/JOSAB.15.001791; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hunt NT, 2007, PHYS CHEM CHEM PHYS, V9, P2167, DOI 10.1039/b616078f; Jungwirth P, 2001, J PHYS CHEM B, V105, P10468, DOI 10.1021/jp012750g; KANO S, 1988, INTRO NONLINEAR LASE; KINOSHITA S, 1995, CHEM PHYS LETT, V236, P259, DOI 10.1016/0009-2614(95)00218-S; Koneshan S, 1998, J PHYS CHEM B, V102, P4193, DOI 10.1021/jp980642x; Krekeler C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2218338; Kropman MF, 2001, SCIENCE, V291, P2118, DOI 10.1126/science.1058190; Kropman MF, 2001, J CHEM PHYS, V115, P8942, DOI 10.1063/1.1412249; Laage D, 2007, P NATL ACAD SCI USA, V104, P11167, DOI 10.1073/pnas.0701699104; Mallik BS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3006032; Mizoguchi K, 1998, J CHEM PHYS, V109, P1867, DOI 10.1063/1.476763; Moilanen DE, 2009, P NATL ACAD SCI USA, V106, P375, DOI 10.1073/pnas.0811489106; Nigro B, 2006, J PHYS CHEM A, V110, P11237, DOI 10.1021/jp064846m; Ohmine I, 1999, ACCOUNTS CHEM RES, V32, P741, DOI 10.1021/ar970161g; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Park S, 2007, P NATL ACAD SCI USA, V104, P16731, DOI 10.1073/pnas.0707824104; Raugei S, 2002, J CHEM PHYS, V116, P196, DOI 10.1063/1.1421366; Tobias DJ, 2001, J CHEM PHYS, V114, P7036, DOI 10.1063/1.1360200; WALRAFEN GE, 1964, J CHEM PHYS, V40, P3249, DOI 10.1063/1.1724992; Wick CA, 2009, J PHYS CHEM B, V113, P4141, DOI 10.1021/jp806782r	27	123	125	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					857	860		10.1126/science.1183799	http://dx.doi.org/10.1126/science.1183799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150500				2022-12-28	WOS:000274408300059
J	Smith, SB; Qu, HQ; Taleb, N; Kishimoto, NY; Scheel, DW; Lu, Y; Patch, AM; Grabs, R; Wang, JH; Lynn, FC; Miyatsuka, T; Mitchell, J; Seerke, R; Desir, J; Eijnden, SV; Abramowicz, M; Kacet, N; Weill, J; Renard, ME; Gentile, M; Hansen, I; Dewar, K; Hattersley, AT; Wang, R; Wilson, ME; Johnson, JD; Polychronakos, C; German, MS				Smith, Stuart B.; Qu, Hui-Qi; Taleb, Nadine; Kishimoto, Nina Y.; Scheel, David W.; Lu, Yang; Patch, Ann-Marie; Grabs, Rosemary; Wang, Juehu; Lynn, Francis C.; Miyatsuka, Takeshi; Mitchell, John; Seerke, Rina; Desir, Julie; Eijnden, Serge Vanden; Abramowicz, Marc; Kacet, Nadine; Weill, Jacques; Renard, Marie-Eve; Gentile, Mattia; Hansen, Inger; Dewar, Ken; Hattersley, Andrew T.; Wang, Rennian; Wilson, Maria E.; Johnson, Jeffrey D.; Polychronakos, Constantin; German, Michael S.			Rfx6 directs islet formation and insulin production in mice and humans	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CONGENITAL MALABSORPTIVE DIARRHEA; AUTOSOMAL RECESSIVE SYNDROME; CELL-DIFFERENTIATION; DNA-BINDING; MUTANT NEUROGENIN-3; ENDOCRINE PANCREAS; PRIMARY CILIA; EXPRESSION; REVEALS	Insulin from the beta-cells of the pancreatic islets of Langerhans controls energy homeostasis in vertebrates, and its deficiency causes diabetes mellitus. During embryonic development, the transcription factor neurogenin 3 (Neurog3) initiates the differentiation of the beta-cells and other islet cell types from pancreatic endoderm, but the genetic program that subsequently completes this differentiation remains incompletely understood. Here we show that the transcription factor Rfx6 directs islet cell differentiation downstream of Neurog3. Mice lacking Rfx6 failed to generate any of the normal islet cell types except for pancreatic-polypeptide-producing cells. In human infants with a similar autosomal recessive syndrome of neonatal diabetes, genetic mapping and subsequent sequencing identified mutations in the human RFX6 gene. These studies demonstrate a unique position for Rfx6 in the hierarchy of factors that coordinate pancreatic islet development in both mice and humans. Rfx6 could prove useful in efforts to generate beta-cells for patients with diabetes.	[Qu, Hui-Qi; Taleb, Nadine; Lu, Yang; Grabs, Rosemary; Mitchell, John; Polychronakos, Constantin] McGill Univ, Dept Paediat, Montreal, PQ H3H 1P3, Canada; [Qu, Hui-Qi; Taleb, Nadine; Lu, Yang; Grabs, Rosemary; Mitchell, John; Polychronakos, Constantin] McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Smith, Stuart B.; Kishimoto, Nina Y.; Scheel, David W.; Wang, Juehu; Lynn, Francis C.; Miyatsuka, Takeshi; Seerke, Rina; German, Michael S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Patch, Ann-Marie; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Desir, Julie; Eijnden, Serge Vanden; Abramowicz, Marc] ULB, Hop Erasme, Dept Neonatol, B-1070 Brussels, Belgium; [Hansen, Inger] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Kacet, Nadine; Weill, Jacques; Renard, Marie-Eve] Hop Calmette, Dept Neonatol, F-59037 Lille, France; [Gentile, Mattia] Di Venere Gen Hosp, Med Genet Unit, I-70012 Bari, Italy; [Dewar, Ken] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Dewar, Ken] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3A 1B1, Canada; [Wang, Rennian] Univ Western Ontario, Child Hlth Res Inst, Dept Physiol, London, ON N6C 2V5, Canada; [Wang, Rennian] Univ Western Ontario, Child Hlth Res Inst, Dept Med & Pharmacol, London, ON N6C 2V5, Canada; [Wilson, Maria E.; Johnson, Jeffrey D.] Metabolex Inc, Hayward, CA 94545 USA; [German, Michael S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	McGill University; McGill University; University of California System; University of California San Francisco; University of Exeter; Universite Libre de Bruxelles; Emory University; Universite de Lille - ISITE; CHU Lille; McGill University; McGill University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California San Francisco	Polychronakos, C (corresponding author), McGill Univ, Dept Paediat, Montreal, PQ H3H 1P3, Canada.	constantin.polychronakos@mcgill.ca; mgerman@diabetes.ucsf.edu	Abramowicz, Marc/AAX-6419-2020; Patch, Ann-Marie/C-4201-2018; Patch, Ann-Marie/F-8060-2011; Qu, Hui-Qi/B-4719-2009; Gentile, Mattia/AEQ-3183-2022; Wang, Rennian/N-3879-2015; Mitchell, John/E-5727-2016	Patch, Ann-Marie/0000-0001-6121-4019; Qu, Hui-Qi/0000-0001-9317-4488; Gentile, Mattia/0000-0002-5299-6036; Lynn, Francis/0000-0001-9318-1063; Abramowicz, Marc/0000-0003-0623-8768; Hattersley, Andrew/0000-0001-5620-473X; Mitchell, John/0000-0002-6055-6858; Polychronakos, Constantin/0000-0002-7624-6635	Larry L. Hillblom Foundation; Juvenile Diabetes Research Foundation; American Diabetes Association; Nora Eccles Treadwell Foundation; Canadian Institutes of Health Research; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, R01DK021344, U19DK061245] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Nora Eccles Treadwell Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the patients and their families for the participation in this study and P. Riley for allowing us access to her clinical data. We thank G. Grodsky, G. Bell, W. Rutter, R. Gasa and members of the German laboratory for discussions, F. Schaufle and the DERC Microscopy Core Laboratory, C. Mrejen and the UCSF DERC Genomics Core, N. Killeen and the UCSF DERC Transgenic Core Laboratory for help with the generation of the Rfx6-targeted mice, R. Koshy for technical assistance, Y. Zhang and S. Zhao for assistance with mouse husbandry and genotyping, the Massively Parallel Sequencing team at the McGill University and Genome Quebec Innovation Center for DNA sequencing and J. Wasserscheid for bioinformatics analyses. This work was supported by grants from the Larry L. Hillblom Foundation (S. B. S. and M. S. G.), the Juvenile Diabetes Research Foundation (S. B. S., F. C. L., T. M., R. W., C. P. and M. S. G.), the American Diabetes Association (M. S. G.), the Nora Eccles Treadwell Foundation (M. S. G.), the Canadian Institutes of Health Research (H.-Q.Q.), and the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (M. S. G.).	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Cano DA, 2006, GASTROENTEROLOGY, V131, P1856, DOI 10.1053/j.gastro.2006.10.050; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chappell L, 2008, AM J MED GENET A, V146A, P1713, DOI 10.1002/ajmg.a.32304; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cortina G, 2007, HUM PATHOL, V38, P570, DOI 10.1016/j.humpath.2006.10.014; DAVID E, 1995, J BIOL CHEM, V270, P8353, DOI 10.1074/jbc.270.14.8353; Emery P, 1996, MOL CELL BIOL, V16, P4486; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gentile M, 1999, AM J MED GENET, V87, P82, DOI 10.1002/(SICI)1096-8628(19991105)87:1<82::AID-AJMG17>3.3.CO;2-S; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Jensen JN, 2007, NEW ENGL J MED, V356, P1781; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; McCarthy MI, 2008, DIABETES, V57, P2889, DOI 10.2337/db08-0343; Mitchell J, 2004, DIABETOLOGIA, V47, P2160, DOI 10.1007/s00125-004-1576-3; Miyatsuka T, 2009, DIABETES, V58, P1863, DOI 10.2337/db09-0390; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; STEFAN Y, 1983, DIABETES, V32, P293, DOI 10.2337/diabetes.32.4.293; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052	42	226	234	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 11	2010	463	7282					775	780		10.1038/nature08748	http://dx.doi.org/10.1038/nature08748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148032	Green Submitted, Green Accepted			2022-12-28	WOS:000274394300032
J	Maxmen, A				Maxmen, Amy			Driving Innovation: Ready, Set, Go!	CELL			English	Editorial Material																			0	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2					171	173		10.1016/j.cell.2010.01.012	http://dx.doi.org/10.1016/j.cell.2010.01.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141828	Bronze			2022-12-28	WOS:000273826500005
J	Todo, Y; Kato, H; Kaneuchi, M; Watari, H; Takeda, M; Sakuragi, N				Todo, Yukiharu; Kato, Hidenori; Kaneuchi, Masanori; Watari, Hidemichi; Takeda, Mahito; Sakuragi, Noriaki			Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis	LANCET			English	Article							PHASE-III TRIAL; THERAPEUTIC ROLE; STAGE-I; CARCINOMA; CHEMOTHERAPY; RISK; ADENOCARCINOMA; RADIOTHERAPY; CORPUS	Background In response to findings that pelvic lymphadenectomy does not have any therapeutic benefit for endometrial cancer, we aimed to establish whether complete, systematic lymphadenectomy, including the para-aortic lymph nodes, should be part of surgical therapy for patients at intermediate and high risk of recurrence. Methods We selected 671 patients with endometrial carcinoma who had been treated with complete, systematic pelvic lymphadenectomy (n=325 patients) or combined pelvic and para-aortic lymphadenectomy (n=346) at two tertiary centres in Japan (January, 1986 June, 2004). Patients at intermediate or high risk of recurrence were offered adjuvant radiotherapy or chemotherapy. The primary outcome measure was overall survival. Findings Overall survival was significantly longer in the pelvic and para-aortic lymphadenectomy group than in the pelvic lymphadenectomy group (HR 0.53, 95% CI 0.38-0.76; p=0.0005). This association was also recorded in 407 patients at intermediate or high risk (p=0.0009), but overall survival was not related to lymphadenectorny type in low-risk patients. Multivariate analysis of prognostic factors showed that in patients with intermediate or high risk of recurrence, pelvic and para-aortic lymphadenectomy reduced the risk of death compared with pelvic lymphadenectomy (0.44, 0.30-0.64; p<0.0001). Analysis of 328 patients with intermediate or high risk who were treated with adjuvant radiotherapy or chemotherapy showed that patient survival improved with pelvic and para-aortic lymphadenectomy (0.48, 0.29-0.83; p=0.0049) and with adjuvant chemotherapy (0.59, 0.37-1.00; p=0.0465) independently of one another. Interpretation Combined pelvic and para-aortic lymphadenectomy is recommended as treatment for patients with endometrial carcinoma of intermediate or high risk of recurrence. If a prospective randomised or comparative cohort study is planned to validate the therapeutic effect of lymphadenectomy, it should include both pelvic and para-aortic lymphadenectomy in patients of intermediate or high risk of recurrence.	[Sakuragi, Noriaki] Hokkaido Univ, Grad Sch Med, Dept Gynaecol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kaneuchi, Masanori; Watari, Hidemichi; Takeda, Mahito; Sakuragi, Noriaki] Hokkaido Univ Hosp, Dept Gynaecol, Sapporo, Hokkaido 060, Japan; [Todo, Yukiharu; Kato, Hidenori] Hokkaido Canc Ctr, Natl Hosp Org, Div Gynaecol Oncol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Sakuragi, N (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Gynaecol, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.	sakuragi@med.hokudai.ac.jp	Sakuragi, Noriaki/D-6507-2012		Japanese Foundation for Multidisciplinary Treatment of Cancer; Japan Society for the Promotion of Science	Japanese Foundation for Multidisciplinary Treatment of Cancer(Japanese Foundation for Multidisciplinary Treatment of Cancer); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Sharon Hanley. Japanese Red Cross Hokkaido College of Nursing, for English editing of the report. This study was partly supported by grants-in-aid for scientific research from the Japanese Foundation for Multidisciplinary Treatment of Cancer, and the Japan Society for the Promotion of Science.	Chan JK, 2007, LANCET ONCOL, V8, P831, DOI 10.1016/S1470-2045(07)70275-9; Chan JK, 2006, CANCER, V107, P1823, DOI 10.1002/cncr.22185; Cragun JM, 2005, J CLIN ONCOL, V23, P3668, DOI 10.1200/JCO.2005.04.144; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Frederick PJ, 2009, CANCER CONTROL, V16, P23, DOI 10.1177/107327480901600104; Fujimoto T, 2007, GYNECOL ONCOL, V107, P253, DOI 10.1016/j.ygyno.2007.06.009; GRIGSBY PW, 1992, INT J RADIAT ONCOL, V22, P905, DOI 10.1016/0360-3016(92)90786-H; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Lutman CV, 2006, GYNECOL ONCOL, V102, P92, DOI 10.1016/j.ygyno.2005.11.032; Maggi R, 2006, BRIT J CANCER, V95, P266, DOI 10.1038/sj.bjc.6603279; Mariani A, 2000, GYNECOL ONCOL, V76, P348, DOI 10.1006/gyno.1999.5688; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; Niikura H, 2004, GYNECOL ONCOL, V92, P669, DOI 10.1016/j.ygyno.2003.10.039; Nishiya M, 1998, INT J CANCER, V79, P521; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Randall ME, 2006, J CLIN ONCOL, V24, P36, DOI 10.1200/JCO.2004.00.7617; Roland PY, 2004, GYNECOL ONCOL, V93, P125, DOI 10.1016/j.ygyno.2003.12.018; Sakuragi N, 2000, ACTA OBSTET GYN SCAN, V79, P311, DOI 10.1034/j.1600-0412.2000.079004311.x; Susumu N, 2008, GYNECOL ONCOL, V108, P226, DOI 10.1016/j.ygyno.2007.09.029; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Watanabe Y, 2007, GYNECOL ONCOL, V105, P325, DOI 10.1016/j.ygyno.2006.12.015; WITTEKIND C, 2005, TNM ATLAS ILLUSTRATE, P250; Yaegashi N, 2007, INT J CLIN ONCOL, V12, P176, DOI 10.1007/s10147-006-0621-2; Yokoyama Y, 1997, GYNECOL ONCOL, V64, P411, DOI 10.1006/gyno.1996.4573	24	529	556	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1165	1172		10.1016/S0140-6736(09)62002-X	http://dx.doi.org/10.1016/S0140-6736(09)62002-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20188410				2022-12-28	WOS:000276858200028
J	Sotillo, R; Schvartzman, JM; Socci, ND; Benezra, R				Sotillo, Rocio; Schvartzman, Juan-Manuel; Socci, Nicholas D.; Benezra, Robert			Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal	NATURE			English	Article							MITOTIC CHECKPOINT; CLONAL EVOLUTION; CANCER; MICE; ADENOCARCINOMAS; TUMORIGENESIS; MECHANISMS; RESISTANCE; MISSEGREGATION; REGRESSION	Inhibition of an initiating oncogene often leads to extensive tumour cell death, a phenomenon known as oncogene addiction(1). This has led to the search for compounds that specifically target and inhibit oncogenes as anticancer agents. However, there has been no systematic exploration of whether chromosomal instability generated as a result of deregulation of the mitotic checkpoint pathway(2,3), a frequent characteristic of solid tumours, has any effect on oncogene addiction. Here we show that induction of chromosome instability by overexpression of the mitotic checkpoint gene Mad2 in mice does not affect the regression of Kras-driven lung tumours when Kras is inhibited. However, tumours that experience transient Mad2 overexpression and consequent chromosome instability recur at markedly elevated rates. The recurrent tumours are highly aneuploid and have varied activation of pro-proliferative pathways. Thus, early chromosomal instability may be responsible for tumour relapse after seemingly effective anticancer treatments.	[Sotillo, Rocio; Schvartzman, Juan-Manuel; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Benezra, R (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	r-benezra@ski.mskcc.org		Sotillo, Rocio/0000-0002-0855-7917; Schvartzman, Juan Manuel/0000-0002-8036-1361	Charles H. Revson Foundation; US Department of Defense; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA124378] Funding Source: NIH RePORTER	Charles H. Revson Foundation; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Varmus and W. Pao for the CCSP-rtTA and TetO-Kras mice; K. Politi, K. Podsypanina and M. Jechlinger for reagents, discussions and critical reading of the manuscript; C. Le and M. Lupu for MR imaging; M. Leversha, C. Kalyani and J. McGuire for FISH staining; K. M. D. La Perle, M. Jiao and M. Squatrito for immunohistochemistry and pathological analysis; A. Viale for CGH and Affymetrix; and Y. Chin, S. Curelariu and C. Coker for excellent technical assistance. Support was provided to R. S. by the Charles H. Revson Foundation, to J. M. S. by a Breast Cancer Research Program (BCRP) Predoctoral Traineeship Award from the US Department of Defense (Congressionally Directed Medical Research Programs) and to R. B. by the National Institutes of Health.	Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Chang S, 2001, SEMIN CANCER BIOL, V11, P227, DOI 10.1006/scbi.2000.0374; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Cortes J, 2004, HEMATOL ONCOL CLIN N, V18, P671, DOI 10.1016/j.hoc.2004.03.012; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Giuriato S, 2003, CELL CYCLE, V2, P329, DOI 10.4161/cc.2.4.415; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; O'Dwyer ME, 2002, BLOOD, V100, P1628, DOI 10.1182/blood-2002-03-0777; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558	28	195	199	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					436	U138		10.1038/nature08803	http://dx.doi.org/10.1038/nature08803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20173739	Green Accepted			2022-12-28	WOS:000275657100052
J	Manduca, CA; Mogk, DW; Tewksbury, B; Macdonald, RH; Fox, SP; Iverson, ER; Kirk, K; McDaris, J; Ormand, C; Bruckner, M				Manduca, Cathryn A.; Mogk, David W.; Tewksbury, Barbara; Macdonald, R. Heather; Fox, Sean P.; Iverson, Ellen R.; Kirk, Karin; McDaris, John; Ormand, Carol; Bruckner, Monica			On the Cutting Edge: Teaching Help for Geoscience Faculty	SCIENCE			English	Editorial Material									[Manduca, Cathryn A.; Fox, Sean P.; Iverson, Ellen R.; Kirk, Karin; McDaris, John; Ormand, Carol; Bruckner, Monica] Carleton Coll, Sci Educ Resource Ctr, Northfield, MN 55057 USA; [Mogk, David W.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Tewksbury, Barbara] Hamilton Coll, Dept Geol, Clinton, NY 13323 USA; [Macdonald, R. Heather] Coll William & Mary, Dept Geol, Williamsburg, VA 23187 USA	Carleton College; Montana State University System; Montana State University Bozeman; Hamilton College; William & Mary	Manduca, CA (corresponding author), Carleton Coll, Sci Educ Resource Ctr, Northfield, MN 55057 USA.	cmanduca@carleton.edu	McDaris, John/AAF-8335-2021	McDaris, John/0000-0002-9868-9496; Ormand, Carol/0000-0002-1586-1706; Bruckner, Monica/0000-0001-8516-540X				[Anonymous], 2005, J GEOSCIENCE ED, DOI [DOI 10.5408/1089-9995-53.3.237, 10.5408/1089-9995-53.3.237]; Loucks-Horsley S., 2009, DESIGNING PROFESSION; Macdonald R. H., 2004, INVENTION IMPACT BUI, P233	3	11	11	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1095	1096		10.1126/science.1183028	http://dx.doi.org/10.1126/science.1183028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560KJ	20185719	Green Published			2022-12-28	WOS:000274901100026
J	Wang, D; Griffitts, J; Starker, C; Fedorova, E; Limpens, E; Ivanov, S; Bisseling, T; Long, SR				Wang, Dong; Griffitts, Joel; Starker, Colby; Fedorova, Elena; Limpens, Erik; Ivanov, Sergey; Bisseling, Ton; Long, Sharon			A Nodule-Specific Protein Secretory Pathway Required for Nitrogen-Fixing Symbiosis	SCIENCE			English	Article							SIGNAL PEPTIDASE ACTIVITY; MEDICAGO-TRUNCATULA; ROOT-NODULES; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; MEMBRANE; FIXATION; MUTANTS; DEFINE; PLANT	The nitrogen-fixing symbiosis between Sinorhizobium meliloti and its leguminous host plant Medicago truncatula occurs in a specialized root organ called the nodule. Bacteria that are released into plant cells are surrounded by a unique plant membrane compartment termed a symbiosome. We found that in the symbiosis-defective dnf1 mutant of M. truncatula, bacteroid and symbiosome development are blocked. We identified the DNF1 gene as encoding a subunit of a signal peptidase complex that is highly expressed in nodules. By analyzing data from whole-genome expression analysis, we propose that correct symbiosome development in M. truncatula requires the orderly secretion of protein constituents through coordinated up-regulation of a nodule-specific pathway exemplified by DNF1.	[Wang, Dong; Griffitts, Joel; Starker, Colby; Long, Sharon] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fedorova, Elena; Limpens, Erik; Ivanov, Sergey; Bisseling, Ton] Wageningen Univ, Grad Sch Expt Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands; [Fedorova, Elena; Ivanov, Sergey] Russian Acad Sci, KA Timiryazev Plant Physiol Inst, Moscow 127392, Russia	Stanford University; Wageningen University & Research; Russian Academy of Sciences; Timiryazev Institute of Plant Physiology	Long, SR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	SRL@stanford.edu	Fedorova, Elena Erika/U-1069-2017; Bisseling, Ton/A-2421-2013	Starker, Colby/0000-0002-6774-7227; Ivanov, Sergey/0000-0002-4191-3928; Fedorova, Elena/0000-0003-3953-1282	Helen Hay Whitney Foundation; National Institutes of Health; Netherlands Organisation for Scientific Research (NWO); Hoover Circle fund; Howard Hughes Medical Institute; U.S. Department of Energy [DE-FG03-90ER20010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093628] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Hoover Circle fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Ehrhardt for assistance with confocal microscope and E. Kondorosi, P. Mergaert, and W. Van de Velde for critical reviews of the manuscript and for sharing unpublished results. This work was supported by the Helen Hay Whitney Foundation (to J.G.), a National Institutes of Health training grant (to C. S.), The Netherlands Organisation for Scientific Research (NWO, to E. L., S. I., E. F., and T. B.), the Hoover Circle fund, and prior support from the Howard Hughes Medical Institute and the U.S. Department of Energy grant no. DE-FG03-90ER20010 (to S. R. L.).	Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Catalano CM, 2007, PLANTA, V225, P541, DOI 10.1007/s00425-006-0369-y; Catalano CM, 2004, ELECTROPHORESIS, V25, P519, DOI 10.1002/elps.200305711; Coque L, 2008, MOL PLANT MICROBE IN, V21, P404, DOI 10.1094/MPMI-21-4-0404; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; de Graaf BHJ, 2005, PLANT CELL, V17, P2564, DOI 10.1105/tpc.105.033183; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Fang H, 1997, J BIOL CHEM, V272, P13152, DOI 10.1074/jbc.272.20.13152; Limpens E, 2009, PLANT CELL, V21, P2811, DOI 10.1105/tpc.108.064410; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; RAIKHEL N, 2000, BIOCH MOL BIOL PLANT, P160; Starker CG, 2006, PLANT PHYSIOL, V140, P671, DOI 10.1104/pp.105.072132; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990	20	179	191	5	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1126	1129		10.1126/science.1184096	http://dx.doi.org/10.1126/science.1184096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185723	Green Accepted			2022-12-28	WOS:000274901100035
J	Nascimbene, S; Navon, N; Jiang, KJ; Chevy, F; Salomon, C				Nascimbene, S.; Navon, N.; Jiang, K. J.; Chevy, F.; Salomon, C.			Exploring the thermodynamics of a universal Fermi gas	NATURE			English	Article							PHASE-DIAGRAM	One of the greatest challenges in modern physics is to understand the behaviour of an ensemble of strongly interacting particles. A class of quantum many-body systems (such as neutron star matter and cold Fermi gases) share the same universal thermodynamic properties when interactions reach the maximum effective value allowed by quantum mechanics, the so-called unitary limit(1,2). This makes it possible in principle to simulate some astrophysical phenomena inside the highly controlled environment of an atomic physics laboratory. Previous work on the thermodynamics of a two-component Fermi gas led to thermodynamic quantities averaged over the trap(3-5), making comparisons with many-body theories developed for uniform gases difficult. Here we develop a general experimental method that yields the equation of state of a uniform gas, as well as enabling a detailed comparison with existing theories(6-15). The precision of our equation of state leads to new physical insights into the unitary gas. For the unpolarized gas, we show that the low-temperature thermodynamics of the strongly interacting normal phase is well described by Fermi liquid theory, and we localize the superfluid transition. For a spin-polarized system(16-18), our equation of state at zero temperature has a 2 per cent accuracy and extends work(19,20) on the phase diagram to a new regime of precision. We show in particular that, despite strong interactions, the normal phase behaves as a mixture of two ideal gases: a Fermi gas of bare majority atoms and a non-interacting gas of dressed quasi-particles, the fermionic polarons(10,18,20-22).	[Nascimbene, S.; Navon, N.; Jiang, K. J.; Chevy, F.; Salomon, C.] UPMC, CNRS, Lab Kastler Brossel, Ecole Normale Super, F-75231 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Nascimbene, S (corresponding author), UPMC, CNRS, Lab Kastler Brossel, Ecole Normale Super, 24 Rue Lhomond, F-75231 Paris, France.	sylvain.nascimbene@ens.fr	Jiang, Kaijun/F-2712-2014; Salomon, Carlos F/L-2167-2013; Nascimbene, Sylvain/L-7595-2016	Jiang, Kaijun/0000-0003-3126-4335; Salomon, Carlos F/0000-0003-4474-0046; Nascimbene, Sylvain/0000-0002-3931-9436; Navon, Nir/0000-0002-8917-3463	ESF (Euroquam); SCALA; ANR FABIOLA; Region Ile de France (IFRAF); ERC; Institut Universitaire de France	ESF (Euroquam); SCALA; ANR FABIOLA(French National Research Agency (ANR)); Region Ile de France (IFRAF)(Region Ile-de-France); ERC(European Research Council (ERC)European Commission); Institut Universitaire de France	We are grateful to R. Combescot, X. Leyronas, Y. Castin, A. Recati, S. Stringari, S. Giorgini, M. Zwierlein and T. Giamarchi for discussions and to C. Cohen-Tannoudji, J. Dalibard, F. Gerbier and G. Shlyapnikov for critical reading of the manuscript. We acknowledge support from ESF (Euroquam), SCALA, ANR FABIOLA, Region Ile de France (IFRAF), ERC and Institut Universitaire de France.	Bulgac A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090404; Bulgac A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023625; Burovski E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.160402; Carlson J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.050401; Chen QJ, 2005, PHYS REP, V412, P1, DOI 10.1016/j.physrep.2005.02.005; Chevy F, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063628; Combescot R, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053640; Combescot R, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.050404; Combescot R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.180402; Greiner M, 2003, NATURE, V426, P537, DOI 10.1038/nature02199; Gubbels KB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140407; Haussmann R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023610; Ho TL, 2010, NAT PHYS, V6, P131, DOI 10.1038/NPHYS1477; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.160404; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Horikoshi M, 2010, SCIENCE, V327, P442, DOI 10.1126/science.1183012; Inada Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.180406; Inguscio M, 2006, P INT SCH PHYS E FER; Liu XJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.160401; Lobo C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200403; Luo L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080402; Luo L, 2009, J LOW TEMP PHYS, V154, P1, DOI 10.1007/s10909-008-9850-2; Nascimbene S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.170402; Partridge GB, 2006, SCIENCE, V311, P503, DOI 10.1126/science.1122876; Pilati S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030401; Prokof'ev N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.020408; RIEDL S, 2009, SUPERFLUID QUENCHING; Rupak G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.090403; Schirotzek A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230402; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401; Shin YI, 2008, NATURE, V451, P689, DOI 10.1038/nature06473; Shin YI, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.041603; Spiegelhalder FM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.223203; Stewart JT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220406	34	419	421	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1057	U73		10.1038/nature08814	http://dx.doi.org/10.1038/nature08814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182507	Green Submitted			2022-12-28	WOS:000275108400031
J	Polatin, PB; Modvig, J; Rytter, T				Polatin, Peter B.; Modvig, Jens; Rytter, Therese			Helping to stop doctors becoming complicit in torture	BRITISH MEDICAL JOURNAL			English	Editorial Material							HUMAN-RIGHTS; INVOLVEMENT		[Polatin, Peter B.; Modvig, Jens; Rytter, Therese] Rehabil & Res Ctr Torture Victims, Int Dept, DK-1014 Copenhagen K, Denmark		Polatin, PB (corresponding author), Rehabil & Res Ctr Torture Victims, Int Dept, Borgergade 13,POB 2107, DK-1014 Copenhagen K, Denmark.	pp@rct.dk						International Committee of the Red Cross, 2007, ICRC REP TREATM 14 H; Jesper Sonntag, 2008, Torture, V18, P161; Lifton RJ, 2004, NEW ENGL J MED, V351, P415, DOI 10.1056/NEJMp048065; Maio G, 2001, LANCET, V357, P1609, DOI 10.1016/S0140-6736(00)04729-2; MILES S, 2008, BRIT MED J, V337, P308; Miles SH, 2004, HIPPOCRATIC OATH ETH; Moszynski P, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5673; *PUBL COMM TORT IS, 2007, TICK BOMBS; RASMUSSEN OV, 1991, J MED ETHICS, V17, P26, DOI 10.1136/jme.17.Suppl.26; Reis C, 2004, JAMA-J AM MED ASSOC, V291, P1480, DOI 10.1001/jama.291.12.1480; *UN, 2001, IST PROT MAN EFF INV; *WORLD MED ASS, DOCT WORK PRIS HUM R; *WORLD MED ASS, 2006, INT COD MEH ETH; World Medical Association, 1975, DECL TOK; 2009, TORTURE S1, V19	15	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 25	2010	340								c973	10.1136/bmj.c973	http://dx.doi.org/10.1136/bmj.c973			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TH	20185496				2022-12-28	WOS:000275001300014
J	Kapur, NA				Kapur, Nitin Agrawal			Doppelganger	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												nitin.kapur@yale.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					711	712		10.1001/jama.2010.173	http://dx.doi.org/10.1001/jama.2010.173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559DD	20179274				2022-12-28	WOS:000274800000001
J	Strand, BH; Groholt, EK; Steingrimsdottir, OA; Blakely, T; Graff-Iversen, S; Naess, O				Strand, Bjorn Heine; Groholt, Else-Karin; Steingrimsdottir, Olof Anna; Blakely, Tony; Graff-Iversen, Sidsel; Naess, Oyvind			Educational inequalities in mortality over four decades in Norway: prospective study of middle aged men and women followed for cause specific mortality, 1960-2000	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE MORTALITY; CARDIOVASCULAR RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; NORWEGIAN MEN; NEW-ZEALAND; EUROPEAN COUNTRIES; HEALTH; TRENDS; DECREASE; SUICIDE	Objectives To determine the extent to which educational inequalities in relation to mortality widened in Norway during 1960-2000 and which causes of death were the main drivers of this disparity. Design Nationally representative prospective study. Setting Four cohorts of the Norwegian population aged 45-64 years in 1960, 1970, 1980, and 1990 and followed up for mortality over 10 years. Participants 359 547 deaths and 32 904 589 person years. Main outcome measures All cause mortality and deaths due to cancer of lung, trachea, or bronchus; other cancer; cardiovascular diseases; suicide; external causes; chronic lower respiratory tract diseases; or other causes. Absolute and relative indices of inequality were used to present differences in mortality by educational level ( basic, secondary, and tertiary). Results Mortality fell from the 1960s to the 1990s in all educational groups. At the same time the proportion of adults in the basic education group, with the highest mortality, decreased substantially. As mortality dropped more among those with the highest level of education, inequalities widened. Absolute inequalities in mortality denoting deaths among the basic education groups minus deaths among the high education groups doubled in men and increased by a third in women. This is equivalent to an increase in the slope index of inequality of 105% in men and 32% in women. Inequalities on a relative scale widened more, from 1.33 to 2.24 among men (P=0.01) and from 1.52 to 2.19 among women (P=0.05). Among men, absolute inequalities mainly increased as a result of cardiovascular diseases, lung cancer, and chronic lower respiratory tract diseases. Among women this was mainly due to lung cancer and chronic lower respiratory tract diseases. Unlike the situation in men, absolute inequalities in deaths due to cardiovascular causes narrowed among women. Chronic lower respiratory tract diseases contributed more to the disparities in inequalities among women than among men. Conclusion All educational groups showed a decline in mortality. Nevertheless, and despite the fact that the Norwegian welfare model is based on an egalitarian ideology, educational inequalities in mortality among middle aged people in Norway are substantial and increased during 1960-2000.	[Strand, Bjorn Heine; Groholt, Else-Karin; Steingrimsdottir, Olof Anna; Graff-Iversen, Sidsel; Naess, Oyvind] Norwegian Inst Publ Hlth, Div Epidemiol, NO-0403 Oslo, Norway; [Blakely, Tony] Univ Otago, Hlth Inequal Res Programme, Wellington, New Zealand; [Graff-Iversen, Sidsel] Univ Tromso, Inst Community Med, N-9001 Tromso, Norway; [Naess, Oyvind] Univ Oslo, Fac Med, Inst Hlth Management & Econ, N-0316 Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Otago; UiT The Arctic University of Tromso; University of Oslo	Strand, BH (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, POB 4404 Nydalen, NO-0403 Oslo, Norway.	bjorn.heine.strand@fhi.no	Strand, Bjørn/AAV-7948-2021	Strand, Bjørn/0000-0003-4385-8886	Norwegian Institute of Public Health; University of Oslo	Norwegian Institute of Public Health; University of Oslo	This study was funded by the Norwegian Institute of Public Health and the University of Oslo and approved by the Norwegian Data Inspectorate. The funders had no role in the study design; collection, analysis, and interpretation of the data; writing of the report; and the decision to submit the article for publication.	Ahmad OB., 2001, AGE STANDARDIZATION; Arnesen KE, 2002, HEALTH POLICY, V62, P329, DOI 10.1016/S0168-8510(02)00052-0; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjartveit K, 1979, Acta Med Scand Suppl, V634, P1; BJARTVEIT K, 1991, Tidsskrift for den Norske Laegeforening, V111, P2063; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Elstad JI, 2008, ED HLTH INEQUALITIES; Engeland A, 1996, CANCER CAUSE CONTROL, V7, P366, DOI 10.1007/BF00052943; Fawcett J, 2005, EUR J EPIDEMIOL, V20, P683, DOI 10.1007/s10654-005-7923-y; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Giertsen J C, 1993, Nord Med, V108, P58; Johnsen JR, 2006, HLTH SYSTEMS TRANSIT; Kristensen Petter, 2004, Tidsskr Nor Laegeforen, V124, P2879; LEIGH JP, 1983, SOC SCI MED, V17, P227, DOI 10.1016/0277-9536(83)90120-X; LINDBAK RL, 2007, TALL TOBAKK 1973 200; Lorant V, 2005, BRIT J PSYCHIAT, V187, P49, DOI 10.1192/bjp.187.1.49; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lorant V, 2003, ACTA PSYCHIAT SCAND, V107, P170, DOI 10.1034/j.1600-0447.2003.00071.x; Lund Karl Erik, 2005, Tidsskr Nor Laegeforen, V125, P560; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; *ORG EC DEV COOP, 2008, OECD FACTB 2008 EC E; Rognerud MA, 2006, EUR J PUBLIC HEALTH, V16, P62, DOI 10.1093/eurpub/cki070; SOGAARD AJ, 2004, INT J EQUITY HEALTH, V3, DOI DOI 10.1186/1475-9276-3-3; *STAT NORW, 2008, UN RAT NORW; *STAT NORW, 2009, NAT ACC; Strand BH, 2006, SOC SCI MED, V63, P2825, DOI 10.1016/j.socscimed.2006.07.020; Strand BH, 2004, J EPIDEMIOL COMMUN H, V58, P705, DOI 10.1136/jech.2003.014563; Strand BH, 2006, EUR J EPIDEMIOL, V21, P731, DOI 10.1007/s10654-006-9046-5; TVERDAL A, 2003, MORTALITY NORWAY DIF; VASSENDEN K, 1987, CENSUSES 1960 1970 1; Wamala S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-164; *WELL SCH MED HLTH, 2007, NZ CENS MORT STUD WE	37	93	94	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2010	340								c654	10.1136/bmj.c654	http://dx.doi.org/10.1136/bmj.c654			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	561TF	20179132	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000275001100019
J	Archer, L; Kilburn-Toppin, F; Sneddon, K; Kemp, H; Smith, R; Toth, T; Tomson, C				Archer, Lesley; Kilburn-Toppin, Fleur; Sneddon, Kiera; Kemp, Helena; Smith, Richard; Toth, Tibor; Tomson, Charles			A "fussy eater"' with renal failure	LANCET			English	Editorial Material							CORTICAL NECROSIS		[Archer, Lesley; Kilburn-Toppin, Fleur] Southmead Hosp, Dept Radiol, Bristol BS10 5NB, Avon, England; [Sneddon, Kiera] Southmead Hosp, Dept Dietet, Bristol BS10 5NB, Avon, England; [Kemp, Helena; Toth, Tibor] Southmead Hosp, Dept Clin Biochem, Bristol BS10 5NB, Avon, England; [Smith, Richard; Tomson, Charles] Southmead Hosp, Dept Nephrol, Bristol BS10 5NB, Avon, England	Southmead Hospital; Southmead Hospital; Southmead Hospital; Southmead Hospital	Archer, L (corresponding author), Southmead Hosp, Dept Radiol, Southmead Rd, Bristol BS10 5NB, Avon, England.	lesley.maynard@tiscali.co.uk		Tomson, Charles/0000-0002-0224-8726				JORDAN J, 1990, J COMPUT ASSIST TOMO, V14, P155, DOI 10.1097/00004728-199001000-00034; Kim Ho-Jung, 1995, Journal of Korean Medical Science, V10, P132; Melhem A, 2009, THROMB J, V7, DOI 10.1186/1477-9560-7-5; Remacha AF, 2002, ANN HEMATOL, V81, P616, DOI 10.1007/s00277-002-0560-6; SEFCZEK RJ, 1984, AM J ROENTGENOL, V142, P553, DOI 10.2214/ajr.142.3.553	5	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					696	696		10.1016/S0140-6736(09)61968-1	http://dx.doi.org/10.1016/S0140-6736(09)61968-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20171405				2022-12-28	WOS:000275210900038
J	Horton, R				Horton, Richard			Offline: AIDS is not zero sum	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					624	624		10.1016/S0140-6736(10)60244-9	http://dx.doi.org/10.1016/S0140-6736(10)60244-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JT	20171387				2022-12-28	WOS:000275210900011
J	Macdonald, H				Macdonald, Helen			Emergency Medicine Doctors on the front line	BRITISH MEDICAL JOURNAL			English	News Item												hmacdonald@bmj.com						[Anonymous], TRAUM WHO CAR	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 18	2010	340								c379	10.1136/bmj.c379	http://dx.doi.org/10.1136/bmj.c379			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JV	20167646				2022-12-28	WOS:000274739000002
J	Macilwain, C				Macilwain, Colin			World view: Calling science to account	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					875	875		10.1038/463875a	http://dx.doi.org/10.1038/463875a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164898	Green Published, Bronze			2022-12-28	WOS:000274582700016
J	Radhakrishnan, J; Uppot, RN; Colvin, RB				Radhakrishnan, Jai; Uppot, Raul N.; Colvin, Robert B.			A Man with HIV Infection, Proteinuria, and Edema Fibrillary glomerulonephritis associated with hepatitis C virus infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESSENTIAL MIXED CRYOGLOBULINEMIA; VIRAL-INFECTION; IMMUNOTACTOID GLOMERULONEPHRITIS; PATHOLOGICAL FEATURES; GLOMERULOPATHY; COINFECTION		[Radhakrishnan, Jai] Columbia Univ, Dept Med, Div Nephrol, Med Ctr, New York, NY 10027 USA; [Uppot, Raul N.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Colvin, Robert B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Uppot, Raul N.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Colvin, Robert B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Radhakrishnan, J (corresponding author), Columbia Univ, Dept Med, Div Nephrol, Med Ctr, New York, NY 10027 USA.		Uppot, Raul/AAF-1859-2019					AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Alpers CE, 2008, J AM SOC NEPHROL, V19, P34, DOI 10.1681/ASN.2007070757; Bridoux F, 2002, KIDNEY INT, V62, P1764, DOI 10.1046/j.1523-1755.2002.00628.x; CARBONE L, 1989, AM J MED, V87, P389, DOI 10.1016/S0002-9343(89)80819-8; Cheng JT, 1999, J AM SOC NEPHROL, V10, P1566; Coroneos E, 1997, AM J KIDNEY DIS, V29, P132, DOI 10.1016/S0272-6386(97)90020-2; Cosio FG, 1996, AM J KIDNEY DIS, V28, P752, DOI 10.1016/S0272-6386(96)90260-7; D'Amico G, 1998, KIDNEY INT, V54, P650, DOI 10.1046/j.1523-1755.1998.00028.x; DAMICO G, 1985, P EUR DIAL TRANS, V21, P527; Estrella M, 2006, CLIN INFECT DIS, V43, P377, DOI 10.1086/505497; Ferri C, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-25; Fine DM, 2008, SEMIN NEPHROL, V28, P545, DOI 10.1016/j.semnephrol.2008.08.007; Guerra G, 2003, CLIN NEPHROL, V60, P364; Haas M, 2000, NEPHROL DIAL TRANSPL, V15, P1679, DOI 10.1093/ndt/15.10.1679; ISKANDAR SS, 1992, KIDNEY INT, V42, P1401, DOI 10.1038/ki.1992.433; JOHNSON RJ, 1994, KIDNEY INT, V46, P1255, DOI 10.1038/ki.1994.393; JOHNSON RJ, 1993, NEW ENGL J MED, V328, P465, DOI 10.1056/NEJM199302183280703; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Markowitz GS, 1998, J AM SOC NEPHROL, V9, P2244; Martin JL, 2003, AM J KIDNEY DIS, V42, DOI 10.1053/j.ajkd.2003.08.034; MISIANI R, 1992, ANN INTERN MED, V117, P573, DOI 10.7326/0003-4819-117-7-573; Ray S, 2008, RENAL FAILURE, V30, P759, DOI 10.1080/08860220802213062; Roccatello D, 2007, AM J KIDNEY DIS, V49, P69, DOI 10.1053/j.ajkd.2006.09.015; Rockstroh JK, 2008, HIV MED, V9, P82, DOI 10.1111/j.1468-1293.2007.00535.x; Rosenstock JL, 2003, KIDNEY INT, V63, P1450, DOI 10.1046/j.1523-1755.2003.00853.x; Saadoun D, 2008, ANN RHEUM DIS, V67, P1431, DOI 10.1136/ard.2007.081653; Sansonno D, 2003, BLOOD, V101, P3818, DOI 10.1182/blood-2002-10-3162; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; STEHMANBREEN C, 1995, CLIN NEPHROL, V44, P141; TARANTINO A, 1995, KIDNEY INT, V47, P618, DOI 10.1038/ki.1995.78; van Biljon G, 2007, PEDIATR NEPHROL, V22, P1387, DOI 10.1007/s00467-007-0496-0; WARREN GV, 1989, AM J KIDNEY DIS, V13, P127, DOI 10.1016/S0272-6386(89)80130-1; YANG GCH, 1992, AM J PATHOL, V141, P409; 2008, KIDNEY INT S, V109, pS1	35	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					636	646		10.1056/NEJMcpc0910091	http://dx.doi.org/10.1056/NEJMcpc0910091			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556ED	20164488				2022-12-28	WOS:000274571200013
J	Wang, JY				Wang, Jiyao			Evidence-based medicine in China	LANCET			English	Editorial Material									Fudan Univ, Zhongshan Hosp, Dept Internal Med, Shanghai 200032, Peoples R China	Fudan University	Wang, JY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Internal Med, Shanghai 200032, Peoples R China.	wang.jiyao@zs-hospital.sh.cn						[Anonymous], 2007, LANCET, V369, P880; He J, 2009, LANCET, V373, P2091, DOI 10.1016/S0140-6736(09)60867-9; International Committee of Medical Journal Editors, BIOMEDICAL J UNPUB; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Schulz KF, 2006, LANCET HDB ESSENTIAL; STRAUS S, 2005, EVIDENCE BASED MED T; Tang JL, 2008, LANCET, V372, P1938, DOI 10.1016/S0140-6736(08)61354-9; The EQUATOR Network, ENH QUAL TRANSP HLTH; WANG J, 2006, EVIDENCE BASED MED C, P383; [王吉耀 WANG Ji-yao], 2010, [中华消化杂志, Chinese Journal of Digestion], V30, P1; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Yu He, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P234	12	25	37	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 13	2010	375	9714					532	533		10.1016/S0140-6736(09)62131-0	http://dx.doi.org/10.1016/S0140-6736(09)62131-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560YO	20159275				2022-12-28	WOS:000274941900007
J	Davis, SJ; Safar, A				Davis, Stephen James; Safar, Ammar			Retinal Arteriolar Occlusions during a Sickle Cell Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Davis, Stephen James; Safar, Ammar] Univ Arkansas, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Davis, SJ (corresponding author), Univ Arkansas, Little Rock, AR 72204 USA.	davisstephenj@uams.edu							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					536	536		10.1056/NEJMicm0902140	http://dx.doi.org/10.1056/NEJMicm0902140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147719				2022-12-28	WOS:000274397200011
J	Stone, JH; Papaliodis, GN; Dunbar, MR; Stone, JR				Stone, John H.; Papaliodis, George N.; Dunbar, Mark R.; Stone, James R.			A Man with Arthralgias, Oral Ulcers, Vision Loss, and Vocal-Cord Paralysis Temporal-artery findings consistent with mild involvement by active giant-cell arteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEGENERS-GRANULOMATOSIS; POLYMYALGIA-RHEUMATICA; BEHCETS-SYNDROME; DISEASE; MANIFESTATIONS; MANAGEMENT; BIOPSY; COMPLICATIONS; DIAGNOSIS; THERAPY		[Stone, John H.] Massachusetts Gen Hosp, Dept Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Papaliodis, George N.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Stone, John H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Papaliodis, George N.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Stone, James R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Dunbar, Mark R.] N Fulton Eye Ctr, Roswell, GA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Stone, JH (corresponding author), Massachusetts Gen Hosp, Dept Rheumatol Allergy & Immunol, Boston, MA 02114 USA.				Genentech	Genentech(Roche HoldingGenentech)	Dr. J.H. Stone reports receiving grant support from Genentech and consulting fees from Merck and Stryker; and Dr. J.R. Stone, consulting fees from Taser International, Proteon Therapeutics, GlaxoSmithKline, and Merck. No other potential conflict of interest relevant to this article was reported. Financial and other disclosures provided by the authors are available with the full text of this article at NEJM.org.	Alaani A, 2004, J LARYNGOL OTOL, V118, P786, DOI 10.1258/0022215042450670; ALBERT DM, 1976, ARCH OPHTHALMOL-CHIC, V94, P2072; ALLSOP CJ, 1981, AM J SURG PATHOL, V5, P317, DOI 10.1097/00000478-198106000-00001; Boyev LR, 1999, AM J OPHTHALMOL, V128, P211, DOI 10.1016/S0002-9394(99)00101-4; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; BREARLEY B F, 1962, Clin Med (Northfield), V69, P2477; BROWN HW, 1973, DOC OPHTHALMOL, V34, P123, DOI 10.1007/BF00151801; Calamia KT, 2005, CURR OPIN RHEUMATOL, V17, P1, DOI 10.1097/01.bor.0000145520.76348.dd; Cantini F, 1999, ANN RHEUM DIS, V58, P230, DOI 10.1136/ard.58.4.230; Ceccato F, 2006, JCR-J CLIN RHEUMATOL, V12, P167, DOI 10.1097/01.rhu.0000231381.21179.e6; Devaney KO, 1998, ANN OTO RHINOL LARYN, V107, P439, DOI 10.1177/000348949810700515; Font RL, 2007, BRIT J OPHTHALMOL, V91, P204, DOI 10.1136/bjo.2006.101725; Gonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001; Gooi P, 2008, CAN J OPHTHALMOL, V43, P119, DOI 10.3129/i07-199; Gordon LK, 1998, JAMA-J AM MED ASSOC, V280, P385, DOI 10.1001/jama.280.4.385; HALL S, 1983, LANCET, V2, P1217; Hausch RC, 1998, SEMIN ARTHRITIS RHEU, V28, P206, DOI 10.1016/S0049-0172(98)80038-3; HORTON BT, 1966, BRIT MED J, V1, P105, DOI 10.1136/bmj.1.5479.105-b; Keogan MT, 2009, CLIN EXP IMMUNOL, V156, P1, DOI 10.1111/j.1365-2249.2008.03857.x; Kitaichi N, 2007, BRIT J OPHTHALMOL, V91, P1579, DOI 10.1136/bjo.2007.123554; Kyle Robert A, 2005, Clin Lymphoma Myeloma, V6, P102, DOI 10.3816/CLM.2005.n.036; Lee MS, 2006, ARTHRITIS RHEUM, V54, P3306, DOI 10.1002/art.22141; LIE JT, 1990, ARTHRITIS RHEUM-US, V33, P1074; Marzo-Ortega H, 2007, ARTHRITIS RHEUM, V56, P3496, DOI 10.1002/art.22942; Moore A T, 1985, J Pediatr Ophthalmol Strabismus, V22, P26; Nesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171; Pakrou N, 2006, SEMIN ARTHRITIS RHEU, V35, P284, DOI 10.1016/j.semarthrit.2005.12.003; Peng YJ, 2004, CAN J OPHTHALMOL, V39, P785, DOI 10.1016/S0008-4182(04)80076-0; Pless M, 2000, J NEURO-OPHTHALMOL, V20, P216, DOI 10.1097/00041327-200020030-00012; Razavi M, 2004, J NEUROPSYCH CLIN N, V16, P505, DOI 10.1176/appi.neuropsych.16.4.505; Rockey JG, 2002, ORAL SURG ORAL MED O, V94, P471, DOI 10.1067/moe.2002.127580; Sack GH, 2009, CLINICIAN'S PEARLS AND MYTHS IN RHEUMATOLOGY, P461, DOI 10.1007/978-1-84800-934-9_46; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Sharma NS, 2007, ANZ J SURG, V77, P437, DOI 10.1111/j.1445-2197.2007.04090.x; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; Staunton H, 2000, ARCH NEUROL-CHICAGO, V57, P581, DOI 10.1001/archneur.57.4.581; Steensma DP, 2007, CONTRIB NEPHROL, V153, P5; Stone JR, 2009, CLINICIAN'S PEARLS AND MYTHS IN RHEUMATOLOGY, P285, DOI 10.1007/978-1-84800-934-9_27; Stone JH, 2004, JAMA-J AM MED ASSOC, V292, P2263, DOI 10.1001/jama.292.18.2263; Sudlow C, 1997, BRIT MED J, V315, P549, DOI 10.1136/bmj.315.7107.549; Tal S, 2007, CLIN GERIATR MED, V23, P649, DOI 10.1016/j.cger.2007.03.004; Tugal-Tutkun I, 2004, AM J OPHTHALMOL, V138, P373, DOI 10.1016/j.ajo.2004.03.022; Williams EL, 2009, RHEUMATOLOGY, V48, P716, DOI 10.1093/rheumatology/kep080; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436; 2006, N ENGL J MED, V354, P623	45	10	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					537	546		10.1056/NEJMcpc0910090	http://dx.doi.org/10.1056/NEJMcpc0910090			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147720				2022-12-28	WOS:000274397200014
J	Curran, M				Curran, Marjorie			Haiti - A View from the Ship	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MassGen Hosp Children, Boston, MA USA	Harvard University; Massachusetts General Hospital									0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMpv1002319	http://dx.doi.org/10.1056/NEJMpv1002319			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20200363	Bronze			2022-12-28	WOS:000275650400041
J	Lemanske, RF; Mauger, DT; Sorkness, CA; Jackson, DJ; Boehmer, SJ; Martinez, FD; Strunk, RC; Szefler, SJ; Zeiger, RS; Bacharier, LB; Covar, RA; Guilbert, TW; Larsen, G; Morgan, WJ; Moss, MH; Spahn, JD; Taussig, LM				Lemanske, Robert F., Jr.; Mauger, David T.; Sorkness, Christine A.; Jackson, Daniel J.; Boehmer, Susan J.; Martinez, Fernando D.; Strunk, Robert C.; Szefler, Stanley J.; Zeiger, Robert S.; Bacharier, Leonard B.; Covar, Ronina A.; Guilbert, Theresa W.; Larsen, Gary; Morgan, Wayne J.; Moss, Mark H.; Spahn, Joseph D.; Taussig, Lynn M.		Natl Heart Lung Blood Inst	Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERSISTENT ASTHMA; BRONCHODILATOR RESPONSIVENESS; CHILDHOOD ASTHMA	Background: For children who have uncontrolled asthma despite the use of low-dose inhaled corticosteroids (ICS), evidence to guide step-up therapy is lacking. Methods: We randomly assigned 182 children (6 to 17 years of age), who had uncontrolled asthma while receiving 100 microg of fluticasone twice daily, to receive each of three blinded step-up therapies in random order for 16 weeks: 250 microg of fluticasone twice daily (ICS step-up), 100 microg of fluticasone plus 50 microg of a long-acting beta-agonist twice daily (LABA step-up), or 100 microg of fluticasone twice daily plus 5 or 10 mg of a leukotriene-receptor antagonist daily (LTRA step-up). We used a triple-crossover design and a composite of three outcomes (exacerbations, asthma-control days, and the forced expiratory volume in 1 second) to determine whether the frequency of a differential response to the step-up regimens was more than 25%. Results: A differential response occurred in 161 of 165 patients who were evaluated (P<0.001). The response to LABA step-up therapy was most likely to be the best response, as compared with responses to LTRA step-up (relative probability, 1.6; 95% confidence interval [CI], 1.1 to 2.3; P=0.004) and ICS step-up (relative probability, 1.7; 95% CI, 1.2 to 2.4; P=0.002). Higher scores on the Asthma Control Test before randomization (indicating better control at baseline) predicted a better response to LABA step-up (P=0.009). White race predicted a better response to LABA step-up, whereas black patients were least likely to have a best response to LTRA step-up (P=0.005). Conclusions: Nearly all the children had a differential response to each step-up therapy. LABA step-up was significantly more likely to provide the best response than either ICS or LTRA step-up. However, many children had a best response to ICS or LTRA step-up therapy, highlighting the need to regularly monitor and appropriately adjust each child's asthma therapy. (ClinicalTrials.gov number, NCT00395304.) N Engl J Med 2010;362:975-85.	[Lemanske, Robert F., Jr.; Sorkness, Christine A.; Jackson, Daniel J.; Guilbert, Theresa W.; Moss, Mark H.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Mauger, David T.; Boehmer, Susan J.] Penn State Univ, Dept Publ Hlth Sci, Hershey, PA USA; [Martinez, Fernando D.; Morgan, Wayne J.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Strunk, Robert C.; Bacharier, Leonard B.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Szefler, Stanley J.; Covar, Ronina A.; Larsen, Gary; Spahn, Joseph D.; Taussig, Lynn M.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Szefler, Stanley J.; Covar, Ronina A.; Larsen, Gary; Spahn, Joseph D.; Taussig, Lynn M.] Univ Colorado, Denver Sch Med, Denver, CO 80202 USA; [Zeiger, Robert S.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Zeiger, Robert S.] Kaiser Permanente, Dept Allergy, San Diego, CA USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Arizona; Washington University (WUSTL); National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California San Diego; Kaiser Permanente	Lemanske, RF (corresponding author), Univ Wisconsin Hosp, 600 Highland Ave,K4-916, Madison, WI 53792 USA.	rfl@medicine.wisc.edu		Zeiger, Robert/0000-0001-5788-5063; Guilbert, Theresa/0000-0002-6932-712X; Bacharier, Leonard/0000-0003-0432-2704	National Heart, Lung, and Blood Institute [HL064307, HL064288, HL064295, HL064287, HL064305, HL064313]; National Institute of Allergy and Infectious Diseases [T32AI007635]; National Center for Research Resources [UL1-RR025011, UL1-RR025780, UL1-RR024992]; General Clinical Research Centers at Washington University School of Medicine [M01-RR00036]; National Jewish Health [M01-RR00051]; University of Wisconsin [M01-RR03186]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, UL1RR025780, M01RR000036, M01RR003186, UL1RR024992, M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL064305, U10HL064288, U10HL064307, U10HL064313, U10HL064287, U10HL064295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007635] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); General Clinical Research Centers at Washington University School of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Jewish Health; University of Wisconsin; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Heart, Lung, and Blood Institute (HL064307, HL064288, HL064295, HL064287, HL064305, and HL064313), the National Institute of Allergy and Infectious Diseases (T32AI007635), and the Clinical Translational Science Award program of the National Center for Research Resources (UL1-RR025011 [Wisconsin], UL1-RR025780 [Colorado], and UL1-RR024992 [St. Louis]). This study was performed in part by the General Clinical Research Centers at Washington University School of Medicine (M01-RR00036), National Jewish Health (M01-RR00051), and the University of Wisconsin (M01-RR03186).	Bensch G, 2002, ANN ALLERG ASTHMA IM, V89, P180, DOI 10.1016/S1081-1206(10)61935-7; Corvol H, 2009, PHARMACOGENET GENOM, V19, P489, DOI 10.1097/FPC.0b013e32832c440e; de Blic J, 2009, PEDIAT ALLERG IMM-UK, V20, P763, DOI 10.1111/j.1399-3038.2009.00861.x; Gappa M, 2009, PEDIATR PULM, V44, P1132, DOI 10.1002/ppul.21120; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Knuffman JE, 2009, J ALLERGY CLIN IMMUN, V123, P411, DOI 10.1016/j.jaci.2008.11.016; Kramer JM, 2009, NEW ENGL J MED, V360, P1592, DOI 10.1056/NEJMp0810561; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Marden JI, 1995, ANAL MODELING RANK D; Moore PE, 2009, PEDIATR PULM, V44, P649, DOI 10.1002/ppul.21033; Naqvi M, 2008, ANN ALLERG ASTHMA IM, V100, P551, DOI 10.1016/S1081-1206(10)60055-5; Naqvi M, 2007, J ASTHMA, V44, P639, DOI 10.1080/02770900701554441; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Ni Chroinin M, 2009, COCHRANE DB SYST REV, V3; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Simons FER, 2001, J PEDIATR-US, V138, P694, DOI 10.1067/mpd.2001.112899; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Strunk RC, 2003, J ALLERGY CLIN IMMUN, V112, P883, DOI 10.1016/j.jaci.2003.08.014; Tal A, 2002, PEDIATR PULM, V34, P342, DOI 10.1002/ppul.10173; Verberne AAPH, 1998, AM J RESP CRIT CARE, V158, P213, DOI 10.1164/ajrccm.158.1.9706048	23	327	333	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					975	985		10.1056/NEJMoa1001278	http://dx.doi.org/10.1056/NEJMoa1001278			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20197425	Green Accepted			2022-12-28	WOS:000275650400008
J	Neumann, H; Wang, KH; Davis, L; Garcia-Alai, M; Chin, JW				Neumann, Heinz; Wang, Kaihang; Davis, Lloyd; Garcia-Alai, Maria; Chin, Jason W.			Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome	NATURE			English	Article							TRANSFER-RNA SYNTHETASE; EXPANDED GENETIC-CODE; ESCHERICHIA-COLI; IN-VIVO; RECOMBINANT PROTEINS; MAMMALIAN-CELLS; MESSENGER-RNA; PYRROLYSINE; SUPPRESSORS; CYCLIZATION	The in vivo, genetically programmed incorporation of designer amino acids allows the properties of proteins to be tailored with molecular precision(1). The Methanococcus jannaschii tyrosyl-transfer-RNA synthetase-tRNA(CUA) (MjTyrRS-tRNA(CUA))(2,3) and the Methanosarcina barkeri pyrrolysyl-tRNA synthetase-tRNACUA (MbPylRS-tRNA(CUA))(4-6) orthogonal pairs have been evolved to incorporate a range of unnatural amino acids in response to the amber codon in Escherichia coli(1,6,7). However, the potential of synthetic genetic code expansion is generally limited to the low efficiency incorporation of a single type of unnatural amino acid at a time, because every triplet codon in the universal genetic code is used in encoding the synthesis of the proteome. To encode efficiently many distinct unnatural amino acids into proteins we require blank codons and mutually orthogonal aminoacyl-tRNA synthetase-tRNA pairs that recognize unnatural amino acids and decode the new codons. Here we synthetically evolve an orthogonal ribosome(8,9) (ribo-Q1) that efficiently decodes a series of quadruplet codons and the amber codon, providing several blank codons on an orthogonal messenger RNA, which it specifically translates(8). By creating mutually orthogonal aminoacyl-tRNA synthetase-tRNA pairs and combining them with ribo-Q1 we direct the incorporation of distinct unnatural amino acids in response to two of the new blank codons on the orthogonal mRNA. Using this code, we genetically direct the formation of a specific, redox-insensitive, nanoscale protein cross-link by the bio-orthogonal cycloaddition of encoded azide-and alkyne-containing amino acids(10). Because the synthetase-tRNA pairs used have been evolved to incorporate numerous unnatural amino acids(1,6,7), it will be possible to encode more than 200 unnatural amino acid combinations using this approach. As ribo-Q1 independently decodes a series of quadruplet codons, this work provides foundational technologies for the encoded synthesis and synthetic evolution of unnatural polymers in cells.	[Neumann, Heinz; Wang, Kaihang; Davis, Lloyd; Garcia-Alai, Maria; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Chin, JW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	chin@mrc-lmb.cam.ac.uk	Neumann, Heinz/ABC-7323-2021; Neumann, Heinz/F-7875-2014	Neumann, Heinz/0000-0001-9657-1913; Wang, Kaihang/0000-0001-7657-8755	ERC; MRC; Trinity College, Cambridge; MRC [MC_UP_A024_1008, MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009, MC_UP_A024_1008] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Trinity College, Cambridge; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to P. B. Kapadnis for synthesizing CAK and to W. An for assistance with some experiments. J. W. C. is grateful to the ERC and the MRC for funding. K. W. is grateful to Trinity College, Cambridge for a fellowship.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Camarero JA, 1998, ANGEW CHEM INT EDIT, V37, P347, DOI 10.1002/(SICI)1521-3773(19980216)37:3<347::AID-ANIE347>3.0.CO;2-5; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Hohsaka T, 2002, CURR OPIN CHEM BIOL, V6, P809, DOI 10.1016/S1367-5931(02)00376-9; KHAZAIE K, 1984, EUR J BIOCHEM, V144, P485, DOI 10.1111/j.1432-1033.1984.tb08491.x; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; LAUGHREA M, 1987, EUR J BIOCHEM, V169, P59, DOI 10.1111/j.1432-1033.1987.tb13580.x; Li Peng, 2002, Current Topics in Medicinal Chemistry, V2, P325, DOI 10.2174/1568026023394209; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; Monahan SL, 2003, CHEM BIOL, V10, P573, DOI 10.1016/S1074-5521(03)00124-8; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Murakami H, 1998, J AM CHEM SOC, V120, P7520, DOI 10.1021/ja971890u; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Ohtsuki T, 2005, FEBS LETT, V579, P6769, DOI 10.1016/j.febslet.2005.11.010; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Rodriguez EA, 2006, P NATL ACAD SCI USA, V103, P8650, DOI 10.1073/pnas.0510817103; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; Steer BA, 1999, J BIOL CHEM, V274, P35601, DOI 10.1074/jbc.274.50.35601; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005	30	449	464	4	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					441	444		10.1038/nature08817	http://dx.doi.org/10.1038/nature08817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20154731				2022-12-28	WOS:000275657100053
J	Srivastava, S; Santos, A; Critchley, K; Kim, KS; Podsiadlo, P; Sun, K; Lee, J; Xu, CL; Lilly, GD; Glotzer, SC; Kotov, NA				Srivastava, Sudhanshu; Santos, Aaron; Critchley, Kevin; Kim, Ki-Sub; Podsiadlo, Paul; Sun, Kai; Lee, Jaebeom; Xu, Chuanlai; Lilly, G. Daniel; Glotzer, Sharon C.; Kotov, Nicholas A.			Light-Controlled Self-Assembly of Semiconductor Nanoparticles into Twisted Ribbons	SCIENCE			English	Article							CDTE NANOCRYSTALS; NANOWIRES; PHOTOLUMINESCENCE; MECHANISM; SHEETS; GROWTH; FILMS	The collective properties of nanoparticles manifest in their ability to self-organize into complex microscale structures. Slow oxidation of tellurium ions in cadmium telluride (CdTe) nanoparticles results in the assembly of 1- to 4-micrometer-long flat ribbons made of several layers of individual cadmium sulfide (CdS)/CdTe nanocrystals. Twisting of the ribbons with an equal distribution of left and right helices was induced by illumination with visible light. The pitch lengths (250 to 1500 nanometers) varied with illumination dose, and the twisting was associated with the relief of mechanical shear stress in assembled ribbons caused by photooxidation of CdS. Unusual shapes of multiparticle assemblies, such as ellipsoidal clouds, dog-bone agglomerates, and ribbon bunches, were observed as intermediate stages. Computer simulations revealed that the balance between attraction and electrostatic repulsion determines the resulting geometry and dimensionality of the nanoparticle assemblies.	[Srivastava, Sudhanshu; Santos, Aaron; Critchley, Kevin; Kim, Ki-Sub; Podsiadlo, Paul; Lee, Jaebeom; Xu, Chuanlai; Lilly, G. Daniel; Glotzer, Sharon C.; Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Critchley, Kevin] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Kim, Ki-Sub] Chungju Natl Univ, Dept Chem & Biol Engn, Chungju 380702, Chungbuk, South Korea; [Podsiadlo, Paul] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Sun, Kai; Kotov, Nicholas A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Glotzer, Sharon C.; Kotov, Nicholas A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Lee, Jaebeom; Kotov, Nicholas A.] Pusan Natl Univ, Coll Nanosci & Nanoengn, Dept Nanomed Engn, Miryang 627706, South Korea; [Xu, Chuanlai] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; University of Leeds; United States Department of Energy (DOE); Argonne National Laboratory; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pusan National University; Jiangnan University	Glotzer, SC (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	sglotzer@umich.edu; kotov@umich.edu	Kotov, Nicholas/AAZ-4204-2021; Critchley, Kevin/D-3123-2018	Kotov, Nicholas/0000-0002-6864-5804; Lee, Jaebeom/0000-0002-8414-7290; Critchley, Kevin/0000-0002-0112-8626	Air Force Office of Scientific Research [FA9550-06-1-0337]; Fannie and John Hertz Foundation; Ministry of Education, Science and Technology [R33-2008-000-10021-0]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-06CH11357]; Argonne National Laboratory; NSF [DMR-9871177, DMR-0320740]; J. S. McDonnell Foundation for the development of BUBBA; Marie Curie Actions [MOIF-CT-2006-039636]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Fannie and John Hertz Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Argonne National Laboratory(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); J. S. McDonnell Foundation for the development of BUBBA; Marie Curie Actions(European Commission)	We acknowledge joint financial support by the Air Force Office of Scientific Research under Multiuniversity Research Initiative grant FA9550-06-1-0337. P. P. thanks the Fannie and John Hertz Foundation for support of his work through a graduate fellowship. This research was supported by the World Class University program through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science and Technology (grant R33-2008-000-10021-0). We thank J. Kim (Univ. of Michigan) for helpful suggestions and discussions and W. Chen (JiangNan University) for assistance with some TEM data. P. P.'s work at the Center for Nanoscale Materials was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract no. DE-AC02-06CH11357. P. P. acknowledges the support of the Willard Frank Libby postdoctoral fellowship from Argonne National Laboratory. The transmission electron microscope used in the study was supported by NSF grant DMR-9871177, and the scanning electron microscope used was supported by NSF grant DMR-0320740. S. C. G. and A. S. acknowledge the support of the J. S. McDonnell Foundation for the development of BUBBA. K. C. thanks Marie Curie Actions MOIF-CT-2006-039636 for financial support.	Bierman MJ, 2008, SCIENCE, V320, P1060, DOI 10.1126/science.1157131; Busch S, 1999, EUR J INORG CHEM, P1643; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; Glotzer SC, 2004, AICHE J, V50, P2978, DOI 10.1002/aic.10413; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Goriely A, 2000, PHYS REV E, V61, P4508, DOI 10.1103/PhysRevE.61.4508; Guo J, 2005, J PHYS CHEM B, V109, P17467, DOI 10.1021/jp044770z; Han XD, 2007, NANO LETT, V7, P452, DOI 10.1021/nl0627689; Jankowski E, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3223834; Li CL, 2005, CHEM LETT, V34, P92, DOI 10.1246/cl.2005.92; Li LS, 2007, ANGEW CHEM INT EDIT, V46, P5873, DOI 10.1002/anie.200701328; McMillen T, 2002, J NONLINEAR SCI, V12, P241, DOI 10.1007/s00332-002-0493-1; NAIR MTS, 1994, J APPL PHYS, V75, P1557, DOI 10.1063/1.356391; RAO KVK, 1968, J AM CERAM SOC, V51, P467, DOI 10.1111/j.1151-2916.1968.tb11923.x; Talapin DV, 2007, J PHYS CHEM C, V111, P14049, DOI 10.1021/jp074319i; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; VOSSMEYER T, 1995, SCIENCE, V267, P1476, DOI 10.1126/science.267.5203.1476; Wang Y, 2003, J AM CHEM SOC, V125, P2830, DOI 10.1021/ja029231r; Yang RS, 2006, J AM CHEM SOC, V128, P1466, DOI 10.1021/ja0578000; Yang S, 2006, J AM CHEM SOC, V128, P10460, DOI 10.1021/ja0619049; Yu MF, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.241403; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhang ZL, 2007, NANO LETT, V7, P1670, DOI 10.1021/nl0706300; Zhou Y, 2006, CHEM MATER, V18, P403, DOI 10.1021/cm051928z	25	291	299	6	499	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1355	1359		10.1126/science.1177218	http://dx.doi.org/10.1126/science.1177218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20150443				2022-12-28	WOS:000275418700035
J	Nichols, LM				Nichols, Len M.			Be Not Afraid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New Amer Fdn, Hlth Policy Program, Washington, DC 20036 USA		Nichols, LM (corresponding author), New Amer Fdn, Hlth Policy Program, Washington, DC 20036 USA.			Nichols, Len/0000-0003-0773-9791				Gawande Atul, 2009, NEW YORKER      1214; HACKBARTH GM, 2009, IMPROVING INCENTIVES; *HLTH CEOS HLTH RE, 2009, REAL US HLTH CAR INC; Nichols LM, 2004, HEALTH AFFAIR, V23, P8, DOI 10.1377/hlthaff.23.2.8; NICHOLS LM, 2009, HASTINGS CENT REP S, P30	5	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMp1001604	http://dx.doi.org/10.1056/NEJMp1001604			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20181965				2022-12-28	WOS:000275365900005
J	Schulte, P; Alegret, L; Arenillas, I; Arz, JA; Barton, PJ; Bown, PR; Bralower, TJ; Christeson, GL; Claeys, P; Cockell, CS; Collins, GS; Deutsch, A; Goldin, TJ; Goto, K; Grajales-Nishimura, JM; Grieve, RAF; Gulick, SPS; Johnson, KR; Kiessling, W; Koeberl, C; Kring, DA; MacLeod, KG; Matsui, T; Melosh, J; Montanari, A; Morgan, JV; Neal, CR; Nichols, DJ; Norris, RD; Pierazzo, E; Ravizza, G; Rebolledo-Vieyra, M; Reimold, WU; Robin, E; Salge, T; Speijer, RP; Sweet, AR; Urrutia-Fucugauchi, J; Vajda, V; Whalen, MT; Willumsen, PS				Schulte, Peter; Alegret, Laia; Arenillas, Ignacio; Arz, Jose A.; Barton, Penny J.; Bown, Paul R.; Bralower, Timothy J.; Christeson, Gail L.; Claeys, Philippe; Cockell, Charles S.; Collins, Gareth S.; Deutsch, Alexander; Goldin, Tamara J.; Goto, Kazuhisa; Grajales-Nishimura, Jose M.; Grieve, Richard A. F.; Gulick, Sean P. S.; Johnson, Kirk R.; Kiessling, Wolfgang; Koeberl, Christian; Kring, David A.; MacLeod, Kenneth G.; Matsui, Takafumi; Melosh, Jay; Montanari, Alessandro; Morgan, Joanna V.; Neal, Clive R.; Nichols, Douglas J.; Norris, Richard D.; Pierazzo, Elisabetta; Ravizza, Greg; Rebolledo-Vieyra, Mario; Reimold, Wolf Uwe; Robin, Eric; Salge, Tobias; Speijer, Robert P.; Sweet, Arthur R.; Urrutia-Fucugauchi, Jaime; Vajda, Vivi; Whalen, Michael T.; Willumsen, Pi S.			The Chicxulub Asteroid Impact and Mass Extinction at the Cretaceous-Paleogene Boundary	SCIENCE			English	Review							TERTIARY BOUNDARY; NEW-ZEALAND; EL KEF; EVENT; PERTURBATIONS; CRATER; CONSEQUENCES; PRODUCTIVITY; TERRESTRIAL; TRANSITION	The Cretaceous-Paleogene boundary similar to 65.5 million years ago marks one of the three largest mass extinctions in the past 500 million years. The extinction event coincided with a large asteroid impact at Chicxulub, Mexico, and occurred within the time of Deccan flood basalt volcanism in India. Here, we synthesize records of the global stratigraphy across this boundary to assess the proposed causes of the mass extinction. Notably, a single ejecta-rich deposit compositionally linked to the Chicxulub impact is globally distributed at the Cretaceous-Paleogene boundary. The temporal match between the ejecta layer and the onset of the extinctions and the agreement of ecological patterns in the fossil record with modeled environmental perturbations (for example, darkness and cooling) lead us to conclude that the Chicxulub impact triggered the mass extinction.	[Schulte, Peter] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Alegret, Laia; Arenillas, Ignacio; Arz, Jose A.] Univ Zaragoza, Dept Ciencias Tierra, E-50009 Zaragoza, Spain; [Alegret, Laia; Arenillas, Ignacio; Arz, Jose A.] Univ Zaragoza, Inst Univ Invest Ciencias Ambientales Aragon, E-50009 Zaragoza, Spain; [Barton, Penny J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Bown, Paul R.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Bralower, Timothy J.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Christeson, Gail L.; Gulick, Sean P. S.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78759 USA; [Claeys, Philippe] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Cockell, Charles S.] Open Univ, Ctr Earth Planetary Space & Astron Res, Milton Keynes MK7 6AA, Bucks, England; [Collins, Gareth S.; Morgan, Joanna V.] Univ London Imperial Coll Sci Technol & Med, London SW7 2BP, England; [Deutsch, Alexander] Univ Munster, Inst Planetol, D-48149 Munster, Germany; [Goldin, Tamara J.; Koeberl, Christian] Univ Vienna, Dept Lithospher Res, A-1090 Vienna, Austria; [Goto, Kazuhisa] Tohoku Univ, Tsunami Engn Lab, Disaster Control Res Ctr, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Grajales-Nishimura, Jose M.] Inst Mexicano Petr, Programa Geol Explorac & Explotac, Direcc Invest & Posgrado, Mexico City 07730, DF, Mexico; [Grieve, Richard A. F.] Nat Resources Canada, Earth Sci Sector, Ottawa, ON K1A 0E4, Canada; [Johnson, Kirk R.; Nichols, Douglas J.] Denver Museum Nat & Sci, Res & Collect Div, Denver, CO 80205 USA; [Kiessling, Wolfgang; Reimold, Wolf Uwe] Humboldt Univ, Leibniz Inst, Museum Nat Kunde, D-10115 Berlin, Germany; [Kring, David A.] Univ Space Res Assoc, Lunar & Planetary Inst, Ctr Lunar Sci & Explorat, Houston, TX 77058 USA; [MacLeod, Kenneth G.] Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA; [Matsui, Takafumi] Chiba Inst Technol, Planetary Explorat Res Ctr, Chiba 2750016, Japan; [Melosh, Jay] Purdue Univ, W Lafayette, IN 47907 USA; [Montanari, Alessandro] Osservatorio Geol Coldigioco, I-62021 Apiro, MC, Italy; [Neal, Clive R.] Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA; [Norris, Richard D.] Scripps Inst Oceanog, SIO Geol Collect, La Jolla, CA 92093 USA; [Pierazzo, Elisabetta] Planetary Sci Inst, Tucson, AZ 85719 USA; [Ravizza, Greg] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Rebolledo-Vieyra, Mario] Ctr Invest Cient Yucatan, Unidad Ciencias Agua, Cancun 77500, Quintana Roo, Mexico; [Robin, Eric] Univ Versailles St Quentin En Yveunes, UMR 1572, Commiss Energie Atom,CNRS, Lab Sci Climat & Environm,Inst Pierre & Simon Lap, F-91198 Gif Sur Yvette, France; [Salge, Tobias] Bruker Nano GmbH, D-12489 Berlin, Germany; [Speijer, Robert P.] Katholieke Univ Leuven, Dept Earth & Environm Sci, B-3001 Leuven, Belgium; [Sweet, Arthur R.] Geol Survey Canada, Nat Resources Canada, Calgary, AB T2L 2A7, Canada; [Urrutia-Fucugauchi, Jaime] Univ Nacl Autonoma Mexico, Lab Paleomagnetismo & Paleoambientes, Programa Univ Perforac Oceanos & Continentes, Inst Geofis, Mexico City 04510, DF, Mexico; [Vajda, Vivi; Willumsen, Pi S.] Lund Univ, Dept Earth & Ecosyst Sci, S-22362 Lund, Sweden; [Whalen, Michael T.] Univ Alaska, Dept Geol & Geophys, Fairbanks, AK 99775 USA	University of Erlangen Nuremberg; University of Zaragoza; University of Zaragoza; University of Cambridge; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Austin; Vrije Universiteit Brussel; Open University - UK; Imperial College London; University of Munster; University of Vienna; Tohoku University; Instituto Mexicano del Petroleo; Natural Resources Canada; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Universities Space Research Association (USRA); University of Missouri System; University of Missouri Columbia; Chiba Institute of Technology; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Notre Dame; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa; Centro de Investigacion Cientifica de Yucatan; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Bruker Corporation; Bruker Nano GmbH; KU Leuven; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Universidad Nacional Autonoma de Mexico; Lund University; University of Alaska System; University of Alaska Fairbanks	Schulte, P (corresponding author), Univ Erlangen Nurnberg, GeoZentrum Nordbayern, Schlossgarten 5, D-91054 Erlangen, Germany.	schulte@geol.uni-erlangen.de	Gulick, Sean/GNH-2042-2022; Bown, Paul/C-5235-2011; (VUB), VRIJE UNIVERSITEIT BRUSSEL/B-4895-2008; Vajda, Vivi/N-7693-2018; MacLeod, Kenneth G./C-4042-2017; Kiessling, Wolfgang/E-2259-2015; Alegret, Laia/B-5420-2008; Arenillas, Ignacio/J-5081-2014; Ravizza, Greg/J-5104-2013; MacLeod, Kenneth/GWU-8940-2022; Christeson, Gail/B-9967-2008; Reimold, Wolf Uwe/AAI-6226-2021; Goto, Kazuhisa/O-2060-2018; Whalen, Michael T/N-6503-2014; Gulick, Sean P. S./C-1039-2008; Arz, Jose A/B-5198-2008; Speijer, Robert/H-5073-2016; Deutsch, Alexander AJ/F-2168-2010; robin, eric/H-8125-2014; Neal, Clive R/C-2316-2014; Christeson, Gail/R-3777-2019	Gulick, Sean/0000-0003-4740-9068; Bown, Paul/0000-0001-6777-4463; (VUB), VRIJE UNIVERSITEIT BRUSSEL/0000-0002-4585-7687; Vajda, Vivi/0000-0003-2987-5559; MacLeod, Kenneth G./0000-0002-6016-0837; Kiessling, Wolfgang/0000-0002-1088-2014; Alegret, Laia/0000-0002-8801-9544; Arenillas, Ignacio/0000-0003-4632-533X; Christeson, Gail/0000-0002-4749-4429; Goto, Kazuhisa/0000-0002-5351-7383; Whalen, Michael T/0000-0003-0556-7471; Gulick, Sean P. S./0000-0003-4740-9068; Arz, Jose A/0000-0003-0063-8752; Speijer, Robert/0000-0002-5873-7203; Deutsch, Alexander AJ/0000-0003-0914-2809; robin, eric/0000-0002-5596-2640; Christeson, Gail/0000-0002-4749-4429; Dr. Salge, Tobias/0000-0002-4414-4917; matsui, takafumi/0000-0001-6470-1189; Hauser, Natalia/0000-0002-6975-6186; Collins, Gareth/0000-0002-6087-6149	Deutsche Forschungsgemeinschaft; Austrian Science Foundation (FWF); Danish Carlsberg Foundation; European Social Fund; Research Foundation Flanders; Mexican Consejo Nacional de Ciencia y Tecnologia; NASA; Japan Society for the Promotion of Science; Joint Oceanographic Institutions; K. U. Leuven Research Fund; UK Natural Environment Research Council; NSF; Swedish Research Council (VR); Royal Swedish Academy of Sciences through the Knut and Alice Wallenberg Foundation; Spanish Ministerio de Ciencia e Innovacion; Division Of Earth Sciences [0843930] Funding Source: National Science Foundation; Natural Environment Research Council [NE/E013589/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/G002452/1, ST/F003102/1] Funding Source: researchfish; NERC [NE/E013589/1] Funding Source: UKRI; STFC [ST/F003102/1, ST/G002452/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Danish Carlsberg Foundation(Carlsberg Foundation); European Social Fund(European Social Fund (ESF)); Research Foundation Flanders(FWO); Mexican Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NASA(National Aeronautics & Space Administration (NASA)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Joint Oceanographic Institutions; K. U. Leuven Research Fund(KU Leuven); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Swedish Research Council (VR)(Swedish Research Council); Royal Swedish Academy of Sciences through the Knut and Alice Wallenberg Foundation; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	D. J. N. passed away during the final revision of this paper. His more than 30 years of work on the Cretaceous-Paleogene boundary influenced the data, ideas, and thesis of this paper. This research used samples and photos provided by the Ocean Drilling Program (ODP) and the International Continental Scientific Drilling Program (ICDP) and was funded by the Deutsche Forschungsgemeinschaft, the Austrian Science Foundation (FWF), Danish Carlsberg Foundation, European Social Fund, Research Foundation Flanders, Mexican Consejo Nacional de Ciencia y Tecnologia, NASA, Japan Society for the Promotion of Science, Joint Oceanographic Institutions, K. U. Leuven Research Fund, UK Natural Environment Research Council, NSF, the Swedish Research Council (VR) and the Royal Swedish Academy of Sciences through the Knut and Alice Wallenberg Foundation, and the Spanish Ministerio de Ciencia e Innovacion. We are grateful to E. Thomas and an anonymous reviewer for valuable comments and thank G. Izett for providing support and photos.	Aberhan M, 2007, GEOLOGY, V35, P227, DOI 10.1130/G23197A.1; Alegret L, 2001, GEOLOGY, V29, P891, DOI 10.1130/0091-7613(2001)029<0891:BFATCT>2.0.CO;2; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Arenillas I, 2000, MICROPALEONTOLOGY, V46, P31; Arenillas I, 2006, EARTH PLANET SC LETT, V249, P241, DOI 10.1016/j.epsl.2006.07.020; Artemieva N, 2009, ICARUS, V201, P768, DOI 10.1016/j.icarus.2009.01.021; Arz JA, 2004, METEORIT PLANET SCI, V39, P1099, DOI 10.1111/j.1945-5100.2004.tb01131.x; BOHOR BF, 1990, TECTONOPHYSICS, V171, P359, DOI 10.1016/0040-1951(90)90110-T; Bown P, 2005, GEOLOGY, V33, P653, DOI 10.1130/G21566.1; Bralower TJ, 1998, GEOLOGY, V26, P331, DOI 10.1130/0091-7613(1998)026<0331:TCTBCC>2.3.CO;2; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Claeys P, 2002, GEOL SOC AM SPEC PAP, V356, P55; D'Hondt S, 2005, ANNU REV ECOL EVOL S, V36, P295, DOI 10.1146/annurev.ecolsys.35.021103.105715; Fastovsky D.E., 2005, GEOLOGICAL SOC AM TO, V15, P4; Goldin TJ, 2009, GEOLOGY, V37, P1135, DOI 10.1130/G30433A.1; Goto K, 2008, CRETACEOUS RES, V29, P217, DOI 10.1016/j.cretres.2007.04.004; Gulick SPS, 2008, NAT GEOSCI, V1, P131, DOI 10.1038/ngeo103; Harvey MC, 2008, GEOLOGY, V36, P355, DOI 10.1130/G24646A.1; HILDEBRAND AR, 1991, GEOLOGY, V19, P867, DOI 10.1130/0091-7613(1991)019<0867:CCAPCT>2.3.CO;2; Ivanov BA, 2005, SOLAR SYST RES+, V39, P381, DOI 10.1007/s11208-005-0051-0; Keller G, 2004, METEORIT PLANET SCI, V39, P1127, DOI 10.1111/j.1945-5100.2004.tb01133.x; Keller G, 2003, EARTH-SCI REV, V62, P327, DOI 10.1016/S0012-8252(02)00162-9; Keller G, 2007, EARTH PLANET SC LETT, V255, P339, DOI 10.1016/j.epsl.2006.12.026; Kring DA, 2007, PALAEOGEOGR PALAEOCL, V255, P4, DOI 10.1016/j.palaeo.2007.02.037; Luder T., 2003, Journal of Geophysical Research, V108, P10, DOI 10.1029/2002JE001894; MacLeod KG, 2007, GEOL SOC AM BULL, V119, P101, DOI 10.1130/B25955.1; Molina E, 2006, EPISODES, V29, P263, DOI 10.18814/epiiugs/2006/v29i4/004; MONTANARI A, 1983, GEOLOGY, V11, P668, DOI 10.1130/0091-7613(1983)11<668:SATCBA>2.0.CO;2; Morgan J, 2006, EARTH PLANET SC LETT, V251, P264, DOI 10.1016/j.epsl.2006.09.009; Nichols DJ, 2008, PLANTS AND THE K-T BOUNDARY, P1, DOI 10.1017/CBO9780511535536; Norris RD, 1999, GEOLOGY, V27, P419, DOI 10.1130/0091-7613(1999)027<0419:SOTKTO>2.3.CO;2; Paul CRC, 2005, PALAEOGEOGR PALAEOCL, V224, P291, DOI 10.1016/j.palaeo.2005.03.038; Pierazzo E, 2003, ASTROBIOLOGY, V3, P99, DOI 10.1089/153110703321632453; Pope KO, 2002, GEOLOGY, V30, P99, DOI 10.1130/0091-7613(2002)030<0099:IDNTCO>2.0.CO;2; Pope KO, 1997, J GEOPHYS RES-PLANET, V102, P21645, DOI 10.1029/97JE01743; Robinson N, 2009, EARTH PLANET SC LETT, V281, P159, DOI 10.1016/j.epsl.2009.02.019; Schulte P, 2009, GEOCHIM COSMOCHIM AC, V73, P1180, DOI 10.1016/j.gca.2008.11.011; Schulte P, 2005, GEOL SOC AM SPEC PAP, V384, P191, DOI 10.1130/0-8137-2384-1.191; Self S, 2006, EARTH PLANET SC LETT, V248, P518, DOI 10.1016/j.epsl.2006.05.041; Sepulveda J, 2009, SCIENCE, V326, P129, DOI 10.1126/science.1176233; Sheehan Peter M., 1996, Geological Society of America Special Paper, V307, P477; SMIT J, 1980, NATURE, V285, P198, DOI 10.1038/285198a0; Smit J, 2004, METEORIT PLANET SCI, V39, P1113, DOI 10.1111/j.1945-5100.2004.tb01132.x; Smit J, 1999, ANNU REV EARTH PL SC, V27, P75, DOI 10.1146/annurev.earth.27.1.75; SMIT J, 1996, SPEC PAP GEOL SOC AM, V307, P151; Sweet AR, 2001, CAN J EARTH SCI, V38, P249, DOI 10.1139/e00-024; Thomas E, 2007, GEOL SOC AM SPEC PAP, V424, P1, DOI 10.1130/2007.2424(01); Toon OB, 1997, REV GEOPHYS, V35, P41, DOI 10.1029/96RG03038; UrrutiaFucugauchi J, 1996, GEOPHYS RES LETT, V23, P1565, DOI 10.1029/96GL01566; Vajda V, 2004, SCIENCE, V303, P1489, DOI 10.1126/science.1093807; Vajda V, 2001, SCIENCE, V294, P1700, DOI 10.1126/science.1064706; Westerhold T, 2008, PALAEOGEOGR PALAEOCL, V257, P377, DOI 10.1016/j.palaeo.2007.09.016; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; Willumsen PS, 2006, CRETACEOUS RES, V27, P954, DOI 10.1016/j.cretres.2006.06.002	55	821	858	13	614	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1214	1218		10.1126/science.1177265	http://dx.doi.org/10.1126/science.1177265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203042	Green Accepted, Green Submitted			2022-12-28	WOS:000275162100028
J	Goldstein, N; Carlson, M; Livote, E; Kutner, JS				Goldstein, Nathan; Carlson, Melissa; Livote, Elayne; Kutner, Jean S.			Brief Communication: Management of Implantable Cardioverter-Defibrillators in Hospice: A Nationwide Survey	ANNALS OF INTERNAL MEDICINE			English	Article							OF-LIFE; CARE; END	Background: Communication about the deactivation of implantable cardioverter-defibrillators (ICDs) in patients near the end of life is rare. Objective: To determine whether hospices are admitting patients with ICDs, whether such patients are receiving shocks, and how hospices manage ICDs. Design: Cross-sectional survey. Setting: Randomly selected hospice facilities. Participants: 900 hospices, 414 of which responded fully. Measurements: Frequency of admission of patients with ICDs, frequency with which patients received shocks, existence of ICD deactivation policies, and frequency of deactivation. Results: 97% of hospices admitted patients with ICDs, and 58% reported that in the past year, a patient had been shocked. Only 10% of hospices had a policy that addressed deactivation. On average, 42% (95% CI, 37% to 48%) of patients with ICDs had the shocking function deactivated. Limitation: The study relied on the knowledge of hospice administrators. Conclusion: Hospices are admitting patients with ICDs, and patients are being shocked at the end of life. Ensuring that hospices have policies in place to address deactivation may improve the care for patients with these devices. The authors provide a sample deactivation policy (available at www.annals.org).	[Goldstein, Nathan] Mt Sinai Sch Med, Dept Geriatr, New York, NY 10029 USA; James J Peters Vet Affairs Med Ctr, Bronx, NY USA; Univ Colorado, Denver Sch Med, Aurora, CO USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Goldstein, N (corresponding author), Mt Sinai Sch Med, Dept Geriatr, Box 1070,1 Gustave Levy Pl, New York, NY 10029 USA.	Nathan.Goldstein@mssm.edu			National Institute of Aging [K23 AG025933K07AG030337-01A2]; National Institute of Nursing Research [1K99NR010495-01]; NATIONAL INSTITUTE OF NURSING RESEARCH [R00NR010495, K99NR010495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG025933, K07AG030337] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institute of Aging, grants K23 AG025933 (Dr. Goldstein) and K07AG030337-01A2 (Dr. Kutner), and the National Institute of Nursing Research, grant 1K99NR010495-01 (Dr. Carlson).	Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Eckert Marion, 2002, Int J Nurs Pract, V8, P152, DOI 10.1046/j.1440-172X.2002.00357.x; Goldenberg S, 2008, ACTA CIR BRAS, V23, P1, DOI 10.1590/S0102-86502008000100001; GOLDSTEIN N, 2008, JUST HEARTBEAT AWAY; Goldstein NE, 2008, J GEN INTERN MED, V23, P2, DOI 10.1007/s11606-007-0237-x; Goldstein NE, 2004, ANN INTERN MED, V141, P835, DOI 10.7326/0003-4819-141-11-200412070-00006; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Kirk Timothy W, 2008, Home Healthc Nurse, V26, P431, DOI 10.1097/01.NHH.0000326324.09466.97; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; National Hospice and Palliative Care Organization, 2009, NHPCO FACTS FIG PED; Puntillo K A, 2001, Am J Crit Care, V10, P216; Sears SF, 2002, HEART, V87, P488, DOI 10.1136/heart.87.5.488; The American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C	14	91	93	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2010	152	5					296	W94		10.7326/0003-4819-152-5-201003020-00007	http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565XJ	20194235	Green Accepted			2022-12-28	WOS:000275329600004
J	Billmann, F				Billmann, Franck			Processus Supracondylaris Humeri	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Vincentius Kliniken, Karlsruhe, Germany		Billmann, F (corresponding author), St Vincentius Kliniken, Karlsruhe, Germany.	franck.billmann@wanadoo.fr							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					739	739		10.1056/NEJMicm0905739	http://dx.doi.org/10.1056/NEJMicm0905739			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181975				2022-12-28	WOS:000274845600012
J	Wang, F; Han, Y; Lim, CS; Lu, YH; Wang, J; Xu, J; Chen, HY; Zhang, C; Hong, MH; Liu, XG				Wang, Feng; Han, Yu; Lim, Chin Seong; Lu, Yunhao; Wang, Juan; Xu, Jun; Chen, Hongyu; Zhang, Chun; Hong, Minghui; Liu, Xiaogang			Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping	NATURE			English	Article							DOPED NAYF4 NANOCRYSTALS; NANOPARTICLES; QUALITY; REDUCTION; EMISSION; IONS	Doping is a widely applied technological process in materials science that involves incorporating atoms or ions of appropriate elements into host lattices to yield hybrid materials with desirable properties and functions. For nanocrystalline materials, doping is of fundamental importance in stabilizing a specific crystallographic phase(1), modifying electronic properties(2-4), modulating magnetism(5) as well as tuning emission properties(6-9). Here we describe a material system in which doping influences the growth process to give simultaneous control over the crystallographic phase, size and optical emission properties of the resulting nanocrystals. We show that NaYF(4) nanocrystals can be rationally tuned in size (down to ten nanometres), phase (cubic or hexagonal) and upconversion(10-12) emission colour (green to blue) through use of trivalent lanthanide dopant ions introduced at precisely defined concentrations. We use first-principles calculations to confirm that the influence of lanthanide doping on crystal phase and size arises from a strong dependence on the size and dipole polarizability of the substitutional dopant ion. Our results suggest that the doping-induced structural and size transition, demonstrated here in NaYF(4) upconversion nanocrystals, could be extended to other lanthanide-doped nanocrystal systems for applications ranging from luminescent biological labels(12) to volumetric three-dimensional displays(13).	[Wang, Feng; Wang, Juan; Zhang, Chun; Liu, Xiaogang] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Han, Yu] King Abdullah Univ Sci & Technol, Div Chem & Life Sci & Engn, Membrane Res Ctr, Thuwal 239556900, Saudi Arabia; [Lim, Chin Seong; Hong, Minghui] ASTAR, Data Storage Inst, Opt Mat & Syst Div, Singapore 117608, Singapore; [Lu, Yunhao; Zhang, Chun] Natl Univ Singapore, Dept Phys, Singapore 117543, Singapore; [Xu, Jun; Chen, Hongyu] Nanyang Technol Univ, Div Chem & Biol Chem, Singapore 637371, Singapore; [Hong, Minghui] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117543, Singapore	National University of Singapore; King Abdullah University of Science & Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Data Storage Institute; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Liu, XG (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.	chmlx@nus.edu.sg	Han, Yu/N-2036-2015; Lu, Yunhao/N-4555-2016; LIU, XIAOGANG/A-8038-2011; Hongyu, Chen/ABZ-9662-2022; Zhang, Chun/F-7638-2012; Lim, Chin Seong/K-4056-2015; chen, hongyu/HHS-4314-2022; xu, jun/B-3105-2011; Han, Yu/GZA-9220-2022; Chen, Hongyu/C-4594-2008; Wang, Juan/L-7686-2017; Wang, Feng/E-2436-2013	Han, Yu/0000-0003-1462-1118; LIU, XIAOGANG/0000-0003-2517-5790; Zhang, Chun/0000-0002-1581-5806; Lim, Chin Seong/0000-0001-9163-8197; Wang, Juan/0000-0002-1340-9011; Wang, Feng/0000-0001-9471-4386; xu, jun/0000-0002-3096-3217	National University of Singapore (NUS); Ministry of Education of Singapore; Singapore-MIT Alliance; Agency for Science, Technology and Research (A*STAR); NUS	National University of Singapore (NUS)(National University of Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); NUS(National University of Singapore)	We thank G. A. Ozin, X. Chen, F. Stellacci, C. Yan, Y. Xia, L. Cademartiri, T. Nann, Y. Li and Y. C. Cao for discussions. This study was supported in part by the National University of Singapore (NUS), the Ministry of Education of Singapore, the Singapore-MIT Alliance, and the Agency for Science, Technology and Research (A*STAR). X. L. is grateful to the NUS for a Young Investigator Award.	Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g; AYYUB P, 1995, PHYS REV B, V51, P6135, DOI 10.1103/PhysRevB.51.6135; BLOCHL PE, 1994, PHYS REV B, V50, P17979; Boyer JC, 2006, J AM CHEM SOC, V128, P7444, DOI 10.1021/ja061848b; Cademartiri L, 2006, J PHYS CHEM B, V110, P671, DOI 10.1021/jp0563585; Chen YF, 2005, J AM CHEM SOC, V127, P13331, DOI 10.1021/ja053151g; Downing E, 1996, SCIENCE, V273, P1185, DOI 10.1126/science.273.5279.1185; Ehlert O, 2008, ACS NANO, V2, P120, DOI 10.1021/nn7002458; Feng XD, 2006, SCIENCE, V312, P1504, DOI 10.1126/science.1125767; Heer S, 2004, ADV MATER, V16, P2102, DOI 10.1002/adma.200400772; Li ZQ, 2008, ADV MATER, V20, P4765, DOI 10.1002/adma.200801056; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Liu CH, 2009, J MATER CHEM, V19, P489, DOI 10.1039/b815682d; Mai HX, 2006, J AM CHEM SOC, V128, P6426, DOI 10.1021/ja060212h; Norris DJ, 2001, NANO LETT, V1, P3, DOI 10.1021/nl005503h; Park YI, 2009, ADV MATER, V21, P4467, DOI 10.1002/adma.200901356; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sivakumar R, 2005, J AM CHEM SOC, V127, P12464, DOI 10.1021/ja052583o; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Suyver JF, 2005, OPT MATER, V27, P1111, DOI 10.1016/j.optmat.2004.10.021; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Wang F, 2008, J AM CHEM SOC, V130, P5642, DOI 10.1021/ja800868a; Wang F, 2009, CHEM SOC REV, V38, P976, DOI 10.1039/b809132n; Wang LY, 2007, CHEM MATER, V19, P727, DOI 10.1021/cm061887m; Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968; Wernsdorfer W, 1997, PHYS REV LETT, V79, P4014, DOI 10.1103/PhysRevLett.79.4014; Yang YA, 2006, J AM CHEM SOC, V128, P12428, DOI 10.1021/ja064818h; Yi GS, 2006, ADV FUNCT MATER, V16, P2324, DOI 10.1002/adfm.200600053	30	2649	2751	107	3471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 25	2010	463	7284					1061	1065		10.1038/nature08777	http://dx.doi.org/10.1038/nature08777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182508				2022-12-28	WOS:000275108400032
J	Cavin, L				Cavin, Lionel			On Giant Filter Feeders	SCIENCE			English	Editorial Material									Nat Hist Museum, Dept Geol & Palaeontol, Geneva, Switzerland		Cavin, L (corresponding author), Nat Hist Museum, Dept Geol & Palaeontol, Geneva, Switzerland.	lionel.cavin@ville-ge.ch	Cavin, Lionel/AAZ-8120-2021	Cavin, Lionel/0000-0001-9666-5864				BUFFETAUT E, 1984, NATURE, V310, P276, DOI 10.1038/310276a0; Cappetta H., 1987, HDB PALEOICHTHYOLO B, V3B; Cavin L, 2007, PALAEOGEOGR PALAEOCL, V245, P353, DOI 10.1016/j.palaeo.2006.08.010; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; LISTON J, 2004, MESOZOIC FISHES, V3, P379; MARTILL DM, 1988, PALAONTOL, P670; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; SANDERSON SL, 1993, SKULL, V3, P37; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060	10	11	11	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					968	969		10.1126/science.1186904	http://dx.doi.org/10.1126/science.1186904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167777				2022-12-28	WOS:000274625800029
J	Friedman, M; Shimada, K; Martin, LD; Everhart, MJ; Liston, J; Maltese, A; Triebold, M				Friedman, Matt; Shimada, Kenshu; Martin, Larry D.; Everhart, Michael J.; Liston, Jeff; Maltese, Anthony; Triebold, Michael			100-Million-Year Dynasty of Giant Planktivorous Bony Fishes in the Mesozoic Seas	SCIENCE			English	Article							SHARK LAMNIFORMES; EVOLUTION	Large-bodied suspension feeders (planktivores), which include the most massive animals to have ever lived, are conspicuously absent from Mesozoic marine environments. The only clear representatives of this trophic guild in the Mesozoic have been an enigmatic and apparently short-lived Jurassic group of extinct pachycormid fishes. Here, we report several new examples of these giant bony fishes from Asia, Europe, and North America. These fossils provide the first detailed anatomical information on this poorly understood clade and extend its range from the lower Middle Jurassic to the end of the Cretaceous, showing that this group persisted for more than 100 million years. Modern large-bodied, planktivorous vertebrates diversified after the extinction of pachycormids at the Cretaceous-Paleogene boundary, which is consistent with an opportunistic refilling of vacated ecospace.	[Friedman, Matt] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Shimada, Kenshu] Depaul Univ, Environm Sci Program, Chicago, IL 60614 USA; [Shimada, Kenshu] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA; [Shimada, Kenshu; Everhart, Michael J.] Ft Hays State Univ, Sternberg Museum Nat Hist, Hays, KS 67601 USA; [Martin, Larry D.] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Martin, Larry D.] Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Liston, Jeff] Univ Glasgow, Fac Biomed & Life Sci, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; [Maltese, Anthony; Triebold, Michael] Triebold Paleontol & Rocky Mt Dinosaur Resource C, Woodland Pk, CO 80863 USA	University of Oxford; DePaul University; DePaul University; University of Kansas; University of Kansas; University of Glasgow	Friedman, M (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	mattf@earth.ox.ac.uk	Friedman, Matt/F-6991-2012; Liston, Jeff J./I-4600-2015	Liston, Jeff J./0000-0002-6763-5452	Environmental Protection Agency [FP916730]	Environmental Protection Agency(United States Environmental Protection Agency)	M. F. was funded by an Environmental Protection Agency Science to Achieve Results Fellowship (award FP916730). We thank T. Uyeno and M. Manabe for provenance data for the Japanese pachycormid, S. Moore-Fay for exacting specimen preparation, R. Nicholls for his reconstruction of + Bonnerichthys, and M. Brazeau, L. Sallan, and three anonymous reviewers for their constructive comments.	Bartholomai Alan, 2004, Memoirs of the Queensland Museum, V49, P521; Cappetta H., 1993, P593; Cavin L, 2002, GEOLOGICAL AND BIOLOGICAL EFFECTS OF IMPACT EVENTS, P141; CAVIN L, 2008, MESOZOIC FISHES, V4, P199; Cione AL, 1998, ANTARCT SCI, V10, P83, DOI 10.1017/S095410209800011X; Collin Rachel, 1997, P451, DOI 10.1016/B978-012155210-7/50024-7; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Freedman JA, 2002, REV FISH BIOL FISHER, V12, P403, DOI 10.1023/A:1025365210414; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; Jarman SN, 2001, BIOL J LINN SOC, V73, P199, DOI 10.1006/bjls.2001.0538; Jessen H., 1972, Fossils Strata, VNo. 1, P1; Lambers P.H., 1992, THESIS RIJKSUUNIVERS; LISTON J, 2004, MESOZOIC FISHES, V3, P379; Liston J.J., 2004, Archives of Natural History, V31, P236, DOI 10.3366/anh.2004.31.2.236; Liston J.J., 2008, MESOZOIC FISHES 4 HO, P181; Mainwaring A.J., 1978, THESIS U LONDON LOND; MARTILL DM, 1988, GEOL PALAEONTOL, P670; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Page LM, 1991, FIELD GUIDE FRESHWAT; Parris DC, 2007, GEOL SOC AM SPEC PAP, V427, P99, DOI 10.1130/2007.2427(07); Sanderson S. Laurie, 1993, P37; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P512, DOI 10.1671/0272-4634(2007)27[512:MOFMSL]2.0.CO;2; STEWART JD, 1988, GEOLOGY PALEONTOLOGY, P80; Woodward A.S, 1902, FOSSIL FISHES ENGLIS	26	88	90	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					990	993		10.1126/science.1184743	http://dx.doi.org/10.1126/science.1184743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167784	Green Accepted, Green Published			2022-12-28	WOS:000274625800038
J	Kim, J; Guermah, M; Roeder, RG				Kim, Jaehoon; Guermah, Mohamed; Roeder, Robert G.			The Human PAF1 Complex Acts in Chromatin Transcription Elongation Both Independently and Cooperatively with SII/TFIIS	CELL			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; HISTONE METHYLATION; H2B UBIQUITYLATION; GENE-EXPRESSION; IN-VIVO; RTF1; INITIATION; NUCLEOSOMES; COMPONENT	Genetic and cell-based studies have implicated the PAF1 complex (PAF1C) in transcription-associated events, but there has been no evidence showing a direct role in facilitating transcription of a natural chromatin template. Here, we demonstrate an intrinsic ability of human PAF1C (hPAF1C) to facilitate activator (p53)- and histone acetyltransferase (p300)-dependent transcription elongation from a recombinant chromatin template in a biochemically defined RNA polymerase II transcription system. This represents a PAF1C function distinct from its established role in histone ubiquitylation and methylation. Importantly, we further demonstrate a strong synergy between hPAF1C and elongation factor SII/TFIIS and an underlying mechanism involving direct hPAF1C-SII interactions and cooperative binding to RNA polymerase II. Apart from a distinct PAF1C function, the present observations provide a molecular mechanism for the cooperative function of distinct transcription elongation factors in chromatin transcription.	[Kim, Jaehoon; Guermah, Mohamed; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Kim, Jaehoon/G-2711-2011	Kim, Jaehoon/0000-0003-4035-0438	NIH [DK071900, CA129325]; Leukemia and Lymphoma Society SCOR; Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. O. Rozenblatt-Rosen and M. Meyerson for anti-hCTR9 antibody and Dr. D. Reinberg for anti-hSKI8 antibody. This work was supported by NIH grants (DK071900 and CA129325), a Leukemia and Lymphoma Society SCOR grant, and a Starr Foundation Cancer Consortium grant. J.K. is a senior fellow of the Charles H. Revson Foundation.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Costa PJ, 2000, GENETICS, V156, P535; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guermah M, 2006, CELL, V125, P275, DOI 10.1016/j.cell.2006.01.055; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Porter SE, 2005, EUKARYOT CELL, V4, P209, DOI 10.1128/EC.4.1.209-220.2005; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Tenney K, 2006, P NATL ACAD SCI USA, V103, P11970, DOI 10.1073/pnas.0603620103; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Wang PF, 2008, MOL CELL BIOL, V28, P2930, DOI 10.1128/MCB.00654-07; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Youn MY, 2007, J BIOL CHEM, V282, P34727, DOI 10.1074/jbc.M705411200; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	48	183	190	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					491	503		10.1016/j.cell.2009.12.050	http://dx.doi.org/10.1016/j.cell.2009.12.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178742	Bronze, Green Accepted			2022-12-28	WOS:000274668400013
J	Romer, W; Pontani, LL; Sorre, B; Rentero, C; Berland, L; Chambon, V; Lamaze, C; Bassereau, P; Sykes, C; Gaus, K; Johannes, L				Roemer, Winfried; Pontani, Lea-Laetitia; Sorre, Benoit; Rentero, Carles; Berland, Ludwig; Chambon, Valerie; Lamaze, Christophe; Bassereau, Patricia; Sykes, Cecile; Gaus, Katharina; Johannes, Ludger			Actin Dynamics Drive Membrane Reorganization and Scission in Clathrin-Independent Endocytosis	CELL			English	Article							GPI-ANCHORED PROTEINS; TOXIN B-SUBUNIT; SHIGA TOXIN; RETROGRADE TRANSPORT; LIPID DOMAINS; PHASE; MODEL; CURVATURE; SEPARATION; ENDOSOMES	Nascent transport intermediates detach from donor membranes by scission. This process can take place in the absence of dynamin, notably in clathrin-independent endocytosis, by mechanisms that are yet poorly defined. We show here that in cells scission of Shiga toxin-induced tubular endocytic membrane invaginations is preceded by cholesterol-dependent membrane reorganization and correlates with the formation of membrane domains on model membranes, suggesting that domain boundary forces are driving tubule membrane constriction. Actin triggers scission by inducing such membrane reorganization process. Tubule occurrence is indeed increased upon cellular depletion of the actin nucleator component Arp2, and the formation of a cortical actin shell in liposomes is sufficient to trigger the scission of Shiga toxin-induced tubules in a cholesterol-dependent but dynamin-independent manner. Our study suggests that membranes in tubular Shiga toxin-induced invaginations are poised to undergo actin-triggered reorganization leading to scission by a physical mechanism that may function independently from or in synergy with pinchase activity.	[Roemer, Winfried; Chambon, Valerie; Lamaze, Christophe; Johannes, Ludger] Inst Curie, CNRS, Ctr Rech, Traff Signaling & Delivery Grp,UMR 144, F-75248 Paris 05, France; [Pontani, Lea-Laetitia; Sykes, Cecile] Univ Paris 06, Inst Curie, Ctr Rech, Biomimetism Cell Movement Grp,CNRS,UMR 168, F-75252 Paris 05, France; [Sorre, Benoit; Berland, Ludwig; Bassereau, Patricia] Univ Paris 06, Inst Curie, Ctr Rech, Membrane & Cell Funct Grp,CNRS,UMR 168, F-75252 Paris 05, France; [Sorre, Benoit] Inst Curie, CNRS, Ctr Rech, Mol Mech Intracellular Transport Grp,UMR 144, F-75248 Paris 05, France; [Rentero, Carles; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Rentero, Carles; Gaus, Katharina] Prince Wales Hosp, Dept Haematol, Sydney, NSW 2052, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of New South Wales Sydney	Romer, W (corresponding author), Inst Curie, CNRS, Ctr Rech, Traff Signaling & Delivery Grp,UMR 144, F-75248 Paris 05, France.	winfried.roemer@curie.fr; johannes@curie.fr	Johannes, Ludger/W-8593-2019; Johannes, Ludger/M-9778-2017; Lamaze, Christophe/M-4912-2017; Sykes, Cécile/B-1271-2016; Rentero Alfonso, Carles/L-4430-2017; Bassereau, Patricia/P-8657-2018	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Sykes, Cécile/0000-0003-3057-2600; Rentero Alfonso, Carles/0000-0003-4684-0278; Gaus, Katharina/0000-0002-8009-9658; Bassereau, Patricia/0000-0002-8544-6778; Sorre, Benoit/0000-0001-8810-3298; LAMAZE, Christophe/0000-0001-5430-2707	Association de Recherche Contre le Cancer [3143]; Curie Institute (PIC Vectorisation); Agence Nationale pour la Recherche (Physicochimie du Vivant); European Commission [NoE/NMP3-CT-2004-502235]; Human Frontier Science Program Organization [RGP26/2007, RPG58/2005]; ANR; CNRS; Direction Generale pour l'Armement and Fondation pour la Recherche Medicale; French Ministry of Science and Technology	Association de Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Curie Institute (PIC Vectorisation); Agence Nationale pour la Recherche (Physicochimie du Vivant)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program Organization(Human Frontier Science Program); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Direction Generale pour l'Armement and Fondation pour la Recherche Medicale; French Ministry of Science and Technology	We thank Satyajit Mayor, Madan Rao, Pierre Sens, Luis Bagatolli, and Emmanuel Derivery for helpful discussions and Dylan Owen for help in Laurdan experiments. The authors acknowledge the help of the PICT-IBiSA imaging staff and the use of the advanced microscopy equipment of the Nikon Imaging Centre at Institut Curie-CNRS. Our laboratories were supported by Association de Recherche Contre le Cancer (n<SUP>o</SUP>3143), Curie Institute (PIC Vectorisation), Agence Nationale pour la Recherche (Physicochimie du Vivant), European Commission (SoftComp, NoE/NMP3-CT-2004-502235), Human Frontier Science Program Organization (RGP26/2007 and RPG58/2005), and ANR program blanc (ProLipScis). W. R. (CNRS), L. B., B. S. (Direction Generale pour l'Armement and Fondation pour la Recherche Medicale), and L. L. P. (French Ministry of Science and Technology) were supported by fellowships from the indicated organizations.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Amessou M, 2006, CURR PROTOC CELL BIO, P15, DOI [10.1002/0471143030.cb1510s32, DOI 10.1002/0471143030.CB1510S32]; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Heuvingh J, 2007, P NATL ACAD SCI USA, V104, P16928, DOI 10.1073/pnas.0704749104; Honerkamp-Smith AR, 2008, BIOPHYS J, V95, P236, DOI 10.1529/biophysj.107.128421; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mallard Frederic, 2003, Methods Mol Med, V73, P209; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Souza CM, 2007, BBA-MOL CELL BIOL L, V1771, P442, DOI 10.1016/j.bbalip.2006.08.006; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Windschiegl B, 2006, LANGMUIR, V22, P7454, DOI 10.1021/la060146x; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0	52	195	196	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					540	553		10.1016/j.cell.2010.01.010	http://dx.doi.org/10.1016/j.cell.2010.01.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178746	Bronze			2022-12-28	WOS:000274668400017
J	Sheather, J				Sheather, Julian			Risk and equality	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMA, London WC1H 9JP, England		Sheather, J (corresponding author), BMA, London WC1H 9JP, England.	jsheather@bma.org.uk						BOYD KM, 1997, NEW DICT MED ETHICS, P143; KING A, 2009, GUARDIAN         SEP; SANDEL MJ, 2009, ALLEN LANE	3	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 18	2010	340								c642	10.1136/bmj.c642	http://dx.doi.org/10.1136/bmj.c642			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	558JV	20167647				2022-12-28	WOS:000274739000003
J	Edwards, RL				Edwards, R. Lawrence			Ice Age Rhythms	SCIENCE			English	Editorial Material							SEA-LEVEL		Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Edwards, RL (corresponding author), Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA.	edwar001@umn.edu	Edwards, R. Lawrence/I-3124-2014	Edwards, R. Lawrence/0000-0002-7027-5881				Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; BROECKER WS, 1968, SCIENCE, V159, P297, DOI 10.1126/science.159.3812.297; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Dorale JA, 2010, SCIENCE, V327, P860, DOI 10.1126/science.1181725; Edwards R.L., 2003, TREATISE GEOCHEMISTR, V6, P343; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Imbrie J., 1986, ICE AGES SOLVING MYS; Lambeck K, 2004, EARTH PLANET SC LETT, V224, P563, DOI 10.1016/j.epsl.2004.05.031; Milankovitch M., 1941, KONIGLICH SERBISCHE, V132; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Thompson WG, 2006, QUATERNARY SCI REV, V25, P3207, DOI 10.1016/j.quascirev.2006.02.007; Wehmiller JF, 2004, QUATERN INT, V120, P3, DOI 10.1016/j.quaint.2004.01.002	14	2	2	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					790	791		10.1126/science.1186256	http://dx.doi.org/10.1126/science.1186256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150473				2022-12-28	WOS:000274408300029
J	Hertzman, C; Siddiqi, A; Hertzman, E; Irwin, LG; Vaghri, Z; Houweling, TAJ; Bell, R; Tinajero, A; Marmot, M				Hertzman, Clyde; Siddiqi, Arjumand; Hertzman, Emily; Irwin, Lori G.; Vaghri, Ziba; Houweling, Tanja A. J.; Bell, Ruth; Tinajero, Alfredo; Marmot, Michael			Bucking the inequality gradient through early child development	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEVELOPING-COUNTRIES; SOCIOECONOMIC INEQUALITIES; HEALTH; PROGRAMS; MORTALITY; INTERVENTION; EDUCATION; NATIONS; WORLD		[Hertzman, Clyde; Hertzman, Emily; Irwin, Lori G.; Vaghri, Ziba] Univ British Columbia, Vancouver, BC V6T 1Z3, Canada; [Siddiqi, Arjumand] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; [Houweling, Tanja A. J.] Inst Child Hlth, UCL Ctr Int Hlth & Dev, London, England; [Tinajero, Alfredo] Hincks Dellcrest Ctr, Toronto, ON, Canada; [Marmot, Michael] UCL, WHO Commiss Social Determinants Hlth, London WC1E 6BT, England	University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; University of London; University College London	Hertzman, C (corresponding author), Univ British Columbia, 440-2206 East Mall, Vancouver, BC V6T 1Z3, Canada.	clyde.hertzman@ubc.ca	Vaghri, Ziba/AAX-9150-2021; Houweling, Tanja/GRF-6127-2022; Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Houweling, Tanja AJ/0000-0001-6090-4376; Vaghri, Dr. Ziba/0000-0001-9708-8704	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G8802774, G0902037, G0100222, G19/35] Funding Source: Medline; MRC [G0902037] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Anderson LM, 2003, AM J PREV MED, V24, P32, DOI 10.1016/S0749-3797(02)00655-4; [Anonymous], 2004, LIFE COURSE APPROACH; [Anonymous], 2009, DOING BETT CHILDR; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Braveman P, 2002, SOC SCI MED, V54, P1621, DOI 10.1016/S0277-9536(01)00331-8; Burchinal MR, 2003, EARLY CHILD RES Q, V18, P401, DOI 10.1016/j.ecresq.2003.09.003; *CIV SOC, 2007, REP COMM SOC DET HLT, P109; Clifford D., 1998, QUALITY CHILD CARE Q; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; *DEP CHILDR SCH FA, SUR START CHILDR CTR; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; EVANS JL, 1993, COORD NOTEB, P13; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; Houweling TAJ, 2001, LANCET, V357, P1671, DOI 10.1016/S0140-6736(00)04829-7; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; Irwin L, 2007, EARLY CHILD DEV POWE; Kershaw P., 2005, BRIT COLUMBIA ATLAS; Kershaw P., 2009, 15 15 COMPREHENSIVE; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P932, DOI 10.2105/AJPH.84.6.932; KUNST AE, 1995, J EPIDEMIOL COMMUN H, V49, P117, DOI 10.1136/jech.49.2.117; Ludwig J., 2007, SOCIAL POLICY REPORT, V21, P3, DOI DOI 10.1002/j.2379-3988.2007.tb00052.x; Melhuish E, 2008, LANCET, V372, P1641, DOI 10.1016/S0140-6736(08)61687-6; Palfrey JS, 2005, PEDIATRICS, V116, P144, DOI 10.1542/peds.2004-2515; Siddiqi A, 2007, INT J HEALTH SERV, V37, P63, DOI 10.2190/JU86-457P-7656-W4W7; Smith JR., 1997, CONSEQUENCES GROWING, P132; Temple JA, 2007, ECON EDUC REV, V26, P126, DOI 10.1016/j.econedurev.2005.11.004; *UN, 2008, CHILD CAR TRANS INN; *UN, 2007, EFA GLOB MON REP STR; *UN, 1 REP 1 INT COMP STU; Unicef, 2007, STAT WORLDS CHILDR 2; Vandell DL, 1996, EARLY CHILD RES Q, V11, P269, DOI 10.1016/S0885-2006(96)90009-5; vanDoorslaer E, 1997, J HEALTH ECON, V16, P93, DOI 10.1016/S0167-6296(96)00532-2; Willms J. D., 2006, 5 UIS UNESCO I STAT	36	32	33	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 10	2010	340								c468	10.1136/bmj.c468	http://dx.doi.org/10.1136/bmj.c468			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	554ZT	20147358	Green Published			2022-12-28	WOS:000274476900003
J	Mechanic, D				Mechanic, David			Replicating High-Quality Medical Care Organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCOUNTABLE CARE; REFORM		Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Mechanic, D (corresponding author), Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, 30 Coll Ave, New Brunswick, NJ 08901 USA.	mechanic@rci.rutgers.edu						BERKOWITZ ED, 1988, GROUP HLTH ASS PORTR; *CTR HLTH POL RES, 2008, TRACK CAR PAT SEV CH; Hing Esther, 2008, Vital Health Stat 13, P1; Linzer M, 2009, ANN INTERN MED, V151, P28, DOI 10.7326/0003-4819-151-1-200907070-00006; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Shortell, 1996, REMAKING HLTH CARE A; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; TOLLEN L, 2008, KEYS STRONGER HOSP P; Wennberg JE, 2007, HEALTH AFFAIR, V26, P1575, DOI 10.1377/hlthaff.26.6.1575; [No title captured]	10	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					555	556		10.1001/jama.2010.100	http://dx.doi.org/10.1001/jama.2010.100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145234				2022-12-28	WOS:000274378700029
J	Jochemsen, AG; Shiloh, Y				Jochemsen, Aart G.; Shiloh, Yosef			USP10: Friend and Foe	CELL			English	Editorial Material							P53		[Jochemsen, Aart G.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Shiloh, Yosef] Tel Aviv Univ, Sackler Sch Med, David & Inez Myers Lab Canc Genet, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tel Aviv University; Sackler Faculty of Medicine	Jochemsen, AG (corresponding author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands.	a.g.jochemsen@lumc.nl						Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026	8	19	23	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 5	2010	140	3					308	310		10.1016/j.cell.2010.01.034	http://dx.doi.org/10.1016/j.cell.2010.01.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144755	Bronze			2022-12-28	WOS:000274297700008
J	Mizushima, N; Yoshimori, T; Levine, B				Mizushima, Noboru; Yoshimori, Tamotsu; Levine, Beth			Methods in Mammalian Autophagy Research	CELL			English	Article							DROSOPHILA FAT-BODY; CELL-DEATH; HUNTINGTONS-DISEASE; MONITORING AUTOPHAGY; 3-KINASE INHIBITORS; SIGNALING PATHWAYS; LC3; PROTEIN; LYSOSOMES; MICE		[Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Yoshimori, Tamotsu] Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	Tokyo Medical & Dental University (TMDU); Osaka University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp; beth.levine@utsouthwestern.edu	Mizushima, Noboru/C-3635-2009; Yoshimori, Tamotsu/K-9626-2014	Mizushima, Noboru/0000-0002-6258-6444; Yoshimori, Tamotsu/0000-0001-9787-3788	NCI NIH HHS [R01 CA084254-10S1, R01 CA084254, R01 CA85254, R01 CA084254-10, R01 CA109618-05, R01 CA109618] Funding Source: Medline; NIAID NIH HHS [U54 AI057156-06S18820, U54 AI057156] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109618, R01CA084254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakaso K, 2004, BRAIN RES, V1012, P42, DOI 10.1016/j.brainres.2004.03.029; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; PUNNONEN EL, 1994, EUR J CELL BIOL, V65, P14; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; SAITOH T, 2009, P NATL ACAD SCI US; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; van der Vaart A, 2008, TRAFFIC, V9, P281, DOI 10.1111/j.1600-0854.2007.00674.x; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xue LZ, 2002, BIOCHEM PHARMACOL, V64, P441, DOI 10.1016/S0006-2952(02)01181-4; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	86	3441	3606	17	703	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 5	2010	140	3					313	326		10.1016/j.cell.2010.01.028	http://dx.doi.org/10.1016/j.cell.2010.01.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144757	Green Accepted, Bronze			2022-12-28	WOS:000274297700010
J	Si, K; Choi, YB; White-Grindley, E; Majumdar, A; Kandel, ER				Si, Kausik; Choi, Yun-Beom; White-Grindley, Erica; Majumdar, Amitabha; Kandel, Eric R.			Aplysia CPEB Can Form Prion-like Multimers in Sensory Neurons that Contribute to Long-Term Facilitation	CELL			English	Article							LOCAL PROTEIN-SYNTHESIS; B1 MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; TRANSLATIONAL CONTROL; SYNAPTIC PLASTICITY; FLUORESCENT PROTEIN; YEAST PRIONS; IN-VITRO; HUNTINGTIN; MECHANISM	Prions are proteins that can assume at least two distinct conformational states, one of which is dominant and self-perpetuating. Previously we found that a translation regulator CPEB from Aplysia, ApCPEB, that stabilizes activity-dependent changes in synaptic efficacy can display prion-like properties in yeast. Here we find that, when exogenously expressed in sensory neurons, ApCPEB can form an amyloidogenic self-sustaining multimer, consistent with it being a prion-like protein. In addition, we find that conversion of both the exogenous and the endogenous ApCPEB to the multimeric state is enhanced by the neurotransmitter serotonin and that an antibody that recognizes preferentially the multimeric ApCPEB blocks persistence of synaptic facilitation. These results are consistent with the idea that ApCPEB can act as a self-sustaining prion-like protein in the nervous system and thereby might allow the activity-dependent change in synaptic efficacy to persist for long periods of time.	[Si, Kausik; White-Grindley, Erica; Majumdar, Amitabha] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Si, Kausik] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Kavli Inst Brain Sci, New York, NY 10032 USA; [Choi, Yun-Beom; Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Neurosci, New York, NY 10032 USA; [Choi, Yun-Beom] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Neurol, New York, NY 10032 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Si, K (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ksi@Stowers-Institute.org		majumdar, amitabha/0000-0002-6594-0672	HHMI; Searle Scholars Program; March of Dimes Basil O'Connor Starter Scholar Award; The Esther A. & Joseph Klingenstein Fund; The McKnight Endowment Fund for Neuroscience	HHMI(Howard Hughes Medical Institute); Searle Scholars Program; March of Dimes Basil O'Connor Starter Scholar Award(March of Dimes); The Esther A. & Joseph Klingenstein Fund; The McKnight Endowment Fund for Neuroscience	We thank Dr. Thomas Jessel and Dr. Richard Axel of Columbia University for their critical comments. Special thanks to Kevin Karl, Agnieszka Janisiewicz, Jonah Lehrer, and Ruby Hsu of Columbia University and Fengzhen Ren of the Stowers Institute for their technical support. We thank Katherine Perko, Joel Schwartz, and Winfried Wiegraebe of the Stowers Institute for their assistance in image processing, Diana Baumann of the Stowers Institute for maintaining Aplysia, and Nancy Lane of the Stowers Institute for her help in preparation of the manuscript. The work was supported by HHMI to E. R. K. K. S. is supported by Searle Scholars Program, March of Dimes Basil O'Connor Starter Scholar Award, The Esther A. & Joseph Klingenstein Fund, and The McKnight Endowment Fund for Neuroscience.	Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Kaang BK, 1996, NEUROSCI LETT, V221, P29, DOI 10.1016/S0304-3940(96)13279-1; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindquist S, 1998, BIOCHEM SOC T, V26, P486, DOI 10.1042/bst0260486; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Miniaci MC, 2008, NEURON, V59, P1024, DOI 10.1016/j.neuron.2008.07.036; Minshall N, 1999, RNA, V5, P27, DOI 10.1017/S1355838299981220; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	49	268	273	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					421	U179		10.1016/j.cell.2010.01.008	http://dx.doi.org/10.1016/j.cell.2010.01.008			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144764	Bronze			2022-12-28	WOS:000274297700019
J	Matsui, T; Leung, D; Miyashita, H; Maksakova, IA; Miyachi, H; Kimura, H; Tachibana, M; Lorincz, MC; Shinkai, Y				Matsui, Toshiyuki; Leung, Danny; Miyashita, Hiroki; Maksakova, Irina A.; Miyachi, Hitoshi; Kimura, Hiroshi; Tachibana, Makoto; Lorincz, Matthew C.; Shinkai, Yoichi			Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; ZINC FINGER PROTEINS; DNA METHYLATION; BINDING-SITE; COMPLEXES; ELEMENTS; H3; HETEROCHROMATIN; RETROVIRUSES; MECHANISM	Endogenous retroviruses (ERVs), retrovirus-like elements with long terminal repeats, are widely dispersed in the euchromatic compartment in mammalian cells, comprising similar to 10% of the mouse genome(1). These parasitic elements are responsible for >10% of spontaneous mutations(2). Whereas DNA methylation has an important role in proviral silencing in somatic and germ-lineage cells(3-5), an additional DNA-methylation-independent pathway also functions in embryonal carcinoma and embryonic stem (ES) cells to inhibit transcription of the exogenous gammaretrovirus murine leukaemia virus (MLV)(6-8). Notably, a recent genome-wide study revealed that ERVs are also marked by histone H3 lysine 9 trimethylation (H3K9me3) and H4K20me3 in ES cells but not in mouse embryonic fibroblasts(9). However, the role that these marks have in proviral silencing remains unexplored. Here we show that the H3K9 methyltransferase ESET (also called SETDB1 or KMT1E) and the Kruppel-associated box (KRAB)associated protein 1 (KAP1, also called TRIM28)(10,11) are required for H3K9me3 and silencing of endogenous and introduced retroviruses specifically in mouse ES cells. Furthermore, whereas ESET enzymatic activity is crucial for HP1 binding and efficient proviral silencing, the H4K20 methyltransferases Suv420h1 and Suv420h2 are dispensable for silencing. Notably, in DNA methyltransferase triple knockout (Dnmt1(-/-) Dnmt3a(-/-) Dnmt3b(-/-)) mouse ES cells, ESET and KAP1 binding and ESET-mediated H3K9me3 are maintained and ERVs are minimally derepressed. We propose that a DNA-methylation-independent pathway involving KAP1 and ESET/ESET-mediated H3K9me3 is required for proviral silencing during the period early in embryogenesis when DNA methylation is dynamically reprogrammed.	[Matsui, Toshiyuki; Miyashita, Hiroki; Miyachi, Hitoshi; Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, Kyoto 6068507, Japan; [Matsui, Toshiyuki; Miyashita, Hiroki; Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068507, Japan; [Leung, Danny; Maksakova, Irina A.; Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; University of British Columbia; Osaka University	Shinkai, Y (corresponding author), Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, 53 Shogoin,Kawara Cho, Kyoto 6068507, Japan.	mlorincz@interchange.ubc.ca; yshinkai@virus.kyoto-u.ac.jp	Kimura, Hiroshi/B-9524-2015; Shinkai, Yoichi/N-3909-2014	Kimura, Hiroshi/0000-0003-0854-083X; Shinkai, Yoichi/0000-0002-6051-2484; Leung, Danny Chi Yeu/0000-0002-2472-894X; Lorincz, Matthew/0000-0003-0885-0467	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; CIHR [77805, 92090]; Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CIHR(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Okano for Dnmt1<SUP>-/-</SUP> Dnmt3a<SUP>-/-</SUP> Dnmt3b<SUP>-/-</SUP> ES cells; T. Jenuwein and P. Singh for Suv39h1<SUP>-/-</SUP> Suv39h2<SUP>-/-</SUP> ES cells; T. Jenuwein and G. Schotta for Suv420h1<SUP>-/-</SUP> Suv420h2<SUP>-/-</SUP> ES cells; K. Hata for Dnmt3l knockout mice testes; M. Hijikata for the large-T antigen expression vector; S. Kuramochi-Miyagawa for IAP and LINE-1 probes; S. Smale for HP1 alpha antiserum; and L. Gaudreau for H2AZ antiserum. We are also grateful to P. Goyal and members of the Shinkai laboratory for technical support and D. Mager for critically reading the manuscript. This work was supported in part by the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grants-in-aid from MEXT to Y.S. and CIHR grants 77805 and 92090 to M. C. L. M. C. L. is a Scholar of the Michael Smith Foundation for Health Research.	Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; HAWLEY RG, 1994, GENE THER, V1, P136; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lorincz MC, 2000, MOL CELL BIOL, V20, P842, DOI 10.1128/MCB.20.3.842-850.2000; Maksakova IA, 2005, J VIROL, V79, P13865, DOI 10.1128/JVI.79.22.13865-13874.2005; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Meunier J, 2005, P NATL ACAD SCI USA, V102, P5471, DOI 10.1073/pnas.0408986102; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; NIWA O, 1983, CELL, V32, P1105, DOI 10.1016/0092-8674(83)90294-5; Pannell D, 2000, EMBO J, V19, P5884, DOI 10.1093/emboj/19.21.5884; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Vernet M, 1996, J VIROL, V70, P5630, DOI 10.1128/JVI.70.8.5630-5633.1996; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	35	489	502	4	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					927	U149		10.1038/nature08858	http://dx.doi.org/10.1038/nature08858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20164836	Green Published			2022-12-28	WOS:000276397300045
J	Fellay, J; Thompson, AJ; Ge, DL; Gumbs, CE; Urban, TJ; Shianna, KV; Little, LD; Qiu, P; Bertelsen, AH; Watson, M; Warner, A; Muir, AJ; Brass, C; Albrecht, J; Sulkowski, M; McHutchison, JG; Goldstein, DB				Fellay, Jacques; Thompson, Alexander J.; Ge, Dongliang; Gumbs, Curtis E.; Urban, Thomas J.; Shianna, Kevin V.; Little, Latasha D.; Qiu, Ping; Bertelsen, Arthur H.; Watson, Mark; Warner, Amelia; Muir, Andrew J.; Brass, Clifford; Albrecht, Janice; Sulkowski, Mark; McHutchison, John G.; Goldstein, David B.			ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C	NATURE			English	Article							TRIPHOSPHATE PYROPHOSPHOHYDROLASE DEFICIENCY; NONSPHEROCYTIC HEMOLYTIC-ANEMIA; WHOLE-GENOME ASSOCIATION; INOSINE TRIPHOSPHATASE; HEXOKINASE DEFICIENCY; MISSENSE MUTATION; POPULATION; PHENOTYPE; RIBAVIRIN	Chronic infection with the hepatitis C virus (HCV) affects 170 million people worldwide and is an important cause of liver-related morbidity and mortality(1). The standard of care therapy combines pegylated interferon (pegIFN) alpha and ribavirin (RBV), and is associated with a range of treatment-limiting adverse effects(2). One of the most important of these is RBV-induced haemolytic anaemia, which affects most patients and is severe enough to require dose modification in up to 15% of patients. Here we show that genetic variants leading to inosine triphosphatase deficiency, a condition not thought to be clinically important, protect against haemolytic anaemia in hepatitis-C-infected patients receiving RBV.	[Fellay, Jacques; Ge, Dongliang; Gumbs, Curtis E.; Urban, Thomas J.; Shianna, Kevin V.; Little, Latasha D.; Goldstein, David B.] Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Thompson, Alexander J.; Muir, Andrew J.; McHutchison, John G.] Duke Univ, Div Gastroenterol, Sch Med, Div Gastroenterol, Durham, NC 27705 USA; [Thompson, Alexander J.; Muir, Andrew J.; McHutchison, John G.] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Qiu, Ping; Bertelsen, Arthur H.; Watson, Mark; Warner, Amelia; Brass, Clifford; Albrecht, Janice] Schering Plough Res Inst, Kenilworth, NJ 07033 USA; [Sulkowski, Mark] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Duke University; Duke University; Duke University; Merck & Company; Schering-Plough Research Institute; Johns Hopkins University	Goldstein, DB (corresponding author), Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA.	mchut001@mc.duke.edu; d.goldstein@duke.edu	Fellay, Jacques/A-6681-2009; Goldstein, David/AAY-8125-2020	Fellay, Jacques/0000-0002-8240-939X; Ge, David/0000-0002-9732-8170	Schering-Plough Research Institute, Kenilworth, New Jersey; National Health and Medical Research Council of Australia; Gastroenterological Society of Australia	Schering-Plough Research Institute, Kenilworth, New Jersey(Merck & Company); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Gastroenterological Society of Australia	We are indebted to the IDEAL principal investigators, the study coordinators, nurses and patients involved in the study. We also thank E. Gustafson, P. Savino, D. Devlin, S. Noviello, M. Geffner, E. L. Heinzen, A. C. Need and E. T. Cirulli for their contributions to the study. This study was funded by the Schering-Plough Research Institute, Kenilworth, New Jersey. A.J.T. receives funding support from the National Health and Medical Research Council of Australia and the Gastroenterological Society of Australia.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arenas M, 2007, BBA-MOL BASIS DIS, V1772, P96, DOI 10.1016/j.bbadis.2006.10.006; Atanasova S, 2007, THER DRUG MONIT, V29, P6, DOI 10.1097/FTD.0b013e3180308554; Bierau J, 2007, PHARMACOGENOMICS, V8, P1221, DOI 10.2217/14622416.8.9.1221; Bonnefond A, 2009, DIABETES, V58, P2687, DOI 10.2337/db09-0652; Cao HN, 2002, J HUM GENET, V47, P620, DOI 10.1007/s100380200095; de Vooght KMK, 2009, HAEMATOL-HEMATOL J, V94, P1203, DOI 10.3324/haematol.2008.002881; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; FRASER JH, 1975, CLIN BIOCHEM, V8, P353, DOI 10.1016/S0009-9120(75)93685-1; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Maeda T, 2005, MOL GENET METAB, V85, P271, DOI 10.1016/j.ymgme.2005.03.011; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MOTULSKY AG, 1957, JAMA-J AM MED ASSOC, V165, P835, DOI 10.1001/jama.1957.72980250010016; Peters LL, 2001, BLOOD CELL MOL DIS, V27, P850, DOI 10.1006/bcmd.2001.0454; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059; Shipkova M, 2006, CLIN CHEM, V52, P240, DOI 10.1373/clinchem.2005.059501; Stepchenkova EI, 2009, J MOL BIOL, V392, P602, DOI 10.1016/j.jmb.2009.07.051; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; van Wijk R, 2003, BLOOD, V101, P345, DOI 10.1182/blood-2002-06-1851; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x	27	372	385	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					405	408		10.1038/nature08825	http://dx.doi.org/10.1038/nature08825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20173735				2022-12-28	WOS:000275657100045
J	Kelly, JD				Kelly, J. Daniel			Haitian Amputees - Lesons Learned from Sierra Leone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Baylor Coll Med, Houston, TX USA	Baylor College of Medicine								Sontag Deborah, 2010, NY TIMES	1	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMpv1002391	http://dx.doi.org/10.1056/NEJMpv1002391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20200359	Bronze			2022-12-28	WOS:000275650400042
J	Agarwal, S; Loh, YH; McLoughlin, EM; Huang, JJ; Park, IH; Miller, JD; Huo, HG; Okuka, M; dos Reis, RM; Loewer, S; Ng, HH; Keefe, DL; Goldman, FD; Klingelhutz, AJ; Liu, L; Daley, GQ				Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Huang, Junjiu; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Okuka, Maja; dos Reis, Rosana Maria; Loewer, Sabine; Ng, Huck-Hui; Keefe, David L.; Goldman, Frederick D.; Klingelhutz, Aloysius J.; Liu, Lin; Daley, George Q.			Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients	NATURE			English	Article							LIFE-SPAN; GENE-EXPRESSION; RNA COMPONENT; MAINTENANCE; MUTATIONS; DISEASE; LYMPHOCYTES; EXTENSION; DELIVERY; HTERT	Patients with dyskeratosis congenita (DC), a disorder of telomere maintenance, suffer degeneration of multiple tissues(1-3). Patient-specific induced pluripotent stem (iPS) cells(4) represent invaluable in vitro models for human degenerative disorders like DC. A cardinal feature of iPS cells is acquisition of indefinite self-renewal capacity, which is accompanied by induction of the telomerase reverse transcriptase gene (TERT)(5-7). We investigated whether defects in telomerase function would limit derivation and maintenance of iPS cells from patients with DC. Here we show that reprogrammed DC cells overcome a critical limitation in telomerase RNA component (TERC) levels to restore telomere maintenance and self-renewal. We discovered that TERC upregulation is a feature of the pluripotent state, that several telomerase components are targeted by pluripotency-associated transcription factors, and that in autosomal dominant DC, transcriptional silencing accompanies a 3' deletion at the TERC locus. Our results demonstrate that reprogramming restores telomere elongation in DC cells despite genetic lesions affecting telomerase, and show that strategies to increase TERC expression may be therapeutically beneficial in DC patients.	[Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Huang, Junjiu; Okuka, Maja; dos Reis, Rosana Maria; Keefe, David L.; Liu, Lin] Univ S Florida, Coll Med, Dept Obstet & Gynecol, MDC 3125, Tampa, FL 33612 USA; [Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Ng, Huck-Hui] Genome Inst Singapore, Gene Regulatory Lab, Singapore 138672, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 138672, Singapore; [Goldman, Frederick D.] Childrens Hosp Alabama, Dept Pediat, Birmingham, AL 35233 USA; [Klingelhutz, Aloysius J.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Liu, Lin] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; State University System of Florida; University of South Florida; Sun Yat Sen University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; University of Iowa; Nankai University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Klingelhutz, Aloysius/L-9081-2018; dos Reis, Rosana Maria/E-3346-2012; Saude da mulher, Inct/J-9403-2013; Loh, Yuin-Han/E-1096-2014; Ng, Huck Hui/A-1135-2009	Klingelhutz, Aloysius/0000-0003-4258-5046; dos Reis, Rosana Maria/0000-0001-9631-4167; Loh, Yuin-Han/0000-0002-4715-6454; NG, HUCK HUI/0000-0001-6352-8417	National Institutes of Health (NIH) [K08HL089150, R01AG0227388]; Manton Center for Orphan Disease Research; Amy Clare Potter Fellowship; Agency of Science, Technology and Research; Institute of Medical Biology, Singapore; James and Esther King Biomedical Research Program; MOST 973 project [2009CB941000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027388] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manton Center for Orphan Disease Research; Amy Clare Potter Fellowship; Agency of Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology, Singapore; James and Esther King Biomedical Research Program; MOST 973 project(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the National Institutes of Health (NIH) and the Manton Center for Orphan Disease Research (G. Q. D.); NIH K08HL089150, Amy Clare Potter Fellowship and Manton Center for Orphan Disease Research (S. A.); the Agency of Science, Technology and Research and the Institute of Medical Biology, Singapore (Y.-H. L.); NIH R01AG0227388 (F. D. G. and A. J. K.); and the James and Esther King Biomedical Research Program and MOST 973 project (2009CB941000) (D. L. K and L. L).	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Atkinson SP, 2005, CANCER RES, V65, P7585, DOI 10.1158/0008-5472.CAN-05-1715; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Greenberg Michael E, 2007, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0410s78; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Kirwan M, 2009, BRIT J HAEMATOL, V144, P771, DOI 10.1111/j.1365-2141.2008.07516.x; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Mason PJ, 2005, CURR MOL MED, V5, P159, DOI 10.2174/1566524053586581; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trahan C, 2009, RNA, V15, P235, DOI 10.1261/rna.1354009; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yi XM, 1999, MOL CELL BIOL, V19, P3989; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	228	238	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					292	U176		10.1038/nature08792	http://dx.doi.org/10.1038/nature08792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20164838	Green Accepted			2022-12-28	WOS:000275366100050
J	Kirch, DG				Kirch, Darrell G.			The Healthcare Innovation Zone A Platform for True Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PAYMENT REFORM		Assoc Amer Med Coll, Washington, DC 20037 USA	Association of American Medical Colleges	Kirch, DG (corresponding author), Assoc Amer Med Coll, 2450 N St NW, Washington, DC 20037 USA.	dgkirch@aamc.org						Brook RH, 2009, JAMA-J AM MED ASSOC, V302, P1465, DOI 10.1001/jama.2009.1427; Crosson FJ, 2009, NEW ENGL J MED, V361, P1324, DOI 10.1056/NEJMp0906917; ENTHOVEN A, 2009, KAISER HLTH NEW 0910; Fuchs VR, 2009, HEALTH AFFAIR, V28, pW180, DOI 10.1377/hlthaff.28.2.w180; Jost TS, 2008, JAMA-J AM MED ASSOC, V299, P2561, DOI 10.1001/jama.299.21.2561; Lee PV, 2010, NEW ENGL J MED, V362, P3, DOI 10.1056/NEJMp0910459; Margolis P, 2009, JAMA-J AM MED ASSOC, V302, P1461, DOI 10.1001/jama.2009.1428; Steinbrook R, 2009, NEW ENGL J MED, V361, P1036, DOI 10.1056/NEJMp0906556	8	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					874	875		10.1001/jama.2010.224	http://dx.doi.org/10.1001/jama.2010.224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197534				2022-12-28	WOS:000275059500021
J	Davis, RL				Davis, Ronald L.			Rac in the Act of Forgetting	CELL			English	Editorial Material							DROSOPHILA; MEMORY		Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute	Davis, RL (corresponding author), Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA.	rdavis@scripps.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608				Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; MENG Y, 2002, NEURON, V35, P431; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	8	14	15	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					456	458		10.1016/j.cell.2010.02.004	http://dx.doi.org/10.1016/j.cell.2010.02.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178738	Bronze			2022-12-28	WOS:000274668400009
J	Srinivas, N; Jetter, P; Ueberbacher, BJ; Werneburg, M; Zerbe, K; Steinmann, J; Van der Meijden, B; Bernardini, F; Lederer, A; Dias, RLA; Misson, PE; Henze, H; Zumbrunn, J; Gombert, FO; Obrecht, D; Hunziker, P; Schauer, S; Ziegler, U; Kach, A; Eberl, L; Riedel, K; DeMarco, SJ; Robinson, JA				Srinivas, Nityakalyani; Jetter, Peter; Ueberbacher, Bernhard J.; Werneburg, Martina; Zerbe, Katja; Steinmann, Jessica; Van der Meijden, Benjamin; Bernardini, Francesca; Lederer, Alexander; Dias, Ricardo L. A.; Misson, Pauline E.; Henze, Heiko; Zumbrunn, Juerg; Gombert, Frank O.; Obrecht, Daniel; Hunziker, Peter; Schauer, Stefan; Ziegler, Urs; Kaech, Andres; Eberl, Leo; Riedel, Kathrin; DeMarco, Steven J.; Robinson, John A.			Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa	SCIENCE			English	Article							ANTIMICROBIAL PEPTIDE PROTEGRIN; SOLID-STATE NMR; CYSTIC-FIBROSIS AIRWAY; ESCHERICHIA-COLI; HAIRPIN MIMETICS; LIPID-BILAYERS; BROAD-SPECTRUM; LIPOPOLYSACCHARIDE; IDENTIFICATION; PERMEABILITY	Antibiotics with new mechanisms of action are urgently required to combat the growing health threat posed by resistant pathogenic microorganisms. We synthesized a family of peptidomimetic antibiotics based on the antimicrobial peptide protegrin I. Several rounds of optimization gave a lead compound that was active in the nanomolar range against Gram-negative Pseudomonas spp., but was largely inactive against other Gram-negative and Gram-positive bacteria. Biochemical and genetic studies showed that the peptidomimetics had a non-membrane-lytic mechanism of action and identified a homolog of the beta-barrel protein LptD (Imp/OstA), which functions in outer-membrane biogenesis, as a cellular target. The peptidomimetic showed potent antimicrobial activity in a mouse septicemia infection model. Drug-resistant strains of Pseudomonas are a serious health problem, so this family of antibiotics may have important therapeutic applications.	[Bernardini, Francesca; Lederer, Alexander; Dias, Ricardo L. A.; Misson, Pauline E.; Henze, Heiko; Zumbrunn, Juerg; Gombert, Frank O.; Obrecht, Daniel; DeMarco, Steven J.] Polyphor AG, CH-4123 Allschwil, Switzerland; [Srinivas, Nityakalyani; Jetter, Peter; Ueberbacher, Bernhard J.; Werneburg, Martina; Zerbe, Katja; Steinmann, Jessica; Van der Meijden, Benjamin; Robinson, John A.] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland; [Hunziker, Peter; Schauer, Stefan] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Ziegler, Urs; Kaech, Andres] Univ Zurich, Ctr Microscopy & Image Anal, CH-8057 Zurich, Switzerland; [Eberl, Leo; Riedel, Kathrin] Univ Zurich, Dept Microbiol, CH-8057 Zurich, Switzerland	Polyphor Ltd; University of Zurich; University of Zurich; University of Zurich	DeMarco, SJ (corresponding author), Polyphor AG, Hegenheimermattweg 125, CH-4123 Allschwil, Switzerland.	steve.demarco@polyphor.com; robinson@oci.uzh.ch	Riedel, Katharina/B-6091-2015; Eberl, Leo/A-8380-2012; Eberl, Leo/AAE-8165-2019	Eberl, Leo/0000-0002-7241-0864; Riedel, Katharina/0000-0002-4629-3019; GOMBERT, Frank Otto/0000-0002-7507-697X	Swiss National Science Foundation; Swiss Commission for Technology and Innovation; European Union	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Commission for Technology and Innovation; European Union(European Commission)	We thank A. Meier for technical support. This study was supported by grants from the Swiss National Science Foundation, the Swiss Commission for Technology and Innovation, and the European Union 7th Framework Programme (project NABATIVI). Relevant patents are WO/2007/079605, WO/2007/079597, and WO/2004/018503. J.R. is a consultant for Polyphor AG. Patents that cover the structure, synthesis, and activity of the antibiotics (AGWO/2007/079605, WO/2007/079597, WO/2004/018503) are owned jointly by University of Zurich and Polyphor AG.	Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Buffy JJ, 2003, BIOPHYS J, V85, P2363, DOI 10.1016/S0006-3495(03)74660-8; Cho Y, 1998, INFECT IMMUN, V66, P2486, DOI 10.1128/IAI.66.6.2486-2493.1998; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Gidalevitz D, 2003, P NATL ACAD SCI USA, V100, P6302, DOI 10.1073/pnas.0934731100; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; Jiang LJ, 2000, HELV CHIM ACTA, V83, P3097, DOI 10.1002/1522-2675(20001220)83:12<3097::AID-HLCA3097>3.0.CO;2-1; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; Mani R, 2006, BIOCHEMISTRY-US, V45, P8341, DOI 10.1021/bi060305b; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; MOORE RA, 1986, ANTIMICROB AGENTS CH, V30, P923, DOI 10.1128/AAC.30.6.923; Robinson JA, 2005, BIOORGAN MED CHEM, V13, P2055, DOI 10.1016/j.bmc.2005.01.009; Robinson JA, 2008, DRUG DISCOV TODAY, V13, P944, DOI 10.1016/j.drudis.2008.07.008; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; SAMPSON BA, 1989, GENETICS, V122, P491; Shankaramma SC, 2002, CHEMBIOCHEM, V3, P1126, DOI 10.1002/1439-7633(20021104)3:11<1126::AID-CBIC1126>3.0.CO;2-I; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	28	397	415	4	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1010	1013		10.1126/science.1182749	http://dx.doi.org/10.1126/science.1182749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	556XE	20167788	Green Accepted			2022-12-28	WOS:000274625800044
J	Abdo, AA; Ackermann, M; Ajello, M; Axelsson, M; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Baughman, BM; Bechtol, K; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bock, DCJ; Bogart, JR; Bonamente, E; Borgland, AW; Bouvier, A; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Burnett, TH; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cavazzuti, E; Cecchi, C; Celik, O; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Collmar, W; Cominsky, LR; Conrad, J; Corbel, S; Corbet, R; Costamante, L; Cutini, S; Dermer, CD; de Angelis, A; de Palma, F; Digel, SW; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Farnier, C; Favuzzi, C; Fegan, SJ; Ferrara, EC; Focke, WB; Fortin, P; Frailis, M; Fuhrmann, L; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giebels, B; Giglietto, N; Giommi, P; Giordano, F; Giroletti, M; Glanzman, T; Godfrey, G; Grenier, IA; Grove, JE; Guillemot, L; Guiriec, S; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Horan, D; Hughes, RE; Iafrate, G; Itoh, R; Jackson, MS; Johannesson, G; Johnson, AS; Johnson, WN; Kadler, M; Kamae, T; Katagiri, H; Kataoka, J; Kawai, N; Kerr, M; Knodlseder, J; Kocian, ML; Kuss, M; Lande, J; Larsson, S; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Macquart, J; Madejski, GM; Makeev, A; Max-Moerbeck, W; Mazziotta, MN; McConville, W; McEnery, JE; McGlynn, S; Meurer, C; Michelson, F; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nestoras, I; Nolan, PL; Norris, JP; Nuss, E; Ohsugi, T; Okumura, A; Omodei, N; Orlando, E; Ormes, JF; Paneque, D; Panetta, JH; Parent, D; Pavlidou, V; Pearson, TJ; Pelassa, V; Pepe, M; Pesce-Rollins, M; Piron, F; Porter, TA; Raino, S; Rando, R; Razzano, M; Readhead, A; Reimer, A; Reimer, O; Reposeur, T; Reyes, LC; Richards, JL; Rochester, LS; Rodriguez, AY; Roth, M; Ryde, F; Sadrozinski, HFW; Sanchez, D; Sander, A; Parkinson, PMS; Scargle, JD; Sgro, C; Shaw, MS; Shrader, C; Siskind, EJ; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Stawarz, L; Stevenson, M; Strickman, MS; Suson, DJ; Tajima, H; Takahashi, H; Takahashi, T; Tanaka, T; Taylor, GB; Thayer, JB; Thayer, JG; Thompson, DJ; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Uchiyama, Y; Usher, TL; Vasileiou, V; Vilchez, N; Vitale, V; Waite, AP; Wang, P; Wehrle, AE; Winer, BL; Wood, KS; Ylinen, T; Zensus, JA; Ziegler, M; Uemura, M; Ikejiri, Y; Kawabata, KS; Kino, M; Sakimoto, K; Sasada, M; Sato, S; Yamanaka, M; Villata, M; Raiteri, CM; Agudo, I; Aller, HD; Aller, MF; Angelakis, E; Arkharov, AA; Bach, U; Benitez, E; Berdyugin, A; Blinov, DA; Boettcher, M; Buemi, CS; Chen, WP; Dolci, M; Dultzin, D; Efimova, NV; Gurwell, MA; Gusbar, C; Gomez, JL; Heidt, J; Hiriart, D; Hovatta, T; Jorstad, SG; Konstantinova, TS; Kopatskaya, EN; Koptelova, E; Kurtanidze, OM; Lahteenmaki, A; Larionov, VM; Larionova, EG; Leto, P; Lin, HC; Lindfors, E; Marscher, AP; McHardy, IM; Melnichuk, DA; Mommert, M; Nilsson, K; Di Paola, A; Reinthal, R; Richter, GM; Roca-Sogorb, M; Roustazadeh, P; Sigua, LA; Takalo, LO; Tornikoski, M; Trigilio, C; Troitsky, IS; Umana, G; Villforth, C; Grainge, K; Moderski, R; Nalewajko, K; Sikora, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Axelsson, M.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Baughman, B. M.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bock, D. C. -J.; Bogart, J. R.; Bonamente, E.; Borgland, A. W.; Bouvier, A.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Burnett, T. H.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cavazzuti, E.; Cecchi, C.; Celik, Oe; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Collmar, W.; Cominsky, L. R.; Conrad, J.; Corbel, S.; Corbet, R.; Costamante, L.; Cutini, S.; Dermer, C. D.; de Angelis, A.; de Palma, F.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Farnier, C.; Favuzzi, C.; Fegan, S. J.; Ferrara, E. C.; Focke, W. B.; Fortin, P.; Frailis, M.; Fuhrmann, L.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giebels, B.; Giglietto, N.; Giommi, P.; Giordano, F.; Giroletti, M.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Horan, D.; Hughes, R. E.; Iafrate, G.; Itoh, R.; Jackson, M. S.; Johannesson, G.; Johnson, A. S.; Johnson, W. N.; Kadler, M.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kawai, N.; Kerr, M.; Knoedlseder, J.; Kocian, M. L.; Kuss, M.; Lande, J.; Larsson, S.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Macquart, J.; Madejski, G. M.; Makeev, A.; Max-Moerbeck, W.; Mazziotta, M. N.; McConville, W.; McEnery, J. E.; McGlynn, S.; Meurer, C.; Michelson, F.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nestoras, I.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohsugi, T.; Okumura, A.; Omodei, N.; Orlando, E.; Ormes, J. F.; Paneque, D.; Panetta, J. H.; Parent, D.; Pavlidou, V.; Pearson, T. J.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Piron, F.; Porter, T. A.; Raino, S.; Rando, R.; Razzano, M.; Readhead, A.; Reimer, A.; Reimer, O.; Reposeur, T.; Reyes, L. C.; Richards, J. L.; Rochester, L. S.; Rodriguez, A. Y.; Roth, M.; Ryde, F.; Sadrozinski, H. F. -W.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Scargle, J. D.; Sgro, C.; Shaw, M. S.; Shrader, C.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Stawarz, L.; Stevenson, M.; Strickman, M. S.; Suson, D. J.; Tajima, H.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Taylor, G. B.; Thayer, J. B.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Vasileiou, V.; Vilchez, N.; Vitale, V.; Waite, A. P.; Wang, P.; Wehrle, A. E.; Winer, B. L.; Wood, K. S.; Ylinen, T.; Zensus, J. A.; Ziegler, M.; Uemura, M.; Ikejiri, Y.; Kawabata, K. S.; Kino, M.; Sakimoto, K.; Sasada, M.; Sato, S.; Yamanaka, M.; Villata, M.; Raiteri, C. M.; Agudo, I.; Aller, H. D.; Aller, M. F.; Angelakis, E.; Arkharov, A. A.; Bach, U.; Benitez, E.; Berdyugin, A.; Blinov, D. A.; Boettcher, M.; Buemi, C. S.; Chen, W. P.; Dolci, M.; Dultzin, D.; Efimova, N. V.; Gurwell, M. A.; Gusbar, C.; Gomez, J. L.; Heidt, J.; Hiriart, D.; Hovatta, T.; Jorstad, S. G.; Konstantinova, T. S.; Kopatskaya, E. N.; Koptelova, E.; Kurtanidze, O. M.; Lahteenmaki, A.; Larionov, V. M.; Larionova, E. G.; Leto, P.; Lin, H. C.; Lindfors, E.; Marscher, A. P.; McHardy, I. M.; Melnichuk, D. A.; Mommert, M.; Nilsson, K.; Di Paola, A.; Reinthal, R.; Richter, G. M.; Roca-Sogorb, M.; Roustazadeh, P.; Sigua, L. A.; Takalo, L. O.; Tornikoski, M.; Trigilio, C.; Troitsky, I. S.; Umana, G.; Villforth, C.; Grainge, K.; Moderski, R.; Nalewajko, K.; Sikora, M.		Fermi LAT Collaboration; 3C 279 Multiband Campaign	A change in the optical polarization associated with a gamma-ray flare in the blazar 3C 279	NATURE			English	Article							ACTIVE GALACTIC NUCLEUS; RADIO; VARIABILITY; TELESCOPE; RADIATION; QUASAR; JET; ULTRAVIOLET; EMISSION; MODEL	It is widely accepted that strong and variable radiation detected over all accessible energy bands in a number of active galaxies arises from a relativistic, Doppler-boosted jet pointing close to our line of sight(1). The size of the emitting zone and the location of this region relative to the central supermassive black hole are, however, poorly known, with estimates ranging from light-hours to a light-year or more. Here we report the coincidence of a gamma (gamma)-ray flare with a dramatic change of optical polarization angle. This provides evidence for co-spatiality of optical and gamma-ray emission regions and indicates a highly ordered jet magnetic field. The results also require a non-axisymmetric structure of the emission zone, implying a curved trajectory for the emitting material within the jet, with the dissipation region located at a considerable distance from the black hole, at about 10(5) gravitational radii.	[Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bogart, J. R.; Borgland, A. W.; Bouvier, A.; Cameron, R. A.; Chiang, J.; Claus, R.; Costamante, L.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Reimer, A.; Reimer, O.; Rochester, L. S.; Shaw, M. S.; Stawarz, L.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, Dept Phys, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Abdo, A. A.; Chekhtman, A.; Cheung, C. C.; Dermer, C. D.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Parent, D.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Abdo, A. A.; Cheung, C. C.] Natl Acad Sci, Natl Res Council Res Associate, Washington, DC 20001 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bogart, J. R.; Borgland, A. W.; Bouvier, A.; Cameron, R. A.; Chiang, J.; Claus, R.; Costamante, L.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Reimer, A.; Reimer, O.; Rochester, L. S.; Shaw, M. S.; Stawarz, L.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Axelsson, M.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Axelsson, M.; Conrad, J.; Jackson, M. S.; Larsson, S.; McGlynn, S.; Meurer, C.; Ryde, F.; Ylinen, T.] AlbaNova, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Corbel, S.; Grenier, I. A.; Tibaldo, L.] Univ Paris Diderot, CEA Saclay, CNRS, IRFU,Lab AIM,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Iafrate, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartmento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis Galileo Galilei, I-35131 Padua, Italy; [Baughman, B. M.; Hughes, R. E.; Sander, A.; Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Bock, D. C. -J.] CARMA, Big Pine, CA 93514 USA; [Bock, D. C. -J.] Univ Calif Berkeley, Radio Astron Lab, Berkeley, CA 94720 USA; [Bonamente, E.; Cecchi, C.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Politecn Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Fortin, P.; Giebels, B.; Horan, D.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burnett, T. H.; Kerr, M.; Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Caliandro, G. A.; Rodriguez, A. Y.; Torres, D. F.] CSIC, IEEC, Inst Ciencies Espai, Barcelona 08193, Spain; [Caraveo, P. A.] Ist Astrofis Spaziale & Fis Cosm, INAF, I-20133 Milan, Italy; [Cavazzuti, E.; Cutini, S.; Gasparrini, D.; Giommi, P.] Sci Data Ctr, ASI, I-00044 Frascati, Roma, Italy; [Celik, Oe; Corbet, R.; Ferrara, E. C.; Gehrels, N.; Harding, A. K.; Hays, E.; Kadler, M.; McConville, W.; McEnery, J. E.; Moiseev, A. A.; Shrader, C.; Thompson, D. J.; Vasileiou, V.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Celik, Oe; Kadler, M.; Moiseev, A. A.; Shrader, C.; Vasileiou, V.] NASA, CRESST, Greenbelt, MD 20771 USA; [Celik, Oe; Corbet, R.; Vasileiou, V.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Celik, Oe; Corbet, R.; Vasileiou, V.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Chekhtman, A.; Makeev, A.; Parent, D.] George Mason Univ, Fairfax, VA 22030 USA; [Cohen-Tanugi, J.; Farnier, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, F-34095 Montpellier, France; [Collmar, W.; Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Larsson, S.; Meurer, C.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Corbel, S.] Inst Univ France, F-75005 Paris, France; [de Angelis, A.; Frailis, M.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.; Frailis, M.] Grp Coll Udine, Ist Nazl Fis Nucl, Sez Trieste, I-33100 Udine, Italy; [Dumora, D.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] CEN Bordeaux Gradignan, CNRS, UMR 5797, IN2P3, F-33175 Gradignan, France; [Dumora, D.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux, CEN Bordeaux Gradignan, UMR 5797, F-33175 Gradignan, France; [Frailis, M.; Iafrate, G.] Osserv Astron Trieste, Ist Nazl Astrofis, I-34143 Trieste, Italy; [Fuhrmann, L.; Guillemot, L.; Nestoras, I.; Zensus, J. A.; Angelakis, E.; Bach, U.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Fukazawa, Y.; Hanabata, Y.; Itoh, R.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.; Ikejiri, Y.; Sakimoto, K.; Sasada, M.; Yamanaka, M.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gehrels, N.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Gehrels, N.; McConville, W.; McEnery, J. E.; Moiseev, A. A.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Gehrels, N.; McConville, W.; McEnery, J. E.; Moiseev, A. A.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Giroletti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [Guiriec, S.] Univ Alabama, Ctr Space Plasma & Aeron Res, Huntsville, AL 35899 USA; [Jackson, M. S.; McGlynn, S.; Ryde, F.; Ylinen, T.] Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Kadler, M.] Dr Remeis Sternwarte Bamberg, D-96049 Bamberg, Germany; [Kadler, M.] Erlangen Ctr Astroparticle Phys, D-91058 Erlangen, Germany; [Kadler, M.] Univ Space Res Assoc, Columbia, MD 21044 USA; [Kataoka, J.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Kawai, N.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Kawai, N.] RIKEN, Inst Phys & Chem Res, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Knoedlseder, J.; Vilchez, N.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Macquart, J.] Curtin Inst Radio Astron, ICRAR, Bentley, WA 6102, Australia; [Max-Moerbeck, W.; Pavlidou, V.; Pearson, T. J.; Readhead, A.; Richards, J. L.; Stevenson, M.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Okumura, A.] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Reyes, L. C.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Stawarz, L.] Jagiellonian Univ, Astron Observ, PL-30244 Krakow, Poland; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Takahashi, T.] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Taylor, G. B.] Univ New Mexico, Albuquerque, NM 87131 USA; [Torres, D. F.] ICREA, Barcelona 08010, Spain; [Tramacere, A.] CIFS, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Wehrle, A. E.] Space Sci Inst, Boulder, CO 80301 USA; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Uemura, M.; Kawabata, K. S.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Kino, M.; Sato, S.] Nagoya Univ, Dept Phys & Astrophys, Nagoya, Aichi 4648602, Japan; [Villata, M.; Raiteri, C. M.] Osserv Astron Torino, INAF, I-10025 Pino Torinese, TO, Italy; [Agudo, I.; Gomez, J. L.; Roca-Sogorb, M.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Aller, H. D.; Aller, M. F.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Arkharov, A. A.; Efimova, N. V.] Pulkovo Observ, St Petersburg 196140, Russia; [Benitez, E.; Dultzin, D.] Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico; [Berdyugin, A.; Blinov, D. A.; Lindfors, E.; Nilsson, K.; Reinthal, R.; Takalo, L. O.; Villforth, C.] Univ Turku, Tuorla Observ, FI-21500 Piikkio, Finland; [Blinov, D. A.; Efimova, N. V.; Konstantinova, T. S.; Kopatskaya, E. N.; Larionov, V. M.; Larionova, E. G.; Melnichuk, D. A.; Troitsky, I. S.] St Petersburg State Univ, Astron Inst, St Petersburg, Russia; [Boettcher, M.; Gusbar, C.; Roustazadeh, P.] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Buemi, C. S.; Leto, P.; Trigilio, C.; Umana, G.] Osserv Astrofis Catania, I-95123 Catania, Italy; [Chen, W. P.; Koptelova, E.; Lin, H. C.] Natl Cent Univ, Grad Inst Astron, Jhongli 32054, Taiwan; [Dolci, M.] Osservatorio Astron Collurania, INAF, I-64100 Teramo, Italy; [Gurwell, M. A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Heidt, J.; Mommert, M.] Heidelberg Univ, D-69117 Heidelberg, Germany; [Hiriart, D.] Univ Nacl Autonoma Mexico, Inst Astron, Ensenada 22860, Baja California, Mexico; [Hovatta, T.; Lahteenmaki, A.; Tornikoski, M.] Aalto Univ, Metsahovi Radio Observ, FIN-02540 Kylmala, Finland; [Jorstad, S. G.; Marscher, A. P.] Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA; [Kurtanidze, O. M.; Sigua, L. A.] Abastumani Observ, GE-0301 Mt Kanobili, Abastumani, Georgia; [McHardy, I. M.] Univ Southampton, Sch Phys & Astron, Southampton SO17 BJ, Hants, England; [Di Paola, A.] Osserv Astron Roma, I-00040 Monte Porzio Catone, Italy; [Richter, G. M.] Astrophys Inst Potsdam, D-14482 Potsdam, Germany; [Grainge, K.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Moderski, R.; Nalewajko, K.; Sikora, M.] Nicolaus Copernicus Astron Ctr, PL-00716 Warsaw, Poland	Stanford University; United States Department of Defense; United States Navy; Naval Research Laboratory; National Academies of Sciences, Engineering & Medicine; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stockholm University; Oskar Klein Centre; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University System of Ohio; Ohio State University; University of California System; University of California Berkeley; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; George Mason University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Max Planck Society; California State University System; Sonoma State University; Stockholm University; Institut Universitaire de France; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Istituto Nazionale Astrofisica (INAF); Max Planck Society; Hiroshima University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Istituto Nazionale Astrofisica (INAF); University of Alabama System; University of Alabama Huntsville; Royal Institute of Technology; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Universities Space Research Association (USRA); Waseda University; Tokyo Institute of Technology; RIKEN; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; University of Tokyo; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Innsbruck; University of Innsbruck; University of Chicago; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Jagiellonian University; Purdue University System; Purdue University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of New Mexico; ICREA; University of Rome Tor Vergata; Linnaeus University; University of Kalmar; Hiroshima University; Nagoya University; Istituto Nazionale Astrofisica (INAF); University of Turin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Michigan System; University of Michigan; Pulkovo Observatory; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Universidad Nacional Autonoma de Mexico; University of Turku; Saint Petersburg State University; University System of Ohio; Ohio University; Istituto Nazionale Astrofisica (INAF); National Central University; Istituto Nazionale Astrofisica (INAF); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Ruprecht Karls University Heidelberg; Universidad Nacional Autonoma de Mexico; Aalto University; Boston University; Ilia State University; University of Southampton; Istituto Nazionale Astrofisica (INAF); University of Cambridge; Polish Academy of Sciences; Nicolaus Copernicus Astronomical Center of the Polish Academy of Sciences	Hayashida, M (corresponding author), Stanford Univ, Dept Phys, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA.	hayasida@stanford.edu; madejski@slac.stanford.edu	Kopatskaya, Evgenia N/H-4720-2013; Giglietto, Nicola/Y-2425-2019; Sgrò, Carmelo/K-3395-2016; Agudo, Ivan/G-1701-2015; Larionova, Elena/AAK-9274-2021; Reimer, Anita/K-5822-2015; Gehrels, Neil/D-2971-2012; Thompson, David J/D-2939-2012; Gargano, Fabio/O-8934-2015; Bastieri, Denis/AAC-5917-2020; Baldini, Luca/E-5396-2012; Gasparrini, Dario/X-6699-2019; Fukazawa, Yasushi/G-2081-2017; Blinov, Dmitry A./G-9925-2013; Hays, Elizabeth/D-3257-2012; giglietto, nicola/I-8951-2012; Troitskiy, Ivan/K-7979-2013; Mazziotta, Mario N/O-8867-2015; Funk, Stefan/B-7629-2015; Moderski, Rafal/ABG-8777-2020; Kawabata, Koji S/G-1957-2017; Reimer, Olaf/A-3117-2013; Larionova, Elena/H-7287-2013; Jorstad, Svetlana G/H-6913-2013; Funk, Stefan/AAI-1568-2021; Blinov, Dmitry/AAG-3376-2019; Morozova, Daria/H-1298-2013; Ryde, Felix/AAE-1086-2021; lubrano, pasquale/F-7269-2012; Torres, Diego F./O-9422-2016; Tajima, Hiroyasu/I-6228-2014; Morselli, Aldo/G-6769-2011; Kurtanidze, Omar M/J-6237-2014; Max-Moerbeck, Walter/AAU-5773-2020; Grishina, Tatiana/H-6873-2013; Rando, Riccardo/M-7179-2013; Torres, Diego F/ABD-7940-2020; Efimova, Natalia Vladimirovna/HDM-7482-2022; Jóhannesson, Guðlaugur/ABC-7216-2020; Johnson, Neil/G-3309-2014; Gómez, José L/C-4195-2008; Moskalenko, Igor V/A-1301-2007; Cutini, Sara/ABB-1787-2020; Gargano, Fabio/AAD-5121-2021; Sasada, Mahito/ABD-5766-2020; Okumura, Akira/I-2468-2014; Nolan, Patrick L/A-5582-2009; Lähteenmäki, Anne/L-5987-2013; Takahashi, Hiromitsu H/T-2713-2017; Kuss, Michael W/H-8959-2012; Caraveo, Patrizia/AAL-5708-2020; Efimova, Natalia V/I-2196-2013; cohen-tanugi, Johann/ABB-1481-2021; McEnery, Julie E/D-6612-2012; Tosti, Gino/E-9976-2013; Torres, Diego F./AAF-7931-2019; Pearson, Timothy J/N-2376-2015; Parkinson, Pablo Miguel Saz/I-7980-2013; Harding, Alice K/D-3160-2012; tramacere, andrea/B-9424-2012; Larionov, Valeri M/H-1349-2013; Kopatskaya, Evgenia/AAN-1057-2021; Rando, Riccardo/O-1302-2019; Jorstad, Svetlana/AAM-3279-2021; Max-Moerbeck, Walter/N-8042-2018; Jóhannesson, Guðlaugur/O-8741-2015; Loparco, Francesco/O-8847-2015; Pavlidou, Vasiliki/C-2944-2011; Macquart, Jean-Pierre R/B-5306-2013; Orlando, Elena/R-5594-2016; giommi, paolo/L-1006-2018	Kopatskaya, Evgenia N/0000-0001-9518-337X; Giglietto, Nicola/0000-0002-9021-2888; Agudo, Ivan/0000-0002-3777-6182; Larionova, Elena/0000-0002-2471-6500; Reimer, Anita/0000-0001-8604-7077; Thompson, David J/0000-0001-5217-9135; Gargano, Fabio/0000-0002-5055-6395; Bastieri, Denis/0000-0002-6954-8862; Gasparrini, Dario/0000-0002-5064-9495; Fukazawa, Yasushi/0000-0002-0921-8837; Blinov, Dmitry A./0000-0003-0611-5784; giglietto, nicola/0000-0002-9021-2888; Troitskiy, Ivan/0000-0002-4218-0148; Mazziotta, Mario N/0000-0001-9325-4672; Funk, Stefan/0000-0002-2012-0080; Moderski, Rafal/0000-0002-8663-3882; Kawabata, Koji S/0000-0001-6099-9539; Reimer, Olaf/0000-0001-6953-1385; Larionova, Elena/0000-0002-2471-6500; Jorstad, Svetlana G/0000-0001-9522-5453; Funk, Stefan/0000-0002-2012-0080; Blinov, Dmitry/0000-0003-0611-5784; Morozova, Daria/0000-0002-9407-7804; Ryde, Felix/0000-0002-9769-8016; lubrano, pasquale/0000-0003-0221-4806; Torres, Diego F./0000-0002-1522-9065; Tajima, Hiroyasu/0000-0002-1721-7252; Morselli, Aldo/0000-0002-7704-9553; Max-Moerbeck, Walter/0000-0002-5491-5244; Grishina, Tatiana/0000-0002-3953-6676; Efimova, Natalia Vladimirovna/0000-0002-8071-4753; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Gómez, José L/0000-0003-4190-7613; Moskalenko, Igor V/0000-0001-6141-458X; Cutini, Sara/0000-0002-1271-2924; Gargano, Fabio/0000-0002-5055-6395; Okumura, Akira/0000-0002-3055-7964; Takahashi, Hiromitsu H/0000-0001-6314-5897; Caraveo, Patrizia/0000-0003-2478-8018; Efimova, Natalia V/0000-0002-8071-4753; cohen-tanugi, Johann/0000-0001-9022-4232; Torres, Diego F./0000-0002-1522-9065; Pearson, Timothy J/0000-0001-5213-6231; tramacere, andrea/0000-0002-8186-3793; Larionov, Valeri M/0000-0002-4640-4356; Kopatskaya, Evgenia/0000-0001-9518-337X; Rando, Riccardo/0000-0001-6992-818X; Jorstad, Svetlana/0000-0001-6158-1708; Max-Moerbeck, Walter/0000-0002-5491-5244; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Loparco, Francesco/0000-0002-1173-5673; Pavlidou, Vasiliki/0000-0002-0870-1368; Macquart, Jean-Pierre R/0000-0001-6763-8234; Ackermann, Markus/0000-0001-8952-588X; Tanaka, Takaaki/0000-0002-4383-0368; Sgro', Carmelo/0000-0001-5676-6214; Di Paola, Andrea/0000-0002-2189-8644; Leto, Paolo/0000-0003-4864-2806; Frailis, Marco/0000-0002-7400-2135; Gurwell, Mark/0000-0003-0685-3621; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Buson, Sara/0000-0002-3308-324X; Sikora, Marek/0000-0003-1667-7334; Berenji, Bijan/0000-0002-4551-772X; Spandre, Gloria/0000-0003-0802-3453; Casandjian, Jean-Marc/0000-0003-1404-0524; Iafrate, Giulia/0000-0002-6185-8292; Uemura, Makoto/0000-0002-7375-7405; Villata, Massimo/0000-0003-1743-6946; de Palma, Francesco/0000-0001-5898-2834; Pepe, Monica/0000-0001-5624-4010; Fusco, Piergiorgio/0000-0002-9383-2425; Chanishvili, Revaz/0000-0002-6410-1084; Omodei, Nicola/0000-0002-5448-7577; Giroletti, Marcello/0000-0002-8657-8852; Raiteri, Claudia Maria/0000-0003-1784-2784; Orlando, Elena/0000-0001-6406-9910; De Angelis, Alessandro/0000-0002-3288-2517; Boettcher, Markus/0000-0002-8434-5692; Baldini, Luca/0000-0002-9785-7726; Sasada, Mahito/0000-0001-5946-9960; Kurtanidze, Omar/0000-0001-5385-0576; Cecchi, Claudia/0000-0002-2192-8233; giommi, paolo/0000-0002-2265-5003; Pesce-Rollins, Melissa/0000-0003-1790-8018	Georgian National Science Foundation; Spanish "Ministerio de Ciencia e Innovacion''; NSF; NASA; Smithsonian Institution in the United States; UK Science and Technology Facilities Council; Academia Sinica in Taiwan; Russian RFBR; Academy of Finland; JSPS; K. A. Wallenberg Foundation; STFC [ST/G003084/1, ST/G009465/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G003084/1, ST/G009465/1] Funding Source: researchfish; ICREA Funding Source: Custom	Georgian National Science Foundation; Spanish "Ministerio de Ciencia e Innovacion''(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Smithsonian Institution in the United States; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Academia Sinica in Taiwan(Academia Sinica - Taiwan); Russian RFBR(Russian Foundation for Basic Research (RFBR)); Academy of Finland(Academy of Finland); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ICREA(ICREA)	The Fermi-LAT Collaboration acknowledges support from a number of agencies and institutes for both development and the operation of the LAT as well as scientific data analysis. These include NASA and DOE in the United States, CEA/Irfu and IN2P3/CNRS in France, ASI and INFN in Italy, MEXT, KEK and JAXA in Japan, and the K. A. Wallenberg Foundation, the Swedish Research Council and the National Space Board in Sweden. Additional support from INAF in Italy for science analysis during the operations phase is also gratefully acknowledged. The GASP-WEBT observatories participating in this work are Abastumani, Calar Alto, Campo Imperatore, Crimean, Kitt Peak (MDM), L'Ampolla, Lowell (Perkins-PRISM), Lulin, Roque de los Muchachos (KVA and Liverpool), San Pedro Martir, St Petersburg for the optical-NIR bands, and Mauna Kea (SMA), Medicina, Metsahovi, Noto and UMRAO for the millimetre radio band, and are supported in part by the Georgian National Science Foundation, the Spanish "Ministerio de Ciencia e Innovacion'', the NSF and NASA and the Smithsonian Institution in the United States, the UK Science and Technology Facilities Council, the Academia Sinica in Taiwan, the Russian RFBR and the Academy of Finland. M. H. is supported by the JSPS for the Postdoctoral Fellowship for Research Abroad. J. Conrad is a Royal Swedish Academy of Sciences Research Fellow, funded by a grant from the K. A. Wallenberg Foundation. L. T. is partially supported by the International Doctorate on Astroparticle Physics (IDAPP) programme.	Abdo AA, 2009, ASTROPHYS J, V699, P817, DOI 10.1088/0004-637X/699/1/817; Albert J, 2008, SCIENCE, V320, P1752, DOI 10.1126/science.1157087; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; BLANDFORD RD, 1995, ASTROPHYS J, V441, P79, DOI 10.1086/175338; DERMER CD, 1992, ASTRON ASTROPHYS, V256, pL27; Fuhrmann L, 2007, AIP CONF PROC, V921, P249; HARTMAN RC, 1992, ASTROPHYS J, V385, pL1, DOI 10.1086/186263; Homan DC, 2002, ASTROPHYS J, V580, P742, DOI 10.1086/343894; Jorstad SG, 2005, ASTRON J, V130, P1418, DOI 10.1086/444593; KNIFFEN DA, 1993, ASTROPHYS J, V411, P133, DOI 10.1086/172813; KONIGL A, 1985, ASTROPHYS J, V289, P188, DOI 10.1086/162877; LAING RA, 1980, MON NOT R ASTRON SOC, V193, P439, DOI 10.1093/mnras/193.3.439; Larionov VM, 2008, ASTRON ASTROPHYS, V492, P389, DOI 10.1051/0004-6361:200810937; Lyutikov M, 2003, ASTROPHYS J, V597, P998, DOI 10.1086/378497; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; NETZER H, 1994, ASTROPHYS J, V430, P191, DOI 10.1086/174393; Nilsson K, 2009, ASTRON ASTROPHYS, V505, P601, DOI 10.1051/0004-6361/200912820; Pian E, 1999, ASTROPHYS J, V521, P112, DOI 10.1086/307548; SIKORA M, 1994, ASTROPHYS J, V421, P153, DOI 10.1086/173633; Sikora M, 2009, ASTROPHYS J, V704, P38, DOI 10.1088/0004-637X/704/1/38; Villata M, 2009, ASTRON ASTROPHYS, V501, P455, DOI 10.1051/0004-6361/200912065; Watanabe M, 2005, PUBL ASTRON SOC PAC, V117, P870, DOI 10.1086/431914; Wehrle AE, 1998, ASTROPHYS J, V497, P178, DOI 10.1086/305461; Woo JH, 2002, ASTROPHYS J, V579, P530, DOI 10.1086/342878	25	252	254	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					919	923		10.1038/nature08841	http://dx.doi.org/10.1038/nature08841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164923	Green Submitted			2022-12-28	WOS:000274582700039
J	Bignell, GR; Greenman, CD; Davies, H; Butler, AP; Edkins, S; Andrews, JM; Buck, G; Chen, LN; Beare, D; Latimer, C; Widaa, S; Hinton, J; Fahey, C; Fu, BY; Swamy, S; Dalgliesh, GL; Teh, BT; Deloukas, P; Yang, FT; Campbell, PJ; Futreal, PA; Stratton, MR				Bignell, Graham R.; Greenman, Chris D.; Davies, Helen; Butler, Adam P.; Edkins, Sarah; Andrews, Jenny M.; Buck, Gemma; Chen, Lina; Beare, David; Latimer, Calli; Widaa, Sara; Hinton, Jonathon; Fahey, Ciara; Fu, Beiyuan; Swamy, Sajani; Dalgliesh, Gillian L.; Teh, Bin T.; Deloukas, Panos; Yang, Fengtang; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.			Signatures of mutation and selection in the cancer genome	NATURE			English	Article							SOMATIC FRAMESHIFT MUTATIONS; CANDIDATE TUMOR-SUPPRESSOR; FRAGILE SITE STABILITY; COPY NUMBER VARIATION; GLIOBLASTOMA-MULTIFORME; CHROMOSOME FRAGILITY; LUNG ADENOCARCINOMA; COLORECTAL CANCERS; COLON CANCERS; GENE	The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous deletions in cancer genomes occur over recessive cancer genes, where they can confer selective growth advantage, and over fragile sites, where they are thought to reflect an increased local rate of DNA breakage. However, most homozygous deletions in cancer genomes are unexplained. Here we identified 2,428 somatic homozygous deletions in 746 cancer cell lines. These overlie 11% of protein-coding genes that, therefore, are not mandatory for survival of human cells. We derived structural signatures that distinguish between homozygous deletions over recessive cancer genes and fragile sites. Application to clusters of unexplained homozygous deletions suggests that many are in regions of inherent fragility, whereas a small subset overlies recessive cancer genes. The results illustrate how structural signatures can be used to distinguish between the influences of mutation and selection in cancer genomes. The extensive copy number, genotyping, sequence and expression data available for this large series of publicly available cancer cell lines renders them informative reagents for future studies of cancer biology and drug discovery.	[Bignell, Graham R.; Greenman, Chris D.; Davies, Helen; Butler, Adam P.; Edkins, Sarah; Andrews, Jenny M.; Buck, Gemma; Chen, Lina; Beare, David; Latimer, Calli; Widaa, Sara; Hinton, Jonathon; Fahey, Ciara; Fu, Beiyuan; Swamy, Sajani; Dalgliesh, Gillian L.; Deloukas, Panos; Yang, Fengtang; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Teh, Bin T.] Van Andel Inst, Grand Rapids, MI 49503 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; Van Andel Institute; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Teh, Muy-Teck/B-9284-2016; Yang, Fan/GYU-4249-2022; Dalgliesh, Gillian/B-7799-2008	Deloukas, Panos/0000-0001-9251-070X; Teh, Muy-Teck/0000-0002-7725-8355; Teh, Bin Tean/0000-0003-1514-1124; Dalgliesh, Gillian/0000-0001-8526-5064; Buck, Gemma/0000-0001-5289-1050; Yang, Fengtang/0000-0002-3573-2354; Edkins, Sarah/0000-0003-0717-1972	Wellcome Trust [077012/Z/05/Z]; NATIONAL CANCER INSTITUTE [P01CA155258] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to acknowledge the support of the Wellcome Trust under grant reference 077012/Z/05/Z.	Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bader S, 1999, ONCOGENE, V18, P8044, DOI 10.1038/sj.onc.1203229; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Dicks E, 2007, BIOINFORMATICS, V23, P1689, DOI 10.1093/bioinformatics/btm152; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Freeman JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-195; Freudenreich CH, 2007, FRONT BIOSCI-LANDMRK, V12, P4911, DOI 10.2741/2437; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Iliopoulos D, 2006, CANCER LETT, V232, P27, DOI 10.1016/j.canlet.2005.06.048; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Sawinska M, 2007, GENE CHROMOSOME CANC, V46, P991, DOI 10.1002/gcc.20484; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P8657, DOI 10.1158/0008-5472.CAN-08-2084; Solomon DA, 2009, CANCER RES, V69, P5630, DOI 10.1158/0008-5472.CAN-09-1055; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Teng DHF, 1997, CANCER RES, V57, P4177; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Vermeulen SJ, 1999, ONCOGENE, V18, P905, DOI 10.1038/sj.onc.1202348; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010	40	511	522	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					893	U61		10.1038/nature08768	http://dx.doi.org/10.1038/nature08768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164919	Green Accepted, hybrid			2022-12-28	WOS:000274582700035
J	Muller, H; Peters, A; Chu, S				Mueller, Holger; Peters, Achim; Chu, Steven			A precision measurement of the gravitational redshift by the interference of matter waves	NATURE			English	Article							GRAVITY; ACCELERATION; CLOCKS	One of the central predictions of metric theories of gravity, such as general relativity, is that a clock in a gravitational potential U will run more slowly by a factor of 1 + U/c(2), where c is the velocity of light, as compared to a similar clock outside the potential(1). This effect, known as gravitational redshift, is important to the operation of the global positioning system(2), timekeeping(3,4) and future experiments with ultra-precise, space-based clocks(5) (such as searches for variations in fundamental constants). The gravitational redshift has been measured using clocks on a tower(6), an aircraft(7) and a rocket(8), currently reaching an accuracy of 7 x 10(-5). Here we show that laboratory experiments based on quantum interference of atoms(9,10) enable a much more precise measurement, yielding an accuracy of 7 x 10(-9). Our result supports the view that gravity is a manifestation of space-time curvature, an underlying principle of general relativity that has come under scrutiny in connection with the search for a theory of quantum gravity(11). Improving the redshift measurement is particularly important because this test has been the least accurate among the experiments that are required to support curved space-time theories(1).	[Mueller, Holger; Chu, Steven] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Mueller, Holger; Chu, Steven] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Peters, Achim] Humboldt Univ, Inst Phys, D-10117 Berlin, Germany; [Chu, Steven] US DOE, Washington, DC 20585 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Humboldt University of Berlin; United States Department of Energy (DOE)	Muller, H (corresponding author), Univ Calif Berkeley, Dept Phys, 366 Le Conte Hall,MS 7300, Berkeley, CA 94720 USA.	hm@berkeley.edu	Mueller, Holger/E-3194-2015; Peters, Achim/G-3742-2010	Peters, Achim/0000-0001-5538-9250	National Science Foundation [9320142, 0400866, 0652332]; Air Force Office of Scientific Research; Department of Energy; David and Lucile Packard Foundation; National Institute of Standards and Technology [60NANB9D9169]; European Science Foundation; European Space Agency; German Space Agency DLR [DLR 50 WM 0346]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Department of Energy(United States Department of Energy (DOE)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); European Science Foundation(European Science Foundation (ESF)European Commission); European Space Agency(European Space AgencyEuropean Commission); German Space Agency DLR(Helmholtz AssociationGerman Aerospace Centre (DLR))	We thank F. Biraben, S.-w. Chiow, S. Herrmann, M. Hohensee, M. Kasevich, G. Tino and P. Wolf for discussions. This material is based on work supported by the National Science Foundation under grants 9320142, 0400866 and 0652332, by the Air Force Office of Scientific Research, and the Department of Energy. H. M. acknowledges support by the David and Lucile Packard Foundation and the National Institute of Standards and Technology under grant 60NANB9D9169. A. P. acknowledges support by the European Science Foundation's EUROCORES program, the European Space Agency, and the German Space Agency DLR (grant DLR 50 WM 0346).	Amelino-Camelia G, 2005, AIP CONF PROC, V758, P30, DOI 10.1063/1.1900507; Ashby Neil, 2003, Living Rev Relativ, V6, P1, DOI 10.12942/lrr-2003-1; Blatt S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140801; BORDE CJ, 1994, INT J MOD PHYS D, V3, P157, DOI 10.1142/S0218271894000186; Cacciapuoti L, 2009, EUR PHYS J-SPEC TOP, V172, P57, DOI 10.1140/epjst/e2009-01041-7; Clade P, 2005, EUROPHYS LETT, V71, P730, DOI 10.1209/epl/i2005-10163-6; Dent T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.041102; Dimopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.111102; Dimopoulos S, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.042003; Feynman R.P., 1965, QUANTUM MECH PATH IN; FITCH VL, 1981, REV MOD PHYS, V53, P367, DOI 10.1103/RevModPhys.53.367; Fortier TM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070801; FUCHS K, 1984, LANDOLTBORNSTEIN G A, V2, P317; GOOD ML, 1961, PHYS REV, V121, P311, DOI 10.1103/PhysRev.121.311; HAFELE JC, 1972, SCIENCE, V177, P168, DOI 10.1126/science.177.4044.168; Ivanov VV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043602; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; Lemoine FG, 1998, DEV JOINT NASA GSFC; Misner C. W., 1970, GRAVITATION; Muller H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.240403; Muller H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.180405; Pavlis NK, 2003, METROLOGIA, V40, P66, DOI 10.1088/0026-1394/40/2/311; Peters A, 2001, METROLOGIA, V38, P25, DOI 10.1088/0026-1394/38/1/4; Peters A, 1999, NATURE, V400, P849, DOI 10.1038/23655; POUND RV, 1965, PHYS REV, V140, pB788, DOI 10.1103/PhysRev.140.B788; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; VESSOT RFC, 1980, PHYS REV LETT, V45, P2081, DOI 10.1103/PhysRevLett.45.2081; Vitushkin L, 2002, METROLOGIA, V39, P407, DOI 10.1088/0026-1394/39/5/2; Will CM, 2006, LIVING REV RELATIV, V9, DOI 10.12942/lrr-2006-3; Young B. C., 1997, ATOM INTERFEROMETRY, P363	30	199	207	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					926	U96		10.1038/nature08776	http://dx.doi.org/10.1038/nature08776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164925				2022-12-28	WOS:000274582700041
J	Adams, KD				Adams, Kristin D.			Lonely	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												doctorkiki@yahoo.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					593	593		10.1001/jama.2010.117	http://dx.doi.org/10.1001/jama.2010.117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555NK	20159862				2022-12-28	WOS:000274518600001
J	Morris, EA				Morris, Elizabeth A.			Should we dispense with preoperative breast MRI?	LANCET			English	Editorial Material							CANCER; ACCURACY; WOMEN		[Morris, Elizabeth A.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Morris, Elizabeth A.] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Morris, EA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA.	morrise@mskcc.org	Giger, Maryellen/AAH-1908-2021	Morris, Elizabeth/0000-0001-5069-0992				Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Brennan ME, 2009, J CLIN ONCOL, V27, P5640, DOI 10.1200/JCO.2008.21.5756; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; KUHL C, 2007, BREAST, V16, P34; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Mann RM, 2010, BREAST CANCER RES TR, V119, P415, DOI 10.1007/s10549-009-0616-6; Solin LJ, 2008, J CLIN ONCOL, V26, P386, DOI 10.1200/JCO.2006.09.5448; Turnbull L, 2010, LANCET, V375, P563, DOI 10.1016/S0140-6736(09)62070-5; Wapnir IL, 2006, J CLIN ONCOL, V24, P2028, DOI 10.1200/JCO.2005.04.3273	9	24	26	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 13	2010	375	9714					528	530		10.1016/S0140-6736(10)60202-4	http://dx.doi.org/10.1016/S0140-6736(10)60202-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560YO	20159274				2022-12-28	WOS:000274941900005
J	Meier, P; Knapp, G; Tamhane, U; Chaturvedi, S; Gurm, HS				Meier, Pascal; Knapp, Guido; Tamhane, Umesh; Chaturvedi, Seemant; Gurm, Hitinder S.			Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomised controlled clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANGIOPLASTY; RISK; BENEFIT; BIAS	Objective To evaluate the relative short term safety and intermediate term efficacy of carotid endarterectomy versus carotid artery stenting. Design Systematic review and meta-analysis. Data sources BIOSIS, Embase, Medline, the Cochrane central register of controlled trials, International Pharmaceutical Abstracts database, ISI Web of Science, and Google scholar and bibliographies, from 1 January 1990 to 25 July 2009. Study selection Randomised controlled trials comparing carotid endarterectomy with carotid artery stenting in patients with carotid artery stenosis with or without symptoms. Data extraction Primary end point was a composite of mortality or stroke. Secondary end points were death, stroke, myocardial infarction, or facial neuropathy ( as individual end points), and mortality or disabling stroke ( as a composite end point). Data synthesis 11 trials were included ( 4796 patients); 10 reported on short term outcomes (n=4709) and nine on intermediate term outcomes (1-4 years). The periprocedural risk of mortality or stroke was lower for carotid endarterectomy ( odds ratio 0.67, 95% confidence interval 0.47 to 0.95; P=0.025) than for carotid stenting, mainly because of a decreased risk of stroke (0.65, 0.43 to 1.00; P=0.049), whereas the risk of death (1.14, 0.56 to 2.31; P=0.727) and the composite end point mortality or disabling stroke (0.74, 0.53 to 1.05; P=0.088) did not differ significantly. The odds of periprocedural myocardial infarction (2.69, 1.06 to 6.79; P=0.036) or cranial nerve injury (10.2, 4.0 to 26.1; P<0.001) was higher in the carotid endarterectomy group than in the carotid stenting group. In the intermediate term, the two treatments did not differ significantly for stroke or death (hazard ratio 0.90, 95% confidence interval 0.74 to 1.1; P=0.314). Conclusions Carotid endarterectomy was found to be superior to carotid artery stenting for short term outcomes but the difference was not significant for intermediate term outcomes; this difference was mainly driven by non-disabling stroke. Significantly fewer cranial nerve injuries and myocardial infarctions occurred with carotid artery stenting.	[Gurm, Hitinder S.] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Gurm, Hitinder S.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Knapp, Guido] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Chaturvedi, Seemant] Wayne State Univ, Dept Neurol, Detroit Med Ctr, Detroit, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Dortmund University of Technology; Detroit Medical Center; Wayne State University	Gurm, HS (corresponding author), Univ Michigan, Ctr Cardiovasc, Floor 2A 394,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	hgurm@umich.med.edu		Gurm, Hitinder/0000-0002-1646-0218; Meier, Pascal/0000-0001-8909-2180	Swiss National Research Foundation; Schweizerische Stiftung fur Medizinisch-Biologische Stipendien	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Schweizerische Stiftung fur Medizinisch-Biologische Stipendien	PM is supported by a postdoctoral fellowship grant from the Swiss National Research Foundation and the Schweizerische Stiftung fur Medizinisch-Biologische Stipendien. The funding organisation had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Aichner FT, 2009, EUR J NEUROL, V16, P902, DOI 10.1111/j.1468-1331.2009.02614.x; Alberts MJ, 2001, STROKE, V32, P325; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonaldi G, 2002, NEURORADIOLOGY, V44, P164, DOI 10.1007/s002340100680; Brooks WH, 2004, NEUROSURGERY, V54, P318, DOI 10.1227/01.NEU.0000103447.30087.D3; Brooks WH, 2001, J AM COLL CARDIOL, V38, P1589, DOI 10.1016/S0735-1097(01)01595-9; Brown MM, 2001, LANCET, V357, P1729; Chambers BR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001923.pub2; CHAMBERS BR, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001923; Chaturvedi S, 2003, ARCH NEUROL-CHICAGO, V60, P774, DOI 10.1001/archneur.60.5.774; CINA CS, 2000, COCHRANE DB SYST REV; Cunningham EJ, 2004, J NEUROSURG, V101, P445, DOI 10.3171/jns.2004.101.3.0445; Ederle J, 2009, STROKE, V40, P1373, DOI 10.1161/STROKEAHA.108.531228; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; *EUR STROK C, 2009, SAF RES INT CAR STEN; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Gray WA, 2009, CIRC-CARDIOVASC INTE, V2, P159, DOI 10.1161/CIRCINTERVENTIONS.108.823013; Gurm HS, 2008, NEW ENGL J MED, V358, P1572, DOI 10.1056/NEJMoa0708028; Gurm HS, 2008, EUR HEART J, V29, P113, DOI 10.1093/eurheartj/ehm362; Harrington RA, 2007, VASC MED, V12, P35, DOI 10.1177/1358863x06076103; Hartung J., 2008, STAT METAANALYSIS AP; HOFFMANN A, 2008, SCHWEIZ ARCH NEUROL, V159, P84, DOI [10.4414/sanp.2008.01926, DOI 10.4414/SANP.2008.01926]; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Linfante I, 2009, J NEUROIMAGING, V19, P158, DOI 10.1111/j.1552-6569.2008.00269.x; Maree AO, 2007, NEW ENGL J MED, V356, P306; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Meier P, 2009, J VASC SURG, V50, P475, DOI 10.1016/j.jvs.2009.04.018; Meier P, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-23; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Naylor AR, 1998, J VASC SURG, V28, P326, DOI 10.1016/S0741-5214(98)70182-X; R Development Core Team, 2009, R LANG ENV STAT COMP; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971; Sankey SS, 1996, COMMUN STAT SIMULAT, V25, P1031, DOI 10.1080/03610919608813357; Sidawy AN, 2009, J VASC SURG, V49, P71, DOI 10.1016/j.jvs.2008.08.039; Sillesen H, 2008, STROKE, V39, P3297, DOI 10.1161/STROKEAHA.108.516450; Steinbauer MGM, 2008, J VASC SURG, V48, P93, DOI 10.1016/j.jvs.2008.02.049; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; van der Vaart MG, 2008, AM J SURG, V195, P259, DOI 10.1016/j.amjsurg.2007.07.022; White RA, 2005, J VASC SURG, V42, P213, DOI 10.1016/j.jvs.2005.04.023; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Yadav JS, 1997, CIRCULATION, V95, P376, DOI 10.1161/01.cir.95.2.376	47	100	111	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2010	340								c467	10.1136/bmj.c467	http://dx.doi.org/10.1136/bmj.c467			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555AB	20154049	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000274477800001
J	Horiuchi, S; Tokunaga, Y; Giovannetti, G; Picozzi, S; Itoh, H; Shimano, R; Kumai, R; Tokura, Y				Horiuchi, Sachio; Tokunaga, Yusuke; Giovannetti, Gianluca; Picozzi, Silvia; Itoh, Hirotake; Shimano, Ryo; Kumai, Reiji; Tokura, Yoshinori			Above-room-temperature ferroelectricity in a single-component molecular crystal	NATURE			English	Article							CROCONIC ACID; POLARIZATION	Ferroelectrics are electro-active materials that can store and switch their polarity (ferroelectricity), sense temperature changes (pyroelectricity), interchange electric and mechanical functions (piezoelectricity), and manipulate light (through optical nonlinearities and the electro-optic effect): all of these functions have practical applications. Topological switching of pi-conjugation in organic molecules, such as the keto-enol transformation, has long been anticipated as a means of realizing these phenomena in molecular assemblies and crystals(1). Croconic acid, an ingredient of black dyes(2), was recently found to have a hydrogen-bonded polar structure in a crystalline state(3). Here we demonstrate that application of an electric field can coherently align the molecular polarities in crystalline croconic acid, as indicated by an increase of optical second harmonic generation, and produce a well-defined polarization hysteresis at room temperature. To make this simple pentagonal molecule ferroelectric, we switched the pi-bond topology using synchronized proton transfer instead of rigid-body rotation. Of the organic ferroelectrics, this molecular crystal exhibits the highest spontaneous polarization (similar to 20 mu C cm(-2)) in spite of its small molecular size, which is in accord with first-principles electronic-structure calculations. Such high polarization, which persists up to 400 K, may find application in active capacitor and nonlinear optics elements in future organic electronics.	[Horiuchi, Sachio; Kumai, Reiji; Tokura, Yoshinori] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Tokunaga, Yusuke; Itoh, Hirotake; Shimano, Ryo; Tokura, Yoshinori] Japan Sci & Technol Agcy, ERATO, Multiferro Project, Wako, Saitama 3510198, Japan; [Giovannetti, Gianluca; Picozzi, Silvia] CNR, INFM, CASTI Reg Lab, I-67100 Laquila, Italy; [Shimano, Ryo] Univ Tokyo, Dept Phys, Tokyo 1138656, Japan; [Giovannetti, Gianluca] Leiden Univ, Inst Lorenz Theoret Phys, NL-2300 RA Leiden, Netherlands; [Tokura, Yoshinori] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Tokyo; Leiden University; Leiden University - Excl LUMC; University of Tokyo	Horiuchi, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan.	s-horiuchi@aist.go.jp; tokura@ap.t.u-tokyo.ac.jp	Kumai, Reiji/R-2453-2017; Horiuchi, Sachio/R-2377-2017; Itoh, Hirotake/O-9448-2018; Giovannetti, Gianluca/L-4339-2013; Tokunaga, Yusuke/B-3008-2013; Picozzi, Silvia/E-2374-2011; Tokura, Yoshinori/C-7352-2009; Shimano, Ryo/H-6337-2013; SPIN-CNR, L'Aquila/C-7274-2011	Kumai, Reiji/0000-0002-5320-0028; Horiuchi, Sachio/0000-0002-7720-4605; Itoh, Hirotake/0000-0002-3371-9316; Picozzi, Silvia/0000-0002-3232-788X; Tokura, Yoshinori/0000-0002-2732-4983; Tokunaga, Yusuke/0000-0002-8913-9978	Ministry of Education, Culture, Sports, Science and Technology of Japan [20110003]; European Research Council under the European Community [203523]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Research Council under the European Community(European Research Council (ERC))	S. H. is grateful for support by a Grant-in-Aid for Scientific Research (No. 20110003) by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The research leading to the theoretical results received funding from the European Research Council under the European Community, 7th Framework Programme-FP7 (2007-2013)/ERC Grant Agreement n. 203523.	Braga D, 2001, NEW J CHEM, V25, P1221, DOI 10.1039/b107317f; BRAGA D, 2001, CRYSTENGCOMM, V6, P1; DALTON LR, 1995, CHEM MATER, V7, P1060, DOI 10.1021/cm00054a006; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; FEDER J, 1976, FERROELECTRICS, V12, P71, DOI 10.1080/00150197608241395; Fiebig M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.144102; Fukunaga M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.064706; GILLI G, 1989, J AM CHEM SOC, V111, P1023, DOI 10.1021/ja00185a035; HELLWEGE KH, 1981, LANDOLTBORNSTEIN, V16, P66; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; KAMISHINA Y, 1991, J PHYS SOC JPN, V60, P2147, DOI 10.1143/JPSJ.60.2147; Katrusiak A, 1999, PHYS REV LETT, V82, P576, DOI 10.1103/PhysRevLett.82.576; KEIL D, 1993, LIEBIGS ANN CHEM, P935; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kroupa J, 1997, FERROELECTRICS, V202, P229, DOI 10.1080/00150199708213480; Lazic P, 2010, COMPUT PHYS COMMUN, V181, P371, DOI 10.1016/j.cpc.2009.09.016; Ling QD, 2008, PROG POLYM SCI, V33, P917, DOI 10.1016/j.progpolymsci.2008.08.001; Noda K, 2003, J APPL PHYS, V93, P2866, DOI 10.1063/1.1540231; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SEITZ G, 1992, CHEM REV, V92, P1227, DOI 10.1021/cr00014a004; SEMMINGSEN D, 1977, J CHEM PHYS, V66, P4405, DOI 10.1063/1.433745; SEMMINGSEN D, 1987, J AM CHEM SOC, V109, P7238, DOI 10.1021/ja00257a081; Sugawara T, 1999, ADV PHYS ORG CHEM, V32, P219, DOI 10.1016/S0065-3160(08)60008-8; TAJITSU Y, 1987, JPN J APPL PHYS 1, V26, P554, DOI 10.1143/JJAP.26.554; WASHINO M, 1958, B CHEM SOC JPN, V31, P552, DOI 10.1246/bcsj.31.552; ZIKMUND Z, 1994, FERROELECTRICS, V58, P223	30	548	555	17	466	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					789	U97		10.1038/nature08731	http://dx.doi.org/10.1038/nature08731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148035				2022-12-28	WOS:000274394300035
J	Horton, R				Horton, Richard			Offline: Speaking up, loudly	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 6	2010	375	9713					446	446		10.1016/S0140-6736(10)60069-4	http://dx.doi.org/10.1016/S0140-6736(10)60069-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20152531				2022-12-28	WOS:000274757900011
J	Singh, JA				Singh, Jerome Amir			Organ transplantation between HIV-infected patients	LANCET			English	Editorial Material									[Singh, Jerome Amir] Univ KwaZulu Natal, CAPRISA, ZA-4001 Durban, Kwazulu Natal, South Africa; [Singh, Jerome Amir] Univ KwaZulu Natal, Howard Coll Sch Law, ZA-4001 Durban, Kwazulu Natal, South Africa; [Singh, Jerome Amir] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Singh, Jerome Amir] Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada	University of Kwazulu Natal; University of Kwazulu Natal; University of Toronto; University of Toronto	Singh, JA (corresponding author), Univ KwaZulu Natal, CAPRISA, ZA-4001 Durban, Kwazulu Natal, South Africa.	singhj9@ukzn.ac.za	Singh, Jerome Amir/ABG-1573-2021					BERESFORD B, 2008, GUARDIAN LOND   1025; BONHAM AC, 2000, 18 INT C TRANSPL SOC; Calabrese LH, 2003, NEW ENGL J MED, V348, P2323, DOI 10.1056/NEJMoa022935; Frassetto LA, 2009, NAT REV NEPHROL, V5, P583, DOI 10.1038/nrneph.2009.140; Gow PJ, 2001, AIDS, V15, P291, DOI 10.1097/00002030-200101260-00029; Halpern SD, 2002, NEW ENGL J MED, V347, P284, DOI 10.1056/NEJMsb020632; Kuo PC, 2001, TRANSPLANTATION, V71, P1689, DOI 10.1097/00007890-200106150-00033; Rizvi SAH, 2003, KIDNEY INT, V63, P96, DOI 10.1046/j.1523-1755.63.s83.20.x; Roland ME, 2003, TRANSPLANTATION, V75, P425, DOI 10.1097/01.TP.0000046943.35335.18; RUTECKI GW, 2004, TRANSPLANTING HIV PO; TZAKIS AG, 1990, TRANSPLANTATION, V49, P354, DOI 10.1097/00007890-199002000-00025; *UN NETW ORG SHAR, 2008, US TRANSPL WAIT LIST; Wright CE, 2002, NEW ENGL J MED, V347, P1801	13	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					442	443		10.1016/S0140-6736(09)60338-X	http://dx.doi.org/10.1016/S0140-6736(09)60338-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20152530				2022-12-28	WOS:000274757900008
J	Little, P; Moore, MV; Turner, S; Rumsby, K; Warner, G; Lowes, JA; Smith, H; Hawke, C; Leydon, G; Arscott, A; Turner, D; Mullee, M				Little, P.; Moore, M. V.; Turner, S.; Rumsby, K.; Warner, G.; Lowes, J. A.; Smith, H.; Hawke, C.; Leydon, G.; Arscott, A.; Turner, D.; Mullee, M.			Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							PRESCRIBING STRATEGIES; PRIMARY-CARE; SORE THROAT; SYMPTOMS; WOMEN; ANTIBIOTICS	Objective To assess the impact of different management strategies in urinary tract infections. Design Randomised controlled trial. Setting Primary care. Participants 309 non-pregnant women aged 18-70 presenting with suspected urinary tract infection. Intervention Patients were randomised to five management approaches: empirical antibiotics; empirical delayed (by 48 hours) antibiotics; or targeted antibiotics based on a symptom score (two or more of urine cloudiness, urine smell, nocturia, or dysuria), a dipstick result (nitrite or both leucocytes and blood), or a positive result on midstream urine analysis. Self help advice was controlled in each group. Main outcome measures Symptom severity (days 2 to 4) and duration, and use of antibiotics. Results Patients had 3.5 days of moderately bad symptoms if they took antibiotics immediately. There were no significant differences in duration or severity of symptoms (mean frequency of symptoms on a 0 to 6 scale: immediate antibiotics 2.15, midstream urine 2.08, dipstick 1.74, symptom score 1.77, delayed antibiotics 2.11; likelihood ratio test for the five groups P=0.177). There were differences in antibiotic use (immediate antibiotics 97%, midstream urine 81%, dipstick 80%, symptom score 90%, delayed antibiotics 77%; P=0.011) and in sending midstream urine samples (immediate antibiotics 23%, midstream urine 89%, dipstick 36%, symptom score 33%, delayed antibiotics 15%; P<0.001). Patients who waited at least 48 hours to start taking antibiotics reconsulted less (hazard ratio 0.57 (95% confidence interval 0.36 to 0.89), P=0.014) but on average had symptoms for 37% longer than those taking immediate antibiotics (incident rate ratio 1.37 (1.11 to 1.68), P=0.003), particularly the midstream urine group (73% longer, 22% to 140%; none of the other groups had more than 22% longer duration). Conclusion All management strategies achieve similar symptom control. There is no advantage in routinely sending midstream urine samples for testing, and antibiotics targeted with dipstick tests with a delayed prescription as backup, or empirical delayed prescription, can help to reduce antibiotic use.	[Little, P.] Univ Southampton, Aldermoor Hlth Ctr, Primary Care Med Grp, Community Clin Sci Div,Sch Med, Southampton SO16 5ST, Hants, England; [Warner, G.] Nightingale Surg, Romsey SO51 7QN, Hants, England; [Lowes, J. A.] Southampton Gen Hosp, Southampton Univ Hosp Trust, Microbiol Lab, Southampton SO16 6YD, Hants, England; [Smith, H.] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England; [Hawke, C.] Univ Sydney, Sch Rural Hlth, Orange, NSW, Australia; [Mullee, M.] Univ Southampton, Southampton Gen Hosp, Community Clin Sci Div, Sch Med,Publ Hlth Sci & Med Stat Grp,RDSU, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Brighton; University of Sussex; University of Sydney; University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Primary Care Med Grp, Community Clin Sci Div,Sch Med, Southampton SO16 5ST, Hants, England.	p.little@soton.ac.uk	Moore, Michael/C-3447-2011; Turner, David A/E-1847-2013; Leydon, Geraldine M/C-4968-2011; Smith, Helen E/M-2449-2016	Moore, Michael/0000-0002-5127-4509; Turner, David A/0000-0002-1689-4147; Smith, Helen E/0000-0003-1883-6124; Leydon, Geraldine Marie/0000-0001-5986-3300; Little, Paul/0000-0003-3664-1873; Rumsby, Kate/0000-0002-8573-3718	Health Technology Programme of UK NHS Research and Development; National Institute for Health Research [97/14/06] Funding Source: researchfish	Health Technology Programme of UK NHS Research and Development; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Health Technology Programme of UK NHS Research and Development. The researchers are independent of the funders, and the funders were not involved in management or analysis of the project.	Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; DOBBS FF, 1987, J ROY COLL GEN PRACT, V37, P100; Eltom A, 2000, SCAND J CLIN LAB INV, V60, P1, DOI 10.1080/00365510050184985; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; *HOUS LORDS SEL CO, 1998, 7 HOUS LORDS SEL COM; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 2004, BMJ-BRIT MED J, V328, P1054, DOI 10.1136/bmj.38037.435972.EE; Little P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5633; Little P, 1998, BMJ-BRIT MED J, V316, P1948, DOI 10.1136/bmj.316.7149.1948; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 1999, BRIT MED J, V319, P736, DOI 10.1136/bmj.319.7212.736; Little P, 2006, BRIT J GEN PRACT, V56, P606; Peveler R, 1997, J PSYCHOSOM RES, V42, P245, DOI 10.1016/S0022-3999(96)00292-9; Richards D, 2005, BMJ-BRIT MED J, V331, P143, DOI 10.1136/bmj.38496.452581.8F; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553; 1994, MORBIDITY STAT GEN P	18	124	126	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 5	2010	340								c199	10.1136/bmj.c199	http://dx.doi.org/10.1136/bmj.c199			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CX	20139214	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000274343700002
J	Guarente, L				Guarente, Leonard			Forever Young	CELL			English	Editorial Material							DAMAGED PROTEINS; YEAST; MECHANISM		MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Paul F Glenn Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; WEISMAN A, 1892, GERM PLASM THEORY HE	9	4	4	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2					176	178		10.1016/j.cell.2010.01.015	http://dx.doi.org/10.1016/j.cell.2010.01.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141830	Bronze, Green Published			2022-12-28	WOS:000273826500007
J	Nikolaev, VO; Moshkov, A; Lyon, AR; Miragoli, M; Novak, P; Paur, H; Lohse, MJ; Korchev, YE; Harding, SE; Gorelik, J				Nikolaev, Viacheslav O.; Moshkov, Alexey; Lyon, Alexander R.; Miragoli, Michele; Novak, Pavel; Paur, Helen; Lohse, Martin J.; Korchev, Yuri E.; Harding, Sian E.; Gorelik, Julia			beta(2)-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation	SCIENCE			English	Article							PROTEIN-KINASE-A; ADULT CARDIAC MYOCYTES; TRANSGENIC MICE; CYCLIC-AMP; PHOSPHORYLATION; CELL; MICRODOMAINS; HYPERTROPHY; PROPAGATION; SURFACE	The beta(1)- and beta(2)-adrenergic receptors (beta ARs) on the surface of cardiomyocytes mediate distinct effects on cardiac function and the development of heart failure by regulating production of the second messenger cyclic adenosine monophosphate (cAMP). The spatial localization in cardiomyocytes of these bARs, which are coupled to heterotrimeric guanine nucleotide-binding proteins (G proteins), and the functional implications of their localization have been unclear. We combined nanoscale live-cell scanning ion conductance and fluorescence resonance energy transfer microscopy techniques and found that, in cardiomyocytes from healthy adult rats and mice, spatially confined beta(2)AR-induced cAMP signals are localized exclusively to the deep transverse tubules, whereas functional beta(1)ARs are distributed across the entire cell surface. In cardiomyocytes derived from a rat model of chronic heart failure, beta(2)ARs were redistributed from the transverse tubules to the cell crest, which led to diffuse receptor-mediated cAMP signaling. Thus, the redistribution of beta(2)ARs in heart failure changes compartmentation of cAMP and might contribute to the failing myocardial phenotype.	[Nikolaev, Viacheslav O.; Moshkov, Alexey; Lyon, Alexander R.; Miragoli, Michele; Novak, Pavel; Paur, Helen; Harding, Sian E.; Gorelik, Julia] Univ London Imperial Coll Sci Technol & Med, Dept Cardiac Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Nikolaev, Viacheslav O.; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Nikolaev, Viacheslav O.; Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany; [Novak, Pavel; Korchev, Yuri E.] Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England	Imperial College London; University of Wurzburg; University of Wurzburg; Imperial College London	Gorelik, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Cardiac Med, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	j.gorelik@imperial.ac.uk	Lohse, Martin J/A-7160-2012; Moshkov, Alexey/C-2825-2014; Novak, Pavel/P-8154-2019; Miragoli, Michele/K-6418-2016; Moshkov, Alexey/AAO-9902-2020; Nikolaev, Vyacheslav/AAT-7746-2020; Novak, Pavel/J-4264-2012	Lohse, Martin J/0000-0002-0599-3510; Moshkov, Alexey/0000-0002-1858-6738; Novak, Pavel/0000-0002-5461-0344; Miragoli, Michele/0000-0002-4058-4368; Moshkov, Alexey/0000-0002-1858-6738; Novak, Pavel/0000-0002-5461-0344; Nikolaev, Viacheslav/0000-0002-7529-5179; Gorelik, Julia/0000-0003-1148-9158; Harding, Sian/0000-0002-3651-6354; Korchev, Yuri/0000-0002-4872-8696	Wellcome Trust [WTN 084064]; Action Medical Research; U.K. Biotechnology and Biological Sciences Research Council; U.K. Medical Research Council; Leducq Foundation; Biotechnology and Biological Sciences Research Council [BB/D020875/1, BB/E52708X/1] Funding Source: researchfish; Medical Research Council [G0500373] Funding Source: researchfish; BBSRC [BB/D020875/1, BB/E52708X/1] Funding Source: UKRI; MRC [G0500373] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research; U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leducq Foundation(Leducq Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. O'Gara for cardiomyocyte isolation; C. Dees for receptor binding assays; and L. Jaffe, F. Klauschen, and S. Gambaryan for critical reading of the manuscript. This study was supported by the Wellcome Trust (WTN 084064 to J.G.), Action Medical Research Grant ( to J.G.), a U.K. Biotechnology and Biological Sciences Research Council grant ( to Y.E.K.), a U.K. Medical Research Council grant ( to J.G. and Y.E.K.) and a grant from Leducq Foundation ( to S. E. H. and M.J.L.). Y.E.K. is a shareholder of, and P.N. has a consultancy agreement with, Ionscope Ltd., a company that sells scanning ion conductance microscopes. The cAMP sensor Epac2-camps used in this study is covered by a patent belonging to the University of Wurzburg. It is being provided at no cost, but with a material transfer agreement, to nonprofit research institutes and universities.	BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DELMONTE F, 1993, CIRCULATION, V88, P854, DOI 10.1161/01.CIR.88.3.854; DeSantiago J, 2008, CIRC RES, V102, P1389, DOI 10.1161/CIRCRESAHA.107.169011; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P6400, DOI 10.1073/pnas.96.11.6400; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Kaumann A, 1999, CIRCULATION, V99, P65, DOI 10.1161/01.CIR.99.1.65; Korchev YE, 2000, NAT CELL BIOL, V2, P616, DOI 10.1038/35023563; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zakhary DR, 2000, CIRCULATION, V101, P1459, DOI 10.1161/01.CIR.101.12.1459; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	29	397	412	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1653	1657		10.1126/science.1185988	http://dx.doi.org/10.1126/science.1185988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20185685				2022-12-28	WOS:000275970600047
J	Barton, AD; Dutkiewicz, S; Flierl, G; Bragg, J; Follows, MJ				Barton, Andrew D.; Dutkiewicz, Stephanie; Flierl, Glenn; Bragg, Jason; Follows, Michael J.			Patterns of Diversity in Marine Phytoplankton	SCIENCE			English	Article							RESOURCE COMPETITION; BIOGEOGRAPHY; GRADIENT; OCEAN; MODEL; COMMUNITIES; SPECIATION	Spatial diversity gradients are a pervasive feature of life on Earth. We examined a global ocean circulation, biogeochemistry, and ecosystem model that indicated a decrease in phytoplankton diversity with increasing latitude, consistent with observations of many marine and terrestrial taxa. In the modeled subpolar oceans, seasonal variability of the environment led to competitive exclusion of phytoplankton with slower growth rates and lower diversity. The relatively weak seasonality of the stable subtropical and tropical oceans in the global model enabled long exclusion time scales and prolonged coexistence of multiple phytoplankton with comparable fitness. Superimposed on the decline in diversity seen from equator to pole were "hot spots" of enhanced diversity in some regions of energetic ocean circulation, which reflected lateral dispersal.	[Barton, Andrew D.; Dutkiewicz, Stephanie; Flierl, Glenn; Follows, Michael J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Bragg, Jason] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Barton, AD (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	adbarton@mit.edu	Bragg, Jason G/A-4473-2012; Bragg, Jason/R-5611-2016; Bragg, Jason/P-7675-2019; Follows, Michael/G-9824-2011	Bragg, Jason G/0000-0003-0093-4981; Bragg, Jason/0000-0002-7621-7295; Bragg, Jason/0000-0002-7621-7295; Barton, Andrew/0000-0002-6480-4433	Gordon and Betty Moore Foundation; NASA; NOAA	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	A. D. B., S. D., J.B., and M.J.F. are grateful for support from the Gordon and Betty Moore Foundation's Marine Microbiology Initiative. M.J.F. and S. D. are also grateful for support from NASA and NOAA.	Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; Cermeno P, 2008, LIMNOL OCEANOGR, V53, P312, DOI 10.4319/lo.2008.53.1.0312; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Dutkiewicz S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003405; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; GROVER JP, 1990, AM NAT, V136, P771, DOI 10.1086/285131; HANSEN SR, 1980, SCIENCE, V207, P1491; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; HONJO S, 1974, Micropaleontology (New York), V20, P209, DOI 10.2307/1485061; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; MAC ARTHUR ROBERT H., 1967; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747	25	230	234	9	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1509	1511		10.1126/science.1184961	http://dx.doi.org/10.1126/science.1184961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20185684	Green Published			2022-12-28	WOS:000275715200048
J	Collinet, C; Stoter, M; Bradshaw, CR; Samusik, N; Rink, JC; Kenski, D; Habermann, B; Buchholz, F; Henschel, R; Mueller, MS; Nagel, WE; Fava, E; Kalaidzidis, Y; Zerial, M				Collinet, Claudio; Stoeter, Martin; Bradshaw, Charles R.; Samusik, Nikolay; Rink, Jochen C.; Kenski, Denise; Habermann, Bianca; Buchholz, Frank; Henschel, Robert; Mueller, Matthias S.; Nagel, Wolfgang E.; Fava, Eugenio; Kalaidzidis, Yannis; Zerial, Marino			Systems survey of endocytosis by multiparametric image analysis	NATURE			English	Article							MEDIATED ENDOCYTOSIS; SIGNAL-TRANSDUCTION; CELL BIOLOGY; ENDOSOMES; CYTOKINESIS; SPECIFICITY; MECHANISMS; PROTEINS; GRADIENT; SCREEN	Endocytosis is a complex process fulfilling many cellular and developmental functions. Understanding how it is regulated and integrated with other cellular processes requires a comprehensive analysis of its molecular constituents and general design principles. Here, we developed a new strategy to phenotypically profile the human genome with respect to transferrin (TF) and epidermal growth factor (EGF) endocytosis by combining RNA interference, automated high-resolution confocal microscopy, quantitative multiparametric image analysis and high-performance computing. We identified several novel components of endocytic trafficking, including genes implicated in human diseases. We found that signalling pathways such as Wnt, integrin/cell adhesion, transforming growth factor (TGF)-beta and Notch regulate the endocytic system, and identified new genes involved in cargo sorting to a subset of signalling endosomes. A systems analysis by Bayesian networks further showed that the number, size, concentration of cargo and intracellular position of endosomes are not determined randomly but are subject to specific regulation, thus uncovering novel properties of the endocytic system.	[Collinet, Claudio; Bradshaw, Charles R.; Samusik, Nikolay; Habermann, Bianca; Buchholz, Frank; Kalaidzidis, Yannis; Zerial, Marino] MPI CBG, Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Henschel, Robert; Mueller, Matthias S.; Nagel, Wolfgang E.] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp ZIH, D-01062 Dresden, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Technische Universitat Dresden; Lomonosov Moscow State University	Zerial, M (corresponding author), MPI CBG, Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Kalaidzidis, Yannis/H-3094-2016; Buchholz, Frank/B-4700-2017; Habermann, Bianca/N-4886-2016	Kalaidzidis, Yannis/0000-0002-6137-1193; Buchholz, Frank/0000-0002-4577-3344; Habermann, Bianca/0000-0002-2457-7504; Collinet, Claudio/0000-0002-8532-2601; Bradshaw, Charles/0000-0002-3528-458X; Fava, Eugenio/0000-0002-3737-0334	Max Planck Society (MPG); HepatoSys of the German Ministry for Education and Research BMBF; DFG; Gottlieb Daimler und Karl Benz Stiftung; European Community	Max Planck Society (MPG)(Max Planck Society); HepatoSys of the German Ministry for Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Gottlieb Daimler und Karl Benz Stiftung; European Community(European Commission)	We acknowledge T. Galvez and G. Marsico, members of the Zerial group for discussions and scientific support. We are particularly indebted to K. Korn who developed transfection protocols and organized various preparatory steps and logistics before the screen and E. Krausz for the management of the HT-TDS, the MPI-CBG screening facility. We thank J. Schmitt, A. Lohmann, S. Christ, N. Tomschke, A. Niederlein, J. Wagner, M. Gierth, E. Krausz for technical, robotics and computational assistance, and M. Boes and J. Oegema for IT support that made the large-scale computational analysis possible. We acknowledge I. C. Baines, T. Galvez, J. Howard, T. Hyman, M. McShane, G. O'Sullivan and P. Tomancak for comments on themanuscript. This work was financially supported by the Max Planck Society (MPG) and by the systems biology network HepatoSys of the German Ministry for Education and Research BMBF, the DFG and the Gottlieb Daimler und Karl Benz Stiftung. This work is also part of the project 'Endotrack', which received research funding from the European Community's Sixth Framework Programme.	Baluska F, 2006, DEV BIOL, V294, P1, DOI 10.1016/j.ydbio.2006.02.047; Baskys A, 2007, ANN NY ACAD SCI, V1122, P313, DOI 10.1196/annals.1403.023; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Dudu V, 2004, CURR OPIN CELL BIOL, V16, P407, DOI 10.1016/j.ceb.2004.06.008; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Entchev EV, 2002, TRAFFIC, V3, P98, DOI 10.1034/j.1600-0854.2002.030203.x; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hayakawa A, 2007, BIOCHEM SOC SYMP, V74, P95, DOI 10.1042/BSS2007c09; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perrimon N, 2007, GENETICS, V175, P7, DOI 10.1534/genetics.106.069963; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6	44	318	328	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					243	U123		10.1038/nature08779	http://dx.doi.org/10.1038/nature08779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20190736				2022-12-28	WOS:000275366100039
J	Bertrand, JY; Chi, NC; Santoso, B; Teng, ST; Stainier, DYR; Traver, D				Bertrand, Julien Y.; Chi, Neil C.; Santoso, Buyung; Teng, Shutian; Stainier, Didier Y. R.; Traver, David			Haematopoietic stem cells derive directly from aortic endothelium during development	NATURE			English	Article							ZEBRAFISH; EXPRESSION; ADULT; BLOOD	A major goal of regenerative medicine is to instruct formation of multipotent, tissue-specific stem cells from induced pluripotent stem cells (iPSCs) for cell replacement therapies. Generation of haematopoietic stem cells (HSCs) from iPSCs or embryonic stem cells (ESCs) is not currently possible, however, necessitating a better understanding of how HSCs normally arise during embryonic development. We previously showed that haematopoiesis occurs through four distinct waves during zebrafish development, with HSCs arising in the final wave in close association with the dorsal aorta. Recent reports have suggested that murine HSCs derive from haemogenic endothelial cells (ECs) lining the aortic floor(1,2). Additional in vitro studies have similarly indicated that the haematopoietic progeny of ESCs arise through intermediates with endothelial potential(3,4). Here we have used the unique strengths of the zebrafish embryo to image directly the generation of HSCs from the ventral wall of the dorsal aorta. Using combinations of fluorescent reporter transgenes, confocal time-lapse microscopy and flow cytometry, we have identified and isolated the stepwise intermediates as aortic haemogenic endothelium transitions to nascent HSCs. Finally, using a permanent lineage tracing strategy, we demonstrate that the HSCs generated from haemogenic endothelium are the lineal founders of the adult haematopoietic system.	[Bertrand, Julien Y.; Santoso, Buyung; Teng, Shutian; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Bertrand, Julien Y.; Santoso, Buyung; Teng, Shutian; Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, San Diego, CA 92093 USA; [Chi, Neil C.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Chi, Neil C.; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco	Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92093 USA.	dtraver@ucsd.edu	BERTRAND, Julien/O-3655-2019	BERTRAND, Julien/0000-0001-6570-4082; Stainier, Didier/0000-0002-0382-0026	Cancer Research Institute; California Institute for Regenerative Medicine (CIRM); National Institutes of Health (NIH) [HL074891, F32DK752433, HL54737, DK074482]; GlaxoSmithKline; American Heart Association; Packard Foundation; American Society of Hematology; CIRM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074891, R01HL054737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482] Funding Source: NIH RePORTER	Cancer Research Institute; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); American Heart Association(American Heart Association); Packard Foundation(The David & Lucile Packard Foundation); American Society of Hematology; CIRM(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Lin for providing kdrl: RFP animals. J.Y.B. was supported by the Irvington program of the Cancer Research Institute and by the California Institute for Regenerative Medicine (CIRM), N.C.C. by National Institutes of Health (NIH) HL074891, a Research and Education Foundation Award from GlaxoSmithKline and a Beginning Grant in Aid Award from the American Heart Association, B. S. by NIH F32DK752433, D.Y.R.S. by the Packard Foundation and NIH HL54737, and D. T. by a Scholar Award from the American Society of Hematology, a New Investigator Award from CIRM, and NIH DK074482.	Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Feng H, 2007, BRIT J HAEMATOL, V138, P169, DOI 10.1111/j.1365-2141.2007.06625.x; Huang HG, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-7; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Liao W, 1997, DEVELOPMENT, V124, P381; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Rozen S, 2000, Methods Mol Biol, V132, P365; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	27	689	709	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					108	U120		10.1038/nature08738	http://dx.doi.org/10.1038/nature08738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20154733	Green Accepted			2022-12-28	WOS:000275117500043
J	Green, SM; Mason, KP				Green, Steven M.; Mason, Keira P.			Reformulation of the Sedation Continuum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROCEDURAL SEDATION; ANALGESIA		[Green, Steven M.] Loma Linda Univ, Med Ctr, Dept Emergency Med, Loma Linda, CA 92354 USA; [Green, Steven M.] Childrens Hosp, Loma Linda, CA USA; [Mason, Keira P.] Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Mason, Keira P.] Harvard Univ, Sch Med, Boston, MA USA	Loma Linda University; Children's Hospital Los Angeles; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Green, SM (corresponding author), Loma Linda Univ, Med Ctr, Dept Emergency Med, A-108,11234 Anderson St, Loma Linda, CA 92354 USA.	steve@viridissimo.com	Mason, Keira/AAS-4734-2020; Mason, Keira/GZN-2525-2022	Mason, Keira/0000-0002-9375-7816; 				[Anonymous], 1985, PEDIATRICS, V76, P317; BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V254, P1073; Casamassimo P, 2006, PEDIATRICS, V118, P2587, DOI 10.1542/peds.2006-2780; Cravero JP, 2004, ANESTH ANALG, V99, P1355, DOI 10.1213/01.ANE.0000134810.60270.E8; Green SM, 2008, ANN EMERG MED, V52, P392, DOI 10.1016/j.annemergmed.2007.12.002; Green SM, 2008, ANN EMERG MED, V52, P9, DOI 10.1016/j.annemergmed.2007.12.001; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; *JOINT COMM, SED AN CAR STAND; Krauss B, 2008, PEDIATR ANESTH, V18, P30, DOI 10.1111/j.1460-9592.2007.02406.x; Krauss B, 2007, ANN EMERG MED, V50, P172, DOI 10.1016/j.annemergmed.2006.10.016	10	20	21	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					876	877		10.1001/jama.2010.217	http://dx.doi.org/10.1001/jama.2010.217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197535				2022-12-28	WOS:000275059500022
J	Clark, JS				Clark, James S.			Individuals and the Variation Needed for High Species Diversity in Forest Trees	SCIENCE			English	Article							LONG-TERM; COEXISTENCE; COMPETITION; NEUTRALITY; NICHE; MECHANISMS; TRADEOFFS; STABILITY	In the past, explanations for high species diversity have been sought at the species level. Theory shows that coexistence requires substantial differences between species, but species-level data rarely provide evidence for such differences. Using data from forests in the southeastern United States, I show here that variation evident at the individual level provides for coexistence of large numbers of competitors. Variation among individuals within populations allows species to differ in their distributions of responses to the environment, despite the fact that the populations to which they belong do not differ, on average. Results are consistent with theory predicting that coexistence depends on competition being stronger within than between species, shown here by analysis of individual-level responses to environmental fluctuation.	[Clark, James S.] Duke Univ, Nicholas Sch Environm, Dept Biol, Durham, NC 27708 USA; [Clark, James S.] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA	Duke University; Duke University	Clark, JS (corresponding author), Duke Univ, Nicholas Sch Environm, Dept Biol, Durham, NC 27708 USA.	jimclark@duke.edu	Clark, James S./G-6331-2011					Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark JS, 2007, ECOL LETT, V10, P647, DOI 10.1111/j.1461-0248.2007.01041.x; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; CLARK JS, 2010, HDB BAYESIAN ANAL, P431; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; CONNELL J H, 1971, P298; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; LEVINS R, 1979, AM NAT, V114, P765, DOI 10.1086/283527; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mohan JE, 2007, ECOL APPL, V17, P1198, DOI 10.1890/05-1690; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TILMAN D, 1988; Zillio T, 2007, OIKOS, V116, P931, DOI 10.1111/j.2007.0030-1299.15662.x	24	250	261	9	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1129	1132		10.1126/science.1183506	http://dx.doi.org/10.1126/science.1183506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185724				2022-12-28	WOS:000274901100036
J	Cummings, SR; Ensrud, K; Delmas, PD; LaCroix, AZ; Vukicevic, S; Reid, DM; Goldstein, S; Sriram, U; Lee, A; Thompson, J; Armstrong, RA; Thompson, DD; Powles, T; Zanchetta, J; Kendler, D; Neven, P; Eastell, R				Cummings, Steven R.; Ensrud, Kristine; Delmas, Pierre D.; LaCroix, Andrea Z.; Vukicevic, Slobodan; Reid, David M.; Goldstein, Steven; Sriram, Usha; Lee, Andy; Thompson, John; Armstrong, Roisin A.; Thompson, David D.; Powles, Trevor; Zanchetta, Jose; Kendler, David; Neven, Patrick; Eastell, Richard		PEARL Study Investigators	Lasofoxifene in Postmenopausal Women with Osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER PREVENTION; ESTROGEN PLUS PROGESTIN; NONVERTEBRAL FRACTURES; CARDIOVASCULAR EVENTS; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; FOLLOW-UP; RALOXIFENE; RISK; TAMOXIFEN	BACKGROUND The effects of lasofoxifene on the risk of fractures, breast cancer, and cardiovascular disease are uncertain. METHODS In this randomized trial, we assigned 8556 women who were between the ages of 59 and 80 years and had a bone mineral density T score of -2.5 or less at the femoral neck or spine to receive once-daily lasofoxifene (at a dose of either 0.25 mg or 0.5 mg) or placebo for 5 years. Primary end points were vertebral fractures, estrogen receptor (ER)-positive breast cancer, and nonvertebral fractures; secondary end points included major coronary heart disease events and stroke. RESULTS Lasofoxifene at a dose of 0.5 mg per day, as compared with placebo, was associated with reduced risks of vertebral fracture (13.1 cases vs. 22.4 cases per 1000 person-years; hazard ratio, 0.58; 95% confidence interval [CI], 0.47 to 0.70), nonvertebral fracture (18.7 vs. 24.5 cases per 1000 person-years; hazard ratio, 0.76; 95% CI, 0.64 to 0.91), ER-positive breast cancer (0.3 vs. 1.7 cases per 1000 person-years; hazard ratio, 0.19; 95% CI, 0.07 to 0.56), coronary heart disease events (5.1 vs. 7.5 cases per 1000 person-years; hazard ratio, 0.68; 95% CI, 0.50 to 0.93), and stroke (2.5 vs. 3.9 cases per 1000 person-years; hazard ratio, 0.64; 95% CI, 0.41 to 0.99). Lasofoxifene at a dose of 0.25 mg per day, as compared with placebo, was associated with reduced risks of vertebral fracture (16.0 vs. 22.4 cases per 1000 person-years; hazard ratio, 0.69; 95% CI, 0.57 to 0.83) and stroke (2.4 vs. 3.9 cases per 1000 person-years; hazard ratio, 0.61; 95% CI, 0.39 to 0.96) Both the lower and higher doses, as compared with placebo, were associated with an increase in venous thromboembolic events (3.8 and 2.9 cases vs. 1.4 cases per 1000 person-years; hazard ratios, 2.67 [95% CI, 1.55 to 4.58] and 2.06 [95% CI, 1.17 to 3.60], respectively). Endometrial cancer occurred in three women in the placebo group, two women in the lower-dose lasofoxifene group, and two women in the higher-dose lasofoxifene group. Rates of death per 1000 person-years were 5.1 in the placebo group, 7.0 in the lower-dose lasofoxifene group, and 5.7 in the higher-dose lasofoxifene group. CONCLUSIONS In postmenopausal women with osteoporosis, lasofoxifene at a dose of 0.5 mg per day was associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke but an increased risk of venous thromboembolic events. (ClinicalTrials.gov number, NCT00141323.)	[Cummings, Steven R.] Calif Pacific Med Ctr, San Francisco Coordinating Ctr, Res Inst, San Francisco, CA USA; [Cummings, Steven R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ensrud, Kristine] Univ Minnesota, Minneapolis, MN USA; [Ensrud, Kristine] Vet Affairs Med Ctr, Minneapolis, MN USA; [Delmas, Pierre D.] Univ Lyon, Lyon, France; [Delmas, Pierre D.] INSERM, Res Unit 831, F-69008 Lyon, France; [LaCroix, Andrea Z.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Vukicevic, Slobodan] Univ Zagreb, Sch Med, Lab Mineralized Tissue, Zagreb 41001, Croatia; [Reid, David M.] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Powles, Trevor] Parkside Oncol Clin, London, England; [Eastell, Richard] Univ Sheffield, Acad Unit Bone Metab, Sheffield, S Yorkshire, England; [Goldstein, Steven] NYU, Sch Med, New York, NY USA; [Sriram, Usha] Associates Clin Endocrinol Educ & Res, Madras, Tamil Nadu, India; [Lee, Andy; Thompson, John; Armstrong, Roisin A.; Thompson, David D.] Pfizer Global Res & Dev, New London, CT USA; [Zanchetta, Jose] Inst Invest Metab, Buenos Aires, DF, Argentina; [Zanchetta, Jose] El Salvador Univ, Sch Med, Buenos Aires, DF, Argentina; [Kendler, David] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Neven, Patrick] Univ Louvain, Leuven, Belgium	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Institut National de la Sante et de la Recherche Medicale (Inserm); Fred Hutchinson Cancer Center; University of Zagreb; University of Aberdeen; University of Sheffield; New York University; Pfizer; St. Paul's Hospital; University of Saskatchewan	Cummings, SR (corresponding author), 185 Berry St,Lobby 4,Suite 5700, San Francisco, CA 94107 USA.	scummings@sfcc-cpmc.net	LaCroix, Andrea/N-9880-2018; Dedov, Ivan I/D-3729-2014; Vukicevic, Slobodan/AEG-2646-2022; Eastell, Richard/G-5851-2011; Colgan, Terence J/J-2339-2016; Melo, Nilson/F-9540-2012; Kucukdeveci, Ayse A./Y-8421-2018	LaCroix, Andrea/0000-0002-9532-976X; Dedov, Ivan I/0000-0002-8175-7886; Vukicevic, Slobodan/0000-0003-4076-0285; Eastell, Richard/0000-0002-0323-3366; Kucukdeveci, Ayse A./0000-0001-7255-7535; Kendler, David/0000-0001-7679-3965; Ensrud, Kristine/0000-0002-9069-3036; Calaf, Joaquin/0000-0002-2407-7884	Pfizer; Amgen; Eli Lilly; University of Massachusetts Global Longitudinal Study of Osteoporosis in Women; PEARL Seattle; Novartis; Wyeth Translational Medical Research Initiative; Wyeth; Servier; Takeda; GlaxoSmithKline; AstraZeneca; Procter Gamble	Pfizer(Pfizer); Amgen(Amgen); Eli Lilly(Eli Lilly); University of Massachusetts Global Longitudinal Study of Osteoporosis in Women; PEARL Seattle; Novartis(Novartis); Wyeth Translational Medical Research Initiative; Wyeth(Wyeth); Servier(Servier); Takeda(Takeda Pharmaceutical Company Ltd); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Procter Gamble(Procter & Gamble)	Supported by Pfizer.; Dr. Cummings reports receiving consulting fees from Amgen, Eli Lilly, GlaxoSmithKline, and Organon, lecture fees from Eli Lilly and Novartis, and grant support from Amgen, Pfizer, and Eli Lilly; Dr. Ensrud, receiving grant support from Pfizer; Dr. Delmas (deceased), receiving lecture fees from Pfizer; Dr. LaCroix, receiving consulting fees from Procter & Gamble, Sanofi-Aventis, and Pfizer, lecture fees from the Center for Excellence in Continuing Medical Education, and grant support from the University of Massachusetts Global Longitudinal Study of Osteoporosis in Women contract and the PEARL Seattle site contract; Dr. Vukicevic, receiving lecture fees from Merck; Dr. Reid, receiving consulting fees from Amgen, Pfizer, Procter & Gamble, and Roche, owning stock in AstraZeneca and GlaxoSmithKline, receiving lecture fees from Roche, Novartis, and Amgen, and receiving grant support from Novartis and Wyeth Translational Medical Research Initiative; Dr. Goldstein, receiving consulting fees from Amgen, Boehringer Ingelheim, Eli Lilly, and Pfizer, and lecture fees from Eli Lilly and Novo Nordisk; Dr. Sriram, receiving grant support from Pfizer and Eli Lilly;. Drs. J. Thompson, Armstrong, D. Thompson, and Mr. Lee, being employees of and receiving stock options from Pfizer; Mr. Lee, Dr. Armstrong, and Dr. D. Thompson, holding patents related to lasofoxifene; Dr. Powles, receiving consulting fees from Eli Lilly and Pfizer; Dr. Zanchetta, receiving consulting fees from Pfizer, Eli Lilly, Servier, and Amgen; Dr. Kendler, receiving consulting fees from Eli Lilly, Novartis, Wyeth, Servier, Amgen, and Zelos, lecture fees from Eli Lilly, Novartis, Pfizer, and Wyeth, and grant support from Wyeth, Pfizer, Servier, Eli Lilly, Novartis, Amgen, Takeda, and GlaxoSmithKline; Dr. Neven, receiving consulting fees from Eli Lilly, Pfizer, and Organon, and lecture fees from AstraZeneca, Eli Lilly, and Pfizer; Dr. Eastell, receiving consulting fees from Amgen, Novartis, Pfizer, Procter & Gamble, Servier, Ono, and GlaxoSmithKline, lecture fees from Eli Lilly, and grant support from AstraZeneca, Procter & Gamble, and Novartis; and Drs. Cummings, Delmas, LaCroix, Vukicevic, Reid, Sriram, and Eastell, serving as paid members of the PEARL Scientific Advisory Committee for Pfizer. No other potential conflict of interest relevant to this article was reported.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; BarrettConnor E, 1997, MATURITAS, V27, P261, DOI 10.1016/S0378-5122(97)00041-8; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Cummings SR, 1999, JAMA-J AM MED ASSOC, V282, P2124; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Felson DT, 2005, ARTHRITIS RHEUM-US, V52, P2594, DOI 10.1002/art.21364; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Genant HK, 1996, J BONE MINER RES, V11, P984; Gennari L, 2007, DRUG AGING, V24, P361, DOI 10.2165/00002512-200724050-00002; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jorgensen EB, 2008, KAIS, V2021, P1, DOI [DOI 10.1002/14651858.CD001155.PUB2, 10.1002/mp.15257]; Land SR, 2007, JAMA-J AM MED ASSOC, V298, P973; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; McCloskey EV, 2007, J BONE MINER RES, V22, P135, DOI 10.1359/JBMR.061008; McClung MR, 2006, MENOPAUSE, V13, P377, DOI 10.1097/01.gme.0000188736.69617.4f; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sobel JD, 1996, OBSTET GYNECOL, V88, P704, DOI 10.1016/0029-7844(96)00123-8; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Walsh BW, 2000, J CLIN ENDOCR METAB, V85, P214, DOI 10.1210/jc.85.1.214	33	266	273	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					686	696		10.1056/NEJMoa0808692	http://dx.doi.org/10.1056/NEJMoa0808692			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181970	Bronze			2022-12-28	WOS:000274845600007
J	Conte, D; Mello, CC				Conte, Darryl, Jr.; Mello, Craig C.			Primal RNAs: The End of the Beginning?	CELL			English	Editorial Material							FISSION YEAST; HETEROCHROMATIN; GENOME		[Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	craig.mello@umassmed.edu						Abbas AK, 2000, CELL, V100, P129, DOI 10.1016/S0092-8674(00)81689-X; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	9	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					452	454		10.1016/j.cell.2010.02.005	http://dx.doi.org/10.1016/j.cell.2010.02.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178736	Bronze			2022-12-28	WOS:000274668400007
J	Fried, LP; Bentley, ME; Buekens, P; Burke, DS; Frenk, JJ; Klag, MJ; Spencer, HC				Fried, Linda P.; Bentley, Margaret E.; Buekens, Pierre; Burke, Donald S.; Frenk, Julio J.; Klag, Michael J.; Spencer, Harrison C.			Global health is public health	LANCET			English	Editorial Material									[Spencer, Harrison C.] Assoc Sch Publ Hlth, Washington, DC 20005 USA; [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Bentley, Margaret E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Frenk, Julio J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Klag, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Columbia University; University of North Carolina; University of North Carolina Chapel Hill; Tulane University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Spencer, HC (corresponding author), Assoc Sch Publ Hlth, Washington, DC 20005 USA.	hspencer@asph.org		/0000-0002-5704-8094	NICHD NIH HHS [R24 HD050924] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1988, FUT PUBL HLTH; Colgrove J, 2010, PUBLIC HEALTH REP, V125, P8, DOI 10.1177/003335491012500104; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; *ROCK FDN, 1915, WELCHR REP SCH PUBL; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Trust for America's Health, 2008, PREV HEALTH AM INV D; World Health Organization, WHO GLOB INF	7	101	107	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					535	537		10.1016/S0140-6736(10)60203-6	http://dx.doi.org/10.1016/S0140-6736(10)60203-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560YO	20159277				2022-12-28	WOS:000274941900009
J	Herrero, M; Thornton, PK; Notenbaert, AM; Wood, S; Msangi, S; Freeman, HA; Bossio, D; Dixon, J; Peters, M; van de Steeg, J; Lynam, J; Rao, PP; Macmillan, S; Gerard, B; McDermott, J; Sere, C; Rosegrant, M				Herrero, M.; Thornton, P. K.; Notenbaert, A. M.; Wood, S.; Msangi, S.; Freeman, H. A.; Bossio, D.; Dixon, J.; Peters, M.; van de Steeg, J.; Lynam, J.; Rao, P. Parthasarathy; Macmillan, S.; Gerard, B.; McDermott, J.; Sere, C.; Rosegrant, M.			Smart Investments in Sustainable Food Production: Revisiting Mixed Crop-Livestock Systems	SCIENCE			English	Editorial Material							INTENSIFICATION; SCIENCE	Farmers in mixed crop-livestock systems produce about half of the world's food. In small holdings around the world, livestock are reared mostly on grass, browse, and nonfood biomass from maize, millet, rice, and sorghum crops and in their turn supply manure and traction for future crops. Animals act as insurance against hard times, and supply farmers with a source of regular income from sales of milk, eggs, and other products. Thus, faced with population growth and climate change, small-holder farmers should be the first target for policies to intensify production by carefully managed inputs of fertilizer, water, and feed to minimize waste and environmental impact, supported by improved access to markets, new varieties, and technologies.	[Herrero, M.; Thornton, P. K.; Notenbaert, A. M.; van de Steeg, J.; Macmillan, S.; McDermott, J.; Sere, C.] ILRI, Nairobi, Kenya; [Wood, S.; Msangi, S.; Rosegrant, M.] IFPRI, Washington, DC 20006 USA; [Freeman, H. A.] Int Finance Corp, World Bank Grp, Washington, DC 20433 USA; [Bossio, D.] IWMI, Colombo, Sri Lanka; [Dixon, J.] Australian Ctr Int Agr Res, Canberra, ACT, Australia; [Peters, M.] CIAT, Cali, Colombia; [Rao, P. Parthasarathy] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Gerard, B.] CGIAR Syst Wide Livestock Programme, Addis Ababa, Ethiopia	CGIAR; International Livestock Research Institute (ILRI); CGIAR; International Food Policy Research Institute (IFPRI); The World Bank; CGIAR; International Water Management Institute (IWMI); Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR	Herrero, M (corresponding author), ILRI, POB 30709, Nairobi, Kenya.	m.herrero@cgiar.org	Thornton, Philip/AAB-8806-2020; Gerard, Bruno/AAG-6592-2019; Herrero, Mario/A-6678-2015	Thornton, Philip/0000-0002-1854-0182; Gerard, Bruno/0000-0002-1079-7493; Herrero, Mario/0000-0002-7741-5090; Notenbaert, An Maria Omer/0000-0002-6266-2240	CGIAR Systemwide Livestock Programme; Canadian International Development Agency; World Bank; Swiss Agency for Development and Cooperation	CGIAR Systemwide Livestock Programme(CGIAR); Canadian International Development Agency; World Bank(The World Bank India); Swiss Agency for Development and Cooperation	This work was funded by the CGIAR Systemwide Livestock Programme. We acknowledge support from the Canadian International Development Agency, the World Bank, and the Swiss Agency for Development and Cooperation. We also thank M. Blummel, W. Thorpe, S. Staal, and S. Tarawali for useful discussions on the topic.	[Anonymous], 2007, WATER FOOD WATER LIF; Blummel M., 2006, Journal of SAT Agricultural Research, V2, P1; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Conant RT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001661; Delgado C., 1999, 28 IFPRIFAOILRI; DIXON J, 2009, FEED FOOD FUEL COMPE; Dixon J, 2009, DRIVERS CHANGE CROP; EEA, 2009, ANN EUR COMM GREENH; Fan SG, 2001, AM J AGR ECON, V83, P1217, DOI 10.1111/0002-9092.00270; FAO, 2007, STAT FOOD AGR PAYING; Gerber P, 2005, BIORESOURCE TECHNOL, V96, P263, DOI 10.1016/j.biortech.2004.05.016; *IEG, 2007, WORLD BANK ASS AGR S; Immerzeel W, 2008, AGR SYST, V96, P52, DOI 10.1016/j.agsy.2007.05.005; *INT ASS AGR SCI T, 2009, GLOB REP; IPCC, 2007, CONTRIBUTION WORKING; Kiers ET, 2008, SCIENCE, V320, P320, DOI 10.1126/science.1158390; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SC, V2; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Perry B, 2007, SCIENCE, V315, P333, DOI 10.1126/science.1138614; ROSEGRANT M, 2009, AGR CROSSROADS; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; The Royal Society, 2009, 1109 RS; Tittonell P, 2009, AGR SYST, V101, P1, DOI 10.1016/j.agsy.2009.02.003; United Nations Environment Programme, 2007, GLOB ENV OUTL; Waithaka MM, 2006, AGR SYST, V90, P243, DOI 10.1016/j.agsy.2005.12.007; Wani S.P., 2009, RAINFED AGR UNLOCKIN; World Bank, 2008, INT TRADE CLIMATE CH	29	482	501	16	319	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					822	825		10.1126/science.1183725	http://dx.doi.org/10.1126/science.1183725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150490	Green Accepted			2022-12-28	WOS:000274408300047
J	Pickup, DJ				Pickup, David J.			Propelling Progeny	SCIENCE			English	Editorial Material							ACTIN-BASED MOTILITY; EXTRACELLULAR ENVELOPED VIRUS; VACCINIA VIRUS; IN-VITRO; NEUTRALIZATION; DISSEMINATION		Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Pickup, DJ (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	picku001@mc.duke.edu						Bell E, 2004, VIROLOGY, V325, P425, DOI 10.1016/j.virol.2004.05.004; Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Berhanu A, 2009, ANTIMICROB AGENTS CH, V53, P4999, DOI 10.1128/AAC.00678-09; BLASCO R, 1992, J VIROL, V66, P4170, DOI 10.1128/JVI.66.7.4170-4179.1992; Chahroudi A, 2005, J VIROL, V79, P10397, DOI 10.1128/JVI.79.16.10397-10407.2005; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Dodding MP, 2009, CELL HOST MICROBE, V6, P536, DOI 10.1016/j.chom.2009.10.011; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Law M, 2001, VIROLOGY, V280, P132, DOI 10.1006/viro.2000.0750; PAYNE LG, 1980, J GEN VIROL, V50, P89, DOI 10.1099/0022-1317-50-1-89; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037	15	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					787	788		10.1126/science.1187160	http://dx.doi.org/10.1126/science.1187160			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150470				2022-12-28	WOS:000274408300026
J	Malekpour, M; Esfandbod, M				Malekpour, Mahdi; Esfandbod, Mohsen			Cutaneous Leishmaniasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Malekpour, Mahdi; Esfandbod, Mohsen] Univ Tehran Med Sci, Tehran, Iran	Tehran University of Medical Sciences	Malekpour, M (corresponding author), Univ Tehran Med Sci, Tehran, Iran.	sfandbod@sina.tums.ac.ir	Malekpour, Mahdi/B-6174-2009	Malekpour, Mahdi/0000-0002-7337-3479; Esfandbod, Mohsen/0000-0002-6497-2306					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					E15	E15		10.1056/NEJMicm0808917	http://dx.doi.org/10.1056/NEJMicm0808917			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147710				2022-12-28	WOS:000274397200012
J	Miyagoshi, T; Kageyama, A; Sato, T				Miyagoshi, Takehiro; Kageyama, Akira; Sato, Tetsuya			Zonal flow formation in the Earth's core	NATURE			English	Article							DEEP CONVECTION; RAYLEIGH NUMBER; DRIVEN; FIELD; JETS	Zonal jets are very common in nature. Well-known examples are those in the atmospheres of giant planets and the alternating jet streams found in the Earth's world ocean(1). Zonal flow formation in nuclear fusion devices is also well studied(2). A common feature of these zonal flows is that they are spontaneously generated in turbulent systems. Because the Earth's outer core is believed to be in a turbulent state, it is possible that there is zonal flow in the liquid iron of the outer core. Here we report an investigation at the current low-viscosity limit of numerical simulations of the geodynamo. We find a previously unknown convection regime of the outer core that has a dual structure comprising inner, sheet-like radial plumes and an outer, westward cylindrical zonal flow. We numerically confirm that the dual-convection structure with such a zonal flow is stable under a strong, self-generated dipole magnetic field.	[Kageyama, Akira] Kobe Univ, Grad Sch Engn, Kobe, Hyogo 6578501, Japan; [Miyagoshi, Takehiro] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa 2360001, Japan; [Sato, Tetsuya] Univ Hyogo, Kobe, Hyogo 6500044, Japan	Kobe University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Hyogo	Kageyama, A (corresponding author), Kobe Univ, Grad Sch Engn, Kobe, Hyogo 6578501, Japan.	kage@cs.kobe-u.ac.jp	Kageyama, Akira/H-4537-2013	Kageyama, Akira/0000-0003-0433-668X; Miyagoshi, Takehiro/0000-0002-8908-9990	KAKENHI [17540404]; Mitsubishi Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Foundation	This work was supported by KAKENHI (17540404) and The Mitsubishi Foundation.	Aubert J, 2001, PHYS EARTH PLANET IN, V128, P51, DOI 10.1016/S0031-9201(01)00277-1; Aurnou JM, 2007, GEOPHYS ASTRO FLUID, V101, P327, DOI 10.1080/03091920701472568; Aurnou JM, 2004, ICARUS, V169, P492, DOI 10.1016/j.icarus.2004.01.013; Busse FH, 2002, PHYS FLUIDS, V14, P1301, DOI 10.1063/1.1455626; CHESSHIRE G, 1990, J COMPUT PHYS, V90, P1, DOI 10.1016/0021-9991(90)90196-8; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Christensen UR, 2008, NATURE, V454, P1058, DOI 10.1038/4541058a; Christensen UR, 2001, GEOPHYS RES LETT, V28, P2553, DOI 10.1029/2000GL012643; DIAMOND PH, 2005, PLASMA PHYS CONTR F, V35, pR161; Gillet N, 2007, J FLUID MECH, V580, P83, DOI 10.1017/S0022112007005265; GILMAN PA, 1981, ASTROPHYS J SUPPL S, V45, P335, DOI 10.1086/190714; Habata S, 2003, NEC RES DEV, V44, P21; Heimpel M, 2005, NATURE, V438, P193, DOI 10.1038/nature04208; Jones CA, 2000, PHILOS T R SOC A, V358, P873, DOI 10.1098/rsta.2000.0565; Kageyama A, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000734; Kageyama A, 1997, PHYS REV E, V55, P4617, DOI 10.1103/PhysRevE.55.4617; KAGEYAMA A, 2004, P ACM IEEE SC2004 C, P35, DOI DOI 10.1109/SC.2004.1; Kageyama A, 2008, NATURE, V454, P1106, DOI 10.1038/nature07227; Kono M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000102; Kono M, 2001, PHYS EARTH PLANET IN, V128, P13, DOI 10.1016/S0031-9201(01)00274-6; Maximenko NA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022728; MOFFAT HK, 1978, MAGNETIC FIELD GENER, P36; Olson P, 2006, EARTH PLANET SC LETT, V250, P561, DOI 10.1016/j.epsl.2006.08.008; Roberts PH, 2000, REV MOD PHYS, V72, P1081, DOI 10.1103/RevModPhys.72.1081; Sumita I, 2000, PHYS EARTH PLANET IN, V117, P153, DOI 10.1016/S0031-9201(99)00094-1; SUN ZP, 1993, SCIENCE, V260, P661, DOI 10.1126/science.260.5108.661	26	43	44	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					793	U102		10.1038/nature08754	http://dx.doi.org/10.1038/nature08754			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148036				2022-12-28	WOS:000274394300036
J	Mostertz, W; Stevenson, M; Acharya, C; Chan, I; Walters, K; Lamlertthon, W; Barry, W; Crawford, J; Nevins, J; Potti, A				Mostertz, William; Stevenson, Marvaretta; Acharya, Chaitanya; Chan, Isaac; Walters, Kelli; Lamlertthon, Wisut; Barry, William; Crawford, Jeffrey; Nevins, Joseph; Potti, Anil			Age- and Sex-Specific Genomic Profiles in Non-Small Cell Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENE-EXPRESSION PROFILES; BREAST-CANCER; ADENOCARCINOMA; SIGNATURES; SURVIVAL; WOMEN; EPIDEMIOLOGY; PROGNOSIS; THERAPY; CLASSIFICATION	Context Gene expression profiling may be useful in examining differences underlying age- and sex-specific outcomes in non-small cell lung cancer (NSCLC). Objective To describe clinically relevant differences in the underlying biology of NSCLC based on patient age and sex. Design, Setting, and Patients Retrospective analysis of 787 patients with predominantly early stage NSCLC performed at Duke University, Durham, North Carolina, from July 2008 to June 2009. Lung tumor samples with corresponding microarray and clinical data were used. All patients were divided into subgroups based on age (<70 vs >= 70 years old) or sex. Gene expression signatures representing oncogenic pathway activation and tumor biology/microenvironment status were applied to these samples to obtain patterns of activation/deregulation. Main Outcome Measures Patterns of oncogenic and molecular signaling pathway activation that are reproducible and correlate with 5-year recurrence-free patient survival. Results Low-and high-risk patient clusters/cohorts were identified with the longest and shortest 5-year recurrence-free survival, respectively, within the age and sex NSCLC subgroups. These cohorts of NSCLC demonstrate similar patterns of pathway activation. In patients younger than 70 years, high-risk patients, with the shortest recurrence-free survival, demonstrated increased activation of the Src (25% vs 6%; P<.001) and tumor necrosis factor (76% vs 42%; P<.001) pathways compared with low-risk patients. High-risk patients aged 70 years or older demonstrated increased activation of the wound healing (40% vs 24%; P=.02) and invasiveness (64% vs 20%; P<.001) pathways compared with low-risk patients. In women, high-risk patients demonstrated increased activation of the invasiveness (99% vs 2%; P<.001) and STAT3 (72% vs 35%; P<.001) pathways while high-risk men demonstrated increased activation of the STAT3 (87% vs 18%; P<.001), tumor necrosis factor (90% vs 46%; P<.001), EGFR (13% vs 2%; P=.003), and wound healing (50% vs 22%; P<.001) pathways. Multivariate analyses confirmed the independent clinical relevance of the pathway-based subphenotypes in women (hazard ratio [HR], 2.02; 95% confidence interval [CI], 1.34-3.03; P<.001) and patients younger than 70 years (HR, 1.83; 95% CI, 1.24-2.71; P=.003). All observations were reproducible in split sample analyses. Conclusions Among a cohort of patients with NSCLC, subgroups defined by oncogenic pathway activation profiles were associated with recurrence-free survival. These findings require validation in independent patient data sets. JAMA. 2010; 303(6): 535-543	[Mostertz, William; Stevenson, Marvaretta; Acharya, Chaitanya; Chan, Isaac; Walters, Kelli; Lamlertthon, Wisut; Nevins, Joseph; Potti, Anil] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Stevenson, Marvaretta; Crawford, Jeffrey; Potti, Anil] Duke Univ, Div Oncol, Dept Med, Durham, NC 27708 USA; [Barry, William] Duke Univ, Dept Computat Biol & Bioinformat, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Potti, A (corresponding author), Duke Univ, Inst Genome Sci & Policy, Box 3382,101 Sci Dr, Durham, NC 27708 USA.	anil.potti@duke.edu	Acharya, Chaitanya/T-3510-2019	Chan, Isaac/0000-0003-2623-3163	Emilene Brown Cancer Research Fund; Harold and Linda Chapman Lung Cancer Fund; Jimmy V Foundation; American Cancer Society; National Cancer Institute	Emilene Brown Cancer Research Fund; Harold and Linda Chapman Lung Cancer Fund; Jimmy V Foundation; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by research grants from the Emilene Brown Cancer Research Fund, the Harold and Linda Chapman Lung Cancer Fund, the Jimmy V Foundation, the American Cancer Society, and the National Cancer Institute.	Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cerfolio RJ, 2006, CHEST, V130, P1796, DOI 10.1378/chest.130.6.1796; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; de Perrot M, 2000, J THORAC CARDIOV SUR, V119, P21, DOI 10.1016/S0022-5223(00)70213-3; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; GARST JDM, 2008, AM SOC CLIN ONC ANN; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Johnson DG, 2006, CURR MOL MED, V6, P731; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Minna JD, 2004, SCIENCE, V304, P1458, DOI 10.1126/science.1099578; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Pauk N, 2005, LUNG CANCER, V48, P1, DOI 10.1016/j.lungcan.2004.10.009; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Ries L MD, 2008, SEER CANC STAT REV 1; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941	38	41	42	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					535	543		10.1001/jama.2010.80	http://dx.doi.org/10.1001/jama.2010.80			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145230	Bronze			2022-12-28	WOS:000274378700025
J	Ratner, TJ				Ratner, Terry J.			The Changing of the Seasons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tjrwriter@aol.com							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					493	494		10.1001/jama.2010.84	http://dx.doi.org/10.1001/jama.2010.84			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145216				2022-12-28	WOS:000274378700001
J	Florman, HM; Jungnickel, MK; Sutton, KA				Florman, Harvey M.; Jungnickel, Melissa K.; Sutton, Keith A.			Shedding Light on Sperm pHertility	CELL			English	Editorial Material							SOLUBLE ADENYLYL-CYCLASE; EXPRESSION		[Florman, Harvey M.; Jungnickel, Melissa K.; Sutton, Keith A.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Florman, HM (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	harvey.florman@umassmed.edu	Sutton, Keith/AAI-2185-2020					Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; FLORMAN HM, 2006, PHYSL REPROD, P55; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Sutton KA, 2008, P NATL ACAD SCI USA, V105, P8661, DOI 10.1073/pnas.0800603105; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104	9	21	22	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					310	312		10.1016/j.cell.2010.01.035	http://dx.doi.org/10.1016/j.cell.2010.01.035			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144756	Bronze			2022-12-28	WOS:000274297700009
J	Tu, WH; Xu, X; Peng, LS; Zhong, XF; Zhang, WF; Soundarapandian, MM; Balel, C; Wang, MQ; Jia, NL; Zhang, W; Lew, F; Chan, SL; Chen, YF; Lu, YM				Tu, Weihong; Xu, Xin; Peng, Lisheng; Zhong, Xiaofen; Zhang, Wenfeng; Soundarapandian, Mangala M.; Balel, Cherine; Wang, Manqi; Jia, Nali; Zhang, Wen; Lew, Frank; Chan, Sic Lung; Chen, Yanfang; Lu, Youming			DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke	CELL			English	Article							PROTEIN-KINASE-II; CELL-DEATH; IN-VIVO; HIPPOCAMPAL-NEURONS; FOREBRAIN ISCHEMIA; GLUTAMATE RELEASE; ION CHANNELS; ACTIVATION; NEURODEGENERATION; CALMODULIN	N-methyl-D-aspartate (NMDA) receptors constitute a major subtype of glutamate receptors at extra-synaptic sites that link multiple intracellular catabolic processes responsible for irreversible neuronal death. Here, we report that cerebral ischemia recruits death-associated protein kinase 1 (DAPK1) into the NMDA receptor NR2B protein complex in the cortex of adult mice. DAPK1 directly binds with the NMDA receptor NR2B C-terminal tail consisting of amino acid 1292-1304 (NR2BCT). A constitutively active DAPK1 phosphorylates NR2B subunit at Ser-1303 and in turn enhances the NR1/NR2B receptor channel conductance. Genetic deletion of DAPK1 or administration of NR2BCT that uncouples an activated DAPK1 from an NMDA receptor NR2B subunit in vivo in mice blocks injurious Ca2+ influx through NMDA receptor channels at extrasynaptic sites and protects neurons against cerebral ischemic insults. Thus, DAPK1 physically and functionally interacts with the NMDA receptor NR2B subunit at extrasynaptic sites and this interaction acts as a central mediator for stroke damage.	[Tu, Weihong; Xu, Xin; Peng, Lisheng; Zhong, Xiaofen; Wang, Manqi; Jia, Nali; Zhang, Wen; Lu, Youming] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Neurol, New Orleans, LA 70112 USA; [Tu, Weihong; Xu, Xin; Peng, Lisheng; Zhong, Xiaofen; Wang, Manqi; Jia, Nali; Zhang, Wen; Lu, Youming] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Ctr Neurosci, New Orleans, LA 70112 USA; [Tu, Weihong; Soundarapandian, Mangala M.; Balel, Cherine; Lew, Frank; Chan, Sic Lung; Lu, Youming] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomed Sci Ctr, Orlando, FL 32816 USA; [Zhang, Wenfeng; Chen, Yanfang] Wright State Univ, Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; State University System of Florida; University of Central Florida; University System of Ohio; Wright State University Dayton	Lu, YM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Neurol, New Orleans, LA 70112 USA.	ylu1@lsuhsc.edu	Zhang, Wen/O-4354-2019; Zhang, Wen/B-2671-2009; Xu, Xin/E-2076-2014	Zhang, Wen/0000-0001-5166-0736; Zhang, Wen/0000-0001-5166-0736; 	American Heart Association [05553413YL, 0535201YC, 0625532 XZ]; National Institute of Health [R01NS5051383YL, R01AG033282YL]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033282] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the American Heart Association (05553413YL; 0535201YC; and 0625532 XZ), National Institute of Health (NIH/NINDS, R01NS5051383YL and NIH/NIA R01AG033282YL). We thank Ryan Labadens at the Neuroscience Center of Excellence, Louisiana State University School of Medicine Health Sciences Center, and for assistance in manuscript preparation and discussion.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Brickley SG, 2003, J NEUROSCI, V23, P4958; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; Gardoni F, 2002, EUR J NEUROSCI, V16, P777, DOI 10.1046/j.1460-9568.2002.02141.x; Ghosh A, 2002, SCIENCE, V295, P449, DOI 10.1126/science.1069391; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; HANSON SK, 1994, STROKE, V25, P466, DOI 10.1161/01.STR.25.2.466; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Petersen JD, 2003, J NEUROSCI, V23, P11270; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schumacher AM, 2004, BIOCHEMISTRY-US, V43, P8116, DOI 10.1021/bi049589v; Shohat G, 2001, J BIOL CHEM, V276, P47460, DOI 10.1074/jbc.M105133200; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Sun MK, 2008, P NATL ACAD SCI USA, V105, P13620, DOI 10.1073/pnas.0805952105; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Van Eldik LJ, 2002, TRENDS PHARMACOL SCI, V23, P302, DOI 10.1016/S0165-6147(02)02049-7; Velentza AV, 2001, J BIOL CHEM, V276, P38956, DOI 10.1074/jbc.M104273200; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wang J, 2003, J NEUROSCI, V23, P826; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	51	338	366	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					222	234		10.1016/j.cell.2009.12.055	http://dx.doi.org/10.1016/j.cell.2009.12.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141836	Green Accepted, Bronze			2022-12-28	WOS:000273826500013
J	Merin, O; Ash, N; Levy, G; Schwaber, MJ; Kreiss, Y				Merin, Ofer; Ash, Nachman; Levy, Gad; Schwaber, Mitchell J.; Kreiss, Yitshak			The Israeli Field Hospital in Haiti -- Ethical Dilemmas in Early Disaster Response.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Merin, Ofer] Shaare Zedek Med Ctr, Trauma Unit, Jerusalem, Israel; [Merin, Ofer] Shaare Zedek Med Ctr, Dept Cardiothorac Surg, Jerusalem, Israel; [Merin, Ofer] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Merin, Ofer; Levy, Gad; Schwaber, Mitchell J.; Kreiss, Yitshak] Israel Def Forces Med Corps Field Hosp, Tel Hashomer, Israel; [Ash, Nachman] Israel Def Forces Off Surg Gen, Tel Hashomer, Israel; [Levy, Gad] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Radiol, IL-69978 Tel Aviv, Israel; [Schwaber, Mitchell J.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Consultat Med, IL-69978 Tel Aviv, Israel; [Schwaber, Mitchell J.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel; [Schwaber, Mitchell J.] Israel Minist Hlth, Natl Ctr Infect Control, Tel Aviv, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Merin, O (corresponding author), Shaare Zedek Med Ctr, Trauma Unit, Jerusalem, Israel.		Ash, Nachman/ABC-2961-2020; Schwaber, Mitchell/AAI-2486-2019						0	88	89	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMp1001693	http://dx.doi.org/10.1056/NEJMp1001693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20200362				2022-12-28	WOS:000275650400006
J	Buve, A; Lynen, L				Buve, Anne; Lynen, Lutgarde			Treating HIV infection with drugs for HSV-2 infection?	LANCET			English	Editorial Material							TRIMETHOPRIM-SULFAMETHOXAZOLE; COTE-DIVOIRE; ACYCLOVIR; THERAPY; WOMEN; TUBERCULOSIS; TRANSMISSION; EFFICACY; ABIDJAN; PLASMA		[Buve, Anne] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium; [Lynen, Lutgarde] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Buve, A (corresponding author), Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium.	abuve@itg.be	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895				Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; *CAMP ACC ESS MED, 2009, PUN SUCC EARL SIGNS; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Ioannidis JPA, 1998, J INFECT DIS, V178, P349, DOI 10.1086/515621; Kumagai H, 2004, BIOFACTORS, V22, P21, DOI 10.1002/biof.5520220103; LINGAPPA JR, 2010, LANCET, DOI DOI 10.1016/50140-6736(09)62038-9; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625; World Health Organization, 2009, RAP ADV ANT THER HIV; Zuckerman RA, 2009, AIDS, V23, P479, DOI 10.1097/QAD.0b013e328326ca62	17	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2010	375	9717					782	784		10.1016/S0140-6736(10)60097-9	http://dx.doi.org/10.1016/S0140-6736(10)60097-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20153889				2022-12-28	WOS:000275682600006
J	Balsari, S; Lemery, J; Williams, TP; Nelson, BD				Balsari, Satchit; Lemery, Jay; Williams, Timothy P.; Nelson, Brett D.			Protecting the Children of Haiti.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Balsari, Satchit; Lemery, Jay; Williams, Timothy P.; Nelson, Brett D.] Harvard Univ, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Nelson, Brett D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Balsari, Satchit; Lemery, Jay] Weill Cornell Med Coll, Div Emergency Med, New York, NY USA	Harvard University; Harvard University; Harvard Medical School; Cornell University	Balsari, S (corresponding author), Harvard Univ, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA.		Nelson, Brett D/I-4218-2014; Nelson, Brett/L-2686-2019	Nelson, Brett D/0000-0002-5049-1798; Nelson, Brett/0000-0002-5049-1798				LEDERER E, 2010, ASS PRESS       0209; Panter-Brick Catherine, 2000, ABANDONED CHILDREN; SEQUERA V, 2010, ASS PRESS       0127; Shahinian G, 2009, REPORT SPECIAL RAPPO	4	26	26	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9								10.1056/NEJMp1001820	http://dx.doi.org/10.1056/NEJMp1001820			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20164477	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000275108300004
J	Briel, M; Meade, M; Mercat, A; Brower, RG; Talmor, D; Walter, SD; Slutsky, AS; Pullenayegum, E; Zhou, Q; Cook, D; Brochard, L; Richard, JCM; Lamontagne, F; Bhatnagar, N; Stewart, TE; Guyatt, G				Briel, Matthias; Meade, Maureen; Mercat, Alain; Brower, Roy G.; Talmor, Daniel; Walter, Stephen D.; Slutsky, Arthur S.; Pullenayegum, Eleanor; Zhou, Qi; Cook, Deborah; Brochard, Laurent; Richard, Jean-Christophe M.; Lamontagne, Francois; Bhatnagar, Neera; Stewart, Thomas E.; Guyatt, Gordon			Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL VENTILATION; RANDOMIZED-TRIALS; TIDAL VOLUME; APACHE-II; RECRUITMENT; STRATEGY; OUTCOMES; MORTALITY; MODELS	Context Trials comparing higher vs lower levels of positive end-expiratory pressure (PEEP) in adults with acute lung injury or acute respiratory distress syndrome ( ARDS) have been underpowered to detect small but potentially important effects on mortality or to explore subgroup differences. Objectives To evaluate the association of higher vs lower PEEP with patient-important outcomes in adults with acute lung injury or ARDS who are receiving ventilation with low tidal volumes and to investigate whether these associations differ across prespecified subgroups. Data Sources Search of MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (1996-January 2010) plus a hand search of conference proceedings (2004-January 2010). Study Selection Two reviewers independently screened articles to identify studies randomly assigning adults with acute lung injury or ARDS to treatment with higher vs lower PEEP ( with low tidal volume ventilation) and also reporting mortality. Data Extraction Data from 2299 individual patients in 3 trials were analyzed using uniform outcome definitions. Prespecified effect modifiers were tested using multivariable hierarchical regression, adjusting for important prognostic factors and clustering effects. Results There were 374 hospital deaths in 1136 patients (32.9%) assigned to treatment with higher PEEP and 409 hospital deaths in 1163 patients (35.2%) assigned to lower PEEP ( adjusted relative risk [RR], 0.94; 95% confidence interval [CI], 0.86-1.04; P=.25). Treatment effects varied with the presence or absence of ARDS, defined by a value of 200 mm Hg or less for the ratio of partial pressure of oxygen to fraction of inspired oxygen concentration (P=.02 for interaction). In patients with ARDS (n=1892), there were 324 hospital deaths (34.1%) in the higher PEEP group and 368 (39.1%) in the lower PEEP group ( adjusted RR, 0.90; 95% CI, 0.81-1.00; P=.049); in patients without ARDS (n=404), there were 50 hospital deaths (27.2%) in the higher PEEP group and 44 (19.4%) in the lower PEEP group (adjusted RR, 1.37; 95% CI, 0.98-1.92; P=.07). Rates of pneumothorax and vasopressor use were similar. Conclusions Treatment with higher vs lower levels of PEEP was not associated with improved hospital survival. However, higher levels were associated with improved survival among the subgroup of patients with ARDS. JAMA. 2010; 303(9):865-873 www.jama.com	[Briel, Matthias; Meade, Maureen; Walter, Stephen D.; Pullenayegum, Eleanor; Zhou, Qi; Cook, Deborah; Lamontagne, Francois; Bhatnagar, Neera; Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; [Mercat, Alain] Univ Hosp Angers, Angers, France; [Brower, Roy G.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA; [Talmor, Daniel] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA; [Talmor, Daniel] Harvard Univ, Sch Med, Boston, MA USA; [Slutsky, Arthur S.; Stewart, Thomas E.] Univ Toronto, Toronto, ON, Canada; [Brochard, Laurent] Univ Hosp Albert Chenevier Henri Mondor, INSERM, Unit 955, Med ICU, Creteil, France; [Brochard, Laurent] Univ Paris Est, Creteil, France; [Richard, Jean-Christophe M.] Univ Hosp Charles Nicolle, Rouen, France; [Richard, Jean-Christophe M.] UPRES EA Unit 3830, Rouen, France; [Lamontagne, Francois] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	McMaster University; University of Basel; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHU de Rouen; University of Sherbrooke	Meade, M (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Room 2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	meadema@hhsc.ca	Briel, Matthias/AAT-9284-2021; Bhatnagar, Neera/B-8004-2013; Pullenayegum, Eleanor/AAT-1712-2020; Zhou, Qi/GSM-9583-2022; Walter, Stephen/AAB-5548-2022; Mercat, Alain/AFU-4426-2022; Slutsky, Arthur/M-3325-2019	Bhatnagar, Neera/0000-0002-5060-5257; Pullenayegum, Eleanor/0000-0003-4265-1330; Walter, Stephen/0000-0003-4157-8928; Briel, Matthias/0000-0002-2070-5230	Canadian Intensive Care Foundation; Swiss National Science Foundation [PASMA-112951/1]; Roche Research Foundation	Canadian Intensive Care Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation	The study was funded in part by a grant from the Canadian Intensive Care Foundation. Dr Briel is supported by a scholarship from the Swiss National Science Foundation (PASMA-112951/1) and the Roche Research Foundation. Dr Cook is a Canada Research Chair of the Canadian Institutes for Health Research.	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Beck DH, 2003, INTENS CARE MED, V29, P249, DOI 10.1007/s00134-002-1607-9; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bernard GR, 1997, SEPSIS, V1, P43, DOI DOI 10.1023/A:1009711301483; Brower RG, 2004, NEW ENGL J MED, V351, P327; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Gattinoni L, 2008, JAMA-J AM MED ASSOC, V299, P691, DOI 10.1001/jama.299.6.691; Gordo-Vidal F, 2008, MED INTENSIVA, V32, P316, DOI 10.1016/S0210-5691(08)70962-8; Gordo-Vidal F., 2007, Med. Intensiva, V31, P491; Guyatt G, 2008, USERS GUIDES MED LIT; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, PLOS MED, V5, P3, DOI 10.1371/journal.pmed.0050004; Halter JM, 2007, CRIT CARE, V11, DOI 10.1186/cc5695; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Koopman L, 2007, J CLIN EPIDEMIOL, V60, P1002, DOI 10.1016/j.jclinepi.2007.01.018; Kumar A, 1973, Crit Care Med, V1, P181, DOI 10.1097/00003246-197307000-00001; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Phoenix SI, 2009, ANESTHESIOLOGY, V110, P1098, DOI 10.1097/ALN.0b013e31819fae06; Pinsky MR, 1997, INTENS CARE MED, V23, P493, DOI 10.1007/s001340050364; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; RUBIN DB, 2002, STAT ANAL MISSING DA, P35; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Snijders T.A., 1999, MULTILEVEL ANAL INTR, P41; Suistomaa M, 2002, INTENS CARE MED, V28, P479, DOI 10.1007/s00134-002-1214-9; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Toth I, 2007, CRIT CARE MED, V35, P787, DOI 10.1097/01.CCM.0000257330.54882.BE; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Villar J, 2007, AM J RESP CRIT CARE, V176, P795, DOI 10.1164/rccm.200610-1534OC	37	901	963	3	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					865	873		10.1001/jama.2010.218	http://dx.doi.org/10.1001/jama.2010.218			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197533	Bronze			2022-12-28	WOS:000275059500020
J	Brookhart, MA; Schneeweiss, S; Avorn, J; Bradbury, BD; Liu, J; Winkelmayer, WC				Brookhart, M. Alan; Schneeweiss, Sebastian; Avorn, Jerry; Bradbury, Brian D.; Liu, Jun; Winkelmayer, Wolfgang C.			Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; INTRAVENOUS IRON THERAPY; STAGE RENAL-DISEASE; EPOETIN-ALPHA; HEMATOCRIT VALUES; HEMOGLOBIN LEVELS; SURVIVAL; HOSPITALIZATION; RESPONSIVENESS; AMELIORATION	Context Controversy exists about optimal management of anemia in end-stage renal disease. Objective To compare the mortality risk of different dialysis center-level patterns of anemia management. Design, Setting, and Patients Using data from Medicare's end-stage renal disease program (1999-2007), we characterized each US dialysis center's annual anemia management practice by estimating its typical use of erythropoiesis-stimulating agents (ESAs) and intravenous iron in hemodialysis patients within 4 hematocrit categories. We used Cox proportional hazards regression to correlate center-level patterns of ESA and iron use with 1-year mortality risk in 269 717 incident hemodialysis patients. Main Outcome Measure One-year all-cause mortality. Results Monthly mortality rates were highest in patients with hematocrit less than 30% (mortality, 2.1%) and lowest for those with hematocrit of 36% or higher (mortality, 0.7%). After adjustment for baseline case-mix differences, dialysis centers that used larger ESA doses in patients with hematocrit less than 30% had lower mortality rates than centers that used smaller doses (highest vs lowest dose group: hazard ratio [HR], 0.94; 95% confidence interval [ CI], 0.90-0.97). Centers that administered iron more frequently to patients with hematocrit less than 33% also had lower mortality rates (highest vs lowest quintile, HR, 0.95; 95% CI, 0.91-0.98). However, centers that used larger ESA doses in patients with hematocrit between 33% and 35.9% had higher mortality rates ( highest vs lowest quintile, HR, 1.07; 95% CI, 1.03-1.12). More intensive use of both ESAs and iron was associated with increased mortality risk in patients with hematocrit of 36% or higher. These findings persisted across a range of secondary analyses. Conclusions Greater ESA and iron use were associated with decreased mortality risk at lower hematocrit levels, in which mortality rates are the highest. Although the overall mortality rate was lower at higher hematocrit levels, elevated mortality risk was associated with greater use of ESAs and iron in these patients. JAMA. 2010;303(9):857-864 www.jama.com	[Winkelmayer, Wolfgang C.] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA; [Brookhart, M. Alan] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Brookhart, M. Alan; Schneeweiss, Sebastian; Avorn, Jerry; Liu, Jun; Winkelmayer, Wolfgang C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02115 USA; [Bradbury, Brian D.] Amgen Inc, Dept Biostat & Epidemiol, Thousand Oaks, CA 91320 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Amgen	Winkelmayer, WC (corresponding author), Stanford Univ, Sch Med, Div Nephrol, 780 Welch Rd,Ste 106, Palo Alto, CA 94304 USA.	wcw1@stanford.edu	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	National Institute on Aging [AG-027400]; American Heart Association; Satellite Healthcare Inc; National Institutes of Health; NATIONAL INSTITUTE ON AGING [K25AG027400] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); Satellite Healthcare Inc; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by an investigator-initiated contract from Amgen to Brigham and Women's Hospital that placed no restrictions on publications. Dr Brookhart is supported by a career development award from the National Institute on Aging (grant AG-027400). Dr Winkelmayer has received support including a Scientist Development Grant from the American Heart Association, a Norman S. Coplon Extramural Research Program Award from Satellite Healthcare Inc, support from the National Institutes of Health for unrelated projects.	Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Bradbury BD, 2008, AM J KIDNEY DIS, V51, P62, DOI 10.1053/j.ajkd.2007.09.015; Bradbury BD, 2009, PHARMACOEPIDEM DR S, V18, P932, DOI 10.1002/pds.1799; Bradbury BD, 2009, AM J KIDNEY DIS, V54, P554, DOI 10.1053/j.ajkd.2009.05.010; Bradbury BD, 2009, CLIN J AM SOC NEPHRO, V4, P630, DOI 10.2215/CJN.03580708; Bradbury BD, 2009, NEPHROL DIAL TRANSPL, V24, P919, DOI 10.1093/ndt/gfn543; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brewster UC, 2004, SEMIN DIALYSIS, V17, P57; Brewster UC, 2006, SEMIN DIALYSIS, V19, P285, DOI 10.1111/j.1525-139X.2006.00174.x; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; Bullen JJ, 2005, FEMS IMMUNOL MED MIC, V43, P325, DOI 10.1016/j.femsim.2004.11.010; CANNELLA G, 1991, NEPHROL DIAL TRANSPL, V6, P31, DOI 10.1093/ndt/6.1.31; Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465; Collins AJ, 1998, J AM SOC NEPHROL, V9, P2108; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; Faich G, 1999, AM J KIDNEY DIS, V33, P464, DOI 10.1016/S0272-6386(99)70183-6; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Feldman HI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133734; Fletes R, 2001, AM J KIDNEY DIS, V37, P743, DOI 10.1016/S0272-6386(01)80123-2; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Johnston SC, 2000, J CLIN EPIDEMIOL, V53, P1236, DOI 10.1016/S0895-4356(00)00251-1; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; KAUPKE CJ, 1993, J AM SOC NEPHROL, V3, P1672; Kilpatrick RD, 2008, CLIN J AM SOC NEPHRO, V3, P1077, DOI 10.2215/CJN.04601007; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; MACDOUGALL IC, 1990, LANCET, V335, P489, DOI 10.1016/0140-6736(90)90733-L; Ofsthun N, 2003, KIDNEY INT, V63, P1908, DOI 10.1046/j.1523-1755.2003.00937.x; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Reddan DN, 2003, NEPHROL DIAL TRANSPL, V18, P147, DOI 10.1093/ndt/18.1.147; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Singh Ajay K, 2007, Nephrol News Issues, V21, P55; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Singh AK, 2010, J AM SOC NEPHROL, V21, P2, DOI 10.1681/ASN.2009111127; SINGH AK, 2007, NEPHROL NEWS ISSUES, V21, P58; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Tentori F, 2009, NEPHROL DIAL TRANSPL, V24, P963, DOI 10.1093/ndt/gfn592; Thamer M, 2007, JAMA-J AM MED ASSOC, V297, P1667, DOI 10.1001/jama.297.15.1667; Unger EF, 2010, NEW ENGL J MED, V362, P189, DOI 10.1056/NEJMp0912328; United States Food and Drug Administration, FDA PUBL HLTH ADV ER; *US REN DAT SYST, 2007, 2004 ANN DAT REP ATL; Vaziri ND, 1999, AM J KIDNEY DIS, V33, P821, DOI 10.1016/S0272-6386(99)70413-0; Vaziri ND, 2001, CURR OPIN NEPHROL HY, V10, P633, DOI 10.1097/00041552-200109000-00013; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; WIZEMANN V, 1992, NEPHRON, V62, P161, DOI 10.1159/000187026; Wolfe RA, 2005, AM J KIDNEY DIS, V45, P127, DOI 10.1053/j.ajkd.2004.09.023; Xia H, 1999, J AM SOC NEPHROL, V10, P1309; Zhang Y, 2004, AM J KIDNEY DIS, V44, P866, DOI 10.1053/j.ajkd.2004.08.002; Zhang Y, 2009, CLIN J AM SOC NEPHRO, V4, P638, DOI 10.2215/CJN.05071008; Zhou XJ, 2002, NEPHROL DIAL TRANSPL, V17, P992, DOI 10.1093/ndt/17.6.992	52	85	88	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					857	864		10.1001/jama.2010.206	http://dx.doi.org/10.1001/jama.2010.206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197532	Bronze			2022-12-28	WOS:000275059500019
J	Aaron, HJ				Aaron, Henry J.			Forging Ahead - Embracing the "Reconciliation" Option for Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8								10.1056/NEJMp1001616	http://dx.doi.org/10.1056/NEJMp1001616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559SA	20147704				2022-12-28	WOS:000274845600005
J	Breslow, DK; Collins, SR; Bodenmiller, B; Aebersold, R; Simons, K; Shevchenko, A; Ejsing, CS; Weissman, JS				Breslow, David K.; Collins, Sean R.; Bodenmiller, Bernd; Aebersold, Ruedi; Simons, Kai; Shevchenko, Andrej; Ejsing, Christer S.; Weissman, Jonathan S.			Orm family proteins mediate sphingolipid homeostasis	NATURE			English	Article							GENOME-WIDE ASSOCIATION; SERINE PALMITOYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; YEAST; ASTHMA; METABOLISM; CERAMIDE; SPHINGOSINE-1-PHOSPHATE; ENZYME; GENE	Despite the essential roles of sphingolipids both as structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM genes (known as ORMDL genes in humans)-a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach in Saccharomyces cerevisiae, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.	[Breslow, David K.; Collins, Sean R.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Breslow, David K.; Collins, Sean R.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Breslow, David K.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Breslow, David K.; Collins, Sean R.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Bodenmiller, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Simons, Kai; Shevchenko, Andrej; Ejsing, Christer S.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Ejsing, Christer S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institute for Systems Biology (ISB); University of Zurich; Max Planck Society; University of Southern Denmark	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 1700 4th St, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276; Weissman, Jonathan/0000-0003-2445-670X; Collins, Sean/0000-0002-4276-5840; Simons, Kai/0000-0002-9231-9996; Breslow, David/0000-0003-0245-3348	Deutsche Forschungsgemeinschaft [SFB/TR 13, A1, D1]; EUFP6 PRISM; ETH Zurich; National Heart, Lung, and Blood Institute, National Institute of Health [N01-HV-28179]; SystemsX.ch; Swiss initiative for systems biology; Boehringer Ingelheim Fonds; Swiss National Science Foundation; Howard Hughes Medical Institute; University of California, San Francisco Strategic Asthma Basic Research Center; National Science Foundation; Fannie and John Hertz Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUFP6 PRISM(European Commission); ETH Zurich(ETH Zurich); National Heart, Lung, and Blood Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); SystemsX.ch; Swiss initiative for systems biology; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of California, San Francisco Strategic Asthma Basic Research Center(University of California System); National Science Foundation(National Science Foundation (NSF)); Fannie and John Hertz Foundation; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge A. Falick, S. Zhou and D. King for identification of proteins by mass spectrometry; M. Schuldiner and S. Wang for E- MAP data collection; D. Fiedler and K. Shokat for providing the phosphate-binding acrylamide reagent; E. Griffis and M. D'Ambrosio for assistance with fluorescence microscopy; N. Ingolia for a codon-optimized mCherry-tagging plasmid; E. Burchard and J. Galanter for discussions of asthma genetics; I. Poser and A. Hyman for advice and providing the HeLa-Kyoto cell line; and M. Bassik, G. Brar, V. Denic, A. Frost, N. Ingolia, E. Quan, B. Toyama and other members of the Weissman laboratory for discussions. This work was supported by funding from Deutsche Forschungsgemeinschaft SFB/TR 13 projects A1 ( K. S.) and D1 ( A. S.), EUFP6 PRISM ( K. S.), ETH Zurich ( R. A.), the National Heart, Lung, and Blood Institute, National Institute of Health (N01-HV-28179) ( R. A.), SystemsX.ch, the Swiss initiative for systems biology ( R. A.), the Boehringer Ingelheim Fonds and the Swiss National Science Foundation (B. B.), the Howard Hughes Medical Institute (J. S. W.), the University of California, San Francisco Strategic Asthma Basic Research Center ( J. S. W.), the National Science Foundation Graduate Research Fellowship Program ( D. K. B.) and the Fannie and John Hertz Foundation ( D. K. B.).	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Blagoveshchenskaya A, 2009, MOL BIOSYST, V5, P36, DOI 10.1039/b810979f; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; JIMENEZ CR, 1998, CURRENT PROTOCOLS PR; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Masini E, 2008, J PHARMACOL EXP THER, V324, P548, DOI 10.1124/jpet.107.131565; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Ryan JJ, 2008, DRUG NEWS PERSPECT, V21, P89, DOI 10.1358/dnp.2008.21.2.1188195; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Wu H, 2009, ALLERGY, V64, P629, DOI 10.1111/j.1398-9995.2008.01912.x	50	412	435	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1048	U65		10.1038/nature08787	http://dx.doi.org/10.1038/nature08787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182505	Green Accepted, Green Submitted			2022-12-28	WOS:000275108400029
J	Smith, DJ; Ghaemi, N				Smith, Daniel J.; Ghaemi, Nassir			Is underdiagnosis the main pitfall when diagnosing bipolar disorder? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIDEPRESSANTS		[Smith, Daniel J.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Ghaemi, Nassir] Tufts Univ, Sch Med, Boston, MA 02111 USA	Cardiff University; Tufts University	Smith, DJ (corresponding author), Cardiff Univ, Sch Med, Cardiff, S Glam, Wales.	smithdj3@cardiff.ac.uk	Ghaemi, Nassir/J-4934-2013		Medical Research Council [G0801418B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Albanese Mark J, 2006, J Psychiatr Pract, V12, P124, DOI 10.1097/00131746-200603000-00010; ANTHONY JC, 1985, ARCH GEN PSYCHIAT, V42, P667; Chen PFM, 2001, SURGERY, V130, P578, DOI 10.1067/msy.2001.116906; CHILAKAMARRI JK, PSYCHIATR A IN PRESS; Cooper J.E., 1972, PSYCHIAT DIAGNOSIS N; DOHRENWEND BP, 1990, PSYCHOL MED, V20, P195, DOI 10.1017/S0033291700013374; Ghaemi SN, 1999, J AFFECT DISORDERS, V52, P135, DOI 10.1016/S0165-0327(98)00076-7; Ghaemi SN, 2000, J CLIN PSYCHIAT, V61, P804, DOI 10.4088/JCP.v61n1013; Goldberg JF, 2008, J CLIN PSYCHIAT, V69, P1792, DOI 10.4088/JCP.v69n1110; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Goodwin GM, 2007, BRIT J PSYCHIAT, V191, P189, DOI 10.1192/bjp.bp.107.036343; Jones R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3058; Lopez OL, 1999, NEUROLOGY, V53, P1292, DOI 10.1212/WNL.53.6.1292; Mealey FH, 2007, AM J MED, V120, P760, DOI 10.1016/j.amjmed.2006.10.015; Pogge DL, 2001, PSYCHIAT RES, V101, P47, DOI 10.1016/S0165-1781(00)00248-1; POPE HG, 1978, ARCH GEN PSYCHIAT, V35, P811; Stewart C, 2007, BIPOLAR DISORD, V9, P646, DOI 10.1111/j.1399-5618.2007.00465.x; Zimmerman M, 2008, J CLIN PSYCHIAT, V69, P935, DOI 10.4088/JCP.v69n0608	18	21	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2010	340								c854	10.1136/bmj.c854	http://dx.doi.org/10.1136/bmj.c854			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	561TE	20176701				2022-12-28	WOS:000275001000013
J	Bingol, B; Wang, CF; Arnott, D; Cheng, DM; Peng, JM; Sheng, M				Bingol, Baris; Wang, Chi-Fong; Arnott, David; Cheng, Dongmei; Peng, Junmin; Sheng, Morgan			Autophosphorylated CaMKII alpha Acts as a Scaffold to Recruit Proteasomes to Dendritic Spines	CELL			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; INTERACTING PROTEINS; HIPPOCAMPAL-NEURONS; TERNARY COMPLEX; DEGRADATION; PLASTICITY; MEMORY; UBIQUITINATION; MAINTENANCE	The molecular mechanisms regulating the ubiquitin proteasome system (UPS) at synapses are poorly understood. We report that CaMKII alpha-an abundant postsynaptic protein kinase-mediates the activity-dependent recruitment of proteasomes to dendritic spines in hippocampal neurons. CaMKII alpha is biochemically associated with proteasomes in the brain. CaMKII alpha translocation to synapses is required for activity-induced proteasome accumulation in spines, and is sufficient to redistribute proteasomes to postsynaptic sites. CaMKII alpha autophosphorylation enhances its binding to proteasomes and promotes proteasome recruitment to spines. In addition to this structural role, CaMKII alpha stimulates proteasome activity by phosphorylating proteasome subunit Rpt6 on Serine 120. However, CaMKII alpha translocation, but not its kinase activity, is required for activity-dependent degradation of polyubiquitinated proteins in spines. Our findings reveal a scaffolding role of postsynaptic CaMKII alpha in activity-dependent proteasome redistribution, which is commensurate with the great abundance of CaMKII alpha in synapses.	[Bingol, Baris; Wang, Chi-Fong; Sheng, Morgan] MIT, Dept Brain & Cognit Sci & Biol, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Bingol, Baris; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Cheng, Dongmei; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Roche Holding; Genentech; Roche Holding; Genentech; Emory University	Sheng, M (corresponding author), MIT, Dept Brain & Cognit Sci & Biol, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Sheng, Morgan/0000-0002-8703-5366				Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bousquet-Dubouch MP, 2009, MOL CELL PROTEOMICS, V8, P1150, DOI 10.1074/mcp.M800193-MCP200; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Goh Amanda M., 2008, BMC Biochemistry, V9, P4, DOI 10.1186/1471-2091-9-4; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; KOLB SJ, 1995, J NEUROCHEM, V64, P2147; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Scanlon TC, 2009, EXP CELL RES, V315, P176, DOI 10.1016/j.yexcr.2008.10.027; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shen H, 2007, J NEUROSCI, V27, P8903, DOI 10.1523/JNEUROSCI.1571-07.2007; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Tao-Cheng JH, 2006, BRAIN CELL BIOL, V35, P117, DOI 10.1007/s11068-007-9012-5; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052	39	210	213	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					567	578		10.1016/j.cell.2010.01.024	http://dx.doi.org/10.1016/j.cell.2010.01.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178748	Green Published, Bronze			2022-12-28	WOS:000274668400019
J	Macdonald, H				Macdonald, Helen			Military Medicine Long road to recovery	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Macdonald, H (corresponding author), BMJ, London WC1H 9JR, England.	hmacdonald@bmj.com						Defence Analytical Services and Advice, 2010, EST PROP PRIS ENGL W; Napo, 2009, ARM FORC CRIM JUST S; National Audit Office, 2010, MIN DEF TREAT INJ IL	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 18	2010	340								c647	10.1136/bmj.c647	http://dx.doi.org/10.1136/bmj.c647			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JV	20167648				2022-12-28	WOS:000274739000004
J	Hawass, Z; Gad, YZ; Ismail, S; Khairat, R; Fathalla, D; Hasan, N; Ahmed, A; Elleithy, H; Ball, M; Gaballah, F; Wasef, S; Fateen, M; Amer, H; Gostner, P; Selim, A; Zink, A; Pusch, CM				Hawass, Zahi; Gad, Yehia Z.; Ismail, Somaia; Khairat, Rabab; Fathalla, Dina; Hasan, Naglaa; Ahmed, Amal; Elleithy, Hisham; Ball, Markus; Gaballah, Fawzi; Wasef, Sally; Fateen, Mohamed; Amer, Hany; Gostner, Paul; Selim, Ashraf; Zink, Albert; Pusch, Carsten M.			Ancestry and Pathology in King Tutankhamun's Family	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMODIUM-FALCIPARUM; MALARIA; DNA; DIAGNOSIS	Context The New Kingdom in ancient Egypt, comprising the 18th, 19th, and 20th dynasties, spanned the mid-16th to the early 11th centuries BC. The late 18th dynasty, which included the reigns of pharaohs Akhenaten and Tutankhamun, was an extraordinary time. The identification of a number of royal mummies from this era, the exact relationships between some members of the royal family, and possible illnesses and causes of death have been matters of debate. Objectives To introduce a new approach to molecular and medical Egyptology, to determine familial relationships among 11 royal mummies of the New Kingdom, and to search for pathological features attributable to possible murder, consanguinity, inherited disorders, and infectious diseases. Design From September 2007 to October 2009, royal mummies underwent detailed anthropological, radiological, and genetic studies as part of the King Tutankhamun Family Project. Mummies distinct from Tutankhamun's immediate lineage served as the genetic and morphological reference. To authenticate DNA results, analytical steps were repeated and independently replicated in a second ancient DNA laboratory staffed by a separate group of personnel. Eleven royal mummies dating from circa 1410-1324 BC and suspected of being kindred of Tutankhamun and 5 royal mummies dating to an earlier period, circa 1550-1479 BC, were examined. Main Outcome Measures Microsatellite-based haplotypes in the mummies, generational segregation of alleles within possible pedigree variants, and correlation of identified diseases with individual age, archeological evidence, and the written historical record. Results Genetic fingerprinting allowed the construction of a 5-generation pedigree of Tutankhamun's immediate lineage. The KV55 mummy and KV35YL were identified as the parents of Tutankhamun. No signs of gynecomastia and craniosynostoses (eg, Antley-Bixler syndrome) or Marfan syndrome were found, but an accumulation of malformations in Tutankhamun's family was evident. Several pathologies including Kohler disease II were diagnosed in Tutankhamun; none alone would have caused death. Genetic testing for STEVOR, AMA1, or MSP1 genes specific for Plasmodium falciparum revealed indications of malaria tropica in 4 mummies, including Tutankhamun's. These results suggest avascular bone necrosis in conjunction with the malarial infection as the most likely cause of death in Tutankhamun. Walking impairment and malarial disease sustained by Tutankhamun is supported by the discovery of canes and an afterlife pharmacy in his tomb. Conclusion Using a multidisciplinary scientific approach, we showed the feasibility of gathering data on Pharaonic kinship and diseases and speculated about individual causes of death. JAMA. 2010;303(7):638-647 www.jama.com	[Khairat, Rabab; Ball, Markus; Pusch, Carsten M.] Univ Tubingen, Div Mol Genet, Inst Human Genet, D-72074 Tubingen, Germany; [Hawass, Zahi; Elleithy, Hisham] Supreme Council Antiqu, Cairo, Egypt; [Gad, Yehia Z.; Ismail, Somaia; Hasan, Naglaa; Ahmed, Amal; Amer, Hany] Natl Res Ctr, Cairo, Egypt; [Gad, Yehia Z.; Ismail, Somaia; Khairat, Rabab; Fathalla, Dina; Hasan, Naglaa; Ahmed, Amal] Egyptian Natl Museum, Ancient DNA Lab, Cairo, Egypt; [Gaballah, Fawzi; Wasef, Sally; Fateen, Mohamed] Cairo Univ, Kasr Al Ainy Fac Med, Learning Resource Ctr, Cairo, Egypt; [Gostner, Paul] Cent Hosp Bolzano, Dept Radiodiagnost, Bolzano, Italy; [Selim, Ashraf] Kasr Al Ainy Fac Med, Dept Radiol, Cairo, Egypt; [Zink, Albert] EURAC, Inst Mummies & Iceman, Bolzano, Italy	Eberhard Karls University of Tubingen; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University; Krankenhaus Bozen; European Academy of Bozen-Bolzano	Pusch, CM (corresponding author), Univ Tubingen, Div Mol Genet, Inst Human Genet, Wilhelmstr 27, D-72074 Tubingen, Germany.	carsten.pusch@uni-tuebingen.de	Zink, Albert/P-4024-2015; gad, yehia/A-6833-2008; Ball, Markus/ABF-2661-2020; Wasef, Sally/L-2853-2016	Zink, Albert/0000-0002-1461-747X; gad, yehia/0000-0002-8432-4541; Wasef, Sally/0000-0002-7207-7395; Amer, Hany/0000-0003-3101-6235; Fathalla, Dina/0000-0003-3845-529X; ismail, somaia/0000-0002-0695-7941; Ball, Markus/0000-0002-2312-8360; Abumandil, Naglaa/0000-0002-4710-2341; Khairat, Rabab/0000-0001-9319-3953	Discovery Channel; Brando Quilici; Mini-Graduiertenkolleg Tubingen; DAAD	Discovery Channel; Brando Quilici; Mini-Graduiertenkolleg Tubingen; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by the Discovery Channel and the Brando Quilici production group. Funding was also obtained from the Mini-Graduiertenkolleg Tubingen and the DAAD (GERLS exchange program). Siemens Medical donated material and installed the multislice computed tomography scanner used in the study.	Bianucci R, 2008, J ARCHAEOL SCI, V35, P1880, DOI 10.1016/j.jas.2007.11.019; Bogdonoff M. D., 1985, GENUINE WORKS HIPPOC; Boyer RS, 2003, AM J NEURORADIOL, V24, P1142; Braverman IM, 2009, ANN INTERN MED, V150, P556, DOI 10.7326/0003-4819-150-8-200904210-00010; BRIER B, 1998, MURDER TUTANKHAMEN T; CARTER H, 1927, TOMB TUT ANKH AMUN, V2; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; COUNSELL DJ, 2008, ANCIENT EGYPT, V10, P34; Cunha Cheston B., 2008, Journal of Vector Borne Diseases, V45, P194; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIENER H, 1986, FACHLEXIKON ABC ARZN; DIETHELM L, 1976, HDB MED RADIOLOGIE; Farag TI, 1998, J ROY SOC MED, V91, P291, DOI 10.1177/014107689809100527; Freed R.E., 1999, PHARAOHS SUN AKHENAT; GERMER R, 2002, HEILPFLANZEN AGYPTER; GERMER R, 1989, HILDESHEIMER AGYPTOL; GERMER R, 2008, HDB ALTAGYPTISCHEN P, V21; Ghazanfar S.A., 1994, HDB ARABIAN MED PLAN; HARER WB, 2007, CHARIOTS HORSES HIPP; HARRIS JE, 1980, XRAY ATLAS ROYAL MUM; HARRISON RG, 1972, ANTIQUITY, V46, P8, DOI 10.1017/S0003598X00053072; HARRISON RG, 1969, NATURE, V224, P325, DOI 10.1038/224325b0; HARRISON RG, 1966, J EGYPT ARCHAEOL, V52, P95; HARRISON RG, 1971, BURIED HIST, V4, P114; HAWASS Z, 2009, ANN SERV ANTIQ EGYPT, V81, P159; HERODOTUS, 2008, HISTORIES, P130; Huppertz A, 2009, RADIOLOGY, V251, P233, DOI 10.1148/radiol.2511081175; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Issifou S, 2001, Afr J Med Med Sci, V30 Suppl, P17; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; King MR, 2004, WHO KILLED KING TUT; Kiwanuka GN, 2009, J VECTOR DIS, V46, P1; LEEK F, 1972, TUTANKHAMUN TOMB SER, V5; Mlambo G, 2007, ACTA TROP, V102, P201, DOI 10.1016/j.actatropica.2007.05.001; Molleson T, 1997, ANCIENT BIOMOLECULES, V1, P193; Nerlich AG, 2008, EMERG INFECT DIS, V14, P1317, DOI 10.3201/eid1408.080235; Neuwinger HD, 2000, AFRICAN TRADITIONAL; Ntoumi F., 2001, Parassitologia (Rome), V42, P197; NUNN JF, 2001, DISEASE; PAULSHOCK BZ, 1980, JAMA-J AM MED ASSOC, V244, P160, DOI 10.1001/jama.244.2.160; Pusch CM, 2004, MOL BIOL EVOL, V21, P957, DOI 10.1093/molbev/msh107; Pusch CM, 2000, ANAL BIOCHEM, V284, P408, DOI 10.1006/abio.2000.4666; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; Reeves N, 1990, COMPLETE TUTANKHAMUN; RICHARDS MB, 1995, J ARCHAEOL SCI, V22, P291, DOI 10.1006/jasc.1995.0031; Roberts C, 2008, INT J OSTEOARCHAEOL, V18, P600, DOI 10.1002/oa.966; SALEH M, 1987, OFFICIAL CATALOGUE E; Sallares R, 2004, MED HIST, V48, P311, DOI 10.1017/S0025727300007651; Sallares R., 2001, ANC BIOMOL, V3, P195; SCHOLZ M, 1997, TRENDS GENET, V13, P249; Strouhal E., 1992, LIFE ANCIENT EGYPTIA; WALSHE JM, 1973, LANCET, V1, P109; Weber J, 2008, NEUROSURG REV, V31, P179, DOI 10.1007/s10143-007-0100-x; WESTENDORF W, 1992, ERWACHEN HEILKUNST M; WILNER HI, 1964, JAMA-J AM MED ASSOC, V187, P490; Zink A., 2001, ANC BIOMOL, V3, P293	56	171	177	3	88	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					638	647		10.1001/jama.2010.121	http://dx.doi.org/10.1001/jama.2010.121			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	555NK	20159872				2022-12-28	WOS:000274518600022
J	Paynter, NP; Chasman, DI; Pare, G; Buring, JE; Cook, NR; Miletich, JP; Ridker, PM				Paynter, Nina P.; Chasman, Daniel I.; Pare, Guillaume; Buring, Julie E.; Cook, Nancy R.; Miletich, Joseph P.; Ridker, Paul M.			Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; HEART-DISEASE RISK; ATHEROSCLEROSIS RISK; PREDICTION; RECLASSIFICATION; GENOTYPE; LOCUS	Context While multiple genetic markers associated with cardiovascular disease have been identified by genome-wide association studies, their aggregate effect on risk beyond traditional factors is uncertain, particularly among women. Objective To test the predictive ability of a literature-based genetic risk score for cardiovascular disease. Design, Setting, and Participants Prospective cohort of 19 313 initially healthy white women in the Women's Genome Health Study followed up over a median of 12.3 years (interquartile range, 11.6-12.8 years). Genetic risk scores were constructed from the National Human Genome Research Institute's catalog of genome-wide association study results published between 2005 and June 2009. Main Outcome Measure Incident myocardial infarction, stroke, arterial revascularization, and cardiovascular death. Results A total of 101 single nucleotide polymorphisms reported to be associated with cardiovascular disease or at least 1 intermediate cardiovascular disease phenotype at a published P value of less than 10(-7) were identified and risk alleles were added to create a genetic risk score. During follow-up, 777 cardiovascular disease events occurred (199 myocardial infarctions, 203 strokes, 63 cardiovascular deaths, 312 revascularizations). After adjustment for age, the genetic risk score had a hazard ratio (HR) for cardiovascular disease of 1.02 per risk allele (95% confidence interval [CI], 1.00-1.03/risk allele; P=.006). This corresponds to an absolute cardiovascular disease risk of 3% over 10 years in the lowest tertile of genetic risk (73-99 risk alleles) and 3.7% in the highest tertile (106-125 risk alleles). However, after adjustment for traditional factors, the genetic risk score did not improve discrimination or reclassification (change in c index from Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults [ATP III] risk score, 0; net reclassification improvement, 0.5%; [P=.24]). The genetic risk score was not associated with cardiovascular disease risk (ATP III-adjusted HR/allele, 1.00; 95% CI, 0.99-1.01). In contrast, self-reported family history remained significantly associated with cardiovascular disease in multivariable models. Conclusion After adjustment for traditional cardiovascular risk factors, a genetic risk score comprising 101 single nucleotide polymorphisms was not significantly associated with the incidence of total cardiovascular disease. JAMA. 2010;303(7):631-637 www.jama.com	[Paynter, Nina P.; Chasman, Daniel I.; Pare, Guillaume; Buring, Julie E.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Paynter, Nina P.; Chasman, Daniel I.; Pare, Guillaume; Buring, Julie E.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; [Paynter, Nina P.; Chasman, Daniel I.; Pare, Guillaume; Buring, Julie E.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiovasc Dis, Boston, MA 02215 USA; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Pare, Guillaume] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Miletich, Joseph P.] Amgen Inc, Thousand Oaks, CA 91320 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; McMaster University; McMaster University; Amgen	Paynter, NP (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	npaynter@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart, Lung, and Blood Institute [HL 043851, HL 080467]; National Cancer Institute [CA 047988]; Donald W. Reynolds Foundation; Leducq Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Leducq Foundation(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Women's Genome Health Study is supported by funds from the National Heart, Lung, and Blood Institute (grants HL 043851 and HL 080467), the National Cancer Institute (grant CA 047988), the Donald W. Reynolds Foundation, and the Leducq Foundation. Genotyping was performed by Amgen Inc. Additional support for DNA extraction, reagents, and data analysis was provided by Roche Diagnostics and Amgen Inc.	BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HINDORFF JA, CATALOG PUBLISHED GE; Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li Y, 2006, AM J HUM GENET S, VS79, P2290; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489	22	262	276	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					631	637		10.1001/jama.2010.119	http://dx.doi.org/10.1001/jama.2010.119			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555NK	20159871	Green Accepted			2022-12-28	WOS:000274518600021
J	Smith, MD; Roheim, CA; Crowder, LB; Halpern, BS; Turnipseed, M; Anderson, JL; Asche, F; Bourillon, L; Guttormsen, AG; Khan, A; Liguori, LA; McNevin, A; O'Connor, MI; Squires, D; Tyedmers, P; Brownstein, C; Carden, K; Klinger, DH; Sagarin, R; Selkoe, KA				Smith, Martin D.; Roheim, Cathy A.; Crowder, Larry B.; Halpern, Benjamin S.; Turnipseed, Mary; Anderson, James L.; Asche, Frank; Bourillon, Luis; Guttormsen, Atle G.; Khan, Ahmed; Liguori, Lisa A.; McNevin, Aaron; O'Connor, Mary I.; Squires, Dale; Tyedmers, Peter; Brownstein, Carrie; Carden, Kristin; Klinger, Dane H.; Sagarin, Raphael; Selkoe, Kimberly A.			Sustainability and Global Seafood	SCIENCE			English	Editorial Material							COMMONS; TRADE; FISH		[Smith, Martin D.; Turnipseed, Mary] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Smith, Martin D.] Duke Univ, Dept Econ, Durham, NC 27708 USA; [Roheim, Cathy A.; Anderson, James L.] Univ Rhode Isl, Dept Environm & Nat Resource Econ, Kingston, RI 02881 USA; [Crowder, Larry B.] Duke Univ, Nicholas Sch Environm, Ctr Marine Conservat, Beaufort, NC 28516 USA; [Halpern, Benjamin S.; O'Connor, Mary I.; Selkoe, Kimberly A.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Asche, Frank] Univ Stavanger, Dept Ind Econ, N-4036 Stavanger, Norway; [Bourillon, Luis] Comunidad & Biodiversidad AC COBI, Guaymas 85420, Sonora, Mexico; [Guttormsen, Atle G.] Norwegian Univ Life Sci, Dept Econ & Resource Management, N-1432 As, Norway; [Khan, Ahmed] Mem Univ Newfoundland, Dept Geog, Int Coastal Network, St John, NF A1B 3X9, Canada; [Liguori, Lisa A.] Univ Georgia, Marine Extens Serv, Brunswick, GA 31520 USA; [McNevin, Aaron] World Wildlife Fund, Washington, DC 20037 USA; [Squires, Dale] SW Fisheries Sci Ctr, La Jolla, CA 92037 USA; [Tyedmers, Peter] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS B3H 3J5, Canada; [Brownstein, Carrie] Whole Foods Market, Austin, TX 78703 USA; [Carden, Kristin] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Klinger, Dane H.] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Stanford, CA 94305 USA; [Sagarin, Raphael] Univ Arizona, Inst Environm, Tucson, AZ 85719 USA; [Selkoe, Kimberly A.] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA	Duke University; Duke University; University of Rhode Island; Duke University; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Universitetet i Stavanger; Norwegian University of Life Sciences; Memorial University Newfoundland; University System of Georgia; University of Georgia; World Wildlife Fund; National Oceanic Atmospheric Admin (NOAA) - USA; Dalhousie University; University of California System; University of California Santa Barbara; Stanford University; University of Arizona	Smith, MD (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	marsmith@duke.edu	Guttormsen, Atle/GZG-2356-2022; O'Connor, Mary I/F-2275-2010; O'Connor, Mary/R-2933-2019; Asche, Frank/AAG-9920-2020; Tyedmers, Peter/N-1334-2019; Tyedmers, Peter H/I-7490-2012; Smith, Martin D/D-9168-2016	O'Connor, Mary I/0000-0001-9583-1592; Asche, Frank/0000-0002-1540-9728; Tyedmers, Peter/0000-0002-5150-0756; Tyedmers, Peter H/0000-0002-5150-0756; Smith, Martin D/0000-0002-4714-463X; Anderson, James L./0000-0003-2942-8345				Anderson J. L., 2002, Marine Resource Economics, V17, P133; Arrow K, 2004, J ECON PERSPECT, V18, P147, DOI 10.1257/0895330042162377; Asche F, 2009, MAR RESOUR ECON, V24, P405, DOI 10.1086/mre.24.4.42629664; Asche F, 2008, MAR RESOUR ECON, V23, P527, DOI 10.1086/mre.23.4.42629678; Bourillon L., 2009, BIODIVERSITAS, V86, P7; Brander JA, 1998, J INT ECON, V44, P181, DOI 10.1016/S0022-1996(97)00029-9; Cinner JE, 2007, BIOL CONSERV, V140, P201, DOI 10.1016/j.biocon.2007.08.008; Copeland BR, 2009, AM ECON REV, V99, P725, DOI 10.1257/aer.99.3.725; COPES P, 1970, SCOT J POLIT ECON, V17, P69, DOI 10.1111/j.1467-9485.1970.tb00487.x; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; FAO, 2009, FISHSTAT PLUS; FAO (Food and Agriculture Organization of the United Nations), 2009, STAT WORLD FISH AQ 2; FAO (Food and Agriculture Organization of the United Nations), 2008, PREV UND TOT POP; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Kaufman Daniel, 2009, 4978 WORLD BANK; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Roos N, 2007, J NUTR, V137, P1106, DOI 10.1093/jn/137.4.1106	22	316	321	5	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					784	786		10.1126/science.1185345	http://dx.doi.org/10.1126/science.1185345			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554AQ	20150469				2022-12-28	WOS:000274408300025
J	van Leeuwen, MT; Webster, AC; McCredie, MRE; Stewart, JH; McDonald, SP; Amin, J; Kaldor, JM; Chapman, JR; Vajdic, CM; Grulich, AE				van Leeuwen, Marina T.; Webster, Angela C.; McCredie, Margaret R. E.; Stewart, John H.; McDonald, Stephen P.; Amin, Janaki; Kaldor, John M.; Chapman, Jeremy R.; Vajdic, Claire M.; Grulich, Andrew E.			Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SWISS HIV COHORT; NON-HODGKIN-LYMPHOMA; KAPOSI-SARCOMA; THYROID-CANCER; DISEASE; ASSOCIATION; RECIPIENTS; END	Objective To compare cancer incidence in kidney transplant recipients during periods of transplant function (and immunosuppression) and after transplant failure (when immunosuppression is ceased or reduced). Design, setting, and participants Nationwide, population based retrospective cohort study of 8173 Australian kidney transplant recipients registered on the Australia and New Zealand Dialysis and Transplant Registry who first received a transplant during 1982-2003. Incident cancers were ascertained using linkage with national cancer registry records. Main outcome measures Cancer-specific standardised incidence ratios for periods of transplant function and for dialysis after transplant failure. Incidence was compared between periods using multivariate incidence rate ratios adjusted for current age, sex, and duration of transplantation. Results All cases of Kaposi's sarcoma occurred during transplant function. Standardised incidence ratios were significantly elevated during transplant function, but not during dialysis after transplant failure, for non-Hodgkin's lymphoma, lip cancer, and melanoma. For each of these cancers, incidence was significantly lower during dialysis after transplant failure in multivariate analysis ( incidence rate ratios 0.20 (95% CI 0.06 to 0.65) for non-Hodgkin's lymphoma, 0.04 (0.01 to 0.31) for lip cancer, and 0.16 (0.04 to 0.64) for melanoma). In contrast, standardised incidence ratios during dialysis after transplant failure remained significantly elevated for leukaemia and lung cancer, and cancers related to end stage kidney disease ( kidney, urinary tract, and thyroid cancers), with thyroid cancer incidence significantly higher during dialysis after transplant failure ( incidence rate ratio 6.77 (2.64 to 17.39)). There was no significant difference in incidence by transplant function for other cancers. Conclusions The effect of immunosuppression on cancer risk is rapidly reversible for some, but not all, cancer types. Risk reversal was mainly observed for cancers with a confirmed infectious cause. Risk of other cancers, especially those related to end stage kidney disease, remained significantly increased after reduction of immunosuppression.	[van Leeuwen, Marina T.; Amin, Janaki; Kaldor, John M.; Grulich, Andrew E.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia; [van Leeuwen, Marina T.] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [Webster, Angela C.; McDonald, Stephen P.] Queen Elizabeth Hosp, Australia & New Zealand Dialysis & Transplant Reg, Woodville, SA 5011, Australia; [Webster, Angela C.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Webster, Angela C.; Chapman, Jeremy R.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Ctr Transplant & Renal Res, Westmead, NSW 2145, Australia; [McCredie, Margaret R. E.; Stewart, John H.] Univ Otago, Dept Prevent & Social Med, Dunedin 9054, New Zealand; [McDonald, Stephen P.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [McDonald, Stephen P.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA 5005, Australia; [Vajdic, Claire M.] Univ New S Wales, Prince Wales Clin Sch, Canc Res Ctr, Sydney, NSW 2052, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Otago; University of Adelaide; University of Adelaide; University of New South Wales Sydney	Grulich, AE (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, 376 Victoria St, Sydney, NSW 2010, Australia.	agrulich@nchecr.unsw.edu.au	Kaldor, John M/D-4545-2011; Vajdic, Claire/AAP-5940-2020; Webster, Angela/J-2186-2012; McDonald, Stephen/G-4010-2013; van Leeuwen, Marina T/AAQ-5339-2021	Webster, Angela/0000-0001-7509-0512; McDonald, Stephen/0000-0001-6103-1386; van Leeuwen, Marina T/0000-0002-1570-2852; Amin, Janaki/0000-0003-2161-9366; Vajdic, Claire/0000-0002-3612-8298	Cancer Council New South Wales [RG 47/03]; National Health and Medical Research Council [ID 510346, ID 401131]; Cancer Institute New South Wales [07/CDF/1-38, 06/RSA/1/28]; Australian Government Department of Health and Ageing; New Zealand Ministry of Health; Kidney Health Australia	Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); New Zealand Ministry of Health; Kidney Health Australia	This work was supported by the Cancer Council New South Wales (RG 47/03); the National Health and Medical Research Council ( ID 510346 to CMV, ID 401131 to MTvL); and the Cancer Institute New South Wales (07/CDF/1-38 to CMV, 06/RSA/1/28 to MTvL). The ANZDATA Registry administrative office is supported by funding from the Australian Government Department of Health and Ageing, the New Zealand Ministry of Health, and Kidney Health Australia; data collection costs were borne by contributing renal units. The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR), 2008, CANC AUSTR OV 2008; Barozzi P, 2008, TRANSPLANTATION, V86, P738, DOI 10.1097/TP.0b013e318184112c; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Breslow NE., 1987, STAT METHODS CANC RE, P81; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Franceschi S, 2008, BRIT J CANCER, V99, P800, DOI 10.1038/sj.bjc.6604520; GLATTRE E, 1989, INT J EPIDEMIOL, V18, P45, DOI 10.1093/ije/18.1.45; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hessol NA, 2007, AM J EPIDEMIOL, V165, P1143, DOI 10.1093/aje/kwm017; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158; *IARC, 1997, IARC MON EV CARC RIS, V8; *INT AG RES CANC, 2007, IARC MON EV CARC RIS; Klyachkin ML, 2001, AM SURGEON, V67, P397; Lebbe Celeste, 2008, Transplant Rev (Orlando), V22, P252, DOI 10.1016/j.trre.2008.05.004; Marcen Roberto, 2008, Transplant Rev (Orlando), V22, P62, DOI 10.1016/j.trre.2007.09.005; McDonald SP, 2002, AM J KIDNEY DIS, V40, P1122, DOI 10.1053/ajkd.2002.36943; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; PENN I, 1994, CANCER DETECT PREV, V18, P241; Penn I, 1998, SPRINGER SEMIN IMMUN, V20, P343, DOI 10.1007/BF00838048; Piaserico S, 2006, J AM ACAD DERMATOL, V54, P338, DOI 10.1016/j.jaad.2005.06.023; Polesel J, 2008, AIDS, V22, P301, DOI 10.1097/QAD.0b013e3282f2705d; STARZL TE, 1984, LANCET, V1, P583; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vajdic CM, 2009, CANCER EPIDEM BIOMAR, V18, P2297, DOI 10.1158/1055-9965.EPI-09-0278; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; van Leeuwen MT, 2009, BLOOD, V114, P630, DOI 10.1182/blood-2009-02-202507; van Leeuwen MT, 2009, CANCER EPIDEM BIOMAR, V18, P561, DOI 10.1158/1055-9965.EPI-08-0919; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604	29	105	106	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2010	340								c570	10.1136/bmj.c570	http://dx.doi.org/10.1136/bmj.c570			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZV	20150194	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000274477200003
J	Nakamura, T; Furuhashi, M; Li, P; Cao, HM; Tuncman, G; Sonenberg, N; Gorgun, CZ; Hotamisligil, GS				Nakamura, Takahisa; Furuhashi, Masato; Li, Ping; Cao, Haiming; Tuncman, Gurol; Sonenberg, Nahum; Gorgun, Cem Z.; Hotamisligil, Goekhan S.			Double-Stranded RNA-Dependent Protein Kinase Links Pathogen Sensing with Stress and Metabolic Homeostasis	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; P38 MAPK ACTIVATION; DS RNA; PKR; MICE; BINDING; OBESITY; ALPHA; JNK	As chronic inflammation is a hallmark of obesity, pathways that integrate nutrient- and pathogen sensing pathways are of great interest in understanding the mechanisms of insulin resistance, type 2 diabetes, and other chronic metabolic pathologies. Here, we provide evidence that double-stranded RNA-dependent protein kinase (PKR) can respond to nutrient signals as well as endoplasmic reticulum (ER) stress and coordinate the activity of other critical inflammatory kinases such as the c-Jun N-terminal kinase (JNK) to regulate insulin action and metabolism. PKR also directly targets and modifies insulin receptor substrate and hence integrates nutrients and insulin action with a defined pathogen response system. Dietary and genetic obesity features marked activation of PKR in adipose and liver tissues and absence of PKR alleviates metabolic deterioration due to nutrient or energy excess in mice. These findings demonstrate PKR as a critical component of an inflammatory complex that responds to nutrients and organelle dysfunction.	[Nakamura, Takahisa; Furuhashi, Masato; Li, Ping; Cao, Haiming; Tuncman, Gurol; Gorgun, Cem Z.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Hotamisligil, Goekhan S.] Harvard MIT Broad Inst, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; McGill University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Furuhashi, Masato/AAT-5518-2021; Cao, Haiming/P-4634-2016; Longo, Kenneth A/A-5631-2010	Furuhashi, Masato/0000-0002-0145-3541; Nakamura, Takahisa/0000-0003-4922-4569	National Institutes of Health; International Human Frontier Science Program; Uehara Memorial Foundation; Japan Society for the Promotion of Science; American Diabetes Association; NIH [DK71507-04]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R90DK071507, R01DK052539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program(Human Frontier Science Program); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the Hotamisligil lab for their scientific input and contributions, especially Brenna Baccaro, Sara Vallerie, Margaret F. Gregor, and Ling Yang for support and discussions and Kristen Gilbert, Rebecca Foote, and Julie Gound for administrative assistance. We are grateful to Jun Eguchi and Atsuo Sasaki for helpful discussions. This study is supported by a grant from the National Institutes of Health (to G. S. H.). T. N. is supported by fellowships from the International Human Frontier Science Program and the Uehara Memorial Foundation. M. F. is supported by fellowships from the Japan Society for the Promotion of Science and the American Diabetes Association. H. C. is supported by a NIH Roadmap Fellowship (DK71507-04) and the American Diabetes Association. G. S. H. is a share owner and on the Scientific Advisory Board of Syndexa Pharmaceuticals.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Antonelli A, 2009, NAT CLIN PRACT ENDOC, V5, P26, DOI 10.1038/ncpendmet1027; Bahtiyar Gul, 2004, Curr Diab Rep, V4, P194, DOI 10.1007/s11892-004-0023-7; Baltzis D, 2002, J BIOL CHEM, V277, P38364, DOI 10.1074/jbc.M203564200; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Chakrabarti A, 2008, J BIOL CHEM, V283, P25132, DOI 10.1074/jbc.M804770200; Delhem N, 2001, ONCOGENE, V20, P5836, DOI 10.1038/sj.onc.1204744; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; GUSELLA GL, 1995, J IMMUNOL, V154, P345; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; MCCORMACK SJ, 1994, VIROLOGY, V198, P92, DOI 10.1006/viro.1994.1011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Scarim AL, 2001, AM J PATHOL, V159, P273, DOI 10.1016/S0002-9440(10)61693-8; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906; Tokumoto Y, 2007, J MED VIROL, V79, P1120, DOI 10.1002/jmv.20902; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; von Herrath M, 2009, DIABETES, V58, P2, DOI 10.2337/db08-9027; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	34	376	400	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					338	U41		10.1016/j.cell.2010.01.001	http://dx.doi.org/10.1016/j.cell.2010.01.001			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144759	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000274297700012
J	Liu, BD; Larsson, L; Caballero, A; Hao, XX; Oling, D; Grantham, J; Nystrom, T				Liu, Beidong; Larsson, Lisa; Caballero, Antonio; Hao, Xinxin; Oling, David; Grantham, Julie; Nystrom, Thomas			The Polarisome Is Required for Segregation and Retrograde Transport of Protein Aggregates	CELL			English	Article							CELL-CYCLE PROGRESSION; ACTIN CYTOSKELETON; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; ASYMMETRIC SEGREGATION; GENETIC INTERACTIONS; DAMAGED PROTEINS; CHAPERONIN CCT; YEAST; SIR2	The paradigm sirtuin, Sir2p, of budding yeast is required for establishing cellular age asymmetry, which includes the retention of damaged and aggregated proteins in mother cells. By establishing the global genetic interaction network of SIR2 we identified the polarisome, the formin Bni1p, and myosin motor protein Myo2p as essential components of the machinery segregating protein aggregates during mitotic cytokinesis. Moreover, we found that daughter cells can clear themselves of damage by a polarisome- and tropomyosin-dependent polarized flow of aggregates into the mother cell compartment. The role of Sir2p in cytoskeletal functions and polarity is linked to the CCT chaperonin in sir2D cells being compromised in folding actin. We discuss the findings in view of recent models hypothesizing that polarity may have evolved to avoid clonal senescence by establishing an aging (soma-like) and rejuvenated (germ-like) lineage.	[Liu, Beidong; Larsson, Lisa; Caballero, Antonio; Hao, Xinxin; Oling, David; Grantham, Julie; Nystrom, Thomas] Gothenburg Univ, Dept Cell & Mol Biol, S-41390 Gothenburg, Sweden	University of Gothenburg	Liu, BD (corresponding author), Gothenburg Univ, Dept Cell & Mol Biol, Medicinaregatan 9C, S-41390 Gothenburg, Sweden.	beidong.liu@cmb.gu.se; thomas.nystrom@cmb.gu.se	Liu, Beidong/L-2485-2015; Grantham, Julie/A-5002-2009; Caballero, Antonio/I-8510-2014	Liu, Beidong/0000-0001-6052-8411; Caballero, Antonio/0000-0001-6042-9245	Swedish Natural Research Council; Wallenberg scholar; Foundation for Strategic Research in Sweden; Goran Gustafsson Foundation; EC	Swedish Natural Research Council(Swedish Research Council); Wallenberg scholar; Foundation for Strategic Research in Sweden; Goran Gustafsson Foundation; EC(European CommissionEuropean Commission Joint Research Centre)	The authors would like to thank Charles Boone for providing strains, software support for the SGA analysis, and helpful suggestions throughout this work. The epsilon AD2 antibody was a kind gift from Keith Willison, and David Sinclair provided useful information on reagents and antibodies. This work was supported by grants from the Swedish Natural Research Council (VR), the Wallenberg scholar award, the Foundation for Strategic Research in Sweden (SSF-BioX program), the Goran Gustafsson Foundation, and the EC (Acronyms: Mimage & Proteomage).	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brackley KI, 2009, CELL STRESS CHAPERON, V14, P23, DOI 10.1007/s12192-008-0057-x; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Erjavec N, 2008, P NATL ACAD SCI USA, V105, P18764, DOI 10.1073/pnas.0804550105; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Erjavec N, 2007, P NATL ACAD SCI USA, V104, P10877, DOI 10.1073/pnas.0701634104; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Guarente L, 2000, GENE DEV, V14, P1021; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jin H, 2000, MOL BIOL CELL, V11, P647, DOI 10.1091/mbc.11.2.647; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KIRKWOOD TBL, 1981, REPAIR ITS EVOLUTION; Lai CY, 2002, GENETICS, V162, P73; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Nystrom T, 2007, PLOS GENET, V3, P2355, DOI 10.1371/journal.pgen.0030224; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shimon L, 2008, J MOL BIOL, V377, P469, DOI 10.1016/j.jmb.2008.01.011; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 2002, MECH AGEING DEV, V123, P857, DOI 10.1016/S0047-6374(02)00023-4; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; SMITH MG, 1995, MOL BIOL CELL, V6, P1381, DOI 10.1091/mbc.6.10.1381; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Wang YS, 2009, J EUR ACAD DERMATOL, V23, P451, DOI 10.1111/j.1468-3083.2008.02895.x; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Weismann A., 1889, ESSAYS HEREDITY KIND; WERTMAN KF, 1992, GENETICS, V132, P337; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899	63	240	241	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					257	267		10.1016/j.cell.2009.12.031	http://dx.doi.org/10.1016/j.cell.2009.12.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141839	Bronze			2022-12-28	WOS:000273826500016
J	Abelev, BI; Aggarwal, MM; Ahammed, Z; Alakhverdyants, AV; Alekseev, I; Anderson, BD; Arkhipkin, D; Averichev, GS; Balewski, J; Barnby, LS; Baumgart, S; Beavis, DR; Bellwied, R; Betancourt, MJ; Betts, RR; Bhasin, A; Bhati, AK; Bichsel, H; Bielcik, J; Bielcikova, J; Biritz, B; Bland, LC; Bonner, BE; Bouchet, J; Braidot, E; Brandin, AV; Bridgeman, A; Bruna, E; Bueltmann, S; Bunzarov, I; Burton, TP; Cai, XZ; Caines, H; Calderon, M; Catu, O; Cebra, D; Cendejas, R; Cervantes, MC; Chajecki, Z; Chaloupka, P; Chattopadhyay, S; Chen, HF; Chen, JH; Chen, JY; Cheng, J; Cherney, M; Chikanian, A; Choi, KE; Christie, W; Chung, P; Clarke, RF; Codrington, MJM; Corliss, R; Cramer, JG; Crawford, HJ; Das, D; Dash, S; Leyva, AD; De Silva, LC; Debbe, RR; Dedovich, TG; DePhillips, M; Derevschikov, AA; de Souza, RD; Didenko, L; Djawotho, P; Dogra, SM; Dong, X; Drachenberg, JL; Draper, JE; Dunlop, JC; Mazumdar, MRD; Efimov, LG; Elhalhuli, E; Elnimr, M; Engelage, J; Eppley, G; Erazmus, B; Estienne, M; Eun, L; Evdokimov, O; Fachini, P; Fatemi, R; Fedorisin, J; Fersch, RG; Filip, P; Finch, E; Fine, V; Fisyak, Y; Gagliardi, CA; Gangadharan, DR; Ganti, MS; Garcia-Solis, EJ; Geromitsos, A; Geurts, F; Ghazikhanian, V; Ghosh, P; Gorbunov, YN; Gordon, A; Grebenyuk, O; Grosnick, D; Grube, B; Guertin, SM; Gupta, A; Gupta, N; Guryn, W; Haag, B; Hamed, A; Han, LX; Harris, JW; Hays-Wehle, JP; Heinz, M; Heppelmann, S; Hirsch, A; Hjort, E; Hoffman, AM; Hoffmann, GW; Hofman, DJ; Hollis, RS; Huang, B; Huang, HZ; Humanic, TJ; Huo, L; Igo, G; Iordanova, A; Jacobs, P; Jacobs, WW; Jakl, P; Jena, C; Jin, F; Jones, CL; Jones, PG; Joseph, J; Judd, EG; Kabana, S; Kajimoto, K; Kang, K; Kapitan, J; Kauder, K; Keane, D; Kechechyan, A; Kettler, D; Kikola, DP; Kiryluk, J; Kisiel, A; Klein, SR; Knospe, AG; Kocoloski, A; Koetke, DD; Kollegger, T; Konzer, J; Kopytine, M; Koralt, I; Koroleva, L; Korsch, W; Kotchenda, L; Kouchpil, V; Kravtsov, P; Krueger, K; Krus, M; Kumar, L; Kurnadi, P; Lamont, MAC; Landgraf, JM; LaPointe, S; Lauret, J; Lebedev, A; Lednicky, R; Lee, CH; Lee, JH; Leight, W; Levine, MJ; Li, C; Li, L; Li, N; Li, W; Li, X; Li, Y; Li, Z; Lin, G; Lindenbaum, SJ; Lisa, MA; Liu, F; Liu, H; Liu, J; Ljubicic, T; Llope, WJ; Longacre, RS; Love, WA; Lu, Y; Luo, X; Ma, GL; Ma, YG; Mahapatra, DP; Majka, R; Mal, OI; Mangotra, LK; Manweiler, R; Margetis, S; Markert, C; Masui, H; Matis, HS; Matulenko, YA; McDonald, D; McShane, TS; Meschanin, A; Milner, R; Minaev, NG; Mioduszewski, S; Mischke, A; Mitrovski, MK; Mohanty, B; Mondal, MM; Morozov, B; Morozov, DA; Munhoz, MG; Nandi, BK; Nattrass, C; Nayak, TK; Nelson, JM; Netrakanti, PK; Ng, MJ; Nogach, LV; Nurushev, SB; Odyniec, G; Ogawa, A; Okada, H; Okorokov, V; Olson, D; Pachr, M; Page, BS; Pal, SK; Pandit, Y; Panebratsev, Y; Pawlak, T; Peitzmann, T; Perevoztchikov, V; Perkins, C; Peryt, W; Phatak, SC; Pile, P; Planinic, M; Ploskon, MA; Pluta, J; Plyku, D; Poljak, N; Poskanzer, AM; Potukuchi, BVKS; Powell, CB; Prindle, D; Pruneau, C; Pruthi, NK; Pujahari, PR; Putschke, J; Qiu, H; Raniwala, R; Raniwala, S; Ray, RL; Redwine, R; Reed, R; Ritter, HG; Roberts, JB; Rogachevskiy, OV; Romero, JL; Rose, A; Roy, C; Ruan, L; Sahoo, R; Sakai, S; Sakrejda, I; Sakuma, T; Salur, S; Sandweiss, J; Sangaline, E; Schambach, J; Scharenberg, RP; Schmitz, N; Schuster, TR; Seele, J; Seger, J; Selyuzhenkov, I; Seyboth, P; Shahaliev, E; Shao, M; Sharma, M; Shi, SS; Sichtermann, EP; Simon, F; Singaraju, RN; Skoby, MJ; Smirnov, N; Sorensen, P; Sowinski, J; Spinka, HM; Srivastava, B; Stanislaus, TDS; Staszak, D; Stevens, JR; Stock, R; Strikhanov, M; Stringfellow, B; Suaide, AAP; Suarez, MC; Subba, NL; Sumbera, M; Sun, XM; Sun, Y; Sun, Z; Surrow, B; Svirida, DN; Symons, TJM; de Toledo, AS; Takahashi, J; Tang, AH; Tang, Z; Tarini, LH; Tarnowsky, T; Thein, D; Thomas, H; Tian, J; Timmins, AR; Timoshenko, S; Tlusty, D; Tokarev, M; Trainor, TA; Tram, VN; Trentalange, S; Tribble, RE; Tsai, OD; Ulery, J; Ullrich, T; Underwood, DG; Van Buren, G; van Leeuwen, M; van Nieuwenhuizen, G; Vanfossen, JA; Varma, R; Vasconcelos, GMS; Vasiliev, AN; Videbaek, F; Viyogi, YP; Vokal, S; Voloshin, SA; Wada, M; Walker, M; Wang, F; Wang, G; Wang, H; Wang, JS; Wang, Q; Wang, XL; Wang, Y; Webb, G; Webb, JC; Westfall, GD; Whitten, C; Wieman, H; Wingfield, E; Wissink, SW; Witt, R; Wu, Y; Xie, W; Xu, H; Xu, N; Xu, QH; Xu, W; Xu, Y; Xu, Z; Xue, L; Yang, Y; Yepes, P; Yip, K; Yoo, IK; Yue, Q; Zawisza, M; Zbroszczyk, H; Zhan, W; Zhang, J; Zhang, S; Zhang, WM; Zhang, XP; Zhang, Y; Zhang, ZP; Zhao, J; Zhong, C; Zhou, J; Zhou, W; Zhu, X; Zhu, YH; Zoulkarneev, R; Zoulkarneeva, Y				Abelev, B. I.; Aggarwal, M. M.; Ahammed, Z.; Alakhverdyants, A. V.; Alekseev, I.; Anderson, B. D.; Arkhipkin, D.; Averichev, G. S.; Balewski, J.; Barnby, L. S.; Baumgart, S.; Beavis, D. R.; Bellwied, R.; Betancourt, M. J.; Betts, R. R.; Bhasin, A.; Bhati, A. K.; Bichsel, H.; Bielcik, J.; Bielcikova, J.; Biritz, B.; Bland, L. C.; Bonner, B. E.; Bouchet, J.; Braidot, E.; Brandin, A. V.; Bridgeman, A.; Bruna, E.; Bueltmann, S.; Bunzarov, I.; Burton, T. P.; Cai, X. Z.; Caines, H.; Calderon, M.; Catu, O.; Cebra, D.; Cendejas, R.; Cervantes, M. C.; Chajecki, Z.; Chaloupka, P.; Chattopadhyay, S.; Chen, H. F.; Chen, J. H.; Chen, J. Y.; Cheng, J.; Cherney, M.; Chikanian, A.; Choi, K. E.; Christie, W.; Chung, P.; Clarke, R. F.; Codrington, M. J. M.; Corliss, R.; Cramer, J. G.; Crawford, H. J.; Das, D.; Dash, S.; Leyva, A. Davila; De Silva, L. C.; Debbe, R. R.; Dedovich, T. G.; DePhillips, M.; Derevschikov, A. A.; de Souza, R. Derradi; Didenko, L.; Djawotho, P.; Dogra, S. M.; Dong, X.; Drachenberg, J. L.; Draper, J. E.; Dunlop, J. C.; Mazumdar, M. R. Dutta; Efimov, L. G.; Elhalhuli, E.; Elnimr, M.; Engelage, J.; Eppley, G.; Erazmus, B.; Estienne, M.; Eun, L.; Evdokimov, O.; Fachini, P.; Fatemi, R.; Fedorisin, J.; Fersch, R. G.; Filip, P.; Finch, E.; Fine, V.; Fisyak, Y.; Gagliardi, C. A.; Gangadharan, D. R.; Ganti, M. S.; Garcia-Solis, E. J.; Geromitsos, A.; Geurts, F.; Ghazikhanian, V.; Ghosh, P.; Gorbunov, Y. N.; Gordon, A.; Grebenyuk, O.; Grosnick, D.; Grube, B.; Guertin, S. M.; Gupta, A.; Gupta, N.; Guryn, W.; Haag, B.; Hamed, A.; Han, L. -X.; Harris, J. W.; Hays-Wehle, J. P.; Heinz, M.; Heppelmann, S.; Hirsch, A.; Hjort, E.; Hoffman, A. M.; Hoffmann, G. W.; Hofman, D. J.; Hollis, R. S.; Huang, B.; Huang, H. Z.; Humanic, T. J.; Huo, L.; Igo, G.; Iordanova, A.; Jacobs, P.; Jacobs, W. W.; Jakl, P.; Jena, C.; Jin, F.; Jones, C. L.; Jones, P. G.; Joseph, J.; Judd, E. G.; Kabana, S.; Kajimoto, K.; Kang, K.; Kapitan, J.; Kauder, K.; Keane, D.; Kechechyan, A.; Kettler, D.; Kikola, D. P.; Kiryluk, J.; Kisiel, A.; Klein, S. R.; Knospe, A. G.; Kocoloski, A.; Koetke, D. D.; Kollegger, T.; Konzer, J.; Kopytine, M.; Koralt, I.; Koroleva, L.; Korsch, W.; Kotchenda, L.; Kouchpil, V.; Kravtsov, P.; Krueger, K.; Krus, M.; Kumar, L.; Kurnadi, P.; Lamont, M. A. C.; Landgraf, J. M.; LaPointe, S.; Lauret, J.; Lebedev, A.; Lednicky, R.; Lee, C. -H.; Lee, J. H.; Leight, W.; Levine, M. J.; Li, C.; Li, L.; Li, N.; Li, W.; Li, X.; Li, Y.; Li, Z.; Lin, G.; Lindenbaum, S. J.; Lisa, M. A.; Liu, F.; Liu, H.; Liu, J.; Ljubicic, T.; Llope, W. J.; Longacre, R. S.; Love, W. A.; Lu, Y.; Luo, X.; Ma, G. L.; Ma, Y. G.; Mahapatra, D. P.; Majka, R.; Mal, O. I.; Mangotra, L. K.; Manweiler, R.; Margetis, S.; Markert, C.; Masui, H.; Matis, H. S.; Matulenko, Yu. A.; McDonald, D.; McShane, T. S.; Meschanin, A.; Milner, R.; Minaev, N. G.; Mioduszewski, S.; Mischke, A.; Mitrovski, M. K.; Mohanty, B.; Mondal, M. M.; Morozov, B.; Morozov, D. A.; Munhoz, M. G.; Nandi, B. K.; Nattrass, C.; Nayak, T. K.; Nelson, J. M.; Netrakanti, P. K.; Ng, M. J.; Nogach, L. V.; Nurushev, S. B.; Odyniec, G.; Ogawa, A.; Okada, H.; Okorokov, V.; Olson, D.; Pachr, M.; Page, B. S.; Pal, S. K.; Pandit, Y.; Panebratsev, Y.; Pawlak, T.; Peitzmann, T.; Perevoztchikov, V.; Perkins, C.; Peryt, W.; Phatak, S. C.; Pile, P.; Planinic, M.; Ploskon, M. A.; Pluta, J.; Plyku, D.; Poljak, N.; Poskanzer, A. M.; Potukuchi, B. V. K. S.; Powell, C. B.; Prindle, D.; Pruneau, C.; Pruthi, N. K.; Pujahari, P. R.; Putschke, J.; Qiu, H.; Raniwala, R.; Raniwala, S.; Ray, R. L.; Redwine, R.; Reed, R.; Ritter, H. G.; Roberts, J. B.; Rogachevskiy, O. V.; Romero, J. L.; Rose, A.; Roy, C.; Ruan, L.; Sahoo, R.; Sakai, S.; Sakrejda, I.; Sakuma, T.; Salur, S.; Sandweiss, J.; Sangaline, E.; Schambach, J.; Scharenberg, R. P.; Schmitz, N.; Schuster, T. R.; Seele, J.; Seger, J.; Selyuzhenkov, I.; Seyboth, P.; Shahaliev, E.; Shao, M.; Sharma, M.; Shi, S. S.; Sichtermann, E. P.; Simon, F.; Singaraju, R. N.; Skoby, M. J.; Smirnov, N.; Sorensen, P.; Sowinski, J.; Spinka, H. M.; Srivastava, B.; Stanislaus, T. D. S.; Staszak, D.; Stevens, J. R.; Stock, R.; Strikhanov, M.; Stringfellow, B.; Suaide, A. A. P.; Suarez, M. C.; Subba, N. L.; Sumbera, M.; Sun, X. M.; Sun, Y.; Sun, Z.; Surrow, B.; Svirida, D. N.; Symons, T. J. M.; de Toledo, A. Szanto; Takahashi, J.; Tang, A. H.; Tang, Z.; Tarini, L. H.; Tarnowsky, T.; Thein, D.; Thomas, H.; Tian, J.; Timmins, A. R.; Timoshenko, S.; Tlusty, D.; Tokarev, M.; Trainor, T. A.; Tram, V. N.; Trentalange, S.; Tribble, R. E.; Tsai, O. D.; Ulery, J.; Ullrich, T.; Underwood, D. G.; Van Buren, G.; van Leeuwen, M.; van Nieuwenhuizen, G.; Vanfossen, J. A., Jr.; Varma, R.; Vasconcelos, G. M. S.; Vasiliev, A. N.; Videbaek, F.; Viyogi, Y. P.; Vokal, S.; Voloshin, S. A.; Wada, M.; Walker, M.; Wang, F.; Wang, G.; Wang, H.; Wang, J. S.; Wang, Q.; Wang, X. L.; Wang, Y.; Webb, G.; Webb, J. C.; Westfall, G. D.; Whitten, C., Jr.; Wieman, H.; Wingfield, E.; Wissink, S. W.; Witt, R.; Wu, Y.; Xie, W.; Xu, H.; Xu, N.; Xu, Q. H.; Xu, W.; Xu, Y.; Xu, Z.; Xue, L.; Yang, Y.; Yepes, P.; Yip, K.; Yoo, I. -K.; Yue, Q.; Zawisza, M.; Zbroszczyk, H.; Zhan, W.; Zhang, J.; Zhang, S.; Zhang, W. M.; Zhang, X. P.; Zhang, Y.; Zhang, Z. P.; Zhao, J.; Zhong, C.; Zhou, J.; Zhou, W.; Zhu, X.; Zhu, Y. H.; Zoulkarneev, R.; Zoulkarneeva, Y.		STAR Collaboration	Observation of an Antimatter Hypernucleus	SCIENCE			English	Article							QUARK-GLUON-PLASMA; STRANGENESS; LIFETIMES; SEARCH	Nuclear collisions recreate conditions in the universe microseconds after the Big Bang. Only a very small fraction of the emitted fragments are light nuclei, but these states are of fundamental interest. We report the observation of antihypertritons-comprising an antiproton, an antineutron, and an antilambda hyperon-produced by colliding gold nuclei at high energy. Our analysis yields 70 +/- 17 antihypertritons (3/Lambda(H) over bar) and 157 +/- 30 hypertritons (H-3(Lambda)). The measured yields of H-3(Lambda) (3/Lambda(H) over bar) and He-3 ((3)(He) over bar) are similar, suggesting an equilibrium in coordinate and momentum space populations of up, down, and strange quarks and antiquarks, unlike the pattern observed at lower collision energies. The production and properties of antinuclei, and of nuclei containing strange quarks, have implications spanning nuclear and particle physics, astrophysics, and cosmology.	[Abelev, B. I.; Betts, R. R.; Evdokimov, O.; Garcia-Solis, E. J.; Hofman, D. J.; Hollis, R. S.; Iordanova, A.; Kauder, K.; Suarez, M. C.] Univ Illinois, Chicago, IL 60607 USA; [Aggarwal, M. M.; Bhati, A. K.; Kumar, L.; Pruthi, N. K.] Panjab Univ, Chandigarh 160014, India; [Ahammed, Z.; Chattopadhyay, S.; Mazumdar, M. R. Dutta; Ganti, M. S.; Ghosh, P.; Mohanty, B.; Nayak, T. K.; Pal, S. K.; Singaraju, R. N.; Viyogi, Y. P.] Bhabha Atom Res Ctr, Ctr Variable Energy Cyclotron, Kolkata 700064, W Bengal, India; [Alakhverdyants, A. V.; Averichev, G. S.; Bunzarov, I.; Dedovich, T. G.; Efimov, L. G.; Fedorisin, J.; Filip, P.; Kechechyan, A.; Lednicky, R.; Panebratsev, Y.; Rogachevskiy, O. V.; Shahaliev, E.; Tokarev, M.; Vokal, S.; Zoulkarneev, R.; Zoulkarneeva, Y.] Joint Inst Nucl Res, Dubna 141980, Russia; [Alekseev, I.; Koroleva, L.; Morozov, B.; Svirida, D. N.] Alikhanov Inst Theoret & Expt Phys, Moscow, Russia; [Anderson, B. D.; Bouchet, J.; Joseph, J.; Keane, D.; Kopytine, M.; Margetis, S.; Pandit, Y.; Subba, N. L.; Vanfossen, J. A., Jr.; Zhang, W. M.] Kent State Univ, Kent, OH 44242 USA; [Arkhipkin, D.; Beavis, D. R.; Bland, L. C.; Christie, W.; Debbe, R. R.; DePhillips, M.; Didenko, L.; Dunlop, J. C.; Fachini, P.; Fine, V.; Fisyak, Y.; Gordon, A.; Guryn, W.; Lamont, M. A. C.; Landgraf, J. M.; Lauret, J.; Lebedev, A.; Lee, J. H.; Levine, M. J.; Ljubicic, T.; Longacre, R. S.; Love, W. A.; Ogawa, A.; Okada, H.; Perevoztchikov, V.; Pile, P.; Ruan, L.; Sorensen, P.; Tang, A. H.; Ullrich, T.; Van Buren, G.; Videbaek, F.; Xu, Z.; Yip, K.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Balewski, J.; Betancourt, M. J.; Corliss, R.; Hays-Wehle, J. P.; Hoffman, A. M.; Jones, C. L.; Kocoloski, A.; Leight, W.; Milner, R.; Redwine, R.; Sakuma, T.; Seele, J.; Surrow, B.; van Nieuwenhuizen, G.; Walker, M.] MIT, Cambridge, MA 02139 USA; [Barnby, L. S.; Burton, T. P.; Elhalhuli, E.; Jones, P. G.; Nelson, J. M.; Westfall, G. D.] Univ Birmingham, Birmingham, W Midlands, England; [Baumgart, S.; Bruna, E.; Caines, H.; Catu, O.; Chikanian, A.; Finch, E.; Harris, J. W.; Heinz, M.; Knospe, A. G.; Lin, G.; Majka, R.; Nattrass, C.; Putschke, J.; Sandweiss, J.; Smirnov, N.] Yale Univ, New Haven, CT 06520 USA; [Bellwied, R.; De Silva, L. C.; Elnimr, M.; LaPointe, S.; Pruneau, C.; Sharma, M.; Tarini, L. H.; Timmins, A. R.; Voloshin, S. A.] Wayne State Univ, Detroit, MI 48201 USA; [Bhasin, A.; Dogra, S. M.; Gupta, A.; Gupta, N.; Mangotra, L. K.; Potukuchi, B. V. K. S.] Univ Jammu, Jammu 180001, India; [Bichsel, H.; Cramer, J. G.; Kettler, D.; Prindle, D.; Trainor, T. A.] Univ Washington, Seattle, WA 98195 USA; [Bielcik, J.; Krus, M.; Pachr, M.] Czech Tech Univ, Fac Nucl Sci & Phys Engn, CR-11519 Prague, Czech Republic; [Bielcikova, J.; Chaloupka, P.; Chung, P.; Jakl, P.; Kapitan, J.; Kouchpil, V.; Sumbera, M.; Tlusty, D.] Nucl Phys Inst AS CR, Prague 25068, Czech Republic; [Biritz, B.; Cendejas, R.; Gangadharan, D. R.; Ghazikhanian, V.; Guertin, S. M.; Huang, H. Z.; Igo, G.; Kurnadi, P.; Sakai, S.; Staszak, D.; Trentalange, S.; Tsai, O. D.; Wang, G.; Whitten, C., Jr.; Xu, W.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Bonner, B. E.; Eppley, G.; Geurts, F.; Liu, J.; Llope, W. J.; McDonald, D.; Roberts, J. B.; Yepes, P.; Zhou, J.] Rice Univ, Houston, TX 77251 USA; [Braidot, E.; Mischke, A.; Peitzmann, T.; van Leeuwen, M.] NIKHEF, Amsterdam, Netherlands; [Braidot, E.; Mischke, A.; Peitzmann, T.; van Leeuwen, M.] Univ Utrecht, Amsterdam, Netherlands; [Brandin, A. V.; Kotchenda, L.; Kravtsov, P.; Okorokov, V.; Strikhanov, M.; Timoshenko, S.] Moscow Engn Phys Inst, Moscow 115409, Russia; [Bridgeman, A.; Krueger, K.; Spinka, H. M.; Underwood, D. G.] Argonne Natl Lab, Argonne, IL 60439 USA; [Bueltmann, S.; Koralt, I.; Plyku, D.] Old Dominion Univ, Norfolk, VA 23529 USA; [Cai, X. Z.; Chen, J. H.; Han, L. -X.; Jin, F.; Li, W.; Ma, G. L.; Ma, Y. G.; Tian, J.; Xue, L.; Zhang, S.; Zhao, J.; Zhong, C.; Zhu, Y. H.] Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Calderon, M.; Cebra, D.; Das, D.; Draper, J. E.; Haag, B.; Liu, H.; Reed, R.; Romero, J. L.; Sangaline, E.] Univ Calif Davis, Davis, CA 95616 USA; [Cervantes, M. C.; Clarke, R. F.; Codrington, M. J. M.; Djawotho, P.; Drachenberg, J. L.; Gagliardi, C. A.; Hamed, A.; Huo, L.; Mioduszewski, S.; Tribble, R. E.] Texas A&M Univ, College Stn, TX 77843 USA; [Chajecki, Z.; Humanic, T. J.; Lisa, M. A.] Ohio State Univ, Columbus, OH 43210 USA; [Chen, H. F.; Huang, B.; Li, C.; Lu, Y.; Luo, X.; Shao, M.; Sun, Y.; Tang, Z.; Wang, X. L.; Xu, Y.; Zhang, Z. P.] Univ Sci & Technol China, Hefei 230026, Peoples R China; [Chen, J. Y.; Li, N.; Li, Z.; Liu, F.; Shi, S. S.; Wu, Y.; Zhang, J.] CCNU HZNU, Inst Particle Phys, Wuhan 430079, Peoples R China; [Cheng, J.; Kang, K.; Li, Y.; Wang, Y.; Yue, Q.; Zhu, X.] Tsinghua Univ, Beijing 100084, Peoples R China; [Cherney, M.; Gorbunov, Y. N.; McShane, T. S.; Seger, J.] Creighton Univ, Omaha, NE 68178 USA; [Choi, K. E.; Grube, B.; Lee, C. -H.; Yoo, I. -K.] Pusan Natl Univ, Pusan, South Korea; [Dash, S.; Jena, C.; Mahapatra, D. P.; Phatak, S. C.] Inst Phys, Bhubaneswar 751005, Orissa, India; [Leyva, A. Davila; Hoffmann, G. W.; Kajimoto, K.; Li, L.; Markert, C.; Ray, R. L.; Schambach, J.; Thein, D.; Wada, M.; Wingfield, E.] Univ Texas Austin, Austin, TX 78712 USA; [Derevschikov, A. A.; Matulenko, Yu. A.; Meschanin, A.; Minaev, N. G.; Morozov, D. A.; Nogach, L. V.; Nurushev, S. B.; Vasiliev, A. N.] Inst High Energy Phys, Protvino, Russia; [de Souza, R. Derradi; Takahashi, J.; Vasconcelos, G. M. S.] Univ Estadual Campinas, Sao Paulo, Brazil; [Dong, X.; Grebenyuk, O.; Hjort, E.; Jacobs, P.; Kikola, D. P.; Kiryluk, J.; Klein, S. R.; Masui, H.; Matis, H. S.; Odyniec, G.; Olson, D.; Ploskon, M. A.; Poskanzer, A. M.; Powell, C. B.; Ritter, H. G.; Rose, A.; Sakrejda, I.; Salur, S.; Sichtermann, E. P.; Sun, X. M.; Symons, T. J. M.; Thomas, H.; Tram, V. N.; Wieman, H.; Xu, N.; Zhang, X. P.; Zhang, Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Erazmus, B.; Estienne, M.; Geromitsos, A.; Kabana, S.; Roy, C.; Sahoo, R.] SUBATECH, Nantes, France; [Eun, L.; Heppelmann, S.] Penn State Univ, University Pk, PA 16802 USA; [Fatemi, R.; Fersch, R. G.; Korsch, W.; Webb, G.] Univ Kentucky, Lexington, KY 40506 USA; [Grosnick, D.; Koetke, D. D.; Manweiler, R.; Stanislaus, T. D. S.; Webb, J. C.] Valparaiso Univ, Valparaiso, IN 46383 USA; [Hirsch, A.; Konzer, J.; Li, X.; Netrakanti, P. K.; Scharenberg, R. P.; Skoby, M. J.; Srivastava, B.; Stringfellow, B.; Ulery, J.; Wang, F.; Wang, Q.; Xie, W.] Purdue Univ, W Lafayette, IN 47907 USA; [Jacobs, W. W.; Mal, O. I.; Page, B. S.; Selyuzhenkov, I.; Sowinski, J.; Stevens, J. R.; Wissink, S. W.] Indiana Univ, Bloomington, IN 47408 USA; [Kisiel, A.; Pawlak, T.; Peryt, W.; Pluta, J.; Zawisza, M.; Zbroszczyk, H.] Warsaw Univ Technol, Warsaw, Poland; [Kollegger, T.; Mitrovski, M. K.; Schuster, T. R.; Stock, R.] Goethe Univ Frankfurt, Frankfurt, Germany; [Lindenbaum, S. J.] CUNY City Coll, New York, NY 10031 USA; [Munhoz, M. G.; Suaide, A. A. P.; de Toledo, A. Szanto] Univ Sao Paulo, Sao Paulo, Brazil; [Nandi, B. K.; Pujahari, P. R.; Varma, R.] Indian Inst Technol, Bombay 400076, Maharashtra, India; [Planinic, M.; Poljak, N.] Univ Zagreb, HR-10002 Zagreb, Croatia; [Qiu, H.; Sun, Z.; Wang, J. S.; Xu, H.; Yang, Y.; Zhan, W.] Inst Modern Phys, Lanzhou, Peoples R China; [Raniwala, R.; Raniwala, S.] Univ Rajasthan, Jaipur 302004, Rajasthan, India; [Schmitz, N.; Seyboth, P.; Simon, F.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Tarnowsky, T.; Wang, H.] Michigan State Univ, E Lansing, MI 48824 USA; [Witt, R.] USN Acad, Annapolis, MD 21402 USA; [Xu, Q. H.; Zhou, W.] Shandong Univ, Jinan 250100, Shandong, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Panjab University; Bhabha Atomic Research Center (BARC); Variable Energy Cyclotron Centre; Joint Institute for Nuclear Research - Russia; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; United States Department of Energy (DOE); Brookhaven National Laboratory; Massachusetts Institute of Technology (MIT); University of Birmingham; Yale University; Wayne State University; University of Jammu; University of Washington; University of Washington Seattle; Czech Technical University Prague; Czech Academy of Sciences; Nuclear Physics Institute of the Czech Academy of Sciences; University of California System; University of California Los Angeles; Rice University; FOM National Institute for Subatomic Physics; Utrecht University; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); United States Department of Energy (DOE); Argonne National Laboratory; Old Dominion University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; University of California System; University of California Davis; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Central China Normal University; Tsinghua University; Creighton University; Pusan National University; Institute of Physics Bhubaneswar (IOPB); University of Texas System; University of Texas Austin; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; Universidade Estadual de Campinas; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; IMT - Institut Mines-Telecom; IMT Atlantique; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Kentucky; Valparaiso University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Warsaw University of Technology; Goethe University Frankfurt; City University of New York (CUNY) System; City College of New York (CUNY); Universidade de Sao Paulo; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Zagreb; Chinese Academy of Sciences; Institute of Modern Physics, CAS; University of Rajasthan; Max Planck Society; Michigan State University; United States Department of Defense; United States Navy; United States Naval Academy; Shandong University	Abelev, BI (corresponding author), Univ Illinois, Chicago, IL 60607 USA.		Krůs, Miroslav/Q-5779-2018; Takahashi, Jun/B-2946-2012; Suaide, Alexandre A P/L-6239-2016; Tang, Zebo/A-9939-2014; Pandit, Yadav/I-2170-2013; Chaloupka, Petr/E-5965-2012; Planinic, Mirko/E-8085-2012; wang, xl/Y-8251-2019; Voloshin, Sergei A/I-4122-2013; Bielcikova, Jana/G-9342-2014; Kabana, Sonia/ABF-5974-2020; Raniwala, Rashmi/AAA-3747-2022; Okorokov, Vitaly/C-4800-2017; Selyuzhenkov, Ilya/AAH-8322-2019; Poljak, Nikola/AAI-4178-2020; Peitzmann, Thomas/K-2206-2012; Sumbera, Michal/O-7497-2014; de Souza, Rafael Derradi/M-4791-2013; Kisiel, Adam/O-8754-2015; Bhasin, Anju/AAS-4745-2021; Vasiliev, Alexander N/N-4742-2017; Matis, Howard/AAO-2082-2021; Strikhanov, Mikhail N/P-7393-2014; Witt, Richard/H-3560-2012; Alekseev, Igor G/J-8070-2014; Ma, Yu-Gang/M-8122-2013; Xue, Liang/F-8077-2013; Selyuzhenkov, Ilya/AAD-6163-2020; Huang, Bingchu/H-6343-2015; Mischke, Andre/D-3614-2011; Yip, Kin/D-6860-2013; Svirida, Dmitry N/R-4909-2016; Lednicky, Richard/K-4164-2013; Hamed, Ahmed Abdeen/AAF-4658-2020; Barnby, Lee S/G-2135-2010; Munhoz, Marcelo Gameiro/C-7939-2013; Yoo, In-Kwon/J-6222-2012; Bielcikova, Jana/AAB-4862-2020; Dogra, Sunil/B-5330-2013; Okorokov, Vitaly/AFM-5721-2022; Shi, Shusu/ABC-6567-2021; Nattrass, Christine E/J-6752-2016; Zhao, Jie/AAD-3191-2022; Xu, Wenqin/H-7553-2014; Fisyak, Yuri/K-2142-2017; Das, Debasish/C-8842-2013; CAI, Xiangzhou/N-8768-2013	Krůs, Miroslav/0000-0002-8595-3139; Takahashi, Jun/0000-0002-4091-1779; Suaide, Alexandre A P/0000-0003-2847-6556; Tang, Zebo/0000-0002-4247-0081; Pandit, Yadav/0000-0003-2809-7943; Planinic, Mirko/0000-0001-6760-2514; Kabana, Sonia/0000-0003-0568-5750; Okorokov, Vitaly/0000-0002-7162-5345; Selyuzhenkov, Ilya/0000-0002-8042-4924; Peitzmann, Thomas/0000-0002-7116-899X; Sumbera, Michal/0000-0002-0639-7323; de Souza, Rafael Derradi/0000-0002-2084-7001; Kisiel, Adam/0000-0001-8322-9510; Strikhanov, Mikhail N/0000-0003-2586-0405; Alekseev, Igor G/0000-0003-3358-9635; Ma, Yu-Gang/0000-0002-0233-9900; Xue, Liang/0000-0002-2321-9019; Huang, Bingchu/0000-0002-3253-3210; Yip, Kin/0000-0002-8576-4311; Svirida, Dmitry N/0000-0002-0334-7304; Lednicky, Richard/0000-0001-6887-1804; Barnby, Lee S/0000-0001-7357-9904; Munhoz, Marcelo Gameiro/0000-0003-3695-3180; Okorokov, Vitaly/0000-0002-7162-5345; Shi, Shusu/0000-0003-2032-0848; Nattrass, Christine E/0000-0002-8768-6468; Zhao, Jie/0000-0001-6408-2314; Xu, Wenqin/0000-0002-5976-4991; Leight, William/0000-0002-2968-7841; van Leeuwen, Marco/0000-0002-5222-4888; Thomas, James/0000-0002-6256-4536; Klein, Spencer/0000-0003-2841-6553; Sorensen, Paul/0000-0001-5056-9391; Luo, Xiaofeng/0000-0002-4919-303X; Pujahari, Prabhat Ranjan/0000-0002-0994-7212; Evdokimov, Olga/0000-0002-1250-8931; Kikola, Daniel/0000-0001-6896-6475; Wada, Masayuki/0000-0002-6414-6944; Fisyak, Yuri/0000-0002-3151-8377; Dogra, Sunil Manohar/0000-0002-0812-0758; Grube, Boris/0000-0001-8473-0454; Bhasin, Anju/0000-0002-3687-8179; M. Hamed, Ahmed/0000-0003-1732-8443; Poljak, Nikola/0000-0002-4512-9620; pruneau, claude/0000-0002-0458-538X; Simon, Frank/0000-0002-5978-0289; Das, Debasish/0000-0002-2685-3111; CAI, Xiangzhou/0000-0002-7108-2344; Finch, Evan/0000-0002-6150-8612	U.S. DOE Office of Science; NSF; Sloan Foundation; DFG cluster of excellence "Origin and Structure of the Universe" [CNRS/IN2P3]; STFC; EPSRC of the United Kingdom; FAPESP CNPq of Brazil; Ministry of Education and Science of the Russian Federation; NNSFC of China; CAS of China; MoST of China; MoE of China; GA of the Czech Republic; MSMT of the Czech Republic; FOM of the Netherlands; NOW of the Netherlands; DAE of India; DST of India; CSIR of India; Polish Ministry of Science and Higher Education; Korea Research Foundation; Ministry of Science, Education and Sports of the Republic of Croatia; Russian Ministry of Science and Technology and RosAtom of Russia; Science and Technology Facilities Council [PP/F001061/1] Funding Source: researchfish; STFC [PP/F001061/1] Funding Source: UKRI	U.S. DOE Office of Science(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); DFG cluster of excellence "Origin and Structure of the Universe"(German Research Foundation (DFG)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FAPESP CNPq of Brazil; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); NNSFC of China(National Natural Science Foundation of China (NSFC)); CAS of China; MoST of China(Ministry of Science and Technology, China); MoE of China(Ministry of Education, China); GA of the Czech Republic; MSMT of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); FOM of the Netherlands(FOM (The Netherlands)); NOW of the Netherlands(Netherlands Government); DAE of India; DST of India; CSIR of India(Council of Scientific & Industrial Research (CSIR) - India); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Korea Research Foundation(National Research Foundation of Korea); Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Russian Ministry of Science and Technology and RosAtom of Russia; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank K. Synder for providing Fig. 1, and the RHIC Operations Group and RCF at BNL, the NERSC Center at LBNL, and the Open Science Grid consortium for providing resources and support. Supported by the Offices of NP and HEP within the U.S. DOE Office of Science; NSF; the Sloan Foundation; the DFG cluster of excellence "Origin and Structure of the Universe," CNRS/IN2P3; STFC and EPSRC of the United Kingdom; FAPESP CNPq of Brazil; Ministry of Education and Science of the Russian Federation; NNSFC, CAS, MoST, and MoE of China; GA and MSMT of the Czech Republic; FOM and NOW of the Netherlands; DAE, DST, and CSIR of India; Polish Ministry of Science and Higher Education; Korea Research Foundation; Ministry of Science, Education and Sports of the Republic of Croatia; and Russian Ministry of Science and Technology and RosAtom of Russia.	Abelev BI, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.152301; Ackermann KH, 2003, NUCL INSTRUM METH A, V499, P624, DOI 10.1016/S0168-9002(02)01960-5; Adams J, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.064906; Adams J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.062301; Adler C, 2001, PHYS REV LETT, V87, DOI [10.1103/PhysRevLett.87.182301, 10.1103/PhysRevLett.262301, 10.1103/PhysRevLett.87.262301]; AHLEN S, 1994, NUCL INSTRUM METH A, V350, P351, DOI 10.1016/0168-9002(94)91184-3; Alcaraz J, 1999, PHYS LETT B, V461, P387, DOI 10.1016/S0370-2693(99)00874-6; Amsler C, 2008, PHYS LETT B, V667, P1, DOI 10.1016/j.physletb.2008.07.018; Anderson M, 2003, NUCL INSTRUM METH A, V499, P659, DOI 10.1016/S0168-9002(02)01964-2; ANTIPOV YM, 1971, SOV J NUCL PHYS+, V12, P171; Armstrong TA, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.024902; Armstrong TA, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.064908; Arsene I, 2005, NUCL PHYS A, V757, P1, DOI 10.1016/j.nuclphysa.2005.02.130; Block M.M., 1964, P INT C HYP, V64-1, P63; BOHM G, 1970, NUCL PHYS B, VB 16, P46, DOI 10.1016/0550-3213(70)90335-4; Braun-Munzinger P, 2007, NATURE, V448, P302, DOI 10.1038/nature06080; DALITZ RH, 1962, PHYS LETT, V1, P58, DOI 10.1016/0031-9163(62)90437-7; DANYSZ M, 1953, PHILOS MAG, V44, P348; Donato F, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.043506; Fuke H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.081101; Gavai RV, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.014004; GREINER C, 1988, PHYS REV D, V38, P2797, DOI 10.1103/PhysRevD.38.2797; Greiner W, 1996, INT J MOD PHYS E, V5, P1, DOI 10.1142/S0218301396000025; HEINZ U, 1986, J PHYS G NUCL PARTIC, V12, P1237, DOI 10.1088/0305-4616/12/11/013; JURIC M, 1973, NUCL PHYS B, V52, P1, DOI 10.1016/0550-3213(73)90084-9; Kamada H, 1998, PHYS REV C, V57, P1595, DOI 10.1103/PhysRevC.57.1595; KEYES G, 1968, PHYS REV LETT, V20, P819, DOI 10.1103/PhysRevLett.20.819; KEYES G, 1973, NUCL PHYS B, VB 67, P269, DOI 10.1016/0550-3213(73)90197-1; KEYES G, 1970, PHYS REV D, V1, P66, DOI 10.1103/PhysRevD.1.66; Koch V, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.182301; Kolesnikov VI, 2008, J PHYS CONF SER, V110, DOI 10.1088/1742-6596/110/3/032010; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; Majumder A, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.054901; PHILLIPS RE, 1969, PHYS REV, V180, P1307, DOI 10.1103/PhysRev.180.1307; PREM RJ, 1964, PHYS REV B, V136, P1803, DOI 10.1103/PhysRev.136.B1803; PRETZL K, 2001, HEAVY ION PHYS, V14, P297; RAFELSKI J, 1982, PHYS REV LETT, V48, P1066, DOI 10.1103/PhysRevLett.48.1066; SATO H, 1981, PHYS LETT B, V98, P153, DOI 10.1016/0370-2693(81)90976-X; SCHAFFNER J, 1992, PHYS REV C, V46, P322, DOI 10.1103/PhysRevC.46.322; Zhang S, 2010, PHYS LETT B, V684, P224, DOI 10.1016/j.physletb.2010.01.034	40	196	200	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					58	62		10.1126/science.1183980	http://dx.doi.org/10.1126/science.1183980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20203011	Green Submitted			2022-12-28	WOS:000276202200033
J	Ahmed, Z; Akerib, DS; Arrenberg, S; Bailey, CN; Balakishiyeva, D; Baudis, L; Bauer, DA; Brink, PL; Bruch, T; Bunker, R; Cabrera, B; Caldwell, DO; Cooley, J; Cushman, P; Daal, M; DeJongh, F; Dragowsky, MR; Duong, L; Fallows, S; Figueroa-Feliciano, E; Filippini, J; Fritts, M; Golwala, SR; Grant, DR; Hall, J; Hennings-Yeomans, R; Hertel, SA; Holmgren, D; Hsu, L; Huber, ME; Kamaev, O; Kiveni, M; Kos, M; Leman, SW; Mahapatra, R; Mandic, V; McCarthy, KA; Mirabolfathi, N; Moore, D; Nelson, H; Ogburn, RW; Phipps, A; Pyle, M; Qiu, X; Ramberg, E; Rau, W; Reisetter, A; Saab, T; Sadoulet, B; Sander, J; Schnee, RW; Seitz, DN; Serfass, B; Sundqvist, KM; Tarka, M; Wikus, P; Yellin, S; Yoo, J; Young, BA; Zhang, J				Ahmed, Z.; Akerib, D. S.; Arrenberg, S.; Bailey, C. N.; Balakishiyeva, D.; Baudis, L.; Bauer, D. A.; Brink, P. L.; Bruch, T.; Bunker, R.; Cabrera, B.; Caldwell, D. O.; Cooley, J.; Cushman, P.; Daal, M.; DeJongh, F.; Dragowsky, M. R.; Duong, L.; Fallows, S.; Figueroa-Feliciano, E.; Filippini, J.; Fritts, M.; Golwala, S. R.; Grant, D. R.; Hall, J.; Hennings-Yeomans, R.; Hertel, S. A.; Holmgren, D.; Hsu, L.; Huber, M. E.; Kamaev, O.; Kiveni, M.; Kos, M.; Leman, S. W.; Mahapatra, R.; Mandic, V.; McCarthy, K. A.; Mirabolfathi, N.; Moore, D.; Nelson, H.; Ogburn, R. W.; Phipps, A.; Pyle, M.; Qiu, X.; Ramberg, E.; Rau, W.; Reisetter, A.; Saab, T.; Sadoulet, B.; Sander, J.; Schnee, R. W.; Seitz, D. N.; Serfass, B.; Sundqvist, K. M.; Tarka, M.; Wikus, P.; Yellin, S.; Yoo, J.; Young, B. A.; Zhang, J.		CDMS II Collaboration	Dark Matter Search Results from the CDMS II Experiment	SCIENCE			English	Article								Astrophysical observations indicate that dark matter constitutes most of the mass in our universe, but its nature remains unknown. Over the past decade, the Cryogenic Dark Matter Search (CDMS II) experiment has provided world-leading sensitivity for the direct detection of weakly interacting massive particle (WIMP) dark matter. The final exposure of our low-temperature germanium particle detectors at the Soudan Underground Laboratory yielded two candidate events, with an expected background of 0.9 +/- 0.2 events. This is not statistically significant evidence for a WIMP signal. The combined CDMS II data place the strongest constraints on the WIMP-nucleon spin-independent scattering cross section for a wide range of WIMP masses and exclude new parameter space in inelastic dark matter models.	[Cooley, J.] So Methodist Univ, Dept Phys, Dallas, TX 75275 USA; [Ahmed, Z.; Filippini, J.; Golwala, S. R.; Moore, D.] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Akerib, D. S.; Bailey, C. N.; Dragowsky, M. R.; Grant, D. R.; Hennings-Yeomans, R.] Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA; [Bauer, D. A.; DeJongh, F.; Hall, J.; Holmgren, D.; Hsu, L.; Ramberg, E.; Yoo, J.] Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA; [Sadoulet, B.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Hertel, S. A.; Leman, S. W.; McCarthy, K. A.; Wikus, P.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Rau, W.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Reisetter, A.] St Olaf Coll, Dept Phys, Northfield, MN 55057 USA; [Young, B. A.] Santa Clara Univ, Dept Phys, Santa Clara, CA 95053 USA; [Brink, P. L.; Cabrera, B.; Ogburn, R. W.; Pyle, M.; Yellin, S.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Kiveni, M.; Kos, M.; Schnee, R. W.] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA; [Mahapatra, R.] Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; [Daal, M.; Mirabolfathi, N.; Phipps, A.; Sadoulet, B.; Seitz, D. N.; Serfass, B.; Sundqvist, K. M.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bunker, R.; Caldwell, D. O.; Nelson, H.; Yellin, S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Huber, M. E.] Univ Colorado, Dept Phys, Denver, CO 80217 USA; [Huber, M. E.] Univ Colorado, Dept Elect Engn, Denver, CO 80217 USA; [Balakishiyeva, D.; Saab, T.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA; [Cushman, P.; Duong, L.; Fallows, S.; Fritts, M.; Kamaev, O.; Mandic, V.; Qiu, X.; Reisetter, A.; Zhang, J.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Arrenberg, S.; Baudis, L.; Bruch, T.; Tarka, M.] Univ Zurich, Inst Phys, CH-8057 Zurich, Switzerland	Southern Methodist University; California Institute of Technology; Case Western Reserve University; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Queens University - Canada; Saint Olaf College; Santa Clara University; Stanford University; Syracuse University; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities; University of Zurich	Cooley, J (corresponding author), So Methodist Univ, Dept Phys, Dallas, TX 75275 USA.	cooley@physics.smu.edu	Yoo, Jonghee/K-8394-2016; Cushman, Priscilla/ABD-2905-2020; Huber, Martin/B-3354-2011; Pyle, Matt/E-7348-2015; Hall, Jeter/F-6108-2013; Moore, David C/Q-2208-2017; Hall, Jeter/E-9294-2015; Qiu, Xinjie/C-6164-2012; Baudis, Laura/ABE-1796-2021; Bailey, Catherine/C-6107-2009	Huber, Martin/0000-0002-7638-902X; Pyle, Matt/0000-0002-3490-6754; Moore, David C/0000-0002-2358-4761; Baudis, Laura/0000-0003-4710-1768; Holmgren, Donald/0000-0001-6701-7737; Saab, Tarek/0000-0003-4463-6011; Cooley, Jodi/0000-0001-6761-2042; Golwala, Sunil/0000-0002-1098-7174; Ahmed, Zeeshan/0000-0002-9957-448X; Bunker, Raymond/0000-0003-2174-7632	National Science Foundation [AST-9978911, PHY-0542066, PHY-0503729, PHY-0503629, PHY-0503641, PHY-0504224, PHY-0705052, PHY-0801708, PHY-0801712, HY-0802575, PHY-0855525]; Department of Energy [DE-AC03-76SF00098, DE-FG02-91ER40688, DE-FG02-92ER40701, DE-FG03-90ER40569, DE-FG03-91ER40618]; Swiss National Foundation [20-118119]; Natural Sciences and Engineering Research Council of Canada [SAPIN 341314-07]; Direct For Mathematical & Physical Scien [0855525] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The CDMS collaboration gratefully acknowledges the contributions of numerous engineers and technicians; we would like to especially thank J. Beaty, B. Hines, L. Novak, R. Schmitt, and A. Tomada. This work is supported in part by the National Science Foundation ( grants AST-9978911, PHY-0542066, PHY-0503729, PHY-0503629, PHY-0503641, PHY-0504224, PHY-0705052, PHY-0801708, PHY-0801712, PHY-0802575, and PHY-0855525), by the Department of Energy ( contracts DE-AC03-76SF00098, DE-FG02-91ER40688, DE-FG02-92ER40701, DE-FG03-90ER40569, and DE-FG03-91ER40618), by the Swiss National Foundation ( SNF grant 20-118119), and by the Natural Sciences and Engineering Research Council of Canada ( grant SAPIN 341314-07).	Ahmed Z, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.011301; Akerib DS, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.052009; Angle J, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.115005; Aprile E, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.045807; Bernabei R, 2008, EUR PHYS J C, V56, P333, DOI 10.1140/epjc/s10052-008-0662-y; Bertone G, 2005, PHYS REP, V405, P279, DOI 10.1016/j.physrep.2004.08.031; Ellis J, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.095007; GOODMAN MW, 1985, PHYS REV D, V31, P3059, DOI 10.1103/PhysRevD.31.3059; Jungman G, 1996, PHYS REP, V267, P195, DOI 10.1016/0370-1573(95)00058-5; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Lebedenko VN, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.052010; LEE BW, 1977, PHYS REV LETT, V39, P165, DOI 10.1103/PhysRevLett.39.165; Lewin JD, 1996, ASTROPART PHYS, V6, P87, DOI 10.1016/S0927-6505(96)00047-3; ROSZKOWSKI L, 2007, J HIGH ENERGY PHYS; Smith D, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.043502; STEIGMAN G, 1985, NUCL PHYS B, V253, P375, DOI 10.1016/0550-3213(85)90537-1; Yellin S, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.032005	18	616	622	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1619	1621		10.1126/science.1186112	http://dx.doi.org/10.1126/science.1186112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20150446	Green Submitted			2022-12-28	WOS:000275970600036
J	Iglehart, JK				Iglehart, John K.			The Democrats' Last Ditch -- Reconciliation or Bust.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		FRIST B, 2010, WALL STREET J   0226, pA15; STOLBERG SG, 2010, NY TIMES        0813, pA1; TRUFFER CJ, 2010, HLTH AFF MILLWO 0218	3	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMp1002479	http://dx.doi.org/10.1056/NEJMp1002479			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20200360				2022-12-28	WOS:000275650400007
J	Jost, TS				Jost, Timothy S.			Can the States Nullify Health Care Reform?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							Balkin JM, 2010, NEW ENGL J MED, V362, P482, DOI 10.1056/NEJMp1000087; CAUCHI R, 2010, NAT C STAT LEG FEBR; OGDEN DW, JUSTICE BLOG INVESTI	3	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					869	871		10.1056/NEJMp1001345	http://dx.doi.org/10.1056/NEJMp1001345			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20147705				2022-12-28	WOS:000275365900002
J	Chamarthi, B; Morris, CA; Kaiser, UB; Katz, JT; Loscalzo, J				Chamarthi, Bindu; Morris, Charles A.; Kaiser, Ursula B.; Katz, Joel T.; Loscalzo, Joseph			Stalking the Diagnosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PITUITARY-GLAND; METASTASES; CARCINOMA; CANCER; FEATURES		Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Katz, JT (corresponding author), 75 Francis St, Boston, MA 02115 USA.	jkatz@partners.org	Loscalzo, Joseph/ABD-8980-2021		NHLBI NIH HHS [T32 HL007609] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007609] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7; DUCHEN LW, 1966, J PATHOL BACTERIOL, V91, P347, DOI 10.1002/path.1700910208; Fassett Daniel R, 2004, Neurosurg Focus, V16, pE8; GURLING KJ, 1957, BRIT J CANCER, V11, P519, DOI 10.1038/bjc.1957.63; HOUCK WA, 1970, CANCER, V26, P656, DOI 10.1002/1097-0142(197009)26:3<656::AID-CNCR2820260325>3.0.CO;2-M; KIMMEL DW, 1983, CANCER, V52, P2355, DOI 10.1002/1097-0142(19831215)52:12<2355::AID-CNCR2820521232>3.0.CO;2-J; KOVACS K, 1973, ONCOLOGY-BASEL, V27, P533, DOI 10.1159/000224763; Kurkjian Carla, 2005, Int J Clin Oncol, V10, P191, DOI 10.1007/s10147-004-0458-5; MARIN F, 1992, MAYO CLIN PROC, V67, P949, DOI 10.1016/S0025-6196(12)60925-2; MAX MB, 1981, NEUROLOGY, V31, P998, DOI 10.1212/WNL.31.8.998; McCormick P C, 1989, Br J Neurosurg, V3, P71, DOI 10.3109/02688698909001028; Morita A, 1998, J NEUROSURG, V89, P69, DOI 10.3171/jns.1998.89.1.0069; SCHUBIGER O, 1992, NEURORADIOLOGY, V34, P131, DOI 10.1007/BF00588159; Sioutos P, 1996, ANN SURG ONCOL, V3, P94, DOI 10.1007/BF02409058; TEEARS RJ, 1975, CANCER, V36, P216, DOI 10.1002/1097-0142(197507)36:1<216::AID-CNCR2820360123>3.0.CO;2-E	15	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					834	839		10.1056/NEJMcps0806157	http://dx.doi.org/10.1056/NEJMcps0806157			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	20200388				2022-12-28	WOS:000275108300012
J	Mechanic, R; Altman, S				Mechanic, Robert; Altman, Stuart			Medicare's Opportunity to Encourage Innovation in Health Care Delivery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mechanic, Robert; Altman, Stuart] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02454 USA	Brandeis University	Mechanic, R (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02454 USA.							ALTMAN S, 2009, FUTURESCAN 2010 HEAL, P11; Etheredge LM, 2007, HEALTH AFFAIR, V26, pW107, DOI 10.1377/hlthaff.26.2.w107; Iglehart JK, 2009, HEALTH AFFAIR, V28, pW688, DOI 10.1377/hlthaff.28.4.w688	3	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					772	774		10.1056/NEJMp1001013	http://dx.doi.org/10.1056/NEJMp1001013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20200381				2022-12-28	WOS:000275108300002
J	Jones, AE; Shapiro, NI; Trzeciak, S; Arnold, RC; Claremont, HA; Kline, JA				Jones, Alan E.; Shapiro, Nathan I.; Trzeciak, Stephen; Arnold, Ryan C.; Claremont, Heather A.; Kline, Jeffrey A.		Emergency Med Shock Res Network	Lactate Clearance vs Central Venous Oxygen Saturation as Goals of Early Sepsis Therapy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BENCH-TO-BEDSIDE; DIRECTED THERAPY; SEPTIC SHOCK; TRANSLATING RESEARCH; UNITED-STATES; ORGAN FAILURE; RESUSCITATION; GUIDELINES; SCORE; IMPLEMENTATION	Context Goal-directed resuscitation for severe sepsis and septic shock has been reported to reduce mortality when applied in the emergency department. Objective To test the hypothesis of noninferiority between lactate clearance and central venous oxygen saturation (ScvO(2)) as goals of early sepsis resuscitation. Design, Setting, and Patients Multicenter randomized, noninferiority trial involving patients with severe sepsis and evidence of hypoperfusion or septic shock who were admitted to the emergency department from January 2007 to January 2009 at 1 of 3 participating US urban hospitals. Interventions We randomly assigned patients to 1 of 2 resuscitation protocols. The ScvO(2) group was resuscitated to normalize central venous pressure, mean arterial pressure, and ScvO(2) of at least 70%; and the lactate clearance group was resuscitated to normalize central venous pressure, mean arterial pressure, and lactate clearance of at least 10%. The study protocol was continued until all goals were achieved or for up to 6 hours. Clinicians who subsequently assumed the care of the patients were blinded to the treatment assignment. Main Outcome Measure The primary outcome was absolute in-hospital mortality rate; the noninferiority threshold was set at Delta equal to -10%. Results Of the 300 patients enrolled, 150 were assigned to each group and patients were well matched by demographic, comorbidities, and physiological features. There were no differences in treatments administered during the initial 72 hours of hospitalization. Thirty-four patients (23%) in the ScvO(2) group died while in the hospital (95% confidence interval [CI], 17%-30%) compared with 25 (17%; 95% CI, 11%-24%) in the lactate clearance group. This observed difference between mortality rates did not reach the predefined -10% threshold (intent-to-treat analysis: 95% CI for the 6% difference, -3% to 15%). There were no differences in treatment-related adverse events between the groups. Conclusion Among patients with septic shock who were treated to normalize central venous and mean arterial pressure, additional management to normalize lactate clearance compared with management to normalize ScvO(2) did not result in significantly different in-hospital mortality.	[Jones, Alan E.; Claremont, Heather A.; Kline, Jeffrey A.] Carolinas Med Ctr, Dept Emergency Med, Charlotte, NC 28203 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Trzeciak, Stephen] Cooper Univ Hosp, Dept Med, Div Crit Care Med, Camden, NJ USA; [Trzeciak, Stephen; Arnold, Ryan C.] Cooper Univ Hosp, Dept Emergency Med, Camden, NJ USA	Carolinas Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Cooper University Hospital; Cooper University Hospital	Kline, JA (corresponding author), Carolinas Med Ctr, Dept Emergency Med, 1000 Blythe Blvd,MEB 304, Charlotte, NC 28203 USA.	jkline@carolinas.org	Shapiro, Nathan/F-1718-2016		National Institutes of Health (NIH) [GM76652, GM83211, HL091757, GM076659]; National Institute of General Medical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM076652, P50GM076659, K23GM083211] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding/Support: This project was supported by grant GM76652 from the National Institutes of Health (NIH), National Institute of General Medical Sciences (Dr Jones). Dr Trzeciak was supported by grant GM83211 from the NIH. Dr Shapiro was supported by grants HL091757 and GM076659 from the NIH.	Agency for Healthcare Research Quality, AG HEALTHC RES QUAL; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Carlbom DJ, 2007, CRIT CARE MED, V35, P2525, DOI 10.1097/01.ccm.0000298122.49245.d7; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Ho BCH, 2006, CRIT CARE, V10, DOI 10.1186/cc4918; Hollenberg SM, 2004, CRIT CARE MED, V32, P1928, DOI 10.1097/01.CCM.0000139761.05492.D6; Jones AE, 2008, CRIT CARE MED, V36, P2734, DOI 10.1097/CCM.0b013e318186f839; Jones AE, 2007, ACAD EMERG MED, V14, P1072, DOI 10.1197/j.aem.2007.04.014; Jones AE, 2007, CHEST, V132, P425, DOI 10.1378/chest.07-0234; Jones Alan E, 2005, Crit Care Med, V33, P1888, DOI 10.1097/01.CCM.0000166872.78449.B1; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nguyen HB, 2007, CRIT CARE MED, V35, P1105, DOI 10.1097/01.CCM.0000259463.33848.3D; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Peake S, 2007, CRIT CARE MED, V35, P994, DOI 10.1097/01.CCM.0000257481.37623.3B; Perel A, 2008, CRIT CARE, V12, DOI 10.1186/cc6979; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shapiro NI, 2010, J EMERG MED, V39, P89, DOI 10.1016/j.jemermed.2009.07.021; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Shapiro NI, 2006, CRIT CARE MED, V34, P1025, DOI 10.1097/01.CCM.0000206104.18647.A8; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Trzeciak S, 2006, CHEST, V129, P225, DOI 10.1378/chest.129.2.225; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989	29	707	801	2	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					739	746		10.1001/jama.2010.158	http://dx.doi.org/10.1001/jama.2010.158			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559DD	20179283	Green Accepted, Bronze			2022-12-28	WOS:000274800000025
J	Leder, P				Leder, Philip			Marshall Warren Nirenberg (1927-2010)	SCIENCE			English	Biographical-Item									Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Leder, P (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	leder@genetics.med.harvard.edu						NIRENBERG MW, PUBLICATION LIST	1	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					972	972		10.1126/science.1187484	http://dx.doi.org/10.1126/science.1187484			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167780				2022-12-28	WOS:000274625800032
J	Marx, FG; Uhen, MD				Marx, Felix G.; Uhen, Mark D.			Climate, Critters, and Cetaceans: Cenozoic Drivers of the Evolution of Modern Whales	SCIENCE			English	Article							ANTARCTIC CIRCUMPOLAR CURRENT; SOUTHERN-OCEAN; DYNAMICS; NUTRIENT	Modern cetaceans, a poster child of evolution, play an important role in the ocean ecosystem as apex predators and nutrient distributors, as well as evolutionary "stepping stones" for the deep sea biota. Recent discussions on the impact of climate change and marine exploitation on current cetacean populations may benefit from insights into what factors have influenced cetacean diversity in the past. Previous studies suggested that the rise of diatoms as dominant marine primary producers and global temperature change were key factors in the evolution of modern whales. Based on a comprehensive diversity data set, we show that much of observed cetacean paleodiversity can indeed be explained by diatom diversity in conjunction with variations in climate as indicated by oxygen stable isotope records (delta(18)O).	[Marx, Felix G.] Univ Otago, Dept Geol, Dunedin 9016, Otago, New Zealand; [Marx, Felix G.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Uhen, Mark D.] George Mason Univ, Dept Atmospher Ocean & Earth Sci, Fairfax, VA 22030 USA	University of Otago; University of Bristol; George Mason University	Marx, FG (corresponding author), Univ Otago, Dept Geol, 360 Leith Walk,POB 56, Dunedin 9016, Otago, New Zealand.	f.g.marx@bristol.ac.uk	Marx, Felix Georg/AAI-3480-2021; Uhen, Mark D/AAZ-3158-2020	Marx, Felix Georg/0000-0002-1029-4001; Uhen, Mark D/0000-0002-2689-0801	University of Otago	University of Otago	We thank three referees for their comments, as well as G. Hunt for advice and help with R programming and M. Katz for the provision of data. L. Kavalieris, I. Jolliffe, M. Carrano, D. Thomas, M. Benton, and the participants of the August 2009 Encyclopedia of Life synthesis meeting on marine tetrapod evolution at the Field Museum, Chicago, provided advice and helpful discussions about earlier versions of this work and related topics. F. M. was supported by a University of Otago Postgraduate Scholarship. This is Paleobiology Database publication 108.	Bannister J.L., 2008, ENCY MARINE MAMMALS, V2nd, P80; Barker PF, 2007, DEEP-SEA RES PT II, V54, P2388, DOI 10.1016/j.dsr2.2007.07.028; Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; BARRETT PM, 2009, R SOC B, V276, P2667; Berger WH, 2007, DEEP-SEA RES PT II, V54, P2399, DOI 10.1016/j.dsr2.2007.07.024; Burnham KP, 2001, MODEL SELECTION MULT; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Fordyce RE, 2003, J VERTEBR PALEONTOL, V23, p50A; FORDYCE RE, 1977, PALAEOGEOGR PALAEOCL, V21, P265; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; FORDYCE RE, 2003, EOCENE OLIGOCENE TRA, P154; HAECKEL E, 1899, KUNSTFORMEN NATUR; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; LIPPS J H, 1976, Paleobiology, V2, P147; Maddala G.S., 1986, LTD DEPENDENT QUALIT; MITCHELL ED, 1989, CAN J FISH AQUAT SCI, V46, P2219, DOI 10.1139/f89-273; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Pondaven P, 1999, DEEP-SEA RES PT I, V46, P1923, DOI 10.1016/S0967-0637(99)00033-3; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Smith AB, 2007, PALAEONTOLOGY, V50, P765, DOI 10.1111/j.1475-4983.2007.00693.x; Spencer-Cervato Cinzia, 1999, Palaeontologia Electronica, V2, pUnpaginated; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	27	144	148	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					993	996		10.1126/science.1185581	http://dx.doi.org/10.1126/science.1185581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167785	Green Published			2022-12-28	WOS:000274625800039
J	Swaminath, A; Feingold, D				Swaminath, Arun; Feingold, Daniel			Fulminant Ulcerative Colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Swaminath, Arun; Feingold, Daniel] Columbia Univ, Med Ctr, New York, NY 10027 USA	Columbia University	Swaminath, A (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.	as3576@columbia.edu	Swaminath, Arun/L-5043-2019	Swaminath, Arun/0000-0003-3495-012X					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					635	635		10.1056/NEJMicm0903348	http://dx.doi.org/10.1056/NEJMicm0903348			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556ED	20164487				2022-12-28	WOS:000274571200011
J	Ash, C; Jasny, BR; Malakoff, DA; Sugden, AM				Ash, Caroline; Jasny, Barbara R.; Malakoff, David A.; Sugden, Andrew M.			Feeding the Future INTRODUCTION	SCIENCE			English	Editorial Material																			0	31	34	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					797	797		10.1126/science.327.5967.797	http://dx.doi.org/10.1126/science.327.5967.797			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554AQ	20150477				2022-12-28	WOS:000274408300033
J	Cals, JWL; Francis, NA				Cals, Jochen W. L.; Francis, Nick A.			10-Minute Consultation Acute cough in adults	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cals, Jochen W. L.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Francis, Nick A.] Cardiff Univ, Sch Med, Dept Publ Hlth & Primary Care, Cardiff CF14 4XN, S Glam, Wales	Maastricht University; Cardiff University	Cals, JWL (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, POB 616, NL-6200 MD Maastricht, Netherlands.	j.cals@hag.unimaas.nl	Francis, Nick/B-7413-2009; Cals, Jochen WL/A-1262-2007	Francis, Nick/0000-0001-8939-7312; Cals, Jochen WL/0000-0001-9550-5674	Netherlands Organisation for Health Research and Development (ZonMW)	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	JWLC is supported by a grant of the Netherlands Organisation for Health Research and Development (ZonMW) as an MD medical research trainee.		0	3	3	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 12	2010	340								c574	10.1136/bmj.c574	http://dx.doi.org/10.1136/bmj.c574			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555AB	20154050	Green Accepted			2022-12-28	WOS:000274477800002
J	Whelan, TJ; Pignol, JP; Levine, MN; Julian, JA; MacKenzie, R; Parpia, S; Shelley, W; Grimard, L; Bowen, J; Lukka, H; Perera, F; Fyles, A; Schneider, K; Gulavita, S; Freeman, C				Whelan, Timothy J.; Pignol, Jean-Philippe; Levine, Mark N.; Julian, Jim A.; MacKenzie, Robert; Parpia, Sameer; Shelley, Wendy; Grimard, Laval; Bowen, Julie; Lukka, Himu; Perera, Francisco; Fyles, Anthony; Schneider, Ken; Gulavita, Sunil; Freeman, Carolyn			Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIAL; CONSERVING THERAPY; RADIOTHERAPY HYPOFRACTIONATION; AXILLARY DISSECTION; UK STANDARDIZATION; FOLLOW-UP; LUMPECTOMY; FRACTIONATION; IRRADIATION; MASTECTOMY	BACKGROUND The optimal fractionation schedule for whole-breast irradiation after breast-conserving surgery is unknown. METHODS We conducted a study to determine whether a hypofractionated 3-week schedule of whole-breast irradiation is as effective as a 5-week schedule. Women with invasive breast cancer who had undergone breast-conserving surgery and in whom resection margins were clear and axillary lymph nodes were negative were randomly assigned to receive whole-breast irradiation either at a standard dose of 50.0 Gy in 25 fractions over a period of 35 days (the control group) or at a dose of 42.5 Gy in 16 fractions over a period of 22 days (the hypofractionated-radiation group). RESULTS The risk of local recurrence at 10 years was 6.7% among the 612 women assigned to standard irradiation as compared with 6.2% among the 622 women assigned to the hypofractionated regimen (absolute difference, 0.5 percentage points; 95% confidence interval [ CI], -2.5 to 3.5). At 10 years, 71.3% of women in the control group as compared with 69.8% of the women in the hypofractionated-radiation group had a good or excellent cosmetic outcome (absolute difference, 1.5 percentage points; 95% CI, -6.9 to 9.8). CONCLUSIONS Ten years after treatment, accelerated, hypofractionated whole-breast irradiation was not inferior to standard radiation treatment in women who had undergone breast-conserving surgery for invasive breast cancer with clear surgical margins and negative axillary nodes. (ClinicalTrials.gov number, NCT00156052.)	[Whelan, Timothy J.; Levine, Mark N.; Julian, Jim A.; Parpia, Sameer; Lukka, Himu] Juravinski Canc Ctr, Hamilton, ON L8V 5C2, Canada; [Whelan, Timothy J.; Levine, Mark N.; Julian, Jim A.; Parpia, Sameer; Lukka, Himu] McMaster Univ, Hamilton, ON, Canada; [Pignol, Jean-Philippe; MacKenzie, Robert] Odette Canc Ctr, Toronto, ON, Canada; [Fyles, Anthony] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Shelley, Wendy] Canc Ctr SE Ontario, Kingston, ON, Canada; [Grimard, Laval] Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada; [Bowen, Julie] NE Reg Canc Ctr, Sudbury, ON, Canada; [Perera, Francisco] London Reg Canc Ctr, London, ON N6A 4L6, Canada; [Schneider, Ken] Windsor Reg Canc Ctr, Windsor, ON, Canada; [Gulavita, Sunil] NW Reg Canc Ctr, Thunder Bay, ON, Canada; [Freeman, Carolyn] McGill Univ, Montreal, PQ, Canada; [Freeman, Carolyn] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada	McMaster University; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Cancer Care Ontario; University of Ottawa; Ottawa Hospital Research Institute; Western University (University of Western Ontario); McGill University; McGill University	Whelan, TJ (corresponding author), Juravinski Canc Ctr, 699 Concess St, Hamilton, ON L8V 5C2, Canada.	tim.whelan@jcc.hhsc.ca	Evans, Diane/F-9258-2017; Whelan, Timothy/D-3185-2017	Whelan, Timothy/0000-0001-9844-2023; Fyles, Anthony/0000-0002-3633-2483; Pignol, Jean-Philippe/0000-0002-0253-8520	Canadian Breast Cancer Research Alliance; Canadian Cancer Society (through the National Cancer Institute of Canada)	Canadian Breast Cancer Research Alliance; Canadian Cancer Society (through the National Cancer Institute of Canada)	Supported by grants from the Canadian Breast Cancer Research Alliance and the Canadian Cancer Society (through the National Cancer Institute of Canada).	AARONSON NK, 1988, EUR J SURG ONCOL, V14, P133; Abe O, 2005, LANCET, V366, P2087; Ash D V, 1995, Clin Oncol (R Coll Radiol), V7, P93, DOI 10.1016/S0936-6555(05)80808-8; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]; Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; Curran D, 1998, EUR J CANCER, V34, P307, DOI 10.1016/S0959-8049(97)00312-2; DEWAR JA, 1988, RADIOTHER ONCOL, V12, P273, DOI 10.1016/0167-8140(88)90016-3; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Forrest AP, 1996, LANCET, V348, P708, DOI 10.1016/S0140-6736(96)02133-2; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Harris JR, 2000, J CLIN ONCOL, V18, p43S; Olivotto IA, 1996, RADIOTHER ONCOL, V41, P7, DOI 10.1016/S0167-8140(96)01824-5; POWELL S, 1990, RADIOTHER ONCOL, V18, P213, DOI 10.1016/0167-8140(90)90057-4; Romestaing P, 1997, J CLIN ONCOL, V15, P963, DOI 10.1200/JCO.1997.15.3.963; Sartor CI, 2002, J NATL CANCER I, V94, P1114; Shelley W, 2000, INT J RADIAT ONCOL, V47, P1219, DOI 10.1016/S0360-3016(00)00567-8; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Taylor CW, 2006, CLIN ONCOL-UK, V18, P236, DOI 10.1016/j.clon.2005.11.003; VERONESI U, 1993, NEW ENGL J MED, V328, P1587, DOI 10.1056/NEJM199306033282202; Virnig B, 2007, BREAST CANCER RES TR, V106, pS188; Whelan T, 2002, J NATL CANCER I, V94, P1143; WINCHESTER DP, 1992, CA-CANCER J CLIN, V42, P134, DOI 10.3322/canjclin.42.3.134	24	1158	1186	2	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					513	520		10.1056/NEJMoa0906260	http://dx.doi.org/10.1056/NEJMoa0906260			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147717				2022-12-28	WOS:000274397200008
J	Ide, S; Miyazaki, T; Maki, H; Kobayashi, T				Ide, Satoru; Miyazaki, Takaaki; Maki, Hisaji; Kobayashi, Takehiko			Abundance of Ribosomal RNA Gene Copies Maintains Genome Integrity	SCIENCE			English	Article							BUDDING YEAST CHROMOSOMES; SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; CONDENSIN; REPLICATION; TRANSCRIPTION; SEGREGATION; MUTANTS; REVEALS	The ribosomal RNA (rDNA) gene repeats are essential housekeeping genes found in all organisms. A gene amplification system maintains large cluster(s) of tandemly repeated copies in the chromosome, with each species having a specific number of copies. Yeast has many untranscribed rDNA copies (extra copies), and we found that when they are lost, the cells become sensitive to DNA damage induced by mutagens. We show that this sensitivity is dependent on rDNA transcriptional activity, which interferes with cohesion between rDNA loci of sister chromatids. The extra rDNA copies facilitate condensin association and sister-chromatid cohesion, thereby facilitating recombinational repair. These results suggest that high concentrations of heavily transcribed genes are toxic to the cells, and therefore amplified genes, such as rDNA, have evolved.	[Ide, Satoru; Miyazaki, Takaaki; Kobayashi, Takehiko] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Miyazaki, Takaaki; Kobayashi, Takehiko] Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan; [Maki, Hisaji] Nara Inst Sci & Technol, Dept Mol Biol, Grad Sch Biol Sci, Nara 6300101, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Nara Institute of Science & Technology	Kobayashi, T (corresponding author), Natl Inst Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	takobaya@lab.nig.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [17080010, 21247003, 17370065]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Nomura (University of California, Irvine), H. Araki National Institute of Genetics, Japan (NIG), A. Murray (Harvard University), and K. Shimada (Friedrich Miescher Institute, Switzerland) for kindly providing plasmids and strains. We thank A. R. D. Ganley (Massey University) and T. Iida (NIG) for critical reading and comments on the manuscript. This work was supported in part by grants-in-aid for Scientific Research (17080010, 21247003, and 17370065 to T. K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Ide S, 2007, MOL CELL BIOL, V27, P568, DOI 10.1128/MCB.00731-06; Johzuka K, 2007, GENES CELLS, V12, P759, DOI 10.1111/j.1365-2443.2007.01085.x; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Lacefield S, 2007, NAT GENET, V39, P1273, DOI 10.1038/ng2120; Lam WW, 2006, GENE DEV, V20, P2973, DOI 10.1101/gad.1468806; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Wang BD, 2006, CELL CYCLE, V5, P2260, DOI 10.4161/cc.5.19.3292; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	20	211	215	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					693	696		10.1126/science.1179044	http://dx.doi.org/10.1126/science.1179044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133573				2022-12-28	WOS:000274251800039
J	Malebranche, LJ				Malebranche, Lionel J.			A Doctor Heads Home to Haiti	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								A second-year medical resident returned to Haiti, his native country, in the aftermath of the 12 January 2010 earthquake. He witnessed the total devastation of Port-au-Prince, the city of his birth, and great human suffering. He describes the emotional and logistical challenges of providing care to the wounded of this impoverished nation.	[Malebranche, Lionel J.] Christiana Care Hlth Syst, Wilmington, DE USA	Christiana Care Health System	Malebranche, LJ (corresponding author), Dept Internal Med, Christiana Care Hlth Serv, 4755 Ogletown Stanton Rd, Newark, DE 19718 USA.								0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					677	678		10.7326/0003-4819-152-10-201005180-00211	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598RJ	20167652				2022-12-28	WOS:000277855500008
J	Sheps, L; Miller, EM; Horvath, S; Thompson, MA; Parson, R; McCoy, AB; Lineberger, WC				Sheps, Leonid; Miller, Elisa M.; Horvath, Samantha; Thompson, Matthew A.; Parson, Robert; McCoy, Anne B.; Lineberger, W. Carl			Solvent-Mediated Electron Hopping: Long-Range Charge Transfer in IBr-(CO2) Photodissociation	SCIENCE			English	Article							TRANSITION-STATE; DYNAMICS; SPECTROSCOPY; CLUSTERS; ANIONS	Chemical bond breaking involves coupled electronic and nuclear dynamics that can take place on multiple electronic surfaces. Here we report a time-resolved experimental and theoretical investigation of nonadiabatic dynamics during photodissociation of a complex of iodine monobromide anion with carbon dioxide [IBr-(CO2)] on the second excited (A') electronic state. Previous experimental work showed that the dissociation of bare IBr- yields only I- + Br products. However, in IBr-(CO2), time-resolved photoelectron spectroscopy reveals that a subset of the dissociating molecules undergoes an electron transfer from iodine to bromine 350 femtoseconds after the initial excitation. Ab initio calculations and molecular dynamics simulations elucidate the mechanism for this charge hop and highlight the crucial role of the carbon dioxide molecule. The charge transfer between two recoiling atoms, assisted by a single solvent-like molecule, provides a notable limiting case of solvent-driven electron transfer over a distance of 7 angstroms.	[Sheps, Leonid; Miller, Elisa M.; Thompson, Matthew A.; Parson, Robert; Lineberger, W. Carl] Univ Colorado, Dept Chem & Biochem, JILA, Boulder, CO 80309 USA; [Horvath, Samantha; McCoy, Anne B.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University of Colorado System; University of Colorado Boulder; University System of Ohio; Ohio State University	Parson, R (corresponding author), Univ Colorado, Dept Chem & Biochem, JILA, Campus Box 215, Boulder, CO 80309 USA.	rparson@jila.colorado.edu; mccoy@chemistry.ohio-state.edu; carl.lineberger@Colorado.edu	Thompson, Matthew A/B-4682-2008	Thompson, Matthew A/0000-0001-6222-6863; Miller, Elisa/0000-0002-7648-5433	NSF; Air Force Office of Scientific Research; Office of Naval Research; Graduate School at The Ohio State University; Division Of Chemistry [0848242] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); Graduate School at The Ohio State University; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the NSF (W. C. L. and A. B. M.), the Air Force Office of Scientific Research (W. C. L.), and the Office of Naval Research (A. B. M.) for support of this work, as well as the Graduate School at The Ohio State University for fellowship support (S. H.). The calculations were performed on the JILA Yotta cluster and on the Glenn Cluster at the Ohio Supercomputer Center. S. H. is grateful to K. A. Peterson for his assistance with the electronic structure calculations.	ARNOLD DW, 1992, J CHEM PHYS, V97, P9468, DOI 10.1063/1.463270; ARNOLD DW, 1995, J CHEM PHYS, V102, P3510, DOI 10.1063/1.468576; Blanchet V, 1999, NATURE, V401, P52, DOI 10.1038/43410; Bragg AE, 2008, SCIENCE, V321, P1817, DOI 10.1126/science.1161511; Clary DC, 2008, P NATL ACAD SCI USA, V105, P12649, DOI 10.1073/pnas.0800088105; Davis AV, 2002, J CHEM PHYS, V117, P4282, DOI 10.1063/1.1497160; Davis AV, 2000, J ELECTRON SPECTROSC, V108, P203, DOI 10.1016/S0368-2048(00)00129-8; ERVIN KM, 1992, ADV GAS PHASE ION CH, V1, P121; Gessner O, 2006, SCIENCE, V311, P219, DOI 10.1126/science.1120779; Greenblatt BJ, 1997, SCIENCE, V276, P1675, DOI 10.1126/science.276.5319.1675; Mabbs R, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1887170; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Neumark DM, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2216709; Neumark DN, 1996, SCIENCE, V272, P1446, DOI 10.1126/science.272.5267.1446; Paik DH, 2003, J CHEM PHYS, V118, P6923, DOI 10.1063/1.1561433; PAPANIKOLAS JM, 1993, J CHEM PHYS, V99, P8733, DOI 10.1063/1.466211; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; Relph RA, 2010, SCIENCE, V327, P308, DOI 10.1126/science.1177118; Sanford T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839178; Sanov A, 2004, PHYS CHEM CHEM PHYS, V6, P2018, DOI 10.1039/b400524d; SCHATZ GC, 1993, SCIENCE, V262, P1828, DOI 10.1126/science.262.5141.1828; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; Szpunar DE, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2165202; THOMPSON MA, 2007, THESIS U COLORADO; Thompson MA, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3033746; Wenthold PG, 1996, SCIENCE, V272, P1456, DOI 10.1126/science.272.5267.1456; Werner HJ, 2008, MOLPRO VERSION 2008; Wernet P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.013001; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587; ZHAO YX, 1993, J CHEM SOC FARADAY T, V89, P1449, DOI 10.1039/ft9938901449	30	24	23	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					220	224		10.1126/science.1184616	http://dx.doi.org/10.1126/science.1184616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20203015				2022-12-28	WOS:000276459600040
J	VanLare, JM; Conway, PH; Sox, HC				VanLare, Jordan M.; Conway, Patrick H.; Sox, Harold C.			Five Next Steps for a New National Program for Comparative-Effectiveness Research.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[VanLare, Jordan M.; Conway, Patrick H.] Dept Hlth & Human Serv, Washington, DC USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Div Hlth Policy & Clin Effectiveness, Cincinnati, OH USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Div Gen Pediat, Cincinnati, OH USA; [Sox, Harold C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Sox, Harold C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dartmouth Inst, Hanover, NH 03756 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Dartmouth College; Dartmouth College	VanLare, JM (corresponding author), Dept Hlth & Human Serv, Washington, DC USA.							Conway PH, 2009, NEW ENGL J MED, V361, P328, DOI 10.1056/NEJMp0905631; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Institute of Medicine, 2009, IN NAT PRIOR COMP EF	3	58	59	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					970	973		10.1056/NEJMp1000096	http://dx.doi.org/10.1056/NEJMp1000096			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20164480				2022-12-28	WOS:000275650400003
J	Auerbach, PS; Norris, RL; Menon, AS; Brown, IP; Kuah, S; Schwieger, J; Kinyon, J; Helderman, TN; Lawry, L				Auerbach, Paul S.; Norris, Robert L.; Menon, Anil S.; Brown, Ian P.; Kuah, Solomon; Schwieger, Jennifer; Kinyon, Jeffrey; Helderman, Trina N.; Lawry, Lynn			Civil-Military Collaboration in the Initial Medical Response to the Earthquake in Haiti	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Auerbach, Paul S.; Norris, Robert L.; Menon, Anil S.; Brown, Ian P.] Stanford Univ, Sch Med, Dept Surg, Div Emergency Med, Palo Alto, CA 94304 USA; [Kuah, Solomon; Schwieger, Jennifer; Kinyon, Jeffrey] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Dept Emergency Med, New York, NY USA; [Helderman, Trina N.] Lafayette Emergency Care, Lafayette, IN USA; [Lawry, Lynn] Off Assistant Secretary Def Hlth Affairs, Falls Church, VA USA	Stanford University; Columbia University; NewYork-Presbyterian Hospital	Auerbach, PS (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Emergency Med, Palo Alto, CA 94304 USA.		Lawry, Lynn/ABE-8391-2021	Lawry, Lynn/0000-0001-8229-8768; Brown, Ian/0000-0003-0656-2621					0	24	27	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMp1001555	http://dx.doi.org/10.1056/NEJMp1001555			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20181962				2022-12-28	WOS:000275365900007
J	Heimann, M				Heimann, Martin			How Stable Is the Methane Cycle?	SCIENCE			English	Editorial Material							HYDRATE STABILITY		Max Planck Inst Biogeochem, D-07745 Jena, Germany	Max Planck Society	Heimann, M (corresponding author), Max Planck Inst Biogeochem, Hans Knoll Str 10, D-07745 Jena, Germany.	martin.heimann@bgc-jena.mpg.de	Heimann, Martin/H-7807-2016	Heimann, Martin/0000-0001-6296-5113				Archer D, 2007, BIOGEOSCIENCES, V4, P521, DOI 10.5194/bg-4-521-2007; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Nisbet E, 2007, NATURE, V450, P789, DOI 10.1038/450789a; Romanovskii NN, 2005, GEO-MAR LETT, V25, P167, DOI 10.1007/s00367-004-0198-6; Shakhova N, 2010, SCIENCE, V327, P1246, DOI 10.1126/science.1182221; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Walter BP, 2000, GLOBAL BIOGEOCHEM CY, V14, P745, DOI 10.1029/1999GB001204; Westbrook CD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038186	9	27	30	9	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1211	1212		10.1126/science.1187270	http://dx.doi.org/10.1126/science.1187270			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203040				2022-12-28	WOS:000275162100026
J	Foulkes, WD				Foulkes, William D.			Traffic Control for BRCA1	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUMOYLATION		[Foulkes, William D.] McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; [Foulkes, William D.] McGill Univ, Lady Davis Inst, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University	Foulkes, WD (corresponding author), McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada.		Foulkes, William D./AAR-9586-2021	Foulkes, William D./0000-0001-7427-4651				Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					755	756		10.1056/NEJMcibr0912412	http://dx.doi.org/10.1056/NEJMcibr0912412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181978				2022-12-28	WOS:000274845600017
J	Shuai, YC; Lu, BY; Hu, Y; Wang, LZ; Sun, K; Zhong, Y				Shuai, Yichun; Lu, Binyan; Hu, Ying; Wang, Lianzhang; Sun, Kan; Zhong, Yi			Forgetting Is Regulated through Rac Activity in Drosophila	CELL			English	Article							RHO-GTPASES; MUSHROOM BODY; ACTIN POLYMERIZATION; OLFACTORY MEMORY; AXON GROWTH; TERM-MEMORY; LIM-KINASE; DISTINCT; COFILIN; PHOSPHORYLATION	Initially acquired memory dissipates rapidly if not consolidated. Such memory decay is thought to result either from the inherently labile nature of newly acquired memories or from interference by subsequently attained information. Here we report that a small G protein Rac-dependent forgetting mechanism contributes to both passive memory decay and interference-induced forgetting in Drosophila. Inhibition of Rac activity leads to slower decay of early memory, extending it from a few hours to more than one day, and to blockade of interference-induced forgetting. Conversely, elevated Rac activity in mushroom body neurons accelerates memory decay. This forgetting mechanism does not affect memory acquisition and is independent of Rutabaga adenylyl cyclase-mediated memory formation mechanisms. Endogenous Rac activation is evoked on different time scales during gradual memory loss in passive decay and during acute memory removal in reversal learning. We suggest that Rac's role in actin cytoskeleton remodeling may contribute to memory erasure.	[Shuai, Yichun; Lu, Binyan; Hu, Ying; Wang, Lianzhang; Sun, Kan; Zhong, Yi] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Tsinghua University; Cold Spring Harbor Laboratory	Zhong, Y (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	zhongyi@cshl.edu		LU, BINYAN/0000-0002-1080-0349; Zhong, Yi/0000-0001-7810-9899; Zhong, Yi/0000-0002-7927-5976	973 program [2006CB500806, 2009CB941301]; Beijing Municipal Science & Technology Plan [Z07000200540705]; Tsinghua-Yue-Yuen Medical Sciences Fund	973 program(National Basic Research Program of China); Beijing Municipal Science & Technology Plan(Beijing Municipal Science & Technology Commission); Tsinghua-Yue-Yuen Medical Sciences Fund	We thank L. Luo, H. Tanimoto, A. Chiba, S. Waddell, and the Bloomington Stock Center for fly stocks; F. Sun and T. Xie for sharing equipment; J. Beshel for critical reading of the manuscript; and W. Ma, Y. Wang, Y. Lu, H. Wang, and L. Shao for helpful comments. This work was supported by "973 program'' (2006CB500806 and 2009CB941301), Beijing Municipal Science & Technology Plan (Z07000200540705), and Tsinghua-Yue-Yuen Medical Sciences Fund (all to Y.Z.).	Altmann EM, 2009, TRENDS COGN SCI, V13, P279, DOI 10.1016/j.tics.2009.04.001; ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim MD, 2003, DEV BIOL, V262, P282, DOI 10.1016/S0012-1606(03)00393-2; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lee T, 1999, DEVELOPMENT, V126, P4065; Lewandowsky S, 2009, TRENDS COGN SCI, V13, P120, DOI 10.1016/j.tics.2008.12.003; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micheau J, 1999, CELL MOL LIFE SCI, V55, P534, DOI 10.1007/s000180050312; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1990, COLD SPRING HARB SYM, V55, P203; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	55	149	156	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					579	589		10.1016/j.cell.2009.12.044	http://dx.doi.org/10.1016/j.cell.2009.12.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178749	Bronze			2022-12-28	WOS:000274668400020
J	Woo, HA; Yim, SH; Shin, DH; Kang, D; Yu, DY; Rhee, SG				Woo, Hyun Ae; Yim, Sun Hee; Shin, Dong Hae; Kang, Dongmin; Yu, Dae-Yeul; Rhee, Sue Goo			Inactivation of Peroxiredoxin I by Phosphorylation Allows Localized H2O2 Accumulation for Cell Signaling	CELL			English	Article							CYSTEINE-SULFINIC ACID; HYDROGEN-PEROXIDE; REDOX REGULATION; REACTIVE OXYGEN; TYROSINE PHOSPHORYLATION; MAMMALIAN PEROXIREDOXIN; GROWTH-FACTORS; NADPH OXIDASE; LIPID RAFTS; C-ABL	Despite its toxicity, H2O2 is produced as a signaling molecule that oxidizes critical cysteine residues of effectors such as protein tyrosine phosphatases in response to activation of cell surface receptors. It has remained unclear, however, how H2O2 concentrations above the threshold required to modify effectors are achieved in the presence of the abundant detoxification enzymes peroxiredoxin (Prx) I and II. We now show that PrxI associated with membranes is transiently phosphorylated on tyrosine-194 and thereby inactivated both in cells stimulated via growth factor or immune receptors in vitro and in those at the margin of healing cutaneous wounds in mice. The localized inactivation of PrxI allows for the transient accumulation of H2O2 around membranes, where signaling components are concentrated, while preventing the toxic accumulation of H2O2 elsewhere. In contrast, PrxII was inactivated not by phosphorylation but rather by hyperoxidation of its catalytic cysteine during sustained oxidative stress.	[Woo, Hyun Ae; Yim, Sun Hee; Shin, Dong Hae; Kang, Dongmin; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Taejon 305333, South Korea	Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Woo, HA (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	hawoo@ewha.ac.kr; rheesg@ewha.ac.kr	Woo, Hyun Ae/AAT-9586-2021	Kang, Dongmin/0000-0001-5997-625X	National Research Foundation of Korea [2009-0052293, M10642040001-07N4204-00110]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by grants from the National Research Foundation of Korea (National Honor Scientist program grant 2009-0052293 and Bio R&D program grant M10642040001-07N4204-00110 to S. G. R.). We thank K. Matsuno and C. Yabe-Nishimura for providing Nox1-deficent mice.	Bae SH, 2009, ANTIOXID REDOX SIGN, V11, P937, DOI [10.1089/ars.2008.2325, 10.1089/ARS.2008.2325]; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Cheng PC, 2001, J IMMUNOL, V166, P3693, DOI 10.4049/jimmunol.166.6.3693; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chiarugi P, 2008, MOL CELLS, V26, P329; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Miceli MC, 2001, SEMIN IMMUNOL, V13, P115, DOI 10.1006/smim.2000.0303; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; PRYWES R, 1986, EMBO J, V5, P2179, DOI 10.1002/j.1460-2075.1986.tb04482.x; Radeva G, 2004, BIOCHEM J, V380, P219, DOI 10.1042/BJ20031348; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; USHIOFUKAI M, 2006, LOCALIZING NADPH OXI; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6	42	465	475	3	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					517	528		10.1016/j.cell.2010.01.009	http://dx.doi.org/10.1016/j.cell.2010.01.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178744	Bronze			2022-12-28	WOS:000274668400015
J	Rodriguez, J; Jiang, R; Johnson, WC; MacKenzie, BA; Smith, LJ; Barr, RG				Rodriguez, Josanna; Jiang, Rui; Johnson, W. Craig; MacKenzie, Barbara A.; Smith, Lewis J.; Barr, R. Graham			The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY-DISEASE; REFERENCE VALUES; PASSIVE SMOKING; MORTALITY; CANCER; ATHEROSCLEROSIS; STANDARDIZATION; DIAGNOSIS; EXPOSURE; SAMPLE	Background: Cigarette smoking is the major cause of chronic obstructive pulmonary disease, but studies on the contribution of other smoking techniques are sparse. Objective: To determine whether pipe and cigar smoking was associated with elevated cotinine levels, decrements in lung function, and increased odds of airflow obstruction. Design: Cross-sectional study. Setting: Population-based sample from 6 U. S. communities. Participants: Men and women aged 48 to 90 years without clinical cardiovascular disease at enrollment who were part of MESA (Multi-Ethnic Study of Atherosclerosis). Measurements: The MESA Lung Study measured spirometry according to American Thoracic Society guidelines and urine cotinine levels by immunoassay on a subsample of MESA. Pipe-years and cigar-years were calculated as years from self-reported age of starting to age of quitting (or to current age in current users) multiplied by pipe-bowls or cigars per day. Results: Of 3528 participants, 9% reported pipe smoking (median, 15 pipe-years), 11% reported cigar smoking (median, 6 cigar-years), and 52% reported cigarette smoking (median, 18 pack-years). Self-reported current pipe and cigar smokers had elevated urine cotinine levels compared with never-smokers. Pipe-years were associated with decrements in FEV1, and cigar-years were associated with decrements in the FEV1-FVC ratio. Participants who smoked pipes or cigars had increased odds of airflow obstruction whether they had also smoked cigarettes (odds ratio, 3.43 [95% CI, 1.75 to 6.71]; P < 0.001) or not (odds ratio, 2.31 [CI, 1.04 to 5.11]; P = 0.039) compared with participants with no smoking history. Limitation: Cross-sectional design. Conclusion: Pipe and cigar smoking increased urine cotinine levels and was associated with decreased lung function and increased odds of airflow obstruction, even in participants who had never smoked cigarettes.	[Barr, R. Graham] Columbia Univ, Med Ctr, New York, NY 10032 USA; Univ Washington, Seattle, WA 98195 USA; NIOSH, Cincinnati, OH 45226 USA; Northwestern Univ, Chicago, IL 60611 USA	Columbia University; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Northwestern University	Barr, RG (corresponding author), Columbia Univ, Med Ctr, 630 W 168th St,PH 9 E,Room 105, New York, NY 10032 USA.	rgb9@columbia.edu		Smith, Lewis J/0000-0002-4728-1562	National Heart, Lung, and Blood Institute, National Institutes of Health; National Institutes of Health [R01-HL077612, N01-HC95159, HC95169, R01-HL075476]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093081, R01HL075476, R21HL095165, R01HL077612, R43HL095169, R44HL095169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG030235] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Heart, Lung, and Blood Institute, National Institutes of Health.; By the National Institutes of Health (R01-HL077612, N01-HC95159 to HC95169, R01-HL075476).	Baker F, 2000, JAMA-J AM MED ASSOC, V284, P735, DOI 10.1001/jama.284.6.735; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boffetta P, 1999, JNCI-J NATL CANCER I, V91, P697, DOI 10.1093/jnci/91.8.697; CARSTENSEN JM, 1987, J EPIDEMIOL COMMUN H, V41, P166, DOI 10.1136/jech.41.2.166; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P509; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; DAYAL HH, 1994, ENVIRON RES, V65, P161, DOI 10.1006/enrs.1994.1029; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; FLINT M, 2005, MMWR SURVEILL SUMM, V54, P297; Funck-Brentano C, 2006, LUNG CANCER, V54, P11, DOI 10.1016/j.lungcan.2006.06.016; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Henley SJ, 2004, JNCI-J NATL CANCER I, V96, P853, DOI 10.1093/jnci/djh144; Hornung R.W., 1990, APPL OCCUP ENV HYG, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; HOYERT DL, 2001, DHHS PUBLICATION; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; LANGE P, 1990, THORAX, V45, P22, DOI 10.1136/thx.45.1.22; Lange P, 1991, Ugeskr Laeger, V153, P2742; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; McDonald LJ, 2002, J NUCL MED, V43, P1591; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; SCHROLL M, 1980, ACTA MED SCAND, V208, P245; Shaper AG, 2003, INT J EPIDEMIOL, V32, P802, DOI 10.1093/ije/dyg206; Streppel MT, 2007, TOB CONTROL, V16, P107, DOI 10.1136/tc.2006.017715; Substance Abuse and Mental Health Services Administration, 2007, NSDUH SER H; Substance Abuse and Mental Health Services Administration, 2007, DHHS PUBL; TAGER IB, 1988, AM REV RESPIR DIS, V138, P837, DOI 10.1164/ajrccm/138.4.837; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; TURNER JAM, 1986, THORAX, V41, P25, DOI 10.1136/thx.41.1.25; *US PHS, 1984, DHHS PUBL; Wald NJ, 1997, BMJ-BRIT MED J, V314, P1860, DOI 10.1136/bmj.314.7098.1860	33	83	83	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2010	152	4					201	U17		10.7326/0003-4819-152-4-201002160-00004	http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560AF	20157134	Green Accepted			2022-12-28	WOS:000274873300001
J	Ge, P; Tsao, J; Schein, S; Green, TJ; Luo, M; Zhou, ZH				Ge, Peng; Tsao, Jun; Schein, Stan; Green, Todd J.; Luo, Ming; Zhou, Z. Hong			Cryo-EM Model of the Bullet-Shaped Vesicular Stomatitis Virus	SCIENCE			English	Article							MATRIX PROTEIN; CRYSTAL-STRUCTURE; GLYCOPROTEIN-G; DOMAIN; NUCLEOPROTEIN; COMPLEX; CELLS; FORM	Vesicular stomatitis virus (VSV) is a bullet-shaped rhabdovirus and a model system of negative-strand RNA viruses. Through direct visualization by means of cryo-electron microscopy, we show that each virion contains two nested, left-handed helices: an outer helix of matrix protein M and an inner helix of nucleoprotein N and RNA. M has a hub domain with four contact sites that link to neighboring M and N subunits, providing rigidity by clamping adjacent turns of the nucleocapsid. Side-by-side interactions between neighboring N subunits are critical for the nucleocapsid to form a bullet shape, and structure-based mutagenesis results support this description. Together, our data suggest a mechanism of VSV assembly in which the nucleocapsid spirals from the tip to become the helical trunk, both subsequently framed and rigidified by the M layer.	[Ge, Peng; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ge, Peng; Schein, Stan; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Ge, Peng; Zhou, Z. Hong] Baylor Coll Med, Struct Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Ge, Peng; Zhou, Z. Hong] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Tsao, Jun; Green, Todd J.; Luo, Ming] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Schein, Stan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	hong.zhou@ucla.edu	Schein, Stan/G-4942-2018; Zhou, Z Hong/HDN-0747-2022	Green, Todd/0000-0003-1158-4710	NIH [AI050066, GM071940, AI069015]; W. M. Keck Foundation through the Keck Center for Virus Imaging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050066, R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation through the Keck Center for Virus Imaging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Qiu and Xin Zhang for their technical assistance, Xiaorui Zhang for assistance in graphics, and M. Yang for proofreading the manuscript. This work was supported in part by NIH grants AI050066 (to M. L.), GM071940 (to Z.H.Z.), and AI069015 (to Z.H.Z.). P. G. was supported in part by a training fellowship from the W. M. Keck Foundation to the Gulf Coast Consortia through the Keck Center for Virus Imaging. The first octant of the helical reconstruction map of the virion trunk and its key segmentations have been deposited with the Electron Microscopy Data Bank (accession code EMD-1663). Flexibly fitted coordinates of N into our cryo-EM density have been deposited with PDB (accession code 2WYY).	BLACK BL, 1993, J VIROL, V67, P4814, DOI 10.1128/JVI.67.8.4814-4821.1993; Connor JH, 2006, J VIROL, V80, P3701, DOI 10.1128/JVI.80.8.3701-3711.2006; Ding HT, 2006, J VIROL, V80, P2808, DOI 10.1128/JVI.80.6.2808-2814.2006; Gaudier M, 2002, EMBO J, V21, P2886, DOI 10.1093/emboj/cdf284; GAUDIN Y, 1995, VIROLOGY, V206, P28, DOI 10.1016/S0042-6822(95)80016-6; Gaudin Y, 1997, J MOL BIOL, V274, P816, DOI 10.1006/jmbi.1997.1439; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000251; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Green TJ, 2009, P NATL ACAD SCI USA, V106, P11713, DOI 10.1073/pnas.0903228106; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Mebatsion T, 1997, CELL, V90, P841, DOI 10.1016/S0092-8674(00)80349-9; ODENWALD WF, 1986, J VIROL, V57, P922, DOI 10.1128/JVI.57.3.922-932.1986; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Schnell MJ, 1997, CELL, V90, P849, DOI 10.1016/S0092-8674(00)80350-5; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; WHITT MA, 1989, J VIROL, V63, P3569, DOI 10.1128/JVI.63.9.3569-3578.1989; Zhang X, 2008, J VIROL, V82, P674, DOI 10.1128/JVI.00935-07; Zhou Y, 1998, VIROLOGY, V246, P83, DOI 10.1006/viro.1998.9169	20	170	176	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					689	693		10.1126/science.1181766	http://dx.doi.org/10.1126/science.1181766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133572	Green Accepted			2022-12-28	WOS:000274251800038
J	Smith-Spangler, CM; Juusola, JL; Enns, EA; Owens, DK; Garber, AM				Smith-Spangler, Crystal M.; Juusola, Jessie L.; Enns, Eva A.; Owens, Douglas K.; Garber, Alan M.			Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							DIETARY-SODIUM; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; STOP HYPERTENSION; SALT; HEALTH; CONSUMPTION; REDUCTION; STROKE; RECOMMENDATIONS	Background: Sodium consumption raises blood pressure, increasing the risk for heart attack and stroke. Several countries, including the United States, are considering strategies to decrease population sodium intake. Objective: To assess the cost-effectiveness of 2 population strategies to reduce sodium intake: government collaboration with food manufacturers to voluntarily cut sodium in processed foods, modeled on the United Kingdom experience, and a sodium tax. Design: A Markov model was constructed with 4 health states: well, acute myocardial infarction (MI), acute stroke, and history of MI or stroke. Data Sources: Medical Panel Expenditure Survey (2006), Framingham Heart Study ( 1980 to 2003), Dietary Approaches to Stop Hypertension trial, and other published data. Target Population: U.S. adults aged 40 to 85 years. Time Horizon: Lifetime. Perspective: Societal. Outcome Measures: Incremental costs ( 2008 U. S. dollars), quality-adjusted life-years (QALYs), and MIs and strokes averted. Results of Base-Case Analysis: Collaboration with industry that decreases mean population sodium intake by 9.5% averts 513 885 strokes and 480 358 MIs over the lifetime of adults aged 40 to 85 years who are alive today compared with the status quo, increasing QALYs by 2.1 million and saving $32.1 billion in medical costs. A tax on sodium that decreases population sodium intake by 6% increases QALYs by 1.3 million and saves $22.4 billion over the same period. Results of Sensitivity Analysis: Results are sensitive to the assumption that consumers have no disutility with modest reductions in sodium intake. Limitation: Efforts to reduce population sodium intake could result in other dietary changes that are difficult to predict. Conclusion: Strategies to reduce sodium intake on a population level in the United States are likely to substantially reduce stroke and MI incidence, which would save billions of dollars in medical expenses.	[Smith-Spangler, Crystal M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Smith-Spangler, CM (corresponding author), Stanford Univ, Ctr Hlth Policy, 117 Encina Commons, Stanford, CA 94305 USA.	smith-spangler@stanford.edu	Garber, Alan M/F-1476-2010	Juusola, Jessie/0000-0002-2885-2008	Department of Veterans Affairs; Stanford University; National Science Foundation	Department of Veterans Affairs(US Department of Veterans Affairs); Stanford University(Stanford University); National Science Foundation(National Science Foundation (NSF))	Primary Funding Source: Department of Veterans Affairs, Stanford University, and National Science Foundation.	*AG HEALTHC RES QU, 2006, HC105 AG HEALTHC RES; Angeletos GM, 2001, J ECON PERSPECT, V15, P47, DOI 10.1257/jep.15.3.47; Ayala C., 2009, Morbidity and Mortality Weekly Report, V58, P281; BEAUCHAMP GK, 1987, JAMA-J AM MED ASSOC, V258, P3275, DOI 10.1001/jama.258.22.3275; BERTINO M, 1982, AM J CLIN NUTR, V36, P1134, DOI 10.1093/ajcn/36.6.1134; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; Brown DL, 2006, NEUROLOGY, V67, P1390, DOI 10.1212/01.wnl.0000237024.16438.20; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; CUPPLES LA, 1993, AM HEART J, V125, P863, DOI 10.1016/0002-8703(93)90182-9; Dall TM, 2009, AM J HEALTH PROMOT, V23, P412, DOI 10.4278/ajhp.080930-QUAN-226; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dasgupta PK, 2008, ENVIRON SCI TECHNOL, V42, P1315, DOI 10.1021/es0719071; *FOOD STAND AG, 2008, SALT LEV CONT FALL; Food Standards Agency, 2009, IMP ASS REV SALT RED; Girgis S, 2003, EUR J CLIN NUTR, V57, P616, DOI 10.1038/sj.ejcn.1601583; Havas S, 2004, AM J PUBLIC HEALTH, V94, P19, DOI 10.2105/AJPH.94.1.19; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Henderson L., 2003, NATL DIET NUTR SURVE, V3, P14; Hopkins DP, 2001, AM J PREV MED, V20, P67, DOI 10.1016/S0749-3797(00)00298-1; *I MED, STRAT RED SOD INT; Kannel WB, 1998, CLIN THER, V20, pB2, DOI 10.1016/S0149-2918(98)80027-1; Karanja N, 2007, J AM DIET ASSOC, V107, P1530, DOI 10.1016/j.jada.2007.06.013; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Kauf TL, 2006, AM HEART J, V151, P206, DOI 10.1016/j.ahj.2005.02.028; Lakdawalla D, 2005, AM ECON REV, V95, P253, DOI 10.1257/000282805774670266; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mathias SD, 1997, STROKE, V28, P1888, DOI 10.1161/01.STR.28.10.1888; MATTES RD, 1991, J AM COLL NUTR, V10, P383; *MIN STAT DEP HLTH, 2008, DEP EXP LIM 2008 200; Mitchell M, 2009, J SENS STUD, V24, P133, DOI 10.1111/j.1745-459X.2008.00199.x; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; *NAT CTR HLTH STAT, MORT DAT ALL AG NAT; *NAT CTR SOC RES H, 2008, ASS DIET SOD LEV AD; *NAT HEART LUNG BL, 2006, NHLBI INC PREV CHART; ORZECHOWKI W, 2006, TAX BURDEN TOBACCO; Pagoulatos E., 1986, INT J IND ORGAN, V4, P237; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; PIGGOTT N, 2003, AM J AGR ECON, V4, P237; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; THALER BI, 1982, NEW ZEAL MED J, V95, P839; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; *US BUR CENS, 2007, NAT POP EST 200S MON; US Bureau of Labor Statistics, CONS PRIC IND; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wilson N, 2004, BRIT MED J, V329, P918, DOI 10.1136/bmj.329.7471.918-c; Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006; World Bank, INT COMP PROGR; Wright Jacqueline D, 2003, Adv Data, P1; WROTH C, 2009, POPULATION VITAL STA	53	183	191	3	40	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2010	152	8					481	U21		10.7326/0003-4819-152-8-201004200-00212	http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00212			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588FV	20194225				2022-12-28	WOS:000277054400001
J	Li, C; Love, GD; Lyons, TW; Fike, DA; Sessions, AL; Chu, XL				Li, Chao; Love, Gordon D.; Lyons, Timothy W.; Fike, David A.; Sessions, Alex L.; Chu, Xuelei			A Stratified Redox Model for the Ediacaran Ocean	SCIENCE			English	Article							SOUTH CHINA; DOUSHANTUO FORMATION; YANGTZE PLATFORM; SULFATE; OXYGENATION; EVOLUTION; OXIDATION; ANIMALS; EMBRYOS; ROCKS	The Ediacaran Period (635 to 542 million years ago) was a time of fundamental environmental and evolutionary change, culminating in the first appearance of macroscopic animals. Here, we present a detailed spatial and temporal record of Ediacaran ocean chemistry for the Doushantuo Formation in the Nanhua Basin, South China. We find evidence for a metastable zone of euxinic (anoxic and sulfidic) waters impinging on the continental shelf and sandwiched within ferruginous [Fe(II)-enriched] deep waters. A stratified ocean with coeval oxic, sulfidic, and ferruginous zones, favored by overall low oceanic sulfate concentrations, was maintained dynamically throughout the Ediacaran Period. Our model reconciles seemingly conflicting geochemical redox conditions proposed previously for Ediacaran deep oceans and helps to explain the patchy temporal record of early metazoan fossils.	[Li, Chao; Love, Gordon D.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Fike, David A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Sessions, Alex L.] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; [Chu, Xuelei] Chinese Acad Sci, Inst Geol & Geophys, State Key Lab Lithospher Evolut, Beijing 100029, Peoples R China	University of California System; University of California Riverside; Washington University (WUSTL); California Institute of Technology; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS	Li, C (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	chaoli@ucr.edu	Fike, David A/D-3634-2011; Sessions, Alex/ABC-9207-2020; Chu, Xuelei/AAE-6623-2022; Sessions, Alex L/C-2752-2008	Fike, David A/0000-0003-2848-0328; Sessions, Alex/0000-0001-6120-2763; Chu, Xuelei/0000-0002-2155-7081; Sessions, Alex L/0000-0001-6120-2763; Li, Chao/0000-0001-9861-661X	NSF of China [EAR-0720362, EAR-0719493, 40532012]; Chinese Academy of Sciences [KZCX3-SW-141]; NASA Astrobiology Institute; Agouron Institute	NSF of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NASA Astrobiology Institute; Agouron Institute(Pfizer)	We are extremely grateful to R. Raiswell, S. Bates, W. Gilhooly, B. Gill, J. Owens, A. Khong, P. Marenco, N. Planavsky, C. Reinhard, M. Rohrssen, C. Scott, S. Severmann, J. Huang, L. Feng, H. Chang, and Q. Zhang for laboratory and field assistance and helpful discussions. The NSF Earth Sciences program (grant EAR-0720362 to G. D. L. and T. W. L. and grant EAR-0719493 to A. L. S.), National Science Foundation of China Fund (grant 40532012 to X. C.), the Chinese Academy of Sciences Fund (grant KZCX3-SW-141 to X. C.), the NASA Astrobiology Institute, and the Agouron Institute provided funding.	BERNER RA, 1984, GEOLOGY, V12, P365, DOI 10.1130/0091-7613(1984)12<365:CMFDFF>2.0.CO;2; Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Gorjan P, 2000, PRECAMBRIAN RES, V100, P151, DOI 10.1016/S0301-9268(99)00073-X; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; Jiang GQ, 2007, EARTH PLANET SC LETT, V261, P303, DOI 10.1016/j.epsl.2007.07.009; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Raiswell R, 2008, AM J SCI, V308, P105, DOI 10.2475/02.2008.01; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2008, P NATL ACAD SCI USA, V105, P7376, DOI 10.1073/pnas.0802168105; Vernhet E, 2006, PRECAMBRIAN RES, V148, P32, DOI 10.1016/j.precamres.2006.03.009; Wang J, 2003, PRECAMBRIAN RES, V122, P141, DOI 10.1016/S0301-9268(02)00209-7; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682; Zhu MY, 2007, PALAEOGEOGR PALAEOCL, V254, P7, DOI 10.1016/j.palaeo.2007.03.025	29	430	500	19	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					80	83		10.1126/science.1182369	http://dx.doi.org/10.1126/science.1182369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20150442				2022-12-28	WOS:000276202200038
J	Moisander, PH; Beinart, RA; Hewson, I; White, AE; Johnson, KS; Carlson, CA; Montoya, JP; Zehr, JP				Moisander, Pia H.; Beinart, Roxanne A.; Hewson, Ian; White, Angelicque E.; Johnson, Kenneth S.; Carlson, Craig A.; Montoya, Joseph P.; Zehr, Jonathan P.			Unicellular Cyanobacterial Distributions Broaden the Oceanic N-2 Fixation Domain	SCIENCE			English	Article							NORTH PACIFIC-OCEAN; NITROGEN-FIXATION; ATLANTIC-OCEAN; DIAZOTROPHIC CYANOBACTERIA; N-2-FIXING CYANOBACTERIA; TRICHODESMIUM; PHYLOTYPES; PHOSPHORUS	Nitrogen (N-2)-fixing microorganisms (diazotrophs) are an important source of biologically available fixed N in terrestrial and aquatic ecosystems and control the productivity of oligotrophic ocean ecosystems. We found that two major groups of unicellular N-2-fixing cyanobacteria (UCYN) have distinct spatial distributions that differ from those of Trichodesmium, the N-2-fixing cyanobacterium previously considered to be the most important contributor to open-ocean N-2 fixation. The distributions and activity of the two UCYN groups were separated as a function of depth, temperature, and water column density structure along an 8000-kilometer transect in the South Pacific Ocean. UCYN group A can be found at high abundances at substantially higher latitudes and deeper in subsurface ocean waters than Trichodesmium. These findings have implications for the geographic extent and magnitude of basin-scale oceanic N-2 fixation rates.	[Moisander, Pia H.; Beinart, Roxanne A.; Hewson, Ian; Zehr, Jonathan P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [White, Angelicque E.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Carlson, Craig A.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Montoya, Joseph P.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University of California System; University of California Santa Cruz; Oregon State University; Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Barbara; University System of Georgia; Georgia Institute of Technology	Moisander, PH (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, 1156 High St, Santa Cruz, CA 95064 USA.	pmoisand@ucsc.edu	Montoya, Joseph/C-3115-2013; Zehr, Jonathan P/B-3513-2014; Johnson, Kenneth S/F-9742-2011; Hewson, Ian/B-4871-2013	Montoya, Joseph/0000-0001-7197-4660; Zehr, Jonathan P/0000-0002-5691-5408; Johnson, Kenneth S/0000-0001-5513-5584; Moisander, Pia/0000-0002-3262-3662; White, angelicque/0000-0002-0938-7948	NSF-Division of Ocean Sciences (OCE) [0425363, 0425583, 0623596]; NSF (Center for Microbial Oceanography: Research and Education) [0424599]	NSF-Division of Ocean Sciences (OCE)(National Science Foundation (NSF)); NSF (Center for Microbial Oceanography: Research and Education)(National Science Foundation (NSF))	We thank R. Paerl, C. Sakamoto, T. Cote, N. Pereira, M. Furnas, B. Carter, M. Ochiai, K. London, E. Preston, M. Hogan, and personnel onboard R/V Kilo Moana for technical assistance and C. Edwards for helpful discussions. This study was supported by NSF-Division of Ocean Sciences (OCE) (grant 0425363), NSF Emerging Frontiers Program (Center for Microbial Oceanography: Research and Education) (grant 0424599), and the Gordon and Betty Moore Foundation for J.P.Z., and NSF-OCE (grant 0425583) for J.P.M. A. E. W. was supported by NSF-OCE (grant 0623596, R. Letelier, principal investigator).	Baird ME, 2008, DEEP-SEA RES PT I, V55, P1438, DOI 10.1016/j.dsr.2008.06.011; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Church MJ, 2008, LIMNOL OCEANOGR, V53, P63, DOI 10.4319/lo.2008.53.1.0063; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Hood RR, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001753; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Rees AP, 2009, MAR ECOL PROG SER, V374, P7, DOI 10.3354/meps07771; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Short SM, 2007, ENVIRON MICROBIOL, V9, P1591, DOI 10.1111/j.1462-2920.2007.01258.x; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Webb EA, 2009, ENVIRON MICROBIOL, V11, P338, DOI 10.1111/j.1462-2920.2008.01771.x; White AE, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004129; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	27	314	326	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1512	1514		10.1126/science.1185468	http://dx.doi.org/10.1126/science.1185468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20185682				2022-12-28	WOS:000275715200049
J	Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Capparelli, EV; Adamson, PC				Glauser, Tracy A.; Cnaan, Avital; Shinnar, Shlomo; Hirtz, Deborah G.; Dlugos, Dennis; Masur, David; Clark, Peggy O.; Capparelli, Edmund V.; Adamson, Peter C.		Childhood Absence Epilepsy Study	Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEIZURES; MONOTHERAPY; DIAGNOSIS; CHILDREN	Background: Childhood absence epilepsy, the most common pediatric epilepsy syndrome, is usually treated with ethosuximide, valproic acid, or lamotrigine. The most efficacious and tolerable initial empirical treatment has not been defined. Methods: In a double-blind, randomized, controlled clinical trial, we compared the efficacy, tolerability, and neuropsychological effects of ethosuximide, valproic acid, and lamotrigine in children with newly diagnosed childhood absence epilepsy. Drug doses were incrementally increased until the child was free of seizures, the maximal allowable or highest tolerable dose was reached, or a criterion indicating treatment failure was met. The primary outcome was freedom from treatment failure after 16 weeks of therapy; the secondary outcome was attentional dysfunction. Differential drug effects were determined by means of pairwise comparisons. Results: The 453 children who were randomly assigned to treatment with ethosuximide (156), lamotrigine (149), or valproic acid (148) were similar with respect to their demographic characteristics. After 16 weeks of therapy, the freedom-from-failure rates for ethosuximide and valproic acid were similar (53% and 58%, respectively; odds ratio with valproic acid vs. ethosuximide, 1.26; 95% confidence interval [CI], 0.80 to 1.98; P=0.35) and were higher than the rate for lamotrigine (29%; odds ratio with ethosuximide vs. lamotrigine, 2.66; 95% CI, 1.65 to 4.28; odds ratio with valproic acid vs. lamotrigine, 3.34; 95% CI, 2.06 to 5.42; P<0.001 for both comparisons). There were no significant differences among the three drugs with regard to discontinuation because of adverse events. Attentional dysfunction was more common with valproic acid than with ethosuximide (in 49% of the children vs. 33%; odds ratio, 1.95; 95% CI, 1.12 to 3.41; P=0.03). Conclusions: Ethosuximide and valproic acid are more effective than lamotrigine in the treatment of childhood absence epilepsy. Ethosuximide is associated with fewer adverse attentional effects. (ClinicalTrials.gov number, NCT00088452.) N Engl J Med 2010;362:790-9.	[Glauser, Tracy A.] Cincinnati Childrens Hosp, Div Neurol, Comprehens Epilepsy Ctr, Cincinnati, OH 45229 USA; [Glauser, Tracy A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Cnaan, Avital] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Shinnar, Shlomo; Masur, David] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA; [Hirtz, Deborah G.] NINDS, Bethesda, MD 20892 USA; [Dlugos, Dennis; Adamson, Peter C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Capparelli, Edmund V.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Capparelli, Edmund V.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Children's National Health System; Montefiore Medical Center; Yeshiva University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Diego; University of California System; University of California San Diego	Glauser, TA (corresponding author), Cincinnati Childrens Hosp, Div Neurol, Comprehens Epilepsy Ctr, 3333 Burnet Ave,MLC 2015, Cincinnati, OH 45229 USA.	tracy.glauser@cchmc.org		Vinks, Alexander/0000-0003-4224-2967; Srodulski, Sarah/0000-0003-3032-5749; Trevathan, Edwin/0000-0003-2370-5970	National Institutes of Health [NS045911, NS045803, 5 U10 HD031318, 5 U10 HD037249, 1 UL1 RR026314, P30 HD26979]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD037249, U10HD031318] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS045911, U10NS077311, U01NS045803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Institutes of Health (NS045911, NS045803, 5 U10 HD031318, 5 U10 HD037249, 1 UL1 RR026314, and P30 HD26979).	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BEERY KE, 1997, BEERYBUKTENICA DEV T; Berg AT, 2000, EPILEPSIA, V41, P1269, DOI 10.1111/j.1528-1157.2000.tb04604.x; Bouma PAD, 1996, NEUROLOGY, V47, P802, DOI 10.1212/WNL.47.3.802; Bourgeois Blaise F D, 2004, J Child Neurol, V19 Suppl 1, pS15, DOI 10.1177/088307380401900103; Brown L., 1997, TEST NONVERBAL INTEL; Buoni S, 1999, BRAIN DEV-JPN, V21, P303, DOI 10.1016/S0387-7604(99)00023-6; CALLAGHAN N, 1982, DEV MED CHILD NEUROL, V24, P830; Conners C., 2002, CPT 2 CONTINUOUS PER; Coppola G, 2004, EPILEPSIA, V45, P1049, DOI 10.1111/j.0013-9580.2004.40903.x; Dunn L.M., 2009, PEABODY PICTURE VOCA; Frank LM, 1999, EPILEPSIA, V40, P973, DOI 10.1111/j.1528-1157.1999.tb00805.x; French JA, 2008, NEW ENGL J MED, V359, P166, DOI 10.1056/NEJMcp0801738; GLAUSER TA, 2005, TREATMENT EPILEPSY P; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Heaton, 1981, WISCONSIN CARD SORTI; Heaton K. R., 1993, WISCONSIN CARD SORTI; Holmes GL, 2008, EPILEPSY RES, V82, P124, DOI 10.1016/j.eplepsyres.2008.07.016; Jallon P, 2001, EPILEPSIA, V42, P464, DOI 10.1046/j.1528-1157.2001.31400.x; KIM K, 1987, BIOMETRIKA, V74, P149, DOI 10.2307/2336029; Korkman M, 2005, NEPSY 2 ADM MANUAL; Korkman M., 2007, NEPSY 2, V2nd; LOISEAU P, 1995, EPILEPSIA, V36, P1182, DOI 10.1111/j.1528-1157.1995.tb01060.x; Martinovic Z., 1983, ADV EPILEPTOL, P301; Masur David M., 1992, V7, P457; Patsalos PN, 2003, LANCET NEUROL, V2, P473, DOI 10.1016/S1474-4422(03)00483-6; Pavone P, 2001, NEUROLOGY, V56, P1047, DOI 10.1212/WNL.56.8.1047; Sabaz M, 2000, EPILEPSIA, V41, P765, DOI 10.1111/j.1528-1157.2000.tb00240.x; Sheslow D, 2003, WIDE RANGE ASSESSMEN; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wheless JW, 2005, J CHILD NEUROL, V20, pS1, DOI 10.1177/088307380502000101; Wilkinson GS., 2006, WRAT 4 WIDE RANGE AC; Wirrell EC, 1997, ARCH PEDIAT ADOL MED, V151, P152, DOI 10.1001/archpedi.1997.02170390042008; WOODCOCK RW, 2007, WOODCOCKJOHNSON III	37	348	355	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					790	799		10.1056/NEJMoa0902014	http://dx.doi.org/10.1056/NEJMoa0902014			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	20200383	Green Accepted, Bronze			2022-12-28	WOS:000275108300006
J	Wunsch, H; Guerra, C; Barnato, AE; Angus, DC; Li, GH; Linde-Zwirble, WT				Wunsch, Hannah; Guerra, Carmen; Barnato, Amber E.; Angus, Derek C.; Li, Guohua; Linde-Zwirble, Walter T.			Three-Year Outcomes for Medicare Beneficiaries Who Survive Intensive Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; ADMISSION; ACCURACY; SERVICES; DELIVERY; SEPSIS; MIX	Context Although hospital mortality has decreased over time in the United States for patients who receive intensive care, little is known about subsequent outcomes for those discharged alive. Objective To assess 3-year outcomes for Medicare beneficiaries who survive intensive care. Design, Setting, and Patients A matched, retrospective cohort study was conducted using a 5% sample of Medicare beneficiaries older than 65 years. A random half of all patients were selected who received intensive care and survived to hospital discharge in 2003 with 3-year follow-up through 2006. From the other half of the sample, 2 matched control groups were generated: hospitalized patients who survived to discharge ( hospital controls) and the general population ( general controls), individually matched on age, sex, race, and whether they had surgery ( for hospital controls). Main Outcome Measure Three-year mortality after hospital discharge. Results There were 35 308 intensive care unit (ICU) patients who survived to hospital discharge. The ICU survivors had a higher 3-year mortality (39.5%; n=13 950) than hospital controls (34.5%; n=12 173) ( adjusted hazard ratio [AHR], 1.07 [95% confidence interval {CI}, 1.04-1.10]; P < .001) and general controls (14.9%; n=5266) (AHR, 2.39 [95% CI, 2.31-2.48]; P < .001). The ICU survivors who did not receive mechanical ventilation had minimal increased risk compared with hospital controls (3-year mortality, 38.3% [n=12 716] vs 34.6% [n=11470], respectively; AHR, 1.04 [95% CI, 1.02-1.07]). Those receiving mechanical ventilation had substantially increased mortality (57.6% [ 1234 ICU survivors] vs 32.8% [703 hospital controls]; AHR, 1.56 [95% CI, 1.40-1.73]), with risk concentrated in the 6 months after the quarter of hospital discharge (6-month mortality, 30.1% (n=645) for those receiving mechanical ventilation vs 9.6% (n=206) for hospital controls; AHR, 2.26 [95% CI, 1.90-2.69]). Discharge to a skilled care facility for ICU survivors (33.0%; n=11 634) and hospital controls (26.4%; n=9328) also was associated with high 6-month mortality (24.1% for ICU survivors and hospital controls discharged to a skilled care facility vs 7.5% for ICU survivors and hospital controls discharged home; AHR, 2.62 [95% CI, 2.50-2.74]; P < .001 for ICU survivors and hospital controls combined). Conclusions There is a large US population of elderly individuals who survived the ICU stay to hospital discharge but who have a high mortality over the subsequent years in excess of that seen in comparable controls. The risk is concentrated early after hospital discharge among those who require mechanical ventilation. JAMA. 2010; 303(9):849-856 www.jama.com	[Wunsch, Hannah; Guerra, Carmen; Li, Guohua] Columbia Univ, Dept Anesthesiol, Div Crit Care, New York, NY 10032 USA; [Barnato, Amber E.] Univ Pittsburgh, Dept Med, Ctr Res Hlth Care, Pittsburgh, PA USA; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA USA; [Linde-Zwirble, Walter T.] ZD Associates, Perkasie, PA USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wunsch, H (corresponding author), Columbia Univ, Dept Anesthesiol, Div Crit Care, 622 W 168th St,PH-527D, New York, NY 10032 USA.	hw2125@columbia.edu	Angus, Derek C/E-9671-2012		Foundation for Anesthesia Education and Research	Foundation for Anesthesia Education and Research	This research was supported by a Foundation for Anesthesia Education and Research fellowship grant.	Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Cuthbertson BH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3723; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Keenan SP, 2002, CRIT CARE MED, V30, P501, DOI 10.1097/00003246-200203000-00002; Linde-Zwirble WT, 2008, CRIT CARE MED, V36, pA8; Niskanen M, 1996, CRIT CARE MED, V24, P1962, DOI 10.1097/00003246-199612000-00006; Polsky D, 2007, MED CARE, V45, P1083, DOI 10.1097/MLR.0b013e3180ca960e; Sirio CA, 1999, CHEST, V115, P793, DOI 10.1378/chest.115.3.793; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Waldo DP, 2004, HEALTH CARE FINANC R, V26, P61; Wright JC, 2003, ANAESTHESIA, V58, P637, DOI 10.1046/j.1365-2044.2003.03205.x; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	23	268	275	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					849	856		10.1001/jama.2010.216	http://dx.doi.org/10.1001/jama.2010.216			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197531	Bronze			2022-12-28	WOS:000275059500018
J	Kidder, SQ; Vonder Haar, TH				Kidder, Stanley Q.; Vonder Haar, Thomas H.			Observing Weather from Space	SCIENCE			English	Editorial Material									[Kidder, Stanley Q.; Vonder Haar, Thomas H.] Colorado State Univ, CIRA, Ft Collins, CO 80523 USA; [Vonder Haar, Thomas H.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Kidder, SQ (corresponding author), Colorado State Univ, CIRA, Ft Collins, CO 80523 USA.	kidder@cira.colostate.edu; vonderhaar@cira.colostate.edu	Vonder Haar, Thomas/F-2048-2011; vonderhaar, thomas H/N-6724-2015	vonderhaar, thomas H/0000-0002-1962-7757				Bader M., 1995, IMAGES WEATHER FOREC; Board S.S., 2007, EARTH SCI APPL SPAC, P190; Kidder S.Q., 1995, SATELLITE METEOROLOG, VVolume 466; *NAT RES COUNC, 2008, SAT OBS BEN SCI SOC; National Research Council, 2009, AM FUT SPAC AL CIV S; National Research Council, 2008, EARTH OBS SPAC 1 50; Rao P.K., 1990, WEATHER SATELLITES S; SHEETS RC, 1990, WEATHER FORECAST, V5, P185, DOI 10.1175/1520-0434(1990)005<0185:TNHCPA>2.0.CO;2; Simmons AJ, 2002, Q J ROY METEOR SOC, V128, P647, DOI 10.1256/003590002321042135; VAETH JG, 1965, WEATHER EYES SKY AM; WEXLER H, 1954, JBIS-J BRIT INTERPLA, V13, P269	11	2	2	4	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1085	1086		10.1126/science.1185867	http://dx.doi.org/10.1126/science.1185867			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185712				2022-12-28	WOS:000274901100019
J	Scharer, K				Scharer, Katherine			Changing Views of the San Andreas Fault	SCIENCE			English	Editorial Material							EARTHQUAKE; CALIFORNIA; RUPTURE		Appalachian State Univ, Dept Geol, Boone, NC 28608 USA	University of North Carolina; Appalachian State University	Scharer, K (corresponding author), Appalachian State Univ, Dept Geol, Boone, NC 28608 USA.	scharerkm@appstate.edu						*2007 WORK GROUP C, 2008, 20071437 2007 WORK G; Akciz SO, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2007JB005285; Biasi GP, 2009, B SEISMOL SOC AM, V99, P471, DOI 10.1785/0120080287; Johnson KM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004842; Liu-Zeng J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003601; Ludwig LG, 2010, SCIENCE, V327, P1117, DOI 10.1126/science.1182837; Parsons T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035887; Scharer KM, 2007, B SEISMOL SOC AM, V97, P1054, DOI 10.1785/0120060137; Scholz C.H., 2002, MECH EARTHQUAKES FAU, DOI 10.1017/CBO9780511818516; SCHWARTZ DP, 1984, J GEOPHYS RES, V89, P5681, DOI 10.1029/JB089iB07p05681; Sieh K. E., 1981, Earthquake Prediction. An International Review. Symposium on Earthquake Prediction, P181, DOI 10.1029/ME004p0181; SIEH KE, 1984, GEOL SOC AM BULL, V95, P883, DOI 10.1130/0016-7606(1984)95<883:HAOTSA>2.0.CO;2; SIEH KE, 1978, B SEISMOL SOC AM, V68, P1421; Van Aalsburg J, 2007, PHYS EARTH PLANET IN, V163, P149, DOI 10.1016/j.pepi.2007.04.020; Wesnousky SG, 2008, B SEISMOL SOC AM, V98, P1609, DOI 10.1785/0120070111; Zielke O, 2010, SCIENCE, V327, P1119, DOI 10.1126/science.1182781	16	5	5	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1089	1090		10.1126/science.1186770	http://dx.doi.org/10.1126/science.1186770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185715				2022-12-28	WOS:000274901100022
J	Supattapone, S				Supattapone, Surachai			What Makes a Prion Infectious?	SCIENCE			English	Editorial Material							IN-VITRO; PROTEIN		Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Supattapone, S (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	supattapone@dartmouth.edu			NINDS NIH HHS [R01 NS055875-05, R01 NS046478-08] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046478, R01NS055875] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Kim JI, 2009, FEBS LETT, V583, P3671, DOI 10.1016/j.febslet.2009.10.049; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	10	20	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1091	1092		10.1126/science.1187790	http://dx.doi.org/10.1126/science.1187790			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185716				2022-12-28	WOS:000274901100023
J	Bahn, RS				Bahn, Rebecca S.			MECHANISMS OF DISEASE Graves' Ophthalmopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							THYROID-ASSOCIATED OPHTHALMOPATHY; HUMAN ORBITAL FIBROBLASTS; THYROTROPIN RECEPTOR EXPRESSION; FACTOR-I RECEPTOR; T-CELL-ACTIVATION; RHEUMATOID-ARTHRITIS; ADIPOSE-TISSUE; PREADIPOCYTE FIBROBLASTS; CONNECTIVE-TISSUE; GLYCOSAMINOGLYCAN PRODUCTION		Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA	Mayo Clinic	Bahn, RS (corresponding author), Mayo Clin, Div Endocrinol Diabet Metab & Nutr, 200 1st St SW, Rochester, MN 55905 USA.	bahn.rebecca@mayo.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK77814]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK077814, R01DK077814] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (DK77814).	ANDERSON RL, 1989, OPHTHALMIC SURG LAS, V20, P568; Aniszewski JP, 2000, J CLIN ENDOCR METAB, V85, P776, DOI 10.1210/jc.85.2.776; Bahn RS, 2003, J CLIN ENDOCR METAB, V88, P1939, DOI 10.1210/jc.2002-030010; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Bahn RS, 1998, J CLIN ENDOCR METAB, V83, P998, DOI 10.1210/jc.83.3.998; Baker G, 2005, ENDOCRINOLOGY, V146, P835, DOI 10.1210/en.2004-1015; Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168; Bartalena L, 2008, THYROID, V18, P333, DOI 10.1089/thy.2007.0315; Bartley G B, 1994, Trans Am Ophthalmol Soc, V92, P477; Basedow, 1840, WOCHENSCHRIFT GESAMM, V6, P197; Bednarczuk T, 2007, CLIN ENDOCRINOL, V67, P3, DOI 10.1111/j.1365-2265.2007.02854.x; Cao HJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1429, DOI 10.1152/ajpcell.00354.2002; Cawood TJ, 2007, J CLIN ENDOCR METAB, V92, P59, DOI 10.1210/jc.2006-1824; Chan LL, 2009, AM J NEURORADIOL, V30, P597, DOI 10.3174/ajnr.A1413; *CLINICALTRIALS GO, TRIAL RIT GRAV OPHTH; Costenbader KH, 2006, LUPUS, V15, P737, DOI 10.1177/0961203306069344; Cozma I, 2007, AM J PHYSIOL-ENDOC M, V293, pE1630, DOI 10.1152/ajpendo.00177.2007; Crisp MS, 1997, J CLIN ENDOCR METAB, V82, P2003; Daumerie C, 2002, EUR J ENDOCRINOL, V146, P35, DOI 10.1530/eje.0.1460035; DAVIES TF, 1978, MOL CELL ENDOCRINOL, V9, P303, DOI 10.1016/0303-7207(78)90072-2; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; DOBYNS BM, 1950, J CLIN ENDOCRINOL, V10, P1202, DOI 10.1210/jcem-10-10-1202; Dorkhan M, 2006, CLIN ENDOCRINOL, V65, P35, DOI 10.1111/j.1365-2265.2006.02542.x; Durrani OM, 2005, ORBIT, V24, P117, DOI 10.1080/01676830590912562; Dutton CM, 1997, THYROID, V7, P879, DOI 10.1089/thy.1997.7.879; Eckstein AK, 2009, BRIT J OPHTHALMOL, V93, P1052, DOI 10.1136/bjo.2007.137265; Eckstein AK, 2004, BRIT J OPHTHALMOL, V88, P803, DOI 10.1136/bjo.2003.035915; Eckstein AK, 2006, J CLIN ENDOCR METAB, V91, P3464, DOI 10.1210/jc.2005-2813; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; El Fassi D, 2006, THYROID, V16, P709; El Fassi D, 2009, CLIN IMMUNOL, V130, P252, DOI 10.1016/j.clim.2008.09.007; ENDO T, 1993, BIOCHEM BIOPH RES CO, V190, P774, DOI 10.1006/bbrc.1993.1116; ENZMANN DR, 1979, J COMPUT ASSIST TOMO, V3, P815; Fatourechi V, 2005, AM J CLIN DERMATOL, V6, P295, DOI 10.2165/00128071-200506050-00003; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Feldon SE, 2005, INVEST OPHTH VIS SCI, V46, P3913, DOI 10.1167/iovs.05-0605; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; FELICIELLO A, 1993, LANCET, V342, P337, DOI 10.1016/0140-6736(93)91475-2; FORBES G, 1986, AM J NEURORADIOL, V7, P651; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gerding MN, 2000, CLIN ENDOCRINOL, V52, P267, DOI 10.1046/j.1365-2265.2000.00959.x; Graves RJ., 1835, LONDON MED SURG J, V7, P516; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; HEUFELDER AE, 1993, THYROID, V3, P297, DOI 10.1089/thy.1993.3.297; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Kalunian KC, 2002, ARTHRITIS RHEUM, V46, P3251, DOI 10.1002/art.10681; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Khoo DH, 2000, THYROID, V10, P1093, DOI 10.1089/thy.2000.10.1093; Khoo TK, 2008, THYROID, V18, P1291, DOI 10.1089/thy.2008.0255; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Konuk EBY, 2006, EUR J ENDOCRINOL, V155, P681, DOI 10.1530/eje.1.02280; KORDUCKI JM, 1992, INVEST OPHTH VIS SCI, V33, P2037; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; KROLL AJ, 1966, ARCH OPHTHALMOL-CHIC, V76, P244, DOI 10.1001/archopht.1966.03850010246017; Kumar S, 2005, J CLIN ENDOCR METAB, V90, P4730, DOI 10.1210/jc.2004-2239; Kumar S, 2003, J CLIN ENDOCR METAB, V88, P4246, DOI 10.1210/jc.2003-030380; Kwan-Morley Jennifer, 2007, Curr Rheumatol Rep, V9, P401, DOI 10.1007/s11926-007-0064-4; Lantz M, 2005, J CLIN ENDOCR METAB, V90, P4784, DOI 10.1210/jc.2004-2275; Lu M, 2008, J ENDOCRINOL, V196, P159, DOI 10.1677/JOE-07-0452; McLachlan SM, 2005, ENDOCR REV, V26, P800, DOI 10.1210/er.2004-0023; MENGISTU M, 1994, J ENDOCRINOL INVEST, V17, P437, DOI 10.1007/BF03347732; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Misharin AV, 2009, ENDOCRINOLOGY, V150, P3944, DOI 10.1210/en.2009-0181; MORRIS JC, 1988, MAYO CLIN PROC, V63, P707, DOI 10.1016/S0025-6196(12)65533-5; Morshed SA, 2009, ENDOCRINOLOGY, V150, P519, DOI 10.1210/en.2008-0878; MULLIN BR, 1976, BIOCHEM BIOPH RES CO, V69, P55, DOI 10.1016/S0006-291X(76)80271-9; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; Neumann S, 2008, ENDOCRINOLOGY, V149, P5945, DOI 10.1210/en.2008-0836; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P691, DOI 10.1038/ncprheum0372; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; Otto AJ, 1997, BRIT J OPHTHALMOL, V81, P175; Otto AJ, 1996, BRIT J OPHTHALMOL, V80, P1042, DOI 10.1136/bjo.80.12.1042; Otto EA, 1996, J CLIN ENDOCR METAB, V81, P3045, DOI 10.1210/jc.81.8.3045; Pappa A, 1997, CLIN EXP IMMUNOL, V109, P362, DOI 10.1046/j.1365-2249.1997.4491347.x; Paridaens D, 2005, EYE, V19, P1286, DOI 10.1038/sj.eye.6701768; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; PARRY CH, 1925, ELEMENTARY PATHOLOGY, V2, P111; PASCHKE R, 1994, J CLIN ENDOCR METAB, V79, P1234, DOI 10.1210/jc.79.5.1234; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Pritchard J, 2003, J IMMUNOL, V170, P6348, DOI 10.4049/jimmunol.170.12.6348; PRUMMEL MF, 1993, JAMA-J AM MED ASSOC, V269, P479, DOI 10.1001/jama.269.4.479; Rapoport B, 2000, THYROID, V10, P685, DOI 10.1089/10507250050137761; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; RILEY FC, 1972, MAYO CLIN PROC, V47, P975; ROOTMAN J, 2003, DIS ORBIT MULTIDISCI, P43; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Salvi M, 2007, EUR J ENDOCRINOL, V156, P33, DOI 10.1530/eje.1.02325; Salvi M, 2009, CLIN IMMUNOL, V131, P360, DOI 10.1016/j.clim.2008.12.005; Sempowski GD, 1998, AM J PHYSIOL-CELL PH, V274, pC707, DOI 10.1152/ajpcell.1998.274.3.C707; Smith AC, 1999, COMMENTARY, V107, P5; Smith TJ, 2008, THYROID, V18, P983, DOI 10.1089/thy.2007.0404; SMITH TJ, 1989, ENDOCR REV, V10, P366, DOI 10.1210/edrv-10-3-366; SMITH TJ, 1995, AM J PHYSIOL-CELL PH, V268, pC382, DOI 10.1152/ajpcell.1995.268.2.C382; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; Smith TJ, 2003, AUTOIMMUNITY, V36, P409, DOI 10.1080/08916930310001603000; Smith TJ, 2002, J CLIN ENDOCR METAB, V87, P385, DOI 10.1210/jc.87.1.385; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Sorisky A, 1996, J CLIN ENDOCR METAB, V81, P3428, DOI 10.1210/jc.81.9.3428; Starkey K, 2003, J CLIN ENDOCR METAB, V88, P55, DOI 10.1210/jc.2002-020987; Starkey KJ, 2003, J MOL ENDOCRINOL, V30, P369, DOI 10.1677/jme.0.0300369; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tan GH, 1996, J CLIN ENDOCR METAB, V81, P449, DOI 10.1210/jc.81.2.449; Terwee C, 2002, EUR J ENDOCRINOL, V146, P751, DOI 10.1530/eje.0.1460751; Tsokos GC, 2004, NEW ENGL J MED, V350, P2546, DOI 10.1056/NEJMp048114; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Valyasevi RW, 1999, J CLIN ENDOCR METAB, V84, P2557, DOI 10.1210/jc.84.7.2557; Valyasevi RW, 2002, J CLIN ENDOCR METAB, V87, P2352, DOI 10.1210/jc.87.5.2352; Valyasevi RW, 2001, J CLIN ENDOCR METAB, V86, P903, DOI 10.1210/jc.86.2.903; Wakelkamp IMMJ, 2003, CLIN ENDOCRINOL, V58, P280, DOI 10.1046/j.1365-2265.2003.01708.x; Wang HS, 1996, J BIOL CHEM, V271, P22718, DOI 10.1074/jbc.271.37.22718; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wertenbruch T, 2007, MED CHEM, V3, P281, DOI 10.2174/157340607780620662; WIERSINGA WM, 1989, OPHTHALMIC RES, V21, P73, DOI 10.1159/000266782; WIERSINGA WM, 1988, J ENDOCRINOL INVEST, V11, P615, DOI 10.1007/BF03350193; Wiersinga WM, 2002, THYROID, V12, P855, DOI 10.1089/105072502761016476; Zhang L, 2006, INVEST OPHTH VIS SCI, V47, P5197, DOI 10.1167/iovs.06-0596; Zhang L, 2009, J BIOL CHEM, V284, P26447, DOI 10.1074/jbc.M109.003616	122	826	899	4	154	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					726	738		10.1056/NEJMra0905750	http://dx.doi.org/10.1056/NEJMra0905750			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181974	Green Accepted			2022-12-28	WOS:000274845600011
J	Regier, JC; Shultz, JW; Zwick, A; Hussey, A; Ball, B; Wetzer, R; Martin, JW; Cunningham, CW				Regier, Jerome C.; Shultz, Jeffrey W.; Zwick, Andreas; Hussey, April; Ball, Bernard; Wetzer, Regina; Martin, Joel W.; Cunningham, Clifford W.			Arthropod relationships revealed by phylogenomic analysis of nuclear protein-coding sequences	NATURE			English	Article							BAYESIAN-INFERENCE; COMPLETE 28S; MITOCHONDRIAL; GENE; HYPOTHESIS; CRUSTACEA; MYRIAPODS; ECDYSOZOA; EVOLUTION; HEXAPODA	The remarkable antiquity, diversity and ecological significance of arthropods have inspired numerous attempts to resolve their deep phylogenetic history, but the results of two decades of intensive molecular phylogenetics have been mixed(1-7). The discovery that terrestrial insects (Hexapoda) are more closely related to aquatic Crustacea than to the terrestrial centipedes and millipedes(2,8) (Myriapoda) was an early, if exceptional, success. More typically, analyses based on limited samples of taxa and genes have generated results that are inconsistent, weakly supported and highly sensitive to analytical conditions(7,9,10). Here we present strongly supported results from likelihood, Bayesian and parsimony analyses of over 41 kilobases of aligned DNA sequence from 62 single-copy nuclear protein-coding genes from 75 arthropod species. These species represent every major arthropod lineage, plus five species of tardigrades and onychophorans as outgroups. Our results strongly support Pancrustacea (Hexapoda plus Crustacea) but also strongly favour the traditional morphology-based Mandibulata(11) (Myriapoda plus Pancrustacea) over the molecule-based Paradoxopoda (Myriapoda plus Chelicerata)(2,5,12). In addition to Hexapoda, Pancrustacea includes three major extant lineages of 'crustaceans', each spanning a significant range of morphological disparity. These are Oligostraca (ostracods, mystacocarids, branchiurans and pentastomids), Vericrustacea (malacostracans, thecostracans, copepods and branchiopods) and Xenocarida (cephalocarids and remipedes). Finally, within Pancrustacea we identify Xenocarida as the long-sought sister group to the Hexapoda, a result confirming that 'crustaceans' are not monophyletic. These results provide a statistically well-supported phylogenetic framework for the largest animal phylum and represent a step towards ending the often-heated, century-long debate on arthropod relationships.	[Ball, Bernard; Cunningham, Clifford W.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Regier, Jerome C.; Shultz, Jeffrey W.; Zwick, Andreas; Hussey, April] Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; [Shultz, Jeffrey W.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Shultz, Jeffrey W.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Wetzer, Regina; Martin, Joel W.] Nat Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA	Duke University; University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Cunningham, CW (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	cliff@duke.edu	Cunningham, Clifford/B-9807-2014; Zwick, Andreas/A-5735-2015	Zwick, Andreas/0000-0002-7532-1752; Cunningham, Clifford/0000-0002-5434-5122; Ball, Bernard/0000-0002-9817-0993	Maryland Agricultural Experiment Station; Whiteley Center; US National Science Foundation; Direct For Biological Sciences [1042845] Funding Source: National Science Foundation	Maryland Agricultural Experiment Station; Whiteley Center; US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	C. W. C. thanks W. Hartman for early insight into questions of arthropod phylogeny and D. Percy for sequencing. J.W.M. and R. W. thank N. Tait, G. Hampson and R. Hessler for help collecting samples. J.C.R. and A.Z. thank M. Cummings and A. Bazinet for making available grid computing, and the DNA Sequencing Facility at the Center for Biosystems Research, University of Maryland Biotechnology Institute. J.W.S. was supported by the Maryland Agricultural Experiment Station. C. W. C. was supported by the Whiteley Center. This work was funded by two programmes at the US National Science Foundation, namely Biocomplexity in the Environment: Genome-Enabled Environmental Science and Engineering, and Assembling the Tree of Life.	ABELE LG, 1989, MOL BIOL EVOL, V6, P685; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Bazinet A. L, 2009, DISTRIBUTED GRID COM; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Boxshall GA, 2007, ZOOTAXA, P313, DOI 10.11646/zootaxa.1668.1.16; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fanenbruck M, 2004, P NATL ACAD SCI USA, V101, P3868, DOI 10.1073/pnas.0306212101; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Gai YH, 2006, ZOOL SCI, V23, P1101, DOI 10.2108/zsj.23.1101; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Goldman N, 1996, J MOL BIOL, V263, P196, DOI 10.1006/jmbi.1996.0569; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Hennig W., 1981, INSECT PHYLOGENY; Holder MT, 2008, PHILOS T R SOC B, V363, P4013, DOI 10.1098/rstb.2008.0162; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Podsiadlowski L, 2008, MOL BIOL EVOL, V25, P42, DOI 10.1093/molbev/msm223; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; Regier JC, 2001, MOL PHYLOGENET EVOL, V20, P136, DOI 10.1006/mpev.2001.0956; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; SCHRAM FR, 1983, CRUSTACEAN PHYLOGENY; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; *SIN ASS, 2002, PAUP V 4 0; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Snodgrass RE, 1938, EVOLUTION ANNELIDA O; Staden R, 2001, Methods Biochem Anal, V43, P303; Timmermans MJTN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-83; *UPPS U EV BIOL CT, 2004, MRMODELTEST V 2; ZRZAVY J, 1997, ARTHROPOD RELATIONSH, P97; Zwickl DJ, 2006, THESIS	43	702	724	4	392	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1079	U98		10.1038/nature08742	http://dx.doi.org/10.1038/nature08742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20147900				2022-12-28	WOS:000275108400036
J	McCaffery, KJ; Irwig, L; Turner, R; Chan, SF; Macaskill, P; Lewicka, M; Clarke, J; Weisberg, E; Barratt, A				McCaffery, Kirsten J.; Irwig, Les; Turner, Robin; Chan, Siew Foong; Macaskill, Petra; Lewicka, Mary; Clarke, Judith; Weisberg, Edith; Barratt, Alex			Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-PAPILLOMAVIRUS; PSYCHOLOGICAL IMPACT; WOMEN; DECISION; CANCER; CHOICE; SCALE; HPV	Objective To assess which of three triage strategies for women with borderline abnormal cervical smear results in the best psychosocial outcomes. Design Pragmatic, non-blinded, multicentre, randomised controlled trial. Setting 18 family planning clinics across Australia, covering both urban and rural areas, between January 2004 and October 2006. Participants Women aged 16-70 years (n=314) who attended routine cervical screening and received a borderline cervical smear. Interventions Patients were randomly assigned to human papillomavirus (HPV) DNA testing (n=104), a repeat smear test at six months (n=106), or the patient's informed choice of either test supported by a decision aid (n=104). Psychosocial outcomes were assessed at multiple time points over 12 months by postal questionnaire. Main outcome measures We assessed health related quality of life (SF36 mental health subscale), cognitive effects (such as perceived risk of cervical cancer, intrusive thoughts), affective outcomes (general anxiety [state-trait anxiety inventory]), specific anxiety about an abnormal smear (cervical screening questionnaire), and behavioural outcomes (sexual health behaviour and visits to the doctor) over 12 months of follow-up. Results At two weeks, some psychosocial outcomes were worse for women allocated to HPV testing compared with those in the smear testing group ( SF36 vitality subscale: t=-1.63, df=131, P=0.10; intrusive thoughts X-2=8.14, df=1, P<0.01). Over 12 months, distress about the abnormal smear was lowest in women allocated to HPV testing and highest in the repeat smear testing group (t=-2.89, df=135, P<0.01). Intrusive thoughts were highest in patients allocated to HPV testing (25%, compared with 13% in the informed choice group; difference=12%, 95% CI -1.1% to 25.1%). Women in the HPV DNA group and the informed choice group were more satisfied with their care than women allocated to repeat smear testing. Conclusions Although the psychosocial effect was initially worse for women allocated to HPV triage, over the full year of follow-up this intervention was better for women's psychosocial health than repeat smear testing. Offering informed choice could have a small advantage for cognitive outcomes, but in view of the additional effort and logistical complexity that this intervention requires, HPV testing alone can be justified for most women.	[Irwig, Les; Chan, Siew Foong; Macaskill, Petra; Lewicka, Mary; Clarke, Judith; Barratt, Alex] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Weisberg, Edith] Sydney Ctr Reprod Hlth Res, Sydney, NSW, Australia	University of Sydney		kirstenm@health.usyd.edu.au	Turner, Robin M/B-4211-2013; McCaffery, Kirsten/K-7945-2019; Barratt, Alexandra/A-7349-2011	McCaffery, Kirsten/0000-0003-2696-5006; Barratt, Alexandra/0000-0002-2561-3319; Macaskill, Petra/0000-0001-5879-6193	Australian National Health and Medical Research Council (NHMRC) [402764]; NHMRC Career Development Award [402836]; CSL; GlaxoSmithKline; GSK	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); CSL; GlaxoSmithKline(GlaxoSmithKline); GSK(GlaxoSmithKline)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) Grant 402764 to the Screening and Test Evaluation Program. KM is supported by a NHMRC Career Development Award 402836. The NHMRC has played no role in the writing of this paper.; Competing interests: KM has received a speaker's fee from CSL (producers of the HPV quadrivalent vaccine Gardasil) and a consultancy fee from GlaxoSmithKline (producers of the bivalent HPV vaccine, Cevarix). EW has received honoraria and research funding from GSK and CSL for her research in the area of HPV vaccination. All other authors have no conflict of interest.	*AUSTR BUR STAT, 1997, 43990 ABS; BENNETTS A, 1995, J CLIN EPIDEMIOL, V48, P1235, DOI 10.1016/0895-4356(95)00015-V; Bossuyt Patrick M M, 2009, Med Decis Making, V29, pE30, DOI 10.1177/0272989X09347013; CAMPION MJ, 1988, BRIT J OBSTET GYNAEC, V95, P175, DOI 10.1111/j.1471-0528.1988.tb06848.x; Contopoulos-Ioannidis DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3006; Cruickshank M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2549; Entwistle VA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1591; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Franco EL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3014; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Irwig L, 2006, BMJ-BRIT MED J, V332, P1148, DOI 10.1136/bmj.332.7550.1148; Kitchener HC, 2008, INT J GYNECOL CANCER, V18, P743, DOI 10.1111/j.1525-1438.2007.01113.x; Kitchener HC, 2004, BJOG-INT J OBSTET GY, V111, P63, DOI 10.1046/j.1471-0528.2003.00007.x; Maissi E, 2005, BRIT J CANCER, V92, P990, DOI 10.1038/sj.bjc.6602411; Maissi E, 2004, BMJ-BRIT MED J, V328, P1293, DOI 10.1136/bmj.328.7451.1293; MARTEAU TM, 1990, BRIT J OBSTET GYNAEC, V97, P859, DOI 10.1111/j.1471-0528.1990.tb02586.x; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McCaffery K, 2004, BJOG-INT J OBSTET GY, V111, P1437, DOI 10.1111/j.1471-0528.2004.00279.x; McCaffery K, 2006, SEX TRANSM INFECT, V82, P169, DOI 10.1136/sti.2005.016436; McCaffery K, 2007, MED DECIS MAKING, V27, P619, DOI 10.1177/0272989x07306787; McCaffery KJ, 2008, PATIENT EDUC COUNS, V73, P473, DOI 10.1016/j.pec.2008.07.021; Moss S, 2006, BRIT MED J, V332, P83, DOI 10.1136/bmj.38701.440961.7C; *NAT HLTH SERV INF, 2008, CERV SCREEN PROGR; OConnor AM, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431, DOI 10.1002/14651858.CD001431]; OCONNOR AM, 1998, OTTAWA DECISION SUPP; Raffle AE, 1997, BRIT MED J, V314, P1762, DOI 10.1136/bmj.314.7096.1762a; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI DOI 10.1515/9781400876136; Sanson-Fisher RW, 1998, J CLIN EPIDEMIOL, V51, P961, DOI 10.1016/S0895-4356(98)00087-0; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schiffman M, 2000, ACTA CYTOL, V44, P726, DOI 10.1159/000328554; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; SUTTON S, 1994, J EPIDEMIOL COMMUN H, V48, P65, DOI 10.1136/jech.48.1.65; Waller J, 2005, BRIT J CANCER, V92, P265, DOI 10.1038/sj.bjc.6602312; Waller J, 2003, SEX TRANSM INFECT, V79, P320, DOI 10.1136/sti.79.4.320; WARDLE J, 1995, PSYCHOL HEALTH, V10, P185, DOI 10.1080/08870449508401948; WARE J, 1994, SF 36 HLTH SURVEY MA; Ware JE, 1976, DEV VALIDATION SCALE	39	52	53	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2010	340								b4491	10.1136/bmj.b4491	http://dx.doi.org/10.1136/bmj.b4491			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	561TF	20179125	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000275001100001
J	Liu, XD; Yang, PS; Yang, WJ; Yue, DT				Liu, Xiaodong; Yang, Philemon S.; Yang, Wanjun; Yue, David T.			Enzyme-inhibitor-like tuning of Ca2+ channel connectivity with calmodulin	NATURE			English	Article							CA2+-DEPENDENT INACTIVATION; CALCIUM-CHANNELS; MECHANISMS; PROTEINS; MICE	Ca2+ channels and calmodulin (CaM) are two prominent signalling hubs(1) that synergistically affect functions as diverse as cardiac excitability(2), synaptic plasticity(3) and gene transcription(4). It is therefore fitting that these hubs are in some sense coordinated, as the opening of Ca(V)1-2 Ca2+ channels are regulated by a single CaM constitutively complexed with channels(5). The Ca2+-free form of CaM (apoCaM) is already pre-associated with the isoleucine-glutamine (IQ) domain on the channel carboxy terminus, and subsequent Ca2+ binding to this 'resident' CaM drives conformational changes that then trigger regulation of channel opening(6). Another potential avenue for channel-CaM coordination could arise from the absence of Ca2+ regulation in channels lacking a pre-associated CaM6,7. Natural fluctuations in CaM concentrations might then influence the fraction of regulable channels and, thereby, the overall strength of Ca2+ feedback. However, the prevailing view has been that the ultrastrong affinity of channels for apoCaM ensures their saturation with CaM8, yielding a significant form of concentration independence between Ca2+ channels and CaM. Here we show that significant exceptions to this autonomy exist, by combining electrophysiology (to characterize channel regulation) with optical fluorescence resonance energy transfer (FRET) sensor determination of free-apoCaM concentration in live cells(9). This approach translates quantitative CaM biochemistry from the traditional test-tube context into the realm of functioning holochannels within intact cells. From this perspective, we find that long splice forms of Ca(V)1.3 and Ca(V)1.4 channels include a distal carboxy tail(10-12) that resembles an enzyme competitive inhibitor that retunes channel affinity for apoCaM such that natural CaM variations affect the strength of Ca2+ feedback modulation. Given the ubiquity of these channels(13,14), the connection between ambient CaM levels and Ca2+ entry through channels is broadly significant for Ca2+ homeostasis. Strategies such as ours promise key advances for the in situ analysis of signalling molecules resistant to in vitro reconstitution, such as Ca2+ channels.	[Liu, Xiaodong; Yang, Philemon S.; Yang, Wanjun; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; [Liu, Xiaodong; Yang, Philemon S.; Yang, Wanjun; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@jhmi.edu	Liu, Xiaodong/N-3373-2019; Liu, Xiaodong/B-1839-2008	Liu, Xiaodong/0000-0002-3171-9611; Liu, Xiaodong/0000-0002-3171-9611	US National Institute of Mental Health; US National Heart, Lung, and Blood Institute; US National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R01DC000276] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Tadross, I. Dick and members of the Calcium Signals Laboratory for comments; M. Tadross for data-acquisition software; D. J. Black and A. Persechini for BSCaM<INF>IQ</INF> and neuromodulin complementary DNA; J. McRory and T. Snutch for human alpha<INF>1F</INF> cDNA; J. Streissnig for human alpha<INF>1D</INF> cDNA; and V. Wu for earlier foundational experiments. This work is supported by grants from the US National Institute of Mental Health, the US National Heart, Lung, and Blood Institute and the US National Institute of Neurological Disorders and Stroke.	Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Black DJ, 2006, BIOCHEMISTRY-US, V45, P6987, DOI 10.1021/bi052533w; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; CANTOR CR, 1980, BIOPHYSICAL CHEM, P887; Chambers JS, 2005, PROG NEURO-PSYCHOPH, V29, P283, DOI 10.1016/j.pnpbp.2004.11.013; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Lee D, 2002, J NEUROCHEM, V82, P1007, DOI 10.1046/j.1471-4159.2002.01024.x; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI13310; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; YANG PS, 2007, BIOPHYS J S	30	74	74	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					968	U149		10.1038/nature08766	http://dx.doi.org/10.1038/nature08766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20139964	Green Accepted			2022-12-28	WOS:000274582700050
J	Vilhais-Neto, GC; Maruhashi, M; Smith, KT; Vasseur-Cognet, M; Peterson, AS; Workman, JL; Pourquie, O				Vilhais-Neto, Goncalo C.; Maruhashi, Mitsuji; Smith, Karen T.; Vasseur-Cognet, Mireille; Peterson, Andrew S.; Workman, Jerry L.; Pourquie, Olivier			Rere controls retinoic acid signalling and somite bilateral symmetry	NATURE			English	Article							LEFT-RIGHT AXIS; HISTONE DEACETYLASE; MOUSE GENE; EXPRESSION; FGF8; SOMITOGENESIS; MESODERM; NOTCH; CHICK	One of the most notable features of the vertebrate body plan organization is its bilateral symmetry, evident at the level of vertebrae and skeletal muscles. Here we show that a mutation in Rere (also known as atrophin2) leads to the formation of asymmetrical somites in mouse embryos, similar to embryos deprived of retinoic acid(1-4). Furthermore, we also demonstrate that Rere controls retinoic acid signalling, which is required to maintain somite symmetry by interacting with Fgf8 in the left-right signalling pathway. Rere forms a complex with Nr2f2, p300 (also known as Ep300) and a retinoic acid receptor, which is recruited to the retinoic acid regulatory element of retinoic acid targets, such as the Rarb promoter. Furthermore, the knockdown of Nr2f2 and/or Rere decreases retinoic acid signalling, suggesting that this complex is required to promote transcriptional activation of retinoic acid targets. The asymmetrical expression of Nr2f2 in the pre-somitic mesoderm overlaps with the asymmetry of the retinoic acid signalling response, supporting its implication in the control of somitic symmetry. Misregulation of this mechanism could be involved in symmetry defects of the human spine, such as those observed in patients with scoliosis.	[Vilhais-Neto, Goncalo C.; Maruhashi, Mitsuji; Smith, Karen T.; Workman, Jerry L.; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Maruhashi, Mitsuji; Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Vasseur-Cognet, Mireille] Univ Paris 05, Inst Cochin, CNRS,UMR 8104, Dept Endocrinol Metab & Canc,Inserm,U567, Paris, France; [Peterson, Andrew S.] Genentech Inc, San Francisco, CA 94080 USA; [Pourquie, Olivier] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Roche Holding; Genentech; University of Kansas; University of Kansas Medical Center	Pourquie, O (corresponding author), Univ Strasbourg, INSERM, U964, Inst Genet & Biol Mol & Cellulaire,CNRS,UMR 7104, F-67400 Illkirch Graffenstaden, France.	pourquie@igbmc.fr	Vasseur, Mireille/L-6958-2017; Pourquié, Olivier/CAJ-5443-2022	Vasseur, Mireille/0000-0001-6963-4114; Pourquié, Olivier/0000-0001-5189-1227	Portuguese Fundacao para a Ciencia e Tecnologia (FCT); American Cancer Society; ALFEDIAM-GlaxoSmithKline; Bonus Qualite Recherche, Universite Paris Descartes; Howard Hughes Medical Institute; Stowers Institute for Medical Research; Muscular Dystrophy Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER	Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); American Cancer Society(American Cancer Society); ALFEDIAM-GlaxoSmithKline(GlaxoSmithKline); Bonus Qualite Recherche, Universite Paris Descartes; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stowers Institute for Medical Research; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Pourquie laboratory for discussions and comments on the manuscript, H. Li for help with the statistics, J. Chatfield for editorial assistance and S. Esteban for artwork. We are grateful to D. Henrique for critical reading of the manuscript. We thank J. Rossant, G. Martin and P. Dolle for providing mouse lines. We thank the Stowers Institute Core Facilities, especially D. Dukes and B. Lewis in the Laboratory Animal Service Facility. G.C.V.-N. was funded by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT). K. T. S. is funded by the American Cancer Society. M. V.-C. was supported by l'Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (grant from ALFEDIAM-GlaxoSmithKline) and Bonus Qualite Recherche, Universite Paris Descartes. This research was supported by the Howard Hughes Medical Institute, the Stowers Institute for Medical Research and the Muscular Dystrophy Association.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Bardoux P, 2005, DIABETES, V54, P1357, DOI 10.2337/diabetes.54.5.1357; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; BRUECKNER M, 1989, P NATL ACAD SCI USA, V86, P5035, DOI 10.1073/pnas.86.13.5035; Dale JK, 2006, DEV CELL, V10, P355, DOI 10.1016/j.devcel.2006.02.011; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Shen S, 1991, DNA Seq, V2, P111, DOI 10.3109/10425179109039679; Shen Y, 2009, CELL MOL LIFE SCI, V66, P437, DOI 10.1007/s00018-008-8403-9; Shen YG, 2007, J BIOL CHEM, V282, P5037, DOI 10.1074/jbc.M610274200; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Wang Lei, 2008, Nucl Recept Signal, V6, pe009, DOI 10.1621/nrs.06009; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	30	83	84	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					953	957		10.1038/nature08763	http://dx.doi.org/10.1038/nature08763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164929				2022-12-28	WOS:000274582700047
J	Mandel, KE				Mandel, Keith Evan			Aligning Rewards With Large-Scale Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE; INNOVATION; QUALITY		[Mandel, Keith Evan] Cincinnati Childrens Hosp Med Ctr, Phys Hosp Org, Cincinnati, OH 45229 USA; [Mandel, Keith Evan] Cincinnati Childrens Hosp Med Ctr, Div Hlth Policy & Clin Effectiveness, Cincinnati, OH 45229 USA; [Mandel, Keith Evan] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Cincinnati	Mandel, KE (corresponding author), Cincinnati Childrens Hosp Med Ctr, Phys Hosp Org, 3333 Burnet Ave,MLC 7023, Cincinnati, OH 45229 USA.	keith.mandel@cchmc.org						Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Brook RH, 2009, JAMA-J AM MED ASSOC, V302, P1465, DOI 10.1001/jama.2009.1427; Mandel KE, 2007, ARCH PEDIAT ADOL MED, V161, P650, DOI 10.1001/archpedi.161.7.650; Margolis P, 2009, JAMA-J AM MED ASSOC, V302, P1461, DOI 10.1001/jama.2009.1428; McCannon CJ, 2007, JT COMM J QUAL PATIE, V33, P477, DOI 10.1016/S1553-7250(07)33051-1; Painter MW, 2008, HEALTH AFFAIR, V27, P1461, DOI 10.1377/hlthaff.27.5.1461; Porter ME., 2006, REDEFINING HLTH CARE, P4; *RW JOHN FDN AM BO, IMPR PERF PRACT IMPR; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95	10	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					663	664		10.1001/jama.2010.156	http://dx.doi.org/10.1001/jama.2010.156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	555NK	20159876				2022-12-28	WOS:000274518600027
J	Matzel, JEP; Ishii, HA; Joswiak, D; Hutcheon, ID; Bradley, JP; Brownlee, D; Weber, PK; Teslich, N; Matrajt, G; McKeegan, KD; MacPherson, GJ				Matzel, J. E. P.; Ishii, H. A.; Joswiak, D.; Hutcheon, I. D.; Bradley, J. P.; Brownlee, D.; Weber, P. K.; Teslich, N.; Matrajt, G.; McKeegan, K. D.; MacPherson, G. J.			Constraints on the Formation Age of Cometary Material from the NASA Stardust Mission	SCIENCE			English	Article							ALUMINUM-RICH INCLUSIONS; EARLY SOLAR-SYSTEM; REFRACTORY INCLUSIONS; AL-26; ALLENDE; CHONDRULES; TRANSPORT; NEBULA	We measured the Al-26-Mg-26 isotope systematics of a similar to 5-micrometer refractory particle, Coki, returned from comet 81P/Wild 2 in order to relate the time scales of formation of cometary inclusions to their meteoritic counterparts. The data show no evidence of radiogenic Mg-26 and define an upper limit to the abundance of Al-26 at the time of particle formation: Al-26/Al-27 < 1 x 10(-5). The absence of Al-26 indicates that Coki formed >1.7 million years after the oldest solids in the solar system, calcium-and aluminum-rich inclusions (CAIs). The data suggest that high-temperature inner solar system material formed, was subsequently transferred to the Kuiper Belt, and was incorporated into comets several million years after CAI formation.	[Matzel, J. E. P.; Ishii, H. A.; Hutcheon, I. D.; Bradley, J. P.; Teslich, N.] Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; [Matzel, J. E. P.; Hutcheon, I. D.; Weber, P. K.] Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94550 USA; [Joswiak, D.; Brownlee, D.; Matrajt, G.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [McKeegan, K. D.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [MacPherson, G. J.] Natl Museum Nat Hist, Dept Mineral Sci, Smithsonian Inst, Washington, DC 20560 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian National Museum of Natural History	Matzel, JEP (corresponding author), Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA.	matzel2@llnl.gov	Weber, Peter Kilian/AAP-9517-2020; Matrajt, Graciela/A-4812-2017; McKeegan, Kevin D/A-4107-2008	Weber, Peter Kilian/0000-0001-6022-6050; McKeegan, Kevin D/0000-0002-1827-729X; Ishii, Hope/0000-0002-7976-5078; Matzel, Jennifer/0000-0003-2898-2790	Lawrence Livermore National Laboratory (LLNL) [DE-AC52-07NA27344, 06-ERI-001]; NASA [NNH07AG46I, NNH04AB47I]	Lawrence Livermore National Laboratory (LLNL); NASA(National Aeronautics & Space Administration (NASA))	This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory (LLNL) under contract DE-AC52-07NA27344. Supported by NASA grants NNH07AG46I (H. A. I.) and NNH04AB47I (I. D. H.) and by LLNL grant 06-ERI-001 (J.P.B.).	Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Boss AP, 2004, ASTROPHYS J, V616, P1265, DOI 10.1086/425118; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Carlson RW, 2009, EARTH PLANET SC LETT, V279, P147, DOI 10.1016/j.epsl.2009.01.017; Huss GR, 2001, METEORIT PLANET SCI, V36, P975, DOI 10.1111/j.1945-5100.2001.tb01934.x; Hutcheon ID, 2009, GEOCHIM COSMOCHIM AC, V73, P5080, DOI 10.1016/j.gca.2009.04.042; Ishii HA, 2008, SCIENCE, V319, P447, DOI 10.1126/science.1150683; Jacobsen B, 2008, EARTH PLANET SC LETT, V272, P353, DOI 10.1016/j.epsl.2008.05.003; Jones R. H., 2000, Protostars and planets 4, P927; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Krot AN, 2007, METEORIT PLANET SCI, V42, P1197, DOI 10.1111/j.1945-5100.2007.tb00569.x; Krot AN, 2007, GEOCHIM COSMOCHIM AC, V71, P4342, DOI 10.1016/j.gca.2007.03.040; Krot AN, 2005, NATURE, V434, P998, DOI 10.1038/nature03470; LaTourrette T, 1998, EARTH PLANET SC LETT, V158, P91, DOI 10.1016/S0012-821X(98)00048-X; Liu MC, 2009, GEOCHIM COSMOCHIM AC, V73, P5051, DOI 10.1016/j.gca.2009.02.039; MacPherson GJ, 2005, GEOCHIM COSMOCHIM AC, V69, P3099, DOI 10.1016/j.gca.2004.12.022; MacPherson GJ, 2005, TREATISE GEOCHEM, V1, P201; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; McKeegan KD, 2000, SCIENCE, V289, P1334, DOI 10.1126/science.289.5483.1334; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995; Russell SS., 2006, METEORITES EARLY SOL; Scott E.R.D., 2005, ASTRONOMICAL SOC PAC, V341, P15; SHENG YJ, 1991, GEOCHIM COSMOCHIM AC, V55, P581, DOI 10.1016/0016-7037(91)90014-V; Simon SB, 2008, METEORIT PLANET SCI, V43, P1861, DOI 10.1111/j.1945-5100.2008.tb00648.x; Thrane K, 2006, ASTROPHYS J, V646, pL159, DOI 10.1086/506910; Villeneuve J, 2009, SCIENCE, V325, P985, DOI 10.1126/science.1173907; WARK DA, 1987, GEOCHIM COSMOCHIM AC, V51, P221, DOI 10.1016/0016-7037(87)90234-1; WASSERBURG GJ, 1977, GEOPHYS RES LETT, V4, P299, DOI 10.1029/GL004i007p00299; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	32	62	62	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					483	486		10.1126/science.1184741	http://dx.doi.org/10.1126/science.1184741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20185683	Green Submitted			2022-12-28	WOS:000276952400038
J	Cox, RM; Calsbeek, R				Cox, Robert M.; Calsbeek, Ryan			Cryptic Sex-Ratio Bias Provides Indirect Genetic Benefits Despite Sexual Conflict	SCIENCE			English	Article							SIZE DIMORPHISM; MATE CHOICE; SELECTION; FITNESS; EVOLUTION; ANOLIS; LINKAGE	When selection favors sexual dimorphism, high-fitness parents often produce low-fitness progeny of the opposite sex. This sexual conflict is thought to overwhelm the genetic benefits of mate choice because preferred males incur a cost through the production of low-fitness daughters. We provide a counterpoint in a lizard (Anolis sagrei) that exhibits sexual conflict over body size. By using mate-choice experiments, we show that female brown anoles produce more sons than daughters via large sires but more daughters than sons via small sires. Measures of progeny fitness in the wild suggest that maximal fitness payoffs can be achieved by shifting offspring production from daughters to sons as sire size increases. These results illustrate how the resolution of sexual conflict can restore the genetic benefits of mate choice.	[Cox, Robert M.; Calsbeek, Ryan] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	Cox, RM (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	robert.m.cox@dartmouth.edu		Calsbeek, Ryan/0000-0002-9236-4092	NSF [DEB 0816862]; Dartmouth College	NSF(National Science Foundation (NSF)); Dartmouth College	We thank M. C. Duryea and M. Najarro for genotyping samples and conducting paternity analyses and M. Callahan, D. Cheney, and L. Symes for assistance with mating trails and animal care. M. C. Duryea, S. Kuchta, M. Logan, M. Najarro, and D. Urbach provided comments on the manuscript. Research was conducted under permits from the Bahamas Ministry of Agriculture and approval from the Dartmouth College Institutional Animal Care and Use Committee (protocol 07-02-03). An award from NSF (DEB 0816862 to R. Calsbeek) and funding from Dartmouth College provided financial support.	ARNQVIST G, 2000, MONOGRAPHS BEHAV ECO; Bedhomme Stephanie, 2007, P185; Bonduriansky R, 2005, EVOLUTION, V59, P1965; Calsbeek R, 2004, J EVOLUTION BIOL, V17, P464, DOI 10.1046/j.1420-9101.2003.00665.x; Calsbeek R, 2008, EVOLUTION, V62, P1137, DOI 10.1111/j.1558-5646.2008.00356.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Connallon T, 2009, EVOLUTION, V63, P2179, DOI 10.1111/j.1558-5646.2009.00692.x; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Cox RM, 2010, EVOLUTION, V64, P798, DOI 10.1111/j.1558-5646.2009.00851.x; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; DELPH LF, 1936, EVOLUTION, V58, P2004; Fairbairn DJ, 2006, HEREDITY, V97, P319, DOI 10.1038/sj.hdy.6800895; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; GORMAN GC, 1966, AM NAT, V100, P579, DOI 10.1086/282451; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Kirkpatrick M, 2004, EVOLUTION, V58, P683; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Rice W.R., 2001, J EVOLUTIONARY BIOL, V14, P865; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Svensson EI, 2009, EVOLUTION, V63, P3124, DOI 10.1111/j.1558-5646.2009.00782.x; Tokarz RR, 1998, HERPETOLOGICA, V54, P388; TRIVERS RL, 1976, EVOLUTION, V30, P253, DOI 10.1111/j.1558-5646.1976.tb00908.x	28	55	55	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					92	94		10.1126/science.1185550	http://dx.doi.org/10.1126/science.1185550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20203012				2022-12-28	WOS:000276202200042
J	Hansen, DV; Lui, JH; Parker, PRL; Kriegstein, AR				Hansen, David V.; Lui, Jan H.; Parker, Philip R. L.; Kriegstein, Arnold R.			Neurogenic radial glia in the outer subventricular zone of human neocortex	NATURE			English	Article							GABAERGIC NEURONS; CELLS; PAX6; DIFFERENTIATION; TELENCEPHALON; EVOLUTION; DIVISION; ORIGIN; CORTEX; ARISE	Neurons in the developing rodent cortex are generated from radial glial cells that function as neural stem cells. These epithelial cells line the cerebral ventricles and generate intermediate progenitor cells that migrate into the subventricular zone (SVZ) and proliferate to increase neuronal number. The developing human SVZ has a massively expanded outer region (OSVZ) thought to contribute to cortical size and complexity. However, OSVZ progenitor cell types and their contribution to neurogenesis are not well understood. Here we show that large numbers of radial glia-like cells and intermediate progenitor cells populate the human OSVZ. We find that OSVZ radial glia-like cells have a long basal process but, surprisingly, are non-epithelial as they lack contact with the ventricular surface. Using real-time imaging and clonal analysis, we demonstrate that these cells can undergo proliferative divisions and self-renewing asymmetric divisions to generate neuronal progenitor cells that can proliferate further. We also show that inhibition of Notch signalling in OSVZ progenitor cells induces their neuronal differentiation. The establishment of non-ventricular radial glia-like cells may have been a critical evolutionary advance underlying increased cortical size and complexity in the human brain.	[Hansen, David V.; Lui, Jan H.; Parker, Philip R. L.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Hansen, David V.; Lui, Jan H.; Parker, Philip R. L.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Lui, Jan H.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Parker, Philip R. L.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 513 Parnassus Ave, San Francisco, CA 94143 USA.	KriegsteinA@stemcell.ucsf.edu		Parker, Philip R. L./0000-0002-6224-9747; Hansen, David/0000-0001-9679-7189	California Institute for Regenerative Medicine; Bernard Osher Foundation; CIRM	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Bernard Osher Foundation; CIRM(California Institute for Regenerative Medicine)	We thank A. Alvarez-Buylla, D. Rowitch and Kriegstein laboratory members for ideas arising from discussions and for critical reading of the manuscript. We thank A. Javaherian for help setting up the conditions for dye electroporation, T. Weissman for advice on 'DiOlistics', Z. Mirzadeh for expertise with whole-mount staining, C. Harwell for retroviral production, and W. Walantus, J. Agudelo, L. Fuentealba, O. Genbacev, M. Donne and S. Kaing for other technical support. We thank R. Kageyama for his gift of the HES1 antibody<SUP>35</SUP>, and F. Gage for GFP-retrovirus reagents. We thank the staff at San Francisco General Hospital for providing access to donated fetal tissue. Artwork in Fig. 5e is by K. X. Probst (Xavier Studio). This work was supported by grants from the California Institute for Regenerative Medicine and the Bernard Osher Foundation. J. H. L. is funded by a CIRM Predoctoral Fellowship.	Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; CHOI BH, 1986, J NEUROPATH EXP NEUR, V45, P408, DOI 10.1097/00005072-198607000-00003; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mo ZC, 2008, CEREB CORTEX, V18, P1455, DOI 10.1093/cercor/bhm181; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; RAKIC P, 1968, J NEUROPATH EXP NEUR, V27, P246; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHMECHEL DE, 1979, NATURE, V277, P303, DOI 10.1038/277303a0; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; SMART IHM, 1973, J ANAT, V116, P67; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714	35	810	825	7	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					554	U110		10.1038/nature08845	http://dx.doi.org/10.1038/nature08845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20154730				2022-12-28	WOS:000275974200040
J	Lingappa, JR; Baeten, JM; Wald, A; Hughes, JP; Thomas, KK; Mujugira, A; Mugo, N; Bukusi, EA; Cohen, CR; Katabira, E; Ronald, A; Kiarie, J; Farquhar, C; Stewart, GJ; Makhema, J; Essex, M; Were, E; Fife, KH; de Bruyn, G; Gray, GE; McIntyre, JA; Manongi, R; Kapiga, S; Coetzee, D; Allen, S; Inambao, M; Kayitenkore, K; Karita, E; Kanweka, W; Delany, S; Rees, H; Vwalika, B; Magaret, AS; Wang, RS; Kidoguchi, L; Barnes, L; Ridzon, R; Corey, L; Celum, C				Lingappa, Jairam R.; Baeten, Jared M.; Wald, Anna; Hughes, James P.; Thomas, Katherine K.; Mujugira, Andrew; Mugo, Nelly; Bukusi, Elizabeth A.; Cohen, Craig R.; Katabira, Elly; Ronald, Allan; Kiarie, James; Farquhar, Carey; Stewart, Grace John; Makhema, Joseph; Essex, Myron; Were, Edwin; Fife, Kenneth H.; de Bruyn, Guy; Gray, Glenda E.; McIntyre, James A.; Manongi, Rachel; Kapiga, Saidi; Coetzee, David; Allen, Susan; Inambao, Mubiana; Kayitenkore, Kayitesi; Karita, Etienne; Kanweka, William; Delany, Sinead; Rees, Helen; Vwalika, Bellington; Magaret, Amalia S.; Wang, Richard S.; Kidoguchi, Lora; Barnes, Linda; Ridzon, Renee; Corey, Lawrence; Celum, Connie		Partners Prevention HSV HIV Transm	Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LINKED-IMMUNOSORBENT-ASSAY; VIRAL LOAD; TRIMETHOPRIM-SULFAMETHOXAZOLE; COTRIMOXAZOLE PROPHYLAXIS; ANTIRETROVIRAL TREATMENT; HIV-1-INFECTED PATIENTS; DISCORDANT COUPLES; CUBIC MILLIMETER; GENITAL HERPES	Background Most people infected with HIV-1 are dually infected with herpes simplex virus type 2. Daily suppression of this herpes virus reduces plasma HIV-1 concentrations, but whether it delays HIV-1 disease progression is unknown. We investigated the effect of aciclovir on HIV-1 progression. Methods In a trial with 14 sites in southern Africa and east Africa, 3381 heterosexual people who were dually infected with herpes simplex virus type 2 and HIV-1 were randomly assigned in a 1:1 ratio to aciclovir 400 mg orally twice daily or placebo, and were followed up for up to 24 months. Eligible participants had CD4 cell counts of 250 cells per mu L or higher and were not taking antiretroviral therapy. We used block randomisation, and patients and investigators were masked to treatment allocation. Effect of aciclovir on HIV-1 disease progression was defined by a primary composite endpoint of first occurrence of CD4 cell counts of fewer than 200 cells per mu L, antiretroviral therapy initiation, or non-trauma related death. As an exploratory analysis, we assessed the endpoint of CD4 falling to <350 cells per mu L. Analysis was by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00194519. Findings At enrolment, the median CD4 cell count was 462 cells per mu L and median HIV-1 plasma RNA was 4.1 log(10) copies per mu L. Aciclovir reduced risk of HIV-1 disease progression by 16%; 284 participants assigned aciclovir versus 324 assigned placebo reached the primary endpoint (hazard ratio [HR] 0.84, 95% CI 0.71-0.98, p=0.03). In those with CD4 counts >= 350 cells per mu L, aciclovir delayed risk of CD4 cell counts falling to <350 cells per mu L by 19% (0.81, 0.71-0.93, p=0.002). Interpretation The role of suppression of herpes simplex virus type 2 in reduction of HIV-1 disease progression before initiation of antiretroviral therapy warrants consideration.	[Lingappa, Jairam R.; Baeten, Jared M.; Mujugira, Andrew; Mugo, Nelly; Bukusi, Elizabeth A.; Wang, Richard S.; Kidoguchi, Lora; Barnes, Linda; Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA; [Lingappa, Jairam R.; Baeten, Jared M.; Wald, Anna; Thomas, Katherine K.; Farquhar, Carey; Stewart, Grace John; Corey, Lawrence; Celum, Connie] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Wald, Anna; Farquhar, Carey; Stewart, Grace John; Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Wald, Anna; Magaret, Amalia S.; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Wald, Anna; Magaret, Amalia S.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Mugo, Nelly; Bukusi, Elizabeth A.; Kiarie, James] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [Mugo, Nelly; Bukusi, Elizabeth A.; Kiarie, James] Kenyatta Natl Hosp, Nairobi, Kenya; [Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Katabira, Elly] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Ronald, Allan] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Makhema, Joseph] Botswana Harvard Partnership, Gaborone, Botswana; [Essex, Myron] Harvard Univ, Dept Immunol & Infect Dis, Cambridge, MA 02138 USA; [Were, Edwin] Moi Univ, Dept Reprod Hlth, Eldoret, Kenya; [Fife, Kenneth H.] Indiana Univ, Dept Med, Indianapolis, IN USA; [de Bruyn, Guy; Gray, Glenda E.; McIntyre, James A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Delany, Sinead; Rees, Helen] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Manongi, Rachel] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Kapiga, Saidi] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Coetzee, David] Univ Cape Town, Infect Dis Epidemiol Unit, ZA-7925 Cape Town, South Africa; [Allen, Susan; Inambao, Mubiana; Kayitenkore, Kayitesi; Karita, Etienne; Kanweka, William; Vwalika, Bellington] Emory Univ, Sch Med, Atlanta, GA USA; [Allen, Susan; Inambao, Mubiana; Kayitenkore, Kayitesi; Karita, Etienne; Kanweka, William; Vwalika, Bellington] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Ridzon, Renee] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Nairobi; Kenyatta National Hospital; Kenya Medical Research Institute; University of California System; University of California San Francisco; Makerere University; University of Manitoba; Harvard University; Moi University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Witwatersrand; University of Witwatersrand; Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; Emory University; Emory University; Rollins School Public Health; Bill & Melinda Gates Foundation	Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, UW Box 359927,325 9th Ave, Seattle, WA 98104 USA.	lingappa@u.washington.edu	John-Stewart, Grace/L-3650-2019; McIntyre, James/V-7115-2019; Corey, Lawrence/AAE-1796-2020; Lingappa, Jairam/N-7760-2017; John-Stewart, Grace/U-3351-2019; Wald, Anna/B-6272-2012; de Bruyn, Guy/E-5574-2010	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; kiarie, james/0000-0003-4180-7858; Rees, Helen/0000-0003-1442-6734; de Bruyn, Guy/0000-0002-8028-4474; Thomas, Katherine K/0000-0002-7024-468X; Kapiga, Saidi/0000-0003-1753-4060; Barnes, Linda/0000-0002-5090-0328; Ronald, Allan/0000-0002-5746-3490; Mujugira, Andrew/0000-0001-6646-6733; Were, Edwin/0000-0002-4783-0795	Bill & Melinda Gates Foundation [26469]; US National Institutes of Health [R01 66767]; NIMH [HR01 MH66767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066767] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the study participants for their dedication; the referral partners, Community Advisory Boards, institutions, and communities that partnered with the study sites for constructive insights; the members of the Data and Safety Monitoring Board (Richard Whitley [chair], Ann Arvin, Francis Kasolo, Alejandros Llanos, Jonathan Matenga, James Neaton, and David Serwadda) for their oversight and wisdom; Toni Maddox for administrative aspects of manuscript preparation; and Deborah Donnell for insightful comments on the analysis and interpretation of the data. DF/Net Research (Seattle, USA) provided data management. Contract Lab Services (University of the Witwatersrand, Johannesburg, South Africa) provided study site laboratory oversight. This study was funded by the Bill & Melinda Gates Foundation (grant ID #26469). The community outreach recruitment strategy used by some sites was adapted from the Influence Network Agent model developed by Emory collaborators with a grant from the US National Institutes of Health (National Institute of Mental Health R01 66767) and the couples' voluntary HIV counselling and testing procedures were based on the CDC/NIMH/Liverpool School of Tropical Medicine procedure manual, including support from a grant from the NIMH (HR01 MH66767).	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Baeten JM, 2004, J INFECT DIS, V189, P1466, DOI 10.1086/383049; Baggaley RF, 2009, AIDS, V23, P1005, DOI 10.1097/QAD.0b013e32832aadf2; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; CORBELL C, SEX TRANSM IN PRESS; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; DEVINE A, 2009, 18 INT SOC SEX TRANS; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Gamiel JL, 2008, CLIN VACCINE IMMUNOL, V15, P888, DOI 10.1128/CVI.00453-07; Gilbert PB, 2005, BIOSTATISTICS, V6, P374, DOI 10.1093/biostatistics/kxi014; Golden MR, 2005, SEX TRANSM DIS, V32, P771, DOI 10.1097/01.olq.0000175377.88358.f3; Gupta R, 2006, EXPERT OPIN PHARMACO, V7, P665, DOI 10.1517/14656566.7.6.665; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Ioannidis JPA, 1998, J INFECT DIS, V178, P349, DOI 10.1086/515621; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Laeyendecker O, 2004, J CLIN MICROBIOL, V42, P1794, DOI 10.1128/JCM.42.4.1794-1796.2004; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lingappa JR, 2007, DRUGS, V67, P155, DOI 10.2165/00003495-200767020-00001; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; Mbopi-Keou FX, 2003, JAIDS-J ACQ IMM DEF, V33, P121, DOI 10.1097/00126334-200306010-00001; McMahon MA, 2008, J BIOL CHEM, V283, P31289, DOI 10.1074/jbc.C800188200; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; Moriuchi M, 2000, VIROLOGY, V278, P534, DOI 10.1006/viro.2000.0667; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Posavad CM, 2004, J INFECT DIS, V190, P693, DOI 10.1086/422755; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; *UN AIDS WHO, 2008, REP GLOB AIDS EP; VICKERMAN P, 2009, 18 INT SOC SEX TRANS; VOLBERDING PA, 1994, JAMA-J AM MED ASSOC, V272, P437, DOI 10.1001/jama.272.6.437; Walson JL, 2008, AIDS, V22, P1601, DOI 10.1097/QAD.0b013e32830a502e; Weiss H, 2004, HERPES S, V11, p24A; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	50	112	115	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 6	2010	375	9717					824	833		10.1016/S0140-6736(09)62038-9	http://dx.doi.org/10.1016/S0140-6736(09)62038-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20153888	Green Accepted			2022-12-28	WOS:000275682600032
J	Nielsen, LP; Risgaard-Petersen, N; Fossing, H; Christensen, PB; Sayama, M				Nielsen, Lars Peter; Risgaard-Petersen, Nils; Fossing, Henrik; Christensen, Peter Bondo; Sayama, Mikio			Electric currents couple spatially separated biogeochemical processes in marine sediment	NATURE			English	Article							PORPHYRY SULFIDE MINERALIZATION; ORGANIC-CARBON; WATER; MODEL; ELECTROCHEMISTRY; COMMUNITIES; DIFFUSION; REDUCTION; TRANSPORT	Some bacteria are capable of extracellular electron transfer, thereby enabling them to use electron acceptors and donors without direct cell contact(1-4). Beyond the micrometre scale, however, no firm evidence has previously existed that spatially segregated biogeochemical processes can be coupled by electric currents in nature. Here we provide evidence that electric currents running through defaunated sediment couple oxygen consumption at the sediment surface to oxidation of hydrogen sulphide and organic carbon deep within the sediment. Altering the oxygen concentration in the sea water overlying the sediment resulted in a rapid (<1-h) change in the hydrogen sulphide concentration within the sediment more than 12 mm below the oxic zone, a change explicable by transmission of electrons but not by diffusion of molecules. Mass balances indicated that more than 40% of total oxygen consumption in the sediment was driven by electrons conducted from the anoxic zone. A distinct pH peak in the oxic zone could be explained by electrochemical oxygen reduction, but not by any conventional sets of aerobic sediment processes. We suggest that the electric current was conducted by bacterial nanowires combined with pyrite, soluble electron shuttles and outer-membrane cytochromes. Electrical communication between distant chemical and biological processes in nature adds a new dimension to our understanding of biogeochemistry and microbial ecology.	[Nielsen, Lars Peter] Aarhus Univ, Dept Biol Sci, DK-8000 Aarhus C, Denmark; [Risgaard-Petersen, Nils] Aarhus Univ, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark; [Fossing, Henrik; Christensen, Peter Bondo] Aarhus Univ, Natl Environm Res Inst, Dept Marine Ecol, DK-8600 Silkeborg, Denmark; [Sayama, Mikio] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan	Aarhus University; Aarhus University; Aarhus University; National Institute of Advanced Industrial Science & Technology (AIST)	Nielsen, LP (corresponding author), Aarhus Univ, Dept Biol Sci, Ny Munkegade 114, DK-8000 Aarhus C, Denmark.	biolpn@biology.au.dk	Risgaard-Petersen, Nils/J-2479-2013; Nielsen, Lars Peter/J-7401-2013; Risgaard-Petersen, Nils/AAX-6747-2021; Fossing, Henrik/J-5646-2013; Nielsen, Lars Peter/AAL-6274-2021	Risgaard-Petersen, Nils/0000-0002-2767-2080; Nielsen, Lars Peter/0000-0002-7269-4860; Risgaard-Petersen, Nils/0000-0002-2767-2080; Nielsen, Lars Peter/0000-0002-7269-4860; Fossing, Henrik/0000-0001-5193-176X	Aarhus University Research Foundation; Danish National Research Foundation; Max Planck Society; Japan Society for the Promotion of Science	Aarhus University Research Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Max Planck Society(Max Planck Society); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was financially supported by the Aarhus University Research Foundation, the Danish National Research Foundation (N.R.-P.), the Max Planck Society (N.R.-P.) and the Japan Society for the Promotion of Science ( M. S.).	Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Bigalke J, 1997, ELECTROCHIM ACTA, V42, P3443, DOI 10.1016/S0013-4686(97)00053-4; CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; CORRY CE, 1985, GEOPHYSICS, V50, P1020, DOI 10.1190/1.1441967; Crank J., 1967, MATH DIFFUSION, P18; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Glud RN, 1996, MAR ECOL PROG SER, V141, P303, DOI 10.3354/meps141303; Glud RN, 1999, MAR ECOL PROG SER, V186, P87, DOI 10.3354/meps186087; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Leang C, 2003, J BACTERIOL, V185, P2096, DOI 10.1128/JB.185.7.2096-2103.2003; LENEY GW, 1986, GEOPHYSICS, V51, P1153; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Naudet V, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022735; Ntarlagiannis D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030426; Rabaey K, 2007, ISME J, V1, P9, DOI 10.1038/ismej.2007.4; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reimers CE, 2001, ENVIRON SCI TECHNOL, V35, P192, DOI 10.1021/es001223s; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Ryckelynck N, 2005, BIOGEOCHEMISTRY, V76, P113, DOI 10.1007/s10533-005-2671-3; Sato M., 1960, GEOPHYSICS, V25, P226, DOI [10.1190/1.1438689, DOI 10.1190/1.1438689]; Sayama M, 2005, APPL ENVIRON MICROB, V71, P7575, DOI 10.1128/AEM.71.11.7575-7577.2005; Soetaert K, 2007, MAR CHEM, V105, P30, DOI 10.1016/j.marchem.2006.12.012; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Stumm W, 1981, AQUAT CHEM, P179; Torres CI, 2008, ENVIRON SCI TECHNOL, V42, P6593, DOI 10.1021/es800970w; TROMP TK, 1995, GEOCHIM COSMOCHIM AC, V59, P1259, DOI 10.1016/0016-7037(95)00042-X; ULLMAN WJ, 1982, LIMNOL OCEANOGR, V27, P552, DOI 10.4319/lo.1982.27.3.0552; Williams KH, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000440	30	345	375	24	371	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1071	1074		10.1038/nature08790	http://dx.doi.org/10.1038/nature08790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182510				2022-12-28	WOS:000275108400034
J	Johnson, PDR				Johnson, Paul D. R.			Should antibiotics be given for Buruli ulcer?	LANCET			English	Editorial Material							MYCOBACTERIUM-ULCERANS; INFECTION; STREPTOMYCIN; COMBINATION; EFFICACY		[Johnson, Paul D. R.] Austin Hosp, Dept Infect Dis, Heidelberg, Vic 3084, Australia; [Johnson, Paul D. R.] Univ Melbourne, Austin Hlth, Austin Hosp, Heidelberg, Vic 3084, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Johnson, PDR (corresponding author), Austin Hosp, Dept Infect Dis, Heidelberg, Vic 3084, Australia.	paul.johnson@austin.org.au						Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; Espey David K., 2002, International Journal of Infectious Diseases, V6, P60, DOI 10.1016/S1201-9712(02)90138-4; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; FEHR H, 1994, TROP DOCT, V24, P61, DOI 10.1177/004947559402400206; Jenkin GA, 2002, MED J AUSTRALIA, V176, P180; Johnson PDR, 2007, MED J AUSTRALIA, V186, P64, DOI 10.5694/j.1326-5377.2007.tb00802.x; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.0020108; NIENHUIS WA, 2010, LANCET; O'Brien DP, 2007, MED J AUSTRALIA, V186, P58, DOI 10.5694/j.1326-5377.2007.tb00800.x; OBRIEN DP, 2009, MED J AUSTRALIA, V191, P154; REVILL WDL, 1973, LANCET, V2, P873; van der Werf TS, 1999, LANCET, V354, P1013, DOI 10.1016/S0140-6736(99)01156-3	12	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					618	619		10.1016/S0140-6736(10)60169-9	http://dx.doi.org/10.1016/S0140-6736(10)60169-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20137806				2022-12-28	WOS:000275210900007
J	Coleman, P				Coleman, Piers			The Lowdown on Heavy Fermions	SCIENCE			English	Editorial Material							MOLECULAR-BEAM EPITAXY		Rutgers State Univ, Ctr Mat Theory, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Coleman, P (corresponding author), Rutgers State Univ, Ctr Mat Theory, Piscataway, NJ 08854 USA.	coleman@physics.rutgers.edu						Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; HOSONO H, 2009, NEW J PHYS, V11, P25003; JOYCE BA, 1985, REP PROG PHYS, V48, P1637, DOI 10.1088/0034-4885/48/12/002; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; McCray WP, 2009, NAT NANOTECHNOL, V4, P2, DOI 10.1038/nnano.2008.380; PANISH MB, 1980, SCIENCE, V208, P916, DOI 10.1126/science.208.4446.916; Sarrao JL, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.051013; Shishido H, 2010, SCIENCE, V327, P980, DOI 10.1126/science.1183376	8	3	4	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					969	970		10.1126/science.1186253	http://dx.doi.org/10.1126/science.1186253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167778				2022-12-28	WOS:000274625800030
J	Toledano, MB; Planson, AG; Delaunay-Moisan, A				Toledano, Michel B.; Planson, Anne-Gaelle; Delaunay-Moisan, Agnes			Reining in H2O2 for Safe Signaling	CELL			English	Editorial Material							PROTEIN-TYROSINE PHOSPHATASES		[Toledano, Michel B.; Planson, Anne-Gaelle; Delaunay-Moisan, Agnes] CEA Saclay, DSV, Lab Stress Oxydants & Canc, IBITECS, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Toledano, MB (corresponding author), CEA Saclay, DSV, Lab Stress Oxydants & Canc, IBITECS, F-91191 Gif Sur Yvette, France.	michel.toledano@cea.fr	Planson, Anne-Gaëlle/AAK-9595-2021	Planson, Anne-Gaelle/0000-0003-4343-3386				Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405	7	32	32	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					454	456		10.1016/j.cell.2010.02.003	http://dx.doi.org/10.1016/j.cell.2010.02.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178737	Bronze			2022-12-28	WOS:000274668400008
J	Gilfanov, M; Bogdan, A				Gilfanov, Marat; Bogdan, Akos			An upper limit on the contribution of accreting white dwarfs to the type Ia supernova rate	NATURE			English	Article							X-RAY SOURCES; PROGENITOR SYSTEMS; MASS; BINARIES; MODELS; EVOLUTION; STARS; M31	There is wide agreement that type Ia supernovae (used as standard candles for cosmology) are associated with the thermonuclear explosions of white dwarf stars(1,2). The nuclear runaway that leads to the explosion could start in a white dwarf gradually accumulating matter from a companion star until it reaches the Chandrasekhar limit(3), or could be triggered by the merger of two white dwarfs in a compact binary system(4,5). The X-ray signatures of these two possible paths are very different. Whereas no strong electromagnetic emission is expected in the merger scenario until shortly before the supernova, the white dwarf accreting material from the normal star becomes a source of copious X-rays for about 10(7) years before the explosion. This offers a means of determining which path dominates. Here we report that the observed X-ray flux from six nearby elliptical galaxies and galaxy bulges is a factor of similar to 30-50 less than predicted in the accretion scenario, based upon an estimate of the supernova rate from their K-band luminosities. We conclude that no more than about five per cent of type Ia supernovae in early-type galaxies can be produced by white dwarfs in accreting binary systems, unless their progenitors are much younger than the bulk of the stellar population in these galaxies, or explosions of sub-Chandrasekhar white dwarfs make a significant contribution to the supernova rate.	[Gilfanov, Marat; Bogdan, Akos] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Gilfanov, Marat] Space Res Inst, Moscow 117997, Russia	Max Planck Society; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences	Gilfanov, M (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85741 Garching, Germany.	gilfanov@mpa-garching.mpg.de	Gilfanov, Marat/K-6867-2017		NASA; NSF	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank F. Meyer and H. Ritter for discussions of various aspects of mass transfer in binary systems and the role of the common envelope evolution and L. Yungelson for discussions on the type Ia supernovae progenitor problem in general. This research has made use of Chandra archival data, provided by the Chandra X-ray Center (CXC) in the application package CIAO. This research has also made use of data products from the Two Micron All Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by NASA and the NSF. The Spitzer Space telescope is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA.	Bogdan A, 2008, MON NOT R ASTRON SOC, V388, P56, DOI 10.1111/j.1365-2966.2008.13391.x; Di Stefano R, 2004, ASTROPHYS J, V610, P247, DOI 10.1086/421696; Fink M, 2007, ASTRON ASTROPHYS, V476, P1133, DOI 10.1051/0004-6361:20078438; Gallagher JS, 2008, ASTROPHYS J, V685, P752, DOI 10.1086/590659; Hachisu I, 1996, ASTROPHYS J, V470, pL97, DOI 10.1086/310303; Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; Hoeflich P., 1996, APJ, V457, P500, DOI DOI 10.1086/176748; IBEN I, 1994, ASTROPHYS J, V431, P264, DOI 10.1086/174484; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; Kahabka P, 1997, ANNU REV ASTRON ASTR, V35, P69, DOI 10.1146/annurev.astro.35.1.69; Li XD, 1997, ASTRON ASTROPHYS, V322, pL9; LIVIO M, 2000, TYPE IA SUPERNOVAE T, P33; Mannucci F, 2005, ASTRON ASTROPHYS, V433, P807, DOI 10.1051/0004-6361:20041411; NOMOTO K, 1979, PUBL ASTRON SOC JPN, V31, P287; Nomoto K, 2007, ASTROPHYS J, V663, P1269, DOI 10.1086/518465; Nugent P, 1997, ASTROPHYS J, V485, P812, DOI 10.1086/304459; Panei JA, 2000, ASTRON ASTROPHYS, V353, P970; Schawinski K, 2009, MON NOT R ASTRON SOC, V397, P717, DOI 10.1111/j.1365-2966.2009.15065.x; Terlevich AI, 2002, MON NOT R ASTRON SOC, V330, P547, DOI 10.1046/j.1365-8711.2002.05073.x; WEBBINK RF, 1984, ASTROPHYS J, V277, P355, DOI 10.1086/161701; Weidemann V, 2000, ASTRON ASTROPHYS, V363, P647; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565; Yaron O, 2005, ASTROPHYS J, V623, P398, DOI 10.1086/428435	23	149	149	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					924	925		10.1038/nature08685	http://dx.doi.org/10.1038/nature08685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164924	Green Submitted			2022-12-28	WOS:000274582700040
J	Lee, CTA; Luffi, P; Hoink, T; Li, J; Dasgupta, R; Hernlund, J				Lee, Cin-Ty A.; Luffi, Peter; Hoeink, Tobias; Li, Jie; Dasgupta, Rajdeep; Hernlund, John			Upside-down differentiation and generation of a 'primordial' lower mantle	NATURE			English	Article							EQUATION-OF-STATE; THERMAL EVOLUTION; HIGH-PRESSURE; MELT; EARTH; DENSITY; PETROGENESIS; SEGREGATION; STABILITY; ELEMENTS	Except for the first 50-100 million years or so of the Earth's history, when most of the mantle may have been subjected to melting, the differentiation of Earth's silicate mantle has been controlled by solid-state convection(1). As the mantle upwells and decompresses across its solidus, it partially melts. These low-density melts rise to the surface and form the continental and oceanic crusts, driving the differentiation of the silicate part of the Earth. Because many trace elements, such as heat-producing U, Th and K, as well as the noble gases, preferentially partition into melts (here referred to as incompatible elements), melt extraction concentrates these elements into the crust (or atmosphere in the case of noble gases), where nearly half of the Earth's budget of these elements now resides(2). In contrast, the upper mantle, as sampled by mid-ocean ridge basalts, is highly depleted in incompatible elements, suggesting a complementary relationship with the crust. Mass balance arguments require that the other half of these incompatible elements be hidden in the Earth's interior. Hypotheses abound for the origin of this hidden reservoir(3-6). The most widely held view has been that this hidden reservoir represents primordial material never processed by melting or degassing. Here, we suggest that a necessary by-product of whole-mantle convection during the Earth's first billion years is deep and hot melting, resulting in the generation of dense liquids that crystallized and sank into the lower mantle. These sunken lithologies would have 'primordial' chemical signatures despite a non-primordial origin.	[Lee, Cin-Ty A.; Luffi, Peter; Hoeink, Tobias; Dasgupta, Rajdeep] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Li, Jie] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [Hernlund, John] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Rice University; University of Michigan System; University of Michigan; University of California System; University of California Berkeley	Lee, CTA (corresponding author), Rice Univ, Dept Earth Sci, MS-126,6100 Main St, Houston, TX 77005 USA.	ctlee@rice.edu	Lee, Cin-Ty/AAV-8155-2021; Luffi, Peter I/C-1229-2013; Lee, Cin-Ty/A-5469-2008; Hernlund, John/A-8931-2014; Dasgupta, Rajdeep/C-7252-2009	Lee, Cin-Ty/0000-0002-3586-0110; Luffi, Peter I/0000-0001-9536-5405; Hernlund, John/0000-0003-1008-0182; Dasgupta, Rajdeep/0000-0001-5392-415X; Li, Jie/0000-0003-4761-722X	Packard Foundation; NSF; University of Illinois	Packard Foundation(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF)); University of Illinois	The ideas for this paper were conceived at Rice University and fine-tuned at the 2008 Cooperative Institute for Deep Earth Research workshop at the Kavli Institute. We thank G. Masters, M. Ishii, M. Manga, M. Jellinek, B. Romanowicz, T. Plank, H. Gonnermann, L. Stixrude and C. Lithgow-Bertelloni for discussions and S. Parman for reviews. G. Masters also helped with velocity calculations. We thank the Packard Foundation and the NSF for support. J. Li also acknowledges support from the University of Illinois.	Abe Y, 1997, PHYS EARTH PLANET IN, V100, P27, DOI 10.1016/S0031-9201(96)03229-3; Agee CB, 2008, EARTH PLANET SC LETT, V265, P641, DOI 10.1016/j.epsl.2007.11.010; Arndt N, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002157; Becker TW, 1999, EARTH PLANET SC LETT, V171, P351, DOI 10.1016/S0012-821X(99)00160-0; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; BINA CR, 1992, ANNU REV EARTH PL SC, V20, P527, DOI 10.1146/annurev.ea.20.050192.002523; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; CHRISTENSEN UR, 1994, J GEOPHYS RES-SOL EA, V99, P19867, DOI 10.1029/93JB03403; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Connolly JAD, 2002, J METAMORPH GEOL, V20, P697, DOI 10.1046/j.1525-1314.2002.00398.x; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; Grove TL, 2004, EARTH PLANET SC LETT, V219, P173, DOI 10.1016/S0012-821X(04)00002-0; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; Hernlund JW, 2008, EARTH PLANET SC LETT, V265, P423, DOI 10.1016/j.epsl.2007.10.042; Herzberg C, 1996, J GEOPHYS RES-SOL EA, V101, P8271, DOI 10.1029/96JB00170; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Ishii M, 2001, GEOPHYS J INT, V145, P77, DOI 10.1111/j.1365-246X.2001.00385.x; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Korenaga J, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000241; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Labrosse S, 2007, EARTH PLANET SC LETT, V260, P465, DOI 10.1016/j.epsl.2007.05.046; LANGE RA, 1987, GEOCHIM COSMOCHIM AC, V51, P2931, DOI 10.1016/0016-7037(87)90368-1; LANGMUIR C, 1992, PETROLOGICAL SYSTEMA; Lee SH, 2009, CORONARY ARTERY DIS, V20, P33, DOI 10.1097/MCA.0b013e328318ecb0; Li L, 2006, PHYS EARTH PLANET IN, V155, P249, DOI 10.1016/j.pepi.2005.12.006; Mattern E, 2005, GEOPHYS J INT, V160, P973, DOI 10.1111/j.1365-246X.2004.02549.x; MILLER GH, 1991, J GEOPHYS RES-SOLID, V96, P11849, DOI 10.1029/91JB01203; OHTANI E, 1989, CONTRIB MINERAL PETR, V103, P263, DOI 10.1007/BF00402913; Ohtani E, 2001, EARTH PLANET SC LETT, V193, P69, DOI 10.1016/S0012-821X(01)00505-2; Putirka KD, 2007, CHEM GEOL, V241, P177, DOI 10.1016/j.chemgeo.2007.01.014; RICHTER FM, 1985, EARTH PLANET SC LETT, V73, P350, DOI 10.1016/0012-821X(85)90083-4; Sakamaki T, 2006, NATURE, V439, P192, DOI 10.1038/nature04352; Stixrude L, 2005, GEOPHYS J INT, V162, P610, DOI 10.1111/j.1365-246X.2005.02642.x; Stixrude L, 2009, EARTH PLANET SC LETT, V278, P226, DOI 10.1016/j.epsl.2008.12.006; STOLPER E, 1981, J GEOPHYS RES, V86, P6261, DOI 10.1029/JB086iB07p06261; Suzuki A, 1998, PHYS EARTH PLANET IN, V107, P53, DOI 10.1016/S0031-9201(97)00123-4; Tackley PJ, 1998, EARTH PLANET SC LETT, V157, P9, DOI 10.1016/S0012-821X(98)00029-6; Tronnes RG, 2002, EARTH PLANET SC LETT, V197, P117, DOI 10.1016/S0012-821X(02)00466-1; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0	41	121	125	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					930	U102		10.1038/nature08824	http://dx.doi.org/10.1038/nature08824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164926				2022-12-28	WOS:000274582700042
J	Roberts, TF; Tschida, KA; Klein, ME; Mooney, R				Roberts, Todd F.; Tschida, Katherine A.; Klein, Marguerita E.; Mooney, Richard			Rapid spine stabilization and synaptic enhancement at the onset of behavioural learning	NATURE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; IN-VIVO; ZEBRA FINCH; SONG; NEURONS; CORTEX; PLASTICITY; DEPRIVATION; INTEGRATION	Behavioural learning depends on the brain's capacity to respond to instructive experience and is often enhanced during a juvenile sensitive period. How instructive experience acts on the juvenile brain to trigger behavioural learning remains unknown. In vitro studies show that forms of synaptic strengthening thought to underlie learning are accompanied by an increase in the stability, number and size of dendritic spines, which are the major sites of excitatory synaptic transmission in the vertebrate brain(1-7). In vivo imaging studies in sensory cortical regions reveal that these structural features can be affected by disrupting sensory experience and that spine turnover increases during sensitive periods for sensory map formation(8-12). These observations support two hypotheses: first, the increased capacity for behavioural learning during a sensitive period is associated with enhanced spine dynamics on sensorimotor neurons important for the learned behaviour; second, instructive experience rapidly stabilizes and strengthens these dynamic spines. Here we report a test of these hypotheses using two-photon in vivo imaging to measure spine dynamics in zebra finches, which learn to sing by imitating a tutor song during a juvenile sensitive period(13,14). Spine dynamics were measured in the forebrain nucleus HVC, the proximal site where auditory information merges with an explicit song motor representation(15-19), immediately before and after juvenile finches first experienced tutor song(20). Higher levels of spine turnover before tutoring correlated with a greater capacity for subsequent song imitation. In juveniles with high levels of spine turnover, hearing a tutor song led to the rapid (similar to 24-h) stabilization, accumulation and enlargement of dendritic spines in HVC. Moreover, in vivo intracellular recordings made immediately before and after the first day of tutoring revealed robust enhancement of synaptic activity in HVC. These findings suggest that behavioural learning results when instructive experience is able to rapidly stabilize and strengthen synapses on sensorimotor neurons important for the control of the learned behaviour.	[Roberts, Todd F.; Tschida, Katherine A.; Klein, Marguerita E.; Mooney, Richard] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu		Mooney, Richard/0000-0002-3308-1367; Tschida, Katherine/0000-0002-8171-1722	US National Science Foundation (NSF); US National Institutes of Health (NIH); Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER	US National Science Foundation (NSF)(National Science Foundation (NSF)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Ehlers and L. Katz for access to the two-photon microscope and support in making lentivirus, K. Hamaguchi for peak detection and analysis software and D. Kloetzer for animal husbandry and laboratory support. D. Fitzpatrick, D. Purves and M. Ehlers provided comments on the manuscript. This work was supported by grants from the US National Science Foundation (NSF) and the US National Institutes of Health (NIH) (R. M.). T. F. R. was supported by a National Research Service Award from the NIH, K. A. T. was supported by a pre-doctoral award from the NSF and M. E. K. was supported by the Howard Hughes Medical Institute (Investigator, M. Ehlers).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Immelmann K., 1969, P61; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	29	209	211	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					948	U123		10.1038/nature08759	http://dx.doi.org/10.1038/nature08759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164928	Green Accepted			2022-12-28	WOS:000274582700046
J	Skinner, J; Staiger, D; Fisher, ES				Skinner, Jonathan; Staiger, Douglas; Fisher, Elliott S.			Looking Back, Moving Forward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE; MEDICARE		[Skinner, Jonathan; Staiger, Douglas; Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Fisher, Elliott S.] Dartmouth Med Sch, Dept Med, Lebanon, NH USA; [Skinner, Jonathan; Staiger, Douglas] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Skinner, J (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA.							Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Chernew ME, 2010, NEW ENGL J MED, V362, P1, DOI 10.1056/NEJMp0910194; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; GOTTLIEB DJ, 2010, HLTH AFFAIRS    0128; Medicare Payment Advisory Committee, 2009, REP C MEAS REG VAR S; Miller HD, 2009, HEALTH AFFAIR, V28, P1418, DOI 10.1377/hlthaff.28.5.1418; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813	9	26	26	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					569	574		10.1056/NEJMp1000448	http://dx.doi.org/10.1056/NEJMp1000448			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556ED	20164482				2022-12-28	WOS:000274571200002
J	Guatelli, J				Guatelli, John			How Innate Immunity Can Inhibit the Release of HIV-1 from Infected Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VPU PROTEIN		[Guatelli, John] Univ Calif San Diego, San Diego, CA 92103 USA; [Guatelli, John] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Guatelli, J (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.				NIAID NIH HHS [R01 AI081668] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081668] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Tokarev A, 2009, AIDS RES HUM RETROV, V25, P1197, DOI 10.1089/aid.2009.0253; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001	5	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					553	554		10.1056/NEJMcibr0911557	http://dx.doi.org/10.1056/NEJMcibr0911557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147723				2022-12-28	WOS:000274397200017
J	Hagen, TP; Vaughan-Sarrazin, MS; Cram, P				Hagen, Tyson P.; Vaughan-Sarrazin, Mary S.; Cram, Peter			Relation between hospital orthopaedic specialisation and outcomes in patients aged 65 and older: retrospective analysis of US Medicare data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGEON PROCEDURE VOLUME; BYPASS GRAFT-SURGERY; KNEE REPLACEMENT; TOTAL HIP; OPERATIVE MORTALITY; SPECIALTY; ASSOCIATION; COMORBIDITY; STATISTICS; QUALITY	Objective To explore the relation between hospital orthopaedic specialisation and postoperative outcomes after total hip or knee replacement surgery. Design Retrospective analysis of US Medicare data, 2001-5. Setting 3818 US hospitals carrying out total joint replacement. Population 1 273 081 Medicare beneficiaries age 65 and older who underwent primary or revision hip or knee replacement. Main outcome measures Hospitals were stratified into fifths on the basis of their degree of orthopaedic specialisation ( lowest fifth, least specialised; highest fifth, most specialised). The primary outcome was defined as a composite representing the occurrence of one or more of pulmonary embolism, deep vein thrombosis, haemorrhage, infection, myocardial infarction, or death within 90 days of the index surgery. Results As hospital orthopaedic specialisation increased from the lowest fifth to highest fifth, the proportion of people admitted who were women or black, or who had diabetes or heart failure progressively decreased (P<0.001), whereas procedural volume increased. Compared with the most specialised hospitals ( highest fifth), after adjustment for patient characteristics and hospital volume, the odds of adverse outcomes increased progressively with decreased hospital specialisation: lowest fifth (odds ratio 1.59, 95% confidence interval 1.53 to 1.65), second fifth (1.32, 1.28 to 1.36), third fifth (1.24, 1.21 to 1.28), and fourth fifth (1.10, 1.07 to 1.13). Conclusions Increased hospital orthopaedic specialisation is associated with improved patient outcomes after adjusting for both patient characteristics and hospital procedural volume. These results should be interpreted with caution because the possibility that other unmeasured confounders related to socioeconomic status or different factors are responsible for the improved patient outcomes rather than hospital specialisation can not be excluded. The findings suggest that hospital specialisation may capture different components of hospital quality than the components captured by hospital volume.	[Vaughan-Sarrazin, Mary S.; Cram, Peter] Iowa City Vet Affairs Med Ctr, CRIISP, Iowa City, IA USA; [Vaughan-Sarrazin, Mary S.; Cram, Peter] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Gen Internal Med, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa		tyson-hagen@uiowa.edu	Cram, Peter/K-4472-2014	Cram, Peter/0000-0002-1910-346X; Vaughan Sarrazin, Mary/0000-0001-8717-1061	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service; National Center for Research Resources, National Institutes of Health [RR01997201]; National Heart, Lung, and Blood Institute, National Institutes of Health [R01 HL085347-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033035] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service(US Department of Veterans Affairs); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MSV-S is a research scientist in the Center for Research in the Implementation of Innovative Strategies in Practice (CRIISP) at the Iowa City VA Medical Center, which is funded through the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service. PC is supported by a K23 career development award (RR01997201) from the National Center for Research Resources, National Institutes of Health; the Robert Wood Johnson faculty scholars programme; and R01 HL085347-01A1 from the National Heart, Lung, and Blood Institute, National Institutes of Health. The views expressed in this article are those of the authors and do not necessarily represent those of the Department of Veterans Affairs.	*AG HEALTHC RES QU, 2007, PAT SAF IND DOWNL; *AM HOSP ASS, 2009, HLTH CAR STAT MARK R; ASH AS, 1997, RISK ADJUSTMENT MEAS; BARKER D, 2009, J HLTH EC IN PRESS; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Cram P, 2005, NEW ENGL J MED, V352, P1454, DOI 10.1056/NEJMsa042325; Cram P, 2007, J BONE JOINT SURG AM, V89A, P1675, DOI 10.2106/JBJS.F.00873; DEVLIN HB, 1986, BRIT J SURG, V73, P123, DOI 10.1002/bjs.1800730217; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gawande A., 2002, COMPLICATIONS SURG N; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hannan EL, 2002, SURGERY, V131, P6, DOI 10.1067/msy.2002.120238; Hwang CW, 2007, MED CARE, V45, P720, DOI 10.1097/MLR.0b013e3180537192; Judge A, 2006, J PUBLIC HEALTH-UK, V28, P116, DOI 10.1093/pubmed/fdl003; Katz JN, 2008, MED CARE, V46, P476, DOI 10.1097/MLR.0b013e31816c43c8; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; *LEAPFR GROUP, 2009, PURCH PRINC; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LUFT HS, 1980, MED CARE, V18, P940, DOI 10.1097/00005650-198009000-00006; LUFT HS, 1987, HEALTH SERV RES, V22, P157; LUFT HS, 1990, HOSP VOLUME PHYS VOL; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; *MED PAYM ADV COMM, 2005, REP C PHYS OWN SPEC; MITCHELL JB, 1994, MED CARE S, V7, pJ38; Nallamothu BK, 2006, CIRCULATION, V113, P222, DOI 10.1161/CIRCULATIONAHA.105.578195; Norton EC, 1998, HEALTH SERV RES, V33, P1191; Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195; Phillips CB, 2003, J BONE JOINT SURG AM, V85A, P20, DOI 10.2106/00004623-200301000-00004; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; Pronovost PJ, 2009, CLIN CHEST MED, V30, P169, DOI 10.1016/j.ccm.2008.09.004; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Sexton JB, 2006, ANESTHESIOLOGY, V105, P877, DOI 10.1097/00000542-200611000-00006; SOWDEN AJ, 1995, BMJ-BRIT MED J, V311, P151, DOI 10.1136/bmj.311.6998.151; Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056; Topal B, 2007, BRIT J SURG, V94, P1377, DOI 10.1002/bjs.5861; *US BUR CENS, 2009, US CENS 2009; *US GEN ACC OFF, 2003, SPEC HOSP INF NAT MA; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	44	38	38	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2010	340								c165	10.1136/bmj.c165	http://dx.doi.org/10.1136/bmj.c165			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	554ZV	20150193	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000274477200002
J	Sun, LJ; Liu, SQ; Chen, ZJJ				Sun, Lijun; Liu, Siqi; Chen, Zhijian J.			SnapShot: Pathways of Antiviral Innate Immunity	CELL			English	Editorial Material									[Sun, Lijun; Liu, Siqi; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, HHMI, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, LJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, HHMI, Dallas, TX 75390 USA.		Sun, Lijun/ABD-4470-2021; Liu, Siqi/D-9325-2014; Chen, Zhijian/C-6039-2012	Liu, Siqi/0000-0002-2767-641X; Chen, Zhijian/0000-0002-8475-8251	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063692-08, R01 GM063692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Fujita T, 2009, IMMUNITY, V31, P4, DOI 10.1016/j.immuni.2009.06.014; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	8	54	55	3	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 5	2010	140	3					436	U182		10.1016/j.cell.2010.01.041	http://dx.doi.org/10.1016/j.cell.2010.01.041			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144765	Green Accepted, Bronze			2022-12-28	WOS:000274297700020
J	Royou, A; Gagou, ME; Karess, R; Sullivan, W				Royou, Anne; Gagou, Mary E.; Karess, Roger; Sullivan, William			BubR1-and Polo-Coated DNA Tethers Facilitate Poleward Segregation of Acentric Chromatids	CELL			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; DROSOPHILA-MELANOGASTER; GENOMIC INSTABILITY; CENTROMERE; DAMAGE; ANAPHASE; TELOMERES; MITOSIS; ARREST; YEAST	The mechanisms that safeguard cells against chromosomal instability (CIN) are of great interest, as CIN contributes to tumorigenesis. To gain insight into these mechanisms, we studied the behavior of cells entering mitosis with damaged chromosomes. We used the endonuclease I-CreI to generate acentric chromosomes in Drosophila larvae. While I-CreI expression produces acentric chromosomes in the majority of neuronal stem cells, remarkably, it has no effect on adult survival. Our live studies reveal that acentric chromatids segregate efficiently to opposite poles. The acentric chromatid poleward movement is mediated through DNA tethers decorated with BubR1, Polo, INCENP, and Aurora-B. Reduced BubR1 or Polo function results in abnormal segregation of acentric chromatids, a decrease in acentric chromosome tethering, and a great reduction in adult survival. We propose that BubR1 and Polo facilitate the accurate segregation of acentric chromatids by maintaining the integrity of the tethers that connect acentric chromosomes to their centric partners.	[Gagou, Mary E.; Karess, Roger] Univ Paris 07, Inst Jacques Monod, F-75205 Paris 13, France; [Royou, Anne; Sullivan, William] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Santa Cruz	Royou, A (corresponding author), Univ Paris 07, Inst Jacques Monod, 4 Rue Marie Andree Lagroua Weill Halle, F-75205 Paris 13, France.	royou@biology.ucsc.edu		Karess, Roger/0000-0002-7299-0600	California Institute for Regenerative Medicine; National Institutes of Health [GM046409]; European Union; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-08-BLAN-0006-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046409, R29GM046409] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kent Golic (University of Utah, UT), Kim McKim (Rutgers University, NJ), Claudio Sunkel (University of Porto, Portugal) and William Earnshaw (University of Edinburgh, UK) for sharing reagents, the Sullivan lab members and Derek McCusker (Institut Europeen de Chimie et Biochimie, Bordeaux, France) for critical reading of the manuscript. We also thank Alfredo Villasante (Universidad Autonoma de Madrid, Spain) for sharing unpublished data. A. R. and W. S. were supported by grants from the California Institute for Regenerative Medicine and the National Institutes of Health (GM046409), respectively. M. E. G. was supported by a training and mobility grant from the Research Training Network program of the European Union. R. K. was supported by the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (ANR-08-BLAN-0006-01).	Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Donaldson MM, 2001, J CELL BIOL, V153, P663, DOI 10.1083/jcb.153.4.663; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Galgoczy DJ, 2001, MOL CELL BIOL, V21, P1710, DOI 10.1128/MCB.21.5.1710-1718.2001; Hartl TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000228; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Kanda T, 2001, J CELL SCI, V114, P49; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; LaFountain JR, 2002, J CELL SCI, V115, P1541; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Melo JA, 2001, GENE DEV, V15, P2809; Moutinho-Santos T, 1999, BIOL CELL, V91, P585, DOI 10.1016/S0248-4900(00)88523-8; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Musaro M, 2008, NAT GENET, V40, P362, DOI 10.1038/ng.2007.64; Platero JS, 1999, MOL CELL, V4, P995, DOI 10.1016/S1097-2765(00)80228-2; Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Royou A, 2005, CURR BIOL, V15, P334, DOI 10.1016/j.cub.2005.02.026; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Titen SWA, 2008, GENETICS, V180, P1821, DOI 10.1534/genetics.108.093625; Tusell L, 2008, CYTOGENET GENOME RES, V122, P315, DOI 10.1159/000167818; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; WILLIAMS BC, 1994, J CELL SCI, V107, P785; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	43	54	54	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2					235	245		10.1016/j.cell.2009.12.043	http://dx.doi.org/10.1016/j.cell.2009.12.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141837	Green Accepted, Bronze			2022-12-28	WOS:000273826500014
J	El-Sadr, WM; Mayer, KH; Hodder, SL				El-Sadr, Wafaa M.; Mayer, Kenneth H.; Hodder, Sally L.			AIDS in America -- Forgotten but Not Gone.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV; BEHAVIORS		[El-Sadr, Wafaa M.] Columbia Univ, Int Ctr AIDS Care & Treatment Programs, Mailman Sch Publ Hlth, New York, NY 10027 USA; [El-Sadr, Wafaa M.] Columbia Univ, Dept Med, Harlem Hosp, New York, NY USA; [El-Sadr, Wafaa M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Mayer, Kenneth H.] Fenway Inst Fenway Hlth, Boston, MA USA; [Mayer, Kenneth H.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Mayer, Kenneth H.] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Hodder, Sally L.] Univ Med & Dent New Jersey, Dept Med, Newark, NJ 07103 USA	Columbia University; Columbia University; Columbia University; Fenway Health; Brown University; Brown University; Rutgers State University New Brunswick; Rutgers State University Medical Center	El-Sadr, WM (corresponding author), Columbia Univ, Int Ctr AIDS Care & Treatment Programs, Mailman Sch Publ Hlth, New York, NY 10027 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068619, UM1AI068619] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*CDCP, 2007, HIV PREV SEL POP HIG; *GOV DISTR COL DEP, 2008, DISTR COL HIV AIDS E; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Nguyen TQ, 2008, AIDS, V22, P281, DOI 10.1097/QAD.0b013e3282f2ef58	5	108	108	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					967	970		10.1056/NEJMp1000069	http://dx.doi.org/10.1056/NEJMp1000069			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20147707	Green Published, Green Accepted			2022-12-28	WOS:000275650400002
J	Rosenbaum, S				Rosenbaum, Sara			Can States Pick Up the Health Reform Torch?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA	George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA.							BALZ D, 2010, WASHINGTON POST 0119; Jost TS, 2010, NEW ENGL J MED, V362, P869, DOI 10.1056/NEJMp1001345; *KAIS FAM FDN, EMPL HLTH BEN 2009 S; MACGILLIS A, 2010, WASH POST       0822, pA4; Ryan P. D., 2010, ROADMAP AM FUTURE VE	5	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMp1001439	http://dx.doi.org/10.1056/NEJMp1001439			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20181967				2022-12-28	WOS:000275365900004
J	Spivak, JL				Spivak, Jerry L.			Narrative Review: Thrombocytosis, Polycythemia Vera, and JAK2 Mutations: The Phenotypic Mimicry of Chronic Myeloproliferation	ANNALS OF INTERNAL MEDICINE			English	Review							TYROSINE KINASE JAK2; RED-CELL MASS; V617F MUTATION; 617V-GREATER-THAN-F MUTATION; ACTIVATING MUTATION; MYELOID METAPLASIA; ALLELE BURDEN; PLASMA-VOLUME; STEM-CELL; DISORDERS	The myeloproliferative disorders polycythemia vera, essential thrombocytosis, and primary myelofibrosis are clonal disorders arising in a pluripotent hematopoietic stem cell, causing an unregulated increase in the number of erythrocytes, leukocytes, or platelets, alone or in combination; eventual marrow dominance by the progeny of the involved stem cell; and a tendency to arterial or venous thrombosis, marrow fibrosis, splenomegaly, or transformation to acute leukemia, albeit at widely varying frequencies. The discovery of an activating mutation (V617F) in the gene for JAK2 (Janus kinase 2), a tyrosine kinase utilized by hematopoietic cell receptors for erythropoietin, thrombopoietin, and granulocyte colony-stimulating factor, provided an explanation for the shared clinical features of these 3 disorders. Constitutive JAK2 activation provides a growth and survival advantage to the hematopoietic cells of the affected clone. Because signaling by the mutated kinase utilizes normal pathways, the result is overproduction of morphologically normal blood cells, an often indolent course, and (in essential thrombocytosis) usually a normal life span. Because the erythropoietin, thrombopoietin, and granulocyte colony-stimulating factor receptors are all constitutively activated, polycythemia vera is the potential ultimate clinical phenotype of the JAK2 V617F mutation and, as a corollary, is the most common of the 3 disorders. The number of cells expressing the JAK2 V617F mutation (the allele burden) seems to correlate with the clinical phenotype. Preliminary results of clinical trials with agents that inhibit the mutated kinase indicate a reduction in splenomegaly and alleviation of night sweats, fatigue, and pruritus.	[Spivak, Jerry L.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Spivak, JL (corresponding author), Johns Hopkins Univ, Sch Med, Div Hematol, Traylor Bldg,Room 924,720 Rutland Ave, Baltimore, MD 21205 USA.	jlspivak@jhmi.edu			National Institutes of Health [P01CA108671]; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	From the National Institutes of Health (P01CA108671).	ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Atallah E, 2009, EXPERT REV ANTICANC, V9, P663, DOI 10.1586/ERA.09.14; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; BERGLUND S, 1992, EUR J HAEMATOL, V48, P20; BESA EC, 1974, ARCH INTERN MED, V133, P418, DOI 10.1001/archinte.133.3.418; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Cassinat B, 2008, LEUKEMIA, V22, P452, DOI 10.1038/sj.leu.2404908; Choi JB, 2006, SLEEP BREATH, V10, P155, DOI 10.1007/s11325-006-0064-z; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; De Keersmaecker K, 2006, LEUKEMIA, V20, P200, DOI 10.1038/sj.leu.2404064; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; GOLDE DW, 1981, ANN INTERN MED, V95, P71, DOI 10.7326/0003-4819-95-1-71; Gordeuk VR, 2005, HAEMATOLOGICA, V90, P109; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jantunen R, 1999, ANN HEMATOL, V78, P219, DOI 10.1007/s002770050505; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Kuku I, 2009, PLATELETS, V20, P401, DOI 10.1080/09537100903137306; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lamy T, 1997, AM J MED, V102, P14, DOI 10.1016/S0002-9343(96)00351-8; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Marchioli R, 2005, J CLIN ONCOL, V23, P2224, DOI 10.1200/JCO.2005.07.062; Mesa RA, 2007, CANCER-AM CANCER SOC, V109, P68, DOI 10.1002/cncr.22365; Moliterno AR, 2008, EXP HEMATOL, V36, P1480, DOI 10.1016/j.exphem.2008.05.006; Moliterno AR, 2006, BLOOD, V108, P3913, DOI 10.1182/blood-2006-03-008805; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Passamonti F, 2004, AM J MED, V117, P755, DOI 10.1016/j.amjmed.2004.06.032; PEARSON TC, 1984, SCAND J HAEMATOL, V33, P68; Pemmaraju N, 2007, LEUKEMIA, V21, P2210, DOI 10.1038/sj.leu.2404755; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Ruggeri M, 2003, ANN INTERN MED, V139, P470, DOI 10.7326/0003-4819-139-6-200309160-00009; Sayyah J, 2009, CURR ONCOL REP, V11, P117, DOI 10.1007/s11912-009-0018-2; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; SEGEL N, 1967, CLIN SCI, V32, P527; Silver RT, 2006, CANCER-AM CANCER SOC, V107, P451, DOI 10.1002/cncr.22026; SMITH JR, 1978, NEW ENGL J MED, V298, P6, DOI 10.1056/NEJM197801052980102; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Spivak JL, 2008, BLOOD, V112, P231, DOI 10.1182/blood-2007-12-128454; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Szpurka H, 2006, BLOOD, V108, P2173, DOI 10.1182/blood-2006-02-005751; Theocharides A, 2007, BLOOD, V110, P375, DOI 10.1182/blood-2006-12-062125; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Vannucchi AM, 2007, LEUKEMIA, V21, P1952, DOI 10.1038/sj.leu.2404854; Vannucchi AM, 2007, BLOOD, V110, P840, DOI 10.1182/blood-2006-12-064287; Verma A, 2003, CANCER METAST REV, V22, P423, DOI 10.1023/A:1023805715476; Williams DM, 2007, EXP HEMATOL, V35, P1641, DOI 10.1016/j.exphem.2007.08.010; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	64	53	61	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2010	152	5					300	W95		10.7326/0003-4819-152-5-201003020-00008	http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565XJ	20194236				2022-12-28	WOS:000275329600005
J	Wheeler, MT; Heidenreich, PA; Froelicher, VF; Hlatky, MA; Ashley, EA				Wheeler, Matthew T.; Heidenreich, Paul A.; Froelicher, Victor F.; Hlatky, Mark A.; Ashley, Euan A.			Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-ASSOCIATION COUNCIL; CORONARY-ARTERY ANOMALIES; BRUGADA-TYPE ECG; HYPERTROPHIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; DEFECTS COMMITTEE; PHYSICAL-ACTIVITY; HIGH-SCHOOL; ELECTROCARDIOGRAPHIC PATTERNS	Background: Inclusion of 12-lead electrocardiography (ECG) in preparticipation screening of young athletes is controversial because of concerns about cost-effectiveness. Objective: To evaluate the cost-effectiveness of ECG plus cardiovascular-focused history and physical examination compared with cardiovascular-focused history and physical examination alone for preparticipation screening. Design: Decision-analysis, cost-effectiveness model. Data Sources: Published epidemiologic and preparticipation screening data, vital statistics, and other publicly available data. Target Population: Competitive athletes in high school and college aged 14 to 22 years. Time Horizon: Lifetime. Perspective: Societal. Intervention: Nonparticipation in competitive athletic activity and disease-specific treatment for identified athletes with heart disease. Outcome Measure: Incremental health care cost per life-year gained. Results of Base-Case Analysis: Addition of ECG to preparticipation screening saves 2.06 life-years per 1000 athletes at an incremental total cost of $89 per athlete and yields a cost-effectiveness ratio of $42 900 per life-year saved (95% CI, $21 200 to $71 300 per life-year saved) compared with cardiovascular-focused history and physical examination alone. Compared with no screening, ECG plus cardiovascular-focused history and physical examination saves 2.6 life-years per 1000 athletes screened and costs $199 per athlete, yielding a cost-effectiveness ratio of $76 100 per life-year saved ($62 400 to $130 000). Results of Sensitivity Analysis: Results are sensitive to the relative risk reduction associated with nonparticipation and the cost of initial screening. Limitations: Effectiveness data are derived from 1 major European study. Patterns of causes of sudden death may vary among countries. Conclusion: Screening young athletes with 12-lead ECG plus cardiovascular-focused history and physical examination may be cost-effective.	[Ashley, Euan A.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Ashley, EA (corresponding author), Stanford Univ, Div Cardiovasc Med, 300 Pasteur Dr,Falk Cardiovasc Res Bldg, Stanford, CA 94305 USA.	euan@stanford.edu	Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490; Hlatky, Mark/0000-0003-4686-9441; Wheeler, Matthew/0000-0001-8721-3022; Froelicher, Victor/0000-0001-8831-4853	Breetwor Foundation; Stanford Cardiovascular Institute; National Heart, Lung, and Blood Institute, National Institutes of Health [5HL 07034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097462, T32HL007034] Funding Source: NIH RePORTER	Breetwor Foundation; Stanford Cardiovascular Institute; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	From the Breetwor Foundation and the Stanford Cardiovascular Institute. Dr. Wheeler was supported by a U.S. Public Health Service training grant (5HL 07034) from the National Heart, Lung, and Blood Institute, National Institutes of Health.	AGNARSSON UT, 1992, J INTERN MED, V232, P499, DOI 10.1111/j.1365-2796.1992.tb00623.x; *AM MED ASS, 2008, MED RBRVS 2008 PHYS; Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291; Bar-Dayan Y, 2005, CARDIOLOGY, V104, P6, DOI 10.1159/000086046; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P2256, DOI 10.1016/j.jacc.2007.12.061; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P1033, DOI 10.1016/j.jacc.2007.10.055; Blangy H, 2005, ARCH MAL COEUR VAISS, V98, P175; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P517, DOI 10.1016/S0895-4356(99)00021-9; Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Chan PS, 2006, J AM COLL CARDIOL, V47, P2513, DOI 10.1016/j.jacc.2006.01.070; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0; Drezner JA, 2008, HEART RHYTHM, V5, P794, DOI 10.1016/j.hrthm.2008.03.001; FIXLER DE, 1990, CIRCULATION, V81, P137, DOI 10.1161/01.CIR.81.1.137; Fuller CM, 2000, MED SCI SPORT EXER, V32, P887; Fuller CM, 1997, MED SCI SPORT EXER, V29, P1131, DOI 10.1097/00005768-199709000-00003; FYLER DC, 1980, PEDIATRICS S, V65, P377; Gallagher MM, 2008, INT J CARDIOL, V130, P44, DOI 10.1016/j.ijcard.2007.07.159; Gemayel C, 2001, J AM COLL CARDIOL, V38, P1773, DOI 10.1016/S0735-1097(01)01654-0; Gold MR, 1996, COST EFFECTIVENESS H; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; Hyduk Alexandra, 2005, Morbidity and Mortality Weekly Report, V54, P1; *INT OL COMM MED C, 2004, SUDD CARD VASC DEATH, V2008; *IT MIN HLTH, 1982, GAZZETTA UFFICI 0305, P63; Joseph A, 1993, J AM COLL CARDIOL, V22, P459, DOI 10.1016/0735-1097(93)90050-B; Junttila MJ, 2004, EUR HEART J, V25, P874, DOI 10.1016/j.ehj.2004.01.011; Kaplan R.M., 1982, HEALTH PSYCHOL, V1, P61, DOI [DOI 10.1037/0278-6133.1.1.61, 10.1037/0278-6133.1.1.61]; KRAHN AD, 1992, ANN INTERN MED, V116, P456, DOI 10.7326/0003-4819-116-6-456; Kyto V, 2007, AM J EPIDEMIOL, V165, P570, DOI 10.1093/aje/kwk076; Lawless CE, 2008, MED SCI SPORT EXER, V40, P787, DOI 10.1249/MSS.0b013e318164dd18; Leslie LK, 2008, CIRC-CARDIOVASC QUAL, V1, P134, DOI 10.1161/CIRCOUTCOMES.108.825232; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; MacAuley D, 2008, BRIT MED J, V337, pa739; Magalski A, 2008, J AM COLL CARDIOL, V51, P2250, DOI 10.1016/j.jacc.2008.01.065; Maron BJ, 2007, CARDIOL CLIN, V25, P399, DOI 10.1016/j.ccl.2007.07.006; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 1998, CIRCULATION, V97, P2294, DOI 10.1161/01.CIR.97.22.2294; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1322, DOI 10.1016/j.jacc.2005.02.007; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; MARON BJ, 1987, J AM COLL CARDIOL, V10, P1214, DOI 10.1016/S0735-1097(87)80121-3; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Mittmann N, 1999, PHARMACOECONOMICS, V15, P369, DOI 10.2165/00019053-199915040-00004; Miura K, 2002, HEART, V87, P126, DOI 10.1136/heart.87.2.126; Myerburg RJ, 2007, CIRCULATION, V116, P2616, DOI 10.1161/CIRCULATIONAHA.107.733519; *NAT COLL ATHL ASS, 2007, 1981 82 2004 05 NCAA, V2008; *NAT CTR HLTH STAT, 2007, DHHS PUBL; *NAT FED STAT HIGH, 2008, 2006 07 HIGH SCH ATH; Nichol G, 2003, CIRCULATION, V108, P697, DOI 10.1161/01.CIR.0000084545.65645.28; Nistri S, 2003, AM J CARDIOL, V91, P1021, DOI 10.1016/S0002-9149(03)00132-2; Nora M, 2007, CIRCULATION, V116, P845; Oe H, 2005, PACE, V28, P549, DOI 10.1111/j.1540-8159.2005.40020.x; *OFF STAT HLTH PLA, 2007, ANN FIN DAT HOSP CHA; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Pelliccia A, 2000, CIRCULATION, V102, P278; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; PELLICCIA A, 1993, AM J CARDIOL, V72, P978, DOI 10.1016/0002-9149(93)91120-7; Pelliccia A, 2007, EUR HEART J, V28, P2006, DOI 10.1093/eurheartj/ehm219; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; Pelliccia Antonio, 2002, Cardiol Rev, V10, P85, DOI 10.1097/00045415-200203000-00006; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; Quaglini S, 2006, EUR HEART J, V27, P1824, DOI 10.1093/eurheartj/ehl115; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; RISSER WL, 1985, J SCHOOL HEALTH, V55, P270, DOI 10.1111/j.1746-1561.1985.tb04140.x; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Sharma S, 1999, BRIT J SPORT MED, V33, P319, DOI 10.1136/bjsm.33.5.319; Smith J, 1998, MAYO CLIN PROC, V73, P419; Sofi F, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a346; Sung L, 2004, J CLIN EPIDEMIOL, V57, P1161, DOI 10.1016/j.jclinepi.2004.05.003; Tanaka Y, 2006, MED SCI SPORT EXER, V38, P2, DOI 10.1249/01.mss.0000183187.88000.53; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; THOMPSON TR, 1982, CLEVELAND CLIN Q, V49, P225, DOI 10.3949/ccjm.49.4.225; *US BUR CENS, 2009, CENS POP; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; Vetter VL, 2008, CIRCULATION, V117, P2407, DOI 10.1161/CIRCULATIONAHA.107.189473; VIDAILLET HJ, 1987, NEW ENGL J MED, V317, P65, DOI 10.1056/NEJM198707093170201; WEIDENBENER EJ, 1995, CLIN J SPORT MED, V5, P86, DOI 10.1097/00042752-199504000-00003; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wilson MG, 2008, BRIT J SPORT MED, V42, P207, DOI 10.1136/bjsm.2007.039420; YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110; Yock CA, 2003, AM J MED, V115, P382, DOI 10.1016/S0002-9343(03)00296-1	90	173	177	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2010	152	5					276	W91		10.7326/0003-4819-152-5-201003020-00005	http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00005			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565XJ	20194233	Green Accepted			2022-12-28	WOS:000275329600002
J	van Kuppeveld, FJM; de Jong, AS; Lanke, KH; Verhaegh, GW; Melchers, WJG; Swanink, CMA; Bleijenberg, G; Netea, MG; Galama, JMD; van der Meer, JWM				van Kuppeveld, Frank J. M.; de Jong, Arjan S.; Lanke, Kjerstin H.; Verhaegh, Gerald W.; Melchers, Willem J. G.; Swanink, Caroline M. A.; Bleijenberg, Gijs; Netea, Mihai G.; Galama, Jochem M. D.; van der Meer, Jos W. M.			Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFECTIOUS RETROVIRUS; PROSTATE-CANCER; BLOOD-CELLS; XMRV; TUMORS	Objective The presence of the retrovirus xenotropic murine leukaemia virus-related virus (XMRV) has been reported in peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Considering the potentially great medical and social relevance of such a discovery, we investigated whether this finding could be confirmed in an independent European cohort of patients with chronic fatigue syndrome. Design Analysis of a well defined cohort of patients and matched neighbourhood controls by polymerase chain reaction. Setting Certified (ISO 15189) laboratory of clinical virology in a university hospital in the Netherlands. Population Between December 1991 and April 1992, peripheral blood mononuclear cells were isolated from 76 patients and 69 matched neighbourhood controls. In this study we tested cells from 32 patients and 43 controls from whom original cryopreserved phials were still available. Main outcome measures Detection of XMRV in peripheral blood mononuclear cells by real time polymerase chain reaction assay targeting the XMRV integrase gene and/or a nested polymerase chain reaction assay targeting the XMRV gag gene. Results We detected no XMRV sequences in any of the patients or controls in either of the assays, in which relevant positive and negative isolation controls and polymerase chain reaction controls were included. Spiking experiments showed that we were able to detect at least 10 copies of XMRV sequences per 105 peripheral blood mononuclear cells by real time as well as by nested polymerase chain reaction, demonstrating high sensitivity of both assays. Conclusions This study failed to show the presence of XMRV in peripheral blood mononuclear cells of patients with chronic fatigue syndrome from a Dutch cohort. These data cast doubt on the claim that XMRV is associated with chronic fatigue syndrome in the majority of patients.	[van Kuppeveld, Frank J. M.; de Jong, Arjan S.; Lanke, Kjerstin H.; Melchers, Willem J. G.; Swanink, Caroline M. A.; Galama, Jochem M. D.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [Netea, Mihai G.; van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands; [Bleijenberg, Gijs] Radboud Univ Nijmegen, Med Ctr, Expert Ctr Chron Fatigue, NL-6500 HB Nijmegen, Netherlands; [van Kuppeveld, Frank J. M.; de Jong, Arjan S.; Lanke, Kjerstin H.; Melchers, Willem J. G.; Bleijenberg, Gijs; Netea, Mihai G.; Galama, Jochem M. D.; van der Meer, Jos W. M.] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [van Kuppeveld, Frank J. M.; Lanke, Kjerstin H.; Melchers, Willem J. G.] Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands; [Bleijenberg, Gijs] Nijmegen Ctr Evidence Based Practice, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Kuppeveld, FJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands.	f.vankuppeveld@ncmls.ru.nl	Bleijenberg, Gijs/E-6984-2010; Netea, Mihai/N-5155-2014; van der Meer, Jos W.M./C-8521-2013; Jong, A.S./L-4416-2015; Melchers, Willem/C-8819-2015; Verhaegh, Gerald/L-4708-2015	van der Meer, Jos W.M./0000-0001-5120-3690; Melchers, Willem/0000-0002-5446-2230; Verhaegh, Gerald/0000-0003-0227-2280; van Kuppeveld, Frank/0000-0001-5800-749X				Cho HJ, 2006, CURR OPIN PSYCHIATR, V19, P67, DOI 10.1097/01.yco.0000194370.40062.b0; Clancy A, 2008, EUR J CLIN MICROBIOL, V27, P1177, DOI 10.1007/s10096-008-0556-9; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; DAUGHERTY SA, 1991, REV INFECT DIS, V13, pS39; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hesselink AT, 2005, J CLIN MICROBIOL, V43, P4868, DOI 10.1128/JCM.43.9.4868-4871.2005; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; HOLMES GP, 1987, JAMA-J AM MED ASSOC, V257, P2297, DOI 10.1001/jama.257.17.2297; Jansen CA, 2006, BLOOD, V107, P1427, DOI 10.1182/blood-2005-07-2907; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyall M, 2003, J PSYCHOSOM RES, V55, P79, DOI 10.1016/S0022-3999(02)00515-9; Mikovits J, 2009, CYTOKINE, V48, P10, DOI 10.1016/j.cyto.2009.07.043; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Swanink CMA, 1996, J INFECT DIS, V173, P460, DOI 10.1093/infdis/173.2.460; SWARTZ MN, 1988, NEW ENGL J MED, V319, P1726, DOI 10.1056/NEJM198812293192608; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6	25	111	111	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2010	340								c1018	10.1136/bmj.c1018	http://dx.doi.org/10.1136/bmj.c1018			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TH	20185493	Green Published, hybrid			2022-12-28	WOS:000275001300001
J	Nestle, M; Ludwig, DS				Nestle, Marion; Ludwig, David S.			Front-of-Package Food Labels Public Health or Propaganda?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLAIMS		[Ludwig, David S.] Childrens Hosp, Div Endocrinol, Optimal Weight Life Program, Dept Med, Boston, MA 02115 USA; [Nestle, Marion] NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY USA	Harvard University; Boston Children's Hospital; New York University	Ludwig, DS (corresponding author), Childrens Hosp, Div Endocrinol, Optimal Weight Life Program, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brandt MB, 2010, FOOD TECHNOL-CHICAGO, V64, P34; *CONS REP, GREEN CHOIC PROD BET; *FDA, CONS RES FOOD LAB; HAMBURG MA, 2009, COMMUNICATION   1019; Kellogg Company, 1985, CIT PET REL DIET HLT; LEVY AS, 1987, PUBLIC HEALTH REP, V102, P398; NEUMAN W, 2009, NY TIMES        0917, pB1; SILVERGLADE B, 2009, CTR SCI PUBLIC INTER; Wansink B, 2003, J CONSUM AFF, V37, P305, DOI 10.1111/j.1745-6606.2003.tb00455.x; 1969 C FOOD NTR HLTH	10	62	65	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					771	772		10.1001/jama.2010.179	http://dx.doi.org/10.1001/jama.2010.179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559DD	20179287	Green Published			2022-12-28	WOS:000274800000029
J	Vaidya, A; Morris, CA; Ross, JJ				Vaidya, Anand; Morris, Charles A.; Ross, John J.			Stalking the Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					E16	E16		10.1056/NEJMimc0900128	http://dx.doi.org/10.1056/NEJMimc0900128			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20175296				2022-12-28	WOS:000274397200013
J	Teno, JM; Mitchell, SL; Gozalo, PL; Dosa, D; Hsu, A; Intrator, O; Mor, V				Teno, Joan M.; Mitchell, Susan L.; Gozalo, Pedro L.; Dosa, David; Hsu, Amy; Intrator, Orna; Mor, Vincent			Hospital Characteristics Associated With Feeding Tube Placement in Nursing Home Residents With Advanced Cognitive Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADVANCED DEMENTIA; CARE; LIFE; END	Context Tube-feeding is of questionable benefit for nursing home residents with advanced dementia. Approximately two-thirds of US nursing home residents who are tube fed had their feeding tube inserted during an acute care hospitalization. Objective To identify US hospital characteristics associated with higher rates of feeding tube insertion in nursing home residents with advanced cognitive impairment. Design, Setting, and Patients The sample included nursing home residents aged 66 years or older with advanced cognitive impairment admitted to acute care hospitals between 2000 and 2007. Rate of feeding tube placement was based on a 20% sample of all Medicare Claims files and was assessed in hospitals with at least 30 such admissions during the 8-year period. A multivariable model with the unit of the analysis being the hospital admission identified hospital-level factors independently associated with feeding tube insertion rates, including bed size, ownership, urban location, and medical school affiliation. Measures of each hospital's care practices for all patients with serious chronic illnesses were evaluated, including intensive care unit (ICU) use in the last 6 months of life, the use of hospice services, and the ratio of specialist to primary care physicians. Patient-level characteristics were also considered. Main Outcome Measure Endoscopic or surgical insertion of a gastrostomy tube during a hospitalization. Results In 2797 acute care hospitals with 280 869 admissions among 163 022 nursing home residents with advanced cognitive impairment, the rate of feeding tube insertion varied from 0 to 38.9 per 100 hospitalizations (mean [SD], 6.5 [5.3]; median [interquartile range], 5.3 [2.6-9.3]). The mean rate of feeding tube insertions per 100 admissions was 7.9 in 2000, decreasing to 6.2 in 2007. Higher insertion rates were associated with the following hospital features: for-profit ownership vs government owned (8.5 vs 5.5 insertions per 100 hospitalizations; adjusted odds ratio [AOR], 1.33; 95% confidence interval [CI], 1.21-1.46), larger size (>310 beds vs <101 beds: 8.0 vs 4.3 insertions per 100 hospitalizations; AOR, 1.48; 95% CI, 1.35-1.63), and greater ICU use in the last 6 months of life (highest vs lowest decile: 10.1 vs 2.9 insertions per 100 hospitalizations; AOR, 2.60; 95% CI, 2.20-3.06). These differences persisted after controlling for patient characteristics. Specialist to primary care ratio and hospice use were weakly or not associated with feeding tube placement. Conclusion Among nursing home residents with advanced cognitive impairment admitted to acute care hospitals, for-profit ownership, larger hospital size, and greater ICU use was associated with increased rates of feeding tube insertion, even after adjusting for patient-level characteristics. JAMA. 2010; 303(6): 544-550	[Teno, Joan M.; Gozalo, Pedro L.; Dosa, David; Hsu, Amy; Intrator, Orna; Mor, Vincent] Brown Univ, Warren Alpert Sch Med, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Mitchell, Susan L.] Harvard Univ, Sch Med, Inst Aging Res, Boston, MA USA; [Dosa, David; Intrator, Orna] Providence Vet Affairs Med Ctr, Providence, RI USA	Brown University; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Teno, JM (corresponding author), Brown Univ, Warren Alpert Sch Med, Ctr Gerontol & Hlth Care Res, 121 S Main St, Providence, RI 02912 USA.	joan_teno@brown.edu			National Institute on Aging [RC1AG036418, P01AG027296, K24AG033640]; NATIONAL INSTITUTE ON AGING [K24AG033640, P01AG027296, RC1AG036418] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by grants RC1AG036418 and P01AG027296 from the National Institute on Aging. Dr Mitchell is supported by grant K24AG033640 from the National Institute on Aging.	Ahronheim JC, 2001, J AM GERIATR SOC, V49, P148, DOI 10.1046/j.1532-5415.2001.49035.x; [Anonymous], ICD 9 PROV DIAGN COD; Braun UK, 2005, J AM GERIATR SOC, V53, P242, DOI 10.1111/j.1532-5415.2005.53109.x; Duszak R, 2003, J VASC INTERV RADIOL, V14, P1031; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Gessert CE, 2000, J AM GERIATR SOC, V48, P1593, DOI 10.1111/j.1532-5415.2000.tb03869.x; Gessert CE, 2006, J AM GERIATR SOC, V54, P1199, DOI 10.1111/j.1532-5415.2006.00824.x; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; Kuo S, 2009, J AM MED DIR ASSOC, V10, P264, DOI 10.1016/j.jamda.2008.10.010; Lin CY, 2009, MED CARE, V47, P524, DOI 10.1097/MLR.0b013e31819261bd; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Mitchell SL, 2007, JAMA-J AM MED ASSOC, V298, P2527, DOI 10.1001/jama.298.17.jrr70001; Mitchell SL, 2007, J AM GERIATR SOC, V55, P432, DOI 10.1111/j.1532-5415.2007.01086.x; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; OBrien LA, 1997, J GEN INTERN MED, V12, P364, DOI 10.1046/j.1525-1497.1997.00061.x; Rhodes R, 2009, J CLIN ONCOL, V27, P5496, DOI 10.1200/JCO.2009.24.2206; Rich SE, 2009, J AM GERIATR SOC, V57, P146, DOI 10.1111/j.1532-5415.2008.02090.x; Teno JM, 2009, J PALLIAT MED, V12, P359, DOI 10.1089/jpm.2008.0168; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Wennberg JE, 2008, TRACKING CARE PATIEN	25	99	101	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					544	550		10.1001/jama.2010.79	http://dx.doi.org/10.1001/jama.2010.79			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553PG	20145231	Green Accepted, Bronze			2022-12-28	WOS:000274378700026
J	Kelly, CM; Juurlink, DN; Gomes, T; Duong-Hua, M; Pritchard, KI; Austin, PC; Paszat, LF				Kelly, Catherine M.; Juurlink, David N.; Gomes, Tara; Duong-Hua, Minh; Pritchard, Kathleen I.; Austin, Peter C.; Paszat, Lawrence F.			Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG-DRUG INTERACTIONS; QUALITY-OF-LIFE; ADJUVANT TAMOXIFEN; HOT FLASHES; IN-VITRO; ANTIDEPRESSANT USE; CYP2D6 GENOTYPE; LOW-INCOME; METABOLISM; RECURRENCE	Objective To characterise whether some selective serotonin reuptake inhibitor (SSRI) antidepressants reduce tamoxifen's effectiveness by inhibiting its bioactivation by cytochrome P450 2D6 (CYP2D6). Design Population based cohort study. Participants Women living in Ontario aged 66 years or older treated with tamoxifen for breast cancer between 1993 and 2005 who had overlapping treatment with a single SSRI. Main outcome measures Risk of death from breast cancer after completion of tamoxifen treatment, as a function of the proportion of time on tamoxifen during which each SSRI had been co-prescribed. Results Of 2430 women treated with tamoxifen and a single SSRI, 374 (15.4%) died of breast cancer during follow-up ( mean follow-up 2.38 years, SD 2.59). After adjustment for age, duration of tamoxifen treatment, and other potential confounders, absolute increases of 25%, 50%, and 75% in the proportion of time on tamoxifen with overlapping use of paroxetine ( an irreversible inhibitor of CYP2D6) were associated with 24%, 54%, and 91% increases in the risk of death from breast cancer, respectively (P<0.05 for each comparison). By contrast, no such risk was seen with other antidepressants. We estimate that use of paroxetine for 41% of tamoxifen treatment ( the median overlap in our sample) would result in one additional breast cancer death within five years of cessation of tamoxifen for every 19.7 (95% confidence interval 12.5 to 46.3) patients so treated; the risk with more extensive overlap would be greater. Conclusion Paroxetine use during tamoxifen treatment is associated with an increased risk of death from breast cancer, supporting the hypothesis that paroxetine can reduce or abolish the benefit of tamoxifen in women with breast cancer.	[Juurlink, David N.; Pritchard, Kathleen I.; Paszat, Lawrence F.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Juurlink, David N.; Pritchard, Kathleen I.; Paszat, Lawrence F.] Sunnybrook Res Inst, Toronto, ON, Canada; [Juurlink, David N.; Pritchard, Kathleen I.; Paszat, Lawrence F.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juurlink, David N.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Juurlink, David N.; Pritchard, Kathleen I.; Austin, Peter C.; Paszat, Lawrence F.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Duong-Hua, Minh] Canadian Inst Hlth Informat, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Canadian Institute Health Information	Juurlink, DN (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca	Hug, Balthasar L./G-1568-2010	Kelly, Professor Catherine M./0000-0001-8355-6714; Austin, Peter/0000-0003-3337-233X; Gomes, Tara/0000-0002-1468-1965	Sunnybrook Hospital Foundation; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Ontario Ministry of Health and Long-Term Care; Ontario Drug Innovation Fund; National Cancer Institute of Canada Clinical Trials Group; AstraZeneca; YM Biosciences; Bristol Myers; Squibb; Sanofi-Aventis; Amgen; Ortho-Biotech; Pfizer; Novartis; GlaxoSmithKline; Ortho Biotech; Roche	Sunnybrook Hospital Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Drug Innovation Fund; National Cancer Institute of Canada Clinical Trials Group; AstraZeneca(AstraZeneca); YM Biosciences; Bristol Myers(Bristol-Myers Squibb); Squibb; Sanofi-Aventis(Sanofi-Aventis); Amgen(Amgen); Ortho-Biotech; Pfizer(Pfizer); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Ortho Biotech; Roche(Roche Holding)	CMK was supported by a fellowship award from the Sunnybrook Hospital Foundation. DNJ was supported by a New Investigator award from the Canadian Institutes of Health Research. PCA is supported by a Career Investigator award from the Heart and Stroke Foundation of Ontario. LFP is supported by a Clinician Scientist award from the Ontario Ministry of Health and Long-Term Care. This research was supported by the Institute for Clinical Evaluative Sciences ( ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The study was supported in part by the Ontario Drug Policy Research Network, funded by the Ontario Drug Innovation Fund. The funder had no role in the design, analysis, conduct or reporting of the study. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.; Competing interests: All authors have completed the Unified Competing Interest form at www. icmje.org_disclosure. pdf (available on request from the corresponding author. During the past three years KIP has been a consultant for Sanofi-Aventis, AstraZeneca, Roche, Pfizer, Ortho-Biotech, YM Biosciences, Novartis, Abraxis, Amgen, and GlaxoSmithKline (GSK). KIP has received research funding either directly through per case funding for studies, or indirectly through the National Cancer Institute of Canada Clinical Trials Group, contracted with pharmaceutical companies including AstraZeneca, YM Biosciences, Bristol Myers, Squibb, Sanofi-Aventis, Amgen, Ortho-Biotech, Pfizer, Novartis, GlaxoSmithKline, and Ortho Biotech. KIP has received honorariums or been part of speaker's bureaux from Sanofi-Aventis, AstraZeneca, Pfizer, Roche, YM Biosciences, and Novartis. KIP has given paid expert testimony for Sanofi-Aventis, AstraZeneca, and GlaxoSmithKline. KIP has been a member of Advisory Committees for Sanofi-Aventis, AstraZeneca, Ortho- Biotech, Roche, Pfizer, Novartis, YM Biosciences, and GlaxoSmithKline. All other authors declare ( 1) no support from any company for the submitted work; ( 2) no relationships with any companies that might have an interest in the submitted work in the previous 3 years; ( 3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and ( 4) no non-financial interests that may be relevant to the submitted work.	AHEM TP, 2009, CANCER EPIDEM BIOMAR, V18, P2562; Alfaro CL, 2000, J CLIN PHARMACOL, V40, P58, DOI 10.1177/00912700022008702; Amchin J, 2001, J CLIN PHARMACOL, V41, P443, DOI 10.1177/00912700122010159; Anderson BO, 2008, CANCER-AM CANCER SOC, V113, P2221, DOI 10.1002/cncr.23844; AUSTIN PC, J CLIN EPIDEMIOL, V63, P46; Ball SE, 1997, BRIT J CLIN PHARMACO, V43, P619, DOI 10.1046/j.1365-2125.1997.00591.x; Bertelsen KM, 2003, DRUG METAB DISPOS, V31, P289, DOI 10.1124/dmd.31.3.289; Borges S, 2006, CLIN PHARMACOL THER, V80, P61, DOI 10.1016/j.clpt.2006.03.013; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Chubak J, 2008, BREAST CANCER RES TR, V112, P123, DOI 10.1007/s10549-007-9828-9; COLE MP, 1971, BRIT J CANCER, V25, P270, DOI 10.1038/bjc.1971.33; Coyne JC, 2004, GEN HOSP PSYCHIAT, V26, P121, DOI 10.1016/j.genhosppsych.2003.08.012; CREWE HK, 1992, BRIT J CLIN PHARMACO, V34, P262, DOI 10.1111/j.1365-2125.1992.tb04134.x; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Early Breast Cancer Trialists' Collaborative G., 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ell K, 2005, J CLIN ONCOL, V23, P3052, DOI 10.1200/JCO.2005.08.041; Fann JR, 2008, GEN HOSP PSYCHIAT, V30, P112, DOI 10.1016/j.genhosppsych.2007.10.008; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Hemeryck A, 2002, CURR DRUG METAB, V3, P13, DOI 10.2174/1389200023338017; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Juurlink DN, 2005, BRIT J CLIN PHARMACO, V59, P102, DOI 10.1111/j.1365-2125.2005.02230.x; Juurlink DN, 2004, J AM GERIATR SOC, V52, P794, DOI 10.1111/j.1532-5415.2004.52221.x; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; Kurdyak PA, 2005, J CLIN PSYCHOPHARM, V25, P561, DOI 10.1097/01.jcp.0000186869.67418.bc; Lash TL, 2008, BRIT J CANCER, V99, P616, DOI 10.1038/sj.bjc.6604533; Lehmann D, 2004, J CLIN PHARMACOL, V44, P861, DOI 10.1177/0091270004266618; Lim YC, 2006, J PHARMACOL EXP THER, V318, P503, DOI 10.1124/jpet.105.100511; Loprinzi CL, 2008, MENOPAUSE, V15, P655, DOI 10.1097/gme.0b013e3181679150; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Mortimer JE, 2008, BREAST CANCER RES TR, V108, P421, DOI 10.1007/s10549-007-9612-x; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Rae JM, 2009, PHARMACOGENOMICS J, V9, P258, DOI 10.1038/tpj.2009.14; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Salkeld E, 2008, J CLIN PSYCHOPHARM, V28, P230, DOI 10.1097/JCP.0b013e318166c52e; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Schroth W, 2009, JAMA-J AM MED ASSOC, V302, P1429, DOI 10.1001/jama.2009.1420; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Venkatakrishnan K, 2007, XENOBIOTICA, V37, P1225, DOI 10.1080/00498250701670945; Venkatakrishnan K, 2005, DRUG METAB DISPOS, V33, P845, DOI 10.1124/dmd.105.004077; Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155	51	264	272	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2010	340								c693	10.1136/bmj.c693	http://dx.doi.org/10.1136/bmj.c693			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZQ	20142325	Green Published, hybrid			2022-12-28	WOS:000274476600004
J	Zhong, L; D'Urso, A; Toiber, D; Sebastian, C; Henry, RE; Vadysirisack, DD; Guimaraes, A; Marinelli, B; Wikstrom, JD; Nir, T; Clish, CB; Vaitheesvaran, B; Iliopoulos, O; Kurland, I; Dor, Y; Weissleder, R; Shirihai, OS; Ellisen, LW; Espinosa, JM; Mostoslavsky, R				Zhong, Lei; D'Urso, Agustina; Toiber, Debra; Sebastian, Carlos; Henry, Ryan E.; Vadysirisack, Douangsone D.; Guimaraes, Alexander; Marinelli, Brett; Wikstrom, Jakob D.; Nir, Tomer; Clish, Clary B.; Vaitheesvaran, Bhavapriya; Iliopoulos, Othon; Kurland, Irwin; Dor, Yuval; Weissleder, Ralph; Shirihai, Orian S.; Ellisen, Leif W.; Espinosa, Joaquin M.; Mostoslavsky, Raul			The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1 alpha	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; CALORIE RESTRICTION; MITOCHONDRIAL-FUNCTION; GENOMIC INSTABILITY; GENE-EXPRESSION; LIFE-SPAN; HIF-1-ALPHA; CELLS; HIF-1; ACETYLATION	SIRT6 is a member of a highly conserved family of NAD(+)-dependent deacetylases with various roles in metabolism, stress resistance, and life span. SIRT6-deficient mice develop normally but succumb to a lethal hypoglycemia early in life; however, the mechanism underlying this hypoglycemia remained unclear. Here, we demonstrate that SIRT6 functions as a histone H3K9 deacetylase to control the expression of multiple glycolytic genes. Specifically, SIRT6 appears to function as a corepressor of the transcription factor Hif1 alpha, a critical regulator of nutrient stress responses. Consistent with this notion, SIRT6-deficient cells exhibit increased Hif1 alpha activity and show increased glucose uptake with upregulation of glycolysis and diminished mitochondrial respiration. Our studies uncover a role for the chromatin factor SIRT6 as a master regulator of glucose homeostasis and may provide the basis for novel therapeutic approaches against metabolic diseases, such as diabetes and obesity.	[Zhong, Lei; D'Urso, Agustina; Toiber, Debra; Sebastian, Carlos; Vadysirisack, Douangsone D.; Iliopoulos, Othon; Ellisen, Leif W.; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Henry, Ryan E.; Espinosa, Joaquin M.] Univ Colorado, Dept Mol Cellular & Dev Biol, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Guimaraes, Alexander; Marinelli, Brett; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Iliopoulos, Othon] Massachusetts Gen Hosp, Dept Med, Hematol Oncol Unit, Boston, MA 02114 USA; [Wikstrom, Jakob D.; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Mol Med, Boston, MA 02118 USA; [Nir, Tomer; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Clish, Clary B.] Broad Inst MIT & Harvard, Ctr Prote, Cambridge, MA 02142 USA; [Vaitheesvaran, Bhavapriya; Kurland, Irwin] Albert Einstein Coll Med, Michael F Price Ctr, Bronx, NY 10461 USA; [Wikstrom, Jakob D.] Stockholm Univ, Arrhenius Labs F3, Wenner Gren Inst, SE-10691 Stockholm, Sweden	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yeshiva University; Albert Einstein College of Medicine; Stockholm University	Mostoslavsky, R (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	rmostoslavsky@mgh.harvard.edu	Ellisen, Leif W/AAA-6572-2022; Sebastian, Carlos/H-8014-2018; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Dor, Yuval/C-2405-2011; Sebastian, Carlos/CAG-6271-2022	Ellisen, Leif W/0000-0003-0444-7910; Sebastian, Carlos/0000-0001-6623-8028; Clish, Clary B/0000-0001-8259-9245; Wikstrom, Jakob/0000-0002-4287-1774; DUrso, Agustina/0000-0003-1406-4390; Shirihai, Orian/0000-0002-9502-2661	V Foundation; Sidney Kimmel Cancer Research Foundation; AFAR; The Massachusetts Life Sciences Center; Joslin Diabetes Center; Metabolic Physiology Core [P30 DK57521]; Brain Power for Israel Fund; NIH [RO1 CA117907]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA122589, R01CA117907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, P30DK057521, R01DK056690, R01DK058132, R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	V Foundation; Sidney Kimmel Cancer Research Foundation; AFAR; The Massachusetts Life Sciences Center; Joslin Diabetes Center; Metabolic Physiology Core; Brain Power for Israel Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the V Foundation (R.M.), the Sidney Kimmel Cancer Research Foundation (R.M.), a New Investigator Grant from AFAR (R.M.), A New Investigator Award from The Massachusetts Life Sciences Center (R.M.), a P&F Award from the Joslin Diabetes Center (R.M.), and Grant P30 DK57521 from the Metabolic Physiology Core (BADERC). D. T. is supported by a fellowship from the Brain Power for Israel Fund. Y.D. is supported by JDRF. J.M.E. is supported by NIH-RO1 CA117907 and the Howard Hughes Medical Institute. We thank Magali Silberman, Daniel Holoch, Pere Puigserver, John Dominy, Matthew Vander Heiden, Mike Zimmer, David Lombard, Bjoern Schwer, Fred Alt, Katrin Chua, and members of the Bardeesy, Hochedlinger, Hock, and Ramaswamy labs for reagents and helpful discussions. We thank Kelly Shay, Laura Prickett-Rice, and Kate Folz-Donahue for technical assistance. We are also thankful to Nabeel Bardeesy and Hanno Hock for critically reading the manuscript and Jose Polo for assistance with the ChIP assays.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Barzilai N, 2009, J GERONTOL A-BIOL, V64, P187, DOI 10.1093/gerona/gln061; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Boiselle PM, 1998, RADIOGRAPHICS, V18, P1061, DOI 10.1148/radiographics.18.5.9747607; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murray-Rust TA, 2006, FEBS LETT, V580, P1911, DOI 10.1016/j.febslet.2006.02.012; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Serikawa KA, 2003, MOL CELL PROTEOMICS, V2, P191, DOI 10.1074/mcp.D200002-MCP200; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Xu J, 2004, ENDOCRINOLOGY, V145, P1087, DOI 10.1210/en.2003-1173; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004	50	739	772	2	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					280	293		10.1016/j.cell.2009.12.041	http://dx.doi.org/10.1016/j.cell.2009.12.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141841	Bronze, Green Accepted			2022-12-28	WOS:000273826500018
J	French, N; Gordon, SB; Mwalukomo, T; White, SA; Mwafulirwa, G; Longwe, H; Mwaiponya, M; Zijlstra, EE; Molyneux, ME; Gilks, CF				French, Neil; Gordon, Stephen B.; Mwalukomo, Thandie; White, Sarah A.; Mwafulirwa, Gershom; Longwe, Herbert; Mwaiponya, Martin; Zijlstra, Eduard E.; Molyneux, Malcolm E.; Gilks, Charles F.			A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults	MALAWI MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; POLYSACCHARIDE VACCINE; DOUBLE-BLIND; DISEASE; EFFICACY; CHILDREN; ERA; IMMUNOGENICITY; MORTALITY	Background Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa. Prevention of this disease by vaccination with the current 23-valent polysaccharide vaccine is suboptimal. Protein conjugate vaccines offer a further option for protection, but data on their clinical efficacy in adults are needed. Methods In this double-blind, randomized, placebo-controlled clinical efficacy trial, we studied the efficacy of a 7-valent conjugate pneumococcal vaccine in predominantly HIV-infected Malawian adolescents and adults who had recovered from documented invasive pneumococcal disease. Two doses of vaccine were given 4 weeks apart. The primary end point was a further episode of pneumococcal infection caused by vaccine serotypes or serotype 6A. Results From February 2003 through October 2007, we followed 496 patients (of whom 44% were male and 88% were HIV-seropositive) for 798 person-years of observation. There were 67 episodes of pneumococcal disease in 52 patients, all in the HIV-infected subgroup. In 24 patients, there were 19 episodes that were caused by vaccine serotypes and 5 episodes that were caused by the 6A serotype. Of these episodes, 5 occurred in the vaccine group and 19 in the placebo group, for a vaccine efficacy of 74% (95% confidence interval [CI], 30 to 90). There were 73 deaths from any cause in the vaccine group and 63 in the placebo group (hazard ratio in the vaccine group, 1.18; 95% CI, 0.84 to 1.66). The number of serious adverse events within 14 days after vaccination was significantly lower in the vaccine group than in the placebo group (3 vs. 17, P = 0.002), and the number of minor adverse events was significantly higher in the vaccine group (41 vs. 13, P = 0.003). Conclusions The 7-valent pneumococcal conjugate vaccine protected HIV-infected adults from recurrent pneumococcal infection caused by vaccine serotypes or serotype 6A.	[French, Neil; Gordon, Stephen B.; White, Sarah A.; Mwafulirwa, Gershom; Longwe, Herbert; Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [French, Neil] London Sch Hyg & Trop Med, Karonga Prevent Study, Karonga, Malawi; [Gordon, Stephen B.; Molyneux, Malcolm E.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Mwalukomo, Thandie; Mwaiponya, Martin; Zijlstra, Eduard E.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Gilks, Charles F.] Imperial Coll London, London, England	University of Malawi; Malawi Epidemiology and Intervention Research Unit; Liverpool School of Tropical Medicine; University of Malawi; Imperial College London	French, N (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.; French, N (corresponding author), London Sch Hyg & Trop Med, Karonga Prevent Study, Karonga, Malawi.	n.french@liverpool.ac.uk	French, Neil/A-2994-2012; Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123; French, Neil/0000-0003-4814-8293; Gordon, Stephen/0000-0001-6576-1116; White, Sarah/0000-0001-5535-8075	Wellcome Trust; GlaxoSmithKline; Novartis	Wellcome Trust(Wellcome Trust); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis)	Supported by the Wellcome Trust. Through an investigator-originated protocol agreement, Wyeth Pharmaceuticals provided the Prevnar vaccine to be administered during the study and to placebo recipients after the release of results. Presented in part at the Sixth International Symposium on Pneumococcus and Pneumococcal Disease, Reykjavik, Iceland, June 8-12, 2008. Dr. French reports serving as a paid member of advisory panels for GlaxoSmithKline and Novartis. No other potential conflict of interest relevant to this article was reported. We thank the members of the trial steering group, including Keith Klugman (chair), James Whitworth (former chair), Helena Makela, John Macfarlane, Di Gibb, Ed Wilkins, and Henry Mwandumba; members of the data and safety monitoring board Tim Peto, Johnstone Kumwenda, and Andrew Nunn; members of the Queen Elizabeth Central Hospital staff, including Rose Malamba, Marie Kunkeyani, Neema Mtunthama, and Mary Matemba; Anne von Gottberg at the Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa; Steve Graham and Michael Boele van Hensbroek for vaccine and placebo blinding; and Helen Tolmie at the Liverpool School of Tropical Medicine and Pontiano Kaleebu at the Medical Research Council, Uganda Virus Research Institute, Entebbe, Uganda.	Anglaret X, 2004, JAIDS-J ACQ IMM DEF, V35, P320, DOI 10.1097/00126334-200403010-00015; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P373; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brichacek B, 1996, J INFECT DIS, V174, P1191, DOI 10.1093/infdis/174.6.1191; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Feikin DR, 2001, VACCINE, V20, P545, DOI 10.1016/S0264-410X(01)00347-4; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gordon SB, 2003, EMERG INFECT DIS, V9, P747; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Janoff EN, 1997, MICROB DRUG RESIST, V3, P215, DOI 10.1089/mdr.1997.3.215; JANOFF EN, 1992, ANN INTERN MED, V117, P314, DOI 10.7326/0003-4819-117-4-314; Klugman Keith P., 2008, P317; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; Masur H, 2002, ANN INTERN MED, V137, P435, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00002; Miiro G, 2005, J INFECT DIS, V192, P1801, DOI 10.1086/497144; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Piantadosi S, 1997, CLIN TRIALS METHODOL, P248; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	29	254	264	0	18	MED COLL MALAWI	CHICHIRI	MALAWAI MEDICAL JOURNAL, PRIVATE BAG 360, CHICHIRI, BLANTYRE 3 00000, MALAWI	1995-7262	1995-7270		MALAWI MED J	Malawi Med. J.	SEP	2016	28	3			SI		115	122		10.1056/NEJMoa0903029	http://dx.doi.org/10.1056/NEJMoa0903029			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	DZ1PR	27895845	Green Accepted, Green Published			2022-12-28	WOS:000385610800012
J	French, N; Gordon, SB; Mwalukomo, T; White, SA; Mwafulirwa, G; Longwe, H; Mwaiponya, M; Zijlstra, EE; Molyneux, ME; Gilks, CF				French, Neil; Gordon, Stephen B.; Mwalukomo, Thandie; White, Sarah A.; Mwafulirwa, Gershom; Longwe, Herbert; Mwaiponya, Martin; Zijlstra, Eduard E.; Molyneux, Malcolm E.; Gilks, Charles F.			A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; POLYSACCHARIDE VACCINE; DOUBLE-BLIND; DISEASE; EFFICACY; CHILDREN; ERA; IMMUNOGENICITY; MORTALITY	Background: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa. Prevention of this disease by vaccination with the current 23-valent polysaccharide vaccine is suboptimal. Protein conjugate vaccines offer a further option for protection, but data on their clinical efficacy in adults are needed. Methods: In this double-blind, randomized, placebo-controlled clinical efficacy trial, we studied the efficacy of a 7-valent conjugate pneumococcal vaccine in predominantly HIV-infected Malawian adolescents and adults who had recovered from documented invasive pneumococcal disease. Two doses of vaccine were given 4 weeks apart. The primary end point was a further episode of pneumococcal infection caused by vaccine serotypes or serotype 6A. Results: From February 2003 through October 2007, we followed 496 patients (of whom 44% were male and 88% were HIV-seropositive) for 798 person-years of observation. There were 67 episodes of pneumococcal disease in 52 patients, all in the HIV-infected subgroup. In 24 patients, there were 19 episodes that were caused by vaccine serotypes and 5 episodes that were caused by the 6A serotype. Of these episodes, 5 occurred in the vaccine group and 19 in the placebo group, for a vaccine efficacy of 74% (95% confidence interval [CI], 30 to 90). There were 73 deaths from any cause in the vaccine group and 63 in the placebo group (hazard ratio in the vaccine group, 1.18; 95% CI, 0.84 to 1.66). The number of serious adverse events within 14 days after vaccination was significantly lower in the vaccine group than in the placebo group (3 vs. 17, P=0.002), and the number of minor adverse events was significantly higher in the vaccine group (41 vs. 13, P=0.003). Conclusions: The 7-valent pneumococcal conjugate vaccine protected HIV-infected adults from recurrent pneumococcal infection caused by vaccine serotypes or serotype 6A. (Current Controlled Trials number, ISRCTN54494731.).	[French, Neil; Gordon, Stephen B.; White, Sarah A.; Mwafulirwa, Gershom; Longwe, Herbert; Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi; [Mwalukomo, Thandie; Mwaiponya, Martin; Zijlstra, Eduard E.] Coll Med, Dept Med, Blantyre, Malawi; [French, Neil] London Sch Hyg & Trop Med, Karonga Prevent Study, Karonga, Malawi; [Gordon, Stephen B.; Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Gilks, Charles F.] Univ London Imperial Coll Sci Technol & Med, London, England	University of Malawi; University of Malawi; Malawi Epidemiology and Intervention Research Unit; Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London	French, N (corresponding author), Karonga Prevent Study, POB 46, Chilumba, Malawi.	neil.french@lshtm.ac.uk	French, Neil/A-2994-2012; Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123; French, Neil/0000-0003-4814-8293; Gordon, Stephen/0000-0001-6576-1116; White, Sarah/0000-0001-5535-8075	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by the Wellcome Trust. Through an investigator-originated protocol agreement, Wyeth Pharmaceuticals provided the Prevnar vaccine to be administered during the study and to placebo recipients after the release of results.	Anglaret X, 2004, JAIDS-J ACQ IMM DEF, V35, P320, DOI 10.1097/00126334-200403010-00015; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P373; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brichacek B, 1996, J INFECT DIS, V174, P1191, DOI 10.1093/infdis/174.6.1191; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Feikin DR, 2001, VACCINE, V20, P545, DOI 10.1016/S0264-410X(01)00347-4; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gordon SB, 2003, EMERG INFECT DIS, V9, P747; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Gordon SB, 2007, J ALLERGY CLIN IMMUN, V120, P208, DOI 10.1016/j.jaci.2007.03.050; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Janoff EN, 1997, MICROB DRUG RESIST, V3, P215, DOI 10.1089/mdr.1997.3.215; JANOFF EN, 1992, ANN INTERN MED, V117, P314, DOI 10.7326/0003-4819-117-4-314; Klugman Keith P., 2008, P317; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; Masur H, 2002, ANN INTERN MED, V137, P435, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00002; Miiro G, 2005, J INFECT DIS, V192, P1801, DOI 10.1086/497144; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Piantadosi S, 1997, CLIN TRIALS METHODOL, P248; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	30	254	264	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					812	822		10.1056/NEJMoa0903029	http://dx.doi.org/10.1056/NEJMoa0903029			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	27895845	Green Accepted, Green Published			2022-12-28	WOS:000275108300008
